id	position	name	GSM2522610	GSM2522611	GSM2522612	GSM2522613	GSM2522618	GSM2522666	GSM2522667	GSM2522668	GSM2522669	GSM2522670	description
B01R02C11	1-11-2	Hs~MGC:NM_175877.3~uORF:IOH22866	1	-1	5	517	780	575	949	488	1898	320	hypothetical protein MGC35023 (MGC35023)
B01R02C12	1-12-2	Hs~MGC:NM_175877.3~uORF:IOH22866	-2	-2	32	542	1057	587	970	529	1635	344	hypothetical protein MGC35023 (MGC35023)
B01R02C13	1-13-2	Hs~MGC:NM_152728.1~uORF:IOH21580	1565	2631	1306	1372	17998	1397	2165	1743	3252	462	Uncharacterized protein C18orf20
B01R02C14	1-14-2	Hs~MGC:NM_152728.1~uORF:IOH21580	1564	2311	1285	1286	16560	1415	2178	1749	3323	426	Uncharacterized protein C18orf20
B01R02C15	1-15-2	Hs~MGC:BC021174.1~uORF:IOH10706	-1	-1	3	0	2177	659	16	1	1	-3	Small EDRK-rich factor 1
B01R02C16	1-16-2	Hs~MGC:BC021174.1~uORF:IOH10706	-2	767	0	-1	1968	2	5	2	68	-1	Small EDRK-rich factor 1
B01R02C17	1-17-2	Hs~MGC:BC017901.1~uORF:IOH12549	1036	911	1338	2166	1455	1275	1871	1041	3916	520	phospholipid scramblase 1 (PLSCR1)
B01R02C18	1-18-2	Hs~MGC:BC017901.1~uORF:IOH12549	896	717	1250	1876	1263	1342	1923	1144	3799	489	phospholipid scramblase 1 (PLSCR1)
B01R02C19	1-19-2	Hs~MGC:BC032499.1~uORF:IOH21893	-3	0	-3	670	1052	105	1656	792	2537	653	globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (GBGT1)
B01R02C20	1-20-2	Hs~MGC:BC032499.1~uORF:IOH21893	22	-2	0	677	1380	593	1692	680	1912	684	globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (GBGT1)
B01R02C21	1-21-2	Hs~Ref:NM_006399.2~uORF:IOH21626	1087	1162	2506	1529	1972	2676	1083	1195	4641	491	basic leucine zipper transcription factor, ATF-like (BATF)
B01R02C22	1-22-2	Hs~Ref:NM_006399.2~uORF:IOH21626	972	1055	2354	1434	2129	2593	1064	1178	3269	414	basic leucine zipper transcription factor, ATF-like (BATF)
B01R03C01	1-1-3	Hs~MGC:BC032302.1~uORF:IOH21655	688	702	1057	528	499	734	1169	527	1436	352	UDP-glucose ceramide glucosyltransferase-like 2 (UGCGL2)
B01R03C02	1-2-3	Hs~MGC:BC032302.1~uORF:IOH21655	697	675	1124	561	514	777	1172	539	1490	283	UDP-glucose ceramide glucosyltransferase-like 2 (UGCGL2)
B01R03C03	1-3-3	Hs~Ref:NM_007254.2~uORF:IOH21884	5492	4237	3594	3481	5027	5436	10347	2760	5158	3803	polynucleotide kinase 3'-phosphatase (PNKP)
B01R03C04	1-4-3	Hs~Ref:NM_007254.2~uORF:IOH21884	5173	3872	3481	3605	4520	5393	9804	2804	5569	4297	polynucleotide kinase 3'-phosphatase (PNKP)
B01R03C05	1-5-3	Hs~Ref:NM_000993.2~uORF:IOH14051	-1	41	3	1091	832	1622	9340	1132	2991	1684	ribosomal protein L31 (RPL31), transcript variant 1
B01R03C06	1-6-3	Hs~Ref:NM_000993.2~uORF:IOH14051	4	-3	7	1087	689	1834	9457	1189	2978	1836	ribosomal protein L31 (RPL31), transcript variant 1
B01R03C07	1-7-3	Hs~Ref:NM_002413.3~uORF:IOH13576	566	561	709	364	564	581	762	451	1141	365	microsomal glutathione S-transferase 2 (MGST2)
B01R03C08	1-8-3	Hs~Ref:NM_002413.3~uORF:IOH13576	584	557	727	368	522	618	815	489	1147	402	microsomal glutathione S-transferase 2 (MGST2)
B01R03C09	1-9-3	Hs~Ref:NM_004450.1~uORF:IOH14288	4012	2105	3069	2159	3086	3572	8717	2722	5814	796	enhancer of rudimentary homolog (Drosophila) (ERH)
B01R03C10	1-10-3	Hs~Ref:NM_004450.1~uORF:IOH14288	3740	1797	2929	1956	4291	3596	8576	2657	5357	1518	enhancer of rudimentary homolog (Drosophila) (ERH)
B01R03C11	1-11-3	Hs~MGC:BC012766.1~uORF:IOH13844	1274	796	1410	287	803	452	663	410	852	132	endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 (ERGIC1)
B01R03C12	1-12-3	Hs~MGC:BC012766.1~uORF:IOH13844	962	811	1173	283	879	540	671	371	741	135	endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 (ERGIC1)
B01R03C13	1-13-3	Hs~MGC:BC015883.1~uORF:IOH10061	473	374	610	311	426	692	849	353	722	265	tubulin, alpha 1b (TUBA1B)
B01R03C14	1-14-3	Hs~MGC:BC015883.1~uORF:IOH10061	455	419	559	342	329	617	827	364	787	254	tubulin, alpha 1b (TUBA1B)
B01R03C15	1-15-3	Hs~MGC:BC016295.1~uORF:IOH10091	1029	1219	1068	915	6158	1666	3742	915	2167	620	eukaryotic translation initiation factor 4A, isoform 2 (EIF4A2)
B01R03C16	1-16-3	Hs~MGC:BC016295.1~uORF:IOH10091	963	1135	982	615	5542	1726	3649	914	2273	576	eukaryotic translation initiation factor 4A, isoform 2 (EIF4A2)
B01R03C17	1-17-3	Hs~MGC:BC015803.1~uORF:IOH10126	2688	1345	1627	1261	1381	1415	2042	1331	2242	2183	interferon regulatory factor 2 (IRF2)
B01R03C18	1-18-3	Hs~MGC:BC015803.1~uORF:IOH10126	2514	1247	1627	1196	1320	1380	2001	1375	2170	2157	interferon regulatory factor 2 (IRF2)
B01R03C19	1-19-3	Hs~Ref:NM_004865.2~uORF:IOH10084	2114	1143	1503	886	591	1301	7228	774	2644	509	TBP-like 1 (TBPL1)
B01R03C20	1-20-3	Hs~Ref:NM_004865.2~uORF:IOH10084	1996	1107	1419	874	628	1332	6807	803	2404	531	TBP-like 1 (TBPL1)
B01R03C21	1-21-3	Hs~MGC:BC018732.1~uORF:IOH14058	-3	-5	-2	-1	1926	1386	2062	1307	3566	1152	cytochrome b5 reductase 1 (CYB5R1)
B01R03C22	1-22-3	Hs~MGC:BC018732.1~uORF:IOH14058	-3	-4	-5	-3	2090	1354	2122	1224	2806	1050	cytochrome b5 reductase 1 (CYB5R1)
B01R04C01	1-1-4	Hs~MGC:BC024281.1~uORF:IOH14073	1602	1036	1499	691	1547	1482	1025	761	2621	508	RAB, member of RAS oncogene family-like 2B (RABL2B)
B01R04C02	1-2-4	Hs~MGC:BC024281.1~uORF:IOH14073	1592	968	1425	709	1526	1532	1014	759	2433	630	RAB, member of RAS oncogene family-like 2B (RABL2B)
B01R04C03	1-3-4	Hs~MGC:BC007658.1~uORF:IOH5956	750	1060	1042	653	545	845	5842	901	1655	2232	BCL2-like 13 (apoptosis facilitator) (BCL2L13)
B01R04C04	1-4-4	Hs~MGC:BC007658.1~uORF:IOH5956	696	960	1057	590	527	879	5792	945	1603	738	BCL2-like 13 (apoptosis facilitator) (BCL2L13)
B01R04C05	1-5-4	Hs~Ref:NM_145252.1~uORF:IOH9864	5291	22786	3690	6505	3424	2793	3247	1275	5560	560	similar to common salivary protein 1 (LOC124220)
B01R04C06	1-6-4	Hs~Ref:NM_145252.1~uORF:IOH9864	4819	20510	3746	6041	3278	3067	3362	1264	5339	1016	similar to common salivary protein 1 (LOC124220)
B01R04C07	1-7-4	Hs~MGC:BC011923.1~uORF:IOH13453	1468	778	1433	666	868	848	3127	1401	1954	549	RNA binding motif protein 33 (RBM33)
B01R04C08	1-8-4	Hs~MGC:BC011923.1~uORF:IOH13453	1407	777	1364	659	890	887	3012	746	1929	533	RNA binding motif protein 33 (RBM33)
B01R04C09	1-9-4	Hs~Ref:NM_020530.2~uORF:IOH13456	2567	1722	2112	1287	1858	1614	7093	1379	6870	951	oncostatin M (OSM)
B01R04C10	1-10-4	Hs~Ref:NM_020530.2~uORF:IOH13456	2497	1618	2078	1357	2084	1550	6771	1252	6296	749	oncostatin M (OSM)
B01R04C11	1-11-4	Hs~Ref:NM_022720.2~uORF:IOH12840	1455	775	921	588	1718	742	1448	1012	2207	353	DiGeorge syndrome critical region gene 8 (DGCR8)
B01R04C12	1-12-4	Hs~Ref:NM_022720.2~uORF:IOH12840	1284	719	982	600	1855	800	1447	1039	2115	308	DiGeorge syndrome critical region gene 8 (DGCR8)
B01R04C13	1-13-4	Hs~Ref:NM_145042.1~uORF:IOH13383	1707	1450	1727	1042	1702	1430	2646	1084	2904	691	Tubulin alpha-3 chain
B01R04C14	1-14-4	Hs~Ref:NM_145042.1~uORF:IOH13383	1621	1370	1638	1071	1673	1434	2312	1107	3122	767	Tubulin alpha-3 chain
B01R04C15	1-15-4	Hs~Ref:NM_007173.3~uORF:IOH3271	381	311	475	382	332	445	639	364	754	145	protease, serine, 23 (PRSS23)
B01R04C16	1-16-4	Hs~Ref:NM_007173.3~uORF:IOH3271	350	325	466	407	313	411	732	337	764	197	protease, serine, 23 (PRSS23)
B01R04C17	1-17-4	Hs~Ref:NM_016034.2~uORF:IOH6982	975	830	796	449	530	824	1127	719	1671	461	mitochondrial ribosomal protein S2 (MRPS2), nuclear gene encoding mitochondrial protein
B01R04C18	1-18-4	Hs~Ref:NM_016034.2~uORF:IOH6982	899	937	840	543	521	665	1111	679	2292	483	mitochondrial ribosomal protein S2 (MRPS2), nuclear gene encoding mitochondrial protein
B01R04C19	1-19-4	Hs~Ref:NM_025083.2~uORF:IOH9818	1713	1273	1203	1519	1057	1414	8835	2192	4348	485	enhancer of mRNA decapping 3 homolog (S. cerevisiae) (EDC3)
B01R04C20	1-20-4	Hs~Ref:NM_025083.2~uORF:IOH9818	1520	1227	1119	1403	1108	1373	8788	2162	4109	468	enhancer of mRNA decapping 3 homolog (S. cerevisiae) (EDC3)
B01R04C21	1-21-4	Hs~MGC:BC011553.1~uORF:IOH12716	542	613	637	461	396	551	932	494	539	426	glutaminyl-peptide cyclotransferase-like (QPCTL)
B01R04C22	1-22-4	Hs~MGC:BC011553.1~uORF:IOH12716	527	591	612	457	398	559	936	499	1362	493	glutaminyl-peptide cyclotransferase-like (QPCTL)
B01R05C01	1-1-5	Hs~Ref:NM_032306.2~uORF:IOH5568	3446	1626	2353	2289	1808	2627	2110	1876	2797	1207	alkB, alkylation repair homolog 7 (E. coli) (ALKBH7)
B01R05C02	1-2-5	Hs~Ref:NM_032306.2~uORF:IOH5568	3112	1502	2125	2301	1690	2664	2208	1898	2490	1132	alkB, alkylation repair homolog 7 (E. coli) (ALKBH7)
B01R05C03	1-3-5	Hs~MGC:BC039269.1~uORF:IOH27269	471	357	764	331	301	598	1069	375	742	176	NLR family, pyrin domain containing 2 (NLRP2)
B01R05C04	1-4-5	Hs~MGC:BC039269.1~uORF:IOH27269	452	335	806	320	387	603	1016	327	708	177	NLR family, pyrin domain containing 2 (NLRP2)
B01R05C05	1-5-5	Hs~Ref:NM_006528.2~uORF:IOH7275	1339	862	1022	629	754	846	3351	711	1477	282	tissue factor pathway inhibitor 2 (TFPI2)
B01R05C06	1-6-5	Hs~Ref:NM_006528.2~uORF:IOH7275	1235	731	1018	599	683	991	3372	759	1249	295	tissue factor pathway inhibitor 2 (TFPI2)
B01R05C07	1-7-5	Hs~Ref:NM_017634.1~uORF:IOH22919	1564	582	512	278	526	602	684	1771	737	111	BTB/POZ domain-containing protein KCTD9
B01R05C08	1-8-5	Hs~Ref:NM_017634.1~uORF:IOH22919	1389	507	450	275	654	578	628	1669	699	94	BTB/POZ domain-containing protein KCTD9
B01R05C09	1-9-5	Hs~Ref:NM_002358.2~uORF:IOH7559	1050	660	1089	455	1223	511	522	652	1985	25	MAD2 mitotic arrest deficient-like 1 (yeast) (MAD2L1)
B01R05C10	1-10-5	Hs~Ref:NM_002358.2~uORF:IOH7559	999	622	1017	482	1239	442	603	694	2174	218	MAD2 mitotic arrest deficient-like 1 (yeast) (MAD2L1)
B01R05C11	1-11-5	Hs~Ref:NM_080916.1~uORF:IOH14211	1254	4076	1398	730	1495	1030	1620	870	2461	646	deoxyguanosine kinase (DGUOK), nuclear gene encoding mitochondrial protein, transcript variant 1
B01R05C12	1-12-5	Hs~Ref:NM_080916.1~uORF:IOH14211	1446	3649	1315	750	1490	1070	1547	876	2695	623	deoxyguanosine kinase (DGUOK), nuclear gene encoding mitochondrial protein, transcript variant 1
B01R05C13	1-13-5	Hs~MGC:BC013019.1~uORF:IOH14884	505	2293	368	220	1143	232	691	1145	748	279	coiled-coil domain containing 28A (CCDC28A)
B01R05C14	1-14-5	Hs~MGC:BC013019.1~uORF:IOH14884	337	1996	185	216	608	285	660	1096	709	90	coiled-coil domain containing 28A (CCDC28A)
B01R05C15	1-15-5	Hs~Ref:NM_002082.1~N/A	475	134	578	337	277	456	856	489	500	120	G protein-coupled receptor kinase 6
B01R05C16	1-16-5	Hs~Ref:NM_002082.1~N/A	426	324	514	333	266	522	975	480	568	184	G protein-coupled receptor kinase 6
B01R05C17	1-17-5	Hs~Ref:NM_003516.2~uORF:IOH4867	2713	1485	1893	1155	2547	1674	7685	1325	4385	718	histone cluster 2, H2aa3 (HIST2H2AA3)
B01R05C18	1-18-5	Hs~Ref:NM_003516.2~uORF:IOH4867	2504	1451	1798	1146	2120	1606	7343	1286	3941	762	histone cluster 2, H2aa3 (HIST2H2AA3)
B01R05C19	1-19-5	Hs~MGC:BC043581.1~uORF:IOH26300	2138	1272	1895	1107	1636	1861	1958	1600	4986	756	keratin 36 (KRT36)
B01R05C20	1-20-5	Hs~MGC:BC043581.1~uORF:IOH26300	1998	1181	1850	1061	1630	1648	2044	1578	5253	896	keratin 36 (KRT36)
B01R05C21	1-21-5	Hs~Ref:NM_004148.2~uORF:IOH28049	1100	974	1451	848	1149	1477	1977	918	3006	660	ninjurin 1 (NINJ1)
B01R05C22	1-22-5	Hs~Ref:NM_004148.2~uORF:IOH28049	1045	961	1455	832	1143	1519	1988	1006	2675	632	ninjurin 1 (NINJ1)
B01R06C01	1-1-6	Hs~Ref:NM_004718.2~uORF:IOH7545	1388	1190	1503	1389	1312	1223	1775	1091	2760	1001	cytochrome c oxidase subunit VIIa polypeptide 2 like (COX7A2L), nuclear gene encoding mitochondrial protein
B01R06C02	1-2-6	Hs~Ref:NM_004718.2~uORF:IOH7545	1370	1091	1489	1425	1288	1144	1835	1048	2676	1129	cytochrome c oxidase subunit VIIa polypeptide 2 like (COX7A2L), nuclear gene encoding mitochondrial protein
B01R06C03	1-3-6	Hs~Ref:NM_018097.1~uORF:IOH12063	563	434	627	396	309	508	927	458	720	148	centrosomal protein 27kDa (CEP27)
B01R06C04	1-4-6	Hs~Ref:NM_018097.1~uORF:IOH12063	632	425	625	401	424	506	981	482	736	152	centrosomal protein 27kDa (CEP27)
B01R06C05	1-5-6	Hs~Ref:NM_002370.2~uORF:IOH10502	938	623	1033	531	518	644	1030	494	1570	1231	mago-nashi homolog, proliferation-associated (Drosophila) (MAGOH)
B01R06C06	1-6-6	Hs~Ref:NM_002370.2~uORF:IOH10502	852	556	1079	559	525	870	1104	503	1580	1277	mago-nashi homolog, proliferation-associated (Drosophila) (MAGOH)
B01R06C07	1-7-6	Hs~Ref:NM_017812.1~uORF:IOH11162	619	432	640	338	494	611	707	425	921	304	coiled-coil-helix-coiled-coil-helix domain containing 3 (CHCHD3)
B01R06C08	1-8-6	Hs~Ref:NM_017812.1~uORF:IOH11162	626	491	654	399	506	565	696	425	987	-7	coiled-coil-helix-coiled-coil-helix domain containing 3 (CHCHD3)
B01R06C09	1-9-6	Hs~Ref:NM_002880.1~uORF:IOH10773	872	750	946	676	655	738	1019	651	1395	796	v-raf-1 murine leukemia viral oncogene homolog 1 (RAF1)
B01R06C10	1-10-6	Hs~Ref:NM_002880.1~uORF:IOH10773	895	836	875	703	642	828	962	650	1455	800	v-raf-1 murine leukemia viral oncogene homolog 1 (RAF1)
B01R06C11	1-11-6	Hs~Ref:NM_001280.1~uORF:IOH2905	3046	1901	2376	1249	1443	1394	7751	1124	3478	1200	cold inducible RNA binding protein (CIRBP)
B01R06C12	1-12-6	Hs~Ref:NM_001280.1~uORF:IOH2905	3200	1781	2307	1256	1456	1439	7634	1139	3464	850	cold inducible RNA binding protein (CIRBP)
B01R06C13	1-13-6	Hs~MGC:BC001304.1~uORF:IOH3065	528	1181	569	397	755	661	701	498	812	219	piccolo (presynaptic cytomatrix protein) (PCLO)
B01R06C14	1-14-6	Hs~MGC:BC001304.1~uORF:IOH3065	465	1100	563	358	608	659	687	479	716	16	piccolo (presynaptic cytomatrix protein) (PCLO)
B01R06C15	1-15-6	Hs~MGC:BC009048.1~uORF:IOH3342	888	1388	1152	656	1427	775	1395	745	1387	444	tubulointerstitial nephritis antigen-like 1 (TINAGL1)
B01R06C16	1-16-6	Hs~MGC:BC009048.1~uORF:IOH3342	949	1210	1056	738	1264	889	1131	762	1709	456	tubulointerstitial nephritis antigen-like 1 (TINAGL1)
B01R06C17	1-17-6	Hs~Ref:NM_014713.2~uORF:IOH3687	678	559	870	412	511	624	861	555	1320	187	lysosomal-associated protein transmembrane 4 alpha (LAPTM4A)
B01R06C18	1-18-6	Hs~Ref:NM_014713.2~uORF:IOH3687	668	556	870	473	390	624	978	569	1050	464	lysosomal-associated protein transmembrane 4 alpha (LAPTM4A)
B01R06C19	1-19-6	Hs~Ref:NM_005402.1~uORF:IOH26207	586	420	686	446	394	3347	849	531	740	218	v-ral simian leukemia viral oncogene homolog A (ras related) (RALA)
B01R06C20	1-20-6	Hs~Ref:NM_005402.1~uORF:IOH26207	614	420	703	428	394	4077	857	535	1140	236	v-ral simian leukemia viral oncogene homolog A (ras related) (RALA)
B01R06C21	1-21-6	Hs~MGC:BC044587.1~uORF:IOH26741	1545	612	612	554	785	850	920	526	1128	194	LSM12 homolog (S. cerevisiae) (LSM12)
B01R06C22	1-22-6	Hs~MGC:BC044587.1~uORF:IOH26741	1337	596	604	548	725	867	972	538	1108	203	LSM12 homolog (S. cerevisiae) (LSM12)
B01R07C01	1-1-7	Hs~MGC:BC048099.1~uORF:IOH26742	1884	1967	1845	1319	1170	1171	2285	1432	2779	649	zinc finger and SCAN domain containing 1 (ZSCAN1)
B01R07C02	1-2-7	Hs~MGC:BC048099.1~uORF:IOH26742	1744	1910	1679	1338	1104	1126	2338	1346	2908	722	zinc finger and SCAN domain containing 1 (ZSCAN1)
B01R07C03	1-3-7	Hs~MGC:BC040036.1~uORF:IOH26343	623	597	611	327	432	737	1044	543	1498	111	chromosome 17 open reading frame 49 (C17orf49)
B01R07C04	1-4-7	Hs~MGC:BC040036.1~uORF:IOH26343	586	535	580	295	498	695	1085	550	1437	343	chromosome 17 open reading frame 49 (C17orf49)
B01R07C05	1-5-7	Hs~MGC:BC005955.1~uORF:IOH7485	2740	1096	1340	914	704	1527	8101	1193	2962	557	chromosome 8 open reading frame 53 (C8orf53)
B01R07C06	1-6-7	Hs~MGC:BC005955.1~uORF:IOH7485	2277	1043	1329	961	728	1631	8379	1152	2995	690	chromosome 8 open reading frame 53 (C8orf53)
B01R07C07	1-7-7	Hs~MGC:BC035217.1~uORF:IOH26791	699	486	1045	534	733	846	1997	372	1089	322	arachidonate 15-lipoxygenase, type B (ALOX15B)
B01R07C08	1-8-7	Hs~MGC:BC035217.1~uORF:IOH26791	651	457	965	528	759	738	1854	408	1043	305	arachidonate 15-lipoxygenase, type B (ALOX15B)
B01R07C09	1-9-7	Hs~MGC:BC028366.1~uORF:IOH22335	2157	954	1222	809	2798	1384	1460	3434	1865	456	testis specific, 10 (TSGA10)
B01R07C10	1-10-7	Hs~MGC:BC028366.1~uORF:IOH22335	2039	874	1216	752	2697	1384	1333	3323	1819	523	testis specific, 10 (TSGA10)
B01R07C11	1-11-7	Hs~MGC:BC035492.1~uORF:IOH25729	1275	548	972	479	668	1065	1300	491	1129	962	mitogen-activated protein kinase 6 (MAPK6)
B01R07C12	1-12-7	Hs~MGC:BC035492.1~uORF:IOH25729	1464	523	992	512	717	1103	1328	470	1247	174	mitogen-activated protein kinase 6 (MAPK6)
B01R07C13	1-13-7	Hs~Ref:XM_374188.3~uORF:IOH44541	1364	1065	1196	755	1815	925	1572	755	2129	667	Putative uncharacterized protein C6orf99
B01R07C14	1-14-7	Hs~Ref:XM_374188.3~uORF:IOH44541	1129	778	1269	806	1406	884	1554	826	1895	32	Putative uncharacterized protein C6orf99
B01R07C15	1-15-7	Hs~Ref:NM_174925.1~uORF:IOH43618	4199	944	1375	677	1074	832	1508	756	1957	587	hypothetical protein LOC205251 (LOC205251)
B01R07C16	1-16-7	Hs~Ref:NM_174925.1~uORF:IOH43618	4317	978	1334	836	988	810	1314	792	2038	669	hypothetical protein LOC205251 (LOC205251)
B01R07C17	1-17-7	Hs~Ref:NM_138640.1~uORF:IOH40942	1320	1294	3142	1801	659	1153	1311	640	2076	727	golgi associated, gamma adaptin ear containing, ARF binding protein 2 (GGA2), transcript variant 2
B01R07C18	1-18-7	Hs~Ref:NM_138640.1~uORF:IOH40942	1230	1138	2950	1648	559	1023	1347	638	1934	758	golgi associated, gamma adaptin ear containing, ARF binding protein 2 (GGA2), transcript variant 2
B01R07C19	1-19-7	Hs~Ref:NM_172014.1~uORF:IOH44426	1595	1480	1816	1058	1546	1135	2432	1153	3392	773	tumor necrosis factor (ligand) superfamily, member 14 (TNFSF14), transcript variant 2
B01R07C20	1-20-7	Hs~Ref:NM_172014.1~uORF:IOH44426	1646	1397	1778	1033	1660	472	2289	1144	3495	709	tumor necrosis factor (ligand) superfamily, member 14 (TNFSF14), transcript variant 2
B01R07C21	1-21-7	Hs~MGC:BC000691.1~uORF:IOH4341	2328	1279	1619	1595	2241	2779	3772	2469	4288	790	tubulin polymerization-promoting protein family member 3 (TPPP3)
B01R07C22	1-22-7	Hs~MGC:BC000691.1~uORF:IOH4341	2233	1255	1530	1549	2338	2724	3615	2359	3950	840	tubulin polymerization-promoting protein family member 3 (TPPP3)
B01R08C01	1-1-8	Hs~Ref:NM_012117.1~uORF:IOH3162	4097	1666	2341	2785	5919	8786	5133	1285	5100	1083	chromobox homolog 5 (HP1 alpha homolog, Drosophila) (CBX5)
B01R08C02	1-2-8	Hs~Ref:NM_012117.1~uORF:IOH3162	3668	1566	2183	2757	4948	8708	5323	1184	4811	1007	chromobox homolog 5 (HP1 alpha homolog, Drosophila) (CBX5)
B01R08C03	1-3-8	Hs~Ref:NM_025133.3~uORF:IOH44015	4996	1072	1627	977	1170	1241	3269	840	2340	0	F-box protein 11 (FBXO11), transcript variant 1
B01R08C04	1-4-8	Hs~Ref:NM_025133.3~uORF:IOH44015	4538	1102	1701	950	1603	1194	3438	827	2494	286	F-box protein 11 (FBXO11), transcript variant 1
B01R08C05	1-5-8	Hs~Ref:NM_002346.1~uORF:IOH42082	1056	766	1083	535	1009	812	1320	660	1663	1322	lymphocyte antigen 6 complex, locus E (LY6E)
B01R08C06	1-6-8	Hs~Ref:NM_002346.1~uORF:IOH42082	963	762	1196	577	990	902	1322	714	1602	310	lymphocyte antigen 6 complex, locus E (LY6E)
B01R08C07	1-7-8	Hs~MGC:BC019247.1~uORF:IOH11023	870	543	993	1287	1011	635	1131	599	3168	354	sperm associated antigen 8 (SPAG8)
B01R08C08	1-8-8	Hs~MGC:BC019247.1~uORF:IOH11023	830	606	926	1276	999	619	1109	505	3378	390	sperm associated antigen 8 (SPAG8)
B01R08C09	1-9-8	Hs~Ref:NM_014214.1~uORF:IOH13690	919	1220	1671	2616	1619	1138	1134	1461	2970	440	inositol(myo)-1(or 4)-monophosphatase 2 (IMPA2)
B01R08C10	1-10-8	Hs~Ref:NM_014214.1~uORF:IOH13690	893	1111	1521	2378	1662	1176	1132	1447	2742	434	inositol(myo)-1(or 4)-monophosphatase 2 (IMPA2)
B01R08C11	1-11-8	Hs~Ref:NM_015343.1~uORF:IOH12711	927	722	786	541	765	546	1009	1227	1047	229	dullard homolog (Xenopus laevis) (DULLARD)
B01R08C12	1-12-8	Hs~Ref:NM_015343.1~uORF:IOH12711	999	735	854	550	728	496	1064	1303	1210	274	dullard homolog (Xenopus laevis) (DULLARD)
B01R08C13	1-13-8	Hs~Ref:NM_032929.1~uORF:IOH7540	1507	1855	942	2235	1264	807	1730	1575	3593	9699	ubiquitin specific protease 45 (USP45)
B01R08C14	1-14-8	Hs~Ref:NM_032929.1~uORF:IOH7540	1180	1538	907	2121	1833	790	1763	1538	3229	8145	ubiquitin specific protease 45 (USP45)
B01R08C15	1-15-8	Hs~MGC:BC037311.1~uORF:IOH27689	1601	1149	1579	870	1211	1079	3302	756	2287	639	Voltage-dependent L-type calcium channel subunit beta-1
B01R08C16	1-16-8	Hs~MGC:BC037311.1~uORF:IOH27689	1531	1164	1501	928	972	1107	2960	834	2377	642	Voltage-dependent L-type calcium channel subunit beta-1
B01R08C17	1-17-8	Hs~MGC:BC042848.1~uORF:IOH27665	692	447	752	440	239	552	1074	405	978	220	tetratricopeptide repeat domain 30A (TTC30A)
B01R08C18	1-18-8	Hs~MGC:BC042848.1~uORF:IOH27665	714	485	811	409	494	817	1038	400	1026	163	tetratricopeptide repeat domain 30A (TTC30A)
B01R08C19	1-19-8	Hs~Ref:NM_002884.1~uORF:IOH14475	544	447	597	3582	575	536	728	418	1363	182	RAP1A, member of RAS oncogene family (RAP1A), transcript variant 2
B01R08C20	1-20-8	Hs~Ref:NM_002884.1~uORF:IOH14475	527	436	598	3745	577	474	737	400	269	154	RAP1A, member of RAS oncogene family (RAP1A), transcript variant 2
B01R08C21	1-21-8	Hs~MGC:BC024004.1~uORF:IOH11309	1907	1210	4112	978	1585	2782	5287	1453	2062	494	Rap guanine nucleotide exchange factor (GEF) 4 (RAPGEF4)
B01R08C22	1-22-8	Hs~MGC:BC024004.1~uORF:IOH11309	1760	1225	3915	919	1576	2773	4910	1486	1962	510	Rap guanine nucleotide exchange factor (GEF) 4 (RAPGEF4)
B01R09C01	1-1-9	Hs~Ref:NM_014420.2~uORF:IOH35309	1371	984	1196	885	901	919	1352	1321	2660	560	dickkopf homolog 4 (Xenopus laevis) (DKK4)
B01R09C02	1-2-9	Hs~Ref:NM_014420.2~uORF:IOH35309	1327	948	1209	881	828	951	1349	1403	2532	600	dickkopf homolog 4 (Xenopus laevis) (DKK4)
B01R09C03	1-3-9	Hs~Ref:NM_025057.1~uORF:IOH35314	921	385	666	568	780	501	1011	788	1260	433	chromosome 14 open reading frame 45 (C14orf45)
B01R09C04	1-4-9	Hs~Ref:NM_025057.1~uORF:IOH35314	895	365	615	535	750	532	951	794	1152	397	chromosome 14 open reading frame 45 (C14orf45)
B01R09C05	1-5-9	Hs~Ref:NM_002169.1~uORF:IOH35227	1008	623	1092	1590	1415	1272	1135	734	1383	597	interferon, alpha 5 (IFNA5)
B01R09C06	1-6-9	Hs~Ref:NM_002169.1~uORF:IOH35227	967	683	1010	1645	1466	775	1209	783	1489	509	interferon, alpha 5 (IFNA5)
B01R09C07	1-7-9	Hs~Ref:NM_022573.1~uORF:IOH35467	469	419	502	761	501	321	31732	631	1341	206	testis specific protein, Y-linked 2 (TSPY2)
B01R09C08	1-8-9	Hs~Ref:NM_022573.1~uORF:IOH35467	439	339	461	749	464	651	29541	764	1371	263	testis specific protein, Y-linked 2 (TSPY2)
B01R09C11	1-11-9	Hs~MGC:BC027911.1~uORF:IOH11846	452	377	505	307	458	393	736	339	808	279	jumonji domain containing 5 (JMJD5)
B01R09C12	1-12-9	Hs~MGC:BC027911.1~uORF:IOH11846	515	361	499	313	475	373	710	339	767	351	jumonji domain containing 5 (JMJD5)
B01R09C13	1-13-9	Hs~MGC:BC021861.1~uORF:IOH11917	572	276	399	238	461	394	1230	249	651	103	hypothetical LOC554202 (LOC554202)
B01R09C14	1-14-9	Hs~MGC:BC021861.1~uORF:IOH11917	371	133	373	233	525	365	1159	231	616	123	hypothetical LOC554202 (LOC554202)
B01R09C17	1-17-9	Hs~MGC:BC036422.1~uORF:IOH27623	-2	0	-2	-2	472	744	928	579	8986	273	hypothetical protein MGC42105 (MGC42105)
B01R09C18	1-18-9	Hs~MGC:BC036422.1~uORF:IOH27623	0	-1	1	0	770	764	895	569	9505	377	hypothetical protein MGC42105 (MGC42105)
B01R09C19	1-19-9	Hs~MGC:BC055314.1~uORF:IOH29446	4776	2255	2386	2054	2363	3855	5654	2699	4370	1676	EMG1 nucleolar protein homolog (S. cerevisiae) (EMG1)
B01R09C20	1-20-9	Hs~MGC:BC055314.1~uORF:IOH29446	4956	1944	2346	2175	2475	3411	5305	2411	3439	1542	EMG1 nucleolar protein homolog (S. cerevisiae) (EMG1)
B01R09C21	1-21-9	Hs~MGC:BC051300.1~uORF:IOH29358	1138	468	997	406	516	527	1263	464	1307	184	Phytanoyl-CoA dioxygenase domain-containing protein 1
B01R09C22	1-22-9	Hs~MGC:BC051300.1~uORF:IOH29358	1111	453	981	395	441	497	1132	441	1570	272	Phytanoyl-CoA dioxygenase domain-containing protein 1
B01R10C01	1-1-10	Hs~MGC:BC014889.1~uORF:IOH10017	1006	577	856	574	360	660	1559	751	1288	323	D4, zinc and double PHD fingers family 2 (DPF2)
B01R10C02	1-2-10	Hs~MGC:BC014889.1~uORF:IOH10017	1010	597	849	548	397	661	1478	751	1132	320	D4, zinc and double PHD fingers family 2 (DPF2)
B01R10C03	1-3-10	Hs~MGC:BC007009.1~uORF:IOH7191	1170	926	1416	760	955	793	1134	1146	2212	536	Carboxypeptidase A2
B01R10C04	1-4-10	Hs~MGC:BC007009.1~uORF:IOH7191	1094	858	1410	783	929	858	1133	1144	2223	438	Carboxypeptidase A2
B01R10C05	1-5-10	Hs~Ref:NM_002539.1~uORF:IOH14694	841	600	789	453	857	1756	1791	567	1709	379	Ornithine decarboxylase
B01R10C06	1-6-10	Hs~Ref:NM_002539.1~uORF:IOH14694	803	574	778	484	845	1800	1964	558	1709	355	Ornithine decarboxylase
B01R10C07	1-7-10	Hs~MGC:BC012575.1~uORF:IOH12167	1649	3689	1373	1273	1426	2970	4309	2746	4561	315	Zinc finger CCCH domain-containing protein 7A
B01R10C08	1-8-10	Hs~MGC:BC012575.1~uORF:IOH12167	1527	3257	1203	1205	1216	2782	3698	2734	3955	277	Zinc finger CCCH domain-containing protein 7A
B01R10C09	1-9-10	Hs~MGC:NM_171998.1~uORF:IOH9931	659	733	815	528	809	451	782	573	3735	330	Ras-related protein Rab-39B
B01R10C10	1-10-10	Hs~MGC:NM_171998.1~uORF:IOH9931	676	697	819	546	845	508	789	585	3600	322	Ras-related protein Rab-39B
B01R11C21	1-21-11	Hs~MGC:BC035314.1~uORF:IOH22146	1773	867	1040	582	741	252	4598	679	1760	383	brix domain containing 1 (BXDC1)
B01R11C22	1-22-11	Hs~MGC:BC035314.1~uORF:IOH22146	1724	806	992	565	739	133	4894	661	1611	327	brix domain containing 1 (BXDC1)
B01R12C01	1-1-12	Hs~MGC:BC016754.1~uORF:IOH13535	213	390	595	384	293	390	566	355	792	222	karyopherin alpha 4 (importin alpha 3) (KPNA4)
B01R12C02	1-2-12	Hs~MGC:BC016754.1~uORF:IOH13535	399	412	538	342	294	430	579	386	781	256	karyopherin alpha 4 (importin alpha 3) (KPNA4)
B01R12C03	1-3-12	Hs~MGC:BC020966.1~uORF:IOH10379	679	652	886	510	490	739	967	587	1281	422	Ectonucleoside triphosphate diphosphohydrolase 5
B01R12C04	1-4-12	Hs~MGC:BC020966.1~uORF:IOH10379	678	615	946	505	500	1270	988	600	1367	4	Ectonucleoside triphosphate diphosphohydrolase 5
B01R12C05	1-5-12	Hs~MGC:BC003548.1~uORF:IOH4864	2326	2344	2700	2466	18811	1556	3550	1184	3272	1618	polymerase (DNA directed), lambda (POLL)
B01R12C06	1-6-12	Hs~MGC:BC003548.1~uORF:IOH4864	2381	2291	2612	2591	19622	1445	3443	1220	3183	1471	polymerase (DNA directed), lambda (POLL)
B01R12C07	1-7-12	Hs~MGC:BC023569.1~uORF:IOH27860	11565	3020	3430	2145	4844	2863	13598	2986	7231	2832	UPF3 regulator of nonsense transcripts homolog A (yeast) (UPF3A)
B01R12C08	1-8-12	Hs~MGC:BC023569.1~uORF:IOH27860	10275	2580	3202	2156	4413	2789	12349	2854	6781	2838	UPF3 regulator of nonsense transcripts homolog A (yeast) (UPF3A)
B01R12C09	1-9-12	Hs~MGC:BC053373.1~uORF:IOH28997	2122	1148	1738	959	1618	1259	2186	1054	3111	687	mitochondrial ribosomal protein L43 (MRPL43)
B01R12C10	1-10-12	Hs~MGC:BC053373.1~uORF:IOH28997	2151	1120	1573	935	1628	1280	2464	1102	3034	659	mitochondrial ribosomal protein L43 (MRPL43)
B01R12C11	1-11-12	Hs~MGC:BC042912.1~uORF:IOH28030	769	682	749	724	653	932	1009	697	1808	490	seryl-tRNA synthetase 2, mitochondrial (SARS2)
B01R12C12	1-12-12	Hs~MGC:BC042912.1~uORF:IOH28030	763	721	782	754	736	961	1154	658	1908	432	seryl-tRNA synthetase 2, mitochondrial (SARS2)
B01R12C13	1-13-12	Hs~MGC:BC030155.1~uORF:IOH23095	1139	747	986	655	1410	1034	1751	813	1858	405	tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) (TNFRSF11B)
B01R12C14	1-14-12	Hs~MGC:BC030155.1~uORF:IOH23095	1257	812	1023	662	1261	1044	1641	807	1994	798	tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) (TNFRSF11B)
B01R12C15	1-15-12	Hs~Ref:NM_139162.2~uORF:IOH12829	409	376	315	152	278	199	469	203	372	48	Smith-Magenis syndrome chromosome region candidate gene 7 protein
B01R12C16	1-16-12	Hs~Ref:NM_139162.2~uORF:IOH12829	365	373	315	214	210	242	492	195	404	55	Smith-Magenis syndrome chromosome region candidate gene 7 protein
B01R12C17	1-17-12	Hs~Ref:NM_003764.2~uORF:IOH27407	404	344	396	361	215	274	313	277	578	137	syntaxin 11 (STX11)
B01R12C18	1-18-12	Hs~Ref:NM_003764.2~uORF:IOH27407	408	365	422	269	372	169	281	348	572	93	syntaxin 11 (STX11)
B01R12C19	1-19-12	Hs~MGC:BC005305.1~uORF:IOH7363	267	247	362	208	311	277	258	211	311	41	collagen, type IV, alpha 6 (COL4A6)
B01R12C20	1-20-12	Hs~MGC:BC005305.1~uORF:IOH7363	278	247	351	199	356	180	234	241	335	66	collagen, type IV, alpha 6 (COL4A6)
B01R12C21	1-21-12	Hs~Ref:NM_032514.2~uORF:IOH10043	432	329	576	276	219	166	389	194	704	83	microtubule-associated protein 1 light chain 3 alpha (MAP1LC3A), transcript variant 1
B01R12C22	1-22-12	Hs~Ref:NM_032514.2~uORF:IOH10043	313	307	608	209	263	159	378	217	822	122	microtubule-associated protein 1 light chain 3 alpha (MAP1LC3A), transcript variant 1
B01R13C01	1-1-13	Hs~MGC:BC023144.1~uORF:IOH10881	4105	5176	11881	1610	2175	2400	10432	1648	3644	1626	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5
B01R13C02	1-2-13	Hs~MGC:BC023144.1~uORF:IOH10881	3907	4670	12061	1534	2020	2165	9561	1637	3589	1663	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5
B01R13C03	1-3-13	Hs~Ref:NM_133490.2~uORF:IOH6166	850	641	930	492	487	1149	1437	634	1105	408	potassium voltage-gated channel, subfamily G, member 4 (KCNG4), transcript variant 2
B01R13C04	1-4-13	Hs~Ref:NM_133490.2~uORF:IOH6166	857	572	942	535	514	729	1255	545	1095	50	potassium voltage-gated channel, subfamily G, member 4 (KCNG4), transcript variant 2
B01R13C07	1-7-13	Hs~Ref:NM_001397.1~uORF:IOH42625	809	719	1276	638	769	925	1292	769	1680	600	endothelin converting enzyme 1 (ECE1)
B01R13C08	1-8-13	Hs~Ref:NM_001397.1~uORF:IOH42625	809	712	1255	596	751	1025	1528	718	1735	567	endothelin converting enzyme 1 (ECE1)
B01R13C15	1-15-13	Hs~MGC:BC022073.1~uORF:IOH62089	879	648	802	450	680	590	1382	560	1383	444	COMM domain-containing protein 7
B01R13C16	1-16-13	Hs~MGC:BC022073.1~uORF:IOH62089	725	551	846	466	668	594	1211	514	1235	262	COMM domain-containing protein 7
B01R13C17	1-17-13	Hs~MGC:BC014315.1~uORF:IOH13047	5711	4488	4115	5549	4612	4002	4389	3571	5170	5378	small nuclear RNA activating complex, polypeptide 5, 19kDa (SNAPC5)
B01R13C18	1-18-13	Hs~MGC:BC014315.1~uORF:IOH13047	5702	4171	4306	3541	5853	4300	4171	3534	5175	3796	small nuclear RNA activating complex, polypeptide 5, 19kDa (SNAPC5)
B01R13C19	1-19-13	Hs~Ref:NM_138784.1~uORF:IOH13439	941	830	967	645	892	885	845	675	915	65	hypothetical protein BC014341 (LOC116123)
B01R13C20	1-20-13	Hs~Ref:NM_138784.1~uORF:IOH13439	949	823	835	629	1002	907	872	616	1412	838	hypothetical protein BC014341 (LOC116123)
B01R13C21	1-21-13	Hs~Ref:NM_020367.2~uORF:IOH13091	1470	3742	1004	1244	1121	1396	1682	1386	1746	606	poly (ADP-ribose) polymerase family, member 11 (PARP11)
B01R13C22	1-22-13	Hs~Ref:NM_020367.2~uORF:IOH13091	1392	3348	962	1180	896	1449	1697	1342	1543	548	poly (ADP-ribose) polymerase family, member 11 (PARP11)
B01R14C01	1-1-14	Hs~MGC:BC014974.1~uORF:IOH12832	1179	784	1459	599	675	849	705	692	1728	555	Protein YIF1B
B01R14C02	1-2-14	Hs~MGC:BC014974.1~uORF:IOH12832	1077	774	1352	647	653	929	907	722	1749	569	Protein YIF1B
B01R14C03	1-3-14	Hs~Ref:NM_005621.1~uORF:IOH40815	743	892	674	537	650	862	626	715	1426	461	S100 calcium binding protein A12 (S100A12)
B01R14C04	1-4-14	Hs~Ref:NM_005621.1~uORF:IOH40815	701	807	672	561	593	815	606	672	1357	491	S100 calcium binding protein A12 (S100A12)
B01R14C05	1-5-14	Hs~MGC:BC003160.1~uORF:IOH5120	397	307	590	314	270	451	901	449	639	113	acid phosphatase 2, lysosomal (ACP2)
B01R14C06	1-6-14	Hs~MGC:BC003160.1~uORF:IOH5120	400	347	603	284	275	356	948	431	575	172	acid phosphatase 2, lysosomal (ACP2)
B01R14C07	1-7-14	Hs~MGC:BC032348.1~uORF:IOH21706	441	366	493	288	325	496	724	323	584	258	kelch-like 6 (Drosophila) (KLHL6)
B01R14C08	1-8-14	Hs~MGC:BC032348.1~uORF:IOH21706	424	375	528	297	399	473	698	350	579	282	kelch-like 6 (Drosophila) (KLHL6)
B01R14C09	1-9-14	Hs~Ref:NM_145183.1~uORF:IOH5614	354	372	462	315	317	567	493	419	612	360	PYD and CARD domain containing (PYCARD), transcript variant 3
B01R14C10	1-10-14	Hs~Ref:NM_145183.1~uORF:IOH5614	379	292	558	317	370	467	444	375	614	307	PYD and CARD domain containing (PYCARD), transcript variant 3
B01R14C11	1-11-14	Hs~Ref:NM_018431.3~uORF:IOH42147	493	623	509	376	318	579	668	456	748	293	Docking protein 5
B01R14C12	1-12-14	Hs~Ref:NM_018431.3~uORF:IOH42147	514	530	603	370	362	545	737	412	737	405	Docking protein 5
B01R14C13	1-13-14	Hs~Ref:NM_152721.2~uORF:IOH42262	1519	1521	1073	690	1319	1378	1334	626	1527	474	Docking protein 6
B01R14C14	1-14-14	Hs~Ref:NM_152721.2~uORF:IOH42262	1836	1400	884	752	1498	1420	1312	602	1582	497	Docking protein 6
B01R14C15	1-15-14	Hs~Ref:NM_172175.1~uORF:IOH42096	749	375	609	344	590	537	692	458	877	150	Interleukin-15
B01R14C16	1-16-14	Hs~Ref:NM_172175.1~uORF:IOH42096	627	361	609	309	529	457	795	467	878	127	Interleukin-15
B01R14C17	1-17-14	Hs~Ref:NM_198483.1~uORF:IOH42754	2319	1496	2713	1836	1283	1339	5919	1146	3171	791	RUN and FYVE domain-containing protein 4
B01R14C18	1-18-14	Hs~Ref:NM_198483.1~uORF:IOH42754	2231	1434	2622	1919	1279	1269	5869	1129	3186	838	RUN and FYVE domain-containing protein 4
B01R14C19	1-19-14	Hs~MGC:BC034236.1~uORF:IOH21619	833	1022	1488	543	994	867	1340	960	2190	346	Sorting nexin-18
B01R14C20	1-20-14	Hs~MGC:BC034236.1~uORF:IOH21619	832	920	1507	577	995	959	1343	925	2404	389	Sorting nexin-18
B01R14C21	1-21-14	Hs~Ref:NM_005092.2~uORF:IOH34742	553	440	799	403	486	656	1085	556	1039	228	tumor necrosis factor (ligand) superfamily, member 18 (TNFSF18)
B01R14C22	1-22-14	Hs~Ref:NM_005092.2~uORF:IOH34742	521	454	762	379	456	666	1126	727	1097	149	tumor necrosis factor (ligand) superfamily, member 18 (TNFSF18)
B01R15C01	1-1-15	Hs~Ref:NM_005142.2~uORF:IOH26056	407	404	706	368	234	659	645	407	645	221	gastric intrinsic factor (vitamin B synthesis) (GIF)
B01R15C02	1-2-15	Hs~Ref:NM_005142.2~uORF:IOH26056	406	384	644	364	235	695	622	369	626	221	gastric intrinsic factor (vitamin B synthesis) (GIF)
B01R15C03	1-3-15	Hs~Ref:NM_018376.2~uORF:IOH7251	483	371	679	430	329	619	1008	473	834	279	nipsnap homolog 3B (C. elegans) (NIPSNAP3B)
B01R15C04	1-4-15	Hs~Ref:NM_018376.2~uORF:IOH7251	445	376	660	439	324	600	1072	518	856	307	nipsnap homolog 3B (C. elegans) (NIPSNAP3B)
B01R15C05	1-5-15	Hs~Ref:NM_153378.1~uORF:IOH45483	870	691	1068	699	686	647	961	758	1580	492	Solute carrier family 22 member 12
B01R15C06	1-6-15	Hs~Ref:NM_153378.1~uORF:IOH45483	805	672	1041	661	773	719	933	723	1524	512	Solute carrier family 22 member 12
B01R15C07	1-7-15	Hs~Ref:NM_004058.2~uORF:IOH45954	526	616	684	498	537	542	562	506	1075	252	calcyphosine (CAPS), transcript variant 1
B01R15C08	1-8-15	Hs~Ref:NM_004058.2~uORF:IOH45954	539	540	677	488	565	543	531	499	1010	291	calcyphosine (CAPS), transcript variant 1
B01R15C09	1-9-15	Hs~Ref:NM_181462.1~uORF:IOH45485	1896	1903	3111	2376	1981	1668	4697	2537	3415	1347	mitochondrial ribosomal protein L55 (MRPL55), nuclear gene encoding mitochondrial protein, transcript variant 4
B01R15C10	1-10-15	Hs~Ref:NM_181462.1~uORF:IOH45485	1714	1729	2512	2212	1975	1571	4367	2397	3197	1316	mitochondrial ribosomal protein L55 (MRPL55), nuclear gene encoding mitochondrial protein, transcript variant 4
B01R15C11	1-11-15	Hs~Ref:NM_017828.2~uORF:IOH45931	822	644	1008	534	861	721	1260	720	1482	411	COMM domain containing 4 (COMMD4)
B01R15C12	1-12-15	Hs~Ref:NM_017828.2~uORF:IOH45931	786	662	1014	544	965	811	1322	684	1410	443	COMM domain containing 4 (COMMD4)
B01R15C15	1-15-15	Hs~Ref:NM_002739.1~CAT:P2228	1193	670	507	377	930	724	1153	362	818	187	protein kinase C, gamma (PRKCG)
B01R15C16	1-16-15	Hs~Ref:NM_002739.1~CAT:P2228	975	612	506	380	930	724	1163	325	836	307	protein kinase C, gamma (PRKCG)
B01R15C17	1-17-15	Hs~Ref:NM_003137.2~CAT:PV4215	313	249	717	376	99	801	319	232	348	58	SFRS protein kinase 1 (SRPK1)
B01R15C18	1-18-15	Hs~Ref:NM_003137.2~CAT:PV4215	313	91	711	361	286	783	289	213	265	47	SFRS protein kinase 1 (SRPK1)
B01R15C21	1-21-15	Hs~Ref:NM_002737.1~CAT:P2227	2394	705	912	1343	355	1309	1617	370	1151	5	protein kinase C, alpha (PRKCA); see catalog number for detailed information on wild-type or point mutant status
B01R15C22	1-22-15	Hs~Ref:NM_002737.1~CAT:P2227	2083	656	886	1302	381	1303	1517	359	925	1	protein kinase C, alpha (PRKCA); see catalog number for detailed information on wild-type or point mutant status
B01R16C01	1-1-16	Hs~Ref:NM_002648.1~CAT:PV3503	249	302	403	303	228	1109	378	334	477	112	pim-1 oncogene (PIM1)
B01R16C02	1-2-16	Hs~Ref:NM_002648.1~CAT:PV3503	263	318	444	281	240	353	349	333	485	126	pim-1 oncogene (PIM1)
B01R16C07	1-7-16	Hs~Ref:NM_017692.1~uORF:IOH4894	299	210	357	279	212	388	674	240	625	102	aprataxin (APTX), transcript variant 4
B01R16C08	1-8-16	Hs~Ref:NM_017692.1~uORF:IOH4894	256	248	407	252	170	272	625	232	656	177	aprataxin (APTX), transcript variant 4
B01R16C09	1-9-16	Hs~MGC:NM_173547.2~uORF:IOH11612	277	177	355	259	81	226	315	180	447	24	tripartite motif-containing 65 (TRIM65)
B01R16C10	1-10-16	Hs~MGC:NM_173547.2~uORF:IOH11612	275	302	365	238	190	275	363	221	467	43	tripartite motif-containing 65 (TRIM65)
B01R16C11	1-11-16	Hs~Ref:NM_002475.2~uORF:IOH14814	657	525	18662	526	379	569	863	432	2428	293	myosin, light chain 6B, alkali, smooth muscle and non-muscle (MYL6B)
B01R16C12	1-12-16	Hs~Ref:NM_002475.2~uORF:IOH14814	595	488	16859	523	380	576	845	417	2361	289	myosin, light chain 6B, alkali, smooth muscle and non-muscle (MYL6B)
B01R16C13	1-13-16	Hs~Ref:NM_006466.1~uORF:IOH14273	394	241	457	323	638	273	554	276	567	228	polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa (POLR3F)
B01R16C14	1-14-16	Hs~Ref:NM_006466.1~uORF:IOH14273	485	296	416	316	401	299	545	266	568	43	polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa (POLR3F)
B01R16C15	1-15-16	Hs~Ref:NM_001641.2~uORF:IOH5081	1643	1321	1671	743	3500	2519	2361	1341	2728	449	APEX nuclease (multifunctional DNA repair enzyme) 1 (APEX1), transcript variant 1
B01R16C16	1-16-16	Hs~Ref:NM_001641.2~uORF:IOH5081	1515	1241	1545	674	3133	2361	2022	1286	2506	572	APEX nuclease (multifunctional DNA repair enzyme) 1 (APEX1), transcript variant 1
B01R16C17	1-17-16	Hs~Ref:NM_005740.1~uORF:IOH4940	1074	1017	1382	758	2603	2020	1813	1146	2755	406	dynein, axonemal, light chain 4 (DNAL4)
B01R16C18	1-18-16	Hs~Ref:NM_005740.1~uORF:IOH4940	1074	995	1322	791	2924	2043	1802	1128	2610	382	dynein, axonemal, light chain 4 (DNAL4)
B01R16C19	1-19-16	Hs~Ref:NM_019070.1~uORF:IOH5264	1980	1831	1755	1172	2777	3636	3465	1702	3926	585	DEAD (Asp-Glu-Ala-Asp) box polypeptide 49 (DDX49)
B01R16C20	1-20-16	Hs~Ref:NM_019070.1~uORF:IOH5264	1956	1798	1626	1158	2598	3630	3230	1784	3015	1314	DEAD (Asp-Glu-Ala-Asp) box polypeptide 49 (DDX49)
B01R16C21	1-21-16	Hs~Ref:NM_001696.2~uORF:IOH5034	945	807	1163	671	1472	1335	1489	916	2603	493	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 (ATP6V1E1), transcript variant 1
B01R16C22	1-22-16	Hs~Ref:NM_001696.2~uORF:IOH5034	918	800	1103	659	1370	1318	1439	897	2694	323	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 (ATP6V1E1), transcript variant 1
B01R17C01	1-1-17	Hs~MGC:BC012485.1~uORF:IOH10861	1083	783	1283	660	1833	1439	1690	1146	2605	539	major histocompatibility complex, class I-related (MR1)
B01R17C02	1-2-17	Hs~MGC:BC012485.1~uORF:IOH10861	1003	779	1326	681	1844	1470	1744	1009	2750	565	major histocompatibility complex, class I-related (MR1)
B01R17C03	1-3-17	Hs~Ref:NM_003978.2~uORF:IOH3303	903	743	1271	568	1278	1042	1201	793	2383	410	proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1)
B01R17C04	1-4-17	Hs~Ref:NM_003978.2~uORF:IOH3303	862	696	1206	584	1237	986	1352	720	2176	411	proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1)
B01R17C05	1-5-17	Hs~Ref:NM_005793.3~uORF:IOH3852	841	747	1152	575	1453	1278	1440	1002	2345	444	non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase) (NME6)
B01R17C06	1-6-17	Hs~Ref:NM_005793.3~uORF:IOH3852	798	722	1117	570	1419	1327	1562	970	2339	437	non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase) (NME6)
B01R17C07	1-7-17	Hs~Ref:NM_002135.3~uORF:IOH10133	662	529	894	534	1446	1008	1181	706	1992	380	nuclear receptor subfamily 4, group A, member 1 (NR4A1), transcript variant 1
B01R17C08	1-8-17	Hs~Ref:NM_002135.3~uORF:IOH10133	648	545	914	562	1543	1041	1249	724	1953	375	nuclear receptor subfamily 4, group A, member 1 (NR4A1), transcript variant 1
B01R17C09	1-9-17	Hs~MGC:BC063110.1~uORF:IOH40721	1317	982	1281	1194	2454	1119	1939	809	2255	796	interleukin 17 receptor E (IL17RE)
B01R17C10	1-10-17	Hs~MGC:BC063110.1~uORF:IOH40721	1329	1097	1253	1160	2399	1267	1803	796	2201	775	interleukin 17 receptor E (IL17RE)
B01R17C11	1-11-17	Hs~Ref:NM_033185.2~uORF:IOH40389	2669	865	1067	665	1359	687	1009	776	2195	392	keratin associated protein 3-3 (KRTAP3-3)
B01R17C12	1-12-17	Hs~Ref:NM_033185.2~uORF:IOH40389	2588	827	1038	649	1395	699	1009	762	2151	411	keratin associated protein 3-3 (KRTAP3-3)
B01R17C13	1-13-17	Hs~MGC:BC040529.1~uORF:IOH27481	790	658	1194	600	787	824	1170	631	1605	702	PCTAIRE protein kinase 3 (PCTK3)
B01R17C14	1-14-17	Hs~MGC:BC040529.1~uORF:IOH27481	806	676	1153	567	887	834	1100	595	1606	447	PCTAIRE protein kinase 3 (PCTK3)
B01R17C15	1-15-17	Hs~Ref:NM_174899.3~uORF:IOH25862	1156	643	782	527	715	780	1794	612	1573	484	F-box protein 36 (FBXO36)
B01R17C16	1-16-17	Hs~Ref:NM_174899.3~uORF:IOH25862	1178	644	782	555	645	823	1584	609	1444	370	F-box protein 36 (FBXO36)
B01R17C17	1-17-17	Hs~Ref:NM_002686.2~uORF:IOH27402	1294	1708	1549	840	1850	1305	1692	931	2979	681	phenylethanolamine N-methyltransferase (PNMT)
B01R17C18	1-18-17	Hs~Ref:NM_002686.2~uORF:IOH27402	1183	1516	1462	902	1925	1278	1612	901	3035	510	phenylethanolamine N-methyltransferase (PNMT)
B01R17C19	1-19-17	Hs~MGC:BC041009.2~uORF:IOH25834	1587	694	1635	3401	1154	3915	4648	834	3169	1642	chromosome 9 open reading frame 25 (C9orf25)
B01R17C20	1-20-17	Hs~MGC:BC041009.2~uORF:IOH25834	1546	679	1461	2959	1257	3787	4649	856	3272	1563	chromosome 9 open reading frame 25 (C9orf25)
B01R17C21	1-21-17	Hs~MGC:BC036075.1~uORF:IOH27252	1166	1053	1311	727	2958	1530	1733	1251	3786	553	GIPC PDZ domain containing family, member 2 (GIPC2)
B01R17C22	1-22-17	Hs~MGC:BC036075.1~uORF:IOH27252	1101	988	1244	700	3166	1580	1684	1293	3302	512	GIPC PDZ domain containing family, member 2 (GIPC2)
B01R18C01	1-1-18	Hs~Ref:NM_002061.1~uORF:IOH25898	1208	1193	1713	685	2891	1564	1550	1096	2774	483	glutamate-cysteine ligase, modifier subunit (GCLM)
B01R18C02	1-2-18	Hs~Ref:NM_002061.1~uORF:IOH25898	1108	1100	1613	674	2615	1496	1534	1013	2606	467	glutamate-cysteine ligase, modifier subunit (GCLM)
B01R18C03	1-3-18	Hs~MGC:BC064834.1~uORF:IOH40742	695	579	781	514	650	804	1010	695	2013	402	LPS-responsive vesicle trafficking, beach and anchor containing (LRBA)
B01R18C04	1-4-18	Hs~MGC:BC064834.1~uORF:IOH40742	666	574	787	511	579	836	1058	639	1835	387	LPS-responsive vesicle trafficking, beach and anchor containing (LRBA)
B01R18C05	1-5-18	Hs~Ref:NM_173518.2~uORF:IOH40744	660	442	668	401	368	669	1077	489	1121	396	chromosome 8 open reading frame 45 (C8orf45)
B01R18C06	1-6-18	Hs~Ref:NM_173518.2~uORF:IOH40744	590	439	681	398	349	650	1061	543	1129	384	chromosome 8 open reading frame 45 (C8orf45)
B01R18C07	1-7-18	Hs~MGC:BC001105.1~uORF:IOH3794	687	405	1015	773	1219	623	840	873	2009	340	dysbindin (dystrobrevin binding protein 1) domain containing 2 (DBNDD2)
B01R18C08	1-8-18	Hs~MGC:BC001105.1~uORF:IOH3794	643	407	1010	795	1233	636	856	872	1936	333	dysbindin (dystrobrevin binding protein 1) domain containing 2 (DBNDD2)
B01R18C09	1-9-18	Hs~MGC:BC025389.1~uORF:IOH11380	447	425	523	319	366	395	613	422	604	259	Proteasome subunit alpha type-7-like
B01R18C10	1-10-18	Hs~MGC:BC025389.1~uORF:IOH11380	411	421	478	325	368	406	543	368	700	238	Proteasome subunit alpha type-7-like
B01R18C11	1-11-18	Hs~Ref:NM_004952.3~uORF:IOH11980	755	650	1095	553	551	852	1176	638	1520	393	ephrin-A3 (EFNA3)
B01R18C12	1-12-18	Hs~Ref:NM_004952.3~uORF:IOH11980	731	617	1000	563	615	842	1134	621	1485	383	ephrin-A3 (EFNA3)
B01R18C13	1-13-18	Hs~Ref:NM_000865.1~uORF:IOH39590	702	503	800	488	755	555	980	620	1198	366	5-hydroxytryptamine (serotonin) receptor 1E (HTR1E)
B01R18C14	1-14-18	Hs~Ref:NM_000865.1~uORF:IOH39590	678	597	924	442	683	587	1092	596	1174	242	5-hydroxytryptamine (serotonin) receptor 1E (HTR1E)
B01R18C15	1-15-18	Hs~Ref:NM_005400.1~N/A	695	320	462	293	251	406	690	399	544	101	protein kinase C, epsilon (PRKCE)
B01R18C16	1-16-18	Hs~Ref:NM_005400.1~N/A	689	332	478	297	317	391	630	348	822	256	protein kinase C, epsilon (PRKCE)
B01R18C17	1-17-18	Hs~MGC:BC008838.1~N/A	548	317	556	357	367	385	732	451	4	70	Dual specificity mitogen-activated protein kinase kinase 5
B01R18C18	1-18-18	Hs~MGC:BC008838.1~N/A	514	331	579	440	328	455	723	410	2134	242	Dual specificity mitogen-activated protein kinase kinase 5
B01R18C19	1-19-18	Hs~Ref:NM_018649.1~uORF:IOH10067	2405	874	1335	743	1223	1182	12397	950	2245	307	H2A histone family, member Y2 (H2AFY2)
B01R18C20	1-20-18	Hs~Ref:NM_018649.1~uORF:IOH10067	2297	869	1228	639	1144	1217	11737	837	2385	360	H2A histone family, member Y2 (H2AFY2)
B01R18C21	1-21-18	Hs~Ref:NM_018014.2~uORF:IOH12520	3217	1526	1405	1137	1878	1238	2464	770	3593	603	B-cell CLL/lymphoma 11A (zinc finger protein) (BCL11A), transcript variant 2
B01R18C22	1-22-18	Hs~Ref:NM_018014.2~uORF:IOH12520	2900	1393	1417	1108	1964	1232	2401	813	3386	436	B-cell CLL/lymphoma 11A (zinc finger protein) (BCL11A), transcript variant 2
B01R19C01	1-1-19	Hs~Ref:NM_017841.1~uORF:IOH5201	682	579	767	403	523	768	819	575	1367	353	chromosome 11 open reading frame 79 (C11orf79)
B01R19C02	1-2-19	Hs~Ref:NM_017841.1~uORF:IOH5201	643	523	729	425	513	616	890	558	1336	378	chromosome 11 open reading frame 79 (C11orf79)
B01R19C03	1-3-19	Hs~Ref:NM_017510.1~uORF:IOH3866	573	444	647	412	497	613	752	458	1215	449	transmembrane emp24 protein transport domain containing 9 (TMED9)
B01R19C04	1-4-19	Hs~Ref:NM_017510.1~uORF:IOH3866	518	432	683	393	484	599	743	515	1099	475	transmembrane emp24 protein transport domain containing 9 (TMED9)
B01R19C05	1-5-19	Hs~MGC:BC014194.1~uORF:IOH12800	378	267	451	275	218	415	551	330	624	153	T-box 22 (TBX22)
B01R19C06	1-6-19	Hs~MGC:BC014194.1~uORF:IOH12800	412	316	436	240	261	421	569	362	696	304	T-box 22 (TBX22)
B01R19C07	1-7-19	Hs~Ref:NM_021245.2~uORF:IOH11059	1357	493	801	523	701	574	1151	561	1192	290	myozenin 1 (MYOZ1)
B01R19C08	1-8-19	Hs~Ref:NM_021245.2~uORF:IOH11059	1389	483	890	535	718	627	1142	566	1336	305	myozenin 1 (MYOZ1)
B01R19C09	1-9-19	Hs~MGC:BC012472.1~uORF:IOH11069	1511	665	930	593	400	838	3957	576	1967	316	ubiquitin D (UBD)
B01R19C10	1-10-19	Hs~MGC:BC012472.1~uORF:IOH11069	1387	635	895	614	379	914	3811	527	1869	327	ubiquitin D (UBD)
B01R19C11	1-11-19	Hs~MGC:BC002794.1~uORF:IOH5309	328	661	430	327	239	635	490	457	708	139	tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) (TNFRSF14)
B01R19C12	1-12-19	Hs~MGC:BC002794.1~uORF:IOH5309	348	543	383	300	308	200	472	491	734	167	tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) (TNFRSF14)
B01R19C13	1-13-19	Hs~MGC:BC036092.1~uORF:IOH27277	396	344	429	361	327	445	548	270	603	114	MYC associated factor X (MAX)
B01R19C14	1-14-19	Hs~MGC:BC036092.1~uORF:IOH27277	418	353	515	369	378	418	514	292	669	143	MYC associated factor X (MAX)
B01R19C15	1-15-19	Hs~Ref:NM_198173.1~uORF:IOH44757	2424	867	1351	851	909	1259	1249	1250	2227	818	grainyhead-like 3 (Drosophila) (GRHL3), transcript variant 2
B01R19C16	1-16-19	Hs~Ref:NM_198173.1~uORF:IOH44757	7827	806	1350	858	822	1286	1171	1242	2044	783	grainyhead-like 3 (Drosophila) (GRHL3), transcript variant 2
B01R19C17	1-17-19	Hs~Ref:NM_145641.1~uORF:IOH44125	3224	777	1029	558	608	1030	1228	770	1826	366	apolipoprotein L, 3 (APOL3), transcript variant beta/a
B01R19C18	1-18-19	Hs~Ref:NM_145641.1~uORF:IOH44125	807	805	940	712	697	1119	1134	753	1543	867	apolipoprotein L, 3 (APOL3), transcript variant beta/a
B01R19C19	1-19-19	Hs~Ref:NM_144620.1~uORF:IOH13940	921	529	706	497	516	675	1210	504	908	532	leucine rich repeat containing 39 (LRRC39)
B01R19C20	1-20-19	Hs~Ref:NM_144620.1~uORF:IOH13940	881	519	660	450	477	726	1188	460	460	455	leucine rich repeat containing 39 (LRRC39)
B01R19C21	1-21-19	Hs~MGC:BC028227.1~uORF:IOH21543	573	547	911	1246	892	715	1599	646	2078	175	zinc finger protein 471 (ZNF471)
B01R19C22	1-22-19	Hs~MGC:BC028227.1~uORF:IOH21543	512	515	834	1157	890	697	1412	623	1859	356	zinc finger protein 471 (ZNF471)
B01R20C01	1-1-20	Hs~Ref:NM_031950.1~uORF:IOH10917	2475	1322	1637	1220	1246	1425	2328	1129	2986	636	fibroblast growth factor binding protein 2 (FGFBP2)
B01R20C02	1-2-20	Hs~Ref:NM_031950.1~uORF:IOH10917	2297	1219	1666	1243	1181	1306	2295	1063	2983	662	fibroblast growth factor binding protein 2 (FGFBP2)
B01R20C03	1-3-20	Hs~Ref:NM_016535.1~uORF:IOH4783	-1	9	-2	-1	492	873	3161	886	1819	381	zinc finger protein 581 (ZNF581)
B01R20C04	1-4-20	Hs~Ref:NM_016535.1~uORF:IOH4783	-4	-4	-6	-2	455	850	3243	872	1722	355	zinc finger protein 581 (ZNF581)
B01R20C05	1-5-20	Hs~Ref:NM_016475.2~uORF:IOH14293	689	764	740	348	329	565	1329	931	988	276	chromosome 14 open reading frame 100 (C14orf100), transcript variant 1
B01R20C06	1-6-20	Hs~Ref:NM_016475.2~uORF:IOH14293	702	795	785	400	310	522	1334	962	978	267	chromosome 14 open reading frame 100 (C14orf100), transcript variant 1
B01R20C07	1-7-20	Hs~Ref:NM_013257.3~uORF:IOH41642	889	612	871	517	501	675	1197	663	1547	286	serum/glucocorticoid regulated kinase family, member 3 (SGK3), transcript variant 1
B01R20C08	1-8-20	Hs~Ref:NM_013257.3~uORF:IOH41642	881	589	901	525	614	669	1253	621	1655	309	serum/glucocorticoid regulated kinase family, member 3 (SGK3), transcript variant 1
B01R20C09	1-9-20	Hs~MGC:BC006769.1~uORF:IOH3146	4109	1383	18993	1668	1960	2609	6369	1527	5638	782	nucleolar and coiled-body phosphoprotein 1 (NOLC1)
B01R20C10	1-10-20	Hs~MGC:BC006769.1~uORF:IOH3146	3906	1336	18963	1652	1929	2543	5835	1516	5360	802	nucleolar and coiled-body phosphoprotein 1 (NOLC1)
B01R20C11	1-11-20	Hs~MGC:BC004301.1~uORF:IOH5532	1041	937	1559	1062	1126	993	1658	1173	11419	602	Krueppel-like factor 6
B01R20C12	1-12-20	Hs~MGC:BC004301.1~uORF:IOH5532	1046	873	1544	966	1166	699	1520	1200	10412	625	Krueppel-like factor 6
B01R20C13	1-13-20	Hs~MGC:BC008825.2~uORF:IOH6387	547	360	1042	470	877	539	906	531	779	314	DEAH (Asp-Glu-Ala-His) box polypeptide 16 (DHX16)
B01R20C14	1-14-20	Hs~MGC:BC008825.2~uORF:IOH6387	551	411	1108	425	1119	532	918	534	943	217	DEAH (Asp-Glu-Ala-His) box polypeptide 16 (DHX16)
B02R02C11	2-11-2	Hs~MGC:BC031053.1~uORF:IOH22523	3031	2955	3146	2879	2442	2535	3185	2054	4240	3269	lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) (LRAT)
B02R02C12	2-12-2	Hs~MGC:BC031053.1~uORF:IOH22523	3113	2918	3052	2836	2407	2526	3149	2371	4206	3018	lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) (LRAT)
B02R02C13	2-13-2	Hs~Ref:NM_032630.2~uORF:IOH4256	552	1112	592	386	1351	632	1278	662	2792	141	cyclin-dependent kinase 2-interacting protein (CINP)
B02R02C14	2-14-2	Hs~Ref:NM_032630.2~uORF:IOH4256	514	1145	555	360	1333	741	1225	610	2663	171	cyclin-dependent kinase 2-interacting protein (CINP)
B02R02C15	2-15-2	Hs~Ref:NM_032316.1~uORF:IOH6534	2355	1871	2251	2143	2437	2379	2705	1626	3233	1528	nicolin 1 (NICN1)
B02R02C16	2-16-2	Hs~Ref:NM_032316.1~uORF:IOH6534	2454	1961	2609	2144	2351	2338	2936	1868	3300	1653	nicolin 1 (NICN1)
B02R02C17	2-17-2	Hs~Ref:NM_032846.2~uORF:IOH13473	566	529	486	468	1177	736	1153	586	1832	35	RAB2B, member RAS oncogene family (RAB2B)
B02R02C18	2-18-2	Hs~Ref:NM_032846.2~uORF:IOH13473	153	527	801	547	1348	642	910	568	1602	164	RAB2B, member RAS oncogene family (RAB2B)
B02R02C19	2-19-2	Hs~MGC:BC000208.1~uORF:IOH4373	1435	927	1827	725	1285	791	1309	1021	2843	510	OTU domain, ubiquitin aldehyde binding 2 (OTUB2)
B02R02C20	2-20-2	Hs~MGC:BC000208.1~uORF:IOH4373	1308	902	1709	660	1199	829	1779	1002	2788	456	OTU domain, ubiquitin aldehyde binding 2 (OTUB2)
B02R02C21	2-21-2	Hs~MGC:BC008095.1~uORF:IOH3312	1487	797	2009	748	1258	803	3303	1207	2847	434	capping protein (actin filament) muscle Z-line, beta (CAPZB)
B02R02C22	2-22-2	Hs~MGC:BC008095.1~uORF:IOH3312	1429	813	2030	772	1473	812	1075	1264	2879	431	capping protein (actin filament) muscle Z-line, beta (CAPZB)
B02R03C01	2-1-3	Hs~MGC:BC008686.1~uORF:IOH3381	666	512	1248	471	1014	672	1300	508	1991	434	c-myc binding protein (MYCBP)
B02R03C02	2-2-3	Hs~MGC:BC008686.1~uORF:IOH3381	577	468	1162	593	1139	662	1210	539	1941	365	c-myc binding protein (MYCBP)
B02R03C03	2-3-3	Hs~Ref:NM_004832.1~uORF:IOH4381	790	796	1046	997	1333	745	1427	1505	2536	670	glutathione S-transferase omega 1 (GSTO1)
B02R03C04	2-4-3	Hs~Ref:NM_004832.1~uORF:IOH4381	1166	726	1057	1246	1412	738	1431	1486	2435	597	glutathione S-transferase omega 1 (GSTO1)
B02R03C05	2-5-3	Hs~Ref:NM_181555.1~uORF:IOH45913	1014	422	844	529	928	968	679	475	1186	250	CKLF-like MARVEL transmembrane domain containing 3 (CMTM3), transcript variant 4
B02R03C06	2-6-3	Hs~Ref:NM_181555.1~uORF:IOH45913	686	437	852	358	578	959	632	482	1369	293	CKLF-like MARVEL transmembrane domain containing 3 (CMTM3), transcript variant 4
B02R03C07	2-7-3	Hs~Ref:NM_182513.1~uORF:IOH44731	734	389	703	376	367	526	632	448	1123	267	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) (SPC24)
B02R03C08	2-8-3	Hs~Ref:NM_182513.1~uORF:IOH44731	760	423	747	369	403	557	691	472	1158	141	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) (SPC24)
B02R03C09	2-9-3	Hs~Ref:NM_015607.2~uORF:IOH41553	6071	1635	2815	1247	630	1488	9252	4033	2905	2525	Uncharacterized protein C1orf77
B02R03C10	2-10-3	Hs~Ref:NM_015607.2~uORF:IOH41553	5726	1706	2753	1401	626	1480	8761	4968	2886	2697	Uncharacterized protein C1orf77
B02R03C11	2-11-3	Hs~Ref:NM_139249.2~uORF:IOH36785	644	464	1146	448	474	452	850	422	945	234	membrane-spanning 4-domains, subfamily A, member 6E (MS4A6E)
B02R03C12	2-12-3	Hs~Ref:NM_139249.2~uORF:IOH36785	596	478	1174	424	453	330	843	341	1119	325	membrane-spanning 4-domains, subfamily A, member 6E (MS4A6E)
B02R03C13	2-13-3	Hs~Ref:NM_001283.2~uORF:IOH42182	339	375	344	247	452	406	585	845	736	271	adaptor-related protein complex 1, sigma 1 subunit (AP1S1), transcript variant 1
B02R03C14	2-14-3	Hs~Ref:NM_001283.2~uORF:IOH42182	313	346	368	265	430	106	585	856	637	37	adaptor-related protein complex 1, sigma 1 subunit (AP1S1), transcript variant 1
B02R03C17	2-17-3	Hs~Ref:NM_201403.1~uORF:IOH42184	14478	15729	7435	15327	14489	3893	4947	6999	9469	12577	MOB1, Mps One Binder kinase activator-like 2C (yeast) (MOBKL2C), transcript variant 2
B02R03C18	2-18-3	Hs~Ref:NM_201403.1~uORF:IOH42184	13494	6390	6324	15303	13703	3475	4899	6998	9169	12862	MOB1, Mps One Binder kinase activator-like 2C (yeast) (MOBKL2C), transcript variant 2
B02R03C19	2-19-3	Hs~Ref:NM_014280.1~uORF:IOH42939	3046	4943	6509	7413	7482	2487	20590	9347	9631	2471	DnaJ homolog subfamily C member 8
B02R03C20	2-20-3	Hs~Ref:NM_014280.1~uORF:IOH42939	2980	5204	6322	6876	8101	2470	18148	8782	8827	2232	DnaJ homolog subfamily C member 8
B02R03C21	2-21-3	Hs~MGC:BC010889.1~uORF:IOH12754	485	592	710	341	581	1096	907	8567	915	107	coiled-coil domain containing 53 (CCDC53)
B02R03C22	2-22-3	Hs~MGC:BC010889.1~uORF:IOH12754	441	537	675	299	614	957	2033	8314	944	780	coiled-coil domain containing 53 (CCDC53)
B02R04C01	2-1-4	Hs~Ref:NM_015646.1~uORF:IOH2916	1471	256	387	9454	414	259	528	309	521	151	RAP1B, member of RAS oncogene family (RAP1B), transcript variant 1
B02R04C02	2-2-4	Hs~Ref:NM_015646.1~uORF:IOH2916	1015	24	388	9311	371	153	499	292	829	34	RAP1B, member of RAS oncogene family (RAP1B), transcript variant 1
B02R04C03	2-3-4	Hs~MGC:BC010078.1~uORF:IOH13024	820	747	844	523	902	661	1106	658	2229	596	Retinoid-inducible serine carboxypeptidase
B02R04C04	2-4-4	Hs~MGC:BC010078.1~uORF:IOH13024	681	655	858	649	675	619	1188	692	2357	342	Retinoid-inducible serine carboxypeptidase
B02R04C05	2-5-4	Hs~Ref:NM_020980.2~uORF:IOH14443	693	587	954	442	786	482	1100	543	1668	450	aquaporin 9 (AQP9)
B02R04C06	2-6-4	Hs~Ref:NM_020980.2~uORF:IOH14443	771	579	916	530	923	558	1048	565	1687	402	aquaporin 9 (AQP9)
B02R04C07	2-7-4	Hs~MGC:BC007724.1~uORF:IOH6498	325	157	246	235	709	332	229	287	1012	72	Bcl-2-related proline-rich protein
B02R04C08	2-8-4	Hs~MGC:BC007724.1~uORF:IOH6498	322	211	46	221	646	332	243	296	737	74	Bcl-2-related proline-rich protein
B02R04C09	2-9-4	Hs~Ref:NM_001269.2~uORF:IOH6933	3925	516	842	509	522	653	1083	1189	1315	513	regulator of chromosome condensation 1 (RCC1), transcript variant 3
B02R04C10	2-10-4	Hs~Ref:NM_001269.2~uORF:IOH6933	3734	583	806	485	514	633	1068	1069	1996	300	regulator of chromosome condensation 1 (RCC1), transcript variant 3
B02R04C11	2-11-4	Hs~Ref:NM_001790.2~uORF:IOH14569	10393	1184	1221	777	2307	795	1549	858	2174	444	cell division cycle 25 homolog C (S. pombe) (CDC25C), transcript variant 1
B02R04C12	2-12-4	Hs~Ref:NM_001790.2~uORF:IOH14569	9585	1137	1333	770	2313	815	1720	886	1942	418	cell division cycle 25 homolog C (S. pombe) (CDC25C), transcript variant 1
B02R04C13	2-13-4	Hs~Ref:NM_000602.1~uORF:IOH9882	1660	1016	1785	1004	984	905	1222	926	2166	450	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 (SERPINE1)
B02R04C14	2-14-4	Hs~Ref:NM_000602.1~uORF:IOH9882	1607	939	1718	935	964	1316	1147	930	2154	410	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 (SERPINE1)
B02R04C15	2-15-4	Hs~Ref:NM_003223.1~uORF:IOH9646	1684	1263	2359	13050	1647	1405	2000	1971	3798	818	transcription factor AP-4 (activating enhancer binding protein 4) (TFAP4)
B02R04C16	2-16-4	Hs~Ref:NM_003223.1~uORF:IOH9646	1637	1243	2275	12825	1643	2152	2606	1897	3659	802	transcription factor AP-4 (activating enhancer binding protein 4) (TFAP4)
B02R04C17	2-17-4	Hs~Ref:NM_000754.2~uORF:IOH14417	601	480	844	477	718	501	546	595	1357	102	catechol-O-methyltransferase (COMT), transcript variant MB-COMT
B02R04C18	2-18-4	Hs~Ref:NM_000754.2~uORF:IOH14417	613	390	726	427	482	521	1052	562	1310	160	catechol-O-methyltransferase (COMT), transcript variant MB-COMT
B02R04C19	2-19-4	Hs~MGC:BC016789.1~uORF:IOH13602	856	798	864	630	797	587	784	731	1266	261	glycine-N-acyltransferase-like 2 (GLYATL2)
B02R04C20	2-20-4	Hs~MGC:BC016789.1~uORF:IOH13602	831	587	872	599	688	655	561	756	1567	379	glycine-N-acyltransferase-like 2 (GLYATL2)
B02R04C21	2-21-4	Hs~MGC:BC009771.1~uORF:IOH12849	935	895	1167	938	1528	699	1189	746	2157	409	BRCA2 and CDKN1A interacting protein (BCCIP)
B02R04C22	2-22-4	Hs~MGC:BC009771.1~uORF:IOH12849	894	884	1089	850	1484	773	1386	804	2035	414	BRCA2 and CDKN1A interacting protein (BCCIP)
B02R05C01	2-1-5	Hs~Ref:NM_025218.2~uORF:IOH43182	795	410	464	262	299	364	562	307	567	36	UL16 binding protein 1 (ULBP1)
B02R05C02	2-2-5	Hs~Ref:NM_025218.2~uORF:IOH43182	197	470	512	398	274	430	608	288	539	-15	UL16 binding protein 1 (ULBP1)
B02R05C05	2-5-5	Hs~Ref:NM_015415.1~uORF:IOH41193	1202	723	724	476	485	381	712	441	446	135	brain protein 44 (BRP44)
B02R05C06	2-6-5	Hs~Ref:NM_015415.1~uORF:IOH41193	910	768	790	536	619	417	666	457	631	220	brain protein 44 (BRP44)
B02R05C07	2-7-5	Hs~Ref:NM_006431.2~uORF:IOH41691	637	509	468	692	512	953	752	572	2453	445	chaperonin containing TCP1, subunit 2 (beta) (CCT2)
B02R05C08	2-8-5	Hs~Ref:NM_006431.2~uORF:IOH41691	627	501	468	648	591	858	794	562	2411	309	chaperonin containing TCP1, subunit 2 (beta) (CCT2)
B02R05C09	2-9-5	Hs~MGC:BC067773.1~uORF:IOH40125	1360	1078	1628	1056	1365	1107	2558	1173	3600	1015	arginine/serine-rich coiled-coil 2 (RSRC2)
B02R05C10	2-10-5	Hs~MGC:BC067773.1~uORF:IOH40125	1315	1010	1462	955	1462	1143	2816	1089	3431	1018	arginine/serine-rich coiled-coil 2 (RSRC2)
B02R05C11	2-11-5	Hs~MGC:BC039318.1~uORF:IOH40224	1889	1106	1843	1159	1709	1117	2831	973	2170	827	baculoviral IAP repeat-containing 8 (BIRC8)
B02R05C12	2-12-5	Hs~MGC:BC039318.1~uORF:IOH40224	1838	1183	1829	1277	1707	1062	2896	974	2239	561	baculoviral IAP repeat-containing 8 (BIRC8)
B02R05C13	2-13-5	Hs~MGC:BC066340.1~uORF:IOH40104	511	632	2679	410	880	599	458	602	1569	303	Biogenesis of lysosome-related organelles complex 1 subunit 1
B02R05C14	2-14-5	Hs~MGC:BC066340.1~uORF:IOH40104	510	569	2418	403	869	459	466	593	1493	144	Biogenesis of lysosome-related organelles complex 1 subunit 1
B02R05C15	2-15-5	Hs~Ref:NM_000590.1~uORF:IOH40159	790	698	968	1495	663	536	1707	618	1270	356	interleukin 9 (IL9)
B02R05C16	2-16-5	Hs~Ref:NM_000590.1~uORF:IOH40159	822	711	956	1443	630	637	1721	642	1302	437	interleukin 9 (IL9)
B02R05C17	2-17-5	Hs~Ref:NM_080832.1~uORF:IOH40754	2665	962	1415	1006	814	1335	4467	929	2210	990	poly(A) binding protein, cytoplasmic 5 (PABPC5)
B02R05C18	2-18-5	Hs~Ref:NM_080832.1~uORF:IOH40754	2494	927	1465	921	892	1172	4507	943	2072	937	poly(A) binding protein, cytoplasmic 5 (PABPC5)
B02R05C19	2-19-5	Hs~Ref:NM_006837.2~uORF:IOH6870	1891	637	2496	2186	1011	1994	6448	1021	1636	314	COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis) (COPS5)
B02R05C20	2-20-5	Hs~Ref:NM_006837.2~uORF:IOH6870	1711	588	2226	2174	996	2226	6063	1103	1419	251	COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis) (COPS5)
B02R05C21	2-21-5	Hs~Ref:NM_152295.3~uORF:IOH40824	24988	638	1981	1135	1094	1531	2338	829	1961	954	threonyl-tRNA synthetase (TARS)
B02R05C22	2-22-5	Hs~Ref:NM_152295.3~uORF:IOH40824	24352	597	1922	1113	1067	1421	2551	684	1843	852	threonyl-tRNA synthetase (TARS)
B02R06C01	2-1-6	Hs~Ref:NM_152260.1~uORF:IOH40870	3219	5360	5120	1759	1596	2576	2622	1401	3469	1335	RNA pseudouridylate synthase domain containing 2 (RPUSD2)
B02R06C02	2-2-6	Hs~Ref:NM_152260.1~uORF:IOH40870	2783	4916	4896	1705	1595	2555	3044	1364	3113	1144	RNA pseudouridylate synthase domain containing 2 (RPUSD2)
B02R06C03	2-3-6	Hs~Ref:NM_207430.1~uORF:IOH59509	3915	1534	2298	1330	1879	1470	3105	1238	4334	811	FLJ46266 protein (FLJ46266), mRNA.
B02R06C04	2-4-6	Hs~Ref:NM_207430.1~uORF:IOH59509	3701	1560	2353	1271	1859	1436	3211	1289	4203	824	FLJ46266 protein (FLJ46266), mRNA.
B02R06C05	2-5-6	Hs~Ref:NM_198219.1~uORF:IOH59467	15564	2948	2218	1291	1610	3614	10757	2818	3431	1193	Inhibitor of growth protein 1
B02R06C06	2-6-6	Hs~Ref:NM_198219.1~uORF:IOH59467	12404	2268	2083	1336	1260	3330	9676	2990	3375	1035	Inhibitor of growth protein 1
B02R06C07	2-7-6	Hs~Ref:NM_001014279.1~uORF:IOH54743	2009	573	531	628	517	497	459	481	-48	113	Annexin-2 receptor
B02R06C08	2-8-6	Hs~Ref:NM_001014279.1~uORF:IOH54743	2192	461	475	604	746	514	458	460	103	92	Annexin-2 receptor
B02R06C09	2-9-6	Hs~Ref:NM_015471.2~uORF:IOH59202	1044	1351	1417	678	978	811	1771	1735	1827	336	Kinetochore-associated protein NSL1 homolog
B02R06C10	2-10-6	Hs~Ref:NM_015471.2~uORF:IOH59202	1019	1339	1350	646	1068	835	1853	1793	1764	294	Kinetochore-associated protein NSL1 homolog
B02R06C11	2-11-6	Hs~Ref:NM_144578.1~uORF:IOH12842	944	2029	889	1228	1119	952	1175	1628	1322	254	chromosome 14 open reading frame 32 (C14orf32)
B02R06C12	2-12-6	Hs~Ref:NM_144578.1~uORF:IOH12842	885	1884	856	1235	1137	896	1184	1791	1029	247	chromosome 14 open reading frame 32 (C14orf32)
B02R06C13	2-13-6	Hs~Ref:NM_032641.1~uORF:IOH4981	7665	6680	7660	5481	6432	12205	7864	6071	14998	3181	splA/ryanodine receptor domain and SOCS box containing 2 (SPSB2)
B02R06C14	2-14-6	Hs~Ref:NM_032641.1~uORF:IOH4981	7656	6343	7503	5571	5778	12307	7863	6250	15853	3117	splA/ryanodine receptor domain and SOCS box containing 2 (SPSB2)
B02R06C15	2-15-6	Hs~Ref:NM_019895.1~uORF:IOH11450	1024	851	1141	677	763	768	1547	924	2560	502	claudin domain containing 1 (CLDND1), transcript variant 2
B02R06C16	2-16-6	Hs~Ref:NM_019895.1~uORF:IOH11450	896	799	1022	685	670	921	1493	800	2494	495	claudin domain containing 1 (CLDND1), transcript variant 2
B02R06C17	2-17-6	Hs~Ref:NM_015399.1~uORF:IOH12808	1356	1790	1216	895	917	877	1955	731	3356	782	breast cancer metastasis suppressor 1 (BRMS1), transcript variant 1
B02R06C18	2-18-6	Hs~Ref:NM_015399.1~uORF:IOH12808	1250	1768	1286	911	920	887	1868	846	3265	611	breast cancer metastasis suppressor 1 (BRMS1), transcript variant 1
B02R06C21	2-21-6	Hs~MGC:BC001351.1~uORF:IOH3711	1696	1195	2163	1020	1041	2602	2849	1457	2339	574	Four and a half LIM domains protein 3
B02R06C22	2-22-6	Hs~MGC:BC001351.1~uORF:IOH3711	1507	1181	1696	965	1084	2824	2388	1443	2707	1117	Four and a half LIM domains protein 3
B02R07C01	2-1-7	Hs~Ref:NM_002150.1~uORF:IOH14718	1167	1037	1065	549	895	940	1334	1116	2456	882	4-hydroxyphenylpyruvate dioxygenase
B02R07C02	2-2-7	Hs~Ref:NM_002150.1~uORF:IOH14718	1110	944	1003	466	897	920	1437	1143	1810	799	4-hydroxyphenylpyruvate dioxygenase
B02R07C03	2-3-7	Hs~Ref:NM_004374.2~uORF:IOH4367	1748	743	829	772	616	584	786	663	674	402	Cytochrome c oxidase polypeptide VIc
B02R07C04	2-4-7	Hs~Ref:NM_004374.2~uORF:IOH4367	1634	742	826	607	657	594	862	712	1556	467	Cytochrome c oxidase polypeptide VIc
B02R07C05	2-5-7	Hs~Ref:NM_015039.2~uORF:IOH41247	6686	1013	4573	2774	1514	2010	1358	3270	4101	1094	nicotinamide nucleotide adenylyltransferase 2 (NMNAT2), transcript variant 1
B02R07C06	2-6-7	Hs~Ref:NM_015039.2~uORF:IOH41247	5766	1047	4727	2203	1644	1995	1318	3149	3831	1080	nicotinamide nucleotide adenylyltransferase 2 (NMNAT2), transcript variant 1
B02R07C07	2-7-7	Hs~Ref:NM_032988.1~uORF:IOH41250	313	278	392	205	455	471	245	313	624	106	transducin (beta)-like 2 (TBL2), transcript variant 2
B02R07C08	2-8-7	Hs~Ref:NM_032988.1~uORF:IOH41250	334	248	384	205	419	339	238	310	588	94	transducin (beta)-like 2 (TBL2), transcript variant 2
B02R07C09	2-9-7	Hs~Ref:NM_206855.1~uORF:IOH41478	22648	873	2049	524	1260	1483	1267	791	2269	171	quaking homolog, KH domain RNA binding (mouse) (QKI), transcript variant 4
B02R07C10	2-10-7	Hs~Ref:NM_206855.1~uORF:IOH41478	20389	863	1996	523	1384	1482	1214	776	1975	246	quaking homolog, KH domain RNA binding (mouse) (QKI), transcript variant 4
B02R07C11	2-11-7	Hs~Ref:XM_293034.2~uORF:IOH41557	1218	1774	922	805	3374	736	1087	1379	1884	349	UPF0566 protein
B02R07C12	2-12-7	Hs~Ref:XM_293034.2~uORF:IOH41557	1169	1606	856	879	3389	785	1149	1383	1921	340	UPF0566 protein
B02R07C13	2-13-7	Hs~MGC:BC017941.1~uORF:IOH13654	830	548	768	1075	979	644	908	646	1378	237	Cation transport regulator-like protein 2
B02R07C14	2-14-7	Hs~MGC:BC017941.1~uORF:IOH13654	804	576	789	1050	1065	749	884	592	262	374	Cation transport regulator-like protein 2
B02R07C15	2-15-7	Hs~MGC:BC026251.1~uORF:IOH13720	1430	797	1255	710	1112	721	1179	667	840	-8	phenylalanine hydroxylase (PAH)
B02R07C16	2-16-7	Hs~MGC:BC026251.1~uORF:IOH13720	1484	789	1315	718	1129	785	1226	713	1103	717	phenylalanine hydroxylase (PAH)
B02R07C17	2-17-7	Hs~MGC:BC009571.1~uORF:IOH13826	1182	3758	966	523	1405	506	2947	565	2236	900	stimulated by retinoic acid 13 homolog (mouse) (STRA13)
B02R07C18	2-18-7	Hs~MGC:BC009571.1~uORF:IOH13826	1105	3433	904	464	1271	509	2854	539	2162	843	stimulated by retinoic acid 13 homolog (mouse) (STRA13)
B02R07C19	2-19-7	Hs~MGC:BC025963.1~uORF:IOH14668	612	463	715	461	444	482	784	470	932	306	acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain (ACADS)
B02R07C20	2-20-7	Hs~MGC:BC025963.1~uORF:IOH14668	634	479	705	475	389	444	864	515	903	320	acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain (ACADS)
B02R08C05	2-5-8	Hs~MGC:BC078663.1~uORF:IOH63026	394	966	527	325	382	488	716	446	466	254	Glycogen debranching enzyme
B02R08C06	2-6-8	Hs~MGC:BC078663.1~uORF:IOH63026	839	907	463	366	339	582	698	446	690	257	Glycogen debranching enzyme
B02R08C07	2-7-8	Hs~MGC:BC021101.1~uORF:IOH12547	1198	595	752	559	621	636	1319	596	1452	533	mediator complex subunit 17 (CRSP6)
B02R08C08	2-8-8	Hs~MGC:BC021101.1~uORF:IOH12547	1036	581	840	531	611	632	1354	645	1442	387	mediator complex subunit 17 (CRSP6)
B02R08C09	2-9-8	Hs~MGC:NM_020531.2~uORF:IOH5450	379	382	619	523	319	431	407	402	1225	133	chromosome 20 open reading frame 3 (C20orf3)
B02R08C10	2-10-8	Hs~MGC:NM_020531.2~uORF:IOH5450	418	364	613	519	411	402	458	357	1210	112	chromosome 20 open reading frame 3 (C20orf3)
B02R08C11	2-11-8	Hs~Ref:NM_032775.1~uORF:IOH12694	745	589	1051	649	744	688	943	595	1848	446	kelch-like 22 (Drosophila) (KLHL22)
B02R08C12	2-12-8	Hs~Ref:NM_032775.1~uORF:IOH12694	817	628	1067	624	692	577	960	595	1890	585	kelch-like 22 (Drosophila) (KLHL22)
B02R08C13	2-13-8	Hs~Ref:NM_002708.1~uORF:IOH4976	680	590	899	666	821	937	1139	686	1579	625	protein phosphatase 1, catalytic subunit, alpha isoform (PPP1CA), transcript variant 1
B02R08C14	2-14-8	Hs~Ref:NM_002708.1~uORF:IOH4976	682	660	968	642	830	1098	1262	684	1750	612	protein phosphatase 1, catalytic subunit, alpha isoform (PPP1CA), transcript variant 1
B02R08C15	2-15-8	Hs~Ref:NM_017503.2~uORF:IOH12519	8184	3299	3568	4339	7064	1813	12755	1818	5969	2998	surfeit 2 (SURF2)
B02R08C16	2-16-8	Hs~Ref:NM_017503.2~uORF:IOH12519	8025	2708	3262	4105	6251	2061	12784	1829	5955	3102	surfeit 2 (SURF2)
B02R08C19	2-19-8	Hs~Ref:NM_130777.1~uORF:IOH13230	2262	796	962	4803	15781	2413	2517	1175	4082	1054	X antigen family, member 2 (XAGE2)
B02R08C20	2-20-8	Hs~Ref:NM_130777.1~uORF:IOH13230	2109	760	930	4539	15630	2426	2246	1117	3984	882	X antigen family, member 2 (XAGE2)
B02R08C21	2-21-8	Hs~MGC:BC009230.2~uORF:IOH12659	1733	3714	770	295	1106	236	790	329	1079	178	P antigen family, member 5 (prostate associated) (PAGE5)
B02R08C22	2-22-8	Hs~MGC:BC009230.2~uORF:IOH12659	1634	3414	758	265	218	236	806	287	1089	193	P antigen family, member 5 (prostate associated) (PAGE5)
B02R09C01	2-1-9	Hs~MGC:BC068094.1~uORF:IOH40788	10091	300	631	2115	3438	730	664	852	2482	2852	SH3 domain and tetratricopeptide repeats 1 (SH3TC1)
B02R09C02	2-2-9	Hs~MGC:BC068094.1~uORF:IOH40788	9226	273	569	1873	3455	709	674	848	2133	2396	SH3 domain and tetratricopeptide repeats 1 (SH3TC1)
B02R09C03	2-3-9	Hs~MGC:BC070290.1~uORF:IOH40799	513	460	415	369	546	379	528	314	492	119	triadin (TRDN)
B02R09C04	2-4-9	Hs~MGC:BC070290.1~uORF:IOH40799	421	279	424	369	572	432	485	364	537	129	triadin (TRDN)
B02R09C05	2-5-9	Hs~MGC:BC069023.1~uORF:IOH40776	1795	882	1104	606	460	968	6029	666	1818	243	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H (APOBEC3H)
B02R09C06	2-6-9	Hs~MGC:BC069023.1~uORF:IOH40776	1824	826	1105	631	445	943	5783	654	1800	218	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H (APOBEC3H)
B02R09C07	2-7-9	Hs~Ref:NM_004278.2~uORF:IOH57310	1706	385	683	315	322	480	748	402	594	176	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase
B02R09C08	2-8-9	Hs~Ref:NM_004278.2~uORF:IOH57310	1605	419	605	312	296	478	806	396	715	175	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase
B02R09C09	2-9-9	Hs~MGC:BC039577.1~uORF:IOH26185	598	356	1693	275	283	432	555	326	571	145	paraneoplastic antigen MA1 (PNMA1)
B02R09C10	2-10-9	Hs~MGC:BC039577.1~uORF:IOH26185	591	344	1710	291	323	408	547	345	546	150	paraneoplastic antigen MA1 (PNMA1)
B02R09C11	2-11-9	Hs~MGC:BC040721.1~uORF:IOH26408	340	478	681	1	399	129	576	377	637	204	coiled-coil domain containing 128 (CCDC128)
B02R09C12	2-12-9	Hs~MGC:BC040721.1~uORF:IOH26408	348	451	704	-2	418	389	559	326	693	61	coiled-coil domain containing 128 (CCDC128)
B02R09C13	2-13-9	Hs~MGC:NM_198282.1~uORF:IOH26670	403	341	548	328	449	261	523	341	991	132	transmembrane protein 173 (TMEM173)
B02R09C14	2-14-9	Hs~MGC:NM_198282.1~uORF:IOH26670	423	431	508	352	146	344	551	341	877	135	transmembrane protein 173 (TMEM173)
B02R09C15	2-15-9	Hs~MGC:BC047722.1~uORF:IOH26651	954	640	885	501	573	592	1552	533	1773	326	hypothetical protein MGC52110 (MGC52110)
B02R09C16	2-16-9	Hs~MGC:BC047722.1~uORF:IOH26651	961	599	876	484	872	768	1652	562	2023	250	hypothetical protein MGC52110 (MGC52110)
B02R09C17	2-17-9	Hs~MGC:BC011576.1~uORF:IOH13248	1840	1457	1737	969	2068	1802	2455	1685	4237	84	ubiquitin specific peptidase 48 (USP48)
B02R09C18	2-18-9	Hs~MGC:BC011576.1~uORF:IOH13248	1881	1459	1774	986	1885	1744	2457	1744	3898	731	ubiquitin specific peptidase 48 (USP48)
B02R09C19	2-19-9	Hs~MGC:BC014218.2~uORF:IOH12802	1115	1645	1875	2261	2150	2677	1135	1332	4177	564	THAP domain-containing protein 3
B02R09C20	2-20-9	Hs~MGC:BC014218.2~uORF:IOH12802	1115	1564	1848	2255	2214	2795	1035	1316	4608	713	THAP domain-containing protein 3
B02R09C21	2-21-9	Hs~MGC:BC026325.1~uORF:IOH11158	1556	1088	1877	1104	2572	1082	1707	3091	2682	510	nucleosome assembly protein 1-like 2 (NAP1L2)
B02R09C22	2-22-9	Hs~MGC:BC026325.1~uORF:IOH11158	1574	1073	1911	1116	2681	1080	1596	3028	2757	328	nucleosome assembly protein 1-like 2 (NAP1L2)
B02R10C01	2-1-10	Hs~MGC:BC018063.1~uORF:IOH10722	2301	2187	4188	2256	1730	2654	2923	2039	6478	1391	potassium channel tetramerisation domain containing 4 (KCTD4)
B02R10C02	2-2-10	Hs~MGC:BC018063.1~uORF:IOH10722	2246	2206	4186	2148	1807	2598	3048	2214	5980	1756	potassium channel tetramerisation domain containing 4 (KCTD4)
B02R10C03	2-3-10	Hs~MGC:BC058003.1~uORF:IOH29430	14900	1400	555	247	497	356	619	569	148	210	N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) (NPL)
B02R10C04	2-4-10	Hs~MGC:BC058003.1~uORF:IOH29430	13383	1345	546	268	495	315	617	584	-1	34	N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) (NPL)
B02R10C05	2-5-10	Hs~MGC:BC051291.1~uORF:IOH29356	465	373	547	333	403	422	699	348	567	32	retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (RDH11)
B02R10C06	2-6-10	Hs~MGC:BC051291.1~uORF:IOH29356	461	396	606	276	301	541	644	430	528	121	retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (RDH11)
B02R10C07	2-7-10	Hs~MGC:BC057840.1~uORF:IOH29244	2535	3386	1549	764	1305	984	1178	927	2447	670	proteasome (prosome, macropain) subunit, beta type, 5 (PSMB5)
B02R10C08	2-8-10	Hs~MGC:BC057840.1~uORF:IOH29244	2369	3072	1522	800	1169	958	1201	883	2211	608	proteasome (prosome, macropain) subunit, beta type, 5 (PSMB5)
B02R10C09	2-9-10	Hs~MGC:BC060824.1~uORF:IOH29189	938	529	1004	2832	734	3628	1538	3732	1411	128	AT rich interactive domain 3B (BRIGHT-like) (ARID3B)
B02R10C10	2-10-10	Hs~MGC:BC060824.1~uORF:IOH29189	833	497	943	2445	692	3382	1516	3366	1235	124	AT rich interactive domain 3B (BRIGHT-like) (ARID3B)
B02R11C21	2-21-11	Hs~MGC:BC058915.1~uORF:IOH29066	527	572	804	375	952	460	725	480	279	226	SEC14-like 2 (S. cerevisiae) (SEC14L2)
B02R11C22	2-22-11	Hs~MGC:BC058915.1~uORF:IOH29066	481	553	710	373	971	515	786	473	215	242	SEC14-like 2 (S. cerevisiae) (SEC14L2)
B02R12C01	2-1-12	Hs~MGC:BC002387.1~uORF:IOH3693	677	416	1635	502	400	1029	561	380	1144	106	nucleosome assembly protein 1-like 1 (NAP1L1)
B02R12C02	2-2-12	Hs~MGC:BC002387.1~uORF:IOH3693	623	400	1555	617	367	966	575	385	827	122	nucleosome assembly protein 1-like 1 (NAP1L1)
B02R12C03	2-3-12	Hs~MGC:BC060838.1~uORF:IOH29287	590	381	573	323	734	654	947	483	1633	206	aryl hydrocarbon receptor nuclear translocator (ARNT)
B02R12C04	2-4-12	Hs~MGC:BC060838.1~uORF:IOH29287	744	372	519	409	728	597	1634	489	1785	299	aryl hydrocarbon receptor nuclear translocator (ARNT)
B02R12C05	2-5-12	Hs~MGC:BC058287.1~uORF:IOH29442	621	601	950	379	567	561	1566	892	938	632	angiopoietin-like 3 (ANGPTL3)
B02R12C06	2-6-12	Hs~MGC:BC058287.1~uORF:IOH29442	597	610	950	344	541	585	1534	897	1114	662	angiopoietin-like 3 (ANGPTL3)
B02R12C07	2-7-12	Hs~Ref:NM_152332.2~uORF:IOH27272	1039	752	1029	669	1026	1221	1558	942	2144	612	tandem C2 domains, nuclear (TC2N)
B02R12C08	2-8-12	Hs~Ref:NM_152332.2~uORF:IOH27272	980	722	1081	671	1245	1161	1617	943	1668	725	tandem C2 domains, nuclear (TC2N)
B02R12C09	2-9-12	Hs~Ref:NM_001910.2~uORF:IOH27398	787	582	860	539	822	808	1080	738	2476	562	cathepsin E (CTSE), transcript variant 1
B02R12C10	2-10-12	Hs~Ref:NM_001910.2~uORF:IOH27398	782	643	860	537	875	873	1006	735	2334	288	cathepsin E (CTSE), transcript variant 1
B02R12C11	2-11-12	Hs~Ref:NM_002435.1~uORF:IOH26367	881	601	796	561	816	673	1334	800	1108	123	mannose phosphate isomerase (MPI)
B02R12C12	2-12-12	Hs~Ref:NM_002435.1~uORF:IOH26367	846	614	817	572	735	739	1350	1031	1048	177	mannose phosphate isomerase (MPI)
B02R12C13	2-13-12	Hs~Ref:NM_005014.1~uORF:IOH26340	993	890	1227	741	1189	1123	1834	1184	2699	663	osteomodulin (OMD)
B02R12C14	2-14-12	Hs~Ref:NM_005014.1~uORF:IOH26340	994	811	1250	773	1094	1126	2015	956	3111	702	osteomodulin (OMD)
B02R12C15	2-15-12	Hs~MGC:NM_178034.1~uORF:IOH21503	794	610	974	538	612	725	968	552	1793	376	phospholipase A2, group IVD (cytosolic) (PLA2G4D)
B02R12C16	2-16-12	Hs~MGC:NM_178034.1~uORF:IOH21503	914	513	993	496	1614	827	986	555	1861	400	phospholipase A2, group IVD (cytosolic) (PLA2G4D)
B02R12C17	2-17-12	Hs~Ref:NM_000737.2~uORF:IOH6333	657	404	838	348	1485	953	797	403	936	159	chorionic gonadotropin, beta polypeptide (CGB)
B02R12C18	2-18-12	Hs~Ref:NM_000737.2~uORF:IOH6333	605	397	758	306	2192	980	728	418	159	168	chorionic gonadotropin, beta polypeptide (CGB)
B02R12C21	2-21-12	Hs~Ref:NM_001611.2~uORF:IOH14225	630	378	656	296	1179	395	1028	379	756	180	acid phosphatase 5, tartrate resistant (ACP5)
B02R12C22	2-22-12	Hs~Ref:NM_001611.2~uORF:IOH14225	629	364	634	286	426	367	1104	381	735	109	acid phosphatase 5, tartrate resistant (ACP5)
B02R13C01	2-1-13	Hs~Ref:NM_002103.3~uORF:IOH6268	13647	7020	3717	8323	4227	5108	10071	5221	8856	5358	glycogen synthase 1 (muscle) (GYS1)
B02R13C02	2-2-13	Hs~Ref:NM_002103.3~uORF:IOH6268	12212	7294	3749	8260	4194	4945	10418	5252	9660	6384	glycogen synthase 1 (muscle) (GYS1)
B02R13C03	2-3-13	Hs~MGC:BC096184.3~uORF:IOH63211	356	331	668	304	327	588	448	434	410	126	Myeloblastin
B02R13C04	2-4-13	Hs~MGC:BC096184.3~uORF:IOH63211	1936	374	652	567	297	505	498	344	601	246	Myeloblastin
B02R13C05	2-5-13	Hs~Ref:NM_004602.2~uORF:IOH62672	2609	768	1332	744	942	914	3535	1120	1914	1265	Double-stranded RNA-binding protein Staufen homolog 1
B02R13C06	2-6-13	Hs~Ref:NM_004602.2~uORF:IOH62672	1811	793	1368	730	1038	985	3352	1046	1874	1208	Double-stranded RNA-binding protein Staufen homolog 1
B02R13C07	2-7-13	Hs~MGC:BC096708.1~uORF:IOH63336	3188	1257	2615	1607	1177	1790	7456	1066	4180	1371	Wilms tumor-associated protein
B02R13C08	2-8-13	Hs~MGC:BC096708.1~uORF:IOH63336	3086	1226	2535	1440	1210	1802	7119	1108	4002	1199	Wilms tumor-associated protein
B02R13C09	2-9-13	Hs~MGC:BC008298.1~uORF:IOH6949	1391	538	1312	532	2764	547	707	688	2032	163	nucleolar protein family 6 (RNA-associated) (NOL6)
B02R13C10	2-10-13	Hs~MGC:BC008298.1~uORF:IOH6949	1431	551	1384	516	2554	492	653	710	2137	538	nucleolar protein family 6 (RNA-associated) (NOL6)
B02R13C11	2-11-13	Hs~Ref:NM_017761.2~uORF:IOH4866	389	340	736	164	7154	335	416	234	1616	47	proline-rich nuclear receptor coactivator 2 (PNRC2)
B02R13C12	2-12-13	Hs~Ref:NM_017761.2~uORF:IOH4866	364	104	714	212	6861	365	384	625	1747	49	proline-rich nuclear receptor coactivator 2 (PNRC2)
B02R13C13	2-13-13	Hs~Ref:NM_031477.1~uORF:IOH5588	330	281	598	1126	441	325	1140	413	686	106	yippee-like 3 (Drosophila) (YPEL3)
B02R13C14	2-14-13	Hs~Ref:NM_031477.1~uORF:IOH5588	322	279	608	1056	402	307	1188	450	634	81	yippee-like 3 (Drosophila) (YPEL3)
B02R13C15	2-15-13	Hs~Ref:NM_030574.1~uORF:IOH5593	760	255	604	233	1296	722	2799	246	1049	66	StAR-related lipid transfer protein 5
B02R13C16	2-16-13	Hs~Ref:NM_030574.1~uORF:IOH5593	742	260	612	204	1304	676	2812	231	1371	69	StAR-related lipid transfer protein 5
B02R13C17	2-17-13	Hs~MGC:BC022996.1~uORF:IOH10666	1593	941	1741	985	1212	1654	1750	820	3106	175	SH3 domain-binding protein 2
B02R13C18	2-18-13	Hs~MGC:BC022996.1~uORF:IOH10666	1460	867	1714	938	1202	1600	1688	795	3026	172	SH3 domain-binding protein 2
B02R13C19	2-19-13	Hs~MGC:BC030027.2~uORF:IOH45985	619	595	752	346	496	638	1051	607	215	211	guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O (GNAO1)
B02R13C20	2-20-13	Hs~MGC:BC030027.2~uORF:IOH45985	639	604	737	328	619	676	957	475	794	197	guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O (GNAO1)
B02R13C21	2-21-13	Hs~MGC:BC066922.1~uORF:IOH40100	547	397	588	282	2897	546	1021	441	593	196	Putative protein phosphatase inhibitor 2-like protein 3
B02R13C22	2-22-13	Hs~MGC:BC066922.1~uORF:IOH40100	539	366	645	269	3912	478	1125	448	13	285	Putative protein phosphatase inhibitor 2-like protein 3
B02R14C01	2-1-14	Hs~Ref:NM_199346.1~uORF:IOH22561	692	581	701	517	1068	603	1102	679	624	444	Profilin-4
B02R14C02	2-2-14	Hs~Ref:NM_199346.1~uORF:IOH22561	732	596	741	489	1142	443	1022	585	607	363	Profilin-4
B02R14C03	2-3-14	Hs~Ref:NM_001007025.1~uORF:IOH59792	2182	1893	1665	5424	2208	1260	4290	4517	3716	858	Golgi SNAP receptor complex member 1
B02R14C04	2-4-14	Hs~Ref:NM_001007025.1~uORF:IOH59792	2064	1788	1554	5170	2103	1182	4275	4436	3216	829	Golgi SNAP receptor complex member 1
B02R14C13	2-13-14	Hs~Ref:NM_005923.3~N/A	90	49	185	37	117	63	361	211	99	35	mitogen-activated protein kinase kinase kinase 5 (MAP3K5)
B02R14C14	2-14-14	Hs~Ref:NM_005923.3~N/A	108	49	194	51	77	73	370	175	108	31	mitogen-activated protein kinase kinase kinase 5 (MAP3K5)
B02R14C15	2-15-14	Hs~Ref:NM_032520.3~uORF:IOH59295	530	706	903	363	377	721	1349	663	674	308	N-acetylglucosamine-1-phosphotransferase subunit gamma
B02R14C16	2-16-14	Hs~Ref:NM_032520.3~uORF:IOH59295	521	701	923	352	406	727	1411	495	858	406	N-acetylglucosamine-1-phosphotransferase subunit gamma
B02R14C17	2-17-14	Hs~Ref:NM_138571.3~uORF:IOH54716	173	284	423	829	718	312	430	364	329	72	histidine triad nucleotide binding protein 3 (HINT3), mRNA
B02R14C18	2-18-14	Hs~Ref:NM_138571.3~uORF:IOH54716	319	309	418	791	612	259	412	178	914	106	histidine triad nucleotide binding protein 3 (HINT3), mRNA
B02R14C19	2-19-14	Hs~MGC:BC012040.1~uORF:IOH9723	1219	1176	1187	1428	3807	1956	931	2574	3365	564	DEP domain containing 6 (DEPDC6)
B02R14C20	2-20-14	Hs~MGC:BC012040.1~uORF:IOH9723	1177	1167	1175	1406	3969	1906	1067	2587	3265	535	DEP domain containing 6 (DEPDC6)
B02R14C21	2-21-14	Hs~Ref:NM_014665.1~uORF:IOH9697	557	454	797	329	668	635	675	580	1304	59	leucine rich repeat containing 14 (LRRC14)
B02R14C22	2-22-14	Hs~Ref:NM_014665.1~uORF:IOH9697	533	443	807	343	696	653	632	568	1328	58	leucine rich repeat containing 14 (LRRC14)
B02R15C01	2-1-15	Hs~MGC:BC043247.2~uORF:IOH28730	1625	1332	1818	2592	1386	1989	3600	2537	4766	587	transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) (TLE3)
B02R15C02	2-2-15	Hs~MGC:BC043247.2~uORF:IOH28730	1408	1194	1715	2519	1332	1943	3422	2288	4382	701	transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) (TLE3)
B02R15C03	2-3-15	Hs~Ref:NM_182826.1~uORF:IOH29144	949	514	815	497	486	737	1237	481	1999	332	Scavenger receptor class A member 3
B02R15C04	2-4-15	Hs~Ref:NM_182826.1~uORF:IOH29144	979	475	831	455	518	660	1158	556	1058	313	Scavenger receptor class A member 3
B02R15C05	2-5-15	Hs~MGC:BC022231.1~uORF:IOH10619	1201	695	1115	601	835	968	1097	875	2649	777	Ets2 repressor factor (ERF)
B02R15C06	2-6-15	Hs~MGC:BC022231.1~uORF:IOH10619	1055	737	1074	563	810	960	1099	831	1485	536	Ets2 repressor factor (ERF)
B02R15C09	2-9-15	Hs~Ref:NM_021962.1~uORF:IOH20993	17175	9076	1189	912	894	4188	10811	886	2121	1056	active BCR-related gene (ABR), transcript variant 1
B02R15C10	2-10-15	Hs~Ref:NM_021962.1~uORF:IOH20993	15320	8359	1110	873	861	3959	10263	830	1966	905	active BCR-related gene (ABR), transcript variant 1
B02R15C11	2-11-15	Hs~Ref:NM_052841.2~uORF:IOH27376	821	2257	780	606	866	825	1344	1527	3171	276	testis-specific serine kinase 3 (TSSK3)
B02R15C12	2-12-15	Hs~Ref:NM_052841.2~uORF:IOH27376	805	2100	769	651	863	822	1362	1493	2835	229	testis-specific serine kinase 3 (TSSK3)
B02R15C17	2-17-15	Hs~Ref:NM_020126.3~CAT:PV5216	450	346	478	864	411	521	746	557	2018	111	sphingosine kinase 2 (SPHK2)
B02R15C18	2-18-15	Hs~Ref:NM_020126.3~CAT:PV5216	490	302	426	813	277	479	712	566	2046	126	sphingosine kinase 2 (SPHK2)
B02R15C19	2-19-15	Hs~Ref:NM_005204.2~CAT:PV4313	351	313	400	434	383	344	524	290	647	336	mitogen-activated protein kinase kinase kinase 8 (MAP3K8)
B02R15C20	2-20-15	Hs~Ref:NM_005204.2~CAT:PV4313	378	337	430	391	380	355	525	295	453	337	mitogen-activated protein kinase kinase kinase 8 (MAP3K8)
B02R15C21	2-21-15	Hs~Ref:NM_014840.2~CAT:PV4127	3825	1955	6951	1827	5749	3830	2600	3464	2574	998	NUAK family, SNF1-like kinase, 1 (NUAK1)
B02R15C22	2-22-15	Hs~Ref:NM_014840.2~CAT:PV4127	3763	1947	6853	1633	6042	3850	2500	3474	2630	993	NUAK family, SNF1-like kinase, 1 (NUAK1)
B02R16C03	2-3-16	Hs~Ref:NM_000584.2~CAT_PHC0884	11	8	9	1	94	3	125	2	15	2	Interleukin-8
B02R16C04	2-4-16	Hs~Ref:NM_000584.2~CAT_PHC0884	9	9	10	7	56	0	38	6	20	6	Interleukin-8
B02R16C07	2-7-16	Hs~Ref:NM_015000.1~uORF:IOH11742	1087	568	889	861	637	659	1322	633	1822	188	Serine/threonine-protein kinase 38-like
B02R16C08	2-8-16	Hs~Ref:NM_015000.1~uORF:IOH11742	1231	535	864	733	575	664	1353	652	1775	265	Serine/threonine-protein kinase 38-like
B02R16C09	2-9-16	Hs~Ref:NM_031939.2~uORF:IOH54858	712	557	768	386	414	467	1365	508	814	173	Protein maestro
B02R16C10	2-10-16	Hs~Ref:NM_031939.2~uORF:IOH54858	813	584	769	397	368	488	1417	543	1240	269	Protein maestro
B02R16C11	2-11-16	Hs~Ref:NM_002315.1~uORF:IOH58985	1311	686	1366	626	1053	1500	2259	1054	2461	340	Rhombotin-1
B02R16C12	2-12-16	Hs~Ref:NM_002315.1~uORF:IOH58985	1293	716	1283	676	1015	1426	2158	1023	2416	347	Rhombotin-1
B02R16C13	2-13-16	Hs~Ref:NM_198098.1~uORF:IOH54894	566	378	690	333	548	400	570	433	736	194	Aquaporin-1
B02R16C14	2-14-16	Hs~Ref:NM_198098.1~uORF:IOH54894	496	349	746	339	563	367	497	472	460	255	Aquaporin-1
B02R16C15	2-15-16	Hs~Ref:NM_015929.2~uORF:IOH7138	1212	669	1293	510	1001	784	2589	1110	1319	438	lipoyltransferase 1 (LIPT1), transcript variant 1
B02R16C16	2-16-16	Hs~Ref:NM_015929.2~uORF:IOH7138	1221	641	1217	574	1025	842	2545	939	1330	386	lipoyltransferase 1 (LIPT1), transcript variant 1
B02R16C17	2-17-16	Hs~Ref:NM_014628.2~uORF:IOH5724	1153	390	866	294	621	953	620	584	1746	40	MAD2L1 binding protein (MAD2L1BP), transcript variant 2
B02R16C18	2-18-16	Hs~Ref:NM_014628.2~uORF:IOH5724	2089	364	836	291	582	892	650	548	1756	123	MAD2L1 binding protein (MAD2L1BP), transcript variant 2
B02R16C19	2-19-16	Hs~Ref:NM_207647.1~uORF:IOH21757	2206	843	1870	1048	1430	1779	1273	896	2322	565	fibronectin type III and SPRY domain containing 1-like (FSD1L), transcript variant 1
B02R16C20	2-20-16	Hs~Ref:NM_207647.1~uORF:IOH21757	1918	852	1961	1022	1486	1770	1240	865	2371	612	fibronectin type III and SPRY domain containing 1-like (FSD1L), transcript variant 1
B02R16C21	2-21-16	Hs~Ref:NM_016070.2~uORF:IOH4356	972	590	1409	512	1531	759	1105	648	2101	399	mitochondrial ribosomal protein S23 (MRPS23), nuclear gene encoding mitochondrial protein
B02R16C22	2-22-16	Hs~Ref:NM_016070.2~uORF:IOH4356	978	578	1239	453	1526	709	1106	662	2162	315	mitochondrial ribosomal protein S23 (MRPS23), nuclear gene encoding mitochondrial protein
B02R17C01	2-1-17	Hs~MGC:BC008250.1~uORF:IOH3397	384	476	666	298	2556	887	1004	426	1916	62	ethylmalonic encephalopathy 1 (ETHE1)
B02R17C02	2-2-17	Hs~MGC:BC008250.1~uORF:IOH3397	382	452	651	310	2276	848	993	510	1692	124	ethylmalonic encephalopathy 1 (ETHE1)
B02R17C03	2-3-17	Hs~Ref:NM_005332.2~uORF:IOH11347	169	232	296	205	2101	116	216	1468	444	65	hemoglobin, zeta (HBZ)
B02R17C04	2-4-17	Hs~Ref:NM_005332.2~uORF:IOH11347	209	252	580	530	2036	85	234	1246	435	38	hemoglobin, zeta (HBZ)
B02R17C05	2-5-17	Hs~Ref:NM_002164.1~uORF:IOH11462	562	344	2053	568	756	880	457	278	1332	123	indoleamine-pyrrole 2,3 dioxygenase (INDO)
B02R17C06	2-6-17	Hs~Ref:NM_002164.1~uORF:IOH11462	525	331	1938	289	757	811	477	273	1253	56	indoleamine-pyrrole 2,3 dioxygenase (INDO)
B02R17C07	2-7-17	Hs~MGC:BC012423.1~uORF:IOH11557	387	394	506	297	414	850	621	459	817	216	superoxide dismutase 2, mitochondrial (SOD2)
B02R17C08	2-8-17	Hs~MGC:BC012423.1~uORF:IOH11557	427	407	485	310	434	837	560	494	514	244	superoxide dismutase 2, mitochondrial (SOD2)
B02R17C09	2-9-17	Hs~Ref:NM_032330.1~uORF:IOH7236	558	120	316	109	1367	188	243	985	-6	80	calpain, small subunit 2 (CAPNS2)
B02R17C10	2-10-17	Hs~Ref:NM_032330.1~uORF:IOH7236	3192	106	335	97	1320	183	243	925	-8	-2	calpain, small subunit 2 (CAPNS2)
B02R17C11	2-11-17	Hs~MGC:BC006142.2~uORF:IOH6636	149	183	247	290	303	768	257	170	-3	-2	proteasomal ATPase-associated factor 1 (WDR71)
B02R17C12	2-12-17	Hs~MGC:BC006142.2~uORF:IOH6636	196	200	280	366	281	756	273	191	-2	-1	proteasomal ATPase-associated factor 1 (WDR71)
B02R17C13	2-13-17	Hs~Ref:NM_032882.1~uORF:IOH6958	120	155	225	93	99	202	351	343	169	20	paraneoplastic antigen like 6A (PNMA6A)
B02R17C14	2-14-17	Hs~Ref:NM_032882.1~uORF:IOH6958	125	166	254	154	107	179	357	349	2	20	paraneoplastic antigen like 6A (PNMA6A)
B02R17C15	2-15-17	Hs~Ref:NM_001056.1~uORF:IOH7147	558	217	346	249	418	901	829	580	796	163	sulfotransferase family, cytosolic, 1C, member 2 (SULT1C2), transcript variant 1
B02R17C16	2-16-17	Hs~Ref:NM_001056.1~uORF:IOH7147	1632	212	322	253	409	855	815	358	622	153	sulfotransferase family, cytosolic, 1C, member 2 (SULT1C2), transcript variant 1
B02R17C17	2-17-17	Hs~MGC:BC100888.1~uORF:IOH63431	1089	322	481	270	314	411	609	389	515	91	CMRF35-like molecule 2
B02R17C18	2-18-17	Hs~MGC:BC100888.1~uORF:IOH63431	683	312	495	260	265	423	651	402	951	95	CMRF35-like molecule 2
B02R17C19	2-19-17	Hs~Ref:NM_020134.2~uORF:IOH5686	1387	849	1144	563	1227	967	6119	661	1484	411	Dihydropyrimidinase-related protein 5
B02R17C20	2-20-17	Hs~Ref:NM_020134.2~uORF:IOH5686	1334	818	1148	527	1200	965	5970	935	1471	196	Dihydropyrimidinase-related protein 5
B02R17C21	2-21-17	Hs~MGC:BC009681.1~uORF:IOH9846	446	403	611	297	418	421	935	535	371	149	Interleukin-24
B02R17C22	2-22-17	Hs~MGC:BC009681.1~uORF:IOH9846	491	361	635	283	392	431	942	509	317	125	Interleukin-24
B02R18C01	2-1-18	Hs~Ref:NM_012427.3~uORF:IOH5874	348	311	428	244	516	394	551	417	-19	-2	Kallikrein-5
B02R18C02	2-2-18	Hs~Ref:NM_012427.3~uORF:IOH5874	348	371	450	281	486	428	565	427	0	-5	Kallikrein-5
B02R18C03	2-3-18	Hs~MGC:BC100017.1~uORF:IOH62781	561	452	695	403	508	807	1081	636	957	429	RAN guanine nucleotide release factor, mRNA (cDNA clone MGC:110973 IMAGE:6156156), complete cds
B02R18C04	2-4-18	Hs~MGC:BC100017.1~uORF:IOH62781	572	475	728	390	535	778	952	746	684	365	RAN guanine nucleotide release factor, mRNA (cDNA clone MGC:110973 IMAGE:6156156), complete cds
B02R18C05	2-5-18	Hs~MGC:BC094767.1~uORF:IOH62635	369	374	655	545	296	376	1453	847	1484	124	pyruvate kinase, muscle, mRNA (cDNA clone MGC:104654 IMAGE:5296639), complete cds
B02R18C06	2-6-18	Hs~MGC:BC094767.1~uORF:IOH62635	515	301	676	322	280	370	1520	759	844	136	pyruvate kinase, muscle, mRNA (cDNA clone MGC:104654 IMAGE:5296639), complete cds
B02R18C07	2-7-18	Hs~MGC:BC063681.1~uORF:IOH61524	581	298	1098	261	401	559	2397	762	1053	96	Melanoma-associated antigen 2
B02R18C08	2-8-18	Hs~MGC:BC063681.1~uORF:IOH61524	614	342	1085	328	447	491	2236	795	465	85	Melanoma-associated antigen 2
B02R18C09	2-9-18	Hs~MGC:BC066265.1~uORF:IOH61828	2808	330	355	221	154	200	581	301	434	67	Interleukin-22
B02R18C10	2-10-18	Hs~MGC:BC066265.1~uORF:IOH61828	108	207	411	201	138	209	570	333	367	80	Interleukin-22
B02R18C11	2-11-18	Hs~Ref:NM_005432.2~uORF:IOH4056	867	3536	943	612	600	928	1348	1294	2933	462	X-ray repair complementing defective repair in Chinese hamster cells 3 (XRCC3), transcript variant 2
B02R18C12	2-12-18	Hs~Ref:NM_005432.2~uORF:IOH4056	801	3231	895	613	628	925	1347	1363	2627	483	X-ray repair complementing defective repair in Chinese hamster cells 3 (XRCC3), transcript variant 2
B02R18C13	2-13-18	Hs~Ref:NM_002617.3~uORF:IOH11620	709	523	803	566	542	794	923	706	2334	476	peroxisome biogenesis factor 10 (PEX10), transcript variant 2
B02R18C14	2-14-18	Hs~Ref:NM_002617.3~uORF:IOH11620	670	528	864	531	494	759	996	1013	2154	430	peroxisome biogenesis factor 10 (PEX10), transcript variant 2
B02R18C15	2-15-18	Hs~Ref:NM_014263.2~uORF:IOH14600	873	781	962	621	612	928	1390	975	2957	553	YME1-like 1 (S. cerevisiae) (YME1L1), nuclear gene encoding mitochondrial protein, transcript variant 3
B02R18C16	2-16-18	Hs~Ref:NM_014263.2~uORF:IOH14600	968	798	967	637	585	837	1333	861	2880	724	YME1-like 1 (S. cerevisiae) (YME1L1), nuclear gene encoding mitochondrial protein, transcript variant 3
B02R18C17	2-17-18	Hs~MGC:BC030783.1~uORF:IOH22247	966	664	762	570	567	752	963	744	2187	443	glycerol-3-phosphate acyltransferase, mitochondrial (GPAM)
B02R18C18	2-18-18	Hs~MGC:BC030783.1~uORF:IOH22247	950	537	726	483	29	651	919	756	2074	13	glycerol-3-phosphate acyltransferase, mitochondrial (GPAM)
B02R18C19	2-19-18	Hs~MGC:BC067873.1~uORF:IOH62500	1727	473	508	672	467	578	636	399	965	-57	Annexin-2 receptor
B02R18C20	2-20-18	Hs~MGC:BC067873.1~uORF:IOH62500	1615	447	545	679	521	531	644	485	676	280	Annexin-2 receptor
B02R18C21	2-21-18	Hs~Ref:NM_001025100.1~uORF:IOH61586	1209	693	1511	1598	630	808	1369	1542	1742	860	Myelin basic protein
B02R18C22	2-22-18	Hs~Ref:NM_001025100.1~uORF:IOH61586	1144	681	1508	1533	621	806	1330	1641	1790	532	Myelin basic protein
B02R19C03	2-3-19	Hs~MGC:BC063390.1~uORF:IOH61531	1854	1217	1627	3614	1726	2174	2690	2942	7134	582	hypothetical protein LOC51233, mRNA (cDNA clone MGC:75009 IMAGE:5170001), complete cds.
B02R19C04	2-4-19	Hs~MGC:BC063390.1~uORF:IOH61531	1655	1179	1542	2676	1688	2098	2417	2830	6090	763	hypothetical protein LOC51233, mRNA (cDNA clone MGC:75009 IMAGE:5170001), complete cds.
B02R19C05	2-5-19	Hs~MGC:BC032654.1~uORF:IOH21978	312	290	294	162	225	261	414	1020	170	80	USO1 homolog, vesicle docking protein (yeast) (VDP)
B02R19C06	2-6-19	Hs~MGC:BC032654.1~uORF:IOH21978	323	250	295	143	225	265	434	1055	241	78	USO1 homolog, vesicle docking protein (yeast) (VDP)
B02R19C07	2-7-19	Hs~Ref:NM_006067.3~uORF:IOH3988	367	146	353	58	1191	86	651	156	1615	28	COX4 neighbor (COX4NB)
B02R19C08	2-8-19	Hs~Ref:NM_006067.3~uORF:IOH3988	348	174	382	90	1082	65	213	186	1718	24	COX4 neighbor (COX4NB)
B02R19C09	2-9-19	Hs~Ref:NM_020381.2~uORF:IOH26178	1051	1071	899	974	1144	626	842	1344	1333	1176	prenyl (decaprenyl) diphosphate synthase, subunit 2 (PDSS2)
B02R19C10	2-10-19	Hs~Ref:NM_020381.2~uORF:IOH26178	1225	1053	859	1034	1066	639	844	1290	1275	1218	prenyl (decaprenyl) diphosphate synthase, subunit 2 (PDSS2)
B02R19C11	2-11-19	Hs~Ref:NM_203454.1~uORF:IOH10788	129	189	314	244	154	359	326	259	309	72	Putative C->U-editing enzyme APOBEC-4
B02R19C12	2-12-19	Hs~Ref:NM_203454.1~uORF:IOH10788	275	300	318	165	200	302	308	243	319	62	Putative C->U-editing enzyme APOBEC-4
B02R19C13	2-13-19	Hs~Ref:NM_181314.1~uORF:IOH58938	681	544	878	451	471	810	1158	806	1557	223	Tafazzin
B02R19C14	2-14-19	Hs~Ref:NM_181314.1~uORF:IOH58938	703	559	866	481	554	792	1272	846	1604	249	Tafazzin
B02R19C15	2-15-19	Hs~Ref:NM_001966.2~uORF:IOH62346	3818	1928	6970	4500	1123	4424	14651	8756	2779	1396	Peroxisomal bifunctional enzyme
B02R19C16	2-16-19	Hs~Ref:NM_001966.2~uORF:IOH62346	3686	1802	6768	4120	1096	4603	14455	8402	2815	1546	Peroxisomal bifunctional enzyme
B02R19C17	2-17-19	Hs~MGC:BC066904.1~uORF:IOH61475	2294	963	634	759	1035	764	1133	771	12961	411	Ras-related protein Rab-34
B02R19C18	2-18-19	Hs~MGC:BC066904.1~uORF:IOH61475	2165	786	594	705	928	752	1079	730	12382	301	Ras-related protein Rab-34
B02R19C19	2-19-19	Hs~MGC:BC085196.1~uORF:IOH63112	577	436	577	353	463	586	893	583	1173	317	Mitogen-activated protein kinase 13
B02R19C20	2-20-19	Hs~MGC:BC085196.1~uORF:IOH63112	534	396	547	385	440	561	929	650	926	280	Mitogen-activated protein kinase 13
B02R19C21	2-21-19	Hs~Ref:NM_002870.1~uORF:IOH3059	451	400	594	373	371	-1	-6	960	-7	-4	RAB13, member RAS oncogene family (RAB13)
B02R19C22	2-22-19	Hs~Ref:NM_002870.1~uORF:IOH3059	455	361	551	389	395	3	-9	1	-5	-3	RAB13, member RAS oncogene family (RAB13)
B02R20C01	2-1-20	Hs~Ref:NM_024047.2~uORF:IOH4171	333	345	485	293	314	1137	499	424	997	35	nudix (nucleoside diphosphate linked moiety X)-type motif 9 (NUDT9), transcript variant 1
B02R20C02	2-2-20	Hs~Ref:NM_024047.2~uORF:IOH4171	360	367	445	292	319	1086	631	453	890	229	nudix (nucleoside diphosphate linked moiety X)-type motif 9 (NUDT9), transcript variant 1
B02R20C05	2-5-20	Hs~Ref:NM_003792.1~uORF:IOH10852	1232	611	1288	622	584	1166	2307	2233	2578	283	endothelial differentiation-related factor 1 (EDF1), transcript variant alpha
B02R20C06	2-6-20	Hs~Ref:NM_003792.1~uORF:IOH10852	1295	579	1174	516	563	1186	2170	2231	2405	283	endothelial differentiation-related factor 1 (EDF1), transcript variant alpha
B02R20C07	2-7-20	Hs~MGC:BC033495.1~uORF:IOH27372	1487	1252	1672	1855	1300	2340	1964	1030	2442	341	ankyrin repeat and MYND domain containing 1 (ANKMY1)
B02R20C08	2-8-20	Hs~MGC:BC033495.1~uORF:IOH27372	1381	1199	1662	1924	1132	2335	2176	960	2438	-40	ankyrin repeat and MYND domain containing 1 (ANKMY1)
B02R20C09	2-9-20	Hs~MGC:BC050709.1~uORF:IOH27039	-3	6	-2	-4	1805	9	6	-6	1	-8	Archaemetzincin-2
B02R20C10	2-10-20	Hs~MGC:BC050709.1~uORF:IOH27039	-3	-4	-2	0	1663	0	1	-1	1	-3	Archaemetzincin-2
B02R20C11	2-11-20	Hs~Ref:NM_002064.1~uORF:IOH58942	750	216	331	183	182	2	2	-6	-3	-2	Glutaredoxin-1
B02R20C12	2-12-20	Hs~Ref:NM_002064.1~uORF:IOH58942	279	198	333	169	228	-3	17	276	-6	-1	Glutaredoxin-1
B02R20C13	2-13-20	Hs~MGC:BC070058.1~uORF:IOH61671	142	150	251	182	130	156	276	212	105	16	Quinone oxidoreductase
B02R20C14	2-14-20	Hs~MGC:BC070058.1~uORF:IOH61671	160	147	287	147	115	122	321	257	28	28	Quinone oxidoreductase
B03R02C11	3-11-2	Hs~MGC:BC034713.1~uORF:IOH22181	1259	691	1342	619	681	1033	1655	964	1610	410	DnaJ (Hsp40) homolog, subfamily C, member 10 (DNAJC10)
B03R02C12	3-12-2	Hs~MGC:BC034713.1~uORF:IOH22181	1289	717	1392	636	654	762	1700	956	1893	395	DnaJ (Hsp40) homolog, subfamily C, member 10 (DNAJC10)
B03R02C13	3-13-2	Hs~Ref:NM_000905.1~uORF:IOH22539	845	581	1079	594	796	490	1962	1038	1600	354	neuropeptide Y (NPY)
B03R02C14	3-14-2	Hs~Ref:NM_000905.1~uORF:IOH22539	928	565	1134	584	765	626	2066	1026	1475	361	neuropeptide Y (NPY)
B03R02C15	3-15-2	Hs~Ref:NM_005031.2~uORF:IOH21828	853	794	1637	623	678	708	1904	1114	2100	428	FXYD domain containing ion transport regulator 1 (phospholemman) (FXYD1), transcript variant a
B03R02C16	3-16-2	Hs~Ref:NM_005031.2~uORF:IOH21828	805	820	1641	592	669	635	1545	1153	2014	370	FXYD domain containing ion transport regulator 1 (phospholemman) (FXYD1), transcript variant a
B03R02C17	3-17-2	Hs~MGC:BC029439.1~uORF:IOH23158	1259	1660	2664	869	1247	959	3232	1671	2496	543	zinc finger, MYM-type 6 (ZMYM6)
B03R02C18	3-18-2	Hs~MGC:BC029439.1~uORF:IOH23158	1468	1724	2806	886	1240	1010	3360	2432	2552	581	zinc finger, MYM-type 6 (ZMYM6)
B03R02C19	3-19-2	Hs~MGC:BC033629.1~uORF:IOH21894	975	1196	1947	477	664	292	1170	529	2411	430	chromosome 20 open reading frame 77 (C20orf77)
B03R02C20	3-20-2	Hs~MGC:BC033629.1~uORF:IOH21894	836	1010	1800	510	668	397	643	272	2388	417	chromosome 20 open reading frame 77 (C20orf77)
B03R02C21	3-21-2	Hs~MGC:BC030557.1~uORF:IOH21719	1840	1177	1212	747	2767	992	48796	1450	4354	459	chromosome 10 open reading frame 118 (C10orf118)
B03R02C22	3-22-2	Hs~MGC:BC030557.1~uORF:IOH21719	1828	1117	1246	763	2628	958	50155	1390	4288	444	chromosome 10 open reading frame 118 (C10orf118)
B03R03C01	3-1-3	Hs~MGC:BC030524.1~uORF:IOH21689	781	772	1058	987	1300	523	742	720	1450	282	claudin 19 (CLDN19)
B03R03C02	3-2-3	Hs~MGC:BC030524.1~uORF:IOH21689	746	784	1106	961	1483	524	756	721	1456	307	claudin 19 (CLDN19)
B03R03C03	3-3-3	Hs~MGC:BC033827.1~uORF:IOH21889	566	617	1521	360	1992	543	1300	590	1115	285	major histocompatibility complex, class II, DR beta 1 (HLA-DRB1)
B03R03C04	3-4-3	Hs~MGC:BC033827.1~uORF:IOH21889	543	551	1445	349	2400	529	1268	549	1072	287	major histocompatibility complex, class II, DR beta 1 (HLA-DRB1)
B03R03C05	3-5-3	Hs~Ref:NM_004475.1~uORF:IOH14024	455	417	662	337	2749	511	427	383	1040	317	flotillin 2 (FLOT2)
B03R03C06	3-6-3	Hs~Ref:NM_004475.1~uORF:IOH14024	486	469	732	337	2801	530	543	420	998	305	flotillin 2 (FLOT2)
B03R03C07	3-7-3	Hs~Ref:NM_003192.1~uORF:IOH14757	1609	872	2846	755	2323	1911	9439	2490	2690	604	tubulin folding cofactor C (TBCC)
B03R03C08	3-8-3	Hs~Ref:NM_003192.1~uORF:IOH14757	1494	860	2808	721	2122	1789	9315	2382	655	595	tubulin folding cofactor C (TBCC)
B03R03C09	3-9-3	Hs~Ref:NM_001124.1~uORF:IOH13846	1018	1095	2410	515	623	915	4133	1680	-272	481	adrenomedullin (ADM)
B03R03C10	3-10-3	Hs~Ref:NM_001124.1~uORF:IOH13846	1044	1101	2305	534	573	907	4105	1562	1276	382	adrenomedullin (ADM)
B03R03C11	3-11-3	Hs~MGC:BC013352.1~uORF:IOH14736	5638	2544	3266	1696	4485	2385	4634	3659	3103	892	HpaII tiny fragments locus 9c protein
B03R03C12	3-12-3	Hs~MGC:BC013352.1~uORF:IOH14736	5423	2472	3179	1609	4081	2470	4736	3595	3151	943	HpaII tiny fragments locus 9c protein
B03R03C13	3-13-3	Hs~Ref:NM_003562.2~uORF:IOH10089	978	731	1160	539	441	705	1341	660	1725	363	solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 (SLC25A11)
B03R03C14	3-14-3	Hs~Ref:NM_003562.2~uORF:IOH10089	1021	651	1200	509	473	655	1257	694	1614	389	solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 (SLC25A11)
B03R03C15	3-15-3	Hs~MGC:BC014928.1~uORF:IOH10102	1374	1072	1846	886	1079	1449	4302	962	2367	529	MYC-induced nuclear antigen
B03R03C16	3-16-3	Hs~MGC:BC014928.1~uORF:IOH10102	1355	1113	1849	871	1097	1323	4324	942	2233	546	MYC-induced nuclear antigen
B03R03C17	3-17-3	Hs~Ref:NM_003776.1~uORF:IOH9812	580	548	824	393	339	604	839	579	927	416	mitochondrial ribosomal protein L40 (MRPL40), nuclear gene encoding mitochondrial protein
B03R03C18	3-18-3	Hs~Ref:NM_003776.1~uORF:IOH9812	589	633	777	417	398	662	888	821	961	432	mitochondrial ribosomal protein L40 (MRPL40), nuclear gene encoding mitochondrial protein
B03R03C19	3-19-3	Hs~Ref:NM_002796.1~uORF:IOH6865	1385	1180	1509	584	1106	1438	1093	1100	1852	554	proteasome (prosome, macropain) subunit, beta type, 4 (PSMB4)
B03R03C20	3-20-3	Hs~Ref:NM_002796.1~uORF:IOH6865	1291	1024	1502	597	1195	1384	2072	909	1783	533	proteasome (prosome, macropain) subunit, beta type, 4 (PSMB4)
B03R03C21	3-21-3	Hs~Ref:NM_138787.1~uORF:IOH9947	1310	3461	2739	1149	1728	978	4532	728	2203	401	Uncharacterized protein C11orf74
B03R03C22	3-22-3	Hs~Ref:NM_138787.1~uORF:IOH9947	1392	3594	2646	1095	1733	959	4298	710	2113	438	Uncharacterized protein C11orf74
B03R04C01	3-1-4	Hs~MGC:BC007654.1~uORF:IOH5936	0	-2	-2	1179	3254	1421	2513	1325	3658	795	NIF3 NGG1 interacting factor 3-like 1 (S. pombe) (NIF3L1)
B03R04C02	3-2-4	Hs~MGC:BC007654.1~uORF:IOH5936	3	0	0	1281	2905	1413	3141	1289	3483	804	NIF3 NGG1 interacting factor 3-like 1 (S. pombe) (NIF3L1)
B03R04C03	3-3-4	Hs~Ref:NM_006460.1~uORF:IOH5964	1911	2426	2688	2828	2343	1383	3354	1600	5535	627	hexamethylene bis-acetamide inducible 1 (HEXIM1)
B03R04C04	3-4-4	Hs~Ref:NM_006460.1~uORF:IOH5964	1947	2456	2665	2718	1466	1412	3368	1689	5483	606	hexamethylene bis-acetamide inducible 1 (HEXIM1)
B03R04C05	3-5-4	Hs~MGC:BC010850.1~uORF:IOH9969	1372	1138	1628	786	1711	1249	1718	992	2645	687	HEAT repeat containing 2 (HEATR2)
B03R04C06	3-6-4	Hs~MGC:BC010850.1~uORF:IOH9969	1342	1203	1660	765	1944	1197	1715	1073	2492	713	HEAT repeat containing 2 (HEATR2)
B03R04C07	3-7-4	Hs~MGC:BC011924.1~uORF:IOH12682	13126	10016	7302	7780	9931	4856	13061	6228	9415	10321	unkempt homolog (Drosophila)-like (UNKL)
B03R04C08	3-8-4	Hs~MGC:BC011924.1~uORF:IOH12682	12356	9558	7030	7497	10928	4737	13052	6564	11050	9119	unkempt homolog (Drosophila)-like (UNKL)
B03R04C09	3-9-4	Hs~Ref:NM_004838.2~uORF:IOH12410	4479	3921	3157	1693	2052	5662	4922	2200	4914	1062	homer homolog 3 (Drosophila) (HOMER3)
B03R04C10	3-10-4	Hs~Ref:NM_004838.2~uORF:IOH12410	4190	3910	3090	1709	1991	5124	4836	2129	4765	978	homer homolog 3 (Drosophila) (HOMER3)
B03R04C11	3-11-4	Hs~Ref:NM_030815.1~uORF:IOH12796	1066	2348	1396	759	1155	788	2228	789	1841	463	p53 and DNA damage regulated 1 (PDRG1)
B03R04C12	3-12-4	Hs~Ref:NM_030815.1~uORF:IOH12796	1041	2193	1390	609	1105	768	2338	794	1821	461	p53 and DNA damage regulated 1 (PDRG1)
B03R04C13	3-13-4	Hs~Ref:NM_016836.1~uORF:IOH12909	1974	1844	2476	1777	1682	1864	3812	1363	4242	1096	RNA binding motif, single stranded interacting protein 1 (RBMS1), transcript variant 1
B03R04C14	3-14-4	Hs~Ref:NM_016836.1~uORF:IOH12909	1975	1670	2356	1780	1697	1815	3902	1439	4052	1131	RNA binding motif, single stranded interacting protein 1 (RBMS1), transcript variant 1
B03R04C15	3-15-4	Hs~Ref:NM_021117.1~uORF:IOH27709	1267	1314	1246	1278	680	740	1869	1116	1933	424	cryptochrome 2 (photolyase-like) (CRY2)
B03R04C16	3-16-4	Hs~Ref:NM_021117.1~uORF:IOH27709	1185	1390	1211	1244	720	815	1690	849	1901	411	cryptochrome 2 (photolyase-like) (CRY2)
B03R04C17	3-17-4	Hs~MGC:BC031689.1~uORF:IOH21504	803	627	1653	388	2096	928	933	1037	2267	252	ret finger protein-like 3 (RFPL3)
B03R04C18	3-18-4	Hs~MGC:BC031689.1~uORF:IOH21504	701	646	1578	392	2099	908	940	1042	2270	284	ret finger protein-like 3 (RFPL3)
B03R04C19	3-19-4	Hs~Ref:NM_021925.1~uORF:IOH13298	1748	1441	549	289	393	397	804	385	1223	182	chromosome 2 open reading frame 43 (C2orf43)
B03R04C20	3-20-4	Hs~Ref:NM_021925.1~uORF:IOH13298	1514	1422	551	282	368	457	837	387	1251	164	chromosome 2 open reading frame 43 (C2orf43)
B03R04C21	3-21-4	Hs~Ref:NM_016150.3~uORF:IOH21720	437	498	709	231	327	195	592	443	728	314	ankyrin repeat and SOCS box-containing 2 (ASB2)
B03R04C22	3-22-4	Hs~Ref:NM_016150.3~uORF:IOH21720	418	392	727	302	272	64	622	426	664	307	ankyrin repeat and SOCS box-containing 2 (ASB2)
B03R05C01	3-1-5	Hs~MGC:BC012266.2~uORF:IOH10538	648	386	742	350	554	532	1293	1106	1509	299	ATG12 autophagy related 12 homolog (S. cerevisiae) (ATG12)
B03R05C02	3-2-5	Hs~MGC:BC012266.2~uORF:IOH10538	648	401	773	357	1493	548	1005	1160	1390	194	ATG12 autophagy related 12 homolog (S. cerevisiae) (ATG12)
B03R05C03	3-3-5	Hs~Ref:NM_003621.1~uORF:IOH10784	4728	4660	2143	1111	2692	2164	19399	2437	5476	1202	PTPRF interacting protein, binding protein 2 (liprin beta 2) (PPFIBP2)
B03R05C04	3-4-5	Hs~Ref:NM_003621.1~uORF:IOH10784	4467	3833	1941	1072	2353	1967	19029	2371	5226	1129	PTPRF interacting protein, binding protein 2 (liprin beta 2) (PPFIBP2)
B03R05C05	3-5-5	Hs~MGC:BC035031.1~uORF:IOH27140	979	490	670	520	537	684	4777	1027	932	104	GA binding protein transcription factor, alpha subunit 60kDa (GABPA)
B03R05C06	3-6-5	Hs~MGC:BC035031.1~uORF:IOH27140	972	549	640	496	852	659	2908	926	1003	101	GA binding protein transcription factor, alpha subunit 60kDa (GABPA)
B03R05C07	3-7-5	Hs~Ref:NM_001022.3~uORF:IOH4572	7178	7636	37364	2650	2442	3584	19126	3502	6027	3023	ribosomal protein S19 (RPS19)
B03R05C08	3-8-5	Hs~Ref:NM_001022.3~uORF:IOH4572	6335	7043	34695	2455	2304	3846	18762	3439	5187	2820	ribosomal protein S19 (RPS19)
B03R05C09	3-9-5	Hs~Ref:NM_032331.1~uORF:IOH10505	1000	794	1015	517	977	546	890	903	1561	493	endothelin converting enzyme 2 (ECE2), transcript variant 3
B03R05C10	3-10-5	Hs~Ref:NM_032331.1~uORF:IOH10505	1021	735	995	562	1098	550	956	882	2128	470	endothelin converting enzyme 2 (ECE2), transcript variant 3
B03R05C11	3-11-5	Hs~MGC:BC021578.1~uORF:IOH13563	1310	1136	1481	985	1806	1059	1954	1019	3554	657	chloride channel 2 (CLCN2)
B03R05C12	3-12-5	Hs~MGC:BC021578.1~uORF:IOH13563	1335	1108	1364	799	1608	1012	1928	1051	2886	711	chloride channel 2 (CLCN2)
B03R05C13	3-13-5	Hs~Ref:NM_001002256.1~uORF:IOH41094	451	428	760	374	247	366	791	568	747	244	ATP synthase lipid-binding protein, mitochondrial
B03R05C14	3-14-5	Hs~Ref:NM_001002256.1~uORF:IOH41094	453	429	742	368	358	445	766	446	697	228	ATP synthase lipid-binding protein, mitochondrial
B03R05C15	3-15-5	Hs~MGC:BC024267.1~uORF:IOH13225	468	372	579	276	229	504	956	843	620	196	TNF receptor-associated factor 7 (TRAF7)
B03R05C16	3-16-5	Hs~MGC:BC024267.1~uORF:IOH13225	475	526	563	281	270	12	1135	644	657	236	TNF receptor-associated factor 7 (TRAF7)
B03R05C17	3-17-5	Hs~MGC:NM_182715.1~uORF:IOH11372	1710	1527	2278	1032	1382	1564	2709	1448	3852	976	synaptophysin-like 1 (SYPL1), transcript variant 2
B03R05C18	3-18-5	Hs~MGC:NM_182715.1~uORF:IOH11372	1821	1568	2121	1081	1313	1513	2746	1452	4042	997	synaptophysin-like 1 (SYPL1), transcript variant 2
B03R05C19	3-19-5	Hs~MGC:NM_182621.1~uORF:IOH28035	2241	1553	2622	1010	1937	1753	2146	1535	4086	805	hypothetical protein MGC52498 (MGC52498)
B03R05C20	3-20-5	Hs~MGC:NM_182621.1~uORF:IOH28035	2562	1545	2628	1106	1975	1795	2049	1579	4217	786	hypothetical protein MGC52498 (MGC52498)
B03R05C21	3-21-5	Hs~Ref:NM_017614.3~uORF:IOH12877	3887	3728	5422	4095	2642	2138	4226	3159	4017	1898	betaine-homocysteine methyltransferase 2 (BHMT2)
B03R05C22	3-22-5	Hs~Ref:NM_017614.3~uORF:IOH12877	4111	3260	5490	3918	2719	2125	4593	3170	4063	1753	betaine-homocysteine methyltransferase 2 (BHMT2)
B03R06C01	3-1-6	Hs~MGC:BC031821.1~uORF:IOH22188	1673	1132	1586	1209	1880	1535	2263	1477	5917	715	Secernin-3
B03R06C02	3-2-6	Hs~MGC:BC031821.1~uORF:IOH22188	1663	1324	1522	1180	3628	1392	2107	1452	5490	708	Secernin-3
B03R06C03	3-3-6	Hs~MGC:BC017020.1~uORF:IOH10629	1116	1690	1048	6965	957	2514	3056	1106	6479	3644	single-stranded DNA binding protein 2 (SSBP2)
B03R06C04	3-4-6	Hs~MGC:BC017020.1~uORF:IOH10629	1094	1521	1022	6903	1126	2601	3574	1087	6455	3464	single-stranded DNA binding protein 2 (SSBP2)
B03R06C05	3-5-6	Hs~Ref:NM_006805.2~uORF:IOH10215	1218	821	1016	577	1258	1215	6279	682	1356	371	heterogeneous nuclear ribonucleoprotein A0 (HNRNPA0)
B03R06C06	3-6-6	Hs~Ref:NM_006805.2~uORF:IOH10215	1231	894	1064	622	933	720	2651	665	1454	413	heterogeneous nuclear ribonucleoprotein A0 (HNRNPA0)
B03R06C07	3-7-6	Hs~MGC:NM_015161.1~uORF:IOH11244	918	1172	1146	530	1007	805	969	892	1750	395	ADP-ribosylation factor-like 6 interacting protein 1 (ARL6IP1)
B03R06C08	3-8-6	Hs~MGC:NM_015161.1~uORF:IOH11244	912	1128	1087	486	942	568	1036	749	1663	369	ADP-ribosylation factor-like 6 interacting protein 1 (ARL6IP1)
B03R06C09	3-9-6	Hs~Ref:NM_003630.1~uORF:IOH10847	477	421	624	331	367	926	817	379	390	270	peroxisomal biogenesis factor 3 (PEX3)
B03R06C10	3-10-6	Hs~Ref:NM_003630.1~uORF:IOH10847	495	437	601	298	199	417	764	450	249	258	peroxisomal biogenesis factor 3 (PEX3)
B03R06C11	3-11-6	Hs~Ref:NM_002128.2~uORF:IOH2937	1631	902	1128	726	777	1312	1935	1073	1686	403	high-mobility group box 1 (HMGB1)
B03R06C12	3-12-6	Hs~Ref:NM_002128.2~uORF:IOH2937	1608	941	1111	633	866	1281	1772	1229	1679	337	high-mobility group box 1 (HMGB1)
B03R06C13	3-13-6	Hs~Ref:NM_080598.2~uORF:IOH3681	1432	1020	1462	555	933	966	1981	720	1473	444	HLA-B associated transcript 1 (BAT1), transcript variant 2
B03R06C14	3-14-6	Hs~Ref:NM_080598.2~uORF:IOH3681	1473	973	1415	536	721	1106	1654	683	1632	424	HLA-B associated transcript 1 (BAT1), transcript variant 2
B03R06C15	3-15-6	Hs~Ref:NM_020200.3~uORF:IOH3385	1061	795	1742	621	356	1401	2154	826	1816	347	phosphoribosyl transferase domain containing 1 (PRTFDC1)
B03R06C16	3-16-6	Hs~Ref:NM_020200.3~uORF:IOH3385	1011	899	1766	650	761	1301	2152	744	1737	331	phosphoribosyl transferase domain containing 1 (PRTFDC1)
B03R06C17	3-17-6	Hs~Ref:NM_001568.1~uORF:IOH3799	571	672	746	395	368	526	705	470	828	385	eukaryotic translation initiation factor 3, subunit E (EIF3E)
B03R06C18	3-18-6	Hs~Ref:NM_001568.1~uORF:IOH3799	597	689	721	367	393	510	795	473	878	369	eukaryotic translation initiation factor 3, subunit E (EIF3E)
B03R06C19	3-19-6	Hs~Ref:NM_003372.3~uORF:IOH26968	949	918	1275	508	1255	1427	1613	623	3242	609	von Hippel-Lindau binding protein 1 (VBP1)
B03R06C20	3-20-6	Hs~Ref:NM_003372.3~uORF:IOH26968	929	859	1313	460	1168	1464	1660	638	2779	653	von Hippel-Lindau binding protein 1 (VBP1)
B03R06C21	3-21-6	Hs~MGC:BC046131.1~uORF:IOH26912	915	514	762	516	359	886	860	467	741	252	COMM domain containing 2 (COMMD2)
B03R06C22	3-22-6	Hs~MGC:BC046131.1~uORF:IOH26912	632	475	680	372	372	264	855	420	877	243	COMM domain containing 2 (COMMD2)
B03R07C01	3-1-7	Hs~MGC:BC041668.1~uORF:IOH26143	935	1547	726	614	530	695	1304	1399	1595	207	receptor-interacting serine-threonine kinase 3 (RIPK3)
B03R07C02	3-2-7	Hs~MGC:BC041668.1~uORF:IOH26143	841	1703	711	520	537	684	1311	1091	1665	308	receptor-interacting serine-threonine kinase 3 (RIPK3)
B03R07C03	3-3-7	Hs~MGC:BC048095.1~uORF:IOH26751	771	656	830	386	2890	516	918	550	1300	409	HRAS-like suppressor (HRASLS)
B03R07C04	3-4-7	Hs~MGC:BC048095.1~uORF:IOH26751	743	680	801	382	1341	529	934	689	1358	376	HRAS-like suppressor (HRASLS)
B03R07C05	3-5-7	Hs~MGC:BC011418.1~uORF:IOH9706	515	529	696	335	304	613	828	451	924	232	retinol saturase (all-trans-retinol 13,14-reductase) (RETSAT)
B03R07C06	3-6-7	Hs~MGC:BC011418.1~uORF:IOH9706	365	560	647	348	679	775	849	442	916	308	retinol saturase (all-trans-retinol 13,14-reductase) (RETSAT)
B03R07C07	3-7-7	Hs~MGC:BC023006.1~uORF:IOH22358	623	1200	677	640	876	1836	912	517	902	340	Heat shock protein HSP 90-alpha
B03R07C08	3-8-7	Hs~MGC:BC023006.1~uORF:IOH22358	579	1111	620	639	920	1935	907	601	879	335	Heat shock protein HSP 90-alpha
B03R07C09	3-9-7	Hs~MGC:BC016312.1~uORF:IOH27887	1910	924	1398	605	1289	1398	4227	1039	1801	352	chromosome 15 open reading frame 15 (C15orf15)
B03R07C10	3-10-7	Hs~MGC:BC016312.1~uORF:IOH27887	2033	958	1416	673	1395	1437	4479	895	1897	379	chromosome 15 open reading frame 15 (C15orf15)
B03R07C11	3-11-7	Hs~MGC:BC032108.1~uORF:IOH23020	1600	618	801	636	863	1005	1137	820	1396	330	vacuolar protein sorting 52 homolog (S. cerevisiae) (VPS52)
B03R07C12	3-12-7	Hs~MGC:BC032108.1~uORF:IOH23020	1616	580	848	451	682	923	1165	713	1533	316	vacuolar protein sorting 52 homolog (S. cerevisiae) (VPS52)
B03R07C15	3-15-7	Hs~Ref:NM_017542.3~uORF:IOH43680	21753	1774	3648	960	1395	1123	1984	1341	6120	533	pogo transposable element with KRAB domain (POGK)
B03R07C16	3-16-7	Hs~Ref:NM_017542.3~uORF:IOH43680	21099	1707	3449	985	1289	1128	1982	1452	8792	532	pogo transposable element with KRAB domain (POGK)
B03R07C17	3-17-7	Hs~Ref:NM_139068.1~uORF:IOH42152	1804	1106	2532	5129	1635	2904	1647	1228	7547	672	mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a1
B03R07C18	3-18-7	Hs~Ref:NM_139068.1~uORF:IOH42152	1626	1109	2558	5024	1816	2914	1679	1181	6763	673	mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a1
B03R07C21	3-21-7	Hs~Ref:NM_016077.1~uORF:IOH3153	1452	2033	3199	2672	1994	17056	6027	6485	4296	1390	peptidyl-tRNA hydrolase 2 (PTRH2), nuclear gene encoding mitochondrial protein
B03R07C22	3-22-7	Hs~Ref:NM_016077.1~uORF:IOH3153	1556	1896	3144	2386	1930	16129	6213	6709	4331	1379	peptidyl-tRNA hydrolase 2 (PTRH2), nuclear gene encoding mitochondrial protein
B03R08C01	3-1-8	Hs~Ref:NM_031469.1~uORF:IOH43495	2466	1385	2772	2711	1164	3205	1625	4352	3240	787	SH3 domain binding glutamic acid-rich protein like 2 (SH3BGRL2)
B03R08C02	3-2-8	Hs~Ref:NM_031469.1~uORF:IOH43495	2473	1493	2784	2483	1425	3215	1666	4573	3471	730	SH3 domain binding glutamic acid-rich protein like 2 (SH3BGRL2)
B03R08C03	3-3-8	Hs~Ref:NM_000609.3~uORF:IOH40945	1364	1094	1428	707	3847	903	1915	902	2321	518	chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) (CXCL12), transcript variant 2
B03R08C04	3-4-8	Hs~Ref:NM_000609.3~uORF:IOH40945	1415	1059	1506	711	2420	889	1861	910	2100	560	chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) (CXCL12), transcript variant 2
B03R08C05	3-5-8	Hs~Ref:NM_003868.1~uORF:IOH42157	11174	15136	7182	10660	10791	5190	9460	7990	9162	10541	fibroblast growth factor 16 (FGF16)
B03R08C06	3-6-8	Hs~Ref:NM_003868.1~uORF:IOH42157	11699	14315	7245	10649	11582	5429	9606	8317	8619	10862	fibroblast growth factor 16 (FGF16)
B03R08C07	3-7-8	Hs~MGC:BC026070.2~uORF:IOH11290	2802	1497	2274	1635	3696	5085	2423	2675	2467	793	tubby like protein 2 (TULP2)
B03R08C08	3-8-8	Hs~MGC:BC026070.2~uORF:IOH11290	2701	1464	2304	1691	3209	5230	2356	2570	2372	725	tubby like protein 2 (TULP2)
B03R08C09	3-9-8	Hs~MGC:BC007742.1~uORF:IOH6517	1627	2061	2350	12006	2795	2472	3526	65483	4295	636	exosome component 5 (EXOSC5)
B03R08C10	3-10-8	Hs~MGC:BC007742.1~uORF:IOH6517	1548	2067	2468	12423	2544	2359	3549	65485	4369	621	exosome component 5 (EXOSC5)
B03R08C11	3-11-8	Hs~Ref:NM_006142.1~uORF:IOH2986	1125	4691	1507	857	650	963	1328	2513	2078	626	stratifin (SFN)
B03R08C12	3-12-8	Hs~Ref:NM_006142.1~uORF:IOH2986	1115	4595	1502	564	959	929	1317	2369	2007	632	stratifin (SFN)
B03R08C13	3-13-8	Hs~MGC:BC008364.1~uORF:IOH5969	1791	1570	1468	1175	1204	1232	3309	899	2173	606	heterogeneous nuclear ribonucleoprotein C (C1/C2) (HNRPC)
B03R08C14	3-14-8	Hs~MGC:BC008364.1~uORF:IOH5969	1861	1560	1495	1169	1318	1240	3208	1069	2189	601	heterogeneous nuclear ribonucleoprotein C (C1/C2) (HNRPC)
B03R08C15	3-15-8	Hs~MGC:BC033795.1~uORF:IOH21810	674	580	865	406	584	581	1046	424	891	325	tetratricopeptide repeat domain 30B (TTC30B)
B03R08C16	3-16-8	Hs~MGC:BC033795.1~uORF:IOH21810	664	693	782	407	561	534	1080	458	1294	347	tetratricopeptide repeat domain 30B (TTC30B)
B03R08C17	3-17-8	Hs~MGC:BC033740.1~uORF:IOH21832	747	667	830	397	603	664	1196	518	1268	289	tenascin XB (TNXB)
B03R08C18	3-18-8	Hs~MGC:BC033740.1~uORF:IOH21832	758	656	828	379	548	608	1098	544	1530	284	tenascin XB (TNXB)
B03R08C19	3-19-8	Hs~Ref:NM_002070.1~uORF:IOH14604	870	1225	995	325	659	477	533	549	1872	214	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 (GNAI2)
B03R08C20	3-20-8	Hs~Ref:NM_002070.1~uORF:IOH14604	938	1160	1047	326	739	485	574	575	1720	222	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 (GNAI2)
B03R08C21	3-21-8	Hs~Ref:NM_006822.1~uORF:IOH1937	1534	839	1344	977	1490	803	1543	860	1519	476	RAB40B, member RAS oncogene family (RAB40B)
B03R08C22	3-22-8	Hs~Ref:NM_006822.1~uORF:IOH1937	1376	797	1333	714	3216	827	1511	830	1569	468	RAB40B, member RAS oncogene family (RAB40B)
B03R09C01	3-1-9	Hs~Ref:NM_015004.2~uORF:IOH12658	1325	870	1407	803	2387	814	3145	1018	3663	498	exosome component 7 (EXOSC7)
B03R09C02	3-2-9	Hs~Ref:NM_015004.2~uORF:IOH12658	1277	863	1378	810	2528	778	3128	790	3496	385	exosome component 7 (EXOSC7)
B03R09C03	3-3-9	Hs~Ref:NM_194310.1~uORF:IOH35456	1313	1093	1708	1071	2721	1290	1974	1442	2513	453	hypothetical protein LOC284837 (LOC284837)
B03R09C04	3-4-9	Hs~Ref:NM_194310.1~uORF:IOH35456	1262	1116	1601	1071	2253	1466	1959	1403	2581	462	hypothetical protein LOC284837 (LOC284837)
B03R09C05	3-5-9	Hs~Ref:NM_033348.1~uORF:IOH35365	853	897	1409	3488	3341	970	2646	890	1557	1215	potassium channel, subfamily K, member 7 (KCNK7), transcript variant B
B03R09C06	3-6-9	Hs~Ref:NM_033348.1~uORF:IOH35365	862	935	1453	3668	3587	1012	2509	835	1550	1232	potassium channel, subfamily K, member 7 (KCNK7), transcript variant B
B03R09C07	3-7-9	Hs~Ref:NM_002625.1~uORF:IOH29862	2771	2486	2210	42347	38192	2311	7854	3195	3745	14352	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
B03R09C08	3-8-9	Hs~Ref:NM_002625.1~uORF:IOH29862	2772	2518	2609	40692	33450	2280	7661	3108	3850	13512	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
B03R09C09	3-9-9	Hs~MGC:BC025697.1~uORF:IOH11332	792	857	1039	650	608	571	892	5924	1245	218	transcription factor 21 (TCF21)
B03R09C10	3-10-9	Hs~MGC:BC025697.1~uORF:IOH11332	775	859	1021	652	517	769	850	5775	1318	207	transcription factor 21 (TCF21)
B03R09C11	3-11-9	Hs~Ref:NM_024679.1~uORF:IOH11353	987	621	836	10292	909	652	1043	549	1543	285	latrophilin 1 (LPHN1), transcript variant 2
B03R09C12	3-12-9	Hs~Ref:NM_024679.1~uORF:IOH11353	1013	641	799	10140	1077	694	1130	575	1256	267	latrophilin 1 (LPHN1), transcript variant 2
B03R09C13	3-13-9	Hs~Ref:NM_021175.1~uORF:IOH13487	2669	1231	1555	1146	1059	1339	3779	1067	2006	556	hepcidin antimicrobial peptide (HAMP)
B03R09C14	3-14-9	Hs~Ref:NM_021175.1~uORF:IOH13487	2709	1130	1496	1137	889	1362	3936	1115	2240	599	hepcidin antimicrobial peptide (HAMP)
B03R09C15	3-15-9	Hs~Ref:NM_001862.2~uORF:IOH6269	1139	1445	1508	837	1344	1114	1435	1142	2574	796	cytochrome c oxidase subunit Vb (COX5B)
B03R09C16	3-16-9	Hs~Ref:NM_001862.2~uORF:IOH6269	1173	1468	1545	884	1282	958	1415	1128	2869	786	cytochrome c oxidase subunit Vb (COX5B)
B03R09C17	3-17-9	Hs~MGC:BC047865.1~uORF:IOH26933	15076	710	1162	946	3358	768	1562	2190	2594	330	mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)
B03R09C18	3-18-9	Hs~MGC:BC047865.1~uORF:IOH26933	14978	662	1136	907	3233	738	1593	2370	2396	331	mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)
B03R09C19	3-19-9	Hs~MGC:BC060809.1~uORF:IOH29275	683	618	1218	572	634	944	768	648	1088	331	elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2 (ELOVL2)
B03R09C20	3-20-9	Hs~MGC:BC060809.1~uORF:IOH29275	852	644	1155	610	641	964	759	577	1051	353	elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2 (ELOVL2)
B03R09C21	3-21-9	Hs~MGC:BC040656.1~uORF:IOH27626	780	790	600	1037	584	451	631	624	757	257	leucine rich repeat containing 3B (LRRC3B)
B03R09C22	3-22-9	Hs~MGC:BC040656.1~uORF:IOH27626	586	728	663	340	463	107	592	536	863	233	leucine rich repeat containing 3B (LRRC3B)
B03R10C01	3-1-10	Hs~MGC:BC017018.1~uORF:IOH11265	1521	822	1014	759	1140	620	2189	873	1731	807	DnaJ (Hsp40) homolog, subfamily C, member 12 (DNAJC12)
B03R10C02	3-2-10	Hs~MGC:BC017018.1~uORF:IOH11265	1590	815	971	737	928	602	2240	888	1687	810	DnaJ (Hsp40) homolog, subfamily C, member 12 (DNAJC12)
B03R10C03	3-3-10	Hs~MGC:BC001669.1~uORF:IOH3770	940	664	1066	578	1063	1171	1358	1024	1973	563	Mitochondrial inner membrane protein OXA1L
B03R10C04	3-4-10	Hs~MGC:BC001669.1~uORF:IOH3770	898	626	1079	585	1025	1328	1269	1032	1775	572	Mitochondrial inner membrane protein OXA1L
B03R10C05	3-5-10	Hs~MGC:BC013051.1~uORF:IOH10509	1226	1042	1363	786	1040	1225	2051	1134	2975	329	LIM domain kinase 2
B03R10C06	3-6-10	Hs~MGC:BC013051.1~uORF:IOH10509	1213	1047	1455	884	1203	1129	1996	1063	3034	459	LIM domain kinase 2
B03R10C07	3-7-10	Hs~MGC:BC004247.1~uORF:IOH5472	1171	810	1537	628	7597	734	1219	932	1641	385	Ras-related C3 botulinum toxin substrate 1
B03R10C08	3-8-10	Hs~MGC:BC004247.1~uORF:IOH5472	1204	842	1782	621	6948	709	1233	930	1714	437	Ras-related C3 botulinum toxin substrate 1
B03R10C09	3-9-10	Hs~MGC:BC025404.1~uORF:IOH11756	1147	944	1697	1109	885	1399	1541	1146	2845	593	Meis homeobox 3 (MEIS3), transcript variant 1, mRNA.
B03R10C10	3-10-10	Hs~MGC:BC025404.1~uORF:IOH11756	1130	935	1281	1138	839	1483	1467	993	2514	648	Meis homeobox 3 (MEIS3), transcript variant 1, mRNA.
B03R11C21	3-21-11	Hs~MGC:BC010642.1~uORF:IOH9701	1560	717	1006	778	496	813	3058	864	1362	441	zinc finger protein 22 (KOX 15) (ZNF22)
B03R11C22	3-22-11	Hs~MGC:BC010642.1~uORF:IOH9701	1107	686	921	923	521	840	3109	997	1407	402	zinc finger protein 22 (KOX 15) (ZNF22)
B03R12C01	3-1-12	Hs~Ref:NM_006685.2~uORF:IOH11229	1104	742	1029	999	821	1139	1155	1413	550	213	submaxillary gland androgen regulated protein 3 homolog B (mouse) (SMR3B)
B03R12C02	3-2-12	Hs~Ref:NM_006685.2~uORF:IOH11229	859	698	734	917	764	1123	1263	1445	406	155	submaxillary gland androgen regulated protein 3 homolog B (mouse) (SMR3B)
B03R12C03	3-3-12	Hs~Ref:NM_024812.1~uORF:IOH9655	942	568	679	4494	940	1117	824	668	2456	1572	Brain and acute leukemia cytoplasmic protein
B03R12C04	3-4-12	Hs~Ref:NM_024812.1~uORF:IOH9655	859	585	721	4316	907	1106	825	691	3007	1352	Brain and acute leukemia cytoplasmic protein
B03R12C05	3-5-12	Hs~MGC:BC004407.1~uORF:IOH5570	568	383	508	295	579	325	752	431	716	259	chromosome 9 open reading frame 64 (C9orf64)
B03R12C06	3-6-12	Hs~MGC:BC004407.1~uORF:IOH5570	559	408	571	291	2511	340	724	346	625	402	chromosome 9 open reading frame 64 (C9orf64)
B03R12C07	3-7-12	Hs~MGC:BC041082.1~uORF:IOH29352	1088	884	1178	702	1293	1154	1454	1158	2508	364	zinc finger protein 695 (ZNF695)
B03R12C08	3-8-12	Hs~MGC:BC041082.1~uORF:IOH29352	1074	935	1324	660	1587	1090	1441	1073	2765	534	zinc finger protein 695 (ZNF695)
B03R12C09	3-9-12	Hs~MGC:BC032539.1~uORF:IOH21974	1101	957	1477	911	1383	1280	1526	1029	3664	570	mitogen-activated protein kinase 9 (MAPK9)
B03R12C10	3-10-12	Hs~MGC:BC032539.1~uORF:IOH21974	1088	907	1378	959	1329	1201	1551	1032	3177	695	mitogen-activated protein kinase 9 (MAPK9)
B03R12C11	3-11-12	Hs~Ref:NM_000061.1~uORF:IOH21063	789	862	982	1144	1850	2271	3654	898	1972	570	Bruton agammaglobulinemia tyrosine kinase (BTK)
B03R12C12	3-12-12	Hs~Ref:NM_000061.1~uORF:IOH21063	817	784	1077	1124	1751	2421	3400	881	1949	519	Bruton agammaglobulinemia tyrosine kinase (BTK)
B03R12C13	3-13-12	Hs~MGC:BC006318.1~uORF:IOH6433	2291	8157	5949	3826	4260	1704	2580	3842	3285	1222	erythrocyte membrane protein band 4.9 (dematin) (EPB49)
B03R12C14	3-14-12	Hs~MGC:BC006318.1~uORF:IOH6433	2181	7541	5897	3765	4108	1715	2593	3675	3299	1209	erythrocyte membrane protein band 4.9 (dematin) (EPB49)
B03R12C15	3-15-12	Hs~Ref:NM_003739.4~uORF:IOH13880	444	319	536	90	250	129	682	253	246	92	aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) (AKR1C3)
B03R12C16	3-16-12	Hs~Ref:NM_003739.4~uORF:IOH13880	4172	116	500	251	157	253	651	290	653	84	aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) (AKR1C3)
B03R12C17	3-17-12	Hs~Ref:NM_020150.3~uORF:IOH5222	126	209	314	291	128	65	219	395	383	87	SAR1 gene homolog A (S. cerevisiae) (SAR1A)
B03R12C18	3-18-12	Hs~Ref:NM_020150.3~uORF:IOH5222	162	124	296	63	162	823	430	238	301	-8	SAR1 gene homolog A (S. cerevisiae) (SAR1A)
B03R12C19	3-19-12	Hs~Ref:NM_002813.4~uORF:IOH3657	1207	1137	1363	1112	1573	766	723	1578	3117	1232	proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 (PSMD9)
B03R12C20	3-20-12	Hs~Ref:NM_002813.4~uORF:IOH3657	1483	1154	1452	1100	1710	724	661	1560	3118	1113	proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 (PSMD9)
B03R12C21	3-21-12	Hs~Ref:NM_004485.2~uORF:IOH11159	317	708	407	844	130	102	255	365	789	156	guanine nucleotide binding protein (G protein), gamma 4 (GNG4), transcript variant 3
B03R12C22	3-22-12	Hs~Ref:NM_004485.2~uORF:IOH11159	297	651	379	932	17	42	249	398	719	149	guanine nucleotide binding protein (G protein), gamma 4 (GNG4), transcript variant 3
B03R13C01	3-1-13	Hs~Ref:NM_024313.1~uORF:IOH5392	3153	1790	3315	1726	2338	1470	9365	1468	3747	633	nucleolar protein 12 (NOL12)
B03R13C02	3-2-13	Hs~Ref:NM_024313.1~uORF:IOH5392	3115	1772	4449	1697	2408	1468	9560	1702	3457	754	nucleolar protein 12 (NOL12)
B03R13C03	3-3-13	Hs~Ref:NM_023938.4~uORF:IOH3759	8547	3036	5056	7471	6836	6475	8826	18459	6213	1413	Specifically androgen-regulated gene protein
B03R13C04	3-4-13	Hs~Ref:NM_023938.4~uORF:IOH3759	7930	2873	5125	6963	6697	6866	8456	17696	6123	1380	Specifically androgen-regulated gene protein
B03R13C05	3-5-13	Hs~Ref:NM_018204.2~uORF:IOH41837	1525	1028	1306	812	2633	1988	3148	1337	2314	693	cytoskeleton associated protein 2 (CKAP2), transcript variant 1
B03R13C06	3-6-13	Hs~Ref:NM_018204.2~uORF:IOH41837	1600	1016	1317	817	1314	1893	3231	912	2237	441	cytoskeleton associated protein 2 (CKAP2), transcript variant 1
B03R13C07	3-7-13	Hs~MGC:BC020550.1~uORF:IOH10324	18172	1108	1691	926	1461	1131	1952	895	3751	658	churchill domain containing 1 (CHURC1)
B03R13C08	3-8-13	Hs~MGC:BC020550.1~uORF:IOH10324	17627	1062	1680	994	1770	1131	1856	1004	3716	448	churchill domain containing 1 (CHURC1)
B03R13C11	3-11-13	Hs~MGC:BC031224.1~uORF:IOH62167	677	429	916	422	577	475	1100	576	633	183	Nucleoside diphosphate-linked moiety X motif 13
B03R13C12	3-12-13	Hs~MGC:BC031224.1~uORF:IOH62167	696	425	878	449	421	451	1069	556	648	382	Nucleoside diphosphate-linked moiety X motif 13
B03R13C17	3-17-13	Hs~MGC:NM_152729.2~uORF:IOH13044	52192	44598	42865	38145	47328	31554	34404	43806	53612	44481	5'-nucleotidase domain containing 1 (NT5DC1)
B03R13C18	3-18-13	Hs~MGC:NM_152729.2~uORF:IOH13044	52917	45247	45308	37775	41330	28978	34020	44949	50659	43039	5'-nucleotidase domain containing 1 (NT5DC1)
B03R13C19	3-19-13	Hs~Ref:NM_005151.2~uORF:IOH5002	65492	65489	65480	52074	64149	42483	48573	65012	65490	65487	ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) (USP14), transcript variant 1
B03R13C20	3-20-13	Hs~Ref:NM_005151.2~uORF:IOH5002	65493	65489	65480	51065	61403	47633	49367	62794	65491	60784	ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) (USP14), transcript variant 1
B03R13C21	3-21-13	Hs~MGC:NM_021227.2~uORF:IOH12645	1282	1558	1559	1103	912	2021	5232	1262	1900	873	DC2 protein (DC2)
B03R13C22	3-22-13	Hs~MGC:NM_021227.2~uORF:IOH12645	1374	1418	1558	1054	861	2048	5308	1317	1835	846	DC2 protein (DC2)
B03R14C01	3-1-14	Hs~MGC:BC007340.1~uORF:IOH5890	1212	832	1009	1252	1014	1073	1299	29	891	840	Bystin
B03R14C02	3-2-14	Hs~MGC:BC007340.1~uORF:IOH5890	1021	853	1443	1101	976	1063	1275	-3	1230	816	Bystin
B03R14C03	3-3-14	Hs~Ref:NM_152734.2~uORF:IOH40907	383	361	872	2927	340	379	884	393	469	76	chromosome 6 open reading frame 89 (C6orf89)
B03R14C04	3-4-14	Hs~Ref:NM_152734.2~uORF:IOH40907	403	348	573	2882	312	470	792	427	308	18	chromosome 6 open reading frame 89 (C6orf89)
B03R14C05	3-5-14	Hs~Ref:NM_000732.3~uORF:IOH40817	647	610	949	351	521	598	1753	740	576	42	CD3d molecule, delta (CD3-TCR complex) (CD3D), transcript variant 1
B03R14C06	3-6-14	Hs~Ref:NM_000732.3~uORF:IOH40817	657	609	942	423	525	626	1650	970	668	207	CD3d molecule, delta (CD3-TCR complex) (CD3D), transcript variant 1
B03R14C07	3-7-14	Hs~Ref:NM_001767.2~uORF:IOH22609	766	614	3659	406	774	690	2421	1018	1693	443	CD2 molecule (CD2)
B03R14C08	3-8-14	Hs~Ref:NM_001767.2~uORF:IOH22609	737	565	3633	441	583	693	2367	876	1517	134	CD2 molecule (CD2)
B03R14C09	3-9-14	Hs~Ref:NM_031300.2~uORF:IOH3726	745	655	827	422	804	550	1161	581	933	506	MAX dimerization protein 3 (MXD3)
B03R14C10	3-10-14	Hs~Ref:NM_031300.2~uORF:IOH3726	782	665	775	442	693	642	1032	733	1013	327	MAX dimerization protein 3 (MXD3)
B03R14C11	3-11-14	Hs~Ref:NM_017772.2~uORF:IOH42187	11445	9062	10257	10122	18643	5525	35069	6138	25297	4103	TBC1 domain family member 22B
B03R14C12	3-12-14	Hs~Ref:NM_017772.2~uORF:IOH42187	10650	8837	9888	10547	18264	6123	33954	6290	22093	3887	TBC1 domain family member 22B
B03R14C13	3-13-14	Hs~Ref:NM_152571.2~uORF:IOH42384	1045	1686	1000	691	987	886	1489	1089	1356	972	Uncharacterized protein C9orf163
B03R14C14	3-14-14	Hs~Ref:NM_152571.2~uORF:IOH42384	936	1550	908	705	765	775	1430	1019	1322	930	Uncharacterized protein C9orf163
B03R14C17	3-17-14	Hs~Ref:NM_152243.1~uORF:IOH42102	3734	1012	19258	909	2019	2420	19261	2585	3766	1482	Cdc42 effector protein 1
B03R14C18	3-18-14	Hs~Ref:NM_152243.1~uORF:IOH42102	3750	1052	19865	913	1706	2508	18649	2819	5172	1465	Cdc42 effector protein 1
B03R14C19	3-19-14	Hs~MGC:BC000819.1~uORF:IOH3103	720	590	1003	363	404	752	945	620	1188	124	cysteine conjugate-beta lyase 2 (CCBL2)
B03R14C20	3-20-14	Hs~MGC:BC000819.1~uORF:IOH3103	694	634	971	331	434	536	911	575	1094	187	cysteine conjugate-beta lyase 2 (CCBL2)
B03R14C21	3-21-14	Hs~MGC:BC044584.1~uORF:IOH26743	1033	863	1254	759	840	798	1449	837	2593	731	DnaJ (Hsp40) homolog, subfamily C, member 4 (DNAJC4)
B03R14C22	3-22-14	Hs~MGC:BC044584.1~uORF:IOH26743	992	836	1249	698	755	766	1508	861	2044	490	DnaJ (Hsp40) homolog, subfamily C, member 4 (DNAJC4)
B03R15C01	3-1-15	Hs~Ref:NM_002995.1~uORF:IOH34717	742	429	1107	639	652	506	2384	1112	956	252	chemokine (C motif) ligand 1 (XCL1)
B03R15C02	3-2-15	Hs~Ref:NM_002995.1~uORF:IOH34717	658	428	1090	688	803	490	2338	1095	929	89	chemokine (C motif) ligand 1 (XCL1)
B03R15C03	3-3-15	Hs~MGC:BC005085.1~uORF:IOH6621	521	609	814	448	763	432	1140	484	17	245	zinc finger protein 607 (ZNF607)
B03R15C04	3-4-15	Hs~MGC:BC005085.1~uORF:IOH6621	541	686	792	481	1004	416	1088	444	790	182	zinc finger protein 607 (ZNF607)
B03R15C05	3-5-15	Hs~Ref:NM_052887.2~uORF:IOH45532	935	823	1028	509	1280	645	1031	778	1716	163	toll-interleukin 1 receptor (TIR) domain containing adaptor protein (TIRAP), transcript variant 1
B03R15C06	3-6-15	Hs~Ref:NM_052887.2~uORF:IOH45532	934	806	969	531	1176	660	1020	729	1642	262	toll-interleukin 1 receptor (TIR) domain containing adaptor protein (TIRAP), transcript variant 1
B03R15C07	3-7-15	Hs~Ref:NM_032131.3~uORF:IOH45465	1424	1116	1333	740	1438	1049	3847	1087	279	484	armadillo repeat containing 2 (ARMC2)
B03R15C08	3-8-15	Hs~Ref:NM_032131.3~uORF:IOH45465	1336	1078	1309	728	1867	917	3591	1040	821	538	armadillo repeat containing 2 (ARMC2)
B03R15C09	3-9-15	Hs~Ref:NM_198183.1~uORF:IOH45533	768	696	897	518	771	686	1981	682	138	279	ubiquitin-conjugating enzyme E2L 6 (UBE2L6), transcript variant 2
B03R15C10	3-10-15	Hs~Ref:NM_198183.1~uORF:IOH45533	790	700	1080	462	838	692	1938	757	1636	15	ubiquitin-conjugating enzyme E2L 6 (UBE2L6), transcript variant 2
B03R15C11	3-11-15	Hs~Ref:NM_032588.2~uORF:IOH45956	799	821	942	534	972	731	1801	814	1535	631	tripartite motif-containing 63 (TRIM63)
B03R15C12	3-12-15	Hs~Ref:NM_032588.2~uORF:IOH45956	696	691	941	733	803	750	1476	781	247	260	tripartite motif-containing 63 (TRIM63)
B03R15C13	3-13-15	Hs~Ref:NM_212535.1~CAT:P2281	1563	1658	3717	821	191	668	3125	395	714	180	protein kinase C, beta 1 (PRKCB1), transcript variant 1
B03R15C14	3-14-15	Hs~Ref:NM_212535.1~CAT:P2281	1552	1608	3607	822	189	675	3044	353	673	189	protein kinase C, beta 1 (PRKCB1), transcript variant 1
B03R15C15	3-15-15	Hs~Ref:NM_001619.2~CAT:PV3361	470	453	593	222	683	329	1070	340	344	33	adrenergic, beta, receptor kinase 1 (ADRBK1)
B03R15C16	3-16-15	Hs~Ref:NM_001619.2~CAT:PV3361	301	486	535	266	708	295	991	316	540	539	adrenergic, beta, receptor kinase 1 (ADRBK1)
B03R15C17	3-17-15	Hs~Ref:NM_004119.1~CAT:PV3182	469	392	694	391	328	671	617	535	188	170	fms-related tyrosine kinase 3 (FLT3); see catalog number for detailed information on wild-type or point mutant status
B03R15C18	3-18-15	Hs~Ref:NM_004119.1~CAT:PV3182	472	428	704	398	385	629	604	510	747	147	fms-related tyrosine kinase 3 (FLT3); see catalog number for detailed information on wild-type or point mutant status
B03R15C19	3-19-15	Hs~Ref:NM_000459.1~CAT:PV3628	870	1963	1227	435	478	513	669	930	1054	386	Angiopoietin-1 receptor
B03R15C20	3-20-15	Hs~Ref:NM_000459.1~CAT:PV3628	787	1845	1191	442	428	519	650	912	1015	310	Angiopoietin-1 receptor
B03R15C21	3-21-15	Hs~Ref:NM_003821.2~CAT:PV4213	1041	166	293	186	272	484	223	268	346	19	receptor-interacting serine-threonine kinase 2 (RIPK2)
B03R15C22	3-22-15	Hs~Ref:NM_003821.2~CAT:PV4213	742	97	307	99	323	646	135	258	412	-9	receptor-interacting serine-threonine kinase 2 (RIPK2)
B03R16C05	3-5-16	Hs~Ref:NM_000575.1~CAT_PHC0017	97	205	457	81	1116	218	559	141	366	84	Interleukin-1 alpha
B03R16C06	3-6-16	Hs~Ref:NM_000575.1~CAT_PHC0017	100	209	120	144	191	248	495	129	254	12	Interleukin-1 alpha
B03R16C07	3-7-16	Hs~Ref:NM_004935.1~uORF:IOH4873	869	1726	458	284	1175	571	1246	377	531	194	cyclin-dependent kinase 5 (CDK5) and p25: CDK5 and p25 sequences are seperated by -- (in protein list file).
B03R16C08	3-8-16	Hs~Ref:NM_004935.1~uORF:IOH4873	862	1707	437	321	759	522	1185	416	527	261	cyclin-dependent kinase 5 (CDK5) and p25: CDK5 and p25 sequences are seperated by -- (in protein list file).
B03R16C09	3-9-16	Hs~Ref:NM_032731.2~uORF:IOH6754	427	285	346	186	90	412	396	280	97	22	thioredoxin domain containing 17 (TXNDC17)
B03R16C10	3-10-16	Hs~Ref:NM_032731.2~uORF:IOH6754	427	239	2984	110	1287	461	396	238	225	61	thioredoxin domain containing 17 (TXNDC17)
B03R16C11	3-11-16	Hs~MGC:BC007863.1~uORF:IOH6769	462	865	784	463	845	540	900	885	574	18	platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit 29kDa (PAFAH1B3)
B03R16C12	3-12-16	Hs~MGC:BC007863.1~uORF:IOH6769	447	816	618	580	355	483	943	976	843	123	platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit 29kDa (PAFAH1B3)
B03R16C13	3-13-16	Hs~MGC:BC010662.1~uORF:IOH9725	430	331	443	304	215	949	569	295	457	90	leucine rich repeat (in FLII) interacting protein 1 (LRRFIP1)
B03R16C14	3-14-16	Hs~MGC:BC010662.1~uORF:IOH9725	432	214	581	307	156	714	559	270	432	54	leucine rich repeat (in FLII) interacting protein 1 (LRRFIP1)
B03R16C15	3-15-16	Hs~Ref:NM_001946.1~uORF:IOH5003	1403	1593	2184	934	2393	2238	2293	1619	3665	622	dual specificity phosphatase 6 (DUSP6), transcript variant 1
B03R16C16	3-16-16	Hs~Ref:NM_001946.1~uORF:IOH5003	1381	1560	2140	909	2373	2180	2257	1658	3702	585	dual specificity phosphatase 6 (DUSP6), transcript variant 1
B03R16C17	3-17-16	Hs~MGC:BC005177.1~uORF:IOH4713	1655	1750	3735	979	3194	2582	2688	3416	3675	898	transmembrane protein 51 (TMEM51)
B03R16C18	3-18-16	Hs~MGC:BC005177.1~uORF:IOH4713	1613	1703	3729	995	3159	2669	2669	3779	3514	831	transmembrane protein 51 (TMEM51)
B03R16C19	3-19-16	Hs~Ref:NM_002695.2~uORF:IOH5025	1311	1520	1961	789	2638	2044	1619	1271	3265	315	polymerase (RNA) II (DNA directed) polypeptide E, 25kDa (POLR2E)
B03R16C20	3-20-16	Hs~Ref:NM_002695.2~uORF:IOH5025	1288	1515	1961	766	2522	2007	1664	1358	3206	-24	polymerase (RNA) II (DNA directed) polypeptide E, 25kDa (POLR2E)
B03R16C21	3-21-16	Hs~Ref:NM_057180.1~uORF:IOH3232	1700	1587	2241	1363	2040	2038	2183	1580	3962	812	vacuolar protein sorting 29 homolog (S. cerevisiae) (VPS29), transcript variant 2
B03R16C22	3-22-16	Hs~Ref:NM_057180.1~uORF:IOH3232	1594	1500	2199	1081	2020	2040	1877	1589	4379	934	vacuolar protein sorting 29 homolog (S. cerevisiae) (VPS29), transcript variant 2
B03R17C01	3-1-17	Hs~Ref:NM_003344.2~uORF:IOH6283	1453	928	1608	790	1688	1179	1283	1032	2722	510	ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast) (UBE2H), transcript variant 1
B03R17C02	3-2-17	Hs~Ref:NM_003344.2~uORF:IOH6283	1097	963	1497	786	1670	1126	1258	1017	2656	526	ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast) (UBE2H), transcript variant 1
B03R17C03	3-3-17	Hs~MGC:BC005807.2~uORF:IOH6261	1926	1231	3379	905	2884	1928	2240	1467	4023	786	stearoyl-CoA desaturase (delta-9-desaturase) (SCD)
B03R17C04	3-4-17	Hs~MGC:BC005807.2~uORF:IOH6261	1872	1202	3173	878	2754	1992	2345	1585	3946	740	stearoyl-CoA desaturase (delta-9-desaturase) (SCD)
B03R17C05	3-5-17	Hs~Ref:NM_199191.1~uORF:IOH3115	1098	1249	1616	668	2834	2319	1801	1523	3017	544	brain and reproductive organ-expressed (TNFRSF1A modulator) (BRE), transcript variant 3
B03R17C06	3-6-17	Hs~Ref:NM_199191.1~uORF:IOH3115	1134	1273	1739	658	3389	2275	1861	1526	3056	620	brain and reproductive organ-expressed (TNFRSF1A modulator) (BRE), transcript variant 3
B03R17C07	3-7-17	Hs~MGC:BC013630.1~uORF:IOH10193	1264	1250	1707	739	3364	2210	1904	1509	3960	484	JTV1 gene (JTV1)
B03R17C08	3-8-17	Hs~MGC:BC013630.1~uORF:IOH10193	1223	1192	1728	745	2569	2210	2144	1386	4268	664	JTV1 gene (JTV1)
B03R17C09	3-9-17	Hs~Ref:NM_020438.3~uORF:IOH40220	936	950	1279	662	961	2358	1425	912	2031	541	dolichyl pyrophosphate phosphatase 1 (DOLPP1)
B03R17C10	3-10-17	Hs~Ref:NM_020438.3~uORF:IOH40220	986	1014	2311	653	1002	2273	1406	882	1799	194	dolichyl pyrophosphate phosphatase 1 (DOLPP1)
B03R17C11	3-11-17	Hs~Ref:NM_022789.2~uORF:IOH40292	1136	1259	1398	805	1059	1024	1283	1039	995	627	interleukin 25 (IL25), transcript variant 1
B03R17C12	3-12-17	Hs~Ref:NM_022789.2~uORF:IOH40292	1109	1159	1248	907	1057	1079	1364	1085	987	750	interleukin 25 (IL25), transcript variant 1
B03R17C13	3-13-17	Hs~Ref:NM_012145.2~uORF:IOH5195	2492	1382	926	1614	851	1276	760	627	1590	262	deoxythymidylate kinase (thymidylate kinase) (DTYMK)
B03R17C14	3-14-17	Hs~Ref:NM_012145.2~uORF:IOH5195	2445	1366	883	1569	815	1199	786	658	1721	281	deoxythymidylate kinase (thymidylate kinase) (DTYMK)
B03R17C15	3-15-17	Hs~MGC:BC006195.1~uORF:IOH5808	1026	1107	2120	1283	681	944	1500	2959	1390	44	ATP citrate lyase (ACLY)
B03R17C16	3-16-17	Hs~MGC:BC006195.1~uORF:IOH5808	1000	1148	2079	1239	710	934	1470	2801	1399	264	ATP citrate lyase (ACLY)
B03R17C17	3-17-17	Hs~Ref:NM_003362.2~uORF:IOH11675	1178	1118	1797	778	2134	1855	2104	1414	3087	41	uracil-DNA glycosylase (UNG), transcript variant 1
B03R17C18	3-18-17	Hs~Ref:NM_003362.2~uORF:IOH11675	1161	1107	1781	809	2206	2087	2183	1316	3125	563	uracil-DNA glycosylase (UNG), transcript variant 1
B03R17C19	3-19-17	Hs~Ref:NM_173468.2~uORF:IOH27138	1512	1776	2278	1151	1847	2233	1860	1730	4830	857	MOB1, Mps One Binder kinase activator-like 1A (yeast) (MOBKL1A)
B03R17C20	3-20-17	Hs~Ref:NM_173468.2~uORF:IOH27138	1538	1831	2328	1305	1846	2148	1875	1779	7057	261	MOB1, Mps One Binder kinase activator-like 1A (yeast) (MOBKL1A)
B03R17C21	3-21-17	Hs~Ref:NM_153345.1~uORF:IOH27468	1200	1093	1881	2133	753	1331	1425	1094	3159	615	transmembrane protein 139 (TMEM139)
B03R17C22	3-22-17	Hs~Ref:NM_153345.1~uORF:IOH27468	2050	1027	1856	1749	1732	1278	1456	1134	3284	574	transmembrane protein 139 (TMEM139)
B03R18C01	3-1-18	Hs~Ref:NM_013322.2~uORF:IOH27109	1489	1091	1579	940	2187	1972	1911	1315	3555	629	sorting nexin 10 (SNX10)
B03R18C02	3-2-18	Hs~Ref:NM_013322.2~uORF:IOH27109	1272	1050	1458	910	2154	1973	1849	1331	3557	614	sorting nexin 10 (SNX10)
B03R18C03	3-3-18	Hs~MGC:BC062696.1~uORF:IOH40720	719	524	1306	445	601	900	1182	680	-20	362	microsomal triglyceride transfer protein (MTTP)
B03R18C04	3-4-18	Hs~MGC:BC062696.1~uORF:IOH40720	752	525	877	516	574	983	1102	594	1002	252	microsomal triglyceride transfer protein (MTTP)
B03R18C05	3-5-18	Hs~Ref:NM_020425.3~uORF:IOH40803	1029	734	1332	1507	926	841	1483	1065	2421	444	chromosome 6 open reading frame 162 (C6orf162), transcript variant 2
B03R18C06	3-6-18	Hs~Ref:NM_020425.3~uORF:IOH40803	1019	761	1339	1518	932	838	1596	1071	2900	454	chromosome 6 open reading frame 162 (C6orf162), transcript variant 2
B03R18C07	3-7-18	Hs~MGC:BC022309.1~uORF:IOH14497	666	626	736	483	841	732	1055	659	655	311	serpin peptidase inhibitor, clade C (antithrombin), member 1 (SERPINC1)
B03R18C08	3-8-18	Hs~MGC:BC022309.1~uORF:IOH14497	667	694	852	475	723	669	1033	672	284	-1	serpin peptidase inhibitor, clade C (antithrombin), member 1 (SERPINC1)
B03R18C09	3-9-18	Hs~MGC:BC020517.1~uORF:IOH10694	444	356	698	325	403	418	792	498	648	169	sideroflexin 1 (SFXN1)
B03R18C10	3-10-18	Hs~MGC:BC020517.1~uORF:IOH10694	445	373	712	319	408	433	758	559	640	12	sideroflexin 1 (SFXN1)
B03R18C11	3-11-18	Hs~Ref:NM_000764.2~uORF:IOH39393	544	448	853	386	441	496	852	716	982	244	cytochrome P450, family 2, subfamily A, polypeptide 7 (CYP2A7), transcript variant 1
B03R18C12	3-12-18	Hs~Ref:NM_000764.2~uORF:IOH39393	608	478	626	434	471	469	912	472	479	2676	cytochrome P450, family 2, subfamily A, polypeptide 7 (CYP2A7), transcript variant 1
B03R18C13	3-13-18	Hs~Ref:NM_147204.1~uORF:IOH39618	646	1023	715	359	422	623	1152	554	1153	15	transient receptor potential cation channel, subfamily V, member 4 (TRPV4), transcript variant 2
B03R18C14	3-14-18	Hs~Ref:NM_147204.1~uORF:IOH39618	632	962	693	372	446	667	1000	518	252	12	transient receptor potential cation channel, subfamily V, member 4 (TRPV4), transcript variant 2
B03R18C15	3-15-18	Hs~Ref:NM_004755.1~N/A	735	472	916	379	328	534	918	647	1039	156	Ribosomal protein S6 kinase alpha-5
B03R18C16	3-16-18	Hs~Ref:NM_004755.1~N/A	702	510	937	363	343	561	935	633	1014	53	Ribosomal protein S6 kinase alpha-5
B03R18C17	3-17-18	Hs~Ref:NM_017988.1~N/A	527	414	537	321	255	430	1183	588	208	89	SCY1-like protein 2
B03R18C18	3-18-18	Hs~Ref:NM_017988.1~N/A	517	437	578	338	227	432	1151	576	1803	136	SCY1-like protein 2
B03R18C19	3-19-18	Hs~MGC:BC033766.1~uORF:IOH21750	6318	5879	4490	2641	1963	3793	3650	3302	4963	770	NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa (NDUFV3)
B03R18C20	3-20-18	Hs~MGC:BC033766.1~uORF:IOH21750	6345	5889	4447	2718	3377	3788	3726	3518	4725	773	NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa (NDUFV3)
B03R18C21	3-21-18	Hs~MGC:NM_173554.1~uORF:IOH25890	903	834	1206	464	678	1128	1027	1004	2206	364	chromosome 10 open reading frame 107 (C10orf107)
B03R18C22	3-22-18	Hs~MGC:NM_173554.1~uORF:IOH25890	1068	836	1212	435	778	1180	1058	979	3740	428	chromosome 10 open reading frame 107 (C10orf107)
B03R19C01	3-1-19	Hs~Ref:NM_002709.1~uORF:IOH5281	766	673	920	603	591	1434	1212	667	548	360	protein phosphatase 1, catalytic subunit, beta isoform (PPP1CB), transcript variant 1
B03R19C02	3-2-19	Hs~Ref:NM_002709.1~uORF:IOH5281	856	667	922	709	674	1409	1272	680	1027	388	protein phosphatase 1, catalytic subunit, beta isoform (PPP1CB), transcript variant 1
B03R19C03	3-3-19	Hs~MGC:BC009415.1~uORF:IOH14115	10484	1303	1545	1263	2166	4808	1530	2441	5558	529	kinesin family member 26A (KIF26A)
B03R19C04	3-4-19	Hs~MGC:BC009415.1~uORF:IOH14115	11226	1230	1549	1172	2127	4681	1544	2317	5741	276	kinesin family member 26A (KIF26A)
B03R19C05	3-5-19	Hs~Ref:NM_145047.1~uORF:IOH10837	747	448	781	349	1189	520	1262	710	918	204	Protein OSCP1
B03R19C06	3-6-19	Hs~Ref:NM_145047.1~uORF:IOH10837	727	419	688	322	577	527	1330	667	845	300	Protein OSCP1
B03R19C07	3-7-19	Hs~Ref:NM_030780.2~uORF:IOH10844	428	346	514	252	866	354	752	345	3745	128	solute carrier family 25, member 32 (SLC25A32)
B03R19C08	3-8-19	Hs~Ref:NM_030780.2~uORF:IOH10844	414	345	503	240	314	333	789	359	424	43	solute carrier family 25, member 32 (SLC25A32)
B03R19C09	3-9-19	Hs~MGC:BC033025.1~uORF:IOH22485	436	364	534	308	404	323	813	437	417	119	phosphatidic acid phosphatase type 2 domain containing 1B (PPAPDC1B)
B03R19C10	3-10-19	Hs~MGC:BC033025.1~uORF:IOH22485	448	384	518	270	172	343	745	465	312	101	phosphatidic acid phosphatase type 2 domain containing 1B (PPAPDC1B)
B03R19C11	3-11-19	Hs~Ref:NM_018983.2~uORF:IOH3041	1759	1177	1486	533	596	923	3604	988	777	245	nucleolar protein family A, member 1 (H/ACA small nucleolar RNPs) (NOLA1), transcript variant 1
B03R19C12	3-12-19	Hs~Ref:NM_018983.2~uORF:IOH3041	1712	1194	1011	672	566	898	3669	1042	348	434	nucleolar protein family A, member 1 (H/ACA small nucleolar RNPs) (NOLA1), transcript variant 1
B03R19C13	3-13-19	Hs~Ref:NM_144686.1~uORF:IOH12593	420	348	502	347	200	354	811	300	325	136	transmembrane channel-like 4 (TMC4)
B03R19C14	3-14-19	Hs~Ref:NM_144686.1~uORF:IOH12593	439	425	495	380	287	477	775	347	339	11	transmembrane channel-like 4 (TMC4)
B03R19C15	3-15-19	Hs~Ref:NM_004503.2~uORF:IOH42979	4823	3947	2642	3229	3199	4053	5369	4596	6055	5820	homeobox C6 (HOXC6), transcript variant 1
B03R19C16	3-16-19	Hs~Ref:NM_004503.2~uORF:IOH42979	5010	3871	2567	3117	3303	3143	5304	4430	5409	5664	homeobox C6 (HOXC6), transcript variant 1
B03R19C17	3-17-19	Hs~Ref:NM_181656.1~uORF:IOH41475	1078	1098	1421	832	826	1120	1543	1172	2649	728	chromosome 17 open reading frame 58 (C17orf58), transcript variant 2
B03R19C18	3-18-19	Hs~Ref:NM_181656.1~uORF:IOH41475	1115	1106	1370	854	838	1175	1645	1252	2370	458	chromosome 17 open reading frame 58 (C17orf58), transcript variant 2
B03R19C19	3-19-19	Hs~Ref:NM_153764.1~uORF:IOH45724	887	877	1014	600	706	881	1444	1670	1808	469	potassium inwardly-rectifying channel, subfamily J, member 1 (KCNJ1), transcript variant rom-k2
B03R19C20	3-20-19	Hs~Ref:NM_153764.1~uORF:IOH45724	921	789	1086	874	710	863	1532	1613	1791	177	potassium inwardly-rectifying channel, subfamily J, member 1 (KCNJ1), transcript variant rom-k2
B03R19C21	3-21-19	Hs~Ref:NM_031492.1~uORF:IOH5506	1320	794	1112	1241	512	1139	2990	1046	1395	63	RNA binding motif protein 4B (RBM4B)
B03R19C22	3-22-19	Hs~Ref:NM_031492.1~uORF:IOH5506	1399	715	1087	1028	552	1188	3121	1005	1397	-23	RNA binding motif protein 4B (RBM4B)
B03R20C01	3-1-20	Hs~MGC:BC025263.1~uORF:IOH13964	873	649	995	842	605	708	1206	1191	1862	397	cell division cycle associated 4 (CDCA4)
B03R20C02	3-2-20	Hs~MGC:BC025263.1~uORF:IOH13964	951	689	1016	923	603	681	1259	736	2028	411	cell division cycle associated 4 (CDCA4)
B03R20C03	3-3-20	Hs~Ref:NM_133325.1~uORF:IOH10336	914	522	617	433	364	484	1156	597	751	99	PHD finger protein 10 (PHF10), transcript variant 2
B03R20C04	3-4-20	Hs~Ref:NM_133325.1~uORF:IOH10336	723	514	1100	469	440	521	1226	557	731	140	PHD finger protein 10 (PHF10), transcript variant 2
B03R20C05	3-5-20	Hs~Ref:NM_002104.1~uORF:IOH26030	1094	523	983	427	596	752	1850	672	1126	244	granzyme K (granzyme 3; tryptase II) (GZMK)
B03R20C06	3-6-20	Hs~Ref:NM_002104.1~uORF:IOH26030	1217	520	833	454	409	635	1845	686	4437	214	granzyme K (granzyme 3; tryptase II) (GZMK)
B03R20C07	3-7-20	Hs~MGC:BC012001.1~uORF:IOH10862	1999	1354	4464	860	1352	2031	1909	1555	3593	879	carcinoembryonic antigen-related cell adhesion molecule 21 (CEACAM21)
B03R20C08	3-8-20	Hs~MGC:BC012001.1~uORF:IOH10862	1629	1362	4665	793	1064	1937	1948	1624	3955	819	carcinoembryonic antigen-related cell adhesion molecule 21 (CEACAM21)
B03R20C09	3-9-20	Hs~MGC:BC018929.1~uORF:IOH22929	21913	27421	65462	14068	14955	55112	17218	27181	40575	24971	pleckstrin homology-like domain, family A, member 1 (PHLDA1)
B03R20C10	3-10-20	Hs~MGC:BC018929.1~uORF:IOH22929	20175	25792	65455	13222	16074	55132	17930	26849	25104	25870	pleckstrin homology-like domain, family A, member 1 (PHLDA1)
B03R20C11	3-11-20	Hs~Ref:NM_003002.1~uORF:IOH7395	418	419	672	269	397	473	665	430	319	113	succinate dehydrogenase complex, subunit D, integral membrane protein (SDHD), nuclear gene encoding mitochondrial protein
B03R20C12	3-12-20	Hs~Ref:NM_003002.1~uORF:IOH7395	383	389	596	605	698	372	647	490	430	145	succinate dehydrogenase complex, subunit D, integral membrane protein (SDHD), nuclear gene encoding mitochondrial protein
B03R20C13	3-13-20	Hs~Ref:NM_003049.1~uORF:IOH40375	348	402	462	298	249	290	615	449	613	110	solute carrier family 10 (sodium/bile acid cotransporter family), member 1 (SLC10A1)
B03R20C14	3-14-20	Hs~Ref:NM_003049.1~uORF:IOH40375	331	367	472	260	152	342	556	305	202	161	solute carrier family 10 (sodium/bile acid cotransporter family), member 1 (SLC10A1)
B04R02C11	4-11-2	Hs~Ref:NM_000850.2~uORF:IOH9886	1252	1866	1484	10019	656	1166	1235	1455	2552	4133	glutathione S-transferase M4 (GSTM4), transcript variant 1
B04R02C12	4-12-2	Hs~Ref:NM_000850.2~uORF:IOH9886	1406	2065	1568	10468	598	649	1273	1476	848	3958	glutathione S-transferase M4 (GSTM4), transcript variant 1
B04R02C13	4-13-2	Hs~Ref:NM_003551.1~uORF:IOH10879	6210	1852	1548	1777	944	762	1466	1488	484	-6	non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) (NME5)
B04R02C14	4-14-2	Hs~Ref:NM_003551.1~uORF:IOH10879	6325	1923	918	1836	965	730	1468	1446	1463	2059	non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) (NME5)
B04R02C15	4-15-2	Hs~MGC:BC016380.1~uORF:IOH23077	64762	65477	65434	58665	49036	53419	52191	43000	65139	60004	cDNA clone MGC:27376 IMAGE:4688477, complete cds
B04R02C16	4-16-2	Hs~MGC:BC016380.1~uORF:IOH23077	65473	65474	65461	59779	65442	56004	51518	41034	65197	52645	cDNA clone MGC:27376 IMAGE:4688477, complete cds
B04R02C17	4-17-2	Hs~MGC:NM_025196.2~uORF:IOH10877	469	460	839	352	1564	435	2162	500	907	231	GrpE-like 1, mitochondrial (E. coli) (GRPEL1)
B04R02C18	4-18-2	Hs~MGC:NM_025196.2~uORF:IOH10877	511	432	932	479	1661	444	2379	553	1128	-43	GrpE-like 1, mitochondrial (E. coli) (GRPEL1)
B04R02C19	4-19-2	Hs~MGC:BC000452.1~uORF:IOH3518	790	2169	1383	283	946	834	844	468	1354	141	peroxiredoxin 2 (PRDX2)
B04R02C20	4-20-2	Hs~MGC:BC000452.1~uORF:IOH3518	809	2142	1385	384	926	799	893	424	1336	89	peroxiredoxin 2 (PRDX2)
B04R02C21	4-21-2	Hs~Ref:NM_016497.2~uORF:IOH4360	640	913	1498	579	723	107	754	599	887	-20	mitochondrial ribosomal protein L51 (MRPL51), nuclear gene encoding mitochondrial protein
B04R02C22	4-22-2	Hs~Ref:NM_016497.2~uORF:IOH4360	609	876	1371	581	639	131	825	571	862	22	mitochondrial ribosomal protein L51 (MRPL51), nuclear gene encoding mitochondrial protein
B04R03C01	4-1-3	Hs~MGC:BC008641.1~uORF:IOH3164	1335	2286	1352	805	2217	78	975	3147	2320	460	centrosomal protein 290kDa (CEP290)
B04R03C02	4-2-3	Hs~MGC:BC008641.1~uORF:IOH3164	1368	1491	1379	1265	2243	2	938	3091	3226	471	centrosomal protein 290kDa (CEP290)
B04R03C03	4-3-3	Hs~Ref:NM_000190.2~uORF:IOH3306	1292	2443	1964	1717	2063	-141	1577	1410	4962	632	hydroxymethylbilane synthase (HMBS), transcript variant 1
B04R03C04	4-4-3	Hs~Ref:NM_000190.2~uORF:IOH3306	1269	1941	2066	1228	2031	2006	1557	1426	4834	553	hydroxymethylbilane synthase (HMBS), transcript variant 1
B04R03C05	4-5-3	Hs~Ref:NM_002991.2~uORF:IOH34716	818	610	939	348	369	377	1018	617	1182	222	C-C motif chemokine 24
B04R03C06	4-6-3	Hs~Ref:NM_002991.2~uORF:IOH34716	794	624	992	357	373	434	1062	645	1194	14	C-C motif chemokine 24
B04R03C07	4-7-3	Hs~Ref:NM_000562.1~uORF:IOH44369	640	376	899	281	275	201	486	377	962	-28	complement component 8, alpha polypeptide (C8A)
B04R03C08	4-8-3	Hs~Ref:NM_000562.1~uORF:IOH44369	664	405	886	288	317	201	542	488	810	-18	complement component 8, alpha polypeptide (C8A)
B04R03C09	4-9-3	Hs~Ref:NM_212461.1~uORF:IOH45870	924	882	1116	438	451	901	824	622	1264	-30	protein kinase, AMP-activated, gamma 1 non-catalytic subunit (PRKAG1), transcript variant 2
B04R03C10	4-10-3	Hs~Ref:NM_212461.1~uORF:IOH45870	939	967	1274	393	478	362	815	609	1260	-11	protein kinase, AMP-activated, gamma 1 non-catalytic subunit (PRKAG1), transcript variant 2
B04R03C13	4-13-3	Hs~Ref:NM_020348.1~uORF:IOH42100	564	771	3246	405	6867	665	1085	1024	870	12	cyclin M1 (CNNM1)
B04R03C14	4-14-3	Hs~Ref:NM_020348.1~uORF:IOH42100	551	929	3217	358	6414	796	1097	1073	581	-153	cyclin M1 (CNNM1)
B04R03C15	4-15-3	Hs~Ref:NM_181718.3~uORF:IOH43722	635	1930	758	394	3860	96	559	536	1399	-22	aspartate beta-hydroxylase domain containing 1 (ASPHD1)
B04R03C16	4-16-3	Hs~Ref:NM_181718.3~uORF:IOH43722	687	2038	828	208	610	2	529	552	905	-15	aspartate beta-hydroxylase domain containing 1 (ASPHD1)
B04R03C17	4-17-3	Hs~Ref:NM_176823.2~uORF:IOH43135	533	647	434	232	743	1000	1383	695	874	-25	S100 calcium binding protein A7A (S100A7A)
B04R03C18	4-18-3	Hs~Ref:NM_176823.2~uORF:IOH43135	478	641	402	353	735	1021	1262	597	865	-96	S100 calcium binding protein A7A (S100A7A)
B04R03C19	4-19-3	Hs~Ref:NM_181892.1~uORF:IOH43701	511	694	544	1296	795	546	930	1018	1245	-137	ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) (UBE2D3), transcript variant 8
B04R03C20	4-20-3	Hs~Ref:NM_181892.1~uORF:IOH43701	507	775	539	1278	700	539	835	1000	1262	-123	ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) (UBE2D3), transcript variant 8
B04R03C21	4-21-3	Hs~MGC:NM_152267.2~uORF:IOH14506	1029	1202	1676	2048	1128	122	1342	888	3518	-172	ring finger protein 185 (RNF185)
B04R03C22	4-22-3	Hs~MGC:NM_152267.2~uORF:IOH14506	1033	211	1521	2048	1008	-8	1145	797	3179	-149	ring finger protein 185 (RNF185)
B04R04C01	4-1-4	Hs~Ref:NM_144593.1~uORF:IOH11628	1354	1885	1310	592	773	849	1240	907	4166	506	Ras homolog enriched in brain like 1 (RHEBL1)
B04R04C02	4-2-4	Hs~Ref:NM_144593.1~uORF:IOH11628	1308	1152	1443	791	814	0	1268	906	3558	488	Ras homolog enriched in brain like 1 (RHEBL1)
B04R04C03	4-3-4	Hs~MGC:BC029399.1~uORF:IOH23147	979	964	1679	1049	967	-28	1199	1569	4527	572	aldolase B, fructose-bisphosphate (ALDOB)
B04R04C04	4-4-4	Hs~MGC:BC029399.1~uORF:IOH23147	961	859	1509	762	973	-45	1154	1483	3721	518	aldolase B, fructose-bisphosphate (ALDOB)
B04R04C05	4-5-4	Hs~MGC:NM_177552.1~uORF:IOH12788	610	701	879	333	575	2265	1053	1824	2565	317	sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (SULT1A3), transcript variant 2
B04R04C06	4-6-4	Hs~MGC:NM_177552.1~uORF:IOH12788	606	737	886	368	584	2087	1079	1861	2412	348	sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (SULT1A3), transcript variant 2
B04R04C07	4-7-4	Hs~MGC:BC027731.1~uORF:IOH14616	1448	1230	1509	726	881	-3	1649	894	1661	722	mitochondrial translational release factor 1 (MTRF1)
B04R04C08	4-8-4	Hs~MGC:BC027731.1~uORF:IOH14616	1484	1151	1656	683	1191	-258	2020	975	1639	-70	mitochondrial translational release factor 1 (MTRF1)
B04R04C09	4-9-4	Hs~MGC:NM_152266.1~uORF:IOH13579	1860	5425	2476	2134	8463	2471	3893	1964	5909	7516	chromosome 19 open reading frame 40 (C19orf40)
B04R04C10	4-10-4	Hs~MGC:NM_152266.1~uORF:IOH13579	1841	5088	2427	2157	8800	2296	3892	1893	5968	7736	chromosome 19 open reading frame 40 (C19orf40)
B04R04C11	4-11-4	Hs~Ref:NM_013232.2~uORF:IOH10469	1749	2344	3749	1754	2720	-20	1592	2065	4277	1663	programmed cell death 6 (PDCD6)
B04R04C12	4-12-4	Hs~Ref:NM_013232.2~uORF:IOH10469	1662	2411	3668	1861	2645	-1020	1631	1805	4315	-114	programmed cell death 6 (PDCD6)
B04R04C13	4-13-4	Hs~MGC:BC017371.1~uORF:IOH14347	2051	767	2106	633	2482	1263	1264	922	980	-172	ELK3, ETS-domain protein (SRF accessory protein 2) (ELK3)
B04R04C14	4-14-4	Hs~MGC:BC017371.1~uORF:IOH14347	2029	1249	2137	616	2219	788	1195	937	-11	-169	ELK3, ETS-domain protein (SRF accessory protein 2) (ELK3)
B04R04C15	4-15-4	Hs~Ref:NM_006351.1~uORF:IOH21740	733	954	1465	865	1165	1760	1748	647	1910	-101	translocase of inner mitochondrial membrane 44 homolog (yeast) (TIMM44)
B04R04C16	4-16-4	Hs~Ref:NM_006351.1~uORF:IOH21740	842	938	1469	949	1969	145	1663	612	1294	-86	translocase of inner mitochondrial membrane 44 homolog (yeast) (TIMM44)
B04R04C17	4-17-4	Hs~MGC:BC008892.1~uORF:IOH6264	931	5124	4388	2717	4196	263	1497	2177	2454	-257	aldehyde dehydrogenase 3 family, memberA1 (ALDH3A1)
B04R04C18	4-18-4	Hs~MGC:BC008892.1~uORF:IOH6264	960	5064	4423	2824	4006	-14	1417	2151	2739	-133	aldehyde dehydrogenase 3 family, memberA1 (ALDH3A1)
B04R04C19	4-19-4	Hs~MGC:BC013294.2~uORF:IOH13234	637	677	1311	575	890	-37	1138	625	1513	-145	DKFZP564O0823 protein (DKFZP564O0823)
B04R04C20	4-20-4	Hs~MGC:BC013294.2~uORF:IOH13234	708	620	1333	552	935	32	1147	660	-154	-131	DKFZP564O0823 protein (DKFZP564O0823)
B04R04C21	4-21-4	Hs~Ref:NM_004094.2~uORF:IOH4059	1144	1766	1596	542	1193	944	1913	602	1472	-166	eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa (EIF2S1)
B04R04C22	4-22-4	Hs~Ref:NM_004094.2~uORF:IOH4059	1134	1718	1494	558	1156	749	1773	502	1812	-264	eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa (EIF2S1)
B04R05C01	4-1-5	Hs~Ref:NM_206909.1~uORF:IOH43255	1656	1475	2098	647	2842	2849	6816	11041	4095	10351	pleckstrin and Sec7 domain containing 3 (PSD3), transcript variant 2
B04R05C02	4-2-5	Hs~Ref:NM_206909.1~uORF:IOH43255	1580	1456	2161	879	2975	3106	6674	11065	4033	10507	pleckstrin and Sec7 domain containing 3 (PSD3), transcript variant 2
B04R05C03	4-3-5	Hs~Ref:NM_138430.3~uORF:IOH43468	4751	508	736	462	478	842	1420	789	1203	312	ADP-ribosylhydrolase like 1 (ADPRHL1), transcript variant 1
B04R05C04	4-4-5	Hs~Ref:NM_138430.3~uORF:IOH43468	4517	524	688	285	481	813	1307	707	1215	311	ADP-ribosylhydrolase like 1 (ADPRHL1), transcript variant 1
B04R05C05	4-5-5	Hs~Ref:NM_007278.1~uORF:IOH41289	4895	1925	4543	1889	854	-35	14010	983	3847	1199	GABA(A) receptor-associated protein (GABARAP)
B04R05C06	4-6-5	Hs~Ref:NM_007278.1~uORF:IOH41289	4750	1981	4663	1914	2141	2449	14192	1121	3715	1186	GABA(A) receptor-associated protein (GABARAP)
B04R05C07	4-7-5	Hs~Ref:NM_181514.1~uORF:IOH43068	674	249	724	368	2110	272	949	588	739	173	mitochondrial ribosomal protein L21 (MRPL21), nuclear gene encoding mitochondrial protein, transcript variant 4
B04R05C08	4-8-5	Hs~Ref:NM_181514.1~uORF:IOH43068	651	565	736	397	3166	-62	1194	478	732	20	mitochondrial ribosomal protein L21 (MRPL21), nuclear gene encoding mitochondrial protein, transcript variant 4
B04R05C09	4-9-5	Hs~MGC:NM_173471.1~uORF:IOH40179	763	602	1134	592	739	6	1393	664	1053	83	S-adenosylmethionine mitochondrial carrier protein
B04R05C10	4-10-5	Hs~MGC:NM_173471.1~uORF:IOH40179	753	675	1305	569	871	403	1493	726	1128	-4	S-adenosylmethionine mitochondrial carrier protein
B04R05C11	4-11-5	Hs~Ref:NM_001004306.1~uORF:IOH40085	3926	2400	4326	2006	5155	2565	3748	2254	6710	1183	similar to hypothetical protein FLJ36492 (MGC87631)
B04R05C12	4-12-5	Hs~Ref:NM_001004306.1~uORF:IOH40085	3531	2621	4311	2377	4872	2535	3760	2078	6676	1037	similar to hypothetical protein FLJ36492 (MGC87631)
B04R05C13	4-13-5	Hs~Ref:NM_207337.1~uORF:IOH40127	1914	1873	2185	1022	2312	2200	2808	1248	3325	-202	antagonist of mitotic exit network 1 homolog (S. cerevisiae) (AMN1)
B04R05C14	4-14-5	Hs~Ref:NM_207337.1~uORF:IOH40127	1992	1070	2101	997	3034	552	2827	1388	3565	-383	antagonist of mitotic exit network 1 homolog (S. cerevisiae) (AMN1)
B04R05C15	4-15-5	Hs~Ref:NM_001004300.1~uORF:IOH40180	1759	1289	2171	1385	1358	623	1780	942	120	-222	zinc finger protein 720 (ZNF720)
B04R05C16	4-16-5	Hs~Ref:NM_001004300.1~uORF:IOH40180	1701	1321	2208	1434	2890	1315	1857	1073	916	-110	zinc finger protein 720 (ZNF720)
B04R05C17	4-17-5	Hs~Ref:NM_006953.2~uORF:IOH40285	677	1596	743	1221	759	2949	1218	1100	1143	-267	uroplakin 3A (UPK3A)
B04R05C18	4-18-5	Hs~Ref:NM_006953.2~uORF:IOH40285	658	1549	929	1251	726	2726	1226	1355	941	-20	uroplakin 3A (UPK3A)
B04R05C19	4-19-5	Hs~Ref:NM_178044.1~uORF:IOH40768	804	924	1558	748	1029	770	1387	875	1815	-203	GIY-YIG domain containing 2 (GIYD2), transcript variant 2
B04R05C20	4-20-5	Hs~Ref:NM_178044.1~uORF:IOH40768	896	938	1537	710	1039	1011	1383	956	1839	-239	GIY-YIG domain containing 2 (GIYD2), transcript variant 2
B04R05C21	4-21-5	Hs~Ref:XM_376764.2~uORF:IOH40703	3432	2010	1615	1142	1237	1834	1345	1300	2002	419	paraneoplastic antigen MA2 (PNMA2)
B04R05C22	4-22-5	Hs~Ref:XM_376764.2~uORF:IOH40703	3450	2104	1541	1116	1094	1872	1365	1052	2174	-217	paraneoplastic antigen MA2 (PNMA2)
B04R06C01	4-1-6	Hs~Ref:NM_021821.2~uORF:IOH40909	659	377	615	282	373	214	687	490	967	250	mitochondrial ribosomal protein S35 (MRPS35), nuclear gene encoding mitochondrial protein
B04R06C02	4-2-6	Hs~Ref:NM_021821.2~uORF:IOH40909	665	406	718	491	309	194	701	499	805	247	mitochondrial ribosomal protein S35 (MRPS35), nuclear gene encoding mitochondrial protein
B04R06C03	4-3-6	Hs~Ref:NM_014508.2~uORF:IOH54737	3725	1580	2478	1717	1667	1927	14775	2018	3097	568	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C (APOBEC3C), mRNA.
B04R06C04	4-4-6	Hs~Ref:NM_014508.2~uORF:IOH54737	3741	1629	2363	1323	2277	-39	14784	1991	3188	523	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C (APOBEC3C), mRNA.
B04R06C05	4-5-6	Hs~Ref:NM_006010.2~uORF:IOH59542	1205	565	892	398	2769	-24	1393	559	1130	282	Protein ARMET
B04R06C06	4-6-6	Hs~Ref:NM_006010.2~uORF:IOH59542	1187	628	905	404	1178	-29	1356	610	1050	290	Protein ARMET
B04R06C07	4-7-6	Hs~Ref:NM_002451.3~uORF:IOH54928	2282	8611	2660	1492	2484	-24	3445	19590	4426	1013	methylthioadenosine phosphorylase (MTAP), mRNA.
B04R06C08	4-8-6	Hs~Ref:NM_002451.3~uORF:IOH54928	2309	8640	2661	1544	2464	-225	3761	20295	4527	1026	methylthioadenosine phosphorylase (MTAP), mRNA.
B04R06C09	4-9-6	Hs~Ref:NM_004862.2~uORF:IOH54666	1253	1211	3831	678	1564	-376	1641	1200	3541	573	Lipopolysaccharide-induced tumor necrosis factor-alpha factor
B04R06C10	4-10-6	Hs~Ref:NM_004862.2~uORF:IOH54666	1319	1129	3788	716	1451	435	1681	1179	3442	-95	Lipopolysaccharide-induced tumor necrosis factor-alpha factor
B04R06C11	4-11-6	Hs~MGC:BC002568.1~uORF:IOH4051	746	1501	2843	907	860	1941	1308	1298	1993	88	cytokine induced apoptosis inhibitor 1 (CIAPIN1)
B04R06C12	4-12-6	Hs~MGC:BC002568.1~uORF:IOH4051	826	1488	2670	913	791	1786	1260	1287	2004	325	cytokine induced apoptosis inhibitor 1 (CIAPIN1)
B04R06C13	4-13-6	Hs~MGC:BC009820.2~uORF:IOH12615	4656	8107	3916	12066	2944	8305	3625	4579	4983	1097	chromosome 11 open reading frame 63 (C11orf63)
B04R06C14	4-14-6	Hs~MGC:BC009820.2~uORF:IOH12615	4634	8538	3862	11400	3071	8613	3289	3557	4646	-18	chromosome 11 open reading frame 63 (C11orf63)
B04R06C15	4-15-6	Hs~MGC:BC022344.1~uORF:IOH14799	3361	35543	6579	6845	4765	3525	3413	2282	7073	5032	twinfilin, actin-binding protein, homolog 1 (Drosophila) (TWF1)
B04R06C16	4-16-6	Hs~MGC:BC022344.1~uORF:IOH14799	3388	35234	6566	6722	4973	3511	3391	2352	7600	1393	twinfilin, actin-binding protein, homolog 1 (Drosophila) (TWF1)
B04R06C17	4-17-6	Hs~Ref:NM_024946.1~uORF:IOH10395	2351	1222	2701	2352	3744	2953	4865	5694	4887	-554	NEFA-interacting nuclear protein NIP30 (NIP30)
B04R06C18	4-18-6	Hs~Ref:NM_024946.1~uORF:IOH10395	2153	1213	2577	2303	3390	2857	5037	5173	4150	-265	NEFA-interacting nuclear protein NIP30 (NIP30)
B04R06C19	4-19-6	Hs~MGC:BC003188.1~uORF:IOH4526	1624	1506	1056	739	2138	168	1397	1437	2635	318	MACRO domain-containing protein 1
B04R06C20	4-20-6	Hs~MGC:BC003188.1~uORF:IOH4526	1842	1745	1186	869	2206	1637	1720	1412	2717	-479	MACRO domain-containing protein 1
B04R07C01	4-1-7	Hs~Ref:NM_003944.2~uORF:IOH2324	1299	656	465	271	2001	443	441	579	1069	222	Selenium-binding protein 1
B04R07C02	4-2-7	Hs~Ref:NM_003944.2~uORF:IOH2324	1330	590	520	392	1621	144	475	609	1112	238	Selenium-binding protein 1
B04R07C05	4-5-7	Hs~Ref:NM_004845.3~uORF:IOH41138	1296	216	580	506	847	-7	114	1582	1026	178	phosphate cytidylyltransferase 1, choline, beta (PCYT1B)
B04R07C06	4-6-7	Hs~Ref:NM_004845.3~uORF:IOH41138	1286	191	594	517	776	29	1083	1604	1050	161	phosphate cytidylyltransferase 1, choline, beta (PCYT1B)
B04R07C07	4-7-7	Hs~Ref:NM_153757.1~uORF:IOH41339	880	592	2110	540	1458	975	1562	658	1619	327	nucleosome assembly protein 1-like 5 (NAP1L5)
B04R07C08	4-8-7	Hs~Ref:NM_153757.1~uORF:IOH41339	883	605	2139	553	1399	1022	1753	715	1623	322	nucleosome assembly protein 1-like 5 (NAP1L5)
B04R07C09	4-9-7	Hs~Ref:NM_022347.1~uORF:IOH41552	1132	627	6548	418	903	-124	813	636	1194	299	interferon responsive gene 15 (IFRG15)
B04R07C10	4-10-7	Hs~Ref:NM_022347.1~uORF:IOH41552	1120	602	6229	383	2712	1791	821	628	1148	148	interferon responsive gene 15 (IFRG15)
B04R07C11	4-11-7	Hs~Ref:NM_021071.2~uORF:IOH42492	581	554	1396	383	1505	741	1059	576	1215	-8	ADP-ribosyltransferase 4 (Dombrock blood group) (ART4)
B04R07C12	4-12-7	Hs~Ref:NM_021071.2~uORF:IOH42492	536	544	1374	511	1522	752	1103	553	1200	-107	ADP-ribosyltransferase 4 (Dombrock blood group) (ART4)
B04R07C13	4-13-7	Hs~Ref:NM_002003.2~uORF:IOH13613	2256	2161	2213	1725	1521	-14	12	-2	2660	1605	Ficolin-1
B04R07C14	4-14-7	Hs~Ref:NM_002003.2~uORF:IOH13613	2214	1963	2195	1496	1682	-1	-2	0	3275	1046	Ficolin-1
B04R07C15	4-15-7	Hs~Ref:NM_002974.1~uORF:IOH14839	569	500	670	439	174	23	20	-1	3537	-144	serpin peptidase inhibitor, clade B (ovalbumin), member 4 (SERPINB4)
B04R07C16	4-16-7	Hs~Ref:NM_002974.1~uORF:IOH14839	631	516	698	458	199	7	17	428	874	-45	serpin peptidase inhibitor, clade B (ovalbumin), member 4 (SERPINB4)
B04R07C17	4-17-7	Hs~MGC:BC025959.1~uORF:IOH14588	669	1311	1236	18174	652	2	1312	-3	7530	-231	dynein, cytoplasmic 1, light intermediate chain 2 (DYNC1LI2)
B04R07C18	4-18-7	Hs~MGC:BC025959.1~uORF:IOH14588	673	1547	1191	17802	736	1404	1382	0	6048	-288	dynein, cytoplasmic 1, light intermediate chain 2 (DYNC1LI2)
B04R07C19	4-19-7	Hs~MGC:BC024289.1~uORF:IOH14745	49542	45214	46869	35534	36903	34176	27943	36245	65059	52996	interferon, alpha-inducible protein 6 (IFI6)
B04R07C20	4-20-7	Hs~MGC:BC024289.1~uORF:IOH14745	46329	43342	45138	39416	36429	33909	28913	38557	65218	58580	interferon, alpha-inducible protein 6 (IFI6)
B04R08C03	4-3-8	Hs~Ref:NM_016230.3~uORF:IOH61410	1372	2070	2420	1479	2313	2286	4164	2069	2826	1156	cytochrome b5 reductase 4 (CYB5R4)
B04R08C04	4-4-8	Hs~Ref:NM_016230.3~uORF:IOH61410	1399	2309	2501	1482	2230	2290	4115	1927	2716	1063	cytochrome b5 reductase 4 (CYB5R4)
B04R08C07	4-7-8	Hs~Ref:NM_015938.2~uORF:IOH12752	736	1249	1608	706	2955	67	1335	726	1422	422	NMD3 homolog (S. cerevisiae) (NMD3)
B04R08C08	4-8-8	Hs~Ref:NM_015938.2~uORF:IOH12752	771	1173	1687	730	523	22	1363	775	1487	420	NMD3 homolog (S. cerevisiae) (NMD3)
B04R08C09	4-9-8	Hs~MGC:BC009249.1~uORF:IOH12481	724	530	1030	514	579	-18	824	678	2086	363	kaptin (actin binding protein) (KPTN)
B04R08C10	4-10-8	Hs~MGC:BC009249.1~uORF:IOH12481	741	564	1028	517	600	-49	821	666	2103	381	kaptin (actin binding protein) (KPTN)
B04R08C11	4-11-8	Hs~Ref:NM_130788.1~uORF:IOH4842	1043	1538	1482	665	822	1226	1151	992	1956	632	WW domain containing oxidoreductase (WWOX), transcript variant 4
B04R08C12	4-12-8	Hs~Ref:NM_130788.1~uORF:IOH4842	1045	1520	1440	751	767	1126	1131	1017	1905	-69	WW domain containing oxidoreductase (WWOX), transcript variant 4
B04R08C13	4-13-8	Hs~MGC:BC002360.1~uORF:IOH3606	1522	1603	1503	1022	643	-41	923	1438	1924	-65	elongation factor Tu GTP binding domain containing 2 (EFTUD2)
B04R08C14	4-14-8	Hs~MGC:BC002360.1~uORF:IOH3606	1530	1517	1398	1081	622	65	891	1527	1274	-459	elongation factor Tu GTP binding domain containing 2 (EFTUD2)
B04R08C19	4-19-8	Hs~MGC:BC009393.2~uORF:IOH12944	725	1174	1066	557	860	452	1034	652	1316	59	HIV-1 Rev binding protein-like (HRBL)
B04R08C20	4-20-8	Hs~MGC:BC009393.2~uORF:IOH12944	937	1140	1095	669	789	237	916	725	2526	-11	HIV-1 Rev binding protein-like (HRBL)
B04R08C21	4-21-8	Hs~MGC:BC017869.1~uORF:IOH13888	839	625	1333	671	649	440	680	779	1162	-30	F-box protein 36 (FBXO36)
B04R08C22	4-22-8	Hs~MGC:BC017869.1~uORF:IOH13888	775	565	1134	603	715	303	706	956	1549	15	F-box protein 36 (FBXO36)
B04R09C01	4-1-9	Hs~MGC:BC070203.1~uORF:IOH40798	487	447	502	274	2114	582	397	409	699	206	collagen, type IV, alpha 6 (COL4A6)
B04R09C02	4-2-9	Hs~MGC:BC070203.1~uORF:IOH40798	498	439	515	323	652	316	447	390	585	210	collagen, type IV, alpha 6 (COL4A6)
B04R09C03	4-3-9	Hs~Ref:NM_198490.1~uORF:IOH40675	1026	539	843	633	907	1186	1593	819	2050	361	RAB43, member RAS oncogene family (RAB43)
B04R09C04	4-4-9	Hs~Ref:NM_198490.1~uORF:IOH40675	1006	578	909	627	763	1232	1621	879	2177	348	RAB43, member RAS oncogene family (RAB43)
B04R09C05	4-5-9	Hs~Ref:NM_001004331.1~uORF:IOH40802	477	631	1221	300	231	5	557	502	869	294	similar to CG32662-PA (MGC88374)
B04R09C06	4-6-9	Hs~Ref:NM_001004331.1~uORF:IOH40802	535	399	1268	305	300	347	565	540	915	320	similar to CG32662-PA (MGC88374)
B04R09C09	4-9-9	Hs~MGC:BC043564.1~uORF:IOH26298	455	405	649	331	307	135	569	460	829	292	potassium voltage-gated channel, shaker-related subfamily, member 2 (KCNA2)
B04R09C10	4-10-9	Hs~MGC:BC043564.1~uORF:IOH26298	457	426	707	322	286	-98	580	439	787	22	potassium voltage-gated channel, shaker-related subfamily, member 2 (KCNA2)
B04R09C11	4-11-9	Hs~MGC:BC041174.1~uORF:IOH26249	311	275	461	246	200	95	360	303	396	31	cytochrome P450, family 2, subfamily B, polypeptide 7 pseudogene 1 (CYP2B7P1)
B04R09C12	4-12-9	Hs~MGC:BC041174.1~uORF:IOH26249	4136	295	434	293	257	71	347	332	406	21	cytochrome P450, family 2, subfamily B, polypeptide 7 pseudogene 1 (CYP2B7P1)
B04R09C13	4-13-9	Hs~MGC:BC044938.1~uORF:IOH26297	886	333	609	292	227	122	449	403	696	17	F-box and leucine-rich repeat protein 21 (FBXL21)
B04R09C14	4-14-9	Hs~MGC:BC044938.1~uORF:IOH26297	575	331	633	261	232	176	500	331	-9	-28	F-box and leucine-rich repeat protein 21 (FBXL21)
B04R09C15	4-15-9	Hs~MGC:BC047869.1~uORF:IOH26925	606	455	467	406	334	1055	487	507	213	21	cytochrome c oxidase subunit IV isoform 1 (COX4I1)
B04R09C16	4-16-9	Hs~MGC:BC047869.1~uORF:IOH26925	571	454	442	438	292	-30	530	493	551	-28	cytochrome c oxidase subunit IV isoform 1 (COX4I1)
B04R09C17	4-17-9	Hs~Ref:NM_144492.1~uORF:IOH12590	1587	1681	2149	818	913	153	2366	2233	3700	-75	claudin 14 (CLDN14), transcript variant 1
B04R09C18	4-18-9	Hs~Ref:NM_144492.1~uORF:IOH12590	1815	1779	2267	947	1158	3959	2583	2275	4319	2	claudin 14 (CLDN14), transcript variant 1
B04R09C19	4-19-9	Hs~MGC:BC021245.2~uORF:IOH12158	1100	1171	1916	736	1020	767	1510	865	1309	-85	AFG3 ATPase family gene 3-like 1 (S. cerevisiae) (AFG3L1)
B04R09C20	4-20-9	Hs~MGC:BC021245.2~uORF:IOH12158	1194	1177	1935	759	1000	871	1778	933	4072	-171	AFG3 ATPase family gene 3-like 1 (S. cerevisiae) (AFG3L1)
B04R09C21	4-21-9	Hs~MGC:NM_152613.1~uORF:IOH10808	1845	1585	1935	1082	1280	2714	2546	1540	5348	-125	WBP2 N-terminal like (WBP2NL)
B04R09C22	4-22-9	Hs~MGC:NM_152613.1~uORF:IOH10808	1738	1413	1739	1103	1203	1095	2452	1477	1503	-8	WBP2 N-terminal like (WBP2NL)
B04R10C01	4-1-10	Hs~Ref:NM_015417.2~uORF:IOH11253	3731	2204	4327	1389	2019	3232	2924	2014	5031	852	sperm flagellar 1 (SPEF1)
B04R10C02	4-2-10	Hs~Ref:NM_015417.2~uORF:IOH11253	3774	2162	3895	1534	1580	3145	2998	1987	4675	890	sperm flagellar 1 (SPEF1)
B04R10C03	4-3-10	Hs~MGC:BC040732.1~uORF:IOH28779	706	813	804	508	329	976	830	407	1471	345	leucine-rich repeats and transmembrane domains 1 (LRTM1)
B04R10C04	4-4-10	Hs~MGC:BC040732.1~uORF:IOH28779	668	833	679	437	267	623	834	456	1388	345	leucine-rich repeats and transmembrane domains 1 (LRTM1)
B04R10C05	4-5-10	Hs~MGC:BC036917.1~uORF:IOH28736	792	2713	791	428	582	3099	1119	483	1193	372	chromosome 6 open reading frame 141 (C6orf141)
B04R10C06	4-6-10	Hs~MGC:BC036917.1~uORF:IOH28736	808	2636	805	422	65	20	1144	531	1170	351	chromosome 6 open reading frame 141 (C6orf141)
B04R10C07	4-7-10	Hs~MGC:BC054033.1~uORF:IOH29124	470	2020	745	294	232	-39	1148	1162	961	268	methionine sulfoxide reductase A (MSRA)
B04R10C08	4-8-10	Hs~MGC:BC054033.1~uORF:IOH29124	441	1987	743	291	611	-31	1187	1097	912	244	methionine sulfoxide reductase A (MSRA)
B04R10C09	4-9-10	Hs~MGC:BC037957.1~uORF:IOH28753	1134	689	969	496	3048	66	1963	605	1144	187	Intermediate filament tail domain-containing protein 1
B04R10C10	4-10-10	Hs~MGC:BC037957.1~uORF:IOH28753	1220	678	976	492	418	52	1920	619	1079	523	Intermediate filament tail domain-containing protein 1
B04R11C21	4-21-11	Hs~MGC:BC020602.1~uORF:IOH23062	375	423	715	835	303	290	576	401	292	189	NOL1/NOP2/Sun domain family, member 3 (NSUN3)
B04R11C22	4-22-11	Hs~MGC:BC020602.1~uORF:IOH23062	442	177	349	1260	165	266	482	341	174	62	NOL1/NOP2/Sun domain family, member 3 (NSUN3)
B04R12C01	4-1-12	Hs~MGC:BC053533.1~uORF:IOH28925	597	1088	539	267	212	110	571	496	768	237	MTERF domain containing 2 (MTERFD2)
B04R12C02	4-2-12	Hs~MGC:BC053533.1~uORF:IOH28925	511	1575	531	2215	176	162	572	594	769	238	MTERF domain containing 2 (MTERFD2)
B04R12C03	4-3-12	Hs~MGC:BC056398.1~uORF:IOH28786	773	548	994	694	334	920	899	468	1426	346	adaptor-related protein complex 3, mu 2 subunit (AP3M2)
B04R12C04	4-4-12	Hs~MGC:BC056398.1~uORF:IOH28786	751	559	1045	1308	730	851	901	510	1271	303	adaptor-related protein complex 3, mu 2 subunit (AP3M2)
B04R12C05	4-5-12	Hs~MGC:BC051849.2~uORF:IOH28888	609	473	1604	1151	839	736	703	660	1356	299	RPA interacting protein (RPAIN)
B04R12C06	4-6-12	Hs~MGC:BC051849.2~uORF:IOH28888	617	447	1866	1127	773	-25	646	651	1335	291	RPA interacting protein (RPAIN)
B04R12C07	4-7-12	Hs~Ref:NM_175733.2~uORF:IOH26388	596	661	845	456	682	232	1001	757	1429	599	synaptotagmin IX (SYT9)
B04R12C08	4-8-12	Hs~Ref:NM_175733.2~uORF:IOH26388	586	681	781	478	3432	546	981	830	1334	501	synaptotagmin IX (SYT9)
B04R12C09	4-9-12	Hs~Ref:NM_005254.3~uORF:IOH27031	688	476	895	795	1101	672	842	506	3564	422	GA binding protein transcription factor, beta subunit 2 (GABPB2), transcript variant beta-1
B04R12C10	4-10-12	Hs~Ref:NM_005254.3~uORF:IOH27031	691	477	898	798	1043	697	833	509	3562	429	GA binding protein transcription factor, beta subunit 2 (GABPB2), transcript variant beta-1
B04R12C11	4-11-12	Hs~Ref:NM_139246.3~uORF:IOH27557	2130	868	1484	863	2165	-9	1567	1155	2996	632	chromosome 9 open reading frame 97 (C9orf97)
B04R12C12	4-12-12	Hs~Ref:NM_139246.3~uORF:IOH27557	2760	906	1500	891	1451	-41	1548	1145	2856	709	chromosome 9 open reading frame 97 (C9orf97)
B04R12C13	4-13-12	Hs~Ref:NM_004997.2~uORF:IOH26421	1457	1959	1742	984	1942	203	2241	1266	3043	4896	myosin binding protein H (MYBPH)
B04R12C14	4-14-12	Hs~Ref:NM_004997.2~uORF:IOH26421	1106	2056	1734	916	3724	-20	2393	1284	3114	3123	myosin binding protein H (MYBPH)
B04R12C15	4-15-12	Hs~MGC:BC033818.1~uORF:IOH21869	1070	478	964	423	4286	-8	741	379	-23	-7	V-set and transmembrane domain containing 2 like (C20orf102)
B04R12C16	4-16-12	Hs~MGC:BC033818.1~uORF:IOH21869	1042	507	1188	435	3656	-5	816	349	208	-33	V-set and transmembrane domain containing 2 like (C20orf102)
B04R12C17	4-17-12	Hs~MGC:NM_152653.1~uORF:IOH13176	1778	889	1745	744	15440	-60	3042	764	4012	402	ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) (UBE2E2)
B04R12C18	4-18-12	Hs~MGC:NM_152653.1~uORF:IOH13176	1893	878	1745	753	17567	-66	3428	774	3986	366	ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) (UBE2E2)
B04R12C19	4-19-12	Hs~Ref:NM_006886.2~uORF:IOH3903	40	261	436	243	1835	52	427	268	340	-14	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit (ATP5E), nuclear gene encoding mitochondrial protein
B04R12C20	4-20-12	Hs~Ref:NM_006886.2~uORF:IOH3903	223	354	445	223	1370	59	429	290	132	86	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit (ATP5E), nuclear gene encoding mitochondrial protein
B04R12C21	4-21-12	Hs~Ref:NM_145044.1~uORF:IOH10819	1033	527	866	471	2315	48	1738	614	186	72	zinc finger protein 501 (ZNF501)
B04R12C22	4-22-12	Hs~Ref:NM_145044.1~uORF:IOH10819	1024	428	666	544	1007	174	1653	522	609	83	zinc finger protein 501 (ZNF501)
B04R13C01	4-1-13	Hs~MGC:BC029480.1~uORF:IOH23188	1315	1297	1618	1741	1292	1170	1655	953	2544	686	hypothetical LOC554203 (LOC554203)
B04R13C02	4-2-13	Hs~MGC:BC029480.1~uORF:IOH23188	1301	1207	1600	1913	1320	1107	1693	127	2454	673	hypothetical LOC554203 (LOC554203)
B04R13C03	4-3-13	Hs~Ref:NM_004332.1~uORF:IOH60535	329	89	722	1181	6328	1391	628	560	1764	414	Valacyclovir hydrolase
B04R13C04	4-4-13	Hs~Ref:NM_004332.1~uORF:IOH60535	297	417	753	1328	6323	1520	807	742	1473	431	Valacyclovir hydrolase
B04R13C05	4-5-13	Hs~MGC:BC094726.1~uORF:IOH62681	2491	1534	2313	1396	1457	1607	4703	1348	4442	709	Inositol polyphosphate 5-phosphatase OCRL-1
B04R13C06	4-6-13	Hs~MGC:BC094726.1~uORF:IOH62681	2521	1547	2433	1355	1426	294	5012	1323	4359	715	Inositol polyphosphate 5-phosphatase OCRL-1
B04R13C07	4-7-13	Hs~MGC:NM_174922.3~uORF:IOH22636	450	395	601	213	291	110	427	375	713	238	Uncharacterized aarF domain-containing protein kinase 5
B04R13C08	4-8-13	Hs~MGC:NM_174922.3~uORF:IOH22636	448	406	618	216	233	246	457	420	713	240	Uncharacterized aarF domain-containing protein kinase 5
B04R13C09	4-9-13	Hs~Ref:NM_014752.1~uORF:IOH5878	398	445	625	333	4486	65	457	410	1321	375	signal peptidase complex subunit 2 homolog (S. cerevisiae) (SPCS2)
B04R13C10	4-10-13	Hs~Ref:NM_014752.1~uORF:IOH5878	397	483	589	362	2319	-109	414	401	1268	356	signal peptidase complex subunit 2 homolog (S. cerevisiae) (SPCS2)
B04R13C11	4-11-13	Hs~Ref:NM_022572.1~uORF:IOH6351	382	398	464	268	414	-21	570	348	855	34	paroxysmal nonkinesigenic dyskinesia (PNKD), transcript variant 2
B04R13C12	4-12-13	Hs~Ref:NM_022572.1~uORF:IOH6351	491	388	620	317	590	-14	463	379	990	41	paroxysmal nonkinesigenic dyskinesia (PNKD), transcript variant 2
B04R13C13	4-13-13	Hs~MGC:BC004369.1~uORF:IOH5590	348	271	2	249	883	-38	366	303	659	76	amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease) (APP)
B04R13C14	4-14-13	Hs~MGC:BC004369.1~uORF:IOH5590	437	274	498	213	775	-33	441	280	652	-90	amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease) (APP)
B04R13C15	4-15-13	Hs~Ref:NM_006923.2~uORF:IOH4099	547	432	812	354	661	26	623	504	1782	9	stromal cell-derived factor 2 (SDF2)
B04R13C16	4-16-13	Hs~Ref:NM_006923.2~uORF:IOH4099	532	453	920	366	1736	-50	684	577	1372	116	stromal cell-derived factor 2 (SDF2)
B04R13C17	4-17-13	Hs~Ref:NM_198538.1~uORF:IOH39839	113	1476	283	129	250	-96	380	261	-230	30	Suprabasin
B04R13C18	4-18-13	Hs~Ref:NM_198538.1~uORF:IOH39839	93	1514	36	103	512	-185	373	214	-244	-44	Suprabasin
B04R13C19	4-19-13	Hs~Ref:NM_015920.3~uORF:IOH57353	1934	1039	2122	931	1347	-80	5565	844	1083	-83	40S ribosomal protein S27-like protein
B04R13C20	4-20-13	Hs~Ref:NM_015920.3~uORF:IOH57353	2041	1000	2096	814	1221	35	5872	821	34	-57	40S ribosomal protein S27-like protein
B04R13C21	4-21-13	Hs~Ref:NM_002432.1~uORF:IOH21730	596	416	523	318	479	-137	727	438	-75	-28	Myeloid cell nuclear differentiation antigen
B04R13C22	4-22-13	Hs~Ref:NM_002432.1~uORF:IOH21730	453	400	515	343	338	18	695	433	203	-20	Myeloid cell nuclear differentiation antigen
B04R14C01	4-1-14	Hs~MGC:BC014409.1~uORF:IOH13355	1044	1697	1850	727	1146	1185	1560	1815	2863	545	phosphopantothenoylcysteine decarboxylase (PPCDC)
B04R14C02	4-2-14	Hs~MGC:BC014409.1~uORF:IOH13355	1070	1653	1726	864	1109	1150	1529	1781	2839	535	phosphopantothenoylcysteine decarboxylase (PPCDC)
B04R14C03	4-3-14	Hs~Ref:NM_003385.4~uORF:IOH59016	322	58	423	542	311	334	176	480	732	113	Visinin-like protein 1
B04R14C04	4-4-14	Hs~Ref:NM_003385.4~uORF:IOH59016	194	124	390	304	296	391	154	466	718	83	Visinin-like protein 1
B04R14C07	4-7-14	Hs~Ref:NM_178550.3~uORF:IOH59725	2474	1228	1522	919	1294	2671	4611	924	5551	823	Coiled-coil domain-containing protein C1orf110
B04R14C08	4-8-14	Hs~Ref:NM_178550.3~uORF:IOH59725	2359	1246	1464	971	1230	2439	4721	913	5666	810	Coiled-coil domain-containing protein C1orf110
B04R14C09	4-9-14	Hs~Ref:NM_000298.4~uORF:IOH11862	943	1029	956	596	5375	1397	2054	1127	2233	361	Pyruvate kinase isozymes R/L
B04R14C10	4-10-14	Hs~Ref:NM_000298.4~uORF:IOH11862	942	1027	953	611	2156	-108	2043	1143	2187	391	Pyruvate kinase isozymes R/L
B04R14C11	4-11-14	Hs~Ref:NM_020423.1~N/A	18	91	309	100	348	26	283	223	151	26	SCY1-like 3 (S. cerevisiae) (SCYL3), transcript variant 1
B04R14C12	4-12-14	Hs~Ref:NM_020423.1~N/A	120	110	204	58	271	9	264	204	139	11	SCY1-like 3 (S. cerevisiae) (SCYL3), transcript variant 1
B04R14C13	4-13-14	Hs~Ref:NM_004304.2~N/A	108	59	251	-4	181	-8	210	232	102	15	ALK tyrosine kinase receptor
B04R14C14	4-14-14	Hs~Ref:NM_004304.2~N/A	25	37	200	38	226	1	272	194	155	9	ALK tyrosine kinase receptor
B04R14C15	4-15-14	Hs~Ref:NM_006891.2~uORF:IOH59488	494	385	870	467	301	534	810	490	2532	251	Gamma-crystallin D
B04R14C16	4-16-14	Hs~Ref:NM_006891.2~uORF:IOH59488	529	444	905	438	671	459	1413	613	2349	199	Gamma-crystallin D
B04R14C19	4-19-14	Hs~MGC:BC059361.1~uORF:IOH29207	514	533	1006	393	354	-92	1002	520	796	-70	ADP-ribosylation factor-like 10 (ARL10)
B04R14C20	4-20-14	Hs~MGC:BC059361.1~uORF:IOH29207	649	559	1071	385	-14	403	1052	499	59	-113	ADP-ribosylation factor-like 10 (ARL10)
B04R14C21	4-21-14	Hs~Ref:NM_001004354.1~uORF:IOH29006	340	1144	3333	487	686	18841	475	717	1236	5151	Notch-regulated ankyrin repeat protein (NRARP)
B04R14C22	4-22-14	Hs~Ref:NM_001004354.1~uORF:IOH29006	347	1096	3297	510	607	19004	425	748	1313	4841	Notch-regulated ankyrin repeat protein (NRARP)
B04R15C01	4-1-15	Hs~MGC:BC054004.1~uORF:IOH29012	864	453	19842	678	1092	738	2355	1003	3146	462	septin 9 (SEPT9)
B04R15C02	4-2-15	Hs~MGC:BC054004.1~uORF:IOH29012	897	462	19169	760	1082	580	2657	1082	3079	455	septin 9 (SEPT9)
B04R15C03	4-3-15	Hs~MGC:BC011419.1~uORF:IOH9719	872	951	1071	577	681	951	1003	881	1633	382	pellino homolog 1 (Drosophila) (PELI1)
B04R15C04	4-4-15	Hs~MGC:BC011419.1~uORF:IOH9719	817	939	989	483	714	986	1041	873	1560	387	pellino homolog 1 (Drosophila) (PELI1)
B04R15C05	4-5-15	Hs~MGC:NM_182554.1~uORF:IOH11558	708	510	705	311	712	577	685	492	953	334	chromosome 10 open reading frame 53 (C10orf53), transcript variant 1
B04R15C06	4-6-15	Hs~MGC:NM_182554.1~uORF:IOH11558	669	536	663	324	691	163	659	508	900	323	chromosome 10 open reading frame 53 (C10orf53), transcript variant 1
B04R15C07	4-7-15	Hs~Ref:NM_012113.1~uORF:IOH27401	434	454	633	384	1	24	673	424	746	273	carbonic anhydrase XIV (CA14)
B04R15C08	4-8-15	Hs~Ref:NM_012113.1~uORF:IOH27401	445	486	602	452	3	-32	570	425	699	337	carbonic anhydrase XIV (CA14)
B04R15C09	4-9-15	Hs~MGC:BC031231.1~uORF:IOH27515	13550	855	1686	782	2	4298	2490	1311	5495	780	serine/threonine kinase 33 (STK33)
B04R15C10	4-10-15	Hs~MGC:BC031231.1~uORF:IOH27515	13440	876	1636	737	2632	4237	2217	1331	5492	789	serine/threonine kinase 33 (STK33)
B04R15C11	4-11-15	Hs~MGC:NM_153356.1~uORF:IOH27369	427	527	496	358	0	316	369	494	992	315	TBC1 domain family, member 21 (TBC1D21)
B04R15C12	4-12-15	Hs~MGC:NM_153356.1~uORF:IOH27369	443	519	549	332	1479	342	431	450	1064	326	TBC1 domain family, member 21 (TBC1D21)
B04R15C13	4-13-15	Hs~Ref:NM_002497.1~CAT:PV3360	1026	1275	1945	908	1350	-25	1803	726	1425	402	NIMA (never in mitosis gene a)-related kinase 2 (NEK2)
B04R15C14	4-14-15	Hs~Ref:NM_002497.1~CAT:PV3360	1088	1259	1960	855	1232	482	1513	715	1492	146	NIMA (never in mitosis gene a)-related kinase 2 (NEK2)
B04R15C15	4-15-15	Hs~Ref:NM_005734.1~CAT:PV4209	153	36	168	98	43	1	405	122	93	37	homeodomain interacting protein kinase 3 (HIPK3), transcript variant 1
B04R15C16	4-16-15	Hs~Ref:NM_005734.1~CAT:PV4209	91	47	156	81	1134	142	406	125	82	20	homeodomain interacting protein kinase 3 (HIPK3), transcript variant 1
B04R15C17	4-17-15	Hs~Ref:NM_003157.1~CAT:PV4315	844	540	1140	2138	243	214	837	2325	1937	163	NIMA (never in mitosis gene a)-related kinase 4 (NEK4)
B04R15C18	4-18-15	Hs~Ref:NM_003157.1~CAT:PV4315	863	596	1071	2461	684	77	891	2334	-4	-1	NIMA (never in mitosis gene a)-related kinase 4 (NEK4)
B04R15C19	4-19-15	Hs~Ref:NM_139012.1~CAT:PV3304	171	60	70	133	676	18	150	64	152	11	mitogen-activated protein kinase 14 (MAPK14), transcript variant 2
B04R15C20	4-20-15	Hs~Ref:NM_139012.1~CAT:PV3304	155	65	61	68	230	12	134	57	149	9	mitogen-activated protein kinase 14 (MAPK14), transcript variant 2
B04R16C07	4-7-16	Hs~Ref:NM_003418.1~uORF:IOH59002	1206	1446	1521	799	1035	1	1726	1339	2689	666	Cellular nucleic acid-binding protein
B04R16C08	4-8-16	Hs~Ref:NM_003418.1~uORF:IOH59002	1180	1520	1465	740	1071	-12	1659	1401	2577	639	Cellular nucleic acid-binding protein
B04R16C09	4-9-16	Hs~Ref:NM_134440.1~uORF:IOH40949	1688	399	1007	519	628	1281	1010	593	1595	297	regulatory factor X-associated ankyrin-containing protein (RFXANK), transcript variant 2, mRNA.
B04R16C10	4-10-16	Hs~Ref:NM_134440.1~uORF:IOH40949	1574	417	984	538	3709	-11	978	608	1432	295	regulatory factor X-associated ankyrin-containing protein (RFXANK), transcript variant 2, mRNA.
B04R16C11	4-11-16	Hs~Ref:NM_001033.2~uORF:IOH61121	361	397	465	321	525	376	712	475	772	248	Ribonucleoside-diphosphate reductase large subunit
B04R16C12	4-12-16	Hs~Ref:NM_001033.2~uORF:IOH61121	396	380	470	324	447	401	681	657	780	226	Ribonucleoside-diphosphate reductase large subunit
B04R16C13	4-13-16	Hs~Ref:NM_170775.1~uORF:IOH43500	771	589	1617	480	747	-89	1184	667	1188	391	Small conductance calcium-activated potassium channel protein 2
B04R16C14	4-14-16	Hs~Ref:NM_170775.1~uORF:IOH43500	784	626	1720	421	628	-12	1202	558	1328	16	Small conductance calcium-activated potassium channel protein 2
B04R16C15	4-15-16	Hs~Ref:NM_014473.2~uORF:IOH9851	2889	1286	2604	843	1943	3199	13684	1269	2412	953	DIM1 dimethyladenosine transferase 1-like (S. cerevisiae) (DIMT1L)
B04R16C16	4-16-16	Hs~Ref:NM_014473.2~uORF:IOH9851	2894	1276	2599	904	3992	3257	13399	1258	2454	-29	DIM1 dimethyladenosine transferase 1-like (S. cerevisiae) (DIMT1L)
B04R16C17	4-17-16	Hs~MGC:BC004549.2~uORF:IOH6358	547	387	778	360	558	218	683	464	313	114	dihydrouridine synthase 3-like (S. cerevisiae) (DUS3L)
B04R16C18	4-18-16	Hs~MGC:BC004549.2~uORF:IOH6358	581	393	516	369	2387	443	509	450	775	8	dihydrouridine synthase 3-like (S. cerevisiae) (DUS3L)
B04R16C19	4-19-16	Hs~Ref:NM_016101.3~uORF:IOH10163	677	628	772	626	745	445	529	468	951	166	nuclear import 7 homolog (S. cerevisiae) (NIP7)
B04R16C20	4-20-16	Hs~Ref:NM_016101.3~uORF:IOH10163	718	643	904	627	514	6	523	599	948	-13	nuclear import 7 homolog (S. cerevisiae) (NIP7)
B04R16C21	4-21-16	Hs~MGC:BC020810.1~uORF:IOH27927	3422	859	2222	1483	2020	2822	2248	1572	2645	-54	chromodomain helicase DNA binding protein 2 (CHD2)
B04R16C22	4-22-16	Hs~MGC:BC020810.1~uORF:IOH27927	3188	901	2205	1514	1801	2948	2275	1701	2778	-75	chromodomain helicase DNA binding protein 2 (CHD2)
B04R17C01	4-1-17	Hs~MGC:BC028721.2~uORF:IOH11718	433	165	390	225	90	17	447	309	723	0	solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 (SLC1A6)
B04R17C02	4-2-17	Hs~MGC:BC028721.2~uORF:IOH11718	331	175	437	912	129	-4	389	324	704	586	solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 (SLC1A6)
B04R17C03	4-3-17	Hs~MGC:BC028123.1~uORF:IOH11565	375	934	492	1015	782	2488	624	883	1760	96	cDNA clone MGC:40177 IMAGE:5167345, complete cds
B04R17C04	4-4-17	Hs~MGC:BC028123.1~uORF:IOH11565	359	976	457	270	659	2439	629	933	1687	265	cDNA clone MGC:40177 IMAGE:5167345, complete cds
B04R17C05	4-5-17	Hs~Ref:NM_001738.1~uORF:IOH11391	339	361	1371	292	158	2	440	400	853	275	carbonic anhydrase I (CA1)
B04R17C06	4-6-17	Hs~Ref:NM_001738.1~uORF:IOH11391	311	314	654	286	118	200	452	337	866	241	carbonic anhydrase I (CA1)
B04R17C07	4-7-17	Hs~Ref:NM_000687.1~uORF:IOH14308	391	432	558	332	434	-26	1096	600	1656	204	S-adenosylhomocysteine hydrolase (AHCY)
B04R17C08	4-8-17	Hs~Ref:NM_000687.1~uORF:IOH14308	371	422	645	339	363	-25	1057	585	1723	241	S-adenosylhomocysteine hydrolase (AHCY)
B04R17C09	4-9-17	Hs~MGC:BC007206.1~uORF:IOH6600	125	213	284	180	43	256	261	337	320	116	Src homology 2 domain containing transforming protein D (SHD)
B04R17C10	4-10-17	Hs~MGC:BC007206.1~uORF:IOH6600	125	58	278	180	3397	307	260	396	363	136	Src homology 2 domain containing transforming protein D (SHD)
B04R17C11	4-11-17	Hs~Ref:NM_024068.1~uORF:IOH6654	677	605	574	267	752	-35	1874	2288	717	494	oligonucleotide/oligosaccharide-binding fold containing 2B (OBFC2B)
B04R17C12	4-12-17	Hs~Ref:NM_024068.1~uORF:IOH6654	615	590	563	302	601	770	2039	2444	715	487	oligonucleotide/oligosaccharide-binding fold containing 2B (OBFC2B)
B04R17C13	4-13-17	Hs~Ref:NM_001659.1~uORF:IOH6999	99	96	55	192	304	211	248	21109	461	114	ADP-ribosylation factor 3 (ARF3)
B04R17C14	4-14-17	Hs~Ref:NM_001659.1~uORF:IOH6999	99	24	214	117	108	207	270	20554	374	72	ADP-ribosylation factor 3 (ARF3)
B04R17C15	4-15-17	Hs~MGC:BC004117.1~uORF:IOH5657	32	90	177	97	496	16	60	52	44	31	dehydrodolichyl diphosphate synthase (DHDDS)
B04R17C16	4-16-17	Hs~MGC:BC004117.1~uORF:IOH5657	112	147	59	30	52	144	1426	154	61	8	dehydrodolichyl diphosphate synthase (DHDDS)
B04R17C17	4-17-17	Hs~MGC:BC036452.1~uORF:IOH22480	463	413	771	386	379	830	18873	514	888	332	Potassium voltage-gated channel subfamily E member 1
B04R17C18	4-18-17	Hs~MGC:BC036452.1~uORF:IOH22480	550	445	861	402	382	145	730	538	1144	256	Potassium voltage-gated channel subfamily E member 1
B04R17C19	4-19-17	Hs~MGC:BC006177.1~uORF:IOH6666	1319	523	1383	511	521	167	1673	603	945	140	Metastasis-associated protein MTA1
B04R17C20	4-20-17	Hs~MGC:BC006177.1~uORF:IOH6666	1094	524	1462	541	321	404	1612	819	-14	59	Metastasis-associated protein MTA1
B04R17C21	4-21-17	Hs~Ref:NM_004456.2~uORF:IOH9963	814	569	1360	510	268	122	1185	1211	1643	104	Polycomb protein EZH2
B04R17C22	4-22-17	Hs~Ref:NM_004456.2~uORF:IOH9963	874	548	1312	595	261	-28	1197	895	1600	-36	Polycomb protein EZH2
B04R18C01	4-1-18	Hs~MGC:BC002914.1~uORF:IOH5733	8974	9787	7626	5644	5744	13914	9504	27982	13424	10850	WAS/WASL-interacting protein family member 1
B04R18C02	4-2-18	Hs~MGC:BC002914.1~uORF:IOH5733	8394	9440	7483	5968	5588	13067	9872	29842	13666	6831	WAS/WASL-interacting protein family member 1
B04R18C07	4-7-18	Hs~MGC:BC096097.2~uORF:IOH63199	228	279	381	203	73	5	568	331	425	81	Histidine ammonia-lyase
B04R18C08	4-8-18	Hs~MGC:BC096097.2~uORF:IOH63199	257	259	397	221	135	72	481	316	449	66	Histidine ammonia-lyase
B04R18C09	4-9-18	Hs~MGC:BC096280.2~uORF:IOH63267	248	277	495	238	502	56	705	410	566	283	Type I inositol-1,4,5-trisphosphate 5-phosphatase
B04R18C10	4-10-18	Hs~MGC:BC096280.2~uORF:IOH63267	255	332	500	235	2503	91	683	413	529	306	Type I inositol-1,4,5-trisphosphate 5-phosphatase
B04R18C11	4-11-18	Hs~Ref:NM_003363.2~uORF:IOH39442	1595	1061	922	731	2128	912	3367	649	2282	411	ubiquitin specific peptidase 4 (proto-oncogene) (USP4), transcript variant 1
B04R18C12	4-12-18	Hs~Ref:NM_003363.2~uORF:IOH39442	1436	1020	940	795	1438	-573	2921	664	2173	425	ubiquitin specific peptidase 4 (proto-oncogene) (USP4), transcript variant 1
B04R18C13	4-13-18	Hs~Ref:NM_004766.1~uORF:IOH3540	1443	2502	1407	1300	2636	1969	2383	1222	3415	679	coatomer protein complex, subunit beta 2 (beta prime) (COPB2)
B04R18C14	4-14-18	Hs~Ref:NM_004766.1~uORF:IOH3540	1449	2518	1438	1332	4023	-147	2531	1151	3439	663	coatomer protein complex, subunit beta 2 (beta prime) (COPB2)
B04R18C15	4-15-18	Hs~Ref:NM_080840.1~uORF:IOH11085	761	648	1221	604	730	-63	1142	901	2480	690	protein tyrosine phosphatase, receptor type, A (PTPRA), transcript variant 2
B04R18C16	4-16-18	Hs~Ref:NM_080840.1~uORF:IOH11085	661	660	1247	572	615	248	1053	838	2983	476	protein tyrosine phosphatase, receptor type, A (PTPRA), transcript variant 2
B04R18C17	4-17-18	Hs~Ref:NM_032490.2~uORF:IOH11134	480	435	852	468	262	183	552	474	120	-6	chromosome 14 open reading frame 142 (C14orf142)
B04R18C18	4-18-18	Hs~Ref:NM_032490.2~uORF:IOH11134	429	403	847	442	294	209	580	480	664	-7	chromosome 14 open reading frame 142 (C14orf142)
B04R18C19	4-19-18	Hs~MGC:BC044582.1~uORF:IOH62427	709	1113	559	639	561	8734	1094	666	1465	101	Ubiquitin-like protein 3
B04R18C20	4-20-18	Hs~MGC:BC044582.1~uORF:IOH62427	619	1116	1075	668	631	1398	1110	672	1431	-195	Ubiquitin-like protein 3
B04R18C21	4-21-18	Hs~MGC:BC073977.1~uORF:IOH61809	756	441	878	469	1675	310	1001	1839	-109	-44	HLA class II histocompatibility antigen, DQ(5) alpha chain
B04R18C22	4-22-18	Hs~MGC:BC073977.1~uORF:IOH61809	566	480	800	609	1804	12	993	1308	165	23	HLA class II histocompatibility antigen, DQ(5) alpha chain
B04R19C01	4-1-19	Hs~MGC:BC047438.1~uORF:IOH62395	1014	1182	1817	1281	2073	2847	1858	1293	2964	651	Homer protein homolog 1
B04R19C02	4-2-19	Hs~MGC:BC047438.1~uORF:IOH62395	958	1057	1801	1310	2104	2673	1852	1267	3326	398	Homer protein homolog 1
B04R19C05	4-5-19	Hs~Ref:NM_024482.1~uORF:IOH4000	951	763	590	227	78	69	531	254	778	51	glucocorticoid modulatory element binding protein 1 (GMEB1), transcript variant 2
B04R19C06	4-6-19	Hs~Ref:NM_024482.1~uORF:IOH4000	950	766	622	223	156	130	519	275	799	77	glucocorticoid modulatory element binding protein 1 (GMEB1), transcript variant 2
B04R19C07	4-7-19	Hs~Ref:NM_032643.3~uORF:IOH3821	638	316	375	210	72	27	333	705	536	47	interferon regulatory factor 5 (IRF5), transcript variant 2
B04R19C08	4-8-19	Hs~Ref:NM_032643.3~uORF:IOH3821	624	280	413	256	72	245	317	667	551	266	interferon regulatory factor 5 (IRF5), transcript variant 2
B04R19C09	4-9-19	Hs~Ref:NM_004526.2~uORF:IOH6721	367	2061	1065	276	696	23	734	518	1566	70	minichromosome maintenance complex component 2 (MCM2)
B04R19C10	4-10-19	Hs~Ref:NM_004526.2~uORF:IOH6721	372	2079	1100	275	4114	-13	793	504	1521	102	minichromosome maintenance complex component 2 (MCM2)
B04R19C11	4-11-19	Hs~MGC:BC023288.1~uORF:IOH28628	842	382	539	320	733	-37	609	314	784	4051	solute carrier family 10 (sodium/bile acid cotransporter family), member 7 (SLC10A7)
B04R19C12	4-12-19	Hs~MGC:BC023288.1~uORF:IOH28628	884	372	578	337	297	-209	577	297	766	335	solute carrier family 10 (sodium/bile acid cotransporter family), member 7 (SLC10A7)
B04R19C13	4-13-19	Hs~Ref:NM_000584.2~uORF:IOH58939	592	494	1517	436	2766	-327	1152	744	1316	251	Interleukin-8
B04R19C14	4-14-19	Hs~Ref:NM_000584.2~uORF:IOH58939	608	504	1559	413	493	87	1173	698	1266	150	Interleukin-8
B04R19C15	4-15-19	Hs~MGC:BC037863.1~uORF:IOH62291	426	310	364	264	136	2	627	821	775	12	solute carrier family 24 (sodium/potassium/calcium exchanger), member 4, mRNA (cDNA clone IMAGE:5272777), complete cds.
B04R19C16	4-16-19	Hs~MGC:BC037863.1~uORF:IOH62291	371	321	598	228	243	-11	692	764	592	-12	solute carrier family 24 (sodium/potassium/calcium exchanger), member 4, mRNA (cDNA clone IMAGE:5272777), complete cds.
B04R19C21	4-21-19	Hs~MGC:BC021258.1~uORF:IOH14670	460	375	839	410	458	23	737	476	885	19	tripartite motif-containing 5 (TRIM5)
B04R19C22	4-22-19	Hs~MGC:BC021258.1~uORF:IOH14670	245	345	649	551	478	-45	683	459	1048	89	tripartite motif-containing 5 (TRIM5)
B04R20C01	4-1-20	Hs~Ref:NM_138820.1~uORF:IOH4234	1424	966	1132	567	783	881	943	991	1414	267	HIG1 domain family, member 2A (HIGD2A)
B04R20C02	4-2-20	Hs~Ref:NM_138820.1~uORF:IOH4234	1427	958	1145	593	748	1075	929	956	2014	328	HIG1 domain family, member 2A (HIGD2A)
B04R20C03	4-3-20	Hs~MGC:BC001286.1~uORF:IOH3272	882	696	1166	564	631	0	-4	1	1	418	dCMP deaminase (DCTD)
B04R20C04	4-4-20	Hs~MGC:BC001286.1~uORF:IOH3272	908	720	1195	432	637	-6	-2	16	2	69	dCMP deaminase (DCTD)
B04R20C05	4-5-20	Hs~MGC:BC015535.1~uORF:IOH11057	360	351	651	327	234	857	566	700	883	200	chromosome 1 open reading frame 80 (C1orf80)
B04R20C06	4-6-20	Hs~MGC:BC015535.1~uORF:IOH11057	310	397	828	324	243	122	577	745	974	65	chromosome 1 open reading frame 80 (C1orf80)
B04R20C07	4-7-20	Hs~Ref:NM_014009.2~uORF:IOH43597	860	571	1285	738	238	-17	894	576	1610	186	forkhead box P3 (FOXP3)
B04R20C08	4-8-20	Hs~Ref:NM_014009.2~uORF:IOH43597	862	568	1272	732	276	-417	969	574	1551	163	forkhead box P3 (FOXP3)
B04R20C09	4-9-20	Hs~Ref:NM_001024646.1~uORF:IOH58964	330	317	465	260	682	-36	740	354	645	46	CDC-like kinase 1 (CLK1), transcript variant 2
B04R20C10	4-10-20	Hs~Ref:NM_001024646.1~uORF:IOH58964	354	348	429	287	1161	1	749	295	616	-13	CDC-like kinase 1 (CLK1), transcript variant 2
B04R20C11	4-11-20	Hs~Ref:NM_001018025.2~uORF:IOH58944	589	694	1678	503	3141	-8	572	-3	-2	-12	Protein p13 MTCP-1
B04R20C12	4-12-20	Hs~Ref:NM_001018025.2~uORF:IOH58944	585	687	1854	532	2394	-7	541	0	2	-3	Protein p13 MTCP-1
B04R20C13	4-13-20	Hs~MGC:BC033864.1~uORF:IOH21842	1027	381	869	358	98	2	752	2	1	-1	branched chain aminotransferase 1, cytosolic (BCAT1)
B04R20C14	4-14-20	Hs~MGC:BC033864.1~uORF:IOH21842	1056	375	883	315	285	-4	636	-1	1	-2	branched chain aminotransferase 1, cytosolic (BCAT1)
B05R02C11	5-11-2	Hs~Ref:NM_024540.2~uORF:IOH14529	4	-2	4	2	617	693	1019	552	1310	380	mitochondrial ribosomal protein L24 (MRPL24), nuclear gene encoding mitochondrial protein, transcript variant 2
B05R02C12	5-12-2	Hs~Ref:NM_024540.2~uORF:IOH14529	2	-1	6	-2	752	677	1046	500	1304	319	mitochondrial ribosomal protein L24 (MRPL24), nuclear gene encoding mitochondrial protein, transcript variant 2
B05R02C13	5-13-2	Hs~MGC:BC015628.1~uORF:IOH13638	560	643	671	328	558	488	864	407	871	314	4-aminobutyrate aminotransferase (ABAT)
B05R02C14	5-14-2	Hs~MGC:BC015628.1~uORF:IOH13638	590	530	633	337	489	531	838	436	945	162	4-aminobutyrate aminotransferase (ABAT)
B05R02C15	5-15-2	Hs~MGC:BC026955.1~uORF:IOH11904	947	603	882	464	656	603	1643	501	1080	283	Poly [ADP-ribose] polymerase 6
B05R02C16	5-16-2	Hs~MGC:BC026955.1~uORF:IOH11904	896	615	767	477	548	618	1719	423	1184	318	Poly [ADP-ribose] polymerase 6
B05R02C17	5-17-2	Hs~MGC:BC015674.1~uORF:IOH13800	1014	1525	2255	1966	1018	1245	1061	970	1902	549	Tripartite motif-containing protein 16
B05R02C18	5-18-2	Hs~MGC:BC015674.1~uORF:IOH13800	1025	1289	2037	2007	923	1144	1046	906	302	462	Tripartite motif-containing protein 16
B05R02C19	5-19-2	Hs~Ref:NM_173579.1~uORF:IOH42346	815	540	748	449	410	418	881	371	-82	122	proline rich 10 (PRR10)
B05R02C20	5-20-2	Hs~Ref:NM_173579.1~uORF:IOH42346	768	521	8	334	428	367	920	472	406	175	proline rich 10 (PRR10)
B05R03C01	5-1-3	Hs~Ref:NM_153044.1~uORF:IOH43644	1134	421	909	415	6904	994	797	1048	1959	247	chromosome 22 open reading frame 27 (C22orf27)
B05R03C02	5-2-3	Hs~Ref:NM_153044.1~uORF:IOH43644	1086	487	910	360	7054	792	779	971	1911	230	chromosome 22 open reading frame 27 (C22orf27)
B05R03C03	5-3-3	Hs~Ref:NM_197973.2~uORF:IOH42306	431	409	545	297	325	342	872	442	509	134	asparagine-linked glycosylation 2 homolog (yeast, alpha-1,3-mannosyltransferase) (ALG2), transcript variant 2
B05R03C04	5-4-3	Hs~Ref:NM_197973.2~uORF:IOH42306	487	400	572	321	281	179	839	395	703	123	asparagine-linked glycosylation 2 homolog (yeast, alpha-1,3-mannosyltransferase) (ALG2), transcript variant 2
B05R03C05	5-5-3	Hs~MGC:NM_177559.2~uORF:IOH13704	1192	1015	1065	1261	589	982	2682	618	1087	1386	casein kinase 2, alpha 1 polypeptide (CSNK2A1), transcript variant 1
B05R03C06	5-6-3	Hs~MGC:NM_177559.2~uORF:IOH13704	1172	935	1028	1206	573	965	2568	569	1129	1418	casein kinase 2, alpha 1 polypeptide (CSNK2A1), transcript variant 1
B05R03C07	5-7-3	Hs~MGC:BC037399.1~uORF:IOH27382	223	256	300	263	180	74	249	239	554	82	KIAA0415 (KIAA0415)
B05R03C08	5-8-3	Hs~MGC:BC037399.1~uORF:IOH27382	267	290	309	234	99	73	258	213	241	80	KIAA0415 (KIAA0415)
B05R03C09	5-9-3	Hs~MGC:BC045809.1~uORF:IOH26434	237	270	308	163	297	552	532	219	433	72	laeverin (FLJ90650)
B05R03C10	5-10-3	Hs~MGC:BC045809.1~uORF:IOH26434	256	292	285	186	280	709	565	221	485	67	laeverin (FLJ90650)
B05R03C11	5-11-3	Hs~MGC:BC013708.1~uORF:IOH25782	1105	874	574	741	5438	2344	6641	758	1358	397	eukaryotic translation initiation factor 4A, isoform 2 (EIF4A2)
B05R03C12	5-12-3	Hs~MGC:BC013708.1~uORF:IOH25782	1044	786	527	713	5677	2350	6497	694	1247	370	eukaryotic translation initiation factor 4A, isoform 2 (EIF4A2)
B05R03C13	5-13-3	Hs~MGC:BC009047.1~uORF:IOH9807	751	677	992	995	1612	829	1365	763	2004	492	phosphodiesterase 9A (PDE9A)
B05R03C14	5-14-3	Hs~MGC:BC009047.1~uORF:IOH9807	796	680	887	955	1498	924	1230	655	1940	419	phosphodiesterase 9A (PDE9A)
B05R03C15	5-15-3	Hs~Ref:NM_014366.1~uORF:IOH4189	2245	1124	2181	745	1377	1344	5805	916	2657	503	guanine nucleotide binding protein-like 3 (nucleolar) (GNL3), transcript variant 1
B05R03C16	5-16-3	Hs~Ref:NM_014366.1~uORF:IOH4189	2114	1090	2203	910	1227	1309	5985	882	4188	490	guanine nucleotide binding protein-like 3 (nucleolar) (GNL3), transcript variant 1
B05R03C17	5-17-3	Hs~MGC:BC001256.1~uORF:IOH3240	772	1152	758	565	740	574	704	605	1988	446	chromosome 1 open reading frame 91 (C1orf91)
B05R03C18	5-18-3	Hs~MGC:BC001256.1~uORF:IOH3240	776	1155	776	560	765	600	929	667	1490	343	chromosome 1 open reading frame 91 (C1orf91)
B05R03C19	5-19-3	Hs~MGC:BC001694.1~uORF:IOH3865	1854	1281	1025	2462	2081	880	1206	1429	4291	641	ubiquitin-conjugating enzyme E2B (RAD6 homolog) (UBE2B)
B05R03C20	5-20-3	Hs~MGC:BC001694.1~uORF:IOH3865	1728	1227	730	2317	2117	870	1096	1405	4199	137	ubiquitin-conjugating enzyme E2B (RAD6 homolog) (UBE2B)
B05R03C21	5-21-3	Hs~MGC:BC029796.1~uORF:IOH22647	12086	12380	4688	10267	11061	5804	14543	21781	7095	13496	hypothetical protein BC014011 (LOC116349)
B05R03C22	5-22-3	Hs~MGC:BC029796.1~uORF:IOH22647	10506	11513	4745	9718	10232	6332	13567	21107	7378	11911	hypothetical protein BC014011 (LOC116349)
B05R04C01	5-1-4	Hs~MGC:BC029775.1~uORF:IOH22665	1358	469	891	485	722	676	1326	879	2404	266	transmembrane protein 61 (TMEM61)
B05R04C02	5-2-4	Hs~MGC:BC029775.1~uORF:IOH22665	1202	485	913	480	718	745	1322	859	2302	237	transmembrane protein 61 (TMEM61)
B05R04C03	5-3-4	Hs~MGC:BC029057.1~uORF:IOH22662	422	596	867	546	788	1260	2847	1305	1533	355	D-amino-acid oxidase (DAO)
B05R04C04	5-4-4	Hs~MGC:BC029057.1~uORF:IOH22662	412	586	868	518	734	1132	2739	1213	1509	356	D-amino-acid oxidase (DAO)
B05R04C05	5-5-4	Hs~Ref:NM_024791.2~uORF:IOH22680	816	1121	920	1452	832	470	839	506	1398	592	PDZ domain containing 3 (PDZD3)
B05R04C06	5-6-4	Hs~Ref:NM_024791.2~uORF:IOH22680	770	1110	931	1446	917	484	947	491	1434	593	PDZ domain containing 3 (PDZD3)
B05R04C07	5-7-4	Hs~MGC:BC003608.1~uORF:IOH4641	1061	1611	3128	712	3866	1404	2044	1143	2919	578	RNA binding protein with multiple splicing (RBPMS)
B05R04C08	5-8-4	Hs~MGC:BC003608.1~uORF:IOH4641	1069	1490	2890	680	3638	1491	1905	1144	2618	570	RNA binding protein with multiple splicing (RBPMS)
B05R04C09	5-9-4	Hs~Ref:NM_133487.1~uORF:IOH4038	1308	626	953	3148	784	776	1972	542	1468	261	RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) (RAD51), transcript variant 2
B05R04C10	5-10-4	Hs~Ref:NM_133487.1~uORF:IOH4038	1227	601	917	3061	811	706	2101	500	1472	260	RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) (RAD51), transcript variant 2
B05R04C11	5-11-4	Hs~MGC:BC003166.1~uORF:IOH5044	384	276	153	85	983	128	302	449	506	40	polymerase (DNA directed), epsilon 3 (p17 subunit) (POLE3)
B05R04C12	5-12-4	Hs~MGC:BC003166.1~uORF:IOH5044	340	15	317	598	1053	245	278	258	460	36	polymerase (DNA directed), epsilon 3 (p17 subunit) (POLE3)
B05R04C13	5-13-4	Hs~Ref:NM_002156.1~uORF:IOH5036	3600	1139	1060	556	1167	418	1712	2651	1240	148	heat shock 60kDa protein 1 (chaperonin) (HSPD1), nuclear gene encoding mitochondrial protein, transcript variant 1
B05R04C14	5-14-4	Hs~Ref:NM_002156.1~uORF:IOH5036	3253	1120	955	551	935	346	1524	2540	1084	120	heat shock 60kDa protein 1 (chaperonin) (HSPD1), nuclear gene encoding mitochondrial protein, transcript variant 1
B05R04C15	5-15-4	Hs~MGC:BC017957.1~uORF:IOH12295	1273	1259	1714	718	1107	742	2145	889	1818	441	Protein WWC2
B05R04C16	5-16-4	Hs~MGC:BC017957.1~uORF:IOH12295	1256	1171	1557	703	1080	761	2074	882	2044	382	Protein WWC2
B05R04C17	5-17-4	Hs~Ref:NM_031482.3~uORF:IOH22840	368	262	399	199	550	467	1288	401	1061	54	ATG10 autophagy related 10 homolog (S. cerevisiae) (ATG10)
B05R04C18	5-18-4	Hs~Ref:NM_031482.3~uORF:IOH22840	353	273	283	128	484	427	1291	394	1060	134	ATG10 autophagy related 10 homolog (S. cerevisiae) (ATG10)
B05R04C19	5-19-4	Hs~Ref:NM_017986.2~uORF:IOH39818	1257	208	417	501	250	139	468	219	396	74	G protein-coupled receptor 172B (GPR172B), transcript variant 2
B05R04C20	5-20-4	Hs~Ref:NM_017986.2~uORF:IOH39818	815	211	427	328	369	282	406	228	286	-10	G protein-coupled receptor 172B (GPR172B), transcript variant 2
B05R04C21	5-21-4	Hs~Ref:NM_144717.2~uORF:IOH40859	386	330	500	244	258	403	697	368	363	93	interleukin 20 receptor beta (IL20RB)
B05R04C22	5-22-4	Hs~Ref:NM_144717.2~uORF:IOH40859	385	280	459	231	259	470	673	337	617	100	interleukin 20 receptor beta (IL20RB)
B05R05C01	5-1-5	Hs~Ref:NM_138414.1~uORF:IOH10524	2751	2283	3364	902	1726	2154	4638	1786	4032	991	coiled-coil domain containing 101 (CCDC101)
B05R05C02	5-2-5	Hs~Ref:NM_138414.1~uORF:IOH10524	2757	1806	3411	941	1418	2138	4742	1706	4146	1025	coiled-coil domain containing 101 (CCDC101)
B05R05C03	5-3-5	Hs~MGC:BC026058.1~uORF:IOH13488	502	1293	632	383	433	691	748	660	874	359	stromal antigen 3-like (FLJ13195)
B05R05C04	5-4-5	Hs~MGC:BC026058.1~uORF:IOH13488	515	1248	645	359	437	587	758	589	881	354	stromal antigen 3-like (FLJ13195)
B05R05C05	5-5-5	Hs~MGC:BC007557.1~uORF:IOH6840	711	571	887	536	513	759	1252	525	1136	355	F-box/LRR-repeat protein 20
B05R05C06	5-6-5	Hs~MGC:BC007557.1~uORF:IOH6840	728	628	907	539	588	895	1339	565	1158	360	F-box/LRR-repeat protein 20
B05R05C07	5-7-5	Hs~Ref:NM_002298.2~uORF:IOH5905	415	503	506	259	132	463	1346	509	720	75	lymphocyte cytosolic protein 1 (L-plastin) (LCP1)
B05R05C08	5-8-5	Hs~Ref:NM_002298.2~uORF:IOH5905	370	460	481	182	162	465	1144	467	687	161	lymphocyte cytosolic protein 1 (L-plastin) (LCP1)
B05R05C09	5-9-5	Hs~MGC:BC047060.1~uORF:IOH26535	668	931	673	289	449	415	597	263	1017	200	regulator of G-protein signaling 22 (RGS22)
B05R05C10	5-10-5	Hs~MGC:BC047060.1~uORF:IOH26535	612	930	682	302	381	352	622	262	1047	134	regulator of G-protein signaling 22 (RGS22)
B05R05C11	5-11-5	Hs~MGC:NM_173545.1~uORF:IOH26160	1702	562	1098	500	760	564	3484	678	1012	187	chromosome 2 open reading frame 13 (C2orf13)
B05R05C12	5-12-5	Hs~MGC:NM_173545.1~uORF:IOH26160	1559	507	1124	494	737	621	3392	646	954	181	chromosome 2 open reading frame 13 (C2orf13)
B05R05C13	5-13-5	Hs~MGC:BC040949.1~uORF:IOH26268	4231	1936	8298	6936	805	1491	3802	1138	2007	801	myocyte enhancer factor 2D (MEF2D)
B05R05C14	5-14-5	Hs~MGC:BC040949.1~uORF:IOH26268	3846	1661	7430	6463	734	1426	3483	1099	1776	790	myocyte enhancer factor 2D (MEF2D)
B05R05C15	5-15-5	Hs~MGC:BC048299.1~uORF:IOH26615	8766	8794	2955	10091	8425	2505	9930	6260	4851	2902	spermatogenesis associated, serine-rich 2 (SPATS2)
B05R05C16	5-16-5	Hs~MGC:BC048299.1~uORF:IOH26615	8468	9127	3256	9072	8405	2438	10424	5777	3567	2841	spermatogenesis associated, serine-rich 2 (SPATS2)
B05R05C17	5-17-5	Hs~Ref:NM_004088.1~uORF:IOH11297	7228	2762	2436	2447	4183	2005	9009	1644	7240	1827	deoxynucleotidyltransferase, terminal (DNTT), transcript variant 1
B05R05C18	5-18-5	Hs~Ref:NM_004088.1~uORF:IOH11297	7100	2483	2374	2353	4011	1957	9228	1586	6520	1689	deoxynucleotidyltransferase, terminal (DNTT), transcript variant 1
B05R05C19	5-19-5	Hs~MGC:BC016615.1~uORF:IOH10688	627	488	1011	1237	697	380	515	965	1900	28	RAB37, member RAS oncogene family (RAB37)
B05R05C20	5-20-5	Hs~MGC:BC016615.1~uORF:IOH10688	536	461	925	1166	745	380	509	937	2567	155	RAB37, member RAS oncogene family (RAB37)
B05R05C21	5-21-5	Hs~Ref:NM_033640.1~uORF:IOH10841	732	477	586	332	532	383	655	395	851	200	SCAN domain containing 2 (SCAND2), transcript variant 6
B05R05C22	5-22-5	Hs~Ref:NM_033640.1~uORF:IOH10841	686	375	627	322	489	420	631	386	1517	119	SCAN domain containing 2 (SCAND2), transcript variant 6
B05R06C01	5-1-6	Hs~Ref:NM_001446.2~uORF:IOH11228	386	274	300	189	184	275	777	254	558	59	fatty acid binding protein 7, brain (FABP7)
B05R06C02	5-2-6	Hs~Ref:NM_001446.2~uORF:IOH11228	174	112	455	120	176	192	486	224	554	41	fatty acid binding protein 7, brain (FABP7)
B05R06C03	5-3-6	Hs~Ref:NM_181738.1~uORF:IOH39994	628	579	660	1499	1025	463	481	397	1140	311	peroxiredoxin 2 (PRDX2), nuclear gene encoding mitochondrial protein, transcript variant 3
B05R06C04	5-4-6	Hs~Ref:NM_181738.1~uORF:IOH39994	577	528	628	1564	1050	357	455	315	1188	302	peroxiredoxin 2 (PRDX2), nuclear gene encoding mitochondrial protein, transcript variant 3
B05R06C05	5-5-6	Hs~MGC:BC063500.1~uORF:IOH39897	2889	2597	1901	27981	914	1908	2306	1951	6187	2973	Tigger transposable element-derived protein 1
B05R06C06	5-6-6	Hs~MGC:BC063500.1~uORF:IOH39897	2807	2168	2171	27204	866	1837	2185	1753	5915	2984	Tigger transposable element-derived protein 1
B05R06C07	5-7-6	Hs~Ref:NM_020312.1~uORF:IOH39954	471	442	644	319	598	2095	1325	411	1379	149	Ubiquinone biosynthesis protein COQ9, mitochondrial
B05R06C08	5-8-6	Hs~Ref:NM_020312.1~uORF:IOH39954	441	429	659	294	399	1924	1182	402	1307	128	Ubiquinone biosynthesis protein COQ9, mitochondrial
B05R06C09	5-9-6	Hs~MGC:BC064841.1~uORF:IOH39998	709	463	636	346	542	381	807	582	781	159	myosin VC (MYO5C)
B05R06C10	5-10-6	Hs~MGC:BC064841.1~uORF:IOH39998	689	502	654	311	465	535	888	559	822	205	myosin VC (MYO5C)
B05R06C11	5-11-6	Hs~Ref:NM_079424.1~uORF:IOH45798	657	3491	509	245	553	513	273	269	1091	140	Myosin light polypeptide 6
B05R06C12	5-12-6	Hs~Ref:NM_079424.1~uORF:IOH45798	619	3379	488	216	524	427	291	265	982	132	Myosin light polypeptide 6
B05R06C13	5-13-6	Hs~Ref:NM_001002033.1~uORF:IOH45892	561	153	26904	152	1837	2759	915	457	1445	35	hematological and neurological expressed 1 (HN1), transcript variant 3
B05R06C14	5-14-6	Hs~Ref:NM_001002033.1~uORF:IOH45892	544	145	24967	74	1779	2649	854	469	1243	67	hematological and neurological expressed 1 (HN1), transcript variant 3
B05R06C15	5-15-6	Hs~Ref:NM_197974.1~uORF:IOH45792	1003	648	853	621	645	783	1278	762	2851	250	butyrophilin, subfamily 3, member A3 (BTN3A3), transcript variant 2
B05R06C16	5-16-6	Hs~Ref:NM_197974.1~uORF:IOH45792	938	579	814	594	585	767	1115	642	2670	265	butyrophilin, subfamily 3, member A3 (BTN3A3), transcript variant 2
B05R06C17	5-17-6	Hs~Ref:NM_199331.1~uORF:IOH45816	2865	2680	6000	3132	2584	4176	5206	2895	4278	1854	Homer protein homolog 2
B05R06C18	5-18-6	Hs~Ref:NM_199331.1~uORF:IOH45816	2734	2547	5898	3186	2617	4194	4950	2956	3894	1388	Homer protein homolog 2
B05R06C19	5-19-6	Hs~Ref:NM_002387.1~uORF:IOH14306	711	700	1416	545	1487	1166	4753	1835	3030	2716	mutated in colorectal cancers (MCC), transcript variant 2
B05R06C20	5-20-6	Hs~Ref:NM_002387.1~uORF:IOH14306	661	644	1331	579	1599	1096	4326	1747	498	2520	mutated in colorectal cancers (MCC), transcript variant 2
B05R07C01	5-1-7	Hs~MGC:BC024256.1~uORF:IOH14000	385	296	479	285	248	331	470	281	731	205	F-box and leucine-rich repeat protein 18 (FBXL18)
B05R07C02	5-2-7	Hs~MGC:BC024256.1~uORF:IOH14000	427	308	554	324	255	383	374	261	693	216	F-box and leucine-rich repeat protein 18 (FBXL18)
B05R07C03	5-3-7	Hs~MGC:BC009785.1~uORF:IOH14325	474	372	738	299	259	1038	525	296	590	247	glycine-N-acyltransferase (GLYAT)
B05R07C04	5-4-7	Hs~MGC:BC009785.1~uORF:IOH14325	460	365	669	299	304	385	502	221	679	247	glycine-N-acyltransferase (GLYAT)
B05R07C05	5-5-7	Hs~Ref:NM_002867.2~uORF:IOH6672	385	302	468	285	441	303	489	434	952	146	RAB3B, member RAS oncogene family (RAB3B)
B05R07C06	5-6-7	Hs~Ref:NM_002867.2~uORF:IOH6672	381	332	464	301	597	267	512	388	888	120	RAB3B, member RAS oncogene family (RAB3B)
B05R07C07	5-7-7	Hs~Ref:NM_001663.2~uORF:IOH4954	524	745	2677	414	1421	873	936	377	1477	2077	ADP-ribosylation factor 6 (ARF6)
B05R07C08	5-8-7	Hs~Ref:NM_001663.2~uORF:IOH4954	476	681	2808	422	1238	836	942	384	1258	1969	ADP-ribosylation factor 6 (ARF6)
B05R07C09	5-9-7	Hs~Ref:NM_017595.2~uORF:IOH6101	465	346	588	421	427	436	492	888	803	255	NFKB inhibitor interacting Ras-like 2 (NKIRAS2), transcript variant 2
B05R07C10	5-10-7	Hs~Ref:NM_017595.2~uORF:IOH6101	457	363	610	467	426	408	490	831	743	289	NFKB inhibitor interacting Ras-like 2 (NKIRAS2), transcript variant 2
B05R07C11	5-11-7	Hs~Ref:NM_002068.1~uORF:IOH9848	360	401	678	332	599	360	513	252	2054	2590	guanine nucleotide binding protein (G protein), alpha 15 (Gq class) (GNA15)
B05R07C12	5-12-7	Hs~Ref:NM_002068.1~uORF:IOH9848	431	384	660	360	450	333	464	282	2084	2584	guanine nucleotide binding protein (G protein), alpha 15 (Gq class) (GNA15)
B05R07C13	5-13-7	Hs~Ref:NM_000317.1~uORF:IOH9965	1076	1181	1377	875	1718	873	1486	847	2722	546	6-pyruvoyltetrahydropterin synthase (PTS)
B05R07C14	5-14-7	Hs~Ref:NM_000317.1~uORF:IOH9965	1091	1066	1455	848	1860	893	1418	841	2564	532	6-pyruvoyltetrahydropterin synthase (PTS)
B05R07C15	5-15-7	Hs~MGC:BC018624.1~uORF:IOH14128	600	793	1014	468	866	581	1020	570	1499	326	prickle homolog 4 (Drosophila) (C6orf49)
B05R07C16	5-16-7	Hs~MGC:BC018624.1~uORF:IOH14128	628	676	1024	485	799	605	1022	581	1582	327	prickle homolog 4 (Drosophila) (C6orf49)
B05R07C17	5-17-7	Hs~MGC:BC008435.1~uORF:IOH7556	2078	3046	3949	1700	2272	2907	2563	1186	3325	1161	peroxiredoxin 3 (PRDX3)
B05R07C18	5-18-7	Hs~MGC:BC008435.1~uORF:IOH7556	1962	2760	3702	1626	1960	2630	2698	1153	624	967	peroxiredoxin 3 (PRDX3)
B05R07C19	5-19-7	Hs~MGC:BC010137.1~uORF:IOH14488	1288	797	1305	766	964	897	1724	635	2797	520	GTP-binding protein 8 (putative) (GTPBP8)
B05R07C20	5-20-7	Hs~MGC:BC010137.1~uORF:IOH14488	1291	847	1287	808	987	1001	1672	661	1895	478	GTP-binding protein 8 (putative) (GTPBP8)
B05R07C21	5-21-7	Hs~Ref:NM_002957.3~uORF:IOH39435	3471	1773	1729	3282	1598	1512	2462	732	3507	302	retinoid X receptor, alpha (RXRA)
B05R07C22	5-22-7	Hs~Ref:NM_002957.3~uORF:IOH39435	3188	1602	1595	2886	1335	1460	2295	680	3101	308	retinoid X receptor, alpha (RXRA)
B05R08C01	5-1-8	Hs~MGC:BC008077.2~uORF:IOH6111	1522	690	1360	843	570	788	1724	651	1160	340	Signal recognition particle receptor subunit alpha
B05R08C02	5-2-8	Hs~MGC:BC008077.2~uORF:IOH6111	1377	636	1323	869	549	783	1897	654	1092	346	Signal recognition particle receptor subunit alpha
B05R08C03	5-3-8	Hs~Ref:NM_003674.2~uORF:IOH39710	529	343	495	245	233	762	537	382	838	183	cyclin-dependent kinase (CDC2-like) 10 (CDK10), transcript variant 1
B05R08C04	5-4-8	Hs~Ref:NM_003674.2~uORF:IOH39710	550	377	428	230	258	475	531	347	830	199	cyclin-dependent kinase (CDC2-like) 10 (CDK10), transcript variant 1
B05R08C05	5-5-8	Hs~Ref:NM_006914.2~uORF:IOH39668	865	1168	754	470	679	713	1551	623	1244	321	RAR-related orphan receptor B (RORB)
B05R08C06	5-6-8	Hs~Ref:NM_006914.2~uORF:IOH39668	875	1062	754	449	787	673	1619	573	1283	344	RAR-related orphan receptor B (RORB)
B05R08C07	5-7-8	Hs~MGC:BC026187.2~uORF:IOH22486	681	891	1215	560	731	606	934	547	1830	391	Cyclin N-terminal domain-containing protein 1
B05R08C08	5-8-8	Hs~MGC:BC026187.2~uORF:IOH22486	680	851	1119	546	719	660	911	562	1935	382	Cyclin N-terminal domain-containing protein 1
B05R08C09	5-9-8	Hs~MGC:BC028396.1~uORF:IOH26867	1197	643	1269	544	529	710	1397	625	1398	415	Polyhomeotic-like protein 2
B05R08C10	5-10-8	Hs~MGC:BC028396.1~uORF:IOH26867	1138	592	1284	528	479	606	1354	724	1432	391	Polyhomeotic-like protein 2
B05R08C11	5-11-8	Hs~MGC:BC021121.1~uORF:IOH23113	1642	843	2953	659	690	1880	2523	710	2320	405	WNK lysine deficient protein kinase 1 (WNK1)
B05R08C12	5-12-8	Hs~MGC:BC021121.1~uORF:IOH23113	1532	771	2964	654	710	1827	2360	697	2036	412	WNK lysine deficient protein kinase 1 (WNK1)
B05R08C13	5-13-8	Hs~Ref:NM_005916.2~uORF:IOH12526	748	600	971	458	731	606	930	527	1315	451	minichromosome maintenance complex component 7 (MCM7), transcript variant 1
B05R08C14	5-14-8	Hs~Ref:NM_005916.2~uORF:IOH12526	758	670	1044	510	1062	596	970	508	1490	450	minichromosome maintenance complex component 7 (MCM7), transcript variant 1
B05R08C15	5-15-8	Hs~Ref:NM_017867.1~uORF:IOH12106	1715	1901	2901	1070	1722	1043	3986	1596	2944	408	chromosome 4 open reading frame 27 (C4orf27)
B05R08C16	5-16-8	Hs~Ref:NM_017867.1~uORF:IOH12106	1735	1899	1598	1052	1514	997	4031	1536	3359	397	chromosome 4 open reading frame 27 (C4orf27)
B05R08C17	5-17-8	Hs~MGC:BC007581.1~uORF:IOH6857	1624	1494	3328	1040	1622	1000	3870	1530	2928	754	aldehyde dehydrogenase 4 family, member A1 (ALDH4A1)
B05R08C18	5-18-8	Hs~MGC:BC007581.1~uORF:IOH6857	1642	1466	3091	1034	1749	1016	3820	1538	2942	756	aldehyde dehydrogenase 4 family, member A1 (ALDH4A1)
B05R08C19	5-19-8	Hs~MGC:BC031010.1~uORF:IOH23142	1812	1446	2742	1003	1406	1107	4245	1281	3587	114	SET and MYND domain containing 3 (SMYD3)
B05R08C20	5-20-8	Hs~MGC:BC031010.1~uORF:IOH23142	5873	1425	2616	1551	1360	1131	4138	1241	3450	452	SET and MYND domain containing 3 (SMYD3)
B05R08C21	5-21-8	Hs~MGC:BC042578.1~uORF:IOH27311	2406	847	1652	447	724	972	3000	1084	1610	302	progastricsin (pepsinogen C) (PGC)
B05R08C22	5-22-8	Hs~MGC:BC042578.1~uORF:IOH27311	898	734	1622	499	622	722	2942	1097	1733	259	progastricsin (pepsinogen C) (PGC)
B05R09C01	5-1-9	Hs~Ref:NM_139313.1~uORF:IOH6704	477	369	637	301	246	295	671	318	960	244	YME1-like 1 (S. cerevisiae) (YME1L1), nuclear gene encoding mitochondrial protein, transcript variant 2
B05R09C02	5-2-9	Hs~Ref:NM_139313.1~uORF:IOH6704	445	335	613	353	275	323	620	290	1068	233	YME1-like 1 (S. cerevisiae) (YME1L1), nuclear gene encoding mitochondrial protein, transcript variant 2
B05R09C03	5-3-9	Hs~MGC:BC001446.2~uORF:IOH4019	431	267	479	379	244	726	326	223	525	162	dipeptidyl-peptidase 3 (DPP3)
B05R09C04	5-4-9	Hs~MGC:BC001446.2~uORF:IOH4019	444	317	461	380	264	647	317	211	509	146	dipeptidyl-peptidase 3 (DPP3)
B05R09C05	5-5-9	Hs~Ref:NM_138819.1~uORF:IOH13823	4543	2551	2398	2688	2383	2820	3400	1298	3400	2079	family with sequence similarity 122C (FAM122C)
B05R09C06	5-6-9	Hs~Ref:NM_138819.1~uORF:IOH13823	4070	2544	2327	2416	2450	2644	3400	1181	3294	2182	family with sequence similarity 122C (FAM122C)
B05R09C07	5-7-9	Hs~MGC:BC006999.1~uORF:IOH7367	1033	580	852	523	780	489	2871	1479	1277	338	Isopentenyl-diphosphate Delta-isomerase 1
B05R09C08	5-8-9	Hs~MGC:BC006999.1~uORF:IOH7367	1036	545	827	527	695	511	2787	1361	1273	308	Isopentenyl-diphosphate Delta-isomerase 1
B05R09C09	5-9-9	Hs~MGC:BC035619.1~uORF:IOH27570	641	604	690	403	778	461	665	371	931	256	Septin-12
B05R09C10	5-10-9	Hs~MGC:BC035619.1~uORF:IOH27570	590	574	688	417	799	412	654	429	980	250	Septin-12
B05R09C11	5-11-9	Hs~MGC:BC036923.1~uORF:IOH25928	3583	1451	1792	1158	3694	2186	2126	2173	3502	438	chromosome 9 open reading frame 150 (C9orf150)
B05R09C12	5-12-9	Hs~MGC:BC036923.1~uORF:IOH25928	3324	1372	1871	1154	3381	2125	2075	2014	3711	436	chromosome 9 open reading frame 150 (C9orf150)
B05R09C13	5-13-9	Hs~MGC:BC056160.1~uORF:IOH29049	598	370	630	335	363	419	762	375	598	205	solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 (SLC25A5)
B05R09C14	5-14-9	Hs~MGC:BC056160.1~uORF:IOH29049	596	373	577	396	517	404	899	366	614	185	solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 (SLC25A5)
B05R09C15	5-15-9	Hs~MGC:BC013366.2~uORF:IOH27815	985	1047	889	700	775	996	1114	456	1290	346	UNC-112 related protein 2 (URP2)
B05R09C16	5-16-9	Hs~MGC:BC013366.2~uORF:IOH27815	928	1237	889	698	1317	680	1256	464	1241	301	UNC-112 related protein 2 (URP2)
B05R09C17	5-17-9	Hs~MGC:BC002759.2~uORF:IOH46070	306	380	562	266	449	187	659	351	715	72	hypothetical protein FLJ20489 (FLJ20489)
B05R09C18	5-18-9	Hs~MGC:BC002759.2~uORF:IOH46070	322	356	482	272	458	307	700	481	685	148	hypothetical protein FLJ20489 (FLJ20489)
B05R09C19	5-19-9	Hs~MGC:BC002381.2~uORF:IOH46138	1439	2443	442	285	423	153	565	384	668	71	selenophosphate synthetase 2 (SEPHS2)
B05R09C20	5-20-9	Hs~MGC:BC002381.2~uORF:IOH46138	2542	2156	463	697	406	157	564	270	590	48	selenophosphate synthetase 2 (SEPHS2)
B05R09C21	5-21-9	Hs~MGC:BC002950.1~uORF:IOH46164	1792	664	1106	1445	887	579	1475	480	1644	78	chromosome 18 open reading frame 8 (C18orf8)
B05R09C22	5-22-9	Hs~MGC:BC002950.1~uORF:IOH46164	705	608	1016	573	929	474	1414	506	1881	65	chromosome 18 open reading frame 8 (C18orf8)
B05R10C01	5-1-10	Hs~MGC:BC020711.1~uORF:IOH46097	460	394	644	291	310	267	651	260	636	165	pregnancy specific beta-1-glycoprotein 11 (PSG11)
B05R10C02	5-2-10	Hs~MGC:BC020711.1~uORF:IOH46097	493	341	743	369	277	300	673	315	639	159	pregnancy specific beta-1-glycoprotein 11 (PSG11)
B05R10C03	5-3-10	Hs~Ref:NM_001899.2~uORF:IOH40718	469	368	508	307	416	439	449	327	940	324	cystatin S (CST4)
B05R10C04	5-4-10	Hs~Ref:NM_001899.2~uORF:IOH40718	470	373	515	312	375	718	454	291	961	110	cystatin S (CST4)
B05R10C05	5-5-10	Hs~MGC:BC026039.1~uORF:IOH40656	14022	13463	8689	21379	12285	6946	6340	12629	11089	17490	mitochondrial GTPase 1 homolog (S. cerevisiae) (MTG1)
B05R10C06	5-6-10	Hs~MGC:BC026039.1~uORF:IOH40656	15083	13097	8290	19513	11585	6378	6325	13158	10742	17531	mitochondrial GTPase 1 homolog (S. cerevisiae) (MTG1)
B05R10C07	5-7-10	Hs~Ref:NM_153229.1~uORF:IOH40698	476	505	2283	406	538	17641	1080	403	1135	243	transmembrane protein 92 (TMEM92)
B05R10C08	5-8-10	Hs~Ref:NM_153229.1~uORF:IOH40698	468	504	2317	394	459	16597	1127	366	1149	247	transmembrane protein 92 (TMEM92)
B05R10C09	5-9-10	Hs~Ref:NM_198083.1~uORF:IOH40660	497	422	710	376	460	490	1142	364	820	313	dehydrogenase/reductase (SDR family) member 4 like 2 (DHRS4L2)
B05R10C10	5-10-10	Hs~Ref:NM_198083.1~uORF:IOH40660	515	390	654	312	437	461	1254	381	843	283	dehydrogenase/reductase (SDR family) member 4 like 2 (DHRS4L2)
B05R11C21	5-21-11	Hs~MGC:BC009689.1~uORF:IOH9910	665	1398	748	705	364	513	608	378	1021	231	cyclin D-type binding-protein 1 (CCNDBP1)
B05R11C22	5-22-11	Hs~MGC:BC009689.1~uORF:IOH9910	553	1250	717	619	438	505	591	307	974	44	cyclin D-type binding-protein 1 (CCNDBP1)
B05R12C01	5-1-12	Hs~MGC:BC017492.1~uORF:IOH10044	462	505	758	547	228	257	5479	525	982	301	component of oligomeric golgi complex 8 (COG8)
B05R12C02	5-2-12	Hs~MGC:BC017492.1~uORF:IOH10044	325	518	751	592	207	247	5637	461	906	283	component of oligomeric golgi complex 8 (COG8)
B05R12C03	5-3-12	Hs~MGC:BC007618.1~uORF:IOH6923	61	389	520	47	254	406	433	789	906	161	immunoglobin superfamily, member 21 (IGSF21)
B05R12C04	5-4-12	Hs~MGC:BC007618.1~uORF:IOH6923	167	388	467	101	125	969	475	300	847	281	immunoglobin superfamily, member 21 (IGSF21)
B05R12C05	5-5-12	Hs~MGC:BC003398.1~uORF:IOH3008	1396	6796	8060	3200	2412	3235	3994	4122	9963	2584	MOB1, Mps One Binder kinase activator-like 1B (yeast) (MOBK1B)
B05R12C06	5-6-12	Hs~MGC:BC003398.1~uORF:IOH3008	1397	6333	8197	3367	2245	2745	4286	3907	10026	2583	MOB1, Mps One Binder kinase activator-like 1B (yeast) (MOBK1B)
B05R12C07	5-7-12	Hs~Ref:NM_033103.1~uORF:IOH22340	1516	754	1425	1170	801	1067	6337	691	2630	1291	rhophilin, Rho GTPase binding protein 2 (RHPN2)
B05R12C08	5-8-12	Hs~Ref:NM_033103.1~uORF:IOH22340	1533	748	1371	1160	813	939	6730	632	2539	1239	rhophilin, Rho GTPase binding protein 2 (RHPN2)
B05R12C09	5-9-12	Hs~MGC:BC032249.1~uORF:IOH21538	812	718	979	638	548	785	1096	574	1536	511	immunoglobulin heavy constant alpha 1 (IGHA1)
B05R12C10	5-10-12	Hs~MGC:BC032249.1~uORF:IOH21538	791	748	922	618	608	730	1111	737	1513	491	immunoglobulin heavy constant alpha 1 (IGHA1)
B05R12C11	5-11-12	Hs~MGC:BC030020.2~uORF:IOH22410	0	-2	-2	2	7	0	9	9	3	-2	DEAD (Asp-Glu-Ala-Asp) box polypeptide 55 (DDX55)
B05R12C12	5-12-12	Hs~MGC:BC030020.2~uORF:IOH22410	1	0	-4	-1	-9	-18	-4	0	1	-3	DEAD (Asp-Glu-Ala-Asp) box polypeptide 55 (DDX55)
B05R12C13	5-13-12	Hs~MGC:BC056669.1~uORF:IOH29465	418	325	538	304	316	196	508	394	433	88	DCN1, defective in cullin neddylation 1, domain containing 2 (S. cerevisiae) (DCUN1D2)
B05R12C14	5-14-12	Hs~MGC:BC056669.1~uORF:IOH29465	432	305	648	349	435	198	512	465	475	74	DCN1, defective in cullin neddylation 1, domain containing 2 (S. cerevisiae) (DCUN1D2)
B05R12C15	5-15-12	Hs~Ref:NM_133336.1~uORF:IOH42549	2852	1131	1639	1092	642	1220	12060	1061	2439	480	Wolf-Hirschhorn syndrome candidate 1 (WHSC1), transcript variant 9
B05R12C16	5-16-12	Hs~Ref:NM_133336.1~uORF:IOH42549	2617	1042	1540	1091	534	1171	10570	878	2389	421	Wolf-Hirschhorn syndrome candidate 1 (WHSC1), transcript variant 9
B05R12C17	5-17-12	Hs~Ref:NM_022977.1~uORF:IOH42656	892	652	991	531	575	578	1530	975	1060	906	acyl-CoA synthetase long-chain family member 4 (ACSL4), transcript variant 2
B05R12C18	5-18-12	Hs~Ref:NM_022977.1~uORF:IOH42656	877	587	967	515	521	579	1651	959	584	915	acyl-CoA synthetase long-chain family member 4 (ACSL4), transcript variant 2
B05R12C19	5-19-12	Hs~Ref:NM_133341.1~uORF:IOH42565	947	464	918	404	528	838	1785	636	1600	168	RAD17 homolog (S. pombe) (RAD17), transcript variant 4
B05R12C20	5-20-12	Hs~Ref:NM_133341.1~uORF:IOH42565	996	487	857	414	520	798	1749	630	1378	160	RAD17 homolog (S. pombe) (RAD17), transcript variant 4
B05R12C21	5-21-12	Hs~Ref:NM_012459.1~uORF:IOH42518	488	350	604	364	462	273	836	335	945	213	translocase of inner mitochondrial membrane 8 homolog B (yeast) (TIMM8B)
B05R12C22	5-22-12	Hs~Ref:NM_012459.1~uORF:IOH42518	439	346	571	289	421	309	815	321	534	175	translocase of inner mitochondrial membrane 8 homolog B (yeast) (TIMM8B)
B05R13C01	5-1-13	Hs~Ref:NM_000638.2~uORF:IOH6660	1737	1053	1755	960	726	1367	3787	1023	3195	769	vitronectin (VTN)
B05R13C02	5-2-13	Hs~Ref:NM_000638.2~uORF:IOH6660	1704	1004	1810	1039	759	1599	3826	1101	3337	863	vitronectin (VTN)
B05R13C03	5-3-13	Hs~Ref:NM_006832.1~uORF:IOH12652	1790	1959	1315	5655	1136	1222	1554	1120	2112	400	pleckstrin homology domain containing, family C (with FERM domain) member 1 (PLEKHC1)
B05R13C04	5-4-13	Hs~Ref:NM_006832.1~uORF:IOH12652	1798	1706	1566	5444	1113	1133	1641	970	2290	421	pleckstrin homology domain containing, family C (with FERM domain) member 1 (PLEKHC1)
B05R13C05	5-5-13	Hs~Ref:NM_000930.2~uORF:IOH29603	810	900	1212	704	687	1078	1347	757	1957	593	plasminogen activator, tissue (PLAT), transcript variant 1
B05R13C06	5-6-13	Hs~Ref:NM_000930.2~uORF:IOH29603	828	768	1210	673	723	1052	1403	680	2170	648	plasminogen activator, tissue (PLAT), transcript variant 1
B05R13C07	5-7-13	Hs~Ref:NM_015886.3~uORF:IOH29651	1105	953	1291	808	876	1308	1745	869	2498	816	peptidase inhibitor 15 (PI15)
B05R13C08	5-8-13	Hs~Ref:NM_015886.3~uORF:IOH29651	1135	939	1482	826	822	1303	1642	899	2673	779	peptidase inhibitor 15 (PI15)
B05R13C11	5-11-13	Hs~Ref:NM_017988.4~uORF:IOH61176	9502	752	482	680	615	2954	1521	535	1929	98	SCY1-like 2 (S. cerevisiae) (SCYL2)
B05R13C12	5-12-13	Hs~Ref:NM_017988.4~uORF:IOH61176	8580	630	445	636	644	2575	1444	514	1806	474	SCY1-like 2 (S. cerevisiae) (SCYL2)
B05R13C15	5-15-13	Hs~Ref:NM_003887.1~uORF:IOH60033	1574	790	1894	623	934	646	1175	1068	3507	567	Development and differentiation-enhancing factor 2
B05R13C16	5-16-13	Hs~Ref:NM_003887.1~uORF:IOH60033	1726	787	1764	636	801	646	1023	975	3699	529	Development and differentiation-enhancing factor 2
B05R13C17	5-17-13	Hs~Ref:NM_001312.2~uORF:IOH3437	1016	819	1054	696	709	978	1303	816	1836	652	cysteine-rich protein 2 (CRIP2)
B05R13C18	5-18-13	Hs~Ref:NM_001312.2~uORF:IOH3437	928	721	1111	677	836	1044	1253	816	2625	690	cysteine-rich protein 2 (CRIP2)
B05R13C19	5-19-13	Hs~Ref:NM_003254.1~uORF:IOH3196	584	571	837	395	472	721	1213	486	3019	510	TIMP metallopeptidase inhibitor 1 (TIMP1)
B05R13C20	5-20-13	Hs~Ref:NM_003254.1~uORF:IOH3196	630	499	770	502	606	741	1187	435	3287	274	TIMP metallopeptidase inhibitor 1 (TIMP1)
B05R13C21	5-21-13	Hs~Ref:NM_002415.1~uORF:IOH3502	814	677	998	1011	809	909	1472	1241	1912	447	macrophage migration inhibitory factor (glycosylation-inhibiting factor) (MIF)
B05R13C22	5-22-13	Hs~Ref:NM_002415.1~uORF:IOH3502	835	732	1021	892	826	917	1417	1290	2157	509	macrophage migration inhibitory factor (glycosylation-inhibiting factor) (MIF)
B05R14C01	5-1-14	Hs~MGC:BC001083.1~uORF:IOH3776	1359	538	1190	495	465	1039	1144	671	1749	399	Protein MYLE
B05R14C02	5-2-14	Hs~MGC:BC001083.1~uORF:IOH3776	1257	559	1230	481	476	1058	1214	634	1862	395	Protein MYLE
B05R14C03	5-3-14	Hs~MGC:BC052966.1~uORF:IOH28846	2351	972	1486	766	816	1206	7860	1134	3179	461	poly (ADP-ribose) glycohydrolase (PARG)
B05R14C04	5-4-14	Hs~MGC:BC052966.1~uORF:IOH28846	2378	974	1594	733	813	1173	7774	954	3001	453	poly (ADP-ribose) glycohydrolase (PARG)
B05R14C05	5-5-14	Hs~MGC:BC020737.1~uORF:IOH14449	422	474	608	316	336	624	741	457	913	256	phosphatidylinositol glycan anchor biosynthesis, class K (PIGK)
B05R14C06	5-6-14	Hs~MGC:BC020737.1~uORF:IOH14449	437	500	718	329	469	473	781	305	834	244	phosphatidylinositol glycan anchor biosynthesis, class K (PIGK)
B05R14C07	5-7-14	Hs~MGC:BC007401.2~uORF:IOH5852	748	2004	1965	2879	1234	1481	4927	538	4086	184	cell division cycle 25 homolog A (S. pombe) (CDC25A)
B05R14C08	5-8-14	Hs~MGC:BC007401.2~uORF:IOH5852	741	1812	1923	2896	1180	1408	4787	482	4152	330	cell division cycle 25 homolog A (S. pombe) (CDC25A)
B05R14C09	5-9-14	Hs~MGC:BC025996.2~uORF:IOH10875	2072	2113	788	439	572	813	1124	839	1147	294	glucuronidase, beta pseudogene (LOC441046)
B05R14C10	5-10-14	Hs~MGC:BC025996.2~uORF:IOH10875	2029	2120	810	444	653	825	1065	795	1222	276	glucuronidase, beta pseudogene (LOC441046)
B05R14C11	5-11-14	Hs~Ref:NM_004985.3~uORF:IOH53851	432	405	502	315	676	468	631	552	763	175	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b, mRNA.
B05R14C12	5-12-14	Hs~Ref:NM_004985.3~uORF:IOH53851	364	393	479	305	735	529	652	527	705	115	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b, mRNA.
B05R14C13	5-13-14	Hs~Ref:NM_139245.2~uORF:IOH53944	400	1012	911	325	849	1125	1756	442	1078	335	Protein phosphatase 1L
B05R14C14	5-14-14	Hs~Ref:NM_139245.2~uORF:IOH53944	355	975	849	343	884	1091	1683	437	1075	356	Protein phosphatase 1L
B05R14C15	5-15-14	Hs~Ref:NM_001008491.1~uORF:IOH53945	971	999	1705	1035	967	761	6656	1616	1504	155	Septin-2
B05R14C16	5-16-14	Hs~Ref:NM_001008491.1~uORF:IOH53945	912	927	1629	1018	962	727	6338	1601	1373	117	Septin-2
B05R14C17	5-17-14	Hs~Ref:NM_001006625.1~uORF:IOH58657	350	209	465	195	276	143	374	327	743	82	Podoplanin
B05R14C18	5-18-14	Hs~Ref:NM_001006625.1~uORF:IOH58657	314	205	422	264	317	298	403	340	356	189	Podoplanin
B05R14C19	5-19-14	Hs~Ref:NM_030641.2~uORF:IOH26930	563	387	643	398	520	562	990	481	1006	302	apolipoprotein L, 6 (APOL6)
B05R14C20	5-20-14	Hs~Ref:NM_030641.2~uORF:IOH26930	653	409	601	405	505	532	939	487	1091	204	apolipoprotein L, 6 (APOL6)
B05R14C21	5-21-14	Hs~MGC:BC043348.2~uORF:IOH26348	694	1972	697	642	485	1091	1778	512	1142	68	retinitis pigmentosa 2 (X-linked recessive) (RP2)
B05R14C22	5-22-14	Hs~MGC:BC043348.2~uORF:IOH26348	652	1781	658	506	463	1060	1723	474	1525	208	retinitis pigmentosa 2 (X-linked recessive) (RP2)
B05R15C01	5-1-15	Hs~MGC:BC047666.1~uORF:IOH26700	1524	674	955	589	627	816	812	599	1852	425	N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1)
B05R15C02	5-2-15	Hs~MGC:BC047666.1~uORF:IOH26700	1546	612	939	613	531	778	817	667	1700	398	N-acetyltransferase 1 (arylamine N-acetyltransferase) (NAT1)
B05R15C03	5-3-15	Hs~MGC:BC051850.1~uORF:IOH27078	606	578	744	465	460	547	959	481	1274	385	Transmembrane protein 120A
B05R15C04	5-4-15	Hs~MGC:BC051850.1~uORF:IOH27078	579	531	766	465	460	565	945	507	1333	361	Transmembrane protein 120A
B05R15C05	5-5-15	Hs~MGC:BC093661.1~uORF:IOH61968	1286	2056	1150	1585	1580	2148	1435	1857	4531	1265	Putative uncharacterized protein C14orf177
B05R15C06	5-6-15	Hs~MGC:BC093661.1~uORF:IOH61968	1302	2039	1160	1628	1533	1909	1468	1616	4774	1318	Putative uncharacterized protein C14orf177
B05R15C07	5-7-15	Hs~MGC:BC016486.2~uORF:IOH61399	1398	1588	5789	3212	1062	2172	3040	6008	3148	990	lectin, galactoside-binding, soluble, 8 (galectin 8) (LGALS8)
B05R15C08	5-8-15	Hs~MGC:BC016486.2~uORF:IOH61399	1285	1583	5612	3248	982	2217	2961	5769	3099	1127	lectin, galactoside-binding, soluble, 8 (galectin 8) (LGALS8)
B05R15C11	5-11-15	Hs~MGC:BC072000.1~uORF:IOH63090	341	297	455	382	419	502	477	283	878	340	GTP-binding nuclear protein Ran
B05R15C12	5-12-15	Hs~MGC:BC072000.1~uORF:IOH63090	316	362	421	407	347	648	483	274	855	302	GTP-binding nuclear protein Ran
B05R15C15	5-15-15	Hs~Ref:NM_006254.3~CAT:P2287	597	3431	3408	368	610	698	2130	304	1540	472	protein kinase C, delta (PRKCD), transcript variant 1
B05R15C16	5-16-15	Hs~Ref:NM_006254.3~CAT:P2287	586	3355	3542	371	599	672	2120	296	1653	516	protein kinase C, delta (PRKCD), transcript variant 1
B05R15C17	5-17-15	Hs~Ref:NM_001895.1~CAT:PV3248	559	377	1135	464	613	716	988	331	778	1675	casein kinase 2, alpha 1 polypeptide (CSNK2A1), transcript variant 2
B05R15C18	5-18-15	Hs~Ref:NM_001895.1~CAT:PV3248	544	393	1163	435	716	612	915	398	589	1645	casein kinase 2, alpha 1 polypeptide (CSNK2A1), transcript variant 2
B05R15C19	5-19-15	Hs~Ref:NM_004073.2~CAT:PV3812	844	1190	775	877	789	1169	918	762	1870	1053	polo-like kinase 3 (Drosophila) (PLK3)
B05R15C20	5-20-15	Hs~Ref:NM_004073.2~CAT:PV3812	894	1131	733	961	665	1117	860	673	1692	952	polo-like kinase 3 (Drosophila) (PLK3)
B05R15C21	5-21-15	Hs~Ref:NM_022048.1~CAT:PV3825	855	681	940	9510	1082	1481	3316	1845	1580	667	casein kinase 1, gamma 1 (CSNK1G1)
B05R15C22	5-22-15	Hs~Ref:NM_022048.1~CAT:PV3825	710	634	904	8399	909	1398	3203	1761	1472	559	casein kinase 1, gamma 1 (CSNK1G1)
B05R16C01	5-1-16	Hs~Ref:NM_001893.3~CAT:PV3665	1735	2656	4076	4783	1552	2498	10087	4215	4762	2126	casein kinase 1, delta (CSNK1D), transcript variant 1
B05R16C02	5-2-16	Hs~Ref:NM_001893.3~CAT:PV3665	1988	2734	4384	4599	1632	2557	10427	4417	4903	2287	casein kinase 1, delta (CSNK1D), transcript variant 1
B05R16C05	5-5-16	Hs~N/A:NM_006206.3~CAT:PV4680	552	230	457	276	1068	419	1336	265	1166	311	platelet-derived growth factor receptor, alpha polypeptide (PDGFRA); see catalog number for detailed information on wild-type or point mutant status
B05R16C06	5-6-16	Hs~N/A:NM_006206.3~CAT:PV4680	567	161	502	277	1111	388	1379	254	1077	306	platelet-derived growth factor receptor, alpha polypeptide (PDGFRA); see catalog number for detailed information on wild-type or point mutant status
B05R16C07	5-7-16	Hs~MGC:BC072396.1~uORF:IOH61805	662	436	1393	0	404	660	988	591	951	359	T cell receptor gamma variable 9, mRNA (cDNA clone MGC:90486 IMAGE:5755352), complete cds
B05R16C08	5-8-16	Hs~MGC:BC072396.1~uORF:IOH61805	543	464	1436	1	449	650	980	569	907	367	T cell receptor gamma variable 9, mRNA (cDNA clone MGC:90486 IMAGE:5755352), complete cds
B05R16C09	5-9-16	Hs~MGC:BC095467.1~uORF:IOH62758	426	471	910	608	607	647	1192	481	872	388	Ras-related protein Rap-1b
B05R16C10	5-10-16	Hs~MGC:BC095467.1~uORF:IOH62758	458	436	948	622	662	629	1254	497	903	382	Ras-related protein Rap-1b
B05R16C13	5-13-16	Hs~MGC:BC092476.1~uORF:IOH62623	816	1080	2054	630	3908	1258	2037	935	2278	563	RNA-binding protein with multiple splicing
B05R16C14	5-14-16	Hs~MGC:BC092476.1~uORF:IOH62623	802	1053	2017	624	4096	1204	2194	961	2200	597	RNA-binding protein with multiple splicing
B05R16C15	5-15-16	Hs~Ref:NM_025219.1~uORF:IOH28943	1086	1232	1036	2029	679	583	1143	557	1189	1829	DnaJ (Hsp40) homolog, subfamily C, member 5 (DNAJC5)
B05R16C16	5-16-16	Hs~Ref:NM_025219.1~uORF:IOH28943	1036	1116	1023	1993	648	539	1146	587	1251	1949	DnaJ (Hsp40) homolog, subfamily C, member 5 (DNAJC5)
B05R16C17	5-17-16	Hs~MGC:BC032825.2~uORF:IOH26816	1067	2079	1551	944	4281	2540	1998	1884	1589	97	SH3-domain GRB2-like 2 (SH3GL2)
B05R16C18	5-18-16	Hs~MGC:BC032825.2~uORF:IOH26816	996	1810	1447	959	4388	2307	1848	1961	1199	85	SH3-domain GRB2-like 2 (SH3GL2)
B05R16C19	5-19-16	Hs~MGC:BC058862.1~uORF:IOH28675	1019	744	1315	1475	1359	703	2092	914	1780	556	testis-specific kinase substrate (TSKS)
B05R16C20	5-20-16	Hs~MGC:BC058862.1~uORF:IOH28675	1044	665	1171	1598	1336	760	1889	872	1953	547	testis-specific kinase substrate (TSKS)
B05R16C21	5-21-16	Hs~MGC:BC040981.2~uORF:IOH27624	650	744	810	903	761	734	902	1150	1861	423	hypothetical protein FLJ30934 (FLJ30934)
B05R16C22	5-22-16	Hs~MGC:BC040981.2~uORF:IOH27624	610	701	818	756	691	747	904	1324	1555	333	hypothetical protein FLJ30934 (FLJ30934)
B05R17C01	5-1-17	Hs~MGC:BC036817.1~uORF:IOH22107	960	934	1440	743	905	794	2324	727	2141	444	FK506 binding protein 6, 36kDa (FKBP6)
B05R17C02	5-2-17	Hs~MGC:BC036817.1~uORF:IOH22107	918	949	1385	775	801	804	2226	772	2107	425	FK506 binding protein 6, 36kDa (FKBP6)
B05R17C03	5-3-17	Hs~Ref:NM_001007258.1~uORF:IOH22078	1038	687	1848	660	671	720	1376	595	2024	558	SET domain containing 4 (SETD4), transcript variant 2
B05R17C04	5-4-17	Hs~Ref:NM_001007258.1~uORF:IOH22078	966	944	1730	610	712	769	1331	601	1873	523	SET domain containing 4 (SETD4), transcript variant 2
B05R17C05	5-5-17	Hs~MGC:BC013107.1~uORF:IOH11160	1008	942	1283	735	1203	1389	1622	678	2773	589	WD repeat-containing protein 42A
B05R17C06	5-6-17	Hs~MGC:BC013107.1~uORF:IOH11160	986	766	1216	741	1148	960	1695	670	2362	633	WD repeat-containing protein 42A
B05R17C07	5-7-17	Hs~Ref:NM_153261.3~uORF:IOH22075	876	925	1462	828	1214	1335	1590	845	2291	675	Transmembrane protein 188
B05R17C08	5-8-17	Hs~Ref:NM_153261.3~uORF:IOH22075	864	877	1431	864	1249	1417	1677	763	2324	639	Transmembrane protein 188
B05R17C09	5-9-17	Hs~MGC:BC087841.1~uORF:IOH62571	350	387	694	378	404	489	803	424	617	328	Ig alpha-1 chain C region
B05R17C10	5-10-17	Hs~MGC:BC087841.1~uORF:IOH62571	416	400	646	349	506	566	814	454	746	366	Ig alpha-1 chain C region
B05R17C13	5-13-17	Hs~MGC:BC066254.1~uORF:IOH61859	290	340	923	314	784	331	2049	821	493	90	Interleukin-2
B05R17C14	5-14-17	Hs~MGC:BC066254.1~uORF:IOH61859	223	326	932	277	814	179	2004	856	577	202	Interleukin-2
B05R17C15	5-15-17	Hs~MGC:BC067811.1~uORF:IOH61678	283	273	376	265	549	326	638	336	591	224	Protein cereblon
B05R17C16	5-16-17	Hs~MGC:BC067811.1~uORF:IOH61678	273	335	441	231	303	314	605	297	741	95	Protein cereblon
B05R17C17	5-17-17	Hs~Ref:NM_016061.1~uORF:IOH3118	1119	881	1739	-1	1695	731	1308	870	3970	575	yippee-like 5 (Drosophila) (YPEL5)
B05R17C18	5-18-17	Hs~Ref:NM_016061.1~uORF:IOH3118	1110	909	1917	0	1775	805	1429	853	3327	600	yippee-like 5 (Drosophila) (YPEL5)
B05R17C19	5-19-17	Hs~MGC:BC008656.1~uORF:IOH3347	947	569	1427	385	822	808	1013	361	-76	324	Spermatogenesis-associated protein 7
B05R17C20	5-20-17	Hs~MGC:BC008656.1~uORF:IOH3347	863	637	1291	393	743	797	955	299	1145	336	Spermatogenesis-associated protein 7
B05R17C21	5-21-17	Hs~Ref:NM_006830.2~uORF:IOH3579	993	697	801	722	401	591	1034	721	1950	300	ubiquinol-cytochrome c reductase, 6.4kDa subunit (UQCR)
B05R17C22	5-22-17	Hs~Ref:NM_006830.2~uORF:IOH3579	699	614	718	475	790	684	1051	592	1880	380	ubiquinol-cytochrome c reductase, 6.4kDa subunit (UQCR)
B05R18C01	5-1-18	Hs~Ref:NM_173621.1~uORF:IOH43334	986	2331	1025	659	597	751	1021	675	2401	593	chromosome 17 open reading frame 44 (C17orf44)
B05R18C02	5-2-18	Hs~Ref:NM_173621.1~uORF:IOH43334	817	2275	1017	632	628	763	1108	671	2309	535	chromosome 17 open reading frame 44 (C17orf44)
B05R18C03	5-3-18	Hs~MGC:BC038294.2~uORF:IOH27125	405	341	433	280	254	454	701	323	917	306	chromosome 10 open reading frame 46 (C10orf46)
B05R18C04	5-4-18	Hs~MGC:BC038294.2~uORF:IOH27125	412	311	504	309	253	458	748	338	854	287	chromosome 10 open reading frame 46 (C10orf46)
B05R18C05	5-5-18	Hs~Ref:NM_139240.2~uORF:IOH27365	1483	598	1200	628	655	2644	1240	528	1272	387	chromosome 1 open reading frame 105 (C1orf105)
B05R18C06	5-6-18	Hs~Ref:NM_139240.2~uORF:IOH27365	1538	500	1138	583	836	2796	1258	475	1369	392	chromosome 1 open reading frame 105 (C1orf105)
B05R18C07	5-7-18	Hs~Ref:NM_019069.3~uORF:IOH26403	804	569	785	349	732	584	2820	422	931	301	WD repeat domain 5B (WDR5B)
B05R18C08	5-8-18	Hs~Ref:NM_019069.3~uORF:IOH26403	762	530	827	445	757	798	2645	558	958	305	WD repeat domain 5B (WDR5B)
B05R18C09	5-9-18	Hs~MGC:BC046645.1~uORF:IOH26386	650	408	1092	656	458	1120	1218	712	954	322	collagen and calcium binding EGF domains 1 (CCBE1)
B05R18C10	5-10-18	Hs~MGC:BC046645.1~uORF:IOH26386	691	413	1038	439	649	1001	1109	605	998	326	collagen and calcium binding EGF domains 1 (CCBE1)
B05R18C11	5-11-18	Hs~Ref:NM_002949.2~uORF:IOH56891	489	352	727	1458	386	573	2831	1646	1181	433	39S ribosomal protein L12, mitochondrial
B05R18C12	5-12-18	Hs~Ref:NM_002949.2~uORF:IOH56891	422	402	730	1528	350	546	2478	1510	1138	417	39S ribosomal protein L12, mitochondrial
B05R18C15	5-15-18	Hs~Ref:NM_016512.2~uORF:IOH58592	331	316	923	273	506	370	643	353	615	236	Sperm-associated antigen 11B
B05R18C16	5-16-18	Hs~Ref:NM_016512.2~uORF:IOH58592	332	360	932	262	302	363	647	332	1847	209	Sperm-associated antigen 11B
B05R18C17	5-17-18	Hs~Ref:NM_002731.2~uORF:IOH53938	570	461	942	664	560	1929	1831	922	1244	338	protein kinase, cAMP-dependent, catalytic, beta (PRKACB), transcript variant 2
B05R18C18	5-18-18	Hs~Ref:NM_002731.2~uORF:IOH53938	571	401	897	614	538	1973	1902	894	1213	217	protein kinase, cAMP-dependent, catalytic, beta (PRKACB), transcript variant 2
B05R18C21	5-21-18	Hs~Ref:NM_022972.1~N/A	864	543	778	717	997	468	943	974	2431	895	Fibroblast growth factor receptor 2
B05R18C22	5-22-18	Hs~Ref:NM_022972.1~N/A	709	460	803	558	1004	529	860	1042	2216	781	Fibroblast growth factor receptor 2
B05R19C01	5-1-19	Hs~Ref:NM_002969.2~N/A	711	595	1105	585	801	501	813	1022	2318	351	mitogen-activated protein kinase 12 (MAPK12)
B05R19C02	5-2-19	Hs~Ref:NM_002969.2~N/A	609	596	1238	528	782	531	850	907	2199	403	mitogen-activated protein kinase 12 (MAPK12)
B05R19C03	5-3-19	Hs~Ref:NM_152727.4~uORF:IOH28984	1659	1758	1668	1850	1162	2622	4250	1814	2632	1496	copine II (CPNE2)
B05R19C04	5-4-19	Hs~Ref:NM_152727.4~uORF:IOH28984	1740	1677	1656	1902	1183	2536	4385	1795	2102	1513	copine II (CPNE2)
B05R19C05	5-5-19	Hs~Ref:NM_017877.2~uORF:IOH11542	348	669	663	246	243	357	843	275	607	165	chromosome 2 open reading frame 18 (C2orf18)
B05R19C06	5-6-19	Hs~Ref:NM_017877.2~uORF:IOH11542	377	373	717	229	311	1021	834	274	554	99	chromosome 2 open reading frame 18 (C2orf18)
B05R19C07	5-7-19	Hs~Ref:NM_001651.1~uORF:IOH22503	751	734	1601	661	664	776	2913	1020	2509	532	aquaporin 5 (AQP5)
B05R19C08	5-8-19	Hs~Ref:NM_001651.1~uORF:IOH22503	702	762	1706	717	618	804	3032	1056	2422	559	aquaporin 5 (AQP5)
B05R19C09	5-9-19	Hs~MGC:NM_152489.1~uORF:IOH22752	574	627	1001	629	604	809	665	693	2210	515	ubiquitin-conjugating enzyme E2U (putative) (UBE2U)
B05R19C10	5-10-19	Hs~MGC:NM_152489.1~uORF:IOH22752	643	618	1016	608	731	768	681	1030	2283	502	ubiquitin-conjugating enzyme E2U (putative) (UBE2U)
B05R19C11	5-11-19	Hs~MGC:BC030295.1~uORF:IOH21572	807	671	1542	623	773	2341	1449	884	2623	533	Williams Beuren syndrome chromosome region 27 (WBSCR27)
B05R19C12	5-12-19	Hs~MGC:BC030295.1~uORF:IOH21572	814	671	1664	640	1291	2196	1426	762	2661	507	Williams Beuren syndrome chromosome region 27 (WBSCR27)
B05R19C15	5-15-19	Hs~MGC:BC013009.1~uORF:IOH13110	653	920	1161	16284	634	450	3661	3123	4515	3810	zinc finger, MYM-type 3 (ZMYM3)
B05R19C16	5-16-19	Hs~MGC:BC013009.1~uORF:IOH13110	627	845	1116	16531	593	369	3621	3140	4561	3666	zinc finger, MYM-type 3 (ZMYM3)
B05R19C17	5-17-19	Hs~Ref:NM_002159.2~uORF:IOH12902	863	531	925	470	561	665	1300	667	1312	309	histatin 1 (HTN1)
B05R19C18	5-18-19	Hs~Ref:NM_002159.2~uORF:IOH12902	831	527	885	441	610	647	1294	709	972	295	histatin 1 (HTN1)
B05R19C19	5-19-19	Hs~MGC:BC029877.1~uORF:IOH22783	722	1600	1035	455	643	731	2145	1363	1451	373	cDNA clone MGC:35221 IMAGE:5172092, complete cds
B05R19C20	5-20-19	Hs~MGC:BC029877.1~uORF:IOH22783	725	1440	928	469	540	792	2253	1350	1344	329	cDNA clone MGC:35221 IMAGE:5172092, complete cds
B05R19C21	5-21-19	Hs~Ref:NM_014248.2~uORF:IOH4015	1143	1512	1306	1212	732	788	1493	1119	2995	537	ring-box 1 (RBX1)
B05R19C22	5-22-19	Hs~Ref:NM_014248.2~uORF:IOH4015	1087	1348	1269	1124	766	575	1407	1492	2927	550	ring-box 1 (RBX1)
B05R20C01	5-1-20	Hs~Ref:NM_004566.1~uORF:IOH27198	1294	5062	2277	1681	1119	2976	4321	2288	4700	756	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3)
B05R20C02	5-2-20	Hs~Ref:NM_004566.1~uORF:IOH27198	1236	5132	2351	1779	972	2723	4108	2145	4379	777	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3)
B05R20C03	5-3-20	Hs~MGC:BC033196.1~uORF:IOH23248	477	585	820	413	491	660	914	448	1584	1434	EF-hand calcium binding domain 4A (EFCAB4A)
B05R20C04	5-4-20	Hs~MGC:BC033196.1~uORF:IOH23248	454	522	853	418	480	603	909	402	1189	1453	EF-hand calcium binding domain 4A (EFCAB4A)
B05R20C05	5-5-20	Hs~Ref:NM_053006.1~uORF:IOH27746	1516	2293	1614	1010	1072	1286	1586	770	3542	709	testis-specific serine kinase 2 (TSSK2)
B05R20C06	5-6-20	Hs~Ref:NM_053006.1~uORF:IOH27746	1556	2328	1608	923	1246	1422	1585	717	3706	640	testis-specific serine kinase 2 (TSSK2)
B05R20C07	5-7-20	Hs~Ref:NM_000666.1~uORF:IOH4147	484	311	1048	474	470	1227	888	681	958	301	aminoacylase 1 (ACY1)
B05R20C08	5-8-20	Hs~Ref:NM_000666.1~uORF:IOH4147	440	305	1070	480	425	1131	866	680	963	290	aminoacylase 1 (ACY1)
B05R20C09	5-9-20	Hs~MGC:BC052600.1~uORF:IOH29370	513	382	687	388	459	529	568	425	896	376	zinc finger protein 718 (ZNF718)
B05R20C10	5-10-20	Hs~MGC:BC052600.1~uORF:IOH29370	484	379	696	386	428	505	506	468	898	355	zinc finger protein 718 (ZNF718)
B05R20C11	5-11-20	Hs~MGC:BC058932.1~uORF:IOH29074	760	412	686	1106	1060	505	649	468	1031	319	inositol polyphosphate-5-phosphatase, 75kDa (INPP5B)
B05R20C12	5-12-20	Hs~MGC:BC058932.1~uORF:IOH29074	727	390	654	1078	1059	486	661	444	951	324	inositol polyphosphate-5-phosphatase, 75kDa (INPP5B)
B05R20C13	5-13-20	Hs~MGC:BC059374.1~uORF:IOH29261	653	408	629	436	671	452	889	476	1086	393	serine/threonine kinase 31 (STK31)
B05R20C14	5-14-20	Hs~MGC:BC059374.1~uORF:IOH29261	634	400	651	410	835	471	852	465	1192	376	serine/threonine kinase 31 (STK31)
B06R02C11	6-11-2	Hs~MGC:BC010352.1~uORF:IOH14239	2778	986	1670	738	1438	994	1289	914	3153	582	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, mRNA (cDNA clone IMAGE:4292790), complete cds.
B06R02C12	6-12-2	Hs~MGC:BC010352.1~uORF:IOH14239	2938	938	1616	786	1172	1001	1303	906	3150	606	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, mRNA (cDNA clone IMAGE:4292790), complete cds.
B06R02C13	6-13-2	Hs~MGC:BC018142.1~uORF:IOH10362	1298	944	2152	2782	961	1091	1815	1039	3979	680	Caspase recruitment domain-containing protein 14
B06R02C14	6-14-2	Hs~MGC:BC018142.1~uORF:IOH10362	1322	914	2037	2593	973	980	1827	976	2530	691	Caspase recruitment domain-containing protein 14
B06R02C15	6-15-2	Hs~MGC:BC053647.1~uORF:IOH28956	1155	934	1246	804	993	1072	2264	1009	2718	575	FERM domain-containing protein 5
B06R02C16	6-16-2	Hs~MGC:BC053647.1~uORF:IOH28956	1225	920	1191	762	743	1004	2125	1067	2632	668	FERM domain-containing protein 5
B06R02C17	6-17-2	Hs~Ref:NM_021063.2~uORF:IOH58956	3191	1624	2768	1470	1913	2116	10536	1742	5160	783	Histone H2B type 1-D
B06R02C18	6-18-2	Hs~Ref:NM_021063.2~uORF:IOH58956	3240	1597	2672	1420	1732	1912	10426	1691	5002	876	Histone H2B type 1-D
B06R02C19	6-19-2	Hs~MGC:BC012596.1~uORF:IOH14331	2829	1526	2057	897	1136	1361	2023	1212	3700	807	Actin-related protein 2/3 complex subunit 4
B06R02C20	6-20-2	Hs~MGC:BC012596.1~uORF:IOH14331	2795	1496	1969	904	1309	1428	2088	1122	3919	706	Actin-related protein 2/3 complex subunit 4
B06R02C21	6-21-2	Hs~Ref:NM_000992.2~uORF:IOH1702	3451	1814	2776	1357	1473	1954	11731	1713	5341	1200	60S ribosomal protein L29
B06R02C22	6-22-2	Hs~Ref:NM_000992.2~uORF:IOH1702	3366	1725	2760	1462	1471	1956	10844	1576	5129	1147	60S ribosomal protein L29
B06R03C01	6-1-3	Hs~Ref:NM_001839.1~uORF:IOH14563	2235	2169	3301	48004	15026	1856	14724	6163	3254	821	Calponin-3
B06R03C02	6-2-3	Hs~Ref:NM_001839.1~uORF:IOH14563	2029	1921	3026	43164	14170	1661	13070	5463	3057	675	Calponin-3
B06R03C03	6-3-3	Hs~Ref:NM_005147.1~uORF:IOH14013	1576	1149	1451	1161	917	1414	2974	1191	182	848	DnaJ homolog subfamily A member 3, mitochondrial
B06R03C04	6-4-3	Hs~Ref:NM_005147.1~uORF:IOH14013	1511	1111	1425	1094	896	1425	2863	1169	3002	706	DnaJ homolog subfamily A member 3, mitochondrial
B06R03C05	6-5-3	Hs~Ref:NM_078630.1~uORF:IOH37755	4563	1613	3733	5173	1625	2020	4024	2198	14770	1507	male-specific lethal 3-like 1 (Drosophila) (MSL3L1), transcript variant 2
B06R03C06	6-6-3	Hs~Ref:NM_078630.1~uORF:IOH37755	4046	1369	3635	5026	1548	2038	3797	2097	13539	1437	male-specific lethal 3-like 1 (Drosophila) (MSL3L1), transcript variant 2
B06R03C07	6-7-3	Hs~MGC:NM_015191.1~uORF:IOH45349	814	1481	1229	364	435	664	686	500	1858	517	SNF1-like kinase 2 (SNF1LK2)
B06R03C08	6-8-3	Hs~MGC:NM_015191.1~uORF:IOH45349	775	1021	1147	355	488	572	697	415	2015	509	SNF1-like kinase 2 (SNF1LK2)
B06R03C09	6-9-3	Hs~Ref:NM_130467.3~uORF:IOH40626	1962	4507	683	267	237	198	1085	258	514	287	P antigen family, member 5 (prostate associated) (PAGE5), transcript variant 1
B06R03C10	6-10-3	Hs~Ref:NM_130467.3~uORF:IOH40626	1679	4392	677	277	337	188	963	250	159	281	P antigen family, member 5 (prostate associated) (PAGE5), transcript variant 1
B06R03C11	6-11-3	Hs~Ref:NM_004349.2~uORF:IOH36626	2539	1416	2164	1768	5007	1070	1907	989	2684	350	runt-related transcription factor 1; translocated to, 1 (cyclin D-related) (RUNX1T1), transcript variant 1
B06R03C12	6-12-3	Hs~Ref:NM_004349.2~uORF:IOH36626	2388	1306	1928	1678	4286	966	1910	990	2447	315	runt-related transcription factor 1; translocated to, 1 (cyclin D-related) (RUNX1T1), transcript variant 1
B06R03C13	6-13-3	Hs~Ref:NM_016276.3~uORF:IOH35747	647	487	883	411	545	360	644	481	1570	265	serum/glucocorticoid regulated kinase 2 (SGK2), transcript variant 2
B06R03C14	6-14-3	Hs~Ref:NM_016276.3~uORF:IOH35747	719	575	922	458	562	362	664	341	1626	241	serum/glucocorticoid regulated kinase 2 (SGK2), transcript variant 2
B06R03C15	6-15-3	Hs~MGC:NM_173809.2~uORF:IOH41035	256	1039	284	482	370	545	832	269	1417	144	biogenesis of lysosome-related organelles complex-1, subunit 2 (BLOC1S2), transcript variant 1
B06R03C16	6-16-3	Hs~MGC:NM_173809.2~uORF:IOH41035	252	971	266	415	352	114	855	281	1415	141	biogenesis of lysosome-related organelles complex-1, subunit 2 (BLOC1S2), transcript variant 1
B06R03C17	6-17-3	Hs~Ref:NM_004282.2~uORF:IOH40925	871	1017	2776	434	1468	22982	1034	1048	1893	326	BCL2-associated athanogene 2 (BAG2)
B06R03C18	6-18-3	Hs~Ref:NM_004282.2~uORF:IOH40925	878	951	2486	431	1644	22008	1066	1163	1796	300	BCL2-associated athanogene 2 (BAG2)
B06R03C19	6-19-3	Hs~Ref:NM_173178.1~uORF:IOH35125	367	351	913	254	339	447	284	281	1028	54	interleukin 1 family, member 8 (eta) (IL1F8), transcript variant 2
B06R03C20	6-20-3	Hs~Ref:NM_173178.1~uORF:IOH35125	388	378	893	250	429	452	271	252	1048	181	interleukin 1 family, member 8 (eta) (IL1F8), transcript variant 2
B06R03C21	6-21-3	Hs~Ref:NM_001671.2~uORF:IOH23108	791	477	784	354	576	662	865	534	973	200	asialoglycoprotein receptor 1 (ASGR1)
B06R03C22	6-22-3	Hs~Ref:NM_001671.2~uORF:IOH23108	727	506	695	407	488	638	772	581	930	210	asialoglycoprotein receptor 1 (ASGR1)
B06R04C01	6-1-4	Hs~MGC:BC007602.1~uORF:IOH6921	4173	441	712	389	473	751	1311	781	1176	240	polycomb group ring finger 6 (PCGF6)
B06R04C02	6-2-4	Hs~MGC:BC007602.1~uORF:IOH6921	4024	440	698	395	468	617	1301	724	1178	178	polycomb group ring finger 6 (PCGF6)
B06R04C03	6-3-4	Hs~MGC:NM_152776.1~uORF:IOH21708	451	420	552	278	331	412	679	502	466	60	hypothetical protein MGC40579 (MGC40579)
B06R04C04	6-4-4	Hs~MGC:NM_152776.1~uORF:IOH21708	476	400	565	553	327	417	686	541	807	271	hypothetical protein MGC40579 (MGC40579)
B06R04C05	6-5-4	Hs~Ref:NM_004829.1~uORF:IOH21540	445	431	541	545	369	238	636	456	908	241	natural cytotoxicity triggering receptor 1 (NCR1)
B06R04C06	6-6-4	Hs~Ref:NM_004829.1~uORF:IOH21540	535	538	555	276	383	471	555	821	1055	296	natural cytotoxicity triggering receptor 1 (NCR1)
B06R04C07	6-7-4	Hs~MGC:BC015416.1~uORF:IOH10998	1526	759	1048	571	621	870	3614	662	1542	279	ring finger protein 32 (RNF32)
B06R04C08	6-8-4	Hs~MGC:BC015416.1~uORF:IOH10998	1424	742	1006	526	592	929	3331	706	1518	423	ring finger protein 32 (RNF32)
B06R04C09	6-9-4	Hs~MGC:BC009006.1~uORF:IOH10201	621	455	639	390	497	645	985	569	244	308	transmembrane protein 30A (TMEM30A)
B06R04C10	6-10-4	Hs~MGC:BC009006.1~uORF:IOH10201	575	446	681	371	758	670	1065	537	1016	345	transmembrane protein 30A (TMEM30A)
B06R04C11	6-11-4	Hs~Ref:NM_032169.2~uORF:IOH10227	399	441	607	329	464	561	600	503	700	363	Acyl-CoA dehydrogenase family member 11
B06R04C12	6-12-4	Hs~Ref:NM_032169.2~uORF:IOH10227	1134	510	645	342	444	517	697	470	970	364	Acyl-CoA dehydrogenase family member 11
B06R04C13	6-13-4	Hs~MGC:BC011239.1~uORF:IOH10245	388	398	697	513	430	438	536	711	349	246	transcobalamin II; macrocytic anemia (TCN2)
B06R04C14	6-14-4	Hs~MGC:BC011239.1~uORF:IOH10245	428	431	718	367	391	475	564	612	713	180	transcobalamin II; macrocytic anemia (TCN2)
B06R04C15	6-15-4	Hs~Ref:NM_015459.3~uORF:IOH37933	562	373	572	327	472	430	850	316	705	116	DKFZP564J0863 protein (DKFZP564J0863)
B06R04C16	6-16-4	Hs~Ref:NM_015459.3~uORF:IOH37933	529	357	576	316	397	298	905	314	744	115	DKFZP564J0863 protein (DKFZP564J0863)
B06R04C17	6-17-4	Hs~Ref:NM_018158.1~uORF:IOH38323	6999	546	877	3358	1578	801	6037	618	3554	48	solute carrier family 4 (anion exchanger), member 1, adaptor protein (SLC4A1AP)
B06R04C18	6-18-4	Hs~Ref:NM_018158.1~uORF:IOH38323	5723	569	809	3137	1520	765	5919	657	3433	97	solute carrier family 4 (anion exchanger), member 1, adaptor protein (SLC4A1AP)
B06R04C19	6-19-4	Hs~Ref:NM_052917.1~uORF:IOH37969	868	504	698	515	880	623	1254	472	971	260	Polypeptide N-acetylgalactosaminyltransferase 13
B06R04C20	6-20-4	Hs~Ref:NM_052917.1~uORF:IOH37969	2913	596	843	535	1044	679	1304	521	835	259	Polypeptide N-acetylgalactosaminyltransferase 13
B06R04C21	6-21-4	Hs~Ref:NM_006873.2~uORF:IOH38227	5053	696	1285	3860	1206	863	2042	1898	1892	1017	stonin 1 (STON1)
B06R04C22	6-22-4	Hs~Ref:NM_006873.2~uORF:IOH38227	4720	654	1333	3477	1137	908	1905	1845	1828	940	stonin 1 (STON1)
B06R05C01	6-1-5	Hs~Ref:NM_015568.2~uORF:IOH37988	1635	656	900	485	619	1091	2121	581	3187	262	protein phosphatase 1, regulatory (inhibitor) subunit 16B (PPP1R16B)
B06R05C02	6-2-5	Hs~Ref:NM_015568.2~uORF:IOH37988	1634	616	1035	500	822	994	1999	548	4010	308	protein phosphatase 1, regulatory (inhibitor) subunit 16B (PPP1R16B)
B06R05C03	6-3-5	Hs~Ref:NM_178275.3~uORF:IOH38420	2802	725	1578	646	1104	1991	2096	586	0	307	eEF1A2 binding protein (DKFZp434B1231)
B06R05C04	6-4-5	Hs~Ref:NM_178275.3~uORF:IOH38420	2909	724	1519	903	1042	2099	2129	954	3228	400	eEF1A2 binding protein (DKFZp434B1231)
B06R05C05	6-5-5	Hs~Ref:NM_198449.1~uORF:IOH29134	1222	752	1819	710	965	1039	2646	738	1593	510	embigin homolog (mouse) (EMB)
B06R05C06	6-6-5	Hs~Ref:NM_198449.1~uORF:IOH29134	1175	791	1782	535	1093	1015	2647	687	1405	492	embigin homolog (mouse) (EMB)
B06R05C07	6-7-5	Hs~Ref:NM_018848.2~uORF:IOH37996	1274	721	949	474	640	702	1094	451	1451	255	McKusick-Kaufman syndrome (MKKS), transcript variant 1
B06R05C08	6-8-5	Hs~Ref:NM_018848.2~uORF:IOH37996	1200	742	945	425	701	601	1050	561	1594	362	McKusick-Kaufman syndrome (MKKS), transcript variant 1
B06R05C09	6-9-5	Hs~Ref:NM_005965.2~N/A	830	481	857	604	555	621	1097	496	575	388	Myosin light chain kinase, smooth muscle
B06R05C10	6-10-5	Hs~Ref:NM_005965.2~N/A	809	539	882	878	546	650	1137	603	1078	150	Myosin light chain kinase, smooth muscle
B06R05C11	6-11-5	Hs~Ref:NM_007194.2~N/A	1026	584	879	459	802	615	1199	1245	1406	279	CHK2 checkpoint homolog (S. pombe) (CHEK2), transcript variant 1
B06R05C12	6-12-5	Hs~Ref:NM_007194.2~N/A	1350	554	978	441	725	631	1228	1399	1549	272	CHK2 checkpoint homolog (S. pombe) (CHEK2), transcript variant 1
B06R05C13	6-13-5	Hs~Ref:NM_004226.1~N/A	1366	602	1913	693	939	1126	923	3804	4419	254	Serine/threonine-protein kinase 17B
B06R05C14	6-14-5	Hs~Ref:NM_004226.1~N/A	1219	585	1863	681	1145	1080	946	3890	4376	273	Serine/threonine-protein kinase 17B
B06R05C15	6-15-5	Hs~Ref:NM_016507.1~N/A	909	677	1303	624	724	696	1530	678	1828	391	Cell division cycle 2-related protein kinase 7
B06R05C16	6-16-5	Hs~Ref:NM_016507.1~N/A	821	633	1255	597	653	759	1592	678	1902	367	Cell division cycle 2-related protein kinase 7
B06R05C19	6-19-5	Hs~Ref:NM_002613.1~N/A	1140	836	1599	679	1647	1135	1748	816	2288	413	3-phosphoinositide-dependent protein kinase 1
B06R05C20	6-20-5	Hs~Ref:NM_002613.1~N/A	1581	863	1657	701	1986	1079	1738	786	2433	433	3-phosphoinositide-dependent protein kinase 1
B06R05C21	6-21-5	Hs~Ref:NM_020397.1~N/A	969	639	2364	391	1143	971	765	744	4286	388	calcium/calmodulin-dependent protein kinase ID (CAMK1D), transcript variant 1
B06R05C22	6-22-5	Hs~Ref:NM_020397.1~N/A	999	593	2244	399	1143	1013	775	718	4210	383	calcium/calmodulin-dependent protein kinase ID (CAMK1D), transcript variant 1
B06R06C01	6-1-6	Hs~Ref:NM_024046.1~N/A	2399	1271	2240	850	1348	1416	6647	999	2979	545	CaM kinase-like vesicle-associated (CAMKV)
B06R06C02	6-2-6	Hs~Ref:NM_024046.1~N/A	2310	1226	2118	931	1362	1308	6137	994	-130	600	CaM kinase-like vesicle-associated (CAMKV)
B06R06C03	6-3-6	Hs~Ref:NM_018137.1~uORF:IOH5353	2562	1449	2019	1033	1622	1350	2400	1011	3776	818	protein arginine methyltransferase 6 (PRMT6)
B06R06C04	6-4-6	Hs~Ref:NM_018137.1~uORF:IOH5353	2439	1445	2002	1333	1351	1352	2559	964	3221	856	protein arginine methyltransferase 6 (PRMT6)
B06R06C05	6-5-6	Hs~Ref:NM_024712.2~uORF:IOH22774	1547	1269	1632	1250	1140	1906	2693	1324	3432	908	engulfment and cell motility 3 (ELMO3)
B06R06C06	6-6-6	Hs~Ref:NM_024712.2~uORF:IOH22774	1537	1246	1607	1217	1210	2042	2543	1269	3827	996	engulfment and cell motility 3 (ELMO3)
B06R06C07	6-7-6	Hs~MGC:BC032451.1~uORF:IOH21663	65485	65486	65476	65487	65429	64183	61646	49981	65414	65476	cDNA clone MGC:40426 IMAGE:5178085, complete cds
B06R06C08	6-8-6	Hs~MGC:BC032451.1~uORF:IOH21663	65473	65483	65440	65480	65434	64967	61036	48391	65414	65473	cDNA clone MGC:40426 IMAGE:5178085, complete cds
B06R06C09	6-9-6	Hs~Ref:NM_002576.2~N/A	1028	550	618	456	893	674	1275	636	1357	235	Serine/threonine-protein kinase PAK 1
B06R06C10	6-10-6	Hs~Ref:NM_002576.2~N/A	910	573	937	610	832	677	1348	711	1379	351	Serine/threonine-protein kinase PAK 1
B06R06C11	6-11-6	Hs~MGC:BC022253.1~uORF:IOH13441	1478	1178	1881	903	1531	1372	3718	1172	3657	744	solute carrier family 6, member 15 (SLC6A15)
B06R06C12	6-12-6	Hs~MGC:BC022253.1~uORF:IOH13441	1364	1123	1911	962	1811	1330	3507	1192	3529	746	solute carrier family 6, member 15 (SLC6A15)
B06R06C13	6-13-6	Hs~Ref:NM_016614.1~uORF:IOH10129	1445	1242	2018	1248	1465	1130	1967	1305	3697	768	TRAF and TNF receptor associated protein (TTRAP)
B06R06C14	6-14-6	Hs~Ref:NM_016614.1~uORF:IOH10129	1428	1267	1950	1232	1369	1110	1949	1088	3590	813	TRAF and TNF receptor associated protein (TTRAP)
B06R06C15	6-15-6	Hs~MGC:BC015842.1~uORF:IOH23072	2012	1600	1629	1078	5613	2632	4776	1335	3765	806	eukaryotic translation initiation factor 4A, isoform 2 (EIF4A2)
B06R06C16	6-16-6	Hs~MGC:BC015842.1~uORF:IOH23072	1992	1530	1604	1106	5658	2486	4958	1537	3815	790	eukaryotic translation initiation factor 4A, isoform 2 (EIF4A2)
B06R06C17	6-17-6	Hs~MGC:BC011781.2~uORF:IOH13131	4855	1777	2894	4377	2343	1982	6281	10337	5950	1436	chromosome 9 open reading frame 37 (C9orf37)
B06R06C18	6-18-6	Hs~MGC:BC011781.2~uORF:IOH13131	4649	1683	2749	4111	2283	1965	6072	10257	5842	1243	chromosome 9 open reading frame 37 (C9orf37)
B06R06C19	6-19-6	Hs~Ref:NM_152597.3~uORF:IOH25870	3225	908	1207	679	1501	689	2329	757	2523	358	Fibrous sheath-interacting protein 1
B06R06C20	6-20-6	Hs~Ref:NM_152597.3~uORF:IOH25870	3164	985	1179	721	1286	833	2137	799	2779	379	Fibrous sheath-interacting protein 1
B06R06C21	6-21-6	Hs~MGC:BC043528.1~uORF:IOH26294	900	699	785	448	729	781	937	604	839	269	Glycosyltransferase 1 domain-containing protein 1
B06R06C22	6-22-6	Hs~MGC:BC043528.1~uORF:IOH26294	847	621	790	477	631	726	829	625	913	361	Glycosyltransferase 1 domain-containing protein 1
B06R07C01	6-1-7	Hs~MGC:BC049216.1~uORF:IOH26610	1207	578	1008	1522	827	967	4541	1260	1802	397	AHNAK nucleoprotein 2 (AHNAK2)
B06R07C02	6-2-7	Hs~MGC:BC049216.1~uORF:IOH26610	1161	542	953	1549	777	797	4002	1180	1512	396	AHNAK nucleoprotein 2 (AHNAK2)
B06R07C03	6-3-7	Hs~Ref:NM_002462.2~uORF:IOH21990	995	8628	895	34841	383	844	3593	8994	1060	145	myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) (MX1)
B06R07C04	6-4-7	Hs~Ref:NM_002462.2~uORF:IOH21990	976	7556	843	33206	429	776	3311	7779	1076	389	myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) (MX1)
B06R07C05	6-5-7	Hs~MGC:BC000574.1~uORF:IOH4174	554	392	827	670	521	64	650	326	778	446	Procollagen C-endopeptidase enhancer 1
B06R07C06	6-6-7	Hs~MGC:BC000574.1~uORF:IOH4174	533	348	753	566	518	305	735	313	790	256	Procollagen C-endopeptidase enhancer 1
B06R07C07	6-7-7	Hs~Ref:NM_018679.2~uORF:IOH26898	350	420	360	575	237	322	290	264	1358	49	t-complex 11 (mouse) (TCP11), transcript variant 2
B06R07C08	6-8-7	Hs~Ref:NM_018679.2~uORF:IOH26898	400	164	225	521	293	291	281	289	1107	26	t-complex 11 (mouse) (TCP11), transcript variant 2
B06R07C09	6-9-7	Hs~Ref:NM_018393.2~uORF:IOH26255	3915	463	215	771	2611	872	497	499	440	136	t-complex 11 (mouse)-like 1 (TCP11L1)
B06R07C10	6-10-7	Hs~Ref:NM_018393.2~uORF:IOH26255	3653	403	1367	777	2484	844	530	506	936	107	t-complex 11 (mouse)-like 1 (TCP11L1)
B06R07C11	6-11-7	Hs~Ref:NM_144988.2~uORF:IOH12542	459	401	721	255	363	372	847	411	1179	303	asparagine-linked glycosylation 14 homolog (S. cerevisiae) (ALG14)
B06R07C12	6-12-7	Hs~Ref:NM_144988.2~uORF:IOH12542	465	404	710	337	472	388	829	437	1178	94	asparagine-linked glycosylation 14 homolog (S. cerevisiae) (ALG14)
B06R07C13	6-13-7	Hs~Ref:NM_000310.2~uORF:IOH7465	1383	429	558	389	570	427	592	549	753	325	palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile) (PPT1)
B06R07C14	6-14-7	Hs~Ref:NM_000310.2~uORF:IOH7465	888	425	626	436	553	425	543	498	997	387	palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile) (PPT1)
B06R07C15	6-15-7	Hs~Ref:NM_003782.3~uORF:IOH21916	511	439	789	422	407	728	870	495	678	337	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 (B3GALT4)
B06R07C16	6-16-7	Hs~Ref:NM_003782.3~uORF:IOH21916	518	452	773	390	458	680	909	418	668	223	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 (B3GALT4)
B06R07C17	6-17-7	Hs~Ref:NM_024508.3~uORF:IOH45853	499	331	483	345	233	437	915	1089	604	144	zinc finger, BED-type containing 2 (ZBED2)
B06R07C18	6-18-7	Hs~Ref:NM_024508.3~uORF:IOH45853	570	364	523	316	336	327	856	528	487	129	zinc finger, BED-type containing 2 (ZBED2)
B06R07C19	6-19-7	Hs~Ref:NM_033306.1~uORF:IOH45759	355	327	395	279	436	272	712	325	480	82	caspase 4, apoptosis-related cysteine peptidase (CASP4), transcript variant gamma
B06R07C20	6-20-7	Hs~Ref:NM_033306.1~uORF:IOH45759	372	321	448	272	373	352	650	411	394	82	caspase 4, apoptosis-related cysteine peptidase (CASP4), transcript variant gamma
B06R07C21	6-21-7	Hs~Ref:NM_002401.2~N/A	4107	3149	3451	4141	3392	4265	5491	5551	5724	1765	Mitogen-activated protein kinase kinase kinase 3
B06R07C22	6-22-7	Hs~Ref:NM_002401.2~N/A	3764	3031	3268	4283	3443	5794	5208	5554	5473	1827	Mitogen-activated protein kinase kinase kinase 3
B06R08C01	6-1-8	Hs~Ref:NM_003177.2~N/A	899	571	867	575	493	895	1275	711	1501	365	Tyrosine-protein kinase SYK
B06R08C02	6-2-8	Hs~Ref:NM_003177.2~N/A	903	636	1019	569	539	649	1395	710	1338	375	Tyrosine-protein kinase SYK
B06R08C03	6-3-8	Hs~Ref:NM_001433.1~N/A	938	615	922	544	539	584	1098	727	1670	369	Serine/threonine-protein kinase/endoribonuclease IRE1
B06R08C04	6-4-8	Hs~Ref:NM_001433.1~N/A	849	579	1030	492	550	540	1147	683	1580	225	Serine/threonine-protein kinase/endoribonuclease IRE1
B06R08C05	6-5-8	Hs~Ref:NM_001315.1~N/A	937	580	993	920	598	849	1167	902	1472	437	Mitogen-activated protein kinase 14
B06R08C06	6-6-8	Hs~Ref:NM_001315.1~N/A	889	655	974	815	570	625	1169	771	1540	325	Mitogen-activated protein kinase 14
B06R08C07	6-7-8	Hs~Ref:NM_014251.1~uORF:IOH13160	790	471	783	363	578	523	897	372	820	371	solute carrier family 25, member 13 (citrin) (SLC25A13)
B06R08C08	6-8-8	Hs~Ref:NM_014251.1~uORF:IOH13160	881	435	764	344	614	517	844	810	412	166	solute carrier family 25, member 13 (citrin) (SLC25A13)
B06R08C09	6-9-8	Hs~MGC:BC033167.1~uORF:IOH23232	1497	548	3	333	1172	734	389	411	-32	522	calcium binding protein 4 (CABP4)
B06R08C10	6-10-8	Hs~MGC:BC033167.1~uORF:IOH23232	1548	531	475	402	1149	716	413	317	1353	472	calcium binding protein 4 (CABP4)
B06R08C11	6-11-8	Hs~MGC:BC014640.1~uORF:IOH12428	803	475	734	417	576	590	2375	767	1577	376	collagen, type XIV, alpha 1 (undulin) (COL14A1)
B06R08C12	6-12-8	Hs~MGC:BC014640.1~uORF:IOH12428	725	513	732	370	665	516	2399	746	1235	197	collagen, type XIV, alpha 1 (undulin) (COL14A1)
B06R08C13	6-13-8	Hs~Ref:NM_001640.3~uORF:IOH3679	1211	634	1003	763	769	849	2627	709	1620	330	N-acylaminoacyl-peptide hydrolase (APEH)
B06R08C14	6-14-8	Hs~Ref:NM_001640.3~uORF:IOH3679	1114	669	1308	808	714	832	2671	922	1908	315	N-acylaminoacyl-peptide hydrolase (APEH)
B06R08C15	6-15-8	Hs~Ref:NM_001834.2~uORF:IOH43456	943	703	808	629	600	1129	1394	1021	5351	351	clathrin, light chain (Lcb) (CLTB), transcript variant 1, mRNA.
B06R08C16	6-16-8	Hs~Ref:NM_001834.2~uORF:IOH43456	332	766	1088	645	744	1102	1278	836	2108	390	clathrin, light chain (Lcb) (CLTB), transcript variant 1, mRNA.
B06R08C17	6-17-8	Hs~Ref:NM_022041.2~uORF:IOH25725	1390	899	1064	820	826	1162	1674	1440	2266	562	Gigaxonin
B06R08C18	6-18-8	Hs~Ref:NM_022041.2~uORF:IOH25725	1286	903	1116	775	1184	1094	1669	1343	2419	580	Gigaxonin
B06R08C19	6-19-8	Hs~Ref:NM_032417.2~uORF:IOH57369	1315	1090	1246	854	1278	1218	2523	1355	3278	648	Sperm protein associated with the nucleus on the X chromosome D
B06R08C20	6-20-8	Hs~Ref:NM_032417.2~uORF:IOH57369	1351	1141	1289	874	1349	1205	2148	1289	3750	607	Sperm protein associated with the nucleus on the X chromosome D
B06R08C21	6-21-8	Hs~Ref:NM_018199.1~uORF:IOH4885	1547	985	1570	1138	1743	1366	18584	1113	1646	503	exonuclease 3'-5' domain-like 2 (EXDL2)
B06R08C22	6-22-8	Hs~Ref:NM_018199.1~uORF:IOH4885	1646	958	1488	1165	1405	650	18556	1112	1663	481	exonuclease 3'-5' domain-like 2 (EXDL2)
B06R09C01	6-1-9	Hs~Ref:NM_182692.1~uORF:IOH38187	1586	1556	1808	14627	934	2093	2413	1424	1788	374	Serine/threonine-protein kinase SRPK2
B06R09C02	6-2-9	Hs~Ref:NM_182692.1~uORF:IOH38187	1492	1413	1763	13460	916	1989	2331	1385	1541	1765	Serine/threonine-protein kinase SRPK2
B06R09C03	6-3-9	Hs~Ref:NM_001003397.1~uORF:IOH58745	484	811	2679	346	776	708	1713	669	1267	26136	Tumor protein D53
B06R09C04	6-4-9	Hs~Ref:NM_001003397.1~uORF:IOH58745	463	709	2323	466	707	673	1667	677	118	26439	Tumor protein D53
B06R09C05	6-5-9	Hs~Ref:NM_003165.1~uORF:IOH52429	1663	1702	2655	2762	3570	1275	17078	1245	1938	668	Syntaxin-binding protein 1
B06R09C06	6-6-9	Hs~Ref:NM_003165.1~uORF:IOH52429	1529	1574	2509	2512	4587	1173	15847	1241	1786	607	Syntaxin-binding protein 1
B06R09C07	6-7-9	Hs~Ref:NM_170746.2~uORF:IOH58679	886	603	782	587	573	646	1475	629	1049	227	Selenoprotein H
B06R09C08	6-8-9	Hs~Ref:NM_170746.2~uORF:IOH58679	989	625	760	552	578	629	1469	798	1071	158	Selenoprotein H
B06R09C09	6-9-9	Hs~Ref:NM_017541.2~uORF:IOH56649	316	365	492	293	257	259	575	323	496	79	Beta-crystallin S
B06R09C10	6-10-9	Hs~Ref:NM_017541.2~uORF:IOH56649	303	306	592	277	261	264	617	307	587	76	Beta-crystallin S
B06R09C11	6-11-9	Hs~Ref:NM_000373.1~uORF:IOH56733	1184	1116	1450	639	956	2214	8561	936	1188	122	uridine monophosphate synthetase (UMPS), mRNA.
B06R09C12	6-12-9	Hs~Ref:NM_000373.1~uORF:IOH56733	1123	1073	1413	580	954	2207	7981	879	1161	230	uridine monophosphate synthetase (UMPS), mRNA.
B06R09C13	6-13-9	Hs~Ref:NM_006900.2~uORF:IOH56629	351	254	447	219	295	461	683	321	569	143	Interferon alpha-1/13
B06R09C14	6-14-9	Hs~Ref:NM_006900.2~uORF:IOH56629	315	171	526	222	340	1002	643	523	543	96	Interferon alpha-1/13
B06R09C15	6-15-9	Hs~MGC:BC009239.2~uORF:IOH57087	4737	2294	3138	1917	1009	1692	2770	1061	4569	338	E3 ubiquitin-protein ligase LRSAM1
B06R09C16	6-16-9	Hs~MGC:BC009239.2~uORF:IOH57087	5020	2228	2990	1648	991	1587	2475	919	4249	321	E3 ubiquitin-protein ligase LRSAM1
B06R09C17	6-17-9	Hs~MGC:NM_152474.2~uORF:IOH25857	590	274	539	348	313	529	1100	381	863	454	chromosome 19 open reading frame 18 (C19orf18)
B06R09C18	6-18-9	Hs~MGC:NM_152474.2~uORF:IOH25857	516	419	540	342	524	484	1153	537	734	339	chromosome 19 open reading frame 18 (C19orf18)
B06R09C19	6-19-9	Hs~MGC:BC005388.1~uORF:IOH7239	356	316	414	235	2203	150	424	541	228	10	Origin recognition complex subunit 4
B06R09C20	6-20-9	Hs~MGC:BC005388.1~uORF:IOH7239	372	323	406	242	342	173	375	603	-5	-16	Origin recognition complex subunit 4
B06R09C21	6-21-9	Hs~MGC:BC006273.1~uORF:IOH6379	1060	816	766	681	669	352	1189	496	970	255	T-cell activation NFKB-like protein (TA-NFKBH)
B06R09C22	6-22-9	Hs~MGC:BC006273.1~uORF:IOH6379	1006	648	734	651	506	14	1200	531	925	231	T-cell activation NFKB-like protein (TA-NFKBH)
B06R10C01	6-1-10	Hs~Ref:NM_018052.2~uORF:IOH6786	438	345	512	314	276	289	631	281	473	167	Protein VAC14 homolog
B06R10C02	6-2-10	Hs~Ref:NM_018052.2~uORF:IOH6786	500	336	499	340	324	391	437	397	109	250	Protein VAC14 homolog
B06R10C03	6-3-10	Hs~Ref:NM_002399.2~uORF:IOH13086	490	1737	1294	11343	1004	1373	983	863	1743	766	Meis homeobox 2 (MEIS2), transcript variant f
B06R10C04	6-4-10	Hs~Ref:NM_002399.2~uORF:IOH13086	472	1595	1223	10586	850	1278	917	838	1575	76	Meis homeobox 2 (MEIS2), transcript variant f
B06R10C05	6-5-10	Hs~MGC:BC007894.2~uORF:IOH6720	825	531	697	1325	1443	594	954	886	1578	293	StAR-related lipid transfer (START) domain containing 7 (STARD7)
B06R10C06	6-6-10	Hs~MGC:BC007894.2~uORF:IOH6720	738	494	717	1081	1643	590	850	909	1488	347	StAR-related lipid transfer (START) domain containing 7 (STARD7)
B06R10C09	6-9-10	Hs~Ref:NM_003337.2~uORF:IOH7555	1074	1067	1218	550	1502	657	1272	1034	485	588	ubiquitin-conjugating enzyme E2B (RAD6 homolog) (UBE2B)
B06R10C10	6-10-10	Hs~Ref:NM_003337.2~uORF:IOH7555	864	716	1180	533	1634	631	1301	850	1395	452	ubiquitin-conjugating enzyme E2B (RAD6 homolog) (UBE2B)
B06R11C21	6-21-11	Hs~Ref:NM_005801.2~uORF:IOH6916	4573	1855	3025	1511	1932	1502	12485	2058	3752	860	eukaryotic translation initiation factor 1 (EIF1)
B06R11C22	6-22-11	Hs~Ref:NM_005801.2~uORF:IOH6916	4345	1743	2813	1595	1934	1420	11739	1923	3641	860	eukaryotic translation initiation factor 1 (EIF1)
B06R12C01	6-1-12	Hs~Ref:NM_000449.2~uORF:IOH10040	2327	5007	2950	1559	3326	2911	4770	4172	2453	848	regulatory factor X, 5 (influences HLA class II expression) (RFX5), transcript variant 1
B06R12C02	6-2-12	Hs~Ref:NM_000449.2~uORF:IOH10040	2156	4701	2755	1426	3302	2715	4269	3812	2420	853	regulatory factor X, 5 (influences HLA class II expression) (RFX5), transcript variant 1
B06R12C03	6-3-12	Hs~Ref:NM_003068.2~uORF:IOH10082	2205	1083	1373	1037	1413	1119	4183	863	2019	2181	snail homolog 2 (Drosophila) (SNAI2)
B06R12C04	6-4-12	Hs~Ref:NM_003068.2~uORF:IOH10082	2131	1098	1399	1019	1303	1012	4005	925	1639	2374	snail homolog 2 (Drosophila) (SNAI2)
B06R12C05	6-5-12	Hs~MGC:BC008318.1~uORF:IOH6883	1193	732	1107	832	1134	732	1830	784	1397	489	Isoleucyl-tRNA synthetase, cytoplasmic
B06R12C06	6-6-12	Hs~MGC:BC008318.1~uORF:IOH6883	1217	736	1154	819	1095	738	1640	815	1413	549	Isoleucyl-tRNA synthetase, cytoplasmic
B06R12C07	6-7-12	Hs~Ref:NM_145268.1~uORF:IOH10668	2418	1077	1819	1073	1133	1215	2182	948	3445	751	chromosome 7 open reading frame 45 (C7orf45)
B06R12C08	6-8-12	Hs~Ref:NM_145268.1~uORF:IOH10668	2426	1098	1717	1112	979	1152	1794	1123	3516	870	chromosome 7 open reading frame 45 (C7orf45)
B06R12C09	6-9-12	Hs~Ref:NM_016230.2~uORF:IOH10958	1059	1514	1722	910	911	1535	2344	1320	2091	543	cytochrome b5 reductase 4 (CYB5R4)
B06R12C10	6-10-12	Hs~Ref:NM_016230.2~uORF:IOH10958	946	1420	1625	870	1102	1491	2183	1236	1995	538	cytochrome b5 reductase 4 (CYB5R4)
B06R12C11	6-11-12	Hs~MGC:BC005258.1~uORF:IOH7193	1293	862	1197	664	970	1054	1751	787	2130	523	cell division cycle 23 homolog (S. cerevisiae) (CDC23)
B06R12C12	6-12-12	Hs~MGC:BC005258.1~uORF:IOH7193	1453	897	1241	678	909	853	1794	1228	2131	552	cell division cycle 23 homolog (S. cerevisiae) (CDC23)
B06R12C13	6-13-12	Hs~Ref:NM_144647.1~uORF:IOH10664	1384	1119	1497	813	1124	996	1590	1318	2453	1141	Calcyphosin-like protein
B06R12C14	6-14-12	Hs~Ref:NM_144647.1~uORF:IOH10664	1144	1093	1382	909	1058	998	1500	1108	2449	1141	Calcyphosin-like protein
B06R12C15	6-15-12	Hs~MGC:BC068483.1~uORF:IOH40534	613	301	581	993	427	443	508	326	766	156	RAD50-interacting protein 1
B06R12C16	6-16-12	Hs~MGC:BC068483.1~uORF:IOH40534	699	357	606	837	402	463	529	311	781	81	RAD50-interacting protein 1
B06R12C17	6-17-12	Hs~MGC:BC066929.1~uORF:IOH40095	504	531	1948	283	406	12129	353	283	828	127	aspartate beta-hydroxylase (ASPH)
B06R12C18	6-18-12	Hs~MGC:BC066929.1~uORF:IOH40095	498	487	1790	176	451	12167	341	274	795	164	aspartate beta-hydroxylase (ASPH)
B06R12C19	6-19-12	Hs~MGC:BC064943.1~uORF:IOH39950	242	256	352	215	195	470	301	262	260	78	LETM1 domain-containing protein 1
B06R12C20	6-20-12	Hs~MGC:BC064943.1~uORF:IOH39950	263	268	334	217	160	189	307	273	343	78	LETM1 domain-containing protein 1
B06R12C21	6-21-12	Hs~MGC:BC013120.1~uORF:IOH40178	358	278	424	175	252	260	725	1184	2475	97	phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1)
B06R12C22	6-22-12	Hs~MGC:BC013120.1~uORF:IOH40178	319	346	407	227	263	260	611	1104	2370	84	phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1)
B06R13C01	6-1-13	Hs~MGC:NM_153702.1~uORF:IOH21427	698	680	1248	429	478	566	1345	476	1938	8	ELMO/CED-12 domain containing 2 (ELMOD2)
B06R13C02	6-2-13	Hs~MGC:NM_153702.1~uORF:IOH21427	638	666	1198	378	617	495	1290	469	1785	214	ELMO/CED-12 domain containing 2 (ELMOD2)
B06R13C03	6-3-13	Hs~MGC:NM_152269.1~uORF:IOH10365	1193	1192	1109	498	678	769	2773	710	2319	360	Uncharacterized protein C12orf65
B06R13C04	6-4-13	Hs~MGC:NM_152269.1~uORF:IOH10365	1104	1246	1105	474	572	829	2578	624	2288	453	Uncharacterized protein C12orf65
B06R13C05	6-5-13	Hs~Ref:NM_000585.1~uORF:IOH21448	861	567	1005	851	682	581	1212	645	2090	261	interleukin 15 (IL15), transcript variant 3
B06R13C06	6-6-13	Hs~Ref:NM_000585.1~uORF:IOH21448	820	559	1094	882	684	611	1077	538	2125	170	interleukin 15 (IL15), transcript variant 3
B06R13C07	6-7-13	Hs~MGC:BC018404.1~uORF:IOH21454	747	543	1615	375	1138	1275	1365	486	2384	374	fibroblast growth factor 21 (FGF21)
B06R13C08	6-8-13	Hs~MGC:BC018404.1~uORF:IOH21454	709	496	1437	343	1012	1212	1155	489	2248	288	fibroblast growth factor 21 (FGF21)
B06R13C09	6-9-13	Hs~MGC:BC020733.1~uORF:IOH13021	505	301	482	260	230	303	516	336	273	109	sushi-repeat-containing protein, X-linked 2 (SRPX2)
B06R13C10	6-10-13	Hs~MGC:BC020733.1~uORF:IOH13021	500	327	495	232	219	246	484	283	524	118	sushi-repeat-containing protein, X-linked 2 (SRPX2)
B06R13C11	6-11-13	Hs~MGC:BC024021.1~uORF:IOH12764	545	351	639	296	328	427	748	329	986	147	dipeptidase 2 (DPEP2)
B06R13C12	6-12-13	Hs~MGC:BC024021.1~uORF:IOH12764	554	364	636	304	419	478	727	524	1053	211	dipeptidase 2 (DPEP2)
B06R13C13	6-13-13	Hs~MGC:BC012106.1~uORF:IOH13202	1090	777	713	338	447	452	636	459	1491	259	major histocompatibility complex, class II, DQ beta 1 (HLA-DQB1)
B06R13C14	6-14-13	Hs~MGC:BC012106.1~uORF:IOH13202	1128	778	678	355	424	423	585	357	1454	164	major histocompatibility complex, class II, DQ beta 1 (HLA-DQB1)
B06R13C15	6-15-13	Hs~Ref:NM_032181.1~uORF:IOH13482	510	347	578	258	317	341	828	255	585	139	transmembrane protein 166 (TMEM166)
B06R13C16	6-16-13	Hs~Ref:NM_032181.1~uORF:IOH13482	493	359	609	261	463	374	797	281	689	170	transmembrane protein 166 (TMEM166)
B06R13C19	6-19-13	Hs~MGC:BC020597.1~uORF:IOH14197	373	358	547	320	367	447	516	455	619	233	general transcription factor IIB (GTF2B)
B06R13C20	6-20-13	Hs~MGC:BC020597.1~uORF:IOH14197	334	380	460	280	367	407	476	444	660	191	general transcription factor IIB (GTF2B)
B06R13C21	6-21-13	Hs~MGC:BC009015.1~uORF:IOH3279	449	366	512	293	251	338	657	456	1073	191	serpin peptidase inhibitor, clade B (ovalbumin), member 1 (SERPINB1)
B06R13C22	6-22-13	Hs~MGC:BC009015.1~uORF:IOH3279	432	364	524	249	276	495	601	424	905	135	serpin peptidase inhibitor, clade B (ovalbumin), member 1 (SERPINB1)
B06R14C01	6-1-14	Hs~MGC:BC025314.1~uORF:IOH13984	400	307	669	252	367	508	562	489	595	145	immunoglobulin heavy constant gamma 1 (G1m marker) (IGHG1)
B06R14C02	6-2-14	Hs~MGC:BC025314.1~uORF:IOH13984	416	334	697	266	394	373	547	415	613	138	immunoglobulin heavy constant gamma 1 (G1m marker) (IGHG1)
B06R14C03	6-3-14	Hs~MGC:BC004305.1~uORF:IOH5525	1966	611	1174	600	641	682	1003	754	1813	279	peptidase D (PEPD)
B06R14C04	6-4-14	Hs~MGC:BC004305.1~uORF:IOH5525	1843	620	1068	577	803	661	954	716	1713	470	peptidase D (PEPD)
B06R14C05	6-5-14	Hs~Ref:NM_006858.2~uORF:IOH4254	1108	650	1152	731	1340	839	1066	671	1922	243	transmembrane emp24 protein transport domain containing 1 (TMED1)
B06R14C06	6-6-14	Hs~Ref:NM_006858.2~uORF:IOH4254	1151	656	1196	750	1350	841	980	688	1782	420	transmembrane emp24 protein transport domain containing 1 (TMED1)
B06R14C07	6-7-14	Hs~MGC:BC009644.1~uORF:IOH9983	894	1117	1252	751	1160	852	1843	1047	2157	710	protein phosphatase 1M (PP2C domain containing) (PPM1M)
B06R14C08	6-8-14	Hs~MGC:BC009644.1~uORF:IOH9983	903	1106	1228	723	1084	955	1921	1163	2302	625	protein phosphatase 1M (PP2C domain containing) (PPM1M)
B06R14C11	6-11-14	Hs~MGC:BC025254.1~uORF:IOH12449	379	301	413	251	448	310	706	347	544	231	integrator complex subunit 3 (INTS3)
B06R14C12	6-12-14	Hs~MGC:BC025254.1~uORF:IOH12449	411	323	405	272	475	292	781	288	611	150	integrator complex subunit 3 (INTS3)
B06R14C13	6-13-14	Hs~MGC:NM_173793.2~uORF:IOH22040	368	349	431	239	304	292	687	557	89	165	UPF0545 protein C22orf39
B06R14C14	6-14-14	Hs~MGC:NM_173793.2~uORF:IOH22040	342	335	392	239	319	316	646	373	656	204	UPF0545 protein C22orf39
B06R14C15	6-15-14	Hs~Ref:NM_020390.3~uORF:IOH27243	463	333	427	199	363	319	525	241	749	59	eukaryotic translation initiation factor 5A2 (EIF5A2)
B06R14C16	6-16-14	Hs~Ref:NM_020390.3~uORF:IOH27243	405	341	430	199	412	345	529	223	629	109	eukaryotic translation initiation factor 5A2 (EIF5A2)
B06R14C17	6-17-14	Hs~Ref:NM_022823.1~uORF:IOH21980	1252	405	674	544	487	439	765	396	1190	216	fibronectin type III domain containing 4 (FNDC4)
B06R14C18	6-18-14	Hs~Ref:NM_022823.1~uORF:IOH21980	1240	405	636	547	504	469	783	390	1084	259	fibronectin type III domain containing 4 (FNDC4)
B06R14C19	6-19-14	Hs~Ref:NM_005218.2~uORF:IOH26662	443	407	644	322	347	362	535	578	763	236	defensin, beta 1 (DEFB1)
B06R14C20	6-20-14	Hs~Ref:NM_005218.2~uORF:IOH26662	448	399	642	344	379	593	475	583	742	216	defensin, beta 1 (DEFB1)
B06R14C21	6-21-14	Hs~Ref:NM_002898.1~uORF:IOH11398	1108	905	969	1138	1017	930	1450	704	1208	375	RNA binding motif, single stranded interacting protein 2 (RBMS2)
B06R14C22	6-22-14	Hs~Ref:NM_002898.1~uORF:IOH11398	1092	902	910	1088	920	798	1378	585	1150	419	RNA binding motif, single stranded interacting protein 2 (RBMS2)
B06R15C01	6-1-15	Hs~Ref:NM_000351.3~uORF:IOH44381	623	462	729	432	434	578	883	532	254	42	steroid sulfatase (microsomal), isozyme S (STS)
B06R15C02	6-2-15	Hs~Ref:NM_000351.3~uORF:IOH44381	596	513	743	460	450	484	815	1152	421	476	steroid sulfatase (microsomal), isozyme S (STS)
B06R15C03	6-3-15	Hs~Ref:NM_018031.2~uORF:IOH42567	912	539	895	406	441	725	2003	891	1341	242	WD repeat domain 6 (WDR6)
B06R15C04	6-4-15	Hs~Ref:NM_018031.2~uORF:IOH42567	872	587	892	437	425	787	1979	881	1382	231	WD repeat domain 6 (WDR6)
B06R15C05	6-5-15	Hs~MGC:BC015932.2~uORF:IOH10047	864	713	1098	542	890	764	1803	683	1568	574	interferon-induced protein 44-like (IFI44L)
B06R15C06	6-6-15	Hs~MGC:BC015932.2~uORF:IOH10047	1045	697	1033	827	941	765	1925	729	1689	575	interferon-induced protein 44-like (IFI44L)
B06R15C07	6-7-15	Hs~MGC:BC027622.2~uORF:IOH26866	2091	2123	2582	2826	2569	2263	3264	2652	5497	2306	pipecolic acid oxidase (PIPOX)
B06R15C08	6-8-15	Hs~MGC:BC027622.2~uORF:IOH26866	1962	2098	2581	2880	2348	2206	3453	2564	5344	2390	pipecolic acid oxidase (PIPOX)
B06R15C09	6-9-15	Hs~MGC:BC032007.1~uORF:IOH22165	1244	550	986	470	666	794	1648	622	1411	346	transmembrane 6 superfamily member 1 (TM6SF1)
B06R15C10	6-10-15	Hs~MGC:BC032007.1~uORF:IOH22165	1089	719	1062	531	611	826	1400	682	1376	294	transmembrane 6 superfamily member 1 (TM6SF1)
B06R15C11	6-11-15	Hs~Ref:NM_019021.1~uORF:IOH3368	1249	704	991	758	685	891	1421	885	1555	483	chromosome 11 open reading frame 71 (C11orf71)
B06R15C12	6-12-15	Hs~Ref:NM_019021.1~uORF:IOH3368	1456	641	1001	790	790	723	1629	772	1771	497	chromosome 11 open reading frame 71 (C11orf71)
B06R15C15	6-15-15	Hs~Ref:NM_002755.2~CAT:P3099	89	74	241	144	150	99	382	344	212	33	mitogen-activated protein kinase kinase 1 (MAP2K1); see catalog number for detailed information on wild-type or point mutant status
B06R15C16	6-16-15	Hs~Ref:NM_002755.2~CAT:P3099	1392	51	299	207	151	148	444	109	161	33	mitogen-activated protein kinase kinase 1 (MAP2K1); see catalog number for detailed information on wild-type or point mutant status
B06R15C17	6-17-15	Hs~Ref:NM_053006.1~CAT:PV3622	3423	2150	2076	1007	1957	1706	1489	1276	2150	660	testis-specific serine kinase 2 (TSSK2)
B06R15C18	6-18-15	Hs~Ref:NM_053006.1~CAT:PV3622	1515	2111	2176	947	2125	1490	1589	1327	2091	704	testis-specific serine kinase 2 (TSSK2)
B06R16C15	6-15-16	Hs~Ref:NM_138781.2~uORF:IOH58618	815	1095	1096	597	1929	1558	1953	1265	2435	386	similar to envelope protein (LOC113386)
B06R16C16	6-16-16	Hs~Ref:NM_138781.2~uORF:IOH58618	983	1080	1064	532	2079	1516	1996	1329	2306	355	similar to envelope protein (LOC113386)
B06R16C17	6-17-16	Hs~Ref:NM_182482.1~uORF:IOH58616	897	652	840	418	619	649	1162	479	889	323	B melanoma antigen 2
B06R16C18	6-18-16	Hs~Ref:NM_182482.1~uORF:IOH58616	677	660	848	418	603	631	1211	560	974	276	B melanoma antigen 2
B06R16C21	6-21-16	Hs~Ref:NM_002230.1~uORF:IOH54131	771	647	1190	612	1579	1410	1708	841	1784	318	Junction plakoglobin
B06R16C22	6-22-16	Hs~Ref:NM_002230.1~uORF:IOH54131	765	598	1155	599	1579	984	1727	803	1701	335	Junction plakoglobin
B06R17C03	6-3-17	Hs~MGC:BC093926.1~uORF:IOH62009	667	314	557	290	341	497	811	376	575	169	Tripartite motif-containing protein 10
B06R17C04	6-4-17	Hs~MGC:BC093926.1~uORF:IOH62009	594	311	612	274	324	508	755	645	998	99	Tripartite motif-containing protein 10
B06R17C05	6-5-17	Hs~Ref:NM_000759.2~uORF:IOH59727	342	255	424	386	279	278	345	278	389	111	Granulocyte colony-stimulating factor
B06R17C06	6-6-17	Hs~Ref:NM_000759.2~uORF:IOH59727	386	267	423	421	279	256	298	274	432	86	Granulocyte colony-stimulating factor
B06R17C07	6-7-17	Hs~MGC:BC032508.1~uORF:IOH62199	3755	812	2199	617	737	1516	7734	793	1977	568	PNMA-like 1, mRNA (cDNA clone MGC:45422 IMAGE:5246377), complete cds
B06R17C08	6-8-17	Hs~MGC:BC032508.1~uORF:IOH62199	3448	835	2075	627	830	1486	6940	761	1885	435	PNMA-like 1, mRNA (cDNA clone MGC:45422 IMAGE:5246377), complete cds
B06R17C09	6-9-17	Hs~MGC:BC034247.1~uORF:IOH21451	812	483	628	441	518	494	666	638	728	224	chromosome 9 open reading frame 105 (C9orf105)
B06R17C10	6-10-17	Hs~MGC:BC034247.1~uORF:IOH21451	785	608	669	399	584	479	689	562	1021	190	chromosome 9 open reading frame 105 (C9orf105)
B06R17C11	6-11-17	Hs~Ref:NM_032352.1~uORF:IOH6326	727	577	1271	528	1014	825	979	588	1399	401	Breast cancer metastasis-suppressor 1-like protein
B06R17C12	6-12-17	Hs~Ref:NM_032352.1~uORF:IOH6326	676	551	1255	505	1082	964	1085	681	1516	449	Breast cancer metastasis-suppressor 1-like protein
B06R17C13	6-13-17	Hs~Ref:NM_001011658.1~uORF:IOH12376	3195	1282	4135	1414	2125	1766	2927	1369	4165	676	trafficking protein particle complex 2 (TRAPPC2), transcript variant 1
B06R17C14	6-14-17	Hs~Ref:NM_001011658.1~uORF:IOH12376	3103	1385	4051	1322	2122	1770	2938	1298	4166	651	trafficking protein particle complex 2 (TRAPPC2), transcript variant 1
B06R17C15	6-15-17	Hs~Ref:NM_001029896.1~uORF:IOH3590	1282	2483	1682	1034	3480	1925	2193	1000	4047	749	WD repeat domain 45 (WDR45), transcript variant 2
B06R17C16	6-16-17	Hs~Ref:NM_001029896.1~uORF:IOH3590	1310	2538	1660	1052	3141	1918	2283	1119	4086	734	WD repeat domain 45 (WDR45), transcript variant 2
B06R17C17	6-17-17	Hs~Ref:NM_001008239.1~uORF:IOH45708	1481	1065	2165	2963	1613	1204	3197	1977	3391	1139	chromosome 18 open reading frame 25 (C18orf25), transcript variant 2
B06R17C18	6-18-17	Hs~Ref:NM_001008239.1~uORF:IOH45708	1531	1135	2228	2974	1509	1219	3150	1867	3499	1165	chromosome 18 open reading frame 25 (C18orf25), transcript variant 2
B06R17C19	6-19-17	Hs~MGC:BC012095.1~uORF:IOH13147	414	353	624	314	313	431	619	198	657	226	bone marrow stromal cell antigen 1 (BST1)
B06R17C20	6-20-17	Hs~MGC:BC012095.1~uORF:IOH13147	405	341	556	320	320	436	538	543	497	203	bone marrow stromal cell antigen 1 (BST1)
B06R17C21	6-21-17	Hs~MGC:BC011399.1~N/A	719	192	334	257	173	280	332	264	208	84	spleen tyrosine kinase (SYK)
B06R17C22	6-22-17	Hs~MGC:BC011399.1~N/A	768	201	311	200	149	377	302	301	379	75	spleen tyrosine kinase (SYK)
B06R18C01	6-1-18	Hs~Ref:NM_014364.1~uORF:IOH22295	3294	274	847	742	258	449	849	522	109	234	glyceraldehyde-3-phosphate dehydrogenase, spermatogenic (GAPDHS)
B06R18C02	6-2-18	Hs~Ref:NM_014364.1~uORF:IOH22295	3167	261	885	697	276	422	726	528	403	415	glyceraldehyde-3-phosphate dehydrogenase, spermatogenic (GAPDHS)
B06R18C03	6-3-18	Hs~Ref:NM_022100.1~uORF:IOH12979	1504	666	1071	554	622	727	3151	677	1177	529	mitochondrial ribosomal protein S14 (MRPS14), nuclear gene encoding mitochondrial protein
B06R18C04	6-4-18	Hs~Ref:NM_022100.1~uORF:IOH12979	1305	649	1106	578	715	781	3020	803	1187	408	mitochondrial ribosomal protein S14 (MRPS14), nuclear gene encoding mitochondrial protein
B06R18C05	6-5-18	Hs~MGC:BC001012.2~uORF:IOH4207	882	551	934	451	674	585	873	581	1226	393	carbonic anhydrase XII (CA12)
B06R18C06	6-6-18	Hs~MGC:BC001012.2~uORF:IOH4207	845	565	994	485	617	596	850	588	1294	332	carbonic anhydrase XII (CA12)
B06R18C07	6-7-18	Hs~MGC:BC043619.1~uORF:IOH26417	2104	1158	1558	811	1055	848	3368	1201	2783	406	methyl-CpG binding domain protein 3 (MBD3)
B06R18C08	6-8-18	Hs~MGC:BC043619.1~uORF:IOH26417	1728	1112	1477	772	1189	888	3143	1267	2695	437	methyl-CpG binding domain protein 3 (MBD3)
B06R18C09	6-9-18	Hs~Ref:NM_000207.1~uORF:IOH7334	509	444	680	371	595	481	738	475	782	366	insulin (INS)
B06R18C10	6-10-18	Hs~Ref:NM_000207.1~uORF:IOH7334	581	474	690	360	643	497	716	461	813	239	insulin (INS)
B06R18C11	6-11-18	Hs~Ref:NM_031496.1~uORF:IOH4571	615	395	574	287	317	445	931	427	829	184	protocadherin alpha 2 (PCDHA2), transcript variant 3
B06R18C12	6-12-18	Hs~Ref:NM_031496.1~uORF:IOH4571	510	410	622	305	314	470	888	535	651	165	protocadherin alpha 2 (PCDHA2), transcript variant 3
B06R18C13	6-13-18	Hs~MGC:BC036767.1~uORF:IOH22101	3689	1962	1910	5148	2131	1587	2594	2857	2931	973	RIB43A domain with coiled-coils 1 (RIBC1)
B06R18C14	6-14-18	Hs~MGC:BC036767.1~uORF:IOH22101	3746	2028	1899	4742	2216	1636	2496	2996	2559	935	RIB43A domain with coiled-coils 1 (RIBC1)
B06R18C15	6-15-18	Hs~Ref:NM_024677.3~uORF:IOH22080	654	436	563	314	336	500	1423	521	688	150	NOL1/NOP2/Sun domain family, member 7 (NSUN7)
B06R18C16	6-16-18	Hs~Ref:NM_024677.3~uORF:IOH22080	541	425	650	325	393	501	1385	523	-36	194	NOL1/NOP2/Sun domain family, member 7 (NSUN7)
B06R18C17	6-17-18	Hs~Ref:NM_013368.2~uORF:IOH1790	942	508	834	376	641	644	1178	775	1064	275	SERTA domain containing 3 (SERTAD3), transcript variant 1
B06R18C18	6-18-18	Hs~Ref:NM_013368.2~uORF:IOH1790	2691	480	747	385	508	709	1095	737	1041	237	SERTA domain containing 3 (SERTAD3), transcript variant 1
B06R18C19	6-19-18	Hs~MGC:BC052601.1~uORF:IOH29371	1125	921	1217	684	820	1191	1682	1109	2299	611	mitochondrial ribosomal protein L10 (MRPL10)
B06R18C20	6-20-18	Hs~MGC:BC052601.1~uORF:IOH29371	1178	935	1257	720	841	1233	1640	1148	2427	608	mitochondrial ribosomal protein L10 (MRPL10)
B06R18C21	6-21-18	Hs~MGC:BC032864.2~uORF:IOH28650	746	616	788	487	554	630	1324	559	1088	465	glycine receptor, alpha 2 (GLRA2)
B06R18C22	6-22-18	Hs~MGC:BC032864.2~uORF:IOH28650	796	663	797	473	489	669	1243	592	949	392	glycine receptor, alpha 2 (GLRA2)
B06R19C01	6-1-19	Hs~Ref:NM_003099.1~uORF:IOH3673	884	392	621	740	1222	720	906	522	1075	310	sorting nexin 1 (SNX1), transcript variant 1
B06R19C02	6-2-19	Hs~Ref:NM_003099.1~uORF:IOH3673	910	409	611	706	1058	712	944	488	720	238	sorting nexin 1 (SNX1), transcript variant 1
B06R19C03	6-3-19	Hs~MGC:AB065755.1~uORF:IOH28258	923	758	1101	680	825	810	1616	734	2425	262	olfactory receptor, family 10, subfamily G, member 8 (OR10G8), mRNA
B06R19C04	6-4-19	Hs~MGC:AB065755.1~uORF:IOH28258	908	781	1095	664	695	801	1591	836	1942	604	olfactory receptor, family 10, subfamily G, member 8 (OR10G8), mRNA
B06R19C05	6-5-19	Hs~Ref:NM_032360.1~uORF:IOH6003	349	296	432	387	360	456	5595	339	789	131	acyl-Coenzyme A binding domain containing 6 (ACBD6)
B06R19C06	6-6-19	Hs~Ref:NM_032360.1~uORF:IOH6003	348	276	431	390	371	453	5318	473	652	142	acyl-Coenzyme A binding domain containing 6 (ACBD6)
B06R19C07	6-7-19	Hs~MGC:BC006499.1~uORF:IOH5767	581	80	324	197	255	253	294	277	165	55	v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS)
B06R19C08	6-8-19	Hs~MGC:BC006499.1~uORF:IOH5767	186	285	400	141	256	177	302	223	180	50	v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS)
B06R19C09	6-9-19	Hs~Ref:NM_002964.3~uORF:IOH7407	255	216	409	217	263	221	234	178	157	76	S100 calcium binding protein A8 (S100A8)
B06R19C10	6-10-19	Hs~Ref:NM_002964.3~uORF:IOH7407	289	150	372	223	257	250	197	203	295	35	S100 calcium binding protein A8 (S100A8)
B06R19C11	6-11-19	Hs~Ref:NM_006555.2~uORF:IOH5843	370	687	372	221	452	270	285	152	221	256	YKT6 v-SNARE homolog (S. cerevisiae) (YKT6)
B06R19C12	6-12-19	Hs~Ref:NM_006555.2~uORF:IOH5843	314	596	374	253	474	280	274	227	-5	241	YKT6 v-SNARE homolog (S. cerevisiae) (YKT6)
B06R19C13	6-13-19	Hs~Ref:NM_000818.1~uORF:IOH42395	575	1647	725	581	7128	662	815	1464	1059	336	Glutamate decarboxylase 2
B06R19C14	6-14-19	Hs~Ref:NM_000818.1~uORF:IOH42395	524	1545	772	571	8421	623	834	1422	1135	279	Glutamate decarboxylase 2
B06R19C15	6-15-19	Hs~Ref:NM_001623.3~uORF:IOH13810	433	173	2896	348	538	24043	1320	324	879	91	allograft inflammatory factor 1 (AIF1), transcript variant 3
B06R19C16	6-16-19	Hs~Ref:NM_001623.3~uORF:IOH13810	446	428	2592	338	461	21827	1268	294	698	115	allograft inflammatory factor 1 (AIF1), transcript variant 3
B06R19C17	6-17-19	Hs~Ref:NM_144602.1~uORF:IOH11852	2871	1804	1367	732	867	1185	7702	1144	2314	442	chromosome 16 open reading frame 78 (C16orf78)
B06R19C18	6-18-19	Hs~Ref:NM_144602.1~uORF:IOH11852	2902	1744	1360	763	838	1239	7313	1238	2208	401	chromosome 16 open reading frame 78 (C16orf78)
B06R19C19	6-19-19	Hs~MGC:BC028120.1~uORF:IOH11613	2243	817	1159	613	701	916	3842	1102	1407	445	ring finger protein 32 (RNF32)
B06R19C20	6-20-19	Hs~MGC:BC028120.1~uORF:IOH11613	1621	818	1224	545	679	943	3697	1069	1620	478	ring finger protein 32 (RNF32)
B06R19C21	6-21-19	Hs~Ref:NM_001906.1~uORF:IOH7194	545	519	667	349	399	487	662	574	1378	317	chymotrypsinogen B1 (CTRB1)
B06R19C22	6-22-19	Hs~Ref:NM_001906.1~uORF:IOH7194	849	461	624	353	366	490	739	544	1185	256	chymotrypsinogen B1 (CTRB1)
B06R20C01	6-1-20	Hs~MGC:BC025399.1~uORF:IOH11285	1011	854	1159	672	778	992	2003	838	1600	566	prokineticin 1 (PROK1)
B06R20C02	6-2-20	Hs~MGC:BC025399.1~uORF:IOH11285	1191	890	1201	625	875	883	2045	974	1393	409	prokineticin 1 (PROK1)
B06R20C03	6-3-20	Hs~Ref:NM_138461.1~uORF:IOH21483	662	483	759	472	423	521	998	569	1256	332	transmembrane 4 L six family member 19 (TM4SF19)
B06R20C04	6-4-20	Hs~Ref:NM_138461.1~uORF:IOH21483	557	474	733	399	378	573	865	699	1112	598	transmembrane 4 L six family member 19 (TM4SF19)
B06R20C07	6-7-20	Hs~MGC:BC030636.1~uORF:IOH22939	450	546	1015	1049	660	320	649	899	1794	118	prolyl endopeptidase (PREP)
B06R20C08	6-8-20	Hs~MGC:BC030636.1~uORF:IOH22939	383	563	942	704	752	384	568	785	1913	215	prolyl endopeptidase (PREP)
B06R20C09	6-9-20	Hs~Ref:NM_001277.1~uORF:IOH21323	393	523	665	216	1259	540	671	259	1796	195	choline kinase alpha (CHKA), transcript variant 1
B06R20C10	6-10-20	Hs~Ref:NM_001277.1~uORF:IOH21323	398	440	628	230	1258	564	572	324	1730	138	choline kinase alpha (CHKA), transcript variant 1
B06R20C11	6-11-20	Hs~MGC:BC012147.1~uORF:IOH62958	677	354	597	293	386	495	695	605	724	125	Junctional adhesion molecule C
B06R20C12	6-12-20	Hs~MGC:BC012147.1~uORF:IOH62958	573	398	615	266	330	480	764	636	988	192	Junctional adhesion molecule C
B06R20C13	6-13-20	Hs~MGC:BC010092.2~uORF:IOH62921	658	500	613	495	514	538	897	627	548	315	Protein fuzzy homolog
B06R20C14	6-14-20	Hs~MGC:BC010092.2~uORF:IOH62921	654	454	662	317	574	534	773	619	527	156	Protein fuzzy homolog
B07R02C11	7-11-2	Hs~Ref:NM_144705.1~uORF:IOH11065	780	1389	1522	1414	804	2845	1326	769	2098	1379	tektin 4 (TEKT4)
B07R02C12	7-12-2	Hs~Ref:NM_144705.1~uORF:IOH11065	766	1330	1376	796	817	3049	1318	737	2175	1233	tektin 4 (TEKT4)
B07R02C13	7-13-2	Hs~Ref:NM_005313.3~uORF:IOH14276	1489	828	4152	513	790	1433	1744	1257	1844	550	protein disulfide isomerase family A, member 3 (PDIA3)
B07R02C14	7-14-2	Hs~Ref:NM_005313.3~uORF:IOH14276	1267	839	4449	491	876	1480	1765	1283	38	501	protein disulfide isomerase family A, member 3 (PDIA3)
B07R02C15	7-15-2	Hs~MGC:BC014667.1~uORF:IOH14303	65303	65488	65426	65478	65364	36259	40852	62003	65336	65458	immunoglobulin heavy constant gamma 1 (G1m marker) (IGHG1)
B07R02C16	7-16-2	Hs~MGC:BC014667.1~uORF:IOH14303	65183	65489	65420	65477	65406	51181	41068	63044	65373	65460	immunoglobulin heavy constant gamma 1 (G1m marker) (IGHG1)
B07R02C17	7-17-2	Hs~MGC:BC015614.1~uORF:IOH14601	356	988	730	369	804	561	2718	607	2824	730	Regulator of G-protein signaling 20
B07R02C18	7-18-2	Hs~MGC:BC015614.1~uORF:IOH14601	399	997	744	355	845	652	2767	630	3060	575	Regulator of G-protein signaling 20
B07R02C19	7-19-2	Hs~Ref:NM_018667.2~uORF:IOH43841	1229	1773	1367	1426	1175	896	1219	753	1530	573	sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (SMPD3)
B07R02C20	7-20-2	Hs~Ref:NM_018667.2~uORF:IOH43841	1334	1723	1275	1620	1189	676	1250	804	-1	656	sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (SMPD3)
B07R03C01	7-1-3	Hs~Ref:NM_178463.2~uORF:IOH40984	981	432	932	659	400	494	878	1314	976	183	chromosome 20 open reading frame 166 (C20orf166)
B07R03C02	7-2-3	Hs~Ref:NM_178463.2~uORF:IOH40984	1048	442	1035	672	456	528	909	1063	1026	182	chromosome 20 open reading frame 166 (C20orf166)
B07R03C03	7-3-3	Hs~Ref:NM_197962.1~uORF:IOH43651	1391	1890	1638	754	1380	2566	2292	1568	1894	661	glutaredoxin 2 (GLRX2), transcript variant 2
B07R03C04	7-4-3	Hs~Ref:NM_197962.1~uORF:IOH43651	1443	1884	1676	741	1362	3028	2242	1492	1919	619	glutaredoxin 2 (GLRX2), transcript variant 2
B07R03C05	7-5-3	Hs~Ref:NM_015129.3~uORF:IOH27517	286	352	199	267	126	200	363	414	276	318	septin 6 (SEPT6), transcript variant II
B07R03C06	7-6-3	Hs~Ref:NM_015129.3~uORF:IOH27517	303	354	2163	212	166	242	357	477	264	296	septin 6 (SEPT6), transcript variant II
B07R03C07	7-7-3	Hs~Ref:NM_015927.2~uORF:IOH3924	734	302	901	264	670	515	670	362	11	759	transforming growth factor beta 1 induced transcript 1 (TGFB1I1), transcript variant 2
B07R03C08	7-8-3	Hs~Ref:NM_015927.2~uORF:IOH3924	797	299	501	294	682	567	660	371	254	680	transforming growth factor beta 1 induced transcript 1 (TGFB1I1), transcript variant 2
B07R03C09	7-9-3	Hs~MGC:BC046106.1~uORF:IOH26919	284	339	344	254	656	547	542	533	409	116	WAP four-disulfide core domain 2 (WFDC2)
B07R03C10	7-10-3	Hs~MGC:BC046106.1~uORF:IOH26919	330	357	327	272	560	554	537	541	828	120	WAP four-disulfide core domain 2 (WFDC2)
B07R03C11	7-11-3	Hs~Ref:NM_006244.1~uORF:IOH27509	527	377	752	382	390	533	460	499	1063	288	protein phosphatase 2, regulatory subunit B', beta isoform (PPP2R5B)
B07R03C12	7-12-3	Hs~Ref:NM_006244.1~uORF:IOH27509	450	409	800	390	446	502	540	549	1104	292	protein phosphatase 2, regulatory subunit B', beta isoform (PPP2R5B)
B07R03C13	7-13-3	Hs~Ref:NM_006468.3~uORF:IOH4100	1335	907	1485	1247	1301	2873	5888	1858	2228	350	polymerase (RNA) III (DNA directed) polypeptide C (62kD) (POLR3C)
B07R03C14	7-14-3	Hs~Ref:NM_006468.3~uORF:IOH4100	1250	914	1409	1187	1313	2723	5601	1891	2434	335	polymerase (RNA) III (DNA directed) polypeptide C (62kD) (POLR3C)
B07R03C15	7-15-3	Hs~Ref:NM_020467.2~uORF:IOH3994	16395	10525	6650	11271	12767	8153	14339	10503	8315	10594	small trans-membrane and glycosylated protein (LOC57228), transcript variant 2
B07R03C16	7-16-3	Hs~Ref:NM_020467.2~uORF:IOH3994	16011	9846	6665	11319	12981	8031	13353	10767	8139	11293	small trans-membrane and glycosylated protein (LOC57228), transcript variant 2
B07R03C17	7-17-3	Hs~MGC:BC010172.2~uORF:IOH12518	1384	1023	1262	679	2688	3922	1641	739	1819	436	Protein FAM41C-like
B07R03C18	7-18-3	Hs~MGC:BC010172.2~uORF:IOH12518	1398	922	1247	627	2318	3186	1592	718	1397	517	Protein FAM41C-like
B07R03C19	7-19-3	Hs~MGC:NM_178191.1~uORF:IOH4850	784	546	703	621	641	712	772	701	969	-22	ATPase inhibitory factor 1 (ATPIF1), nuclear gene encoding mitochondrial protein, transcript variant 3
B07R03C20	7-20-3	Hs~MGC:NM_178191.1~uORF:IOH4850	702	500	711	731	480	586	913	757	1385	-4	ATPase inhibitory factor 1 (ATPIF1), nuclear gene encoding mitochondrial protein, transcript variant 3
B07R03C21	7-21-3	Hs~MGC:NM_152435.1~uORF:IOH22648	1139	756	1046	796	915	1050	3339	889	1876	656	amidohydrolase domain containing 1 (AMDHD1)
B07R03C22	7-22-3	Hs~MGC:NM_152435.1~uORF:IOH22648	1160	692	1066	729	932	1088	3203	897	1981	692	amidohydrolase domain containing 1 (AMDHD1)
B07R04C01	7-1-4	Hs~Ref:NM_145071.1~uORF:IOH22653	801	472	883	564	371	566	1228	531	1197	307	cytokine inducible SH2-containing protein (CISH)
B07R04C02	7-2-4	Hs~Ref:NM_145071.1~uORF:IOH22653	792	517	936	575	429	796	1378	593	1216	402	cytokine inducible SH2-containing protein (CISH)
B07R04C03	7-3-4	Hs~MGC:NM_173625.3~uORF:IOH22664	1111	798	1564	533	615	1375	2096	3497	1430	317	chromosome 17 open reading frame 78 (C17orf78)
B07R04C04	7-4-4	Hs~MGC:NM_173625.3~uORF:IOH22664	1088	788	1472	523	518	868	1984	2780	1488	268	chromosome 17 open reading frame 78 (C17orf78)
B07R04C05	7-5-4	Hs~MGC:NM_153237.1~uORF:IOH22672	407	457	641	580	533	608	764	520	1768	202	chromosome 9 open reading frame 71 (C9orf71)
B07R04C06	7-6-4	Hs~MGC:NM_153237.1~uORF:IOH22672	416	481	846	563	528	645	773	617	1745	203	chromosome 9 open reading frame 71 (C9orf71)
B07R04C07	7-7-4	Hs~Ref:NM_031473.1~uORF:IOH6215	1394	672	2362	787	1425	2114	1378	2149	1627	476	Intraflagellar transport protein 81 homolog
B07R04C08	7-8-4	Hs~Ref:NM_031473.1~uORF:IOH6215	1425	662	2187	772	1204	2102	1436	1891	1719	405	Intraflagellar transport protein 81 homolog
B07R04C09	7-9-4	Hs~Ref:NM_016495.1~uORF:IOH7137	780	1181	1034	1588	1155	791	886	989	1488	312	TBC1 domain family, member 7 (TBC1D7)
B07R04C10	7-10-4	Hs~Ref:NM_016495.1~uORF:IOH7137	793	1153	1104	1538	1087	747	873	1042	333	323	TBC1 domain family, member 7 (TBC1D7)
B07R04C11	7-11-4	Hs~Ref:NM_003313.2~uORF:IOH4998	1238	899	6579	1489	961	9470	13676	1817	344	503	tissue specific transplantation antigen P35B (TSTA3)
B07R04C12	7-12-4	Hs~Ref:NM_003313.2~uORF:IOH4998	1322	918	6082	1601	970	9348	13833	1876	2161	490	tissue specific transplantation antigen P35B (TSTA3)
B07R04C13	7-13-4	Hs~MGC:BC003624.1~uORF:IOH3856	453	349	871	329	1475	490	525	455	858	180	interferon gamma receptor 2 (interferon gamma transducer 1) (IFNGR2)
B07R04C14	7-14-4	Hs~MGC:BC003624.1~uORF:IOH3856	455	367	888	287	1159	516	540	429	599	205	interferon gamma receptor 2 (interferon gamma transducer 1) (IFNGR2)
B07R04C15	7-15-4	Hs~Ref:NM_178496.2~uORF:IOH26761	1602	1319	622	1183	668	643	856	819	1176	1967	chromosome 3 open reading frame 59 (C3orf59)
B07R04C16	7-16-4	Hs~Ref:NM_178496.2~uORF:IOH26761	1638	1323	612	1149	662	658	863	752	1162	2356	chromosome 3 open reading frame 59 (C3orf59)
B07R04C17	7-17-4	Hs~Ref:NM_145315.2~uORF:IOH39795	863	1029	1854	543	1221	1109	1598	846	1043	312	lactation elevated 1 (LACE1)
B07R04C18	7-18-4	Hs~Ref:NM_145315.2~uORF:IOH39795	882	951	1834	526	1143	989	1545	761	1370	316	lactation elevated 1 (LACE1)
B07R04C19	7-19-4	Hs~Ref:NM_016145.1~uORF:IOH39838	536	509	726	470	536	2579	1219	693	1417	259	chromosome 19 open reading frame 56 (C19orf56)
B07R04C20	7-20-4	Hs~Ref:NM_016145.1~uORF:IOH39838	545	499	718	456	555	2498	1212	708	1383	292	chromosome 19 open reading frame 56 (C19orf56)
B07R04C21	7-21-4	Hs~Ref:NM_153320.1~uORF:IOH12336	711	471	807	387	678	577	1204	581	1226	273	solute carrier family 22 (organic anion transporter), member 7 (SLC22A7), transcript variant 2
B07R04C22	7-22-4	Hs~Ref:NM_153320.1~uORF:IOH12336	799	455	815	355	697	583	1207	633	1204	52	solute carrier family 22 (organic anion transporter), member 7 (SLC22A7), transcript variant 2
B07R05C01	7-1-5	Hs~MGC:BC014299.2~uORF:IOH12128	1548	603	1579	3331	903	1322	3890	1021	1609	217	Uncharacterized protein C14orf93
B07R05C02	7-2-5	Hs~MGC:BC014299.2~uORF:IOH12128	1704	607	1653	3402	900	1648	3998	1116	1635	266	Uncharacterized protein C14orf93
B07R05C03	7-3-5	Hs~Ref:NM_138333.1~uORF:IOH10239	1692	2063	3474	1164	2595	18511	2190	1431	3590	484	family with sequence similarity 122A (FAM122A)
B07R05C04	7-4-5	Hs~Ref:NM_138333.1~uORF:IOH10239	1704	2164	3281	1153	2559	17957	2338	1345	3458	457	family with sequence similarity 122A (FAM122A)
B07R05C05	7-5-5	Hs~MGC:BC005889.2~uORF:IOH5867	3166	1348	2186	1250	1690	1773	2822	2075	4206	594	pelota homolog (Drosophila) (PELO)
B07R05C06	7-6-5	Hs~MGC:BC005889.2~uORF:IOH5867	3082	1357	1845	1206	1628	1779	2919	2003	4053	598	pelota homolog (Drosophila) (PELO)
B07R05C07	7-7-5	Hs~Ref:NM_015926.2~uORF:IOH5918	1252	527	2438	454	589	2261	1790	1136	1221	199	testis expressed 264 (TEX264)
B07R05C08	7-8-5	Hs~Ref:NM_015926.2~uORF:IOH5918	1263	545	654	507	647	2129	1732	892	1167	145	testis expressed 264 (TEX264)
B07R05C09	7-9-5	Hs~Ref:NM_005518.1~uORF:IOH26365	568	483	468	825	1124	665	1679	1757	2206	251	3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) (HMGCS2)
B07R05C10	7-10-5	Hs~Ref:NM_005518.1~uORF:IOH26365	608	447	463	816	1061	696	1696	1421	2297	269	3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) (HMGCS2)
B07R05C13	7-13-5	Hs~MGC:BC039729.1~uORF:IOH26128	704	360	711	359	346	556	928	478	810	250	RIO kinase 3 (yeast) (RIOK3)
B07R05C14	7-14-5	Hs~MGC:BC039729.1~uORF:IOH26128	693	394	673	352	297	560	856	430	822	326	RIO kinase 3 (yeast) (RIOK3)
B07R05C15	7-15-5	Hs~MGC:BC041157.1~uORF:IOH26254	518	116	376	236	74	143	368	200	102	63	thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) (TBXAS1)
B07R05C16	7-16-5	Hs~MGC:BC041157.1~uORF:IOH26254	544	267	348	248	80	1	364	190	160	61	thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) (TBXAS1)
B07R05C17	7-17-5	Hs~Ref:NM_018147.1~uORF:IOH11086	458	427	626	334	2185	427	1015	260	1592	128	Fas apoptotic inhibitory molecule (FAIM), transcript variant 4
B07R05C18	7-18-5	Hs~Ref:NM_018147.1~uORF:IOH11086	460	435	647	324	2168	443	970	284	1631	63	Fas apoptotic inhibitory molecule (FAIM), transcript variant 4
B07R05C21	7-21-5	Hs~Ref:NM_015918.2~uORF:IOH10987	2320	916	2087	849	1104	961	1414	996	2018	407	processing of precursor 5, ribonuclease P/MRP subunit (S. cerevisiae) (POP5), transcript variant 1
B07R05C22	7-22-5	Hs~Ref:NM_015918.2~uORF:IOH10987	2329	890	2041	874	1089	976	1385	909	1910	391	processing of precursor 5, ribonuclease P/MRP subunit (S. cerevisiae) (POP5), transcript variant 1
B07R06C01	7-1-6	Hs~Ref:NM_145168.1~uORF:IOH10914	891	550	773	429	796	559	713	534	1183	120	NAD(P) dependent steroid dehydrogenase-like (HSPC105)
B07R06C02	7-2-6	Hs~Ref:NM_145168.1~uORF:IOH10914	1001	647	791	383	609	561	1054	520	1224	250	NAD(P) dependent steroid dehydrogenase-like (HSPC105)
B07R06C03	7-3-6	Hs~MGC:BC066960.1~uORF:IOH40071	389	264	436	1064	203	499	617	2894	769	100	glycerol kinase 3 pseudogene (GK3P)
B07R06C04	7-4-6	Hs~MGC:BC066960.1~uORF:IOH40071	379	286	429	1133	232	551	725	3080	754	111	glycerol kinase 3 pseudogene (GK3P)
B07R06C05	7-5-6	Hs~MGC:BC064634.1~uORF:IOH39924	1390	666	908	6120	959	2063	916	17210	3528	404	alcohol dehydrogenase, iron containing, 1 (ADHFE1)
B07R06C06	7-6-6	Hs~MGC:BC064634.1~uORF:IOH39924	1418	642	905	6120	1283	2014	1037	16969	3780	343	alcohol dehydrogenase, iron containing, 1 (ADHFE1)
B07R06C07	7-7-6	Hs~Ref:NM_203284.1~uORF:IOH39978	26087	13359	24291	52018	34738	49722	10724	65444	47060	8988	recombination signal binding protein for immunoglobulin kappa J region (RBPJ), transcript variant 4
B07R06C08	7-8-6	Hs~Ref:NM_203284.1~uORF:IOH39978	26169	13395	22961	52416	38926	49649	10814	65448	47105	8741	recombination signal binding protein for immunoglobulin kappa J region (RBPJ), transcript variant 4
B07R06C09	7-9-6	Hs~MGC:BC066353.1~uORF:IOH40075	342	124	436	451	597	631	3127	1376	945	51	LIM homeobox transcription factor 1, alpha (LMX1A)
B07R06C10	7-10-6	Hs~MGC:BC066353.1~uORF:IOH40075	333	177	472	429	573	686	3060	877	738	103	LIM homeobox transcription factor 1, alpha (LMX1A)
B07R06C11	7-11-6	Hs~Ref:NM_032464.1~uORF:IOH45837	1664	803	745	415	484	909	641	572	1452	244	linker for activation of T cells family, member 2 (LAT2), transcript variant 1
B07R06C12	7-12-6	Hs~Ref:NM_032464.1~uORF:IOH45837	1685	803	732	573	541	893	720	639	1377	225	linker for activation of T cells family, member 2 (LAT2), transcript variant 1
B07R06C13	7-13-6	Hs~Ref:NM_002713.2~uORF:IOH45768	13884	2591	2778	2361	1694	7519	3991	1364	4502	846	protein phosphatase 1, regulatory (inhibitor) subunit 8 (PPP1R8), transcript variant 3
B07R06C14	7-14-6	Hs~Ref:NM_002713.2~uORF:IOH45768	13752	2549	2912	1925	1738	8012	3884	1388	4559	803	protein phosphatase 1, regulatory (inhibitor) subunit 8 (PPP1R8), transcript variant 3
B07R06C15	7-15-6	Hs~Ref:NM_212530.1~uORF:IOH45821	1025	1179	712	537	796	600	1329	1211	971	207	cell division cycle 25B (CDC25B), transcript variant 5
B07R06C16	7-16-6	Hs~Ref:NM_212530.1~uORF:IOH45821	1009	1167	740	576	747	584	1314	1272	36	349	cell division cycle 25B (CDC25B), transcript variant 5
B07R06C17	7-17-6	Hs~Ref:NM_198038.1~uORF:IOH45894	272	350	506	327	348	1920	432	186	626	219	nudix (nucleoside diphosphate linked moiety X)-type motif 9 (NUDT9), transcript variant 3
B07R06C18	7-18-6	Hs~Ref:NM_198038.1~uORF:IOH45894	282	371	485	346	297	1833	407	5116	687	64	nudix (nucleoside diphosphate linked moiety X)-type motif 9 (NUDT9), transcript variant 3
B07R06C19	7-19-6	Hs~MGC:BC017355.1~uORF:IOH14046	796	1326	1026	4059	3346	1084	2125	903	4424	598	karyopherin alpha 3 (importin alpha 4) (KPNA3)
B07R06C20	7-20-6	Hs~MGC:BC017355.1~uORF:IOH14046	765	1361	1036	4290	3374	935	2135	857	4435	606	karyopherin alpha 3 (importin alpha 4) (KPNA3)
B07R06C21	7-21-6	Hs~MGC:BC017440.1~uORF:IOH14659	3729	2218	2677	1720	2639	1053	2290	1555	2879	1124	trafficking protein particle complex 2-like (TRAPPC2L)
B07R06C22	7-22-6	Hs~MGC:BC017440.1~uORF:IOH14659	3550	2295	2664	1588	2667	1478	2340	1614	2915	1149	trafficking protein particle complex 2-like (TRAPPC2L)
B07R07C01	7-1-7	Hs~MGC:NM_153001.1~uORF:IOH13837	902	356	718	649	570	659	1582	609	1325	243	proteasome (prosome, macropain) 26S subunit, ATPase, 4 (PSMC4), transcript variant 2
B07R07C02	7-2-7	Hs~MGC:NM_153001.1~uORF:IOH13837	848	388	723	617	552	779	1548	635	1313	243	proteasome (prosome, macropain) 26S subunit, ATPase, 4 (PSMC4), transcript variant 2
B07R07C03	7-3-7	Hs~MGC:BC009949.2~uORF:IOH14336	731	763	903	428	734	824	863	908	1244	297	neurocalcin delta (NCALD)
B07R07C04	7-4-7	Hs~MGC:BC009949.2~uORF:IOH14336	756	758	913	427	766	801	892	909	1165	365	neurocalcin delta (NCALD)
B07R07C05	7-5-7	Hs~MGC:BC004522.1~uORF:IOH5691	309	310	519	264	287	293	538	871	621	107	RAB, member RAS oncogene family-like 5 (RABL5)
B07R07C06	7-6-7	Hs~MGC:BC004522.1~uORF:IOH5691	304	323	454	311	400	269	535	507	565	115	RAB, member RAS oncogene family-like 5 (RABL5)
B07R07C07	7-7-7	Hs~Ref:NM_023940.1~uORF:IOH6072	367	355	556	406	480	343	837	676	5887	114	RAS-like, family 11, member B (RASL11B)
B07R07C08	7-8-7	Hs~Ref:NM_023940.1~uORF:IOH6072	356	342	580	172	235	343	707	692	5745	79	RAS-like, family 11, member B (RASL11B)
B07R07C09	7-9-7	Hs~Ref:NM_001664.1~uORF:IOH7574	443	202	340	115	372	273	351	482	406	18	ras homolog gene family, member A (RHOA)
B07R07C10	7-10-7	Hs~Ref:NM_001664.1~uORF:IOH7574	434	228	332	170	390	247	352	326	456	67	ras homolog gene family, member A (RHOA)
B07R07C11	7-11-7	Hs~Ref:NM_020673.1~uORF:IOH10004	656	437	639	355	420	689	805	904	204	245	RAB22A, member RAS oncogene family (RAB22A)
B07R07C12	7-12-7	Hs~Ref:NM_020673.1~uORF:IOH10004	730	441	707	504	426	614	849	619	26	60	RAB22A, member RAS oncogene family (RAB22A)
B07R07C13	7-13-7	Hs~Ref:NM_003104.2~uORF:IOH14671	6867	1928	3085	4346	2190	1754	3062	1905	5418	1126	sorbitol dehydrogenase (SORD)
B07R07C14	7-14-7	Hs~Ref:NM_003104.2~uORF:IOH14671	6796	1939	3029	3982	2293	1721	3204	1971	5376	1249	sorbitol dehydrogenase (SORD)
B07R07C15	7-15-7	Hs~MGC:BC009738.1~uORF:IOH9861	2772	3250	2216	2064	1609	2569	2524	3152	3624	1010	phenazine biosynthesis-like protein domain containing (PBLD)
B07R07C16	7-16-7	Hs~MGC:BC009738.1~uORF:IOH9861	2735	3356	1890	2017	1565	2449	2569	2970	3604	1031	phenazine biosynthesis-like protein domain containing (PBLD)
B07R07C17	7-17-7	Hs~MGC:BC011710.2~uORF:IOH13726	1577	1194	1804	977	913	1317	2602	1154	3223	793	Putative HIF-prolyl hydroxylase PH-4
B07R07C18	7-18-7	Hs~MGC:BC011710.2~uORF:IOH13726	1661	1252	1846	950	988	1647	2580	1143	3053	807	Putative HIF-prolyl hydroxylase PH-4
B07R07C19	7-19-7	Hs~Ref:NM_032476.1~uORF:IOH13845	3717	2940	4671	3902	2696	2885	5276	1990	3633	1184	mitochondrial ribosomal protein S6 (MRPS6), nuclear gene encoding mitochondrial protein
B07R07C20	7-20-7	Hs~Ref:NM_032476.1~uORF:IOH13845	3749	2854	4907	4043	2716	2704	5203	1970	3459	1120	mitochondrial ribosomal protein S6 (MRPS6), nuclear gene encoding mitochondrial protein
B07R07C21	7-21-7	Hs~Ref:NM_005803.2~uORF:IOH4826	635	693	899	527	1129	31	927	496	2833	384	flotillin 1 (FLOT1)
B07R07C22	7-22-7	Hs~Ref:NM_005803.2~uORF:IOH4826	599	691	958	510	1134	670	903	616	2773	363	flotillin 1 (FLOT1)
B07R08C01	7-1-8	Hs~Ref:NM_005011.2~uORF:IOH11918	705	296	805	470	283	611	2664	619	1380	150	nuclear respiratory factor 1 (NRF1), transcript variant 1
B07R08C02	7-2-8	Hs~Ref:NM_005011.2~uORF:IOH11918	728	317	736	442	303	624	2696	642	1308	140	nuclear respiratory factor 1 (NRF1), transcript variant 1
B07R08C03	7-3-8	Hs~Ref:NM_014110.3~uORF:IOH39485	18454	3294	3173	2816	2933	4710	5520	1994	17964	865	protein phosphatase 1, regulatory (inhibitor) subunit 8 (PPP1R8), transcript variant 1
B07R08C04	7-4-8	Hs~Ref:NM_014110.3~uORF:IOH39485	20034	3135	3407	2796	3499	5114	5093	1697	17353	836	protein phosphatase 1, regulatory (inhibitor) subunit 8 (PPP1R8), transcript variant 1
B07R08C05	7-5-8	Hs~Ref:NM_170603.1~uORF:IOH39528	1777	1612	1578	4236	1918	1668	2609	1790	2306	757	RAS guanyl-releasing protein 4
B07R08C06	7-6-8	Hs~Ref:NM_170603.1~uORF:IOH39528	1814	1567	1418	3959	2017	1684	2899	1629	2314	782	RAS guanyl-releasing protein 4
B07R08C07	7-7-8	Hs~Ref:NM_033122.1~uORF:IOH26918	902	1771	730	2170	1292	527	655	636	603	4337	chromosome 4 open reading frame 35 (C4orf35)
B07R08C08	7-8-8	Hs~Ref:NM_033122.1~uORF:IOH26918	891	1794	683	2227	1099	535	634	413	599	3994	chromosome 4 open reading frame 35 (C4orf35)
B07R08C09	7-9-8	Hs~Ref:NM_078476.1~uORF:IOH10883	685	531	708	447	466	682	973	557	1003	227	butyrophilin, subfamily 2, member A1 (BTN2A1), transcript variant 2
B07R08C10	7-10-8	Hs~Ref:NM_078476.1~uORF:IOH10883	662	516	760	389	417	762	986	526	888	326	butyrophilin, subfamily 2, member A1 (BTN2A1), transcript variant 2
B07R08C11	7-11-8	Hs~MGC:NM_153498.1~uORF:IOH26033	1605	978	1065	372	854	1040	775	999	1427	-16	calcium/calmodulin-dependent protein kinase ID (CAMK1D), transcript variant 2
B07R08C12	7-12-8	Hs~MGC:NM_153498.1~uORF:IOH26033	1630	968	1035	472	844	1064	779	1084	1377	177	calcium/calmodulin-dependent protein kinase ID (CAMK1D), transcript variant 2
B07R08C13	7-13-8	Hs~MGC:BC011792.1~uORF:IOH13815	1229	819	927	550	638	643	1000	538	1402	1002	enoyl Coenzyme A hydratase 1, peroxisomal (ECH1)
B07R08C14	7-14-8	Hs~MGC:BC011792.1~uORF:IOH13815	1192	821	855	518	823	667	965	589	1409	992	enoyl Coenzyme A hydratase 1, peroxisomal (ECH1)
B07R08C15	7-15-8	Hs~MGC:BC031608.1~uORF:IOH22796	2509	2562	3175	1359	1440	1543	5367	2107	3438	582	REST corepressor 3 (RCOR3)
B07R08C16	7-16-8	Hs~MGC:BC031608.1~uORF:IOH22796	2429	2507	2941	1363	1473	1454	5407	2016	3377	307	REST corepressor 3 (RCOR3)
B07R08C17	7-17-8	Hs~MGC:BC029509.1~uORF:IOH22569	1045	1028	2559	796	1149	1191	3271	1567	2588	445	DnaJ homolog subfamily C member 28
B07R08C18	7-18-8	Hs~MGC:BC029509.1~uORF:IOH22569	1082	1070	2529	782	1064	1088	3348	1551	2582	455	DnaJ homolog subfamily C member 28
B07R08C19	7-19-8	Hs~MGC:BC023286.1~uORF:IOH26797	633	839	1198	949	621	156	1232	966	1898	407	vesicle-associated membrane protein 1 (synaptobrevin 1) (VAMP1)
B07R08C20	7-20-8	Hs~MGC:BC023286.1~uORF:IOH26797	636	813	1137	807	624	929	1229	977	2007	363	vesicle-associated membrane protein 1 (synaptobrevin 1) (VAMP1)
B07R08C21	7-21-8	Hs~MGC:BC018049.1~uORF:IOH26801	1641	1106	2547	1422	1518	4757	2119	1391	3592	544	profilin 2 (PFN2)
B07R08C22	7-22-8	Hs~MGC:BC018049.1~uORF:IOH26801	1609	1051	2586	1446	1517	1062	1978	1346	3483	518	profilin 2 (PFN2)
B07R09C01	7-1-9	Hs~Ref:NM_002486.3~uORF:IOH4014	499	320	765	2348	312	427	673	383	3416	67	nuclear cap binding protein subunit 1, 80kDa (NCBP1)
B07R09C02	7-2-9	Hs~Ref:NM_002486.3~uORF:IOH4014	489	354	744	2335	319	393	604	368	3260	108	nuclear cap binding protein subunit 1, 80kDa (NCBP1)
B07R09C03	7-3-9	Hs~MGC:BC002582.2~uORF:IOH4120	1531	563	2125	11952	1862	960	2356	4946	1683	820	ubiquitin protein ligase E3A (human papilloma virus E6-associated protein, Angelman syndrome) (UBE3A)
B07R09C04	7-4-9	Hs~MGC:BC002582.2~uORF:IOH4120	1540	560	2317	12271	2045	998	2303	4880	1714	796	ubiquitin protein ligase E3A (human papilloma virus E6-associated protein, Angelman syndrome) (UBE3A)
B07R09C05	7-5-9	Hs~MGC:BC021704.1~uORF:IOH10916	592	446	701	347	359	517	986	385	748	228	MORN repeat containing 1 (MORN1)
B07R09C06	7-6-9	Hs~MGC:BC021704.1~uORF:IOH10916	591	485	715	341	359	569	995	429	725	146	MORN repeat containing 1 (MORN1)
B07R09C07	7-7-9	Hs~MGC:BC005279.1~uORF:IOH7369	2136	671	2287	543	560	818	2438	1225	2225	250	carboxypeptidase A1 (pancreatic) (CPA1)
B07R09C08	7-8-9	Hs~MGC:BC005279.1~uORF:IOH7369	2045	653	2409	563	510	793	2400	1168	2088	183	carboxypeptidase A1 (pancreatic) (CPA1)
B07R09C09	7-9-9	Hs~MGC:BC038934.1~uORF:IOH27574	690	599	1153	852	559	516	824	597	933	213	gap junction protein, beta 6 (GJB6)
B07R09C10	7-10-9	Hs~MGC:BC038934.1~uORF:IOH27574	753	634	759	878	519	582	893	496	647	302	gap junction protein, beta 6 (GJB6)
B07R09C11	7-11-9	Hs~MGC:BC032698.1~uORF:IOH27591	807	733	955	604	442	711	1139	767	2	154	ephrin-A1 (EFNA1)
B07R09C12	7-12-9	Hs~MGC:BC032698.1~uORF:IOH27591	839	732	1003	858	431	604	1118	1143	1138	228	ephrin-A1 (EFNA1)
B07R09C13	7-13-9	Hs~MGC:BC057829.1~uORF:IOH29166	581	467	678	461	256	502	737	811	878	153	family with sequence similarity 3, member B (FAM3B)
B07R09C14	7-14-9	Hs~MGC:BC057829.1~uORF:IOH29166	542	469	714	327	434	506	779	422	820	278	family with sequence similarity 3, member B (FAM3B)
B07R09C15	7-15-9	Hs~MGC:BC013768.1~uORF:IOH11543	364	339	570	292	156	287	673	313	506	161	propionyl Coenzyme A carboxylase, beta polypeptide (PCCB)
B07R09C16	7-16-9	Hs~MGC:BC013768.1~uORF:IOH11543	362	378	404	279	263	305	764	315	488	160	propionyl Coenzyme A carboxylase, beta polypeptide (PCCB)
B07R09C17	7-17-9	Hs~MGC:BC007242.1~uORF:IOH46096	590	464	1558	1555	1187	1063	3416	541	1204	77	ets variant gene 4 (E1A enhancer binding protein, E1AF) (ETV4)
B07R09C18	7-18-9	Hs~MGC:BC007242.1~uORF:IOH46096	581	451	1530	1546	1034	1027	3540	536	1242	179	ets variant gene 4 (E1A enhancer binding protein, E1AF) (ETV4)
B07R09C19	7-19-9	Hs~MGC:BC000226.1~uORF:IOH46086	973	440	599	1857	378	858	761	550	1185	205	ubiquitin specific peptidase 47 (USP47)
B07R09C20	7-20-9	Hs~MGC:BC000226.1~uORF:IOH46086	978	449	624	1955	336	865	770	554	1230	241	ubiquitin specific peptidase 47 (USP47)
B07R09C21	7-21-9	Hs~MGC:BC004884.2~uORF:IOH46071	319	346	546	336	116	336	1021	507	682	217	fucosyltransferase 10 (alpha (1,3) fucosyltransferase) (FUT10)
B07R09C22	7-22-9	Hs~MGC:BC004884.2~uORF:IOH46071	301	357	634	362	580	-4	901	463	415	188	fucosyltransferase 10 (alpha (1,3) fucosyltransferase) (FUT10)
B07R10C01	7-1-10	Hs~MGC:BC011636.2~uORF:IOH46091	498	310	433	609	271	308	574	708	481	123	Protein phosphatase Slingshot homolog 2
B07R10C02	7-2-10	Hs~MGC:BC011636.2~uORF:IOH46091	945	311	511	568	371	481	717	749	442	73	Protein phosphatase Slingshot homolog 2
B07R10C03	7-3-10	Hs~Ref:NM_004906.3~uORF:IOH40770	494	348	793	1557	687	1175	3353	1259	632	139	Wilms tumor 1 associated protein (WTAP), transcript variant 1
B07R10C04	7-4-10	Hs~Ref:NM_004906.3~uORF:IOH40770	472	327	831	1588	712	1094	3348	1249	685	148	Wilms tumor 1 associated protein (WTAP), transcript variant 1
B07R10C05	7-5-10	Hs~MGC:BC062359.1~uORF:IOH40676	341	248	4517	224	257	440	7207	245	813	139	chromosome 8 open reading frame 47 (C8orf47)
B07R10C06	7-6-10	Hs~MGC:BC062359.1~uORF:IOH40676	328	271	4450	233	266	432	7284	235	798	141	chromosome 8 open reading frame 47 (C8orf47)
B07R10C07	7-7-10	Hs~Ref:NM_006552.1~uORF:IOH40719	728	431	644	352	276	488	1330	496	843	181	secretoglobin, family 1D, member 1 (SCGB1D1)
B07R10C08	7-8-10	Hs~Ref:NM_006552.1~uORF:IOH40719	691	393	817	361	567	469	1198	896	692	192	secretoglobin, family 1D, member 1 (SCGB1D1)
B07R10C09	7-9-10	Hs~Ref:NM_178232.2~uORF:IOH40677	684	478	832	404	578	501	1420	665	1278	234	hyaluronan and proteoglycan link protein 3 (HAPLN3)
B07R10C10	7-10-10	Hs~Ref:NM_178232.2~uORF:IOH40677	675	455	777	400	529	580	1488	439	550	261	hyaluronan and proteoglycan link protein 3 (HAPLN3)
B07R11C21	7-21-11	Hs~MGC:BC029487.1~uORF:IOH22545	253	267	452	291	139	26	394	263	492	220	Transmembrane protein 120A
B07R11C22	7-22-11	Hs~MGC:BC029487.1~uORF:IOH22545	284	276	411	260	144	-6	490	288	341	147	Transmembrane protein 120A
B07R12C03	7-3-12	Hs~Ref:NM_006752.4~uORF:IOH26279	11840	2406	3371	1349	814	21479	3908	541	1404	333	surfeit 5 (SURF5), transcript variant a
B07R12C04	7-4-12	Hs~Ref:NM_006752.4~uORF:IOH26279	11436	2390	3211	1277	850	20872	3652	546	1295	305	surfeit 5 (SURF5), transcript variant a
B07R12C07	7-7-12	Hs~Ref:NM_006202.1~uORF:IOH22369	-2	1	1	-3	-4	1	-7	-2	-3	-3	phosphodiesterase 4A, cAMP-specific (phosphodiesterase E2 dunce homolog, Drosophila) (PDE4A)
B07R12C08	7-8-12	Hs~Ref:NM_006202.1~uORF:IOH22369	0	-1	1	-3	-4	3	9	4	-4	1	phosphodiesterase 4A, cAMP-specific (phosphodiesterase E2 dunce homolog, Drosophila) (PDE4A)
B07R12C11	7-11-12	Hs~MGC:BC050444.1~uORF:IOH26738	267	292	412	368	100	159	422	605	265	119	golgi autoantigen, golgin subfamily a, 4 (GOLGA4)
B07R12C12	7-12-12	Hs~MGC:BC050444.1~uORF:IOH26738	235	304	426	228	172	235	490	644	250	52	golgi autoantigen, golgin subfamily a, 4 (GOLGA4)
B07R12C13	7-13-12	Hs~MGC:BC037567.1~uORF:IOH27585	461	538	374	319	148	185	518	612	705	134	alanine-glyoxylate aminotransferase 2-like 2 (AGXT2L2)
B07R12C14	7-14-12	Hs~MGC:BC037567.1~uORF:IOH27585	486	526	284	263	94	229	548	897	610	78	alanine-glyoxylate aminotransferase 2-like 2 (AGXT2L2)
B07R12C15	7-15-12	Hs~Ref:NM_022650.1~uORF:IOH41794	13629	2413	2160	1666	1608	2714	5805	2091	3276	1369	RAS p21 protein activator (GTPase activating protein) 1 (RASA1), transcript variant 2
B07R12C16	7-16-12	Hs~Ref:NM_022650.1~uORF:IOH41794	13600	2399	2160	1493	1432	2657	5980	2055	3151	1244	RAS p21 protein activator (GTPase activating protein) 1 (RASA1), transcript variant 2
B07R12C17	7-17-12	Hs~Ref:NM_024953.2~uORF:IOH44869	849	702	813	449	365	18	1507	510	1062	277	chromosome 12 open reading frame 30 (C12orf30)
B07R12C18	7-18-12	Hs~Ref:NM_024953.2~uORF:IOH44869	797	640	806	428	573	620	1471	496	1001	123	chromosome 12 open reading frame 30 (C12orf30)
B07R12C19	7-19-12	Hs~Ref:NM_182644.1~uORF:IOH44403	622	396	614	475	741	443	837	483	917	240	Ephrin receptor A3 (EPHA3), transcript variant 2
B07R12C20	7-20-12	Hs~Ref:NM_182644.1~uORF:IOH44403	582	397	640	440	941	397	810	474	939	232	Ephrin receptor A3 (EPHA3), transcript variant 2
B07R12C21	7-21-12	Hs~Ref:NM_024012.1~uORF:IOH42519	527	599	1019	454	492	401	1040	491	1310	339	5-hydroxytryptamine (serotonin) receptor 5A (HTR5A)
B07R12C22	7-22-12	Hs~Ref:NM_024012.1~uORF:IOH42519	530	585	975	370	513	703	1213	595	1127	340	5-hydroxytryptamine (serotonin) receptor 5A (HTR5A)
B07R13C01	7-1-13	Hs~Ref:NM_032901.2~uORF:IOH6728	1329	869	1580	1087	876	915	1927	1085	2685	513	chromosome 12 open reading frame 62 (C12orf62)
B07R13C02	7-2-13	Hs~Ref:NM_032901.2~uORF:IOH6728	1479	894	1620	1078	952	1095	1886	988	2737	625	chromosome 12 open reading frame 62 (C12orf62)
B07R13C03	7-3-13	Hs~Ref:NM_006912.3~uORF:IOH29584	5031	2405	5406	3487	1941	2635	12242	3184	6155	1712	Ras-like without CAAX 1 (RIT1)
B07R13C04	7-4-13	Hs~Ref:NM_006912.3~uORF:IOH29584	5286	2370	5372	3485	1951	2617	14275	3244	6039	1749	Ras-like without CAAX 1 (RIT1)
B07R13C05	7-5-13	Hs~MGC:BC008840.2~uORF:IOH46146	1252	843	1440	768	722	1259	1656	1123	2633	658	Thrombospondin type-1 domain-containing protein 4
B07R13C06	7-6-13	Hs~MGC:BC008840.2~uORF:IOH46146	1147	901	1385	827	800	120	1579	1077	1311	625	Thrombospondin type-1 domain-containing protein 4
B07R13C07	7-7-13	Hs~MGC:BC014210.2~uORF:IOH46147	1445	1047	1321	964	917	1304	2084	1381	3160	967	arylsulfatase A (ARSA)
B07R13C08	7-8-13	Hs~MGC:BC014210.2~uORF:IOH46147	1497	1076	1148	877	772	1832	2049	1411	3640	525	arylsulfatase A (ARSA)
B07R13C11	7-11-13	Hs~Ref:NM_001892.4~uORF:IOH59150	861	895	1278	304	653	5607	363	712	948	130	casein kinase 1, alpha 1 (CSNK1A1), transcript variant 2
B07R13C12	7-12-13	Hs~Ref:NM_001892.4~uORF:IOH59150	857	892	1250	418	631	5418	384	761	857	96	casein kinase 1, alpha 1 (CSNK1A1), transcript variant 2
B07R13C13	7-13-13	Hs~MGC:BC074765.2~uORF:IOH59064	507	535	743	457	562	502	750	569	2562	396	POU domain, class 6, transcription factor 1
B07R13C14	7-14-13	Hs~MGC:BC074765.2~uORF:IOH59064	497	518	999	534	661	512	769	557	79	436	POU domain, class 6, transcription factor 1
B07R13C15	7-15-13	Hs~Ref:NM_000175.2~uORF:IOH5104	284	269	486	256	209	261	477	407	1369	75	Glucose-6-phosphate isomerase
B07R13C16	7-16-13	Hs~Ref:NM_000175.2~uORF:IOH5104	289	291	365	251	206	295	516	294	1394	122	Glucose-6-phosphate isomerase
B07R13C17	7-17-13	Hs~Ref:NM_004310.2~uORF:IOH13574	727	830	1032	599	664	789	1367	887	1640	796	ras homolog gene family, member H (RHOH)
B07R13C18	7-18-13	Hs~Ref:NM_004310.2~uORF:IOH13574	733	754	889	604	768	807	1369	794	1611	599	ras homolog gene family, member H (RHOH)
B07R13C19	7-19-13	Hs~MGC:BC001030.1~uORF:IOH4266	992	669	1002	624	757	1082	1572	810	1734	427	phosphatidylinositol glycan anchor biosynthesis, class O (PIGO)
B07R13C20	7-20-13	Hs~MGC:BC001030.1~uORF:IOH4266	923	652	1046	627	645	1038	1548	761	1735	564	phosphatidylinositol glycan anchor biosynthesis, class O (PIGO)
B07R13C21	7-21-13	Hs~Ref:NM_002592.1~uORF:IOH3449	3360	1106	1453	993	1521	1546	1642	1248	2569	705	proliferating cell nuclear antigen (PCNA), transcript variant 1
B07R13C22	7-22-13	Hs~Ref:NM_002592.1~uORF:IOH3449	3246	1078	1463	970	986	1166	1574	1206	2755	627	proliferating cell nuclear antigen (PCNA), transcript variant 1
B07R14C01	7-1-14	Hs~Ref:NM_004493.1~uORF:IOH3421	3538	1442	2451	3195	1878	2248	2047	2871	3107	970	hydroxysteroid (17-beta) dehydrogenase 10 (HSD17B10), nuclear gene encoding mitochondrial protein, transcript variant 1
B07R14C02	7-2-14	Hs~Ref:NM_004493.1~uORF:IOH3421	3383	1514	2492	2831	1921	2226	2019	2840	3158	985	hydroxysteroid (17-beta) dehydrogenase 10 (HSD17B10), nuclear gene encoding mitochondrial protein, transcript variant 1
B07R14C03	7-3-14	Hs~MGC:BC027612.2~uORF:IOH11844	2323	461	9464	4194	1084	1439	1233	802	1616	470	EP300-interacting inhibitor of differentiation 3
B07R14C04	7-4-14	Hs~MGC:BC027612.2~uORF:IOH11844	2417	442	9228	4066	1155	489	1252	782	1670	498	EP300-interacting inhibitor of differentiation 3
B07R14C05	7-5-14	Hs~MGC:BC059371.1~uORF:IOH29259	2654	407	627	343	346	542	932	484	750	264	RING finger and WD repeat domain-containing protein 3
B07R14C06	7-6-14	Hs~MGC:BC059371.1~uORF:IOH29259	2655	388	607	383	277	362	967	509	765	219	RING finger and WD repeat domain-containing protein 3
B07R14C07	7-7-14	Hs~Ref:NM_004645.1~uORF:IOH14379	65476	2341	4408	2860	2359	2244	6376	3134	3608	1404	coilin (COIL)
B07R14C08	7-8-14	Hs~Ref:NM_004645.1~uORF:IOH14379	65447	2370	3907	2941	2387	2306	6292	3399	3663	1404	coilin (COIL)
B07R14C09	7-9-14	Hs~Ref:NM_000184.1~uORF:IOH13644	455	338	572	256	406	178	661	748	535	133	hemoglobin, gamma G (HBG2)
B07R14C10	7-10-14	Hs~Ref:NM_000184.1~uORF:IOH13644	417	364	420	327	409	125	696	704	437	142	hemoglobin, gamma G (HBG2)
B07R14C11	7-11-14	Hs~Ref:NM_002799.2~uORF:IOH53883	706	373	661	335	455	421	767	445	1522	198	Proteasome subunit beta type-7
B07R14C12	7-12-14	Hs~Ref:NM_002799.2~uORF:IOH53883	736	384	586	438	459	438	777	544	1533	218	Proteasome subunit beta type-7
B07R14C13	7-13-14	Hs~Ref:NM_006243.2~uORF:IOH54021	513	451	671	564	464	572	1797	1107	1035	425	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform
B07R14C14	7-14-14	Hs~Ref:NM_006243.2~uORF:IOH54021	496	449	625	391	512	494	1787	712	357	454	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform
B07R14C17	7-17-14	Hs~Ref:NM_001176.2~uORF:IOH53858	627	333	517	282	388	371	896	3520	894	198	Rho GDP-dissociation inhibitor 3
B07R14C18	7-18-14	Hs~Ref:NM_001176.2~uORF:IOH53858	600	336	501	275	199	318	840	2928	829	252	Rho GDP-dissociation inhibitor 3
B07R14C19	7-19-14	Hs~Ref:NM_006698.1~uORF:IOH26699	628	652	689	505	614	601	919	586	1026	473	bladder cancer associated protein (BLCAP)
B07R14C20	7-20-14	Hs~Ref:NM_006698.1~uORF:IOH26699	632	635	698	402	729	648	961	651	1012	180	bladder cancer associated protein (BLCAP)
B07R14C21	7-21-14	Hs~MGC:BC050393.1~uORF:IOH26678	582	450	691	397	360	1223	1078	631	990	389	F-box protein 25 (FBXO25)
B07R14C22	7-22-14	Hs~MGC:BC050393.1~uORF:IOH26678	564	487	664	386	730	1056	917	531	1170	319	F-box protein 25 (FBXO25)
B07R15C01	7-1-15	Hs~MGC:BC044612.1~uORF:IOH26756	3148	541	563	559	699	636	972	472	896	218	glycoprotein M6A (GPM6A)
B07R15C02	7-2-15	Hs~MGC:BC044612.1~uORF:IOH26756	2329	564	549	509	678	491	941	727	981	255	glycoprotein M6A (GPM6A)
B07R15C03	7-3-15	Hs~Ref:NM_001980.1~uORF:IOH26517	654	1141	778	495	660	271	1010	747	1743	412	Syntaxin-2
B07R15C04	7-4-15	Hs~Ref:NM_001980.1~uORF:IOH26517	647	1147	771	483	593	337	931	606	1509	352	Syntaxin-2
B07R15C05	7-5-15	Hs~MGC:BC093700.1~uORF:IOH61973	428	639	887	1549	371	968	999	564	712	328	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4
B07R15C06	7-6-15	Hs~MGC:BC093700.1~uORF:IOH61973	425	607	939	1485	296	972	1005	631	729	424	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4
B07R15C13	7-13-15	Hs~Ref:NM_002742.1~CAT:PV3791	665	442	1662	10054	861	621	725	1207	1564	178	Serine/threonine-protein kinase D1
B07R15C14	7-14-15	Hs~Ref:NM_002742.1~CAT:PV3791	661	452	1845	10164	874	747	729	1088	1608	249	Serine/threonine-protein kinase D1
B07R15C17	7-17-15	Hs~Ref:NM_006281.1~CAT:PV4805	979	604	549	277	308	514	1163	2057	1539	254	serine/threonine kinase 3 (STE20 homolog, yeast) (STK3)
B07R15C18	7-18-15	Hs~Ref:NM_006281.1~CAT:PV4805	975	602	597	271	319	507	1045	1858	1527	341	serine/threonine kinase 3 (STE20 homolog, yeast) (STK3)
B07R16C03	7-3-16	Hs~Ref:NM_014002.1~CAT:PV4875	1115	343	748	467	645	670	1096	821	861	290	Inhibitor of nuclear factor kappa-B kinase subunit epsilon
B07R16C04	7-4-16	Hs~Ref:NM_014002.1~CAT:PV4875	543	347	711	484	861	864	1079	684	866	258	Inhibitor of nuclear factor kappa-B kinase subunit epsilon
B07R16C09	7-9-16	Hs~MGC:BC067431.1~uORF:IOH62524	517	416	831	368	326	244	1049	527	1005	263	Cytochrome P450 2B6
B07R16C10	7-10-16	Hs~MGC:BC067431.1~uORF:IOH62524	528	407	931	394	289	773	1006	542	93	249	Cytochrome P450 2B6
B07R16C11	7-11-16	Hs~MGC:BC072436.1~uORF:IOH61814	1163	653	1307	912	685	788	1962	910	1984	278	Hypoxia up-regulated protein 1
B07R16C12	7-12-16	Hs~MGC:BC072436.1~uORF:IOH61814	1199	691	1200	942	742	925	2020	832	2219	352	Hypoxia up-regulated protein 1
B07R16C13	7-13-16	Hs~MGC:BC095401.1~uORF:IOH62645	900	1296	1524	892	1278	837	1577	738	1535	346	AKT-interacting protein
B07R16C14	7-14-16	Hs~MGC:BC095401.1~uORF:IOH62645	986	1314	1660	752	1180	602	1790	774	1410	425	AKT-interacting protein
B07R16C15	7-15-16	Hs~MGC:BC051695.1~uORF:IOH26532	1172	903	2015	875	844	1290	3198	2825	1784	497	FERM domain containing 8 (FRMD8)
B07R16C16	7-16-16	Hs~MGC:BC051695.1~uORF:IOH26532	1140	873	1831	877	812	1352	3605	2738	1860	385	FERM domain containing 8 (FRMD8)
B07R16C17	7-17-16	Hs~Ref:NM_153337.1~uORF:IOH27298	821	607	1033	744	693	400	1458	680	-13	426	selectin ligand interactor cytoplasmic-1 (SLIC1), transcript variant 1
B07R16C18	7-18-16	Hs~Ref:NM_153337.1~uORF:IOH27298	827	669	946	700	643	105	1458	756	147	420	selectin ligand interactor cytoplasmic-1 (SLIC1), transcript variant 1
B07R16C19	7-19-16	Hs~Ref:NM_001033551.1~uORF:IOH26533	516	428	2495	371	959	1137	2535	534	1300	251	TOM1-like protein 2
B07R16C20	7-20-16	Hs~Ref:NM_001033551.1~uORF:IOH26533	506	421	2820	327	992	124	2485	517	1317	314	TOM1-like protein 2
B07R16C21	7-21-16	Hs~MGC:BC054347.1~uORF:IOH28965	576	458	1205	658	702	482	1566	653	2204	462	early B-cell factor 4 (RP5-860F19.3)
B07R16C22	7-22-16	Hs~MGC:BC054347.1~uORF:IOH28965	548	447	1230	634	674	227	1617	714	2422	455	early B-cell factor 4 (RP5-860F19.3)
B07R17C01	7-1-17	Hs~Ref:NM_021210.2~uORF:IOH21962	1806	1169	1817	1641	1624	1002	1865	1309	1704	377	trafficking protein particle complex 1 (TRAPPC1)
B07R17C02	7-2-17	Hs~Ref:NM_021210.2~uORF:IOH21962	1663	1117	1833	1478	1478	944	1781	1277	1747	391	trafficking protein particle complex 1 (TRAPPC1)
B07R17C03	7-3-17	Hs~Ref:NM_016616.2~uORF:IOH22105	830	524	881	1164	466	830	1068	1060	952	352	thioredoxin domain containing 3 (spermatozoa) (TXNDC3)
B07R17C04	7-4-17	Hs~Ref:NM_016616.2~uORF:IOH22105	810	548	902	1166	479	606	1069	1083	948	364	thioredoxin domain containing 3 (spermatozoa) (TXNDC3)
B07R17C05	7-5-17	Hs~Ref:NM_001167.2~uORF:IOH21984	2226	5296	1752	2027	2262	1449	5340	4218	2895	3505	baculoviral IAP repeat-containing 4 (BIRC4)
B07R17C06	7-6-17	Hs~Ref:NM_001167.2~uORF:IOH21984	2212	4476	1722	2052	2248	1700	5459	3976	2981	3397	baculoviral IAP repeat-containing 4 (BIRC4)
B07R17C07	7-7-17	Hs~Ref:NM_178821.1~uORF:IOH22298	1460	1232	1658	1393	2058	1160	2820	1117	3505	513	WD repeat domain 69 (WDR69)
B07R17C08	7-8-17	Hs~Ref:NM_178821.1~uORF:IOH22298	1414	1243	1651	1359	2197	1182	2854	1151	3516	581	WD repeat domain 69 (WDR69)
B07R17C11	7-11-17	Hs~MGC:BC067435.1~uORF:IOH62535	320	374	471	350	175	630	791	465	659	306	Cytochrome P450 2E1
B07R17C12	7-12-17	Hs~MGC:BC067435.1~uORF:IOH62535	345	380	455	356	197	737	785	482	1144	376	Cytochrome P450 2E1
B07R17C17	7-17-17	Hs~Ref:NM_003374.1~uORF:IOH7514	588	565	743	466	491	415	1039	609	2137	262	voltage-dependent anion channel 1 (VDAC1)
B07R17C18	7-18-17	Hs~Ref:NM_003374.1~uORF:IOH7514	619	545	1307	449	462	658	1288	625	2074	552	voltage-dependent anion channel 1 (VDAC1)
B07R17C19	7-19-17	Hs~Ref:NM_078470.1~uORF:IOH3663	829	703	1602	821	614	547	1561	671	1163	624	COX15 homolog, cytochrome c oxidase assembly protein (yeast) (COX15), nuclear gene encoding mitochondrial protein, transcript variant 1
B07R17C20	7-20-17	Hs~Ref:NM_078470.1~uORF:IOH3663	870	755	1108	619	652	428	971	762	2333	708	COX15 homolog, cytochrome c oxidase assembly protein (yeast) (COX15), nuclear gene encoding mitochondrial protein, transcript variant 1
B07R18C01	7-1-18	Hs~MGC:BC002755.1~N/A	3347	1271	2136	10800	1416	2522	2491	1292	5814	574	MAP kinase-interacting serine/threonine-protein kinase 1
B07R18C02	7-2-18	Hs~MGC:BC002755.1~N/A	3204	1218	2111	10815	1345	2595	2495	1228	5924	530	MAP kinase-interacting serine/threonine-protein kinase 1
B07R18C03	7-3-18	Hs~MGC:BC040558.1~uORF:IOH27718	531	328	515	296	299	580	767	476	575	140	dynein, cytoplasmic 2, light intermediate chain 1 (DYNC2LI1)
B07R18C04	7-4-18	Hs~MGC:BC040558.1~uORF:IOH27718	561	329	421	275	291	508	745	429	605	184	dynein, cytoplasmic 2, light intermediate chain 1 (DYNC2LI1)
B07R18C05	7-5-18	Hs~MGC:BC051687.1~uORF:IOH26538	2082	647	1952	490	1091	1207	4192	1102	1386	254	Kruppel-like factor 3 (basic) (KLF3)
B07R18C06	7-6-18	Hs~MGC:BC051687.1~uORF:IOH26538	2050	678	1947	529	1065	1404	4119	828	1380	264	Kruppel-like factor 3 (basic) (KLF3)
B07R18C07	7-7-18	Hs~MGC:BC047472.1~uORF:IOH26486	580	424	684	363	356	596	923	492	829	115	Olfactomedin-like protein 2B
B07R18C08	7-8-18	Hs~MGC:BC047472.1~uORF:IOH26486	551	442	658	367	358	586	914	509	771	178	Olfactomedin-like protein 2B
B07R18C09	7-9-18	Hs~Ref:NM_005191.2~uORF:IOH27312	537	333	548	343	287	557	724	462	689	149	CD80 molecule (CD80)
B07R18C10	7-10-18	Hs~Ref:NM_005191.2~uORF:IOH27312	505	361	817	354	229	521	751	543	601	123	CD80 molecule (CD80)
B07R18C13	7-13-18	Hs~Ref:NM_018154.2~uORF:IOH56957	929	1140	1057	1282	574	1098	1174	2521	2195	218	Histone chaperone ASF1B
B07R18C14	7-14-18	Hs~Ref:NM_018154.2~uORF:IOH56957	962	1206	1039	1172	493	1157	1149	2261	2165	298	Histone chaperone ASF1B
B07R18C19	7-19-18	Hs~Ref:NM_003656.3~N/A	398	342	885	349	607	412	529	408	780	131	Calcium/calmodulin-dependent protein kinase type 1
B07R18C20	7-20-18	Hs~Ref:NM_003656.3~N/A	414	357	824	259	595	284	507	431	722	150	Calcium/calmodulin-dependent protein kinase type 1
B07R18C21	7-21-18	Hs~Ref:NM_001274.2~N/A	1213	1038	1970	1014	1123	77	-3	9	-3	-2	CHK1 checkpoint homolog (S. pombe) (CHEK1)
B07R18C22	7-22-18	Hs~Ref:NM_001274.2~N/A	1189	1018	1826	990	1108	-9	8	-7	-4	-3	CHK1 checkpoint homolog (S. pombe) (CHEK1)
B07R19C01	7-1-19	Hs~Ref:NM_001715.1~N/A	947	742	970	644	751	1289	1636	846	2051	353	Tyrosine-protein kinase BLK
B07R19C02	7-2-19	Hs~Ref:NM_001715.1~N/A	959	678	1050	529	653	1140	1741	879	2319	328	Tyrosine-protein kinase BLK
B07R19C03	7-3-19	Hs~Ref:NM_032806.4~uORF:IOH29140	528	352	464	278	417	251	672	338	594	174	chromosome 3 open reading frame 39 (C3orf39)
B07R19C04	7-4-19	Hs~Ref:NM_032806.4~uORF:IOH29140	447	337	488	317	390	420	703	296	550	200	chromosome 3 open reading frame 39 (C3orf39)
B07R19C05	7-5-19	Hs~Ref:NM_145020.1~uORF:IOH22338	1208	1112	1911	1070	1439	1188	5738	2924	4126	1033	coiled-coil domain containing 11 (CCDC11)
B07R19C06	7-6-19	Hs~Ref:NM_145020.1~uORF:IOH22338	1201	1071	2023	1015	1234	1427	5577	3235	4180	1266	coiled-coil domain containing 11 (CCDC11)
B07R19C07	7-7-19	Hs~MGC:BC031606.1~uORF:IOH22809	734	620	1004	575	542	740	1384	853	2009	-37	peroxisomal biogenesis factor 7 (PEX7)
B07R19C08	7-8-19	Hs~MGC:BC031606.1~uORF:IOH22809	727	623	1017	677	545	649	1367	834	1951	447	peroxisomal biogenesis factor 7 (PEX7)
B07R19C09	7-9-19	Hs~MGC:BC030260.1~uORF:IOH21521	845	585	832	555	542	833	1114	930	2362	378	Trypsin-2
B07R19C10	7-10-19	Hs~MGC:BC030260.1~uORF:IOH21521	836	605	1234	515	560	873	1056	977	2238	375	Trypsin-2
B07R19C11	7-11-19	Hs~MGC:BC033871.1~uORF:IOH21866	704	574	891	564	586	915	1106	867	2823	461	tripartite motif-containing 74 (TRIM74)
B07R19C12	7-12-19	Hs~MGC:BC033871.1~uORF:IOH21866	700	627	880	546	593	973	1081	921	2501	466	tripartite motif-containing 74 (TRIM74)
B07R19C13	7-13-19	Hs~MGC:BC007766.1~uORF:IOH6455	635	557	952	487	444	775	1068	671	829	251	transmembrane channel-like 6 (TMC6)
B07R19C14	7-14-19	Hs~MGC:BC007766.1~uORF:IOH6455	651	559	470	459	421	441	1098	685	544	310	transmembrane channel-like 6 (TMC6)
B07R19C17	7-17-19	Hs~MGC:BC029562.1~uORF:IOH21575	1328	740	1094	601	565	772	1204	947	2137	407	Putative uncharacterized protein C8orf34
B07R19C18	7-18-19	Hs~MGC:BC029562.1~uORF:IOH21575	1275	749	1296	694	607	748	1231	1115	2064	376	Putative uncharacterized protein C8orf34
B07R19C19	7-19-19	Hs~MGC:NM_152717.1~uORF:IOH22811	796	629	952	611	515	898	1229	593	2011	271	hypothetical protein MGC35295 (MGC35295), transcript variant 2
B07R19C20	7-20-19	Hs~MGC:NM_152717.1~uORF:IOH22811	796	654	819	468	567	788	1247	657	1215	20	hypothetical protein MGC35295 (MGC35295), transcript variant 2
B07R19C21	7-21-19	Hs~Ref:NM_000486.2~uORF:IOH27325	625	700	858	501	452	629	1178	1106	1257	618	aquaporin 2 (collecting duct) (AQP2)
B07R19C22	7-22-19	Hs~Ref:NM_000486.2~uORF:IOH27325	674	668	861	556	427	1163	1211	1216	1280	576	aquaporin 2 (collecting duct) (AQP2)
B07R20C01	7-1-20	Hs~MGC:NM_182665.1~uORF:IOH25788	1079	1801	1110	1126	710	905	1647	1054	2252	378	Ras association (RalGDS/AF-6) domain family 5 (RASSF5), transcript variant 3
B07R20C02	7-2-20	Hs~MGC:NM_182665.1~uORF:IOH25788	1020	1785	1102	1009	688	1042	1575	1083	2233	335	Ras association (RalGDS/AF-6) domain family 5 (RASSF5), transcript variant 3
B07R20C03	7-3-20	Hs~MGC:BC037333.1~uORF:IOH27700	688	548	812	836	511	687	922	514	1743	272	guanine nucleotide binding protein (G protein), alpha z polypeptide (GNAZ)
B07R20C04	7-4-20	Hs~MGC:BC037333.1~uORF:IOH27700	618	506	807	821	437	566	919	553	1579	312	guanine nucleotide binding protein (G protein), alpha z polypeptide (GNAZ)
B07R20C05	7-5-20	Hs~MGC:NM_198081.1~uORF:IOH25820	1116	2902	1165	716	1851	91	-11	1	-2	-4	sex comb on midleg-like 4 (Drosophila) (SCML4)
B07R20C06	7-6-20	Hs~MGC:NM_198081.1~uORF:IOH25820	1082	2875	1096	723	1902	68	-8	0	0	-1	sex comb on midleg-like 4 (Drosophila) (SCML4)
B07R20C07	7-7-20	Hs~Ref:NM_032182.2~uORF:IOH10212	1234	375	642	403	326	472	642	789	647	90	KIAA0157 (KIAA0157)
B07R20C08	7-8-20	Hs~Ref:NM_032182.2~uORF:IOH10212	1238	367	754	562	159	447	621	661	714	69	KIAA0157 (KIAA0157)
B07R20C09	7-9-20	Hs~MGC:BC020577.1~uORF:IOH21439	582	319	489	624	349	618	658	417	870	276	carbonic anhydrase X (CA10)
B07R20C10	7-10-20	Hs~MGC:BC020577.1~uORF:IOH21439	561	372	491	503	348	585	654	461	685	22	carbonic anhydrase X (CA10)
B07R20C11	7-11-20	Hs~MGC:BC003656.1~uORF:IOH27778	591	434	1021	415	446	589	931	483	918	23	minichromosome maintenance complex component 5 (MCM5)
B07R20C12	7-12-20	Hs~MGC:BC003656.1~uORF:IOH27778	526	422	2087	363	400	647	866	520	925	153	minichromosome maintenance complex component 5 (MCM5)
B07R20C13	7-13-20	Hs~MGC:BC053602.1~uORF:IOH28986	305	900	2040	401	470	492	431	495	861	126	chromosome 15 open reading frame 38 (C15orf38)
B07R20C14	7-14-20	Hs~MGC:BC053602.1~uORF:IOH28986	301	907	2155	309	442	427	404	520	849	13	chromosome 15 open reading frame 38 (C15orf38)
B08R02C11	8-11-2	Hs~MGC:BC032589.1~uORF:IOH21955	1667	1215	1866	1122	1104	1252	2872	1152	3703	631	Beta-2-microglobulin
B08R02C12	8-12-2	Hs~MGC:BC032589.1~uORF:IOH21955	1695	1286	1928	1206	1188	1332	2855	1174	4065	398	Beta-2-microglobulin
B08R02C13	8-13-2	Hs~MGC:BC026296.1~uORF:IOH14813	2294	1048	1641	981	1108	3895	1289	2272	3717	547	Pantothenate kinase 1
B08R02C14	8-14-2	Hs~MGC:BC026296.1~uORF:IOH14813	2434	1028	1612	891	1931	3671	1299	2274	3706	398	Pantothenate kinase 1
B08R02C15	8-15-2	Hs~Ref:NM_021034.1~uORF:IOH58755	1221	1038	1504	886	1004	943	1418	1103	3281	724	Interferon-induced transmembrane protein 3
B08R02C16	8-16-2	Hs~Ref:NM_021034.1~uORF:IOH58755	1264	1169	1527	905	919	52	1490	1127	2731	505	Interferon-induced transmembrane protein 3
B08R02C17	8-17-2	Hs~Ref:NM_006334.2~uORF:IOH58962	4242	1209	1701	878	3777	-26	2524	997	2956	447	Noelin
B08R02C18	8-18-2	Hs~Ref:NM_006334.2~uORF:IOH58962	4390	1133	1791	923	1545	142	2409	1056	3333	-20	Noelin
B08R02C19	8-19-2	Hs~MGC:BC006969.1~uORF:IOH7343	5106	730	1580	1141	3460	916	1154	1300	2023	252	dynein, cytoplasmic 2, light intermediate chain 1, mRNA (cDNA clone MGC:12166 IMAGE:3828551), complete cds
B08R02C20	8-20-2	Hs~MGC:BC006969.1~uORF:IOH7343	5267	721	1671	1092	3665	899	1153	1284	1992	267	dynein, cytoplasmic 2, light intermediate chain 1, mRNA (cDNA clone MGC:12166 IMAGE:3828551), complete cds
B08R02C21	8-21-2	Hs~MGC:BC011498.1~uORF:IOH9619	1536	1072	2004	1161	2190	-102	1407	1199	3671	627	Histone deacetylase 6
B08R02C22	8-22-2	Hs~MGC:BC011498.1~uORF:IOH9619	1616	1125	1955	1218	1970	-570	1415	1158	3601	528	Histone deacetylase 6
B08R03C01	8-1-3	Hs~Ref:NM_004202.1~uORF:IOH11127	1503	1194	2366	1035	1569	2015	1962	3023	4428	30	Thymosin beta-4, Y-chromosomal
B08R03C02	8-2-3	Hs~Ref:NM_004202.1~uORF:IOH11127	1398	1261	2446	1057	1455	1953	1970	3017	4381	-24	Thymosin beta-4, Y-chromosomal
B08R03C03	8-3-3	Hs~Ref:NM_016371.1~uORF:IOH7352	1340	1013	1557	931	1189	1254	1437	1086	2802	616	3-keto-steroid reductase
B08R03C04	8-4-3	Hs~Ref:NM_016371.1~uORF:IOH7352	1323	989	1568	915	1136	1306	1629	1155	3366	311	3-keto-steroid reductase
B08R03C05	8-5-3	Hs~Ref:NM_000961.3~uORF:IOH37838	234	321	753	272	229	200	420	323	32	23	prostaglandin I2 (prostacyclin) synthase (PTGIS)
B08R03C06	8-6-3	Hs~Ref:NM_000961.3~uORF:IOH37838	388	289	2693	289	253	-3	329	338	79	24	prostaglandin I2 (prostacyclin) synthase (PTGIS)
B08R03C07	8-7-3	Hs~Ref:NM_194318.2~uORF:IOH37836	398	602	556	348	350	281	524	452	659	65	beta 1,3-galactosyltransferase-like (B3GALTL)
B08R03C08	8-8-3	Hs~Ref:NM_194318.2~uORF:IOH37836	529	638	2727	366	356	266	525	401	607	1	beta 1,3-galactosyltransferase-like (B3GALTL)
B08R03C09	8-9-3	Hs~Ref:NM_153289.2~uORF:IOH40759	717	385	326	340	261	10	366	331	333	45	defensin, beta 119 (DEFB119), transcript variant 1
B08R03C10	8-10-3	Hs~Ref:NM_153289.2~uORF:IOH40759	731	397	728	338	266	-5	359	316	31	12	defensin, beta 119 (DEFB119), transcript variant 1
B08R03C11	8-11-3	Hs~Ref:NM_199054.1~uORF:IOH37765	800	660	710	586	520	527	1327	473	3840	123	MAP kinase interacting serine/threonine kinase 2 (MKNK2), transcript variant 2
B08R03C12	8-12-3	Hs~Ref:NM_199054.1~uORF:IOH37765	853	680	832	603	474	563	1355	446	3195	-11	MAP kinase interacting serine/threonine kinase 2 (MKNK2), transcript variant 2
B08R03C13	8-13-3	Hs~Ref:NM_001985.2~uORF:IOH40972	693	478	862	605	2177	474	1645	891	-100	37	electron-transfer-flavoprotein, beta polypeptide (ETFB), transcript variant 1
B08R03C14	8-14-3	Hs~Ref:NM_001985.2~uORF:IOH40972	660	477	738	535	2123	-109	1575	870	-50	93	electron-transfer-flavoprotein, beta polypeptide (ETFB), transcript variant 1
B08R03C15	8-15-3	Hs~Ref:NM_022908.1~uORF:IOH44482	28	38	292	155	476	4	62	128	-3	5	5'-nucleotidase domain containing 2 (NT5DC2)
B08R03C16	8-16-3	Hs~Ref:NM_022908.1~uORF:IOH44482	35	46	157	121	17	42	106	145	2	0	5'-nucleotidase domain containing 2 (NT5DC2)
B08R03C17	8-17-3	Hs~Ref:NM_145311.1~uORF:IOH41041	338	456	533	327	214	302	443	410	-7	19	crystallin, zeta (quinone reductase)-like 1 (CRYZL1), transcript variant 2
B08R03C18	8-18-3	Hs~Ref:NM_145311.1~uORF:IOH41041	338	429	599	331	3164	33	405	431	2	-25	crystallin, zeta (quinone reductase)-like 1 (CRYZL1), transcript variant 2
B08R03C19	8-19-3	Hs~Ref:NM_145865.1~uORF:IOH35802	1456	487	2254	724	1441	528	889	1281	-32	227	ankyrin repeat and sterile alpha motif domain containing 4B (ANKS4B)
B08R03C20	8-20-3	Hs~Ref:NM_145865.1~uORF:IOH35802	1497	585	2296	731	1249	420	948	1247	-1139	-14	ankyrin repeat and sterile alpha motif domain containing 4B (ANKS4B)
B08R03C21	8-21-3	Hs~MGC:BC029760.1~uORF:IOH22119	2928	1235	1622	2856	1942	198	7304	1263	4457	274	OTU domain containing 6B (OTUD6B)
B08R03C22	8-22-3	Hs~MGC:BC029760.1~uORF:IOH22119	2685	1250	1557	2933	1174	1364	6887	1289	4040	-123	OTU domain containing 6B (OTUD6B)
B08R04C01	8-1-4	Hs~MGC:BC000026.1~uORF:IOH4716	454	387	731	337	170	670	670	451	582	151	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) (AGPAT2)
B08R04C02	8-2-4	Hs~MGC:BC000026.1~uORF:IOH4716	405	386	716	297	298	750	609	460	851	143	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) (AGPAT2)
B08R04C03	8-3-4	Hs~MGC:NM_174923.1~uORF:IOH14835	647	418	556	611	742	731	844	480	782	-25	coiled-coil domain containing 107 (CCDC107)
B08R04C04	8-4-4	Hs~MGC:NM_174923.1~uORF:IOH14835	520	382	535	630	746	616	821	435	806	3541	coiled-coil domain containing 107 (CCDC107)
B08R04C05	8-5-4	Hs~Ref:NM_139242.1~uORF:IOH21859	1272	501	806	405	328	358	1045	765	399	152	mitochondrial methionyl-tRNA formyltransferase (MTFMT)
B08R04C06	8-6-4	Hs~Ref:NM_139242.1~uORF:IOH21859	1491	477	1060	457	374	3	980	869	-12	33	mitochondrial methionyl-tRNA formyltransferase (MTFMT)
B08R04C07	8-7-4	Hs~Ref:NM_018279.2~uORF:IOH10199	455	420	778	244	272	-12	571	467	472	117	transmembrane protein 19 (TMEM19)
B08R04C08	8-8-4	Hs~Ref:NM_018279.2~uORF:IOH10199	417	412	1291	189	312	135	546	542	435	231	transmembrane protein 19 (TMEM19)
B08R04C09	8-9-4	Hs~MGC:BC010240.1~uORF:IOH10210	426	372	929	330	321	398	593	495	20	167	cathepsin B (CTSB)
B08R04C10	8-10-4	Hs~MGC:BC010240.1~uORF:IOH10210	423	394	833	322	349	-18	620	487	506	-8	cathepsin B (CTSB)
B08R04C11	8-11-4	Hs~Ref:NM_058169.1~uORF:IOH10242	912	535	1057	485	401	87	714	748	457	-16	loss of heterozygosity, 12, chromosomal region 1 (LOH12CR1)
B08R04C12	8-12-4	Hs~Ref:NM_058169.1~uORF:IOH10242	831	512	1116	532	458	24	677	655	160	571	loss of heterozygosity, 12, chromosomal region 1 (LOH12CR1)
B08R04C13	8-13-4	Hs~Ref:NM_006054.1~uORF:IOH10268	494	508	817	526	2027	546	781	659	1152	214	reticulon 3 (RTN3), transcript variant 1
B08R04C14	8-14-4	Hs~Ref:NM_006054.1~uORF:IOH10268	453	485	890	454	936	550	786	638	942	-17	reticulon 3 (RTN3), transcript variant 1
B08R04C15	8-15-4	Hs~Ref:NM_181349.1~uORF:IOH38225	1316	788	1320	956	1494	-26	1973	813	1737	5	SMAD specific E3 ubiquitin protein ligase 1 (SMURF1), transcript variant 2
B08R04C16	8-16-4	Hs~Ref:NM_181349.1~uORF:IOH38225	1371	778	1279	1076	1674	979	1972	786	1088	333	SMAD specific E3 ubiquitin protein ligase 1 (SMURF1), transcript variant 2
B08R04C17	8-17-4	Hs~Ref:NM_006403.2~uORF:IOH27637	1461	1271	1829	1771	1204	3135	1785	1376	1017	457	neural precursor cell expressed, developmentally down-regulated 9 (NEDD9), transcript variant 1
B08R04C18	8-18-4	Hs~Ref:NM_006403.2~uORF:IOH27637	1685	1425	1813	1659	1113	3142	1862	1440	664	185	neural precursor cell expressed, developmentally down-regulated 9 (NEDD9), transcript variant 1
B08R04C19	8-19-4	Hs~Ref:NM_152716.1~uORF:IOH38079	13545	14431	10391	14705	18806	9100	8326	7716	13398	8758	FLJ36874 protein (FLJ36874)
B08R04C20	8-20-4	Hs~Ref:NM_152716.1~uORF:IOH38079	14320	14426	10462	15600	24633	7153	8315	8121	13127	7572	FLJ36874 protein (FLJ36874)
B08R04C21	8-21-4	Hs~Ref:NM_005338.4~uORF:IOH38605	1394	1969	1176	3018	4268	2938	8333	1045	6265	485	huntingtin interacting protein 1 (HIP1)
B08R04C22	8-22-4	Hs~Ref:NM_005338.4~uORF:IOH38605	1428	2014	1207	3096	1946	2948	8317	1036	2634	405	huntingtin interacting protein 1 (HIP1)
B08R05C01	8-1-5	Hs~Ref:NM_015833.1~uORF:IOH38242	4298	1670	2792	1566	1341	2090	13847	1685	3419	661	adenosine deaminase, RNA-specific, B1 (RED1 homolog rat) (ADARB1), transcript variant 2
B08R05C02	8-2-5	Hs~Ref:NM_015833.1~uORF:IOH38242	3904	1744	2730	1559	1278	2206	12852	1726	3362	672	adenosine deaminase, RNA-specific, B1 (RED1 homolog rat) (ADARB1), transcript variant 2
B08R05C03	8-3-5	Hs~Ref:NM_178425.1~uORF:IOH38634	3803	2523	2242	1333	1243	1814	4063	1589	2150	2451	histone deacetylase 9 (HDAC9), transcript variant 5
B08R05C04	8-4-5	Hs~Ref:NM_178425.1~uORF:IOH38634	5057	2969	2292	1216	1197	1741	4057	1717	2281	2328	histone deacetylase 9 (HDAC9), transcript variant 5
B08R05C05	8-5-5	Hs~Ref:NM_001883.2~uORF:IOH29569	912	432	752	365	292	121	930	363	825	6	corticotropin releasing hormone receptor 2 (CRHR2)
B08R05C06	8-6-5	Hs~Ref:NM_001883.2~uORF:IOH29569	705	476	871	411	316	-16	1118	488	850	115	corticotropin releasing hormone receptor 2 (CRHR2)
B08R05C07	8-7-5	Hs~Ref:NM_000697.1~uORF:IOH38131	548	579	456	110	381	134	859	590	409	196	arachidonate 12-lipoxygenase (ALOX12)
B08R05C08	8-8-5	Hs~Ref:NM_000697.1~uORF:IOH38131	513	568	509	65	305	2	982	642	467	156	arachidonate 12-lipoxygenase (ALOX12)
B08R05C09	8-9-5	Hs~Ref:NM_004071.1~N/A	1229	854	1306	648	576	25	1483	778	1522	350	Dual specificity protein kinase CLK1
B08R05C10	8-10-5	Hs~Ref:NM_004071.1~N/A	1260	865	1467	641	642	868	1501	809	1458	312	Dual specificity protein kinase CLK1
B08R05C11	8-11-5	Hs~Ref:NM_002344.1~N/A	718	2794	1121	503	532	12	968	568	773	202	Leukocyte tyrosine kinase receptor
B08R05C12	8-12-5	Hs~Ref:NM_002344.1~N/A	746	627	1157	538	350	-20	977	537	807	51	Leukocyte tyrosine kinase receptor
B08R05C13	8-13-5	Hs~Ref:NM_002748.2~N/A	1422	1210	2214	765	4064	1356	1302	1875	7921	415	mitogen-activated protein kinase 6 (MAPK6)
B08R05C14	8-14-5	Hs~Ref:NM_002748.2~N/A	1414	1199	2188	749	2012	1423	1309	1897	7630	432	mitogen-activated protein kinase 6 (MAPK6)
B08R05C15	8-15-5	Hs~Ref:NM_004431.1~N/A	872	833	1220	663	738	-26	2771	600	907	291	Ephrin type-A receptor 2
B08R05C16	8-16-5	Hs~Ref:NM_004431.1~N/A	929	924	1211	711	665	38	2660	568	767	-41	Ephrin type-A receptor 2
B08R05C17	8-17-5	Hs~Ref:NM_003691.1~N/A	1548	1429	3143	1011	1713	1674	1729	1080	4754	-6	Serine/threonine-protein kinase 16
B08R05C18	8-18-5	Hs~Ref:NM_003691.1~N/A	1568	1440	3190	1016	2112	1656	1727	1080	4839	464	Serine/threonine-protein kinase 16
B08R05C19	8-19-5	Hs~Ref:NM_006257.1~N/A	1032	956	1486	616	933	329	1401	781	979	196	Protein kinase C theta type
B08R05C20	8-20-5	Hs~Ref:NM_006257.1~N/A	1045	667	1361	640	1007	253	1391	795	348	416	Protein kinase C theta type
B08R05C21	8-21-5	Hs~Ref:NM_012395.1~N/A	999	942	1835	974	622	-55	1361	724	1482	-67	Serine/threonine-protein kinase PFTAIRE-1
B08R05C22	8-22-5	Hs~Ref:NM_012395.1~N/A	991	1022	1815	991	4067	8	1427	692	1662	191	Serine/threonine-protein kinase PFTAIRE-1
B08R06C03	8-3-6	Hs~Ref:NM_002053.1~uORF:IOH5246	1586	935	1306	970	1187	1639	1801	1044	2026	580	guanylate binding protein 1, interferon-inducible, 67kDa (GBP1)
B08R06C04	8-4-6	Hs~Ref:NM_002053.1~uORF:IOH5246	1851	971	1334	891	1160	1658	1747	1088	2347	702	guanylate binding protein 1, interferon-inducible, 67kDa (GBP1)
B08R06C05	8-5-6	Hs~MGC:BC033689.1~uORF:IOH21871	2920	1733	2815	1516	1164	3105	2726	1690	4202	1627	MARVEL domain containing 2 (MARVELD2)
B08R06C06	8-6-6	Hs~MGC:BC033689.1~uORF:IOH21871	2818	1774	2913	1559	1266	3726	3042	1646	4110	1504	MARVEL domain containing 2 (MARVELD2)
B08R06C07	8-7-6	Hs~MGC:BC036910.1~uORF:IOH25910	2091	2286	1875	1417	1467	1981	3252	1388	3529	1369	hypothetical LOC388882 (LOC388882)
B08R06C08	8-8-6	Hs~MGC:BC036910.1~uORF:IOH25910	2087	2268	1866	1415	1477	1967	3548	1435	3469	1338	hypothetical LOC388882 (LOC388882)
B08R06C09	8-9-6	Hs~Ref:NM_031452.1~uORF:IOH3904	735	804	1075	644	564	1724	812	552	1324	440	family with sequence similarity 103, member A1 (FAM103A1)
B08R06C10	8-10-6	Hs~Ref:NM_031452.1~uORF:IOH3904	816	809	1163	698	596	1752	862	568	1405	-2	family with sequence similarity 103, member A1 (FAM103A1)
B08R06C11	8-11-6	Hs~MGC:BC010458.1~uORF:IOH9663	1480	1419	14625	1295	1244	2037	2386	1361	3851	1016	NDRG family member 2 (NDRG2)
B08R06C12	8-12-6	Hs~MGC:BC010458.1~uORF:IOH9663	1522	1312	13914	1346	1300	2194	2249	1381	3708	1040	NDRG family member 2 (NDRG2)
B08R06C13	8-13-6	Hs~MGC:BC025407.1~uORF:IOH11128	1594	1290	1910	1108	1275	2082	2651	1111	2595	6	layilin (LAYN)
B08R06C14	8-14-6	Hs~MGC:BC025407.1~uORF:IOH11128	1700	1195	1938	997	5192	1846	2602	1123	3166	1065	layilin (LAYN)
B08R06C15	8-15-6	Hs~MGC:BC029652.1~uORF:IOH22862	1775	1558	2233	1297	2550	2472	2913	1861	4209	1126	allantoicase (ALLC)
B08R06C16	8-16-6	Hs~MGC:BC029652.1~uORF:IOH22862	1773	1620	2303	1328	1935	2217	3147	1811	3374	1334	allantoicase (ALLC)
B08R06C17	8-17-6	Hs~MGC:BC029566.1~uORF:IOH21579	3459	1727	2469	3099	1882	3602	3664	1591	4335	1094	Doublesex- and mab-3-related transcription factor B1
B08R06C18	8-18-6	Hs~MGC:BC029566.1~uORF:IOH21579	3446	1745	2551	3030	1782	3659	3539	1612	4394	1017	Doublesex- and mab-3-related transcription factor B1
B08R06C19	8-19-6	Hs~MGC:BC040020.2~uORF:IOH26263	9359	8686	7852	5434	8525	7010	15248	3105	4593	5271	zinc finger protein 280B (SUHW2)
B08R06C20	8-20-6	Hs~MGC:BC040020.2~uORF:IOH26263	8110	8761	7453	5249	7630	5039	15388	3055	4868	4768	zinc finger protein 280B (SUHW2)
B08R06C21	8-21-6	Hs~MGC:BC014924.1~uORF:IOH25747	3200	2061	3124	3910	1872	2804	2780	2713	2863	1850	kinesin family member 2C (KIF2C)
B08R06C22	8-22-6	Hs~MGC:BC014924.1~uORF:IOH25747	3160	2094	3140	4099	1818	3187	2798	2536	2961	2051	kinesin family member 2C (KIF2C)
B08R07C01	8-1-7	Hs~MGC:BC038113.1~uORF:IOH26873	759	470	895	689	628	559	2895	1124	183	212	C-Maf-inducing protein
B08R07C02	8-2-7	Hs~MGC:BC038113.1~uORF:IOH26873	750	502	876	674	616	521	3036	1029	712	176	C-Maf-inducing protein
B08R07C03	8-3-7	Hs~MGC:BC006354.1~uORF:IOH6429	600	928	811	2023	704	1062	993	844	836	460	Coenzyme A synthase (COASY)
B08R07C04	8-4-7	Hs~MGC:BC006354.1~uORF:IOH6429	585	869	816	2001	716	941	910	843	-174	500	Coenzyme A synthase (COASY)
B08R07C05	8-5-7	Hs~Ref:NM_052820.1~uORF:IOH4591	4556	3043	6409	4943	2608	4289	2661	3576	5798	2238	Coronin-2A
B08R07C06	8-6-7	Hs~Ref:NM_052820.1~uORF:IOH4591	4422	3638	6749	4482	2494	4836	2463	3361	6319	2036	Coronin-2A
B08R07C07	8-7-7	Hs~Ref:NM_145914.2~uORF:IOH26562	1727	1855	1222	1763	1383	1040	2264	742	2309	1087	zinc finger and SCAN domain containing 21 (ZSCAN21)
B08R07C08	8-8-7	Hs~Ref:NM_145914.2~uORF:IOH26562	1774	1819	1145	1735	1398	1211	2193	742	2344	1108	zinc finger and SCAN domain containing 21 (ZSCAN21)
B08R07C09	8-9-7	Hs~MGC:BC020616.1~uORF:IOH27932	461	650	801	356	351	624	732	466	9	157	cytochrome P450, family 20, subfamily A, polypeptide 1 (CYP20A1)
B08R07C10	8-10-7	Hs~MGC:BC020616.1~uORF:IOH27932	453	648	969	378	429	163	753	418	-16	100	cytochrome P450, family 20, subfamily A, polypeptide 1 (CYP20A1)
B08R07C11	8-11-7	Hs~MGC:BC005008.1~uORF:IOH5603	681	579	910	481	454	-1	755	500	10	-27	carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) (CEACAM6)
B08R07C12	8-12-7	Hs~MGC:BC005008.1~uORF:IOH5603	786	543	860	509	278	-9	746	476	59	-22	carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) (CEACAM6)
B08R07C13	8-13-7	Hs~Ref:NM_003897.2~uORF:IOH6603	1636	707	2485	688	436	-73	2689	736	670	37	immediate early response 3 (IER3)
B08R07C14	8-14-7	Hs~Ref:NM_003897.2~uORF:IOH6603	1825	708	2344	655	573	787	2664	744	766	177	immediate early response 3 (IER3)
B08R07C15	8-15-7	Hs~Ref:NM_000199.2~uORF:IOH26596	297	210	700	317	2221	30	535	393	186	4	N-sulfoglucosamine sulfohydrolase (sulfamidase) (SGSH)
B08R07C16	8-16-7	Hs~Ref:NM_000199.2~uORF:IOH26596	367	316	396	403	211	275	634	353	202	-8	N-sulfoglucosamine sulfohydrolase (sulfamidase) (SGSH)
B08R07C17	8-17-7	Hs~Ref:NM_033307.1~uORF:IOH45758	332	137	315	415	172	259	782	405	207	108	Caspase-4
B08R07C18	8-18-7	Hs~Ref:NM_033307.1~uORF:IOH45758	323	186	665	399	351	293	714	472	283	62	Caspase-4
B08R07C19	8-19-7	Hs~MGC:BC035970.1~uORF:IOH27975	179	176	252	255	375	1130	386	193	142	8	cell death-inducing DFFA-like effector b (CIDEB)
B08R07C20	8-20-7	Hs~MGC:BC035970.1~uORF:IOH27975	165	116	279	238	181	27	403	175	161	30	cell death-inducing DFFA-like effector b (CIDEB)
B08R07C21	8-21-7	Hs~Ref:NM_004850.2~N/A	1215	919	1551	875	628	201	11	-15	976	133	Rho-associated protein kinase 2
B08R07C22	8-22-7	Hs~Ref:NM_004850.2~N/A	1151	890	1404	841	642	-8	-14	365	1	131	Rho-associated protein kinase 2
B08R08C01	8-1-8	Hs~Ref:NM_000208.1~N/A	923	613	981	673	550	774	1016	868	1894	396	Insulin receptor
B08R08C02	8-2-8	Hs~Ref:NM_000208.1~N/A	903	600	998	1104	607	1016	1154	675	855	377	Insulin receptor
B08R08C03	8-3-8	Hs~Ref:NM_004445.1~N/A	1203	1014	1227	1356	585	1177	1491	898	1850	713	Ephrin type-B receptor 6
B08R08C04	8-4-8	Hs~Ref:NM_004445.1~N/A	1374	1101	1293	630	589	1164	1535	837	2127	716	Ephrin type-B receptor 6
B08R08C07	8-7-8	Hs~Ref:NM_003146.2~uORF:IOH4845	839	837	2286	722	1242	256	3162	861	2561	455	structure specific recognition protein 1 (SSRP1)
B08R08C08	8-8-8	Hs~Ref:NM_003146.2~uORF:IOH4845	808	832	2219	743	1309	1263	3137	827	2759	518	structure specific recognition protein 1 (SSRP1)
B08R08C09	8-9-8	Hs~MGC:BC034937.1~uORF:IOH23263	685	606	1011	550	492	25	933	603	-170	17	chromosome 10 open reading frame 64 (C10orf64)
B08R08C10	8-10-8	Hs~MGC:BC034937.1~uORF:IOH23263	675	619	1289	599	651	81	1034	602	-60	-15	chromosome 10 open reading frame 64 (C10orf64)
B08R08C11	8-11-8	Hs~MGC:BC003666.2~uORF:IOH6106	1055	772	1215	1263	822	891	1943	590	1753	367	NAD synthetase 1 (NADSYN1)
B08R08C12	8-12-8	Hs~MGC:BC003666.2~uORF:IOH6106	1135	788	1146	1347	972	808	1931	678	1431	341	NAD synthetase 1 (NADSYN1)
B08R08C13	8-13-8	Hs~MGC:BC033195.1~uORF:IOH23247	225	2800	4823	278	489	2238	4222	2374	1350	141	killer cell immunoglobulin-like receptor, three domains, X1 (KIR3DX1)
B08R08C14	8-14-8	Hs~MGC:BC033195.1~uORF:IOH23247	623	2773	4905	265	603	2271	4196	2238	-539	143	killer cell immunoglobulin-like receptor, three domains, X1 (KIR3DX1)
B08R08C15	8-15-8	Hs~Ref:NM_003808.2~uORF:IOH43552	1564	1397	1978	1097	617	4313	2870	1072	143	30	Tumor necrosis factor ligand superfamily member 13
B08R08C16	8-16-8	Hs~Ref:NM_003808.2~uORF:IOH43552	1554	1391	2114	1418	957	169	2828	1092	3	532	Tumor necrosis factor ligand superfamily member 13
B08R08C17	8-17-8	Hs~MGC:BC033677.1~uORF:IOH40219	3592	1697	2751	1826	1243	2337	14912	1634	-248	988	Uncharacterized protein C9orf114
B08R08C18	8-18-8	Hs~MGC:BC033677.1~uORF:IOH40219	3644	1727	2733	1738	1424	1684	15005	1688	-106	811	Uncharacterized protein C9orf114
B08R09C01	8-1-9	Hs~Ref:NM_001007072.1~uORF:IOH59911	509	287	385	112	663	182	274	356	630	297	Zinc finger and SCAN domain-containing protein 2
B08R09C02	8-2-9	Hs~Ref:NM_001007072.1~uORF:IOH59911	480	249	428	120	716	162	196	665	562	352	Zinc finger and SCAN domain-containing protein 2
B08R09C03	8-3-9	Hs~Ref:NM_033377.1~uORF:IOH58752	12529	23644	6644	24225	14851	10139	10140	19595	25577	15653	chorionic gonadotropin, beta polypeptide 1  [Source:RefSeq peptide;Acc:NP_203695]
B08R09C04	8-4-9	Hs~Ref:NM_033377.1~uORF:IOH58752	13727	22772	6525	20567	15491	10315	10085	20508	21358	16281	chorionic gonadotropin, beta polypeptide 1  [Source:RefSeq peptide;Acc:NP_203695]
B08R09C05	8-5-9	Hs~Ref:NM_181838.1~uORF:IOH58950	1019	470	997	409	575	634	775	520	918	254	Ubiquitin-conjugating enzyme E2 D2
B08R09C06	8-6-9	Hs~Ref:NM_181838.1~uORF:IOH58950	1019	551	1013	429	565	578	795	541	827	254	Ubiquitin-conjugating enzyme E2 D2
B08R09C07	8-7-9	Hs~Ref:NM_139274.1~uORF:IOH52437	821	710	969	2091	888	1853	1732	918	1613	273	Acetyl-coenzyme A synthetase, cytoplasmic
B08R09C08	8-8-9	Hs~Ref:NM_139274.1~uORF:IOH52437	803	714	1016	2101	945	1861	1750	966	1643	220	Acetyl-coenzyme A synthetase, cytoplasmic
B08R09C09	8-9-9	Hs~Ref:NM_022445.2~uORF:IOH53866	402	645	639	511	72	746	1215	1569	2317	242	Thiamin pyrophosphokinase 1
B08R09C10	8-10-9	Hs~Ref:NM_022445.2~uORF:IOH53866	450	637	727	486	216	717	1261	1586	2390	-72	Thiamin pyrophosphokinase 1
B08R09C11	8-11-9	Hs~Ref:NM_014972.1~uORF:IOH55892	2076	791	1970	5587	936	1232	2891	712	2757	515	Transcription factor 25
B08R09C12	8-12-9	Hs~Ref:NM_014972.1~uORF:IOH55892	1997	789	1880	5637	1014	1139	2752	709	2821	578	Transcription factor 25
B08R09C13	8-13-9	Hs~Ref:NM_005335.3~uORF:IOH57089	1606	9250	3328	6506	10893	957	4977	481	11694	869	Hematopoietic lineage cell-specific protein
B08R09C14	8-14-9	Hs~Ref:NM_005335.3~uORF:IOH57089	1663	9370	3372	6530	10529	-35	4921	464	11693	884	Hematopoietic lineage cell-specific protein
B08R09C15	8-15-9	Hs~Ref:NM_001011700.1~uORF:IOH54583	974	652	1506	624	1749	1310	6546	1057	1166	377	Mitochondrial coiled-coil domain protein 1
B08R09C16	8-16-9	Hs~Ref:NM_001011700.1~uORF:IOH54583	964	701	1521	681	1617	1317	6329	1048	2990	427	Mitochondrial coiled-coil domain protein 1
B08R09C17	8-17-9	Hs~MGC:BC028424.1~uORF:IOH11463	404	250	719	398	221	92	581	377	-12	-19	E3 ubiquitin-protein ligase rififylin
B08R09C18	8-18-9	Hs~MGC:BC028424.1~uORF:IOH11463	320	274	732	355	1459	199	636	370	80	-15	E3 ubiquitin-protein ligase rififylin
B08R09C19	8-19-9	Hs~Ref:NM_032693.1~uORF:IOH6370	7202	553	902	360	924	1061	651	939	1287	144	N-terminal acetyltransferase complex ARD1 subunit homolog B
B08R09C20	8-20-9	Hs~Ref:NM_032693.1~uORF:IOH6370	7191	568	710	347	735	115	659	970	-17	142	N-terminal acetyltransferase complex ARD1 subunit homolog B
B08R09C21	8-21-9	Hs~Ref:NM_004596.1~uORF:IOH6628	11572	3231	3958	4853	1953	2138	6877	3046	2035	2839	small nuclear ribonucleoprotein polypeptide A (SNRPA)
B08R09C22	8-22-9	Hs~Ref:NM_004596.1~uORF:IOH6628	11016	3104	3797	4900	1856	3940	6481	2823	-269	2214	small nuclear ribonucleoprotein polypeptide A (SNRPA)
B08R10C01	8-1-10	Hs~MGC:BC007242.1~uORF:IOH6808	791	782	1694	1243	1012	1342	3515	1361	1853	457	ets variant gene 4 (E1A enhancer binding protein, E1AF) (ETV4)
B08R10C02	8-2-10	Hs~MGC:BC007242.1~uORF:IOH6808	759	867	1663	1324	997	1281	3276	1418	1563	482	ets variant gene 4 (E1A enhancer binding protein, E1AF) (ETV4)
B08R10C03	8-3-10	Hs~Ref:NM_024316.1~uORF:IOH12150	50035	45054	26013	65209	42459	28493	28749	54458	28058	44468	leukocyte receptor cluster (LRC) member 1 (LENG1)
B08R10C04	8-4-10	Hs~Ref:NM_024316.1~uORF:IOH12150	49437	45998	25320	65476	46507	28297	30126	54948	25968	45725	leukocyte receptor cluster (LRC) member 1 (LENG1)
B08R10C05	8-5-10	Hs~MGC:BC007862.2~uORF:IOH6770	802	788	1556	525	849	1039	1182	910	1555	436	G protein-coupled receptor 108 (GPR108)
B08R10C06	8-6-10	Hs~MGC:BC007862.2~uORF:IOH6770	710	813	1553	535	885	1090	1117	895	1771	563	G protein-coupled receptor 108 (GPR108)
B08R10C07	8-7-10	Hs~Ref:NM_016485.3~uORF:IOH7511	1206	894	2178	4447	1286	1821	3842	812	1755	489	Vps20-associated 1 homolog (S. cerevisiae) (VTA1)
B08R10C08	8-8-10	Hs~Ref:NM_016485.3~uORF:IOH7511	1236	901	1969	4416	1228	1494	3887	775	1678	460	Vps20-associated 1 homolog (S. cerevisiae) (VTA1)
B08R10C09	8-9-10	Hs~Ref:NM_006406.1~uORF:IOH7551	846	871	1223	653	760	199	1294	847	1710	465	peroxiredoxin 4 (PRDX4)
B08R10C10	8-10-10	Hs~Ref:NM_006406.1~uORF:IOH7551	916	970	1385	668	812	783	1399	793	1726	21	peroxiredoxin 4 (PRDX4)
B08R11C21	8-21-11	Hs~Ref:NM_017444.2~uORF:IOH10035	779	615	1265	514	1012	609	1407	517	1412	209	chromatin accessibility complex 1 (CHRAC1)
B08R11C22	8-22-11	Hs~Ref:NM_017444.2~uORF:IOH10035	893	797	630	635	662	618	1341	522	1194	57	chromatin accessibility complex 1 (CHRAC1)
B08R12C01	8-1-12	Hs~Ref:NM_003420.2~uORF:IOH9658	2958	863	1479	853	1249	951	2275	1095	1797	524	zinc finger protein 35 (ZNF35)
B08R12C02	8-2-12	Hs~Ref:NM_003420.2~uORF:IOH9658	2498	835	1603	1367	1270	1250	2396	1024	1382	559	zinc finger protein 35 (ZNF35)
B08R12C03	8-3-12	Hs~MGC:BC016148.1~uORF:IOH10092	1538	891	1658	903	962	1243	2261	693	1084	426	integral membrane protein 2B (ITM2B)
B08R12C04	8-4-12	Hs~MGC:BC016148.1~uORF:IOH10092	1802	1019	1679	1380	999	1241	2231	847	1616	432	integral membrane protein 2B (ITM2B)
B08R12C05	8-5-12	Hs~Ref:NM_006653.1~uORF:IOH9654	1776	1828	1636	3358	1237	1432	2663	1661	2007	718	fibroblast growth factor receptor substrate 3 (FRS3)
B08R12C06	8-6-12	Hs~Ref:NM_006653.1~uORF:IOH9654	1708	1869	1735	3478	1336	1409	2651	1355	2359	718	fibroblast growth factor receptor substrate 3 (FRS3)
B08R12C07	8-7-12	Hs~Ref:NM_003338.2~uORF:IOH7482	999	1002	1128	636	878	523	1149	743	2094	485	ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) (UBE2D1)
B08R12C08	8-8-12	Hs~Ref:NM_003338.2~uORF:IOH7482	1033	975	1152	628	835	858	1190	783	1828	534	ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) (UBE2D1)
B08R12C09	8-9-12	Hs~Ref:NM_002966.1~uORF:IOH14651	1007	1182	1857	667	1452	1515	1972	865	1905	538	S100 calcium binding protein A10 (S100A10)
B08R12C10	8-10-12	Hs~Ref:NM_002966.1~uORF:IOH14651	1011	1250	1808	654	1404	1641	1991	885	1937	585	S100 calcium binding protein A10 (S100A10)
B08R12C11	8-11-12	Hs~MGC:BC005339.1~uORF:IOH7206	867	3292	1128	620	3165	915	1758	906	1661	938	thiopurine S-methyltransferase (TPMT)
B08R12C12	8-12-12	Hs~MGC:BC005339.1~uORF:IOH7206	906	3263	1131	657	3112	945	1776	762	1706	825	thiopurine S-methyltransferase (TPMT)
B08R12C13	8-13-12	Hs~MGC:BC007102.1~uORF:IOH7474	1161	1124	1593	951	839	32	1939	971	3028	1139	Cell differentiation protein RCD1 homolog
B08R12C14	8-14-12	Hs~MGC:BC007102.1~uORF:IOH7474	1137	1189	1600	821	844	1170	1907	954	2906	911	Cell differentiation protein RCD1 homolog
B08R12C15	8-15-12	Hs~MGC:BC065522.1~uORF:IOH39948	320	278	288	300	42	233	344	237	467	-12	vascular endothelial growth factor A (VEGFA)
B08R12C16	8-16-12	Hs~MGC:BC065522.1~uORF:IOH39948	3153	300	302	344	15	268	342	230	471	-26	vascular endothelial growth factor A (VEGFA)
B08R12C17	8-17-12	Hs~Ref:NM_002427.2~uORF:IOH40173	33	164	464	130	11	26	364	219	417	-6	matrix metallopeptidase 13 (collagenase 3) (MMP13)
B08R12C18	8-18-12	Hs~Ref:NM_002427.2~uORF:IOH40173	23	148	493	254	173	9	410	225	432	8	matrix metallopeptidase 13 (collagenase 3) (MMP13)
B08R12C19	8-19-12	Hs~MGC:BC067822.1~uORF:IOH40096	1391	1417	1662	792	1635	2760	977	596	1209	781	3-hydroxyisobutyryl-Coenzyme A hydrolase (HIBCH)
B08R12C20	8-20-12	Hs~MGC:BC067822.1~uORF:IOH40096	1360	1539	2204	744	1031	3807	1034	643	1276	863	3-hydroxyisobutyryl-Coenzyme A hydrolase (HIBCH)
B08R12C21	8-21-12	Hs~Ref:NM_013347.1~uORF:IOH40374	344	1119	3827	674	1046	718	1312	582	1311	342	replication protein A4, 34kDa (RPA4)
B08R12C22	8-22-12	Hs~Ref:NM_013347.1~uORF:IOH40374	362	1162	2793	675	1032	258	1261	572	1394	297	replication protein A4, 34kDa (RPA4)
B08R13C01	8-1-13	Hs~MGC:BC031469.1~uORF:IOH21458	619	487	603	370	951	1023	1385	657	1190	358	hypothetical LOC554207 (LOC554207)
B08R13C02	8-2-13	Hs~MGC:BC031469.1~uORF:IOH21458	619	442	590	451	917	343	1443	649	1732	390	hypothetical LOC554207 (LOC554207)
B08R13C03	8-3-13	Hs~MGC:BC020985.1~uORF:IOH21447	603	717	743	673	587	957	727	508	433	383	Coenzyme A synthase (COASY)
B08R13C04	8-4-13	Hs~MGC:BC020985.1~uORF:IOH21447	656	705	766	670	585	962	726	486	1305	375	Coenzyme A synthase (COASY)
B08R13C05	8-5-13	Hs~Ref:NM_021709.1~uORF:IOH21450	750	646	899	545	512	855	1298	609	1744	333	Apoptosis regulatory protein Siva
B08R13C06	8-6-13	Hs~Ref:NM_021709.1~uORF:IOH21450	786	613	908	521	585	950	1327	789	1816	361	Apoptosis regulatory protein Siva
B08R13C07	8-7-13	Hs~MGC:BC013112.2~uORF:IOH21474	1407	639	987	549	525	-41	6414	877	2842	452	solute carrier family 23 (nucleobase transporters), member 2 (SLC23A2)
B08R13C08	8-8-13	Hs~MGC:BC013112.2~uORF:IOH21474	1447	691	956	580	565	0	6294	950	2802	451	solute carrier family 23 (nucleobase transporters), member 2 (SLC23A2)
B08R13C09	8-9-13	Hs~MGC:BC019045.1~uORF:IOH14378	5414	3796	5139	17227	3633	6207	6336	4295	6983	2001	Docking protein 6
B08R13C10	8-10-13	Hs~MGC:BC019045.1~uORF:IOH14378	5347	3949	5516	17490	3580	5756	6623	4367	6690	1859	Docking protein 6
B08R13C11	8-11-13	Hs~MGC:BC017888.1~uORF:IOH13193	461	421	777	334	254	90	691	343	642	54	coiled-coil domain containing 132 (CCDC132)
B08R13C12	8-12-13	Hs~MGC:BC017888.1~uORF:IOH13193	473	392	775	388	223	335	666	359	688	13	coiled-coil domain containing 132 (CCDC132)
B08R13C13	8-13-13	Hs~MGC:BC013161.1~uORF:IOH10686	331	300	448	277	229	151	562	284	577	4	receptor (chemosensory) transporter protein 4 (RTP4)
B08R13C14	8-14-13	Hs~MGC:BC013161.1~uORF:IOH10686	346	282	554	364	152	234	566	291	530	159	receptor (chemosensory) transporter protein 4 (RTP4)
B08R13C15	8-15-13	Hs~Ref:NM_144586.1~uORF:IOH13321	2908	1138	699	533	870	2741	1498	431	2532	908	LY6/PLAUR domain containing 1 (LYPD1), transcript variant 1
B08R13C16	8-16-13	Hs~Ref:NM_144586.1~uORF:IOH13321	3121	1197	726	569	919	2380	1504	450	2507	1034	LY6/PLAUR domain containing 1 (LYPD1), transcript variant 1
B08R13C17	8-17-13	Hs~MGC:BC005033.1~uORF:IOH6631	594	1079	883	382	524	50	875	503	1378	24	actinin, alpha 4 (ACTN4)
B08R13C18	8-18-13	Hs~MGC:BC005033.1~uORF:IOH6631	757	1043	872	405	1272	129	858	499	1344	227	actinin, alpha 4 (ACTN4)
B08R13C19	8-19-13	Hs~MGC:BC017305.1~uORF:IOH12450	545	491	619	369	1714	191	693	495	1069	250	sirtuin (silent mating type information regulation 2 homolog) 7 (S. cerevisiae) (SIRT7)
B08R13C20	8-20-13	Hs~MGC:BC017305.1~uORF:IOH12450	345	552	616	362	532	649	704	470	31	241	sirtuin (silent mating type information regulation 2 homolog) 7 (S. cerevisiae) (SIRT7)
B08R13C21	8-21-13	Hs~MGC:BC013955.2~uORF:IOH29308	2096	1163	2255	1239	1131	360	3387	1134	2431	1008	Fibroblast growth factor receptor-like 1
B08R13C22	8-22-13	Hs~MGC:BC013955.2~uORF:IOH29308	2329	1239	2007	1240	1200	1408	3472	994	2881	427	Fibroblast growth factor receptor-like 1
B08R14C01	8-1-14	Hs~MGC:BC003400.1~uORF:IOH3003	421	416	836	321	250	258	774	417	814	258	TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa (TAF9)
B08R14C02	8-2-14	Hs~MGC:BC003400.1~uORF:IOH3003	415	440	830	395	180	201	729	462	733	314	TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa (TAF9)
B08R14C03	8-3-14	Hs~Ref:NM_014188.2~uORF:IOH5813	897	614	1011	983	690	1106	1569	1436	1923	417	SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae) (SSU72)
B08R14C04	8-4-14	Hs~Ref:NM_014188.2~uORF:IOH5813	901	808	1017	709	721	1112	1572	1425	1931	407	SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae) (SSU72)
B08R14C05	8-5-14	Hs~Ref:NM_020804.2~uORF:IOH27387	1018	883	1676	815	790	1795	13720	1188	2356	530	protein kinase C and casein kinase substrate in neurons 1 (PACSIN1)
B08R14C06	8-6-14	Hs~Ref:NM_020804.2~uORF:IOH27387	1020	911	1780	756	822	1842	12866	1284	2120	588	protein kinase C and casein kinase substrate in neurons 1 (PACSIN1)
B08R14C07	8-7-14	Hs~MGC:BC002448.2~uORF:IOH4300	30196	27382	14837	61558	18965	13139	16470	51581	25916	23243	actin binding LIM protein 1 (ABLIM1)
B08R14C08	8-8-14	Hs~MGC:BC002448.2~uORF:IOH4300	32705	27434	12800	62423	17987	13705	16780	53632	26647	22835	actin binding LIM protein 1 (ABLIM1)
B08R14C09	8-9-14	Hs~Ref:NM_003953.4~uORF:IOH6689	995	1056	1724	801	584	455	1941	944	2617	637	myelin protein zero-like 1 (MPZL1), transcript variant 1
B08R14C10	8-10-14	Hs~Ref:NM_003953.4~uORF:IOH6689	854	1027	1913	731	582	-75	1919	958	2152	738	myelin protein zero-like 1 (MPZL1), transcript variant 1
B08R14C11	8-11-14	Hs~MGC:BC012746.1~uORF:IOH14565	677	281	1157	322	738	538	616	313	430	174	mesoderm development candidate 2 (MESDC2)
B08R14C12	8-12-14	Hs~MGC:BC012746.1~uORF:IOH14565	722	267	1283	351	782	228	680	317	705	166	mesoderm development candidate 2 (MESDC2)
B08R14C13	8-13-14	Hs~Ref:NM_005205.2~uORF:IOH27397	1244	954	1411	836	514	-5	1302	861	1369	480	cytochrome c oxidase subunit VIa polypeptide 2 (COX6A2), nuclear gene encoding mitochondrial protein
B08R14C14	8-14-14	Hs~Ref:NM_005205.2~uORF:IOH27397	1128	1023	1425	786	499	-3	1306	809	1365	354	cytochrome c oxidase subunit VIa polypeptide 2 (COX6A2), nuclear gene encoding mitochondrial protein
B08R14C15	8-15-14	Hs~MGC:BC045167.2~uORF:IOH25851	714	319	1304	678	519	2164	4027	562	10760	496	D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae) (DTD1)
B08R14C16	8-16-14	Hs~MGC:BC045167.2~uORF:IOH25851	757	695	1602	803	484	1780	4016	614	10959	12	D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae) (DTD1)
B08R14C17	8-17-14	Hs~MGC:NM_198395.1~uORF:IOH7337	7735	4885	65458	9354	3668	5133	12828	4013	37013	9962	GTPase activating protein (SH3 domain) binding protein 1 (G3BP1), transcript variant 2
B08R14C18	8-18-14	Hs~MGC:NM_198395.1~uORF:IOH7337	7477	4567	65322	9241	9700	6041	12509	4560	37274	9991	GTPase activating protein (SH3 domain) binding protein 1 (G3BP1), transcript variant 2
B08R14C19	8-19-14	Hs~MGC:BC051874.1~uORF:IOH27064	686	555	6012	432	2257	880	614	682	2196	1333	carnitine O-octanoyltransferase (CROT)
B08R14C20	8-20-14	Hs~MGC:BC051874.1~uORF:IOH27064	652	697	3911	447	1747	975	665	849	3415	1240	carnitine O-octanoyltransferase (CROT)
B08R14C21	8-21-14	Hs~Ref:NM_001008710.1~uORF:IOH59674	987	1036	1378	576	3479	1214	1481	707	2468	78	RNA-binding protein with multiple splicing
B08R14C22	8-22-14	Hs~Ref:NM_001008710.1~uORF:IOH59674	1086	1039	1299	605	2935	-29	1484	557	2331	-47	RNA-binding protein with multiple splicing
B08R15C01	8-1-15	Hs~Ref:NM_024506.3~uORF:IOH41839	516	701	758	420	279	212	1001	827	912	273	Beta-galactosidase-1-like protein
B08R15C02	8-2-15	Hs~Ref:NM_024506.3~uORF:IOH41839	515	731	734	1229	338	432	1034	929	865	262	Beta-galactosidase-1-like protein
B08R15C03	8-3-15	Hs~MGC:BC053876.1~uORF:IOH28964	415	314	529	578	85	116	664	537	455	265	transmembrane and coiled-coil domain family 2 (TMCC2)
B08R15C04	8-4-15	Hs~MGC:BC053876.1~uORF:IOH28964	447	627	626	409	185	194	688	547	270	189	transmembrane and coiled-coil domain family 2 (TMCC2)
B08R15C05	8-5-15	Hs~Ref:NM_000998.3~uORF:IOH1576	2035	1048	1365	849	1029	1399	6053	1107	1608	593	ribosomal protein L37a (RPL37A)
B08R15C06	8-6-15	Hs~Ref:NM_000998.3~uORF:IOH1576	1946	989	1414	878	938	1449	5375	942	2291	598	ribosomal protein L37a (RPL37A)
B08R15C07	8-7-15	Hs~Ref:NM_015364.2~uORF:IOH12176	1057	754	1341	618	578	948	2035	784	1439	480	lymphocyte antigen 96 (LY96)
B08R15C08	8-8-15	Hs~Ref:NM_015364.2~uORF:IOH12176	991	783	1388	696	597	-9	2062	750	1330	400	lymphocyte antigen 96 (LY96)
B08R15C09	8-9-15	Hs~Ref:NM_152677.1~uORF:IOH34851	1708	1297	3927	2764	1306	1164	2686	1184	3690	2589	zinc finger and SCAN domain containing 4 (ZSCAN4)
B08R15C10	8-10-15	Hs~Ref:NM_152677.1~uORF:IOH34851	1731	1353	4077	2837	1269	1139	2727	1215	3632	2766	zinc finger and SCAN domain containing 4 (ZSCAN4)
B08R15C11	8-11-15	Hs~Ref:NM_001005339.1~uORF:IOH13018	14420	5023	4271	7581	1141	4791	3187	2802	3788	508	regulator of G-protein signaling 10 (RGS10), transcript variant 1
B08R15C12	8-12-15	Hs~Ref:NM_001005339.1~uORF:IOH13018	15104	4988	4095	7777	1183	4870	3229	2759	3032	495	regulator of G-protein signaling 10 (RGS10), transcript variant 1
B08R15C13	8-13-15	Hs~Ref:NM_000061.1~CAT:PV3363	2094	3315	3823	1915	1600	5955	4401	2410	2807	1108	Bruton agammaglobulinemia tyrosine kinase (BTK)
B08R15C14	8-14-15	Hs~Ref:NM_000061.1~CAT:PV3363	1997	3479	4840	1735	1663	5289	4675	2322	3429	1102	Bruton agammaglobulinemia tyrosine kinase (BTK)
B08R15C15	8-15-15	Hs~N/A:NM_004972.2~CAT:PV4210	700	978	1435	1895	176	876	613	344	1265	-4	Janus kinase 2 (a protein tyrosine kinase) (JAK2) ; see catalog number for detailed information on wild-type or point mutant status
B08R15C16	8-16-15	Hs~N/A:NM_004972.2~CAT:PV4210	689	803	888	2103	148	664	627	359	1226	-1	Janus kinase 2 (a protein tyrosine kinase) (JAK2) ; see catalog number for detailed information on wild-type or point mutant status
B08R15C19	8-19-15	Hs~Ref:NM_004972.2~CAT:PV4393	805	463	385	946	310	10	490	310	1074	-6	Janus kinase 2 (a protein tyrosine kinase) (JAK2) ; see catalog number for detailed information on wild-type or point mutant status
B08R15C20	8-20-15	Hs~Ref:NM_004972.2~CAT:PV4393	786	673	410	977	350	136	462	347	1090	-6	Janus kinase 2 (a protein tyrosine kinase) (JAK2) ; see catalog number for detailed information on wild-type or point mutant status
B08R16C01	8-1-16	Hs~N/A:NM_000594.2~CAT_PHC3016	51	120	98	96	148	1023	216	186	112	20	tumor necrosis factor (TNF superfamily, member 2) (TNF); see catalog number for detailed information on wild-type or point mutant status
B08R16C02	8-2-16	Hs~N/A:NM_000594.2~CAT_PHC3016	56	82	85	40	93	22	223	34	130	17	tumor necrosis factor (TNF superfamily, member 2) (TNF); see catalog number for detailed information on wild-type or point mutant status
B08R16C03	8-3-16	Hs~Ref:NM_002314.2~CAT:PV4337	2674	2449	5202	3355	3252	4050	3845	2282	3366	1677	LIM domain kinase 1
B08R16C04	8-4-16	Hs~Ref:NM_002314.2~CAT:PV4337	2502	3087	5376	2887	3059	4232	4461	2534	3560	841	LIM domain kinase 1
B08R16C05	8-5-16	Hs~Ref:NM_003656.3~CAT:PV4391	45	93	86	46	28	1175	207	221	70	-4	Calcium/calmodulin-dependent protein kinase type 1
B08R16C06	8-6-16	Hs~Ref:NM_003656.3~CAT:PV4391	1845	119	3	47	30	218	191	198	1	1	Calcium/calmodulin-dependent protein kinase type 1
B08R16C11	8-11-16	Hs~MGC:BC100863.2~uORF:IOH63510	502	525	894	467	337	-10	903	612	494	1	Neuritin-like protein
B08R16C12	8-12-16	Hs~MGC:BC100863.2~uORF:IOH63510	535	609	972	530	409	-73	853	540	643	-33	Neuritin-like protein
B08R16C15	8-15-16	Hs~Ref:NM_001006666.1~uORF:IOH58588	750	759	1207	629	475	444	1720	613	1037	465	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F (APOBEC3F), transcript variant 2, mRNA.
B08R16C16	8-16-16	Hs~Ref:NM_001006666.1~uORF:IOH58588	759	692	1261	711	359	1499	1637	614	994	243	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F (APOBEC3F), transcript variant 2, mRNA.
B08R16C17	8-17-16	Hs~Ref:NM_130463.2~uORF:IOH58658	1373	4196	2580	2012	3110	-8	1977	918	2883	1067	V-type proton ATPase subunit G 2
B08R16C18	8-18-16	Hs~Ref:NM_130463.2~uORF:IOH58658	1225	4461	2628	1989	2457	102	2004	944	3144	1174	V-type proton ATPase subunit G 2
B08R16C19	8-19-16	Hs~Ref:NM_031457.1~uORF:IOH53868	889	561	1201	453	2459	671	1031	556	1157	26	Membrane-spanning 4-domains subfamily A member 8B
B08R16C20	8-20-16	Hs~Ref:NM_031457.1~uORF:IOH53868	898	734	1153	429	3875	-6	983	550	1174	-15	Membrane-spanning 4-domains subfamily A member 8B
B08R17C01	8-1-17	Hs~MGC:BC038381.1~uORF:IOH62022	668	276	1748	286	432	757	486	529	683	124	Breast carcinoma-amplified sequence 4
B08R17C02	8-2-17	Hs~MGC:BC038381.1~uORF:IOH62022	670	279	1394	314	373	377	493	510	103	85	Breast carcinoma-amplified sequence 4
B08R17C03	8-3-17	Hs~MGC:BC034963.1~uORF:IOH62055	940	341	940	485	1529	1079	621	1100	1002	57	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1
B08R17C04	8-4-17	Hs~MGC:BC034963.1~uORF:IOH62055	916	339	856	510	1496	1167	686	1068	1008	122	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1
B08R17C11	8-11-17	Hs~Ref:NM_001032293.1~uORF:IOH3584	5881	6771	9234	6740	5109	6409	7824	6260	9581	4916	zinc finger protein 207 (ZNF207), transcript variant 2
B08R17C12	8-12-17	Hs~Ref:NM_001032293.1~uORF:IOH3584	5799	7138	9244	7461	5236	6457	7636	6812	9510	5089	zinc finger protein 207 (ZNF207), transcript variant 2
B08R17C13	8-13-17	Hs~Ref:NM_005735.2~uORF:IOH5572	996	1196	1421	820	702	621	1458	909	938	453	ARP1 actin-related protein 1 homolog B, centractin beta (yeast) (ACTR1B)
B08R17C14	8-14-17	Hs~Ref:NM_005735.2~uORF:IOH5572	1045	1099	1505	741	638	223	1431	980	2648	605	ARP1 actin-related protein 1 homolog B, centractin beta (yeast) (ACTR1B)
B08R17C15	8-15-17	Hs~Ref:NM_002631.2~uORF:IOH3407	1322	1592	1819	4299	1101	2067	3576	1317	3114	714	phosphogluconate dehydrogenase (PGD)
B08R17C16	8-16-17	Hs~Ref:NM_002631.2~uORF:IOH3407	1359	1586	1763	4415	1407	2008	3586	1138	3056	703	phosphogluconate dehydrogenase (PGD)
B08R17C17	8-17-17	Hs~Ref:NM_003211.1~uORF:IOH27535	1272	698	1466	618	720	220	2203	546	2921	341	thymine-DNA glycosylase (TDG)
B08R17C18	8-18-17	Hs~Ref:NM_003211.1~uORF:IOH27535	1242	627	1438	619	693	338	2289	585	3800	313	thymine-DNA glycosylase (TDG)
B08R17C19	8-19-17	Hs~Ref:NM_004196.2~N/A	2148	1229	1483	1402	1070	3060	4338	1446	2958	1047	Cyclin-dependent kinase-like 1
B08R17C20	8-20-17	Hs~Ref:NM_004196.2~N/A	2110	1178	1505	1384	1150	3354	4471	1363	2910	1192	Cyclin-dependent kinase-like 1
B08R17C21	8-21-17	Hs~Ref:NM_018413.2~uORF:IOH12727	135	46	692	139	40	-21	363	217	53	4	carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11)
B08R17C22	8-22-17	Hs~Ref:NM_018413.2~uORF:IOH12727	125	66	308	229	34	49	352	187	122	13	carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11)
B08R18C01	8-1-18	Hs~Ref:NM_145169.1~uORF:IOH14571	333	280	647	258	253	88	646	471	469	167	SFT2 domain containing 1 (SFT2D1)
B08R18C02	8-2-18	Hs~Ref:NM_145169.1~uORF:IOH14571	365	375	628	266	242	380	633	417	558	287	SFT2 domain containing 1 (SFT2D1)
B08R18C03	8-3-18	Hs~MGC:BC028917.1~uORF:IOH22195	1360	1413	1684	1057	1268	1072	1430	930	2428	507	zinc finger, C3HC-type containing 1 (ZC3HC1)
B08R18C04	8-4-18	Hs~MGC:BC028917.1~uORF:IOH22195	1365	1360	1474	873	1244	1030	1552	885	2734	507	zinc finger, C3HC-type containing 1 (ZC3HC1)
B08R18C05	8-5-18	Hs~Ref:NM_006687.2~uORF:IOH10967	1392	568	871	879	661	851	998	766	1519	386	actin-like 7A (ACTL7A)
B08R18C06	8-6-18	Hs~Ref:NM_006687.2~uORF:IOH10967	1705	549	942	872	538	809	957	811	1685	346	actin-like 7A (ACTL7A)
B08R18C07	8-7-18	Hs~Ref:NM_014399.2~uORF:IOH21837	701	476	865	464	487	704	1166	581	990	-2	tetraspanin 13 (TSPAN13)
B08R18C08	8-8-18	Hs~Ref:NM_014399.2~uORF:IOH21837	585	527	828	438	442	619	1124	609	1039	-7	tetraspanin 13 (TSPAN13)
B08R18C09	8-9-18	Hs~Ref:NM_032037.2~uORF:IOH10991	733	627	929	541	381	217	1562	675	3326	-1	testis-specific serine kinase 6 (TSSK6)
B08R18C10	8-10-18	Hs~Ref:NM_032037.2~uORF:IOH10991	785	589	1053	506	407	496	1516	727	3186	98	testis-specific serine kinase 6 (TSSK6)
B08R18C11	8-11-18	Hs~MGC:BC032715.1~uORF:IOH21958	522	428	448	361	275	1130	1168	523	1806	182	Bardet-Biedl syndrome 9 (BBS9)
B08R18C12	8-12-18	Hs~MGC:BC032715.1~uORF:IOH21958	576	607	422	443	493	201	1166	475	1448	141	Bardet-Biedl syndrome 9 (BBS9)
B08R18C13	8-13-18	Hs~Ref:NM_175923.2~uORF:IOH22051	2292	1235	1665	872	995	727	9347	935	2426	601	hypothetical protein MGC42630 (MGC42630)
B08R18C14	8-14-18	Hs~Ref:NM_175923.2~uORF:IOH22051	2257	1075	1656	857	754	1103	9268	853	2040	542	hypothetical protein MGC42630 (MGC42630)
B08R18C15	8-15-18	Hs~Ref:NM_133496.3~uORF:IOH39796	629	243	976	367	112	1005	1093	542	233	10	Zinc transporter 7
B08R18C16	8-16-18	Hs~Ref:NM_133496.3~uORF:IOH39796	243	481	925	450	493	418	964	525	-25	-7	Zinc transporter 7
B08R18C17	8-17-18	Hs~MGC:NM_181533.3~uORF:IOH22363	395	363	533	364	529	747	948	551	1038	8	abhydrolase domain containing 12B (ABHD12B), transcript variant 2
B08R18C18	8-18-18	Hs~MGC:NM_181533.3~uORF:IOH22363	599	374	490	383	364	417	998	521	915	189	abhydrolase domain containing 12B (ABHD12B), transcript variant 2
B08R18C19	8-19-18	Hs~MGC:BC001321.1~uORF:IOH3117	1093	1077	1260	696	809	1158	1863	774	2368	763	ankyrin repeat and SOCS box-containing 8 (ASB8)
B08R18C20	8-20-18	Hs~MGC:BC001321.1~uORF:IOH3117	1024	1062	1256	737	682	-30	1860	711	2331	111	ankyrin repeat and SOCS box-containing 8 (ASB8)
B08R18C21	8-21-18	Hs~MGC:BC022379.1~uORF:IOH12058	1248	923	1471	833	740	948	1526	758	2192	269	solute carrier family 22 (organic anion/cation transporter), member 9 (SLC22A9)
B08R18C22	8-22-18	Hs~MGC:BC022379.1~uORF:IOH12058	188	1092	1553	871	716	945	1519	856	2169	262	solute carrier family 22 (organic anion/cation transporter), member 9 (SLC22A9)
B08R19C01	8-1-19	Hs~MGC:BC008919.1~uORF:IOH7021	886	664	1059	571	578	347	1515	617	1924	475	TBC1 domain family member 9B
B08R19C02	8-2-19	Hs~MGC:BC008919.1~uORF:IOH7021	895	716	1008	735	699	955	1553	688	1691	464	TBC1 domain family member 9B
B08R19C03	8-3-19	Hs~MGC:BC042193.1~uORF:IOH26104	2142	1599	1598	1360	1129	1870	4537	1197	2735	834	G patch domain containing 2 (GPATCH2)
B08R19C04	8-4-19	Hs~MGC:BC042193.1~uORF:IOH26104	2094	1567	1539	1123	1475	1863	4828	1160	3253	736	G patch domain containing 2 (GPATCH2)
B08R19C05	8-5-19	Hs~MGC:BC000479.1~uORF:IOH3692	236	226	184	260	355	17	316	241	557	146	v-akt murine thymoma viral oncogene homolog 1 (AKT1)
B08R19C06	8-6-19	Hs~MGC:BC000479.1~uORF:IOH3692	158	297	233	210	139	117	314	238	186	64	v-akt murine thymoma viral oncogene homolog 1 (AKT1)
B08R19C07	8-7-19	Hs~Ref:NM_018064.1~uORF:IOH6070	404	228	402	349	308	44	337	293	380	14	chromosome 6 open reading frame 166 (C6orf166)
B08R19C08	8-8-19	Hs~Ref:NM_018064.1~uORF:IOH6070	406	183	217	327	334	4	373	292	128	-18	chromosome 6 open reading frame 166 (C6orf166)
B08R19C09	8-9-19	Hs~MGC:BC022363.1~uORF:IOH23061	549	158	280	226	258	45	565	140	-26	-16	vacuolar protein sorting 37 homolog A (S. cerevisiae) (VPS37A)
B08R19C10	8-10-19	Hs~MGC:BC022363.1~uORF:IOH23061	539	271	251	142	115	247	497	232	-51	32	vacuolar protein sorting 37 homolog A (S. cerevisiae) (VPS37A)
B08R19C11	8-11-19	Hs~Ref:NM_004215.2~uORF:IOH10322	795	68	242	313	345	101	450	474	-63	70	estrogen receptor binding site associated, antigen, 9 (EBAG9), transcript variant 1
B08R19C12	8-12-19	Hs~Ref:NM_004215.2~uORF:IOH10322	770	120	239	308	277	179	452	464	402	125	estrogen receptor binding site associated, antigen, 9 (EBAG9), transcript variant 1
B08R19C13	8-13-19	Hs~Ref:NM_178539.3~uORF:IOH42328	675	819	1077	435	570	131	1312	563	442	176	Protein FAM19A2
B08R19C14	8-14-19	Hs~Ref:NM_178539.3~uORF:IOH42328	673	1002	951	430	456	512	1327	595	1086	171	Protein FAM19A2
B08R19C15	8-15-19	Hs~Ref:NM_020168.3~uORF:IOH20961	2714	1539	2317	1411	2436	3113	5816	1137	3703	760	p21(CDKN1A)-activated kinase 6 (PAK6)
B08R19C16	8-16-19	Hs~Ref:NM_020168.3~uORF:IOH20961	2693	1624	2198	1494	2482	3560	5675	1212	2978	905	p21(CDKN1A)-activated kinase 6 (PAK6)
B08R19C17	8-17-19	Hs~Ref:NM_145810.1~uORF:IOH11712	1645	1061	1313	748	490	-39	1455	616	1876	585	cell division cycle associated 7 (CDCA7), transcript variant 2
B08R19C18	8-18-19	Hs~Ref:NM_145810.1~uORF:IOH11712	1634	949	1343	742	470	132	1526	716	1917	-5	cell division cycle associated 7 (CDCA7), transcript variant 2
B08R19C19	8-19-19	Hs~Ref:NM_139355.1~uORF:IOH4506	21822	7631	4505	8843	4995	3094	8144	5393	12972	4083	megakaryocyte-associated tyrosine kinase (MATK), transcript variant 1
B08R19C20	8-20-19	Hs~Ref:NM_139355.1~uORF:IOH4506	21640	7804	4539	9055	5209	3343	8379	5591	13268	4172	megakaryocyte-associated tyrosine kinase (MATK), transcript variant 1
B08R19C21	8-21-19	Hs~Ref:NM_019613.2~uORF:IOH6706	254	211	462	339	95	303	644	391	714	22	WDR45-like (WDR45L)
B08R19C22	8-22-19	Hs~Ref:NM_019613.2~uORF:IOH6706	571	198	318	415	116	304	683	342	727	-6	WDR45-like (WDR45L)
B08R20C01	8-1-20	Hs~MGC:BC009674.1~uORF:IOH9894	362	291	409	421	231	2	597	842	509	169	Yip1 domain family, member 1 (YIPF1)
B08R20C02	8-2-20	Hs~MGC:BC009674.1~uORF:IOH9894	377	373	459	665	202	47	555	363	1325	316	Yip1 domain family, member 1 (YIPF1)
B08R20C07	8-7-20	Hs~Ref:NM_030579.1~uORF:IOH5585	850	174	184	166	341	16	479	247	1167	850	cytochrome b5 type B (outer mitochondrial membrane) (CYB5B)
B08R20C08	8-8-20	Hs~Ref:NM_030579.1~uORF:IOH5585	193	276	275	174	85	-28	565	204	-29	57	cytochrome b5 type B (outer mitochondrial membrane) (CYB5B)
B08R20C09	8-9-20	Hs~MGC:BC014020.1~uORF:IOH13375	5202	7613	4071	5038	6246	4818	4028	2410	15379	2016	BAI1-associated protein 2 (BAIAP2)
B08R20C10	8-10-20	Hs~MGC:BC014020.1~uORF:IOH13375	5257	7885	4004	5134	5691	4020	4012	2412	15390	2694	BAI1-associated protein 2 (BAIAP2)
B08R20C11	8-11-20	Hs~Ref:NM_001039724.1~uORF:IOH63165	6055	1730	1993	1420	1096	4916	7986	1377	3843	1626	Nostrin
B08R20C12	8-12-20	Hs~Ref:NM_001039724.1~uORF:IOH63165	6379	1696	2096	1601	1230	4897	7736	1457	3392	1582	Nostrin
B08R20C13	8-13-20	Hs~MGC:BC073791.1~uORF:IOH63073	10501	10901	10780	11336	6099	13653	10580	8564	15892	10553	immunoglobulin kappa constant, mRNA (cDNA clone MGC:88809 IMAGE:6279986), complete cds
B08R20C14	8-14-20	Hs~MGC:BC073791.1~uORF:IOH63073	10282	11070	11278	11498	8099	13741	10620	8276	16776	10519	immunoglobulin kappa constant, mRNA (cDNA clone MGC:88809 IMAGE:6279986), complete cds
B09R02C11	9-11-2	Hs~MGC:BC031617.1~uORF:IOH22754	703	468	896	509	413	689	1464	758	1408	374	family with sequence similarity 27-like (FAM27L)
B09R02C12	9-12-2	Hs~MGC:BC031617.1~uORF:IOH22754	703	420	1182	475	666	648	1483	784	1439	364	family with sequence similarity 27-like (FAM27L)
B09R02C13	9-13-2	Hs~Ref:NM_006228.2~uORF:IOH22728	850	532	937	550	643	691	1272	655	1442	414	prepronociceptin (PNOC)
B09R02C14	9-14-2	Hs~Ref:NM_006228.2~uORF:IOH22728	789	494	964	562	1329	719	1302	639	1608	389	prepronociceptin (PNOC)
B09R02C15	9-15-2	Hs~Ref:NM_005145.1~uORF:IOH12762	425	300	552	287	403	279	1258	507	1069	54	guanine nucleotide binding protein (G protein), gamma 7 (GNG7)
B09R02C16	9-16-2	Hs~Ref:NM_005145.1~uORF:IOH12762	369	308	552	284	375	277	1249	495	1070	241	guanine nucleotide binding protein (G protein), gamma 7 (GNG7)
B09R02C17	9-17-2	Hs~MGC:BC008699.1~uORF:IOH6051	618	1646	1130	553	675	1026	1608	1405	2061	463	cDNA clone MGC:15427 IMAGE:2822641, complete cds
B09R02C18	9-18-2	Hs~MGC:BC008699.1~uORF:IOH6051	548	1477	1185	591	877	839	1653	1248	1917	449	cDNA clone MGC:15427 IMAGE:2822641, complete cds
B09R02C19	9-19-2	Hs~MGC:BC030538.2~uORF:IOH21627	-1	-2	1	2	1031	892	4653	690	2063	466	hypothetical protein FLJ21986 (FLJ21986)
B09R02C20	9-20-2	Hs~MGC:BC030538.2~uORF:IOH21627	-2	-3	-2	0	982	961	4638	763	2120	496	hypothetical protein FLJ21986 (FLJ21986)
B09R02C21	9-21-2	Hs~Ref:NM_014303.2~uORF:IOH21738	3289	3050	1418	1639	1946	1344	4381	1644	3918	1395	pescadillo homolog 1, containing BRCT domain (zebrafish) (PES1)
B09R02C22	9-22-2	Hs~Ref:NM_014303.2~uORF:IOH21738	2973	-18	1363	1595	1721	522	3835	1501	3223	1119	pescadillo homolog 1, containing BRCT domain (zebrafish) (PES1)
B09R03C01	9-1-3	Hs~MGC:BC034229.1~uORF:IOH21596	1392	1140	1638	657	821	1032	2165	753	2318	444	Zinc finger B-box domain containing protein 1
B09R03C02	9-2-3	Hs~MGC:BC034229.1~uORF:IOH21596	1087	1075	1495	674	864	933	2067	736	2137	440	Zinc finger B-box domain containing protein 1
B09R03C03	9-3-3	Hs~Ref:NM_002012.1~uORF:IOH21676	1024	1442	1179	933	685	896	1402	1149	1806	394	fragile histidine triad gene (FHIT)
B09R03C04	9-4-3	Hs~Ref:NM_002012.1~uORF:IOH21676	951	1416	1190	895	668	911	1403	1162	1838	414	fragile histidine triad gene (FHIT)
B09R03C05	9-5-3	Hs~MGC:BC010175.1~uORF:IOH13983	554	457	755	452	585	495	872	491	1334	350	ubiquitin-conjugating enzyme E2A (RAD6 homolog) (UBE2A)
B09R03C06	9-6-3	Hs~MGC:BC010175.1~uORF:IOH13983	568	457	723	409	673	868	936	468	1312	366	ubiquitin-conjugating enzyme E2A (RAD6 homolog) (UBE2A)
B09R03C07	9-7-3	Hs~Ref:NM_007002.1~uORF:IOH13967	152	1058	236	367	290	514	804	128	512	89	adhesion regulating molecule 1 (ADRM1), transcript variant 1
B09R03C08	9-8-3	Hs~Ref:NM_007002.1~uORF:IOH13967	177	635	230	345	252	457	880	168	523	83	adhesion regulating molecule 1 (ADRM1), transcript variant 1
B09R03C09	9-9-3	Hs~Ref:NM_000860.1~uORF:IOH14612	566	451	1090	583	477	1054	1927	651	1363	306	hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD)
B09R03C10	9-10-3	Hs~Ref:NM_000860.1~uORF:IOH14612	526	444	1200	584	502	1008	1946	659	1291	314	hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD)
B09R03C11	9-11-3	Hs~MGC:BC017407.1~uORF:IOH14158	817	491	885	400	439	655	1399	453	1030	367	zinc finger protein 266 (ZNF266)
B09R03C12	9-12-3	Hs~MGC:BC017407.1~uORF:IOH14158	824	467	896	411	438	614	1490	474	971	382	zinc finger protein 266 (ZNF266)
B09R03C13	9-13-3	Hs~MGC:BC017079.1~uORF:IOH10377	872	626	1107	548	980	876	1074	1219	1399	605	SET and MYND domain containing 3 (SMYD3)
B09R03C14	9-14-3	Hs~MGC:BC017079.1~uORF:IOH10377	894	591	1075	517	666	797	1108	1251	1442	583	SET and MYND domain containing 3 (SMYD3)
B09R03C15	9-15-3	Hs~Ref:NM_005617.2~uORF:IOH10433	1261	669	1047	586	503	811	3707	654	1283	442	ribosomal protein S14 (RPS14), transcript variant 3
B09R03C16	9-16-3	Hs~Ref:NM_005617.2~uORF:IOH10433	1287	746	1185	574	432	831	3766	654	1437	439	ribosomal protein S14 (RPS14), transcript variant 3
B09R03C17	9-17-3	Hs~Ref:NM_018683.2~uORF:IOH10466	835	589	951	988	771	1096	1263	702	1493	343	zinc finger protein 313 (ZNF313)
B09R03C18	9-18-3	Hs~Ref:NM_018683.2~uORF:IOH10466	847	580	948	996	730	928	1220	772	1730	353	zinc finger protein 313 (ZNF313)
B09R03C19	9-19-3	Hs~Ref:NM_018200.2~uORF:IOH10020	1174	598	1854	1359	1511	776	1987	65493	1084	366	high-mobility group 20A (HMG20A)
B09R03C20	9-20-3	Hs~Ref:NM_018200.2~uORF:IOH10020	1283	637	1783	1356	1371	755	2050	65494	1148	387	high-mobility group 20A (HMG20A)
B09R03C21	9-21-3	Hs~Ref:NM_001673.2~uORF:IOH5751	851	1091	1796	772	1647	1360	1639	2706	2075	456	asparagine synthetase (ASNS), transcript variant 2
B09R03C22	9-22-3	Hs~Ref:NM_001673.2~uORF:IOH5751	864	1057	1831	756	1781	1435	1552	2622	1993	472	asparagine synthetase (ASNS), transcript variant 2
B09R04C01	9-1-4	Hs~MGC:BC018766.1~uORF:IOH13547	1600	1342	1942	882	1312	1075	1863	969	2896	631	5,10-methylenetetrahydrofolate reductase (NADPH) (MTHFR)
B09R04C02	9-2-4	Hs~MGC:BC018766.1~uORF:IOH13547	1448	1192	2056	891	1273	1100	2016	1024	2927	639	5,10-methylenetetrahydrofolate reductase (NADPH) (MTHFR)
B09R04C03	9-3-4	Hs~Ref:NM_002028.2~uORF:IOH14750	1860	1313	2260	686	894	1319	2245	655	2270	498	farnesyltransferase, CAAX box, beta (FNTB)
B09R04C04	9-4-4	Hs~Ref:NM_002028.2~uORF:IOH14750	2107	1363	2273	691	866	1314	2324	662	2261	494	farnesyltransferase, CAAX box, beta (FNTB)
B09R04C05	9-5-4	Hs~Ref:NM_004051.1~uORF:IOH5792	1814	1099	2606	934	1133	1082	2515	1240	2539	751	3-hydroxybutyrate dehydrogenase, type 1 (BDH1), nuclear gene encoding mitochondrial protein, transcript variant 1
B09R04C06	9-6-4	Hs~Ref:NM_004051.1~uORF:IOH5792	1511	1106	2442	908	1332	1275	2608	1211	2392	720	3-hydroxybutyrate dehydrogenase, type 1 (BDH1), nuclear gene encoding mitochondrial protein, transcript variant 1
B09R04C07	9-7-4	Hs~MGC:BC024187.2~uORF:IOH10699	7911	4394	6938	10891	3331	5407	15303	5176	8781	5383	DEAH (Asp-Glu-Ala-His) box polypeptide 40 (DHX40)
B09R04C08	9-8-4	Hs~MGC:BC024187.2~uORF:IOH10699	7815	5123	6979	9829	3343	5020	14752	5147	8958	5430	DEAH (Asp-Glu-Ala-His) box polypeptide 40 (DHX40)
B09R04C09	9-9-4	Hs~Ref:NM_001637.1~uORF:IOH10670	1057	1817	1351	729	842	1127	2384	1423	2105	574	acyloxyacyl hydrolase (neutrophil) (AOAH)
B09R04C10	9-10-4	Hs~Ref:NM_001637.1~uORF:IOH10670	1080	1409	1371	756	838	1112	2443	1180	1870	587	acyloxyacyl hydrolase (neutrophil) (AOAH)
B09R04C11	9-11-4	Hs~MGC:BC011936.1~uORF:IOH12777	823	531	1051	322	1083	485	912	446	1443	123	mediator complex subunit 28 (MED28)
B09R04C12	9-12-4	Hs~MGC:BC011936.1~uORF:IOH12777	810	478	1070	330	1097	438	957	424	1429	165	mediator complex subunit 28 (MED28)
B09R04C13	9-13-4	Hs~Ref:NM_032122.2~uORF:IOH13153	1167	1048	1140	1011	990	1029	1972	951	2958	627	dystrobrevin binding protein 1 (DTNBP1), transcript variant 1
B09R04C14	9-14-4	Hs~Ref:NM_032122.2~uORF:IOH13153	1173	1056	1112	974	1189	1021	1828	929	2862	607	dystrobrevin binding protein 1 (DTNBP1), transcript variant 1
B09R04C15	9-15-4	Hs~Ref:NM_145018.2~uORF:IOH27254	584	411	576	290	332	398	999	470	555	279	chromosome 11 open reading frame 82 (C11orf82)
B09R04C16	9-16-4	Hs~Ref:NM_145018.2~uORF:IOH27254	566	358	619	293	345	424	925	430	697	296	chromosome 11 open reading frame 82 (C11orf82)
B09R04C17	9-17-4	Hs~Ref:NM_007242.3~uORF:IOH3925	1398	3781	575	6753	518	1199	1391	899	1134	928	DEAD (Asp-Glu-Ala-As) box polypeptide 19B (DDX19B), transcript variant 1
B09R04C18	9-18-4	Hs~Ref:NM_007242.3~uORF:IOH3925	1314	3345	584	6579	500	970	1381	1035	1163	944	DEAD (Asp-Glu-Ala-As) box polypeptide 19B (DDX19B), transcript variant 1
B09R04C19	9-19-4	Hs~MGC:BC050683.1~uORF:IOH27027	1170	688	905	546	575	846	3642	1042	728	309	zinc finger protein 410 (ZNF410)
B09R04C20	9-20-4	Hs~MGC:BC050683.1~uORF:IOH27027	1146	679	828	541	544	802	3294	988	1102	370	zinc finger protein 410 (ZNF410)
B09R04C21	9-21-4	Hs~Ref:NM_031213.2~uORF:IOH21446	385	295	490	276	237	734	718	458	640	132	Abhydrolase domain-containing protein FAM108A1
B09R04C22	9-22-4	Hs~Ref:NM_031213.2~uORF:IOH21446	376	312	521	281	236	94	691	376	7	185	Abhydrolase domain-containing protein FAM108A1
B09R05C01	9-1-5	Hs~MGC:BC063463.1~uORF:IOH39865	650	586	1850	417	461	703	1393	624	871	303	coenzyme Q3 homolog, methyltransferase (S. cerevisiae) (COQ3)
B09R05C02	9-2-5	Hs~MGC:BC063463.1~uORF:IOH39865	606	606	1585	426	413	682	1531	591	876	332	coenzyme Q3 homolog, methyltransferase (S. cerevisiae) (COQ3)
B09R05C03	9-3-5	Hs~MGC:BC036572.2~uORF:IOH28725	425	511	695	331	256	424	701	405	781	379	zinc finger, CCHC domain containing 12 (ZCCHC12)
B09R05C04	9-4-5	Hs~MGC:BC036572.2~uORF:IOH28725	913	529	659	311	284	383	660	428	890	362	zinc finger, CCHC domain containing 12 (ZCCHC12)
B09R05C05	9-5-5	Hs~Ref:NM_031279.2~uORF:IOH10786	650	806	1627	567	806	555	1556	563	1150	423	alanine-glyoxylate aminotransferase 2-like 1 (AGXT2L1)
B09R05C06	9-6-5	Hs~Ref:NM_031279.2~uORF:IOH10786	469	779	1746	572	899	652	1682	571	1142	401	alanine-glyoxylate aminotransferase 2-like 1 (AGXT2L1)
B09R05C07	9-7-5	Hs~Ref:NM_001615.2~uORF:IOH13748	495	347	573	297	349	679	735	382	728	259	actin, gamma 2, smooth muscle, enteric (ACTG2)
B09R05C08	9-8-5	Hs~Ref:NM_001615.2~uORF:IOH13748	465	337	575	292	356	469	744	383	707	250	actin, gamma 2, smooth muscle, enteric (ACTG2)
B09R05C09	9-9-5	Hs~Ref:NM_005627.1~uORF:IOH3192	1748	1510	2600	1352	1910	1269	2433	1385	4674	1226	serum/glucocorticoid regulated kinase (SGK)
B09R05C10	9-10-5	Hs~Ref:NM_005627.1~uORF:IOH3192	1691	1502	2704	1373	1922	1288	2536	1411	4410	1312	serum/glucocorticoid regulated kinase (SGK)
B09R05C11	9-11-5	Hs~Ref:NM_014891.1~uORF:IOH4282	5693	7927	9809	9526	5157	4719	11965	4573	11038	5966	PDGFA associated protein 1 (PDAP1)
B09R05C12	9-12-5	Hs~Ref:NM_014891.1~uORF:IOH4282	5778	7720	9790	9525	5455	4635	11730	4277	10719	6009	PDGFA associated protein 1 (PDAP1)
B09R05C13	9-13-5	Hs~Ref:NM_002638.1~uORF:IOH13658	1251	889	1715	941	1767	1020	1855	977	2857	658	peptidase inhibitor 3, skin-derived (SKALP) (PI3)
B09R05C14	9-14-5	Hs~Ref:NM_002638.1~uORF:IOH13658	1186	934	1684	895	2144	1018	1802	912	2984	638	peptidase inhibitor 3, skin-derived (SKALP) (PI3)
B09R05C15	9-15-5	Hs~Ref:NM_080671.1~uORF:IOH12642	849	794	1338	690	1366	808	1677	901	1641	505	potassium voltage-gated channel, Isk-related family, member 4 (KCNE4)
B09R05C16	9-16-5	Hs~Ref:NM_080671.1~uORF:IOH12642	843	732	1389	694	1210	827	1526	922	1718	473	potassium voltage-gated channel, Isk-related family, member 4 (KCNE4)
B09R05C17	9-17-5	Hs~Ref:NM_144659.1~uORF:IOH21795	101	59	464	36	251	380	335	212	638	527	t-complex 10 (mouse)-like (TCP10L)
B09R05C18	9-18-5	Hs~Ref:NM_144659.1~uORF:IOH21795	88	32	381	36	112	328	359	193	208	490	t-complex 10 (mouse)-like (TCP10L)
B09R05C19	9-19-5	Hs~Ref:NM_152736.2~uORF:IOH14153	3705	1318	1723	1058	1903	1516	5538	1233	3891	885	Zinc finger protein 187
B09R05C20	9-20-5	Hs~Ref:NM_152736.2~uORF:IOH14153	2395	1262	1728	1033	1806	1428	5268	1209	4070	945	Zinc finger protein 187
B09R05C21	9-21-5	Hs~Ref:NM_001219.2~uORF:IOH14786	2696	1214	2637	2386	1198	3239	2774	896	2961	835	calumenin (CALU)
B09R05C22	9-22-5	Hs~Ref:NM_001219.2~uORF:IOH14786	2578	1153	2532	2312	1165	3405	2657	870	2915	739	calumenin (CALU)
B09R06C01	9-1-6	Hs~MGC:NM_177999.1~uORF:IOH4544	912	1566	1395	689	983	974	1447	985	2178	631	ankyrin repeat and SOCS box-containing 6 (ASB6), transcript variant 2
B09R06C02	9-2-6	Hs~MGC:NM_177999.1~uORF:IOH4544	870	1277	1326	690	1048	849	1484	946	2223	722	ankyrin repeat and SOCS box-containing 6 (ASB6), transcript variant 2
B09R06C03	9-3-6	Hs~Ref:NM_025165.1~uORF:IOH12994	685	451	910	396	291	558	863	458	1079	318	elongation factor RNA polymerase II-like 3 (ELL3)
B09R06C04	9-4-6	Hs~Ref:NM_025165.1~uORF:IOH12994	673	465	875	368	285	461	872	454	991	388	elongation factor RNA polymerase II-like 3 (ELL3)
B09R06C05	9-5-6	Hs~MGC:NM_178585.1~uORF:IOH12602	1167	558	1122	891	1260	855	4349	752	5644	499	WD repeat and FYVE domain containing 3 (WDFY3), transcript variant 3
B09R06C06	9-6-6	Hs~MGC:NM_178585.1~uORF:IOH12602	1036	560	1081	949	1650	835	4464	806	5914	480	WD repeat and FYVE domain containing 3 (WDFY3), transcript variant 3
B09R06C07	9-7-6	Hs~Ref:NM_004346.2~uORF:IOH11204	511	7267	818	404	1567	920	1960	402	1648	338	caspase 3, apoptosis-related cysteine peptidase (CASP3), transcript variant alpha
B09R06C08	9-8-6	Hs~Ref:NM_004346.2~uORF:IOH11204	568	6648	765	396	1555	688	1896	382	1701	289	caspase 3, apoptosis-related cysteine peptidase (CASP3), transcript variant alpha
B09R06C09	9-9-6	Hs~Ref:NM_018135.2~uORF:IOH12060	1636	974	1156	742	543	1071	5154	774	1604	580	mitochondrial ribosomal protein S18A (MRPS18A), nuclear gene encoding mitochondrial protein
B09R06C10	9-10-6	Hs~Ref:NM_018135.2~uORF:IOH12060	1630	861	1238	742	452	1047	5252	686	1585	611	mitochondrial ribosomal protein S18A (MRPS18A), nuclear gene encoding mitochondrial protein
B09R06C11	9-11-6	Hs~Ref:NM_014062.1~uORF:IOH39919	3604	2597	6407	4944	1403	2169	6893	1706	17139	3441	NIN1/RPN12 binding protein 1 homolog (S. cerevisiae) (NOB1)
B09R06C12	9-12-6	Hs~Ref:NM_014062.1~uORF:IOH39919	3679	2558	5946	5160	1854	1967	6443	1663	17060	3672	NIN1/RPN12 binding protein 1 homolog (S. cerevisiae) (NOB1)
B09R06C13	9-13-6	Hs~MGC:BC067132.1~uORF:IOH39989	438	408	436	512	688	429	930	144	635	100	WD repeat domain 23 (WDR23)
B09R06C14	9-14-6	Hs~MGC:BC067132.1~uORF:IOH39989	578	478	1049	485	1087	428	1116	468	607	200	WD repeat domain 23 (WDR23)
B09R06C15	9-15-6	Hs~Ref:NM_013975.1~uORF:IOH40893	3549	1448	2322	2314	27642	1187	6369	1840	3334	1452	ligase III, DNA, ATP-dependent (LIG3), nuclear gene encoding mitochondrial protein, transcript variant alpha
B09R06C16	9-16-6	Hs~Ref:NM_013975.1~uORF:IOH40893	3638	1486	2230	2391	28917	1104	6413	1866	3307	1403	ligase III, DNA, ATP-dependent (LIG3), nuclear gene encoding mitochondrial protein, transcript variant alpha
B09R06C17	9-17-6	Hs~Ref:NM_145716.2~uORF:IOH39990	2452	4396	4174	4924	734	2511	6172	1988	5331	960	single stranded DNA binding protein 3 (SSBP3), transcript variant 1
B09R06C18	9-18-6	Hs~Ref:NM_145716.2~uORF:IOH39990	4903	4203	4138	4889	687	2584	6231	1734	4181	1061	single stranded DNA binding protein 3 (SSBP3), transcript variant 1
B09R06C19	9-19-6	Hs~MGC:BC010033.1~uORF:IOH27835	2579	3563	1289	623	513	1070	4677	1339	1707	482	quinolinate phosphoribosyltransferase (nicotinate-nucleotide pyrophosphorylase (carboxylating)) (QPRT)
B09R06C20	9-20-6	Hs~MGC:BC010033.1~uORF:IOH27835	1379	3125	1316	587	513	1108	4608	1706	1684	514	quinolinate phosphoribosyltransferase (nicotinate-nucleotide pyrophosphorylase (carboxylating)) (QPRT)
B09R06C21	9-21-6	Hs~MGC:BC040946.1~uORF:IOH26289	2438	1526	4994	2871	1793	2761	1911	3060	2007	712	CWC15 homolog (S. cerevisiae) (HSPC148)
B09R06C22	9-22-6	Hs~MGC:BC040946.1~uORF:IOH26289	2277	1394	4592	3002	1858	3193	1777	2947	1934	574	CWC15 homolog (S. cerevisiae) (HSPC148)
B09R07C01	9-1-7	Hs~Ref:NM_005675.2~uORF:IOH26597	448	656	1385	889	2334	504	730	519	2266	357	DiGeorge syndrome critical region gene 6 (DGCR6)
B09R07C02	9-2-7	Hs~Ref:NM_005675.2~uORF:IOH26597	407	579	1371	910	2154	485	736	527	2188	362	DiGeorge syndrome critical region gene 6 (DGCR6)
B09R07C03	9-3-7	Hs~MGC:NM_173806.2~uORF:IOH26314	649	424	757	364	277	437	758	359	973	327	chromosome 16 open reading frame 65 (C16orf65)
B09R07C04	9-4-7	Hs~MGC:NM_173806.2~uORF:IOH26314	736	424	775	335	258	474	776	351	997	333	chromosome 16 open reading frame 65 (C16orf65)
B09R07C05	9-5-7	Hs~MGC:BC003383.1~uORF:IOH2969	421	330	533	226	205	312	666	294	897	212	transcription factor B2, mitochondrial (TFB2M)
B09R07C06	9-6-7	Hs~MGC:BC003383.1~uORF:IOH2969	375	336	620	244	142	429	695	296	840	310	transcription factor B2, mitochondrial (TFB2M)
B09R07C07	9-7-7	Hs~MGC:NM_181795.1~uORF:IOH27983	278	257	585	254	364	732	489	387	1146	108	protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 1
B09R07C08	9-8-7	Hs~MGC:NM_181795.1~uORF:IOH27983	301	241	535	249	388	489	491	410	1198	182	protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 1
B09R07C09	9-9-7	Hs~Ref:NM_000181.1~uORF:IOH29680	387	343	498	243	325	475	643	396	1436	235	glucuronidase, beta (GUSB)
B09R07C10	9-10-7	Hs~Ref:NM_000181.1~uORF:IOH29680	379	298	598	273	173	421	630	339	1425	258	glucuronidase, beta (GUSB)
B09R07C11	9-11-7	Hs~MGC:BC001149.1~uORF:IOH4457	1216	753	1085	540	703	3370	3134	1420	5345	418	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast) (UTP14A)
B09R07C12	9-12-7	Hs~MGC:BC001149.1~uORF:IOH4457	1200	720	1241	657	785	3442	3053	1520	5698	383	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast) (UTP14A)
B09R07C13	9-13-7	Hs~Ref:NM_005746.1~uORF:IOH44532	1129	3511	3731	929	794	945	1533	1984	2883	384	pre-B-cell colony enhancing factor 1 (PBEF1)
B09R07C14	9-14-7	Hs~Ref:NM_005746.1~uORF:IOH44532	1101	2979	3715	922	1303	823	1649	1996	2877	404	pre-B-cell colony enhancing factor 1 (PBEF1)
B09R07C15	9-15-7	Hs~Ref:NM_178154.1~uORF:IOH44218	1032	1203	1877	824	3089	1231	1878	1116	2051	707	fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 2
B09R07C16	9-16-7	Hs~Ref:NM_178154.1~uORF:IOH44218	1037	1031	1715	829	3018	1206	1917	1024	2278	644	fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 2
B09R07C17	9-17-7	Hs~Ref:NM_012170.2~uORF:IOH42104	1107	869	1246	765	1059	921	2493	800	2450	574	F-box protein 22 (FBXO22), transcript variant 2
B09R07C18	9-18-7	Hs~Ref:NM_012170.2~uORF:IOH42104	3926	894	1237	708	1055	894	2186	780	2340	538	F-box protein 22 (FBXO22), transcript variant 2
B09R07C19	9-19-7	Hs~Ref:NM_052936.2~uORF:IOH42076	392	252	354	748	1107	496	601	218	678	137	ATG4 autophagy related 4 homolog A (S. cerevisiae) (ATG4A), transcript variant 1
B09R07C20	9-20-7	Hs~Ref:NM_052936.2~uORF:IOH42076	21228	296	341	734	1161	476	638	424	945	165	ATG4 autophagy related 4 homolog A (S. cerevisiae) (ATG4A), transcript variant 1
B09R07C21	9-21-7	Hs~MGC:BC024269.1~uORF:IOH13934	1480	821	1309	787	836	1018	2174	801	2759	674	major histocompatibility complex, class II, DR beta 1 (HLA-DRB1)
B09R07C22	9-22-7	Hs~MGC:BC024269.1~uORF:IOH13934	1343	798	1217	793	887	1159	2001	815	2394	719	major histocompatibility complex, class II, DR beta 1 (HLA-DRB1)
B09R08C01	9-1-8	Hs~Ref:NM_016641.2~uORF:IOH14021	1408	1258	1647	889	1185	1457	2567	1038	2980	842	membrane interacting protein of RGS16 (MIR16)
B09R08C02	9-2-8	Hs~Ref:NM_016641.2~uORF:IOH14021	1314	1525	2485	853	1035	1415	2638	1088	2814	806	membrane interacting protein of RGS16 (MIR16)
B09R08C05	9-5-8	Hs~MGC:BC010081.2~uORF:IOH13727	701	785	1102	767	1062	1254	1740	1307	2793	513	mannosidase, alpha, class 2C, member 1 (MAN2C1)
B09R08C06	9-6-8	Hs~MGC:BC010081.2~uORF:IOH13727	677	770	1079	771	893	1258	1796	1233	2577	475	mannosidase, alpha, class 2C, member 1 (MAN2C1)
B09R08C07	9-7-8	Hs~Ref:NM_005268.1~uORF:IOH5587	962	675	1208	877	1221	700	1263	718	2522	887	gap junction protein, beta 5 (GJB5)
B09R08C08	9-8-8	Hs~Ref:NM_005268.1~uORF:IOH5587	973	652	1167	907	1194	590	1028	671	2339	858	gap junction protein, beta 5 (GJB5)
B09R08C09	9-9-8	Hs~Ref:NM_004155.2~uORF:IOH4093	392	453	523	277	334	591	751	262	766	220	serpin peptidase inhibitor, clade B (ovalbumin), member 9 (SERPINB9)
B09R08C10	9-10-8	Hs~Ref:NM_004155.2~uORF:IOH4093	383	376	541	278	367	576	761	266	739	108	serpin peptidase inhibitor, clade B (ovalbumin), member 9 (SERPINB9)
B09R08C11	9-11-8	Hs~Ref:NM_005666.1~uORF:IOH13657	717	470	943	485	549	592	1371	501	957	339	complement factor H-related 2 (CFHR2)
B09R08C12	9-12-8	Hs~Ref:NM_005666.1~uORF:IOH13657	691	458	954	509	738	659	1469	473	1046	361	complement factor H-related 2 (CFHR2)
B09R08C13	9-13-8	Hs~MGC:BC010451.1~uORF:IOH9645	2117	1030	1284	2437	1167	740	2654	511	2000	2301	CDC42 effector protein (Rho GTPase binding) 4 (CDC42EP4)
B09R08C14	9-14-8	Hs~MGC:BC010451.1~uORF:IOH9645	2051	964	1248	2457	1139	746	2554	533	1898	2393	CDC42 effector protein (Rho GTPase binding) 4 (CDC42EP4)
B09R08C15	9-15-8	Hs~Ref:NM_018105.1~uORF:IOH10776	2027	1047	1921	1092	851	1196	8765	951	2552	573	THAP domain containing, apoptosis associated protein 1 (THAP1), transcript variant 1
B09R08C16	9-16-8	Hs~Ref:NM_018105.1~uORF:IOH10776	2109	1076	1910	1079	897	1158	9094	904	2542	542	THAP domain containing, apoptosis associated protein 1 (THAP1), transcript variant 1
B09R08C17	9-17-8	Hs~MGC:BC037780.2~uORF:IOH27748	1700	686	1795	1193	585	760	1164	606	1157	356	Glutamate decarboxylase 1
B09R08C18	9-18-8	Hs~MGC:BC037780.2~uORF:IOH27748	11150	688	1751	1201	557	755	1117	586	1071	334	Glutamate decarboxylase 1
B09R08C19	9-19-8	Hs~MGC:BC036077.1~uORF:IOH27290	16792	405	1486	500	446	938	4710	502	2076	330	G1 to S phase transition 2 (GSPT2)
B09R08C20	9-20-8	Hs~MGC:BC036077.1~uORF:IOH27290	6022	390	1493	517	439	896	4556	490	1906	352	G1 to S phase transition 2 (GSPT2)
B09R08C21	9-21-8	Hs~MGC:BC030530.1~uORF:IOH21699	566	1477	1950	410	342	621	954	762	1740	305	synovial apoptosis inhibitor 1, synoviolin (SYVN1)
B09R08C22	9-22-8	Hs~MGC:BC030530.1~uORF:IOH21699	463	1331	1827	388	482	452	904	1185	1430	329	synovial apoptosis inhibitor 1, synoviolin (SYVN1)
B09R09C01	9-1-9	Hs~MGC:BC001487.2~uORF:IOH12155	2467	1283	2384	1093	2337	1162	8156	1348	3126	790	TAR DNA-binding protein 43
B09R09C02	9-2-9	Hs~MGC:BC001487.2~uORF:IOH12155	2313	1318	2475	1143	2178	1226	8306	1392	2987	764	TAR DNA-binding protein 43
B09R09C03	9-3-9	Hs~Ref:NM_145699.2~uORF:IOH35258	1417	1253	1765	701	1275	1036	1623	948	3058	577	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A (APOBEC3A)
B09R09C04	9-4-9	Hs~Ref:NM_145699.2~uORF:IOH35258	1404	1273	1801	723	1299	1098	1673	961	3083	517	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A (APOBEC3A)
B09R09C05	9-5-9	Hs~Ref:NM_005118.2~uORF:IOH35359	881	966	1415	779	867	943	1608	1063	2685	634	tumor necrosis factor (ligand) superfamily, member 15 (TNFSF15)
B09R09C06	9-6-9	Hs~Ref:NM_005118.2~uORF:IOH35359	869	965	1405	826	939	1054	1713	1110	2642	585	tumor necrosis factor (ligand) superfamily, member 15 (TNFSF15)
B09R09C07	9-7-9	Hs~Ref:NM_006634.2~uORF:IOH12607	854	766	948	817	735	974	1349	589	1562	495	vesicle-associated membrane protein 5 (myobrevin) (VAMP5)
B09R09C08	9-8-9	Hs~Ref:NM_006634.2~uORF:IOH12607	840	767	1002	792	746	735	1181	571	1529	540	vesicle-associated membrane protein 5 (myobrevin) (VAMP5)
B09R09C09	9-9-9	Hs~Ref:NM_000371.1~uORF:IOH14065	755	315	454	253	311	381	565	286	622	162	transthyretin (prealbumin, amyloidosis type I) (TTR)
B09R09C10	9-10-9	Hs~Ref:NM_000371.1~uORF:IOH14065	730	334	476	234	306	343	545	291	596	361	transthyretin (prealbumin, amyloidosis type I) (TTR)
B09R09C11	9-11-9	Hs~MGC:BC017981.1~uORF:IOH13989	903	623	1039	600	900	656	1089	747	1152	379	chromosome 8 open reading frame 22 (C8orf22)
B09R09C12	9-12-9	Hs~MGC:BC017981.1~uORF:IOH13989	941	622	1113	569	963	699	1130	702	1225	371	chromosome 8 open reading frame 22 (C8orf22)
B09R09C13	9-13-9	Hs~MGC:BC028711.2~uORF:IOH11814	2391	931	2047	906	947	1134	9381	1270	2195	569	cancer/testis antigen CT45-3 (CT45-3)
B09R09C14	9-14-9	Hs~MGC:BC028711.2~uORF:IOH11814	2246	948	2061	865	957	1083	8512	1305	2115	570	cancer/testis antigen CT45-3 (CT45-3)
B09R09C15	9-15-9	Hs~MGC:BC022888.1~uORF:IOH14209	379	338	591	442	320	468	646	354	627	254	xin actin-binding repeat containing 2 (CMYA3)
B09R09C16	9-16-9	Hs~MGC:BC022888.1~uORF:IOH14209	398	291	601	408	310	414	640	291	623	302	xin actin-binding repeat containing 2 (CMYA3)
B09R09C19	9-19-9	Hs~MGC:BC006252.1~uORF:IOH6330	1496	442	1030	441	554	542	2065	503	1324	356	solute carrier family 6 (neurotransmitter transporter, taurine), member 6 (SLC6A6)
B09R09C20	9-20-9	Hs~MGC:BC006252.1~uORF:IOH6330	788	441	970	444	525	508	2086	541	1474	336	solute carrier family 6 (neurotransmitter transporter, taurine), member 6 (SLC6A6)
B09R09C21	9-21-9	Hs~MGC:NM_175630.1~uORF:IOH27070	603	300	809	299	282	404	812	302	2182	263	DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A), transcript variant 4
B09R09C22	9-22-9	Hs~MGC:NM_175630.1~uORF:IOH27070	591	242	732	267	278	350	750	381	2255	229	DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A), transcript variant 4
B09R10C01	9-1-10	Hs~MGC:BC051790.1~uORF:IOH26984	1428	1470	1488	912	982	831	2706	2733	2049	470	syntaxin 17 (STX17)
B09R10C02	9-2-10	Hs~MGC:BC051790.1~uORF:IOH26984	1340	1463	1452	896	902	983	2823	2745	2095	577	syntaxin 17 (STX17)
B09R10C03	9-3-10	Hs~MGC:BC021995.1~uORF:IOH14627	913	1377	1631	704	599	980	1306	906	2509	653	Signal recognition particle 9 kDa protein
B09R10C04	9-4-10	Hs~MGC:BC021995.1~uORF:IOH14627	918	780	1026	757	615	1060	1391	829	2458	736	Signal recognition particle 9 kDa protein
B09R10C05	9-5-10	Hs~Ref:NM_000431.1~uORF:IOH10122	1367	1040	1946	983	1173	1517	1693	1259	4010	578	Mevalonate kinase
B09R10C06	9-6-10	Hs~Ref:NM_000431.1~uORF:IOH10122	1227	1033	1936	1006	1154	1452	1756	1294	3940	622	Mevalonate kinase
B09R10C07	9-7-10	Hs~Ref:NM_022369.2~uORF:IOH13935	791	634	1122	549	577	755	1585	793	2649	684	stimulated by retinoic acid gene 6 homolog (mouse), mRNA (cDNA clone MGC:39134 IMAGE:4892821), complete cds
B09R10C08	9-8-10	Hs~Ref:NM_022369.2~uORF:IOH13935	770	643	1096	518	654	870	1603	842	2554	727	stimulated by retinoic acid gene 6 homolog (mouse), mRNA (cDNA clone MGC:39134 IMAGE:4892821), complete cds
B09R10C09	9-9-10	Hs~MGC:BC012381.1~uORF:IOH10496	4008	1501	3090	1334	2425	1444	3283	1935	5220	813	Neuropilin and tolloid-like protein 2
B09R10C10	9-10-10	Hs~MGC:BC012381.1~uORF:IOH10496	3871	1579	2924	1322	2667	1336	3389	1839	5313	780	Neuropilin and tolloid-like protein 2
B09R11C21	9-21-11	Hs~MGC:BC026175.1~uORF:IOH12735	248	106	271	196	128	148	368	301	80	39	activating transcription factor 2 (ATF2)
B09R11C22	9-22-11	Hs~MGC:BC026175.1~uORF:IOH12735	236	164	268	194	122	138	366	264	154	118	activating transcription factor 2 (ATF2)
B09R12C01	9-1-12	Hs~Ref:NM_024633.2~uORF:IOH6971	921	652	851	546	2093	574	992	1798	1441	406	chromosome 14 open reading frame 139 (C14orf139)
B09R12C02	9-2-12	Hs~Ref:NM_024633.2~uORF:IOH6971	778	658	890	539	2141	595	1015	1413	1392	426	chromosome 14 open reading frame 139 (C14orf139)
B09R12C03	9-3-12	Hs~MGC:BC035878.1~uORF:IOH25903	597	994	780	411	417	589	787	541	1108	351	solute carrier family 2 (facilitated glucose/fructose transporter), member 5 (SLC2A5)
B09R12C04	9-4-12	Hs~MGC:BC035878.1~uORF:IOH25903	597	1027	1557	476	241	592	875	518	1123	389	solute carrier family 2 (facilitated glucose/fructose transporter), member 5 (SLC2A5)
B09R12C05	9-5-12	Hs~Ref:NM_001832.2~uORF:IOH7303	2378	482	790	462	695	929	863	467	904	434	colipase, pancreatic (CLPS)
B09R12C06	9-6-12	Hs~Ref:NM_001832.2~uORF:IOH7303	948	467	669	458	743	1004	908	470	849	425	colipase, pancreatic (CLPS)
B09R12C07	9-7-12	Hs~MGC:BC057779.1~uORF:IOH29149	1417	629	749	527	634	743	1000	634	1825	462	cytochrome c oxidase subunit IV isoform 2 (lung) (COX4I2)
B09R12C08	9-8-12	Hs~MGC:BC057779.1~uORF:IOH29149	718	600	763	447	699	822	1023	680	1838	499	cytochrome c oxidase subunit IV isoform 2 (lung) (COX4I2)
B09R12C09	9-9-12	Hs~MGC:BC058843.1~uORF:IOH29501	1545	936	2126	955	994	2147	2567	1062	3277	737	zinc finger and BTB domain containing 8 opposite strand (ZBTB8OS)
B09R12C10	9-10-12	Hs~MGC:BC058843.1~uORF:IOH29501	1481	966	2213	890	1142	2507	2571	1086	3084	754	zinc finger and BTB domain containing 8 opposite strand (ZBTB8OS)
B09R12C11	9-11-12	Hs~MGC:BC052639.1~uORF:IOH29043	943	1104	1231	646	1139	967	1831	830	2036	545	mitochondrial ribosomal protein L43 (MRPL43)
B09R12C12	9-12-12	Hs~MGC:BC052639.1~uORF:IOH29043	1008	944	1213	674	1225	980	1903	811	2123	488	mitochondrial ribosomal protein L43 (MRPL43)
B09R12C13	9-13-12	Hs~MGC:BC024038.1~uORF:IOH27782	1235	485	766	603	924	702	874	649	1818	435	tubulin, beta 2C (TUBB2C)
B09R12C14	9-14-12	Hs~MGC:BC024038.1~uORF:IOH27782	1267	484	682	504	994	571	838	629	1845	419	tubulin, beta 2C (TUBB2C)
B09R12C15	9-15-12	Hs~MGC:BC005220.1~uORF:IOH7383	1423	190	430	165	290	583	706	286	2162	150	chaperonin containing TCP1, subunit 8 (theta) (CCT8)
B09R12C16	9-16-12	Hs~MGC:BC005220.1~uORF:IOH7383	1209	92	308	161	258	514	712	252	2044	68	chaperonin containing TCP1, subunit 8 (theta) (CCT8)
B09R12C17	9-17-12	Hs~Ref:NM_014463.1~uORF:IOH7376	437	266	482	226	347	648	373	227	573	78	LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM3)
B09R12C18	9-18-12	Hs~Ref:NM_014463.1~uORF:IOH7376	388	252	476	219	325	824	356	203	577	96	LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM3)
B09R12C19	9-19-12	Hs~MGC:BC054892.1~uORF:IOH29485	190	195	303	250	375	171	243	231	249	61	dynein, light chain, roadblock-type 2 (DYNLRB2)
B09R12C20	9-20-12	Hs~MGC:BC054892.1~uORF:IOH29485	251	258	247	151	282	151	249	259	691	72	dynein, light chain, roadblock-type 2 (DYNLRB2)
B09R12C21	9-21-12	Hs~Ref:NM_000594.2~uORF:IOH21536	577	108	295	202	176	269	390	201	254	641	tumor necrosis factor (TNF superfamily, member 2) (TNF); see catalog number for detailed information on wild-type or point mutant status
B09R12C22	9-22-12	Hs~Ref:NM_000594.2~uORF:IOH21536	228	139	276	210	167	172	420	209	332	80	tumor necrosis factor (TNF superfamily, member 2) (TNF); see catalog number for detailed information on wild-type or point mutant status
B09R13C01	9-1-13	Hs~Ref:NM_004633.3~uORF:IOH26113	609	567	951	449	381	531	940	606	2016	514	interleukin 1 receptor, type II (IL1R2), transcript variant 1
B09R13C02	9-2-13	Hs~Ref:NM_004633.3~uORF:IOH26113	586	593	1003	402	393	625	931	502	2029	511	interleukin 1 receptor, type II (IL1R2), transcript variant 1
B09R13C03	9-3-13	Hs~Ref:NM_032332.2~uORF:IOH6146	1449	1104	62944	1291	681	1787	3443	706	7606	1059	mitogen-activated protein kinase organizer 1 (MORG1), transcript variant 2
B09R13C04	9-4-13	Hs~Ref:NM_032332.2~uORF:IOH6146	1388	1378	65425	1270	894	1936	3451	716	7554	1061	mitogen-activated protein kinase organizer 1 (MORG1), transcript variant 2
B09R13C05	9-5-13	Hs~Ref:NM_000326.3~uORF:IOH5232	688	422	1055	290	384	651	768	414	1071	188	retinaldehyde binding protein 1 (RLBP1)
B09R13C06	9-6-13	Hs~Ref:NM_000326.3~uORF:IOH5232	904	331	607	305	217	592	801	393	1039	188	retinaldehyde binding protein 1 (RLBP1)
B09R13C07	9-7-13	Hs~Ref:NM_000889.1~uORF:IOH12535	597	310	596	347	314	398	806	389	727	284	Integrin beta-7
B09R13C08	9-8-13	Hs~Ref:NM_000889.1~uORF:IOH12535	414	317	606	325	314	857	753	368	727	216	Integrin beta-7
B09R13C09	9-9-13	Hs~Ref:NM_002952.2~uORF:IOH10056	861	651	633	409	369	743	940	483	928	300	40S ribosomal protein S2
B09R13C10	9-10-13	Hs~Ref:NM_002952.2~uORF:IOH10056	766	647	722	382	450	749	937	563	846	295	40S ribosomal protein S2
B09R13C11	9-11-13	Hs~Ref:NM_018091.2~uORF:IOH3126	387	311	524	300	337	315	798	391	602	206	elongation protein 3 homolog (S. cerevisiae) (ELP3)
B09R13C12	9-12-13	Hs~Ref:NM_018091.2~uORF:IOH3126	371	311	626	316	586	483	644	349	589	238	elongation protein 3 homolog (S. cerevisiae) (ELP3)
B09R13C13	9-13-13	Hs~MGC:BC005056.1~uORF:IOH6527	799	726	1243	1030	1268	913	1114	1122	1436	435	Williams Beuren syndrome chromosome region 18 (WBSCR18)
B09R13C14	9-14-13	Hs~MGC:BC005056.1~uORF:IOH6527	778	715	1304	1016	764	908	1147	1152	1511	426	Williams Beuren syndrome chromosome region 18 (WBSCR18)
B09R13C15	9-15-13	Hs~MGC:BC002877.2~uORF:IOH5717	406	281	623	291	275	286	754	408	567	215	Metallophosphoesterase 1
B09R13C16	9-16-13	Hs~MGC:BC002877.2~uORF:IOH5717	414	254	604	256	324	274	694	340	542	247	Metallophosphoesterase 1
B09R13C17	9-17-13	Hs~Ref:NM_006215.2~uORF:IOH12257	692	541	933	459	534	690	1223	517	1475	416	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 (SERPINA4)
B09R13C18	9-18-13	Hs~Ref:NM_006215.2~uORF:IOH12257	714	588	916	513	748	705	1283	544	1638	411	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 (SERPINA4)
B09R13C19	9-19-13	Hs~MGC:BC014452.1~uORF:IOH14883	681	472	942	447	569	543	1239	512	1401	365	cDNA clone IMAGE:4903661, complete cds
B09R13C20	9-20-13	Hs~MGC:BC014452.1~uORF:IOH14883	612	524	894	445	520	543	1209	518	1332	350	cDNA clone IMAGE:4903661, complete cds
B09R13C21	9-21-13	Hs~Ref:NM_002395.2~uORF:IOH12418	614	438	729	412	443	1039	900	447	1183	364	malic enzyme 1, NADP(+)-dependent, cytosolic (ME1)
B09R13C22	9-22-13	Hs~Ref:NM_002395.2~uORF:IOH12418	510	368	746	400	407	1243	952	449	1162	362	malic enzyme 1, NADP(+)-dependent, cytosolic (ME1)
B09R14C01	9-1-14	Hs~MGC:BC028151.1~uORF:IOH11514	480	379	1038	376	294	608	1035	735	1191	384	splicing factor, arginine/serine-rich 17A (SFRS17A)
B09R14C02	9-2-14	Hs~MGC:BC028151.1~uORF:IOH11514	373	384	1095	400	310	667	989	658	1120	331	splicing factor, arginine/serine-rich 17A (SFRS17A)
B09R14C03	9-3-14	Hs~Ref:NM_144970.1~uORF:IOH12670	286	219	599	226	263	861	891	368	720	54	Uncharacterized protein CXorf38
B09R14C04	9-4-14	Hs~Ref:NM_144970.1~uORF:IOH12670	254	235	549	217	105	865	951	413	742	100	Uncharacterized protein CXorf38
B09R14C05	9-5-14	Hs~Ref:NM_152420.1~uORF:IOH23039	1590	842	1758	1138	707	1159	3051	1524	1586	543	chromosome 9 open reading frame 41 (C9orf41)
B09R14C06	9-6-14	Hs~Ref:NM_152420.1~uORF:IOH23039	1516	741	1706	1122	801	1011	3013	1466	1454	512	chromosome 9 open reading frame 41 (C9orf41)
B09R14C07	9-7-14	Hs~MGC:BC070125.1~uORF:IOH40801	511	387	664	359	485	709	1295	562	800	307	ATP-binding cassette, sub-family A (ABC1), member 6 (ABCA6)
B09R14C08	9-8-14	Hs~MGC:BC070125.1~uORF:IOH40801	492	332	692	362	506	865	1360	534	863	323	ATP-binding cassette, sub-family A (ABC1), member 6 (ABCA6)
B09R14C09	9-9-14	Hs~MGC:BC001152.1~uORF:IOH4425	3195	2017	1673	887	3418	1311	2667	1128	3671	795	growth arrest-specific 7 (GAS7)
B09R14C10	9-10-14	Hs~MGC:BC001152.1~uORF:IOH4425	3169	2006	1652	832	3487	1140	2594	1112	3811	812	growth arrest-specific 7 (GAS7)
B09R14C11	9-11-14	Hs~Ref:NM_032019.4~uORF:IOH42550	337	291	647	357	410	694	656	417	1342	349	Histone deacetylase 10
B09R14C12	9-12-14	Hs~Ref:NM_032019.4~uORF:IOH42550	369	450	579	418	700	549	632	434	1330	366	Histone deacetylase 10
B09R14C13	9-13-14	Hs~Ref:NM_175634.1~uORF:IOH42249	1163	1070	2281	1391	3836	831	2222	782	3367	494	Protein CBFA2T1
B09R14C14	9-14-14	Hs~Ref:NM_175634.1~uORF:IOH42249	1132	1083	2222	1339	2684	871	2103	797	3380	495	Protein CBFA2T1
B09R14C15	9-15-14	Hs~Ref:NM_003945.3~uORF:IOH41102	257	286	509	245	255	294	578	349	484	228	V-type proton ATPase subunit e 1
B09R14C16	9-16-14	Hs~Ref:NM_003945.3~uORF:IOH41102	274	314	530	250	290	440	547	366	531	220	V-type proton ATPase subunit e 1
B09R14C17	9-17-14	Hs~Ref:NM_016203.2~uORF:IOH42382	1621	682	1331	644	869	1991	2132	826	1916	551	protein kinase, AMP-activated, gamma 2 non-catalytic subunit (PRKAG2), transcript variant a, mRNA.
B09R14C18	9-18-14	Hs~Ref:NM_016203.2~uORF:IOH42382	1669	718	1343	673	868	1878	2082	905	2018	621	protein kinase, AMP-activated, gamma 2 non-catalytic subunit (PRKAG2), transcript variant a, mRNA.
B09R14C19	9-19-14	Hs~Ref:NM_033064.1~uORF:IOH11249	883	448	1623	1436	458	798	905	1820	678	657	ataxia, cerebellar, Cayman type (caytaxin) (ATCAY)
B09R14C20	9-20-14	Hs~Ref:NM_033064.1~uORF:IOH11249	394	507	1707	1438	490	874	892	1689	549	638	ataxia, cerebellar, Cayman type (caytaxin) (ATCAY)
B09R14C21	9-21-14	Hs~MGC:BC029609.1~uORF:IOH21622	649	351	697	360	2635	542	1428	673	1543	291	hypothetical LOC554206
B09R14C22	9-22-14	Hs~MGC:BC029609.1~uORF:IOH21622	583	349	725	342	2772	555	1424	651	1061	249	hypothetical LOC554206
B09R15C01	9-1-15	Hs~Ref:NM_005750.2~uORF:IOH34751	396	322	639	391	314	447	787	446	724	4	chromosome 4 open reading frame 6 (C4orf6)
B09R15C02	9-2-15	Hs~Ref:NM_005750.2~uORF:IOH34751	396	349	619	406	322	509	777	741	790	101	chromosome 4 open reading frame 6 (C4orf6)
B09R15C03	9-3-15	Hs~Ref:NM_001425.1~uORF:IOH9872	338	307	507	283	238	403	657	667	699	329	epithelial membrane protein 3 (EMP3)
B09R15C04	9-4-15	Hs~Ref:NM_001425.1~uORF:IOH9872	347	290	501	294	196	427	685	428	612	320	epithelial membrane protein 3 (EMP3)
B09R15C05	9-5-15	Hs~Ref:NM_013354.4~uORF:IOH45495	1028	1166	1146	608	760	847	1844	728	1844	518	CCR4-NOT transcription complex, subunit 7 (CNOT7), transcript variant 1
B09R15C06	9-6-15	Hs~Ref:NM_013354.4~uORF:IOH45495	995	865	1297	622	777	907	1685	738	1887	537	CCR4-NOT transcription complex, subunit 7 (CNOT7), transcript variant 1
B09R15C07	9-7-15	Hs~Ref:NM_006062.1~uORF:IOH45944	703	616	1038	766	907	732	1447	620	1829	395	SMYD family member 5 (SMYD5)
B09R15C08	9-8-15	Hs~Ref:NM_006062.1~uORF:IOH45944	739	653	1108	772	958	753	1440	582	1847	401	SMYD family member 5 (SMYD5)
B09R15C09	9-9-15	Hs~Ref:NM_201443.1~uORF:IOH45504	8091	2590	5906	2258	1709	1454	2352	2668	6813	1224	TEA domain family member 4 (TEAD4), transcript variant 3
B09R15C10	9-10-15	Hs~Ref:NM_201443.1~uORF:IOH45504	8220	2526	5923	2148	1892	1252	2296	2514	7062	1256	TEA domain family member 4 (TEAD4), transcript variant 3
B09R15C11	9-11-15	Hs~Ref:NM_201278.1~uORF:IOH45482	2030	976	1470	1064	1376	1362	3491	1555	2439	576	myotubularin related protein 2 (MTMR2), transcript variant 2
B09R15C12	9-12-15	Hs~Ref:NM_201278.1~uORF:IOH45482	2035	967	1418	1100	1414	1211	3386	1539	2448	637	myotubularin related protein 2 (MTMR2), transcript variant 2
B09R15C17	9-17-15	Hs~Ref:NM_000222.1~CAT:P3081	904	595	2035	565	479	855	1355	686	1091	444	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), transcript variant 1; see catalog number for detailed information on wild-type or point mutant status
B09R15C18	9-18-15	Hs~Ref:NM_000222.1~CAT:P3081	1005	619	2049	549	451	833	1431	637	1161	453	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), transcript variant 1; see catalog number for detailed information on wild-type or point mutant status
B09R15C19	9-19-15	Hs~Ref:NM_001014796.1~CAT:PV3870	718	401	1245	1255	469	551	1522	466	2656	632	discoidin domain receptor family, member 2 (DDR2), transcript variant 1
B09R15C20	9-20-15	Hs~Ref:NM_001014796.1~CAT:PV3870	690	401	1209	1202	500	607	1576	545	3008	611	discoidin domain receptor family, member 2 (DDR2), transcript variant 1
B09R15C21	9-21-15	Hs~Ref:NM_144685.3~CAT:PV3852	1209	1706	391	256	374	672	711	1339	422	159	homeodomain interacting protein kinase 4 (HIPK4)
B09R15C22	9-22-15	Hs~Ref:NM_144685.3~CAT:PV3852	1131	1653	349	249	391	630	652	1638	437	209	homeodomain interacting protein kinase 4 (HIPK4)
B09R16C01	9-1-16	Hs~Ref:NM_003993.2~CAT:PV4201	477	412	511	321	180	508	553	465	642	10	CDC-like kinase 2 (CLK2), transcript variant 1
B09R16C02	9-2-16	Hs~Ref:NM_003993.2~CAT:PV4201	424	429	490	301	136	556	571	471	662	8	CDC-like kinase 2 (CLK2), transcript variant 1
B09R16C03	9-3-16	Hs~Ref:NM_006251.4~CAT:PV4672	29	36	712	68	77	1537	250	219	344	22	AMP-activated protein_kinase A1/B1/G1: PRKAA1/B1/G1 sequences are seperated by -- (in protein list file).
B09R16C04	9-4-16	Hs~Ref:NM_006251.4~CAT:PV4672	33	36	765	41	53	1553	264	237	283	26	AMP-activated protein_kinase A1/B1/G1: PRKAA1/B1/G1 sequences are seperated by -- (in protein list file).
B09R16C07	9-7-16	Hs~MGC:BC033817.1~uORF:IOH21867	400	311	275	238	202	305	567	230	518	188	PC4 and SFRS1 interacting protein 1 (PSIP1)
B09R16C08	9-8-16	Hs~MGC:BC033817.1~uORF:IOH21867	386	232	607	253	336	328	553	235	522	176	PC4 and SFRS1 interacting protein 1 (PSIP1)
B09R16C09	9-9-16	Hs~MGC:BC011892.1~uORF:IOH14730	404	1051	553	300	341	779	521	391	606	92	cofactor of BRCA1 (COBRA1)
B09R16C10	9-10-16	Hs~MGC:BC011892.1~uORF:IOH14730	375	1087	574	278	384	949	514	355	589	78	cofactor of BRCA1 (COBRA1)
B09R16C11	9-11-16	Hs~Ref:NM_018243.1~uORF:IOH5880	3037	441	590	285	400	7379	880	1273	755	214	septin 11 (SEPT11)
B09R16C12	9-12-16	Hs~Ref:NM_018243.1~uORF:IOH5880	3089	410	563	279	459	6683	895	1202	697	218	septin 11 (SEPT11)
B09R16C13	9-13-16	Hs~MGC:BC007363.1~uORF:IOH21168	505	3732	701	494	647	652	970	533	1309	449	branched chain ketoacid dehydrogenase kinase (BCKDK)
B09R16C14	9-14-16	Hs~MGC:BC007363.1~uORF:IOH21168	485	2439	778	513	713	571	991	489	1279	484	branched chain ketoacid dehydrogenase kinase (BCKDK)
B09R16C15	9-15-16	Hs~MGC:BC059947.1~uORF:IOH39895	4166	3445	3739	3848	3795	2873	6378	17208	7376	14968	chondrosarcoma associated gene 1 (CSAG1)
B09R16C16	9-16-16	Hs~MGC:BC059947.1~uORF:IOH39895	4081	3335	3831	3771	3756	2864	6166	16497	7503	15309	chondrosarcoma associated gene 1 (CSAG1)
B09R16C17	9-17-16	Hs~Ref:NM_001008896.1~uORF:IOH50198	1283	1262	1852	1058	2661	2166	3015	1572	4560	833	chromosome 1 open reading frame 213 (C1orf213), transcript variant 2
B09R16C18	9-18-16	Hs~Ref:NM_001008896.1~uORF:IOH50198	1312	1113	1836	1054	2441	1980	2954	1530	4434	868	chromosome 1 open reading frame 213 (C1orf213), transcript variant 2
B09R16C19	9-19-16	Hs~Ref:NM_139168.1~uORF:IOH37855	1282	813	1325	877	1951	1231	6826	847	1973	449	splicing factor, arginine/serine-rich 12 (SFRS12), transcript variant 2
B09R16C20	9-20-16	Hs~Ref:NM_139168.1~uORF:IOH37855	1210	824	1273	917	1987	1339	6640	894	2098	453	splicing factor, arginine/serine-rich 12 (SFRS12), transcript variant 2
B09R16C21	9-21-16	Hs~MGC:BC067301.1~uORF:IOH40043	771	735	1020	636	1582	1138	1765	902	2204	821	AT-rich interactive domain-containing protein 5A
B09R16C22	9-22-16	Hs~MGC:BC067301.1~uORF:IOH40043	777	755	1051	625	1694	1070	1837	949	2223	793	AT-rich interactive domain-containing protein 5A
B09R17C01	9-1-17	Hs~MGC:BC011414.1~uORF:IOH9720	1023	965	2174	1342	2668	1448	2257	863	3891	1719	chromosome 5 open reading frame 3 (C5orf3)
B09R17C02	9-2-17	Hs~MGC:BC011414.1~uORF:IOH9720	957	1030	2270	1356	2687	1472	2141	896	4162	1501	chromosome 5 open reading frame 3 (C5orf3)
B09R17C03	9-3-17	Hs~Ref:NM_198513.1~uORF:IOH11823	1059	749	2696	968	1767	1685	2510	1593	3287	520	PHD finger protein 20-like 1 (PHF20L1), transcript variant 3
B09R17C04	9-4-17	Hs~Ref:NM_198513.1~uORF:IOH11823	1038	739	2499	998	1721	1695	2414	1923	3162	481	PHD finger protein 20-like 1 (PHF20L1), transcript variant 3
B09R17C05	9-5-17	Hs~Ref:NM_006252.2~uORF:IOH29876	940	788	1359	644	1505	1717	2318	1296	2636	501	AMP-activated protein_kinase A2/B1/G1: PRKAA2/B1/G1 sequences are seperated by -- (in protein list file).
B09R17C06	9-6-17	Hs~Ref:NM_006252.2~uORF:IOH29876	960	784	1631	665	1563	1592	2122	973	2624	522	AMP-activated protein_kinase A2/B1/G1: PRKAA2/B1/G1 sequences are seperated by -- (in protein list file).
B09R17C07	9-7-17	Hs~MGC:BC028244.1~uORF:IOH11643	861	642	2462	613	1093	1288	1704	841	1893	428	E2F transcription factor 8 (E2F8)
B09R17C08	9-8-17	Hs~MGC:BC028244.1~uORF:IOH11643	795	631	2276	600	1241	1284	1765	841	1922	453	E2F transcription factor 8 (E2F8)
B09R17C09	9-9-17	Hs~MGC:BC010056.2~uORF:IOH13015	892	627	1258	647	705	1105	2255	791	1817	493	melanoma antigen family F, 1 (MAGEF1)
B09R17C10	9-10-17	Hs~MGC:BC010056.2~uORF:IOH13015	885	717	1298	676	674	1163	2150	799	1929	494	melanoma antigen family F, 1 (MAGEF1)
B09R17C11	9-11-17	Hs~MGC:BC036031.1~uORF:IOH27208	865	799	1116	563	721	897	1321	734	1735	497	snRNA-activating protein complex subunit 3
B09R17C12	9-12-17	Hs~MGC:BC036031.1~uORF:IOH27208	804	766	1064	634	856	863	1512	674	1861	600	snRNA-activating protein complex subunit 3
B09R17C13	9-13-17	Hs~Ref:NM_139010.1~uORF:IOH35167	699	833	1187	603	780	1065	1432	632	2005	500	hemochromatosis (HFE), transcript variant 10
B09R17C14	9-14-17	Hs~Ref:NM_139010.1~uORF:IOH35167	686	677	1153	659	962	838	1515	627	1961	506	hemochromatosis (HFE), transcript variant 10
B09R17C15	9-15-17	Hs~Ref:XM_496191.1~uORF:IOH35170	642	616	924	572	1594	752	1233	641	1476	511	PREDICTED: Homo sapiens family with sequence similarity 106, member B (FAM106B)
B09R17C16	9-16-17	Hs~Ref:XM_496191.1~uORF:IOH35170	640	559	888	586	1433	42	1312	614	1489	529	PREDICTED: Homo sapiens family with sequence similarity 106, member B (FAM106B)
B09R17C17	9-17-17	Hs~Ref:NM_001786.2~uORF:IOH14583	1280	1372	2005	1116	3218	2484	3072	1745	4318	858	cell division cycle 2, G1 to S and G2 to M (CDC2), transcript variant 1
B09R17C18	9-18-17	Hs~Ref:NM_001786.2~uORF:IOH14583	1205	1257	1925	1061	3162	2385	3026	1691	4310	866	cell division cycle 2, G1 to S and G2 to M (CDC2), transcript variant 1
B09R17C19	9-19-17	Hs~MGC:BC027900.1~uORF:IOH27306	983	879	1573	826	2085	1648	2624	1250	3169	625	rhomboid domain containing 1 (RHBDD1)
B09R17C20	9-20-17	Hs~MGC:BC027900.1~uORF:IOH27306	981	977	1521	838	2006	1713	2834	1153	3074	628	rhomboid domain containing 1 (RHBDD1)
B09R17C21	9-21-17	Hs~MGC:BC035006.2~uORF:IOH27161	952	1052	1521	700	2341	2032	2571	1186	3296	617	forty-two-three domain containing 1 (FYTTD1)
B09R17C22	9-22-17	Hs~MGC:BC035006.2~uORF:IOH27161	938	969	1521	712	2607	1910	2445	1187	2828	647	forty-two-three domain containing 1 (FYTTD1)
B09R18C01	9-1-18	Hs~Ref:NM_178552.2~uORF:IOH27375	1541	2315	4528	1339	3159	1901	5163	1195	2959	740	chromosome 22 open reading frame 33 (C22orf33)
B09R18C02	9-2-18	Hs~Ref:NM_178552.2~uORF:IOH27375	1296	2325	4610	1275	3170	1964	5179	1242	3063	828	chromosome 22 open reading frame 33 (C22orf33)
B09R18C03	9-3-18	Hs~MGC:BC062422.1~uORF:IOH40746	592	532	946	457	388	806	1076	565	1291	378	interleukin 27 (IL27)
B09R18C04	9-4-18	Hs~MGC:BC062422.1~uORF:IOH40746	621	550	935	454	395	807	1036	572	1271	378	interleukin 27 (IL27)
B09R18C05	9-5-18	Hs~Ref:NM_024567.2~uORF:IOH40784	698	914	652	988	3373	1088	3278	5197	2221	376	homeobox containing 1 (HMBOX1)
B09R18C06	9-6-18	Hs~Ref:NM_024567.2~uORF:IOH40784	638	1181	622	984	3449	1154	3158	5482	2284	379	homeobox containing 1 (HMBOX1)
B09R18C07	9-7-18	Hs~MGC:BC062663.1~uORF:IOH40734	684	837	1420	460	583	652	1357	505	1144	351	ADAM metallopeptidase domain 33 (ADAM33)
B09R18C08	9-8-18	Hs~MGC:BC062663.1~uORF:IOH40734	732	605	1294	471	525	712	1266	524	1248	391	ADAM metallopeptidase domain 33 (ADAM33)
B09R18C09	9-9-18	Hs~Ref:NM_001008218.1~uORF:IOH40716	444	370	746	346	403	463	711	506	962	315	amylase, alpha 1B (salivary) (AMY1B)
B09R18C10	9-10-18	Hs~Ref:NM_001008218.1~uORF:IOH40716	490	389	674	373	438	782	703	464	997	382	amylase, alpha 1B (salivary) (AMY1B)
B09R18C11	9-11-18	Hs~Ref:NM_182943.2~uORF:IOH41898	474	415	588	344	394	666	1039	619	938	365	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
B09R18C12	9-12-18	Hs~Ref:NM_182943.2~uORF:IOH41898	558	402	673	398	1774	748	981	516	854	385	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
B09R18C13	9-13-18	Hs~MGC:BC030262.1~uORF:IOH21525	462	426	751	357	672	646	850	548	983	325	ADAMTS-like 1 (ADAMTSL1)
B09R18C14	9-14-18	Hs~MGC:BC030262.1~uORF:IOH21525	473	1071	752	369	558	607	894	556	890	319	ADAMTS-like 1 (ADAMTSL1)
B09R18C15	9-15-18	Hs~Ref:NM_003862.1~uORF:IOH6319	1214	1173	973	586	523	947	5511	887	1220	484	Fibroblast growth factor 18
B09R18C16	9-16-18	Hs~Ref:NM_003862.1~uORF:IOH6319	1249	726	1065	598	479	903	3899	658	1177	511	Fibroblast growth factor 18
B09R18C17	9-17-18	Hs~Ref:NM_014044.4~uORF:IOH11358	899	945	1376	834	834	876	2483	1105	1591	577	Protein unc-50 homolog
B09R18C18	9-18-18	Hs~Ref:NM_014044.4~uORF:IOH11358	921	918	1285	851	1030	826	2235	1049	1725	522	Protein unc-50 homolog
B09R18C19	9-19-18	Hs~MGC:BC017702.1~uORF:IOH11854	590	531	864	579	708	692	1312	733	1611	450	zinc finger, DHHC-type containing 7 (ZDHHC7)
B09R18C20	9-20-18	Hs~MGC:BC017702.1~uORF:IOH11854	607	568	791	515	638	955	1468	684	1403	446	zinc finger, DHHC-type containing 7 (ZDHHC7)
B09R18C21	9-21-18	Hs~MGC:BC057393.1~uORF:IOH28895	773	503	787	880	765	808	2064	725	1471	529	Myotubularin-related protein 12
B09R18C22	9-22-18	Hs~MGC:BC057393.1~uORF:IOH28895	762	438	741	860	1057	801	2048	644	1634	495	Myotubularin-related protein 12
B09R19C01	9-1-19	Hs~MGC:BC054893.1~uORF:IOH29495	8517	7196	7835	8815	6989	6196	7075	6154	9584	7998	immunoglobulin lambda variable 2-14 (IGLV2-14)
B09R19C02	9-2-19	Hs~MGC:BC054893.1~uORF:IOH29495	8126	7230	7958	7799	6924	6309	7453	6391	10442	8205	immunoglobulin lambda variable 2-14 (IGLV2-14)
B09R19C03	9-3-19	Hs~MGC:BC013013.2~uORF:IOH12505	738	663	1002	551	2273	771	2118	629	1331	369	zinc finger protein 526 (ZNF526)
B09R19C04	9-4-19	Hs~MGC:BC013013.2~uORF:IOH12505	737	661	929	567	2318	676	2154	561	1258	366	zinc finger protein 526 (ZNF526)
B09R19C05	9-5-19	Hs~MGC:BC027617.1~uORF:IOH12034	514	403	624	339	261	409	860	533	4388	347	poly(A) binding protein, cytoplasmic 3 (PABPC3)
B09R19C06	9-6-19	Hs~MGC:BC027617.1~uORF:IOH12034	555	381	664	321	254	457	896	795	4418	336	poly(A) binding protein, cytoplasmic 3 (PABPC3)
B09R19C07	9-7-19	Hs~Ref:NM_015895.2~uORF:IOH7292	704	499	1109	533	463	2184	2300	2098	9240	476	geminin, DNA replication inhibitor (GMNN)
B09R19C08	9-8-19	Hs~Ref:NM_015895.2~uORF:IOH7292	1046	462	1038	558	485	2350	2255	2453	8683	478	geminin, DNA replication inhibitor (GMNN)
B09R19C09	9-9-19	Hs~MGC:BC022054.1~uORF:IOH13695	1105	275	653	246	1064	559	831	1410	572	184	chromosome 10 open reading frame 83 (C10orf83)
B09R19C10	9-10-19	Hs~MGC:BC022054.1~uORF:IOH13695	443	287	598	258	1198	661	871	1419	543	161	chromosome 10 open reading frame 83 (C10orf83)
B09R19C11	9-11-19	Hs~MGC:BC012124.1~uORF:IOH12569	794	397	645	370	395	685	1016	436	964	323	cancer susceptibility candidate 4 (CASC4)
B09R19C12	9-12-19	Hs~MGC:BC012124.1~uORF:IOH12569	831	396	699	380	478	852	1009	414	803	328	cancer susceptibility candidate 4 (CASC4)
B09R19C13	9-13-19	Hs~Ref:NM_007029.1~uORF:IOH6398	356	422	611	214	544	653	809	252	515	205	stathmin-like 2 (STMN2)
B09R19C14	9-14-19	Hs~Ref:NM_007029.1~uORF:IOH6398	358	541	591	255	647	626	802	229	362	210	stathmin-like 2 (STMN2)
B09R19C15	9-15-19	Hs~Ref:NM_001422.1~uORF:IOH22142	595	815	875	501	1024	634	1109	698	1317	461	E74-like factor 5 (ets domain transcription factor) (ELF5), transcript variant 2
B09R19C16	9-16-19	Hs~Ref:NM_001422.1~uORF:IOH22142	611	584	876	486	1013	632	514	826	1294	489	E74-like factor 5 (ets domain transcription factor) (ELF5), transcript variant 2
B09R19C17	9-17-19	Hs~MGC:NM_175887.2~uORF:IOH27336	4666	1629	3520	1982	1398	3170	19658	1434	4196	1649	proline rich 15 (PRR15)
B09R19C18	9-18-19	Hs~MGC:NM_175887.2~uORF:IOH27336	4549	1578	3466	1993	1298	3152	20077	1490	4139	1668	proline rich 15 (PRR15)
B09R19C19	9-19-19	Hs~MGC:BC029795.1~uORF:IOH22708	516	387	537	378	367	481	1031	365	1616	352	brain-derived neurotrophic factor (BDNF)
B09R19C20	9-20-19	Hs~MGC:BC029795.1~uORF:IOH22708	472	383	516	356	570	568	944	408	2403	374	brain-derived neurotrophic factor (BDNF)
B09R19C21	9-21-19	Hs~MGC:BC015993.1~uORF:IOH14875	524	337	504	272	351	861	1095	416	720	365	Protein FAM151A
B09R19C22	9-22-19	Hs~MGC:BC015993.1~uORF:IOH14875	532	294	514	306	254	985	1164	515	702	346	Protein FAM151A
B09R20C01	9-1-20	Hs~MGC:BC012535.1~uORF:IOH14189	840	403	814	514	345	685	981	660	919	371	LPS-responsive vesicle trafficking, beach and anchor containing (LRBA)
B09R20C02	9-2-20	Hs~MGC:BC012535.1~uORF:IOH14189	639	391	853	343	338	693	1032	568	894	471	LPS-responsive vesicle trafficking, beach and anchor containing (LRBA)
B09R20C03	9-3-20	Hs~MGC:BC000702.1~uORF:IOH4311	359	312	642	279	327	494	759	411	645	318	Mitochondrial carrier homolog 1
B09R20C04	9-4-20	Hs~MGC:BC000702.1~uORF:IOH4311	398	341	645	263	310	470	887	349	722	263	Mitochondrial carrier homolog 1
B09R20C05	9-5-20	Hs~Ref:NM_006746.1~uORF:IOH22321	523	300	1186	366	569	679	1112	636	1393	260	sex comb on midleg-like 1 (Drosophila) (SCML1), transcript variant 2
B09R20C06	9-6-20	Hs~Ref:NM_006746.1~uORF:IOH22321	425	344	1261	400	569	727	1112	549	1400	298	sex comb on midleg-like 1 (Drosophila) (SCML1), transcript variant 2
B09R20C07	9-7-20	Hs~MGC:BC030592.2~uORF:IOH22341	2602	2498	46132	2415	1339	2964	2834	3503	7284	6553	HIV-1 Rev binding protein (HRB)
B09R20C08	9-8-20	Hs~MGC:BC030592.2~uORF:IOH22341	2937	2126	51036	2334	1350	3554	2657	3406	7340	6539	HIV-1 Rev binding protein (HRB)
B09R20C09	9-9-20	Hs~MGC:BC000001.1~uORF:IOH4593	1605	374	966	494	324	579	1003	537	812	294	chitinase domain containing 1 (CHID1)
B09R20C10	9-10-20	Hs~MGC:BC000001.1~uORF:IOH4593	1251	398	761	475	298	704	1012	535	830	279	chitinase domain containing 1 (CHID1)
B09R20C11	9-11-20	Hs~MGC:BC000082.1~uORF:IOH4680	772	576	910	474	585	755	1280	653	1070	337	Arsenite-resistance protein 2
B09R20C12	9-12-20	Hs~MGC:BC000082.1~uORF:IOH4680	808	590	976	467	678	758	1272	589	1049	398	Arsenite-resistance protein 2
B09R20C13	9-13-20	Hs~Ref:NM_001004299.1~uORF:IOH45686	515	597	1109	780	867	639	7293	476	2700	452	FLJ43980 protein (FLJ43980)
B09R20C14	9-14-20	Hs~Ref:NM_001004299.1~uORF:IOH45686	492	529	1093	825	1101	548	7259	485	2718	473	FLJ43980 protein (FLJ43980)
B10R02C11	10-11-2	Hs~Ref:NM_138451.1~uORF:IOH10717	488	360	553	335	415	386	472	426	839	101	IQ domain-containing protein D
B10R02C12	10-12-2	Hs~Ref:NM_138451.1~uORF:IOH10717	576	346	511	307	460	298	485	457	716	130	IQ domain-containing protein D
B10R02C13	10-13-2	Hs~MGC:BC017717.1~uORF:IOH11300	570	971	627	764	959	1008	1235	483	1002	294	deiodinase, iodothyronine, type III (DIO3)
B10R02C14	10-14-2	Hs~MGC:BC017717.1~uORF:IOH11300	476	685	598	731	895	824	2052	418	1035	300	deiodinase, iodothyronine, type III (DIO3)
B10R02C15	10-15-2	Hs~Ref:NM_021943.1~uORF:IOH22137	514	348	601	521	498	505	2617	606	861	375	zinc finger, AN1-type domain 3 (ZFAND3)
B10R02C16	10-16-2	Hs~Ref:NM_021943.1~uORF:IOH22137	488	357	441	368	609	432	3291	558	878	364	zinc finger, AN1-type domain 3 (ZFAND3)
B10R02C17	10-17-2	Hs~MGC:BC017769.1~uORF:IOH13448	1501	842	695	703	978	1076	1065	740	1023	621	leucine rich repeat transmembrane neuronal 4 (LRRTM4)
B10R02C18	10-18-2	Hs~MGC:BC017769.1~uORF:IOH13448	1564	840	1078	705	899	881	901	750	864	649	leucine rich repeat transmembrane neuronal 4 (LRRTM4)
B10R02C19	10-19-2	Hs~Ref:NM_005324.3~uORF:IOH5791	1244	968	1984	794	1288	830	1463	1023	1897	463	H3 histone, family 3B (H3.3B) (H3F3B)
B10R02C20	10-20-2	Hs~Ref:NM_005324.3~uORF:IOH5791	1569	1002	1558	839	1276	885	1558	1019	1869	413	H3 histone, family 3B (H3.3B) (H3F3B)
B10R02C21	10-21-2	Hs~MGC:BC002526.1~uORF:IOH4058	2267	679	1465	805	1667	921	1821	955	1771	257	heat shock 70kDa protein 4 (HSPA4)
B10R02C22	10-22-2	Hs~MGC:BC002526.1~uORF:IOH4058	2429	672	1421	845	2160	889	1888	870	1767	262	heat shock 70kDa protein 4 (HSPA4)
B10R03C01	10-1-3	Hs~Ref:NM_001707.2~uORF:IOH3200	1134	646	1057	5151	2072	1017	2748	481	2006	207	B-cell CLL/lymphoma 7B (BCL7B)
B10R03C02	10-2-3	Hs~Ref:NM_001707.2~uORF:IOH3200	1059	577	1089	4986	2128	935	2550	527	1904	198	B-cell CLL/lymphoma 7B (BCL7B)
B10R03C03	10-3-3	Hs~MGC:BC000686.1~uORF:IOH4305	1364	1049	1689	745	1236	3667	1499	908	1866	349	Mammalian ependymin-related protein 1
B10R03C04	10-4-3	Hs~MGC:BC000686.1~uORF:IOH4305	1419	1012	1565	701	1250	3606	1495	831	1894	344	Mammalian ependymin-related protein 1
B10R03C05	10-5-3	Hs~Ref:NM_002620.1~uORF:IOH34711	922	426	915	369	511	426	958	438	758	176	platelet factor 4 variant 1 (PF4V1)
B10R03C06	10-6-3	Hs~Ref:NM_002620.1~uORF:IOH34711	811	448	895	348	695	430	957	512	648	112	platelet factor 4 variant 1 (PF4V1)
B10R03C07	10-7-3	Hs~Ref:NM_002824.4~uORF:IOH44357	128	119	1368	178	211	199	459	174	302	23	parathymosin (PTMS)
B10R03C08	10-8-3	Hs~Ref:NM_002824.4~uORF:IOH44357	234	146	1239	181	155	170	433	175	277	21	parathymosin (PTMS)
B10R03C09	10-9-3	Hs~Ref:NM_006664.2~uORF:IOH34759	649	350	684	302	482	339	643	382	491	112	chemokine (C-C motif) ligand 27 (CCL27)
B10R03C10	10-10-3	Hs~Ref:NM_006664.2~uORF:IOH34759	604	357	722	286	426	307	644	339	435	104	chemokine (C-C motif) ligand 27 (CCL27)
B10R03C11	10-11-3	Hs~Ref:NM_001012979.1~uORF:IOH41536	2177	860	1482	468	38166	4567	2318	1185	1544	117	transcription elongation factor A (SII)-like 5 (TCEAL5)
B10R03C12	10-12-3	Hs~Ref:NM_001012979.1~uORF:IOH41536	2431	759	1354	490	38720	4164	2163	958	1032	216	transcription elongation factor A (SII)-like 5 (TCEAL5)
B10R03C15	10-15-3	Hs~Ref:NM_001008393.1~uORF:IOH43514	394	223	294	367	1187	704	748	287	764	175	hypothetical protein LOC201725 (LOC201725)
B10R03C16	10-16-3	Hs~Ref:NM_001008393.1~uORF:IOH43514	376	282	239	355	1331	693	922	268	754	184	hypothetical protein LOC201725 (LOC201725)
B10R03C17	10-17-3	Hs~Ref:NM_016174.3~uORF:IOH42094	392	211	426	175	252	211	338	232	181	43	Glycosyltransferase 25 family member 3
B10R03C18	10-18-3	Hs~Ref:NM_016174.3~uORF:IOH42094	243	235	803	208	220	127	334	193	220	43	Glycosyltransferase 25 family member 3
B10R03C19	10-19-3	Hs~Ref:NM_001009609.1~uORF:IOH44772	1483	730	3040	2331	1358	7015	1399	1886	2408	763	SPANX family, member N3 (SPANXN3)
B10R03C20	10-20-3	Hs~Ref:NM_001009609.1~uORF:IOH44772	1318	764	2716	2345	1360	7109	1448	1846	2393	786	SPANX family, member N3 (SPANXN3)
B10R03C21	10-21-3	Hs~MGC:BC009762.2~uORF:IOH14113	2503	1297	1590	960	1155	1201	6670	956	3099	792	Tripartite motif-containing protein 41
B10R03C22	10-22-3	Hs~MGC:BC009762.2~uORF:IOH14113	2426	1243	1561	917	1112	1232	6875	965	3167	739	Tripartite motif-containing protein 41
B10R04C01	10-1-4	Hs~Ref:NM_031472.1~uORF:IOH5640	2190	2967	3073	2249	2426	6143	6702	2378	1854	1755	tRNA phosphotransferase 1 (TRPT1), transcript variant 2
B10R04C02	10-2-4	Hs~Ref:NM_031472.1~uORF:IOH5640	2127	2763	3020	2216	2548	5499	6216	2530	1858	1698	tRNA phosphotransferase 1 (TRPT1), transcript variant 2
B10R04C03	10-3-4	Hs~Ref:NM_003278.1~uORF:IOH14450	2077	687	1433	650	856	806	4441	680	2023	277	C-type lectin domain family 3, member B (CLEC3B)
B10R04C04	10-4-4	Hs~Ref:NM_003278.1~uORF:IOH14450	2134	660	1384	646	860	735	4485	719	2098	260	C-type lectin domain family 3, member B (CLEC3B)
B10R04C05	10-5-4	Hs~Ref:NM_016401.2~uORF:IOH3734	1757	657	479	340	1316	497	802	577	1520	226	chromosome 11 open reading frame 73 (C11orf73)
B10R04C06	10-6-4	Hs~Ref:NM_016401.2~uORF:IOH3734	1709	634	564	368	1344	462	762	442	1432	185	chromosome 11 open reading frame 73 (C11orf73)
B10R04C07	10-7-4	Hs~MGC:BC020568.1~uORF:IOH10333	713	534	1118	599	1193	669	1067	1708	1331	260	chromosome 10 open reading frame 54 (C10orf54)
B10R04C08	10-8-4	Hs~MGC:BC020568.1~uORF:IOH10333	766	551	1113	586	1294	492	1098	1590	1347	289	chromosome 10 open reading frame 54 (C10orf54)
B10R04C09	10-9-4	Hs~MGC:BC005922.1~uORF:IOH7526	874	697	1019	613	793	605	1186	920	1162	487	islet cell autoantigen 1, 69kDa (ICA1)
B10R04C10	10-10-4	Hs~MGC:BC005922.1~uORF:IOH7526	836	665	986	644	648	653	1160	706	1193	386	islet cell autoantigen 1, 69kDa (ICA1)
B10R04C11	10-11-4	Hs~Ref:NM_000039.1~uORF:IOH7318	156	35	185	19	172	101	109	146	137	21	apolipoprotein A-I (APOA1)
B10R04C12	10-12-4	Hs~Ref:NM_000039.1~uORF:IOH7318	258	70	172	21	82	103	122	96	78	21	apolipoprotein A-I (APOA1)
B10R04C13	10-13-4	Hs~Ref:NM_018668.2~uORF:IOH10175	2789	12614	1400	1593	1041	1665	3023	2665	1519	10003	vacuolar protein sorting 33 homolog B (yeast) (VPS33B)
B10R04C14	10-14-4	Hs~Ref:NM_018668.2~uORF:IOH10175	2678	12257	1318	1651	1121	1579	3134	2040	1501	9562	vacuolar protein sorting 33 homolog B (yeast) (VPS33B)
B10R04C15	10-15-4	Hs~MGC:BC004259.1~uORF:IOH5453	1674	1500	2026	4422	2113	1895	2245	2051	5114	862	chromosome 14 open reading frame 140 (C14orf140)
B10R04C16	10-16-4	Hs~MGC:BC004259.1~uORF:IOH5453	1947	1510	1655	4855	2200	1897	2102	1751	5105	792	chromosome 14 open reading frame 140 (C14orf140)
B10R04C17	10-17-4	Hs~MGC:NM_152769.1~uORF:IOH21544	1089	1637	1212	825	1160	1029	7944	3354	3079	337	Protein Dos
B10R04C18	10-18-4	Hs~MGC:NM_152769.1~uORF:IOH21544	1199	1529	1600	895	1120	982	8484	3336	2936	336	Protein Dos
B10R04C19	10-19-4	Hs~Ref:NM_016607.1~uORF:IOH7393	1419	8864	1589	968	1371	1028	4020	1083	2075	432	armadillo repeat containing, X-linked 3 (ARMCX3), transcript variant 1
B10R04C20	10-20-4	Hs~Ref:NM_016607.1~uORF:IOH7393	1272	8596	1485	973	1206	1083	4145	1126	2090	394	armadillo repeat containing, X-linked 3 (ARMCX3), transcript variant 1
B10R04C21	10-21-4	Hs~Ref:NM_004159.1~uORF:IOH3858	874	975	1039	512	677	736	1376	663	1493	320	proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) (PSMB8), transcript variant 1
B10R04C22	10-22-4	Hs~Ref:NM_004159.1~uORF:IOH3858	856	964	1027	529	588	751	1352	635	1399	297	proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) (PSMB8), transcript variant 1
B10R05C01	10-1-5	Hs~Ref:NM_003746.1~uORF:IOH43452	607	793	670	479	425	4573	1757	420	872	181	dynein, light chain, LC8-type 1 (DYNLL1), transcript variant 3
B10R05C02	10-2-5	Hs~Ref:NM_003746.1~uORF:IOH43452	624	798	669	457	440	4301	1702	475	811	173	dynein, light chain, LC8-type 1 (DYNLL1), transcript variant 3
B10R05C05	10-5-5	Hs~Ref:NM_031296.1~uORF:IOH43454	918	960	65407	2728	1852	2720	5310	915	17801	3036	RAB33B, member RAS oncogene family (RAB33B)
B10R05C06	10-6-5	Hs~Ref:NM_031296.1~uORF:IOH43454	853	964	65466	2835	1976	2635	4910	776	17677	3176	RAB33B, member RAS oncogene family (RAB33B)
B10R05C07	10-7-5	Hs~Ref:NM_001169.2~uORF:IOH43240	396	332	613	514	456	97	542	362	645	72	aquaporin 8 (AQP8)
B10R05C08	10-8-5	Hs~Ref:NM_001169.2~uORF:IOH43240	553	346	599	505	383	415	521	335	556	86	aquaporin 8 (AQP8)
B10R05C09	10-9-5	Hs~MGC:BC067755.1~uORF:IOH40120	12579	7453	6984	7358	6988	7857	14120	7899	8416	4466	potassium channel tetramerisation domain containing 18 (KCTD18)
B10R05C10	10-10-5	Hs~MGC:BC067755.1~uORF:IOH40120	12814	6705	6899	7235	7378	7377	13790	7408	8474	3891	potassium channel tetramerisation domain containing 18 (KCTD18)
B10R05C11	10-11-5	Hs~MGC:BC032416.1~uORF:IOH40215	2500	1210	1742	2772	1336	1407	1364	777	2117	269	serine/arginine repetitive matrix 2 (SRRM2)
B10R05C12	10-12-5	Hs~MGC:BC032416.1~uORF:IOH40215	2399	1094	1733	2503	1333	1307	1397	758	2084	10	serine/arginine repetitive matrix 2 (SRRM2)
B10R05C13	10-13-5	Hs~MGC:BC035143.1~uORF:IOH40223	2669	2793	2602	31425	1457	3449	2990	2858	4122	1573	Tigger transposable element-derived protein 1
B10R05C14	10-14-5	Hs~MGC:BC035143.1~uORF:IOH40223	2857	3307	2348	31282	1469	3165	2687	2826	4076	1587	Tigger transposable element-derived protein 1
B10R05C15	10-15-5	Hs~MGC:BC068594.1~uORF:IOH40084	2085	2106	42468	10764	1806	3700	2618	1674	2212	521	chromosome 1 open reading frame 213 (C1orf213)
B10R05C16	10-16-5	Hs~MGC:BC068594.1~uORF:IOH40084	2122	1769	44073	11277	1835	3499	2622	1451	2183	508	chromosome 1 open reading frame 213 (C1orf213)
B10R05C17	10-17-5	Hs~Ref:NM_206918.1~uORF:IOH39844	612	431	587	376	377	411	619	545	601	86	Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2
B10R05C18	10-18-5	Hs~Ref:NM_206918.1~uORF:IOH39844	553	444	633	424	355	440	622	463	690	155	Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2
B10R05C19	10-19-5	Hs~MGC:BC024194.2~uORF:IOH40195	905	739	1555	632	1158	1070	1434	656	1420	503	3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase-like 1 (HMGCLL1)
B10R05C20	10-20-5	Hs~MGC:BC024194.2~uORF:IOH40195	875	850	1430	629	1050	933	1477	682	1499	427	3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase-like 1 (HMGCLL1)
B10R05C21	10-21-5	Hs~Ref:NM_173517.3~uORF:IOH40649	492	627	3316	321	398	508	695	481	957	191	vitamin K epoxide reductase complex, subunit 1-like 1 (VKORC1L1)
B10R05C22	10-22-5	Hs~Ref:NM_173517.3~uORF:IOH40649	853	602	2863	326	394	462	765	469	931	171	vitamin K epoxide reductase complex, subunit 1-like 1 (VKORC1L1)
B10R06C01	10-1-6	Hs~MGC:BC005286.1~uORF:IOH7309	412	371	434	347	420	398	590	506	823	150	epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A)
B10R06C02	10-2-6	Hs~MGC:BC005286.1~uORF:IOH7309	578	364	473	349	458	382	538	391	272	135	epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A)
B10R06C03	10-3-6	Hs~Ref:NM_001005404.3~uORF:IOH58661	2864	1645	13959	1951	5101	1831	3495	1890	3345	971	Protein yippee-like 2
B10R06C04	10-4-6	Hs~Ref:NM_001005404.3~uORF:IOH58661	2869	1566	14114	1941	5023	1748	3286	2142	3267	925	Protein yippee-like 2
B10R06C05	10-5-6	Hs~Ref:NM_001876.2~uORF:IOH52786	729	797	1233	414	596	738	1663	460	956	249	Carnitine O-palmitoyltransferase 1, liver isoform
B10R06C06	10-6-6	Hs~Ref:NM_001876.2~uORF:IOH52786	676	765	1167	451	703	760	1426	493	980	309	Carnitine O-palmitoyltransferase 1, liver isoform
B10R06C07	10-7-6	Hs~Ref:NM_206853.1~uORF:IOH59363	24822	771	1374	851	948	2456	1516	886	1174	124	Protein quaking
B10R06C08	10-8-6	Hs~Ref:NM_206853.1~uORF:IOH59363	22805	756	1384	789	993	2969	1491	898	1176	131	Protein quaking
B10R06C09	10-9-6	Hs~Ref:NM_080820.3~uORF:IOH54776	1026	623	1646	852	1063	2264	3628	841	8906	573	D-tyrosyl-tRNA(Tyr) deacylase 1
B10R06C10	10-10-6	Hs~Ref:NM_080820.3~uORF:IOH54776	982	633	1577	935	943	2051	3376	952	8274	470	D-tyrosyl-tRNA(Tyr) deacylase 1
B10R06C11	10-11-6	Hs~MGC:BC000108.1~uORF:IOH4735	1424	5461	2702	1531	2229	3222	2994	2025	5932	2908	WW domain containing E3 ubiquitin protein ligase 2 (WWP2)
B10R06C12	10-12-6	Hs~MGC:BC000108.1~uORF:IOH4735	1581	4896	2355	1493	2223	3018	3083	1799	5977	2864	WW domain containing E3 ubiquitin protein ligase 2 (WWP2)
B10R06C13	10-13-6	Hs~MGC:BC000084.1~uORF:IOH4697	1269	733	1093	772	817	1830	1860	908	3013	498	Protein SOLO
B10R06C14	10-14-6	Hs~MGC:BC000084.1~uORF:IOH4697	1156	969	1036	699	845	1738	1971	957	2704	505	Protein SOLO
B10R06C15	10-15-6	Hs~MGC:BC017296.2~uORF:IOH13381	805	617	829	551	1019	644	1157	711	1923	470	sestrin 3 (SESN3)
B10R06C16	10-16-6	Hs~MGC:BC017296.2~uORF:IOH13381	1207	642	896	564	677	672	980	634	1925	480	sestrin 3 (SESN3)
B10R06C17	10-17-6	Hs~MGC:BC009956.1~uORF:IOH12720	845	619	825	544	614	706	1157	848	1837	477	major histocompatibility complex, class II, DP alpha 1 (HLA-DPA1)
B10R06C18	10-18-6	Hs~MGC:BC009956.1~uORF:IOH12720	792	678	867	574	687	666	1293	829	1841	322	major histocompatibility complex, class II, DP alpha 1 (HLA-DPA1)
B10R06C19	10-19-6	Hs~Ref:NM_022491.2~uORF:IOH62643	2145	969	1132	2834	8481	2149	3950	741	4382	299	Sin3 histone deacetylase corepressor complex component SDS3
B10R06C20	10-20-6	Hs~Ref:NM_022491.2~uORF:IOH62643	2134	977	1104	2993	8232	2339	3570	765	4418	300	Sin3 histone deacetylase corepressor complex component SDS3
B10R06C21	10-21-6	Hs~Ref:NM_001003892.1~uORF:IOH60467	1500	971	1328	482	736	580	451	771	17045	149	Dual specificity phosphatase DUPD1
B10R06C22	10-22-6	Hs~Ref:NM_001003892.1~uORF:IOH60467	1461	1038	1283	479	725	579	401	759	16659	155	Dual specificity phosphatase DUPD1
B10R07C01	10-1-7	Hs~MGC:BC006818.1~uORF:IOH3186	406	551	761	544	598	1928	730	738	1164	190	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha), mRNA (cDNA clone IMAGE:3448169), complete cds.
B10R07C02	10-2-7	Hs~MGC:BC006818.1~uORF:IOH3186	610	596	742	503	744	1866	724	805	1072	196	1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha), mRNA (cDNA clone IMAGE:3448169), complete cds.
B10R07C03	10-3-7	Hs~MGC:BC004395.1~uORF:IOH5579	620	1234	1926	668	635	1638	1845	517	968	253	Apolipoprotein L2
B10R07C04	10-4-7	Hs~MGC:BC004395.1~uORF:IOH5579	579	1117	1844	649	566	1535	1797	472	914	255	Apolipoprotein L2
B10R07C05	10-5-7	Hs~Ref:NM_152991.1~uORF:IOH41083	1507	802	1969	884	945	927	3892	864	2518	725	embryonic ectoderm development (EED), transcript variant 2
B10R07C06	10-6-7	Hs~Ref:NM_152991.1~uORF:IOH41083	1550	800	1939	878	983	869	3515	833	2301	743	embryonic ectoderm development (EED), transcript variant 2
B10R07C09	10-9-7	Hs~Ref:NM_058229.2~uORF:IOH41318	982	764	1397	643	619	733	1666	915	1643	229	F-box protein 32 (FBXO32), transcript variant 1
B10R07C10	10-10-7	Hs~Ref:NM_058229.2~uORF:IOH41318	991	739	1444	654	657	657	1600	819	1403	349	F-box protein 32 (FBXO32), transcript variant 1
B10R07C11	10-11-7	Hs~Ref:NM_001010971.1~uORF:IOH41645	376	368	725	291	489	346	671	556	1046	177	sterile alpha motif domain containing 13 (SAMD13)
B10R07C12	10-12-7	Hs~Ref:NM_001010971.1~uORF:IOH41645	382	340	653	308	454	373	699	629	1072	143	sterile alpha motif domain containing 13 (SAMD13)
B10R07C13	10-13-7	Hs~MGC:BC024725.1~uORF:IOH11143	2882	737	2571	1405	7305	3507	4592	1434	4771	1275	ankyrin repeat domain 50 (ANKRD50)
B10R07C14	10-14-7	Hs~MGC:BC024725.1~uORF:IOH11143	2874	739	2278	1671	7907	3413	4573	1502	4496	1229	ankyrin repeat domain 50 (ANKRD50)
B10R07C15	10-15-7	Hs~MGC:BC022964.1~uORF:IOH10646	1385	915	1173	5736	812	1157	2785	1049	1334	449	chromosome 1 open reading frame 107 (C1orf107)
B10R07C16	10-16-7	Hs~MGC:BC022964.1~uORF:IOH10646	1429	986	1284	5866	710	1131	2631	1010	1338	452	chromosome 1 open reading frame 107 (C1orf107)
B10R07C17	10-17-7	Hs~Ref:NM_002827.2~uORF:IOH14245	667	485	453	369	595	507	3342	426	1025	374	protein tyrosine phosphatase, non-receptor type 1 (PTPN1)
B10R07C18	10-18-7	Hs~Ref:NM_002827.2~uORF:IOH14245	605	512	484	404	630	518	3474	504	1055	233	protein tyrosine phosphatase, non-receptor type 1 (PTPN1)
B10R07C19	10-19-7	Hs~Ref:NM_003907.1~uORF:IOH9815	2579	1328	2281	2008	949	2034	1222	935	20690	460	eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa (EIF2B5)
B10R07C20	10-20-7	Hs~Ref:NM_003907.1~uORF:IOH9815	2528	1254	2354	2187	954	2093	1165	833	19778	455	eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa (EIF2B5)
B10R07C21	10-21-7	Hs~MGC:BC062302.1~uORF:IOH62980	1004	579	1883	338	983	1169	2872	497	1158	270	Phosphoglycerate mutase 1
B10R07C22	10-22-7	Hs~MGC:BC062302.1~uORF:IOH62980	1049	577	1795	365	935	1176	2929	469	1189	268	Phosphoglycerate mutase 1
B10R08C07	10-7-8	Hs~MGC:BC030773.2~uORF:IOH22301	640	1088	1332	501	593	527	884	621	1462	550	Neuroplastin
B10R08C08	10-8-8	Hs~MGC:BC030773.2~uORF:IOH22301	607	1111	1367	593	756	512	812	662	1436	680	Neuroplastin
B10R08C09	10-9-8	Hs~MGC:BC028983.1~uORF:IOH22379	859	563	884	539	1110	664	1701	766	1483	241	fragile X mental retardation, autosomal homolog 1 (FXR1)
B10R08C10	10-10-8	Hs~MGC:BC028983.1~uORF:IOH22379	790	579	942	587	1085	562	1723	738	1728	331	fragile X mental retardation, autosomal homolog 1 (FXR1)
B10R08C11	10-11-8	Hs~MGC:BC013005.2~uORF:IOH13631	947	1005	1143	723	973	728	2321	790	732	506	IK cytokine, down-regulator of HLA II (IK)
B10R08C12	10-12-8	Hs~MGC:BC013005.2~uORF:IOH13631	989	963	1144	764	808	731	2358	1016	1552	411	IK cytokine, down-regulator of HLA II (IK)
B10R08C13	10-13-8	Hs~MGC:BC013796.1~uORF:IOH21478	2048	887	1937	824	857	1081	6603	973	1791	471	adaptor-related protein complex 2, mu 1 subunit (AP2M1)
B10R08C14	10-14-8	Hs~MGC:BC013796.1~uORF:IOH21478	2282	960	2171	1077	872	1079	6984	835	1772	502	adaptor-related protein complex 2, mu 1 subunit (AP2M1)
B10R08C15	10-15-8	Hs~Ref:NM_004089.1~uORF:IOH10420	489	301	324	361	2263	224	334	1675	3384	1107	TSC22 domain family, member 3 (TSC22D3), transcript variant 2
B10R08C16	10-16-8	Hs~Ref:NM_004089.1~uORF:IOH10420	435	290	336	286	2299	229	315	1610	3375	1095	TSC22 domain family, member 3 (TSC22D3), transcript variant 2
B10R08C17	10-17-8	Hs~MGC:BC018028.1~uORF:IOH11035	1017	588	870	528	577	547	1078	691	1170	449	DTW domain containing 1 (DTWD1)
B10R08C18	10-18-8	Hs~MGC:BC018028.1~uORF:IOH11035	845	609	849	529	595	597	1047	625	1313	396	DTW domain containing 1 (DTWD1)
B10R08C19	10-19-8	Hs~MGC:BC025791.1~uORF:IOH10822	4387	556	1628	570	2210	943	1484	968	1472	324	ghrelin/obestatin preprohormone (GHRL)
B10R08C20	10-20-8	Hs~MGC:BC025791.1~uORF:IOH10822	4269	555	1553	578	2275	956	1433	1027	1519	316	ghrelin/obestatin preprohormone (GHRL)
B10R08C21	10-21-8	Hs~Ref:NM_138463.1~uORF:IOH12071	691	637	890	611	552	775	1282	648	1492	459	TLC domain containing 1 (TLCD1)
B10R08C22	10-22-8	Hs~Ref:NM_138463.1~uORF:IOH12071	640	668	789	597	612	803	1197	683	1445	431	TLC domain containing 1 (TLCD1)
B10R09C01	10-1-9	Hs~Ref:NM_020247.3~uORF:IOH40578	906	462	748	661	484	802	1098	481	1190	212	chaperone, ABC1 activity of bc1 complex homolog (S. pombe) (CABC1), nuclear gene encoding mitochondrial protein
B10R09C02	10-2-9	Hs~Ref:NM_020247.3~uORF:IOH40578	840	661	748	490	494	712	1019	447	778	151	chaperone, ABC1 activity of bc1 complex homolog (S. pombe) (CABC1), nuclear gene encoding mitochondrial protein
B10R09C03	10-3-9	Hs~MGC:BC064939.1~uORF:IOH40487	558	473	602	387	381	588	1535	457	855	171	vezatin, adherens junctions transmembrane protein (VEZT)
B10R09C04	10-4-9	Hs~MGC:BC064939.1~uORF:IOH40487	557	381	609	388	354	545	1570	482	1394	188	vezatin, adherens junctions transmembrane protein (VEZT)
B10R09C05	10-5-9	Hs~Ref:NM_032625.1~uORF:IOH40804	429	339	652	331	322	443	1119	525	620	179	chromosome 7 open reading frame 13 (C7orf13)
B10R09C06	10-6-9	Hs~Ref:NM_032625.1~uORF:IOH40804	487	347	633	317	290	389	1170	561	714	127	chromosome 7 open reading frame 13 (C7orf13)
B10R09C07	10-7-9	Hs~Ref:NM_001004312.1~uORF:IOH40785	529	369	661	338	419	462	951	443	546	156	receptor (chemosensory) transporter protein 2 (RTP2)
B10R09C08	10-8-9	Hs~Ref:NM_001004312.1~uORF:IOH40785	484	344	641	572	578	441	908	472	835	222	receptor (chemosensory) transporter protein 2 (RTP2)
B10R09C09	10-9-9	Hs~MGC:BC044567.1~uORF:IOH26762	802	378	345	563	378	549	674	455	297	180	pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 3 (PLEKHA3)
B10R09C10	10-10-9	Hs~MGC:BC044567.1~uORF:IOH26762	886	380	378	556	375	591	657	445	502	96	pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 3 (PLEKHA3)
B10R09C11	10-11-9	Hs~Ref:NM_021644.2~uORF:IOH26282	531	395	724	438	553	308	527	372	665	372	heterogeneous nuclear ribonucleoprotein H3 (2H9) (HNRPH3), transcript variant 2H9A
B10R09C12	10-12-9	Hs~Ref:NM_021644.2~uORF:IOH26282	536	391	715	403	502	306	588	362	813	19	heterogeneous nuclear ribonucleoprotein H3 (2H9) (HNRPH3), transcript variant 2H9A
B10R09C13	10-13-9	Hs~MGC:BC044569.1~uORF:IOH26901	333	271	486	344	168	242	337	350	375	75	SEC31 homolog B (S. cerevisiae) (SEC31B)
B10R09C14	10-14-9	Hs~MGC:BC044569.1~uORF:IOH26901	494	266	397	533	165	231	362	281	607	151	SEC31 homolog B (S. cerevisiae) (SEC31B)
B10R09C15	10-15-9	Hs~MGC:NM_173642.1~uORF:IOH26158	295	325	377	264	258	255	402	289	131	209	family with sequence similarity 80, member A (FAM80A)
B10R09C16	10-16-9	Hs~MGC:NM_173642.1~uORF:IOH26158	284	335	486	257	255	270	419	275	377	228	family with sequence similarity 80, member A (FAM80A)
B10R09C17	10-17-9	Hs~Ref:NM_145061.1~uORF:IOH12828	1810	595	4988	887	2598	683	2239	1027	1663	320	chromosome 13 open reading frame 3 (C13orf3)
B10R09C18	10-18-9	Hs~Ref:NM_145061.1~uORF:IOH12828	1823	639	4617	929	2503	711	2253	968	1695	349	chromosome 13 open reading frame 3 (C13orf3)
B10R09C19	10-19-9	Hs~MGC:BC009510.1~uORF:IOH12049	2240	1286	2501	1245	1490	1950	2751	1060	3054	619	chromosome 9 open reading frame 123 (C9orf123)
B10R09C20	10-20-9	Hs~MGC:BC009510.1~uORF:IOH12049	2276	1269	2567	1223	1650	2058	2829	1299	3140	612	chromosome 9 open reading frame 123 (C9orf123)
B10R09C21	10-21-9	Hs~Ref:NM_053050.2~uORF:IOH13265	1459	774	1293	1050	775	1140	904	903	2302	406	mitochondrial ribosomal protein L53 (MRPL53), nuclear gene encoding mitochondrial protein
B10R09C22	10-22-9	Hs~Ref:NM_053050.2~uORF:IOH13265	1481	822	1289	1157	734	1248	992	586	2287	481	mitochondrial ribosomal protein L53 (MRPL53), nuclear gene encoding mitochondrial protein
B10R10C01	10-1-10	Hs~MGC:BC012330.1~uORF:IOH13295	763	754	1098	4918	821	1186	4274	681	1689	185	basic leucine zipper transcription factor, ATF-like 2 (BATF2)
B10R10C02	10-2-10	Hs~MGC:BC012330.1~uORF:IOH13295	810	709	1092	4613	855	1165	3984	600	1532	156	basic leucine zipper transcription factor, ATF-like 2 (BATF2)
B10R10C03	10-3-10	Hs~MGC:BC056917.1~uORF:IOH29050	430	415	492	255	233	351	535	561	480	181	apolipoprotein A-I binding protein (APOA1BP)
B10R10C04	10-4-10	Hs~MGC:BC056917.1~uORF:IOH29050	340	274	418	268	233	350	536	292	334	130	apolipoprotein A-I binding protein (APOA1BP)
B10R10C05	10-5-10	Hs~MGC:BC021670.1~uORF:IOH27879	547	755	727	425	845	662	813	1057	1396	260	ferritin, light polypeptide (FTL)
B10R10C06	10-6-10	Hs~MGC:BC021670.1~uORF:IOH27879	557	745	683	431	884	628	746	1064	1175	245	ferritin, light polypeptide (FTL)
B10R10C09	10-9-10	Hs~MGC:BC056270.1~uORF:IOH29486	439	371	536	306	252	381	740	383	506	260	Methyltransferase-like protein 4
B10R10C10	10-10-10	Hs~MGC:BC056270.1~uORF:IOH29486	397	323	487	273	288	303	672	362	483	117	Methyltransferase-like protein 4
B10R12C01	10-1-12	Hs~MGC:BC017269.2~uORF:IOH29346	1560	387	1492	1308	515	1343	797	3127	2724	275	chromosome 10 open reading frame 47 (C10orf47)
B10R12C02	10-2-12	Hs~MGC:BC017269.2~uORF:IOH29346	1370	408	1427	1297	611	1280	724	2694	2670	305	chromosome 10 open reading frame 47 (C10orf47)
B10R12C05	10-5-12	Hs~MGC:BC046152.1~uORF:IOH28874	428	365	585	353	422	431	687	389	560	349	Selenoprotein P
B10R12C06	10-6-12	Hs~MGC:BC046152.1~uORF:IOH28874	484	401	627	416	456	425	527	409	910	626	Selenoprotein P
B10R12C07	10-7-12	Hs~Ref:NM_006279.2~uORF:IOH26679	1022	774	1103	764	774	1105	1369	1244	3641	790	ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (ST3GAL3), transcript variant 10
B10R12C08	10-8-12	Hs~Ref:NM_006279.2~uORF:IOH26679	986	779	1162	1385	867	1048	1426	1279	3160	679	ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (ST3GAL3), transcript variant 10
B10R12C09	10-9-12	Hs~Ref:NM_032632.3~uORF:IOH27195	1904	765	806	2366	945	1038	1134	1035	2530	2105	poly(A) polymerase alpha (PAPOLA)
B10R12C10	10-10-12	Hs~Ref:NM_032632.3~uORF:IOH27195	1837	762	837	1608	955	970	1131	1033	2531	2165	poly(A) polymerase alpha (PAPOLA)
B10R12C11	10-11-12	Hs~MGC:BC038104.2~uORF:IOH27177	567	648	777	530	692	768	999	823	1709	477	regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1 (RCBTB1)
B10R12C12	10-12-12	Hs~MGC:BC038104.2~uORF:IOH27177	569	604	799	600	560	730	1694	849	1638	550	regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1 (RCBTB1)
B10R12C13	10-13-12	Hs~MGC:BC042674.1~uORF:IOH27340	855	678	1000	632	749	763	3689	844	1499	108	phospholipase B1 (PLB1)
B10R12C14	10-14-12	Hs~MGC:BC042674.1~uORF:IOH27340	920	635	949	879	781	880	1462	821	1557	340	phospholipase B1 (PLB1)
B10R12C15	10-15-12	Hs~MGC:BC100950.1~uORF:IOH63434	475	1671	453	514	328	254	515	371	387	180	Ras association domain-containing protein 3
B10R12C16	10-16-12	Hs~MGC:BC100950.1~uORF:IOH63434	455	1034	479	248	291	245	561	314	408	198	Ras association domain-containing protein 3
B10R12C17	10-17-12	Hs~Ref:NM_022406.1~uORF:IOH13122	568	287	683	366	293	790	455	759	768	168	DNA repair protein XRCC4
B10R12C18	10-18-12	Hs~Ref:NM_022406.1~uORF:IOH13122	512	297	671	238	313	840	441	682	777	60	DNA repair protein XRCC4
B10R12C19	10-19-12	Hs~Ref:NM_018330.2~uORF:IOH12545	679	811	293	297	789	157	1247	652	685	71	KIAA1598 (KIAA1598)
B10R12C20	10-20-12	Hs~Ref:NM_018330.2~uORF:IOH12545	716	790	272	290	689	152	1179	624	667	84	KIAA1598 (KIAA1598)
B10R12C21	10-21-12	Hs~MGC:NM_152670.1~uORF:IOH22560	478	274	389	297	347	365	589	423	785	210	chromosome 2 open reading frame 51 (C2orf51)
B10R12C22	10-22-12	Hs~MGC:NM_152670.1~uORF:IOH22560	459	283	434	316	284	396	592	417	873	92	chromosome 2 open reading frame 51 (C2orf51)
B10R13C01	10-1-13	Hs~MGC:BC030950.1~uORF:IOH23190	751	314	550	349	1266	534	721	477	1321	137	Small nuclear protein PRAC
B10R13C02	10-2-13	Hs~MGC:BC030950.1~uORF:IOH23190	735	370	493	318	1461	509	720	465	1310	140	Small nuclear protein PRAC
B10R13C03	10-3-13	Hs~MGC:BC014949.1~uORF:IOH13331	1241	1391	1342	1991	1036	1622	2608	1791	1944	538	DEXH (Asp-Glu-X-His) box polypeptide 58 (DHX58)
B10R13C04	10-4-13	Hs~MGC:BC014949.1~uORF:IOH13331	1077	1436	1357	2069	1064	1586	2637	1868	2042	503	DEXH (Asp-Glu-X-His) box polypeptide 58 (DHX58)
B10R13C05	10-5-13	Hs~Ref:NM_003910.2~uORF:IOH23209	1682	1412	1841	6001	2208	1120	6727	1087	1880	872	BUD31 homolog (S. cerevisiae) (BUD31)
B10R13C06	10-6-13	Hs~Ref:NM_003910.2~uORF:IOH23209	1830	1355	1897	6058	2239	1109	6473	1077	1851	834	BUD31 homolog (S. cerevisiae) (BUD31)
B10R13C07	10-7-13	Hs~Ref:NM_021999.2~uORF:IOH4165	2159	1007	3178	2245	1288	1153	7863	1498	2037	4252	integral membrane protein 2B (ITM2B)
B10R13C08	10-8-13	Hs~Ref:NM_021999.2~uORF:IOH4165	1690	944	3188	2024	1256	1149	7413	1805	2076	4309	integral membrane protein 2B (ITM2B)
B10R13C09	10-9-13	Hs~Ref:NM_006072.4~uORF:IOH40395	878	475	875	843	575	524	2230	840	1074	237	chemokine (C-C motif) ligand 26 (CCL26)
B10R13C10	10-10-13	Hs~Ref:NM_006072.4~uORF:IOH40395	1017	450	874	779	565	541	2189	731	1191	129	chemokine (C-C motif) ligand 26 (CCL26)
B10R13C11	10-11-13	Hs~MGC:BC063111.1~uORF:IOH40740	457	367	580	422	421	407	1519	667	885	144	gamma-glutamyltransferase 6 homolog (rat) (GGT6)
B10R13C12	10-12-13	Hs~MGC:BC063111.1~uORF:IOH40740	515	388	516	376	412	343	1890	641	640	219	gamma-glutamyltransferase 6 homolog (rat) (GGT6)
B10R13C13	10-13-13	Hs~MGC:BC065041.1~uORF:IOH39974	906	397	895	985	969	533	1246	1015	1030	167	phospholipase B1 (PLB1)
B10R13C14	10-14-13	Hs~MGC:BC065041.1~uORF:IOH39974	954	386	918	1579	985	550	610	933	1048	251	phospholipase B1 (PLB1)
B10R13C15	10-15-13	Hs~Ref:NM_033332.1~uORF:IOH37777	295	294	317	416	581	355	207	374	574	69	CDC14 cell division cycle 14 homolog B (S. cerevisiae) (CDC14B), transcript variant 3
B10R13C16	10-16-13	Hs~Ref:NM_033332.1~uORF:IOH37777	261	343	304	259	582	333	145	352	588	115	CDC14 cell division cycle 14 homolog B (S. cerevisiae) (CDC14B), transcript variant 3
B10R13C19	10-19-13	Hs~Ref:NM_005000.2~uORF:IOH3084	331	264	384	262	244	363	766	292	517	136	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa (NDUFA5), nuclear gene encoding mitochondrial protein
B10R13C20	10-20-13	Hs~Ref:NM_005000.2~uORF:IOH3084	346	258	382	254	209	355	800	341	684	197	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa (NDUFA5), nuclear gene encoding mitochondrial protein
B10R13C21	10-21-13	Hs~Ref:NM_005333.1~uORF:IOH3923	253	225	327	249	283	265	514	237	466	146	holocytochrome c synthase (cytochrome c heme-lyase) (HCCS)
B10R13C22	10-22-13	Hs~Ref:NM_005333.1~uORF:IOH3923	270	243	340	248	215	305	497	236	520	66	holocytochrome c synthase (cytochrome c heme-lyase) (HCCS)
B10R14C01	10-1-14	Hs~MGC:BC015066.1~uORF:IOH13784	357	283	405	725	423	255	1013	687	1142	172	core-binding factor, runt domain, alpha subunit 2; translocated to, 2 (CBFA2T2)
B10R14C02	10-2-14	Hs~MGC:BC015066.1~uORF:IOH13784	373	298	407	661	458	258	968	787	1122	140	core-binding factor, runt domain, alpha subunit 2; translocated to, 2 (CBFA2T2)
B10R14C05	10-5-14	Hs~Ref:NM_053031.2~uORF:IOH59941	595	618	430	245	264	453	1211	1318	165	2808	Myosin light chain kinase, smooth muscle
B10R14C06	10-6-14	Hs~Ref:NM_053031.2~uORF:IOH59941	593	561	423	237	266	430	1187	1532	406	2920	Myosin light chain kinase, smooth muscle
B10R14C09	10-9-14	Hs~Ref:NM_005808.2~uORF:IOH53465	556	358	706	324	443	784	974	425	756	101	CTD small phosphatase-like protein
B10R14C10	10-10-14	Hs~Ref:NM_005808.2~uORF:IOH53465	612	319	662	334	516	747	1051	482	781	158	CTD small phosphatase-like protein
B10R14C11	10-11-14	Hs~MGC:BC104212.1~uORF:IOH63625	5113	312	898	293	473	460	389	408	561	24	Nuclease EXOG, mitochondrial
B10R14C12	10-12-14	Hs~MGC:BC104212.1~uORF:IOH63625	5419	304	876	287	476	442	494	363	573	93	Nuclease EXOG, mitochondrial
B10R14C13	10-13-14	Hs~MGC:BC013396.2~uORF:IOH60266	5177	312	1054	479	625	647	4768	578	14900	193	Titin
B10R14C14	10-14-14	Hs~MGC:BC013396.2~uORF:IOH60266	5110	311	977	505	603	670	4301	577	15866	203	Titin
B10R14C15	10-15-14	Hs~MGC:BC027951.1~uORF:IOH11889	1958	2217	2192	2510	1390	1951	2005	2078	3776	1578	Cas scaffolding protein family member 4
B10R14C16	10-16-14	Hs~MGC:BC027951.1~uORF:IOH11889	1966	2671	2333	2680	1417	1954	2055	2176	3965	1601	Cas scaffolding protein family member 4
B10R14C17	10-17-14	Hs~Ref:NM_004635.2~N/A	206	521	551	181	341	303	848	601	552	84	mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3)
B10R14C18	10-18-14	Hs~Ref:NM_004635.2~N/A	266	523	545	170	319	305	868	523	736	176	mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3)
B10R14C19	10-19-14	Hs~Ref:NM_172201.1~uORF:IOH44398	766	615	826	393	539	727	1107	529	1384	409	Potassium voltage-gated channel subfamily E member 2
B10R14C20	10-20-14	Hs~Ref:NM_172201.1~uORF:IOH44398	761	619	859	431	461	784	994	510	1571	421	Potassium voltage-gated channel subfamily E member 2
B10R14C21	10-21-14	Hs~MGC:BC001632.1~uORF:IOH4852	534	346	536	342	260	666	577	418	977	184	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial
B10R14C22	10-22-14	Hs~MGC:BC001632.1~uORF:IOH4852	479	389	500	329	236	692	596	425	921	182	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial
B10R15C05	10-5-15	Hs~MGC:BC041339.1~uORF:IOH25831	340	384	522	278	332	451	628	396	426	247	chromosome 22 open reading frame 25 (C22orf25)
B10R15C06	10-6-15	Hs~MGC:BC041339.1~uORF:IOH25831	337	372	477	290	346	380	636	385	590	249	chromosome 22 open reading frame 25 (C22orf25)
B10R15C07	10-7-15	Hs~MGC:BC031999.1~uORF:IOH22178	760	939	1172	577	927	1152	1775	655	1321	414	hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (HSD3B1)
B10R15C08	10-8-15	Hs~MGC:BC031999.1~uORF:IOH22178	720	936	1129	583	740	1197	1707	543	1280	400	hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (HSD3B1)
B10R15C09	10-9-15	Hs~MGC:BC036015.1~uORF:IOH27212	353	417	569	909	452	499	617	358	458	330	exostoses (multiple)-like 2 (EXTL2)
B10R15C10	10-10-15	Hs~MGC:BC036015.1~uORF:IOH27212	403	371	572	1114	370	500	536	417	703	311	exostoses (multiple)-like 2 (EXTL2)
B10R15C11	10-11-15	Hs~MGC:NM_178863.2~uORF:IOH27502	1461	650	885	514	512	752	1260	544	1027	429	potassium channel tetramerisation domain containing 13 (KCTD13)
B10R15C12	10-12-15	Hs~MGC:NM_178863.2~uORF:IOH27502	1354	747	921	596	494	697	1236	470	1068	459	potassium channel tetramerisation domain containing 13 (KCTD13)
B10R15C17	10-17-15	Hs~Ref:NM_005923.3~CAT:PV3809	180	565	420	168	173	238	325	212	357	51	mitogen-activated protein kinase kinase kinase 5 (MAP3K5)
B10R15C18	10-18-15	Hs~Ref:NM_005923.3~CAT:PV3809	202	334	421	242	169	241	309	198	362	65	mitogen-activated protein kinase kinase kinase 5 (MAP3K5)
B10R15C19	10-19-15	Hs~Ref:NM_033118.2~CAT:PV3757	837	283	759	4288	213	1248	674	275	2509	106	myosin light chain kinase 2, skeletal muscle (MYLK2)
B10R15C20	10-20-15	Hs~Ref:NM_033118.2~CAT:PV3757	915	298	669	4075	226	1140	691	289	2623	61	myosin light chain kinase 2, skeletal muscle (MYLK2)
B10R16C01	10-1-16	Hs~Ref:NM_001039468.1~CAT:PV3878	2284	1400	1692	2802	1150	1956	4009	6224	2061	1944	MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 3
B10R16C02	10-2-16	Hs~Ref:NM_001039468.1~CAT:PV3878	2227	1444	1590	2404	1223	2364	4249	6649	2004	2011	MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 3
B10R16C03	10-3-16	Hs~Ref:NM_000576.1~CAT_PHC0816	3	7	32	-11	79	9	194	8	28	17	interleukin 1, beta (IL1B)
B10R16C04	10-4-16	Hs~Ref:NM_000576.1~CAT_PHC0816	297	9	100	125	42	52	201	3	33	17	interleukin 1, beta (IL1B)
B10R16C07	10-7-16	Hs~Ref:NM_001002262.1~uORF:IOH53496	1591	314	683	767	456	529	789	2385	1571	210	Zinc finger FYVE domain-containing protein 27
B10R16C08	10-8-16	Hs~Ref:NM_001002262.1~uORF:IOH53496	1429	341	641	800	403	543	817	2328	1619	269	Zinc finger FYVE domain-containing protein 27
B10R16C09	10-9-16	Hs~Ref:NM_001008711.1~uORF:IOH59712	715	1414	2835	1309	4235	1291	2590	863	1781	511	RNA-binding protein with multiple splicing
B10R16C10	10-10-16	Hs~Ref:NM_001008711.1~uORF:IOH59712	657	1308	2822	1019	4441	1252	2863	759	1811	456	RNA-binding protein with multiple splicing
B10R16C11	10-11-16	Hs~Ref:NM_145909.1~uORF:IOH45888	2511	1064	1759	1168	1032	1415	7898	1242	2619	927	Zinc finger protein 323
B10R16C12	10-12-16	Hs~Ref:NM_145909.1~uORF:IOH45888	2493	1078	1672	1143	1143	1369	6986	1282	2574	929	Zinc finger protein 323
B10R16C13	10-13-16	Hs~Ref:NM_015143.1~uORF:IOH59999	697	709	664	364	665	882	793	729	893	139	Methionine aminopeptidase 1
B10R16C14	10-14-16	Hs~Ref:NM_015143.1~uORF:IOH59999	667	699	656	370	713	696	750	709	977	271	Methionine aminopeptidase 1
B10R16C15	10-15-16	Hs~Ref:NM_000918.2~uORF:IOH9865	325	285	315	255	275	553	337	259	366	221	procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (P4HB)
B10R16C16	10-16-16	Hs~Ref:NM_000918.2~uORF:IOH9865	290	719	351	243	256	332	339	316	436	129	procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (P4HB)
B10R16C17	10-17-16	Hs~Ref:NM_018120.3~uORF:IOH13750	667	449	1381	316	499	748	716	792	2	0	armadillo repeat containing 1 (ARMC1)
B10R16C18	10-18-16	Hs~Ref:NM_018120.3~uORF:IOH13750	803	340	1385	298	474	809	683	638	1	0	armadillo repeat containing 1 (ARMC1)
B10R16C19	10-19-16	Hs~MGC:BC004872.2~uORF:IOH5609	2072	391	5024	498	4209	576	1183	956	879	170	family with sequence similarity 107, member B (FAM107B)
B10R16C20	10-20-16	Hs~MGC:BC004872.2~uORF:IOH5609	1975	400	4795	510	4659	618	1212	962	909	134	family with sequence similarity 107, member B (FAM107B)
B10R16C21	10-21-16	Hs~MGC:BC008288.1~uORF:IOH6248	252	242	615	192	507	369	289	467	841	89	UBX domain containing 1 (UBXD1)
B10R16C22	10-22-16	Hs~MGC:BC008288.1~uORF:IOH6248	238	206	571	230	547	386	284	486	863	102	UBX domain containing 1 (UBXD1)
B10R17C01	10-1-17	Hs~MGC:BC024209.1~uORF:IOH14787	290	259	570	237	237	475	533	481	359	107	centromere protein J (CENPJ)
B10R17C02	10-2-17	Hs~MGC:BC024209.1~uORF:IOH14787	260	269	513	249	430	454	572	497	468	149	centromere protein J (CENPJ)
B10R17C03	10-3-17	Hs~Ref:NM_001993.2~uORF:IOH13709	298	380	301	215	128	243	375	1447	301	69	coagulation factor III (thromboplastin, tissue factor) (F3)
B10R17C04	10-4-17	Hs~Ref:NM_001993.2~uORF:IOH13709	391	395	321	230	205	265	383	1153	303	57	coagulation factor III (thromboplastin, tissue factor) (F3)
B10R17C05	10-5-17	Hs~MGC:BC015821.1~uORF:IOH14398	284	209	334	136	368	258	522	824	370	132	myosin, light chain 2, regulatory, cardiac, slow (MYL2)
B10R17C06	10-6-17	Hs~MGC:BC015821.1~uORF:IOH14398	273	249	331	157	394	351	518	821	340	162	myosin, light chain 2, regulatory, cardiac, slow (MYL2)
B10R17C07	10-7-17	Hs~Ref:NM_017566.2~uORF:IOH11408	411	1035	1227	401	1481	436	951	876	4637	327	kelch domain containing 4 (KLHDC4)
B10R17C08	10-8-17	Hs~Ref:NM_017566.2~uORF:IOH11408	387	928	1197	442	1136	481	885	918	4893	180	kelch domain containing 4 (KLHDC4)
B10R17C09	10-9-17	Hs~MGC:BC001214.1~uORF:IOH4802	329	145	359	284	106	227	237	365	194	33	leucine carboxyl methyltransferase 1 (LCMT1)
B10R17C10	10-10-17	Hs~MGC:BC001214.1~uORF:IOH4802	295	158	370	242	145	241	263	361	141	36	leucine carboxyl methyltransferase 1 (LCMT1)
B10R17C11	10-11-17	Hs~Ref:NM_020992.2~uORF:IOH2948	14867	1108	3298	2355	679	2092	2457	17363	927	256	PDZ and LIM domain 1 (elfin) (PDLIM1)
B10R17C12	10-12-17	Hs~Ref:NM_020992.2~uORF:IOH2948	15090	1057	3083	2539	759	1855	2339	16229	926	266	PDZ and LIM domain 1 (elfin) (PDLIM1)
B10R17C13	10-13-17	Hs~MGC:BC003168.1~uORF:IOH5086	203	226	414	159	284	251	943	357	347	-1	Oxysterol-binding protein-related protein 10
B10R17C14	10-14-17	Hs~MGC:BC003168.1~uORF:IOH5086	196	225	362	177	265	128	904	382	354	10	Oxysterol-binding protein-related protein 10
B10R17C15	10-15-17	Hs~MGC:BC005383.1~uORF:IOH7229	1339	361	215	72	2320	348	210	332	128	35	centrin, EF-hand protein, 3 (CDC31 homolog, yeast) (CETN3)
B10R17C16	10-16-17	Hs~MGC:BC005383.1~uORF:IOH7229	1006	329	227	122	2554	358	274	288	142	43	centrin, EF-hand protein, 3 (CDC31 homolog, yeast) (CETN3)
B10R17C17	10-17-17	Hs~Ref:NM_203418.1~uORF:IOH41499	2251	1432	1722	3542	1898	1100	2458	3364	1619	1248	regulator of calcineurin 1 (RCAN1), transcript variant 3
B10R17C18	10-18-17	Hs~Ref:NM_203418.1~uORF:IOH41499	2482	1464	1715	3727	1803	1332	2531	3436	1708	1244	regulator of calcineurin 1 (RCAN1), transcript variant 3
B10R17C21	10-21-17	Hs~MGC:NM_015660.1~uORF:IOH12432	650	387	1082	404	594	696	1091	770	916	398	GTPase IMAP family member 2
B10R17C22	10-22-17	Hs~MGC:NM_015660.1~uORF:IOH12432	643	411	1050	436	677	813	1061	736	943	356	GTPase IMAP family member 2
B10R18C01	10-1-18	Hs~MGC:BC098112.1~uORF:IOH63324	1288	512	2018	812	873	1438	5337	874	1634	375	Histone H2B type 1-N
B10R18C02	10-2-18	Hs~MGC:BC098112.1~uORF:IOH63324	1291	521	2007	721	803	1353	5163	875	1460	333	Histone H2B type 1-N
B10R18C03	10-3-18	Hs~MGC:BC067427.1~uORF:IOH62526	190	192	344	220	167	139	419	226	272	57	Cytochrome P450 1A2
B10R18C04	10-4-18	Hs~MGC:BC067427.1~uORF:IOH62526	291	160	295	267	158	183	424	244	167	50	Cytochrome P450 1A2
B10R18C11	10-11-18	Hs~Ref:NM_002089.1~uORF:IOH13606	676	912	948	849	582	652	1070	831	1594	431	chemokine (C-X-C motif) ligand 2 (CXCL2)
B10R18C12	10-12-18	Hs~Ref:NM_002089.1~uORF:IOH13606	705	875	935	639	574	619	1022	840	1350	444	chemokine (C-X-C motif) ligand 2 (CXCL2)
B10R18C15	10-15-18	Hs~Ref:NM_001047.1~uORF:IOH7304	580	628	898	587	580	780	856	805	1720	604	steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) (SRD5A1)
B10R18C16	10-16-18	Hs~Ref:NM_001047.1~uORF:IOH7304	634	553	981	880	609	743	847	793	1594	381	steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) (SRD5A1)
B10R18C17	10-17-18	Hs~Ref:NM_173608.1~uORF:IOH9994	556	630	818	494	676	966	1016	823	1521	492	chromosome 14 open reading frame 80 (C14orf80)
B10R18C18	10-18-18	Hs~Ref:NM_173608.1~uORF:IOH9994	600	630	787	498	754	822	1160	781	1773	434	chromosome 14 open reading frame 80 (C14orf80)
B10R18C19	10-19-18	Hs~Ref:NM_002561.1~uORF:IOH29559	673	515	785	383	430	3049	983	524	944	191	purinergic receptor P2X, ligand-gated ion channel, 5 (P2RX5), transcript variant 1
B10R18C20	10-20-18	Hs~Ref:NM_002561.1~uORF:IOH29559	496	475	787	382	337	2937	925	490	854	428	purinergic receptor P2X, ligand-gated ion channel, 5 (P2RX5), transcript variant 1
B10R18C21	10-21-18	Hs~MGC:BC058890.1~uORF:IOH29083	572	386	564	346	291	552	1331	564	861	301	TBC1 domain family, member 3 pseudogene 2 (TBC1D3P2)
B10R18C22	10-22-18	Hs~MGC:BC058890.1~uORF:IOH29083	544	358	633	334	259	577	1328	501	744	172	TBC1 domain family, member 3 pseudogene 2 (TBC1D3P2)
B10R19C01	10-1-19	Hs~MGC:BC035364.1~uORF:IOH28677	680	401	1174	501	561	644	2303	689	1051	349	FYVE, RhoGEF and PH domain containing 5 (FGD5)
B10R19C02	10-2-19	Hs~MGC:BC035364.1~uORF:IOH28677	681	437	1111	591	549	634	2125	673	1123	337	FYVE, RhoGEF and PH domain containing 5 (FGD5)
B10R19C03	10-3-19	Hs~MGC:BC028212.1~uORF:IOH28685	1182	344	613	427	743	587	1150	631	915	303	phosphoinositide-3-kinase, regulatory subunit 5, p101 (PIK3R5)
B10R19C04	10-4-19	Hs~MGC:BC028212.1~uORF:IOH28685	1068	393	598	418	767	541	1087	621	672	247	phosphoinositide-3-kinase, regulatory subunit 5, p101 (PIK3R5)
B10R19C05	10-5-19	Hs~MGC:BC063416.1~uORF:IOH61550	331	196	335	274	140	233	320	219	239	94	Cytosolic phospholipase A2 gamma
B10R19C06	10-6-19	Hs~MGC:BC063416.1~uORF:IOH61550	335	295	358	286	179	290	332	203	351	275	Cytosolic phospholipase A2 gamma
B10R19C07	10-7-19	Hs~Ref:NM_014410.4~uORF:IOH11005	180	68	311	148	254	196	249	232	119	28	clusterin-like 1 (retinal) (CLUL1), transcript variant 1
B10R19C08	10-8-19	Hs~Ref:NM_014410.4~uORF:IOH11005	143	79	269	164	125	217	240	214	198	41	clusterin-like 1 (retinal) (CLUL1), transcript variant 1
B10R19C09	10-9-19	Hs~Ref:NM_022060.2~uORF:IOH11269	679	151	330	210	229	157	277	318	-9	47	abhydrolase domain containing 4 (ABHD4)
B10R19C10	10-10-19	Hs~Ref:NM_022060.2~uORF:IOH11269	686	65	336	96	206	143	296	211	284	42	abhydrolase domain containing 4 (ABHD4)
B10R19C11	10-11-19	Hs~Ref:NM_014284.1~uORF:IOH11121	298	64	235	428	152	218	1298	892	649	68	neurochondrin (NCDN), transcript variant 3
B10R19C12	10-12-19	Hs~Ref:NM_014284.1~uORF:IOH11121	177	26	214	429	141	243	1007	999	733	56	neurochondrin (NCDN), transcript variant 3
B10R19C13	10-13-19	Hs~Ref:NM_002876.2~uORF:IOH58772	881	656	1283	646	599	901	1842	1325	1756	268	DNA repair protein RAD51 homolog 3
B10R19C14	10-14-19	Hs~Ref:NM_002876.2~uORF:IOH58772	883	709	1240	635	743	885	1881	1249	1919	213	DNA repair protein RAD51 homolog 3
B10R19C15	10-15-19	Hs~Ref:NM_003339.2~uORF:IOH58973	574	573	920	599	788	766	892	1278	1537	154	Ubiquitin-conjugating enzyme E2 D2
B10R19C16	10-16-19	Hs~Ref:NM_003339.2~uORF:IOH58973	572	542	971	662	993	794	909	1317	1566	164	Ubiquitin-conjugating enzyme E2 D2
B10R19C17	10-17-19	Hs~MGC:NM_198829.1~uORF:IOH58974	608	570	958	409	501	716	1143	973	1096	196	Ras-related C3 botulinum toxin substrate 1
B10R19C18	10-18-19	Hs~MGC:NM_198829.1~uORF:IOH58974	659	560	939	441	521	773	1091	889	1168	84	Ras-related C3 botulinum toxin substrate 1
B10R19C19	10-19-19	Hs~Ref:NM_021128.3~uORF:IOH58928	622	379	587	508	389	593	827	660	890	88	DNA-directed RNA polymerases I, II, and III subunit RPABC5
B10R19C20	10-20-19	Hs~Ref:NM_021128.3~uORF:IOH58928	370	392	502	482	410	580	810	575	890	164	DNA-directed RNA polymerases I, II, and III subunit RPABC5
B10R19C21	10-21-19	Hs~Ref:NM_000854.2~uORF:IOH4186	285	241	478	557	185	342	630	296	602	130	glutathione S-transferase theta 2 (GSTT2)
B10R19C22	10-22-19	Hs~Ref:NM_000854.2~uORF:IOH4186	294	205	433	355	164	281	596	325	561	114	glutathione S-transferase theta 2 (GSTT2)
B10R20C01	10-1-20	Hs~MGC:BC008605.1~uORF:IOH3330	252	226	495	251	415	277	499	472	2182	174	glyoxalase domain containing 4 (GLOD4)
B10R20C02	10-2-20	Hs~MGC:BC008605.1~uORF:IOH3330	261	241	454	330	349	274	518	392	2193	243	glyoxalase domain containing 4 (GLOD4)
B10R20C03	10-3-20	Hs~Ref:NM_005620.1~uORF:IOH4079	221	260	345	198	253	366	303	260	413	99	S100 calcium binding protein A11 (S100A11)
B10R20C04	10-4-20	Hs~Ref:NM_005620.1~uORF:IOH4079	291	300	368	220	292	329	323	296	437	118	S100 calcium binding protein A11 (S100A11)
B10R20C05	10-5-20	Hs~Ref:NM_003662.1~uORF:IOH4076	391	2084	576	344	319	477	700	415	728	344	pirin (iron-binding nuclear protein) (PIR), transcript variant 1
B10R20C06	10-6-20	Hs~Ref:NM_003662.1~uORF:IOH4076	331	1975	567	380	299	460	683	391	657	432	pirin (iron-binding nuclear protein) (PIR), transcript variant 1
B10R20C07	10-7-20	Hs~Ref:NM_021805.1~uORF:IOH5038	1338	878	2109	970	1223	1005	1623	1013	3125	531	single immunoglobulin and toll-interleukin 1 receptor (TIR) domain (SIGIRR)
B10R20C08	10-8-20	Hs~Ref:NM_021805.1~uORF:IOH5038	1305	812	2182	1013	1044	1073	1568	1017	3342	477	single immunoglobulin and toll-interleukin 1 receptor (TIR) domain (SIGIRR)
B10R20C09	10-9-20	Hs~Ref:NM_001197.3~uORF:IOH4916	1001	857	1836	862	1004	867	1167	1010	2079	537	BCL2-interacting killer (apoptosis-inducing) (BIK)
B10R20C10	10-10-20	Hs~Ref:NM_001197.3~uORF:IOH4916	935	868	1918	1045	1013	826	1184	963	1881	517	BCL2-interacting killer (apoptosis-inducing) (BIK)
B10R20C11	10-11-20	Hs~MGC:BC007782.2~uORF:IOH6514	1197	1184	2026	1208	914	848	1232	886	2066	538	immunoglobulin lambda constant 1 (Mcg marker) (IGLC1)
B10R20C12	10-12-20	Hs~MGC:BC007782.2~uORF:IOH6514	1086	1136	2061	993	935	811	1188	986	1867	547	immunoglobulin lambda constant 1 (Mcg marker) (IGLC1)
B10R20C13	10-13-20	Hs~MGC:NM_178553.2~uORF:IOH25885	3850	4809	7706	4302	3373	4491	4988	4541	4973	2452	Uncharacterized protein C2orf53
B10R20C14	10-14-20	Hs~MGC:NM_178553.2~uORF:IOH25885	4116	4780	7085	4454	3873	4727	4657	4593	5375	2560	Uncharacterized protein C2orf53
B11R02C13	11-13-2	Hs~MGC:BC032003.1~uORF:IOH22182	809	585	1541	607	1503	733	832	653	1638	318	serine peptidase inhibitor, Kazal type 6 (SPINK6)
B11R02C14	11-14-2	Hs~MGC:BC032003.1~uORF:IOH22182	778	580	1075	658	1284	577	900	693	1417	371	serine peptidase inhibitor, Kazal type 6 (SPINK6)
B11R02C15	11-15-2	Hs~MGC:BC007228.1~uORF:IOH6059	3715	2215	3027	2769	2334	2257	10955	3419	4170	796	CSAG family, member 3A (CSAG3A)
B11R02C16	11-16-2	Hs~MGC:BC007228.1~uORF:IOH6059	3644	2234	3178	2798	2292	2351	11830	3548	4383	843	CSAG family, member 3A (CSAG3A)
B11R02C17	11-17-2	Hs~MGC:BC029526.1~uORF:IOH22575	452	322	1892	395	597	383	5242	547	1192	620	acyl-Coenzyme A binding domain containing 7 (ACBD7)
B11R02C18	11-18-2	Hs~MGC:BC029526.1~uORF:IOH22575	379	307	1857	368	624	404	5206	515	1266	538	acyl-Coenzyme A binding domain containing 7 (ACBD7)
B11R02C19	11-19-2	Hs~MGC:BC032334.1~uORF:IOH21658	1021	638	910	2977	941	912	2073	593	2555	1897	putative homeodomain transcription factor 2 (PHTF2)
B11R02C20	11-20-2	Hs~MGC:BC032334.1~uORF:IOH21658	1083	663	1631	3019	1069	684	2008	629	3737	2173	putative homeodomain transcription factor 2 (PHTF2)
B11R02C21	11-21-2	Hs~Ref:NM_175907.3~uORF:IOH21771	65479	65451	65440	65482	65460	65464	65391	65435	65465	65481	zinc binding alcohol dehydrogenase, domain containing 2 (ZADH2)
B11R02C22	11-22-2	Hs~Ref:NM_175907.3~uORF:IOH21771	65473	65466	65471	65487	65465	65470	65421	65467	65474	65486	zinc binding alcohol dehydrogenase, domain containing 2 (ZADH2)
B11R03C01	11-1-3	Hs~Ref:NM_001008388.1~uORF:IOH21642	677	607	2261	855	638	529	1180	534	948	248	CDGSH iron sulfur domain-containing protein 2
B11R03C02	11-2-3	Hs~Ref:NM_001008388.1~uORF:IOH21642	666	603	1306	760	606	559	1222	575	954	68	CDGSH iron sulfur domain-containing protein 2
B11R03C03	11-3-3	Hs~MGC:BC030521.2~uORF:IOH21677	177	363	3394	259	378	765	553	131	834	161	mitochondrial ribosomal protein S27 (MRPS27)
B11R03C04	11-4-3	Hs~MGC:BC030521.2~uORF:IOH21677	75	385	2769	261	351	396	547	873	817	213	mitochondrial ribosomal protein S27 (MRPS27)
B11R03C05	11-5-3	Hs~Ref:NM_006578.2~uORF:IOH14466	2643	564	913	464	729	704	927	517	1199	212	guanine nucleotide binding protein (G protein), beta 5 (GNB5), transcript variant 1
B11R03C06	11-6-3	Hs~Ref:NM_006578.2~uORF:IOH14466	2434	555	983	571	687	3451	975	575	1313	348	guanine nucleotide binding protein (G protein), beta 5 (GNB5), transcript variant 1
B11R03C07	11-7-3	Hs~Ref:NM_032837.1~uORF:IOH14641	1321	1165	2502	2635	1138	2072	1248	1715	3335	1589	family with sequence similarity 104, member A (FAM104A), transcript variant 2
B11R03C08	11-8-3	Hs~Ref:NM_032837.1~uORF:IOH14641	1304	1202	2458	2385	1289	2036	1179	1753	3313	1573	family with sequence similarity 104, member A (FAM104A), transcript variant 2
B11R03C09	11-9-3	Hs~MGC:BC014008.1~uORF:IOH13883	654	640	816	478	702	656	959	579	880	311	TNFAIP3 interacting protein 1 (TNIP1)
B11R03C10	11-10-3	Hs~MGC:BC014008.1~uORF:IOH13883	775	695	1017	459	476	687	980	570	1134	47	TNFAIP3 interacting protein 1 (TNIP1)
B11R03C11	11-11-3	Hs~MGC:BC017314.2~uORF:IOH14156	2012	706	1955	442	504	1466	592	781	2246	218	v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) (ETS1)
B11R03C12	11-12-3	Hs~MGC:BC017314.2~uORF:IOH14156	2010	714	1564	455	783	1492	612	800	2374	295	v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) (ETS1)
B11R03C13	11-13-3	Hs~Ref:NM_001250.2~uORF:IOH10427	958	671	1099	654	1188	2814	957	930	1353	508	CD40 molecule, TNF receptor superfamily member 5 (CD40), transcript variant 1
B11R03C14	11-14-3	Hs~Ref:NM_001250.2~uORF:IOH10427	1020	619	1147	788	1113	3150	942	874	1369	547	CD40 molecule, TNF receptor superfamily member 5 (CD40), transcript variant 1
B11R03C15	11-15-3	Hs~Ref:NM_022110.2~uORF:IOH10458	2255	370	910	5116	349	504	617	4651	1139	209	FK506 binding protein like (FKBPL)
B11R03C16	11-16-3	Hs~Ref:NM_022110.2~uORF:IOH10458	2252	376	896	5319	205	590	615	4550	1460	261	FK506 binding protein like (FKBPL)
B11R03C17	11-17-3	Hs~MGC:BC012397.1~uORF:IOH10484	993	546	1207	407	544	284	2689	556	210	399	protein phosphatase 1, regulatory (inhibitor) subunit 7 (PPP1R7)
B11R03C18	11-18-3	Hs~MGC:BC012397.1~uORF:IOH10484	934	587	1278	440	663	647	2567	553	800	409	protein phosphatase 1, regulatory (inhibitor) subunit 7 (PPP1R7)
B11R03C19	11-19-3	Hs~MGC:BC015944.1~uORF:IOH10042	6427	2887	3335	2684	2820	3100	18020	4597	3893	1496	TIA1 cytotoxic granule-associated RNA binding protein (TIA1)
B11R03C20	11-20-3	Hs~MGC:BC015944.1~uORF:IOH10042	6383	3096	1049	2842	2639	2863	18157	4005	3937	1334	TIA1 cytotoxic granule-associated RNA binding protein (TIA1)
B11R03C21	11-21-3	Hs~Ref:NM_001561.3~uORF:IOH5753	1254	1121	1447	904	1098	1340	2042	1123	2948	702	tumor necrosis factor receptor superfamily, member 9 (TNFRSF9)
B11R03C22	11-22-3	Hs~Ref:NM_001561.3~uORF:IOH5753	1224	1081	1417	860	1217	1435	1985	1034	3321	627	tumor necrosis factor receptor superfamily, member 9 (TNFRSF9)
B11R04C01	11-1-4	Hs~Ref:NM_003794.1~uORF:IOH14878	1908	1033	2862	1192	1066	2021	2511	1066	3677	592	sorting nexin 4 (SNX4)
B11R04C02	11-2-4	Hs~Ref:NM_003794.1~uORF:IOH14878	1956	1037	2334	1138	984	1973	2435	914	3610	662	sorting nexin 4 (SNX4)
B11R04C03	11-3-4	Hs~MGC:BC021120.1~uORF:IOH14846	2572	1358	2620	970	1320	1461	5345	1043	2990	472	RNA binding motif protein 4 (RBM4)
B11R04C04	11-4-4	Hs~MGC:BC021120.1~uORF:IOH14846	2564	1337	2895	945	1341	1490	5280	1250	2934	507	RNA binding motif protein 4 (RBM4)
B11R04C05	11-5-4	Hs~Ref:NM_004309.2~uORF:IOH5797	2571	1664	2616	798	1590	1397	3107	783	2757	1191	Rho GDP dissociation inhibitor (GDI) alpha (ARHGDIA)
B11R04C06	11-6-4	Hs~Ref:NM_004309.2~uORF:IOH5797	2637	1663	2659	969	1565	1339	3156	768	2764	1174	Rho GDP dissociation inhibitor (GDI) alpha (ARHGDIA)
B11R04C07	11-7-4	Hs~MGC:BC025729.1~uORF:IOH10931	1420	1077	1534	1047	1238	1854	1996	1056	2243	635	CD99 molecule-like 2 (CD99L2)
B11R04C08	11-8-4	Hs~MGC:BC025729.1~uORF:IOH10931	1419	1088	1937	1033	1097	1691	2053	1087	2354	580	CD99 molecule-like 2 (CD99L2)
B11R04C09	11-9-4	Hs~Ref:NM_138722.1~uORF:IOH10975	3080	1388	1803	983	1855	1741	2242	1275	3666	732	BCL2-like 14 (apoptosis facilitator) (BCL2L14), transcript variant 1
B11R04C10	11-10-4	Hs~Ref:NM_138722.1~uORF:IOH10975	3046	1399	1771	958	1826	1610	2332	1287	3810	698	BCL2-like 14 (apoptosis facilitator) (BCL2L14), transcript variant 1
B11R04C11	11-11-4	Hs~Ref:NM_024610.2~uORF:IOH13320	2047	1153	1630	729	1125	1277	1709	1043	2771	673	HSPB (heat shock 27kDa) associated protein 1 (HSPBAP1)
B11R04C12	11-12-4	Hs~Ref:NM_024610.2~uORF:IOH13320	2089	1114	1690	785	1331	1208	1857	954	2778	683	HSPB (heat shock 27kDa) associated protein 1 (HSPBAP1)
B11R04C13	11-13-4	Hs~Ref:NM_016310.2~uORF:IOH12571	1580	1022	1699	1259	1678	1245	1016	1082	2538	598	polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa (POLR3K)
B11R04C14	11-14-4	Hs~Ref:NM_016310.2~uORF:IOH12571	1623	993	1776	1274	1650	1245	1068	1101	2543	575	polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa (POLR3K)
B11R04C17	11-17-4	Hs~Ref:NM_002739.1~uORF:IOH21330	600	529	685	357	329	145	883	501	619	340	protein kinase C, gamma (PRKCG)
B11R04C18	11-18-4	Hs~Ref:NM_002739.1~uORF:IOH21330	573	479	797	371	438	351	797	405	722	246	protein kinase C, gamma (PRKCG)
B11R04C19	11-19-4	Hs~Ref:NM_017861.1~uORF:IOH10774	519	324	698	506	350	273	734	313	565	244	phosphatidylinositol glycan anchor biosynthesis, class X (PIGX)
B11R04C20	11-20-4	Hs~Ref:NM_017861.1~uORF:IOH10774	570	345	389	315	300	291	735	359	575	250	phosphatidylinositol glycan anchor biosynthesis, class X (PIGX)
B11R04C21	11-21-4	Hs~Ref:NM_144770.1~uORF:IOH22581	644	501	3278	451	431	707	832	472	767	450	RNA binding motif protein 11 (RBM11)
B11R04C22	11-22-4	Hs~Ref:NM_144770.1~uORF:IOH22581	508	591	1235	461	568	672	833	427	410	405	RNA binding motif protein 11 (RBM11)
B11R05C01	11-1-5	Hs~MGC:BC032578.1~uORF:IOH21927	538	407	601	535	325	371	948	468	656	117	WD repeat domain 19 (WDR19)
B11R05C02	11-2-5	Hs~MGC:BC032578.1~uORF:IOH21927	443	388	1498	359	320	452	805	476	648	257	WD repeat domain 19 (WDR19)
B11R05C03	11-3-5	Hs~MGC:BC000897.1~uORF:IOH3214	504	551	1002	457	516	582	840	570	1009	167	interferon induced transmembrane protein 1 (9-27) (IFITM1)
B11R05C04	11-4-5	Hs~MGC:BC000897.1~uORF:IOH3214	520	573	776	8352	510	111	896	533	904	187	interferon induced transmembrane protein 1 (9-27) (IFITM1)
B11R05C05	11-5-5	Hs~Ref:NM_024854.2~uORF:IOH12803	1134	618	781	424	697	184	956	676	1223	225	pyridine nucleotide-disulphide oxidoreductase domain 1 (PYROXD1)
B11R05C06	11-6-5	Hs~Ref:NM_024854.2~uORF:IOH12803	1122	579	794	450	755	491	959	673	1224	180	pyridine nucleotide-disulphide oxidoreductase domain 1 (PYROXD1)
B11R05C07	11-7-5	Hs~Ref:NM_005030.2~uORF:IOH5070	7086	3737	35142	3897	10017	3152	10927	3215	3699	2007	polo-like kinase 1 (Drosophila) (PLK1)
B11R05C08	11-8-5	Hs~Ref:NM_005030.2~uORF:IOH5070	6864	3830	36263	4235	10008	3223	10672	3617	3866	2320	polo-like kinase 1 (Drosophila) (PLK1)
B11R05C09	11-9-5	Hs~MGC:BC017328.2~uORF:IOH14721	1172	1051	1291	754	1117	1161	1462	921	2554	624	angiotensin II receptor-associated protein (AGTRAP)
B11R05C10	11-10-5	Hs~MGC:BC017328.2~uORF:IOH14721	1070	918	1441	702	1118	1233	1455	934	2754	443	angiotensin II receptor-associated protein (AGTRAP)
B11R05C11	11-11-5	Hs~MGC:BC014851.1~uORF:IOH11293	1192	1041	1537	782	1602	1274	1450	1100	2753	675	LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (LFNG)
B11R05C12	11-12-5	Hs~MGC:BC014851.1~uORF:IOH11293	1219	1001	1436	773	1561	1485	1518	1088	2564	710	LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (LFNG)
B11R05C13	11-13-5	Hs~Ref:NM_005317.2~uORF:IOH12008	1023	803	1272	873	1204	1076	1424	972	2115	554	granzyme M (lymphocyte met-ase 1) (GZMM)
B11R05C14	11-14-5	Hs~Ref:NM_005317.2~uORF:IOH12008	977	786	1660	919	1178	890	1469	1421	2178	546	granzyme M (lymphocyte met-ase 1) (GZMM)
B11R05C15	11-15-5	Hs~MGC:BC001135.1~uORF:IOH3862	1884	1526	2059	1177	1701	1768	2819	2097	3414	828	transient receptor potential cation channel, subfamily M, member 8 (TRPM8)
B11R05C16	11-16-5	Hs~MGC:BC001135.1~uORF:IOH3862	1817	1548	1859	1172	1701	1847	2612	1439	3354	786	transient receptor potential cation channel, subfamily M, member 8 (TRPM8)
B11R05C17	11-17-5	Hs~MGC:BC052995.2~uORF:IOH28910	1383	772	1312	593	804	911	1830	676	2155	1458	SAPS domain family, member 2 (SAPS2)
B11R05C18	11-18-5	Hs~MGC:BC052995.2~uORF:IOH28910	1371	783	1386	737	802	1110	1869	683	2331	1445	SAPS domain family, member 2 (SAPS2)
B11R05C19	11-19-5	Hs~Ref:NM_016526.3~uORF:IOH28695	1501	1492	1991	1346	1486	1891	2210	1763	3761	376	blocked early in transport 1 homolog (S. cerevisiae)-like (BET1L), transcript variant 2
B11R05C20	11-20-5	Hs~Ref:NM_016526.3~uORF:IOH28695	1477	1505	1827	1079	1439	2114	2143	1709	3590	771	blocked early in transport 1 homolog (S. cerevisiae)-like (BET1L), transcript variant 2
B11R05C21	11-21-5	Hs~MGC:BC029360.1~uORF:IOH23138	1512	1200	2346	801	1302	1809	1841	1043	2706	681	suppressor of variegation 3-9 homolog 2 (Drosophila) (SUV39H2)
B11R05C22	11-22-5	Hs~MGC:BC029360.1~uORF:IOH23138	1350	1180	2153	857	1526	1553	1976	1181	3070	603	suppressor of variegation 3-9 homolog 2 (Drosophila) (SUV39H2)
B11R06C01	11-1-6	Hs~Ref:NM_006924.3~uORF:IOH11039	4765	1996	3507	1996	2089	2013	16403	1941	4702	1265	splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor) (SFRS1), transcript variant 1
B11R06C02	11-2-6	Hs~Ref:NM_006924.3~uORF:IOH11039	4780	1946	3441	1942	2145	2092	16549	1837	4662	1382	splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor) (SFRS1), transcript variant 1
B11R06C03	11-3-6	Hs~Ref:NM_025099.1~uORF:IOH13233	647	452	649	368	397	511	930	495	908	224	chromosome 17 open reading frame 68 (C17orf68)
B11R06C04	11-4-6	Hs~Ref:NM_025099.1~uORF:IOH13233	676	741	642	370	382	469	844	432	849	6	chromosome 17 open reading frame 68 (C17orf68)
B11R06C05	11-5-6	Hs~Ref:NM_020374.2~uORF:IOH11080	738	946	790	556	443	623	1060	1081	920	350	chromosome 12 open reading frame 4 (C12orf4)
B11R06C06	11-6-6	Hs~Ref:NM_020374.2~uORF:IOH11080	712	948	836	605	475	589	1033	1109	1008	326	chromosome 12 open reading frame 4 (C12orf4)
B11R06C07	11-7-6	Hs~MGC:BC009416.1~uORF:IOH12693	697	410	699	480	414	1259	1013	1958	1100	255	mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae) (MRM1)
B11R06C08	11-8-6	Hs~MGC:BC009416.1~uORF:IOH12693	694	420	621	494	392	903	991	1260	1166	234	mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae) (MRM1)
B11R06C09	11-9-6	Hs~Ref:NM_014182.2~uORF:IOH12795	698	634	989	449	486	595	1017	511	1051	243	ORM1-like 2 (S. cerevisiae) (ORMDL2)
B11R06C10	11-10-6	Hs~Ref:NM_014182.2~uORF:IOH12795	674	587	899	436	437	534	892	485	1343	190	ORM1-like 2 (S. cerevisiae) (ORMDL2)
B11R06C11	11-11-6	Hs~MGC:BC065928.1~uORF:IOH39967	698	428	1822	392	265	692	1134	566	1185	184	ubiquitin specific peptidase 28 (USP28)
B11R06C12	11-12-6	Hs~MGC:BC065928.1~uORF:IOH39967	763	426	1541	403	381	595	1074	689	1652	101	ubiquitin specific peptidase 28 (USP28)
B11R06C13	11-13-6	Hs~Ref:NM_021204.1~uORF:IOH40021	162	994	340	411	186	194	275	130	418	116	enolase-phosphatase 1 (ENOPH1)
B11R06C14	11-14-6	Hs~Ref:NM_021204.1~uORF:IOH40021	147	994	165	629	148	177	276	1078	454	98	enolase-phosphatase 1 (ENOPH1)
B11R06C15	11-15-6	Hs~Ref:NM_183059.1~uORF:IOH39968	1237	829	1208	663	1399	738	1264	890	1201	401	retinal degeneration 3 (RD3)
B11R06C16	11-16-6	Hs~Ref:NM_183059.1~uORF:IOH39968	1249	870	982	566	1522	726	1297	750	1111	383	retinal degeneration 3 (RD3)
B11R06C17	11-17-6	Hs~Ref:NM_005884.2~uORF:IOH2475	4031	8543	2972	6630	20606	5681	9604	8599	7081	1597	p21(CDKN1A)-activated kinase 4 (PAK4), transcript variant 1
B11R06C18	11-18-6	Hs~Ref:NM_005884.2~uORF:IOH2475	3828	8564	2910	6933	20826	5695	10205	8368	6692	1583	p21(CDKN1A)-activated kinase 4 (PAK4), transcript variant 1
B11R06C19	11-19-6	Hs~Ref:NM_002787.1~uORF:IOH26683	796	467	126	325	385	63	887	366	803	162	proteasome (prosome, macropain) subunit, alpha type, 2 (PSMA2)
B11R06C20	11-20-6	Hs~Ref:NM_002787.1~uORF:IOH26683	899	389	14	335	421	349	807	388	681	145	proteasome (prosome, macropain) subunit, alpha type, 2 (PSMA2)
B11R06C21	11-21-6	Hs~Ref:NM_007022.1~uORF:IOH26702	884	550	1128	420	464	425	1001	518	1198	208	cytochrome b-561 domain containing 2 (CYB561D2)
B11R06C22	11-22-6	Hs~Ref:NM_007022.1~uORF:IOH26702	743	586	1023	386	496	382	999	512	911	254	cytochrome b-561 domain containing 2 (CYB561D2)
B11R07C01	11-1-7	Hs~MGC:BC039855.1~uORF:IOH26182	806	508	668	534	266	501	871	455	699	166	chromosome 6 open reading frame 117 (C6orf117)
B11R07C02	11-2-7	Hs~MGC:BC039855.1~uORF:IOH26182	702	575	644	598	334	530	990	642	753	200	chromosome 6 open reading frame 117 (C6orf117)
B11R07C03	11-3-7	Hs~Ref:NM_031477.1~uORF:IOH27026	1107	598	1160	547	657	656	1100	664	1063	232	yippee-like 3 (Drosophila) (YPEL3)
B11R07C04	11-4-7	Hs~Ref:NM_031477.1~uORF:IOH27026	1142	847	1356	545	619	705	1129	547	1027	203	yippee-like 3 (Drosophila) (YPEL3)
B11R07C05	11-5-7	Hs~MGC:BC003376.1~uORF:IOH2942	905	1206	1186	694	486	686	1596	521	918	454	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) (ELAVL1)
B11R07C06	11-6-7	Hs~MGC:BC003376.1~uORF:IOH2942	955	1190	955	724	559	665	1572	574	926	412	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) (ELAVL1)
B11R07C07	11-7-7	Hs~MGC:BC000961.2~uORF:IOH3037	427	406	631	328	299	789	824	655	628	113	degenerative spermatocyte homolog 1, lipid desaturase (Drosophila) (DEGS1)
B11R07C08	11-8-7	Hs~MGC:BC000961.2~uORF:IOH3037	438	408	599	339	298	487	839	853	711	101	degenerative spermatocyte homolog 1, lipid desaturase (Drosophila) (DEGS1)
B11R07C09	11-9-7	Hs~MGC:BC002880.1~uORF:IOH5687	1613	1485	1222	701	747	2461	3292	733	1906	496	cysteinyl-tRNA synthetase (CARS)
B11R07C10	11-10-7	Hs~MGC:BC002880.1~uORF:IOH5687	1609	1520	1217	699	769	2658	3528	878	1945	500	cysteinyl-tRNA synthetase (CARS)
B11R07C11	11-11-7	Hs~MGC:BC039859.1~uORF:IOH26212	512	321	414	319	379	491	1656	407	642	158	transmembrane and coiled-coil domain family 1 (TMCC1)
B11R07C12	11-12-7	Hs~MGC:BC039859.1~uORF:IOH26212	538	323	388	276	341	347	1457	387	-14	230	transmembrane and coiled-coil domain family 1 (TMCC1)
B11R07C13	11-13-7	Hs~Ref:XM_171154.3~uORF:IOH43663	1794	1956	2030	1435	1472	1469	1973	1148	4279	893	Myelin protein zero-like protein 1
B11R07C14	11-14-7	Hs~Ref:XM_171154.3~uORF:IOH43663	1992	2026	2010	1576	1494	1552	2040	1185	4436	854	Myelin protein zero-like protein 1
B11R07C15	11-15-7	Hs~Ref:NM_017451.1~uORF:IOH42068	10838	11263	6083	5962	9567	5430	6320	2681	15528	2514	BAI1-associated protein 2 (BAIAP2), transcript variant 2
B11R07C16	11-16-7	Hs~Ref:NM_017451.1~uORF:IOH42068	10539	11159	5996	5926	9737	5202	6569	2734	15735	2511	BAI1-associated protein 2 (BAIAP2), transcript variant 2
B11R07C17	11-17-7	Hs~Ref:NM_178169.2~uORF:IOH43677	1438	1214	1939	926	2339	1757	2032	1060	2978	903	Ras association (RalGDS/AF-6) domain family 3 (RASSF3)
B11R07C18	11-18-7	Hs~Ref:NM_178169.2~uORF:IOH43677	1386	1233	2127	1062	2215	1800	2165	912	2969	824	Ras association (RalGDS/AF-6) domain family 3 (RASSF3)
B11R07C19	11-19-7	Hs~Ref:NM_078625.2~uORF:IOH42141	1155	940	1403	719	933	1035	1978	730	1745	601	vanin 3 (VNN3), transcript variant 2
B11R07C20	11-20-7	Hs~Ref:NM_078625.2~uORF:IOH42141	1266	968	1479	803	976	1078	2004	762	1849	572	vanin 3 (VNN3), transcript variant 2
B11R07C21	11-21-7	Hs~Ref:NM_032855.1~uORF:IOH14623	11308	11103	13337	17273	7386	8536	10191	6944	11762	9232	hematopoietic SH2 domain containing (HSH2D)
B11R07C22	11-22-7	Hs~Ref:NM_032855.1~uORF:IOH14623	10952	11229	13590	18522	7548	8409	10347	6884	11801	9277	hematopoietic SH2 domain containing (HSH2D)
B11R08C01	11-1-8	Hs~Ref:NM_021822.1~uORF:IOH13894	3094	1848	2414	1567	1470	1982	9257	1730	3954	869	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G)
B11R08C02	11-2-8	Hs~Ref:NM_021822.1~uORF:IOH13894	3459	1847	2389	1562	1500	2004	9053	1641	4075	842	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G)
B11R08C03	11-3-8	Hs~Ref:NM_145063.1~uORF:IOH13839	3817	2306	2123	1601	2567	2263	7165	1345	4079	743	chromosome 6 open reading frame 130 (C6orf130)
B11R08C04	11-4-8	Hs~Ref:NM_145063.1~uORF:IOH13839	3865	2306	2165	1689	2792	2222	7104	1417	4151	695	chromosome 6 open reading frame 130 (C6orf130)
B11R08C05	11-5-8	Hs~Ref:NM_017706.2~uORF:IOH4301	1889	1450	1736	1055	1162	1466	2321	1124	3082	720	WD repeat-containing protein 55
B11R08C06	11-6-8	Hs~Ref:NM_017706.2~uORF:IOH4301	1907	1267	2104	1119	1156	1420	2324	1179	3042	667	WD repeat-containing protein 55
B11R08C07	11-7-8	Hs~MGC:BC011379.1~uORF:IOH9728	1576	1133	65472	613	1311	1507	1604	843	2995	476	Uncharacterized protein C15orf39
B11R08C08	11-8-8	Hs~MGC:BC011379.1~uORF:IOH9728	1580	1159	65478	638	1317	1186	1686	999	2949	436	Uncharacterized protein C15orf39
B11R08C09	11-9-8	Hs~Ref:NM_145245.1~uORF:IOH12245	2084	1587	1394	4404	1453	988	3306	10396	1921	573	ecotropic viral integration site 5-like (EVI5L)
B11R08C10	11-10-8	Hs~Ref:NM_145245.1~uORF:IOH12245	2113	1561	1409	4419	1546	1009	3716	11454	1869	562	ecotropic viral integration site 5-like (EVI5L)
B11R08C11	11-11-8	Hs~Ref:NM_004589.1~uORF:IOH10823	1043	1008	1921	393	706	969	1447	680	1359	402	SCO cytochrome oxidase deficient homolog 1 (yeast) (SCO1), nuclear gene encoding mitochondrial protein
B11R08C12	11-12-8	Hs~Ref:NM_004589.1~uORF:IOH10823	1042	1044	1928	401	677	1065	1493	637	2638	414	SCO cytochrome oxidase deficient homolog 1 (yeast) (SCO1), nuclear gene encoding mitochondrial protein
B11R08C13	11-13-8	Hs~Ref:NM_139012.1~uORF:IOH4647	1104	549	1088	971	554	6167	769	491	2231	185	mitogen-activated protein kinase 14 (MAPK14), transcript variant 2
B11R08C14	11-14-8	Hs~Ref:NM_139012.1~uORF:IOH4647	1097	565	991	1012	545	6007	766	554	2462	159	mitogen-activated protein kinase 14 (MAPK14), transcript variant 2
B11R08C15	11-15-8	Hs~MGC:BC030519.1~uORF:IOH27533	844	686	1035	506	428	702	1343	550	1201	383	cryptochrome 1 (photolyase-like) (CRY1)
B11R08C16	11-16-8	Hs~MGC:BC030519.1~uORF:IOH27533	878	688	959	412	469	639	1329	504	1136	382	cryptochrome 1 (photolyase-like) (CRY1)
B11R08C17	11-17-8	Hs~MGC:BC029120.1~uORF:IOH22695	1707	1073	926	383	421	757	2146	507	1048	161	chromosome 12 open reading frame 26 (C12orf26)
B11R08C18	11-18-8	Hs~MGC:BC029120.1~uORF:IOH22695	1677	1033	1057	428	430	716	2036	439	1204	36	chromosome 12 open reading frame 26 (C12orf26)
B11R08C19	11-19-8	Hs~MGC:BC042607.1~uORF:IOH27367	1184	670	1133	367	475	664	1536	581	2877	549	protein disulfide isomerase-like protein of the testis (PDILT)
B11R08C20	11-20-8	Hs~MGC:BC042607.1~uORF:IOH27367	1290	718	1354	369	521	804	1486	655	3183	291	protein disulfide isomerase-like protein of the testis (PDILT)
B11R08C21	11-21-8	Hs~MGC:BC031828.1~uORF:IOH22203	4263	1820	2364	1918	1314	1899	9694	2155	4296	385	kinesin heavy chain member 2A (KIF2A)
B11R08C22	11-22-8	Hs~MGC:BC031828.1~uORF:IOH22203	4283	1881	2590	2233	1301	1770	9858	2217	4639	590	kinesin heavy chain member 2A (KIF2A)
B11R09C01	11-1-9	Hs~Ref:NM_170678.1~uORF:IOH35216	978	917	1442	1160	706	830	1882	860	3399	246	integrin beta 1 binding protein 3 (ITGB1BP3)
B11R09C02	11-2-9	Hs~Ref:NM_170678.1~uORF:IOH35216	958	930	1427	1357	718	849	1826	863	3362	508	integrin beta 1 binding protein 3 (ITGB1BP3)
B11R09C03	11-3-9	Hs~Ref:NM_012131.1~uORF:IOH35308	995	888	1109	531	589	963	1476	702	1766	621	Claudin-17
B11R09C04	11-4-9	Hs~Ref:NM_012131.1~uORF:IOH35308	1026	874	1164	552	650	955	1392	916	1805	567	Claudin-17
B11R09C05	11-5-9	Hs~Ref:NM_194299.1~uORF:IOH35431	1786	2649	1906	905	1206	1474	2130	2109	1842	496	Synaptonemal complex protein 2-like
B11R09C06	11-6-9	Hs~Ref:NM_194299.1~uORF:IOH35431	1796	2671	1853	917	1166	1476	2096	1921	1816	456	Synaptonemal complex protein 2-like
B11R09C07	11-7-9	Hs~Ref:NM_000605.2~uORF:IOH35221	851	745	774	421	648	685	795	1173	1058	130	interferon, alpha 2 (IFNA2)
B11R09C08	11-8-9	Hs~Ref:NM_000605.2~uORF:IOH35221	862	726	798	431	666	662	801	1221	1006	215	interferon, alpha 2 (IFNA2)
B11R09C09	11-9-9	Hs~Ref:NM_145235.1~uORF:IOH10778	424	297	162	481	355	245	878	306	577	48	fibronectin type III and ankyrin repeat domains 1 (FANK1)
B11R09C10	11-10-9	Hs~Ref:NM_145235.1~uORF:IOH10778	428	317	301	495	375	323	903	303	632	136	fibronectin type III and ankyrin repeat domains 1 (FANK1)
B11R09C11	11-11-9	Hs~MGC:BC022003.1~uORF:IOH11205	535	427	673	300	449	556	624	485	816	280	myotubularin related protein 9 (MTMR9)
B11R09C12	11-12-9	Hs~MGC:BC022003.1~uORF:IOH11205	553	472	655	305	453	512	603	454	896	187	myotubularin related protein 9 (MTMR9)
B11R09C13	11-13-9	Hs~MGC:NM_152391.2~uORF:IOH11899	1053	543	1222	576	411	735	1840	571	1420	239	PQ loop repeat containing 3 (PQLC3)
B11R09C14	11-14-9	Hs~MGC:NM_152391.2~uORF:IOH11899	1052	574	1130	630	423	774	1816	621	1417	218	PQ loop repeat containing 3 (PQLC3)
B11R09C15	11-15-9	Hs~MGC:BC026104.2~uORF:IOH11605	1703	3294	1317	1083	1019	1222	1040	730	4055	1632	programmed cell death 4 (neoplastic transformation inhibitor) (PDCD4)
B11R09C16	11-16-9	Hs~MGC:BC026104.2~uORF:IOH11605	1724	3439	1367	1073	1146	1115	1077	699	3756	1617	programmed cell death 4 (neoplastic transformation inhibitor) (PDCD4)
B11R09C17	11-17-9	Hs~Ref:NM_016505.2~uORF:IOH6093	3839	1586	2154	1133	972	1883	17514	1294	3368	521	zinc finger, CCHC domain containing 17 (ZCCHC17)
B11R09C18	11-18-9	Hs~Ref:NM_016505.2~uORF:IOH6093	3873	1583	2381	1258	982	1927	17296	1292	3382	706	zinc finger, CCHC domain containing 17 (ZCCHC17)
B11R09C19	11-19-9	Hs~MGC:BC000052.1~uORF:IOH4650	1153	580	1073	571	545	578	1489	554	1448	366	peroxisome proliferator-activated receptor alpha (PPARA)
B11R09C20	11-20-9	Hs~MGC:BC000052.1~uORF:IOH4650	1185	589	1292	513	502	589	1567	520	1506	609	peroxisome proliferator-activated receptor alpha (PPARA)
B11R09C21	11-21-9	Hs~MGC:NM_182553.1~uORF:IOH26395	898	441	834	290	420	360	843	473	566	163	cornichon homolog 2 (Drosophila) (CNIH2)
B11R09C22	11-22-9	Hs~MGC:NM_182553.1~uORF:IOH26395	746	463	995	294	405	371	946	440	-15	98	cornichon homolog 2 (Drosophila) (CNIH2)
B11R10C01	11-1-10	Hs~MGC:NM_181707.1~uORF:IOH26565	2324	1242	1925	919	3	3474	5231	1124	10530	469	chromosome 17 open reading frame 64 (C17orf64)
B11R10C02	11-2-10	Hs~MGC:NM_181707.1~uORF:IOH26565	2340	1251	1895	1264	-1	3409	4674	1114	10431	543	chromosome 17 open reading frame 64 (C17orf64)
B11R10C03	11-3-10	Hs~MGC:BC016340.1~uORF:IOH12308	1424	899	1290	697	680	1078	1590	1087	2872	261	N-terminal EF-hand calcium-binding protein 1
B11R10C04	11-4-10	Hs~MGC:BC016340.1~uORF:IOH12308	1366	944	1281	678	749	1080	1537	1782	2857	797	N-terminal EF-hand calcium-binding protein 1
B11R10C05	11-5-10	Hs~MGC:BC018349.1~uORF:IOH9679	23645	947	1301	727	953	1174	1797	1489	3358	780	IKAROS family zinc finger 1 (Ikaros), mRNA (cDNA clone MGC:17055 IMAGE:4338834), complete cds
B11R10C06	11-6-10	Hs~MGC:BC018349.1~uORF:IOH9679	23377	944	1361	678	1079	1168	1873	1625	3373	673	IKAROS family zinc finger 1 (Ikaros), mRNA (cDNA clone MGC:17055 IMAGE:4338834), complete cds
B11R10C07	11-7-10	Hs~Ref:NM_001311.2~uORF:IOH5361	1177	1273	1719	1324	2151	1687	2563	1873	2373	388	Cysteine-rich protein 1
B11R10C08	11-8-10	Hs~Ref:NM_001311.2~uORF:IOH5361	1186	1243	1720	1335	2121	1643	2520	1814	2328	486	Cysteine-rich protein 1
B11R10C09	11-9-10	Hs~MGC:BC014057.1~uORF:IOH14544	1002	815	1199	537	734	2548	1299	820	2943	516	Dehydrogenase/reductase SDR family member 1
B11R10C10	11-10-10	Hs~MGC:BC014057.1~uORF:IOH14544	1002	874	1188	504	721	2841	1287	771	3079	597	Dehydrogenase/reductase SDR family member 1
B11R11C21	11-21-11	Hs~MGC:BC001553.1~uORF:IOH10899	2273	1128	1608	1087	871	2320	3377	1102	3527	554	chromatin modifying protein 2B (CHMP2B)
B11R11C22	11-22-11	Hs~MGC:BC001553.1~uORF:IOH10899	2399	1113	1493	1199	891	2270	3436	1094	1413	279	chromatin modifying protein 2B (CHMP2B)
B11R12C01	11-1-12	Hs~Ref:NM_014050.1~uORF:IOH25727	769	470	578	887	564	506	795	769	805	317	28S ribosomal protein S32, mitochondrial
B11R12C02	11-2-12	Hs~Ref:NM_014050.1~uORF:IOH25727	552	457	633	729	590	511	750	602	891	307	28S ribosomal protein S32, mitochondrial
B11R12C03	11-3-12	Hs~Ref:NM_024092.1~uORF:IOH3088	570	502	676	415	390	564	797	605	1046	238	transmembrane protein 109 (TMEM109)
B11R12C04	11-4-12	Hs~Ref:NM_024092.1~uORF:IOH3088	523	543	685	406	426	681	806	677	1123	496	transmembrane protein 109 (TMEM109)
B11R12C05	11-5-12	Hs~MGC:BC020651.1~uORF:IOH12789	1306	883	1191	418	640	885	2566	1053	1695	563	mitochondrial ribosomal protein L35 (MRPL35)
B11R12C06	11-6-12	Hs~MGC:BC020651.1~uORF:IOH12789	1280	1036	1186	397	638	940	2552	917	1753	558	mitochondrial ribosomal protein L35 (MRPL35)
B11R12C07	11-7-12	Hs~MGC:BC017887.1~uORF:IOH27931	672	600	802	538	661	786	1098	766	1508	357	eukaryotic translation initiation factor 3, subunit E (EIF3S6)
B11R12C08	11-8-12	Hs~MGC:BC017887.1~uORF:IOH27931	643	581	894	535	628	749	1233	799	1257	469	eukaryotic translation initiation factor 3, subunit E (EIF3S6)
B11R12C09	11-9-12	Hs~MGC:BC060512.1~uORF:IOH29424	945	750	1239	653	759	1205	1538	990	2079	478	Transmembrane protein 156
B11R12C10	11-10-12	Hs~MGC:BC060512.1~uORF:IOH29424	905	761	1422	648	803	1111	1490	992	1809	490	Transmembrane protein 156
B11R12C11	11-11-12	Hs~MGC:BC021973.2~uORF:IOH27816	589	418	645	419	720	495	832	730	1171	487	carbonyl reductase 4 (CBR4)
B11R12C12	11-12-12	Hs~MGC:BC021973.2~uORF:IOH27816	618	517	387	393	637	849	819	621	1443	423	carbonyl reductase 4 (CBR4)
B11R12C13	11-13-12	Hs~MGC:BC060830.1~uORF:IOH29146	1032	893	1169	714	893	1372	1712	951	515	794	leptin (obesity homolog, mouse) (LEP)
B11R12C14	11-14-12	Hs~MGC:BC060830.1~uORF:IOH29146	1020	864	1672	737	891	1278	1756	1001	0	636	leptin (obesity homolog, mouse) (LEP)
B11R12C15	11-15-12	Hs~Ref:NM_024292.2~uORF:IOH7374	358	295	226	202	726	285	342	258	248	544	ubiquitin-like 5 (UBL5), transcript variant 1
B11R12C16	11-16-12	Hs~Ref:NM_024292.2~uORF:IOH7374	447	325	278	248	701	295	380	255	493	550	ubiquitin-like 5 (UBL5), transcript variant 1
B11R12C17	11-17-12	Hs~MGC:BC009699.2~uORF:IOH9878	138	113	165	179	522	246	253	232	229	99	metallothionein 1E (MT1E)
B11R12C18	11-18-12	Hs~MGC:BC009699.2~uORF:IOH9878	139	179	164	154	341	253	250	216	402	125	metallothionein 1E (MT1E)
B11R12C19	11-19-12	Hs~MGC:BC005382.1~uORF:IOH7371	202	265	246	242	212	145	370	222	27	99	SPANX family, member E (SPANXE)
B11R12C20	11-20-12	Hs~MGC:BC005382.1~uORF:IOH7371	279	274	263	181	113	132	329	454	467	105	SPANX family, member E (SPANXE)
B11R12C21	11-21-12	Hs~Ref:NM_001258.1~uORF:IOH29645	898	1543	654	340	188	226	569	727	434	174	cyclin-dependent kinase 3 (CDK3)
B11R12C22	11-22-12	Hs~Ref:NM_001258.1~uORF:IOH29645	783	1570	699	342	200	238	644	797	544	47	cyclin-dependent kinase 3 (CDK3)
B11R13C01	11-1-13	Hs~MGC:BC007565.1~uORF:IOH6820	1676	1812	2052	2401	1555	1848	2017	1626	3128	1063	phospholipase C, gamma 2 (phosphatidylinositol-specific) (PLCG2)
B11R13C02	11-2-13	Hs~MGC:BC007565.1~uORF:IOH6820	1594	1866	2096	2574	1743	1891	1992	1768	3625	1037	phospholipase C, gamma 2 (phosphatidylinositol-specific) (PLCG2)
B11R13C03	11-3-13	Hs~MGC:BC040902.1~uORF:IOH26326	800	577	789	531	489	523	980	639	865	63	PRAME family member 2 (PRAMEF2)
B11R13C04	11-4-13	Hs~MGC:BC040902.1~uORF:IOH26326	741	547	823	536	549	543	984	415	693	240	PRAME family member 2 (PRAMEF2)
B11R13C05	11-5-13	Hs~MGC:BC007346.2~uORF:IOH7023	33525	2283	2151	4983	14427	2138	2931	5740	4911	1351	Uncharacterized protein C16orf14
B11R13C06	11-6-13	Hs~MGC:BC007346.2~uORF:IOH7023	34909	2388	2080	5179	15316	2196	2920	5791	4920	1334	Uncharacterized protein C16orf14
B11R13C07	11-7-13	Hs~Ref:NM_018127.4~uORF:IOH3722	671	866	1120	515	2152	1540	909	897	1147	369	elaC homolog 2 (E. coli) (ELAC2)
B11R13C08	11-8-13	Hs~Ref:NM_018127.4~uORF:IOH3722	708	818	1075	536	1988	1444	897	968	1646	331	elaC homolog 2 (E. coli) (ELAC2)
B11R13C09	11-9-13	Hs~Ref:NM_019101.2~uORF:IOH12125	10352	2059	2556	11799	915	2087	3532	966	3355	610	apolipoprotein M (APOM)
B11R13C10	11-10-13	Hs~Ref:NM_019101.2~uORF:IOH12125	10583	2142	2379	12335	917	1857	3327	976	3058	610	apolipoprotein M (APOM)
B11R13C11	11-11-13	Hs~MGC:BC030229.1~uORF:IOH22611	1910	546	873	370	499	663	837	474	1421	188	glycoprotein IX (platelet) (GP9)
B11R13C12	11-12-13	Hs~MGC:BC030229.1~uORF:IOH22611	1940	553	988	372	476	685	867	466	1417	134	glycoprotein IX (platelet) (GP9)
B11R13C13	11-13-13	Hs~Ref:NM_020529.1~uORF:IOH4138	642	386	1021	317	388	598	1320	600	891	225	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA)
B11R13C14	11-14-13	Hs~Ref:NM_020529.1~uORF:IOH4138	668	394	1193	412	394	582	1295	559	1008	239	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA)
B11R13C15	11-15-13	Hs~Ref:NM_030588.1~uORF:IOH1868	744	1945	1693	387	467	585	1613	657	-181	195	ATP-dependent RNA helicase A
B11R13C16	11-16-13	Hs~Ref:NM_030588.1~uORF:IOH1868	778	1794	2093	449	504	559	1571	637	505	225	ATP-dependent RNA helicase A
B11R13C17	11-17-13	Hs~Ref:NM_002945.2~uORF:IOH11757	911	1352	1035	998	680	873	1404	758	2401	458	replication protein A1, 70kDa (RPA1)
B11R13C18	11-18-13	Hs~Ref:NM_002945.2~uORF:IOH11757	947	1363	939	1026	694	853	1469	766	2247	396	replication protein A1, 70kDa (RPA1)
B11R13C19	11-19-13	Hs~MGC:BC017844.1~uORF:IOH14384	881	629	1050	543	676	691	914	601	1531	330	immunoglobulin superfamily, member 6 (IGSF6)
B11R13C20	11-20-13	Hs~MGC:BC017844.1~uORF:IOH14384	911	640	1040	546	678	749	924	583	1457	253	immunoglobulin superfamily, member 6 (IGSF6)
B11R13C21	11-21-13	Hs~Ref:NM_001179.2~uORF:IOH14107	2128	977	888	1547	788	962	1557	723	1411	254	ADP-ribosyltransferase 3 (ART3)
B11R13C22	11-22-13	Hs~Ref:NM_001179.2~uORF:IOH14107	2143	997	863	1357	776	1841	1554	714	1516	375	ADP-ribosyltransferase 3 (ART3)
B11R14C01	11-1-14	Hs~MGC:NM_153215.1~uORF:IOH11594	1752	768	1147	760	723	1055	2005	717	1823	397	chromosome 3 open reading frame 45 (C3orf45)
B11R14C02	11-2-14	Hs~MGC:NM_153215.1~uORF:IOH11594	1300	763	1201	854	702	1055	2063	910	1996	373	chromosome 3 open reading frame 45 (C3orf45)
B11R14C03	11-3-14	Hs~Ref:NM_138459.2~uORF:IOH12773	1091	630	1070	591	606	821	2566	784	1109	352	Nogo-B receptor
B11R14C04	11-4-14	Hs~Ref:NM_138459.2~uORF:IOH12773	1049	648	1054	558	650	862	2603	737	1085	378	Nogo-B receptor
B11R14C05	11-5-14	Hs~Ref:NM_032831.1~uORF:IOH40779	489	422	759	388	510	530	722	520	604	358	ORAI calcium release-activated calcium modulator 2 (ORAI2)
B11R14C06	11-6-14	Hs~Ref:NM_032831.1~uORF:IOH40779	415	408	724	339	413	506	683	498	816	367	ORAI calcium release-activated calcium modulator 2 (ORAI2)
B11R14C07	11-7-14	Hs~MGC:BC007840.2~uORF:IOH6710	371	341	920	342	486	431	910	467	-9	254	succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (SDHB)
B11R14C08	11-8-14	Hs~MGC:BC007840.2~uORF:IOH6710	365	352	368	379	299	456	857	480	553	282	succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (SDHB)
B11R14C09	11-9-14	Hs~Ref:NM_014773.2~uORF:IOH6737	474	362	682	381	362	577	727	621	745	106	KIAA0141 (KIAA0141)
B11R14C10	11-10-14	Hs~Ref:NM_014773.2~uORF:IOH6737	483	384	618	348	305	496	700	621	789	282	KIAA0141 (KIAA0141)
B11R14C11	11-11-14	Hs~Ref:NM_019083.1~uORF:IOH42080	809	532	561	616	541	1180	1182	1769	1489	251	coiled-coil domain containing 76, mRNA (cDNA clone MGC:87928 IMAGE:5104751), complete cds
B11R14C12	11-12-14	Hs~Ref:NM_019083.1~uORF:IOH42080	883	525	540	612	538	1282	1182	1750	1522	257	coiled-coil domain containing 76, mRNA (cDNA clone MGC:87928 IMAGE:5104751), complete cds
B11R14C13	11-13-14	Hs~Ref:NM_178226.1~uORF:IOH42134	386	330	656	261	256	415	560	410	917	261	F-box/WD repeat-containing protein 5
B11R14C14	11-14-14	Hs~Ref:NM_178226.1~uORF:IOH42134	388	291	594	302	284	366	520	407	49	295	F-box/WD repeat-containing protein 5
B11R14C15	11-15-14	Hs~Ref:NM_016205.1~uORF:IOH42087	589	328	482	285	342	363	564	344	3	248	platelet derived growth factor C (PDGFC), mRNA.
B11R14C16	11-16-14	Hs~Ref:NM_016205.1~uORF:IOH42087	568	333	297	298	3956	265	552	374	-15	210	platelet derived growth factor C (PDGFC), mRNA.
B11R14C17	11-17-14	Hs~Ref:NM_032981.2~uORF:IOH42089	512	409	304	456	388	495	585	673	852	328	dystrobrevin, alpha (DTNA), transcript variant 8, mRNA.
B11R14C18	11-18-14	Hs~Ref:NM_032981.2~uORF:IOH42089	522	349	1057	434	344	541	580	670	816	187	dystrobrevin, alpha (DTNA), transcript variant 8, mRNA.
B11R14C19	11-19-14	Hs~MGC:BC047450.1~uORF:IOH26520	465	365	499	360	222	503	828	462	781	306	KIAA0562 (KIAA0562)
B11R14C20	11-20-14	Hs~MGC:BC047450.1~uORF:IOH26520	490	329	611	382	305	605	776	458	907	214	KIAA0562 (KIAA0562)
B11R15C01	11-1-15	Hs~Ref:NM_001086.1~uORF:IOH2181	696	299	541	284	243	395	1010	414	558	191	Arylacetamide deacetylase
B11R15C02	11-2-15	Hs~Ref:NM_001086.1~uORF:IOH2181	525	343	565	642	254	442	1012	431	616	33	Arylacetamide deacetylase
B11R15C03	11-3-15	Hs~Ref:NM_174939.2~uORF:IOH21601	2589	523	884	368	395	572	1326	601	982	224	chromosome 11 open reading frame 64 (C11orf64)
B11R15C04	11-4-15	Hs~Ref:NM_174939.2~uORF:IOH21601	512	460	872	384	449	639	1273	607	874	279	chromosome 11 open reading frame 64 (C11orf64)
B11R15C05	11-5-15	Hs~Ref:NM_001008756.1~uORF:IOH45529	753	679	1113	517	908	571	1122	542	1833	362	germinal center expressed transcript 2 (GCET2), transcript variant 2
B11R15C06	11-6-15	Hs~Ref:NM_001008756.1~uORF:IOH45529	716	672	1132	505	936	573	1129	640	1859	287	germinal center expressed transcript 2 (GCET2), transcript variant 2
B11R15C07	11-7-15	Hs~Ref:NM_001004285.1~uORF:IOH45460	863	1040	1940	763	1315	949	3795	1063	1549	322	DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) (DFFB), transcript variant 3
B11R15C08	11-8-15	Hs~Ref:NM_001004285.1~uORF:IOH45460	900	995	1905	749	1315	924	3620	1202	1546	291	DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) (DFFB), transcript variant 3
B11R15C09	11-9-15	Hs~Ref:NM_130465.3~uORF:IOH45925	689	658	896	640	769	893	1176	726	1380	387	tetraspanin 17 (TSPAN17), transcript variant 2
B11R15C10	11-10-15	Hs~Ref:NM_130465.3~uORF:IOH45925	733	698	1052	631	855	717	1187	750	1604	331	tetraspanin 17 (TSPAN17), transcript variant 2
B11R15C11	11-11-15	Hs~Ref:NM_006585.2~uORF:IOH45947	1310	2449	650	649	572	555	2109	1658	3998	381	chaperonin containing TCP1, subunit 8 (theta) (CCT8)
B11R15C12	11-12-15	Hs~Ref:NM_006585.2~uORF:IOH45947	1334	2420	613	685	555	569	2093	1674	3910	393	chaperonin containing TCP1, subunit 8 (theta) (CCT8)
B11R15C13	11-13-15	Hs~Ref:NM_002577.3~CAT:PV4565	302	677	1	651	252	450	623	174	1037	172	p21 (CDKN1A)-activated kinase 2 (PAK2)
B11R15C14	11-14-15	Hs~Ref:NM_002577.3~CAT:PV4565	277	4	0	862	210	487	593	189	1014	165	p21 (CDKN1A)-activated kinase 2 (PAK2)
B11R15C15	11-15-15	Hs~Ref:NM_004714.1~CAT:PV4649	1622	2131	2480	3504	1277	9737	1575	1884	4827	1558	Dual specificity tyrosine-phosphorylation-regulated kinase 1B
B11R15C16	11-16-15	Hs~Ref:NM_004714.1~CAT:PV4649	1630	2241	2215	3592	1340	9951	1581	1918	5095	1544	Dual specificity tyrosine-phosphorylation-regulated kinase 1B
B11R15C17	11-17-15	Hs~Ref:NM_032028.2~CAT:PV3505	618	889	2650	816	293	7	1761	1617	2749	472	testis-specific serine kinase 1B (TSSK1B)
B11R15C18	11-18-15	Hs~Ref:NM_032028.2~CAT:PV3505	561	889	3088	793	296	1371	854	1523	2517	385	testis-specific serine kinase 1B (TSSK1B)
B11R15C19	11-19-15	Hs~Ref:NM_004586.1~CAT:PV3323	66	177	136	121	377	419	297	375	-2	102	ribosomal protein S6 kinase, 90kDa, polypeptide 3 (RPS6KA3)
B11R15C20	11-20-15	Hs~Ref:NM_004586.1~CAT:PV3323	67	145	140	85	249	510	280	367	452	70	ribosomal protein S6 kinase, 90kDa, polypeptide 3 (RPS6KA3)
B11R15C21	11-21-15	Hs~Ref:NM_002253.1~CAT:PV3660	357	441	1252	506	179	944	833	484	873	55	kinase insert domain receptor (a type III receptor tyrosine kinase) (KDR)
B11R15C22	11-22-15	Hs~Ref:NM_002253.1~CAT:PV3660	472	483	1038	501	175	851	836	545	821	79	kinase insert domain receptor (a type III receptor tyrosine kinase) (KDR)
B11R16C01	11-1-16	Hs~Ref:NM_004103.2~CAT:PV4567	1055	810	972	1109	635	979	1564	804	1173	571	Protein tyrosine kinase 2 beta
B11R16C02	11-2-16	Hs~Ref:NM_004103.2~CAT:PV4567	1039	833	916	1207	766	933	1515	706	1203	513	Protein tyrosine kinase 2 beta
B11R16C07	11-7-16	Hs~Ref:NM_016200.2~uORF:IOH5331	446	810	556	302	293	352	737	404	526	151	LSM8 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM8)
B11R16C08	11-8-16	Hs~Ref:NM_016200.2~uORF:IOH5331	413	638	178	313	305	376	771	397	640	97	LSM8 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM8)
B11R16C09	11-9-16	Hs~Ref:NM_019023.1~uORF:IOH2924	558	258	474	253	146	925	394	206	1063	133	protein arginine methyltransferase 7 (PRMT7)
B11R16C10	11-10-16	Hs~Ref:NM_019023.1~uORF:IOH2924	566	285	445	153	157	984	420	332	1028	157	protein arginine methyltransferase 7 (PRMT7)
B11R16C11	11-11-16	Hs~MGC:BC020523.1~uORF:IOH21466	277	259	411	230	144	234	423	250	42	1	integrator complex subunit 7 (INTS7)
B11R16C12	11-12-16	Hs~MGC:BC020523.1~uORF:IOH21466	255	252	334	204	56	272	444	223	28	6	integrator complex subunit 7 (INTS7)
B11R16C13	11-13-16	Hs~Ref:NM_021138.2~uORF:IOH21846	505	2670	434	409	640	5408	834	373	1032	257	TNF receptor-associated factor 2 (TRAF2)
B11R16C14	11-14-16	Hs~Ref:NM_021138.2~uORF:IOH21846	565	2671	451	819	711	6060	780	394	961	262	TNF receptor-associated factor 2 (TRAF2)
B11R16C15	11-15-16	Hs~Ref:NM_145214.2~uORF:IOH40773	1200	1505	1679	926	3409	2816	2518	1504	3134	566	tripartite motif-containing 11 (TRIM11)
B11R16C16	11-16-16	Hs~Ref:NM_145214.2~uORF:IOH40773	1156	1493	1679	768	3496	2761	2537	1545	3060	658	tripartite motif-containing 11 (TRIM11)
B11R16C17	11-17-16	Hs~Ref:NM_005476.3~uORF:IOH36644	1048	1229	1391	776	2264	2007	2149	1220	3131	599	glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE)
B11R16C18	11-18-16	Hs~Ref:NM_005476.3~uORF:IOH36644	1069	1211	1359	832	2296	1966	2132	1242	2992	617	glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE)
B11R16C19	11-19-16	Hs~Ref:NM_198461.1~uORF:IOH37860	1380	1341	1645	1065	2537	2538	2469	1419	3784	402	LON peptidase N-terminal domain and ring finger 2 (LONRF2)
B11R16C20	11-20-16	Hs~Ref:NM_198461.1~uORF:IOH37860	1423	1310	1846	1014	2497	2254	2609	1373	3604	648	LON peptidase N-terminal domain and ring finger 2 (LONRF2)
B11R16C21	11-21-16	Hs~Ref:NM_152793.1~uORF:IOH50202	1015	890	1716	844	1038	2414	1802	1216	2456	569	chromosome 7 open reading frame 41 (C7orf41)
B11R16C22	11-22-16	Hs~Ref:NM_152793.1~uORF:IOH50202	1016	940	1592	802	1016	2400	1756	1214	2539	519	chromosome 7 open reading frame 41 (C7orf41)
B11R17C01	11-1-17	Hs~Ref:NM_007373.2~uORF:IOH26711	995	775	1277	1010	1530	2100	2231	988	2371	392	soc-2 suppressor of clear homolog (C. elegans) (SHOC2)
B11R17C02	11-2-17	Hs~Ref:NM_007373.2~uORF:IOH26711	985	772	1257	1015	1664	2215	2183	977	2462	339	soc-2 suppressor of clear homolog (C. elegans) (SHOC2)
B11R17C03	11-3-17	Hs~MGC:BC050603.1~uORF:IOH27069	1186	808	1814	659	3722	1708	2241	2701	2646	521	Putative methyltransferase METT10D
B11R17C04	11-4-17	Hs~MGC:BC050603.1~uORF:IOH27069	1204	774	1744	685	3694	1663	2158	2840	2764	551	Putative methyltransferase METT10D
B11R17C05	11-5-17	Hs~Ref:NM_002591.2~uORF:IOH12383	1031	934	1348	596	2183	1620	1489	982	2315	411	phosphoenolpyruvate carboxykinase 1 (soluble) (PCK1)
B11R17C06	11-6-17	Hs~Ref:NM_002591.2~uORF:IOH12383	1009	967	1385	622	2158	1587	1731	963	2161	314	phosphoenolpyruvate carboxykinase 1 (soluble) (PCK1)
B11R17C07	11-7-17	Hs~Ref:NM_001860.1~uORF:IOH12315	766	710	1218	658	1312	1041	1096	967	2218	455	solute carrier family 31 (copper transporters), member 2 (SLC31A2)
B11R17C08	11-8-17	Hs~Ref:NM_001860.1~uORF:IOH12315	831	969	928	637	1279	1064	1171	925	2248	404	solute carrier family 31 (copper transporters), member 2 (SLC31A2)
B11R17C11	11-11-17	Hs~Ref:NM_173610.1~uORF:IOH35028	926	935	1101	865	818	1120	1710	944	2418	670	transmembrane protein 84 (TMEM84)
B11R17C12	11-12-17	Hs~Ref:NM_173610.1~uORF:IOH35028	996	942	1076	824	900	1092	1760	936	2273	694	transmembrane protein 84 (TMEM84)
B11R17C13	11-13-17	Hs~Ref:NM_003784.1~uORF:IOH35656	898	628	801	567	757	733	1215	603	1640	424	serpin peptidase inhibitor, clade B (ovalbumin), member 7 (SERPINB7), transcript variant 1
B11R17C14	11-14-17	Hs~Ref:NM_003784.1~uORF:IOH35656	869	594	841	582	633	701	1288	616	1714	502	serpin peptidase inhibitor, clade B (ovalbumin), member 7 (SERPINB7), transcript variant 1
B11R17C15	11-15-17	Hs~Ref:NM_000891.2~uORF:IOH35746	1034	797	1047	755	1014	1194	1590	879	2759	711	potassium inwardly-rectifying channel, subfamily J, member 2 (KCNJ2)
B11R17C16	11-16-17	Hs~Ref:NM_000891.2~uORF:IOH35746	997	820	1087	674	1155	1040	1680	847	2640	697	potassium inwardly-rectifying channel, subfamily J, member 2 (KCNJ2)
B11R17C17	11-17-17	Hs~MGC:BC019902.1~uORF:IOH11985	857	865	1257	698	917	1409	1390	684	1964	422	coiled-coil domain containing 21 (CCDC21)
B11R17C18	11-18-17	Hs~MGC:BC019902.1~uORF:IOH11985	904	884	1285	804	874	1406	1410	732	1920	271	coiled-coil domain containing 21 (CCDC21)
B11R17C19	11-19-17	Hs~Ref:NM_032124.3~uORF:IOH27146	2748	1521	1609	911	2452	2402	2480	1645	3967	642	haloacid dehalogenase-like hydrolase domain containing 2 (HDHD2)
B11R17C20	11-20-17	Hs~Ref:NM_032124.3~uORF:IOH27146	2892	1490	1669	917	2436	2322	2488	1712	3939	674	haloacid dehalogenase-like hydrolase domain containing 2 (HDHD2)
B11R17C21	11-21-17	Hs~MGC:BC026274.1~uORF:IOH27920	1778	874	1359	702	1830	1354	1815	1132	3879	496	retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (RDH11)
B11R17C22	11-22-17	Hs~MGC:BC026274.1~uORF:IOH27920	2213	885	1487	647	1812	1370	1791	1169	5796	538	retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (RDH11)
B11R18C01	11-1-18	Hs~Ref:XM_290936.2~uORF:IOH27440	1193	921	1416	821	1776	1695	2018	1050	2884	578	Kinesin-like protein KIF26B
B11R18C02	11-2-18	Hs~Ref:XM_290936.2~uORF:IOH27440	1161	950	1409	898	1919	1783	1991	1048	2871	4	Kinesin-like protein KIF26B
B11R18C03	11-3-18	Hs~Ref:NM_147197.2~uORF:IOH40750	768	462	771	384	384	629	1025	419	1144	314	WAP four-disulfide core domain 11 (WFDC11)
B11R18C04	11-4-18	Hs~Ref:NM_147197.2~uORF:IOH40750	727	501	744	375	406	614	1050	500	1397	318	WAP four-disulfide core domain 11 (WFDC11)
B11R18C05	11-5-18	Hs~MGC:BC067219.1~uORF:IOH40730	1551	662	1163	554	747	943	1231	676	1446	499	statherin (STATH)
B11R18C06	11-6-18	Hs~MGC:BC067219.1~uORF:IOH40730	888	678	1216	546	764	982	1241	718	1363	423	statherin (STATH)
B11R18C07	11-7-18	Hs~Ref:NM_015963.4~uORF:IOH40797	1771	999	1606	951	853	1426	5196	988	2772	447	THAP domain containing 4 (THAP4)
B11R18C08	11-8-18	Hs~Ref:NM_015963.4~uORF:IOH40797	1841	1149	1625	967	904	1522	5742	1078	2917	427	THAP domain containing 4 (THAP4)
B11R18C09	11-9-18	Hs~MGC:BC065717.1~uORF:IOH40735	547	649	724	392	441	599	951	529	1183	193	V-set domain containing T cell activation inhibitor 1 (VTCN1)
B11R18C10	11-10-18	Hs~MGC:BC065717.1~uORF:IOH40735	566	555	678	432	444	701	959	491	1245	241	V-set domain containing T cell activation inhibitor 1 (VTCN1)
B11R18C11	11-11-18	Hs~MGC:BC008406.1~uORF:IOH14434	469	442	634	399	409	550	871	622	1068	367	CD36 molecule (thrombospondin receptor) (CD36)
B11R18C12	11-12-18	Hs~MGC:BC008406.1~uORF:IOH14434	469	434	578	428	466	607	857	575	1076	334	CD36 molecule (thrombospondin receptor) (CD36)
B11R18C13	11-13-18	Hs~MGC:BC032330.1~uORF:IOH21654	3727	854	1466	1259	779	882	2425	921	2789	397	lectin, mannose-binding, 1 (LMAN1)
B11R18C14	11-14-18	Hs~MGC:BC032330.1~uORF:IOH21654	3757	876	1485	1413	762	1139	2410	879	2842	403	lectin, mannose-binding, 1 (LMAN1)
B11R18C15	11-15-18	Hs~MGC:BC035281.1~uORF:IOH27313	2005	564	627	391	395	586	1184	533	1026	271	fibromodulin (FMOD)
B11R18C16	11-16-18	Hs~MGC:BC035281.1~uORF:IOH27313	1791	610	675	429	415	543	1009	568	976	293	fibromodulin (FMOD)
B11R18C17	11-17-18	Hs~MGC:BC017716.1~uORF:IOH11983	1658	514	821	370	420	617	1077	712	17	242	secreted and transmembrane 1 (SECTM1)
B11R18C18	11-18-18	Hs~MGC:BC017716.1~uORF:IOH11983	1338	510	733	374	360	704	1077	727	909	224	secreted and transmembrane 1 (SECTM1)
B11R18C19	11-19-18	Hs~MGC:BC060780.1~uORF:IOH29159	928	434	677	454	364	880	939	576	1389	334	alpha-kinase 1 (ALPK1)
B11R18C20	11-20-18	Hs~MGC:BC060780.1~uORF:IOH29159	860	418	710	418	387	747	1055	606	1412	444	alpha-kinase 1 (ALPK1)
B11R18C21	11-21-18	Hs~MGC:BC007412.1~uORF:IOH5835	1429	457	951	558	495	560	2819	638	7435	328	chromosome 14 open reading frame 153 (C14orf153)
B11R18C22	11-22-18	Hs~MGC:BC007412.1~uORF:IOH5835	1517	499	1051	539	478	568	2785	650	1710	329	chromosome 14 open reading frame 153 (C14orf153)
B11R19C01	11-1-19	Hs~Ref:NM_004553.1~uORF:IOH26967	751	1733	874	522	605	644	895	894	1544	285	NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) (NDUFS6)
B11R19C02	11-2-19	Hs~Ref:NM_004553.1~uORF:IOH26967	716	1754	894	607	694	640	857	892	1487	269	NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) (NDUFS6)
B11R19C03	11-3-19	Hs~MGC:BC002707.1~uORF:IOH5356	735	568	750	469	484	618	942	505	1113	277	spondin 2, extracellular matrix protein (SPON2)
B11R19C04	11-4-19	Hs~MGC:BC002707.1~uORF:IOH5356	667	575	760	475	510	597	1052	502	1261	381	spondin 2, extracellular matrix protein (SPON2)
B11R19C07	11-7-19	Hs~MGC:BC005895.1~uORF:IOH7427	375	296	437	265	150	351	695	343	584	187	COX11 homolog, cytochrome c oxidase assembly protein (yeast) (COX11)
B11R19C08	11-8-19	Hs~MGC:BC005895.1~uORF:IOH7427	387	330	173	280	139	360	752	327	534	167	COX11 homolog, cytochrome c oxidase assembly protein (yeast) (COX11)
B11R19C09	11-9-19	Hs~MGC:BC013902.1~uORF:IOH12236	363	306	431	279	139	388	642	456	494	115	FAD-dependent oxidoreductase domain containing 1 (FOXRED1)
B11R19C10	11-10-19	Hs~MGC:BC013902.1~uORF:IOH12236	417	277	415	261	140	413	704	381	538	143	FAD-dependent oxidoreductase domain containing 1 (FOXRED1)
B11R19C11	11-11-19	Hs~Ref:NM_138408.1~uORF:IOH13484	1088	445	749	451	5527	557	3341	789	2050	184	general transcription factor IIIC, polypeptide 6, alpha 35kDa (GTF3C6)
B11R19C12	11-12-19	Hs~Ref:NM_138408.1~uORF:IOH13484	1501	461	772	485	5527	601	3383	823	2041	198	general transcription factor IIIC, polypeptide 6, alpha 35kDa (GTF3C6)
B11R19C13	11-13-19	Hs~Ref:NM_001545.1~uORF:IOH11951	3137	1367	1909	1422	1166	1509	7298	2601	2336	690	immature colon carcinoma transcript 1 (ICT1)
B11R19C14	11-14-19	Hs~Ref:NM_001545.1~uORF:IOH11951	2890	1426	1779	1469	1164	1912	7217	2557	2375	814	immature colon carcinoma transcript 1 (ICT1)
B11R19C15	11-15-19	Hs~Ref:NM_017665.1~uORF:IOH7282	2191	5949	2251	1768	11226	1855	4866	1573	2495	905	Zinc finger CCHC domain-containing protein 10
B11R19C16	11-16-19	Hs~Ref:NM_017665.1~uORF:IOH7282	2098	5983	2258	1541	11515	1924	4842	1601	2458	912	Zinc finger CCHC domain-containing protein 10
B11R19C17	11-17-19	Hs~Ref:NM_016071.2~uORF:IOH11088	994	432	644	334	262	491	1550	335	658	92	mitochondrial ribosomal protein S33 (MRPS33), nuclear gene encoding mitochondrial protein, transcript variant 1
B11R19C18	11-18-19	Hs~Ref:NM_016071.2~uORF:IOH11088	969	404	673	374	259	515	1530	349	720	156	mitochondrial ribosomal protein S33 (MRPS33), nuclear gene encoding mitochondrial protein, transcript variant 1
B11R19C19	11-19-19	Hs~Ref:NM_001177.2~uORF:IOH7362	720	550	769	393	581	1939	505	431	967	191	ADP-ribosylation factor-like 1 (ARL1)
B11R19C20	11-20-19	Hs~Ref:NM_001177.2~uORF:IOH7362	701	554	811	424	601	1918	494	432	1057	290	ADP-ribosylation factor-like 1 (ARL1)
B11R19C21	11-21-19	Hs~Ref:NM_005019.3~uORF:IOH11117	973	764	20925	6064	746	980	35917	733	6372	1193	phosphodiesterase 1A, calmodulin-dependent (PDE1A), transcript variant 1
B11R19C22	11-22-19	Hs~Ref:NM_005019.3~uORF:IOH11117	953	828	21893	5772	709	1095	33179	799	4861	1154	phosphodiesterase 1A, calmodulin-dependent (PDE1A), transcript variant 1
B11R20C01	11-1-20	Hs~MGC:NM_175840.1~uORF:IOH4308	1048	317	619	286	221	479	994	429	637	82	spermine oxidase (SMOX), transcript variant 2
B11R20C02	11-2-20	Hs~MGC:NM_175840.1~uORF:IOH4308	575	326	692	425	260	446	948	435	653	142	spermine oxidase (SMOX), transcript variant 2
B11R20C03	11-3-20	Hs~Ref:NM_016483.3~uORF:IOH22255	2545	1319	1837	1156	675	1193	8992	1057	2125	521	PHD finger protein 7 (PHF7), transcript variant 1
B11R20C04	11-4-20	Hs~Ref:NM_016483.3~uORF:IOH22255	4388	1355	1755	1019	699	1266	9772	976	2513	559	PHD finger protein 7 (PHF7), transcript variant 1
B11R20C05	11-5-20	Hs~MGC:BC029785.1~uORF:IOH22702	1229	547	902	493	392	640	1509	606	1284	378	FLJ42875 protein (FLJ42875)
B11R20C06	11-6-20	Hs~MGC:BC029785.1~uORF:IOH22702	1443	537	897	519	375	585	1398	672	1008	330	FLJ42875 protein (FLJ42875)
B11R20C07	11-7-20	Hs~MGC:BC024272.1~uORF:IOH12488	975	751	1208	716	584	816	1414	887	1488	376	CD74 molecule, major histocompatibility complex, class II invariant chain (CD74)
B11R20C08	11-8-20	Hs~MGC:BC024272.1~uORF:IOH12488	886	886	1376	634	588	830	1363	963	1458	400	CD74 molecule, major histocompatibility complex, class II invariant chain (CD74)
B11R20C09	11-9-20	Hs~Ref:NM_015696.2~uORF:IOH21874	525	368	639	365	320	431	952	479	572	125	glutathione peroxidase 7 (GPX7)
B11R20C10	11-10-20	Hs~Ref:NM_015696.2~uORF:IOH21874	537	365	589	432	297	444	970	519	570	197	glutathione peroxidase 7 (GPX7)
B11R20C11	11-11-20	Hs~Ref:NM_203302.2~uORF:IOH45642	882	796	1084	644	590	1007	1697	863	1981	440	similar to RPL23AP7 protein (MGC70863), transcript variant 2
B11R20C12	11-12-20	Hs~Ref:NM_203302.2~uORF:IOH45642	789	721	993	658	591	1184	1773	797	2006	554	similar to RPL23AP7 protein (MGC70863), transcript variant 2
B11R20C13	11-13-20	Hs~Ref:NM_145333.1~uORF:IOH37873	1039	3030	1345	723	525	1299	1457	1325	2713	563	mitogen-activated protein kinase kinase kinase 7 (MAP3K7), transcript variant D, mRNA.
B11R20C14	11-14-20	Hs~Ref:NM_145333.1~uORF:IOH37873	1116	3150	1443	851	535	1287	1477	1451	2647	601	mitogen-activated protein kinase kinase kinase 7 (MAP3K7), transcript variant D, mRNA.
B12R02C11	12-11-2	Hs~MGC:BC016905.1~uORF:IOH10994	902	720	1242	630	590	38	851	737	1260	527	coiled-coil domain containing 98 (CCDC98)
B12R02C12	12-12-2	Hs~MGC:BC016905.1~uORF:IOH10994	943	894	1202	711	522	8	847	644	1025	518	coiled-coil domain containing 98 (CCDC98)
B12R02C13	12-13-2	Hs~MGC:BC020569.1~uORF:IOH10736	571	504	759	374	190	-9	670	671	639	413	exportin, tRNA (nuclear export receptor for tRNAs) (XPOT)
B12R02C14	12-14-2	Hs~MGC:BC020569.1~uORF:IOH10736	766	744	479	391	378	59	642	489	347	18	exportin, tRNA (nuclear export receptor for tRNAs) (XPOT)
B12R02C15	12-15-2	Hs~Ref:NM_019062.1~uORF:IOH23145	1776	1832	2366	1190	965	-33	2034	1526	6192	3452	ring finger protein 186 (RNF186)
B12R02C16	12-16-2	Hs~Ref:NM_019062.1~uORF:IOH23145	1771	1466	2346	1419	963	-167	2469	1492	6388	3527	ring finger protein 186 (RNF186)
B12R02C17	12-17-2	Hs~MGC:BC020233.1~uORF:IOH14752	37808	38371	40067	43212	28608	31348	33391	33734	48035	35267	cDNA clone MGC:31936 IMAGE:4765518, complete cds
B12R02C18	12-18-2	Hs~MGC:BC020233.1~uORF:IOH14752	37732	38820	35836	42264	29175	31423	33251	32582	47259	36210	cDNA clone MGC:31936 IMAGE:4765518, complete cds
B12R02C19	12-19-2	Hs~MGC:BC045641.1~uORF:IOH25886	1031	858	1542	814	720	670	1085	897	1835	341	glutamine-fructose-6-phosphate transaminase 1 (GFPT1)
B12R02C20	12-20-2	Hs~MGC:BC045641.1~uORF:IOH25886	1262	825	1507	780	698	763	1033	927	2600	461	glutamine-fructose-6-phosphate transaminase 1 (GFPT1)
B12R02C21	12-21-2	Hs~Ref:NM_024039.1~uORF:IOH4379	2394	1758	1149	445	755	574	1049	518	4680	199	MIS12, MIND kinetochore complex component, homolog (yeast) (MIS12)
B12R02C22	12-22-2	Hs~Ref:NM_024039.1~uORF:IOH4379	2337	1789	1154	473	761	164	1068	557	4825	181	MIS12, MIND kinetochore complex component, homolog (yeast) (MIS12)
B12R03C01	12-1-3	Hs~Ref:NM_015400.1~uORF:IOH3643	1596	1149	3756	909	1562	1886	1330	1136	2519	415	SMAD family member 3 (SMAD3)
B12R03C02	12-2-3	Hs~Ref:NM_015400.1~uORF:IOH3643	1585	1120	3128	1026	1756	2266	1356	1098	2637	447	SMAD family member 3 (SMAD3)
B12R03C03	12-3-3	Hs~MGC:BC000507.1~uORF:IOH3546	939	535	1800	771	1218	5915	2302	705	2121	384	39S ribosomal protein L28, mitochondrial
B12R03C04	12-4-3	Hs~MGC:BC000507.1~uORF:IOH3546	942	493	1457	710	1586	5958	2307	887	2125	128	39S ribosomal protein L28, mitochondrial
B12R03C05	12-5-3	Hs~Ref:NM_018226.3~uORF:IOH44724	551	1185	857	321	802	65	822	467	1248	150	Arginyl aminopeptidase-like 1
B12R03C06	12-6-3	Hs~Ref:NM_018226.3~uORF:IOH44724	612	940	1095	302	677	63	692	404	1045	220	Arginyl aminopeptidase-like 1
B12R03C07	12-7-3	Hs~Ref:NM_001001935.1~uORF:IOH45901	1496	702	1205	494	732	-12	932	870	1323	226	ATP synthase subunit alpha, mitochondrial
B12R03C08	12-8-3	Hs~Ref:NM_001001935.1~uORF:IOH45901	1581	709	1359	515	476	-21	903	938	1360	180	ATP synthase subunit alpha, mitochondrial
B12R03C09	12-9-3	Hs~Ref:NM_007045.2~uORF:IOH44725	5431	1197	854	636	462	1864	1376	1344	1386	137	FGFR1 oncogene partner (FGFR1OP), transcript variant 1
B12R03C10	12-10-3	Hs~Ref:NM_007045.2~uORF:IOH44725	5602	1236	959	660	498	1872	1363	1509	1475	199	FGFR1 oncogene partner (FGFR1OP), transcript variant 1
B12R03C11	12-11-3	Hs~Ref:NM_198086.1~uORF:IOH45877	447	591	822	484	519	-73	1986	829	2053	338	jub, ajuba homolog (Xenopus laevis) (JUB), transcript variant 2
B12R03C12	12-12-3	Hs~Ref:NM_198086.1~uORF:IOH45877	475	673	839	552	596	-26	2016	766	2220	234	jub, ajuba homolog (Xenopus laevis) (JUB), transcript variant 2
B12R03C15	12-15-3	Hs~Ref:NM_172211.1~uORF:IOH43696	239	181	1006	247	351	2501	1112	282	603	98	colony stimulating factor 1 (macrophage) (CSF1), transcript variant 3
B12R03C16	12-16-3	Hs~Ref:NM_172211.1~uORF:IOH43696	228	163	1035	318	359	3187	1069	1966	568	91	colony stimulating factor 1 (macrophage) (CSF1), transcript variant 3
B12R03C17	12-17-3	Hs~Ref:NM_198325.1~uORF:IOH43467	464	259	3635	863	1183	29367	7609	1387	1722	711	Transcription factor E2F6
B12R03C18	12-18-3	Hs~Ref:NM_198325.1~uORF:IOH43467	431	682	3576	695	1221	29264	7448	1151	1772	698	Transcription factor E2F6
B12R03C19	12-19-3	Hs~Ref:NM_014276.2~uORF:IOH43732	769	1088	319	842	669	113	394	255	715	33	recombination signal binding protein for immunoglobulin kappa J region-like (RBPJL)
B12R03C20	12-20-3	Hs~Ref:NM_014276.2~uORF:IOH43732	185	1044	392	742	618	131	414	248	-38	89	recombination signal binding protein for immunoglobulin kappa J region-like (RBPJL)
B12R03C21	12-21-3	Hs~Ref:NM_006241.2~uORF:IOH5954	910	703	4038	465	475	1160	2537	568	4180	152	protein phosphatase 1, regulatory (inhibitor) subunit 2 (PPP1R2)
B12R03C22	12-22-3	Hs~Ref:NM_006241.2~uORF:IOH5954	920	712	4280	493	480	1204	2533	566	4258	140	protein phosphatase 1, regulatory (inhibitor) subunit 2 (PPP1R2)
B12R04C01	12-1-4	Hs~MGC:BC011842.2~uORF:IOH14099	3885	1610	2516	1864	1928	1999	12558	1365	4498	831	hypothetical protein FLJ11184 (FLJ11184)
B12R04C02	12-2-4	Hs~MGC:BC011842.2~uORF:IOH14099	3881	1625	2459	1818	1816	2065	12728	1359	4393	943	hypothetical protein FLJ11184 (FLJ11184)
B12R04C03	12-3-4	Hs~MGC:BC021241.2~uORF:IOH14238	725	661	873	453	691	499	1333	601	2957	331	keratin 81 (KRT81)
B12R04C04	12-4-4	Hs~MGC:BC021241.2~uORF:IOH14238	739	638	754	419	1027	1163	1389	592	3390	330	keratin 81 (KRT81)
B12R04C05	12-5-4	Hs~MGC:BC000903.2~uORF:IOH2920	3608	1920	4912	1249	1782	2520	10460	2727	4366	654	High mobility group protein B2
B12R04C06	12-6-4	Hs~MGC:BC000903.2~uORF:IOH2920	3702	2050	4925	1346	1651	3123	11789	2945	4381	559	High mobility group protein B2
B12R04C07	12-7-4	Hs~MGC:BC014891.1~uORF:IOH10029	1198	820	1238	604	539	15	1684	711	1342	204	KIAA0701 protein (KIAA0701)
B12R04C08	12-8-4	Hs~MGC:BC014891.1~uORF:IOH10029	1234	736	1205	591	608	645	1751	1022	1103	246	KIAA0701 protein (KIAA0701)
B12R04C09	12-9-4	Hs~Ref:NM_004772.1~uORF:IOH14022	1172	668	6170	820	709	-94	977	655	1244	357	chromosome 5 open reading frame 13 (C5orf13)
B12R04C10	12-10-4	Hs~Ref:NM_004772.1~uORF:IOH14022	1166	727	6293	844	681	389	996	674	1237	288	chromosome 5 open reading frame 13 (C5orf13)
B12R04C11	12-11-4	Hs~MGC:BC021275.1~uORF:IOH13914	574	510	645	343	1220	188	540	573	1164	183	hypothetical protein MGC29506 (MGC29506)
B12R04C12	12-12-4	Hs~MGC:BC021275.1~uORF:IOH13914	598	359	677	326	1478	-234	537	508	1276	100	hypothetical protein MGC29506 (MGC29506)
B12R04C13	12-13-4	Hs~MGC:BC021560.1~uORF:IOH14110	872	423	971	531	488	229	795	546	916	-2	deleted in bladder cancer 1 (DBC1)
B12R04C14	12-14-4	Hs~MGC:BC021560.1~uORF:IOH14110	850	435	982	561	454	15	1004	601	1043	379	deleted in bladder cancer 1 (DBC1)
B12R04C15	12-15-4	Hs~MGC:BC020600.1~uORF:IOH12780	828	2206	1088	651	592	-2	1147	810	1195	210	STEAP family member 4 (STEAP4)
B12R04C16	12-16-4	Hs~MGC:BC020600.1~uORF:IOH12780	784	2246	1208	751	715	117	1047	1865	852	325	STEAP family member 4 (STEAP4)
B12R04C17	12-17-4	Hs~MGC:BC033708.1~uORF:IOH21753	3051	2957	2159	14744	10063	4261	26664	9946	3743	6095	Ral GEF with PH domain and SH3 binding motif 1 (RALGPS1)
B12R04C18	12-18-4	Hs~MGC:BC033708.1~uORF:IOH21753	2941	3104	2172	12582	10386	4208	27117	7435	3617	5614	Ral GEF with PH domain and SH3 binding motif 1 (RALGPS1)
B12R04C19	12-19-4	Hs~Ref:NM_001517.1~uORF:IOH5457	643	665	965	624	439	45	890	573	1164	28	general transcription factor IIH, polypeptide 4, 52kDa (GTF2H4)
B12R04C20	12-20-4	Hs~Ref:NM_001517.1~uORF:IOH5457	13	666	1072	658	493	437	958	605	986	56	general transcription factor IIH, polypeptide 4, 52kDa (GTF2H4)
B12R04C21	12-21-4	Hs~Ref:NM_002431.1~uORF:IOH3100	1363	852	1210	735	758	764	1304	792	1663	1347	menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis) (MNAT1)
B12R04C22	12-22-4	Hs~Ref:NM_002431.1~uORF:IOH3100	1307	823	1373	781	671	771	1247	675	2037	117	menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis) (MNAT1)
B12R05C01	12-1-5	Hs~Ref:NM_001010844.1~uORF:IOH43230	2636	2387	2056	2033	4931	2384	9515	5222	4487	1349	Interleukin-1 receptor-associated kinase 1-binding protein 1
B12R05C02	12-2-5	Hs~Ref:NM_001010844.1~uORF:IOH43230	2798	2400	2044	3784	4701	2028	9477	5566	3394	1384	Interleukin-1 receptor-associated kinase 1-binding protein 1
B12R05C03	12-3-5	Hs~MGC:NM_006223.2~uORF:IOH43393	101	109	298	190	40	59	245	221	110	27	protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin) (PIN4)
B12R05C04	12-4-5	Hs~MGC:NM_006223.2~uORF:IOH43393	49	90	380	304	36	1531	299	215	62	48	protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin) (PIN4)
B12R05C05	12-5-5	Hs~Ref:NM_147148.1~uORF:IOH43362	977	605	956	574	656	-160	977	571	1373	205	glutathione S-transferase M4 (GSTM4), transcript variant 2
B12R05C06	12-6-5	Hs~Ref:NM_147148.1~uORF:IOH43362	940	1050	935	595	587	555	1066	586	948	242	glutathione S-transferase M4 (GSTM4), transcript variant 2
B12R05C07	12-7-5	Hs~Ref:NM_182536.2~uORF:IOH43315	1277	245	455	385	140	35	870	621	479	173	gastrokine 2 (GKN2)
B12R05C08	12-8-5	Hs~Ref:NM_182536.2~uORF:IOH43315	739	169	423	719	1458	46	838	517	458	71	gastrokine 2 (GKN2)
B12R05C09	12-9-5	Hs~MGC:BC067446.1~uORF:IOH40156	1223	741	1755	4305	914	-23	2366	795	3208	498	disabled homolog 1 (Drosophila) (DAB1)
B12R05C10	12-10-5	Hs~MGC:BC067446.1~uORF:IOH40156	1335	715	1746	4459	921	1773	2319	779	3119	156	disabled homolog 1 (Drosophila) (DAB1)
B12R05C11	12-11-5	Hs~Ref:NM_139280.1~uORF:IOH40176	1628	1477	2187	2422	1277	1414	2513	1285	2522	643	ORM1-like 3 (S. cerevisiae) (ORMDL3)
B12R05C12	12-12-5	Hs~Ref:NM_139280.1~uORF:IOH40176	1695	1508	2108	2816	1361	1681	2435	1290	2423	609	ORM1-like 3 (S. cerevisiae) (ORMDL3)
B12R05C13	12-13-5	Hs~MGC:BC069329.1~uORF:IOH40250	1210	1235	1513	1044	924	-23	2430	1137	1803	311	interferon, alpha 21 (IFNA21)
B12R05C14	12-14-5	Hs~MGC:BC069329.1~uORF:IOH40250	1312	1217	1534	1040	1011	-8	2433	1156	2024	361	interferon, alpha 21 (IFNA21)
B12R05C15	12-15-5	Hs~MGC:BC066316.1~uORF:IOH40103	2058	1453	1877	1094	935	229	4574	1133	1818	667	60S ribosomal protein L26
B12R05C16	12-16-5	Hs~MGC:BC066316.1~uORF:IOH40103	2302	1308	1880	1028	939	389	4470	1168	2475	701	60S ribosomal protein L26
B12R05C17	12-17-5	Hs~Ref:NM_145251.2~uORF:IOH10157	704	764	653	645	1178	1381	1562	3218	1569	252	serine/threonine/tyrosine interacting protein (STYX)
B12R05C18	12-18-5	Hs~Ref:NM_145251.2~uORF:IOH10157	697	748	613	570	1114	-64	1565	3286	1546	205	serine/threonine/tyrosine interacting protein (STYX)
B12R05C19	12-19-5	Hs~MGC:BC064984.1~uORF:IOH40665	4985	3542	3338	2324	2510	3915	10950	3112	3686	1598	additional sex combs like 1 (Drosophila) (ASXL1)
B12R05C20	12-20-5	Hs~MGC:BC064984.1~uORF:IOH40665	4973	3812	3263	2410	2523	3402	11043	3123	3689	1543	additional sex combs like 1 (Drosophila) (ASXL1)
B12R05C21	12-21-5	Hs~MGC:BC062423.1~uORF:IOH40739	2433	1040	1638	1136	1163	1620	2918	934	2610	150	chromosome 7 open reading frame 41 (C7orf41)
B12R05C22	12-22-5	Hs~MGC:BC062423.1~uORF:IOH40739	1759	1089	1578	1102	1144	1636	2827	1013	2850	65	chromosome 7 open reading frame 41 (C7orf41)
B12R06C01	12-1-6	Hs~MGC:BC064514.1~uORF:IOH40669	1424	1166	1784	1066	899	1554	1540	1176	2248	426	coronin 6 (CORO6)
B12R06C02	12-2-6	Hs~MGC:BC064514.1~uORF:IOH40669	1378	1155	1802	2199	872	1580	1471	1130	2246	353	coronin 6 (CORO6)
B12R06C03	12-3-6	Hs~Ref:NM_003226.2~uORF:IOH58738	663	759	1236	1191	641	416	665	736	1903	308	Trefoil factor 3
B12R06C04	12-4-6	Hs~Ref:NM_003226.2~uORF:IOH58738	647	255	1198	477	617	-45	706	755	2243	271	Trefoil factor 3
B12R06C05	12-5-6	Hs~Ref:NM_021068.1~uORF:IOH54736	466	366	595	323	368	146	627	409	683	138	Interferon alpha-4
B12R06C06	12-6-6	Hs~Ref:NM_021068.1~uORF:IOH54736	467	404	540	374	387	96	87	434	722	142	Interferon alpha-4
B12R06C07	12-7-6	Hs~Ref:NM_001017417.1~uORF:IOH54734	8691	4459	5065	4639	3574	2709	9112	6948	6925	3064	cancer/testis antigen family 45, member A1 (CT45A1), mRNA.
B12R06C08	12-8-6	Hs~Ref:NM_001017417.1~uORF:IOH54734	8191	4291	4853	4651	3550	2659	9206	6918	6991	2734	cancer/testis antigen family 45, member A1 (CT45A1), mRNA.
B12R06C09	12-9-6	Hs~Ref:NM_199129.1~uORF:IOH59436	836	880	1149	578	695	-176	1006	803	1791	-48	Transmembrane protein 189
B12R06C10	12-10-6	Hs~Ref:NM_199129.1~uORF:IOH59436	810	874	1195	533	687	422	1036	969	1798	65	Transmembrane protein 189
B12R06C11	12-11-6	Hs~Ref:NM_032636.2~uORF:IOH4088	10992	10071	5425	8553	15283	6532	10983	4325	9702	3369	proline/serine-rich coiled-coil 1 (PSRC1), transcript variant 1
B12R06C12	12-12-6	Hs~Ref:NM_032636.2~uORF:IOH4088	11282	10272	5356	8837	15007	5835	11019	4625	10688	3563	proline/serine-rich coiled-coil 1 (PSRC1), transcript variant 1
B12R06C13	12-13-6	Hs~MGC:BC007320.2~uORF:IOH5857	1396	1118	967	656	1051	-12	1405	1539	1936	337	annexin A10 (ANXA10)
B12R06C14	12-14-6	Hs~MGC:BC007320.2~uORF:IOH5857	1411	1119	946	638	1156	-596	1409	1526	1905	337	annexin A10 (ANXA10)
B12R06C15	12-15-6	Hs~MGC:BC019107.1~uORF:IOH13408	2125	2193	1686	1305	1114	-12	1994	1121	2377	895	Dual specificity protein phosphatase 7
B12R06C16	12-16-6	Hs~MGC:BC019107.1~uORF:IOH13408	1775	1912	1637	1344	904	-105	1966	950	2163	29	Dual specificity protein phosphatase 7
B12R06C17	12-17-6	Hs~Ref:NM_016052.1~uORF:IOH13661	2303	2014	3262	1700	2022	1033	2116	1483	5160	1004	ribosomal RNA processing 15 homolog (S. cerevisiae) (RRP15)
B12R06C18	12-18-6	Hs~Ref:NM_016052.1~uORF:IOH13661	2287	2114	3295	1496	2071	1022	2175	1528	5156	696	ribosomal RNA processing 15 homolog (S. cerevisiae) (RRP15)
B12R06C19	12-19-6	Hs~MGC:BC095406.1~uORF:IOH62661	742	653	884	371	272	97	1149	478	0	72	Core histone macro-H2A.1
B12R06C20	12-20-6	Hs~MGC:BC095406.1~uORF:IOH62661	249	587	771	390	271	109	1319	494	838	24	Core histone macro-H2A.1
B12R06C21	12-21-6	Hs~MGC:BC094719.1~uORF:IOH62673	4643	3105	7193	3810	6794	8074	6918	2816	8894	2199	Rho GTPase-activating protein 12
B12R06C22	12-22-6	Hs~MGC:BC094719.1~uORF:IOH62673	3682	3180	7098	3882	6579	7727	7033	2982	8602	1849	Rho GTPase-activating protein 12
B12R07C05	12-5-7	Hs~Ref:NM_054022.2~uORF:IOH41241	848	931	1206	652	843	223	1210	953	1508	104	golgi SNAP receptor complex member 2 (GOSR2), transcript variant B
B12R07C06	12-6-7	Hs~Ref:NM_054022.2~uORF:IOH41241	843	959	1154	663	908	738	1244	954	1657	233	golgi SNAP receptor complex member 2 (GOSR2), transcript variant B
B12R07C07	12-7-7	Hs~Ref:NM_194453.1~uORF:IOH42461	553	636	1322	448	292	3507	930	470	1368	210	ring finger protein 121 (RNF121), transcript variant 3
B12R07C08	12-8-7	Hs~Ref:NM_194453.1~uORF:IOH42461	1480	629	1198	506	287	141	909	443	1150	49	ring finger protein 121 (RNF121), transcript variant 3
B12R07C09	12-9-7	Hs~Ref:NM_016815.2~uORF:IOH41541	468	612	1071	2777	491	-220	2271	592	1713	171	glycophorin C (Gerbich blood group) (GYPC), transcript variant 2
B12R07C10	12-10-7	Hs~Ref:NM_016815.2~uORF:IOH41541	524	578	1074	2960	458	-270	2284	658	1645	183	glycophorin C (Gerbich blood group) (GYPC), transcript variant 2
B12R07C11	12-11-7	Hs~Ref:NM_006621.3~uORF:IOH41131	11746	1399	5560	2803	1698	3141	2218	4691	3953	1101	S-adenosylhomocysteine hydrolase-like 1 (AHCYL1)
B12R07C12	12-12-7	Hs~Ref:NM_006621.3~uORF:IOH41131	11599	1467	5468	2968	1740	3113	2242	4812	3979	998	S-adenosylhomocysteine hydrolase-like 1 (AHCYL1)
B12R07C13	12-13-7	Hs~MGC:BC022983.1~uORF:IOH10747	1027	308	1085	501	458	391	1920	1201	1485	-12	ligand of numb-protein X 1 (LNX1)
B12R07C14	12-14-7	Hs~MGC:BC022983.1~uORF:IOH10747	2435	479	1188	502	505	-22	1819	1109	1585	114	ligand of numb-protein X 1 (LNX1)
B12R07C15	12-15-7	Hs~Ref:NM_006453.2~uORF:IOH10246	2930	828	777	436	331	-12	873	419	1202	185	transducin (beta)-like 3 (TBL3)
B12R07C16	12-16-7	Hs~Ref:NM_006453.2~uORF:IOH10246	3099	681	775	493	348	9	894	364	1127	76	transducin (beta)-like 3 (TBL3)
B12R07C17	12-17-7	Hs~MGC:BC020981.1~uORF:IOH10388	3367	945	1755	999	684	452	4825	785	1877	-20	General transcription factor 3C polypeptide 2
B12R07C18	12-18-7	Hs~MGC:BC020981.1~uORF:IOH10388	3366	1039	1699	972	842	465	4437	861	1842	113	General transcription factor 3C polypeptide 2
B12R07C19	12-19-7	Hs~Ref:NM_018270.3~uORF:IOH14702	2409	1183	1816	3395	1712	2269	4372	1283	2533	518	MRG-binding protein
B12R07C20	12-20-7	Hs~Ref:NM_018270.3~uORF:IOH14702	2565	1078	1786	3438	1688	2235	4545	1312	2544	603	MRG-binding protein
B12R08C03	12-3-8	Hs~MGC:BC066935.1~uORF:IOH61468	1478	654	423	354	339	166	465	345	808	154	Uncharacterized protein C8orf41
B12R08C04	12-4-8	Hs~MGC:BC066935.1~uORF:IOH61468	1503	545	491	336	264	118	431	365	944	226	Uncharacterized protein C8orf41
B12R08C07	12-7-8	Hs~Ref:NM_006948.1~uORF:IOH22345	481	1070	885	634	549	559	3030	1106	1820	446	stress 70 protein chaperone, microsome-associated, 60kDa (STCH)
B12R08C08	12-8-8	Hs~Ref:NM_006948.1~uORF:IOH22345	1579	1040	775	628	553	564	3025	1086	1697	442	stress 70 protein chaperone, microsome-associated, 60kDa (STCH)
B12R08C09	12-9-8	Hs~Ref:NM_015510.2~uORF:IOH5674	961	880	956	645	495	262	1155	659	1304	7	Dehydrogenase/reductase SDR family member 7B
B12R08C10	12-10-8	Hs~Ref:NM_015510.2~uORF:IOH5674	890	864	1045	600	468	89	1078	702	1104	367	Dehydrogenase/reductase SDR family member 7B
B12R08C11	12-11-8	Hs~MGC:BC022237.1~uORF:IOH21440	842	617	2067	275	454	-53	995	1182	1011	66	ubiquitin-conjugating enzyme E2O (UBE2O)
B12R08C12	12-12-8	Hs~MGC:BC022237.1~uORF:IOH21440	854	576	1949	199	462	-376	1069	171	1116	-40	ubiquitin-conjugating enzyme E2O (UBE2O)
B12R08C13	12-13-8	Hs~MGC:BC018928.1~uORF:IOH12116	2224	1881	2687	2194	1746	5017	2471	2085	4	-4	SEC24 related gene family, member C (S. cerevisiae) (SEC24C)
B12R08C14	12-14-8	Hs~MGC:BC018928.1~uORF:IOH12116	2874	1881	2867	2175	1583	4801	2444	2209	30	-2	SEC24 related gene family, member C (S. cerevisiae) (SEC24C)
B12R08C15	12-15-8	Hs~MGC:BC022471.1~uORF:IOH11199	2833	1524	2343	1189	768	1628	7778	1301	3320	12	myelin-associated oligodendrocyte basic protein (MOBP)
B12R08C16	12-16-8	Hs~MGC:BC022471.1~uORF:IOH11199	3047	1382	2247	1364	912	402	7706	1256	3134	466	myelin-associated oligodendrocyte basic protein (MOBP)
B12R08C17	12-17-8	Hs~Ref:NM_080739.1~uORF:IOH11067	949	824	1074	763	521	253	1439	790	1298	537	chromosome 20 open reading frame 141 (C20orf141)
B12R08C18	12-18-8	Hs~Ref:NM_080739.1~uORF:IOH11067	1085	915	1178	727	567	-20	1393	769	2565	-37	chromosome 20 open reading frame 141 (C20orf141)
B12R08C19	12-19-8	Hs~Ref:NM_052950.2~uORF:IOH13317	1147	877	2194	743	849	571	1396	672	3138	401	WD repeat and FYVE domain containing 2 (WDFY2)
B12R08C20	12-20-8	Hs~Ref:NM_052950.2~uORF:IOH13317	1136	740	2102	832	857	607	1460	719	3175	349	WD repeat and FYVE domain containing 2 (WDFY2)
B12R08C21	12-21-8	Hs~MGC:BC011906.1~uORF:IOH12531	6116	2665	2721	4535	2544	2997	3167	3509	4006	1126	iron-sulfur cluster scaffold homolog (E. coli) (ISCU)
B12R08C22	12-22-8	Hs~MGC:BC011906.1~uORF:IOH12531	5582	2766	2745	4394	2522	2553	3180	3188	4204	489	iron-sulfur cluster scaffold homolog (E. coli) (ISCU)
B12R09C01	12-1-9	Hs~Ref:NM_022776.3~uORF:IOH40437	6661	6342	3329	1585	2960	3047	9938	1391	11120	1627	oxysterol binding protein-like 11 (OSBPL11)
B12R09C02	12-2-9	Hs~Ref:NM_022776.3~uORF:IOH40437	6965	6588	2903	1639	2904	2985	9805	1470	13768	2046	oxysterol binding protein-like 11 (OSBPL11)
B12R09C03	12-3-9	Hs~Ref:NM_032875.1~uORF:IOH40622	534	278	512	339	259	230	925	449	680	143	F-box and leucine-rich repeat protein 20 (FBXL20)
B12R09C04	12-4-9	Hs~Ref:NM_032875.1~uORF:IOH40622	563	310	616	326	208	230	958	425	621	235	F-box and leucine-rich repeat protein 20 (FBXL20)
B12R09C05	12-5-9	Hs~MGC:BC068071.1~uORF:IOH40780	531	207	555	410	174	58	595	327	413	21	chromosome 19 open reading frame 39 (C19orf39)
B12R09C06	12-6-9	Hs~MGC:BC068071.1~uORF:IOH40780	492	953	491	403	167	440	572	400	420	36	chromosome 19 open reading frame 39 (C19orf39)
B12R09C07	12-7-9	Hs~MGC:BC070189.1~uORF:IOH40809	602	412	643	347	274	243	883	444	920	41	FK506 binding protein 6, 36kDa pseudogene (LOC541473)
B12R09C08	12-8-9	Hs~MGC:BC070189.1~uORF:IOH40809	1201	347	635	398	325	405	857	460	946	184	FK506 binding protein 6, 36kDa pseudogene (LOC541473)
B12R09C09	12-9-9	Hs~Ref:NM_024749.1~uORF:IOH27040	2226	252	530	325	223	52	568	559	548	144	Vasohibin-2
B12R09C10	12-10-9	Hs~Ref:NM_024749.1~uORF:IOH27040	474	242	523	335	213	-26	497	522	429	104	Vasohibin-2
B12R09C11	12-11-9	Hs~MGC:NM_178540.2~uORF:IOH26200	481	625	664	580	250	191	651	503	837	168	C1q and tumor necrosis factor related protein 9 (C1QTNF9)
B12R09C12	12-12-9	Hs~MGC:NM_178540.2~uORF:IOH26200	425	532	693	762	230	233	585	576	960	168	C1q and tumor necrosis factor related protein 9 (C1QTNF9)
B12R09C13	12-13-9	Hs~Ref:NM_016135.1~uORF:IOH26043	533	778	716	400	318	-10	896	528	2159	195	ets variant gene 7 (TEL2 oncogene) (ETV7)
B12R09C14	12-14-9	Hs~Ref:NM_016135.1~uORF:IOH26043	859	539	687	327	330	20	969	560	2180	74	ets variant gene 7 (TEL2 oncogene) (ETV7)
B12R09C15	12-15-9	Hs~MGC:NM_182494.1~uORF:IOH26292	195	301	503	324	77	35	309	308	534	26	family with sequence similarity 26, member A (FAM26A)
B12R09C16	12-16-9	Hs~MGC:NM_182494.1~uORF:IOH26292	506	434	597	291	86	76	311	298	203	7	family with sequence similarity 26, member A (FAM26A)
B12R09C17	12-17-9	Hs~MGC:BC009506.1~uORF:IOH12068	1891	1177	1408	1153	934	-10	2164	1378	5303	1793	TIP41, TOR signaling pathway regulator-like (S. cerevisiae) (TIPRL)
B12R09C18	12-18-9	Hs~MGC:BC009506.1~uORF:IOH12068	1883	1261	1521	1087	1061	1330	2081	1352	5062	1913	TIP41, TOR signaling pathway regulator-like (S. cerevisiae) (TIPRL)
B12R09C19	12-19-9	Hs~MGC:BC012109.1~uORF:IOH12380	5820	5069	8893	10118	12174	6579	14415	65453	8673	3748	homer homolog 2 (Drosophila) (HOMER2)
B12R09C20	12-20-9	Hs~MGC:BC012109.1~uORF:IOH12380	5899	5047	8943	10796	11567	6929	14170	65471	8691	3835	homer homolog 2 (Drosophila) (HOMER2)
B12R09C21	12-21-9	Hs~Ref:NM_022780.2~uORF:IOH13276	1819	1055	1586	1315	1165	1674	3046	982	2733	680	required for meiotic nuclear division 5 homolog A (S. cerevisiae) (RMND5A)
B12R09C22	12-22-9	Hs~Ref:NM_022780.2~uORF:IOH13276	2150	1039	1648	1391	1057	1576	2762	952	2660	667	required for meiotic nuclear division 5 homolog A (S. cerevisiae) (RMND5A)
B12R10C01	12-1-10	Hs~Ref:NM_020384.1~uORF:IOH12584	1643	975	1558	883	788	1114	2823	950	2822	668	claudin 2 (CLDN2)
B12R10C02	12-2-10	Hs~Ref:NM_020384.1~uORF:IOH12584	1528	1002	1494	1893	754	1024	2915	940	191	599	claudin 2 (CLDN2)
B12R10C03	12-3-10	Hs~MGC:BC057243.1~uORF:IOH29436	523	670	550	499	313	486	777	483	272	349	N-acetylated alpha-linked acidic dipeptidase-like 2 (NAALADL2)
B12R10C04	12-4-10	Hs~MGC:BC057243.1~uORF:IOH29436	459	447	557	338	287	565	726	475	773	293	N-acetylated alpha-linked acidic dipeptidase-like 2 (NAALADL2)
B12R10C09	12-9-10	Hs~MGC:BC013928.1~uORF:IOH27869	1252	1240	853	602	982	-7	1037	1521	2037	381	ferritin, light polypeptide (FTL)
B12R10C10	12-10-10	Hs~MGC:BC013928.1~uORF:IOH27869	940	1338	861	632	953	355	1093	1554	1943	491	ferritin, light polypeptide (FTL)
B12R11C21	12-21-11	Hs~MGC:BC042195.1~uORF:IOH28766	324	402	495	392	1444	311	764	451	420	79	malonyl CoA:ACP acyltransferase (mitochondrial) (MCAT)
B12R11C22	12-22-11	Hs~MGC:BC042195.1~uORF:IOH28766	770	401	555	461	158	320	652	322	213	33	malonyl CoA:ACP acyltransferase (mitochondrial) (MCAT)
B12R12C01	12-1-12	Hs~MGC:BC057810.1~uORF:IOH29262	365	337	295	272	127	1751	476	265	36	237	tubulin, alpha 3d (TUBA3D)
B12R12C02	12-2-12	Hs~MGC:BC057810.1~uORF:IOH29262	407	97	246	329	141	437	436	367	15	263	tubulin, alpha 3d (TUBA3D)
B12R12C05	12-5-12	Hs~MGC:BC052805.1~uORF:IOH29378	2175	5701	5303	4951	7220	1745	2483	4185	3523	1919	erythrocyte membrane protein band 4.9 (dematin) (EPB49)
B12R12C06	12-6-12	Hs~MGC:BC052805.1~uORF:IOH29378	2087	6272	4803	5000	6956	1753	2407	4032	3486	1889	erythrocyte membrane protein band 4.9 (dematin) (EPB49)
B12R12C07	12-7-12	Hs~Ref:NM_173519.1~uORF:IOH27342	3446	693	754	899	679	2250	1382	2009	3742	474	retinaldehyde binding protein 1-like 1 (RLBP1L1)
B12R12C08	12-8-12	Hs~Ref:NM_173519.1~uORF:IOH27342	3887	2400	708	892	715	2288	1415	1876	4268	503	retinaldehyde binding protein 1-like 1 (RLBP1L1)
B12R12C09	12-9-12	Hs~MGC:BC047870.1~uORF:IOH26949	1281	1321	818	570	513	406	1274	750	594	17	src kinase associated phosphoprotein 1 (SKAP1)
B12R12C10	12-10-12	Hs~MGC:BC047870.1~uORF:IOH26949	866	1168	896	618	466	-34	1174	641	833	257	src kinase associated phosphoprotein 1 (SKAP1)
B12R12C11	12-11-12	Hs~Ref:NM_021038.3~uORF:IOH26398	1644	1636	1700	1344	1045	310	4543	1303	2112	800	muscleblind-like (Drosophila) (MBNL1), transcript variant 1
B12R12C12	12-12-12	Hs~Ref:NM_021038.3~uORF:IOH26398	1662	1479	1685	1359	1039	1464	4278	1336	2586	775	muscleblind-like (Drosophila) (MBNL1), transcript variant 1
B12R12C13	12-13-12	Hs~Ref:NM_002558.2~uORF:IOH26134	997	908	1128	736	602	1143	1420	959	1972	505	purinergic receptor P2X, ligand-gated ion channel, 1 (P2RX1)
B12R12C14	12-14-12	Hs~Ref:NM_002558.2~uORF:IOH26134	904	925	1180	681	636	-2	1474	1069	709	569	purinergic receptor P2X, ligand-gated ion channel, 1 (P2RX1)
B12R12C15	12-15-12	Hs~MGC:BC098152.1~uORF:IOH63303	376	260	656	282	214	-3	704	315	193	91	Retinoic acid early transcript 1G protein
B12R12C16	12-16-12	Hs~MGC:BC098152.1~uORF:IOH63303	291	391	639	294	235	263	664	293	449	94	Retinoic acid early transcript 1G protein
B12R12C17	12-17-12	Hs~MGC:BC103660.1~uORF:IOH63319	1253	690	1187	675	432	741	1874	603	1532	572	Putative RNA-binding protein 15
B12R12C18	12-18-12	Hs~MGC:BC103660.1~uORF:IOH63319	1436	765	1156	686	501	296	1838	638	1895	555	Putative RNA-binding protein 15
B12R12C19	12-19-12	Hs~Ref:NM_145051.1~uORF:IOH12052	207	81	745	252	1742	103	359	269	283	140	ring finger protein 183 (RNF183)
B12R12C20	12-20-12	Hs~Ref:NM_145051.1~uORF:IOH12052	78	224	592	248	1841	3	373	253	151	103	ring finger protein 183 (RNF183)
B12R12C21	12-21-12	Hs~MGC:BC007681.2~uORF:IOH6233	424	378	812	515	781	570	700	679	606	47	Ras-related protein Rab-26
B12R12C22	12-22-12	Hs~MGC:BC007681.2~uORF:IOH6233	840	444	784	497	1561	552	633	674	483	408	Ras-related protein Rab-26
B12R13C01	12-1-13	Hs~MGC:BC032919.1~uORF:IOH23210	1704	691	1048	533	903	3205	1242	664	1144	285	2-oxoglutarate and iron-dependent oxygenase domain containing 1 (OGFOD1)
B12R13C02	12-2-13	Hs~MGC:BC032919.1~uORF:IOH23210	1719	740	1018	522	831	867	1233	659	929	302	2-oxoglutarate and iron-dependent oxygenase domain containing 1 (OGFOD1)
B12R13C03	12-3-13	Hs~MGC:BC033088.1~uORF:IOH23217	1510	2197	1714	2723	1442	396	3210	1810	3960	879	lamin A/C (LMNA)
B12R13C04	12-4-13	Hs~MGC:BC033088.1~uORF:IOH23217	1478	2207	1865	2717	1396	1934	3193	1944	3738	910	lamin A/C (LMNA)
B12R13C05	12-5-13	Hs~Ref:NM_014270.3~uORF:IOH12317	3016	708	1134	633	1002	1294	1179	941	773	304	solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 (SLC7A9)
B12R13C06	12-6-13	Hs~Ref:NM_014270.3~uORF:IOH12317	2883	1659	1073	619	962	831	1155	914	1496	335	solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 (SLC7A9)
B12R13C07	12-7-13	Hs~Ref:NM_001001550.1~uORF:IOH13204	2355	2457	2316	3740	1872	3262	11360	3448	3698	2694	growth factor receptor-bound protein 10 (GRB10), transcript variant 3
B12R13C08	12-8-13	Hs~Ref:NM_001001550.1~uORF:IOH13204	2257	2172	2353	3793	1735	3099	11729	3644	3338	2708	growth factor receptor-bound protein 10 (GRB10), transcript variant 3
B12R13C09	12-9-13	Hs~Ref:NM_133443.1~uORF:IOH40699	1844	1635	1733	1994	2639	1209	7416	3417	2170	1065	glutamic pyruvate transaminase (alanine aminotransferase) 2 (GPT2)
B12R13C10	12-10-13	Hs~Ref:NM_133443.1~uORF:IOH40699	1924	1688	1834	1910	2697	-44	7503	3366	2295	999	glutamic pyruvate transaminase (alanine aminotransferase) 2 (GPT2)
B12R13C11	12-11-13	Hs~Ref:NM_018894.1~uORF:IOH37773	566	605	632	1505	291	54	346	294	-5	93	EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1), transcript variant 2
B12R13C12	12-12-13	Hs~Ref:NM_018894.1~uORF:IOH37773	445	728	572	1641	265	-46	371	309	928	87	EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1), transcript variant 2
B12R13C13	12-13-13	Hs~MGC:BC053533.1~uORF:IOH39790	195	310	517	302	245	-14	439	316	391	13	MTERF domain containing 2 (MTERFD2)
B12R13C14	12-14-13	Hs~MGC:BC053533.1~uORF:IOH39790	500	172	244	285	232	125	459	331	254	398	MTERF domain containing 2 (MTERFD2)
B12R13C15	12-15-13	Hs~MGC:BC064518.1~uORF:IOH39887	609	499	775	412	471	56	900	437	358	283	CD40 molecule, TNF receptor superfamily member 5 (CD40)
B12R13C16	12-16-13	Hs~MGC:BC064518.1~uORF:IOH39887	600	485	743	401	511	653	866	423	943	-7	CD40 molecule, TNF receptor superfamily member 5 (CD40)
B12R13C17	12-17-13	Hs~MGC:BC022075.1~uORF:IOH10954	899	763	1099	584	764	10966	1545	659	1575	507	LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2)
B12R13C18	12-18-13	Hs~MGC:BC022075.1~uORF:IOH10954	947	821	1066	576	721	11333	1596	708	1555	496	LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2)
B12R13C19	12-19-13	Hs~Ref:NM_014380.1~uORF:IOH4519	23	608	503	656	736	644	1003	673	884	3202	nerve growth factor receptor (TNFRSF16) associated protein 1 (NGFRAP1), transcript variant 3
B12R13C20	12-20-13	Hs~Ref:NM_014380.1~uORF:IOH4519	448	558	492	669	1510	586	1000	684	744	3218	nerve growth factor receptor (TNFRSF16) associated protein 1 (NGFRAP1), transcript variant 3
B12R13C21	12-21-13	Hs~Ref:NM_030920.1~uORF:IOH2956	1319	345	422	510	1215	746	600	718	8308	135	acidic (leucine-rich) nuclear phosphoprotein 32 family, member E (ANP32E)
B12R13C22	12-22-13	Hs~Ref:NM_030920.1~uORF:IOH2956	1372	370	406	542	1470	556	570	647	8112	-3	acidic (leucine-rich) nuclear phosphoprotein 32 family, member E (ANP32E)
B12R14C01	12-1-14	Hs~Ref:NM_001009957.1~uORF:IOH57345	530	415	694	1073	566	500	726	353	828	256	Zinc finger protein 655
B12R14C02	12-2-14	Hs~Ref:NM_001009957.1~uORF:IOH57345	545	498	589	1064	475	414	780	372	-60	259	Zinc finger protein 655
B12R14C03	12-3-14	Hs~Ref:NM_001005473.1~uORF:IOH59368	822	874	1602	286	301	516	1544	572	189	387	Phosphatidylinositol-specific phospholipase C X domain-containing protein 3
B12R14C04	12-4-14	Hs~Ref:NM_001005473.1~uORF:IOH59368	819	869	1947	256	296	541	1574	572	1030	360	Phosphatidylinositol-specific phospholipase C X domain-containing protein 3
B12R14C05	12-5-14	Hs~Ref:NM_001008270.1~uORF:IOH59742	427	232	596	282	199	42	531	629	140	196	Peptidase S1 domain-containing protein LOC136242
B12R14C06	12-6-14	Hs~Ref:NM_001008270.1~uORF:IOH59742	431	245	624	309	291	2	595	546	147	202	Peptidase S1 domain-containing protein LOC136242
B12R14C07	12-7-14	Hs~Ref:NM_012217.2~uORF:IOH59766	989	427	596	627	374	515	1199	741	-25	248	Tryptase delta
B12R14C08	12-8-14	Hs~Ref:NM_012217.2~uORF:IOH59766	938	285	638	627	362	461	1256	666	-27	212	Tryptase delta
B12R14C11	12-11-14	Hs~Ref:NM_006792.2~uORF:IOH58223	1300	902	1290	579	733	179	1710	912	1089	356	mortality factor 4 (MORF4), mRNA.
B12R14C12	12-12-14	Hs~Ref:NM_006792.2~uORF:IOH58223	1364	762	1292	621	725	10	1596	866	2110	394	mortality factor 4 (MORF4), mRNA.
B12R14C13	12-13-14	Hs~MGC:NM_000461.3~uORF:IOH29857	317	668	720	302	213	167	938	412	620	58	Thyroid hormone receptor beta
B12R14C14	12-14-14	Hs~MGC:NM_000461.3~uORF:IOH29857	299	711	702	287	264	65	927	392	397	8	Thyroid hormone receptor beta
B12R14C15	12-15-14	Hs~Ref:NM_181268.1~uORF:IOH58697	436	214	724	351	314	376	637	437	271	25	CKLF-like MARVEL transmembrane domain containing 1 (CMTM1), transcript variant 18, mRNA.
B12R14C16	12-16-14	Hs~Ref:NM_181268.1~uORF:IOH58697	2044	471	865	435	243	65	638	527	147	303	CKLF-like MARVEL transmembrane domain containing 1 (CMTM1), transcript variant 18, mRNA.
B12R15C03	12-3-15	Hs~Ref:NM_030761.3~uORF:IOH29127	642	588	658	638	447	206	897	553	1340	393	wingless-type MMTV integration site family, member 4 (WNT4)
B12R15C04	12-4-15	Hs~Ref:NM_030761.3~uORF:IOH29127	536	531	840	632	423	224	1021	-11	624	368	wingless-type MMTV integration site family, member 4 (WNT4)
B12R15C05	12-5-15	Hs~Ref:NM_001216.1~uORF:IOH14740	524	484	1263	419	318	22	-2	-7	895	353	carbonic anhydrase IX (CA9)
B12R15C06	12-6-15	Hs~Ref:NM_001216.1~uORF:IOH14740	609	380	1466	500	301	-2	6	785	232	368	carbonic anhydrase IX (CA9)
B12R15C07	12-7-15	Hs~Ref:NM_017594.2~uORF:IOH5904	721	910	903	565	532	632	1305	936	1328	355	DIRAS family, GTP-binding RAS-like 2 (DIRAS2)
B12R15C08	12-8-15	Hs~Ref:NM_017594.2~uORF:IOH5904	824	675	1029	592	460	48	1391	702	1072	370	DIRAS family, GTP-binding RAS-like 2 (DIRAS2)
B12R15C09	12-9-15	Hs~Ref:NM_024430.1~uORF:IOH27423	1222	845	717	1010	298	367	688	497	224	362	proline-serine-threonine phosphatase interacting protein 2 (PSTPIP2)
B12R15C10	12-10-15	Hs~Ref:NM_024430.1~uORF:IOH27423	1212	709	661	1029	281	76	725	457	333	233	proline-serine-threonine phosphatase interacting protein 2 (PSTPIP2)
B12R15C11	12-11-15	Hs~MGC:BC040527.1~uORF:IOH27478	1235	1040	1264	636	455	1	1614	652	2400	600	coiled-coil domain containing 100 (CCDC100)
B12R15C12	12-12-15	Hs~MGC:BC040527.1~uORF:IOH27478	1335	1129	1265	720	460	-29	1481	681	1443	6	coiled-coil domain containing 100 (CCDC100)
B12R15C15	12-15-15	Hs~Ref:NM_004440.1~CAT:PV3689	158	133	397	300	298	-10	413	329	161	-4	Ephrin type-A receptor 7
B12R15C16	12-16-15	Hs~Ref:NM_004440.1~CAT:PV3689	-3	155	401	272	265	351	417	376	88	2	Ephrin type-A receptor 7
B12R15C17	12-17-15	Hs~Ref:NM_004409.2~CAT:PV3784	1195	454	290	656	505	-10	815	428	208	211	dystrophia myotonica-protein kinase (DMPK), transcript variant 2
B12R15C18	12-18-15	Hs~Ref:NM_004409.2~CAT:PV3784	571	521	261	618	514	70	812	433	1134	286	dystrophia myotonica-protein kinase (DMPK), transcript variant 2
B12R15C21	12-21-15	Hs~Ref:NM_016123.1~CAT:PV3362	672	275	973	321	127	22	681	397	408	70	interleukin-1 receptor-associated kinase 4 (IRAK4)
B12R15C22	12-22-15	Hs~Ref:NM_016123.1~CAT:PV3362	724	264	2611	286	124	369	639	402	295	-7	interleukin-1 receptor-associated kinase 4 (IRAK4)
B12R16C01	12-1-16	Hs~Ref:NM_000880.2~CAT_PHC0076	18971	2518	510	310	102	690	721	681	1006	653	interleukin 7 (IL7)
B12R16C02	12-2-16	Hs~Ref:NM_000880.2~CAT_PHC0076	19297	2510	565	848	203	820	703	669	1037	658	interleukin 7 (IL7)
B12R16C03	12-3-16	Hs~Ref:NM_002983.1~CAT_PHC1105	36	31	121	63	23	-32	212	67	197	73	chemokine (C-C motif) ligand 3 (CCL3)
B12R16C04	12-4-16	Hs~Ref:NM_002983.1~CAT_PHC1105	37	26	127	141	34	-18	204	1129	67	72	chemokine (C-C motif) ligand 3 (CCL3)
B12R16C07	12-7-16	Hs~Ref:NM_005416.1~uORF:IOH59847	904	746	1724	634	962	1292	1622	977	2379	395	Small proline-rich protein 3
B12R16C08	12-8-16	Hs~Ref:NM_005416.1~uORF:IOH59847	804	628	1622	635	904	1170	1572	1019	2614	374	Small proline-rich protein 3
B12R16C09	12-9-16	Hs~MGC:BC065912.1~uORF:IOH40442	1220	1513	2525	1286	1327	2060	1948	2011	1805	1117	Tyrosine-protein kinase ABL2
B12R16C10	12-10-16	Hs~MGC:BC065912.1~uORF:IOH40442	1315	1696	2474	1233	1392	2093	1974	1769	1761	1155	Tyrosine-protein kinase ABL2
B12R16C11	12-11-16	Hs~Ref:NM_182770.1~uORF:IOH53444	919	566	779	7660	600	-76	1129	698	1494	711	cAMP responsive element modulator (CREM), transcript variant 14, mRNA.
B12R16C12	12-12-16	Hs~Ref:NM_182770.1~uORF:IOH53444	1157	688	756	8102	606	0	1134	684	1172	637	cAMP responsive element modulator (CREM), transcript variant 14, mRNA.
B12R16C13	12-13-16	Hs~Ref:NM_002031.2~uORF:IOH56137	397	445	637	423	230	722	720	442	492	314	fyn-related kinase (FRK)
B12R16C14	12-14-16	Hs~Ref:NM_002031.2~uORF:IOH56137	370	442	682	359	222	17	734	457	452	306	fyn-related kinase (FRK)
B12R16C15	12-15-16	Hs~Ref:NM_020215.2~uORF:IOH28060	193	96	435	287	294	3	560	364	367	8	chromosome 14 open reading frame 132 (C14orf132)
B12R16C16	12-16-16	Hs~Ref:NM_020215.2~uORF:IOH28060	194	8	563	340	333	254	606	550	102	239	chromosome 14 open reading frame 132 (C14orf132)
B12R16C17	12-17-16	Hs~Ref:NM_020672.1~uORF:IOH5597	425	1003	1241	260	270	8493	594	1603	703	139	S100 calcium binding protein A14 (S100A14)
B12R16C18	12-18-16	Hs~Ref:NM_020672.1~uORF:IOH5597	429	1002	1244	254	320	8588	623	1504	650	130	S100 calcium binding protein A14 (S100A14)
B12R16C19	12-19-16	Hs~Ref:NM_005850.3~uORF:IOH5494	401	163	295	306	190	580	466	379	-83	464	splicing factor 3b, subunit 4, 49kDa (SF3B4)
B12R16C20	12-20-16	Hs~Ref:NM_005850.3~uORF:IOH5494	343	340	295	318	249	485	579	366	526	251	splicing factor 3b, subunit 4, 49kDa (SF3B4)
B12R16C21	12-21-16	Hs~Ref:NM_002923.1~uORF:IOH7121	623	664	1309	2486	608	2043	1727	603	86	354	regulator of G-protein signaling 2, 24kDa (RGS2)
B12R16C22	12-22-16	Hs~Ref:NM_002923.1~uORF:IOH7121	588	694	1419	2581	608	1482	1752	632	1692	372	regulator of G-protein signaling 2, 24kDa (RGS2)
B12R17C01	12-1-17	Hs~MGC:NM_170693.1~uORF:IOH14023	1967	437	1378	382	336	389	592	709	1462	251	serum/glucocorticoid regulated kinase 2 (SGK2), transcript variant 1
B12R17C02	12-2-17	Hs~MGC:NM_170693.1~uORF:IOH14023	737	514	1233	530	357	-10	654	703	1461	240	serum/glucocorticoid regulated kinase 2 (SGK2), transcript variant 1
B12R17C03	12-3-17	Hs~MGC:BC010931.1~uORF:IOH14302	529	194	124	1207	158	606	256	523	422	207	myocyte enhancer factor 2B (MEF2B)
B12R17C04	12-4-17	Hs~MGC:BC010931.1~uORF:IOH14302	180	145	134	265	145	167	262	376	434	169	myocyte enhancer factor 2B (MEF2B)
B12R17C05	12-5-17	Hs~MGC:BC010947.1~uORF:IOH14455	1719	425	521	359	214	151	4594	519	1224	280	signal recognition particle 19kDa (SRP19)
B12R17C06	12-6-17	Hs~MGC:BC010947.1~uORF:IOH14455	1805	434	528	352	68	483	5360	511	944	264	signal recognition particle 19kDa (SRP19)
B12R17C07	12-7-17	Hs~MGC:BC028725.2~uORF:IOH11761	1153	1755	320	274	211	316	485	389	331	225	ELMO/CED-12 domain containing 1 (ELMOD1)
B12R17C08	12-8-17	Hs~MGC:BC028725.2~uORF:IOH11761	1199	104	334	296	167	209	427	418	384	235	ELMO/CED-12 domain containing 1 (ELMOD1)
B12R17C09	12-9-17	Hs~MGC:NM_175738.2~uORF:IOH27507	640	102	2258	376	348	1250	419	798	310	303	RAB37, member RAS oncogene family (RAB37), transcript variant 3
B12R17C10	12-10-17	Hs~MGC:NM_175738.2~uORF:IOH27507	645	98	177	361	365	61	402	772	441	279	RAB37, member RAS oncogene family (RAB37), transcript variant 3
B12R17C11	12-11-17	Hs~MGC:NM_173607.2~uORF:IOH21621	154	55	454	201	423	190	296	541	420	39	chromosome 14 open reading frame 24 (C14orf24), transcript variant 1
B12R17C12	12-12-17	Hs~MGC:NM_173607.2~uORF:IOH21621	62	50	352	262	436	-17	226	605	148	30	chromosome 14 open reading frame 24 (C14orf24), transcript variant 1
B12R17C13	12-13-17	Hs~MGC:NM_173088.1~uORF:IOH5097	210	238	1044	481	192	-10	710	378	627	162	calpain 3, (p94) (CAPN3), transcript variant 4
B12R17C14	12-14-17	Hs~MGC:NM_173088.1~uORF:IOH5097	228	155	912	554	208	-34	705	440	563	316	calpain 3, (p94) (CAPN3), transcript variant 4
B12R17C15	12-15-17	Hs~Ref:NM_032328.1~uORF:IOH7232	45	49	56	19	74	24	88	131	98	9	EF-hand calcium binding domain 2 (EFCAB2)
B12R17C16	12-16-17	Hs~Ref:NM_032328.1~uORF:IOH7232	40	14	64	66	72	19	89	140	266	-1	EF-hand calcium binding domain 2 (EFCAB2)
B12R17C21	12-21-17	Hs~MGC:NM_178177.2~uORF:IOH22674	1620	217	242	263	120	4	717	366	513	13	Nicotinamide mononucleotide adenylyltransferase 3
B12R17C22	12-22-17	Hs~MGC:NM_178177.2~uORF:IOH22674	205	284	624	329	124	8	583	328	1128	-11	Nicotinamide mononucleotide adenylyltransferase 3
B12R18C01	12-1-18	Hs~MGC:BC100765.2~uORF:IOH63417	654	252	1412	324	302	1091	2497	833	879	251	Xg blood group, mRNA (cDNA clone MGC:118759 IMAGE:40000158), complete cds
B12R18C02	12-2-18	Hs~MGC:BC100765.2~uORF:IOH63417	449	316	1544	604	300	145	2530	941	921	282	Xg blood group, mRNA (cDNA clone MGC:118759 IMAGE:40000158), complete cds
B12R18C03	12-3-18	Hs~MGC:BC094759.1~uORF:IOH62624	192	324	385	237	1115	-12	774	308	412	189	Synphilin-1
B12R18C04	12-4-18	Hs~MGC:BC094759.1~uORF:IOH62624	189	125	281	247	1135	14	754	358	460	55	Synphilin-1
B12R18C07	12-7-18	Hs~MGC:BC073959.1~uORF:IOH62556	427	1892	970	262	238	991	1048	427	537	200	vacuolar protein sorting 16 homolog (S. cerevisiae), mRNA (cDNA clone MGC:87858 IMAGE:6182570), complete cds
B12R18C08	12-8-18	Hs~MGC:BC073959.1~uORF:IOH62556	191	2354	819	262	239	194	1050	420	618	223	vacuolar protein sorting 16 homolog (S. cerevisiae), mRNA (cDNA clone MGC:87858 IMAGE:6182570), complete cds
B12R18C11	12-11-18	Hs~Ref:NM_138972.2~uORF:IOH39612	681	688	786	652	394	1378	1138	903	1780	532	beta-site APP-cleaving enzyme 1 (BACE1), transcript variant b
B12R18C12	12-12-18	Hs~Ref:NM_138972.2~uORF:IOH39612	732	659	686	730	457	736	1250	1083	1286	595	beta-site APP-cleaving enzyme 1 (BACE1), transcript variant b
B12R18C13	12-13-18	Hs~MGC:BC032662.1~uORF:IOH21986	1527	1691	1730	2485	1638	1212	3214	1276	3364	1132	polymerase (DNA directed) iota (POLI)
B12R18C14	12-14-18	Hs~MGC:BC032662.1~uORF:IOH21986	1466	1738	1796	2423	1594	1019	3922	1253	3224	1273	polymerase (DNA directed) iota (POLI)
B12R18C15	12-15-18	Hs~Ref:NM_001961.2~uORF:IOH39624	829	760	907	574	414	-23	1250	834	1849	623	eukaryotic translation elongation factor 2 (EEF2)
B12R18C16	12-16-18	Hs~Ref:NM_001961.2~uORF:IOH39624	503	630	889	633	490	-45	1167	874	1840	349	eukaryotic translation elongation factor 2 (EEF2)
B12R18C17	12-17-18	Hs~Ref:NM_012096.1~uORF:IOH11629	528	788	1180	665	862	-8	1510	985	1282	464	adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 (APPL1)
B12R18C18	12-18-18	Hs~Ref:NM_012096.1~uORF:IOH11629	1022	760	961	659	850	511	1532	884	1774	476	adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 (APPL1)
B12R18C19	12-19-18	Hs~Ref:NM_000861.2~uORF:IOH29722	465	500	748	385	269	93	1009	724	605	344	histamine receptor H1 (HRH1), transcript variant 4
B12R18C20	12-20-18	Hs~Ref:NM_000861.2~uORF:IOH29722	1587	496	751	392	360	140	1227	536	1198	388	histamine receptor H1 (HRH1), transcript variant 4
B12R18C21	12-21-18	Hs~MGC:BC007956.1~uORF:IOH29317	327	408	438	402	340	78	1232	528	531	9	prolyl-tRNA synthetase 2, mitochondrial (putative) (PARS2)
B12R18C22	12-22-18	Hs~MGC:BC007956.1~uORF:IOH29317	-14	390	565	422	329	57	1144	493	111	-18	prolyl-tRNA synthetase 2, mitochondrial (putative) (PARS2)
B12R19C01	12-1-19	Hs~Ref:NM_012368.1~uORF:IOH28406	541	569	635	373	311	672	1294	595	824	293	olfactory receptor, family 2, subfamily C, member 1 (OR2C1)
B12R19C02	12-2-19	Hs~Ref:NM_012368.1~uORF:IOH28406	543	553	629	419	352	96	1321	663	1115	325	olfactory receptor, family 2, subfamily C, member 1 (OR2C1)
B12R19C03	12-3-19	Hs~Ref:NM_006136.1~uORF:IOH7253	806	442	948	737	625	682	1841	852	1540	411	capping protein (actin filament) muscle Z-line, alpha 2 (CAPZA2)
B12R19C04	12-4-19	Hs~Ref:NM_006136.1~uORF:IOH7253	799	454	1007	703	612	978	1784	878	1640	402	capping protein (actin filament) muscle Z-line, alpha 2 (CAPZA2)
B12R19C05	12-5-19	Hs~Ref:NM_020166.2~uORF:IOH3833	189	416	124	83	78	147	416	187	564	43	methylcrotonoyl-Coenzyme A carboxylase 1 (alpha) (MCCC1)
B12R19C06	12-6-19	Hs~Ref:NM_020166.2~uORF:IOH3833	199	370	162	52	119	161	324	242	396	78	methylcrotonoyl-Coenzyme A carboxylase 1 (alpha) (MCCC1)
B12R19C07	12-7-19	Hs~MGC:BC000478.2~uORF:IOH3690	547	2171	729	324	495	1412	16623	335	2311	191	heat shock 70kDa protein 9 (mortalin) (HSPA9)
B12R19C08	12-8-19	Hs~MGC:BC000478.2~uORF:IOH3690	649	2173	896	295	508	2858	16116	327	1784	213	heat shock 70kDa protein 9 (mortalin) (HSPA9)
B12R19C09	12-9-19	Hs~Ref:NM_006775.1~uORF:IOH10720	7211	648	753	456	1006	1108	1064	570	1119	300	quaking homolog, KH domain RNA binding (mouse) (QKI), transcript variant 1
B12R19C10	12-10-19	Hs~Ref:NM_006775.1~uORF:IOH10720	8024	789	593	415	941	98	1130	583	1457	330	quaking homolog, KH domain RNA binding (mouse) (QKI), transcript variant 1
B12R19C11	12-11-19	Hs~Ref:NM_005915.4~uORF:IOH21645	159	68	321	92	144	13	658	554	1488	34	minichromosome maintenance complex component 6 (MCM6)
B12R19C12	12-12-19	Hs~Ref:NM_005915.4~uORF:IOH21645	97	169	79	250	156	93	651	264	240	52	minichromosome maintenance complex component 6 (MCM6)
B12R19C15	12-15-19	Hs~Ref:NM_001012965.1~uORF:IOH58966	879	792	1089	555	525	706	1520	976	1427	75	Kallikrein-6
B12R19C16	12-16-19	Hs~Ref:NM_001012965.1~uORF:IOH58966	793	876	978	588	555	20	1408	1046	1859	380	Kallikrein-6
B12R19C21	12-21-19	Hs~MGC:BC000809.1~uORF:IOH3070	919	847	1021	594	575	3488	1102	693	1701	809	Transcription elongation factor A protein-like 1
B12R19C22	12-22-19	Hs~MGC:BC000809.1~uORF:IOH3070	944	793	999	628	584	3526	1074	737	2009	814	Transcription elongation factor A protein-like 1
B12R20C01	12-1-20	Hs~MGC:BC021303.1~uORF:IOH14570	525	292	573	312	239	611	524	451	846	218	calpain 2, (m/II) large subunit (CAPN2)
B12R20C02	12-2-20	Hs~MGC:BC021303.1~uORF:IOH14570	559	328	570	495	243	681	543	466	1062	222	calpain 2, (m/II) large subunit (CAPN2)
B12R20C03	12-3-20	Hs~MGC:BC001017.1~uORF:IOH4237	238	338	465	445	326	254	365	879	662	101	PDZ and LIM domain protein 3
B12R20C04	12-4-20	Hs~MGC:BC001017.1~uORF:IOH4237	217	336	484	361	317	479	474	1021	616	244	PDZ and LIM domain protein 3
B12R20C05	12-5-20	Hs~Ref:NM_000375.1~uORF:IOH4136	362	250	428	377	335	-13	697	-11	-1	12	uroporphyrinogen III synthase (congenital erythropoietic porphyria) (UROS)
B12R20C06	12-6-20	Hs~Ref:NM_000375.1~uORF:IOH4136	363	209	389	387	306	178	837	254	5353	-1	uroporphyrinogen III synthase (congenital erythropoietic porphyria) (UROS)
B12R20C07	12-7-20	Hs~Ref:NM_052969.1~uORF:IOH12514	1432	1202	2148	1183	1124	507	3385	1163	2752	569	ribosomal protein L39-like (RPL39L)
B12R20C08	12-8-20	Hs~Ref:NM_052969.1~uORF:IOH12514	1463	1168	1992	1159	1117	1520	3338	1159	2511	566	ribosomal protein L39-like (RPL39L)
B12R20C09	12-9-20	Hs~MGC:BC007991.2~uORF:IOH6109	1863	1072	1681	987	709	483	2508	1135	2941	660	chromosome 15 open reading frame 44 (C15orf44)
B12R20C10	12-10-20	Hs~MGC:BC007991.2~uORF:IOH6109	2092	1178	1696	940	716	1044	2709	1099	2921	603	chromosome 15 open reading frame 44 (C15orf44)
B12R20C11	12-11-20	Hs~Ref:NM_014049.3~uORF:IOH6788	1624	1352	1899	1626	1010	1373	1828	1391	2829	630	acyl-Coenzyme A dehydrogenase family, member 9 (ACAD9)
B12R20C12	12-12-20	Hs~Ref:NM_014049.3~uORF:IOH6788	1260	1165	2006	1823	974	1478	1763	1258	3002	596	acyl-Coenzyme A dehydrogenase family, member 9 (ACAD9)
B12R20C13	12-13-20	Hs~MGC:BC013331.1~uORF:IOH13858	1452	1413	2424	1167	871	1700	1966	1201	3408	764	H2A histone family, member Y (H2AFY)
B12R20C14	12-14-20	Hs~MGC:BC013331.1~uORF:IOH13858	1316	1383	2387	1117	899	1698	2023	1391	3548	653	H2A histone family, member Y (H2AFY)
B13R02C11	13-11-2	Hs~MGC:NM_174909.1~uORF:IOH14735	-1	-5	314	633	879	822	854	638	1652	398	transmembrane protein 167 (TMEM167)
B13R02C12	13-12-2	Hs~MGC:NM_174909.1~uORF:IOH14735	-3	-1	-5	660	1033	661	982	617	1700	412	transmembrane protein 167 (TMEM167)
B13R02C13	13-13-2	Hs~MGC:BC011600.1~uORF:IOH13680	27501	21391	19893	25078	23525	13371	24447	11675	27447	15316	cDNA clone IMAGE:3050953, **** WARNING: chimeric clone ****
B13R02C14	13-14-2	Hs~MGC:BC011600.1~uORF:IOH13680	28531	20871	20143	25291	26550	12458	23138	11423	26662	14564	cDNA clone IMAGE:3050953, **** WARNING: chimeric clone ****
B13R02C15	13-15-2	Hs~MGC:NM_172240.1~uORF:IOH10829	1918	864	1984	780	811	927	1391	627	1592	500	WD repeat domain 51B (WDR51B)
B13R02C16	13-16-2	Hs~MGC:NM_172240.1~uORF:IOH10829	1774	783	1892	794	763	787	1249	672	1504	479	WD repeat domain 51B (WDR51B)
B13R02C17	13-17-2	Hs~Ref:NM_004221.2~uORF:IOH14487	12532	1693	517	286	1123	696	563	507	744	177	interleukin 32 (IL32), transcript variant 2
B13R02C18	13-18-2	Hs~Ref:NM_004221.2~uORF:IOH14487	12356	1581	500	300	1256	509	577	461	743	211	interleukin 32 (IL32), transcript variant 2
B13R02C21	13-21-2	Hs~Ref:NM_201521.1~uORF:IOH43964	3874	1043	2540	3683	1814	1049	9037	1941	1756	710	kinesin light chain 4 (KLC4), transcript variant 1
B13R02C22	13-22-2	Hs~Ref:NM_201521.1~uORF:IOH43964	3759	938	2175	3944	1797	966	7760	1878	2126	739	kinesin light chain 4 (KLC4), transcript variant 1
B13R03C01	13-1-3	Hs~Ref:NM_022730.1~uORF:IOH42071	5162	4295	1099	2372	381	1066	1116	3481	3135	651	COP9 constitutive photomorphogenic homolog subunit 7B (Arabidopsis) (COPS7B)
B13R03C02	13-2-3	Hs~Ref:NM_022730.1~uORF:IOH42071	5922	3199	1148	1766	368	1050	1132	3437	3035	536	COP9 constitutive photomorphogenic homolog subunit 7B (Arabidopsis) (COPS7B)
B13R03C03	13-3-3	Hs~Ref:NM_021649.3~uORF:IOH43638	448	255	721	251	315	347	548	620	583	203	toll-like receptor adaptor molecule 2 (TICAM2)
B13R03C04	13-4-3	Hs~Ref:NM_021649.3~uORF:IOH43638	398	329	780	289	360	319	548	554	530	179	toll-like receptor adaptor molecule 2 (TICAM2)
B13R03C05	13-5-3	Hs~MGC:BC046214.1~uORF:IOH26987	1078	212	551	290	167	262	244	911	391	97	M-phase phosphoprotein 8 (HSMPP8)
B13R03C06	13-6-3	Hs~MGC:BC046214.1~uORF:IOH26987	1111	231	735	246	203	230	208	477	360	101	M-phase phosphoprotein 8 (HSMPP8)
B13R03C07	13-7-3	Hs~Ref:NM_002612.1~uORF:IOH25726	4721	526	2010	526	2206	916	817	825	1171	1512	pyruvate dehydrogenase kinase, isozyme 4 (PDK4)
B13R03C08	13-8-3	Hs~Ref:NM_002612.1~uORF:IOH25726	4591	488	1938	553	2193	757	799	915	1202	1583	pyruvate dehydrogenase kinase, isozyme 4 (PDK4)
B13R03C09	13-9-3	Hs~MGC:BC013173.1~uORF:IOH11125	557	601	1216	548	393	361	498	713	606	314	ring finger and SPRY domain containing 1 (RSPRY1)
B13R03C10	13-10-3	Hs~MGC:BC013173.1~uORF:IOH11125	661	411	1356	567	1976	389	532	662	613	355	ring finger and SPRY domain containing 1 (RSPRY1)
B13R03C11	13-11-3	Hs~Ref:NM_006356.1~uORF:IOH26157	792	383	651	368	650	1285	618	325	1109	301	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d (ATP5H), nuclear gene encoding mitochondrial protein, transcript variant 1
B13R03C12	13-12-3	Hs~Ref:NM_006356.1~uORF:IOH26157	693	410	617	374	841	1307	682	374	1041	284	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d (ATP5H), nuclear gene encoding mitochondrial protein, transcript variant 1
B13R03C13	13-13-3	Hs~MGC:BC002954.1~uORF:IOH4913	448	389	1893	660	752	28350	858	521	1534	269	UDP-glucose pyrophosphorylase 2 (UGP2)
B13R03C14	13-14-3	Hs~MGC:BC002954.1~uORF:IOH4913	442	372	2079	653	924	29649	821	531	1502	282	UDP-glucose pyrophosphorylase 2 (UGP2)
B13R03C15	13-15-3	Hs~MGC:BC008803.1~uORF:IOH6345	931	640	1359	587	960	943	1246	925	1648	449	eyes absent homolog 2 (Drosophila) (EYA2)
B13R03C16	13-16-3	Hs~MGC:BC008803.1~uORF:IOH6345	880	746	1138	601	887	890	1237	946	1583	500	eyes absent homolog 2 (Drosophila) (EYA2)
B13R03C17	13-17-3	Hs~MGC:BC002430.1~uORF:IOH4273	996	901	1179	696	917	869	3070	644	1398	442	aldehyde dehydrogenase 3 family, member A2 (ALDH3A2)
B13R03C18	13-18-3	Hs~MGC:BC002430.1~uORF:IOH4273	1062	757	1286	687	1027	882	3044	674	1444	425	aldehyde dehydrogenase 3 family, member A2 (ALDH3A2)
B13R03C19	13-19-3	Hs~Ref:NM_005842.2~uORF:IOH13536	1837	940	8282	1036	1084	1058	17882	996	2814	725	sprouty homolog 2 (Drosophila) (SPRY2)
B13R03C20	13-20-3	Hs~Ref:NM_005842.2~uORF:IOH13536	1846	934	7683	950	1573	925	17748	1159	3302	715	sprouty homolog 2 (Drosophila) (SPRY2)
B13R03C21	13-21-3	Hs~Ref:NM_012420.1~uORF:IOH22625	523	453	1267	648	2370	794	1322	757	2134	322	interferon-induced protein with tetratricopeptide repeats 5 (IFIT5)
B13R03C22	13-22-3	Hs~Ref:NM_012420.1~uORF:IOH22625	544	361	1153	845	2553	692	1250	803	2121	310	interferon-induced protein with tetratricopeptide repeats 5 (IFIT5)
B13R04C01	13-1-4	Hs~Ref:NM_016564.1~uORF:IOH22629	2098	784	2918	2127	866	3922	2562	1193	7089	1359	cell cycle exit and neuronal differentiation 1 (CEND1)
B13R04C02	13-2-4	Hs~Ref:NM_016564.1~uORF:IOH22629	1808	623	2890	1845	817	4029	2597	1174	7056	1299	cell cycle exit and neuronal differentiation 1 (CEND1)
B13R04C03	13-3-4	Hs~MGC:NM_152389.1~uORF:IOH22642	1119	620	1263	642	778	890	2078	542	1564	388	coiled-coil domain containing 108 (CCDC108), transcript variant 2
B13R04C04	13-4-4	Hs~MGC:NM_152389.1~uORF:IOH22642	926	604	1274	555	703	799	2246	539	1512	377	coiled-coil domain containing 108 (CCDC108), transcript variant 2
B13R04C05	13-5-4	Hs~Ref:NM_019099.1~uORF:IOH22645	428	366	800	392	450	652	665	375	951	263	chromosome 1 open reading frame 183 (C1orf183), transcript variant 1
B13R04C06	13-6-4	Hs~Ref:NM_019099.1~uORF:IOH22645	468	332	719	373	602	665	660	376	971	245	chromosome 1 open reading frame 183 (C1orf183), transcript variant 1
B13R04C07	13-7-4	Hs~Ref:NM_002120.2~uORF:IOH6668	394	324	579	417	365	348	650	435	534	217	major histocompatibility complex, class II, DO beta (HLA-DOB)
B13R04C08	13-8-4	Hs~Ref:NM_002120.2~uORF:IOH6668	394	353	639	445	338	209	621	423	555	203	major histocompatibility complex, class II, DO beta (HLA-DOB)
B13R04C09	13-9-4	Hs~MGC:BC007704.1~uORF:IOH6307	556	584	921	1023	569	812	770	746	1831	348	synaptojanin 2 binding protein (SYNJ2BP)
B13R04C10	13-10-4	Hs~MGC:BC007704.1~uORF:IOH6307	585	560	916	1046	587	796	767	758	1825	381	synaptojanin 2 binding protein (SYNJ2BP)
B13R04C11	13-11-4	Hs~Ref:NM_016306.2~uORF:IOH4824	930	573	2150	789	806	1305	1022	885	1158	351	DnaJ (Hsp40) homolog, subfamily B, member 11 (DNAJB11)
B13R04C12	13-12-4	Hs~Ref:NM_016306.2~uORF:IOH4824	907	558	2031	782	949	1355	991	931	1173	338	DnaJ (Hsp40) homolog, subfamily B, member 11 (DNAJB11)
B13R04C13	13-13-4	Hs~MGC:BC007546.1~uORF:IOH6804	1006	362	859	426	645	1063	679	459	901	162	Aminomethyltransferase, mitochondrial
B13R04C14	13-14-4	Hs~MGC:BC007546.1~uORF:IOH6804	964	355	882	428	778	1208	716	445	989	180	Aminomethyltransferase, mitochondrial
B13R04C15	13-15-4	Hs~MGC:BC060813.1~uORF:IOH39816	925	1157	2028	971	889	1653	1726	1630	2382	706	AMME syndrome candidate gene 1 protein
B13R04C16	13-16-4	Hs~MGC:BC060813.1~uORF:IOH39816	861	1064	2211	1023	896	1544	1652	1258	2566	762	AMME syndrome candidate gene 1 protein
B13R04C17	13-17-4	Hs~MGC:BC014959.1~uORF:IOH13467	1444	3456	2305	2431	1662	3135	2767	1727	5116	886	RING1 and YY1 binding protein (RYBP)
B13R04C18	13-18-4	Hs~MGC:BC014959.1~uORF:IOH13467	1418	3344	2345	2498	1714	3089	2720	1905	5181	826	RING1 and YY1 binding protein (RYBP)
B13R04C19	13-19-4	Hs~Ref:NM_033453.2~uORF:IOH13043	295	393	443	252	424	1967	1530	359	726	116	inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (ITPA), transcript variant 1
B13R04C20	13-20-4	Hs~Ref:NM_033453.2~uORF:IOH13043	309	418	441	264	430	1924	1538	376	745	116	inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (ITPA), transcript variant 1
B13R04C21	13-21-4	Hs~Ref:NM_024708.2~uORF:IOH39832	653	522	824	568	487	452	2388	854	821	218	ankyrin repeat and SOCS box-containing 7 (ASB7), transcript variant 1
B13R04C22	13-22-4	Hs~Ref:NM_024708.2~uORF:IOH39832	567	468	945	530	522	371	1180	633	833	260	ankyrin repeat and SOCS box-containing 7 (ASB7), transcript variant 1
B13R05C01	13-1-5	Hs~MGC:BC009462.1~uORF:IOH12111	692	473	918	832	599	644	826	617	952	369	family with sequence similarity 119, member A (FAM119A)
B13R05C02	13-2-5	Hs~MGC:BC009462.1~uORF:IOH12111	669	448	1005	772	527	607	837	496	1026	374	family with sequence similarity 119, member A (FAM119A)
B13R05C03	13-3-5	Hs~MGC:BC017100.1~uORF:IOH12953	874	620	1484	990	632	758	1908	703	1502	448	ring finger protein 130 (RNF130)
B13R05C04	13-4-5	Hs~MGC:BC017100.1~uORF:IOH12953	873	624	1444	635	661	745	1918	697	1401	485	ring finger protein 130 (RNF130)
B13R05C05	13-5-5	Hs~MGC:BC017376.2~uORF:IOH12616	936	906	2195	843	1129	1095	1557	927	1734	623	RING finger protein 31
B13R05C06	13-6-5	Hs~MGC:BC017376.2~uORF:IOH12616	1042	998	2308	923	2131	1099	1987	883	1861	543	RING finger protein 31
B13R05C07	13-7-5	Hs~Ref:NM_022104.1~uORF:IOH12306	1382	2015	5600	1663	609	2142	1943	1347	2285	418	chromosome 20 open reading frame 67 (C20orf67)
B13R05C08	13-8-5	Hs~Ref:NM_022104.1~uORF:IOH12306	1322	1927	5410	1688	604	1889	2060	1434	2375	409	chromosome 20 open reading frame 67 (C20orf67)
B13R05C09	13-9-5	Hs~MGC:BC045758.1~uORF:IOH26432	594	457	1103	986	864	1038	1339	370	1426	1100	NIMA (never in mitosis gene a)- related kinase 10 (NEK10)
B13R05C10	13-10-5	Hs~MGC:BC045758.1~uORF:IOH26432	543	1110	1091	976	832	1015	1382	395	1431	1136	NIMA (never in mitosis gene a)- related kinase 10 (NEK10)
B13R05C11	13-11-5	Hs~MGC:BC050704.1~uORF:IOH27028	7254	1258	916	627	4538	661	4361	352	1771	458	doublecortin domain containing 2 (DCDC2)
B13R05C12	13-12-5	Hs~MGC:BC050704.1~uORF:IOH27028	7141	1308	1301	615	4916	720	4089	369	1655	418	doublecortin domain containing 2 (DCDC2)
B13R05C13	13-13-5	Hs~MGC:BC040955.1~uORF:IOH26197	2559	96	237	96	493	110	195	167	197	51	bactericidal/permeability-increasing protein (BPI)
B13R05C14	13-14-5	Hs~MGC:BC040955.1~uORF:IOH26197	2726	79	254	159	602	34	197	195	227	92	bactericidal/permeability-increasing protein (BPI)
B13R05C15	13-15-5	Hs~MGC:BC047945.1~uORF:IOH26362	779	1090	613	348	980	1034	1563	553	2396	72	tripartite motif-containing 69 (TRIM69)
B13R05C16	13-16-5	Hs~MGC:BC047945.1~uORF:IOH26362	738	941	619	353	977	981	1572	730	2553	87	tripartite motif-containing 69 (TRIM69)
B13R05C17	13-17-5	Hs~Ref:NM_020070.1~uORF:IOH10617	1332	828	1220	852	984	929	1229	742	2028	648	immunoglobulin lambda-like polypeptide 1 (IGLL1), transcript variant 1
B13R05C18	13-18-5	Hs~Ref:NM_020070.1~uORF:IOH10617	1319	891	1310	844	862	874	1433	705	1962	600	immunoglobulin lambda-like polypeptide 1 (IGLL1), transcript variant 1
B13R05C19	13-19-5	Hs~MGC:BC024919.1~uORF:IOH11019	616	521	2383	463	801	2205	1754	642	2163	308	nucleotide binding protein-like (NUBPL)
B13R05C20	13-20-5	Hs~MGC:BC024919.1~uORF:IOH11019	619	459	2344	447	689	2166	1717	639	2163	311	nucleotide binding protein-like (NUBPL)
B13R05C21	13-21-5	Hs~Ref:NM_018956.2~uORF:IOH11209	3712	1924	4218	2317	2361	1850	11431	1338	5816	2606	chromosome 9 open reading frame 9 (C9orf9)
B13R05C22	13-22-5	Hs~Ref:NM_018956.2~uORF:IOH11209	3833	1862	4497	2482	2288	2025	11581	1359	6671	2712	chromosome 9 open reading frame 9 (C9orf9)
B13R06C01	13-1-6	Hs~Ref:NM_021101.3~uORF:IOH10602	478	1086	65475	1197	550	525	637	531	1112	274	claudin 1 (CLDN1)
B13R06C02	13-2-6	Hs~Ref:NM_021101.3~uORF:IOH10602	452	993	65475	347	521	534	645	469	1045	289	claudin 1 (CLDN1)
B13R06C03	13-3-6	Hs~Ref:NM_144769.1~uORF:IOH40875	477	344	951	563	253	360	673	331	850	356	forkhead box I1 (FOXI1), transcript variant 2
B13R06C04	13-4-6	Hs~Ref:NM_144769.1~uORF:IOH40875	495	379	819	335	257	384	704	322	815	346	forkhead box I1 (FOXI1), transcript variant 2
B13R06C05	13-5-6	Hs~Ref:NM_016355.3~uORF:IOH39973	2097	1095	2004	797	527	1907	9584	1086	1931	458	DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 (DDX47), transcript variant 1
B13R06C06	13-6-6	Hs~Ref:NM_016355.3~uORF:IOH39973	1978	1059	2144	838	598	1750	9413	1038	1860	424	DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 (DDX47), transcript variant 1
B13R06C07	13-7-6	Hs~MGC:BC070073.1~uORF:IOH40070	1415	703	1179	565	455	973	5172	654	1390	325	Protein ZNF365
B13R06C08	13-8-6	Hs~MGC:BC070073.1~uORF:IOH40070	1275	713	1299	579	420	940	5044	661	1399	350	Protein ZNF365
B13R06C09	13-9-6	Hs~MGC:BC065195.1~uORF:IOH39893	380	273	459	496	300	320	488	294	558	168	patatin-like phospholipase domain containing 3 (PNPLA3)
B13R06C10	13-10-6	Hs~MGC:BC065195.1~uORF:IOH39893	380	1135	548	553	161	343	519	298	575	81	patatin-like phospholipase domain containing 3 (PNPLA3)
B13R06C11	13-11-6	Hs~Ref:NM_198252.1~uORF:IOH45790	561	810	2516	807	617	3181	2243	600	1711	1949	gelsolin (amyloidosis, Finnish type) (GSN), transcript variant 2
B13R06C12	13-12-6	Hs~Ref:NM_198252.1~uORF:IOH45790	477	623	2719	790	673	2818	2304	558	1711	1905	gelsolin (amyloidosis, Finnish type) (GSN), transcript variant 2
B13R06C13	13-13-6	Hs~Ref:NM_130766.1~uORF:IOH45827	391	292	544	297	425	925	565	285	602	178	skeletal muscle and kidney enriched inositol phosphatase (SKIP), transcript variant 2
B13R06C14	13-14-6	Hs~Ref:NM_130766.1~uORF:IOH45827	429	321	471	292	656	825	569	299	535	170	skeletal muscle and kidney enriched inositol phosphatase (SKIP), transcript variant 2
B13R06C15	13-15-6	Hs~Ref:NM_138349.2~uORF:IOH45741	1037	628	1150	523	475	855	3517	700	1166	339	Tumor protein p53-inducible protein 13
B13R06C16	13-16-6	Hs~Ref:NM_138349.2~uORF:IOH45741	1021	597	1126	553	356	870	3618	659	1140	336	Tumor protein p53-inducible protein 13
B13R06C17	13-17-6	Hs~Ref:NM_015942.3~uORF:IOH45791	813	410	757	429	497	596	1503	1081	794	334	MTERF domain containing 1 (MTERFD1)
B13R06C18	13-18-6	Hs~Ref:NM_015942.3~uORF:IOH45791	818	929	859	435	384	338	1405	818	832	298	MTERF domain containing 1 (MTERFD1)
B13R06C19	13-19-6	Hs~Ref:NM_014236.1~uORF:IOH55614	745	860	522	273	319	265	565	245	715	107	Dihydroxyacetone phosphate acyltransferase
B13R06C20	13-20-6	Hs~Ref:NM_014236.1~uORF:IOH55614	681	548	499	278	275	807	533	306	744	156	Dihydroxyacetone phosphate acyltransferase
B13R07C01	13-1-7	Hs~MGC:BC009507.1~uORF:IOH13554	382	426	643	1398	594	2202	2701	286	2523	373	ISG15 ubiquitin-like modifier (ISG15)
B13R07C02	13-2-7	Hs~MGC:BC009507.1~uORF:IOH13554	438	396	665	353	576	2102	2772	309	2443	367	ISG15 ubiquitin-like modifier (ISG15)
B13R07C03	13-3-7	Hs~MGC:BC011635.1~uORF:IOH14421	2503	474	2189	654	496	1034	1082	643	1192	825	SET domain and mariner transposase fusion gene (SETMAR)
B13R07C04	13-4-7	Hs~MGC:BC011635.1~uORF:IOH14421	1230	467	2206	580	515	1008	1217	592	1079	859	SET domain and mariner transposase fusion gene (SETMAR)
B13R07C05	13-5-7	Hs~Ref:NM_033256.1~uORF:IOH13214	1657	837	1354	1094	1223	2320	2943	10989	5641	594	protein phosphatase 1, regulatory (inhibitor) subunit 14A (PPP1R14A)
B13R07C06	13-6-7	Hs~Ref:NM_033256.1~uORF:IOH13214	1639	792	1648	1144	1185	2306	2777	10737	5605	618	protein phosphatase 1, regulatory (inhibitor) subunit 14A (PPP1R14A)
B13R07C07	13-7-7	Hs~Ref:NM_014241.2~uORF:IOH12805	311	289	546	267	621	338	523	432	607	283	protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A, mRNA (cDNA clone MGC:13358 IMAGE:4293342), complete cds
B13R07C08	13-8-7	Hs~Ref:NM_014241.2~uORF:IOH12805	354	291	519	293	314	306	501	378	539	219	protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A, mRNA (cDNA clone MGC:13358 IMAGE:4293342), complete cds
B13R07C09	13-9-7	Hs~Ref:NM_016103.1~uORF:IOH5421	391	279	400	327	397	335	387	272	624	207	SAR1 gene homolog B (S. cerevisiae) (SAR1B), transcript variant 2
B13R07C10	13-10-7	Hs~Ref:NM_016103.1~uORF:IOH5421	431	364	411	291	342	364	424	270	548	221	SAR1 gene homolog B (S. cerevisiae) (SAR1B), transcript variant 2
B13R07C11	13-11-7	Hs~Ref:NM_016361.2~uORF:IOH13822	426	1937	355	363	249	426	423	2930	612	172	acid phosphatase 6, lysophosphatidic (ACP6)
B13R07C12	13-12-7	Hs~Ref:NM_016361.2~uORF:IOH13822	314	155	355	351	264	404	419	2894	640	169	acid phosphatase 6, lysophosphatidic (ACP6)
B13R07C13	13-13-7	Hs~Ref:NM_000160.1~uORF:IOH39475	1003	362	1346	311	495	501	742	388	1320	265	glucagon receptor (GCGR)
B13R07C14	13-14-7	Hs~Ref:NM_000160.1~uORF:IOH39475	967	344	564	333	563	534	706	465	1226	261	glucagon receptor (GCGR)
B13R07C15	13-15-7	Hs~Ref:NM_020744.2~uORF:IOH5213	399	399	676	370	539	749	681	565	709	273	metastasis associated 1 family, member 3 (MTA3)
B13R07C16	13-16-7	Hs~Ref:NM_020744.2~uORF:IOH5213	447	394	684	387	510	781	740	617	778	291	metastasis associated 1 family, member 3 (MTA3)
B13R07C17	13-17-7	Hs~Ref:NM_005037.3~uORF:IOH39661	3135	3009	794	731	2218	2173	2124	1200	1616	434	peroxisome proliferator-activated receptor gamma (PPARG), transcript variant 4
B13R07C18	13-18-7	Hs~Ref:NM_005037.3~uORF:IOH39661	3097	3298	780	771	1822	2185	2075	1026	1545	470	peroxisome proliferator-activated receptor gamma (PPARG), transcript variant 4
B13R07C19	13-19-7	Hs~MGC:NM_024493.1~uORF:IOH6566	1452	1676	3305	5531	1337	21605	2292	1446	4471	701	zinc finger with KRAB and SCAN domains 3 (ZKSCAN3)
B13R07C20	13-20-7	Hs~MGC:NM_024493.1~uORF:IOH6566	1404	1550	3217	5701	1244	21532	2250	1187	4166	683	zinc finger with KRAB and SCAN domains 3 (ZKSCAN3)
B13R07C21	13-21-7	Hs~Ref:NM_003159.1~N/A	-2	0	-2	-1	11	847	1534	2500	4559	484	Cyclin-dependent kinase-like 5
B13R07C22	13-22-7	Hs~Ref:NM_003159.1~N/A	-1	0	-1	1	-1	773	1565	2577	4884	476	Cyclin-dependent kinase-like 5
B13R08C01	13-1-8	Hs~Ref:NM_173191.2~uORF:IOH39568	995	1188	1224	1012	295	792	428	527	837	20	Kv channel interacting protein 2 (KCNIP2), transcript variant 2
B13R08C02	13-2-8	Hs~Ref:NM_173191.2~uORF:IOH39568	977	1413	1207	520	281	637	412	478	777	61	Kv channel interacting protein 2 (KCNIP2), transcript variant 2
B13R08C03	13-3-8	Hs~Ref:NM_015149.2~uORF:IOH39464	932	721	1654	1179	761	785	1647	1101	2154	534	ral guanine nucleotide dissociation stimulator-like 1 (RGL1)
B13R08C04	13-4-8	Hs~Ref:NM_015149.2~uORF:IOH39464	859	609	1609	1295	746	802	1672	1157	2204	535	ral guanine nucleotide dissociation stimulator-like 1 (RGL1)
B13R08C05	13-5-8	Hs~Ref:NM_003702.2~uORF:IOH39665	705	535	821	280	349	527	1443	379	1101	368	Regulator of G-protein signaling 20
B13R08C06	13-6-8	Hs~Ref:NM_003702.2~uORF:IOH39665	722	534	904	271	450	509	1368	354	1086	388	Regulator of G-protein signaling 20
B13R08C09	13-9-8	Hs~MGC:BC010434.1~uORF:IOH22935	1371	2391	1006	747	904	1032	1183	726	1759	598	spectrin, beta, erythrocytic (includes spherocytosis, clinical type I) (SPTB)
B13R08C10	13-10-8	Hs~MGC:BC010434.1~uORF:IOH22935	1438	2249	1001	713	866	1077	1110	763	1712	577	spectrin, beta, erythrocytic (includes spherocytosis, clinical type I) (SPTB)
B13R08C11	13-11-8	Hs~MGC:BC004292.1~uORF:IOH22899	21686	9443	6107	577	879	1263	10384	541	22650	394	PHD finger protein 15 (PHF15)
B13R08C12	13-12-8	Hs~MGC:BC004292.1~uORF:IOH22899	36936	9002	6039	582	1060	1211	10000	478	22622	438	PHD finger protein 15 (PHF15)
B13R08C15	13-15-8	Hs~Ref:NM_033415.2~uORF:IOH45656	892	519	1373	1146	966	1550	1110	2506	1966	554	Armadillo repeat-containing protein 6
B13R08C16	13-16-8	Hs~Ref:NM_033415.2~uORF:IOH45656	874	512	1363	1150	964	1578	1128	2574	1979	542	Armadillo repeat-containing protein 6
B13R08C17	13-17-8	Hs~Ref:NM_181493.1~uORF:IOH44551	1030	1007	1938	916	1237	989	1510	1106	2166	623	Inosine triphosphate pyrophosphatase
B13R08C18	13-18-8	Hs~Ref:NM_181493.1~uORF:IOH44551	1116	944	1835	899	1191	1035	1505	1096	2047	618	Inosine triphosphate pyrophosphatase
B13R08C19	13-19-8	Hs~Ref:NM_024623.1~uORF:IOH44690	1160	1115	2207	810	1553	888	1603	1155	2245	419	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2
B13R08C20	13-20-8	Hs~Ref:NM_024623.1~uORF:IOH44690	1166	1005	2242	813	1448	920	1610	1187	2287	437	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2
B13R08C21	13-21-8	Hs~Ref:NM_031285.1~uORF:IOH22841	1093	1159	1316	613	908	825	2256	1020	1812	495	tetraspanin 9 (TSPAN9)
B13R08C22	13-22-8	Hs~Ref:NM_031285.1~uORF:IOH22841	1066	1164	1323	589	910	853	2166	1013	2045	450	tetraspanin 9 (TSPAN9)
B13R09C01	13-1-9	Hs~Ref:NM_000137.1~uORF:IOH4075	621	800	673	758	426	464	972	611	1494	253	fumarylacetoacetate hydrolase (fumarylacetoacetase) (FAH)
B13R09C02	13-2-9	Hs~Ref:NM_000137.1~uORF:IOH4075	572	946	655	435	418	519	1030	613	1415	270	fumarylacetoacetate hydrolase (fumarylacetoacetase) (FAH)
B13R09C03	13-3-9	Hs~MGC:BC042625.1~uORF:IOH27415	1240	808	1096	850	864	1320	1648	2852	4655	309	LUC7-like 2 (S. cerevisiae) (LUC7L2)
B13R09C04	13-4-9	Hs~MGC:BC042625.1~uORF:IOH27415	1144	747	1158	850	879	1284	1790	2490	4620	309	LUC7-like 2 (S. cerevisiae) (LUC7L2)
B13R09C05	13-5-9	Hs~Ref:NM_139279.3~uORF:IOH25779	1055	452	1219	397	436	3317	923	505	1186	239	multiple coagulation factor deficiency 2 (MCFD2)
B13R09C06	13-6-9	Hs~Ref:NM_139279.3~uORF:IOH25779	1106	471	1304	399	546	3123	924	512	1305	231	multiple coagulation factor deficiency 2 (MCFD2)
B13R09C07	13-7-9	Hs~Ref:NM_018025.2~uORF:IOH6539	2155	665	1449	1282	887	1224	4014	651	1646	374	G patch domain containing 1 (GPATCH1)
B13R09C08	13-8-9	Hs~Ref:NM_018025.2~uORF:IOH6539	2146	615	1338	1174	820	1295	3799	639	1727	378	G patch domain containing 1 (GPATCH1)
B13R09C09	13-9-9	Hs~MGC:BC038406.1~uORF:IOH27357	775	706	821	424	462	464	1280	456	989	294	Uncharacterized protein C3orf20
B13R09C10	13-10-9	Hs~MGC:BC038406.1~uORF:IOH27357	807	735	769	383	476	523	1262	428	844	280	Uncharacterized protein C3orf20
B13R09C11	13-11-9	Hs~MGC:BC044242.1~uORF:IOH28797	770	472	600	456	417	574	668	340	686	249	Radial spoke head 10 homolog B2
B13R09C12	13-12-9	Hs~MGC:BC044242.1~uORF:IOH28797	1001	676	718	438	467	499	716	401	751	291	Radial spoke head 10 homolog B2
B13R09C13	13-13-9	Hs~MGC:BC041099.1~uORF:IOH25949	11045	744	933	1612	579	1140	1186	813	1173	282	nudix (nucleoside diphosphate linked moiety X)-type motif 12 (NUDT12)
B13R09C14	13-14-9	Hs~MGC:BC041099.1~uORF:IOH25949	8520	554	1180	1540	1017	1213	1197	671	1204	303	nudix (nucleoside diphosphate linked moiety X)-type motif 12 (NUDT12)
B13R09C15	13-15-9	Hs~MGC:BC047363.1~uORF:IOH26485	442	398	732	451	433	359	773	546	764	256	DnaJ (Hsp40) homolog, subfamily C, member 16 (DNAJC16)
B13R09C16	13-16-9	Hs~MGC:BC047363.1~uORF:IOH26485	430	424	696	430	404	502	823	543	765	272	DnaJ (Hsp40) homolog, subfamily C, member 16 (DNAJC16)
B13R09C17	13-17-9	Hs~MGC:BC008902.2~uORF:IOH46064	4959	3617	4051	2722	3667	1891	12104	2487	4431	7371	GRIP and coiled-coil domain-containing protein 1
B13R09C18	13-18-9	Hs~MGC:BC008902.2~uORF:IOH46064	5144	3531	3856	2615	3794	1844	11856	2238	4418	6691	GRIP and coiled-coil domain-containing protein 1
B13R09C19	13-19-9	Hs~MGC:BC015586.2~uORF:IOH46065	1544	1452	1690	931	959	964	5214	780	2069	585	laminin, gamma 1 (formerly LAMB2) (LAMC1)
B13R09C20	13-20-9	Hs~MGC:BC015586.2~uORF:IOH46065	1549	1214	1645	934	672	986	5180	1552	2149	550	laminin, gamma 1 (formerly LAMB2) (LAMC1)
B13R09C21	13-21-9	Hs~MGC:BC000742.2~uORF:IOH46095	520	296	534	291	429	277	444	719	572	121	glutathione peroxidase 1 (GPX1)
B13R09C22	13-22-9	Hs~MGC:BC000742.2~uORF:IOH46095	449	264	611	243	535	219	440	262	608	168	glutathione peroxidase 1 (GPX1)
B13R10C01	13-1-10	Hs~MGC:BC003127.1~uORF:IOH46076	593	364	682	861	390	463	584	406	986	220	selenoprotein X, 1 (SEPX1)
B13R10C02	13-2-10	Hs~MGC:BC003127.1~uORF:IOH46076	576	470	606	365	421	535	702	402	824	206	selenoprotein X, 1 (SEPX1)
B13R10C03	13-3-10	Hs~MGC:BC062338.1~uORF:IOH40690	1670	2095	1255	1529	2615	1731	3910	1191	4023	6039	SET binding protein 1 (SETBP1)
B13R10C04	13-4-10	Hs~MGC:BC062338.1~uORF:IOH40690	1705	1942	1261	1777	2456	1729	3915	1201	4082	5994	SET binding protein 1 (SETBP1)
B13R10C05	13-5-10	Hs~MGC:BC062353.1~uORF:IOH40673	2440	1050	1510	1202	1045	2311	2505	920	3713	561	chromosome 1 open reading frame 131 (C1orf131)
B13R10C06	13-6-10	Hs~MGC:BC062353.1~uORF:IOH40673	1919	1070	1501	1185	846	2113	2499	817	3704	520	chromosome 1 open reading frame 131 (C1orf131)
B13R10C07	13-7-10	Hs~Ref:NM_178817.3~uORF:IOH40717	505	442	748	334	748	463	1066	684	1003	254	melanocortin 2 receptor accessory protein (MRAP), transcript variant 1
B13R10C08	13-8-10	Hs~Ref:NM_178817.3~uORF:IOH40717	544	376	718	397	705	498	1032	474	994	248	melanocortin 2 receptor accessory protein (MRAP), transcript variant 1
B13R10C09	13-9-10	Hs~Ref:NM_013444.2~uORF:IOH40769	242	160	76	13	300	140	225	236	329	29	ubiquilin 2 (UBQLN2)
B13R10C10	13-10-10	Hs~Ref:NM_013444.2~uORF:IOH40769	100	195	263	-1	150	19	214	242	373	67	ubiquilin 2 (UBQLN2)
B13R11C21	13-21-11	Hs~Ref:NM_138401.2~uORF:IOH14104	1443	541	1039	2452	528	727	2432	1701	1355	332	family with sequence similarity 125, member A (FAM125A)
B13R11C22	13-22-11	Hs~Ref:NM_138401.2~uORF:IOH14104	1350	411	1375	2367	528	785	2426	1715	1580	348	family with sequence similarity 125, member A (FAM125A)
B13R12C01	13-1-12	Hs~Ref:NM_014909.2~uORF:IOH27006	495	999	1971	1142	398	630	538	415	2057	677	vasohibin 1 (VASH1)
B13R12C02	13-2-12	Hs~Ref:NM_014909.2~uORF:IOH27006	614	1014	1813	438	515	573	542	410	1478	732	vasohibin 1 (VASH1)
B13R12C03	13-3-12	Hs~Ref:NM_004111.4~uORF:IOH3530	1392	6208	9434	1038	696	2451	1786	1336	1974	2350	flap structure-specific endonuclease 1 (FEN1)
B13R12C04	13-4-12	Hs~Ref:NM_004111.4~uORF:IOH3530	1499	5907	9630	984	707	2469	1797	1398	1942	2359	flap structure-specific endonuclease 1 (FEN1)
B13R12C05	13-5-12	Hs~Ref:NM_006640.2~uORF:IOH12164	1156	974	65451	1581	1818	4758	3813	1288	5292	3242	septin 9 (SEPT9)
B13R12C06	13-6-12	Hs~Ref:NM_006640.2~uORF:IOH12164	1094	1006	65460	1381	1927	5200	3785	1294	4836	3224	septin 9 (SEPT9)
B13R12C07	13-7-12	Hs~MGC:BC030253.1~uORF:IOH21512	575	815	790	678	1383	1855	2424	1122	2805	388	glutathione S-transferase M3 (brain) (GSTM3)
B13R12C08	13-8-12	Hs~MGC:BC030253.1~uORF:IOH21512	594	763	677	681	1503	1800	2473	1156	2845	401	glutathione S-transferase M3 (brain) (GSTM3)
B13R12C09	13-9-12	Hs~Ref:NM_014326.2~uORF:IOH21336	2312	3826	1262	441	495	3663	805	787	2179	315	Death-associated protein kinase 2
B13R12C10	13-10-12	Hs~Ref:NM_014326.2~uORF:IOH21336	2368	3795	1216	432	484	3490	817	733	2112	288	Death-associated protein kinase 2
B13R12C11	13-11-12	Hs~MGC:BC011392.1~uORF:IOH21419	1297	951	1718	1142	3114	2329	3336	1243	4626	576	3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1)
B13R12C12	13-12-12	Hs~MGC:BC011392.1~uORF:IOH21419	1236	996	1720	1148	3388	2320	3369	1311	4712	574	3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1)
B13R12C13	13-13-12	Hs~MGC:BC030776.1~uORF:IOH22290	-4	1087	-1	-1	-11	1	4	2	0	1	Intraflagellar transport protein 88 homolog
B13R12C14	13-14-12	Hs~MGC:BC030776.1~uORF:IOH22290	1	-4	0	2	382	1	4	2	-1	1	Intraflagellar transport protein 88 homolog
B13R12C15	13-15-12	Hs~MGC:BC028141.1~uORF:IOH21529	1549	670	1783	648	899	1175	3158	1388	1409	427	mixed lineage kinase domain-like (MLKL)
B13R12C16	13-16-12	Hs~MGC:BC028141.1~uORF:IOH21529	1842	708	1536	621	956	1138	3107	1446	1478	403	mixed lineage kinase domain-like (MLKL)
B13R12C17	13-17-12	Hs~Ref:NM_022133.2~uORF:IOH21896	690	826	529	521	1047	752	1053	844	1220	202	sorting nexin 16 (SNX16), transcript variant 1
B13R12C18	13-18-12	Hs~Ref:NM_022133.2~uORF:IOH21896	694	773	561	542	1061	714	1071	729	1279	155	sorting nexin 16 (SNX16), transcript variant 1
B13R12C19	13-19-12	Hs~Ref:NM_015214.1~uORF:IOH41859	1357	333	624	364	564	800	1665	434	1052	315	Phospholipase DDHD2
B13R12C20	13-20-12	Hs~Ref:NM_015214.1~uORF:IOH41859	1432	335	617	431	526	713	1590	483	1060	331	Phospholipase DDHD2
B13R12C21	13-21-12	Hs~Ref:NM_014923.2~uORF:IOH44828	7361	866	1395	1391	2625	1572	1894	1312	2539	395	fibronectin type III domain containing 3A (FNDC3A), transcript variant 2
B13R12C22	13-22-12	Hs~Ref:NM_014923.2~uORF:IOH44828	7402	643	1510	1353	3235	1540	1931	1444	2653	375	fibronectin type III domain containing 3A (FNDC3A), transcript variant 2
B13R13C01	13-1-13	Hs~Ref:NM_032926.1~uORF:IOH6818	320	248	497	2886	4256	1613	499	222	2382	20	transcription elongation factor A (SII)-like 3 (TCEAL3), transcript variant 2
B13R13C02	13-2-13	Hs~Ref:NM_032926.1~uORF:IOH6818	307	202	518	75	4426	1649	531	215	2370	48	transcription elongation factor A (SII)-like 3 (TCEAL3), transcript variant 2
B13R13C03	13-3-13	Hs~Ref:NM_032883.1~uORF:IOH6975	439	224	448	195	259	479	386	249	2713	170	TOX high mobility group box family member 2 (TOX2), transcript variant 3
B13R13C04	13-4-13	Hs~Ref:NM_032883.1~uORF:IOH6975	420	221	716	233	269	496	421	247	2729	94	TOX high mobility group box family member 2 (TOX2), transcript variant 3
B13R13C05	13-5-13	Hs~Ref:NM_004454.1~uORF:IOH5884	1578	1275	15990	1032	1226	1084	1992	936	2762	519	ets variant gene 5 (ets-related molecule) (ETV5)
B13R13C06	13-6-13	Hs~Ref:NM_004454.1~uORF:IOH5884	1564	1313	16155	759	1277	1069	2055	892	2666	522	ets variant gene 5 (ets-related molecule) (ETV5)
B13R13C07	13-7-13	Hs~MGC:BC000594.2~uORF:IOH4296	1158	881	1289	897	843	1266	2133	1797	2797	786	lysyl oxidase-like 2 (LOXL2)
B13R13C08	13-8-13	Hs~MGC:BC000594.2~uORF:IOH4296	1165	846	1335	879	897	1189	2136	1862	2762	819	lysyl oxidase-like 2 (LOXL2)
B13R13C17	13-17-13	Hs~MGC:BC065534.1~uORF:IOH39945	735	571	886	706	806	882	1270	1065	1864	631	ATG9 autophagy related 9 homolog A (S. cerevisiae) (ATG9A)
B13R13C18	13-18-13	Hs~MGC:BC065534.1~uORF:IOH39945	728	654	908	665	812	963	1233	1233	1751	591	ATG9 autophagy related 9 homolog A (S. cerevisiae) (ATG9A)
B13R13C19	13-19-13	Hs~MGC:BC001184.1~uORF:IOH4545	757	843	1041	750	1228	1173	1469	872	4153	744	zinc finger protein 574 (ZNF574)
B13R13C20	13-20-13	Hs~MGC:BC001184.1~uORF:IOH4545	764	928	1130	768	1018	950	1418	1092	4279	781	zinc finger protein 574 (ZNF574)
B13R13C21	13-21-13	Hs~MGC:BC008623.1~uORF:IOH3309	631	552	835	450	662	656	767	676	1270	451	roundabout, axon guidance receptor, homolog 3 (Drosophila) (ROBO3)
B13R13C22	13-22-13	Hs~MGC:BC008623.1~uORF:IOH3309	620	525	878	462	607	586	766	551	1294	403	roundabout, axon guidance receptor, homolog 3 (Drosophila) (ROBO3)
B13R14C01	13-1-14	Hs~Ref:NM_014759.2~uORF:IOH22215	614	469	740	952	368	600	823	476	978	358	phytanoyl-CoA 2-hydroxylase interacting protein (PHYHIP), transcript variant 2
B13R14C02	13-2-14	Hs~Ref:NM_014759.2~uORF:IOH22215	556	466	830	1754	325	614	848	479	1133	358	phytanoyl-CoA 2-hydroxylase interacting protein (PHYHIP), transcript variant 2
B13R14C03	13-3-14	Hs~MGC:BC045639.1~uORF:IOH28733	1072	434	1002	545	443	720	1720	496	1222	354	SUMO1/sentrin specific peptidase 1 (SENP1)
B13R14C04	13-4-14	Hs~MGC:BC045639.1~uORF:IOH28733	1147	477	860	515	439	714	1722	518	1143	369	SUMO1/sentrin specific peptidase 1 (SENP1)
B13R14C05	13-5-14	Hs~MGC:BC059386.1~uORF:IOH29132	1209	620	821	1035	1051	757	1502	600	1755	526	SKI-like oncogene (SKIL)
B13R14C06	13-6-14	Hs~MGC:BC059386.1~uORF:IOH29132	1148	665	878	1222	1298	763	1481	656	1949	570	SKI-like oncogene (SKIL)
B13R14C07	13-7-14	Hs~Ref:NM_003636.1~uORF:IOH29625	50333	45612	28903	65497	42986	29376	24083	65494	27836	65498	potassium voltage-gated channel, shaker-related subfamily, beta member 2 (KCNAB2), transcript variant 1
B13R14C08	13-8-14	Hs~Ref:NM_003636.1~uORF:IOH29625	53815	43421	28600	65495	43596	29363	24079	63854	26652	65497	potassium voltage-gated channel, shaker-related subfamily, beta member 2 (KCNAB2), transcript variant 1
B13R14C09	13-9-14	Hs~MGC:BC054508.1~uORF:IOH28891	2445	575	3400	1020	3300	1213	4019	630	1786	409	erythrocyte membrane protein band 4.1 like 5 (EPB41L5)
B13R14C10	13-10-14	Hs~MGC:BC054508.1~uORF:IOH28891	2351	583	3404	976	3384	1248	3927	580	1756	408	erythrocyte membrane protein band 4.1 like 5 (EPB41L5)
B13R14C11	13-11-14	Hs~Ref:NM_017881.1~uORF:IOH3973	330	422	615	304	460	705	3576	533	828	303	chromosome 9 open reading frame 95 (C9orf95)
B13R14C12	13-12-14	Hs~Ref:NM_017881.1~uORF:IOH3973	362	390	580	310	560	780	3499	502	773	276	chromosome 9 open reading frame 95 (C9orf95)
B13R14C13	13-13-14	Hs~Ref:NM_016185.1~uORF:IOH4078	602	297	17892	482	2253	1073	1791	2864	2089	374	hematological and neurological expressed 1 (HN1), transcript variant 1
B13R14C14	13-14-14	Hs~Ref:NM_016185.1~uORF:IOH4078	610	429	17416	497	2459	1031	1856	2982	2228	366	hematological and neurological expressed 1 (HN1), transcript variant 1
B13R14C15	13-15-14	Hs~Ref:NM_014184.1~uORF:IOH4181	414	562	552	446	558	694	810	622	978	419	cornichon homolog 4 (Drosophila) (CNIH4)
B13R14C16	13-16-14	Hs~Ref:NM_014184.1~uORF:IOH4181	407	384	916	449	542	687	769	685	983	462	cornichon homolog 4 (Drosophila) (CNIH4)
B13R14C17	13-17-14	Hs~Ref:NM_002764.2~uORF:IOH4906	325	343	1025	364	510	2154	730	1117	650	263	phosphoribosyl pyrophosphate synthetase 1 (PRPS1)
B13R14C18	13-18-14	Hs~Ref:NM_002764.2~uORF:IOH4906	325	333	919	358	519	2107	744	1140	621	304	phosphoribosyl pyrophosphate synthetase 1 (PRPS1)
B13R15C03	13-3-15	Hs~MGC:BC032576.1~uORF:IOH61732	368	277	583	358	271	565	480	422	638	245	Cell division cycle-associated 7-like protein
B13R15C04	13-4-15	Hs~MGC:BC032576.1~uORF:IOH61732	354	647	502	312	269	506	516	357	641	243	Cell division cycle-associated 7-like protein
B13R15C05	13-5-15	Hs~MGC:BC060819.1~uORF:IOH29138	364	361	1015	440	1704	1966	379	505	858	293	zinc finger E-box binding homeobox 2 (ZEB2)
B13R15C06	13-6-15	Hs~MGC:BC060819.1~uORF:IOH29138	409	264	976	437	1972	1944	388	516	855	272	zinc finger E-box binding homeobox 2 (ZEB2)
B13R15C09	13-9-15	Hs~MGC:BC062740.1~uORF:IOH62863	543	797	642	1589	657	2493	4943	4524	1507	508	Tropomyosin alpha-3 chain
B13R15C10	13-10-15	Hs~MGC:BC062740.1~uORF:IOH62863	574	817	624	1583	733	2566	4919	4648	1538	527	Tropomyosin alpha-3 chain
B13R15C15	13-15-15	Hs~Ref:NM_014397.2~CAT:PV3353	1605	1432	627	964	1917	1503	697	1053	1303	1109	NIMA (never in mitosis gene a)-related kinase 6 (NEK6)
B13R15C16	13-16-15	Hs~Ref:NM_014397.2~CAT:PV3353	836	1001	736	991	2319	1158	729	975	1645	1101	NIMA (never in mitosis gene a)-related kinase 6 (NEK6)
B13R15C17	13-17-15	Hs~Ref:NM_002744.2~CAT:P2268	2295	8759	1015	778	712	326	829	313	3148	1005	protein kinase C, zeta (PRKCZ), transcript variant 1
B13R15C18	13-18-15	Hs~Ref:NM_002744.2~CAT:P2268	2478	8979	591	795	654	281	866	282	3063	967	protein kinase C, zeta (PRKCZ), transcript variant 1
B13R16C05	13-5-16	Hs~MGC:NM_000461.3~CAT:PV4764	287	282	350	145	167	1007	553	558	501	70	Thyroid hormone receptor beta
B13R16C06	13-6-16	Hs~MGC:NM_000461.3~CAT:PV4764	304	112	390	473	223	954	553	546	496	39	Thyroid hormone receptor beta
B13R16C07	13-7-16	Hs~MGC:BC092477.1~uORF:IOH62628	1398	665	11320	2329	1278	864	1615	880	1691	1257	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform
B13R16C08	13-8-16	Hs~MGC:BC092477.1~uORF:IOH62628	1350	670	11291	1036	1447	926	1646	918	1629	1347	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform
B13R16C09	13-9-16	Hs~MGC:BC092404.1~uORF:IOH62574	8557	9648	6415	7076	4006	9608	4813	31360	7628	3370	Rap guanine nucleotide exchange factor 3
B13R16C10	13-10-16	Hs~MGC:BC092404.1~uORF:IOH62574	8757	9779	6493	6900	4039	9246	4613	32511	7962	3480	Rap guanine nucleotide exchange factor 3
B13R16C15	13-15-16	Hs~MGC:BC054049.2~uORF:IOH29102	871	2549	935	598	882	754	1748	632	1743	400	zinc finger protein 364 (ZNF364)
B13R16C16	13-16-16	Hs~MGC:BC054049.2~uORF:IOH29102	797	2399	960	594	932	817	1779	607	1764	431	zinc finger protein 364 (ZNF364)
B13R16C17	13-17-16	Hs~Ref:NM_181705.1~uORF:IOH26509	1081	614	1344	537	1428	4296	1317	674	1189	473	Lyrm7 homolog (mouse) (LYRM7)
B13R16C18	13-18-16	Hs~Ref:NM_181705.1~uORF:IOH26509	1078	597	1159	491	1305	4101	1194	722	1170	472	Lyrm7 homolog (mouse) (LYRM7)
B13R16C19	13-19-16	Hs~Ref:NM_002931.3~uORF:IOH27050	523	522	1530	636	1172	1050	1599	710	1517	836	ring finger protein 1 (RING1)
B13R16C20	13-20-16	Hs~Ref:NM_002931.3~uORF:IOH27050	490	506	1543	644	1140	928	1683	871	1607	756	ring finger protein 1 (RING1)
B13R16C21	13-21-16	Hs~Ref:NM_173665.1~uORF:IOH27294	775	617	1022	810	1531	930	2293	801	1418	539	Uncharacterized protein C5orf36
B13R16C22	13-22-16	Hs~Ref:NM_173665.1~uORF:IOH27294	788	831	1007	796	1528	848	2294	947	1479	512	Uncharacterized protein C5orf36
B13R17C01	13-1-17	Hs~Ref:NM_015679.1~uORF:IOH4013	1184	818	1650	7465	1065	1710	2187	1852	3785	919	TruB pseudouridine (psi) synthase homolog 2 (E. coli) (TRUB2)
B13R17C02	13-2-17	Hs~Ref:NM_015679.1~uORF:IOH4013	1234	824	1464	8582	1078	1688	2345	1810	3686	895	TruB pseudouridine (psi) synthase homolog 2 (E. coli) (TRUB2)
B13R17C03	13-3-17	Hs~Ref:NM_014583.2~uORF:IOH4194	674	619	1421	940	29254	1126	2330	1110	2007	397	LIM and cysteine-rich domains 1 (LMCD1)
B13R17C04	13-4-17	Hs~Ref:NM_014583.2~uORF:IOH4194	658	587	1514	1145	29437	1088	2322	1047	2337	449	LIM and cysteine-rich domains 1 (LMCD1)
B13R17C05	13-5-17	Hs~MGC:BC010741.1~uORF:IOH9986	1199	778	1265	1087	1017	1948	3152	1354	3275	708	tRNA isopentenyltransferase, mitochondrial
B13R17C06	13-6-17	Hs~MGC:BC010741.1~uORF:IOH9986	1328	784	1107	1965	1149	1911	2924	1281	3088	676	tRNA isopentenyltransferase, mitochondrial
B13R17C07	13-7-17	Hs~MGC:BC007252.1~uORF:IOH6830	1037	675	1075	711	1016	1288	1768	973	2191	578	collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital) (COL2A1)
B13R17C08	13-8-17	Hs~MGC:BC007252.1~uORF:IOH6830	1014	627	1053	683	1112	1257	1806	998	2130	523	collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital) (COL2A1)
B13R17C15	13-15-17	Hs~MGC:BC071651.1~uORF:IOH61799	175	286	219	227	631	210	287	372	454	161	Protein Dom3Z
B13R17C16	13-16-17	Hs~MGC:BC071651.1~uORF:IOH61799	206	196	279	213	585	424	265	485	463	284	Protein Dom3Z
B13R17C17	13-17-17	Hs~Ref:NM_016283.2~uORF:IOH5842	1484	474	1155	834	740	2387	967	783	1641	261	TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa (TAF9), transcript variant 2
B13R17C18	13-18-17	Hs~Ref:NM_016283.2~uORF:IOH5842	1498	495	1010	807	841	2218	967	804	1712	300	TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa (TAF9), transcript variant 2
B13R17C19	13-19-17	Hs~Ref:NM_033019.1~uORF:IOH6258	3926	867	1312	1550	1430	1811	2217	5488	27082	1380	PCTAIRE protein kinase 1 (PCTK1), transcript variant 3
B13R17C20	13-20-17	Hs~Ref:NM_033019.1~uORF:IOH6258	4240	828	1492	1564	1604	1805	2368	5098	28523	1386	PCTAIRE protein kinase 1 (PCTK1), transcript variant 3
B13R17C21	13-21-17	Hs~Ref:NM_002045.1~uORF:IOH6708	1102	3079	3979	781	1831	901	3202	744	733	6468	growth associated protein 43 (GAP43)
B13R17C22	13-22-17	Hs~Ref:NM_002045.1~uORF:IOH6708	1085	2912	3641	764	2135	851	3290	829	821	6401	growth associated protein 43 (GAP43)
B13R18C01	13-1-18	Hs~MGC:BC008374.1~uORF:IOH7134	1139	669	807	1303	769	996	1360	791	7281	278	SH3 domain containing, Ysc84-like 1 (S. cerevisiae) (SH3YL1)
B13R18C02	13-2-18	Hs~MGC:BC008374.1~uORF:IOH7134	1188	681	854	1162	761	1037	1419	770	7517	321	SH3 domain containing, Ysc84-like 1 (S. cerevisiae) (SH3YL1)
B13R18C05	13-5-18	Hs~MGC:BC001651.1~uORF:IOH3740	1543	464	1052	488	456	736	1508	726	1872	453	cell division cycle associated 8 (CDCA8)
B13R18C06	13-6-18	Hs~MGC:BC001651.1~uORF:IOH3740	1743	614	700	409	478	741	1495	836	1910	359	cell division cycle associated 8 (CDCA8)
B13R18C07	13-7-18	Hs~Ref:NM_003885.1~uORF:IOH11747	1582	517	793	939	522	1336	1863	841	3218	423	cyclin-dependent kinase 5, regulatory subunit 1 (p35) (CDK5R1)
B13R18C08	13-8-18	Hs~Ref:NM_003885.1~uORF:IOH11747	872	516	829	646	489	1231	2010	781	3166	449	cyclin-dependent kinase 5, regulatory subunit 1 (p35) (CDK5R1)
B13R18C09	13-9-18	Hs~Ref:NM_214461.1~uORF:IOH26301	1461	393	837	461	488	987	752	521	1479	182	MGC50273 protein (MGC50273)
B13R18C10	13-10-18	Hs~Ref:NM_214461.1~uORF:IOH26301	1552	399	810	473	540	839	772	553	1491	140	MGC50273 protein (MGC50273)
B13R18C21	13-21-18	Hs~Ref:NM_006201.2~N/A	420	452	550	400	1370	431	692	611	1432	301	Serine/threonine-protein kinase PCTAIRE-3
B13R18C22	13-22-18	Hs~Ref:NM_006201.2~N/A	389	385	594	391	1270	463	682	664	1650	331	Serine/threonine-protein kinase PCTAIRE-3
B13R19C01	13-1-19	Hs~Ref:NM_005012.1~N/A	411	551	1470	757	690	1571	564	722	3841	259	Tyrosine-protein kinase transmembrane receptor ROR1
B13R19C02	13-2-19	Hs~Ref:NM_005012.1~N/A	400	625	1442	874	700	1581	640	726	3804	322	Tyrosine-protein kinase transmembrane receptor ROR1
B13R19C03	13-3-19	Hs~Ref:NM_005607.1~N/A	489	477	1995	893	704	963	897	868	5068	376	Focal adhesion kinase 1
B13R19C04	13-4-19	Hs~Ref:NM_005607.1~N/A	488	445	1954	842	692	989	863	861	5109	347	Focal adhesion kinase 1
B13R19C05	13-5-19	Hs~MGC:BC004932.1~uORF:IOH5521	401	298	650	275	251	395	753	381	803	237	chromosome 16 open reading frame 30 (C16orf30)
B13R19C06	13-6-19	Hs~MGC:BC004932.1~uORF:IOH5521	402	511	548	297	348	358	752	426	738	227	chromosome 16 open reading frame 30 (C16orf30)
B13R19C07	13-7-19	Hs~MGC:BC037854.1~uORF:IOH27633	3107	1199	1217	977	1131	1176	3857	1994	1609	256	dynein, cytoplasmic 1, intermediate chain 1 (DYNC1I1)
B13R19C08	13-8-19	Hs~MGC:BC037854.1~uORF:IOH27633	2850	1105	1212	855	1332	1147	3939	1883	1652	117	dynein, cytoplasmic 1, intermediate chain 1 (DYNC1I1)
B13R19C09	13-9-19	Hs~Ref:NM_004466.3~uORF:IOH26127	315	166	414	224	130	306	635	276	441	130	glypican 5 (GPC5)
B13R19C10	13-10-19	Hs~Ref:NM_004466.3~uORF:IOH26127	333	192	431	210	142	290	635	289	375	145	glypican 5 (GPC5)
B13R19C11	13-11-19	Hs~MGC:BC039582.1~uORF:IOH26251	356	216	590	237	365	370	583	288	564	165	dynein, axonemal, intermediate chain 2 (DNAI2)
B13R19C12	13-12-19	Hs~MGC:BC039582.1~uORF:IOH26251	364	240	550	252	324	365	547	302	550	177	dynein, axonemal, intermediate chain 2 (DNAI2)
B13R19C13	13-13-19	Hs~Ref:NM_022076.2~uORF:IOH42893	900	876	1715	1086	1372	996	1564	943	1355	738	dual specificity phosphatase 21 (DUSP21)
B13R19C14	13-14-19	Hs~Ref:NM_022076.2~uORF:IOH42893	928	893	1728	1167	821	989	1673	873	1486	752	dual specificity phosphatase 21 (DUSP21)
B13R19C17	13-17-19	Hs~Ref:NM_001009880.1~uORF:IOH42078	13511	8936	8622	33040	9771	25192	12098	14238	11180	11806	chromosome 22 open reading frame 9 (C22orf9), transcript variant 2
B13R19C18	13-18-19	Hs~Ref:NM_001009880.1~uORF:IOH42078	14224	9321	8269	31683	10514	22831	12960	16318	11628	11401	chromosome 22 open reading frame 9 (C22orf9), transcript variant 2
B13R19C19	13-19-19	Hs~Ref:NM_019854.2~uORF:IOH11043	512	359	628	335	441	508	1480	413	651	133	Protein arginine N-methyltransferase 8
B13R19C20	13-20-19	Hs~Ref:NM_019854.2~uORF:IOH11043	552	321	580	320	426	503	1466	362	637	210	Protein arginine N-methyltransferase 8
B13R19C21	13-21-19	Hs~MGC:BC036029.1~uORF:IOH27232	658	583	745	541	741	599	1073	660	1690	381	ADAM metallopeptidase domain 22 (ADAM22)
B13R19C22	13-22-19	Hs~MGC:BC036029.1~uORF:IOH27232	754	498	832	484	651	609	1073	674	1687	409	ADAM metallopeptidase domain 22 (ADAM22)
B13R20C01	13-1-20	Hs~MGC:AB065662.1~uORF:IOH28287	610	522	829	567	512	752	1109	1039	1753	398	olfactory receptor, family 6, subfamily B, member 3 (OR6B3), mRNA
B13R20C02	13-2-20	Hs~MGC:AB065662.1~uORF:IOH28287	683	573	913	977	568	787	1231	703	1740	461	olfactory receptor, family 6, subfamily B, member 3 (OR6B3), mRNA
B13R20C03	13-3-20	Hs~Ref:NM_139169.2~uORF:IOH22254	1974	2491	1675	1248	1848	1940	5233	2117	2732	829	TruB pseudouridine (psi) synthase homolog 1 (E. coli) (TRUB1)
B13R20C04	13-4-20	Hs~Ref:NM_139169.2~uORF:IOH22254	1928	2443	1643	1355	1877	1963	4863	2164	2744	856	TruB pseudouridine (psi) synthase homolog 1 (E. coli) (TRUB1)
B13R20C05	13-5-20	Hs~MGC:BC034954.2~uORF:IOH26830	1676	2040	1604	4123	1494	1954	9087	3978	3537	740	nucleosome assembly protein 1-like 3 (NAP1L3)
B13R20C06	13-6-20	Hs~MGC:BC034954.2~uORF:IOH26830	1633	1952	1640	4124	1737	1894	8965	4120	3611	716	nucleosome assembly protein 1-like 3 (NAP1L3)
B13R20C07	13-7-20	Hs~MGC:BC015813.1~uORF:IOH10085	1127	681	1039	961	849	2533	2170	1650	1274	354	eukaryotic translation elongation factor 1 gamma (EEF1G)
B13R20C08	13-8-20	Hs~MGC:BC015813.1~uORF:IOH10085	1098	608	1130	840	814	2453	2230	1552	1268	343	eukaryotic translation elongation factor 1 gamma (EEF1G)
B13R20C09	13-9-20	Hs~Ref:NM_023937.1~uORF:IOH4594	929	744	979	680	585	976	2681	775	1213	422	mitochondrial ribosomal protein L34 (MRPL34), nuclear gene encoding mitochondrial protein
B13R20C10	13-10-20	Hs~Ref:NM_023937.1~uORF:IOH4594	948	740	943	670	543	876	2533	787	1169	427	mitochondrial ribosomal protein L34 (MRPL34), nuclear gene encoding mitochondrial protein
B13R20C11	13-11-20	Hs~MGC:BC007609.1~uORF:IOH6912	516	353	498	284	1967	3	197	241	-2	0	E2F transcription factor 2 (E2F2)
B13R20C12	13-12-20	Hs~MGC:BC007609.1~uORF:IOH6912	563	372	537	271	2262	187	3	-5	-4	-1	E2F transcription factor 2 (E2F2)
B13R20C13	13-13-20	Hs~MGC:BC014975.1~uORF:IOH14285	8758	626	1045	416	2399	1825	755	6258	2164	329	family with sequence similarity 136, member A (FAM136A)
B13R20C14	13-14-20	Hs~MGC:BC014975.1~uORF:IOH14285	8726	555	1087	428	1951	1976	733	6252	2195	357	family with sequence similarity 136, member A (FAM136A)
B14R02C11	14-11-2	Hs~Ref:NM_080548.1~uORF:IOH4085	11254	2125	4350	2423	2368	3179	8671	2040	5305	1091	Tyrosine-protein phosphatase non-receptor type 6
B14R02C12	14-12-2	Hs~Ref:NM_080548.1~uORF:IOH4085	10866	2079	4442	2386	2246	3035	8487	1996	5232	1082	Tyrosine-protein phosphatase non-receptor type 6
B14R02C13	14-13-2	Hs~Ref:NM_022756.2~uORF:IOH13235	14757	3937	7297	8839	8345	4165	7160	1921	7718	749	Uncharacterized protein C1orf149
B14R02C14	14-14-2	Hs~Ref:NM_022756.2~uORF:IOH13235	12726	3907	6676	8647	9142	4982	7515	1880	7896	804	Uncharacterized protein C1orf149
B14R02C15	14-15-2	Hs~MGC:BC008375.1~uORF:IOH7243	1231	1576	1571	3835	1243	1031	1579	1201	3120	642	SH3 domain containing, Ysc84-like 1 (S. cerevisiae), mRNA (cDNA clone MGC:12275 IMAGE:3996120), complete cds
B14R02C16	14-16-2	Hs~MGC:BC008375.1~uORF:IOH7243	1312	1509	1479	5042	1338	1634	1472	1065	3041	910	SH3 domain containing, Ysc84-like 1 (S. cerevisiae), mRNA (cDNA clone MGC:12275 IMAGE:3996120), complete cds
B14R02C17	14-17-2	Hs~MGC:BC028675.1~uORF:IOH23010	1549	921	1327	1278	1100	1690	1972	1331	3690	717	Protein FAM125B
B14R02C18	14-18-2	Hs~MGC:BC028675.1~uORF:IOH23010	1473	991	1435	1460	970	1681	2030	1369	3864	662	Protein FAM125B
B14R02C19	14-19-2	Hs~MGC:BC000313.1~uORF:IOH3491	1983	1187	1747	2742	1406	1224	2167	1767	3147	618	nucleolar protein 4, mRNA (cDNA clone MGC:8430 IMAGE:2821116), complete cds
B14R02C20	14-20-2	Hs~MGC:BC000313.1~uORF:IOH3491	2075	1144	1707	2844	1400	1181	2269	1819	3164	621	nucleolar protein 4, mRNA (cDNA clone MGC:8430 IMAGE:2821116), complete cds
B14R02C21	14-21-2	Hs~MGC:BC019909.1~uORF:IOH12023	1681	852	1302	934	809	1137	2183	1331	3730	679	ATPase family AAA domain-containing protein 2
B14R02C22	14-22-2	Hs~MGC:BC019909.1~uORF:IOH12023	1657	824	1222	907	799	1133	2118	1341	3569	662	ATPase family AAA domain-containing protein 2
B14R03C01	14-1-3	Hs~Ref:NM_006788.2~uORF:IOH10874	1387	1164	1714	1782	1402	1818	6248	2147	4291	1036	RalA-binding protein 1
B14R03C02	14-2-3	Hs~Ref:NM_006788.2~uORF:IOH10874	1291	1199	1601	1826	1417	1797	6267	2197	4540	1063	RalA-binding protein 1
B14R03C03	14-3-3	Hs~MGC:BC014133.1~uORF:IOH12958	1968	623	1062	774	1401	11498	2078	736	3069	474	Hsp90 co-chaperone Cdc37-like 1
B14R03C04	14-4-3	Hs~MGC:BC014133.1~uORF:IOH12958	1890	613	1112	736	1564	11804	2018	748	3152	445	Hsp90 co-chaperone Cdc37-like 1
B14R03C05	14-5-3	Hs~Ref:NM_016152.2~uORF:IOH36705	546	492	1211	371	415	3175	1258	282	616	102	retinoic acid receptor, beta (RARB), transcript variant 2
B14R03C06	14-6-3	Hs~Ref:NM_016152.2~uORF:IOH36705	578	461	1156	360	386	2462	1235	279	645	93	retinoic acid receptor, beta (RARB), transcript variant 2
B14R03C07	14-7-3	Hs~Ref:NM_005975.2~uORF:IOH37738	378	330	460	552	425	1059	694	419	754	546	PTK6 protein tyrosine kinase 6 (PTK6)
B14R03C08	14-8-3	Hs~Ref:NM_005975.2~uORF:IOH37738	395	345	417	566	470	400	668	424	725	487	PTK6 protein tyrosine kinase 6 (PTK6)
B14R03C09	14-9-3	Hs~Ref:NM_198467.1~uORF:IOH40427	1010	548	830	512	561	960	3333	637	1092	319	round spermatid basic protein 1-like (RSBN1L)
B14R03C10	14-10-3	Hs~Ref:NM_198467.1~uORF:IOH40427	986	586	844	715	509	993	3063	601	1262	318	round spermatid basic protein 1-like (RSBN1L)
B14R03C11	14-11-3	Hs~Ref:NM_194289.1~uORF:IOH40643	2099	321	485	517	523	273	362	322	678	222	hypothetical protein LOC152195 (LOC152195)
B14R03C12	14-12-3	Hs~Ref:NM_194289.1~uORF:IOH40643	1420	336	566	261	495	257	377	350	600	97	hypothetical protein LOC152195 (LOC152195)
B14R03C13	14-13-3	Hs~Ref:NM_198287.1~uORF:IOH41021	124	364	406	70	323	241	337	680	334	163	Inhibitor of growth protein 4
B14R03C14	14-14-3	Hs~Ref:NM_198287.1~uORF:IOH41021	96	381	401	66	158	242	344	673	361	36	Inhibitor of growth protein 4
B14R03C15	14-15-3	Hs~Ref:NM_173080.1~uORF:IOH34934	1555	1112	2069	4996	1592	1570	2622	1679	2580	531	small proline-rich protein 4 (SPRR4)
B14R03C16	14-16-3	Hs~Ref:NM_173080.1~uORF:IOH34934	1508	1069	2079	5540	1551	1954	2814	1654	2715	767	small proline-rich protein 4 (SPRR4)
B14R03C17	14-17-3	Hs~Ref:NM_170713.1~uORF:IOH40971	1255	53	237	129	55	142	184	177	74	189	Ras association (RalGDS/AF-6) domain family 1 (RASSF1), transcript variant C
B14R03C18	14-18-3	Hs~Ref:NM_170713.1~uORF:IOH40971	64	49	240	88	25	121	194	134	75	17	Ras association (RalGDS/AF-6) domain family 1 (RASSF1), transcript variant C
B14R03C19	14-19-3	Hs~Ref:NM_080827.1~uORF:IOH34944	303	298	334	253	346	263	461	735	562	120	WAP four-disulfide core domain 6 (WFDC6)
B14R03C20	14-20-3	Hs~Ref:NM_080827.1~uORF:IOH34944	305	322	320	271	358	273	457	306	527	66	WAP four-disulfide core domain 6 (WFDC6)
B14R03C21	14-21-3	Hs~MGC:BC032775.1~uORF:IOH21765	2992	4524	1151	2158	1611	2423	4567	754	1960	266	chromosome 1 open reading frame 142 (C1orf142)
B14R03C22	14-22-3	Hs~MGC:BC032775.1~uORF:IOH21765	2942	4655	1052	2180	1689	2094	4671	827	2023	270	chromosome 1 open reading frame 142 (C1orf142)
B14R04C01	14-1-4	Hs~MGC:BC002940.1~uORF:IOH5740	705	684	922	1007	697	2725	2058	524	1041	268	Zinc finger protein ZXDC
B14R04C02	14-2-4	Hs~MGC:BC002940.1~uORF:IOH5740	656	640	823	1014	771	2781	2035	527	1237	258	Zinc finger protein ZXDC
B14R04C03	14-3-4	Hs~MGC:BC031052.1~uORF:IOH22518	372	321	541	306	435	471	629	412	613	300	TNF receptor-associated factor 6 (TRAF6)
B14R04C04	14-4-4	Hs~MGC:BC031052.1~uORF:IOH22518	388	326	526	290	350	467	649	421	605	315	TNF receptor-associated factor 6 (TRAF6)
B14R04C05	14-5-4	Hs~MGC:BC012888.1~uORF:IOH11770	371	327	558	331	274	634	942	544	689	168	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1
B14R04C06	14-6-4	Hs~MGC:BC012888.1~uORF:IOH11770	463	351	619	327	309	723	950	533	670	172	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1
B14R04C07	14-7-4	Hs~Ref:NM_002927.3~uORF:IOH11040	1352	811	1583	703	885	1019	4872	1236	1501	485	regulator of G-protein signaling 13 (RGS13), transcript variant 1
B14R04C08	14-8-4	Hs~Ref:NM_002927.3~uORF:IOH11040	1363	842	1624	720	1097	916	4844	1262	1553	414	regulator of G-protein signaling 13 (RGS13), transcript variant 1
B14R04C09	14-9-4	Hs~Ref:NM_003874.1~uORF:IOH11227	292	386	640	333	315	503	553	390	596	308	SLAM family member 5
B14R04C10	14-10-4	Hs~Ref:NM_003874.1~uORF:IOH11227	327	363	558	313	402	437	510	399	566	290	SLAM family member 5
B14R04C11	14-11-4	Hs~Ref:NM_013401.2~uORF:IOH10925	614	379	1529	593	622	681	1794	885	1530	349	RAB3A interacting protein (rabin3)-like 1 (RAB3IL1)
B14R04C12	14-12-4	Hs~Ref:NM_013401.2~uORF:IOH10925	625	409	1473	538	626	749	1772	928	1444	55	RAB3A interacting protein (rabin3)-like 1 (RAB3IL1)
B14R04C13	14-13-4	Hs~Ref:NM_002362.2~uORF:IOH11259	264	252	431	249	345	315	319	353	1269	144	melanoma antigen family A, 4 (MAGEA4), transcript variant 2
B14R04C14	14-14-4	Hs~Ref:NM_002362.2~uORF:IOH11259	211	241	432	249	235	303	324	369	1373	125	melanoma antigen family A, 4 (MAGEA4), transcript variant 2
B14R04C15	14-15-4	Hs~Ref:NM_181837.1~uORF:IOH38202	896	546	785	517	429	498	1554	524	846	210	origin recognition complex, subunit 3-like (yeast) (ORC3L), transcript variant 1
B14R04C16	14-16-4	Hs~Ref:NM_181837.1~uORF:IOH38202	1016	599	800	479	527	452	1682	579	860	234	origin recognition complex, subunit 3-like (yeast) (ORC3L), transcript variant 1
B14R04C17	14-17-4	Hs~MGC:BC060770.1~uORF:IOH29229	1044	495	761	393	657	481	1129	500	795	160	Sushi domain-containing protein 1
B14R04C18	14-18-4	Hs~MGC:BC060770.1~uORF:IOH29229	827	419	787	361	396	467	1054	461	903	241	Sushi domain-containing protein 1
B14R04C19	14-19-4	Hs~Ref:NM_176824.1~uORF:IOH38205	787	496	746	939	422	594	1017	427	947	259	Bardet-Biedl syndrome 7 (BBS7), transcript variant 1
B14R04C20	14-20-4	Hs~Ref:NM_176824.1~uORF:IOH38205	797	494	824	834	357	608	1166	420	832	271	Bardet-Biedl syndrome 7 (BBS7), transcript variant 1
B14R04C21	14-21-4	Hs~Ref:NM_007368.2~uORF:IOH25931	2997	1565	3846	1779	1494	1845	9943	1440	3215	826	RAS p21 protein activator 3 (RASA3)
B14R04C22	14-22-4	Hs~Ref:NM_007368.2~uORF:IOH25931	3130	1579	3710	1845	1476	2121	10056	1449	3300	951	RAS p21 protein activator 3 (RASA3)
B14R05C01	14-1-5	Hs~MGC:BC017781.1~uORF:IOH12143	2070	719	11862	2316	722	1097	3486	4655	1207	758	endomucin (EMCN)
B14R05C02	14-2-5	Hs~MGC:BC017781.1~uORF:IOH12143	1936	692	11608	2315	784	1110	3365	4233	1353	730	endomucin (EMCN)
B14R05C03	14-3-5	Hs~Ref:NM_032861.2~uORF:IOH29307	761	496	807	1094	389	414	1271	1001	635	276	serine active site containing 1 (SERAC1)
B14R05C04	14-4-5	Hs~Ref:NM_032861.2~uORF:IOH29307	780	573	779	1235	435	320	1436	582	1523	227	serine active site containing 1 (SERAC1)
B14R05C05	14-5-5	Hs~Ref:NM_133332.1~uORF:IOH38113	1891	1032	1587	1713	1441	2025	6216	1485	2326	408	Wolf-Hirschhorn syndrome candidate 1 (WHSC1), transcript variant 5
B14R05C06	14-6-5	Hs~Ref:NM_133332.1~uORF:IOH38113	1875	987	1566	1760	1489	1918	6337	1593	2341	436	Wolf-Hirschhorn syndrome candidate 1 (WHSC1), transcript variant 5
B14R05C07	14-7-5	Hs~MGC:BC036319.1~uORF:IOH27661	845	459	717	896	787	520	1255	436	883	336	phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) (PDE4D)
B14R05C08	14-8-5	Hs~MGC:BC036319.1~uORF:IOH27661	832	527	754	900	1729	497	1245	423	900	307	phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) (PDE4D)
B14R05C09	14-9-5	Hs~Ref:NM_005884.2~N/A	3900	7954	4321	2210	16529	2329	7811	2008	5082	1368	p21(CDKN1A)-activated kinase 4 (PAK4), transcript variant 1
B14R05C10	14-10-5	Hs~Ref:NM_005884.2~N/A	4001	8329	4262	2811	17879	2346	8389	2013	5170	1340	p21(CDKN1A)-activated kinase 4 (PAK4), transcript variant 1
B14R05C13	14-13-5	Hs~Ref:NM_001893.3~N/A	2480	1171	1860	1132	1134	1125	3753	995	1629	661	casein kinase 1, delta (CSNK1D), transcript variant 1
B14R05C14	14-14-5	Hs~Ref:NM_001893.3~N/A	1711	1109	1796	1033	1129	1002	3737	962	1638	608	casein kinase 1, delta (CSNK1D), transcript variant 1
B14R05C17	14-17-5	Hs~Ref:NM_003561.1~uORF:IOH40301	1171	938	1332	769	1128	913	1585	1018	1964	250	phospholipase A2, group X (PLA2G10)
B14R05C18	14-18-5	Hs~Ref:NM_003561.1~uORF:IOH40301	1155	858	1331	813	1024	972	1652	1102	2029	502	phospholipase A2, group X (PLA2G10)
B14R05C19	14-19-5	Hs~Ref:NM_207331.1~uORF:IOH40118	1104	911	1287	735	820	1041	2444	888	1695	562	glucuronidase, beta pseudogene 1 (GUSBP1)
B14R05C20	14-20-5	Hs~Ref:NM_207331.1~uORF:IOH40118	1138	996	1389	720	799	971	2241	817	1730	575	glucuronidase, beta pseudogene 1 (GUSBP1)
B14R05C21	14-21-5	Hs~Ref:NM_000394.2~uORF:IOH40243	1839	1325	1601	1015	903	1018	1211	875	2218	640	crystallin, alpha A (CRYAA)
B14R05C22	14-22-5	Hs~Ref:NM_000394.2~uORF:IOH40243	1807	1359	1540	1066	920	1098	1334	945	2364	749	crystallin, alpha A (CRYAA)
B14R06C03	14-3-6	Hs~MGC:BC018060.1~uORF:IOH11303	6785	4118	4911	2314	4142	4814	5213	3339	4053	1106	Ras-like without CAAX 2 (RIT2)
B14R06C04	14-4-6	Hs~MGC:BC018060.1~uORF:IOH11303	6341	3923	4995	2455	4291	4440	5220	3113	4074	1084	Ras-like without CAAX 2 (RIT2)
B14R06C05	14-5-6	Hs~Ref:NM_001307.1~uORF:IOH4602	1205	1199	1714	1089	983	1316	2135	1276	2390	656	claudin 7 (CLDN7)
B14R06C06	14-6-6	Hs~Ref:NM_001307.1~uORF:IOH4602	1230	1172	1535	1096	1158	1315	1964	1110	2461	664	claudin 7 (CLDN7)
B14R06C07	14-7-6	Hs~Ref:NM_002881.1~uORF:IOH11519	1052	924	1462	787	1385	6971	1359	993	2111	640	v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) (RALB)
B14R06C08	14-8-6	Hs~Ref:NM_002881.1~uORF:IOH11519	1118	873	1333	783	1405	6788	1374	1099	2155	757	v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) (RALB)
B14R06C09	14-9-6	Hs~Ref:NM_016364.2~uORF:IOH12214	5584	1902	3249	3209	2562	3213	4345	2788	4620	1477	dual specificity phosphatase 13 (DUSP13), transcript variant 6
B14R06C10	14-10-6	Hs~Ref:NM_016364.2~uORF:IOH12214	5415	2023	3587	3290	2864	3457	4447	2870	4737	1480	dual specificity phosphatase 13 (DUSP13), transcript variant 6
B14R06C11	14-11-6	Hs~Ref:NM_001005360.1~uORF:IOH53617	2114	3045	3726	1132	919	2124	3135	759	3403	430	Dynamin-2
B14R06C12	14-12-6	Hs~Ref:NM_001005360.1~uORF:IOH53617	2832	2987	3154	1020	923	5434	3070	715	3099	402	Dynamin-2
B14R06C13	14-13-6	Hs~Ref:NM_173698.1~uORF:IOH59790	2148	1510	2399	3346	2496	3217	4039	3234	2852	2285	Protein FAM133A
B14R06C14	14-14-6	Hs~Ref:NM_173698.1~uORF:IOH59790	1639	1618	2308	3341	2342	2422	3425	3227	2900	2405	Protein FAM133A
B14R06C15	14-15-6	Hs~Ref:NM_001004332.1~uORF:IOH59656	717	563	840	443	728	692	907	633	783	247	FLJ41170 protein (FLJ41170), mRNA.
B14R06C16	14-16-6	Hs~Ref:NM_001004332.1~uORF:IOH59656	730	571	817	449	613	724	933	623	793	131	FLJ41170 protein (FLJ41170), mRNA.
B14R06C17	14-17-6	Hs~Ref:NM_001003712.1~uORF:IOH52892	3177	1163	2053	731	1337	7919	1559	911	1953	849	Oxysterol-binding protein-related protein 8
B14R06C18	14-18-6	Hs~Ref:NM_001003712.1~uORF:IOH52892	2948	1109	1966	792	1235	8480	1721	925	1937	792	Oxysterol-binding protein-related protein 8
B14R06C19	14-19-6	Hs~Ref:NM_148957.2~uORF:IOH26603	595	415	969	806	592	513	1188	764	1763	455	tumor necrosis factor receptor superfamily, member 19 (TNFRSF19), transcript variant 2
B14R06C20	14-20-6	Hs~Ref:NM_148957.2~uORF:IOH26603	616	503	907	851	612	523	1126	654	1878	414	tumor necrosis factor receptor superfamily, member 19 (TNFRSF19), transcript variant 2
B14R06C21	14-21-6	Hs~Ref:NM_138342.2~uORF:IOH25758	526	486	722	356	330	782	836	480	701	260	hypothetical protein BC008326 (LOC89944)
B14R06C22	14-22-6	Hs~Ref:NM_138342.2~uORF:IOH25758	587	415	764	356	317	881	835	564	695	23	hypothetical protein BC008326 (LOC89944)
B14R07C01	14-1-7	Hs~Ref:NM_018960.4~uORF:IOH21907	531	616	910	443	479	589	998	657	948	293	glycine N-methyltransferase (GNMT)
B14R07C02	14-2-7	Hs~Ref:NM_018960.4~uORF:IOH21907	602	704	843	457	516	562	977	599	965	301	glycine N-methyltransferase (GNMT)
B14R07C03	14-3-7	Hs~MGC:BC031556.1~uORF:IOH27349	599	421	780	551	484	631	1100	598	827	456	F-box and leucine-rich repeat protein 2 (FBXL2)
B14R07C04	14-4-7	Hs~MGC:BC031556.1~uORF:IOH27349	665	421	747	705	505	612	1102	540	735	323	F-box and leucine-rich repeat protein 2 (FBXL2)
B14R07C07	14-7-7	Hs~Ref:NM_000846.3~uORF:IOH5711	516	420	329	417	441	1546	775	177	700	308	Glutathione S-transferase A2
B14R07C08	14-8-7	Hs~Ref:NM_000846.3~uORF:IOH5711	383	416	586	406	512	1563	582	230	720	238	Glutathione S-transferase A2
B14R07C09	14-9-7	Hs~MGC:BC003152.1~uORF:IOH5139	400	350	719	320	820	67	2581	1393	567	244	Zinc transporter ZIP1
B14R07C10	14-10-7	Hs~MGC:BC003152.1~uORF:IOH5139	422	376	964	368	343	57	1070	1789	707	144	Zinc transporter ZIP1
B14R07C11	14-11-7	Hs~Ref:NM_134425.1~uORF:IOH11026	479	403	1062	1196	403	948	945	628	1455	215	Sulfate anion transporter 1
B14R07C12	14-12-7	Hs~Ref:NM_134425.1~uORF:IOH11026	109	490	979	955	406	389	785	610	1315	240	Sulfate anion transporter 1
B14R07C13	14-13-7	Hs~MGC:BC015202.1~uORF:IOH9835	1320	1488	1642	695	1005	1077	1101	570	1550	484	Centromere protein T
B14R07C14	14-14-7	Hs~MGC:BC015202.1~uORF:IOH9835	1068	1470	1605	671	1011	1133	1116	576	1526	441	Centromere protein T
B14R07C15	14-15-7	Hs~MGC:BC012981.2~uORF:IOH13857	780	542	919	515	538	626	955	705	1249	341	ankyrin repeat and sterile alpha motif domain containing 6 (ANKS6)
B14R07C16	14-16-7	Hs~MGC:BC012981.2~uORF:IOH13857	773	578	911	488	502	647	949	741	1162	278	ankyrin repeat and sterile alpha motif domain containing 6 (ANKS6)
B14R07C19	14-19-7	Hs~Ref:NM_006233.3~uORF:IOH13698	309	251	342	375	291	305	487	360	524	319	polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa (POLR2I)
B14R07C20	14-20-7	Hs~Ref:NM_006233.3~uORF:IOH13698	319	1685	345	288	313	296	485	332	692	35	polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa (POLR2I)
B14R07C21	14-21-7	Hs~Ref:NM_004177.3~uORF:IOH5893	515	907	676	370	451	586	839	3039	959	198	syntaxin 3 (STX3)
B14R07C22	14-22-7	Hs~Ref:NM_004177.3~uORF:IOH5893	504	524	663	429	463	616	970	3250	1011	114	syntaxin 3 (STX3)
B14R08C01	14-1-8	Hs~MGC:BC019266.1~uORF:IOH13740	582	315	718	270	376	1455	1707	521	1132	180	dystrophia myotonica, WD repeat containing, mRNA (cDNA clone IMAGE:3503856), complete cds.
B14R08C02	14-2-8	Hs~MGC:BC019266.1~uORF:IOH13740	576	347	615	279	385	1606	1742	468	1079	100	dystrophia myotonica, WD repeat containing, mRNA (cDNA clone IMAGE:3503856), complete cds.
B14R08C07	14-7-8	Hs~Ref:NM_004712.3~uORF:IOH4952	2248	1208	4515	1270	1218	1035	2641	822	3344	399	hepatocyte growth factor-regulated tyrosine kinase substrate (HGS)
B14R08C08	14-8-8	Hs~Ref:NM_004712.3~uORF:IOH4952	2411	1230	4410	1277	1461	937	2847	866	3071	494	hepatocyte growth factor-regulated tyrosine kinase substrate (HGS)
B14R08C09	14-9-8	Hs~MGC:BC002955.1~uORF:IOH4931	5706	4512	7006	6373	3929	11634	16526	7970	8328	3656	ubiquitin specific peptidase 2 (USP2)
B14R08C10	14-10-8	Hs~MGC:BC002955.1~uORF:IOH4931	5642	5136	8963	7022	3826	12794	17352	8044	9097	3826	ubiquitin specific peptidase 2 (USP2)
B14R08C11	14-11-8	Hs~Ref:NM_002749.2~uORF:IOH13115	1502	964	62879	5085	1683	1108	2489	1027	1612	703	mitogen-activated protein kinase 7 (MAPK7), transcript variant 3
B14R08C12	14-12-8	Hs~Ref:NM_002749.2~uORF:IOH13115	1471	882	47859	5117	1593	1067	2979	896	1847	769	mitogen-activated protein kinase 7 (MAPK7), transcript variant 3
B14R08C13	14-13-8	Hs~MGC:BC033178.1~uORF:IOH23236	65484	65449	65487	65491	65340	65492	65483	65491	65486	65485	immunoglobulin heavy constant gamma 3 (G3m marker) (IGHG3)
B14R08C14	14-14-8	Hs~MGC:BC033178.1~uORF:IOH23236	65494	65486	65484	65493	65434	65492	65482	65489	65490	65491	immunoglobulin heavy constant gamma 3 (G3m marker) (IGHG3)
B14R08C15	14-15-8	Hs~Ref:NM_139317.1~uORF:IOH44697	1076	1028	1509	918	1920	1123	1641	1342	2360	811	Baculoviral IAP repeat-containing protein 7
B14R08C16	14-16-8	Hs~Ref:NM_139317.1~uORF:IOH44697	1086	1019	1469	913	1883	1125	1717	1370	2428	760	Baculoviral IAP repeat-containing protein 7
B14R08C17	14-17-8	Hs~Ref:NM_018841.3~uORF:IOH57343	814	740	1061	662	732	886	1228	929	1431	526	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
B14R08C18	14-18-8	Hs~Ref:NM_018841.3~uORF:IOH57343	928	730	1089	810	700	952	1199	993	1595	525	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
B14R08C19	14-19-8	Hs~Ref:NM_005805.2~uORF:IOH40112	1133	1077	1547	786	690	1339	1718	1520	2545	713	26S proteasome non-ATPase regulatory subunit 14
B14R08C20	14-20-8	Hs~Ref:NM_005805.2~uORF:IOH40112	1172	1122	1479	852	718	1212	1554	1379	2515	757	26S proteasome non-ATPase regulatory subunit 14
B14R08C21	14-21-8	Hs~Ref:NM_001008917.1~uORF:IOH50160	911	817	1188	662	529	819	1225	992	1751	535	Similar to RIKEN cDNA 2210021J22 (OTTHUMP00000028822).
B14R08C22	14-22-8	Hs~Ref:NM_001008917.1~uORF:IOH50160	928	760	1267	678	578	946	1310	855	1700	236	Similar to RIKEN cDNA 2210021J22 (OTTHUMP00000028822).
B14R09C01	14-1-9	Hs~Ref:NM_153453.1~uORF:IOH59895	1143	291	1036	266	338	1900	650	334	743	178	Transcription cofactor vestigial-like protein 2
B14R09C02	14-2-9	Hs~Ref:NM_153453.1~uORF:IOH59895	1062	328	757	291	346	2015	567	281	562	211	Transcription cofactor vestigial-like protein 2
B14R09C03	14-3-9	Hs~Ref:NM_004069.3~uORF:IOH58971	455	314	903	311	411	434	1556	618	518	134	AP-2 complex subunit sigma-1
B14R09C04	14-4-9	Hs~Ref:NM_004069.3~uORF:IOH58971	439	316	871	383	421	429	1493	634	454	204	AP-2 complex subunit sigma-1
B14R09C05	14-5-9	Hs~Ref:NM_003135.1~uORF:IOH59899	2499	921	1753	1630	608	1919	18105	986	2736	419	Signal recognition particle 19 kDa protein
B14R09C06	14-6-9	Hs~Ref:NM_003135.1~uORF:IOH59899	2500	873	1643	1610	618	1894	19494	994	2730	421	Signal recognition particle 19 kDa protein
B14R09C07	14-7-9	Hs~Ref:NM_018973.3~uORF:IOH58681	559	335	610	327	419	380	623	435	405	138	Dolichol-phosphate mannosyltransferase subunit 3
B14R09C08	14-8-9	Hs~Ref:NM_018973.3~uORF:IOH58681	495	332	669	313	491	383	642	505	539	166	Dolichol-phosphate mannosyltransferase subunit 3
B14R09C09	14-9-9	Hs~Ref:NM_000114.2~uORF:IOH57032	713	658	1191	782	683	500	1535	561	748	127	Endothelin-3
B14R09C10	14-10-9	Hs~Ref:NM_000114.2~uORF:IOH57032	755	712	1190	1096	610	522	1369	587	60	159	Endothelin-3
B14R09C11	14-11-9	Hs~MGC:BC007709.1~uORF:IOH57301	847	2101	1627	1858	7221	938	2174	666	957	427	Protein phosphatase Slingshot homolog 3
B14R09C12	14-12-9	Hs~MGC:BC007709.1~uORF:IOH57301	809	2104	1463	1692	8009	1031	2458	689	1155	334	Protein phosphatase Slingshot homolog 3
B14R09C15	14-15-9	Hs~Ref:NM_005197.2~uORF:IOH56874	1222	4113	1845	1509	1105	1060	1695	1555	2857	842	Forkhead box protein N3
B14R09C16	14-16-9	Hs~Ref:NM_005197.2~uORF:IOH56874	1437	3959	1816	1595	930	1086	1589	1535	2954	850	Forkhead box protein N3
B14R09C17	14-17-9	Hs~MGC:BC002606.1~uORF:IOH4132	1621	846	1346	649	576	1967	4446	734	1331	393	PDZ domain-containing protein 4
B14R09C18	14-18-9	Hs~MGC:BC002606.1~uORF:IOH4132	1934	826	1397	1005	513	2249	4728	750	1378	467	PDZ domain-containing protein 4
B14R09C19	14-19-9	Hs~Ref:NM_138775.1~uORF:IOH10820	776	387	646	352	230	448	1272	338	768	187	alkB, alkylation repair homolog 8 (E. coli) (ALKBH8)
B14R09C20	14-20-9	Hs~Ref:NM_138775.1~uORF:IOH10820	748	385	632	360	244	463	1295	355	798	165	alkB, alkylation repair homolog 8 (E. coli) (ALKBH8)
B14R09C21	14-21-9	Hs~Ref:NM_002119.1~uORF:IOH10959	355	649	558	368	241	324	690	377	489	376	major histocompatibility complex, class II, DO alpha (HLA-DOA)
B14R09C22	14-22-9	Hs~Ref:NM_002119.1~uORF:IOH10959	327	297	516	289	229	289	426	372	460	-9	major histocompatibility complex, class II, DO alpha (HLA-DOA)
B14R10C01	14-1-10	Hs~Ref:NM_004286.2~uORF:IOH14552	5607	3104	65455	20112	4746	2620	12270	2215	5468	4026	GTP binding protein 1 (GTPBP1)
B14R10C02	14-2-10	Hs~Ref:NM_004286.2~uORF:IOH14552	5746	2905	65478	19796	4429	2615	12306	2492	4973	3944	GTP binding protein 1 (GTPBP1)
B14R10C03	14-3-10	Hs~Ref:NM_199415.1~uORF:IOH26936	1084	804	2880	1394	1137	1816	2609	962	1816	8049	U-box domain containing 5 (UBOX5), transcript variant 2
B14R10C04	14-4-10	Hs~Ref:NM_199415.1~uORF:IOH26936	1147	712	2862	1461	1174	1798	2543	1019	1889	8210	U-box domain containing 5 (UBOX5), transcript variant 2
B14R10C05	14-5-10	Hs~Ref:NM_020664.3~uORF:IOH9825	1787	1735	4172	2671	3428	6365	2476	6183	3787	2335	2,4-dienoyl CoA reductase 2, peroxisomal (DECR2)
B14R10C06	14-6-10	Hs~Ref:NM_020664.3~uORF:IOH9825	1928	1682	4065	2581	3476	6334	2536	6213	4589	2333	2,4-dienoyl CoA reductase 2, peroxisomal (DECR2)
B14R10C07	14-7-10	Hs~MGC:BC005378.1~uORF:IOH7320	619	558	1281	631	1171	670	1258	758	3430	407	complement component 4 binding protein, beta (C4BPB)
B14R10C08	14-8-10	Hs~MGC:BC005378.1~uORF:IOH7320	667	529	1404	577	1249	666	1216	912	3578	419	complement component 4 binding protein, beta (C4BPB)
B14R10C09	14-9-10	Hs~Ref:NM_004281.2~uORF:IOH6609	2641	5363	65472	16698	4952	4710	9495	5036	22214	7724	BCL2-associated athanogene 3 (BAG3)
B14R10C10	14-10-10	Hs~Ref:NM_004281.2~uORF:IOH6609	2754	5065	65479	17504	4635	4603	8501	5216	26753	7808	BCL2-associated athanogene 3 (BAG3)
B14R11C21	14-21-11	Hs~Ref:NM_030938.2~uORF:IOH22902	2	0	-1	0	2	208	335	2	1	-4	transmembrane protein 49 (TMEM49)
B14R11C22	14-22-11	Hs~Ref:NM_030938.2~uORF:IOH22902	3	-1	3	0	2	15	46	0	0	0	transmembrane protein 49 (TMEM49)
B14R12C01	14-1-12	Hs~MGC:NM_178151.1~uORF:IOH22620	979	1669	1854	1672	1105	1152	2540	984	1288	412	doublecortex; lissencephaly, X-linked (doublecortin) (DCX), transcript variant 4
B14R12C02	14-2-12	Hs~MGC:NM_178151.1~uORF:IOH22620	897	1996	1620	1748	1126	1226	2614	850	1389	459	doublecortex; lissencephaly, X-linked (doublecortin) (DCX), transcript variant 4
B14R12C03	14-3-12	Hs~MGC:BC012291.1~uORF:IOH10483	1100	6175	1713	811	4461	1160	2154	701	1559	496	activating signal cointegrator 1 complex subunit 1 (ASCC1)
B14R12C04	14-4-12	Hs~MGC:BC012291.1~uORF:IOH10483	1224	5402	1780	856	4060	1176	2138	725	1466	442	activating signal cointegrator 1 complex subunit 1 (ASCC1)
B14R12C05	14-5-12	Hs~Ref:NM_002862.2~uORF:IOH9832	843	780	960	785	1205	1235	1562	1202	1261	597	phosphorylase, glycogen; brain (PYGB)
B14R12C06	14-6-12	Hs~Ref:NM_002862.2~uORF:IOH9832	832	750	996	608	1117	1197	1496	1286	1171	612	phosphorylase, glycogen; brain (PYGB)
B14R12C07	14-7-12	Hs~Ref:NM_145021.1~uORF:IOH10856	1272	1312	2214	1321	1299	1314	12065	2023	3568	1155	membrane-associated ring finger (C3HC4) 8 (MARCH8), transcript variant 8
B14R12C08	14-8-12	Hs~Ref:NM_145021.1~uORF:IOH10856	1374	1261	2226	1363	1349	1407	13936	1930	3612	1250	membrane-associated ring finger (C3HC4) 8 (MARCH8), transcript variant 8
B14R12C09	14-9-12	Hs~Ref:NM_005710.1~uORF:IOH13398	1769	5482	3149	1883	2291	2771	5446	5733	3859	605	polyglutamine binding protein 1 (PQBP1), transcript variant 1
B14R12C10	14-10-12	Hs~Ref:NM_005710.1~uORF:IOH13398	1917	5726	2993	2000	2737	3445	3334	6338	4321	506	polyglutamine binding protein 1 (PQBP1), transcript variant 1
B14R12C11	14-11-12	Hs~MGC:BC015634.1~uORF:IOH14765	448	915	1626	691	705	860	1488	838	889	218	Hexaprenyldihydroxybenzoate methyltransferase, mitochondrial
B14R12C12	14-12-12	Hs~MGC:BC015634.1~uORF:IOH14765	401	909	1436	644	761	908	1514	855	967	171	Hexaprenyldihydroxybenzoate methyltransferase, mitochondrial
B14R12C13	14-13-12	Hs~Ref:NM_033105.1~uORF:IOH11096	783	679	1189	1062	1215	862	1219	602	1787	596	DnaJ (Hsp40) homolog, subfamily C, member 5 beta (DNAJC5B)
B14R12C14	14-14-12	Hs~Ref:NM_033105.1~uORF:IOH11096	802	648	1154	1013	1043	809	1241	641	1814	500	DnaJ (Hsp40) homolog, subfamily C, member 5 beta (DNAJC5B)
B14R12C15	14-15-12	Hs~Ref:NM_017735.3~uORF:IOH40508	577	252	534	258	477	305	1892	433	649	202	Tetratricopeptide repeat protein 27
B14R12C16	14-16-12	Hs~Ref:NM_017735.3~uORF:IOH40508	584	255	532	259	407	309	1978	432	770	164	Tetratricopeptide repeat protein 27
B14R12C17	14-17-12	Hs~MGC:BC066645.1~uORF:IOH39925	1019	4695	587	1022	790	1191	850	2782	1220	433	methionine adenosyltransferase II, beta (MAT2B)
B14R12C18	14-18-12	Hs~MGC:BC066645.1~uORF:IOH39925	1044	4903	555	1060	810	1313	826	2838	1267	434	methionine adenosyltransferase II, beta (MAT2B)
B14R12C19	14-19-12	Hs~Ref:NM_000805.2~uORF:IOH40360	739	280	861	247	263	743	377	329	1324	176	gastrin (GAST)
B14R12C20	14-20-12	Hs~Ref:NM_000805.2~uORF:IOH40360	720	280	855	265	262	426	407	315	1438	65	gastrin (GAST)
B14R12C21	14-21-12	Hs~MGC:BC064428.1~uORF:IOH39937	321	501	478	291	278	330	357	385	644	131	Sodium channel and clathrin linker 1
B14R12C22	14-22-12	Hs~MGC:BC064428.1~uORF:IOH39937	303	522	427	270	287	311	322	386	590	60	Sodium channel and clathrin linker 1
B14R13C03	14-3-13	Hs~MGC:BC034275.1~uORF:IOH21410	935	769	1142	616	821	884	1466	850	3779	507	Aspartate beta-hydroxylase domain-containing protein 1
B14R13C04	14-4-13	Hs~MGC:BC034275.1~uORF:IOH21410	910	754	1192	642	750	844	1470	736	3592	507	Aspartate beta-hydroxylase domain-containing protein 1
B14R13C05	14-5-13	Hs~MGC:NM_173192.1~uORF:IOH21409	444	770	650	407	238	375	272	216	728	123	Kv channel interacting protein 2 (KCNIP2), transcript variant 3
B14R13C06	14-6-13	Hs~MGC:NM_173192.1~uORF:IOH21409	440	758	662	390	240	358	265	225	396	68	Kv channel interacting protein 2 (KCNIP2), transcript variant 3
B14R13C07	14-7-13	Hs~MGC:BC015219.1~uORF:IOH21424	622	7387	830	767	790	1502	1256	918	1855	257	RanBP-type and C3HC4-type zinc finger-containing protein 1
B14R13C08	14-8-13	Hs~MGC:BC015219.1~uORF:IOH21424	635	7085	789	809	908	1450	1505	915	1994	4633	RanBP-type and C3HC4-type zinc finger-containing protein 1
B14R13C09	14-9-13	Hs~MGC:BC000448.1~uORF:IOH3504	551	413	1024	444	1889	710	2848	898	1089	336	THUMP domain containing 1 (THUMPD1)
B14R13C10	14-10-13	Hs~MGC:BC000448.1~uORF:IOH3504	578	458	1025	422	1109	570	1738	850	1142	318	THUMP domain containing 1 (THUMPD1)
B14R13C11	14-11-13	Hs~MGC:BC000552.1~uORF:IOH4161	783	484	796	978	839	548	1101	456	47	191	chromosome 16 open reading frame 67 (C16orf67)
B14R13C12	14-12-13	Hs~MGC:BC000552.1~uORF:IOH4161	772	501	801	849	994	559	1042	466	669	216	chromosome 16 open reading frame 67 (C16orf67)
B14R13C13	14-13-13	Hs~MGC:BC000250.1~uORF:IOH4515	895	340	2154	337	578	660	3254	1210	1160	154	non-metastatic cells 3, protein expressed in (NME3)
B14R13C14	14-14-13	Hs~MGC:BC000250.1~uORF:IOH4515	954	309	2048	335	620	705	3208	1236	1256	237	non-metastatic cells 3, protein expressed in (NME3)
B14R13C15	14-15-13	Hs~MGC:BC009011.1~uORF:IOH3300	484	325	671	291	341	391	614	360	622	127	fatty acid desaturase 2 (FADS2)
B14R13C16	14-16-13	Hs~MGC:BC009011.1~uORF:IOH3300	499	337	684	281	273	439	605	342	649	250	fatty acid desaturase 2 (FADS2)
B14R13C17	14-17-13	Hs~MGC:BC057811.1~uORF:IOH29291	285	251	429	261	197	217	448	267	253	77	tubulin, alpha 3e (TUBA3E)
B14R13C18	14-18-13	Hs~MGC:BC057811.1~uORF:IOH29291	284	236	402	268	118	217	451	245	254	79	tubulin, alpha 3e (TUBA3E)
B14R13C19	14-19-13	Hs~MGC:BC016967.1~uORF:IOH28624	464	336	578	293	225	392	1922	350	488	211	RNA pseudouridylate synthase domain-containing protein 2
B14R13C20	14-20-13	Hs~MGC:BC016967.1~uORF:IOH28624	399	326	548	294	236	514	774	340	491	180	RNA pseudouridylate synthase domain-containing protein 2
B14R13C21	14-21-13	Hs~MGC:BC055427.1~uORF:IOH28811	913	820	873	488	429	739	1475	485	1542	222	TRAF2 and NCK interacting kinase (TNIK)
B14R13C22	14-22-13	Hs~MGC:BC055427.1~uORF:IOH28811	894	919	873	521	423	836	1608	539	1491	256	TRAF2 and NCK interacting kinase (TNIK)
B14R14C01	14-1-14	Hs~MGC:BC053670.1~uORF:IOH29013	341	251	628	273	286	341	683	330	610	205	carboxylesterase 3 (brain) (CES3)
B14R14C02	14-2-14	Hs~MGC:BC053670.1~uORF:IOH29013	380	300	590	287	265	377	701	375	395	184	carboxylesterase 3 (brain) (CES3)
B14R14C03	14-3-14	Hs~MGC:BC006124.1~uORF:IOH6586	1626	2949	2077	4136	1858	995	1800	1222	2977	662	IMP (inosine monophosphate) dehydrogenase 2 (IMPDH2)
B14R14C04	14-4-14	Hs~MGC:BC006124.1~uORF:IOH6586	1720	2793	2151	4347	1783	1022	1795	1079	2808	672	IMP (inosine monophosphate) dehydrogenase 2 (IMPDH2)
B14R14C05	14-5-14	Hs~Ref:XM_378175.2~uORF:IOH26505	738	695	1077	661	648	810	1304	777	2440	479	PREDICTED: Homo sapiens hypothetical protein BC017488 (LOC124446)
B14R14C06	14-6-14	Hs~Ref:XM_378175.2~uORF:IOH26505	751	630	1208	615	740	770	1172	796	2455	430	PREDICTED: Homo sapiens hypothetical protein BC017488 (LOC124446)
B14R14C07	14-7-14	Hs~Ref:NM_004697.3~uORF:IOH12861	1285	1371	2812	2563	7258	4921	2929	1799	4423	1132	PRP4 pre-mRNA processing factor 4 homolog (yeast) (PRPF4)
B14R14C08	14-8-14	Hs~Ref:NM_004697.3~uORF:IOH12861	1273	1363	2670	2545	9284	4810	3115	1710	4867	1933	PRP4 pre-mRNA processing factor 4 homolog (yeast) (PRPF4)
B14R14C09	14-9-14	Hs~MGC:BC023973.1~uORF:IOH27304	859	805	1160	595	792	799	1333	734	2124	1009	immunoglobulin lambda variable 6-57 (IGLV6-57)
B14R14C10	14-10-14	Hs~MGC:BC023973.1~uORF:IOH27304	847	712	1137	605	832	742	1382	712	2337	783	immunoglobulin lambda variable 6-57 (IGLV6-57)
B14R14C11	14-11-14	Hs~Ref:NM_004753.1~uORF:IOH5360	301	900	395	329	841	279	479	279	430	530	dehydrogenase/reductase (SDR family) member 3 (DHRS3)
B14R14C12	14-12-14	Hs~Ref:NM_004753.1~uORF:IOH5360	320	1141	470	335	244	284	485	380	341	393	dehydrogenase/reductase (SDR family) member 3 (DHRS3)
B14R14C13	14-13-14	Hs~MGC:BC033711.1~uORF:IOH21762	1095	912	7929	1577	692	824	3017	1530	1514	548	ataxin 3 (ATXN3)
B14R14C14	14-14-14	Hs~MGC:BC033711.1~uORF:IOH21762	1210	781	7214	1645	738	912	3092	1470	1693	498	ataxin 3 (ATXN3)
B14R14C15	14-15-14	Hs~Ref:NM_005111.4~uORF:IOH22501	467	412	691	724	368	583	467	598	1325	145	crystallin, zeta (quinone reductase)-like 1 (CRYZL1)
B14R14C16	14-16-14	Hs~Ref:NM_005111.4~uORF:IOH22501	492	477	705	760	190	590	444	664	1353	156	crystallin, zeta (quinone reductase)-like 1 (CRYZL1)
B14R14C17	14-17-14	Hs~MGC:BC006323.1~uORF:IOH6466	2302	1028	1145	733	1101	912	1212	514	1498	299	ATP-binding cassette, sub-family B (MDR/TAP), member 7 (ABCB7)
B14R14C18	14-18-14	Hs~MGC:BC006323.1~uORF:IOH6466	2538	978	1191	702	935	786	2181	567	1468	362	ATP-binding cassette, sub-family B (MDR/TAP), member 7 (ABCB7)
B14R14C19	14-19-14	Hs~Ref:NM_004955.1~uORF:IOH3983	432	329	756	335	278	328	899	389	463	239	solute carrier family 29 (nucleoside transporters), member 1 (SLC29A1), nuclear gene encoding mitochondrial protein, transcript variant 5
B14R14C20	14-20-14	Hs~Ref:NM_004955.1~uORF:IOH3983	412	327	719	274	283	441	598	402	480	208	solute carrier family 29 (nucleoside transporters), member 1 (SLC29A1), nuclear gene encoding mitochondrial protein, transcript variant 5
B14R14C21	14-21-14	Hs~MGC:NM_173802.2~uORF:IOH26328	401	343	630	346	260	892	505	457	806	0	hypothetical protein MGC50559 (MGC50559)
B14R14C22	14-22-14	Hs~MGC:NM_173802.2~uORF:IOH26328	436	437	565	347	269	489	478	499	671	488	hypothetical protein MGC50559 (MGC50559)
B14R15C01	14-1-15	Hs~Ref:NM_012261.1~uORF:IOH27036	373	309	649	297	349	466	608	412	1134	273	chromosome 20 open reading frame 103 (C20orf103)
B14R15C02	14-2-15	Hs~Ref:NM_012261.1~uORF:IOH27036	418	325	628	311	327	424	609	406	587	293	chromosome 20 open reading frame 103 (C20orf103)
B14R15C03	14-3-15	Hs~MGC:BC039814.1~uORF:IOH26283	729	1024	1557	1675	838	1225	1000	2640	2358	651	zinc finger, RAN-binding domain containing 2 (ZRANB2)
B14R15C04	14-4-15	Hs~MGC:BC039814.1~uORF:IOH26283	746	975	1562	1799	904	1245	1089	2682	2268	642	zinc finger, RAN-binding domain containing 2 (ZRANB2)
B14R15C05	14-5-15	Hs~Ref:NM_182527.1~uORF:IOH26942	2194	621	1080	933	1268	884	1152	850	1509	392	calcium binding protein 7 (CABP7)
B14R15C06	14-6-15	Hs~Ref:NM_182527.1~uORF:IOH26942	2391	597	1170	917	1112	871	1174	863	1606	366	calcium binding protein 7 (CABP7)
B14R15C07	14-7-15	Hs~Ref:NM_000904.1~uORF:IOH6580	518	475	793	413	557	564	1469	592	1043	238	NAD(P)H dehydrogenase, quinone 2 (NQO2)
B14R15C08	14-8-15	Hs~Ref:NM_000904.1~uORF:IOH6580	569	497	775	404	660	547	1523	555	1289	233	NAD(P)H dehydrogenase, quinone 2 (NQO2)
B14R15C09	14-9-15	Hs~Ref:NM_006212.1~uORF:IOH34755	2997	6882	2945	3681	4882	2882	5874	9647	6720	1559	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (PFKFB2), transcript variant 1
B14R15C10	14-10-15	Hs~Ref:NM_006212.1~uORF:IOH34755	3088	7412	2973	4089	5554	2994	5583	9932	7157	1605	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (PFKFB2), transcript variant 1
B14R15C11	14-11-15	Hs~Ref:NM_000231.1~uORF:IOH1957	654	579	1026	644	772	828	1364	873	1627	530	sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) (SGCG)
B14R15C12	14-12-15	Hs~Ref:NM_000231.1~uORF:IOH1957	639	590	1010	843	746	716	1337	746	1473	508	sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) (SGCG)
B14R15C15	14-15-15	Hs~Ref:NM_002613.3~CAT:P3001	327	166	1241	262	324	409	1504	1277	159	112	3-phosphoinositide dependent protein kinase-1 (PDPK1), transcript variant 1
B14R15C16	14-16-15	Hs~Ref:NM_002613.3~CAT:P3001	309	161	1216	232	118	427	1329	1628	169	61	3-phosphoinositide dependent protein kinase-1 (PDPK1), transcript variant 1
B14R15C17	14-17-15	Hs~Ref:NM_002447.1~CAT:PV4314	285	329	618	975	730	984	423	514	3543	596	Macrophage-stimulating protein receptor
B14R15C18	14-18-15	Hs~Ref:NM_002447.1~CAT:PV4314	289	309	603	996	669	1035	674	559	3641	618	Macrophage-stimulating protein receptor
B14R15C19	14-19-15	Hs~Ref:NM_002756.2~CAT:PV3662	1085	692	1496	1217	858	2219	1385	528	975	331	Dual specificity mitogen-activated protein kinase kinase 3
B14R15C20	14-20-15	Hs~Ref:NM_002756.2~CAT:PV3662	1022	672	1535	1064	902	2159	1083	560	941	255	Dual specificity mitogen-activated protein kinase kinase 3
B14R16C03	14-3-16	Hs~Ref:NM_003691.1~CAT:PV4311	20	79	34	300	57	67	113	83	334	27	Serine/threonine-protein kinase 16
B14R16C04	14-4-16	Hs~Ref:NM_003691.1~CAT:PV4311	75	177	165	37	98	56	62	220	351	33	Serine/threonine-protein kinase 16
B14R16C05	14-5-16	Hs~Ref:NM_006258.1~CAT:PV4340	385	502	267	369	566	976	801	266	1230	168	cGMP-dependent protein kinase 1, beta isozyme
B14R16C06	14-6-16	Hs~Ref:NM_006258.1~CAT:PV4340	555	526	292	264	563	939	791	219	1086	135	cGMP-dependent protein kinase 1, beta isozyme
B14R16C11	14-11-16	Hs~Ref:NM_022770.2~uORF:IOH56910	364	271	427	296	216	329	534	433	419	68	DNA replication complex GINS protein PSF3
B14R16C12	14-12-16	Hs~Ref:NM_022770.2~uORF:IOH56910	391	261	473	331	580	356	653	410	532	97	DNA replication complex GINS protein PSF3
B14R16C15	14-15-16	Hs~MGC:BC008877.2~uORF:IOH57031	1361	1841	1422	2055	1307	1586	4033	1874	1261	878	Caspase recruitment domain-containing protein 9
B14R16C16	14-16-16	Hs~MGC:BC008877.2~uORF:IOH57031	1142	1956	1369	2055	1175	1739	4015	1896	1287	908	Caspase recruitment domain-containing protein 9
B14R16C17	14-17-16	Hs~Ref:NM_032905.3~uORF:IOH56977	1608	3155	1727	994	1084	1932	2510	2614	2582	719	Splicing factor 45
B14R16C18	14-18-16	Hs~Ref:NM_032905.3~uORF:IOH56977	1663	3225	1667	1023	1050	1920	6615	2683	2708	702	Splicing factor 45
B14R16C21	14-21-16	Hs~Ref:NM_001009613.1~uORF:IOH58584	15460	1470	4135	2885	1431	2221	8272	2894	3023	1206	Sperm protein associated with the nucleus on the X chromosome N4
B14R16C22	14-22-16	Hs~Ref:NM_001009613.1~uORF:IOH58584	16204	1462	3935	2920	1421	2297	8990	2919	3101	1262	Sperm protein associated with the nucleus on the X chromosome N4
B14R17C03	14-3-17	Hs~Ref:NM_012249.2~uORF:IOH59719	257	182	358	186	279	287	388	231	309	151	Rho-related GTP-binding protein RhoQ
B14R17C04	14-4-17	Hs~Ref:NM_012249.2~uORF:IOH59719	315	179	331	218	255	341	346	249	132	78	Rho-related GTP-binding protein RhoQ
B14R17C05	14-5-17	Hs~MGC:BC074764.2~uORF:IOH61918	256	40	335	346	120	157	483	177	212	72	Apolipoprotein A-IV
B14R17C06	14-6-17	Hs~MGC:BC074764.2~uORF:IOH61918	369	33	312	344	150	163	474	184	239	48	Apolipoprotein A-IV
B14R17C09	14-9-17	Hs~Ref:NM_145013.1~uORF:IOH10783	1099	606	1144	809	1027	990	1822	827	1694	323	chromosome 11 open reading frame 45 (C11orf45)
B14R17C10	14-10-17	Hs~Ref:NM_145013.1~uORF:IOH10783	1064	630	1181	829	1101	1048	1609	850	1779	523	chromosome 11 open reading frame 45 (C11orf45)
B14R17C11	14-11-17	Hs~MGC:BC029395.1~uORF:IOH23151	461	383	606	373	804	497	495	865	1130	318	M-phase phosphoprotein 6 (MPHOSPH6)
B14R17C12	14-12-17	Hs~MGC:BC029395.1~uORF:IOH23151	457	397	602	453	842	474	515	837	922	112	M-phase phosphoprotein 6 (MPHOSPH6)
B14R17C13	14-13-17	Hs~Ref:NM_002095.1~uORF:IOH22963	3066	1478	2061	1508	1515	1693	9823	1636	3297	1489	general transcription factor IIE, polypeptide 2, beta 34kDa (GTF2E2)
B14R17C14	14-14-17	Hs~Ref:NM_002095.1~uORF:IOH22963	2924	1471	2061	1628	1523	1686	9756	1482	3127	1396	general transcription factor IIE, polypeptide 2, beta 34kDa (GTF2E2)
B14R17C15	14-15-17	Hs~MGC:BC031549.1~uORF:IOH21007	1530	1883	1523	875	1137	3119	2086	1290	2637	696	CDC-like kinase 1 (CLK1)
B14R17C16	14-16-17	Hs~MGC:BC031549.1~uORF:IOH21007	1490	1992	1579	968	949	3365	2149	1380	2696	705	CDC-like kinase 1 (CLK1)
B14R17C17	14-17-17	Hs~Ref:NM_153283.1~uORF:IOH45449	456	373	591	307	281	461	1315	448	990	284	hyaluronoglucosaminidase 1 (HYAL1), transcript variant 3
B14R17C18	14-18-17	Hs~Ref:NM_153283.1~uORF:IOH45449	443	395	656	319	269	454	1719	481	849	230	hyaluronoglucosaminidase 1 (HYAL1), transcript variant 3
B14R17C19	14-19-17	Hs~Ref:NM_021967.1~uORF:IOH45915	1740	807	1767	1661	8995	1012	2472	1178	2235	1181	small EDRK-rich factor 1A (telomeric) (SERF1A)
B14R17C20	14-20-17	Hs~Ref:NM_021967.1~uORF:IOH45915	1422	829	1715	1617	9299	1078	2897	1159	2708	1188	small EDRK-rich factor 1A (telomeric) (SERF1A)
B14R17C21	14-21-17	Hs~Ref:NM_173042.1~uORF:IOH45456	529	529	1264	406	583	677	2572	553	1067	289	interleukin 18 binding protein (IL18BP), transcript variant A
B14R17C22	14-22-17	Hs~Ref:NM_173042.1~uORF:IOH45456	506	480	1144	383	586	866	2752	574	1113	364	interleukin 18 binding protein (IL18BP), transcript variant A
B14R18C01	14-1-18	Hs~Ref:NM_153759.2~uORF:IOH45457	550	1166	7662	466	772	863	1395	666	3321	390	DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A), transcript variant 2
B14R18C02	14-2-18	Hs~Ref:NM_153759.2~uORF:IOH45457	565	536	7362	441	1005	829	1412	689	3910	427	DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A), transcript variant 2
B14R18C03	14-3-18	Hs~MGC:BC023603.2~uORF:IOH29334	436	665	446	723	617	541	1062	3149	936	281	Uncharacterized protein C16orf45
B14R18C04	14-4-18	Hs~MGC:BC023603.2~uORF:IOH29334	486	641	409	734	575	489	1022	3280	122	148	Uncharacterized protein C16orf45
B14R18C05	14-5-18	Hs~MGC:BC009650.1~uORF:IOH11334	576	515	856	4551	1176	589	1362	8336	762	528	PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) (SCC-112)
B14R18C06	14-6-18	Hs~MGC:BC009650.1~uORF:IOH11334	574	554	806	4789	1228	563	1236	8990	1288	465	PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) (SCC-112)
B14R18C07	14-7-18	Hs~Ref:NM_004181.2~uORF:IOH5072	88	185	367	278	429	362	688	266	363	107	ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) (UCHL1)
B14R18C08	14-8-18	Hs~Ref:NM_004181.2~uORF:IOH5072	229	189	351	247	279	152	722	221	302	52	ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) (UCHL1)
B14R18C09	14-9-18	Hs~Ref:NM_017971.1~uORF:IOH13615	1066	1269	1058	653	851	775	2801	1425	1663	386	mitochondrial ribosomal protein L20 (MRPL20), nuclear gene encoding mitochondrial protein
B14R18C10	14-10-18	Hs~Ref:NM_017971.1~uORF:IOH13615	978	1300	1023	661	958	837	2653	1546	1634	480	mitochondrial ribosomal protein L20 (MRPL20), nuclear gene encoding mitochondrial protein
B14R18C11	14-11-18	Hs~MGC:NM_178122.2~uORF:IOH26674	531	420	708	429	460	758	5808	609	1082	299	chromosome 1 open reading frame 201 (C1orf201)
B14R18C12	14-12-18	Hs~MGC:NM_178122.2~uORF:IOH26674	564	402	769	855	472	682	5759	669	940	377	chromosome 1 open reading frame 201 (C1orf201)
B14R18C13	14-13-18	Hs~MGC:NM_000953.2~uORF:IOH26261	438	346	634	339	317	435	826	511	609	202	prostaglandin D2 receptor (DP) (PTGDR)
B14R18C14	14-14-18	Hs~MGC:NM_000953.2~uORF:IOH26261	513	664	637	310	340	451	887	466	606	197	prostaglandin D2 receptor (DP) (PTGDR)
B14R18C15	14-15-18	Hs~Ref:NM_000401.2~uORF:IOH14553	414	354	619	324	283	431	871	501	663	307	exostoses (multiple) 2 (EXT2), transcript variant 1
B14R18C16	14-16-18	Hs~Ref:NM_000401.2~uORF:IOH14553	433	406	631	321	264	500	933	621	798	258	exostoses (multiple) 2 (EXT2), transcript variant 1
B14R18C17	14-17-18	Hs~Ref:NM_025159.1~uORF:IOH13469	520	358	537	291	267	405	1098	445	633	217	chromosome X open reading frame 21 (CXorf21)
B14R18C18	14-18-18	Hs~Ref:NM_025159.1~uORF:IOH13469	591	378	527	311	256	475	812	472	601	140	chromosome X open reading frame 21 (CXorf21)
B14R18C19	14-19-18	Hs~Ref:NM_153822.1~uORF:IOH41107	3607	1487	3193	1611	921	1458	17452	1216	3180	853	proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 (PSMD4), transcript variant 2
B14R18C20	14-20-18	Hs~Ref:NM_153822.1~uORF:IOH41107	3410	1322	3161	1738	895	1569	19132	1264	3367	823	proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 (PSMD4), transcript variant 2
B14R19C01	14-1-19	Hs~Ref:NM_000864.3~uORF:IOH6478	519	855	712	413	464	597	1100	542	913	311	5-hydroxytryptamine (serotonin) receptor 1D (HTR1D)
B14R19C02	14-2-19	Hs~Ref:NM_000864.3~uORF:IOH6478	548	706	816	426	598	643	1097	689	1233	322	5-hydroxytryptamine (serotonin) receptor 1D (HTR1D)
B14R19C03	14-3-19	Hs~MGC:BC042174.1~uORF:IOH28018	875	773	1170	673	1322	1014	1476	990	2485	760	keratin 4 (KRT4)
B14R19C04	14-4-19	Hs~MGC:BC042174.1~uORF:IOH28018	969	798	1148	677	811	968	1506	937	2174	725	keratin 4 (KRT4)
B14R19C05	14-5-19	Hs~MGC:BC025726.1~uORF:IOH10934	233	230	403	231	213	326	403	368	781	83	potassium channel, subfamily K, member 17 (KCNK17)
B14R19C06	14-6-19	Hs~MGC:BC025726.1~uORF:IOH10934	276	51	428	260	258	298	459	350	301	66	potassium channel, subfamily K, member 17 (KCNK17)
B14R19C07	14-7-19	Hs~Ref:NM_014245.1~uORF:IOH7569	780	350	1021	344	651	566	455	433	1061	175	ring finger protein 7 (RNF7), transcript variant 1
B14R19C08	14-8-19	Hs~Ref:NM_014245.1~uORF:IOH7569	832	370	1014	314	691	505	518	501	1197	208	ring finger protein 7 (RNF7), transcript variant 1
B14R19C09	14-9-19	Hs~Ref:NM_017855.2~uORF:IOH23051	313	275	458	433	646	398	642	417	3571	287	odontogenic, ameloblast asssociated (ODAM)
B14R19C10	14-10-19	Hs~Ref:NM_017855.2~uORF:IOH23051	362	276	445	427	524	406	597	438	3508	324	odontogenic, ameloblast asssociated (ODAM)
B14R19C11	14-11-19	Hs~MGC:BC000468.1~uORF:IOH3618	496	429	532	332	467	652	553	358	738	413	ubiquitin-conjugating enzyme E2 variant 1 (UBE2V1)
B14R19C12	14-12-19	Hs~MGC:BC000468.1~uORF:IOH3618	513	420	500	736	527	673	571	360	676	455	ubiquitin-conjugating enzyme E2 variant 1 (UBE2V1)
B14R19C13	14-13-19	Hs~Ref:NM_016618.1~uORF:IOH10031	876	528	886	560	486	808	2379	612	1063	229	lysine-rich coiled-coil 1 (KRCC1)
B14R19C14	14-14-19	Hs~Ref:NM_016618.1~uORF:IOH10031	949	691	869	488	453	617	2309	617	1111	240	lysine-rich coiled-coil 1 (KRCC1)
B14R19C15	14-15-19	Hs~MGC:BC032462.1~uORF:IOH21685	882	600	842	475	384	501	1543	638	1265	532	vacuolar protein sorting 29 homolog (S. cerevisiae) (VPS29)
B14R19C16	14-16-19	Hs~MGC:BC032462.1~uORF:IOH21685	905	571	808	516	387	570	1874	569	1143	282	vacuolar protein sorting 29 homolog (S. cerevisiae) (VPS29)
B14R19C17	14-17-19	Hs~Ref:NM_001010874.2~uORF:IOH44524	733	526	873	420	389	560	1856	884	849	359	steroid 5 alpha-reductase 2-like 2 (SRD5A2L2)
B14R19C18	14-18-19	Hs~Ref:NM_001010874.2~uORF:IOH44524	758	491	961	401	346	570	1726	813	781	293	steroid 5 alpha-reductase 2-like 2 (SRD5A2L2)
B14R19C19	14-19-19	Hs~Ref:NM_004013.1~uORF:IOH36376	809	4324	1711	1202	1000	1453	4714	991	1390	553	dystrophin (muscular dystrophy, Duchenne and Becker types) (DMD), transcript variant Dp140
B14R19C20	14-20-19	Hs~Ref:NM_004013.1~uORF:IOH36376	832	4296	1610	1187	1077	1482	5947	1055	1396	499	dystrophin (muscular dystrophy, Duchenne and Becker types) (DMD), transcript variant Dp140
B14R19C21	14-21-19	Hs~MGC:BC004878.1~uORF:IOH5623	468	357	660	278	288	540	744	433	703	168	TM2 domain-containing protein 2
B14R19C22	14-22-19	Hs~MGC:BC004878.1~uORF:IOH5623	441	353	653	272	314	517	712	403	770	137	TM2 domain-containing protein 2
B14R20C01	14-1-20	Hs~Ref:NM_019884.2~uORF:IOH11473	873	1211	1191	685	511	29248	1955	1272	2237	364	glycogen synthase kinase 3 alpha (GSK3A)
B14R20C02	14-2-20	Hs~Ref:NM_019884.2~uORF:IOH11473	867	1141	1140	723	529	29265	1822	1184	2383	396	glycogen synthase kinase 3 alpha (GSK3A)
B14R20C03	14-3-20	Hs~Ref:NM_015596.1~uORF:IOH40279	204	87	291	144	955	250	333	300	122	44	kallikrein-related peptidase 13 (KLK13)
B14R20C04	14-4-20	Hs~Ref:NM_015596.1~uORF:IOH40279	342	100	305	125	232	197	388	276	435	18	kallikrein-related peptidase 13 (KLK13)
B14R20C05	14-5-20	Hs~Ref:NM_052958.1~uORF:IOH42627	2386	706	1057	2015	1211	1436	2858	5154	1565	351	chromosome 8 open reading frame 34 (C8orf34)
B14R20C06	14-6-20	Hs~Ref:NM_052958.1~uORF:IOH42627	2496	751	1029	2174	1381	1353	2694	5814	1627	397	chromosome 8 open reading frame 34 (C8orf34)
B14R20C07	14-7-20	Hs~MGC:BC026100.2~uORF:IOH11308	227	266	346	629	277	157	404	11	200	117	testis-specific transcript, Y-linked 8
B14R20C08	14-8-20	Hs~MGC:BC026100.2~uORF:IOH11308	109	238	325	617	247	45	397	230	618	34	testis-specific transcript, Y-linked 8
B14R20C09	14-9-20	Hs~Ref:NM_001161.3~uORF:IOH5534	308	545	503	228	612	318	455	613	1222	220	nudix (nucleoside diphosphate linked moiety X)-type motif 2 (NUDT2), transcript variant 1
B14R20C10	14-10-20	Hs~Ref:NM_001161.3~uORF:IOH5534	411	584	502	216	537	328	380	442	1207	197	nudix (nucleoside diphosphate linked moiety X)-type motif 2 (NUDT2), transcript variant 1
B14R20C11	14-11-20	Hs~MGC:BC001868.1~uORF:IOH4965	195	284	425	194	280	251	389	148	1386	133	zinc finger protein 44 (ZNF44)
B14R20C12	14-12-20	Hs~MGC:BC001868.1~uORF:IOH4965	200	289	405	132	257	235	345	88	1558	48	zinc finger protein 44 (ZNF44)
B14R20C13	14-13-20	Hs~MGC:BC028113.1~uORF:IOH21569	117	664	212	56	408	-1	4	-3	485	21	glutaredoxin 2 (GLRX2)
B14R20C14	14-14-20	Hs~MGC:BC028113.1~uORF:IOH21569	89	667	216	33	402	573	0	-2	471	28	glutaredoxin 2 (GLRX2)
B15R02C11	15-11-2	Hs~Ref:NM_002391.1~uORF:IOH13794	1728	961	1692	815	836	1066	5135	830	1985	342	midkine (neurite growth-promoting factor 2) (MDK), transcript variant 3
B15R02C12	15-12-2	Hs~Ref:NM_002391.1~uORF:IOH13794	1755	957	1650	791	829	1113	5232	848	2002	359	midkine (neurite growth-promoting factor 2) (MDK), transcript variant 3
B15R02C13	15-13-2	Hs~MGC:BC022034.1~uORF:IOH10988	920	746	1009	557	585	594	1325	604	1135	253	lactate dehydrogenase A-like 6B (LDHAL6B)
B15R02C14	15-14-2	Hs~MGC:BC022034.1~uORF:IOH10988	943	711	966	586	581	495	1227	845	1216	237	lactate dehydrogenase A-like 6B (LDHAL6B)
B15R02C15	15-15-2	Hs~Ref:NM_138551.1~uORF:IOH13700	2075	1230	2060	982	2417	1099	6239	1134	2217	410	thymic stromal lymphopoietin (TSLP), transcript variant 2
B15R02C16	15-16-2	Hs~Ref:NM_138551.1~uORF:IOH13700	2034	1230	2045	912	2404	1074	6247	865	2061	397	thymic stromal lymphopoietin (TSLP), transcript variant 2
B15R02C17	15-17-2	Hs~MGC:BC017382.1~uORF:IOH14830	1055	681	1115	550	717	568	1251	536	1044	319	ubiquitin specific peptidase 53 (USP53)
B15R02C18	15-18-2	Hs~MGC:BC017382.1~uORF:IOH14830	950	670	1112	546	658	634	1338	535	1121	377	ubiquitin specific peptidase 53 (USP53)
B15R02C19	15-19-2	Hs~Ref:NM_018186.2~uORF:IOH43824	560	410	653	432	341	496	1143	405	818	169	chromosome 1 open reading frame 112 (C1orf112)
B15R02C20	15-20-2	Hs~Ref:NM_018186.2~uORF:IOH43824	559	448	665	385	296	462	1076	440	708	243	chromosome 1 open reading frame 112 (C1orf112)
B15R03C01	15-1-3	Hs~Ref:NM_201564.1~uORF:IOH42223	858	343	1050	168	605	1704	973	481	1224	1124	synaptonemal complex central element protein 1 (SYCE1), transcript variant 2
B15R03C02	15-2-3	Hs~Ref:NM_201564.1~uORF:IOH42223	913	357	971	123	631	1879	936	476	1222	1031	synaptonemal complex central element protein 1 (SYCE1), transcript variant 2
B15R03C03	15-3-3	Hs~Ref:NM_198205.1~uORF:IOH40943	371	836	512	271	323	8501	4636	477	1416	929	MAX-like protein X (MLX), transcript variant 1
B15R03C04	15-4-3	Hs~Ref:NM_198205.1~uORF:IOH40943	386	823	504	277	314	8667	4761	476	1411	866	MAX-like protein X (MLX), transcript variant 1
B15R03C05	15-5-3	Hs~MGC:BC046912.1~uORF:IOH26890	637	658	344	419	586	863	598	708	726	157	magnesium-dependent phosphatase 1 (MDP-1)
B15R03C06	15-6-3	Hs~MGC:BC046912.1~uORF:IOH26890	734	631	334	450	610	870	594	738	696	138	magnesium-dependent phosphatase 1 (MDP-1)
B15R03C07	15-7-3	Hs~MGC:BC016995.1~uORF:IOH25796	501	293	471	202	180	257	321	229	404	105	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 (GNAI2)
B15R03C08	15-8-3	Hs~MGC:BC016995.1~uORF:IOH25796	457	291	668	181	193	241	395	262	595	95	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 (GNAI2)
B15R03C09	15-9-3	Hs~MGC:BC039742.1~uORF:IOH26173	603	641	597	380	1601	406	1182	985	1226	225	poly(rC) binding protein 1 (PCBP1)
B15R03C10	15-10-3	Hs~MGC:BC039742.1~uORF:IOH26173	646	707	708	378	1552	482	1141	1033	1125	188	poly(rC) binding protein 1 (PCBP1)
B15R03C11	15-11-3	Hs~MGC:BC046199.1~uORF:IOH26969	476	487	736	218	573	650	831	558	889	129	family with sequence similarity 72, member B (FAM72B)
B15R03C12	15-12-3	Hs~MGC:BC046199.1~uORF:IOH26969	476	470	727	293	582	653	812	557	995	92	family with sequence similarity 72, member B (FAM72B)
B15R03C13	15-13-3	Hs~MGC:BC015754.1~uORF:IOH13637	1127	783	772	614	871	1543	1090	638	1668	317	Ca2+-dependent secretion activator (CADPS)
B15R03C14	15-14-3	Hs~MGC:BC015754.1~uORF:IOH13637	1164	757	743	608	874	1214	1099	795	1620	184	Ca2+-dependent secretion activator (CADPS)
B15R03C15	15-15-3	Hs~MGC:BC002758.1~uORF:IOH5367	2349	844	1239	1372	2060	1284	7791	1281	2943	610	adenosine deaminase, tRNA-specific 1 (ADAT1)
B15R03C16	15-16-3	Hs~MGC:BC002758.1~uORF:IOH5367	2231	905	1201	1370	2097	1220	7831	1025	2766	602	adenosine deaminase, tRNA-specific 1 (ADAT1)
B15R03C17	15-17-3	Hs~MGC:BC022361.1~uORF:IOH14170	4025	1815	4602	1507	2454	2190	18790	1412	3950	617	rRNA-processing protein FCF1 homolog
B15R03C18	15-18-3	Hs~MGC:BC022361.1~uORF:IOH14170	4006	1784	4731	1575	2425	1875	19063	1416	4227	1277	rRNA-processing protein FCF1 homolog
B15R03C19	15-19-3	Hs~Ref:NM_021992.1~uORF:IOH4359	519	400	595	1365	656	1225	593	1937	1641	1034	thymosin-like 8 (TMSL8)
B15R03C20	15-20-3	Hs~Ref:NM_021992.1~uORF:IOH4359	520	415	570	1414	672	1244	580	2095	1586	281	thymosin-like 8 (TMSL8)
B15R03C21	15-21-3	Hs~MGC:BC031551.1~uORF:IOH22627	596	420	795	421	500	528	920	434	905	250	T cell receptor alpha locus (TRA@)
B15R03C22	15-22-3	Hs~MGC:BC031551.1~uORF:IOH22627	583	433	738	399	496	546	977	371	904	261	T cell receptor alpha locus (TRA@)
B15R04C01	15-1-4	Hs~Ref:NM_000049.1~uORF:IOH22633	499	1216	1210	1236	455	4786	622	448	1380	248	aspartoacylase (Canavan disease) (ASPA)
B15R04C02	15-2-4	Hs~Ref:NM_000049.1~uORF:IOH22633	531	1276	1106	1568	455	5086	589	462	1357	214	aspartoacylase (Canavan disease) (ASPA)
B15R04C03	15-3-4	Hs~MGC:BC029176.1~uORF:IOH22643	590	273	411	551	333	329	529	250	586	56	secretoglobin, family 3A, member 1 (SCGB3A1)
B15R04C04	15-4-4	Hs~MGC:BC029176.1~uORF:IOH22643	549	297	473	332	376	330	529	267	657	107	secretoglobin, family 3A, member 1 (SCGB3A1)
B15R04C05	15-5-4	Hs~Ref:NM_018452.1~uORF:IOH22646	739	914	1123	355	1550	1351	2027	989	2058	454	chromosome 6 open reading frame 35 (C6orf35)
B15R04C06	15-6-4	Hs~Ref:NM_018452.1~uORF:IOH22646	803	880	1091	376	1645	1440	2094	1054	2269	450	chromosome 6 open reading frame 35 (C6orf35)
B15R04C07	15-7-4	Hs~MGC:BC007028.1~uORF:IOH7155	856	359	707	322	391	347	537	336	436	114	elastase 3A, pancreatic (ELA3A)
B15R04C08	15-8-4	Hs~MGC:BC007028.1~uORF:IOH7155	700	349	855	283	305	358	506	220	429	104	elastase 3A, pancreatic (ELA3A)
B15R04C09	15-9-4	Hs~Ref:NM_014268.1~uORF:IOH5850	1765	1178	43696	2288	1712	2057	3356	1290	2694	866	microtubule-associated protein, RP/EB family, member 2 (MAPRE2)
B15R04C10	15-10-4	Hs~Ref:NM_014268.1~uORF:IOH5850	1998	1164	42301	2492	1749	2212	3367	1414	2791	893	microtubule-associated protein, RP/EB family, member 2 (MAPRE2)
B15R04C11	15-11-4	Hs~Ref:NM_006512.1~uORF:IOH7161	1152	590	614	321	383	395	309	552	482	33	serum amyloid A4, constitutive (SAA4)
B15R04C12	15-12-4	Hs~Ref:NM_006512.1~uORF:IOH7161	1097	351	516	337	371	363	294	507	485	41	serum amyloid A4, constitutive (SAA4)
B15R04C13	15-13-4	Hs~MGC:BC003551.1~uORF:IOH4964	2323	700	1183	843	760	1397	1389	866	2006	457	transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) (TGM2)
B15R04C14	15-14-4	Hs~MGC:BC003551.1~uORF:IOH4964	2360	707	1211	831	806	1096	1319	796	2139	298	transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) (TGM2)
B15R04C15	15-15-4	Hs~MGC:BC063469.1~uORF:IOH39876	605	8659	565	559	339	605	1260	387	1161	346	RELT-like 2 (RELL2)
B15R04C16	15-16-4	Hs~MGC:BC063469.1~uORF:IOH39876	602	8347	582	421	345	675	1321	417	1078	349	RELT-like 2 (RELL2)
B15R04C17	15-17-4	Hs~MGC:BC050405.1~uORF:IOH26718	475	317	472	234	352	1255	519	348	872	221	DNA-directed RNA polymerase II subunit RPB11-b1
B15R04C18	15-18-4	Hs~MGC:BC050405.1~uORF:IOH26718	451	305	473	214	353	817	532	394	850	92	DNA-directed RNA polymerase II subunit RPB11-b1
B15R04C21	15-21-4	Hs~Ref:NM_032439.1~uORF:IOH40856	631	412	660	437	509	1047	2377	671	3224	342	phytanoyl-CoA 2-hydroxylase interacting protein-like (PHYHIPL)
B15R04C22	15-22-4	Hs~Ref:NM_032439.1~uORF:IOH40856	639	414	675	418	469	983	2570	706	3350	316	phytanoyl-CoA 2-hydroxylase interacting protein-like (PHYHIPL)
B15R05C01	15-1-5	Hs~MGC:BC017098.1~uORF:IOH13421	779	546	898	894	834	667	1995	682	970	764	poly(rC) binding protein 4 (PCBP4)
B15R05C02	15-2-5	Hs~MGC:BC017098.1~uORF:IOH13421	675	572	922	1156	900	632	2098	658	937	787	poly(rC) binding protein 4 (PCBP4)
B15R05C03	15-3-5	Hs~MGC:BC009423.1~uORF:IOH12920	701	623	944	895	628	650	871	666	984	251	suppressor of G2 allele of SKP1 pseudogene (S. cerevisiae) (SUGT1P)
B15R05C04	15-4-5	Hs~MGC:BC009423.1~uORF:IOH12920	703	651	1035	588	690	643	833	625	1042	407	suppressor of G2 allele of SKP1 pseudogene (S. cerevisiae) (SUGT1P)
B15R05C05	15-5-5	Hs~MGC:NM_148904.2~uORF:IOH12103	669	3104	837	510	932	28786	1642	1866	1353	317	oxysterol binding protein-like 9 (OSBPL9), transcript variant 1
B15R05C06	15-6-5	Hs~MGC:NM_148904.2~uORF:IOH12103	645	3117	830	520	934	29605	1692	1937	1321	317	oxysterol binding protein-like 9 (OSBPL9), transcript variant 1
B15R05C07	15-7-5	Hs~MGC:BC009485.1~uORF:IOH12968	3613	580	838	968	3720	795	32324	884	1366	658	chromosome 4 open reading frame 16 (C4orf16)
B15R05C08	15-8-5	Hs~MGC:BC009485.1~uORF:IOH12968	3582	604	808	1040	3989	773	32988	903	1455	641	chromosome 4 open reading frame 16 (C4orf16)
B15R05C09	15-9-5	Hs~MGC:BC046151.1~uORF:IOH26994	531	472	673	1062	2699	410	5920	387	950	2052	target of myb1 (chicken) (TOM1)
B15R05C10	15-10-5	Hs~MGC:BC046151.1~uORF:IOH26994	550	519	620	1150	2817	425	5896	381	1362	1977	target of myb1 (chicken) (TOM1)
B15R05C11	15-11-5	Hs~MGC:NM_182918.2~uORF:IOH26275	1531	400	372	293	74	408	678	171	636	249	v-ets erythroblastosis virus E26 oncogene homolog (avian) (ERG), transcript variant 1
B15R05C12	15-12-5	Hs~MGC:NM_182918.2~uORF:IOH26275	1540	263	346	230	172	393	651	203	448	146	v-ets erythroblastosis virus E26 oncogene homolog (avian) (ERG), transcript variant 1
B15R05C13	15-13-5	Hs~MGC:NM_052913.2~uORF:IOH26380	546	270	399	232	106	174	551	252	508	186	KIAA1913 (KIAA1913)
B15R05C14	15-14-5	Hs~MGC:NM_052913.2~uORF:IOH26380	631	303	397	325	219	125	549	217	465	130	KIAA1913 (KIAA1913)
B15R05C15	15-15-5	Hs~Ref:NM_001203.1~uORF:IOH26729	390	345	417	555	268	526	412	199	626	169	bone morphogenetic protein receptor, type IB (BMPR1B)
B15R05C16	15-16-5	Hs~Ref:NM_001203.1~uORF:IOH26729	367	349	496	729	252	494	327	196	632	149	bone morphogenetic protein receptor, type IB (BMPR1B)
B15R05C17	15-17-5	Hs~Ref:NM_138421.1~uORF:IOH10769	563	359	829	297	395	566	509	487	1069	254	serum amyloid A-like 1 (SAAL1)
B15R05C18	15-18-5	Hs~Ref:NM_138421.1~uORF:IOH10769	571	398	861	296	397	649	540	512	1085	121	serum amyloid A-like 1 (SAAL1)
B15R05C19	15-19-5	Hs~MGC:BC012033.1~uORF:IOH10766	1086	475	618	344	500	516	672	455	846	55	PRELI domain-containing protein 2
B15R05C20	15-20-5	Hs~MGC:BC012033.1~uORF:IOH10766	950	476	705	429	476	503	751	449	869	168	PRELI domain-containing protein 2
B15R05C21	15-21-5	Hs~Ref:NM_024009.1~uORF:IOH11015	677	701	710	454	587	556	883	650	906	134	gap junction protein, beta 3, 31kDa (GJB3), transcript variant 1
B15R05C22	15-22-5	Hs~Ref:NM_024009.1~uORF:IOH11015	642	677	720	411	634	567	1053	468	927	133	gap junction protein, beta 3, 31kDa (GJB3), transcript variant 1
B15R06C01	15-1-6	Hs~Ref:NM_138798.1~uORF:IOH10640	1222	833	809	829	461	803	1144	1093	1655	277	MIT, microtubule interacting and transport, domain containing 1 (MITD1)
B15R06C02	15-2-6	Hs~Ref:NM_138798.1~uORF:IOH10640	940	842	808	941	508	961	1094	631	1580	307	MIT, microtubule interacting and transport, domain containing 1 (MITD1)
B15R06C03	15-3-6	Hs~Ref:NM_144613.3~uORF:IOH39922	353	299	507	504	323	266	673	348	540	97	cytochrome c oxidase subunit VIb polypeptide 2 (testis) (COX6B2)
B15R06C04	15-4-6	Hs~Ref:NM_144613.3~uORF:IOH39922	334	319	507	316	334	279	676	257	530	144	cytochrome c oxidase subunit VIb polypeptide 2 (testis) (COX6B2)
B15R06C05	15-5-6	Hs~MGC:BC067257.1~uORF:IOH39993	1012	536	805	843	381	546	1076	552	852	318	alkB, alkylation repair homolog 3 (E. coli) (ALKBH3)
B15R06C06	15-6-6	Hs~MGC:BC067257.1~uORF:IOH39993	1026	622	746	906	391	552	977	525	974	217	alkB, alkylation repair homolog 3 (E. coli) (ALKBH3)
B15R06C07	15-7-6	Hs~Ref:NM_183243.1~uORF:IOH40877	740	2553	1379	698	713	1010	1083	573	1248	207	IMP (inosine monophosphate) dehydrogenase 1 (IMPDH1), transcript variant 2
B15R06C08	15-8-6	Hs~Ref:NM_183243.1~uORF:IOH40877	2090	2573	1402	751	782	1049	1109	636	1517	239	IMP (inosine monophosphate) dehydrogenase 1 (IMPDH1), transcript variant 2
B15R06C09	15-9-6	Hs~Ref:NM_015907.2~uORF:IOH39976	14555	1148	1227	1581	1497	1539	2559	2048	3615	660	leucine aminopeptidase 3 (LAP3)
B15R06C10	15-10-6	Hs~Ref:NM_015907.2~uORF:IOH39976	9915	1131	1227	1643	1451	1611	2554	2198	3668	609	leucine aminopeptidase 3 (LAP3)
B15R06C11	15-11-6	Hs~Ref:NM_032548.2~uORF:IOH45815	1475	555	1195	539	610	1116	2805	547	1828	245	ankyrin repeat and BTB (POZ) domain containing 1 (ABTB1), transcript variant 1
B15R06C12	15-12-6	Hs~Ref:NM_032548.2~uORF:IOH45815	1497	544	1221	521	647	1098	2705	579	1698	143	ankyrin repeat and BTB (POZ) domain containing 1 (ABTB1), transcript variant 1
B15R06C13	15-13-6	Hs~Ref:NM_178002.1~uORF:IOH45891	485	380	611	315	346	426	735	339	739	52	protein phosphatase 2A, regulatory subunit B' (PR 53) (PPP2R4), transcript variant 4
B15R06C14	15-14-6	Hs~Ref:NM_178002.1~uORF:IOH45891	494	382	595	396	565	409	717	341	868	100	protein phosphatase 2A, regulatory subunit B' (PR 53) (PPP2R4), transcript variant 4
B15R06C15	15-15-6	Hs~Ref:NM_183383.1~uORF:IOH45765	388	361	588	420	330	746	552	533	884	127	ring finger protein 13 (RNF13), transcript variant 3
B15R06C16	15-16-6	Hs~Ref:NM_183383.1~uORF:IOH45765	366	386	590	455	368	773	546	562	851	-4	ring finger protein 13 (RNF13), transcript variant 3
B15R06C17	15-17-6	Hs~Ref:NM_013301.1~uORF:IOH45819	1263	958	1423	896	463	1018	2263	920	1235	229	Coiled-coil domain-containing protein 106
B15R06C18	15-18-6	Hs~Ref:NM_013301.1~uORF:IOH45819	1270	944	1462	941	722	1042	2150	934	1187	241	Coiled-coil domain-containing protein 106
B15R06C19	15-19-6	Hs~Ref:NM_020232.3~uORF:IOH57190	356	355	250	39	1333	1002	482	226	422	145	Proteasome assembly chaperone 2
B15R06C20	15-20-6	Hs~Ref:NM_020232.3~uORF:IOH57190	271	337	376	87	192	175	489	275	409	302	Proteasome assembly chaperone 2
B15R07C01	15-1-7	Hs~MGC:BC013039.1~uORF:IOH13569	4258	919	970	3815	2274	964	2164	1029	3307	417	Growth arrest and DNA-damage-inducible proteins-interacting protein 1
B15R07C02	15-2-7	Hs~MGC:BC013039.1~uORF:IOH13569	4012	899	916	3820	2414	1087	2430	926	3417	408	Growth arrest and DNA-damage-inducible proteins-interacting protein 1
B15R07C03	15-3-7	Hs~MGC:BC011636.2~uORF:IOH14389	500	434	591	422	379	449	939	521	608	901	Protein phosphatase Slingshot homolog 2
B15R07C04	15-4-7	Hs~MGC:BC011636.2~uORF:IOH14389	448	454	597	373	360	506	962	509	640	816	Protein phosphatase Slingshot homolog 2
B15R07C05	15-5-7	Hs~Ref:NM_007240.1~uORF:IOH6325	287	318	405	292	304	542	524	304	577	144	dual specificity phosphatase 12 (DUSP12)
B15R07C06	15-6-7	Hs~Ref:NM_007240.1~uORF:IOH6325	276	332	399	304	315	560	538	289	601	122	dual specificity phosphatase 12 (DUSP12)
B15R07C07	15-7-7	Hs~MGC:BC009196.1~uORF:IOH12943	310	292	509	321	308	334	522	464	-6	137	phosphatidic acid phosphatase type 2B (PPAP2B)
B15R07C08	15-8-7	Hs~MGC:BC009196.1~uORF:IOH12943	670	291	507	308	302	317	526	507	642	157	phosphatidic acid phosphatase type 2B (PPAP2B)
B15R07C09	15-9-7	Hs~MGC:NM_177554.1~uORF:IOH13715	2041	308	458	319	182	431	712	432	561	171	acid phosphatase 1, soluble (ACP1), transcript variant 1
B15R07C10	15-10-7	Hs~MGC:NM_177554.1~uORF:IOH13715	368	240	426	281	289	324	645	390	473	107	acid phosphatase 1, soluble (ACP1), transcript variant 1
B15R07C11	15-11-7	Hs~Ref:NM_002710.1~uORF:IOH14587	399	308	567	354	352	840	720	400	418	184	protein phosphatase 1, catalytic subunit, gamma isoform (PPP1CC)
B15R07C12	15-12-7	Hs~Ref:NM_002710.1~uORF:IOH14587	391	640	582	367	336	805	747	391	1581	146	protein phosphatase 1, catalytic subunit, gamma isoform (PPP1CC)
B15R07C13	15-13-7	Hs~Ref:NM_014296.2~uORF:IOH39472	1403	495	799	1764	585	837	815	974	6859	556	calpain 7 (CAPN7)
B15R07C14	15-14-7	Hs~Ref:NM_014296.2~uORF:IOH39472	1512	473	697	1563	531	936	825	927	6269	601	calpain 7 (CAPN7)
B15R07C15	15-15-7	Hs~Ref:NM_021203.2~uORF:IOH39667	470	451	645	366	323	413	588	391	733	216	signal recognition particle receptor, B subunit (SRPRB)
B15R07C16	15-16-7	Hs~Ref:NM_021203.2~uORF:IOH39667	486	433	646	309	326	506	552	414	652	209	signal recognition particle receptor, B subunit (SRPRB)
B15R07C17	15-17-7	Hs~MGC:BC034984.1~uORF:IOH26875	450	367	576	343	316	416	650	431	643	218	Kinesin-like protein KIF16B
B15R07C18	15-18-7	Hs~MGC:BC034984.1~uORF:IOH26875	460	447	580	368	313	486	628	397	662	62	Kinesin-like protein KIF16B
B15R07C19	15-19-7	Hs~Ref:NM_004853.1~uORF:IOH9940	1916	2500	2469	2429	2771	9317	7017	7898	6457	988	syntaxin 8 (STX8)
B15R07C20	15-20-7	Hs~Ref:NM_004853.1~uORF:IOH9940	1872	2520	2506	2393	2524	9493	7189	7861	6370	980	syntaxin 8 (STX8)
B15R07C21	15-21-7	Hs~Ref:NM_003915.2~uORF:IOH4538	3060	5439	4707	2208	3321	8237	8056	2905	3173	1768	copine I (CPNE1), transcript variant 3
B15R07C22	15-22-7	Hs~Ref:NM_003915.2~uORF:IOH4538	2974	5497	4615	2313	2112	8435	8125	2888	3192	1533	copine I (CPNE1), transcript variant 3
B15R08C01	15-1-8	Hs~Ref:NM_000151.1~uORF:IOH39425	463	384	556	277	244	390	530	509	483	187	glucose-6-phosphatase, catalytic subunit (G6PC)
B15R08C02	15-2-8	Hs~Ref:NM_000151.1~uORF:IOH39425	373	375	599	318	251	378	555	422	481	168	glucose-6-phosphatase, catalytic subunit (G6PC)
B15R08C03	15-3-8	Hs~Ref:NM_173194.2~uORF:IOH39571	898	911	891	483	245	662	277	381	903	12	Kv channel interacting protein 2 (KCNIP2), transcript variant 5
B15R08C04	15-4-8	Hs~Ref:NM_173194.2~uORF:IOH39571	916	909	843	487	271	714	282	411	937	78	Kv channel interacting protein 2 (KCNIP2), transcript variant 5
B15R08C05	15-5-8	Hs~Ref:NM_005279.2~uORF:IOH39674	477	376	510	277	287	435	722	379	594	154	Probable G-protein coupled receptor 1
B15R08C06	15-6-8	Hs~Ref:NM_005279.2~uORF:IOH39674	490	347	508	246	296	415	695	366	671	124	Probable G-protein coupled receptor 1
B15R08C07	15-7-8	Hs~MGC:NM_152777.2~uORF:IOH22473	719	627	1588	595	1014	1452	2895	2336	1814	302	chromosome 14 open reading frame 48 (C14orf48)
B15R08C08	15-8-8	Hs~MGC:NM_152777.2~uORF:IOH22473	904	639	1575	611	1064	1553	2834	2346	1772	291	chromosome 14 open reading frame 48 (C14orf48)
B15R08C09	15-9-8	Hs~MGC:BC014170.1~uORF:IOH22995	2175	828	1042	1258	988	1015	1207	2208	2513	518	Phosphatidylinositol 3-kinase regulatory subunit beta
B15R08C10	15-10-8	Hs~MGC:BC014170.1~uORF:IOH22995	1927	835	1055	1294	1025	1070	1312	2077	2952	488	Phosphatidylinositol 3-kinase regulatory subunit beta
B15R08C11	15-11-8	Hs~MGC:BC030814.1~uORF:IOH23035	38925	37835	36191	36135	31527	33561	31923	30453	46155	34249	immunoglobulin kappa variable 1-5 (IGKV1-5)
B15R08C12	15-12-8	Hs~MGC:BC030814.1~uORF:IOH23035	37681	36412	36641	35349	31725	35123	29769	30637	40235	34521	immunoglobulin kappa variable 1-5 (IGKV1-5)
B15R08C13	15-13-8	Hs~MGC:BC014117.1~uORF:IOH22991	786	623	760	378	532	639	1026	598	1049	350	thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) (TBXAS1)
B15R08C14	15-14-8	Hs~MGC:BC014117.1~uORF:IOH22991	806	595	898	774	559	680	974	566	1664	259	thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) (TBXAS1)
B15R08C15	15-15-8	Hs~Ref:NM_181527.1~uORF:IOH43652	3030	1238	2474	1234	1093	1399	2189	1190	3348	647	N-acetyltransferase 5
B15R08C16	15-16-8	Hs~Ref:NM_181527.1~uORF:IOH43652	3036	1246	2454	1387	1131	1355	2246	1177	3139	639	N-acetyltransferase 5
B15R08C17	15-17-8	Hs~Ref:NM_080923.1~uORF:IOH44598	1164	937	1579	745	786	825	1170	852	1916	485	Leukocyte common antigen
B15R08C18	15-18-8	Hs~Ref:NM_080923.1~uORF:IOH44598	1089	931	1569	777	845	749	1214	937	1782	474	Leukocyte common antigen
B15R08C19	15-19-8	Hs~Ref:NM_017850.1~uORF:IOH45670	48	-2	1	4	1458	1420	3368	1876	2458	412	Uncharacterized protein C1orf109
B15R08C20	15-20-8	Hs~Ref:NM_017850.1~uORF:IOH45670	2	0	0	0	1636	1530	3343	1913	2480	449	Uncharacterized protein C1orf109
B15R08C21	15-21-8	Hs~Ref:NM_012110.1~uORF:IOH22161	2173	2397	2041	914	1586	1162	3111	1202	2122	638	cysteine-rich hydrophobic domain 2 (CHIC2)
B15R08C22	15-22-8	Hs~Ref:NM_012110.1~uORF:IOH22161	2248	2335	2075	915	1973	1177	3046	1135	2118	641	cysteine-rich hydrophobic domain 2 (CHIC2)
B15R09C01	15-1-9	Hs~MGC:BC035058.1~uORF:IOH27691	670	600	732	879	547	1804	759	811	899	243	protein kinase, cAMP-dependent, catalytic, beta (PRKACB)
B15R09C02	15-2-9	Hs~MGC:BC035058.1~uORF:IOH27691	712	685	684	984	622	2078	801	970	1060	124	protein kinase, cAMP-dependent, catalytic, beta (PRKACB)
B15R09C03	15-3-9	Hs~Ref:NM_203326.1~uORF:IOH3915	986	3115	729	994	595	748	1462	1407	840	435	5-azacytidine induced 2 (AZI2), transcript variant 2
B15R09C04	15-4-9	Hs~Ref:NM_203326.1~uORF:IOH3915	996	3046	732	973	629	742	1494	1376	942	503	5-azacytidine induced 2 (AZI2), transcript variant 2
B15R09C05	15-5-9	Hs~MGC:BC035601.1~uORF:IOH27560	1126	1692	1357	516	435	669	2644	663	879	302	WWC family member 3 (WWC3)
B15R09C06	15-6-9	Hs~MGC:BC035601.1~uORF:IOH27560	1103	1713	1325	510	483	727	2401	675	868	243	WWC family member 3 (WWC3)
B15R09C09	15-9-9	Hs~MGC:BC052591.1~uORF:IOH29389	437	494	572	367	364	314	702	384	6	0	EGF-like-domain, multiple 8 (EGFL8)
B15R09C10	15-10-9	Hs~MGC:BC052591.1~uORF:IOH29389	448	482	557	356	307	335	671	377	2	7	EGF-like-domain, multiple 8 (EGFL8)
B15R09C11	15-11-9	Hs~MGC:BC046634.2~uORF:IOH25856	484	457	671	462	418	372	632	446	15	149	tubulin, gamma complex associated protein 3 (TUBGCP3)
B15R09C12	15-12-9	Hs~MGC:BC046634.2~uORF:IOH25856	549	513	750	498	227	462	894	506	-1	8	tubulin, gamma complex associated protein 3 (TUBGCP3)
B15R09C13	15-13-9	Hs~MGC:BC039895.1~uORF:IOH26171	2337	1397	4131	5501	3006	5203	5390	3707	4235	1005	breast cancer anti-estrogen resistance 3 (BCAR3)
B15R09C14	15-14-9	Hs~MGC:BC039895.1~uORF:IOH26171	2367	1474	4011	5582	2709	5025	5286	3674	3856	1079	breast cancer anti-estrogen resistance 3 (BCAR3)
B15R09C15	15-15-9	Hs~MGC:BC042151.1~uORF:IOH27998	677	682	736	445	398	453	815	423	1186	189	glycerate kinase (GLYCTK)
B15R09C16	15-16-9	Hs~MGC:BC042151.1~uORF:IOH27998	639	710	628	581	306	517	859	392	1543	197	glycerate kinase (GLYCTK)
B15R09C17	15-17-9	Hs~MGC:BC022820.1~uORF:IOH46094	673	330	532	313	284	450	482	337	835	29	Glutathione peroxidase 2
B15R09C18	15-18-9	Hs~MGC:BC022820.1~uORF:IOH46094	693	320	583	384	343	278	504	350	762	4105	Glutathione peroxidase 2
B15R09C19	15-19-9	Hs~Ref:NM_001025202.1~uORF:IOH46069	218	308	321	283	362	1865	427	355	432	15	STAG3-like (LOC442582)
B15R09C20	15-20-9	Hs~Ref:NM_001025202.1~uORF:IOH46069	296	338	322	343	265	280	494	438	421	12	STAG3-like (LOC442582)
B15R09C21	15-21-9	Hs~MGC:BC023567.2~uORF:IOH46137	387	526	1365	850	1568	714	1711	713	1347	252	cytokine receptor-like factor 3 (CRLF3)
B15R09C22	15-22-9	Hs~MGC:BC023567.2~uORF:IOH46137	375	556	1311	747	1632	652	1698	592	1268	294	cytokine receptor-like factor 3 (CRLF3)
B15R10C01	15-1-10	Hs~Ref:NM_024668.2~uORF:IOH46162	940	696	1380	1390	941	1661	1195	1180	6	15	ankyrin repeat and KH domain containing 1 (ANKHD1), transcript variant 3
B15R10C02	15-2-10	Hs~Ref:NM_024668.2~uORF:IOH46162	875	714	1432	1405	976	1705	1256	1375	1186	330	ankyrin repeat and KH domain containing 1 (ANKHD1), transcript variant 3
B15R10C03	15-3-10	Hs~Ref:NM_183241.1~uORF:IOH40652	561	685	578	472	1861	844	3093	768	1445	158	chromosome 9 open reading frame 142 (C9orf142)
B15R10C04	15-4-10	Hs~Ref:NM_183241.1~uORF:IOH40652	574	710	588	443	1974	881	3235	666	1508	97	chromosome 9 open reading frame 142 (C9orf142)
B15R10C05	15-5-10	Hs~MGC:BC062297.1~uORF:IOH40691	823	2018	756	533	490	727	1647	613	1079	231	fibronectin type III domain containing 5 (FNDC5)
B15R10C06	15-6-10	Hs~MGC:BC062297.1~uORF:IOH40691	743	1989	766	541	489	695	1531	670	1202	181	fibronectin type III domain containing 5 (FNDC5)
B15R10C07	15-7-10	Hs~MGC:BC063126.1~uORF:IOH40737	346	305	449	226	412	516	890	278	606	104	family with sequence similarity 13, member A1 (FAM13A1)
B15R10C08	15-8-10	Hs~MGC:BC063126.1~uORF:IOH40737	442	320	460	256	434	534	934	291	632	157	family with sequence similarity 13, member A1 (FAM13A1)
B15R10C09	15-9-10	Hs~Ref:NM_212492.1~uORF:IOH40694	978	1906	934	475	723	805	1268	561	1215	335	G protein pathway suppressor 1 (GPS1), transcript variant 1
B15R10C10	15-10-10	Hs~Ref:NM_212492.1~uORF:IOH40694	900	1915	895	462	699	775	1263	566	39	375	G protein pathway suppressor 1 (GPS1), transcript variant 1
B15R11C21	15-21-11	Hs~Ref:NM_032319.1~uORF:IOH6578	467	519	1266	740	288	897	474	276	2771	1421	chromosome 2 open reading frame 7 (C2orf7)
B15R11C22	15-22-11	Hs~Ref:NM_032319.1~uORF:IOH6578	385	513	1388	684	245	680	479	271	2581	1043	chromosome 2 open reading frame 7 (C2orf7)
B15R12C01	15-1-12	Hs~MGC:BC033230.1~uORF:IOH23262	3158	8638	5663	21303	9561	7793	4938	11000	5839	6462	zinc finger protein 808 (ZNF808)
B15R12C02	15-2-12	Hs~MGC:BC033230.1~uORF:IOH23262	3671	9378	4969	22968	9999	8379	5438	11887	6374	7102	zinc finger protein 808 (ZNF808)
B15R12C03	15-3-12	Hs~MGC:BC042090.1~uORF:IOH28785	1491	1013	1542	1565	848	1488	1919	893	1475	504	muscleblind-like 3 (Drosophila) (MBNL3)
B15R12C04	15-4-12	Hs~MGC:BC042090.1~uORF:IOH28785	1500	996	1489	765	829	1569	1774	887	1651	476	muscleblind-like 3 (Drosophila) (MBNL3)
B15R12C05	15-5-12	Hs~MGC:BC007925.1~uORF:IOH6787	426	348	485	325	328	430	627	314	403	232	retinoid X receptor, alpha (RXRA)
B15R12C06	15-6-12	Hs~MGC:BC007925.1~uORF:IOH6787	419	390	549	315	454	422	716	331	544	258	retinoid X receptor, alpha (RXRA)
B15R12C07	15-7-12	Hs~Ref:NM_016508.2~uORF:IOH21339	6455	5653	3524	6257	5219	3702	15820	3090	6079	3848	Cyclin-dependent kinase-like 3
B15R12C08	15-8-12	Hs~Ref:NM_016508.2~uORF:IOH21339	6201	5810	3535	6643	5584	3875	16037	3323	6209	3793	Cyclin-dependent kinase-like 3
B15R12C09	15-9-12	Hs~MGC:BC034718.1~uORF:IOH21418	3216	1963	1987	2030	1300	1877	12746	1222	4339	842	erythrocyte membrane protein band 4.1-like 2 (EPB41L2)
B15R12C10	15-10-12	Hs~MGC:BC034718.1~uORF:IOH21418	3065	1987	1932	2100	1328	1917	12894	1252	4250	853	erythrocyte membrane protein band 4.1-like 2 (EPB41L2)
B15R12C11	15-11-12	Hs~MGC:BC019954.1~uORF:IOH21472	2150	1435	1513	1496	5146	1741	2077	1396	2023	545	RNA guanylyltransferase and 5'-phosphatase (RNGTT)
B15R12C12	15-12-12	Hs~MGC:BC019954.1~uORF:IOH21472	2100	1394	1583	1533	5378	1788	2100	1395	2114	532	RNA guanylyltransferase and 5'-phosphatase (RNGTT)
B15R12C13	15-13-12	Hs~MGC:BC034483.1~uORF:IOH22297	955	599	1666	1197	656	1869	1320	654	2750	310	heat shock 70kDa protein 1-like (HSPA1L)
B15R12C14	15-14-12	Hs~MGC:BC034483.1~uORF:IOH22297	892	590	1601	1340	671	1796	1345	662	2856	185	heat shock 70kDa protein 1-like (HSPA1L)
B15R12C15	15-15-12	Hs~MGC:BC013778.1~uORF:IOH10676	1333	1224	1924	4115	650	2227	2133	1530	1653	540	solute carrier family 7, member 6 opposite strand (SLC7A6OS)
B15R12C16	15-16-12	Hs~MGC:BC013778.1~uORF:IOH10676	1378	1201	1861	4076	621	2229	2228	1548	1409	510	solute carrier family 7, member 6 opposite strand (SLC7A6OS)
B15R12C17	15-17-12	Hs~Ref:NM_016655.3~uORF:IOH44326	598	292	523	559	545	822	934	275	4351	253	GA binding protein transcription factor, beta subunit 2 (GABPB2), transcript variant gamma-2
B15R12C18	15-18-12	Hs~Ref:NM_016655.3~uORF:IOH44326	615	296	522	557	532	718	912	262	4326	225	GA binding protein transcription factor, beta subunit 2 (GABPB2), transcript variant gamma-2
B15R12C19	15-19-12	Hs~Ref:NM_177951.1~uORF:IOH44340	815	658	863	7832	475	839	2786	430	1260	199	protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform (PPM1A), transcript variant 2
B15R12C20	15-20-12	Hs~Ref:NM_177951.1~uORF:IOH44340	809	648	873	7621	632	922	2949	430	1804	218	protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform (PPM1A), transcript variant 2
B15R12C21	15-21-12	Hs~Ref:NM_001359.1~uORF:IOH44360	909	684	934	592	726	702	3064	588	1599	389	2,4-dienoyl CoA reductase 1, mitochondrial (DECR1), nuclear gene encoding mitochondrial protein
B15R12C22	15-22-12	Hs~Ref:NM_001359.1~uORF:IOH44360	837	653	932	554	671	735	2911	583	1415	383	2,4-dienoyl CoA reductase 1, mitochondrial (DECR1), nuclear gene encoding mitochondrial protein
B15R13C01	15-1-13	Hs~Ref:NM_002093.2~uORF:IOH4507	571	499	576	223	226	437	1035	745	561	98	glycogen synthase kinase 3 beta (GSK3B)
B15R13C02	15-2-13	Hs~Ref:NM_002093.2~uORF:IOH4507	601	537	571	188	259	392	1123	765	590	39	glycogen synthase kinase 3 beta (GSK3B)
B15R13C03	15-3-13	Hs~Ref:NM_006620.2~uORF:IOH4029	4110	2029	5703	1856	2606	1967	11338	2322	5115	1261	HBS1-like (S. cerevisiae) (HBS1L)
B15R13C04	15-4-13	Hs~Ref:NM_006620.2~uORF:IOH4029	4262	2003	5247	1874	2656	1987	12000	2298	5196	1237	HBS1-like (S. cerevisiae) (HBS1L)
B15R13C05	15-5-13	Hs~Ref:NM_134323.1~uORF:IOH6090	3231	1774	4600	2057	3345	1854	12621	1940	4612	802	TAR (HIV-1) RNA binding protein 2 (TARBP2), transcript variant 1
B15R13C06	15-6-13	Hs~Ref:NM_134323.1~uORF:IOH6090	3377	1725	4315	2069	3351	1877	11459	1945	4657	815	TAR (HIV-1) RNA binding protein 2 (TARBP2), transcript variant 1
B15R13C07	15-7-13	Hs~MGC:BC007637.1~uORF:IOH6973	1309	1029	1714	1163	848	1529	3328	2010	2321	599	chromosome 1 open reading frame 94 (C1orf94)
B15R13C08	15-8-13	Hs~MGC:BC007637.1~uORF:IOH6973	1269	1031	1740	1240	892	1412	2987	2174	2302	487	chromosome 1 open reading frame 94 (C1orf94)
B15R13C15	15-15-13	Hs~Ref:NM_014431.1~uORF:IOH60022	605	546	740	488	518	618	797	628	2094	344	Paladin
B15R13C16	15-16-13	Hs~Ref:NM_014431.1~uORF:IOH60022	609	537	720	539	559	675	844	578	1691	320	Paladin
B15R13C17	15-17-13	Hs~Ref:NM_138468.3~uORF:IOH40023	1390	1053	1354	828	832	1590	1891	1152	2636	605	islet cell autoantigen 1,69kDa-like (ICA1L), transcript variant 1
B15R13C18	15-18-13	Hs~Ref:NM_138468.3~uORF:IOH40023	1537	1127	1377	894	933	1330	1860	1039	3025	728	islet cell autoantigen 1,69kDa-like (ICA1L), transcript variant 1
B15R13C19	15-19-13	Hs~MGC:BC009348.2~uORF:IOH12064	6261	2115	6216	2331	3510	1964	3757	4314	4934	1050	cirrhosis, autosomal recessive 1A (cirhin) (CIRH1A)
B15R13C20	15-20-13	Hs~MGC:BC009348.2~uORF:IOH12064	6114	1930	6320	2256	3927	1852	3706	4080	5100	979	cirrhosis, autosomal recessive 1A (cirhin) (CIRH1A)
B15R13C21	15-21-13	Hs~MGC:BC000974.2~uORF:IOH3026	1304	998	1580	1203	1992	1264	2233	955	2664	576	WDR45-like (WDR45L)
B15R13C22	15-22-13	Hs~MGC:BC000974.2~uORF:IOH3026	1165	937	1524	1186	1915	1211	2178	965	2447	580	WDR45-like (WDR45L)
B15R14C01	15-1-14	Hs~Ref:NM_004461.1~uORF:IOH5778	941	893	1604	588	616	764	1555	809	1695	468	phenylalanyl-tRNA synthetase, alpha subunit (FARSA)
B15R14C02	15-2-14	Hs~Ref:NM_004461.1~uORF:IOH5778	927	932	1550	732	589	768	1523	784	1694	414	phenylalanyl-tRNA synthetase, alpha subunit (FARSA)
B15R14C03	15-3-14	Hs~MGC:BC035494.2~uORF:IOH29313	1410	1070	1062	927	677	938	3541	843	1106	511	origin recognition complex, subunit 3-like (yeast) (ORC3L)
B15R14C04	15-4-14	Hs~MGC:BC035494.2~uORF:IOH29313	1451	1099	953	821	637	857	3603	750	1170	442	origin recognition complex, subunit 3-like (yeast) (ORC3L)
B15R14C05	15-5-14	Hs~MGC:BC056415.1~uORF:IOH29068	2657	2064	1824	1243	1485	1317	2650	1112	2184	795	RNA polymerase II-associated protein 3
B15R14C06	15-6-14	Hs~MGC:BC056415.1~uORF:IOH29068	2649	2046	1727	1223	1503	1411	2631	1169	2186	775	RNA polymerase II-associated protein 3
B15R14C07	15-7-14	Hs~MGC:BC054030.1~uORF:IOH29089	835	500	682	413	697	662	1929	602	674	183	WD repeat domain 53 (WDR53)
B15R14C08	15-8-14	Hs~MGC:BC054030.1~uORF:IOH29089	781	533	676	445	723	891	2565	565	689	173	WD repeat domain 53 (WDR53)
B15R14C09	15-9-14	Hs~MGC:BC023546.2~uORF:IOH29323	1550	937	1332	1756	9735	4434	13544	1176	3140	549	LIM and calponin homology domains 1 (LIMCH1)
B15R14C10	15-10-14	Hs~MGC:BC023546.2~uORF:IOH29323	1439	882	1294	1943	10088	4372	13910	1490	3173	548	LIM and calponin homology domains 1 (LIMCH1)
B15R14C11	15-11-14	Hs~MGC:BC001419.1~uORF:IOH4071	6432	5239	3626	8535	5187	5101	5480	8270	5831	6495	mitochondrial trans-2-enoyl-CoA reductase (MECR)
B15R14C12	15-12-14	Hs~MGC:BC001419.1~uORF:IOH4071	5782	5307	3439	8069	5325	5106	5113	8527	7826	7944	mitochondrial trans-2-enoyl-CoA reductase (MECR)
B15R14C13	15-13-14	Hs~Ref:NM_006432.2~uORF:IOH4108	330	746	434	314	265	334	516	412	645	142	Niemann-Pick disease, type C2 (NPC2)
B15R14C14	15-14-14	Hs~Ref:NM_006432.2~uORF:IOH4108	292	453	397	783	266	336	548	407	75	248	Niemann-Pick disease, type C2 (NPC2)
B15R14C15	15-15-14	Hs~Ref:NM_015994.2~uORF:IOH4090	747	392	645	399	430	513	1347	788	-6	265	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D (ATP6V1D)
B15R14C16	15-16-14	Hs~Ref:NM_015994.2~uORF:IOH4090	759	400	608	455	449	581	1328	832	-1	250	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D (ATP6V1D)
B15R14C17	15-17-14	Hs~Ref:NM_032959.3~uORF:IOH58642	492	375	561	309	440	640	1117	565	745	135	DNA-directed RNA polymerase II subunit RPB11-a
B15R14C18	15-18-14	Hs~Ref:NM_032959.3~uORF:IOH58642	445	352	542	295	451	476	1013	554	289	110	DNA-directed RNA polymerase II subunit RPB11-a
B15R14C21	15-21-14	Hs~MGC:BC032844.1~uORF:IOH61607	1187	701	1323	801	1679	811	846	734	2053	457	Angiogenic factor with G patch and FHA domains 1
B15R14C22	15-22-14	Hs~MGC:BC032844.1~uORF:IOH61607	1054	698	1319	768	1778	765	878	686	2105	442	Angiogenic factor with G patch and FHA domains 1
B15R15C01	15-1-15	Hs~Ref:NM_001040624.1~uORF:IOH61538	458	527	1332	411	424	1399	2454	1339	1565	233	Neurocalcin-delta
B15R15C02	15-2-15	Hs~Ref:NM_001040624.1~uORF:IOH61538	558	495	1356	424	426	1519	2453	1384	1587	152	Neurocalcin-delta
B15R15C03	15-3-15	Hs~MGC:BC009327.2~uORF:IOH12082	427	599	715	1581	416	1292	5280	540	836	332	Nucleoredoxin
B15R15C04	15-4-15	Hs~MGC:BC009327.2~uORF:IOH12082	430	585	667	1492	436	1359	5232	559	827	267	Nucleoredoxin
B15R15C05	15-5-15	Hs~MGC:BC013163.1~uORF:IOH28616	295	254	347	1002	218	314	483	740	443	98	DCN1-like protein 1
B15R15C06	15-6-15	Hs~MGC:BC013163.1~uORF:IOH28616	316	243	398	981	208	233	473	740	512	93	DCN1-like protein 1
B15R15C07	15-7-15	Hs~MGC:BC036184.1~uORF:IOH62166	1488	2032	2641	3544	2142	1988	2992	2027	2610	360	Tropomodulin-2
B15R15C08	15-8-15	Hs~MGC:BC036184.1~uORF:IOH62166	1500	2018	2580	3803	2136	2145	3025	2030	2610	346	Tropomodulin-2
B15R15C09	15-9-15	Hs~MGC:BC063137.1~uORF:IOH62857	296	349	360	510	257	434	456	345	640	223	[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial
B15R15C10	15-10-15	Hs~MGC:BC063137.1~uORF:IOH62857	202	316	373	552	168	473	466	306	307	253	[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial
B15R15C13	15-13-15	Hs~Ref:NM_016276.3~CAT:PV3858	401	815	656	3510	311	247	642	319	231	48	serum/glucocorticoid regulated kinase 2 (SGK2), transcript variant 2
B15R15C14	15-14-15	Hs~Ref:NM_016276.3~CAT:PV3858	412	1815	683	3542	333	255	609	288	-16	37	serum/glucocorticoid regulated kinase 2 (SGK2), transcript variant 2
B15R15C15	15-15-15	Hs~Ref:NM_005044.1~CAT:PV3813	369	485	791	391	384	2530	880	308	80	93	protein kinase, X-linked (PRKX)
B15R15C16	15-16-15	Hs~Ref:NM_005044.1~CAT:PV3813	408	433	814	458	401	2480	992	296	319	61	protein kinase, X-linked (PRKX)
B15R15C17	15-17-15	Hs~Ref:NM_006213.1~CAT:PV3853	592	325	497	450	343	429	712	409	1827	152	Phosphorylase b kinase gamma catalytic chain, skeletal muscle isoform
B15R15C18	15-18-15	Hs~Ref:NM_006213.1~CAT:PV3853	582	323	517	455	326	398	655	412	2	125	Phosphorylase b kinase gamma catalytic chain, skeletal muscle isoform
B15R15C19	15-19-15	Hs~Ref:NM_002750.2~CAT:PV3319	367	29	251	305	46	264	390	154	41	17	mitogen-activated protein kinase 8 (MAPK8), transcript variant JNK1-a1
B15R15C20	15-20-15	Hs~Ref:NM_002750.2~CAT:PV3319	375	31	262	304	47	424	423	163	26	14	mitogen-activated protein kinase 8 (MAPK8), transcript variant JNK1-a1
B15R16C03	15-3-16	Hs~Ref:NM_003331.1~CAT:PV4790	224	138	239	403	187	131	272	205	508	32	Non-receptor tyrosine-protein kinase TYK2
B15R16C04	15-4-16	Hs~Ref:NM_003331.1~CAT:PV4790	234	167	253	197	211	161	278	219	426	23	Non-receptor tyrosine-protein kinase TYK2
B15R16C05	15-5-16	Hs~Ref:NM_032294.2~CAT:PV4670	113	37	282	220	139	347	135	74	123	18	Calcium/calmodulin-dependent protein kinase kinase 1
B15R16C06	15-6-16	Hs~Ref:NM_032294.2~CAT:PV4670	70	34	295	154	107	287	97	82	115	26	Calcium/calmodulin-dependent protein kinase kinase 1
B15R16C07	15-7-16	Hs~MGC:BC090864.1~uORF:IOH62569	1224	877	1337	1773	736	892	2853	861	2077	826	Importin subunit alpha-1
B15R16C08	15-8-16	Hs~MGC:BC090864.1~uORF:IOH62569	1170	952	1238	1864	738	975	3012	1023	2137	840	Importin subunit alpha-1
B15R16C09	15-9-16	Hs~MGC:BC103966.1~uORF:IOH63474	515	369	1174	310	385	771	1376	427	927	225	Interleukin-1 family member 10
B15R16C10	15-10-16	Hs~MGC:BC103966.1~uORF:IOH63474	592	361	1159	300	296	780	1381	340	956	241	Interleukin-1 family member 10
B15R16C11	15-11-16	Hs~MGC:BC067523.1~uORF:IOH62530	1025	575	872	497	529	834	1476	534	1032	266	Collagenase 3
B15R16C12	15-12-16	Hs~MGC:BC067523.1~uORF:IOH62530	966	611	970	531	498	865	1759	591	640	209	Collagenase 3
B15R16C13	15-13-16	Hs~MGC:BC099907.1~uORF:IOH62625	65476	65472	41617	65473	65480	63307	51153	65450	43429	65487	General transcription factor II-I
B15R16C14	15-14-16	Hs~MGC:BC099907.1~uORF:IOH62625	65455	65470	40921	65472	65480	64933	50856	65480	45257	65488	General transcription factor II-I
B15R16C15	15-15-16	Hs~MGC:BC057812.1~uORF:IOH29129	665	640	745	531	435	1245	1294	631	994	357	transmembrane protein 88 (TMEM88)
B15R16C16	15-16-16	Hs~MGC:BC057812.1~uORF:IOH29129	578	568	744	597	459	1042	1152	643	1350	124	transmembrane protein 88 (TMEM88)
B15R16C17	15-17-16	Hs~MGC:BC036301.1~uORF:IOH26789	716	600	763	505	788	732	1280	633	263	606	Transmembrane protein 192
B15R16C18	15-18-16	Hs~MGC:BC036301.1~uORF:IOH26789	743	626	797	527	761	661	1315	699	86	550	Transmembrane protein 192
B15R16C19	15-19-16	Hs~Ref:NM_178571.2~uORF:IOH26524	2247	1184	1928	1033	2058	1403	8733	1170	2759	479	hypothetical protein MGC51025 (MGC51025)
B15R16C20	15-20-16	Hs~Ref:NM_178571.2~uORF:IOH26524	2238	1188	1993	1046	1972	1576	8739	1191	2696	437	hypothetical protein MGC51025 (MGC51025)
B15R16C21	15-21-16	Hs~Ref:NM_014015.3~uORF:IOH27586	645	608	948	1203	677	741	909	614	1474	226	dexamethasone-induced transcript (DEXI)
B15R16C22	15-22-16	Hs~Ref:NM_014015.3~uORF:IOH27586	642	564	918	1158	667	1174	905	638	1279	112	dexamethasone-induced transcript (DEXI)
B15R17C01	15-1-17	Hs~MGC:BC020739.1~uORF:IOH14471	938	875	1246	687	898	1322	1750	1081	2265	481	interleukin 13 receptor, alpha 2 (IL13RA2)
B15R17C02	15-2-17	Hs~MGC:BC020739.1~uORF:IOH14471	1091	820	1223	695	925	1364	1697	1111	2244	562	interleukin 13 receptor, alpha 2 (IL13RA2)
B15R17C03	15-3-17	Hs~Ref:NM_022372.2~uORF:IOH11516	905	1055	1151	876	830	1200	1695	1033	1932	485	G protein beta subunit-like (GBL)
B15R17C04	15-4-17	Hs~Ref:NM_022372.2~uORF:IOH11516	1027	1102	1144	723	793	1151	1734	1016	1575	476	G protein beta subunit-like (GBL)
B15R17C05	15-5-17	Hs~MGC:BC017763.1~uORF:IOH14236	1659	709	1088	688	908	1044	1207	857	2028	512	HSPB (heat shock 27kDa) associated protein 1 (HSPBAP1)
B15R17C06	15-6-17	Hs~MGC:BC017763.1~uORF:IOH14236	1665	747	1033	666	908	1053	1216	841	2040	434	HSPB (heat shock 27kDa) associated protein 1 (HSPBAP1)
B15R17C07	15-7-17	Hs~Ref:NM_025221.4~uORF:IOH21934	1010	523	598	350	767	567	985	714	825	213	Kv channel interacting protein 4 (KCNIP4), transcript variant 1
B15R17C08	15-8-17	Hs~Ref:NM_025221.4~uORF:IOH21934	1024	506	561	382	797	570	976	691	806	201	Kv channel interacting protein 4 (KCNIP4), transcript variant 1
B15R17C15	15-15-17	Hs~MGC:BC071702.1~uORF:IOH61790	268	257	465	255	374	433	856	473	387	80	Deleted in bladder cancer protein 1
B15R17C16	15-16-17	Hs~MGC:BC071702.1~uORF:IOH61790	237	228	457	399	361	400	809	476	473	312	Deleted in bladder cancer protein 1
B15R17C17	15-17-17	Hs~MGC:BC005857.1~uORF:IOH5858	1265	511	542	302	372	606	2611	369	779	145	Sequestosome-1
B15R17C18	15-18-17	Hs~MGC:BC005857.1~uORF:IOH5858	1276	520	534	323	390	1046	2549	315	748	176	Sequestosome-1
B15R17C19	15-19-17	Hs~MGC:BC006231.1~uORF:IOH6284	469	412	443	305	267	353	532	303	1242	205	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKBKB)
B15R17C20	15-20-17	Hs~MGC:BC006231.1~uORF:IOH6284	414	459	438	366	260	218	565	320	653	98	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKBKB)
B15R17C21	15-21-17	Hs~MGC:BC007872.1~uORF:IOH6779	1024	14944	969	846	1821	1205	1426	1825	2086	620	thymidine kinase 1, soluble (TK1)
B15R17C22	15-22-17	Hs~MGC:BC007872.1~uORF:IOH6779	1031	15100	990	817	1775	945	1415	1943	2059	623	thymidine kinase 1, soluble (TK1)
B15R18C01	15-1-18	Hs~Ref:NM_001827.1~uORF:IOH5978	553	570	5374	466	2139	1356	1380	1419	1145	188	CDC28 protein kinase regulatory subunit 2 (CKS2)
B15R18C02	15-2-18	Hs~Ref:NM_001827.1~uORF:IOH5978	625	602	5333	459	2238	1182	1407	1547	1136	166	CDC28 protein kinase regulatory subunit 2 (CKS2)
B15R18C03	15-3-18	Hs~MGC:BC032852.2~uORF:IOH27153	13027	10311	4957	12032	12074	12282	12674	14245	19259	12903	melanoma antigen family B, 4 (MAGEB4)
B15R18C04	15-4-18	Hs~MGC:BC032852.2~uORF:IOH27153	13698	10438	4661	12965	12840	12370	12652	13947	19795	12871	melanoma antigen family B, 4 (MAGEB4)
B15R18C05	15-5-18	Hs~Ref:NM_003188.2~uORF:IOH21077	820	2184	925	442	424	936	1168	767	1000	244	mitogen-activated protein kinase kinase kinase 7 (MAP3K7), transcript variant A
B15R18C06	15-6-18	Hs~Ref:NM_003188.2~uORF:IOH21077	808	2409	943	395	429	929	1131	744	1047	203	mitogen-activated protein kinase kinase kinase 7 (MAP3K7), transcript variant A
B15R18C07	15-7-18	Hs~MGC:BC035048.2~uORF:IOH27687	1714	429	723	485	452	816	2021	636	978	203	neurogenic differentiation 6 (NEUROD6)
B15R18C08	15-8-18	Hs~MGC:BC035048.2~uORF:IOH27687	1821	506	734	497	426	764	1982	657	1043	221	neurogenic differentiation 6 (NEUROD6)
B15R18C09	15-9-18	Hs~Ref:NM_152864.2~uORF:IOH25895	413	326	528	267	291	443	618	446	577	108	Na+/K+ transporting ATPase interacting 4 (NKAIN4)
B15R18C10	15-10-18	Hs~Ref:NM_152864.2~uORF:IOH25895	430	314	550	320	316	472	635	468	11	184	Na+/K+ transporting ATPase interacting 4 (NKAIN4)
B15R18C11	15-11-18	Hs~Ref:NM_018230.2~uORF:IOH55812	889	329	534	333	103	406	1142	692	890	319	Nuclear pore complex protein Nup133
B15R18C12	15-12-18	Hs~Ref:NM_018230.2~uORF:IOH55812	1772	334	529	419	168	414	1109	539	185	240	Nuclear pore complex protein Nup133
B15R18C13	15-13-18	Hs~Ref:NM_203290.1~uORF:IOH57020	452	609	602	1528	290	864	874	648	1493	236	DNA-directed RNA polymerases I and III subunit RPAC1
B15R18C14	15-14-18	Hs~Ref:NM_203290.1~uORF:IOH57020	407	616	620	1467	293	900	970	703	1629	334	DNA-directed RNA polymerases I and III subunit RPAC1
B15R18C19	15-19-18	Hs~Ref:NM_015978.1~N/A	562	554	1234	458	874	389	729	711	2806	335	Serine/threonine-protein kinase TNNI3K
B15R18C20	15-20-18	Hs~Ref:NM_015978.1~N/A	562	536	1292	421	834	521	738	687	2389	296	Serine/threonine-protein kinase TNNI3K
B15R18C21	15-21-18	Hs~Ref:NM_001895.1~N/A	574	540	691	451	782	766	815	564	1289	324	casein kinase 2, alpha 1 polypeptide (CSNK2A1), transcript variant 2
B15R18C22	15-22-18	Hs~Ref:NM_001895.1~N/A	498	501	647	421	776	637	831	584	1388	275	casein kinase 2, alpha 1 polypeptide (CSNK2A1), transcript variant 2
B15R19C03	15-3-19	Hs~Ref:NM_002740.1~N/A	1033	485	861	476	776	511	1206	917	1272	249	protein kinase C, iota (PRKCI)
B15R19C04	15-4-19	Hs~Ref:NM_002740.1~N/A	923	503	878	456	765	527	1269	917	1483	255	protein kinase C, iota (PRKCI)
B15R19C05	15-5-19	Hs~Ref:NM_001178.3~uORF:IOH28764	671	720	641	553	463	556	1212	499	629	260	aryl hydrocarbon receptor nuclear translocator-like (ARNTL), transcript variant 1
B15R19C06	15-6-19	Hs~Ref:NM_001178.3~uORF:IOH28764	649	700	606	482	472	635	1231	491	645	280	aryl hydrocarbon receptor nuclear translocator-like (ARNTL), transcript variant 1
B15R19C07	15-7-19	Hs~Ref:NM_007199.1~uORF:IOH29139	507	277	481	259	304	10	739	288	438	83	interleukin-1 receptor-associated kinase 3 (IRAK3)
B15R19C08	15-8-19	Hs~Ref:NM_007199.1~uORF:IOH29139	513	276	505	230	275	406	668	279	499	97	interleukin-1 receptor-associated kinase 3 (IRAK3)
B15R19C09	15-9-19	Hs~MGC:BC011989.1~uORF:IOH11771	604	347	545	301	356	809	761	371	672	67	endothelial cell-specific molecule 1 (ESM1)
B15R19C10	15-10-19	Hs~MGC:BC011989.1~uORF:IOH11771	603	336	537	308	335	788	840	421	730	89	endothelial cell-specific molecule 1 (ESM1)
B15R19C11	15-11-19	Hs~Ref:NM_005437.1~uORF:IOH11864	1242	1255	846	1919	360	515	707	632	1310	941	nuclear receptor coactivator 4 (NCOA4)
B15R19C12	15-12-19	Hs~Ref:NM_005437.1~uORF:IOH11864	1324	1289	894	1967	396	613	701	762	936	1094	nuclear receptor coactivator 4 (NCOA4)
B15R19C13	15-13-19	Hs~Ref:NM_019000.2~uORF:IOH43613	1074	1115	1509	2177	320	1608	2375	982	973	243	family with sequence similarity 134, member B (FAM134B), transcript variant 2
B15R19C14	15-14-19	Hs~Ref:NM_019000.2~uORF:IOH43613	1124	1121	1490	2323	313	1685	2382	1006	1260	-6	family with sequence similarity 134, member B (FAM134B), transcript variant 2
B15R19C15	15-15-19	Hs~Ref:NM_001459.2~uORF:IOH40930	336	1001	412	829	354	536	774	538	512	260	fms-related tyrosine kinase 3 ligand (FLT3LG)
B15R19C16	15-16-19	Hs~Ref:NM_001459.2~uORF:IOH40930	330	1020	426	913	331	558	775	554	-12	115	fms-related tyrosine kinase 3 ligand (FLT3LG)
B15R19C17	15-17-19	Hs~Ref:NM_203471.1~uORF:IOH44569	818	329	327	493	338	976	1006	1204	1195	521	lectin, galactoside-binding, soluble, 14 (LGALS14), transcript variant 2
B15R19C18	15-18-19	Hs~Ref:NM_203471.1~uORF:IOH44569	782	314	313	436	349	989	980	1254	1196	503	lectin, galactoside-binding, soluble, 14 (LGALS14), transcript variant 2
B15R19C19	15-19-19	Hs~MGC:BC033005.1~uORF:IOH22281	707	498	499	413	378	696	1181	508	756	297	PCTAIRE protein kinase 2 (PCTK2)
B15R19C20	15-20-19	Hs~MGC:BC033005.1~uORF:IOH22281	676	410	514	394	356	689	1168	440	743	322	PCTAIRE protein kinase 2 (PCTK2)
B15R19C21	15-21-19	Hs~MGC:BC040499.1~uORF:IOH27240	716	607	812	610	614	542	1134	816	1862	539	TGF-beta receptor type-2
B15R19C22	15-22-19	Hs~MGC:BC040499.1~uORF:IOH27240	774	664	739	571	618	909	1085	755	1613	5	TGF-beta receptor type-2
B15R20C01	15-1-20	Hs~MGC:BC032309.1~uORF:IOH27536	637	570	809	429	406	561	1016	603	1781	376	arylacetamide deacetylase (esterase) (AADAC)
B15R20C02	15-2-20	Hs~MGC:BC032309.1~uORF:IOH27536	1494	566	742	475	434	733	956	607	1214	418	arylacetamide deacetylase (esterase) (AADAC)
B15R20C03	15-3-20	Hs~MGC:BC038807.1~uORF:IOH25914	1621	625	955	726	518	814	1379	1288	1810	377	amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 7 (ALS2CR7)
B15R20C04	15-4-20	Hs~MGC:BC038807.1~uORF:IOH25914	798	623	810	549	483	720	1405	1344	1946	389	amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 7 (ALS2CR7)
B15R20C05	15-5-20	Hs~MGC:BC034726.1~uORF:IOH25776	1028	645	1225	813	606	783	1529	760	2365	286	Ras-related GTP binding B (RRAGB)
B15R20C06	15-6-20	Hs~MGC:BC034726.1~uORF:IOH25776	1013	670	1197	1007	598	804	1582	749	2399	333	Ras-related GTP binding B (RRAGB)
B15R20C07	15-7-20	Hs~Ref:NM_015414.2~uORF:IOH4985	2814	1222	2291	992	805	1348	8114	1141	2278	949	ribosomal protein L36 (RPL36), transcript variant 2
B15R20C08	15-8-20	Hs~Ref:NM_015414.2~uORF:IOH4985	2740	1325	2152	968	735	1407	7925	1189	2395	779	ribosomal protein L36 (RPL36), transcript variant 2
B15R20C09	15-9-20	Hs~Ref:NM_014183.1~uORF:IOH4293	266	299	403	263	590	-1	339	242	1	-1	dynein, light chain, roadblock-type 1 (DYNLRB1)
B15R20C10	15-10-20	Hs~Ref:NM_014183.1~uORF:IOH4293	247	272	446	275	609	0	0	-1	1	1	dynein, light chain, roadblock-type 1 (DYNLRB1)
B15R20C11	15-11-20	Hs~MGC:BC016901.1~uORF:IOH11722	679	406	531	314	266	-1	1	1	-3	1	Hermansky-Pudlak syndrome 3 (HPS3)
B15R20C12	15-12-20	Hs~MGC:BC016901.1~uORF:IOH11722	625	374	555	334	240	-3	16	-4	-1	-2	Hermansky-Pudlak syndrome 3 (HPS3)
B15R20C13	15-13-20	Hs~MGC:BC018111.1~uORF:IOH11272	1598	559	1019	571	1021	1901	1294	878	1663	477	pim-2 oncogene (PIM2)
B15R20C14	15-14-20	Hs~MGC:BC018111.1~uORF:IOH11272	1624	554	1008	549	1068	2058	1416	939	1360	464	pim-2 oncogene (PIM2)
B16R02C11	16-11-2	Hs~Ref:NM_013293.1~uORF:IOH9999	5857	2271	5286	2520	1455	2788	20610	2210	5999	1262	Transformer-2 protein homolog
B16R02C12	16-12-2	Hs~Ref:NM_013293.1~uORF:IOH9999	5392	2391	4886	2485	1523	2807	20219	2173	5997	1271	Transformer-2 protein homolog
B16R02C13	16-13-2	Hs~Ref:NM_015690.2~uORF:IOH11118	1179	1173	1523	809	630	671	1300	905	2574	771	Serine/threonine-protein kinase 36
B16R02C14	16-14-2	Hs~Ref:NM_015690.2~uORF:IOH11118	1173	1353	1655	734	616	144	1262	865	2665	591	Serine/threonine-protein kinase 36
B16R02C15	16-15-2	Hs~Ref:NM_006413.2~uORF:IOH7208	4015	1518	3287	1213	1987	1936	3878	1308	4356	694	Ribonuclease P protein subunit p30
B16R02C16	16-16-2	Hs~Ref:NM_006413.2~uORF:IOH7208	4039	1456	3415	1213	1961	235	3867	1246	4662	706	Ribonuclease P protein subunit p30
B16R02C17	16-17-2	Hs~MGC:BC002509.1~uORF:IOH3968	667	542	1604	591	1443	2207	1651	737	4420	430	PHD finger protein 23
B16R02C18	16-18-2	Hs~MGC:BC002509.1~uORF:IOH3968	749	531	1537	615	1496	2183	1654	732	4520	434	PHD finger protein 23
B16R02C19	16-19-2	Hs~MGC:BC017660.1~uORF:IOH13777	1204	1163	1683	2441	1075	1752	1911	1415	3274	772	chromosome 6 open reading frame 48 (C6orf48), transcript variant 1, mRNA.
B16R02C20	16-20-2	Hs~MGC:BC017660.1~uORF:IOH13777	1454	1164	17	2331	1007	1689	1833	1292	3490	787	chromosome 6 open reading frame 48 (C6orf48), transcript variant 1, mRNA.
B16R02C21	16-21-2	Hs~MGC:BC009350.1~uORF:IOH14087	2182	1245	1593	990	989	2136	3842	1196	3183	856	Eukaryotic translation initiation factor 2-alpha kinase 4
B16R02C22	16-22-2	Hs~MGC:BC009350.1~uORF:IOH14087	1702	1170	1703	1060	1144	1708	3795	1114	2840	611	Eukaryotic translation initiation factor 2-alpha kinase 4
B16R03C01	16-1-3	Hs~MGC:NM_173509.2~uORF:IOH14185	1196	1117	1342	1538	1006	1233	1632	1018	6429	1293	UPF0417 protein FAM163A
B16R03C02	16-2-3	Hs~MGC:NM_173509.2~uORF:IOH14185	1216	1111	1297	1650	941	1269	1693	1068	6492	1294	UPF0417 protein FAM163A
B16R03C03	16-3-3	Hs~MGC:BC012576.1~uORF:IOH12217	5020	2055	4779	28633	6514	11221	6606	6678	6371	1532	bromodomain adjacent to zinc finger domain, 2B, mRNA (cDNA clone IMAGE:4290975), complete cds.
B16R03C04	16-4-3	Hs~MGC:BC012576.1~uORF:IOH12217	5036	2120	4736	29533	6760	11717	6307	6293	6280	1503	bromodomain adjacent to zinc finger domain, 2B, mRNA (cDNA clone IMAGE:4290975), complete cds.
B16R03C05	16-5-3	Hs~Ref:NM_145651.1~uORF:IOH40401	198	205	321	227	253	296	225	1201	441	79	secretoglobin, family 1C, member 1 (SCGB1C1)
B16R03C06	16-6-3	Hs~Ref:NM_145651.1~uORF:IOH40401	244	177	306	182	258	323	232	223	727	80	secretoglobin, family 1C, member 1 (SCGB1C1)
B16R03C07	16-7-3	Hs~Ref:NM_030669.1~uORF:IOH36740	699	1067	1523	311	463	907	1203	579	779	289	protein tyrosine phosphatase, receptor type, O (PTPRO), transcript variant 3
B16R03C08	16-8-3	Hs~Ref:NM_030669.1~uORF:IOH36740	805	1070	1490	323	427	946	1207	434	891	279	protein tyrosine phosphatase, receptor type, O (PTPRO), transcript variant 3
B16R03C09	16-9-3	Hs~MGC:BC070089.1~uORF:IOH40551	251	181	493	288	291	230	2712	350	678	258	leucine rich repeat containing 8 family, member E (LRRC8E)
B16R03C10	16-10-3	Hs~MGC:BC070089.1~uORF:IOH40551	489	194	403	307	343	325	2622	325	562	241	leucine rich repeat containing 8 family, member E (LRRC8E)
B16R03C11	16-11-3	Hs~Ref:NM_001095.2~uORF:IOH36580	907	177	277	359	1578	229	289	291	539	212	amiloride-sensitive cation channel 2, neuronal (ACCN2), transcript variant 2
B16R03C12	16-12-3	Hs~Ref:NM_001095.2~uORF:IOH36580	135	429	219	462	1546	144	299	272	595	281	amiloride-sensitive cation channel 2, neuronal (ACCN2), transcript variant 2
B16R03C13	16-13-3	Hs~Ref:NM_000364.2~uORF:IOH44471	1247	1207	722	848	290	91	8453	388	1138	297	troponin T type 2 (cardiac) (TNNT2), transcript variant 1
B16R03C14	16-14-3	Hs~Ref:NM_000364.2~uORF:IOH44471	1046	1333	933	836	436	1	7601	376	914	165	troponin T type 2 (cardiac) (TNNT2), transcript variant 1
B16R03C15	16-15-3	Hs~Ref:NM_002604.1~uORF:IOH35734	226	103	283	305	161	7	346	251	404	107	phosphodiesterase 7A (PDE7A), transcript variant 2
B16R03C16	16-16-3	Hs~Ref:NM_002604.1~uORF:IOH35734	628	21	426	318	243	137	356	242	152	156	phosphodiesterase 7A (PDE7A), transcript variant 2
B16R03C17	16-17-3	Hs~Ref:NM_182525.1~uORF:IOH44477	354	139	401	268	288	2156	561	230	493	228	chromosome 8 open reading frame 78 (C8orf78)
B16R03C18	16-18-3	Hs~Ref:NM_182525.1~uORF:IOH44477	442	-9	339	296	169	1950	624	242	338	84	chromosome 8 open reading frame 78 (C8orf78)
B16R03C19	16-19-3	Hs~Ref:NM_018293.1~uORF:IOH35442	1761	198	781	825	373	979	959	1387	6150	177	Zinc finger protein 654
B16R03C20	16-20-3	Hs~Ref:NM_018293.1~uORF:IOH35442	1462	204	1705	831	382	1153	961	1428	5872	149	Zinc finger protein 654
B16R03C21	16-21-3	Hs~Ref:NM_012265.1~uORF:IOH5339	1254	512	907	483	615	521	758	504	928	298	rhomboid domain containing 3 (RHBDD3)
B16R03C22	16-22-3	Hs~Ref:NM_012265.1~uORF:IOH5339	624	427	1692	810	709	568	1052	488	810	-4	rhomboid domain containing 3 (RHBDD3)
B16R04C01	16-1-4	Hs~Ref:NM_006686.2~uORF:IOH21791	469	498	624	367	380	436	671	-5	980	348	actin-like 7B (ACTL7B)
B16R04C02	16-2-4	Hs~Ref:NM_006686.2~uORF:IOH21791	497	478	633	344	305	545	749	231	1107	234	actin-like 7B (ACTL7B)
B16R04C03	16-3-4	Hs~Ref:NM_000690.1~uORF:IOH4924	346	429	561	336	302	-4	7	-1	704	344	aldehyde dehydrogenase 2 family (mitochondrial) (ALDH2), nuclear gene encoding mitochondrial protein
B16R04C04	16-4-4	Hs~Ref:NM_000690.1~uORF:IOH4924	355	394	571	327	430	0	8	6	668	345	aldehyde dehydrogenase 2 family (mitochondrial) (ALDH2), nuclear gene encoding mitochondrial protein
B16R04C05	16-5-4	Hs~MGC:BC015878.1~uORF:IOH23080	483	478	586	502	3559	682	1393	671	757	311	N-acetyltransferase 2 (arylamine N-acetyltransferase) (NAT2)
B16R04C06	16-6-4	Hs~MGC:BC015878.1~uORF:IOH23080	466	570	618	510	2411	733	1369	662	856	380	N-acetyltransferase 2 (arylamine N-acetyltransferase) (NAT2)
B16R04C07	16-7-4	Hs~MGC:BC015413.1~uORF:IOH10971	386	505	570	321	1435	696	760	544	633	399	Ropporin-1B
B16R04C08	16-8-4	Hs~MGC:BC015413.1~uORF:IOH10971	421	478	622	321	2227	450	745	543	711	370	Ropporin-1B
B16R04C09	16-9-4	Hs~Ref:NM_025026.1~uORF:IOH10990	1105	1415	1041	649	2631	1453	996	911	1502	655	hypothetical protein FLJ14107 (FLJ14107)
B16R04C10	16-10-4	Hs~Ref:NM_025026.1~uORF:IOH10990	1158	1017	1270	620	2022	991	930	921	1273	673	hypothetical protein FLJ14107 (FLJ14107)
B16R04C11	16-11-4	Hs~MGC:BC015409.1~uORF:IOH10948	436	399	900	295	591	488	740	544	770	320	collagen, type IX, alpha 1 (COL9A1)
B16R04C12	16-12-4	Hs~MGC:BC015409.1~uORF:IOH10948	584	410	986	333	466	184	732	434	792	276	collagen, type IX, alpha 1 (COL9A1)
B16R04C13	16-13-4	Hs~Ref:NM_016176.2~uORF:IOH10229	1236	621	1270	381	1821	2157	727	501	1367	297	stromal cell derived factor 4 (SDF4)
B16R04C14	16-14-4	Hs~Ref:NM_016176.2~uORF:IOH10229	1058	732	1380	391	394	2176	745	524	1294	348	stromal cell derived factor 4 (SDF4)
B16R04C15	16-15-4	Hs~MGC:BC035959.1~uORF:IOH27984	1006	380	1025	671	56	4	894	382	32	216	cytochrome P450, family 19, subfamily A, polypeptide 1 (CYP19A1)
B16R04C16	16-16-4	Hs~MGC:BC035959.1~uORF:IOH27984	1100	281	691	657	207	68	932	307	45	98	cytochrome P450, family 19, subfamily A, polypeptide 1 (CYP19A1)
B16R04C17	16-17-4	Hs~Ref:NM_014920.2~uORF:IOH38087	1995	1639	4472	1042	1210	400	2731	909	803	933	intestinal cell (MAK-like) kinase (ICK), transcript variant 1
B16R04C18	16-18-4	Hs~Ref:NM_014920.2~uORF:IOH38087	2271	1408	4248	1028	1284	549	2642	895	1574	990	intestinal cell (MAK-like) kinase (ICK), transcript variant 1
B16R04C19	16-19-4	Hs~Ref:NM_017437.1~uORF:IOH38302	1892	714	2060	1653	2334	717	1114	610	1578	320	cleavage and polyadenylation specific factor 2, 100kDa (CPSF2)
B16R04C20	16-20-4	Hs~Ref:NM_017437.1~uORF:IOH38302	1582	683	2001	1649	1270	759	1174	627	1583	313	cleavage and polyadenylation specific factor 2, 100kDa (CPSF2)
B16R04C21	16-21-4	Hs~MGC:BC059360.1~uORF:IOH29131	1371	781	727	1111	907	819	1285	1084	1558	236	phosphoglucomutase 2-like 1 (PGM2L1)
B16R04C22	16-22-4	Hs~MGC:BC059360.1~uORF:IOH29131	1282	828	717	1060	1296	804	1334	1034	1542	133	phosphoglucomutase 2-like 1 (PGM2L1)
B16R05C01	16-1-5	Hs~Ref:NM_080816.1~uORF:IOH12104	1123	940	3025	777	722	0	-1	1	1663	565	signal-regulatory protein gamma (SIRPG), transcript variant 2
B16R05C02	16-2-5	Hs~Ref:NM_080816.1~uORF:IOH12104	1073	956	2905	745	665	0	-2	-2	1665	329	signal-regulatory protein gamma (SIRPG), transcript variant 2
B16R05C03	16-3-5	Hs~MGC:BC057803.1~uORF:IOH29253	957	712	999	1255	557	1056	1519	-1	1281	244	heparan sulfate (glucosamine) 3-O-sulfotransferase 1 (HS3ST1)
B16R05C04	16-4-5	Hs~MGC:BC057803.1~uORF:IOH29253	989	710	1009	1310	3883	1035	1494	1	1179	470	heparan sulfate (glucosamine) 3-O-sulfotransferase 1 (HS3ST1)
B16R05C05	16-5-5	Hs~Ref:NM_199188.1~uORF:IOH38224	6833	3743	9515	7396	7284	5696	26051	6271	6312	10665	La ribonucleoprotein domain family, member 4 (LARP4), transcript variant 2
B16R05C06	16-6-5	Hs~Ref:NM_199188.1~uORF:IOH38224	5786	3842	9328	7535	4043	5175	26254	6438	6177	10655	La ribonucleoprotein domain family, member 4 (LARP4), transcript variant 2
B16R05C07	16-7-5	Hs~Ref:NM_020426.1~uORF:IOH29483	733	559	1145	438	713	122	1047	503	977	259	lysozyme-like 6 (LYZL6)
B16R05C08	16-8-5	Hs~Ref:NM_020426.1~uORF:IOH29483	835	1290	1267	431	1163	61	1065	481	960	232	lysozyme-like 6 (LYZL6)
B16R05C09	16-9-5	Hs~Ref:NM_006282.1~N/A	984	877	1677	564	1091	610	1322	1	2590	436	Serine/threonine-protein kinase 4
B16R05C10	16-10-5	Hs~Ref:NM_006282.1~N/A	981	741	1678	570	1297	972	1280	-1	2565	350	Serine/threonine-protein kinase 4
B16R05C11	16-11-5	Hs~Ref:NM_001626.2~N/A	994	647	1060	550	694	488	2	2	1143	353	v-akt murine thymoma viral oncogene homolog 2 (AKT2)
B16R05C12	16-12-5	Hs~Ref:NM_001626.2~N/A	731	802	1082	583	639	243	17	3	1170	395	v-akt murine thymoma viral oncogene homolog 2 (AKT2)
B16R05C13	16-13-5	Hs~Ref:NM_001826.1~N/A	1692	1851	3520	990	2431	9	12	0	3431	1065	CDC28 protein kinase regulatory subunit 1B (CKS1B)
B16R05C14	16-14-5	Hs~Ref:NM_001826.1~N/A	1798	1806	3747	936	1519	-7	-2	2	2916	666	CDC28 protein kinase regulatory subunit 1B (CKS1B)
B16R05C15	16-15-5	Hs~Ref:NM_001721.2~N/A	1410	983	734	765	937	-6	0	-3	2427	275	BMX non-receptor tyrosine kinase (BMX), transcript variant 2
B16R05C16	16-16-5	Hs~Ref:NM_001721.2~N/A	1105	1182	592	715	1146	-7	-11	46	2152	16	BMX non-receptor tyrosine kinase (BMX), transcript variant 2
B16R05C17	16-17-5	Hs~MGC:BC068448.1~uORF:IOH40093	423	930	1122	664	772	949	4469	942	-216	207	EF-hand calcium binding protein 1 (EFCBP1)
B16R05C18	16-18-5	Hs~MGC:BC068448.1~uORF:IOH40093	864	898	1268	699	715	947	4649	941	2235	141	EF-hand calcium binding protein 1 (EFCBP1)
B16R05C21	16-21-5	Hs~Ref:NM_017433.1~N/A	1686	1390	1543	856	2377	1422	2165	1245	2209	220	Myosin IIIA
B16R05C22	16-22-5	Hs~Ref:NM_017433.1~N/A	1554	1386	1479	859	2803	1368	1620	1298	2564	411	Myosin IIIA
B16R06C01	16-1-6	Hs~Ref:NM_020328.1~N/A	868	719	1364	604	1024	765	1495	692	1600	251	Activin receptor type-1B
B16R06C02	16-2-6	Hs~Ref:NM_020328.1~N/A	936	774	1251	638	916	747	1412	778	1642	233	Activin receptor type-1B
B16R06C03	16-3-6	Hs~MGC:BC010519.1~uORF:IOH10222	1570	1904	1898	1107	1087	1692	2476	1272	3353	1082	chromosome 7 open reading frame 42 (C7orf42)
B16R06C04	16-4-6	Hs~MGC:BC010519.1~uORF:IOH10222	1504	1889	1952	1147	4701	1642	2468	1374	3329	968	chromosome 7 open reading frame 42 (C7orf42)
B16R06C05	16-5-6	Hs~MGC:BC020844.1~uORF:IOH12056	1486	1127	1672	761	1704	1252	1760	1031	2051	566	SPRY domain-containing protein 4
B16R06C06	16-6-6	Hs~MGC:BC020844.1~uORF:IOH12056	1436	1077	1731	704	1277	1293	1751	1067	2065	548	SPRY domain-containing protein 4
B16R06C07	16-7-6	Hs~MGC:BC017968.1~uORF:IOH14358	1441	1880	1772	1638	1671	1961	2374	1249	3094	1007	solute carrier family 16, member 10 (aromatic amino acid transporter) (SLC16A10)
B16R06C08	16-8-6	Hs~MGC:BC017968.1~uORF:IOH14358	1550	2029	1776	1713	1800	1904	2251	1248	3332	943	solute carrier family 16, member 10 (aromatic amino acid transporter) (SLC16A10)
B16R06C09	16-9-6	Hs~Ref:NM_138280.1~uORF:IOH22167	1480	1493	1621	1007	1799	1422	2201	1050	2261	982	citrate lyase beta like (CLYBL), transcript variant 1
B16R06C10	16-10-6	Hs~Ref:NM_138280.1~uORF:IOH22167	1683	1209	1513	985	964	1855	2055	1077	2258	908	citrate lyase beta like (CLYBL), transcript variant 1
B16R06C11	16-11-6	Hs~MGC:BC035578.1~uORF:IOH27608	1073	2094	1262	682	1213	1294	1954	1195	1167	279	Serine/threonine-protein kinase 24
B16R06C12	16-12-6	Hs~MGC:BC035578.1~uORF:IOH27608	2416	2286	1287	692	1192	1111	1999	1092	1172	657	Serine/threonine-protein kinase 24
B16R06C13	16-13-6	Hs~Ref:NM_006907.2~uORF:IOH59071	985	2581	1692	1321	753	1289	3006	1184	1880	491	Pyrroline-5-carboxylate reductase 1, mitochondrial
B16R06C14	16-14-6	Hs~Ref:NM_006907.2~uORF:IOH59071	918	2505	1684	1217	728	1556	3103	1094	1889	498	Pyrroline-5-carboxylate reductase 1, mitochondrial
B16R06C15	16-15-6	Hs~Ref:NM_003287.2~uORF:IOH59709	1080	680	988	464	548	-7	847	468	1468	2324	Tumor protein D53
B16R06C16	16-16-6	Hs~Ref:NM_003287.2~uORF:IOH59709	1026	702	894	543	496	278	998	499	1069	2833	Tumor protein D53
B16R06C17	16-17-6	Hs~MGC:BC010167.2~uORF:IOH13169	1897	2239	2413	1416	1675	2770	2890	1426	4643	825	chromosome 14 open reading frame 172 (C14orf172)
B16R06C18	16-18-6	Hs~MGC:BC010167.2~uORF:IOH13169	1975	2153	2691	1494	1590	3093	2993	1552	4424	1572	chromosome 14 open reading frame 172 (C14orf172)
B16R06C19	16-19-6	Hs~Ref:NM_174938.3~uORF:IOH27753	2557	763	1117	545	663	723	1921	504	1128	281	FERM domain-containing protein 3
B16R06C20	16-20-6	Hs~Ref:NM_174938.3~uORF:IOH27753	3239	521	927	534	701	645	2149	511	1102	243	FERM domain-containing protein 3
B16R06C21	16-21-6	Hs~MGC:BC048251.1~uORF:IOH26606	59	5	649	784	268	330	664	419	468	305	zinc finger, DHHC-type containing 12 (ZDHHC12)
B16R06C22	16-22-6	Hs~MGC:BC048251.1~uORF:IOH26606	689	644	603	631	261	382	759	358	838	111	zinc finger, DHHC-type containing 12 (ZDHHC12)
B16R07C01	16-1-7	Hs~Ref:NM_033542.2~uORF:IOH26587	771	624	890	434	615	793	845	620	1043	307	SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae) (SYS1), transcript variant 1
B16R07C02	16-2-7	Hs~Ref:NM_033542.2~uORF:IOH26587	762	701	865	533	625	813	896	551	1064	299	SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae) (SYS1), transcript variant 1
B16R07C03	16-3-7	Hs~Ref:NM_173574.1~uORF:IOH27216	958	760	1017	685	614	967	1204	575	2056	384	zinc finger protein 683 (ZNF683)
B16R07C04	16-4-7	Hs~Ref:NM_173574.1~uORF:IOH27216	975	765	1009	694	573	880	1374	588	2141	348	zinc finger protein 683 (ZNF683)
B16R07C05	16-5-7	Hs~MGC:BC014353.1~uORF:IOH23005	2039	603	660	1133	2522	2314	2819	715	1560	159	Stathmin
B16R07C06	16-6-7	Hs~MGC:BC014353.1~uORF:IOH23005	2084	589	651	1140	1128	2347	2837	726	1615	165	Stathmin
B16R07C07	16-7-7	Hs~MGC:BC001755.1~uORF:IOH4451	7672	5397	3400	7199	5623	13292	8926	4158	12924	1757	Leiomodin-1
B16R07C08	16-8-7	Hs~MGC:BC001755.1~uORF:IOH4451	7886	5525	3389	6890	8628	13208	9042	4443	13044	1871	Leiomodin-1
B16R07C11	16-11-7	Hs~MGC:NM_152321.1~uORF:IOH22595	1771	1431	1207	1622	1509	3418	15377	2240	2393	571	Endoplasmic reticulum resident protein ERp27
B16R07C12	16-12-7	Hs~MGC:NM_152321.1~uORF:IOH22595	1752	1577	1186	1628	1652	3526	15737	2216	2411	182	Endoplasmic reticulum resident protein ERp27
B16R07C13	16-13-7	Hs~MGC:BC009198.1~uORF:IOH14404	851	604	1277	579	393	748	842	574	1821	282	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene (RRN3)
B16R07C14	16-14-7	Hs~MGC:BC009198.1~uORF:IOH14404	796	649	1241	547	408	931	863	562	1860	247	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene (RRN3)
B16R07C15	16-15-7	Hs~MGC:BC009825.2~uORF:IOH14857	1093	759	884	576	387	16	949	572	1611	285	Dehydrogenase/reductase SDR family member 12
B16R07C16	16-16-7	Hs~MGC:BC009825.2~uORF:IOH14857	989	828	977	763	505	-8	1016	617	1619	139	Dehydrogenase/reductase SDR family member 12
B16R07C17	16-17-7	Hs~MGC:BC009297.1~uORF:IOH14160	1174	1428	1322	944	782	1685	1980	1415	2939	484	hypothetical protein FLJ22222 (FLJ22222)
B16R07C18	16-18-7	Hs~MGC:BC009297.1~uORF:IOH14160	1219	1428	1351	853	787	1876	1900	1463	3051	412	hypothetical protein FLJ22222 (FLJ22222)
B16R07C21	16-21-7	Hs~Ref:NM_006913.2~uORF:IOH3743	460	579	1154	499	561	1230	1531	570	825	205	ring finger protein 5 (RNF5)
B16R07C22	16-22-7	Hs~Ref:NM_006913.2~uORF:IOH3743	759	589	1125	598	562	10	1616	588	1157	175	ring finger protein 5 (RNF5)
B16R08C01	16-1-8	Hs~MGC:BC021134.1~uORF:IOH23115	5531	732	1225	628	910	870	1257	765	1950	717	centrobin, centrosomal BRCA2 interacting protein (CNTROB)
B16R08C02	16-2-8	Hs~MGC:BC021134.1~uORF:IOH23115	5340	811	1225	585	940	953	1314	721	1850	422	centrobin, centrosomal BRCA2 interacting protein (CNTROB)
B16R08C03	16-3-8	Hs~Ref:NM_001261.2~N/A	1166	816	1274	679	640	941	1634	782	2125	521	cyclin K and cyclin-dependent kinase 9 (CDC2-related kinase) (CDK9): cyclin K and CDK9 sequences are seperated by -- (in the protein list file).
B16R08C04	16-4-8	Hs~Ref:NM_001261.2~N/A	1195	760	1259	734	631	963	1624	843	2157	405	cyclin K and cyclin-dependent kinase 9 (CDC2-related kinase) (CDK9): cyclin K and CDK9 sequences are seperated by -- (in the protein list file).
B16R08C07	16-7-8	Hs~Ref:NM_003177.3~uORF:IOH4914	11348	2502	2293	2111	3204	3104	10844	1106	2638	872	spleen tyrosine kinase (SYK)
B16R08C08	16-8-8	Hs~Ref:NM_003177.3~uORF:IOH4914	11105	2467	2238	2140	949	3041	10995	1115	2450	756	spleen tyrosine kinase (SYK)
B16R08C09	16-9-8	Hs~Ref:NM_000593.5~uORF:IOH14037	910	840	1218	675	460	1464	1078	756	1455	336	transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) (TAP1)
B16R08C10	16-10-8	Hs~Ref:NM_000593.5~uORF:IOH14037	874	859	1280	691	481	1860	1031	758	1409	95	transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) (TAP1)
B16R08C11	16-11-8	Hs~Ref:NM_004656.2~uORF:IOH4938	2451	1023	2743	3470	715	2920	2219	8142	2591	942	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (BAP1)
B16R08C12	16-12-8	Hs~Ref:NM_004656.2~uORF:IOH4938	2387	1088	2671	3575	824	3030	2159	8190	2559	947	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (BAP1)
B16R08C13	16-13-8	Hs~Ref:NM_003504.3~uORF:IOH6286	1511	706	1175	758	692	761	1468	505	1825	299	CDC45 cell division cycle 45-like (S. cerevisiae) (CDC45L)
B16R08C14	16-14-8	Hs~Ref:NM_003504.3~uORF:IOH6286	1452	716	1152	721	737	966	1398	543	1819	522	CDC45 cell division cycle 45-like (S. cerevisiae) (CDC45L)
B16R08C15	16-15-8	Hs~Ref:NM_032649.5~uORF:IOH42043	1236	1092	1562	842	760	1617	1420	1076	2612	611	Beta-Ala-His dipeptidase
B16R08C16	16-16-8	Hs~Ref:NM_032649.5~uORF:IOH42043	1168	1119	1560	1018	808	42	1609	1032	2611	755	Beta-Ala-His dipeptidase
B16R08C17	16-17-8	Hs~Ref:NM_153500.1~uORF:IOH37934	1602	1130	1698	932	1024	1336	2151	1057	2917	770	calcium/calmodulin-dependent protein kinase kinase 2, beta (CAMKK2), transcript variant 4, mRNA.
B16R08C18	16-18-8	Hs~Ref:NM_153500.1~uORF:IOH37934	1644	1073	1663	907	976	1612	2254	1089	2931	752	calcium/calmodulin-dependent protein kinase kinase 2, beta (CAMKK2), transcript variant 4, mRNA.
B16R08C19	16-19-8	Hs~Ref:NM_002411.1~uORF:IOH50178	848	608	1101	554	591	256	1758	668	1231	51	Mammaglobin-A
B16R08C20	16-20-8	Hs~Ref:NM_002411.1~uORF:IOH50178	789	642	1034	571	546	571	1424	717	1630	354	Mammaglobin-A
B16R08C21	16-21-8	Hs~Ref:NM_032485.4~uORF:IOH36748	2919	1652	2101	1381	878	2130	4264	1464	3403	983	DNA replication licensing factor MCM8
B16R08C22	16-22-8	Hs~Ref:NM_032485.4~uORF:IOH36748	2525	1598	2104	1504	1047	1875	4246	1465	3457	858	DNA replication licensing factor MCM8
B16R09C01	16-1-9	Hs~Ref:NM_003524.2~uORF:IOH58715	2572	1136	1898	825	751	1372	8067	809	2249	451	Histone H2B type 1-H
B16R09C02	16-2-9	Hs~Ref:NM_003524.2~uORF:IOH58715	2368	1113	1833	855	759	1364	7927	817	2257	520	Histone H2B type 1-H
B16R09C03	16-3-9	Hs~Ref:NM_133494.1~uORF:IOH45126	4838	2327	3509	2262	2048	2684	6079	1708	5981	3075	NIMA (never in mitosis gene a)- related kinase 7 (NEK7)
B16R09C04	16-4-9	Hs~Ref:NM_133494.1~uORF:IOH45126	4874	2316	3496	2296	1992	2734	6055	1737	5865	2810	NIMA (never in mitosis gene a)- related kinase 7 (NEK7)
B16R09C05	16-5-9	Hs~Ref:NM_001006667.1~uORF:IOH58767	645	822	810	805	660	937	981	769	1611	1266	Tachykinin-3
B16R09C06	16-6-9	Hs~Ref:NM_001006667.1~uORF:IOH58767	639	803	857	789	607	924	916	748	1461	1276	Tachykinin-3
B16R09C07	16-7-9	Hs~Ref:NM_004830.2~uORF:IOH53662	450	392	600	386	216	416	646	331	678	50	Mediator of RNA polymerase II transcription subunit 23
B16R09C08	16-8-9	Hs~Ref:NM_004830.2~uORF:IOH53662	460	304	603	435	135	266	558	348	633	124	Mediator of RNA polymerase II transcription subunit 23
B16R09C11	16-11-9	Hs~Ref:NM_018448.2~uORF:IOH55833	860	2312	583	337	231	425	1295	633	646	182	Cullin-associated NEDD8-dissociated protein 1
B16R09C12	16-12-9	Hs~Ref:NM_018448.2~uORF:IOH55833	798	2456	590	372	262	638	1288	629	643	149	Cullin-associated NEDD8-dissociated protein 1
B16R09C13	16-13-9	Hs~Ref:NM_014547.3~uORF:IOH55947	1259	2837	1246	814	4022	1297	1931	924	3250	494	Tropomodulin-3
B16R09C14	16-14-9	Hs~Ref:NM_014547.3~uORF:IOH55947	1278	2828	1263	792	5733	1276	1958	814	3341	537	Tropomodulin-3
B16R09C15	16-15-9	Hs~Ref:NM_201998.1~uORF:IOH56887	31787	31479	21454	43033	30024	23114	38378	29590	26689	33326	Splicing factor 1
B16R09C16	16-16-9	Hs~Ref:NM_201998.1~uORF:IOH56887	35185	32781	20509	40324	47989	24254	38705	30334	28396	33539	Splicing factor 1
B16R09C17	16-17-9	Hs~Ref:NM_145206.1~uORF:IOH11028	1548	854	2062	619	585	1953	638	1154	1112	184	vesicle transport through interaction with t-SNAREs homolog 1A (yeast) (VTI1A), transcript variant 2
B16R09C18	16-18-9	Hs~Ref:NM_145206.1~uORF:IOH11028	1481	853	2090	630	507	1831	835	1239	1041	237	vesicle transport through interaction with t-SNAREs homolog 1A (yeast) (VTI1A), transcript variant 2
B16R09C19	16-19-9	Hs~MGC:BC015239.1~uORF:IOH10789	1857	552	1080	1714	796	431	1000	500	567	295	zinc finger and BTB domain containing 8 (ZBTB8)
B16R09C20	16-20-9	Hs~MGC:BC015239.1~uORF:IOH10789	2137	603	1250	1816	848	467	1197	496	1198	20	zinc finger and BTB domain containing 8 (ZBTB8)
B16R09C21	16-21-9	Hs~Ref:NM_052935.1~uORF:IOH10842	654	423	652	363	106	207	448	463	546	283	Cytosolic 5prime-nucleotidase III-like protein
B16R09C22	16-22-9	Hs~Ref:NM_052935.1~uORF:IOH10842	139	430	766	752	89	112	391	400	542	136	Cytosolic 5prime-nucleotidase III-like protein
B16R10C01	16-1-10	Hs~MGC:BC025392.1~uORF:IOH10724	607	346	566	370	303	206	548	392	576	208	WD repeat domain 16 (WDR16)
B16R10C02	16-2-10	Hs~MGC:BC025392.1~uORF:IOH10724	652	362	577	384	213	409	548	441	621	102	WD repeat domain 16 (WDR16)
B16R10C03	16-3-10	Hs~Ref:NM_005770.3~uORF:IOH3348	1417	1005	1331	746	1336	1149	4565	1211	2045	617	small EDRK-rich factor 2 (SERF2)
B16R10C04	16-4-10	Hs~Ref:NM_005770.3~uORF:IOH3348	1457	931	1259	705	1391	1095	4406	807	2051	591	small EDRK-rich factor 2 (SERF2)
B16R10C05	16-5-10	Hs~MGC:BC005297.1~uORF:IOH7259	1175	936	1357	791	1295	1092	1794	906	1703	701	kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) (KMO)
B16R10C06	16-6-10	Hs~MGC:BC005297.1~uORF:IOH7259	1282	960	1201	894	1340	1103	1703	948	1763	679	kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) (KMO)
B16R10C07	16-7-10	Hs~Ref:NM_001328.1~uORF:IOH12818	1385	437	1013	1251	1000	920	2188	1039	1649	61	C-terminal binding protein 1 (CTBP1), transcript variant 1
B16R10C08	16-8-10	Hs~Ref:NM_001328.1~uORF:IOH12818	1427	480	983	1295	1047	892	2171	1052	1827	238	C-terminal binding protein 1 (CTBP1), transcript variant 1
B16R10C09	16-9-10	Hs~MGC:BC001052.2~uORF:IOH3752	1779	1533	2458	1414	1406	2098	3031	1241	5671	818	RecQ protein-like (DNA helicase Q1-like) (RECQL)
B16R10C10	16-10-10	Hs~MGC:BC001052.2~uORF:IOH3752	1869	1405	2420	1410	1379	2136	3107	1274	6300	799	RecQ protein-like (DNA helicase Q1-like) (RECQL)
B16R11C21	16-21-11	Hs~Ref:NM_004311.1~uORF:IOH22951	924	3233	1868	1057	2174	1270	1550	659	2456	513	ADP-ribosylation factor-like 3 (ARL3)
B16R11C22	16-22-11	Hs~Ref:NM_004311.1~uORF:IOH22951	930	3055	2064	1099	2105	1257	1519	667	2402	129	ADP-ribosylation factor-like 3 (ARL3)
B16R12C01	16-1-12	Hs~Ref:NM_002774.2~uORF:IOH10423	949	770	1007	604	693	764	1318	747	2589	524	kallikrein-related peptidase 6 (KLK6), transcript variant A
B16R12C02	16-2-12	Hs~Ref:NM_002774.2~uORF:IOH10423	1014	795	1054	624	671	855	1270	620	2090	597	kallikrein-related peptidase 6 (KLK6), transcript variant A
B16R12C03	16-3-12	Hs~MGC:NM_181503.1~uORF:IOH10049	854	705	973	574	634	737	1665	647	478	392	exosome component 8 (EXOSC8)
B16R12C04	16-4-12	Hs~MGC:NM_181503.1~uORF:IOH10049	872	701	916	545	605	773	1632	882	1254	418	exosome component 8 (EXOSC8)
B16R12C05	16-5-12	Hs~MGC:BC017163.1~uORF:IOH10096	1026	914	1167	751	923	1290	1023	2542	1612	419	LUC7-like 2 (S. cerevisiae) (LUC7L2)
B16R12C06	16-6-12	Hs~MGC:BC017163.1~uORF:IOH10096	1017	945	1238	750	910	1310	1032	2333	1478	398	LUC7-like 2 (S. cerevisiae) (LUC7L2)
B16R12C07	16-7-12	Hs~Ref:NM_012383.2~uORF:IOH7180	2152	1615	2038	1476	895	1928	2475	1158	3730	725	osteoclast stimulating factor 1 (OSTF1)
B16R12C08	16-8-12	Hs~Ref:NM_012383.2~uORF:IOH7180	2153	1571	1999	1374	911	1944	2422	1279	3976	696	osteoclast stimulating factor 1 (OSTF1)
B16R12C09	16-9-12	Hs~MGC:BC005259.1~uORF:IOH7202	1388	1531	1345	785	830	2075	1789	1374	2314	642	X-ray repair complementing defective repair in Chinese hamster cells 4 (XRCC4)
B16R12C10	16-10-12	Hs~MGC:BC005259.1~uORF:IOH7202	1825	1323	1347	770	813	2033	1868	1401	2325	646	X-ray repair complementing defective repair in Chinese hamster cells 4 (XRCC4)
B16R12C13	16-13-12	Hs~Ref:NM_024668.1~uORF:IOH5012	1498	1329	1937	2179	3744	3222	2231	1573	2406	754	ankyrin repeat and KH domain containing 1 (ANKHD1), transcript variant 3
B16R12C14	16-14-12	Hs~Ref:NM_024668.1~uORF:IOH5012	1379	1276	1891	2121	2917	3088	2271	1492	2555	732	ankyrin repeat and KH domain containing 1 (ANKHD1), transcript variant 3
B16R12C17	16-17-12	Hs~Ref:NM_001003937.1~uORF:IOH40055	1720	147	696	323	261	211	649	337	3135	756	Testis-specific Y-encoded-like protein 6
B16R12C18	16-18-12	Hs~Ref:NM_001003937.1~uORF:IOH40055	1526	143	681	347	1636	10	552	269	3392	710	Testis-specific Y-encoded-like protein 6
B16R12C19	16-19-12	Hs~MGC:BC063792.1~uORF:IOH40513	626	477	275	898	1360	-13	642	1010	3863	207	Uncharacterized protein KIAA1310
B16R12C20	16-20-12	Hs~MGC:BC063792.1~uORF:IOH40513	616	499	380	824	910	-3	633	894	4120	274	Uncharacterized protein KIAA1310
B16R12C21	16-21-12	Hs~Ref:NM_020525.4~uORF:IOH40162	904	269	202	306	1224	235	261	263	1222	55	interleukin 22 (IL22)
B16R12C22	16-22-12	Hs~Ref:NM_020525.4~uORF:IOH40162	143	359	318	386	479	221	284	337	1039	46	interleukin 22 (IL22)
B16R13C01	16-1-13	Hs~Ref:NM_025161.2~uORF:IOH14763	841	560	881	490	2181	-10	1044	483	2352	553	Fanconi anemia-associated protein of 100 kDa
B16R13C02	16-2-13	Hs~Ref:NM_025161.2~uORF:IOH14763	729	532	977	529	1812	2004	1141	489	2024	427	Fanconi anemia-associated protein of 100 kDa
B16R13C03	16-3-13	Hs~Ref:NM_024060.1~uORF:IOH21405	425	487	641	826	1785	1885	949	368	1670	387	AHNAK nucleoprotein (AHNAK), transcript variant 2
B16R13C04	16-4-13	Hs~Ref:NM_024060.1~uORF:IOH21405	345	420	382	844	391	1855	923	368	1751	68	AHNAK nucleoprotein (AHNAK), transcript variant 2
B16R13C05	16-5-13	Hs~MGC:BC009631.1~uORF:IOH21422	709	547	795	447	426	702	957	620	2050	514	dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase) (DCI)
B16R13C06	16-6-13	Hs~MGC:BC009631.1~uORF:IOH21422	715	530	846	465	461	731	971	658	2095	553	dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase) (DCI)
B16R13C07	16-7-13	Hs~MGC:NM_173541.1~uORF:IOH21426	1507	1436	4036	3563	945	2802	5168	1347	4916	613	chromosome 10 open reading frame 91 (C10orf91)
B16R13C08	16-8-13	Hs~MGC:NM_173541.1~uORF:IOH21426	1499	1353	4047	1281	963	2760	5267	1519	4763	587	chromosome 10 open reading frame 91 (C10orf91)
B16R13C09	16-9-13	Hs~Ref:NM_004927.1~uORF:IOH5582	594	2203	656	323	650	667	775	449	641	190	mitochondrial ribosomal protein L49 (MRPL49), nuclear gene encoding mitochondrial protein
B16R13C10	16-10-13	Hs~Ref:NM_004927.1~uORF:IOH5582	646	1056	657	334	657	414	737	461	66	190	mitochondrial ribosomal protein L49 (MRPL49), nuclear gene encoding mitochondrial protein
B16R13C11	16-11-13	Hs~MGC:BC002374.1~uORF:IOH3595	998	613	720	439	485	3956	11777	2590	3816	2631	karyopherin alpha 1 (importin alpha 5) (KPNA1)
B16R13C12	16-12-13	Hs~MGC:BC002374.1~uORF:IOH3595	1083	606	714	370	2256	3507	11729	2612	3463	2580	karyopherin alpha 1 (importin alpha 5) (KPNA1)
B16R13C13	16-13-13	Hs~MGC:BC000623.1~uORF:IOH4257	337	582	529	283	70	622	871	372	773	277	transmembrane protein 103 (TMEM103)
B16R13C14	16-14-13	Hs~MGC:BC000623.1~uORF:IOH4257	484	587	597	292	99	664	710	340	920	152	transmembrane protein 103 (TMEM103)
B16R13C15	16-15-13	Hs~MGC:BC002424.1~uORF:IOH4157	3284	1905	1876	1310	1280	1811	11752	1103	3442	842	integral membrane protein 2C (ITM2C)
B16R13C16	16-16-13	Hs~MGC:BC002424.1~uORF:IOH4157	3212	1926	1782	1310	961	1806	12758	1063	3605	786	integral membrane protein 2C (ITM2C)
B16R13C17	16-17-13	Hs~MGC:BC037168.2~uORF:IOH29347	449	314	525	280	287	584	748	349	494	230	WD repeat domain 48 (WDR48)
B16R13C18	16-18-13	Hs~MGC:BC037168.2~uORF:IOH29347	359	384	512	287	748	-13	616	321	556	202	WD repeat domain 48 (WDR48)
B16R13C19	16-19-13	Hs~MGC:BC054520.1~uORF:IOH28900	378	259	751	388	1208	-33	612	274	594	124	myocyte enhancer factor 2D (MEF2D)
B16R13C20	16-20-13	Hs~MGC:BC054520.1~uORF:IOH28900	387	351	583	358	1167	66	649	302	623	115	myocyte enhancer factor 2D (MEF2D)
B16R13C21	16-21-13	Hs~MGC:BC052991.1~uORF:IOH28907	2867	396	770	660	931	331	786	417	657	125	sphingosine-1-phosphate lyase 1 (SGPL1)
B16R13C22	16-22-13	Hs~MGC:BC052991.1~uORF:IOH28907	1947	424	609	471	393	284	726	419	767	73	sphingosine-1-phosphate lyase 1 (SGPL1)
B16R14C01	16-1-14	Hs~MGC:BC032833.2~uORF:IOH28637	1	5	-1	1	1298	-6	-13	-4	4	749	ankyrin repeat domain 13A (ANKRD13A)
B16R14C02	16-2-14	Hs~MGC:BC032833.2~uORF:IOH28637	1	-11	-7	4	-40	-30	315	5	-6	-13	ankyrin repeat domain 13A (ANKRD13A)
B16R14C03	16-3-14	Hs~MGC:BC004236.2~uORF:IOH3887	4893	1673	3734	1988	1473	2122	20819	1344	3542	535	ubiquitin-conjugating enzyme E2S (UBE2S)
B16R14C04	16-4-14	Hs~MGC:BC004236.2~uORF:IOH3887	4564	1606	3659	1963	669	2182	22355	1313	3542	650	ubiquitin-conjugating enzyme E2S (UBE2S)
B16R14C05	16-5-14	Hs~Ref:NM_031219.2~uORF:IOH6593	982	747	1254	1405	781	1087	2236	616	1822	462	haloacid dehalogenase-like hydrolase domain containing 3 (HDHD3)
B16R14C06	16-6-14	Hs~Ref:NM_031219.2~uORF:IOH6593	946	698	1265	1701	749	1197	2169	627	1701	506	haloacid dehalogenase-like hydrolase domain containing 3 (HDHD3)
B16R14C07	16-7-14	Hs~Ref:NM_183373.2~uORF:IOH29104	1076	756	1146	813	809	930	1744	868	1550	529	chromosome 6 open reading frame 145 (C6orf145)
B16R14C08	16-8-14	Hs~Ref:NM_183373.2~uORF:IOH29104	1090	721	1165	563	772	1018	1710	907	1585	529	chromosome 6 open reading frame 145 (C6orf145)
B16R14C09	16-9-14	Hs~Ref:NM_198204.1~uORF:IOH9777	657	640	583	419	286	13218	4620	495	2018	769	MAX-like protein X (MLX), transcript variant 2
B16R14C10	16-10-14	Hs~Ref:NM_198204.1~uORF:IOH9777	674	630	587	428	227	13151	4636	484	2200	757	MAX-like protein X (MLX), transcript variant 2
B16R14C11	16-11-14	Hs~Ref:NM_018032.2~uORF:IOH4849	1185	1039	1085	703	2021	1182	1424	782	1236	887	LUC7-like (S. cerevisiae) (LUC7L), transcript variant 1
B16R14C12	16-12-14	Hs~Ref:NM_018032.2~uORF:IOH4849	1142	1036	1121	750	1341	1060	1459	720	1438	436	LUC7-like (S. cerevisiae) (LUC7L), transcript variant 1
B16R14C13	16-13-14	Hs~Ref:NM_006459.1~uORF:IOH22186	2153	344	420	318	-21	363	515	317	1185	396	ER lipid raft associated 1 (ERLIN1)
B16R14C14	16-14-14	Hs~Ref:NM_006459.1~uORF:IOH22186	286	340	498	298	600	179	820	357	838	-4	ER lipid raft associated 1 (ERLIN1)
B16R14C15	16-15-14	Hs~Ref:NM_002754.3~uORF:IOH3435	1738	1704	1310	790	1209	2141	1617	2583	1737	-95	mitogen-activated protein kinase 13 (MAPK13)
B16R14C16	16-16-14	Hs~Ref:NM_002754.3~uORF:IOH3435	1726	1688	1260	830	996	2482	1510	2681	1961	222	mitogen-activated protein kinase 13 (MAPK13)
B16R14C17	16-17-14	Hs~MGC:BC001045.1~uORF:IOH4660	790	487	801	1626	638	241	659	364	1164	539	RUN and SH3 domain containing 1 (RUSC1)
B16R14C18	16-18-14	Hs~MGC:BC001045.1~uORF:IOH4660	770	504	867	1627	439	-11	622	427	-12	593	RUN and SH3 domain containing 1 (RUSC1)
B16R14C19	16-19-14	Hs~MGC:BC002559.1~uORF:IOH4053	11532	4436	5678	2454	2432	3986	11255	3410	9827	1986	YTH domain family, member 2 (YTHDF2)
B16R14C20	16-20-14	Hs~MGC:BC002559.1~uORF:IOH4053	10509	4436	5755	2669	2571	4078	11344	3340	9589	1786	YTH domain family, member 2 (YTHDF2)
B16R14C21	16-21-14	Hs~MGC:NM_152912.3~uORF:IOH26907	2093	1103	1508	1198	1139	2853	4437	1128	1911	687	mitochondrial translational initiation factor 3 (MTIF3)
B16R14C22	16-22-14	Hs~MGC:NM_152912.3~uORF:IOH26907	2033	1222	1538	1327	2515	2545	4300	1259	1888	639	mitochondrial translational initiation factor 3 (MTIF3)
B16R15C01	16-1-15	Hs~MGC:BC048301.1~uORF:IOH26612	1245	693	1304	1000	4273	1278	2211	1696	1092	105	zinc finger, CCHC domain containing 11 (ZCCHC11)
B16R15C02	16-2-15	Hs~MGC:BC048301.1~uORF:IOH26612	1231	676	1304	1071	1748	1369	2022	1616	1832	280	zinc finger, CCHC domain containing 11 (ZCCHC11)
B16R15C03	16-3-15	Hs~Ref:NM_138413.1~uORF:IOH26880	560	420	755	419	1952	602	732	510	24	213	chromosome 10 open reading frame 65 (C10orf65)
B16R15C04	16-4-15	Hs~Ref:NM_138413.1~uORF:IOH26880	528	459	753	416	234	564	725	452	724	202	chromosome 10 open reading frame 65 (C10orf65)
B16R15C05	16-5-15	Hs~Ref:NM_015869.2~uORF:IOH36704	2989	3204	4594	878	981	2215	2958	846	2318	246	peroxisome proliferator-activated receptor gamma (PPARG), transcript variant 2
B16R15C06	16-6-15	Hs~Ref:NM_015869.2~uORF:IOH36704	2921	3211	4482	1048	1176	2110	3032	887	2427	240	peroxisome proliferator-activated receptor gamma (PPARG), transcript variant 2
B16R15C07	16-7-15	Hs~Ref:NM_004882.3~uORF:IOH26927	2041	1444	2591	5365	1699	2087	11175	1503	3724	960	CBF1-interacting corepressor
B16R15C08	16-8-15	Hs~Ref:NM_004882.3~uORF:IOH26927	2050	1457	2607	4746	1786	2274	10979	1579	3735	1005	CBF1-interacting corepressor
B16R15C09	16-9-15	Hs~Ref:NM_000402.2~uORF:IOH2390	900	1351	2957	1336	3143	1882	1367	808	4359	468	Glucose-6-phosphate 1-dehydrogenase
B16R15C10	16-10-15	Hs~Ref:NM_000402.2~uORF:IOH2390	902	1324	2965	1386	2512	1881	1371	868	3904	550	Glucose-6-phosphate 1-dehydrogenase
B16R15C11	16-11-15	Hs~MGC:BC015548.1~uORF:IOH10351	1758	1742	2001	1726	1758	1347	2646	1378	3673	345	RAB3A interacting protein (rabin3) (RAB3IP)
B16R15C12	16-12-15	Hs~MGC:BC015548.1~uORF:IOH10351	1702	1730	1608	1883	2053	1039	2694	1227	3630	643	RAB3A interacting protein (rabin3) (RAB3IP)
B16R15C13	16-13-15	Hs~Ref:NM_001799.2~CAT:PV3868	335	468	1006	843	592	242	519	534	389	207	cyclin-dependent kinase 7
B16R15C14	16-14-15	Hs~Ref:NM_001799.2~CAT:PV3868	344	505	1078	888	1013	357	633	573	412	154	cyclin-dependent kinase 7
B16R15C17	16-17-15	Hs~Ref:NM_001319.5~CAT:PV3499	1473	1866	1750	896	4782	523	2159	2106	2728	669	casein kinase 1, gamma 2 (CSNK1G2)
B16R15C18	16-18-15	Hs~Ref:NM_001319.5~CAT:PV3499	1486	1851	1770	861	1917	2757	1999	2208	2414	226	casein kinase 1, gamma 2 (CSNK1G2)
B16R15C19	16-19-15	Hs~Ref:NM_000142.2~CAT:PV4392	864	385	988	432	179	-15	530	423	589	275	fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) (FGFR3), transcript variant 1
B16R15C20	16-20-15	Hs~Ref:NM_000142.2~CAT:PV4392	869	344	929	443	172	628	517	419	649	77	fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) (FGFR3), transcript variant 1
B16R16C01	16-1-16	Hs~Ref:NM_000899.3~CAT_PHC2116	165	194	410	529	30	612	2413	90	-221	119	KIT ligand (KITLG), transcript variant b
B16R16C02	16-2-16	Hs~Ref:NM_000899.3~CAT_PHC2116	196	133	458	538	1280	174	2277	95	1305	110	KIT ligand (KITLG), transcript variant b
B16R16C03	16-3-16	Hs~Ref:NM_002608.1~CAT_PHG0046	732	1206	706	726	3148	573	572	376	857	96	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) (PDGFB), transcript variant 1
B16R16C04	16-4-16	Hs~Ref:NM_002608.1~CAT_PHG0046	725	1266	712	745	5262	581	513	360	418	400	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) (PDGFB), transcript variant 1
B16R16C07	16-7-16	Hs~Ref:NM_001001709.1~uORF:IOH58672	1069	642	745	607	1979	1787	1133	447	1191	140	chromosome 9 open reading frame 170 (C9orf170), mRNA.
B16R16C08	16-8-16	Hs~Ref:NM_001001709.1~uORF:IOH58672	1093	635	791	593	828	1952	1198	456	1326	296	chromosome 9 open reading frame 170 (C9orf170), mRNA.
B16R16C09	16-9-16	Hs~MGC:BC032747.1~uORF:IOH56229	863	735	591	1232	1748	806	748	731	1358	312	Melanoregulin
B16R16C10	16-10-16	Hs~MGC:BC032747.1~uORF:IOH56229	859	766	571	1253	951	757	766	709	1218	61	Melanoregulin
B16R16C15	16-15-16	Hs~MGC:BC025930.1~uORF:IOH57231	516	525	747	387	3589	1330	1352	1206	1265	97	Nuclear protein localization protein 4 homolog
B16R16C16	16-16-16	Hs~MGC:BC025930.1~uORF:IOH57231	573	516	747	405	359	1350	1366	1250	1407	472	Nuclear protein localization protein 4 homolog
B16R16C17	16-17-16	Hs~Ref:NM_006844.3~uORF:IOH57193	256	467	578	272	173	343	680	404	745	92	ilvB (bacterial acetolactate synthase)-like (ILVBL), mRNA.
B16R16C18	16-18-16	Hs~Ref:NM_006844.3~uORF:IOH57193	247	510	633	238	165	373	670	378	784	81	ilvB (bacterial acetolactate synthase)-like (ILVBL), mRNA.
B16R16C21	16-21-16	Hs~Ref:NM_199173.2~uORF:IOH58586	784	587	1009	625	561	846	1404	857	1338	97	Osteocalcin
B16R16C22	16-22-16	Hs~Ref:NM_199173.2~uORF:IOH58586	830	594	1026	766	548	524	1346	883	1315	284	Osteocalcin
B16R17C03	16-3-17	Hs~MGC:BC093743.1~uORF:IOH61985	842	493	1013	446	824	603	1547	609	919	233	bone morphogenetic protein 8a, mRNA (cDNA clone IMAGE:7939588), complete cds.
B16R17C04	16-4-17	Hs~MGC:BC093743.1~uORF:IOH61985	866	537	1016	452	1209	645	1556	539	933	445	bone morphogenetic protein 8a, mRNA (cDNA clone IMAGE:7939588), complete cds.
B16R17C07	16-7-17	Hs~Ref:NM_001039656.1~uORF:IOH62081	2506	2632	637	350	1267	892	615	372	1094	704	Tesmin
B16R17C08	16-8-17	Hs~Ref:NM_001039656.1~uORF:IOH62081	2593	2532	625	366	166	853	632	438	1074	115	Tesmin
B16R17C09	16-9-17	Hs~MGC:BC011562.1~uORF:IOH12462	1396	674	1215	793	1660	1013	1507	841	1613	428	SP100 nuclear antigen (SP100)
B16R17C10	16-10-17	Hs~MGC:BC011562.1~uORF:IOH12462	1453	808	1158	792	1335	1013	1483	921	1539	403	SP100 nuclear antigen (SP100)
B16R17C11	16-11-17	Hs~MGC:NM_153350.2~uORF:IOH22461	1459	783	727	488	1018	749	1173	566	1306	204	F-box and leucine-rich repeat protein 16 (FBXL16)
B16R17C12	16-12-17	Hs~MGC:NM_153350.2~uORF:IOH22461	1630	602	792	530	964	749	1387	545	1354	212	F-box and leucine-rich repeat protein 16 (FBXL16)
B16R17C15	16-15-17	Hs~Ref:NM_022048.1~uORF:IOH21026	1796	1068	1632	8933	730	1884	4837	2708	2448	579	casein kinase 1, gamma 1 (CSNK1G1)
B16R17C16	16-16-17	Hs~Ref:NM_022048.1~uORF:IOH21026	1784	1145	1704	10077	754	1992	5203	3047	2414	653	casein kinase 1, gamma 1 (CSNK1G1)
B16R17C17	16-17-17	Hs~Ref:NM_016082.3~uORF:IOH45468	487	371	954	356	514	378	783	486	1045	216	CDK5 regulatory subunit associated protein 1 (CDK5RAP1), transcript variant 2
B16R17C18	16-18-17	Hs~Ref:NM_016082.3~uORF:IOH45468	540	435	925	371	468	536	697	495	972	263	CDK5 regulatory subunit associated protein 1 (CDK5RAP1), transcript variant 2
B16R17C19	16-19-17	Hs~Ref:NM_004059.3~uORF:IOH45917	636	404	665	366	366	180	630	475	1149	987	cysteine conjugate-beta lyase; cytoplasmic (glutamine transaminase K, kyneurenine aminotransferase) (CCBL1)
B16R17C20	16-20-17	Hs~Ref:NM_004059.3~uORF:IOH45917	698	429	735	342	503	4	613	480	1119	2	cysteine conjugate-beta lyase; cytoplasmic (glutamine transaminase K, kyneurenine aminotransferase) (CCBL1)
B16R17C21	16-21-17	Hs~Ref:NM_207316.1~uORF:IOH45939	785	1622	777	522	551	-40	1008	548	1382	244	Transmembrane protein 207
B16R17C22	16-22-17	Hs~Ref:NM_207316.1~uORF:IOH45939	836	1674	767	664	519	-23	1020	513	1339	-8	Transmembrane protein 207
B16R18C01	16-1-18	Hs~MGC:BC039362.1~uORF:IOH27730	370	326	452	328	290	357	749	409	786	180	carboxypeptidase A5 (CPA5)
B16R18C02	16-2-18	Hs~MGC:BC039362.1~uORF:IOH27730	354	191	500	305	420	106	718	397	839	173	carboxypeptidase A5 (CPA5)
B16R18C03	16-3-18	Hs~Ref:NM_006739.1~uORF:IOH2893	520	1836	732	403	410	514	756	386	926	184	minichromosome maintenance complex component 5 (MCM5)
B16R18C04	16-4-18	Hs~Ref:NM_006739.1~uORF:IOH2893	561	1880	695	353	6575	526	739	651	876	287	minichromosome maintenance complex component 5 (MCM5)
B16R18C05	16-5-18	Hs~MGC:NM_014089.2~uORF:IOH4601	568	1058	678	291	6011	580	644	465	1037	143	nucleoporin like 1 (NUPL1), transcript variant 1
B16R18C06	16-6-18	Hs~MGC:NM_014089.2~uORF:IOH4601	575	1031	599	413	2300	503	697	407	1140	222	nucleoporin like 1 (NUPL1), transcript variant 1
B16R18C07	16-7-18	Hs~MGC:BC009780.1~uORF:IOH13685	573	542	708	447	1869	621	904	550	970	323	splicing factor 3b, subunit 3, 130kDa (SF3B3)
B16R18C08	16-8-18	Hs~MGC:BC009780.1~uORF:IOH13685	574	501	769	397	1917	711	896	795	1034	345	splicing factor 3b, subunit 3, 130kDa (SF3B3)
B16R18C09	16-9-18	Hs~Ref:NM_024056.1~uORF:IOH3247	762	649	1373	540	3127	785	1649	1003	1632	399	transmembrane protein 106C (TMEM106C)
B16R18C10	16-10-18	Hs~Ref:NM_024056.1~uORF:IOH3247	846	765	1394	536	3419	778	1598	677	1642	397	transmembrane protein 106C (TMEM106C)
B16R18C11	16-11-18	Hs~Ref:NM_012153.1~uORF:IOH26169	2149	1163	1209	772	3496	1874	4088	911	1937	587	ets homologous factor (EHF)
B16R18C12	16-12-18	Hs~Ref:NM_012153.1~uORF:IOH26169	2361	1075	1279	819	3626	1726	4971	894	2001	820	ets homologous factor (EHF)
B16R18C13	16-13-18	Hs~MGC:BC041164.1~uORF:IOH26258	357	389	662	409	184	413	869	410	713	154	sphingomyelin phosphodiesterase 1, acid lysosomal (acid sphingomyelinase) (SMPD1)
B16R18C14	16-14-18	Hs~MGC:BC041164.1~uORF:IOH26258	238	440	642	320	278	247	925	548	726	176	sphingomyelin phosphodiesterase 1, acid lysosomal (acid sphingomyelinase) (SMPD1)
B16R18C15	16-15-18	Hs~Ref:NM_058170.1~uORF:IOH10815	247	402	627	339	194	180	1003	455	668	159	olfactomedin 3 (OLFM3)
B16R18C16	16-16-18	Hs~Ref:NM_058170.1~uORF:IOH10815	610	390	606	409	249	93	1013	402	626	136	olfactomedin 3 (OLFM3)
B16R18C17	16-17-18	Hs~Ref:NM_005736.2~uORF:IOH4325	582	451	676	339	252	341	967	536	901	202	ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) (ACTR1A)
B16R18C18	16-18-18	Hs~Ref:NM_005736.2~uORF:IOH4325	683	436	673	362	270	433	937	483	936	192	ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) (ACTR1A)
B16R18C19	16-19-18	Hs~Ref:NM_001007067.1~uORF:IOH41337	765	588	786	565	571	21	701	569	1214	294	syndecan binding protein (syntenin) (SDCBP), transcript variant 2
B16R18C20	16-20-18	Hs~Ref:NM_001007067.1~uORF:IOH41337	686	550	728	560	595	102	693	519	1239	311	syndecan binding protein (syntenin) (SDCBP), transcript variant 2
B16R18C21	16-21-18	Hs~Ref:NM_198243.1~uORF:IOH42495	663	493	719	563	548	388	926	583	1056	332	ankyrin repeat and SOCS box-containing 7 (ASB7), transcript variant 2
B16R18C22	16-22-18	Hs~Ref:NM_198243.1~uORF:IOH42495	296	556	759	645	471	367	904	584	1190	-13	ankyrin repeat and SOCS box-containing 7 (ASB7), transcript variant 2
B16R19C01	16-1-19	Hs~Ref:NM_138809.1~uORF:IOH11307	1174	778	787	560	642	1099	1533	1282	1868	462	Carboxymethylenebutenolidase homolog
B16R19C02	16-2-19	Hs~Ref:NM_138809.1~uORF:IOH11307	1188	764	912	531	837	1151	1512	1725	2018	510	Carboxymethylenebutenolidase homolog
B16R19C03	16-3-19	Hs~MGC:BC035911.1~uORF:IOH25946	1491	1005	1401	853	1092	1682	4335	1204	3327	701	DEAD (Asp-Glu-Ala-Asp) box polypeptide 55 (DDX55)
B16R19C04	16-4-19	Hs~MGC:BC035911.1~uORF:IOH25946	1552	1024	1365	912	1063	1718	4495	1042	3344	737	DEAD (Asp-Glu-Ala-Asp) box polypeptide 55 (DDX55)
B16R19C05	16-5-19	Hs~MGC:NM_173796.2~uORF:IOH23049	248	236	310	74	80	112	179	323	550	131	hypothetical protein MGC24125 (MGC24125)
B16R19C06	16-6-19	Hs~MGC:NM_173796.2~uORF:IOH23049	238	275	262	740	108	250	233	141	560	129	hypothetical protein MGC24125 (MGC24125)
B16R19C07	16-7-19	Hs~Ref:NM_032757.1~uORF:IOH6930	283	174	376	278	146	268	400	3163	739	405	hypothetical protein MGC15705 (MGC15705)
B16R19C08	16-8-19	Hs~Ref:NM_032757.1~uORF:IOH6930	259	37	389	191	251	203	435	3291	740	272	hypothetical protein MGC15705 (MGC15705)
B16R19C09	16-9-19	Hs~MGC:BC008417.1~uORF:IOH7579	291	139	567	210	378	3131	275	378	583	100	interferon induced transmembrane protein 3 (1-8U) (IFITM3)
B16R19C10	16-10-19	Hs~MGC:BC008417.1~uORF:IOH7579	819	148	597	278	448	3263	278	279	562	80	interferon induced transmembrane protein 3 (1-8U) (IFITM3)
B16R19C13	16-13-19	Hs~Ref:NM_006911.2~uORF:IOH7561	939	775	909	526	412	1042	1672	597	1174	8	relaxin 1 (RLN1)
B16R19C14	16-14-19	Hs~Ref:NM_006911.2~uORF:IOH7561	954	798	855	534	470	509	1658	646	1276	260	relaxin 1 (RLN1)
B16R19C15	16-15-19	Hs~Ref:NM_005112.4~uORF:IOH21634	932	741	1051	577	466	868	938	674	1410	945	WD repeat domain 1 (WDR1), transcript variant 2
B16R19C16	16-16-19	Hs~Ref:NM_005112.4~uORF:IOH21634	930	746	898	534	462	364	915	622	1371	978	WD repeat domain 1 (WDR1), transcript variant 2
B16R19C17	16-17-19	Hs~Ref:NM_014055.2~uORF:IOH41832	784	521	703	468	364	116	1382	579	1088	345	intraflagellar transport 81 homolog (Chlamydomonas) (IFT81), transcript variant 1
B16R19C18	16-18-19	Hs~Ref:NM_014055.2~uORF:IOH41832	800	508	835	460	516	602	1322	583	987	451	intraflagellar transport 81 homolog (Chlamydomonas) (IFT81), transcript variant 1
B16R19C19	16-19-19	Hs~Ref:NM_024787.2~uORF:IOH42086	514	391	632	269	171	244	708	454	765	214	RING finger protein 122
B16R19C20	16-20-19	Hs~Ref:NM_024787.2~uORF:IOH42086	561	393	545	271	350	759	733	482	730	178	RING finger protein 122
B16R19C21	16-21-19	Hs~Ref:NM_005127.2~uORF:IOH54638	845	545	761	395	290	335	827	499	759	-14	C-type lectin domain family 2 member B
B16R19C22	16-22-19	Hs~Ref:NM_005127.2~uORF:IOH54638	522	527	682	421	267	236	839	421	736	36	C-type lectin domain family 2 member B
B16R20C01	16-1-20	Hs~MGC:BC068530.1~uORF:IOH40123	222	176	244	246	42	93	429	219	291	55	Transportin-3
B16R20C02	16-2-20	Hs~MGC:BC068530.1~uORF:IOH40123	248	162	302	271	614	218	407	249	420	60	Transportin-3
B16R20C03	16-3-20	Hs~Ref:NM_015891.2~uORF:IOH44384	7772	3435	3142	2976	1909	3948	16601	7897	8120	16211	cell division cycle 40 homolog (S. cerevisiae) (CDC40)
B16R20C04	16-4-20	Hs~Ref:NM_015891.2~uORF:IOH44384	7171	3492	3006	2917	1869	3711	16521	6958	8498	16078	cell division cycle 40 homolog (S. cerevisiae) (CDC40)
B16R20C05	16-5-20	Hs~MGC:BC008726.1~N/A	4263	896	2697	1258	571	1030	4074	655	4088	2357	Serine/threonine-protein kinase OSR1
B16R20C06	16-6-20	Hs~MGC:BC008726.1~N/A	4189	847	2727	1211	6	1016	4202	680	4084	2402	Serine/threonine-protein kinase OSR1
B16R20C07	16-7-20	Hs~MGC:BC003595.1~uORF:IOH3758	326	370	817	167	338	200	487	279	1253	105	chromosome 17 open reading frame 62 (C17orf62)
B16R20C08	16-8-20	Hs~MGC:BC003595.1~uORF:IOH3758	308	293	748	226	566	316	484	268	1246	134	chromosome 17 open reading frame 62 (C17orf62)
B16R20C09	16-9-20	Hs~MGC:BC031997.1~uORF:IOH22163	55	103	79	39	323	191	92	87	89	10	skin aspartic protease (SASP)
B16R20C10	16-10-20	Hs~MGC:BC031997.1~uORF:IOH22163	48	110	28	45	293	35	52	115	51	272	skin aspartic protease (SASP)
B16R20C11	16-11-20	Hs~Ref:NM_002805.1~uORF:IOH3508	1713	835	771	356	569	568	1193	1464	2112	148	proteasome (prosome, macropain) 26S subunit, ATPase, 5 (PSMC5)
B16R20C12	16-12-20	Hs~Ref:NM_002805.1~uORF:IOH3508	992	559	780	612	563	465	1127	1647	1993	120	proteasome (prosome, macropain) 26S subunit, ATPase, 5 (PSMC5)
B16R20C13	16-13-20	Hs~MGC:BC031661.1~uORF:IOH22763	211	266	486	184	221	400	668	231	1787	75	hypothetical gene supported by BC031661 (LOC389458)
B16R20C14	16-14-20	Hs~MGC:BC031661.1~uORF:IOH22763	221	342	525	179	249	192	587	205	1688	68	hypothetical gene supported by BC031661 (LOC389458)
B17R02C11	17-11-2	Hs~MGC:BC010128.2~uORF:IOH12234	917	804	1745	899	1265	779	1454	771	2296	517	transmembrane protein 100 (TMEM100)
B17R02C12	17-12-2	Hs~MGC:BC010128.2~uORF:IOH12234	850	810	1647	847	1237	781	1480	834	2472	526	transmembrane protein 100 (TMEM100)
B17R02C13	17-13-2	Hs~Ref:NM_003280.1~uORF:IOH21526	283	525	558	398	947	401	875	316	8389	278	troponin C type 1 (slow) (TNNC1)
B17R02C14	17-14-2	Hs~Ref:NM_003280.1~uORF:IOH21526	292	532	586	405	452	348	873	310	8613	169	troponin C type 1 (slow) (TNNC1)
B17R02C15	17-15-2	Hs~MGC:NM_152353.1~uORF:IOH22553	509	428	800	427	600	785	781	655	1205	372	claudin domain containing 2 (CLDND2)
B17R02C16	17-16-2	Hs~MGC:NM_152353.1~uORF:IOH22553	481	469	774	420	651	552	759	760	1261	370	claudin domain containing 2 (CLDND2)
B17R02C19	17-19-2	Hs~MGC:BC032452.1~uORF:IOH21664	1	-3	-8	-2	26696	17371	16057	15836	26843	20962	immunoglobulin lambda locus (IGL@)
B17R02C20	17-20-2	Hs~MGC:BC032452.1~uORF:IOH21664	-1	1	4281	0	26711	17393	16176	14443	27471	21901	immunoglobulin lambda locus (IGL@)
B17R02C21	17-21-2	Hs~MGC:BC032567.1~uORF:IOH21895	712	568	1665	471	690	659	1254	669	1819	346	neuroligin 4, Y-linked (NLGN4Y)
B17R02C22	17-22-2	Hs~MGC:BC032567.1~uORF:IOH21895	701	558	1986	450	706	695	1176	708	2210	332	neuroligin 4, Y-linked (NLGN4Y)
B17R03C01	17-1-3	Hs~Ref:NM_024900.2~uORF:IOH21646	1659	786	1539	496	750	1504	1995	588	1799	348	PHD finger protein 17 (PHF17), transcript variant S
B17R03C02	17-2-3	Hs~Ref:NM_024900.2~uORF:IOH21646	1565	648	1480	1040	727	1426	2053	576	1702	385	PHD finger protein 17 (PHF17), transcript variant S
B17R03C03	17-3-3	Hs~MGC:BC032393.1~uORF:IOH21681	1030	738	1487	1195	581	799	1569	636	1417	376	ring finger protein 170 (RNF170)
B17R03C04	17-4-3	Hs~MGC:BC032393.1~uORF:IOH21681	1085	749	1645	711	653	791	1499	688	1402	359	ring finger protein 170 (RNF170)
B17R03C05	17-5-3	Hs~MGC:BC018728.1~uORF:IOH14027	618	555	608	384	391	487	755	381	990	310	eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa (EIF2B3)
B17R03C06	17-6-3	Hs~MGC:BC018728.1~uORF:IOH14027	618	610	633	401	421	491	749	1344	954	342	eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa (EIF2B3)
B17R03C07	17-7-3	Hs~Ref:NM_004492.1~uORF:IOH6006	634	559	740	418	433	543	733	686	917	353	general transcription factor IIA, 2, 12kDa (GTF2A2)
B17R03C08	17-8-3	Hs~Ref:NM_004492.1~uORF:IOH6006	653	481	873	499	577	577	944	534	1037	465	general transcription factor IIA, 2, 12kDa (GTF2A2)
B17R03C09	17-9-3	Hs~Ref:NM_002904.4~uORF:IOH14621	27527	21970	16331	22355	27834	14367	22364	10191	24874	13888	RD RNA binding protein (RDBP)
B17R03C10	17-10-3	Hs~Ref:NM_002904.4~uORF:IOH14621	27730	20850	16006	24357	27004	14160	22996	10834	25017	14587	RD RNA binding protein (RDBP)
B17R03C11	17-11-3	Hs~Ref:NM_006815.2~uORF:IOH14559	525	415	771	339	560	437	737	378	732	275	transmembrane emp24 domain trafficking protein 2 (TMED2)
B17R03C12	17-12-3	Hs~Ref:NM_006815.2~uORF:IOH14559	441	346	601	276	557	458	622	412	682	239	transmembrane emp24 domain trafficking protein 2 (TMED2)
B17R03C13	17-13-3	Hs~Ref:NM_020830.1~uORF:IOH27506	251	149	307	296	417	165	192	339	652	158	WD repeat and FYVE domain containing 1 (WDFY1)
B17R03C14	17-14-3	Hs~Ref:NM_020830.1~uORF:IOH27506	197	178	208	167	431	1188	190	240	620	184	WD repeat and FYVE domain containing 1 (WDFY1)
B17R03C15	17-15-3	Hs~MGC:BC034554.1~uORF:IOH25751	429	342	510	720	515	705	292	795	937	249	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 (SERPINA3)
B17R03C16	17-16-3	Hs~MGC:BC034554.1~uORF:IOH25751	429	337	513	710	602	642	305	809	957	33	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 (SERPINA3)
B17R03C17	17-17-3	Hs~Ref:NM_000071.1~uORF:IOH10211	572	481	1790	555	592	2214	1635	831	1737	329	cystathionine-beta-synthase (CBS)
B17R03C18	17-18-3	Hs~Ref:NM_000071.1~uORF:IOH10211	510	498	1768	546	565	2383	1729	796	1772	325	cystathionine-beta-synthase (CBS)
B17R03C19	17-19-3	Hs~Ref:NM_003805.2~uORF:IOH10393	412	539	674	863	757	623	1673	620	832	415	CASP2 and RIPK1 domain containing adaptor with death domain (CRADD)
B17R03C20	17-20-3	Hs~Ref:NM_003805.2~uORF:IOH10393	417	509	1016	876	769	600	1793	623	762	419	CASP2 and RIPK1 domain containing adaptor with death domain (CRADD)
B17R03C21	17-21-3	Hs~MGC:BC005911.1~uORF:IOH7548	593	503	1255	451	657	557	749	467	1061	336	sterol carrier protein 2 (SCP2)
B17R03C22	17-22-3	Hs~MGC:BC005911.1~uORF:IOH7548	606	519	1199	443	690	561	717	523	1113	306	sterol carrier protein 2 (SCP2)
B17R04C01	17-1-4	Hs~Ref:NM_001983.1~uORF:IOH5754	2047	1114	2811	1171	4797	1272	5295	1052	2861	734	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) (ERCC1), transcript variant 2
B17R04C02	17-2-4	Hs~Ref:NM_001983.1~uORF:IOH5754	2045	1096	2814	1323	4824	1285	5421	1044	2771	773	excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) (ERCC1), transcript variant 2
B17R04C03	17-3-4	Hs~Ref:NM_032712.1~uORF:IOH6582	1113	1008	1196	918	804	1082	1784	793	1917	596	MGC13170 gene (MGC13170)
B17R04C04	17-4-4	Hs~Ref:NM_032712.1~uORF:IOH6582	1101	1021	1294	732	838	1113	1933	915	1802	625	MGC13170 gene (MGC13170)
B17R04C05	17-5-4	Hs~Ref:NM_025108.1~uORF:IOH13954	1409	1025	1609	990	970	1650	2548	935	1858	7268	chromosome 16 open reading frame 59 (C16orf59)
B17R04C06	17-6-4	Hs~Ref:NM_025108.1~uORF:IOH13954	1204	1103	1598	1047	1119	1422	2800	1378	1842	7964	chromosome 16 open reading frame 59 (C16orf59)
B17R04C07	17-7-4	Hs~Ref:NM_032461.2~uORF:IOH22292	834	786	1571	2247	640	6669	1905	689	1635	331	SPANX family, member B1 (SPANXB1)
B17R04C08	17-8-4	Hs~Ref:NM_032461.2~uORF:IOH22292	1540	711	1686	2381	741	6710	1956	927	1638	326	SPANX family, member B1 (SPANXB1)
B17R04C09	17-9-4	Hs~MGC:BC036365.1~uORF:IOH22309	1227	1337	2061	537	1137	21085	1769	828	7657	642	PH domain-containing protein C10orf81
B17R04C10	17-10-4	Hs~MGC:BC036365.1~uORF:IOH22309	1027	1310	2178	611	1469	20957	1689	647	7717	658	PH domain-containing protein C10orf81
B17R04C11	17-11-4	Hs~Ref:NM_147180.1~uORF:IOH22320	200	359	781	235	343	465	695	347	805	238	protein phosphatase 3 (formerly 2B), regulatory subunit B, beta isoform (PPP3R2)
B17R04C12	17-12-4	Hs~Ref:NM_147180.1~uORF:IOH22320	126	390	769	234	421	419	689	364	799	111	protein phosphatase 3 (formerly 2B), regulatory subunit B, beta isoform (PPP3R2)
B17R04C13	17-13-4	Hs~MGC:BC014607.2~uORF:IOH10910	519	1732	1029	372	1079	1426	1362	2181	1013	303	Ropporin-1-like protein
B17R04C14	17-14-4	Hs~MGC:BC014607.2~uORF:IOH10910	538	1706	1050	353	581	1415	1422	2256	995	93	Ropporin-1-like protein
B17R04C15	17-15-4	Hs~Ref:NM_006120.2~uORF:IOH12744	726	448	996	510	548	691	904	485	1149	299	major histocompatibility complex, class II, DM alpha (HLA-DMA)
B17R04C16	17-16-4	Hs~Ref:NM_006120.2~uORF:IOH12744	733	457	942	490	657	562	925	483	1219	275	major histocompatibility complex, class II, DM alpha (HLA-DMA)
B17R04C17	17-17-4	Hs~MGC:BC007833.2~uORF:IOH6700	1196	3713	1805	783	587	959	2858	1120	1437	339	phosphatidylinositol-4-phosphate 5-kinase, type I, alpha (PIP5K1A)
B17R04C18	17-18-4	Hs~MGC:BC007833.2~uORF:IOH6700	1137	3866	1793	803	520	924	3060	1227	1327	349	phosphatidylinositol-4-phosphate 5-kinase, type I, alpha (PIP5K1A)
B17R04C19	17-19-4	Hs~Ref:NM_153339.1~uORF:IOH22364	1090	822	1061	734	734	890	1790	1430	1265	558	pseudouridylate synthase-like 1 (PUSL1)
B17R04C20	17-20-4	Hs~Ref:NM_153339.1~uORF:IOH22364	1212	903	1092	814	646	941	1734	1489	1243	593	pseudouridylate synthase-like 1 (PUSL1)
B17R04C21	17-21-4	Hs~MGC:NM_152542.2~uORF:IOH27547	952	461	933	451	603	544	787	458	975	290	protein phosphatase 1K (PP2C domain containing) (PPM1K)
B17R04C22	17-22-4	Hs~MGC:NM_152542.2~uORF:IOH27547	915	509	986	422	781	597	780	481	1163	289	protein phosphatase 1K (PP2C domain containing) (PPM1K)
B17R05C01	17-1-5	Hs~Ref:NM_130809.2~uORF:IOH40868	806	480	1230	239	277	847	1241	485	1013	197	Protein PPRC1
B17R05C02	17-2-5	Hs~Ref:NM_130809.2~uORF:IOH40868	781	349	1261	241	273	870	1288	494	909	184	Protein PPRC1
B17R05C03	17-3-5	Hs~MGC:BC026030.1~uORF:IOH14611	4572	2185	5585	2635	1719	1576	4365	1597	3585	749	zinc finger protein 239 (ZNF239)
B17R05C04	17-4-5	Hs~MGC:BC026030.1~uORF:IOH14611	4710	2125	5892	2586	1664	1751	4425	1578	3850	810	zinc finger protein 239 (ZNF239)
B17R05C05	17-5-5	Hs~Ref:NM_019617.2~uORF:IOH39863	669	386	554	302	399	509	656	447	575	214	gastrokine 1 (GKN1)
B17R05C06	17-6-5	Hs~Ref:NM_019617.2~uORF:IOH39863	715	426	618	317	558	470	655	445	607	221	gastrokine 1 (GKN1)
B17R05C07	17-7-5	Hs~Ref:NM_000376.1~uORF:IOH39811	668	190	656	955	1772	1265	717	753	1403	296	vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR), transcript variant 1
B17R05C08	17-8-5	Hs~Ref:NM_000376.1~uORF:IOH39811	809	479	633	1002	1905	1233	722	846	1445	294	vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR), transcript variant 1
B17R05C09	17-9-5	Hs~MGC:BC017785.1~uORF:IOH12191	1390	1013	2062	1066	1414	1341	2477	1004	2688	786	protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (PTPN22)
B17R05C10	17-10-5	Hs~MGC:BC017785.1~uORF:IOH12191	1387	1110	1989	978	1627	1261	2334	1064	2757	819	protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (PTPN22)
B17R05C11	17-11-5	Hs~MGC:BC017589.2~uORF:IOH10834	910	791	1040	783	1472	793	1435	686	1913	463	tumor protein D52-like 3 (TPD52L3)
B17R05C12	17-12-5	Hs~MGC:BC017589.2~uORF:IOH10834	993	780	1196	757	1628	781	1361	812	1997	465	tumor protein D52-like 3 (TPD52L3)
B17R05C13	17-13-5	Hs~Ref:NM_032140.1~uORF:IOH6250	7481	7889	6680	7958	6996	3860	6406	3964	5770	4547	chromosome 16 open reading frame 48 (C16orf48)
B17R05C14	17-14-5	Hs~Ref:NM_032140.1~uORF:IOH6250	8288	7987	6793	7633	5827	3088	6541	4169	5944	5108	chromosome 16 open reading frame 48 (C16orf48)
B17R05C15	17-15-5	Hs~Ref:NM_007099.1~uORF:IOH6098	1612	1577	1958	1714	2784	2995	2149	2820	3910	1021	acid phosphatase 1, soluble (ACP1), transcript variant 2
B17R05C16	17-16-5	Hs~Ref:NM_007099.1~uORF:IOH6098	1587	1660	1828	1807	2760	2594	2195	2587	4204	1058	acid phosphatase 1, soluble (ACP1), transcript variant 2
B17R05C17	17-17-5	Hs~MGC:BC020898.1~uORF:IOH13022	270	312	368	106	360	160	418	193	1453	156	transmembrane protein 182 (TMEM182)
B17R05C18	17-18-5	Hs~MGC:BC020898.1~uORF:IOH13022	240	313	360	125	362	196	409	198	1378	81	transmembrane protein 182 (TMEM182)
B17R05C19	17-19-5	Hs~Ref:NM_016490.3~uORF:IOH40879	68	66	212	998	203	44	203	111	276	165	hypothetical protein LOC51252 (LOC51252)
B17R05C20	17-20-5	Hs~Ref:NM_016490.3~uORF:IOH40879	100	2205	216	985	294	269	192	97	309	13	hypothetical protein LOC51252 (LOC51252)
B17R06C03	17-3-6	Hs~Ref:NM_020142.2~uORF:IOH12540	746	1947	842	2305	490	830	837	639	943	298	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 (NDUFA4L2)
B17R06C04	17-4-6	Hs~Ref:NM_020142.2~uORF:IOH12540	718	1850	888	2210	466	885	885	692	917	293	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 (NDUFA4L2)
B17R06C05	17-5-6	Hs~MGC:BC012120.1~uORF:IOH12484	1004	695	1157	498	530	733	1284	494	1320	354	nuclear factor I/C (CCAAT-binding transcription factor) (NFIC)
B17R06C06	17-6-6	Hs~MGC:BC012120.1~uORF:IOH12484	1064	778	1170	529	627	736	1330	501	1265	376	nuclear factor I/C (CCAAT-binding transcription factor) (NFIC)
B17R06C07	17-7-6	Hs~Ref:NM_007271.1~uORF:IOH13030	1160	584	923	740	869	2157	1182	445	2452	507	serine/threonine kinase 38 (STK38)
B17R06C08	17-8-6	Hs~Ref:NM_007271.1~uORF:IOH13030	1156	489	980	1042	1043	1959	1279	389	2391	515	serine/threonine kinase 38 (STK38)
B17R06C09	17-9-6	Hs~Ref:NM_014034.1~uORF:IOH12142	2210	1604	595	1304	2168	888	1628	563	1044	311	ASF1 anti-silencing function 1 homolog A (S. cerevisiae) (ASF1A)
B17R06C10	17-10-6	Hs~Ref:NM_014034.1~uORF:IOH12142	758	1729	636	1176	2668	900	1624	804	1076	300	ASF1 anti-silencing function 1 homolog A (S. cerevisiae) (ASF1A)
B17R06C11	17-11-6	Hs~Ref:NM_053055.2~uORF:IOH39985	1108	2522	1401	2027	1355	792	1583	1173	1548	925	thioesterase superfamily member 4 (THEM4)
B17R06C12	17-12-6	Hs~Ref:NM_053055.2~uORF:IOH39985	1152	2548	1672	1968	1499	809	1536	659	1560	1110	thioesterase superfamily member 4 (THEM4)
B17R06C13	17-13-6	Hs~Ref:NM_002540.3~uORF:IOH40890	1451	1258	1095	641	1677	837	790	766	1312	409	outer dense fiber of sperm tails 2 (ODF2), transcript variant 1
B17R06C14	17-14-6	Hs~Ref:NM_002540.3~uORF:IOH40890	1521	1227	1092	677	1268	810	872	827	1417	487	outer dense fiber of sperm tails 2 (ODF2), transcript variant 1
B17R06C15	17-15-6	Hs~Ref:NM_001007246.1~uORF:IOH39941	2138	797	1215	997	1498	933	636	1076	7258	917	bromodomain and WD repeat domain containing 1 (BRWD1), transcript variant 3
B17R06C16	17-16-6	Hs~Ref:NM_001007246.1~uORF:IOH39941	2165	829	1212	994	1577	773	647	979	7305	900	bromodomain and WD repeat domain containing 1 (BRWD1), transcript variant 3
B17R06C17	17-17-6	Hs~Ref:NM_175614.2~uORF:IOH40018	413	352	515	293	380	390	613	301	503	226	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa (NDUFA11)
B17R06C18	17-18-6	Hs~Ref:NM_175614.2~uORF:IOH40018	407	347	497	299	385	624	595	321	528	211	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa (NDUFA11)
B17R06C19	17-19-6	Hs~Ref:NM_018222.2~uORF:IOH27894	717	1080	809	550	863	962	7448	462	1797	342	parvin, alpha (PARVA)
B17R06C20	17-20-6	Hs~Ref:NM_018222.2~uORF:IOH27894	679	1518	785	541	956	969	7269	510	1792	332	parvin, alpha (PARVA)
B17R06C21	17-21-6	Hs~MGC:BC051304.1~uORF:IOH28074	606	722	812	455	1842	1578	1208	741	1627	313	tensin 1 (TNS1)
B17R06C22	17-22-6	Hs~MGC:BC051304.1~uORF:IOH28074	605	523	732	446	1800	1591	1218	730	1764	290	tensin 1 (TNS1)
B17R07C01	17-1-7	Hs~MGC:BC011719.1~uORF:IOH27841	430	154	538	283	283	352	623	260	483	238	transmembrane protein 43 (TMEM43)
B17R07C02	17-2-7	Hs~MGC:BC011719.1~uORF:IOH27841	416	212	570	329	161	345	733	291	497	207	transmembrane protein 43 (TMEM43)
B17R07C03	17-3-7	Hs~MGC:BC017917.1~uORF:IOH27928	642	593	1393	921	401	826	3166	457	1259	288	triosephosphate isomerase 1 (TPI1)
B17R07C04	17-4-7	Hs~MGC:BC017917.1~uORF:IOH27928	603	519	1416	881	444	799	3311	531	1260	326	triosephosphate isomerase 1 (TPI1)
B17R07C05	17-5-7	Hs~MGC:BC029482.1~uORF:IOH27979	612	326	656	383	519	504	712	464	1275	334	hypothetical protein HSPC152 (HSPC152)
B17R07C06	17-6-7	Hs~MGC:BC029482.1~uORF:IOH27979	665	301	651	403	567	469	698	396	1247	346	hypothetical protein HSPC152 (HSPC152)
B17R07C07	17-7-7	Hs~MGC:NM_199001.1~uORF:IOH28105	582	662	1400	564	1583	2072	1032	1846	2364	683	Similar to RIKEN cDNA 2310002J15 gene (MGC59937)
B17R07C08	17-8-7	Hs~MGC:NM_199001.1~uORF:IOH28105	523	660	1523	529	1519	2127	1010	1896	2239	736	Similar to RIKEN cDNA 2310002J15 gene (MGC59937)
B17R07C09	17-9-7	Hs~Ref:NM_007054.1~uORF:IOH26900	4014	2423	3710	1749	1619	2766	15308	1462	3617	773	kinesin family member 3A (KIF3A)
B17R07C10	17-10-7	Hs~Ref:NM_007054.1~uORF:IOH26900	4677	2199	3847	1539	1660	2701	15063	1593	3691	828	kinesin family member 3A (KIF3A)
B17R07C11	17-11-7	Hs~MGC:BC044590.1~uORF:IOH26759	327	313	492	245	276	303	456	507	796	244	ARP3 actin-related protein 3 homolog (yeast) (ACTR3)
B17R07C12	17-12-7	Hs~MGC:BC044590.1~uORF:IOH26759	359	275	367	235	379	312	556	376	708	216	ARP3 actin-related protein 3 homolog (yeast) (ACTR3)
B17R07C13	17-13-7	Hs~Ref:NM_009588.1~uORF:IOH44736	815	837	1093	607	1750	1020	1268	728	1330	481	lymphotoxin beta (TNF superfamily, member 3) (LTB), transcript variant 2
B17R07C14	17-14-7	Hs~Ref:NM_009588.1~uORF:IOH44736	800	837	1042	568	1119	1009	1262	828	1375	447	lymphotoxin beta (TNF superfamily, member 3) (LTB), transcript variant 2
B17R07C15	17-15-7	Hs~Ref:NM_000415.1~uORF:IOH43658	1014	997	1449	1362	1090	1436	1731	987	2185	708	islet amyloid polypeptide (IAPP)
B17R07C16	17-16-7	Hs~Ref:NM_000415.1~uORF:IOH43658	1084	955	1511	1382	1173	1233	1688	955	2102	729	islet amyloid polypeptide (IAPP)
B17R07C17	17-17-7	Hs~Ref:NM_173578.1~uORF:IOH42338	1684	3628	2476	1310	1652	1255	2545	1385	2197	1035	chromosome 11 open reading frame 72 (C11orf72)
B17R07C18	17-18-7	Hs~Ref:NM_173578.1~uORF:IOH42338	1749	3567	2511	1370	1726	1268	2390	1372	2400	1042	chromosome 11 open reading frame 72 (C11orf72)
B17R07C19	17-19-7	Hs~Ref:NM_024492.2~uORF:IOH42061	1145	1376	1796	1042	2050	1201	2334	1287	3137	573	lipoprotein, Lp(a)-like 2 (LPAL2), transcript variant 1
B17R07C20	17-20-7	Hs~Ref:NM_024492.2~uORF:IOH42061	1089	1525	1812	988	1971	1178	2307	1259	3312	598	lipoprotein, Lp(a)-like 2 (LPAL2), transcript variant 1
B17R07C21	17-21-7	Hs~MGC:BC022098.1~uORF:IOH14790	18325	16234	17909	16414	19797	13700	13127	11580	17744	13423	cDNA clone MGC:31944 IMAGE:4878869, complete cds
B17R07C22	17-22-7	Hs~MGC:BC022098.1~uORF:IOH14790	18955	16349	17050	16194	18939	13501	13441	11055	19863	14457	cDNA clone MGC:31944 IMAGE:4878869, complete cds
B17R08C01	17-1-8	Hs~Ref:NM_004722.2~uORF:IOH14632	2509	2142	2537	1202	1397	1472	2478	1965	6461	1121	adaptor-related protein complex 4, mu 1 subunit (AP4M1)
B17R08C02	17-2-8	Hs~Ref:NM_004722.2~uORF:IOH14632	2723	2007	2692	1346	1420	1501	2442	1927	6507	1198	adaptor-related protein complex 4, mu 1 subunit (AP4M1)
B17R08C03	17-3-8	Hs~MGC:BC025281.1~uORF:IOH14071	2229	1581	2668	1698	2009	2052	4602	1643	3523	1048	RNA binding motif protein 9 (RBM9)
B17R08C04	17-4-8	Hs~MGC:BC025281.1~uORF:IOH14071	2152	1621	2588	1599	2017	2014	4719	1546	3663	1074	RNA binding motif protein 9 (RBM9)
B17R08C05	17-5-8	Hs~Ref:NM_144608.1~uORF:IOH14178	1874	1428	1953	1166	3805	1626	3278	1614	3551	826	hexamthylene bis-acetamide inducible 2 (HEXIM2)
B17R08C06	17-6-8	Hs~Ref:NM_144608.1~uORF:IOH14178	1881	1474	1966	1284	3676	1690	3401	1470	3570	832	hexamthylene bis-acetamide inducible 2 (HEXIM2)
B17R08C07	17-7-8	Hs~MGC:BC012547.1~uORF:IOH14261	1171	931	883	667	3982	2071	4938	667	1521	404	eukaryotic translation initiation factor 4A, isoform 2 (EIF4A2)
B17R08C08	17-8-8	Hs~MGC:BC012547.1~uORF:IOH14261	1203	911	884	706	3847	2107	4862	618	1529	394	eukaryotic translation initiation factor 4A, isoform 2 (EIF4A2)
B17R08C09	17-9-8	Hs~Ref:NM_031302.2~uORF:IOH13397	1073	375	551	513	372	601	610	388	441	111	glycosyltransferase 8 domain containing 2 (GLT8D2)
B17R08C10	17-10-8	Hs~Ref:NM_031302.2~uORF:IOH13397	985	386	557	329	352	559	655	363	636	45	glycosyltransferase 8 domain containing 2 (GLT8D2)
B17R08C11	17-11-8	Hs~MGC:BC004424.1~uORF:IOH5017	542	789	836	539	753	952	900	1017	1313	352	polymerase (RNA) III (DNA directed) polypeptide C (62kD) (POLR3C)
B17R08C12	17-12-8	Hs~MGC:BC004424.1~uORF:IOH5017	529	752	791	540	782	979	807	896	1305	334	polymerase (RNA) III (DNA directed) polypeptide C (62kD) (POLR3C)
B17R08C13	17-13-8	Hs~Ref:NM_032567.1~uORF:IOH21814	1602	1047	1712	1113	1094	901	4124	1191	1432	1324	spermatogenic leucine zipper 1 (SPZ1)
B17R08C14	17-14-8	Hs~Ref:NM_032567.1~uORF:IOH21814	1654	1034	1655	1208	1000	1047	3966	828	1459	1413	spermatogenic leucine zipper 1 (SPZ1)
B17R08C15	17-15-8	Hs~Ref:NM_018285.1~uORF:IOH10307	1041	608	1037	578	522	744	2258	568	1115	315	IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) (IMP3)
B17R08C16	17-16-8	Hs~Ref:NM_018285.1~uORF:IOH10307	1024	620	1048	548	644	798	2302	560	1099	354	IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) (IMP3)
B17R08C17	17-17-8	Hs~MGC:BC017423.1~uORF:IOH12806	692	325	680	773	582	509	1183	569	675	265	mesoderm induction early response 1 homolog (Xenopus laevis) (MIER1)
B17R08C18	17-18-8	Hs~MGC:BC017423.1~uORF:IOH12806	654	314	696	748	541	455	1170	582	702	266	mesoderm induction early response 1 homolog (Xenopus laevis) (MIER1)
B17R08C21	17-21-8	Hs~MGC:BC006182.1~uORF:IOH5966	502	365	575	288	451	377	459	400	560	248	calmodulin 3 (phosphorylase kinase, delta) (CALM3)
B17R08C22	17-22-8	Hs~MGC:BC006182.1~uORF:IOH5966	502	434	430	268	461	371	464	348	521	209	calmodulin 3 (phosphorylase kinase, delta) (CALM3)
B17R09C01	17-1-9	Hs~Ref:NM_002177.1~uORF:IOH35249	752	693	908	488	610	634	975	674	1102	377	interferon, omega 1 (IFNW1)
B17R09C02	17-2-9	Hs~Ref:NM_002177.1~uORF:IOH35249	760	627	930	494	595	656	974	526	1091	386	interferon, omega 1 (IFNW1)
B17R09C05	17-5-9	Hs~Ref:NM_020646.1~uORF:IOH35199	1772	1516	1923	1613	1427	1211	1900	1322	2401	706	achaete-scute complex homolog 3 (Drosophila) (ASCL3)
B17R09C06	17-6-9	Hs~Ref:NM_020646.1~uORF:IOH35199	1771	1587	1984	1674	1564	1113	1955	1278	2231	731	achaete-scute complex homolog 3 (Drosophila) (ASCL3)
B17R09C07	17-7-9	Hs~Ref:NM_012315.1~uORF:IOH35357	820	791	981	587	780	822	1249	718	1525	531	kallikrein-related peptidase 9 (KLK9)
B17R09C08	17-8-9	Hs~Ref:NM_012315.1~uORF:IOH35357	866	742	1028	586	722	835	1114	662	1521	525	kallikrein-related peptidase 9 (KLK9)
B17R09C09	17-9-9	Hs~Ref:NM_000045.2~uORF:IOH14233	669	617	1280	1337	642	876	1089	676	1914	370	arginase, liver (ARG1)
B17R09C10	17-10-9	Hs~Ref:NM_000045.2~uORF:IOH14233	733	649	1243	1530	682	756	1050	628	1932	398	arginase, liver (ARG1)
B17R09C11	17-11-9	Hs~Ref:NM_004508.1~uORF:IOH7273	440	260	565	302	320	359	865	801	553	264	isopentenyl-diphosphate delta isomerase 1 (IDI1)
B17R09C12	17-12-9	Hs~Ref:NM_004508.1~uORF:IOH7273	413	334	543	264	326	298	704	835	541	294	isopentenyl-diphosphate delta isomerase 1 (IDI1)
B17R09C13	17-13-9	Hs~MGC:BC022374.1~uORF:IOH14795	401	286	467	283	749	510	455	533	551	244	PHD finger protein 19
B17R09C14	17-14-9	Hs~MGC:BC022374.1~uORF:IOH14795	453	289	446	277	524	599	463	366	556	222	PHD finger protein 19
B17R09C15	17-15-9	Hs~Ref:NM_002960.1~uORF:IOH11798	598	360	724	445	456	545	873	367	788	269	S100 calcium binding protein A3 (S100A3)
B17R09C16	17-16-9	Hs~Ref:NM_002960.1~uORF:IOH11798	593	377	722	445	478	581	858	368	759	270	S100 calcium binding protein A3 (S100A3)
B17R09C17	17-17-9	Hs~MGC:BC005169.1~uORF:IOH5215	515	313	622	1055	861	414	789	592	649	258	Serine/threonine-protein kinase 40
B17R09C18	17-18-9	Hs~MGC:BC005169.1~uORF:IOH5215	575	321	586	1108	734	365	823	575	661	248	Serine/threonine-protein kinase 40
B17R09C19	17-19-9	Hs~MGC:BC001213.1~uORF:IOH4785	630	464	776	376	2301	944	673	1294	709	283	Putative methyltransferase METT10D
B17R09C20	17-20-9	Hs~MGC:BC001213.1~uORF:IOH4785	649	475	918	404	2220	949	746	1324	657	251	Putative methyltransferase METT10D
B17R09C21	17-21-9	Hs~Ref:NM_002946.2~uORF:IOH4896	784	640	1051	1042	616	397	832	1042	1840	418	replication protein A2, 32kDa (RPA2)
B17R09C22	17-22-9	Hs~Ref:NM_002946.2~uORF:IOH4896	813	691	878	1024	719	421	853	1073	1806	421	replication protein A2, 32kDa (RPA2)
B17R10C01	17-1-10	Hs~Ref:NM_024057.1~uORF:IOH3194	1719	536	1076	327	350	427	533	567	838	326	Nucleoporin Nup37
B17R10C02	17-2-10	Hs~Ref:NM_024057.1~uORF:IOH3194	529	427	816	364	334	440	578	392	885	301	Nucleoporin Nup37
B17R10C03	17-3-10	Hs~Ref:NM_078467.1~uORF:IOH4470	2089	1229	1861	1591	1105	1717	3768	1177	3680	853	Cyclin-dependent kinase inhibitor 1
B17R10C04	17-4-10	Hs~Ref:NM_078467.1~uORF:IOH4470	2041	1183	1892	1603	1074	1609	3860	1262	3547	904	Cyclin-dependent kinase inhibitor 1
B17R10C05	17-5-10	Hs~MGC:BC025727.1~uORF:IOH11431	1056	1047	1175	816	645	1077	1282	920	2372	665	T-cell receptor alpha chain C region
B17R10C06	17-6-10	Hs~MGC:BC025727.1~uORF:IOH11431	980	1120	1154	729	786	999	1480	973	2375	641	T-cell receptor alpha chain C region
B17R10C07	17-7-10	Hs~MGC:BC011878.2~uORF:IOH13403	1591	1123	1580	853	914	1320	4659	1182	2762	656	Ring finger and transmembrane domain-containing protein 2
B17R10C08	17-8-10	Hs~MGC:BC011878.2~uORF:IOH13403	1794	1057	1688	898	937	1337	4729	1165	2592	669	Ring finger and transmembrane domain-containing protein 2
B17R12C03	17-3-12	Hs~Ref:NM_015849.2~uORF:IOH40271	521	933	782	461	375	567	730	819	0	1	elastase 2B (ELA2B)
B17R12C04	17-4-12	Hs~Ref:NM_015849.2~uORF:IOH40271	562	807	709	894	397	587	795	692	-1	0	elastase 2B (ELA2B)
B17R12C05	17-5-12	Hs~MGC:BC058288.1~uORF:IOH29443	580	642	1027	1110	1972	4006	623	573	-1	6	coiled-coil domain containing 40 (CCDC40)
B17R12C06	17-6-12	Hs~MGC:BC058288.1~uORF:IOH29443	583	733	1030	603	2606	3865	587	611	-1	0	coiled-coil domain containing 40 (CCDC40)
B17R12C07	17-7-12	Hs~MGC:BC040280.1~uORF:IOH27452	995	1402	1206	816	1046	1186	1582	1114	2261	764	coiled-coil domain containing 83 (CCDC83)
B17R12C08	17-8-12	Hs~MGC:BC040280.1~uORF:IOH27452	1041	1239	1212	778	996	1246	1668	1107	2165	818	coiled-coil domain containing 83 (CCDC83)
B17R12C09	17-9-12	Hs~MGC:BC051835.1~uORF:IOH27073	739	661	1003	588	719	836	1249	919	1500	517	mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B (MGAT4B)
B17R12C10	17-10-12	Hs~MGC:BC051835.1~uORF:IOH27073	1391	634	1025	1368	742	800	1224	983	1451	450	mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B (MGAT4B)
B17R12C11	17-11-12	Hs~MGC:BC047016.1~uORF:IOH26591	1577	1154	1803	1472	1421	1099	1702	1460	2784	599	FCH and double SH3 domains 1 (FCHSD1)
B17R12C12	17-12-12	Hs~MGC:BC047016.1~uORF:IOH26591	1271	1084	1695	801	1465	1121	1787	1447	2824	632	FCH and double SH3 domains 1 (FCHSD1)
B17R12C13	17-13-12	Hs~Ref:NM_032338.2~uORF:IOH7537	3136	1991	2235	1327	3078	1924	9441	1511	1804	697	chromosome 12 open reading frame 31 (C12orf31)
B17R12C14	17-14-12	Hs~Ref:NM_032338.2~uORF:IOH7537	3153	1937	2237	1407	2060	2016	9540	1486	1849	674	chromosome 12 open reading frame 31 (C12orf31)
B17R12C15	17-15-12	Hs~Ref:NM_198097.1~uORF:IOH13150	319	284	324	233	295	245	359	2141	441	204	chromosome 7 open reading frame 28B (C7orf28B)
B17R12C16	17-16-12	Hs~Ref:NM_198097.1~uORF:IOH13150	1040	246	370	238	279	793	352	920	462	201	chromosome 7 open reading frame 28B (C7orf28B)
B17R12C17	17-17-12	Hs~Ref:NM_006443.2~uORF:IOH12302	355	1650	484	416	361	407	1190	451	760	264	chromosome 6 open reading frame 108 (C6orf108), transcript variant 1
B17R12C18	17-18-12	Hs~Ref:NM_006443.2~uORF:IOH12302	386	1713	459	406	377	412	1148	424	743	175	chromosome 6 open reading frame 108 (C6orf108), transcript variant 1
B17R12C19	17-19-12	Hs~MGC:BC033758.1~uORF:IOH21879	749	471	621	456	262	549	1665	476	1245	288	centaurin, alpha 2 (CENTA2)
B17R12C20	17-20-12	Hs~MGC:BC033758.1~uORF:IOH21879	708	467	1369	403	335	494	1716	506	1099	284	centaurin, alpha 2 (CENTA2)
B17R12C21	17-21-12	Hs~Ref:NM_080659.1~uORF:IOH7410	631	1021	1274	512	621	587	752	1077	1014	1729	chromosome 11 open reading frame 52 (C11orf52)
B17R12C22	17-22-12	Hs~Ref:NM_080659.1~uORF:IOH7410	609	1054	1515	522	501	882	658	1155	1053	1950	chromosome 11 open reading frame 52 (C11orf52)
B17R13C01	17-1-13	Hs~MGC:BC018950.2~uORF:IOH14350	985	946	1054	2440	1579	2200	1153	1301	2106	973	TNF receptor-associated protein 1 (TRAP1)
B17R13C02	17-2-13	Hs~MGC:BC018950.2~uORF:IOH14350	904	875	932	2678	1496	2191	1234	1221	2103	1019	TNF receptor-associated protein 1 (TRAP1)
B17R13C03	17-3-13	Hs~Ref:NM_173565.1~uORF:IOH22306	1348	682	1258	1169	461	840	1638	731	1830	361	Radial spoke head 10 homolog B2
B17R13C04	17-4-13	Hs~Ref:NM_173565.1~uORF:IOH22306	1370	695	1169	1712	418	855	1547	759	1895	337	Radial spoke head 10 homolog B2
B17R13C05	17-5-13	Hs~Ref:NM_000100.2~uORF:IOH2908	417	438	433	300	310	328	237	236	619	234	cystatin B (stefin B) (CSTB)
B17R13C06	17-6-13	Hs~Ref:NM_000100.2~uORF:IOH2908	406	447	423	282	423	317	236	240	639	193	cystatin B (stefin B) (CSTB)
B17R13C07	17-7-13	Hs~MGC:BC034488.2~uORF:IOH22312	0	0	-4	1	-2	1	7	0	-1	0	ATP-binding cassette, sub-family F (GCN20), member 1 (ABCF1)
B17R13C08	17-8-13	Hs~MGC:BC034488.2~uORF:IOH22312	-1	0	122	-2	5	4	8	-2	-4	-1	ATP-binding cassette, sub-family F (GCN20), member 1 (ABCF1)
B17R13C09	17-9-13	Hs~Ref:NM_021955.1~uORF:IOH23153	1786	2719	1805	763	1113	1320	1584	967	1958	475	guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 (GNGT1)
B17R13C10	17-10-13	Hs~Ref:NM_021955.1~uORF:IOH23153	1665	2725	1799	946	1248	1356	1619	980	1996	466	guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 (GNGT1)
B17R13C11	17-11-13	Hs~MGC:BC001935.1~uORF:IOH5068	1338	445	763	487	562	703	951	999	11120	301	cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A)
B17R13C12	17-12-13	Hs~MGC:BC001935.1~uORF:IOH5068	1297	423	794	384	586	670	971	1011	11512	330	cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A)
B17R13C13	17-13-13	Hs~Ref:NM_020412.1~uORF:IOH22953	722	359	595	538	788	3900	741	443	1427	281	chromatin modifying protein 1B (CHMP1B)
B17R13C14	17-14-13	Hs~Ref:NM_020412.1~uORF:IOH22953	705	409	600	559	555	3953	712	499	1513	235	chromatin modifying protein 1B (CHMP1B)
B17R13C15	17-15-13	Hs~Ref:NM_002861.1~uORF:IOH3644	1054	842	1167	423	665	1036	947	942	6035	253	phosphate cytidylyltransferase 2, ethanolamine (PCYT2)
B17R13C16	17-16-13	Hs~Ref:NM_002861.1~uORF:IOH3644	1074	874	1200	421	652	1046	993	995	6033	180	phosphate cytidylyltransferase 2, ethanolamine (PCYT2)
B17R13C17	17-17-13	Hs~MGC:BC014847.1~uORF:IOH11791	701	817	1042	567	832	791	1187	748	1257	381	origin recognition complex, subunit 4-like (yeast) (ORC4L)
B17R13C18	17-18-13	Hs~MGC:BC014847.1~uORF:IOH11791	664	792	1068	574	836	754	1288	906	1159	399	origin recognition complex, subunit 4-like (yeast) (ORC4L)
B17R13C19	17-19-13	Hs~Ref:NM_005240.1~uORF:IOH13301	538	957	557	305	478	616	800	970	781	279	ets variant gene 3 (ETV3)
B17R13C20	17-20-13	Hs~Ref:NM_005240.1~uORF:IOH13301	500	1004	1312	297	588	595	730	1012	742	261	ets variant gene 3 (ETV3)
B17R13C21	17-21-13	Hs~Ref:NM_138769.1~uORF:IOH13192	898	741	1789	868	1159	1022	1493	987	1941	514	ras homolog gene family, member T2 (RHOT2)
B17R13C22	17-22-13	Hs~Ref:NM_138769.1~uORF:IOH13192	845	744	1360	888	1139	1135	1561	1045	2042	532	ras homolog gene family, member T2 (RHOT2)
B17R14C01	17-1-14	Hs~MGC:BC018140.1~uORF:IOH11816	477	688	729	339	415	687	885	476	1067	298	ribosomal protein S21 (RPS21)
B17R14C02	17-2-14	Hs~MGC:BC018140.1~uORF:IOH11816	478	615	896	402	373	623	875	448	1012	342	ribosomal protein S21 (RPS21)
B17R14C03	17-3-14	Hs~Ref:NM_152441.1~uORF:IOH11609	527	286	746	345	276	483	1049	453	653	354	F-box and leucine-rich repeat protein 14 (FBXL14)
B17R14C04	17-4-14	Hs~Ref:NM_152441.1~uORF:IOH11609	535	293	793	422	272	507	1021	428	729	398	F-box and leucine-rich repeat protein 14 (FBXL14)
B17R14C05	17-5-14	Hs~Ref:NM_001007097.1~uORF:IOH22213	498	465	640	1887	310	597	954	440	697	339	neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant b
B17R14C06	17-6-14	Hs~Ref:NM_001007097.1~uORF:IOH22213	491	502	542	308	363	522	958	418	696	332	neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant b
B17R14C07	17-7-14	Hs~MGC:BC028138.1~uORF:IOH11540	354	385	475	266	352	396	558	296	616	262	ubiquitin associated and SH3 domain containing, A (UBASH3A)
B17R14C08	17-8-14	Hs~MGC:BC028138.1~uORF:IOH11540	1067	275	503	318	447	392	573	325	632	232	ubiquitin associated and SH3 domain containing, A (UBASH3A)
B17R14C09	17-9-14	Hs~Ref:NM_004588.3~uORF:IOH22111	731	436	916	396	642	643	958	491	1187	313	sodium channel, voltage-gated, type II, beta (SCN2B)
B17R14C10	17-10-14	Hs~Ref:NM_004588.3~uORF:IOH22111	578	426	946	416	605	621	1034	501	1278	300	sodium channel, voltage-gated, type II, beta (SCN2B)
B17R14C11	17-11-14	Hs~Ref:NM_198920.1~uORF:IOH41177	703	406	696	1072	431	579	1245	554	1146	281	ubiquitin-conjugating enzyme E2C binding protein (UBE2CBP), mRNA.
B17R14C12	17-12-14	Hs~Ref:NM_198920.1~uORF:IOH41177	798	409	677	384	482	570	1202	492	1218	281	ubiquitin-conjugating enzyme E2C binding protein (UBE2CBP), mRNA.
B17R14C13	17-13-14	Hs~Ref:NM_017923.2~uORF:IOH42112	353	276	453	226	652	330	473	350	585	239	E3 ubiquitin-protein ligase MARCH1
B17R14C14	17-14-14	Hs~Ref:NM_017923.2~uORF:IOH42112	307	261	516	224	590	398	410	349	591	266	E3 ubiquitin-protein ligase MARCH1
B17R14C15	17-15-14	Hs~Ref:NM_002215.1~uORF:IOH42545	344	286	607	323	370	361	492	449	642	330	Inter-alpha-trypsin inhibitor heavy chain H1
B17R14C16	17-16-14	Hs~Ref:NM_002215.1~uORF:IOH42545	440	287	472	298	475	412	497	436	639	283	Inter-alpha-trypsin inhibitor heavy chain H1
B17R14C17	17-17-14	Hs~Ref:NM_003939.2~uORF:IOH42069	1535	790	1260	893	1018	1196	5578	863	1787	484	beta-transducin repeat containing (BTRC), transcript variant 2, mRNA.
B17R14C18	17-18-14	Hs~Ref:NM_003939.2~uORF:IOH42069	1587	803	1227	922	839	1214	5205	1035	1759	498	beta-transducin repeat containing (BTRC), transcript variant 2, mRNA.
B17R14C19	17-19-14	Hs~MGC:BC005345.1~uORF:IOH7283	556	320	573	334	399	539	1121	426	829	263	general transcription factor IIH, polypeptide 2, 44kDa (GTF2H2)
B17R14C20	17-20-14	Hs~MGC:BC005345.1~uORF:IOH7283	504	338	641	300	497	544	1125	416	635	264	general transcription factor IIH, polypeptide 2, 44kDa (GTF2H2)
B17R14C21	17-21-14	Hs~MGC:BC008429.1~uORF:IOH7505	535	352	688	382	496	524	746	432	640	342	chromosome 20 open reading frame 114 (C20orf114)
B17R14C22	17-22-14	Hs~MGC:BC008429.1~uORF:IOH7505	491	331	706	405	474	590	1274	741	642	370	chromosome 20 open reading frame 114 (C20orf114)
B17R15C01	17-1-15	Hs~MGC:BC032474.1~uORF:IOH21712	657	617	988	741	486	648	910	616	1194	311	toll-interleukin 1 receptor (TIR) domain containing adaptor protein (TIRAP)
B17R15C02	17-2-15	Hs~MGC:BC032474.1~uORF:IOH21712	688	643	1138	697	496	637	893	599	1175	358	toll-interleukin 1 receptor (TIR) domain containing adaptor protein (TIRAP)
B17R15C03	17-3-15	Hs~Ref:NM_182691.1~uORF:IOH26788	2648	1625	3225	13109	1071	2555	6513	2008	2315	546	SFRS protein kinase 2 (SRPK2), transcript variant 2
B17R15C04	17-4-15	Hs~Ref:NM_182691.1~uORF:IOH26788	2666	1567	3311	14131	1041	2442	6407	2130	2324	587	SFRS protein kinase 2 (SRPK2), transcript variant 2
B17R15C07	17-7-15	Hs~Ref:NM_174931.1~uORF:IOH45940	459	82	541	316	361	823	1051	366	671	262	coiled-coil domain containing 75 (CCDC75)
B17R15C08	17-8-15	Hs~Ref:NM_174931.1~uORF:IOH45940	462	292	526	359	353	791	1078	360	611	228	coiled-coil domain containing 75 (CCDC75)
B17R15C09	17-9-15	Hs~Ref:NM_173456.1~uORF:IOH45493	1118	513	843	456	792	678	1797	647	1050	418	phosphodiesterase 8A (PDE8A), transcript variant 4
B17R15C10	17-10-15	Hs~Ref:NM_173456.1~uORF:IOH45493	1115	519	802	494	767	684	1760	613	1130	471	phosphodiesterase 8A (PDE8A), transcript variant 4
B17R15C11	17-11-15	Hs~Ref:NM_000187.1~uORF:IOH45942	762	826	1144	1756	1482	1051	2041	874	1770	604	homogentisate 1,2-dioxygenase (homogentisate oxidase) (HGD)
B17R15C12	17-12-15	Hs~Ref:NM_000187.1~uORF:IOH45942	842	788	1214	1674	1675	1075	2041	820	1788	615	homogentisate 1,2-dioxygenase (homogentisate oxidase) (HGD)
B17R15C17	17-17-15	Hs~Ref:NM_004938.1~CAT:PV3969	983	275	1270	391	498	417	665	636	1429	235	Death-associated protein kinase 1
B17R15C18	17-18-15	Hs~Ref:NM_004938.1~CAT:PV3969	999	283	1224	428	427	331	669	684	1474	144	Death-associated protein kinase 1
B17R15C19	17-19-15	Hs~Ref:NM_001721.2~CAT:PV3371	1154	1665	1717	1274	1035	1488	1617	1577	3022	836	BMX non-receptor tyrosine kinase (BMX), transcript variant 2
B17R15C20	17-20-15	Hs~Ref:NM_001721.2~CAT:PV3371	1307	1749	1974	1225	1057	1448	1800	1660	2631	943	BMX non-receptor tyrosine kinase (BMX), transcript variant 2
B17R15C21	17-21-15	Hs~Ref:NM_004302.3~CAT:PV4312	149	332	929	625	734	902	337	339	416	276	activin A receptor, type IB (ACVR1B), transcript variant 1
B17R15C22	17-22-15	Hs~Ref:NM_004302.3~CAT:PV4312	210	309	649	651	135	951	350	351	371	119	activin A receptor, type IB (ACVR1B), transcript variant 1
B17R16C01	17-1-16	Hs~Ref:NM_004560.2~CAT:PV3861	1416	647	13475	558	445	1010	717	579	2096	769	Tyrosine-protein kinase transmembrane receptor ROR2
B17R16C02	17-2-16	Hs~Ref:NM_004560.2~CAT:PV3861	1475	631	13082	591	405	1008	759	563	2085	745	Tyrosine-protein kinase transmembrane receptor ROR2
B17R16C07	17-7-16	Hs~MGC:NM_172207.1~uORF:IOH22804	351	131	435	239	253	276	458	215	837	157	Calcium/calmodulin-dependent protein kinase kinase 1
B17R16C08	17-8-16	Hs~MGC:NM_172207.1~uORF:IOH22804	367	229	424	229	288	267	467	211	775	73	Calcium/calmodulin-dependent protein kinase kinase 1
B17R16C09	17-9-16	Hs~MGC:BC006376.1~uORF:IOH6481	528	304	547	267	502	571	1079	263	691	247	N-myristoyltransferase 2 (NMT2)
B17R16C10	17-10-16	Hs~MGC:BC006376.1~uORF:IOH6481	435	313	567	275	529	588	1046	319	641	254	N-myristoyltransferase 2 (NMT2)
B17R16C11	17-11-16	Hs~Ref:NM_000477.3~uORF:IOH23065	335	330	388	345	427	336	612	230	506	212	albumin (ALB)
B17R16C12	17-12-16	Hs~Ref:NM_000477.3~uORF:IOH23065	367	297	418	231	630	368	619	309	529	144	albumin (ALB)
B17R16C13	17-13-16	Hs~Ref:NM_022493.1~uORF:IOH21554	335	310	382	190	581	271	876	212	428	173	nuclear prelamin A recognition factor-like (NARFL)
B17R16C14	17-14-16	Hs~Ref:NM_022493.1~uORF:IOH21554	306	312	400	199	466	281	915	210	506	164	nuclear prelamin A recognition factor-like (NARFL)
B17R16C15	17-15-16	Hs~Ref:NM_001011667.1~uORF:IOH57352	506	458	683	406	569	644	673	608	1059	365	Coiled-coil-helix-coiled-coil-helix domain-containing protein 7
B17R16C16	17-16-16	Hs~Ref:NM_001011667.1~uORF:IOH57352	455	377	587	372	561	625	760	556	1036	363	Coiled-coil-helix-coiled-coil-helix domain-containing protein 7
B17R16C17	17-17-16	Hs~Ref:NM_001018062.1~uORF:IOH57354	770	506	902	452	933	923	1022	550	1075	361	UPF0544 protein C5orf45  [Source:UniProtKB/Swiss-Prot;Acc:Q6NTE8]
B17R16C18	17-18-16	Hs~Ref:NM_001018062.1~uORF:IOH57354	683	479	897	462	552	663	907	584	1106	358	UPF0544 protein C5orf45  [Source:UniProtKB/Swiss-Prot;Acc:Q6NTE8]
B17R16C19	17-19-16	Hs~Ref:NM_001284.2~uORF:IOH3063	939	593	1281	625	1002	905	1466	810	1449	350	AP-3 complex subunit sigma-1
B17R16C20	17-20-16	Hs~Ref:NM_001284.2~uORF:IOH3063	1058	577	1486	609	1039	904	1603	559	1396	360	AP-3 complex subunit sigma-1
B17R16C21	17-21-16	Hs~MGC:BC070055.1~uORF:IOH40142	477	412	712	432	542	736	767	545	1066	376	Guanylate-binding protein 4
B17R16C22	17-22-16	Hs~MGC:BC070055.1~uORF:IOH40142	486	450	643	411	493	671	816	552	1109	374	Guanylate-binding protein 4
B17R17C01	17-1-17	Hs~MGC:BC005026.1~uORF:IOH6532	1265	1255	2125	903	2237	3324	2570	1602	4113	694	sirtuin (silent mating type information regulation 2 homolog) 6 (S. cerevisiae) (SIRT6)
B17R17C02	17-2-17	Hs~MGC:BC005026.1~uORF:IOH6532	1317	1314	2005	898	2195	3354	2641	1603	4033	716	sirtuin (silent mating type information regulation 2 homolog) 6 (S. cerevisiae) (SIRT6)
B17R17C03	17-3-17	Hs~Ref:NM_003161.1~uORF:IOH29907	1461	2122	1634	835	3045	3304	1921	1690	3892	778	ribosomal protein S6 kinase, 70kDa, polypeptide 1 (RPS6KB1)
B17R17C04	17-4-17	Hs~Ref:NM_003161.1~uORF:IOH29907	1519	1926	1550	826	3111	3032	2035	1557	3989	762	ribosomal protein S6 kinase, 70kDa, polypeptide 1 (RPS6KB1)
B17R17C05	17-5-17	Hs~MGC:BC003408.2~uORF:IOH3031	1004	876	1891	872	1753	1988	2193	1682	2563	563	melanoma antigen family A, 12 (MAGEA12)
B17R17C06	17-6-17	Hs~MGC:BC003408.2~uORF:IOH3031	1021	855	1826	802	2342	2049	2123	1648	2589	550	melanoma antigen family A, 12 (MAGEA12)
B17R17C07	17-7-17	Hs~Ref:NM_024548.2~uORF:IOH27601	838	989	1137	616	1119	1306	1750	864	2605	572	leucine-rich repeats and IQ motif containing 2 (LRRIQ2)
B17R17C08	17-8-17	Hs~Ref:NM_024548.2~uORF:IOH27601	914	914	1135	629	1020	1264	1893	916	2752	529	leucine-rich repeats and IQ motif containing 2 (LRRIQ2)
B17R17C09	17-9-17	Hs~Ref:NM_032312.2~uORF:IOH5615	1315	831	1129	779	882	1152	1462	976	2504	839	Yip1 domain family, member 4 (YIPF4)
B17R17C10	17-10-17	Hs~Ref:NM_032312.2~uORF:IOH5615	1057	867	1216	877	1020	1111	1463	1119	2585	868	Yip1 domain family, member 4 (YIPF4)
B17R17C11	17-11-17	Hs~Ref:NM_006993.1~uORF:IOH29468	844	640	1455	817	3650	1048	1007	828	1434	375	nucleophosmin/nucleoplasmin, 3 (NPM3)
B17R17C12	17-12-17	Hs~Ref:NM_006993.1~uORF:IOH29468	800	625	1442	922	4034	1045	978	869	1428	392	nucleophosmin/nucleoplasmin, 3 (NPM3)
B17R17C13	17-13-17	Hs~Ref:NM_000799.1~uORF:IOH44362	574	612	827	523	857	589	1045	583	1383	486	Erythropoietin
B17R17C14	17-14-17	Hs~Ref:NM_000799.1~uORF:IOH44362	486	595	768	442	1118	609	990	623	1323	431	Erythropoietin
B17R17C17	17-17-17	Hs~MGC:NM_152377.1~uORF:IOH11555	6801	2962	3864	1901	3686	1928	5958	4993	4219	1106	chromosome 1 open reading frame 87 (C1orf87)
B17R17C18	17-18-17	Hs~MGC:NM_152377.1~uORF:IOH11555	6410	3186	4302	1997	3593	1791	5846	5136	4041	1178	chromosome 1 open reading frame 87 (C1orf87)
B17R17C19	17-19-17	Hs~Ref:NM_138492.1~uORF:IOH11385	728	720	1253	575	1993	1494	2264	1126	1854	492	PRELI domain-containing protein 2
B17R17C20	17-20-17	Hs~Ref:NM_138492.1~uORF:IOH11385	754	743	1230	612	1902	1519	2317	1034	1906	492	PRELI domain-containing protein 2
B17R17C21	17-21-17	Hs~MGC:BC010357.1~uORF:IOH14260	1279	1050	2002	691	2081	1762	2195	1376	2787	720	Arginine/serine-rich coiled-coil protein 1
B17R17C22	17-22-17	Hs~MGC:BC010357.1~uORF:IOH14260	1313	1004	1941	693	1939	1810	2207	1147	2890	654	Arginine/serine-rich coiled-coil protein 1
B17R18C01	17-1-18	Hs~Ref:NM_001319.5~uORF:IOH10417	1073	1077	1678	816	1735	2020	2210	1521	3110	747	casein kinase 1, gamma 2 (CSNK1G2)
B17R18C02	17-2-18	Hs~Ref:NM_001319.5~uORF:IOH10417	1072	1129	1634	838	1751	1980	2349	1452	3168	768	casein kinase 1, gamma 2 (CSNK1G2)
B17R18C03	17-3-18	Hs~MGC:BC012883.1~uORF:IOH28614	552	472	600	375	307	559	751	498	1005	346	Voltage-dependent anion-selective channel protein 2
B17R18C04	17-4-18	Hs~MGC:BC012883.1~uORF:IOH28614	581	2271	1387	372	335	584	693	460	1021	368	Voltage-dependent anion-selective channel protein 2
B17R18C05	17-5-18	Hs~MGC:BC053610.1~uORF:IOH28998	786	634	829	481	437	1077	1535	1264	1498	434	protein kinase, AMP-activated, beta 2 non-catalytic subunit (PRKAB2)
B17R18C06	17-6-18	Hs~MGC:BC053610.1~uORF:IOH28998	829	623	982	790	474	1068	1449	895	1500	432	protein kinase, AMP-activated, beta 2 non-catalytic subunit (PRKAB2)
B17R18C07	17-7-18	Hs~MGC:BC012368.1~uORF:IOH10555	717	873	900	515	535	695	833	691	1171	520	angiopoietin-like 2 (ANGPTL2)
B17R18C08	17-8-18	Hs~MGC:BC012368.1~uORF:IOH10555	718	679	822	528	524	733	890	604	1130	467	angiopoietin-like 2 (ANGPTL2)
B17R18C09	17-9-18	Hs~Ref:NM_019107.3~uORF:IOH13900	731	372	823	380	487	533	958	556	883	288	UPF0556 protein C19orf10
B17R18C10	17-10-18	Hs~Ref:NM_019107.3~uORF:IOH13900	681	379	838	399	500	519	977	539	879	330	UPF0556 protein C19orf10
B17R18C11	17-11-18	Hs~Ref:NM_153709.1~uORF:IOH21517	751	937	1310	2184	837	1076	1193	836	16816	420	chromosome 1 open reading frame 211 (C1orf211)
B17R18C12	17-12-18	Hs~Ref:NM_153709.1~uORF:IOH21517	792	918	1238	2673	918	1031	1342	846	16414	438	chromosome 1 open reading frame 211 (C1orf211)
B17R18C13	17-13-18	Hs~Ref:NM_014045.3~uORF:IOH41955	498	422	907	362	748	594	937	477	1016	353	low density lipoprotein receptor-related protein 10 (LRP10)
B17R18C14	17-14-18	Hs~Ref:NM_014045.3~uORF:IOH41955	1137	444	892	364	881	594	962	443	934	333	low density lipoprotein receptor-related protein 10 (LRP10)
B17R18C15	17-15-18	Hs~Ref:NM_003588.2~uORF:IOH27494	918	497	726	435	481	760	1498	461	985	317	cullin 4B (CUL4B), transcript variant 1
B17R18C16	17-16-18	Hs~Ref:NM_003588.2~uORF:IOH27494	660	438	795	485	473	711	1586	495	1000	312	cullin 4B (CUL4B), transcript variant 1
B17R18C17	17-17-18	Hs~Ref:NM_174964.1~uORF:IOH37722	372	309	653	290	421	482	707	444	1126	288	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase
B17R18C18	17-18-18	Hs~Ref:NM_174964.1~uORF:IOH37722	369	316	601	294	435	469	672	419	1074	273	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase
B17R18C19	17-19-18	Hs~Ref:NM_004637.5~uORF:IOH40569	1090	937	3567	3950	4383	2635	1307	919	3091	465	Ras-related protein Rab-7a
B17R18C20	17-20-18	Hs~Ref:NM_004637.5~uORF:IOH40569	1099	958	3450	3948	3653	2573	1282	899	3313	453	Ras-related protein Rab-7a
B17R18C21	17-21-18	Hs~Ref:NM_199290.2~uORF:IOH40757	738	489	2863	480	2098	836	854	600	1224	376	Nascent polypeptide-associated complex subunit alpha-2
B17R18C22	17-22-18	Hs~Ref:NM_199290.2~uORF:IOH40757	729	470	2578	460	1781	933	846	592	1313	385	Nascent polypeptide-associated complex subunit alpha-2
B17R19C01	17-1-19	Hs~MGC:BC067262.1~uORF:IOH40509	777	840	971	583	588	1006	1234	695	2088	487	Rho guanine nucleotide exchange factor 1
B17R19C02	17-2-19	Hs~MGC:BC067262.1~uORF:IOH40509	792	883	983	551	591	911	1273	726	1917	451	Rho guanine nucleotide exchange factor 1
B17R19C05	17-5-19	Hs~MGC:BC056413.1~uORF:IOH29098	3092	936	1357	1172	1155	955	1406	1541	2646	312	PHD finger protein 20-like 1 (PHF20L1)
B17R19C06	17-6-19	Hs~MGC:BC056413.1~uORF:IOH29098	3207	701	1292	1078	1318	1041	1414	1406	2652	314	PHD finger protein 20-like 1 (PHF20L1)
B17R19C07	17-7-19	Hs~Ref:NM_013323.1~uORF:IOH3822	1106	811	1730	1059	821	1352	1386	899	2210	568	sorting nexin 11 (SNX11), transcript variant 2
B17R19C08	17-8-19	Hs~Ref:NM_013323.1~uORF:IOH3822	1129	776	1757	951	838	1193	1334	843	2188	556	sorting nexin 11 (SNX11), transcript variant 2
B17R19C09	17-9-19	Hs~Ref:NM_002652.1~uORF:IOH12199	984	1178	1288	628	1334	1193	1719	983	1640	444	prolactin-induced protein (PIP)
B17R19C10	17-10-19	Hs~Ref:NM_002652.1~uORF:IOH12199	1109	1190	1352	655	1461	1209	1743	884	1594	434	prolactin-induced protein (PIP)
B17R19C11	17-11-19	Hs~MGC:BC007835.1~uORF:IOH6703	274	129	488	191	425	358	463	406	562	177	Serine/threonine-protein kinase 40
B17R19C12	17-12-19	Hs~MGC:BC007835.1~uORF:IOH6703	289	120	483	601	520	314	430	390	461	209	Serine/threonine-protein kinase 40
B17R19C13	17-13-19	Hs~Ref:NM_020963.1~uORF:IOH4005	453	387	594	210	493	447	1066	459	624	262	Mov10, Moloney leukemia virus 10, homolog (mouse) (MOV10)
B17R19C14	17-14-19	Hs~Ref:NM_020963.1~uORF:IOH4005	831	365	500	298	734	435	1085	372	580	214	Mov10, Moloney leukemia virus 10, homolog (mouse) (MOV10)
B17R19C15	17-15-19	Hs~Ref:NM_000444.1~uORF:IOH29637	653	422	612	337	397	568	1146	382	757	291	phosphate regulating endopeptidase homolog, X-linked (hypophosphatemia, vitamin D resistant rickets) (PHEX), transcript variant 1843529
B17R19C16	17-16-19	Hs~Ref:NM_000444.1~uORF:IOH29637	465	461	750	312	339	608	1066	377	821	278	phosphate regulating endopeptidase homolog, X-linked (hypophosphatemia, vitamin D resistant rickets) (PHEX), transcript variant 1843529
B17R19C17	17-17-19	Hs~MGC:BC053985.1~uORF:IOH29363	431	283	514	219	210	459	701	423	473	259	CD244 molecule, natural killer cell receptor 2B4 (CD244)
B17R19C18	17-18-19	Hs~MGC:BC053985.1~uORF:IOH29363	431	258	377	224	381	457	733	443	502	245	CD244 molecule, natural killer cell receptor 2B4 (CD244)
B17R19C19	17-19-19	Hs~MGC:BC047690.1~uORF:IOH28834	1497	738	1169	587	1154	1128	4959	816	2193	358	Ras-related protein M-Ras
B17R19C20	17-20-19	Hs~MGC:BC047690.1~uORF:IOH28834	1412	713	1215	597	928	1127	5246	810	2360	338	Ras-related protein M-Ras
B17R19C21	17-21-19	Hs~Ref:NM_032174.2~uORF:IOH13297	338	247	468	275	296	514	606	337	451	250	translocase of outer mitochondrial membrane 40 homolog (yeast)-like (TOMM40L)
B17R19C22	17-22-19	Hs~Ref:NM_032174.2~uORF:IOH13297	351	284	629	238	295	479	649	369	519	247	translocase of outer mitochondrial membrane 40 homolog (yeast)-like (TOMM40L)
B17R20C01	17-1-20	Hs~MGC:BC044215.1~uORF:IOH26376	725	647	1146	469	427	801	1998	585	1019	354	Interleukin-18-binding protein
B17R20C02	17-2-20	Hs~MGC:BC044215.1~uORF:IOH26376	723	771	1113	456	478	788	2078	510	875	340	Interleukin-18-binding protein
B17R20C03	17-3-20	Hs~MGC:BC056256.1~uORF:IOH29440	18569	16625	16610	17960	14273	16123	13720	14765	21516	16841	immunoglobulin kappa constant (IGKC)
B17R20C04	17-4-20	Hs~MGC:BC056256.1~uORF:IOH29440	19067	16593	16320	17805	13906	16401	13558	14891	21163	17066	immunoglobulin kappa constant (IGKC)
B17R20C05	17-5-20	Hs~Ref:NM_025128.3~uORF:IOH45812	523	1155	717	424	321	582	1351	517	712	345	MUS81 endonuclease homolog (S. cerevisiae) (MUS81)
B17R20C06	17-6-20	Hs~Ref:NM_025128.3~uORF:IOH45812	524	490	670	508	309	610	1404	517	686	352	MUS81 endonuclease homolog (S. cerevisiae) (MUS81)
B17R20C07	17-7-20	Hs~Ref:NM_018037.1~uORF:IOH45458	515	441	346	187	435	277	370	306	754	183	Ral GEF with PH domain and SH3 binding motif 2 (RALGPS2), transcript variant 1
B17R20C08	17-8-20	Hs~Ref:NM_018037.1~uORF:IOH45458	529	422	334	218	380	265	364	232	777	40	Ral GEF with PH domain and SH3 binding motif 2 (RALGPS2), transcript variant 1
B17R20C09	17-9-20	Hs~Ref:NM_017851.4~uORF:IOH45910	663	686	906	1518	796	609	746	442	2429	360	poly (ADP-ribose) polymerase family, member 16 (PARP16)
B17R20C10	17-10-20	Hs~Ref:NM_017851.4~uORF:IOH45910	1214	687	849	1596	859	654	762	425	2263	372	poly (ADP-ribose) polymerase family, member 16 (PARP16)
B17R20C11	17-11-20	Hs~Ref:NM_001007024.1~uORF:IOH45919	205	310	342	217	314	223	316	241	578	97	golgi SNAP receptor complex member 1 (GOSR1), transcript variant 3
B17R20C12	17-12-20	Hs~Ref:NM_001007024.1~uORF:IOH45919	230	334	407	233	361	209	256	247	532	151	golgi SNAP receptor complex member 1 (GOSR1), transcript variant 3
B17R20C13	17-13-20	Hs~MGC:BC016911.1~uORF:IOH11149	530	474	575	635	530	565	1193	586	665	282	RecQ protein-like 5 (RECQL5)
B17R20C14	17-14-20	Hs~MGC:BC016911.1~uORF:IOH11149	595	453	642	316	628	540	1116	511	795	288	RecQ protein-like 5 (RECQL5)
B17R21C05	17-5-21	Hs~Ref:NM_006675.3~uORF:IOH41496	735	2046	1129	588	289	365	467	257	591	285	tetraspanin 9 (TSPAN9)
B17R21C06	17-6-21	Hs~Ref:NM_006675.3~uORF:IOH41496	806	1528	1039	1159	260	393	461	254	525	279	tetraspanin 9 (TSPAN9)
B18R02C11	18-11-2	Hs~MGC:BC029510.1~uORF:IOH22576	749	528	1960	17939	1349	892	866	742	496	156	3-hydroxyanthranilate 3,4-dioxygenase (HAAO)
B18R02C12	18-12-2	Hs~MGC:BC029510.1~uORF:IOH22576	414	477	1817	20026	108	572	916	1121	556	198	3-hydroxyanthranilate 3,4-dioxygenase (HAAO)
B18R02C13	18-13-2	Hs~MGC:NM_152452.1~uORF:IOH11129	632	417	906	521	557	535	1002	496	770	212	hypothetical protein MGC18216 (MGC18216)
B18R02C14	18-14-2	Hs~MGC:NM_152452.1~uORF:IOH11129	617	411	859	385	643	501	945	533	732	151	hypothetical protein MGC18216 (MGC18216)
B18R02C15	18-15-2	Hs~MGC:BC018109.1~uORF:IOH11274	349	288	470	235	889	340	422	342	540	156	chromosome 1 open reading frame 109 (C1orf109)
B18R02C16	18-16-2	Hs~MGC:BC018109.1~uORF:IOH11274	338	335	526	221	284	298	488	301	602	182	chromosome 1 open reading frame 109 (C1orf109)
B18R02C17	18-17-2	Hs~MGC:BC031041.1~uORF:IOH22517	847	499	862	429	486	498	1241	574	905	299	IQ domain-containing protein H
B18R02C18	18-18-2	Hs~MGC:BC031041.1~uORF:IOH22517	851	463	851	511	513	521	1315	551	935	311	IQ domain-containing protein H
B18R02C19	18-19-2	Hs~MGC:BC000112.1~uORF:IOH4632	881	727	1859	794	979	978	1210	970	2347	380	retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (RDH11)
B18R02C20	18-20-2	Hs~MGC:BC000112.1~uORF:IOH4632	981	717	1860	762	981	943	1273	960	2252	391	retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (RDH11)
B18R02C21	18-21-2	Hs~MGC:BC010074.2~uORF:IOH13694	2248	2115	2961	2780	2574	2174	2665	2057	2403	711	FUS interacting protein (serine/arginine-rich) 1 (FUSIP1)
B18R02C22	18-22-2	Hs~MGC:BC010074.2~uORF:IOH13694	2177	2162	2764	2584	2516	2189	2684	2151	2432	766	FUS interacting protein (serine/arginine-rich) 1 (FUSIP1)
B18R03C01	18-1-3	Hs~Ref:NM_014042.1~uORF:IOH5151	920	493	1734	986	2541	1379	1347	1220	2247	342	chromosome 11 open reading frame 51 (C11orf51)
B18R03C02	18-2-3	Hs~Ref:NM_014042.1~uORF:IOH5151	954	483	1672	989	2543	1370	1286	1203	2128	314	chromosome 11 open reading frame 51 (C11orf51)
B18R03C03	18-3-3	Hs~MGC:BC001715.2~uORF:IOH4551	2510	1266	2855	1115	1263	1237	1731	1350	2665	714	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (NDUFS7)
B18R03C04	18-4-3	Hs~MGC:BC001715.2~uORF:IOH4551	2318	1221	2887	1095	1196	1210	1767	1421	2710	694	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (NDUFS7)
B18R03C05	18-5-3	Hs~Ref:NM_032329.4~uORF:IOH44706	592	923	1002	525	1030	1556	1409	1728	1633	335	inhibitor of growth family, member 5 (ING5)
B18R03C06	18-6-3	Hs~Ref:NM_032329.4~uORF:IOH44706	573	825	1079	574	1099	1550	2436	1760	1301	295	inhibitor of growth family, member 5 (ING5)
B18R03C07	18-7-3	Hs~Ref:NM_002489.2~uORF:IOH41391	372	373	534	674	656	719	1549	446	588	199	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa (NDUFA4), nuclear gene encoding mitochondrial protein
B18R03C08	18-8-3	Hs~Ref:NM_002489.2~uORF:IOH41391	405	392	524	596	653	674	605	457	536	203	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa (NDUFA4), nuclear gene encoding mitochondrial protein
B18R03C09	18-9-3	Hs~Ref:NM_006799.2~uORF:IOH45736	357	421	551	449	743	344	403	412	398	278	protease, serine, 21 (testisin) (PRSS21), transcript variant 1
B18R03C10	18-10-3	Hs~Ref:NM_006799.2~uORF:IOH45736	421	429	626	551	419	324	552	422	355	132	protease, serine, 21 (testisin) (PRSS21), transcript variant 1
B18R03C11	18-11-3	Hs~Ref:NM_080390.3~uORF:IOH41393	1334	2003	2680	8432	2214	3108	2268	2103	1839	1017	transcription elongation factor A (SII)-like 2 (TCEAL2)
B18R03C12	18-12-3	Hs~Ref:NM_080390.3~uORF:IOH41393	1408	2108	2422	8377	2330	3070	2207	2224	2043	1015	transcription elongation factor A (SII)-like 2 (TCEAL2)
B18R03C13	18-13-3	Hs~Ref:NM_144969.1~uORF:IOH43013	230	292	337	357	434	310	428	182	423	69	zinc finger, DHHC-type containing 15 (ZDHHC15)
B18R03C14	18-14-3	Hs~Ref:NM_144969.1~uORF:IOH43013	208	291	325	447	536	300	558	262	404	37	zinc finger, DHHC-type containing 15 (ZDHHC15)
B18R03C15	18-15-3	Hs~MGC:NM_005737.3~uORF:IOH44753	975	2544	1260	1176	2005	1683	1935	1438	1507	948	ADP-ribosylation factor-like 4C (ARL4C)
B18R03C16	18-16-3	Hs~MGC:NM_005737.3~uORF:IOH44753	1133	2956	1198	1158	2152	1562	1953	1320	1626	950	ADP-ribosylation factor-like 4C (ARL4C)
B18R03C19	18-19-3	Hs~Ref:NM_016829.1~uORF:IOH42070	459	340	580	345	334	317	448	297	325	57	8-oxoguanine DNA glycosylase (OGG1), nuclear gene encoding mitochondrial protein, transcript variant 2e
B18R03C20	18-20-3	Hs~Ref:NM_016829.1~uORF:IOH42070	510	344	577	351	346	287	420	347	438	82	8-oxoguanine DNA glycosylase (OGG1), nuclear gene encoding mitochondrial protein, transcript variant 2e
B18R03C21	18-21-3	Hs~MGC:BC011006.1~uORF:IOH14184	704	595	1038	651	491	729	780	602	1825	477	Apoptosis-related protein 3
B18R03C22	18-22-3	Hs~MGC:BC011006.1~uORF:IOH14184	620	562	1087	556	476	738	692	584	1848	413	Apoptosis-related protein 3
B18R04C01	18-1-4	Hs~MGC:BC008438.1~uORF:IOH7448	632	574	1789	428	1047	1174	3816	1627	9815	560	latexin (LXN)
B18R04C02	18-2-4	Hs~MGC:BC008438.1~uORF:IOH7448	644	588	1729	437	998	1207	3830	1548	8799	564	latexin (LXN)
B18R04C03	18-3-4	Hs~Ref:NM_004578.2~uORF:IOH5541	679	419	2152	368	466	18110	2237	506	2650	374	RAB4A, member RAS oncogene family (RAB4A)
B18R04C04	18-4-4	Hs~Ref:NM_004578.2~uORF:IOH5541	617	365	2183	366	441	18557	2151	535	2728	368	RAB4A, member RAS oncogene family (RAB4A)
B18R04C05	18-5-4	Hs~Ref:NM_003825.2~uORF:IOH3269	521	482	1285	437	1396	610	1083	1708	2076	217	synaptosomal-associated protein, 23kDa (SNAP23), transcript variant 1
B18R04C06	18-6-4	Hs~Ref:NM_003825.2~uORF:IOH3269	496	436	1236	496	1580	652	1064	1800	2186	293	synaptosomal-associated protein, 23kDa (SNAP23), transcript variant 1
B18R04C07	18-7-4	Hs~MGC:BC019292.1~uORF:IOH13802	624	524	947	485	591	759	1234	593	881	277	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) (AGPAT2)
B18R04C08	18-8-4	Hs~MGC:BC019292.1~uORF:IOH13802	609	547	951	476	582	746	943	612	892	235	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) (AGPAT2)
B18R04C09	18-9-4	Hs~MGC:BC015802.1~uORF:IOH10059	386	338	445	341	779	563	1906	336	924	198	RWD domain containing 1 (RWDD1)
B18R04C10	18-10-4	Hs~MGC:BC015802.1~uORF:IOH10059	442	356	423	343	888	556	1947	350	963	134	RWD domain containing 1 (RWDD1)
B18R04C11	18-11-4	Hs~Ref:NM_016304.2~uORF:IOH7552	3569	1915	3680	1575	2721	1793	11039	1854	3429	1413	chromosome 15 open reading frame 15 (C15orf15)
B18R04C12	18-12-4	Hs~Ref:NM_016304.2~uORF:IOH7552	3932	1883	3463	1649	2742	1871	10426	1880	3499	1352	chromosome 15 open reading frame 15 (C15orf15)
B18R04C13	18-13-4	Hs~Ref:NM_145237.1~uORF:IOH6581	397	410	554	306	419	468	778	478	722	351	similar to RNA polymerase I transcription factor RRN3 (LOC94431)
B18R04C14	18-14-4	Hs~Ref:NM_145237.1~uORF:IOH6581	416	414	642	461	444	465	616	503	685	277	similar to RNA polymerase I transcription factor RRN3 (LOC94431)
B18R04C15	18-15-4	Hs~Ref:NM_021969.1~uORF:IOH22604	722	582	1010	498	794	600	736	710	1081	319	nuclear receptor subfamily 0, group B, member 2 (NR0B2)
B18R04C16	18-16-4	Hs~Ref:NM_021969.1~uORF:IOH22604	763	549	1081	571	775	655	575	1429	1102	340	nuclear receptor subfamily 0, group B, member 2 (NR0B2)
B18R04C17	18-17-4	Hs~MGC:BC030290.1~uORF:IOH21571	2901	1358	2837	2572	2396	1899	7389	1026	2480	460	RNA-binding motif, single-stranded-interacting protein 3
B18R04C18	18-18-4	Hs~MGC:BC030290.1~uORF:IOH21571	3018	1197	2848	2445	2219	1359	8505	1049	3209	417	RNA-binding motif, single-stranded-interacting protein 3
B18R04C19	18-19-4	Hs~MGC:BC000450.1~uORF:IOH3506	980	1133	1024	514	615	559	684	419	1251	145	glyceronephosphate O-acyltransferase (GNPAT)
B18R04C20	18-20-4	Hs~MGC:BC000450.1~uORF:IOH3506	1053	1136	1038	488	1160	495	660	424	1144	247	glyceronephosphate O-acyltransferase (GNPAT)
B18R04C21	18-21-4	Hs~MGC:BC013119.1~uORF:IOH10459	1850	1239	2702	1092	2473	1240	1588	925	3528	759	signal-induced proliferation-associated 1 like 2 (SIPA1L2)
B18R04C22	18-22-4	Hs~MGC:BC013119.1~uORF:IOH10459	1803	1253	2558	1060	2367	1400	1629	920	3740	813	signal-induced proliferation-associated 1 like 2 (SIPA1L2)
B18R05C01	18-1-5	Hs~Ref:NM_001788.3~uORF:IOH43444	533	1030	955	636	562	478	1624	520	1043	273	septin 7 (SEPT7), transcript variant 1
B18R05C02	18-2-5	Hs~Ref:NM_001788.3~uORF:IOH43444	582	1079	758	622	454	462	1636	616	1163	231	septin 7 (SEPT7), transcript variant 1
B18R05C03	18-3-5	Hs~Ref:NM_018698.3~uORF:IOH43204	10144	3783	3541	2750	3125	4685	2576	3340	4620	3012	nuclear transport factor 2-like export factor 2 (NXT2)
B18R05C04	18-4-5	Hs~Ref:NM_018698.3~uORF:IOH43204	10175	3878	3883	2893	3204	4628	2729	3318	5079	2761	nuclear transport factor 2-like export factor 2 (NXT2)
B18R05C05	18-5-5	Hs~Ref:NM_001009959.1~uORF:IOH43447	2271	1182	1385	2858	2099	1385	3800	1625	8975	842	Ermin
B18R05C06	18-6-5	Hs~Ref:NM_001009959.1~uORF:IOH43447	2283	1198	1370	2889	2108	1401	3801	1665	9142	818	Ermin
B18R05C07	18-7-5	Hs~Ref:NM_181726.1~uORF:IOH43299	1559	431	1428	526	796	734	822	739	1537	213	ankyrin repeat domain 37 (ANKRD37)
B18R05C08	18-8-5	Hs~Ref:NM_181726.1~uORF:IOH43299	1409	406	1399	527	700	667	824	767	1431	206	ankyrin repeat domain 37 (ANKRD37)
B18R05C09	18-9-5	Hs~MGC:BC031090.1~uORF:IOH22578	654	421	1772	433	357	593	3770	1434	810	312	RALY RNA binding protein-like (RALYL)
B18R05C10	18-10-5	Hs~MGC:BC031090.1~uORF:IOH22578	645	413	1682	398	472	558	3576	1409	887	152	RALY RNA binding protein-like (RALYL)
B18R05C11	18-11-5	Hs~Ref:NM_019612.2~uORF:IOH40077	1192	1006	1317	1221	1154	986	2617	925	1581	524	immunity-related GTPase family, cinema (IRGC)
B18R05C12	18-12-5	Hs~Ref:NM_019612.2~uORF:IOH40077	1138	1025	1301	1247	1039	917	2669	868	1618	558	immunity-related GTPase family, cinema (IRGC)
B18R05C13	18-13-5	Hs~Ref:NM_004391.1~uORF:IOH40170	1132	771	1297	896	703	947	2075	909	1030	408	cytochrome P450, family 8, subfamily B, polypeptide 1 (CYP8B1)
B18R05C14	18-14-5	Hs~Ref:NM_004391.1~uORF:IOH40170	1133	816	1340	1118	1148	962	1648	863	1073	418	cytochrome P450, family 8, subfamily B, polypeptide 1 (CYP8B1)
B18R05C15	18-15-5	Hs~MGC:BC069568.1~uORF:IOH40320	967	972	1379	822	934	1094	2073	1062	1579	527	tripartite motif-containing 46 (TRIM46)
B18R05C16	18-16-5	Hs~MGC:BC069568.1~uORF:IOH40320	1031	1056	1336	977	942	984	2152	1015	1236	508	tripartite motif-containing 46 (TRIM46)
B18R05C17	18-17-5	Hs~Ref:NM_004179.1~uORF:IOH35768	2418	761	963	2659	864	3457	1228	883	1831	295	tryptophan hydroxylase 1 (tryptophan 5-monooxygenase) (TPH1)
B18R05C18	18-18-5	Hs~Ref:NM_004179.1~uORF:IOH35768	442	689	1304	3115	1004	3453	1582	1402	1911	252	tryptophan hydroxylase 1 (tryptophan 5-monooxygenase) (TPH1)
B18R05C19	18-19-5	Hs~Ref:NM_000956.2~uORF:IOH35606	931	1360	1327	325	359	381	793	601	415	153	prostaglandin E receptor 2 (subtype EP2), 53kDa (PTGER2)
B18R05C20	18-20-5	Hs~Ref:NM_000956.2~uORF:IOH35606	749	826	1028	351	235	320	618	601	671	178	prostaglandin E receptor 2 (subtype EP2), 53kDa (PTGER2)
B18R05C21	18-21-5	Hs~Ref:NM_052926.1~uORF:IOH35779	1250	1537	2020	1066	1978	1441	6024	1381	2519	384	Paraneoplastic antigen-like protein 5
B18R05C22	18-22-5	Hs~Ref:NM_052926.1~uORF:IOH35779	1249	1500	1874	967	1646	1554	6028	1294	2516	404	Paraneoplastic antigen-like protein 5
B18R06C01	18-1-6	Hs~Ref:NM_177973.1~uORF:IOH22150	724	1667	65336	12727	1962	3724	2244	1117	17660	1067	sulfotransferase family, cytosolic, 2B, member 1 (SULT2B1), transcript variant 2
B18R06C02	18-2-6	Hs~Ref:NM_177973.1~uORF:IOH22150	782	1756	65458	12835	1887	3781	2186	1079	19643	1122	sulfotransferase family, cytosolic, 2B, member 1 (SULT2B1), transcript variant 2
B18R06C03	18-3-6	Hs~Ref:NM_015584.2~uORF:IOH4335	404	435	1419	249	450	491	802	401	2180	120	polymerase (DNA-directed), delta interacting protein 2 (POLDIP2)
B18R06C04	18-4-6	Hs~Ref:NM_015584.2~uORF:IOH4335	347	428	1210	257	415	454	879	356	2414	178	polymerase (DNA-directed), delta interacting protein 2 (POLDIP2)
B18R06C05	18-5-6	Hs~MGC:BC005941.1~uORF:IOH7423	19	205	329	123	214	244	780	257	784	26	vesicle-associated membrane protein 3 (cellubrevin) (VAMP3)
B18R06C06	18-6-6	Hs~MGC:BC005941.1~uORF:IOH7423	391	201	333	55	180	281	692	265	588	18	vesicle-associated membrane protein 3 (cellubrevin) (VAMP3)
B18R06C09	18-9-6	Hs~MGC:BC007104.1~uORF:IOH7532	214	191	308	154	182	174	456	260	184	138	peptidylprolyl isomerase A (cyclophilin A) (PPIA)
B18R06C10	18-10-6	Hs~MGC:BC007104.1~uORF:IOH7532	195	222	353	147	306	136	462	269	239	25	peptidylprolyl isomerase A (cyclophilin A) (PPIA)
B18R06C11	18-11-6	Hs~Ref:NM_052848.1~uORF:IOH13249	1077	642	1341	882	757	1150	1904	945	2683	499	coiled-coil domain containing 97 (CCDC97)
B18R06C12	18-12-6	Hs~Ref:NM_052848.1~uORF:IOH13249	1071	642	1300	910	671	1085	2131	987	2746	526	coiled-coil domain containing 97 (CCDC97)
B18R06C13	18-13-6	Hs~MGC:BC021092.1~uORF:IOH13243	1184	1461	1340	996	964	1347	1969	1543	7053	624	zinc finger, FYVE domain containing 19 (ZFYVE19)
B18R06C14	18-14-6	Hs~MGC:BC021092.1~uORF:IOH13243	1181	1586	1345	1009	1097	1331	1833	1408	7391	547	zinc finger, FYVE domain containing 19 (ZFYVE19)
B18R06C15	18-15-6	Hs~Ref:NM_004881.1~uORF:IOH3658	1052	1937	1731	1893	1305	1438	1653	1403	2160	590	tumor protein p53 inducible protein 3 (TP53I3), transcript variant 1
B18R06C16	18-16-6	Hs~Ref:NM_004881.1~uORF:IOH3658	1033	2147	1642	1938	1318	1326	1623	1402	3022	539	tumor protein p53 inducible protein 3 (TP53I3), transcript variant 1
B18R06C17	18-17-6	Hs~MGC:BC003132.1~uORF:IOH5147	725	603	892	452	808	626	1848	361	1896	221	nuclear distribution gene C homolog (A. nidulans) (NUDC)
B18R06C18	18-18-6	Hs~MGC:BC003132.1~uORF:IOH5147	611	584	844	490	799	588	1939	413	3410	94	nuclear distribution gene C homolog (A. nidulans) (NUDC)
B18R06C19	18-19-6	Hs~Ref:NM_207181.1~uORF:IOH60410	693	2026	1169	941	972	963	804	2120	2337	318	Nephrocystin-1
B18R06C20	18-20-6	Hs~Ref:NM_207181.1~uORF:IOH60410	768	2137	1110	974	994	935	833	2114	2134	376	Nephrocystin-1
B18R06C21	18-21-6	Hs~MGC:BC089411.1~uORF:IOH62715	733	502	950	692	694	571	1074	721	795	308	Diacylglycerol kinase gamma
B18R06C22	18-22-6	Hs~MGC:BC089411.1~uORF:IOH62715	653	490	881	641	528	566	1014	595	822	225	Diacylglycerol kinase gamma
B18R07C03	18-3-7	Hs~MGC:BC096212.2~uORF:IOH63220	733	1415	65484	1875	1882	2309	2282	1017	1299	342	proline-rich protein BstNI subfamily 3, mRNA (cDNA clone IMAGE:40004745), complete cds.
B18R07C04	18-4-7	Hs~MGC:BC096212.2~uORF:IOH63220	772	1473	65486	1747	1982	2205	2309	1027	1387	358	proline-rich protein BstNI subfamily 3, mRNA (cDNA clone IMAGE:40004745), complete cds.
B18R07C05	18-5-7	Hs~Ref:NM_182612.1~uORF:IOH42453	263	228	430	136	141	175	378	1732	404	82	Parkinson disease 7 domain containing 1 (PDDC1)
B18R07C06	18-6-7	Hs~Ref:NM_182612.1~uORF:IOH42453	345	51	433	164	316	286	375	262	419	152	Parkinson disease 7 domain containing 1 (PDDC1)
B18R07C07	18-7-7	Hs~Ref:NM_016226.2~uORF:IOH41532	454	438	758	637	615	1003	1941	460	825	208	vacuolar protein sorting 29 homolog (S. cerevisiae) (VPS29), transcript variant 1
B18R07C08	18-8-7	Hs~Ref:NM_016226.2~uORF:IOH41532	499	467	722	480	620	998	1851	463	964	205	vacuolar protein sorting 29 homolog (S. cerevisiae) (VPS29), transcript variant 1
B18R07C09	18-9-7	Hs~Ref:NM_080838.1~uORF:IOH42456	622	468	862	327	406	502	1497	445	742	183	WNT1-inducible-signaling pathway protein 1
B18R07C10	18-10-7	Hs~Ref:NM_080838.1~uORF:IOH42456	659	440	887	330	725	468	1470	452	639	98	WNT1-inducible-signaling pathway protein 1
B18R07C11	18-11-7	Hs~Ref:XM_293886.3~uORF:IOH41635	1201	472	1534	537	717	823	1235	928	1858	286	Ubiquitin carboxyl-terminal hydrolase 7
B18R07C12	18-12-7	Hs~Ref:XM_293886.3~uORF:IOH41635	1342	472	1540	556	636	821	1225	881	1925	200	Ubiquitin carboxyl-terminal hydrolase 7
B18R07C13	18-13-7	Hs~Ref:NM_005053.2~uORF:IOH22983	173	24	439	56	369	103	834	552	105	16	RAD23 homolog A (S. cerevisiae) (RAD23A)
B18R07C14	18-14-7	Hs~Ref:NM_005053.2~uORF:IOH22983	176	57	428	44	372	126	834	478	237	62	RAD23 homolog A (S. cerevisiae) (RAD23A)
B18R07C15	18-15-7	Hs~MGC:BC006429.1~uORF:IOH6564	169	114	252	21	101	242	164	113	424	9	Coiled-coil domain-containing protein 115
B18R07C16	18-16-7	Hs~MGC:BC006429.1~uORF:IOH6564	64	84	239	22	140	297	161	124	451	15	Coiled-coil domain-containing protein 115
B18R07C17	18-17-7	Hs~Ref:NM_003688.1~N/A	595	495	560	123	649	201	308	187	783	87	Peripheral plasma membrane protein CASK
B18R07C18	18-18-7	Hs~Ref:NM_003688.1~N/A	561	345	521	186	565	211	310	234	1363	70	Peripheral plasma membrane protein CASK
B18R07C19	18-19-7	Hs~Ref:NM_003242.2~N/A	306	360	336	107	109	159	297	293	1685	38	transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2
B18R07C20	18-20-7	Hs~Ref:NM_003242.2~N/A	293	368	392	181	178	168	308	305	876	39	transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2
B18R07C21	18-21-7	Hs~Ref:NM_001031617.1~uORF:IOH63148	1613	1649	2818	1670	1931	2331	4376	2667	2674	810	Cytochrome c oxidase assembly protein COX19
B18R07C22	18-22-7	Hs~Ref:NM_001031617.1~uORF:IOH63148	1657	1746	2638	1511	2088	2437	4665	2660	2825	756	Cytochrome c oxidase assembly protein COX19
B18R08C03	18-3-8	Hs~MGC:BC066944.1~uORF:IOH61484	598	543	619	745	519	1896	2672	1602	1267	387	Adenylate kinase isoenzyme 4, mitochondrial
B18R08C04	18-4-8	Hs~MGC:BC066944.1~uORF:IOH61484	669	574	636	757	373	1795	2516	1570	1414	370	Adenylate kinase isoenzyme 4, mitochondrial
B18R08C07	18-7-8	Hs~MGC:BC011713.2~uORF:IOH22973	1114	769	1082	2071	1128	791	1400	3667	5975	536	tRNA methyltransferase 12 homolog (S. cerevisiae) (TRMT12)
B18R08C08	18-8-8	Hs~MGC:BC011713.2~uORF:IOH22973	1204	860	1048	1820	1160	797	1449	3647	6117	459	tRNA methyltransferase 12 homolog (S. cerevisiae) (TRMT12)
B18R08C09	18-9-8	Hs~Ref:NM_080423.1~uORF:IOH23012	3139	778	1388	1542	1060	3026	5660	1132	2669	627	protein tyrosine phosphatase, non-receptor type 2 (PTPN2), transcript variant 3
B18R08C10	18-10-8	Hs~Ref:NM_080423.1~uORF:IOH23012	3226	739	1248	1532	1140	2977	5981	1105	2828	1220	protein tyrosine phosphatase, non-receptor type 2 (PTPN2), transcript variant 3
B18R08C11	18-11-8	Hs~Ref:NM_006147.1~uORF:IOH10956	447	528	1031	1583	557	647	882	684	3267	1018	interferon regulatory factor 6 (IRF6)
B18R08C12	18-12-8	Hs~Ref:NM_006147.1~uORF:IOH10956	490	588	934	1643	596	659	862	664	3325	1019	interferon regulatory factor 6 (IRF6)
B18R08C13	18-13-8	Hs~MGC:BC029054.1~uORF:IOH22631	3828	2324	4238	2124	3985	23055	3244	1834	4120	1532	PDZ domain containing 7 (PDZD7)
B18R08C14	18-14-8	Hs~MGC:BC029054.1~uORF:IOH22631	4476	2453	4279	2329	4331	24068	3296	1929	4042	1522	PDZ domain containing 7 (PDZD7)
B18R08C15	18-15-8	Hs~Ref:NM_145271.1~uORF:IOH14111	2318	875	1896	1035	1313	1596	3773	1282	2214	590	zinc finger protein 688 (ZNF688), transcript variant 1
B18R08C16	18-16-8	Hs~Ref:NM_145271.1~uORF:IOH14111	2357	878	1887	820	1398	1680	3708	1056	2030	607	zinc finger protein 688 (ZNF688), transcript variant 1
B18R08C17	18-17-8	Hs~MGC:BC011014.1~uORF:IOH12165	702	557	828	463	429	804	1058	537	1425	872	fracture callus 1 homolog (rat) (FXC1)
B18R08C18	18-18-8	Hs~MGC:BC011014.1~uORF:IOH12165	744	577	806	448	428	858	1112	576	1544	814	fracture callus 1 homolog (rat) (FXC1)
B18R08C21	18-21-8	Hs~MGC:BC012984.2~uORF:IOH13016	449	470	504	243	798	765	465	385	1216	440	amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 19
B18R08C22	18-22-8	Hs~MGC:BC012984.2~uORF:IOH13016	382	485	502	252	809	698	476	403	1256	438	amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 19
B18R09C01	18-1-9	Hs~Ref:NM_020427.2~uORF:IOH40403	445	421	635	300	426	448	803	551	531	238	secreted LY6/PLAUR domain containing 1 (SLURP1)
B18R09C02	18-2-9	Hs~Ref:NM_020427.2~uORF:IOH40403	486	326	595	303	366	428	728	501	601	201	secreted LY6/PLAUR domain containing 1 (SLURP1)
B18R09C03	18-3-9	Hs~Ref:NM_032506.1~uORF:IOH40533	729	419	768	542	530	465	1391	542	852	259	KIAA1841 (KIAA1841)
B18R09C04	18-4-9	Hs~Ref:NM_032506.1~uORF:IOH40533	734	400	813	558	526	471	1422	511	1184	238	KIAA1841 (KIAA1841)
B18R09C05	18-5-9	Hs~MGC:BC014519.1~uORF:IOH40595	308	293	489	275	317	381	702	438	140	170	Calcium-binding mitochondrial carrier protein SCaMC-1
B18R09C06	18-6-9	Hs~MGC:BC014519.1~uORF:IOH40595	390	279	482	300	401	370	585	504	470	1000	Calcium-binding mitochondrial carrier protein SCaMC-1
B18R09C07	18-7-9	Hs~MGC:BC059405.1~uORF:IOH40433	1262	1086	1656	2411	1318	1463	2200	866	20057	869	Transducin-like enhancer protein 4
B18R09C08	18-8-9	Hs~MGC:BC059405.1~uORF:IOH40433	1354	1065	1619	2459	1398	1388	2512	847	19688	826	Transducin-like enhancer protein 4
B18R09C09	18-9-9	Hs~MGC:BC039711.1~uORF:IOH26100	1076	5215	3690	3401	2051	1781	4387	2313	2504	1118	centrosomal protein 57kDa (CEP57)
B18R09C10	18-10-9	Hs~MGC:BC039711.1~uORF:IOH26100	1037	5770	3587	3576	2076	1793	4737	2435	2704	1062	centrosomal protein 57kDa (CEP57)
B18R09C11	18-11-9	Hs~MGC:NM_152376.2~uORF:IOH26515	1293	2004	3453	1287	1777	1855	3402	3289	4224	931	UBX domain containing 3 (UBXD3)
B18R09C12	18-12-9	Hs~MGC:NM_152376.2~uORF:IOH26515	1480	2036	3281	1315	1829	1896	3009	3415	3997	883	UBX domain containing 3 (UBXD3)
B18R09C13	18-13-9	Hs~MGC:BC044574.1~uORF:IOH26906	508	367	677	346	481	362	599	428	607	253	enoyl Coenzyme A hydratase domain containing 2 (ECHDC2)
B18R09C14	18-14-9	Hs~MGC:BC044574.1~uORF:IOH26906	546	375	632	416	607	521	564	440	552	312	enoyl Coenzyme A hydratase domain containing 2 (ECHDC2)
B18R09C15	18-15-9	Hs~MGC:BC038998.1~uORF:IOH26172	2474	565	4555	671	587	626	1491	2113	819	873	fragile X mental retardation 1 (FMR1)
B18R09C16	18-16-9	Hs~MGC:BC038998.1~uORF:IOH26172	2362	584	4270	645	641	605	1614	2200	880	861	fragile X mental retardation 1 (FMR1)
B18R09C17	18-17-9	Hs~Ref:NM_005138.1~uORF:IOH1913	1446	832	1652	869	1006	1035	2066	1088	2401	740	SCO cytochrome oxidase deficient homolog 2 (yeast) (SCO2), nuclear gene encoding mitochondrial protein
B18R09C18	18-18-9	Hs~Ref:NM_005138.1~uORF:IOH1913	1715	901	1733	849	983	1061	2054	1021	2280	633	SCO cytochrome oxidase deficient homolog 2 (yeast) (SCO2), nuclear gene encoding mitochondrial protein
B18R09C19	18-19-9	Hs~Ref:NM_018438.2~uORF:IOH1960	1441	1375	3238	1857	1014	1738	2025	2867	2931	834	F-box protein 6 (FBXO6)
B18R09C20	18-20-9	Hs~Ref:NM_018438.2~uORF:IOH1960	1465	1351	3097	1885	1067	1775	2012	2641	3040	752	F-box protein 6 (FBXO6)
B18R09C21	18-21-9	Hs~Ref:NM_000067.1~uORF:IOH1900	1424	954	1347	782	924	983	1382	1216	2887	692	carbonic anhydrase II (CA2)
B18R09C22	18-22-9	Hs~Ref:NM_000067.1~uORF:IOH1900	1170	973	1348	817	967	971	1283	1202	2827	698	carbonic anhydrase II (CA2)
B18R10C01	18-1-10	Hs~Ref:NM_138453.1~uORF:IOH13462	782	996	1123	643	1056	840	1365	817	2241	448	RAB3C, member RAS oncogene family (RAB3C)
B18R10C02	18-2-10	Hs~Ref:NM_138453.1~uORF:IOH13462	830	915	1070	658	1078	854	1322	827	2178	458	RAB3C, member RAS oncogene family (RAB3C)
B18R10C03	18-3-10	Hs~MGC:BC057219.1~uORF:IOH29425	378	323	1057	265	346	462	2074	919	832	279	pyrophosphatase (inorganic) 2 (PPA2)
B18R10C04	18-4-10	Hs~MGC:BC057219.1~uORF:IOH29425	353	359	1086	291	401	390	2092	897	924	282	pyrophosphatase (inorganic) 2 (PPA2)
B18R10C05	18-5-10	Hs~MGC:BC041421.1~uORF:IOH28778	532	420	549	220	341	407	742	463	569	313	nuclear receptor subfamily 2, group E, member 3 (NR2E3)
B18R10C06	18-6-10	Hs~MGC:BC041421.1~uORF:IOH28778	556	389	646	277	432	460	581	489	856	309	nuclear receptor subfamily 2, group E, member 3 (NR2E3)
B18R10C07	18-7-10	Hs~MGC:BC056872.1~uORF:IOH29082	1115	4749	3484	2241	2165	3132	1708	6004	3201	3331	Nuclear receptor coactivator 5
B18R10C08	18-8-10	Hs~MGC:BC056872.1~uORF:IOH29082	1173	4836	3705	2155	2339	2952	1557	5744	3423	3300	Nuclear receptor coactivator 5
B18R10C09	18-9-10	Hs~MGC:BC051382.1~uORF:IOH28098	596	748	1051	1486	682	999	2446	2903	3905	752	magnesium-dependent phosphatase 1 (MDP-1)
B18R10C10	18-10-10	Hs~MGC:BC051382.1~uORF:IOH28098	594	758	1033	1462	731	1029	2405	2908	3928	606	magnesium-dependent phosphatase 1 (MDP-1)
B18R11C21	18-21-11	Hs~MGC:BC050616.1~uORF:IOH27025	1467	940	944	622	2228	12025	2416	1261	2839	2512	tumor suppressing subtransferable candidate 4 (TSSC4)
B18R11C22	18-22-11	Hs~MGC:BC050616.1~uORF:IOH27025	1292	929	889	659	2318	12147	2523	1261	2965	2441	tumor suppressing subtransferable candidate 4 (TSSC4)
B18R12C01	18-1-12	Hs~MGC:BC042110.1~uORF:IOH26318	1579	1263	1225	658	881	901	1164	840	1925	617	coiled-coil domain containing 78 (CCDC78)
B18R12C02	18-2-12	Hs~MGC:BC042110.1~uORF:IOH26318	1489	1500	1327	702	825	884	1030	787	2553	529	coiled-coil domain containing 78 (CCDC78)
B18R12C03	18-3-12	Hs~MGC:BC010855.1~uORF:IOH9926	511	762	2247	838	687	931	1844	837	8569	449	phosphomannomutase 1 (PMM1)
B18R12C04	18-4-12	Hs~MGC:BC010855.1~uORF:IOH9926	523	798	2127	816	719	957	2706	848	8937	471	phosphomannomutase 1 (PMM1)
B18R12C05	18-5-12	Hs~MGC:BC009829.1~uORF:IOH12161	749	579	839	481	462	709	2648	601	1230	423	Histone deacetylase complex subunit SAP30L
B18R12C06	18-6-12	Hs~MGC:BC009829.1~uORF:IOH12161	739	503	773	490	442	736	1810	587	1074	458	Histone deacetylase complex subunit SAP30L
B18R12C07	18-7-12	Hs~MGC:BC041031.1~uORF:IOH28000	749	688	1009	551	670	924	1213	908	2384	556	mutS homolog 5 (E. coli) (MSH5)
B18R12C08	18-8-12	Hs~MGC:BC041031.1~uORF:IOH28000	793	640	960	617	695	937	1096	843	2472	937	mutS homolog 5 (E. coli) (MSH5)
B18R12C09	18-9-12	Hs~MGC:BC010362.1~uORF:IOH27799	1063	684	1160	695	685	932	1630	1455	2316	291	vacuolar protein sorting 35 homolog (S. cerevisiae) (VPS35)
B18R12C10	18-10-12	Hs~MGC:BC010362.1~uORF:IOH27799	1033	752	1189	646	605	856	1831	1207	2359	570	vacuolar protein sorting 35 homolog (S. cerevisiae) (VPS35)
B18R12C11	18-11-12	Hs~Ref:NM_033540.2~uORF:IOH27728	732	735	1171	565	721	977	1680	1311	1892	579	mitofusin 1 (MFN1), nuclear gene encoding mitochondrial protein
B18R12C12	18-12-12	Hs~Ref:NM_033540.2~uORF:IOH27728	763	699	1115	574	1069	987	1474	881	1905	520	mitofusin 1 (MFN1), nuclear gene encoding mitochondrial protein
B18R12C13	18-13-12	Hs~Ref:NM_020931.1~uORF:IOH26150	1193	844	1218	601	962	1259	1341	1193	2970	597	KIAA1586 (KIAA1586)
B18R12C14	18-14-12	Hs~Ref:NM_020931.1~uORF:IOH26150	1067	807	1206	672	872	1236	1543	1019	2781	609	KIAA1586 (KIAA1586)
B18R12C15	18-15-12	Hs~MGC:BC012815.1~uORF:IOH13053	303	226	402	549	247	343	378	268	175	47	ATP-binding cassette sub-family D member 4
B18R12C16	18-16-12	Hs~MGC:BC012815.1~uORF:IOH13053	337	207	379	170	136	1231	392	327	-16	59	ATP-binding cassette sub-family D member 4
B18R12C17	18-17-12	Hs~Ref:NM_005780.1~uORF:IOH13636	320	286	479	274	255	422	409	424	5	153	Lipoma HMGIC fusion partner
B18R12C18	18-18-12	Hs~Ref:NM_005780.1~uORF:IOH13636	2080	281	490	250	236	319	460	469	377	497	Lipoma HMGIC fusion partner
B18R12C19	18-19-12	Hs~MGC:BC098149.1~uORF:IOH63298	1931	719	1975	537	602	886	2537	812	2629	589	Variable charge X-linked protein 3
B18R12C20	18-20-12	Hs~MGC:BC098149.1~uORF:IOH63298	1494	684	1874	877	612	971	2541	667	2656	152	Variable charge X-linked protein 3
B18R12C21	18-21-12	Hs~MGC:BC098117.1~uORF:IOH63340	900	2486	1107	1184	486	1193	1033	581	2892	541	CaiB/baiF CoA-transferase family protein C7orf10
B18R12C22	18-22-12	Hs~MGC:BC098117.1~uORF:IOH63340	977	2693	993	1008	505	1074	949	559	3248	494	CaiB/baiF CoA-transferase family protein C7orf10
B18R13C01	18-1-13	Hs~MGC:BC017918.1~uORF:IOH12709	1958	1990	1714	3048	2496	1936	1717	3724	5794	1413	chromosome 9 open reading frame 19 (C9orf19)
B18R13C02	18-2-13	Hs~MGC:BC017918.1~uORF:IOH12709	1855	1951	1598	3092	2438	1862	1673	3372	4565	1368	chromosome 9 open reading frame 19 (C9orf19)
B18R13C03	18-3-13	Hs~MGC:BC029427.1~uORF:IOH23192	2451	2330	1078	863	1187	2241	2266	994	3684	713	coiled-coil domain containing 23 (CCDC23)
B18R13C04	18-4-13	Hs~MGC:BC029427.1~uORF:IOH23192	2703	2528	1060	835	1082	2300	2866	1017	3753	721	coiled-coil domain containing 23 (CCDC23)
B18R13C05	18-5-13	Hs~Ref:NM_032204.3~uORF:IOH12073	1029	2364	1783	1683	2573	850	1461	1876	5536	842	activating signal cointegrator 1 complex subunit 2 (ASCC2)
B18R13C06	18-6-13	Hs~Ref:NM_032204.3~uORF:IOH12073	1017	2494	1797	1686	2270	837	1601	2186	6222	818	activating signal cointegrator 1 complex subunit 2 (ASCC2)
B18R13C07	18-7-13	Hs~MGC:BC029359.1~uORF:IOH23174	504	385	1117	746	1237	609	856	2241	1687	306	chromosome 2 open reading frame 34 (C2orf34)
B18R13C08	18-8-13	Hs~MGC:BC029359.1~uORF:IOH23174	516	410	1262	806	1196	592	916	1963	1860	530	chromosome 2 open reading frame 34 (C2orf34)
B18R13C09	18-9-13	Hs~Ref:NM_017431.2~uORF:IOH40966	425	425	685	315	650	422	745	409	1461	188	protein kinase, AMP-activated, gamma 3 non-catalytic subunit (PRKAG3)
B18R13C10	18-10-13	Hs~Ref:NM_017431.2~uORF:IOH40966	471	468	666	302	417	461	865	655	1160	323	protein kinase, AMP-activated, gamma 3 non-catalytic subunit (PRKAG3)
B18R13C11	18-11-13	Hs~Ref:NM_032054.1~uORF:IOH36169	423	337	648	473	428	401	521	522	917	250	protocadherin gamma subfamily A, 5 (PCDHGA5), transcript variant 2
B18R13C12	18-12-13	Hs~Ref:NM_032054.1~uORF:IOH36169	520	366	656	464	130	388	564	405	548	208	protocadherin gamma subfamily A, 5 (PCDHGA5), transcript variant 2
B18R13C13	18-13-13	Hs~Ref:NM_007000.2~uORF:IOH35385	1415	3322	1422	1333	1078	1685	1788	2024	1803	813	uroplakin 1A (UPK1A)
B18R13C14	18-14-13	Hs~Ref:NM_007000.2~uORF:IOH35385	1324	3505	1353	1357	1112	1644	1850	2079	1911	770	uroplakin 1A (UPK1A)
B18R13C15	18-15-13	Hs~Ref:NM_183382.1~uORF:IOH40957	3304	3859	2482	2250	3425	2113	3858	8060	2484	3736	ring finger protein 13 (RNF13), transcript variant 2
B18R13C16	18-16-13	Hs~Ref:NM_183382.1~uORF:IOH40957	3661	3587	2331	1837	3231	3076	3944	9998	2834	3638	ring finger protein 13 (RNF13), transcript variant 2
B18R13C17	18-17-13	Hs~MGC:BC015904.1~uORF:IOH10110	376	405	591	272	270	474	645	360	724	282	mitochondrial ribosomal protein L10 (MRPL10)
B18R13C18	18-18-13	Hs~MGC:BC015904.1~uORF:IOH10110	373	314	632	275	227	459	606	314	677	229	mitochondrial ribosomal protein L10 (MRPL10)
B18R13C19	18-19-13	Hs~MGC:BC033819.1~uORF:IOH21870	479	377	624	1090	209	476	691	350	567	416	cell adhesion molecule 3 (CADM3)
B18R13C20	18-20-13	Hs~MGC:BC033819.1~uORF:IOH21870	390	308	569	474	243	473	648	402	540	759	cell adhesion molecule 3 (CADM3)
B18R13C21	18-21-13	Hs~MGC:BC036450.1~uORF:IOH22401	502	333	695	417	283	543	1551	275	724	277	SAM domain and HD domain 1 (SAMHD1)
B18R13C22	18-22-13	Hs~MGC:BC036450.1~uORF:IOH22401	544	361	720	867	295	569	1640	260	742	139	SAM domain and HD domain 1 (SAMHD1)
B18R14C01	18-1-14	Hs~MGC:NM_138778.1~uORF:IOH14208	2538	1482	2763	4724	1647	604	5952	1290	4556	949	WD repeat domain 85 (WDR85)
B18R14C02	18-2-14	Hs~MGC:NM_138778.1~uORF:IOH14208	2808	1515	2731	4693	1660	874	6310	1318	3865	1143	WD repeat domain 85 (WDR85)
B18R14C03	18-3-14	Hs~Ref:NM_153183.1~uORF:IOH54677	217	3624	490	314	305	558	1461	418	298	160	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha
B18R14C04	18-4-14	Hs~Ref:NM_153183.1~uORF:IOH54677	321	535	457	303	375	521	1529	404	917	269	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha
B18R14C05	18-5-14	Hs~Ref:NM_031431.2~uORF:IOH52865	842	794	1354	315	278	628	906	786	890	661	Conserved oligomeric Golgi complex subunit 3
B18R14C06	18-6-14	Hs~Ref:NM_031431.2~uORF:IOH52865	906	838	1310	334	251	611	906	552	773	609	Conserved oligomeric Golgi complex subunit 3
B18R14C07	18-7-14	Hs~Ref:NM_134268.3~uORF:IOH54738	198	115	312	247	216	244	288	438	339	122	Cytoglobin
B18R14C08	18-8-14	Hs~Ref:NM_134268.3~uORF:IOH54738	242	238	317	266	326	225	282	296	315	85	Cytoglobin
B18R14C09	18-9-14	Hs~Ref:NM_005101.1~uORF:IOH54680	269	299	475	311	570	3268	2815	323	1648	140	Interferon-induced 17 kDa protein
B18R14C10	18-10-14	Hs~Ref:NM_005101.1~uORF:IOH54680	331	276	476	296	578	3191	2913	337	1767	329	Interferon-induced 17 kDa protein
B18R14C11	18-11-14	Hs~Ref:NM_033214.2~uORF:IOH60256	221	216	364	193	134	282	392	269	345	218	Glycerol kinase 2
B18R14C12	18-12-14	Hs~Ref:NM_033214.2~uORF:IOH60256	242	214	393	210	181	228	386	301	554	135	Glycerol kinase 2
B18R14C13	18-13-14	Hs~Ref:NM_000758.2~uORF:IOH44352	466	313	590	267	388	446	750	429	1244	588	Granulocyte-macrophage colony-stimulating factor
B18R14C14	18-14-14	Hs~Ref:NM_000758.2~uORF:IOH44352	346	335	613	247	374	452	784	430	1182	507	Granulocyte-macrophage colony-stimulating factor
B18R14C15	18-15-14	Hs~MGC:BC102024.1~uORF:IOH63593	470	244	597	440	183	329	525	377	497	147	Protein SCO2 homolog, mitochondrial
B18R14C16	18-16-14	Hs~MGC:BC102024.1~uORF:IOH63593	470	232	523	228	166	329	562	346	483	82	Protein SCO2 homolog, mitochondrial
B18R14C17	18-17-14	Hs~MGC:BC005127.2~uORF:IOH5658	335	1402	1039	258	179	3097	539	417	541	118	Adipophilin
B18R14C18	18-18-14	Hs~MGC:BC005127.2~uORF:IOH5658	458	1402	1005	266	179	2995	599	450	495	81	Adipophilin
B18R15C01	18-1-15	Hs~Ref:NM_002642.1~uORF:IOH14889	17521	32536	16711	19086	11506	15136	9939	9378	18295	12311	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C
B18R15C02	18-2-15	Hs~Ref:NM_002642.1~uORF:IOH14889	18294	31649	17007	20162	11316	14218	10961	11209	16779	12030	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C
B18R15C05	18-5-15	Hs~MGC:BC024243.2~uORF:IOH22385	486	549	935	423	365	828	788	681	911	452	Regulator of microtubule dynamics protein 2
B18R15C06	18-6-15	Hs~MGC:BC024243.2~uORF:IOH22385	541	548	943	502	365	804	702	674	931	305	Regulator of microtubule dynamics protein 2
B18R15C07	18-7-15	Hs~MGC:BC041793.1~uORF:IOH27245	400	396	549	313	376	451	533	482	845	318	kelch domain containing 3 (KLHDC3)
B18R15C08	18-8-15	Hs~MGC:BC041793.1~uORF:IOH27245	417	389	670	329	541	437	530	408	718	287	kelch domain containing 3 (KLHDC3)
B18R15C09	18-9-15	Hs~Ref:NM_000167.1~uORF:IOH27543	277	357	519	257	527	457	639	342	1038	243	glycerol kinase (GK), transcript variant 2
B18R15C10	18-10-15	Hs~Ref:NM_000167.1~uORF:IOH27543	370	323	494	260	429	468	557	360	939	206	glycerol kinase (GK), transcript variant 2
B18R15C11	18-11-15	Hs~MGC:BC047056.1~uORF:IOH27319	758	774	818	398	706	1022	1025	635	1454	367	DnaJ (Hsp40) homolog, subfamily B, member 2 (DNAJB2)
B18R15C12	18-12-15	Hs~MGC:BC047056.1~uORF:IOH27319	748	749	848	403	716	966	916	807	1583	337	DnaJ (Hsp40) homolog, subfamily B, member 2 (DNAJB2)
B18R15C15	18-15-15	Hs~Ref:NM_006875.1~CAT:PV3649	657	282	1226	407	372	1183	928	718	2421	337	Serine/threonine-protein kinase Pim-2
B18R15C16	18-16-15	Hs~Ref:NM_006875.1~CAT:PV3649	719	323	1149	515	381	1140	950	628	2361	360	Serine/threonine-protein kinase Pim-2
B18R15C17	18-17-15	Hs~Ref:NM_005607.1~CAT:PV3832	902	5324	2804	1316	1035	1413	2425	36261	3778	386	Focal adhesion kinase 1
B18R15C18	18-18-15	Hs~Ref:NM_005607.1~CAT:PV3832	1061	5536	2537	1311	1129	1263	2418	35519	4336	282	Focal adhesion kinase 1
B18R15C21	18-21-15	Hs~Ref:NM_001896.2~CAT:PV3624	697	526	757	434	340	694	1178	590	1533	1891	casein kinase 2, alpha prime polypeptide (CSNK2A2)
B18R15C22	18-22-15	Hs~Ref:NM_001896.2~CAT:PV3624	786	535	700	390	375	696	1231	563	1539	1655	casein kinase 2, alpha prime polypeptide (CSNK2A2)
B18R16C03	18-3-16	Hs~Ref:NM_021803.1~CAT_PHC0215	411	160	345	313	274	1036	722	3070	715	732	interleukin 21 (IL21)
B18R16C04	18-4-16	Hs~Ref:NM_021803.1~CAT_PHC0215	409	218	351	325	141	1068	736	3183	708	765	interleukin 21 (IL21)
B18R16C07	18-7-16	Hs~Ref:NM_001025239.1~uORF:IOH58999	357	280	653	261	297	387	1045	483	1061	172	Tetraspanin-4
B18R16C08	18-8-16	Hs~Ref:NM_001025239.1~uORF:IOH58999	360	296	684	546	371	348	1014	492	526	183	Tetraspanin-4
B18R16C09	18-9-16	Hs~Ref:NM_207448.1~uORF:IOH59696	494	387	615	552	526	472	793	484	893	213	Putative uncharacterized protein FLJ45256
B18R16C10	18-10-16	Hs~Ref:NM_207448.1~uORF:IOH59696	507	393	626	283	676	493	704	485	1934	303	Putative uncharacterized protein FLJ45256
B18R16C11	18-11-16	Hs~Ref:NM_006850.2~uORF:IOH59724	449	380	649	311	446	434	698	502	868	199	Interleukin-24
B18R16C12	18-12-16	Hs~Ref:NM_006850.2~uORF:IOH59724	452	408	687	311	405	438	657	469	329	174	Interleukin-24
B18R16C13	18-13-16	Hs~Ref:NM_014220.2~uORF:IOH59024	496	351	757	276	429	402	688	419	655	225	Transmembrane 4 L6 family member 1
B18R16C14	18-14-16	Hs~Ref:NM_014220.2~uORF:IOH59024	498	373	737	480	371	455	619	553	814	106	Transmembrane 4 L6 family member 1
B18R16C15	18-15-16	Hs~Ref:NM_001012424.1~uORF:IOH57355	1015	621	2336	943	891	840	1995	2222	2170	338	YY1-associated factor 2
B18R16C16	18-16-16	Hs~Ref:NM_001012424.1~uORF:IOH57355	1051	660	2279	1065	862	848	1994	2223	2143	371	YY1-associated factor 2
B18R16C17	18-17-16	Hs~MGC:BC023251.1~uORF:IOH25816	2029	1003	3844	1375	1170	1409	2534	3465	3282	343	KIAA1609, mRNA (cDNA clone MGC:25024 IMAGE:4470095), complete cds
B18R16C18	18-18-16	Hs~MGC:BC023251.1~uORF:IOH25816	1855	1015	3744	1333	805	1357	2574	3451	3347	355	KIAA1609, mRNA (cDNA clone MGC:25024 IMAGE:4470095), complete cds
B18R16C19	18-19-16	Hs~Ref:NM_006004.1~uORF:IOH57362	961	831	1226	479	869	717	1055	669	1691	206	Cytochrome b-c1 complex subunit 6, mitochondrial
B18R16C20	18-20-16	Hs~Ref:NM_006004.1~uORF:IOH57362	906	893	1230	489	864	749	1076	623	1659	200	Cytochrome b-c1 complex subunit 6, mitochondrial
B18R16C21	18-21-16	Hs~MGC:BC064898.1~uORF:IOH39949	633	465	810	393	502	550	1175	755	791	361	chromosome 3 open reading frame 33 (C3orf33)
B18R16C22	18-22-16	Hs~MGC:BC064898.1~uORF:IOH39949	663	414	818	364	484	519	1135	903	815	327	chromosome 3 open reading frame 33 (C3orf33)
B18R17C01	18-1-17	Hs~MGC:BC011676.1~uORF:IOH13772	221	839	305	186	190	269	265	226	485	108	NF-kappa-B inhibitor epsilon
B18R17C02	18-2-17	Hs~MGC:BC011676.1~uORF:IOH13772	226	73	362	189	375	277	295	278	331	65	NF-kappa-B inhibitor epsilon
B18R17C03	18-3-17	Hs~Ref:NM_138385.1~uORF:IOH13771	373	171	506	169	94	156	246	257	52	71	transmembrane protein 129 (TMEM129)
B18R17C04	18-4-17	Hs~Ref:NM_138385.1~uORF:IOH13771	248	65	411	196	92	151	255	236	122	46	transmembrane protein 129 (TMEM129)
B18R17C05	18-5-17	Hs~Ref:NM_002065.3~uORF:IOH13814	374	436	1193	263	362	424	1869	1406	973	322	glutamate-ammonia ligase (glutamine synthetase) (GLUL), transcript variant 1
B18R17C06	18-6-17	Hs~Ref:NM_002065.3~uORF:IOH13814	409	434	1118	266	339	450	1464	1209	980	398	glutamate-ammonia ligase (glutamine synthetase) (GLUL), transcript variant 1
B18R17C09	18-9-17	Hs~MGC:BC064566.1~uORF:IOH39906	301	380	589	310	236	349	547	380	1402	101	UEV and lactate/malate dehyrogenase domains (UEVLD)
B18R17C10	18-10-17	Hs~MGC:BC064566.1~uORF:IOH39906	364	352	596	205	249	310	439	375	500	101	UEV and lactate/malate dehyrogenase domains (UEVLD)
B18R17C11	18-11-17	Hs~MGC:BC011526.1~uORF:IOH9712	583	467	473	491	727	422	611	491	924	751	PCTAIRE protein kinase 3 (PCTK3)
B18R17C12	18-12-17	Hs~MGC:BC011526.1~uORF:IOH9712	563	503	508	478	713	398	626	499	1118	619	PCTAIRE protein kinase 3 (PCTK3)
B18R17C13	18-13-17	Hs~MGC:BC022270.1~uORF:IOH12872	1194	725	1812	1458	7838	1789	1728	889	1819	732	CDKN2A interacting protein (CDKN2AIP)
B18R17C14	18-14-17	Hs~MGC:BC022270.1~uORF:IOH12872	1400	778	1658	1790	6662	1716	1926	950	1589	684	CDKN2A interacting protein (CDKN2AIP)
B18R17C15	18-15-17	Hs~Ref:NM_032138.2~uORF:IOH10969	482	635	929	842	368	772	1011	1140	1256	581	kelch repeat and BTB (POZ) domain containing 7 (KBTBD7)
B18R17C16	18-16-17	Hs~Ref:NM_032138.2~uORF:IOH10969	486	598	964	730	354	878	1052	1176	1207	560	kelch repeat and BTB (POZ) domain containing 7 (KBTBD7)
B18R17C17	18-17-17	Hs~Ref:NM_172028.1~uORF:IOH42497	1417	731	2002	502	701	1093	1677	772	1765	274	ankyrin repeat and BTB (POZ) domain containing 1 (ABTB1), transcript variant 3
B18R17C18	18-18-17	Hs~Ref:NM_172028.1~uORF:IOH42497	1431	681	1905	515	679	1101	1738	773	1742	254	ankyrin repeat and BTB (POZ) domain containing 1 (ABTB1), transcript variant 3
B18R17C19	18-19-17	Hs~Ref:NM_153284.1~uORF:IOH41629	691	451	836	384	390	685	1019	546	802	266	hyaluronoglucosaminidase 1 (HYAL1), transcript variant 4
B18R17C20	18-20-17	Hs~Ref:NM_153284.1~uORF:IOH41629	749	539	765	394	416	797	1155	624	843	200	hyaluronoglucosaminidase 1 (HYAL1), transcript variant 4
B18R17C21	18-21-17	Hs~Ref:NM_177974.1~uORF:IOH41242	3709	1544	1077	651	594	2074	2937	871	1470	633	cancer susceptibility candidate 4 (CASC4), transcript variant 2
B18R17C22	18-22-17	Hs~Ref:NM_177974.1~uORF:IOH41242	3664	1444	974	623	554	1936	2950	823	1422	593	cancer susceptibility candidate 4 (CASC4), transcript variant 2
B18R18C01	18-1-18	Hs~Ref:NM_006438.2~uORF:IOH42479	549	540	662	388	418	531	974	824	1518	314	Collectin-10
B18R18C02	18-2-18	Hs~Ref:NM_006438.2~uORF:IOH42479	556	452	744	425	416	538	1018	833	1812	334	Collectin-10
B18R18C03	18-3-18	Hs~MGC:BC058924.1~uORF:IOH29105	8786	711	1023	2128	1696	2107	5595	1294	1577	286	ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast) (UBE2M)
B18R18C04	18-4-18	Hs~MGC:BC058924.1~uORF:IOH29105	9254	841	987	2148	1898	2116	5651	1602	1582	268	ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast) (UBE2M)
B18R18C05	18-5-18	Hs~Ref:NM_003856.1~uORF:IOH29806	102	69	321	161	153	437	512	321	380	39	interleukin 1 receptor-like 1 (IL1RL1), transcript variant 2
B18R18C06	18-6-18	Hs~Ref:NM_003856.1~uORF:IOH29806	100	246	285	188	143	392	318	278	322	99	interleukin 1 receptor-like 1 (IL1RL1), transcript variant 2
B18R18C07	18-7-18	Hs~MGC:BC067741.1~uORF:IOH61679	756	362	1985	311	2866	17889	2406	752	1318	535	26S protease regulatory subunit 4
B18R18C08	18-8-18	Hs~MGC:BC067741.1~uORF:IOH61679	572	350	1967	653	2703	17611	2775	748	1376	159	26S protease regulatory subunit 4
B18R18C09	18-9-18	Hs~MGC:BC101006.1~uORF:IOH63457	242	308	467	463	448	594	913	575	431	84	ANKRD26-like family B member 1
B18R18C10	18-10-18	Hs~MGC:BC101006.1~uORF:IOH63457	317	298	540	408	494	543	811	571	621	115	ANKRD26-like family B member 1
B18R18C11	18-11-18	Hs~MGC:BC072409.1~uORF:IOH62546	819	338	763	442	5367	563	6316	559	1175	278	Serine/threonine-protein phosphatase 4 regulatory subunit 3A
B18R18C12	18-12-18	Hs~MGC:BC072409.1~uORF:IOH62546	802	368	803	437	5688	650	6173	556	1197	200	Serine/threonine-protein phosphatase 4 regulatory subunit 3A
B18R18C13	18-13-18	Hs~MGC:BC000967.2~uORF:IOH61493	757	486	1022	540	444	2457	2635	602	1209	332	NudC domain-containing protein 1
B18R18C14	18-14-18	Hs~MGC:BC000967.2~uORF:IOH61493	827	510	954	552	444	2373	2461	618	1152	355	NudC domain-containing protein 1
B18R18C15	18-15-18	Hs~MGC:BC005139.2~uORF:IOH4709	461	431	961	403	595	933	992	635	1747	444	ubiquitin specific peptidase 5 (isopeptidase T) (USP5)
B18R18C16	18-16-18	Hs~MGC:BC005139.2~uORF:IOH4709	459	440	898	414	638	946	984	641	1905	449	ubiquitin specific peptidase 5 (isopeptidase T) (USP5)
B18R18C17	18-17-18	Hs~Ref:NM_014815.2~uORF:IOH9726	689	592	859	530	617	716	913	743	1632	950	mediator complex subunit 24 (MED24), transcript variant 1
B18R18C18	18-18-18	Hs~Ref:NM_014815.2~uORF:IOH9726	624	587	825	502	607	873	883	689	1557	961	mediator complex subunit 24 (MED24), transcript variant 1
B18R18C19	18-19-18	Hs~MGC:BC047883.2~uORF:IOH26992	487	391	739	446	515	614	1107	491	959	338	SEC31 homolog A (S. cerevisiae) (SEC31A)
B18R18C20	18-20-18	Hs~MGC:BC047883.2~uORF:IOH26992	531	503	735	462	526	597	1150	506	982	286	SEC31 homolog A (S. cerevisiae) (SEC31A)
B18R18C21	18-21-18	Hs~Ref:NM_005926.2~uORF:IOH27077	858	570	883	605	475	1067	1691	744	1058	409	microfibrillar-associated protein 1 (MFAP1)
B18R18C22	18-22-18	Hs~Ref:NM_005926.2~uORF:IOH27077	832	549	843	555	476	905	1759	717	1207	452	microfibrillar-associated protein 1 (MFAP1)
B18R19C01	18-1-19	Hs~MGC:BC056257.1~uORF:IOH29441	471	351	579	355	405	496	759	727	954	352	adaptor-related protein complex 3, mu 2 subunit (AP3M2)
B18R19C02	18-2-19	Hs~MGC:BC056257.1~uORF:IOH29441	464	248	635	329	423	546	940	532	608	350	adaptor-related protein complex 3, mu 2 subunit (AP3M2)
B18R19C03	18-3-19	Hs~MGC:BC035972.1~uORF:IOH27964	750	434	707	359	405	559	916	611	993	313	glypican 3 (GPC3)
B18R19C04	18-4-19	Hs~MGC:BC035972.1~uORF:IOH27964	804	395	759	363	383	600	960	606	891	287	glypican 3 (GPC3)
B18R19C05	18-5-19	Hs~MGC:BC067826.1~uORF:IOH61627	3150	1244	630	516	2683	711	4214	788	1287	353	mortality factor 4 like 1, mRNA (cDNA clone MGC:87361 IMAGE:4824022), complete cds
B18R19C06	18-6-19	Hs~MGC:BC067826.1~uORF:IOH61627	3093	1289	585	529	2240	700	3958	810	1283	321	mortality factor 4 like 1, mRNA (cDNA clone MGC:87361 IMAGE:4824022), complete cds
B18R19C07	18-7-19	Hs~MGC:BC093051.1~uORF:IOH63174	5218	4202	3584	4353	8052	1538	3747	1439	1269	489	Nuclear protein Hcc-1
B18R19C08	18-8-19	Hs~MGC:BC093051.1~uORF:IOH63174	5469	4377	3560	4331	7917	1530	4335	1520	1564	181	Nuclear protein Hcc-1
B18R19C09	18-9-19	Hs~MGC:BC064422.1~uORF:IOH61572	232	256	447	255	256	236	486	311	791	107	Calcium/calmodulin-dependent protein kinase type 1B
B18R19C10	18-10-19	Hs~MGC:BC064422.1~uORF:IOH61572	258	257	424	201	262	238	395	305	704	138	Calcium/calmodulin-dependent protein kinase type 1B
B18R19C13	18-13-19	Hs~Ref:NM_012339.3~uORF:IOH6065	498	435	807	372	403	441	981	496	977	232	tetraspanin 15 (TSPAN15)
B18R19C14	18-14-19	Hs~Ref:NM_012339.3~uORF:IOH6065	501	400	712	392	380	449	927	507	771	282	tetraspanin 15 (TSPAN15)
B18R19C15	18-15-19	Hs~Ref:NM_006327.2~uORF:IOH40094	512	298	507	284	281	306	536	454	312	66	translocase of inner mitochondrial membrane 23 homolog (yeast) (TIMM23)
B18R19C16	18-16-19	Hs~Ref:NM_006327.2~uORF:IOH40094	432	299	532	272	271	321	600	397	569	110	translocase of inner mitochondrial membrane 23 homolog (yeast) (TIMM23)
B18R19C17	18-17-19	Hs~Ref:NM_206834.1~uORF:IOH40081	1390	895	1242	3197	850	1013	4437	1154	2017	953	Uncharacterized protein C6orf201
B18R19C18	18-18-19	Hs~Ref:NM_206834.1~uORF:IOH40081	1437	875	1244	2674	863	1031	4383	1357	1903	940	Uncharacterized protein C6orf201
B18R19C19	18-19-19	Hs~MGC:BC068537.1~uORF:IOH40089	1105	502	616	287	541	495	843	390	586	177	serine palmitoyltransferase, long chain base subunit 1 (SPTLC1)
B18R19C20	18-20-19	Hs~MGC:BC068537.1~uORF:IOH40089	2144	466	622	298	537	538	824	417	691	120	serine palmitoyltransferase, long chain base subunit 1 (SPTLC1)
B18R19C21	18-21-19	Hs~MGC:BC000607.1~uORF:IOH4250	583	494	508	296	345	607	596	489	818	170	Anaphase-promoting complex subunit 11
B18R19C22	18-22-19	Hs~MGC:BC000607.1~uORF:IOH4250	312	404	508	325	375	634	597	469	727	8	Anaphase-promoting complex subunit 11
B18R20C01	18-1-20	Hs~Ref:NM_001549.1~uORF:IOH3948	310	317	1176	882	259	432	486	411	816	178	interferon-induced protein with tetratricopeptide repeats 3 (IFIT3)
B18R20C02	18-2-20	Hs~Ref:NM_001549.1~uORF:IOH3948	337	190	414	889	219	487	482	508	622	140	interferon-induced protein with tetratricopeptide repeats 3 (IFIT3)
B18R20C03	18-3-20	Hs~MGC:BC000651.1~uORF:IOH4188	444	824	733	9833	303	634	722	879	858	215	solute carrier family 1 (glutamate transporter), member 7 (SLC1A7)
B18R20C04	18-4-20	Hs~MGC:BC000651.1~uORF:IOH4188	447	428	756	9572	295	710	752	921	803	247	solute carrier family 1 (glutamate transporter), member 7 (SLC1A7)
B18R20C05	18-5-20	Hs~MGC:BC022524.1~uORF:IOH10757	1677	1201	1748	902	519	1509	10061	928	-9	0	fibroblast growth factor 12 (FGF12)
B18R20C06	18-6-20	Hs~MGC:BC022524.1~uORF:IOH10757	1693	1241	1891	855	602	1454	8644	936	-2	-1	fibroblast growth factor 12 (FGF12)
B18R20C07	18-7-20	Hs~MGC:BC007919.2~uORF:IOH40619	767	686	1819	579	585	626	967	1882	1614	306	StAR-related lipid transfer (START) domain containing 10 (STARD10)
B18R20C08	18-8-20	Hs~MGC:BC007919.2~uORF:IOH40619	837	729	1769	617	538	629	1123	1885	1757	237	StAR-related lipid transfer (START) domain containing 10 (STARD10)
B18R20C09	18-9-20	Hs~Ref:NM_002355.2~uORF:IOH40579	1214	871	2211	923	1065	1000	1580	1038	2323	526	mannose-6-phosphate receptor (cation dependent) (M6PR)
B18R20C10	18-10-20	Hs~Ref:NM_002355.2~uORF:IOH40579	1128	843	2152	784	1060	1061	1529	1053	2187	542	mannose-6-phosphate receptor (cation dependent) (M6PR)
B18R20C11	18-11-20	Hs~MGC:BC000601.1~uORF:IOH4258	808	720	1491	650	946	976	1943	1326	1671	465	HIG1 domain family, member 1A (HIGD1A)
B18R20C12	18-12-20	Hs~MGC:BC000601.1~uORF:IOH4258	812	753	1536	644	833	1027	1942	1371	1373	435	HIG1 domain family, member 1A (HIGD1A)
B18R20C13	18-13-20	Hs~Ref:NM_174933.2~uORF:IOH12686	1312	311	4732	1801	633	1689	2164	1106	1472	2174	Phytanoyl-CoA dioxygenase domain-containing protein 1
B18R20C14	18-14-20	Hs~Ref:NM_174933.2~uORF:IOH12686	1483	324	4338	2026	710	1651	2233	1102	1537	2126	Phytanoyl-CoA dioxygenase domain-containing protein 1
B19R02C11	19-11-2	Hs~Ref:NM_006658.1~uORF:IOH21548	3079	931	2579	4953	28475	2903	3344	2034	2416	1311	chromosome 7 open reading frame 16 (C7orf16)
B19R02C12	19-12-2	Hs~Ref:NM_006658.1~uORF:IOH21548	3336	929	2450	5374	29900	2928	3275	1759	2369	1337	chromosome 7 open reading frame 16 (C7orf16)
B19R02C13	19-13-2	Hs~MGC:NM_182541.1~uORF:IOH21588	1453	581	858	618	1091	665	1029	912	2341	521	transmembrane protein 31 (TMEM31)
B19R02C14	19-14-2	Hs~MGC:NM_182541.1~uORF:IOH21588	1235	568	853	630	1140	627	1022	842	2290	505	transmembrane protein 31 (TMEM31)
B19R02C15	19-15-2	Hs~MGC:NM_174903.2~uORF:IOH22522	716	602	985	506	1128	705	1156	1258	1846	1091	RING finger protein 151
B19R02C16	19-16-2	Hs~MGC:NM_174903.2~uORF:IOH22522	697	602	1029	544	1099	808	1162	1300	1874	841	RING finger protein 151
B19R02C17	19-17-2	Hs~MGC:BC020814.1~uORF:IOH12692	686	592	795	500	996	572	877	874	1546	403	SGT1, suppressor of G2 allele of SKP1 like 1 (S. cerevisiae) (SUGT1L1)
B19R02C18	19-18-2	Hs~MGC:BC020814.1~uORF:IOH12692	791	529	793	504	658	622	868	615	12	206	SGT1, suppressor of G2 allele of SKP1 like 1 (S. cerevisiae) (SUGT1L1)
B19R02C19	19-19-2	Hs~MGC:BC032454.1~uORF:IOH21666	2566	980	1435	1506	1319	1367	2372	1768	1732	399	serologically defined colon cancer antigen 8 (SDCCAG8)
B19R02C20	19-20-2	Hs~MGC:BC032454.1~uORF:IOH21666	2450	976	1365	1483	1374	1501	2412	1882	1966	398	serologically defined colon cancer antigen 8 (SDCCAG8)
B19R02C21	19-21-2	Hs~MGC:BC032372.1~uORF:IOH21643	1449	903	1025	1442	6032	1353	42343	3975	2512	975	Ral GEF with PH domain and SH3 binding motif 1 (RALGPS1)
B19R02C22	19-22-2	Hs~MGC:BC032372.1~uORF:IOH21643	1411	898	1021	1432	6141	1359	38366	4020	2333	350	Ral GEF with PH domain and SH3 binding motif 1 (RALGPS1)
B19R03C01	19-1-3	Hs~Ref:NM_145177.1~uORF:IOH21679	606	573	1006	427	695	869	769	821	2163	1211	dehydrogenase/reductase (SDR family) X-linked (DHRSX)
B19R03C02	19-2-3	Hs~Ref:NM_145177.1~uORF:IOH21679	584	753	961	447	667	911	782	1159	2178	1133	dehydrogenase/reductase (SDR family) X-linked (DHRSX)
B19R03C03	19-3-3	Hs~Ref:NM_152789.1~uORF:IOH21683	1654	843	5473	2282	2360	1889	2583	1623	2243	1318	family with sequence similarity 133, member B (FAM133B), transcript variant 1
B19R03C04	19-4-3	Hs~Ref:NM_152789.1~uORF:IOH21683	1398	823	5268	2320	2479	2144	2641	1590	2405	1287	family with sequence similarity 133, member B (FAM133B), transcript variant 1
B19R03C05	19-5-3	Hs~Ref:NM_005339.3~uORF:IOH13913	630	504	611	345	485	2592	658	394	957	289	huntingtin interacting protein 2 (HIP2)
B19R03C06	19-6-3	Hs~Ref:NM_005339.3~uORF:IOH13913	608	534	599	419	548	1679	625	370	1066	305	huntingtin interacting protein 2 (HIP2)
B19R03C07	19-7-3	Hs~MGC:BC025278.1~uORF:IOH14045	400	444	613	422	378	531	890	384	836	314	androgen-induced 1 (AIG1)
B19R03C08	19-8-3	Hs~MGC:BC025278.1~uORF:IOH14045	387	455	546	383	391	469	908	403	789	44	androgen-induced 1 (AIG1)
B19R03C09	19-9-3	Hs~Ref:NM_021105.1~uORF:IOH13995	1019	675	1235	619	532	916	1171	641	1717	426	phospholipid scramblase 1 (PLSCR1)
B19R03C10	19-10-3	Hs~Ref:NM_021105.1~uORF:IOH13995	1032	675	1229	618	516	1032	1364	552	1565	509	phospholipid scramblase 1 (PLSCR1)
B19R03C13	19-13-3	Hs~Ref:NM_007208.2~uORF:IOH2930	67	171	189	326	30	203	185	216	138	84	mitochondrial ribosomal protein L3 (MRPL3), nuclear gene encoding mitochondrial protein
B19R03C14	19-14-3	Hs~Ref:NM_007208.2~uORF:IOH2930	66	212	297	176	25	204	137	183	66	27	mitochondrial ribosomal protein L3 (MRPL3), nuclear gene encoding mitochondrial protein
B19R03C15	19-15-3	Hs~MGC:BC042869.1~uORF:IOH26487	40	111	192	125	39	201	173	269	5	1507	Dynein heavy chain 14, axonemal
B19R03C16	19-16-3	Hs~MGC:BC042869.1~uORF:IOH26487	116	31	289	194	294	132	193	251	87	38	Dynein heavy chain 14, axonemal
B19R03C17	19-17-3	Hs~Ref:NM_007268.1~uORF:IOH10254	537	452	556	442	482	463	723	556	508	215	V-set and immunoglobulin domain containing 4 (VSIG4), transcript variant 1
B19R03C18	19-18-3	Hs~Ref:NM_007268.1~uORF:IOH10254	542	382	546	423	526	474	711	493	512	198	V-set and immunoglobulin domain containing 4 (VSIG4), transcript variant 1
B19R03C19	19-19-3	Hs~Ref:NM_024102.2~uORF:IOH10338	964	658	844	502	1130	995	1340	552	1429	401	WD repeat domain 77 (WDR77)
B19R03C20	19-20-3	Hs~Ref:NM_024102.2~uORF:IOH10338	959	610	819	511	551	1006	1317	590	1891	371	WD repeat domain 77 (WDR77)
B19R03C21	19-21-3	Hs~MGC:BC005930.1~uORF:IOH7549	1327	1157	1236	759	886	1092	2247	971	2556	266	CD58 molecule (CD58)
B19R03C22	19-22-3	Hs~MGC:BC005930.1~uORF:IOH7549	1326	1194	1287	745	885	1052	2115	950	2503	536	CD58 molecule (CD58)
B19R04C01	19-1-4	Hs~MGC:BC019102.1~uORF:IOH14069	896	1055	2454	652	895	1137	2014	1317	1920	483	Dedicator of cytokinesis protein 8
B19R04C02	19-2-4	Hs~MGC:BC019102.1~uORF:IOH14069	912	1054	2262	624	934	1134	2047	1218	1976	464	Dedicator of cytokinesis protein 8
B19R04C03	19-3-4	Hs~MGC:BC021105.1~uORF:IOH14081	3331	1386	2308	2394	2020	2399	2564	1802	4970	702	cutC copper transporter homolog (E. coli) (CUTC)
B19R04C04	19-4-4	Hs~MGC:BC021105.1~uORF:IOH14081	3581	1332	2231	2679	2161	2592	2692	1809	5306	679	cutC copper transporter homolog (E. coli) (CUTC)
B19R04C05	19-5-4	Hs~Ref:NM_001168.1~uORF:IOH5749	5402	310	461	454	917	4043	1215	371	1028	147	baculoviral IAP repeat-containing 5 (survivin) (BIRC5), transcript variant 1
B19R04C06	19-6-4	Hs~Ref:NM_001168.1~uORF:IOH5749	6797	310	418	484	859	249	1271	363	1101	164	baculoviral IAP repeat-containing 5 (survivin) (BIRC5), transcript variant 1
B19R04C07	19-7-4	Hs~MGC:BC030643.2~uORF:IOH22296	690	527	800	925	729	1317	1401	492	1596	118	Williams-Beuren syndrome chromosomal region 28 protein
B19R04C08	19-8-4	Hs~MGC:BC030643.2~uORF:IOH22296	654	590	779	881	741	707	1410	512	1513	65	Williams-Beuren syndrome chromosomal region 28 protein
B19R04C09	19-9-4	Hs~MGC:NM_152763.2~uORF:IOH22315	2107	1020	1686	2652	2632	1923	2382	1964	4189	586	chromosome 1 open reading frame 62 (C1orf62)
B19R04C10	19-10-4	Hs~MGC:NM_152763.2~uORF:IOH22315	2119	1006	1731	2706	2833	2028	2428	1912	4297	603	chromosome 1 open reading frame 62 (C1orf62)
B19R04C11	19-11-4	Hs~MGC:BC033009.2~uORF:IOH22324	-1	-1	4	3	286	982	1	0	4	-3	alcohol dehydrogenase IB (class I), beta polypeptide (ADH1B)
B19R04C12	19-12-4	Hs~MGC:BC033009.2~uORF:IOH22324	-1	-3	3	0	-6	-2	1	1	1	-1	alcohol dehydrogenase IB (class I), beta polypeptide (ADH1B)
B19R04C13	19-13-4	Hs~Ref:NM_000023.1~uORF:IOH10645	1552	1816	1673	941	1289	1363	2945	1794	2827	800	sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) (SGCA)
B19R04C14	19-14-4	Hs~Ref:NM_000023.1~uORF:IOH10645	1879	1920	1724	1013	1189	1350	2893	1753	3034	757	sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) (SGCA)
B19R04C15	19-15-4	Hs~Ref:NM_004227.3~uORF:IOH11547	1072	917	1020	974	872	1179	2678	607	1578	1028	pleckstrin homology, Sec7 and coiled-coil domains 3 (PSCD3)
B19R04C16	19-16-4	Hs~Ref:NM_004227.3~uORF:IOH11547	900	883	1007	1018	972	1258	2709	620	1657	1103	pleckstrin homology, Sec7 and coiled-coil domains 3 (PSCD3)
B19R04C17	19-17-4	Hs~Ref:NM_006870.2~uORF:IOH12247	828	378	2115	396	921	840	701	865	-44	104	destrin (actin depolymerizing factor) (DSTN), transcript variant 1
B19R04C18	19-18-4	Hs~Ref:NM_006870.2~uORF:IOH12247	835	376	2126	391	725	746	684	739	53	188	destrin (actin depolymerizing factor) (DSTN), transcript variant 1
B19R04C19	19-19-4	Hs~MGC:BC007722.2~uORF:IOH6489	480	399	571	344	299	449	952	695	-10	-19	glycyl-tRNA synthetase (GARS)
B19R04C20	19-20-4	Hs~MGC:BC007722.2~uORF:IOH6489	569	351	523	365	325	514	889	664	29	123	glycyl-tRNA synthetase (GARS)
B19R04C21	19-21-4	Hs~Ref:NM_002046.2~uORF:IOH3380	886	1503	695	1250	715	912	1585	806	2189	339	glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
B19R04C22	19-22-4	Hs~Ref:NM_002046.2~uORF:IOH3380	847	1497	710	1242	808	934	1544	781	2281	315	glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
B19R05C01	19-1-5	Hs~Ref:NM_024117.3~uORF:IOH3756	594	324	531	294	129	517	1242	481	658	208	mitogen-activated protein kinase associated protein 1 (MAPKAP1), transcript variant 2, mRNA.
B19R05C02	19-2-5	Hs~Ref:NM_024117.3~uORF:IOH3756	591	331	551	305	250	546	1273	381	730	184	mitogen-activated protein kinase associated protein 1 (MAPKAP1), transcript variant 2, mRNA.
B19R05C03	19-3-5	Hs~Ref:NM_001011538.1~uORF:IOH39826	686	367	575	883	857	550	773	598	493	230	similar to 60S ribosomal protein L21 (LOC402176)
B19R05C04	19-4-5	Hs~Ref:NM_001011538.1~uORF:IOH39826	692	384	564	839	1009	601	770	536	742	235	similar to 60S ribosomal protein L21 (LOC402176)
B19R05C05	19-5-5	Hs~Ref:NM_152688.1~uORF:IOH22222	1621	624	1041	858	733	1936	2937	1075	1541	313	KH domain containing, RNA binding, signal transduction associated 2 (KHDRBS2)
B19R05C06	19-6-5	Hs~Ref:NM_152688.1~uORF:IOH22222	1683	667	995	934	741	997	3065	1035	1491	305	KH domain containing, RNA binding, signal transduction associated 2 (KHDRBS2)
B19R05C07	19-7-5	Hs~Ref:NM_014321.2~uORF:IOH39827	827	561	2376	596	1013	1235	2151	793	1455	668	origin recognition complex, subunit 6 like (yeast) (ORC6L)
B19R05C08	19-8-5	Hs~Ref:NM_014321.2~uORF:IOH39827	855	584	2302	608	1024	1301	2112	779	1520	741	origin recognition complex, subunit 6 like (yeast) (ORC6L)
B19R05C09	19-9-5	Hs~MGC:BC011904.1~uORF:IOH13374	1141	935	1299	809	1533	1244	2535	958	2250	702	Probable O-sialoglycoprotein endopeptidase 2
B19R05C10	19-10-5	Hs~MGC:BC011904.1~uORF:IOH13374	1162	891	1247	779	1565	1240	2241	1013	2225	673	Probable O-sialoglycoprotein endopeptidase 2
B19R05C11	19-11-5	Hs~Ref:NM_024295.1~uORF:IOH4224	1263	1077	1519	853	1077	1353	2205	1084	2055	726	Der1-like domain family, member 1 (DERL1)
B19R05C12	19-12-5	Hs~Ref:NM_024295.1~uORF:IOH4224	1316	1079	1475	959	1759	1349	2291	1090	2020	685	Der1-like domain family, member 1 (DERL1)
B19R05C13	19-13-5	Hs~MGC:BC001116.1~uORF:IOH3881	984	1188	1112	849	1304	1031	1103	787	2247	467	adenylate kinase 1 (AK1)
B19R05C14	19-14-5	Hs~MGC:BC001116.1~uORF:IOH3881	1161	1236	1146	859	1280	1024	1127	810	2480	572	adenylate kinase 1 (AK1)
B19R05C15	19-15-5	Hs~Ref:NM_003404.2~uORF:IOH3955	1393	861	1085	691	1420	1349	1527	766	2286	1056	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (YWHAB), transcript variant 1
B19R05C16	19-16-5	Hs~Ref:NM_003404.2~uORF:IOH3955	1181	900	1092	789	1370	1298	1478	771	2755	950	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (YWHAB), transcript variant 1
B19R05C17	19-17-5	Hs~Ref:NM_021735.1~uORF:IOH29577	132	162	233	47	65	60	240	273	608	25	chloride channel 6 (CLCN6), transcript variant ClC-6b
B19R05C18	19-18-5	Hs~Ref:NM_021735.1~uORF:IOH29577	93	161	234	279	112	54	215	350	783	21	chloride channel 6 (CLCN6), transcript variant ClC-6b
B19R05C19	19-19-5	Hs~MGC:BC042147.1~uORF:IOH27991	178	306	459	130	191	362	486	148	1416	55	potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 (KCNN3)
B19R05C20	19-20-5	Hs~MGC:BC042147.1~uORF:IOH27991	287	332	455	169	256	413	483	147	1814	45	potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 (KCNN3)
B19R05C21	19-21-5	Hs~Ref:NM_138771.2~uORF:IOH40866	413	1138	484	116	216	313	469	837	1043	-8	coiled-coil domain containing 126 (CCDC126)
B19R05C22	19-22-5	Hs~Ref:NM_138771.2~uORF:IOH40866	392	1106	501	138	216	331	502	836	1103	-2	coiled-coil domain containing 126 (CCDC126)
B19R06C01	19-1-6	Hs~Ref:NM_144711.3~uORF:IOH40820	85	73	214	78	56	143	132	193	74	46	kelch-like 23 (Drosophila) (KLHL23)
B19R06C02	19-2-6	Hs~Ref:NM_144711.3~uORF:IOH40820	97	250	220	117	71	156	177	184	77	32	kelch-like 23 (Drosophila) (KLHL23)
B19R06C03	19-3-6	Hs~MGC:BC012333.1~uORF:IOH12139	545	470	667	357	547	481	863	592	1031	315	sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like (SC5DL)
B19R06C04	19-4-6	Hs~MGC:BC012333.1~uORF:IOH12139	596	420	666	386	440	505	951	505	932	491	sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like (SC5DL)
B19R06C05	19-5-6	Hs~MGC:BC012056.1~uORF:IOH13300	618	500	737	521	355	551	990	389	1240	296	ankyrin repeat and SOCS box-containing 13 (ASB13)
B19R06C06	19-6-6	Hs~MGC:BC012056.1~uORF:IOH13300	650	481	683	557	547	568	1018	373	1170	152	ankyrin repeat and SOCS box-containing 13 (ASB13)
B19R06C07	19-7-6	Hs~MGC:BC015912.1~uORF:IOH13084	479	504	613	375	252	551	780	428	875	46	transmembrane protein 186 (TMEM186)
B19R06C08	19-8-6	Hs~MGC:BC015912.1~uORF:IOH13084	461	492	626	389	257	484	779	474	828	444	transmembrane protein 186 (TMEM186)
B19R06C09	19-9-6	Hs~MGC:BC010394.1~uORF:IOH12343	448	410	542	332	236	461	730	427	859	295	FCH and double SH3 domains 2 (FCHSD2)
B19R06C10	19-10-6	Hs~MGC:BC010394.1~uORF:IOH12343	412	388	570	367	504	555	772	453	816	282	FCH and double SH3 domains 2 (FCHSD2)
B19R06C11	19-11-6	Hs~Ref:NM_138334.1~uORF:IOH40016	783	712	1695	425	508	23809	1075	450	1724	343	Josephin domain containing 2 (JOSD2)
B19R06C12	19-12-6	Hs~Ref:NM_138334.1~uORF:IOH40016	763	725	1650	471	365	24831	1064	450	1708	374	Josephin domain containing 2 (JOSD2)
B19R06C13	19-13-6	Hs~MGC:BC064545.1~uORF:IOH39915	859	975	1176	959	685	2853	2405	632	2024	264	hypothetical protein FLJ35220 (FLJ35220)
B19R06C14	19-14-6	Hs~MGC:BC064545.1~uORF:IOH39915	1062	937	1243	1052	709	2970	2392	692	2317	453	hypothetical protein FLJ35220 (FLJ35220)
B19R06C15	19-15-6	Hs~MGC:BC066364.1~uORF:IOH39987	781	451	796	382	426	757	760	441	848	380	SIN3 homolog A, transcription regulator (yeast) (SIN3A)
B19R06C16	19-16-6	Hs~MGC:BC066364.1~uORF:IOH39987	536	451	723	543	428	787	713	445	62	342	SIN3 homolog A, transcription regulator (yeast) (SIN3A)
B19R06C17	19-17-6	Hs~Ref:NM_033495.2~uORF:IOH40892	432	347	376	269	187	2214	530	315	101	210	kelch-like 13 (Drosophila) (KLHL13)
B19R06C18	19-18-6	Hs~Ref:NM_033495.2~uORF:IOH40892	591	364	418	282	314	770	510	354	26	215	kelch-like 13 (Drosophila) (KLHL13)
B19R06C19	19-19-6	Hs~MGC:BC013900.1~uORF:IOH27818	1221	959	1158	1116	1241	2122	1294	1345	2215	2296	chromosome 12 open reading frame 41 (C12orf41)
B19R06C20	19-20-6	Hs~MGC:BC013900.1~uORF:IOH27818	1178	990	1153	1098	1228	2183	1299	1235	2086	2349	chromosome 12 open reading frame 41 (C12orf41)
B19R06C21	19-21-6	Hs~MGC:BC035969.1~uORF:IOH27974	566	391	457	335	311	463	710	462	853	426	albumin (ALB)
B19R06C22	19-22-6	Hs~MGC:BC035969.1~uORF:IOH27974	540	369	496	332	320	434	702	421	759	12	albumin (ALB)
B19R07C01	19-1-7	Hs~MGC:BC009251.1~uORF:IOH27776	506	1035	491	251	761	495	767	343	584	228	farnesyl-diphosphate farnesyltransferase 1 (FDFT1)
B19R07C02	19-2-7	Hs~MGC:BC009251.1~uORF:IOH27776	499	1107	478	269	430	536	803	317	730	207	farnesyl-diphosphate farnesyltransferase 1 (FDFT1)
B19R07C03	19-3-7	Hs~MGC:BC035968.1~uORF:IOH27970	623	705	595	696	410	1111	1492	484	1215	296	chloride intracellular channel 5 (CLIC5)
B19R07C04	19-4-7	Hs~MGC:BC035968.1~uORF:IOH27970	620	689	596	632	427	1062	1528	521	1240	298	chloride intracellular channel 5 (CLIC5)
B19R07C05	19-5-7	Hs~MGC:BC051031.1~uORF:IOH26563	1438	3226	2128	1917	1318	791	3040	554	1498	337	chromosome 11 open reading frame 74 (C11orf74)
B19R07C06	19-6-7	Hs~MGC:BC051031.1~uORF:IOH26563	1683	3274	1933	2089	1402	885	3146	547	1558	327	chromosome 11 open reading frame 74 (C11orf74)
B19R07C07	19-7-7	Hs~MGC:BC000157.2~uORF:IOH2943	3586	2457	2436	959	1101	1487	6513	843	2168	730	zinc finger protein 691 (ZNF691)
B19R07C08	19-8-7	Hs~MGC:BC000157.2~uORF:IOH2943	3387	2354	2211	984	1044	1678	6265	863	2201	700	zinc finger protein 691 (ZNF691)
B19R07C09	19-9-7	Hs~MGC:BC041563.1~uORF:IOH28055	398	490	956	477	602	510	7106	1290	1718	328	oxysterol binding protein-like 1A (OSBPL1A)
B19R07C10	19-10-7	Hs~MGC:BC041563.1~uORF:IOH28055	399	480	941	450	576	530	6990	1253	1660	287	oxysterol binding protein-like 1A (OSBPL1A)
B19R07C11	19-11-7	Hs~MGC:BC000934.2~uORF:IOH2996	3183	1122	1984	1012	1033	1869	16636	965	3090	878	eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa (EIF2S2)
B19R07C12	19-12-7	Hs~MGC:BC000934.2~uORF:IOH2996	3263	1123	1983	1057	1084	2015	16430	987	3079	1035	eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa (EIF2S2)
B19R07C15	19-15-7	Hs~Ref:NM_175571.2~uORF:IOH44212	3278	1898	2139	1294	1813	2509	4238	1369	2921	868	GTPase, IMAP family member 8 (GIMAP8)
B19R07C16	19-16-7	Hs~Ref:NM_175571.2~uORF:IOH44212	3182	1879	2190	1413	1826	2290	4151	1336	3383	873	GTPase, IMAP family member 8 (GIMAP8)
B19R07C21	19-21-7	Hs~Ref:NM_016207.2~uORF:IOH14059	7005	11535	6480	6535	4605	6047	7377	4430	8071	6111	cleavage and polyadenylation specific factor 3, 73kDa (CPSF3)
B19R07C22	19-22-7	Hs~Ref:NM_016207.2~uORF:IOH14059	6860	11114	6342	6415	4626	6041	7355	4271	8319	5977	cleavage and polyadenylation specific factor 3, 73kDa (CPSF3)
B19R08C01	19-1-8	Hs~MGC:BC021561.1~uORF:IOH14131	2759	1306	2183	1171	1929	1443	4705	1314	3186	703	FACT complex subunit SPT16
B19R08C02	19-2-8	Hs~MGC:BC021561.1~uORF:IOH14131	2858	1284	2168	1248	2001	1438	4797	1325	3319	733	FACT complex subunit SPT16
B19R08C03	19-3-8	Hs~Ref:NM_005347.2~uORF:IOH14762	1097	890	1681	961	1070	922	1350	914	2820	553	heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) (HSPA5)
B19R08C04	19-4-8	Hs~Ref:NM_005347.2~uORF:IOH14762	1098	891	1570	1024	1068	927	1343	851	2869	636	heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) (HSPA5)
B19R08C05	19-5-8	Hs~MGC:BC028840.1~uORF:IOH13887	1846	1452	3253	2150	1556	1615	1916	4458	9360	510	ankyrin repeat domain 13C (ANKRD13C)
B19R08C06	19-6-8	Hs~MGC:BC028840.1~uORF:IOH13887	2077	1482	3165	2274	1527	1696	1910	4308	10097	525	ankyrin repeat domain 13C (ANKRD13C)
B19R08C07	19-7-8	Hs~MGC:BC017810.1~uORF:IOH12948	1978	909	1770	1093	3138	3181	1805	622	2251	516	tropomodulin 4 (muscle) (TMOD4)
B19R08C08	19-8-8	Hs~MGC:BC017810.1~uORF:IOH12948	1935	934	1752	1088	3266	3472	1916	656	2320	443	tropomodulin 4 (muscle) (TMOD4)
B19R08C09	19-9-8	Hs~Ref:NM_000327.2~uORF:IOH3307	502	507	878	411	526	442	1595	1203	1212	157	retinal outer segment membrane protein 1 (ROM1)
B19R08C10	19-10-8	Hs~Ref:NM_000327.2~uORF:IOH3307	533	498	954	404	521	451	1569	1135	1103	244	retinal outer segment membrane protein 1 (ROM1)
B19R08C11	19-11-8	Hs~MGC:BC031068.1~uORF:IOH22548	2105	1170	1256	1953	1253	3688	2086	1347	4656	326	aminoadipate aminotransferase (AADAT)
B19R08C12	19-12-8	Hs~MGC:BC031068.1~uORF:IOH22548	2048	1152	1266	1931	1327	3846	2069	1432	5157	386	aminoadipate aminotransferase (AADAT)
B19R08C13	19-13-8	Hs~Ref:NM_018107.2~uORF:IOH4028	730	735	3007	1320	1708	1877	924	1319	1954	608	RNA binding motif protein 23 (RBM23), transcript variant 2
B19R08C14	19-14-8	Hs~Ref:NM_018107.2~uORF:IOH4028	830	727	2978	1375	1722	1951	939	1369	1958	607	RNA binding motif protein 23 (RBM23), transcript variant 2
B19R08C15	19-15-8	Hs~Ref:NM_016041.1~uORF:IOH14205	302	296	360	288	244	418	715	282	452	240	Der1-like domain family, member 2 (DERL2)
B19R08C16	19-16-8	Hs~Ref:NM_016041.1~uORF:IOH14205	379	303	411	345	231	485	662	286	381	198	Der1-like domain family, member 2 (DERL2)
B19R08C17	19-17-8	Hs~Ref:NM_005851.2~uORF:IOH5446	4172	978	2163	1881	845	1380	2194	1200	3298	522	CDK2-associated protein 2 (CDK2AP2)
B19R08C18	19-18-8	Hs~Ref:NM_005851.2~uORF:IOH5446	4194	987	2117	1822	839	1362	2199	1211	3314	537	CDK2-associated protein 2 (CDK2AP2)
B19R08C19	19-19-8	Hs~Ref:NM_004223.1~uORF:IOH21743	428	12096	383	642	331	3227	552	329	824	215	ubiquitin-conjugating enzyme E2L 6 (UBE2L6), transcript variant 1
B19R08C20	19-20-8	Hs~Ref:NM_004223.1~uORF:IOH21743	443	12796	429	652	336	3233	561	341	742	145	ubiquitin-conjugating enzyme E2L 6 (UBE2L6), transcript variant 1
B19R08C21	19-21-8	Hs~Ref:NM_004066.1~uORF:IOH22566	937	530	582	1169	347	560	735	509	960	1650	centrin, EF-hand protein, 1 (CETN1)
B19R08C22	19-22-8	Hs~Ref:NM_004066.1~uORF:IOH22566	882	515	634	1085	380	539	809	569	881	1701	centrin, EF-hand protein, 1 (CETN1)
B19R09C01	19-1-9	Hs~Ref:NM_182578.1~uORF:IOH35353	1160	1117	1442	864	1215	1118	1595	983	2048	657	thioesterase superfamily member 5 (THEM5)
B19R09C02	19-2-9	Hs~Ref:NM_182578.1~uORF:IOH35353	1094	1220	1472	821	1143	1257	1621	929	2354	671	thioesterase superfamily member 5 (THEM5)
B19R09C03	19-3-9	Hs~Ref:NM_176870.1~uORF:IOH11808	922	577	972	620	1354	445	661	713	1550	461	metallothionein 1M (MT1M)
B19R09C04	19-4-9	Hs~Ref:NM_176870.1~uORF:IOH11808	890	594	964	594	1355	494	652	703	1513	213	metallothionein 1M (MT1M)
B19R09C05	19-5-9	Hs~Ref:NM_025212.1~uORF:IOH35255	1119	963	1214	786	1532	835	1429	885	2457	534	CXXC-type zinc finger protein 4
B19R09C06	19-6-9	Hs~Ref:NM_025212.1~uORF:IOH35255	1237	955	1251	925	1522	851	1509	867	2482	483	CXXC-type zinc finger protein 4
B19R09C07	19-7-9	Hs~Ref:NM_006246.2~uORF:IOH29856	1434	946	5349	949	1083	901	1475	774	2046	853	protein phosphatase 2, regulatory subunit B', epsilon isoform (PPP2R5E)
B19R09C08	19-8-9	Hs~Ref:NM_006246.2~uORF:IOH29856	1391	872	5606	879	1069	1174	1505	866	2107	940	protein phosphatase 2, regulatory subunit B', epsilon isoform (PPP2R5E)
B19R09C09	19-9-9	Hs~MGC:BC024001.2~uORF:IOH11161	423	2363	1011	4268	695	914	804	737	1001	409	leucine rich repeat containing 20 (LRRC20)
B19R09C10	19-10-9	Hs~MGC:BC024001.2~uORF:IOH11161	426	2358	970	4222	707	990	840	685	972	105	leucine rich repeat containing 20 (LRRC20)
B19R09C11	19-11-9	Hs~Ref:NM_017946.1~uORF:IOH7284	667	550	678	1741	315	632	1400	465	1118	320	FK506 binding protein 14, 22 kDa (FKBP14)
B19R09C12	19-12-9	Hs~Ref:NM_017946.1~uORF:IOH7284	687	540	604	1845	318	626	1376	479	1180	355	FK506 binding protein 14, 22 kDa (FKBP14)
B19R09C13	19-13-9	Hs~Ref:NM_138796.1~uORF:IOH10943	273	243	330	254	189	270	429	246	519	208	spermatogenesis associated 17 (SPATA17)
B19R09C14	19-14-9	Hs~Ref:NM_138796.1~uORF:IOH10943	294	236	347	378	174	326	416	233	341	197	spermatogenesis associated 17 (SPATA17)
B19R09C15	19-15-9	Hs~MGC:BC020692.1~uORF:IOH13652	991	446	1092	857	387	1502	794	393	806	264	deleted in lymphocytic leukemia, 1 (DLEU1)
B19R09C16	19-16-9	Hs~MGC:BC020692.1~uORF:IOH13652	1101	480	1020	874	397	1066	821	395	850	258	deleted in lymphocytic leukemia, 1 (DLEU1)
B19R09C17	19-17-9	Hs~Ref:NM_025187.2~uORF:IOH6362	1408	781	1520	756	868	603	1369	809	2408	383	chromosome 16 open reading frame 70 (C16orf70)
B19R09C18	19-18-9	Hs~Ref:NM_025187.2~uORF:IOH6362	1420	794	1477	768	811	653	1404	750	2518	380	chromosome 16 open reading frame 70 (C16orf70)
B19R09C19	19-19-9	Hs~MGC:NM_002791.1~uORF:IOH4917	637	547	781	660	960	631	2248	715	1909	342	proteasome (prosome, macropain) subunit, alpha type, 6 (PSMA6)
B19R09C20	19-20-9	Hs~MGC:NM_002791.1~uORF:IOH4917	630	560	775	664	969	600	2148	720	1811	152	proteasome (prosome, macropain) subunit, alpha type, 6 (PSMA6)
B19R09C21	19-21-9	Hs~Ref:NM_016025.2~uORF:IOH4369	433	421	994	412	398	417	794	431	403	240	methyltransferase like 9 (METTL9), transcript variant 1
B19R09C22	19-22-9	Hs~Ref:NM_016025.2~uORF:IOH4369	412	412	980	354	408	406	736	496	822	277	methyltransferase like 9 (METTL9), transcript variant 1
B19R10C01	19-1-10	Hs~MGC:BC008959.1~uORF:IOH6087	356	305	648	224	346	292	628	343	658	121	histocompatibility (minor) 13 (HM13)
B19R10C02	19-2-10	Hs~MGC:BC008959.1~uORF:IOH6087	369	287	609	264	258	292	574	369	693	159	histocompatibility (minor) 13 (HM13)
B19R10C05	19-5-10	Hs~MGC:BC004938.1~uORF:IOH5465	783	637	1054	676	829	869	1342	1067	2319	465	chromosome 11 open reading frame 9, mRNA (cDNA clone IMAGE:3608282), complete cds.
B19R10C06	19-6-10	Hs~MGC:BC004938.1~uORF:IOH5465	805	659	987	710	845	925	1277	899	2305	605	chromosome 11 open reading frame 9, mRNA (cDNA clone IMAGE:3608282), complete cds.
B19R10C07	19-7-10	Hs~MGC:BC015899.1~uORF:IOH10023	642	567	874	586	795	766	1140	681	2170	472	ATPase, H+ transporting V0 subunit e2, mRNA (cDNA clone MGC:17890 IMAGE:3908757), complete cds.
B19R10C08	19-8-10	Hs~MGC:BC015899.1~uORF:IOH10023	597	559	800	564	799	741	1025	681	2226	548	ATPase, H+ transporting V0 subunit e2, mRNA (cDNA clone MGC:17890 IMAGE:3908757), complete cds.
B19R10C09	19-9-10	Hs~MGC:BC001511.1~uORF:IOH14531	665	881	1382	370	475	801	2542	848	1726	230	Exocyst complex component 3
B19R10C10	19-10-10	Hs~MGC:BC001511.1~uORF:IOH14531	670	875	1395	381	469	881	2562	863	1755	242	Exocyst complex component 3
B19R12C01	19-1-12	Hs~Ref:NM_018038.1~uORF:IOH35119	415	413	737	365	339	416	776	401	944	315	hypothetical protein FLJ10246 (FLJ10246)
B19R12C02	19-2-12	Hs~Ref:NM_018038.1~uORF:IOH35119	461	447	780	388	461	417	907	418	968	320	hypothetical protein FLJ10246 (FLJ10246)
B19R12C03	19-3-12	Hs~Ref:NM_020415.2~uORF:IOH40390	482	475	976	792	532	478	763	509	1376	922	resistin (RETN)
B19R12C04	19-4-12	Hs~Ref:NM_020415.2~uORF:IOH40390	526	931	991	411	385	518	772	527	1444	813	resistin (RETN)
B19R12C05	19-5-12	Hs~Ref:NM_006349.2~uORF:IOH27942	716	533	755	543	551	690	1664	717	1171	471	zinc finger, HIT type 1 (ZNHIT1)
B19R12C06	19-6-12	Hs~Ref:NM_006349.2~uORF:IOH27942	652	556	756	480	524	698	1818	657	1090	400	zinc finger, HIT type 1 (ZNHIT1)
B19R12C07	19-7-12	Hs~Ref:NM_002429.3~uORF:IOH26664	696	1032	945	796	778	907	1329	912	1987	485	matrix metallopeptidase 19 (MMP19), transcript variant 1
B19R12C08	19-8-12	Hs~Ref:NM_002429.3~uORF:IOH26664	763	1156	944	597	707	965	1316	919	1863	429	matrix metallopeptidase 19 (MMP19), transcript variant 1
B19R12C09	19-9-12	Hs~Ref:NM_014466.2~uORF:IOH27569	2262	2358	3585	1414	3278	2665	4117	5391	8675	973	tektin 2 (testicular) (TEKT2)
B19R12C10	19-10-12	Hs~Ref:NM_014466.2~uORF:IOH27569	2359	2460	3409	1537	3403	2417	4232	5335	9063	983	tektin 2 (testicular) (TEKT2)
B19R12C11	19-11-12	Hs~Ref:NM_004873.1~uORF:IOH26366	2416	1485	1811	993	2990	1703	2327	1634	2544	1337	BCL2-associated athanogene 5 (BAG5), transcript variant 2
B19R12C12	19-12-12	Hs~Ref:NM_004873.1~uORF:IOH26366	2501	1554	1731	983	2985	1792	2438	1477	2457	1352	BCL2-associated athanogene 5 (BAG5), transcript variant 2
B19R12C13	19-13-12	Hs~MGC:BC042628.1~uORF:IOH27650	1364	799	1490	712	1411	1104	2470	1082	2379	509	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 (SERPINE2)
B19R12C14	19-14-12	Hs~MGC:BC042628.1~uORF:IOH27650	1395	840	1539	771	1407	1064	2360	1113	2279	541	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 (SERPINE2)
B19R12C15	19-15-12	Hs~MGC:BC024011.2~uORF:IOH10804	299	237	348	247	210	152	356	317	687	190	neuroblastoma breakpoint family, member 3 (NBPF3)
B19R12C16	19-16-12	Hs~MGC:BC024011.2~uORF:IOH10804	1356	242	318	335	200	223	314	321	495	180	neuroblastoma breakpoint family, member 3 (NBPF3)
B19R12C17	19-17-12	Hs~Ref:NM_004085.2~uORF:IOH7324	1552	210	274	286	196	4438	266	196	521	162	translocase of inner mitochondrial membrane 8 homolog A (yeast) (TIMM8A), nuclear gene encoding mitochondrial protein
B19R12C18	19-18-12	Hs~Ref:NM_004085.2~uORF:IOH7324	142	265	271	277	164	484	254	184	443	156	translocase of inner mitochondrial membrane 8 homolog A (yeast) (TIMM8A), nuclear gene encoding mitochondrial protein
B19R12C19	19-19-12	Hs~Ref:NM_001643.1~uORF:IOH7290	478	249	254	219	170	129	254	222	255	187	apolipoprotein A-II (APOA2)
B19R12C20	19-20-12	Hs~Ref:NM_001643.1~uORF:IOH7290	420	217	242	227	156	319	228	236	79	88	apolipoprotein A-II (APOA2)
B19R12C21	19-21-12	Hs~MGC:BC047023.1~uORF:IOH26604	339	256	384	11	198	397	382	241	-9	224	Rab9 effector protein with kelch motifs (RABEPK)
B19R12C22	19-22-12	Hs~MGC:BC047023.1~uORF:IOH26604	478	255	376	295	183	393	427	213	793	197	Rab9 effector protein with kelch motifs (RABEPK)
B19R13C01	19-1-13	Hs~MGC:BC028583.1~uORF:IOH11658	1071	568	833	490	784	657	2394	589	1175	376	Sentrin-specific protease 6
B19R13C02	19-2-13	Hs~MGC:BC028583.1~uORF:IOH11658	1001	559	836	454	832	610	2440	623	1172	375	Sentrin-specific protease 6
B19R13C03	19-3-13	Hs~Ref:NM_006247.2~uORF:IOH3193	467	2668	1330	2198	554	771	1219	615	1005	344	protein phosphatase 5, catalytic subunit (PPP5C)
B19R13C04	19-4-13	Hs~Ref:NM_006247.2~uORF:IOH3193	433	2713	1308	2172	563	931	1162	620	1041	326	protein phosphatase 5, catalytic subunit (PPP5C)
B19R13C05	19-5-13	Hs~MGC:BC011686.2~uORF:IOH13816	680	764	841	461	445	766	1207	529	1105	864	damage-specific DNA binding protein 1, 127kDa (DDB1)
B19R13C06	19-6-13	Hs~MGC:BC011686.2~uORF:IOH13816	637	635	876	433	431	761	1278	524	1084	448	damage-specific DNA binding protein 1, 127kDa (DDB1)
B19R13C07	19-7-13	Hs~MGC:BC025765.1~uORF:IOH10803	375	426	577	389	402	435	531	436	1027	149	Rhotekin-2
B19R13C08	19-8-13	Hs~MGC:BC025765.1~uORF:IOH10803	431	410	736	360	329	453	655	455	903	386	Rhotekin-2
B19R13C09	19-9-13	Hs~MGC:NM_177435.1~uORF:IOH5357	1373	816	1030	617	627	975	1509	760	2513	157	peroxisome proliferative activated receptor, delta (PPARD), transcript variant 2
B19R13C10	19-10-13	Hs~MGC:NM_177435.1~uORF:IOH5357	1416	785	943	665	663	849	1487	779	2476	263	peroxisome proliferative activated receptor, delta (PPARD), transcript variant 2
B19R13C11	19-11-13	Hs~MGC:BC013648.1~uORF:IOH10208	5580	1114	1875	1253	1426	1645	2280	5318	26091	611	EF-hand domain family, member D2 (EFHD2)
B19R13C12	19-12-13	Hs~MGC:BC013648.1~uORF:IOH10208	5644	1129	1822	1232	1508	1722	2344	4832	27830	615	EF-hand domain family, member D2 (EFHD2)
B19R13C13	19-13-13	Hs~MGC:BC016440.1~uORF:IOH10264	610	405	731	365	269	1385	865	530	1061	329	nuclear prelamin A recognition factor (NARF)
B19R13C14	19-14-13	Hs~MGC:BC016440.1~uORF:IOH10264	580	416	691	403	282	1347	869	457	978	308	nuclear prelamin A recognition factor (NARF)
B19R13C15	19-15-13	Hs~Ref:NM_001564.1~uORF:IOH22913	2441	749	937	1561	644	549	1057	1892	1440	336	inhibitor of growth family, member 2 (ING2)
B19R13C16	19-16-13	Hs~Ref:NM_001564.1~uORF:IOH22913	2665	769	934	1595	671	570	1107	1716	1398	322	inhibitor of growth family, member 2 (ING2)
B19R13C17	19-17-13	Hs~Ref:NM_021149.1~uORF:IOH12644	1119	732	931	572	581	819	2287	632	1616	508	coactosin-like 1 (Dictyostelium) (COTL1)
B19R13C18	19-18-13	Hs~Ref:NM_021149.1~uORF:IOH12644	857	711	930	629	597	803	2238	628	1681	506	coactosin-like 1 (Dictyostelium) (COTL1)
B19R13C19	19-19-13	Hs~Ref:NM_022905.2~uORF:IOH13278	2388	1609	6519	1356	1318	2900	7828	2838	3049	1171	tetratricopeptide repeat domain 23 (TTC23), transcript variant 2
B19R13C20	19-20-13	Hs~Ref:NM_022905.2~uORF:IOH13278	2425	1584	6362	1313	1398	3272	7765	2737	2663	1303	tetratricopeptide repeat domain 23 (TTC23), transcript variant 2
B19R13C21	19-21-13	Hs~MGC:BC014486.1~uORF:IOH13590	971	1630	1227	811	659	3644	1972	518	2151	562	CAP-Gly domain-containing linker protein 3
B19R13C22	19-22-13	Hs~MGC:BC014486.1~uORF:IOH13590	968	1631	1204	769	660	3585	2025	515	741	548	CAP-Gly domain-containing linker protein 3
B19R14C01	19-1-14	Hs~MGC:BC022851.1~uORF:IOH12748	852	570	954	548	637	745	920	536	1879	408	cytochrome P450, family 4, subfamily A, polypeptide 11 (CYP4A11)
B19R14C02	19-2-14	Hs~MGC:BC022851.1~uORF:IOH12748	835	592	910	543	663	587	886	531	1808	455	cytochrome P450, family 4, subfamily A, polypeptide 11 (CYP4A11)
B19R14C03	19-3-14	Hs~MGC:BC013187.1~uORF:IOH22114	374	324	543	1536	311	428	905	394	726	4	major histocompatibility complex, class I, B (HLA-B)
B19R14C04	19-4-14	Hs~MGC:BC013187.1~uORF:IOH22114	354	336	581	1517	329	366	897	388	686	228	major histocompatibility complex, class I, B (HLA-B)
B19R14C05	19-5-14	Hs~MGC:BC028135.1~uORF:IOH11327	455	361	928	349	344	456	1422	589	801	245	purinergic receptor P2Y, G-protein coupled, 2 (P2RY2)
B19R14C06	19-6-14	Hs~MGC:BC028135.1~uORF:IOH11327	485	338	946	341	339	485	1409	620	787	325	purinergic receptor P2Y, G-protein coupled, 2 (P2RY2)
B19R14C07	19-7-14	Hs~Ref:NM_005785.2~uORF:IOH21937	412	336	594	466	395	830	1033	530	942	263	ring finger protein 41 (RNF41), transcript variant 1
B19R14C08	19-8-14	Hs~Ref:NM_005785.2~uORF:IOH21937	443	364	562	447	412	889	1524	613	999	479	ring finger protein 41 (RNF41), transcript variant 1
B19R14C09	19-9-14	Hs~Ref:NM_024038.2~uORF:IOH5926	8862	8730	11293	7813	7939	5078	8095	11294	18111	5716	chromosome 19 open reading frame 43 (C19orf43)
B19R14C10	19-10-14	Hs~Ref:NM_024038.2~uORF:IOH5926	8761	9100	10622	7949	8497	5732	8598	11571	18791	5769	chromosome 19 open reading frame 43 (C19orf43)
B19R14C11	19-11-14	Hs~Ref:NM_000788.1~uORF:IOH42066	558	451	667	1253	539	597	796	550	3892	240	Deoxycytidine kinase
B19R14C12	19-12-14	Hs~Ref:NM_000788.1~uORF:IOH42066	590	420	634	1196	505	596	709	502	4020	246	Deoxycytidine kinase
B19R14C13	19-13-14	Hs~Ref:NM_001012978.1~uORF:IOH42168	1882	648	381	434	2621	508	1180	665	1305	285	Protein BEX5
B19R14C14	19-14-14	Hs~Ref:NM_001012978.1~uORF:IOH42168	1857	647	378	444	2816	515	1195	619	1283	273	Protein BEX5
B19R14C15	19-15-14	Hs~Ref:NM_002875.2~uORF:IOH41191	286	301	409	316	213	607	630	327	878	274	DNA repair protein RAD51 homolog 1
B19R14C16	19-16-14	Hs~Ref:NM_002875.2~uORF:IOH41191	327	294	352	413	196	512	561	363	780	273	DNA repair protein RAD51 homolog 1
B19R14C17	19-17-14	Hs~Ref:NM_032263.2~uORF:IOH42364	2015	363	551	328	798	698	1060	451	713	230	IQ domain-containing protein G
B19R14C18	19-18-14	Hs~Ref:NM_032263.2~uORF:IOH42364	601	379	541	369	274	865	1018	505	639	254	IQ domain-containing protein G
B19R14C19	19-19-14	Hs~MGC:NM_178324.1~uORF:IOH7417	633	449	734	679	396	602	844	426	846	313	serine palmitoyltransferase, long chain base subunit 1 (SPTLC1), transcript variant 2
B19R14C20	19-20-14	Hs~MGC:NM_178324.1~uORF:IOH7417	658	483	755	673	399	640	869	437	1223	294	serine palmitoyltransferase, long chain base subunit 1 (SPTLC1), transcript variant 2
B19R14C21	19-21-14	Hs~Ref:NM_032027.2~uORF:IOH22514	1786	285	449	280	272	424	693	321	20	232	TM2 domain containing 1 (TM2D1)
B19R14C22	19-22-14	Hs~Ref:NM_032027.2~uORF:IOH22514	1783	300	373	340	260	344	624	340	351	241	TM2 domain containing 1 (TM2D1)
B19R15C01	19-1-15	Hs~Ref:NM_152563.1~uORF:IOH21932	609	405	574	367	376	435	731	498	815	260	Protein FAM86C
B19R15C02	19-2-15	Hs~Ref:NM_152563.1~uORF:IOH21932	572	325	623	369	341	460	725	461	816	340	Protein FAM86C
B19R15C03	19-3-15	Hs~Ref:NM_004867.2~uORF:IOH26247	544	385	865	587	543	1085	866	551	1105	194	integral membrane protein 2A (ITM2A)
B19R15C04	19-4-15	Hs~Ref:NM_004867.2~uORF:IOH26247	544	374	915	680	582	973	989	531	1128	249	integral membrane protein 2A (ITM2A)
B19R15C05	19-5-15	Hs~Ref:NM_004871.2~uORF:IOH45920	2035	1387	1472	3993	1712	1159	3489	2240	3496	1520	golgi SNAP receptor complex member 1 (GOSR1), transcript variant 1
B19R15C06	19-6-15	Hs~Ref:NM_004871.2~uORF:IOH45920	2173	1407	1474	4279	1746	1090	3214	2209	3666	1613	golgi SNAP receptor complex member 1 (GOSR1), transcript variant 1
B19R15C07	19-7-15	Hs~Ref:NM_207519.1~uORF:IOH45475	1551	1570	3845	949	3355	574	1954	518	1522	306	zeta-chain (TCR) associated protein kinase 70kDa (ZAP70), transcript variant 2
B19R15C08	19-8-15	Hs~Ref:NM_207519.1~uORF:IOH45475	1561	1534	3894	911	3353	567	1894	475	1452	316	zeta-chain (TCR) associated protein kinase 70kDa (ZAP70), transcript variant 2
B19R15C09	19-9-15	Hs~Ref:NM_006800.2~uORF:IOH45528	6113	1239	4613	5821	1412	2382	3649	2007	15018	2275	male-specific lethal 3-like 1 (Drosophila) (MSL3L1), transcript variant 3
B19R15C10	19-10-15	Hs~Ref:NM_006800.2~uORF:IOH45528	6350	1249	4461	5913	1465	2566	3890	1974	15605	2467	male-specific lethal 3-like 1 (Drosophila) (MSL3L1), transcript variant 3
B19R15C11	19-11-15	Hs~Ref:NM_199163.2~uORF:IOH45459	421	214	277	382	275	183	277	211	527	130	WAS protein family homolog 1
B19R15C12	19-12-15	Hs~Ref:NM_199163.2~uORF:IOH45459	398	199	276	359	259	485	255	189	573	78	WAS protein family homolog 1
B19R15C13	19-13-15	Hs~N/A:NM_006206.3~CAT:PV4203	442	493	748	352	553	654	1591	441	892	323	platelet-derived growth factor receptor, alpha polypeptide (PDGFRA); see catalog number for detailed information on wild-type or point mutant status
B19R15C14	19-14-15	Hs~N/A:NM_006206.3~CAT:PV4203	422	487	700	372	564	689	1534	526	850	267	platelet-derived growth factor receptor, alpha polypeptide (PDGFRA); see catalog number for detailed information on wild-type or point mutant status
B19R15C15	19-15-15	Hs~Ref:NM_002969.2~CAT:PV3654	18	17	122	16	12	57	52	22	98	46	mitogen-activated protein kinase 12 (MAPK12)
B19R15C16	19-16-15	Hs~Ref:NM_002969.2~CAT:PV3654	18	17	67	660	15	20	28	23	54	55	mitogen-activated protein kinase 12 (MAPK12)
B19R15C17	19-17-15	Hs~Ref:NM_006257.2~CAT:P2996	896	866	1386	1059	276	644	541	470	1456	263	protein kinase C, theta (PRKCQ)
B19R15C18	19-18-15	Hs~Ref:NM_006257.2~CAT:P2996	997	843	1529	502	289	643	550	448	1732	285	protein kinase C, theta (PRKCQ)
B19R15C19	19-19-15	Hs~Ref:NM_005627.1~CAT:PV3818	154	232	562	410	472	373	523	238	1221	156	serum/glucocorticoid regulated kinase (SGK)
B19R15C20	19-20-15	Hs~Ref:NM_005627.1~CAT:PV3818	18	257	560	397	463	401	585	243	832	147	serum/glucocorticoid regulated kinase (SGK)
B19R15C21	19-21-15	Hs~Ref:NM_002578.1~CAT:PV3789	2244	375	802	394	324	811	1378	206	22	372	p21 (CDKN1A)-activated kinase 3 (PAK3)
B19R15C22	19-22-15	Hs~Ref:NM_002578.1~CAT:PV3789	2182	371	808	387	319	810	2814	222	427	370	p21 (CDKN1A)-activated kinase 3 (PAK3)
B19R16C01	19-1-16	Hs~Ref:NM_138993.1~CAT:PV3679	1815	304	651	265	639	668	447	493	633	167	mitogen-activated protein kinase 11 (MAPK11), transcript variant 2
B19R16C02	19-2-16	Hs~Ref:NM_138993.1~CAT:PV3679	1839	310	654	277	644	605	482	367	640	153	mitogen-activated protein kinase 11 (MAPK11), transcript variant 2
B19R16C03	19-3-16	Hs~Ref:NM_021976.3~CAT:PV4390	102	310	117	197	254	280	196	165	950	122	Retinoic acid receptor RXR-beta
B19R16C04	19-4-16	Hs~Ref:NM_021976.3~CAT:PV4390	58	335	144	162	242	327	223	165	996	130	Retinoic acid receptor RXR-beta
B19R16C05	19-5-16	Hs~Ref:NM_002755.2~CAT:P3093	139	52	283	225	192	51	617	124	803	42	mitogen-activated protein kinase kinase 1 (MAP2K1); see catalog number for detailed information on wild-type or point mutant status
B19R16C06	19-6-16	Hs~Ref:NM_002755.2~CAT:P3093	169	652	283	222	224	65	598	157	817	65	mitogen-activated protein kinase kinase 1 (MAP2K1); see catalog number for detailed information on wild-type or point mutant status
B19R16C07	19-7-16	Hs~Ref:NM_005828.1~uORF:IOH3135	272	186	350	275	163	268	377	223	623	56	WD repeat domain 68 (WDR68)
B19R16C08	19-8-16	Hs~Ref:NM_005828.1~uORF:IOH3135	275	224	360	188	165	331	343	204	601	66	WD repeat domain 68 (WDR68)
B19R16C09	19-9-16	Hs~Ref:NM_006112.1~uORF:IOH5219	258	286	458	290	212	549	858	239	143	398	peptidylprolyl isomerase E (cyclophilin E) (PPIE), transcript variant 1
B19R16C10	19-10-16	Hs~Ref:NM_006112.1~uORF:IOH5219	291	325	436	274	208	501	863	244	480	387	peptidylprolyl isomerase E (cyclophilin E) (PPIE), transcript variant 1
B19R16C11	19-11-16	Hs~Ref:NM_021972.2~uORF:IOH13586	265	291	391	436	246	137	402	213	559	105	sphingosine kinase 1 (SPHK1), transcript variant 1
B19R16C12	19-12-16	Hs~Ref:NM_021972.2~uORF:IOH13586	277	255	387	428	246	115	412	228	485	184	sphingosine kinase 1 (SPHK1), transcript variant 1
B19R16C13	19-13-16	Hs~Ref:NM_005276.1~uORF:IOH22621	230	222	359	198	199	268	395	202	595	64	glycerol-3-phosphate dehydrogenase 1 (soluble) (GPD1)
B19R16C14	19-14-16	Hs~Ref:NM_005276.1~uORF:IOH22621	250	253	365	220	225	273	393	215	580	192	glycerol-3-phosphate dehydrogenase 1 (soluble) (GPD1)
B19R16C15	19-15-16	Hs~Ref:NM_001010918.1~uORF:IOH57360	649	558	817	707	482	709	1200	666	1486	423	Novel protein (Similar to bA90M5.1)  [Source:UniProtKB/TrEMBL;Acc:Q5TAE0]
B19R16C16	19-16-16	Hs~Ref:NM_001010918.1~uORF:IOH57360	613	548	641	761	480	649	1085	595	1413	501	Novel protein (Similar to bA90M5.1)  [Source:UniProtKB/TrEMBL;Acc:Q5TAE0]
B19R16C17	19-17-16	Hs~Ref:NM_012320.3~uORF:IOH39852	1028	315	496	402	285	282	549	334	1194	358	1-O-acylceramide synthase
B19R16C18	19-18-16	Hs~Ref:NM_012320.3~uORF:IOH39852	172	370	475	361	292	445	572	423	966	337	1-O-acylceramide synthase
B19R16C19	19-19-16	Hs~Ref:NM_004889.2~uORF:IOH57366	1045	1232	902	550	645	683	1271	789	1684	384	ATP synthase subunit f, mitochondrial
B19R16C20	19-20-16	Hs~Ref:NM_004889.2~uORF:IOH57366	1235	1324	895	557	670	718	1543	787	1905	400	ATP synthase subunit f, mitochondrial
B19R16C21	19-21-16	Hs~Ref:NM_017646.3~uORF:IOH37769	2246	1451	2238	1192	2531	2682	6288	2086	5228	1184	tRNA isopentenyltransferase 1 (TRIT1)
B19R16C22	19-22-16	Hs~Ref:NM_017646.3~uORF:IOH37769	2144	1457	2237	1187	2488	2752	6456	2084	5089	1182	tRNA isopentenyltransferase 1 (TRIT1)
B19R17C01	19-1-17	Hs~MGC:BC042864.1~uORF:IOH26525	874	782	876	555	1351	1893	3979	776	2512	389	SH3-domain GRB2-like 3 (SH3GL3)
B19R17C02	19-2-17	Hs~MGC:BC042864.1~uORF:IOH26525	751	747	844	560	1380	1753	3880	733	2458	189	SH3-domain GRB2-like 3 (SH3GL3)
B19R17C03	19-3-17	Hs~Ref:NM_203305.1~uORF:IOH26383	2933	2266	2382	3352	1680	1973	2624	1957	8459	690	family with sequence similarity 102, member A (FAM102A), transcript variant 2
B19R17C04	19-4-17	Hs~Ref:NM_203305.1~uORF:IOH26383	3010	2255	2193	3081	1657	1917	2549	1976	8753	704	family with sequence similarity 102, member A (FAM102A), transcript variant 2
B19R17C05	19-5-17	Hs~MGC:BC008748.2~uORF:IOH5941	2788	1841	2653	1676	2511	2704	2416	1900	17065	1065	protein-L-isoaspartate (D-aspartate) O-methyltransferase (PCMT1)
B19R17C06	19-6-17	Hs~MGC:BC008748.2~uORF:IOH5941	2713	1781	2656	1658	2547	2763	2415	1846	17464	1059	protein-L-isoaspartate (D-aspartate) O-methyltransferase (PCMT1)
B19R17C07	19-7-17	Hs~MGC:BC035404.2~uORF:IOH27426	1140	2143	2324	1146	1715	1555	2478	7349	4427	749	PTK2 protein tyrosine kinase 2 (PTK2)
B19R17C08	19-8-17	Hs~MGC:BC035404.2~uORF:IOH27426	1160	2223	2080	1029	1705	1526	2565	7144	4494	667	PTK2 protein tyrosine kinase 2 (PTK2)
B19R17C09	19-9-17	Hs~Ref:NM_145310.1~uORF:IOH7356	886	1055	1059	735	791	914	1415	824	2601	778	zinc finger protein 258 (ZNF258), transcript variant 2
B19R17C10	19-10-17	Hs~Ref:NM_145310.1~uORF:IOH7356	869	1145	1190	754	729	959	1419	826	2735	874	zinc finger protein 258 (ZNF258), transcript variant 2
B19R17C11	19-11-17	Hs~Ref:NM_152480.1~uORF:IOH12619	1122	992	1125	762	737	883	2568	762	2032	821	chromosome 19 open reading frame 23 (C19orf23)
B19R17C12	19-12-17	Hs~Ref:NM_152480.1~uORF:IOH12619	1065	884	1109	753	750	996	2509	784	2143	722	chromosome 19 open reading frame 23 (C19orf23)
B19R17C13	19-13-17	Hs~MGC:BC022360.1~uORF:IOH29341	491	506	680	412	445	522	832	487	1205	410	Transmembrane protein 116
B19R17C14	19-14-17	Hs~MGC:BC022360.1~uORF:IOH29341	492	506	652	503	455	529	844	472	1218	438	Transmembrane protein 116
B19R17C15	19-15-17	Hs~MGC:BC010942.1~uORF:IOH13002	977	549	705	658	769	665	1200	564	1454	538	acetyl-Coenzyme A acetyltransferase 1 (acetoacetyl Coenzyme A thiolase) (ACAT1)
B19R17C16	19-16-17	Hs~MGC:BC010942.1~uORF:IOH13002	1100	578	769	695	810	652	1192	797	1804	495	acetyl-Coenzyme A acetyltransferase 1 (acetoacetyl Coenzyme A thiolase) (ACAT1)
B19R17C17	19-17-17	Hs~MGC:BC001280.1~uORF:IOH21165	2068	2023	4571	14704	3482	3442	3169	2834	4861	1704	Serine/threonine-protein kinase 6
B19R17C18	19-18-17	Hs~MGC:BC001280.1~uORF:IOH21165	2717	2018	4473	14874	3523	3271	3429	2597	5276	1703	Serine/threonine-protein kinase 6
B19R17C19	19-19-17	Hs~MGC:BC025307.1~uORF:IOH14776	1352	633	1040	540	684	1014	1464	666	1970	376	Serine/threonine-protein kinase D2
B19R17C20	19-20-17	Hs~MGC:BC025307.1~uORF:IOH14776	773	645	1001	510	689	970	1455	702	2123	382	Serine/threonine-protein kinase D2
B19R17C21	19-21-17	Hs~Ref:NM_006223.1~uORF:IOH7192	1883	2077	1993	971	2030	1983	4095	1592	3742	682	protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin) (PIN4)
B19R17C22	19-22-17	Hs~Ref:NM_006223.1~uORF:IOH7192	1828	2217	1985	922	2082	2026	4817	1519	3758	668	protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin) (PIN4)
B19R18C01	19-1-18	Hs~MGC:BC016330.1~uORF:IOH14709	13771	13859	7738	2364	3888	4467	13800	3700	5658	2637	RAD51 associated protein 1 (RAD51AP1)
B19R18C02	19-2-18	Hs~MGC:BC016330.1~uORF:IOH14709	15644	14575	7430	2357	4059	4203	13939	3503	5767	2485	RAD51 associated protein 1 (RAD51AP1)
B19R18C03	19-3-18	Hs~MGC:BC035572.1~uORF:IOH27588	600	455	656	418	395	623	1098	710	1458	406	ecotropic viral integration site 2A (EVI2A)
B19R18C04	19-4-18	Hs~MGC:BC035572.1~uORF:IOH27588	597	485	657	405	366	548	983	570	1315	250	ecotropic viral integration site 2A (EVI2A)
B19R18C05	19-5-18	Hs~MGC:BC027937.1~uORF:IOH11501	12353	915	2043	755	1304	3104	3489	1052	3384	412	retinoic acid induced 2 (RAI2)
B19R18C06	19-6-18	Hs~MGC:BC027937.1~uORF:IOH11501	10842	1084	1935	814	1329	3272	3685	1058	3499	377	retinoic acid induced 2 (RAI2)
B19R18C07	19-7-18	Hs~MGC:NM_182906.1~uORF:IOH26131	600	687	688	467	439	743	1015	572	1382	472	C-type lectin domain family 10, member A (CLEC10A), transcript variant 1
B19R18C08	19-8-18	Hs~MGC:NM_182906.1~uORF:IOH26131	562	680	719	460	459	673	978	504	1294	491	C-type lectin domain family 10, member A (CLEC10A), transcript variant 1
B19R18C09	19-9-18	Hs~Ref:NM_032906.2~uORF:IOH6693	498	457	617	2294	693	508	802	1017	1110	307	phosphatidylinositol glycan anchor biosynthesis, class Y (PIGY), transcript variant 1
B19R18C10	19-10-18	Hs~Ref:NM_032906.2~uORF:IOH6693	514	472	606	2293	683	512	823	1080	1155	327	phosphatidylinositol glycan anchor biosynthesis, class Y (PIGY), transcript variant 1
B19R18C11	19-11-18	Hs~Ref:NM_199190.1~uORF:IOH42760	5645	3097	6127	10591	4743	4527	22465	7202	3474	17033	La ribonucleoprotein domain family, member 4 (LARP4), transcript variant 3
B19R18C12	19-12-18	Hs~Ref:NM_199190.1~uORF:IOH42760	5898	3322	5587	9213	5122	4298	23550	6626	3460	17551	La ribonucleoprotein domain family, member 4 (LARP4), transcript variant 3
B19R18C13	19-13-18	Hs~Ref:NM_170672.1~uORF:IOH27295	1758	843	2037	2120	1181	1055	2118	1048	2714	446	RAS guanyl releasing protein 3 (calcium and DAG-regulated) (RASGRP3)
B19R18C14	19-14-18	Hs~Ref:NM_170672.1~uORF:IOH27295	1762	839	2005	1979	1206	1017	2165	1064	2707	436	RAS guanyl releasing protein 3 (calcium and DAG-regulated) (RASGRP3)
B19R18C15	19-15-18	Hs~MGC:BC050522.1~uORF:IOH26996	465	423	506	519	338	651	776	400	975	306	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae) (DDX11)
B19R18C16	19-16-18	Hs~MGC:BC050522.1~uORF:IOH26996	673	358	522	548	315	644	731	405	710	331	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae) (DDX11)
B19R18C17	19-17-18	Hs~Ref:NM_015638.2~uORF:IOH41869	737	375	475	316	272	466	846	680	832	303	Trpc4-associated protein
B19R18C18	19-18-18	Hs~Ref:NM_015638.2~uORF:IOH41869	830	391	468	347	280	500	834	415	829	277	Trpc4-associated protein
B19R18C19	19-19-18	Hs~MGC:BC014217.2~uORF:IOH14859	895	524	701	610	505	627	937	593	1428	414	Leucine carboxyl methyltransferase 1
B19R18C20	19-20-18	Hs~MGC:BC014217.2~uORF:IOH14859	769	657	708	627	519	710	1087	644	1611	415	Leucine carboxyl methyltransferase 1
B19R18C21	19-21-18	Hs~Ref:NM_052875.2~uORF:IOH14292	1489	1832	1299	3267	1459	4818	1581	1102	2536	666	Vacuolar protein sorting-associated protein 26B
B19R18C22	19-22-18	Hs~Ref:NM_052875.2~uORF:IOH14292	1456	1904	1346	3208	1457	5090	1404	1045	2781	644	Vacuolar protein sorting-associated protein 26B
B19R19C01	19-1-19	Hs~Ref:NM_003512.3~uORF:IOH14485	3030	1054	1567	797	1188	1322	8528	986	2963	635	Histone H2A type 1-C
B19R19C02	19-2-19	Hs~Ref:NM_003512.3~uORF:IOH14485	2817	1046	1609	874	1183	1327	8908	960	3150	580	Histone H2A type 1-C
B19R19C03	19-3-19	Hs~MGC:BC052946.1~uORF:IOH28826	381	532	414	470	428	448	1700	484	527	216	neural cell adhesion molecule 2 (NCAM2)
B19R19C04	19-4-19	Hs~MGC:BC052946.1~uORF:IOH28826	372	498	394	495	444	418	1703	429	540	211	neural cell adhesion molecule 2 (NCAM2)
B19R19C05	19-5-19	Hs~MGC:BC061590.1~uORF:IOH29302	781	595	2122	509	607	21622	1180	749	1131	401	GTF2I repeat domain containing 2 (GTF2IRD2)
B19R19C06	19-6-19	Hs~MGC:BC061590.1~uORF:IOH29302	825	750	1960	522	625	22509	1156	678	1138	287	GTF2I repeat domain containing 2 (GTF2IRD2)
B19R19C07	19-7-19	Hs~MGC:BC004101.1~uORF:IOH5622	642	1007	897	529	603	858	830	421	1158	348	bridging integrator 1 (BIN1)
B19R19C08	19-8-19	Hs~MGC:BC004101.1~uORF:IOH5622	676	1084	894	504	622	770	817	395	1204	357	bridging integrator 1 (BIN1)
B19R19C09	19-9-19	Hs~MGC:BC047703.2~uORF:IOH26704	356	287	441	285	200	366	784	342	559	245	phospholipase A1 member A (PLA1A)
B19R19C10	19-10-19	Hs~MGC:BC047703.2~uORF:IOH26704	368	281	486	274	200	345	701	363	550	244	phospholipase A1 member A (PLA1A)
B19R19C11	19-11-19	Hs~MGC:BC027607.1~uORF:IOH11737	874	451	508	352	248	463	1355	424	800	323	zinc finger CCCH-type containing 14 (ZC3H14)
B19R19C12	19-12-19	Hs~MGC:BC027607.1~uORF:IOH11737	898	455	574	324	253	508	1479	455	812	257	zinc finger CCCH-type containing 14 (ZC3H14)
B19R19C13	19-13-19	Hs~MGC:BC057808.1~uORF:IOH29176	891	676	889	761	545	878	1736	553	1098	660	hyaluronan and proteoglycan link protein 1 (HAPLN1)
B19R19C14	19-14-19	Hs~MGC:BC057808.1~uORF:IOH29176	936	690	931	791	572	879	1740	573	1177	616	hyaluronan and proteoglycan link protein 1 (HAPLN1)
B19R19C15	19-15-19	Hs~Ref:NM_002426.1~uORF:IOH29597	372	304	470	256	277	326	567	278	479	188	matrix metallopeptidase 12 (macrophage elastase) (MMP12)
B19R19C16	19-16-19	Hs~Ref:NM_002426.1~uORF:IOH29597	510	286	417	263	255	370	610	263	654	197	matrix metallopeptidase 12 (macrophage elastase) (MMP12)
B19R19C17	19-17-19	Hs~MGC:BC000850.1~uORF:IOH3242	695	368	585	385	320	551	917	729	890	265	F-box and WD repeat domain containing 5 (FBXW5)
B19R19C18	19-18-19	Hs~MGC:BC000850.1~uORF:IOH3242	620	389	521	382	329	510	899	655	869	296	F-box and WD repeat domain containing 5 (FBXW5)
B19R19C19	19-19-19	Hs~MGC:BC047575.1~uORF:IOH26425	607	1122	935	582	663	1394	1694	984	1730	1763	dishevelled associated activator of morphogenesis 2 (DAAM2)
B19R19C20	19-20-19	Hs~MGC:BC047575.1~uORF:IOH26425	753	1095	916	543	703	1401	1727	995	1812	1768	dishevelled associated activator of morphogenesis 2 (DAAM2)
B19R19C21	19-21-19	Hs~Ref:NM_013343.1~uORF:IOH11992	218	231	447	258	213	439	592	276	319	235	loss of heterozygosity, 3, chromosomal region 2, gene A (LOH3CR2A)
B19R19C22	19-22-19	Hs~Ref:NM_013343.1~uORF:IOH11992	254	297	470	249	223	332	639	281	131	228	loss of heterozygosity, 3, chromosomal region 2, gene A (LOH3CR2A)
B19R20C01	19-1-20	Hs~MGC:BC035365.1~uORF:IOH28679	261	241	446	224	196	354	588	311	547	260	Sialic acid-binding Ig-like lectin 9
B19R20C02	19-2-20	Hs~MGC:BC035365.1~uORF:IOH28679	257	232	378	199	268	401	639	338	566	254	Sialic acid-binding Ig-like lectin 9
B19R20C03	19-3-20	Hs~MGC:BC059376.1~uORF:IOH29245	360	221	501	245	452	158	552	272	667	229	gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE)
B19R20C04	19-4-20	Hs~MGC:BC059376.1~uORF:IOH29245	322	249	494	297	428	322	592	329	966	130	gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE)
B19R20C05	19-5-20	Hs~Ref:NM_014279.2~uORF:IOH46139	624	545	580	599	313	617	722	561	684	605	olfactomedin 1 (OLFM1), transcript variant 1
B19R20C06	19-6-20	Hs~Ref:NM_014279.2~uORF:IOH46139	598	768	640	631	308	667	708	553	678	646	olfactomedin 1 (OLFM1), transcript variant 1
B19R20C07	19-7-20	Hs~Ref:NM_002452.3~uORF:IOH45904	41	46	136	248	36	73	310	145	206	162	nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 1
B19R20C08	19-8-20	Hs~Ref:NM_002452.3~uORF:IOH45904	35	48	160	25	35	82	290	21	69	8	nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 1
B19R20C09	19-9-20	Hs~Ref:NM_004740.3~uORF:IOH45454	197	286	378	209	209	264	277	154	1464	101	TGFB1-induced anti-apoptotic factor 1 (TIAF1)
B19R20C10	19-10-20	Hs~Ref:NM_004740.3~uORF:IOH45454	235	279	409	173	224	265	397	147	1486	47	TGFB1-induced anti-apoptotic factor 1 (TIAF1)
B19R20C11	19-11-20	Hs~MGC:BC020786.1~uORF:IOH14667	967	460	687	642	911	983	1499	516	881	488	pleiotropic regulator 1 (PRL1 homolog, Arabidopsis) (PLRG1)
B19R20C12	19-12-20	Hs~MGC:BC020786.1~uORF:IOH14667	994	456	733	863	882	986	1552	640	889	400	pleiotropic regulator 1 (PRL1 homolog, Arabidopsis) (PLRG1)
B19R20C13	19-13-20	Hs~Ref:NM_138807.1~uORF:IOH12627	503	351	519	399	290	487	920	471	656	287	chromosome 3 open reading frame 31 (C3orf31)
B19R20C14	19-14-20	Hs~Ref:NM_138807.1~uORF:IOH12627	471	334	542	374	283	451	855	553	913	314	chromosome 3 open reading frame 31 (C3orf31)
B20R02C11	20-11-2	Hs~MGC:BC020107.1~uORF:IOH11079	1023	970	1330	588	512	1192	1564	541	1658	317	nucleoporin 133kDa (NUP133)
B20R02C12	20-12-2	Hs~MGC:BC020107.1~uORF:IOH11079	1034	1151	1349	623	523	1283	1599	572	1606	273	nucleoporin 133kDa (NUP133)
B20R02C13	20-13-2	Hs~Ref:NM_144563.1~uORF:IOH11053	840	860	1014	673	677	1322	6451	1190	1899	-10	ribose 5-phosphate isomerase A (ribose 5-phosphate epimerase) (RPIA)
B20R02C14	20-14-2	Hs~Ref:NM_144563.1~uORF:IOH11053	859	893	882	821	682	1295	6561	1052	1782	220	ribose 5-phosphate isomerase A (ribose 5-phosphate epimerase) (RPIA)
B20R02C15	20-15-2	Hs~MGC:NM_152261.1~uORF:IOH10854	2741	762	2727	2341	739	1110	1104	1061	1682	23	chromosome 12 open reading frame 23 (C12orf23)
B20R02C16	20-16-2	Hs~MGC:NM_152261.1~uORF:IOH10854	2533	750	2535	2357	823	1225	1195	977	1868	314	chromosome 12 open reading frame 23 (C12orf23)
B20R02C17	20-17-2	Hs~MGC:BC013162.1~uORF:IOH10924	921	786	1336	766	1492	1224	1855	618	3108	429	selenoprotein K (SELK)
B20R02C18	20-18-2	Hs~MGC:BC013162.1~uORF:IOH10924	921	787	1346	871	1882	1198	1881	728	3188	465	selenoprotein K (SELK)
B20R02C19	20-19-2	Hs~Ref:NM_024299.2~uORF:IOH4080	982	834	1704	2516	1253	1273	1414	1388	3301	2542	chromosome 20 open reading frame 149 (C20orf149)
B20R02C20	20-20-2	Hs~Ref:NM_024299.2~uORF:IOH4080	902	826	1647	2033	1292	1262	1385	1546	2889	2787	chromosome 20 open reading frame 149 (C20orf149)
B20R02C21	20-21-2	Hs~Ref:NM_012247.3~uORF:IOH3018	1047	1475	1857	846	1106	1096	2207	1626	3457	764	selenophosphate synthetase 1 (SEPHS1)
B20R02C22	20-22-2	Hs~Ref:NM_012247.3~uORF:IOH3018	1016	1560	1864	909	1086	995	1921	1673	3713	761	selenophosphate synthetase 1 (SEPHS1)
B20R03C01	20-1-3	Hs~MGC:BC009819.1~uORF:IOH12608	1516	1162	2355	920	1021	1088	1566	1147	3444	581	UDP-glucuronic acid decarboxylase 1
B20R03C02	20-2-3	Hs~MGC:BC009819.1~uORF:IOH12608	1483	1173	2545	924	1001	1037	1538	1180	3447	421	UDP-glucuronic acid decarboxylase 1
B20R03C03	20-3-3	Hs~Ref:NM_001674.1~uORF:IOH6465	868	987	9070	746	1196	939	1419	914	3629	628	activating transcription factor 3 (ATF3), transcript variant 1
B20R03C04	20-4-3	Hs~Ref:NM_001674.1~uORF:IOH6465	876	1036	8827	780	1220	1283	1439	977	3243	446	activating transcription factor 3 (ATF3), transcript variant 1
B20R03C05	20-5-3	Hs~Ref:NM_003182.1~uORF:IOH44355	626	465	794	340	362	542	711	430	514	90	tachykinin, precursor 1 (substance K, substance P, neurokinin 1, neurokinin 2, neuromedin L, neurokinin alpha, neuropeptide K, neuropeptide gamma) (TAC1), transcript variant beta
B20R03C06	20-6-3	Hs~Ref:NM_003182.1~uORF:IOH44355	679	436	768	418	309	514	753	1093	683	10	tachykinin, precursor 1 (substance K, substance P, neurokinin 1, neurokinin 2, neuromedin L, neurokinin alpha, neuropeptide K, neuropeptide gamma) (TAC1), transcript variant beta
B20R03C07	20-7-3	Hs~Ref:NM_001006605.1~uORF:IOH45941	590	558	1019	363	340	1579	1050	421	1410	147	family with sequence similarity 69, member A (FAM69A)
B20R03C08	20-8-3	Hs~Ref:NM_001006605.1~uORF:IOH45941	576	659	826	349	381	1449	1066	426	795	151	family with sequence similarity 69, member A (FAM69A)
B20R03C09	20-9-3	Hs~Ref:NM_172244.2~uORF:IOH44356	665	605	756	338	329	581	822	408	983	92	sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) (SGCD), transcript variant 2
B20R03C10	20-10-3	Hs~Ref:NM_172244.2~uORF:IOH44356	711	633	790	402	357	670	841	388	861	-7	sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) (SGCD), transcript variant 2
B20R03C11	20-11-3	Hs~Ref:NM_004724.2~uORF:IOH42575	1501	411	1292	1832	507	1738	1624	960	1202	228	ZW10, kinetochore associated, homolog (Drosophila) (ZW10)
B20R03C12	20-12-3	Hs~Ref:NM_004724.2~uORF:IOH42575	1524	517	1284	1875	1026	1745	1635	945	1228	207	ZW10, kinetochore associated, homolog (Drosophila) (ZW10)
B20R03C13	20-13-3	Hs~Ref:NM_199124.1~uORF:IOH43439	18486	13807	9439	40117	10386	23737	12839	10965	6908	3141	chromosome 11 open reading frame 63 (C11orf63), transcript variant 2
B20R03C14	20-14-3	Hs~Ref:NM_199124.1~uORF:IOH43439	21212	15531	9337	37707	9752	24889	12325	11385	6624	3059	chromosome 11 open reading frame 63 (C11orf63), transcript variant 2
B20R03C15	20-15-3	Hs~Ref:NM_001017980.1~uORF:IOH43503	367	385	565	540	769	417	444	354	2141	213	hypothetical protein LOC203547 (LOC203547)
B20R03C16	20-16-3	Hs~Ref:NM_001017980.1~uORF:IOH43503	363	345	516	596	343	375	430	340	2106	215	hypothetical protein LOC203547 (LOC203547)
B20R03C17	20-17-3	Hs~Ref:NM_018584.4~uORF:IOH42130	706	561	687	2022	1632	1879	2711	938	3283	130	calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1)
B20R03C18	20-18-3	Hs~Ref:NM_018584.4~uORF:IOH42130	716	506	670	1981	2049	1868	2407	1036	2906	252	calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1)
B20R03C19	20-19-3	Hs~Ref:NM_007333.1~uORF:IOH43048	783	823	1100	4559	1788	1039	3420	592	1638	864	NKG2-E type II integral membrane protein
B20R03C20	20-20-3	Hs~Ref:NM_007333.1~uORF:IOH43048	724	853	1057	4420	1405	1072	2898	637	1528	1166	NKG2-E type II integral membrane protein
B20R03C21	20-21-3	Hs~MGC:BC010959.1~uORF:IOH13742	786	796	1023	1129	673	892	822	1172	2618	248	BCL2/adenovirus E1B 19kDa interacting protein 1 (BNIP1)
B20R03C22	20-22-3	Hs~MGC:BC010959.1~uORF:IOH13742	756	847	1010	1187	685	689	901	1144	2528	538	BCL2/adenovirus E1B 19kDa interacting protein 1 (BNIP1)
B20R04C01	20-1-4	Hs~MGC:BC007312.1~uORF:IOH6926	1158	568	1631	648	535	994	1219	622	2507	273	Kin of IRRE-like protein 2
B20R04C02	20-2-4	Hs~MGC:BC007312.1~uORF:IOH6926	1082	600	1620	696	536	1058	1350	657	2536	171	Kin of IRRE-like protein 2
B20R04C03	20-3-4	Hs~Ref:NM_006007.1~uORF:IOH14289	2429	937	13102	3904	1745	22205	2300	1146	4150	194	zinc finger, AN1-type domain 5 (ZFAND5), transcript variant c
B20R04C04	20-4-4	Hs~Ref:NM_006007.1~uORF:IOH14289	2551	976	12603	3618	1706	21384	2269	1087	3925	553	zinc finger, AN1-type domain 5 (ZFAND5), transcript variant c
B20R04C05	20-5-4	Hs~MGC:BC017101.1~uORF:IOH14448	937	665	1272	1563	459	1936	1172	654	4128	1116	POM121 and ZP3 fusion protein
B20R04C06	20-6-4	Hs~MGC:BC017101.1~uORF:IOH14448	934	628	1114	1830	568	1008	1453	688	4093	1275	POM121 and ZP3 fusion protein
B20R04C07	20-7-4	Hs~MGC:BC015886.1~uORF:IOH10052	974	592	969	498	566	702	1470	789	1389	157	Repulsive guidance molecule A
B20R04C08	20-8-4	Hs~MGC:BC015886.1~uORF:IOH10052	1060	612	968	495	515	703	1305	721	987	393	Repulsive guidance molecule A
B20R04C11	20-11-4	Hs~MGC:BC013073.1~uORF:IOH10173	1639	1132	1669	878	1273	1090	3371	860	1844	889	transmembrane protein 183A (TMEM183A)
B20R04C12	20-12-4	Hs~MGC:BC013073.1~uORF:IOH10173	1761	1172	1649	974	913	1189	3124	852	1492	1185	transmembrane protein 183A (TMEM183A)
B20R04C13	20-13-4	Hs~MGC:NM_170679.1~uORF:IOH13678	351	161	452	270	480	636	433	361	4883	85	S-phase kinase-associated protein 1A (p19A) (SKP1A), transcript variant 2
B20R04C14	20-14-4	Hs~MGC:NM_170679.1~uORF:IOH13678	356	151	471	263	449	647	432	374	4944	73	S-phase kinase-associated protein 1A (p19A) (SKP1A), transcript variant 2
B20R04C15	20-15-4	Hs~Ref:NM_003006.2~uORF:IOH22638	425	1077	655	405	470	1378	772	407	1051	178	selectin P ligand (SELPLG)
B20R04C16	20-16-4	Hs~Ref:NM_003006.2~uORF:IOH22638	406	1069	649	425	241	1423	795	405	952	183	selectin P ligand (SELPLG)
B20R04C17	20-17-4	Hs~MGC:BC004925.1~uORF:IOH5520	575	511	721	471	1629	616	930	1044	1175	-18	G protein-coupled receptor, family C, group 5, member C (GPRC5C)
B20R04C18	20-18-4	Hs~MGC:BC004925.1~uORF:IOH5520	611	512	791	479	1795	522	1023	1246	1247	54	G protein-coupled receptor, family C, group 5, member C (GPRC5C)
B20R04C19	20-19-4	Hs~Ref:NM_000282.1~uORF:IOH2968	762	11165	1148	1104	1396	1199	1793	1649	1239	999	propionyl Coenzyme A carboxylase, alpha polypeptide (PCCA)
B20R04C20	20-20-4	Hs~Ref:NM_000282.1~uORF:IOH2968	743	11361	1128	1062	1552	1136	1645	1563	32	1009	propionyl Coenzyme A carboxylase, alpha polypeptide (PCCA)
B20R04C21	20-21-4	Hs~MGC:BC022429.1~uORF:IOH23036	918	939	3385	732	4147	2093	6168	674	3914	371	Lyrm7 homolog (mouse) (LYRM7)
B20R04C22	20-22-4	Hs~MGC:BC022429.1~uORF:IOH23036	902	981	3663	797	4037	2090	6353	694	3998	15	Lyrm7 homolog (mouse) (LYRM7)
B20R05C01	20-1-5	Hs~Ref:NM_080911.1~uORF:IOH43486	8595	8956	6716	13265	10836	16275	7804	14853	6694	8108	uracil-DNA glycosylase (UNG), transcript variant 2
B20R05C02	20-2-5	Hs~Ref:NM_080911.1~uORF:IOH43486	8949	8647	6774	13965	11520	16289	8195	15816	7209	8492	uracil-DNA glycosylase (UNG), transcript variant 2
B20R05C03	20-3-5	Hs~Ref:NM_205848.1~uORF:IOH43389	5774	2960	3910	5144	1966	2736	9140	2132	5121	2478	synaptotagmin VI (SYT6)
B20R05C04	20-4-5	Hs~Ref:NM_205848.1~uORF:IOH43389	5894	3007	3999	5603	2037	2588	8735	2067	4907	1958	synaptotagmin VI (SYT6)
B20R05C07	20-7-5	Hs~MGC:NM_174972.1~uORF:IOH43392	2140	2038	4009	1602	3206	2464	3266	1574	6745	1104	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase
B20R05C08	20-8-5	Hs~MGC:NM_174972.1~uORF:IOH43392	2169	1989	3962	1540	4403	2436	3277	1539	6760	1251	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase
B20R05C09	20-9-5	Hs~Ref:NM_001711.3~uORF:IOH5449	465	206	423	283	208	331	722	399	263	-3	biglycan (BGN)
B20R05C10	20-10-5	Hs~Ref:NM_001711.3~uORF:IOH5449	370	224	520	281	1414	388	814	373	365	22	biglycan (BGN)
B20R05C11	20-11-5	Hs~Ref:NM_053005.2~uORF:IOH40119	3207	1947	3163	3309	5675	2191	3509	1931	6067	2797	HCCA2 protein (HCCA2)
B20R05C12	20-12-5	Hs~Ref:NM_053005.2~uORF:IOH40119	3233	2307	3353	3438	5714	2261	3519	1913	5815	2971	HCCA2 protein (HCCA2)
B20R05C13	20-13-5	Hs~Ref:NM_006607.1~uORF:IOH40244	6406	2123	3968	2227	3285	2759	10693	4432	4505	862	pituitary tumor-transforming 2 (PTTG2)
B20R05C14	20-14-5	Hs~Ref:NM_006607.1~uORF:IOH40244	7003	2272	3810	2190	3346	2757	10685	4236	4299	870	pituitary tumor-transforming 2 (PTTG2)
B20R05C15	20-15-5	Hs~Ref:NM_148912.2~uORF:IOH40097	4317	3063	4047	4389	4176	2907	5214	3330	3366	2851	abhydrolase domain containing 11 (ABHD11)
B20R05C16	20-16-5	Hs~Ref:NM_148912.2~uORF:IOH40097	4338	3177	4140	4445	3283	3051	5074	3244	3257	2966	abhydrolase domain containing 11 (ABHD11)
B20R05C17	20-17-5	Hs~Ref:NM_057176.2~uORF:IOH35514	1300	480	1270	456	341	730	1669	371	884	176	Bartter syndrome, infantile, with sensorineural deafness (Barttin) (BSND)
B20R05C18	20-18-5	Hs~Ref:NM_057176.2~uORF:IOH35514	1250	410	1279	444	237	595	1893	433	799	168	Bartter syndrome, infantile, with sensorineural deafness (Barttin) (BSND)
B20R05C19	20-19-5	Hs~Ref:NM_080873.1~uORF:IOH35526	378	300	504	268	174	292	420	365	74	0	ankyrin repeat and SOCS box-containing 11 (ASB11), transcript variant 1
B20R05C20	20-20-5	Hs~Ref:NM_080873.1~uORF:IOH35526	364	329	471	257	118	233	479	335	315	60	ankyrin repeat and SOCS box-containing 11 (ASB11), transcript variant 1
B20R05C21	20-21-5	Hs~MGC:BC001861.2~uORF:IOH40580	741	564	908	482	574	817	918	504	1089	298	testis expressed 101 (TEX101)
B20R05C22	20-22-5	Hs~MGC:BC001861.2~uORF:IOH40580	684	598	903	519	484	792	914	501	1233	298	testis expressed 101 (TEX101)
B20R06C01	20-1-6	Hs~Ref:NM_000304.2~uORF:IOH40638	438	303	429	248	294	329	516	340	13	146	peripheral myelin protein 22 (PMP22), transcript variant 1
B20R06C02	20-2-6	Hs~Ref:NM_000304.2~uORF:IOH40638	391	321	469	272	286	387	534	387	521	135	peripheral myelin protein 22 (PMP22), transcript variant 1
B20R06C03	20-3-6	Hs~MGC:BC003586.1~uORF:IOH4499	413	395	562	99	274	1032	692	468	1979	81	armadillo repeat containing 10, mRNA (cDNA clone MGC:3195 IMAGE:3357276), complete cds
B20R06C04	20-4-6	Hs~MGC:BC003586.1~uORF:IOH4499	436	411	533	57	291	1039	801	460	1467	84	armadillo repeat containing 10, mRNA (cDNA clone MGC:3195 IMAGE:3357276), complete cds
B20R06C05	20-5-6	Hs~Ref:NM_018132.1~uORF:IOH10019	231	205	479	91	177	335	682	232	1307	59	Centromere protein Q
B20R06C06	20-6-6	Hs~Ref:NM_018132.1~uORF:IOH10019	295	179	502	129	109	185	682	181	1463	52	Centromere protein Q
B20R06C07	20-7-6	Hs~MGC:BC077077.1~uORF:IOH62554	340	241	551	696	248	347	395	268	361	69	Dihydropyrimidinase-related protein 3
B20R06C08	20-8-6	Hs~MGC:BC077077.1~uORF:IOH62554	371	215	512	634	2418	424	373	286	351	36	Dihydropyrimidinase-related protein 3
B20R06C09	20-9-6	Hs~Ref:NM_138443.1~uORF:IOH14717	40	68	168	120	131	127	262	194	162	36	coiled-coil domain containing 5 (spindle associated) (CCDC5)
B20R06C10	20-10-6	Hs~Ref:NM_138443.1~uORF:IOH14717	57	60	104	88	207	69	266	748	155	31	coiled-coil domain containing 5 (spindle associated) (CCDC5)
B20R06C11	20-11-6	Hs~Ref:NM_007370.2~uORF:IOH4957	1009	725	1077	627	1035	677	1274	656	3410	408	replication factor C (activator 1) 5, 36.5kDa (RFC5), transcript variant 1
B20R06C12	20-12-6	Hs~Ref:NM_007370.2~uORF:IOH4957	994	751	1128	659	1132	727	1318	681	2960	392	replication factor C (activator 1) 5, 36.5kDa (RFC5), transcript variant 1
B20R06C13	20-13-6	Hs~Ref:NM_002363.1~uORF:IOH10928	7100	4227	4007	12059	4424	3055	9951	2977	9308	5347	melanoma antigen family B, 1 (MAGEB1), transcript variant 1
B20R06C14	20-14-6	Hs~Ref:NM_002363.1~uORF:IOH10928	7372	4387	3736	12299	4045	3082	9783	3072	10074	5446	melanoma antigen family B, 1 (MAGEB1), transcript variant 1
B20R06C15	20-15-6	Hs~Ref:NM_004582.2~uORF:IOH14064	536	629	689	393	245	625	712	357	1565	338	Rab geranylgeranyltransferase, beta subunit (RABGGTB)
B20R06C16	20-16-6	Hs~Ref:NM_004582.2~uORF:IOH14064	506	672	700	361	384	799	715	327	1553	187	Rab geranylgeranyltransferase, beta subunit (RABGGTB)
B20R06C17	20-17-6	Hs~MGC:BC006091.1~uORF:IOH6616	763	1002	672	379	564	2402	1192	617	2161	962	tumor suppressing subtransferable candidate 4 (TSSC4)
B20R06C18	20-18-6	Hs~MGC:BC006091.1~uORF:IOH6616	778	930	675	376	594	2220	1309	651	2117	863	tumor suppressing subtransferable candidate 4 (TSSC4)
B20R06C21	20-21-6	Hs~Ref:NM_003695.2~uORF:IOH53843	582	449	616	380	206	672	875	535	1055	250	Lymphocyte antigen 6D
B20R06C22	20-22-6	Hs~Ref:NM_003695.2~uORF:IOH53843	489	455	581	370	476	627	877	530	1100	194	Lymphocyte antigen 6D
B20R07C01	20-1-7	Hs~MGC:BC095404.1~uORF:IOH62648	1536	2387	2586	1316	1334	6925	3115	1547	4433	855	Protein transport protein Sec23B
B20R07C02	20-2-7	Hs~MGC:BC095404.1~uORF:IOH62648	1610	2443	2602	1303	1389	6782	3129	1609	4466	819	Protein transport protein Sec23B
B20R07C05	20-5-7	Hs~Ref:NM_012325.1~uORF:IOH41294	5671	14056	3856	10653	6282	9175	14986	7192	7479	4034	microtubule-associated protein, RP/EB family, member 1 (MAPRE1)
B20R07C06	20-6-7	Hs~Ref:NM_012325.1~uORF:IOH41294	5480	13984	3924	9875	6410	8931	15766	7864	9315	4458	microtubule-associated protein, RP/EB family, member 1 (MAPRE1)
B20R07C07	20-7-7	Hs~Ref:NM_184237.1~uORF:IOH41717	1111	1255	1252	685	755	1919	1481	999	1844	500	RNA binding motif protein 39 (RBM39), transcript variant 3
B20R07C08	20-8-7	Hs~Ref:NM_184237.1~uORF:IOH41717	1108	1284	1225	647	1178	1767	1618	1014	1764	485	RNA binding motif protein 39 (RBM39), transcript variant 3
B20R07C09	20-9-7	Hs~Ref:NM_003289.3~uORF:IOH41299	779	876	1079	1075	1268	2497	2498	3747	2058	793	tropomyosin 2 (beta) (TPM2), transcript variant 1
B20R07C10	20-10-7	Hs~Ref:NM_003289.3~uORF:IOH41299	721	1162	1082	1048	1212	2528	2473	3744	2145	801	tropomyosin 2 (beta) (TPM2), transcript variant 1
B20R07C11	20-11-7	Hs~Ref:NM_014343.1~uORF:IOH42459	1035	1537	207	63	46	224	276	142	135	39	claudin 15 (CLDN15)
B20R07C12	20-12-7	Hs~Ref:NM_014343.1~uORF:IOH42459	-4	75	151	97	53	208	299	141	64	31	claudin 15 (CLDN15)
B20R07C13	20-13-7	Hs~Ref:NM_002793.2~uORF:IOH27925	124	173	583	61	143	91	300	204	812	211	proteasome (prosome, macropain) subunit, beta type, 1 (PSMB1)
B20R07C14	20-14-7	Hs~Ref:NM_002793.2~uORF:IOH27925	120	126	450	69	142	107	273	185	-11	36	proteasome (prosome, macropain) subunit, beta type, 1 (PSMB1)
B20R07C17	20-17-7	Hs~Ref:NM_025195.1~N/A	677	527	1119	269	319	339	778	468	1310	138	Tribbles homolog 1
B20R07C18	20-18-7	Hs~Ref:NM_025195.1~N/A	687	587	1077	299	262	311	712	281	972	125	Tribbles homolog 1
B20R07C19	20-19-7	Hs~MGC:NM_175878.2~uORF:IOH26879	272	192	203	214	48	73	448	216	2716	1438	XK-related protein 3
B20R07C20	20-20-7	Hs~MGC:NM_175878.2~uORF:IOH26879	197	110	407	92	15	147	430	239	2815	1551	XK-related protein 3
B20R08C03	20-3-8	Hs~MGC:BC068068.1~uORF:IOH63001	2448	2351	5830	3691	1307	3334	2707	6637	3750	1006	Galectin-3
B20R08C04	20-4-8	Hs~MGC:BC068068.1~uORF:IOH63001	2618	2414	5756	3997	1199	3486	3230	6643	3657	1041	Galectin-3
B20R08C07	20-7-8	Hs~MGC:BC014237.1~uORF:IOH22994	1265	757	1194	700	881	877	1577	759	1689	508	DEAH (Asp-Glu-Ala-His) box polypeptide 30 (DHX30)
B20R08C08	20-8-8	Hs~MGC:BC014237.1~uORF:IOH22994	1332	712	1159	645	873	879	1554	755	1662	541	DEAH (Asp-Glu-Ala-His) box polypeptide 30 (DHX30)
B20R08C09	20-9-8	Hs~MGC:BC021701.1~uORF:IOH23015	552	486	682	574	579	585	647	496	1010	322	chromosome 14 open reading frame 147 (C14orf147)
B20R08C10	20-10-8	Hs~MGC:BC021701.1~uORF:IOH23015	530	1286	668	529	552	598	660	489	961	369	chromosome 14 open reading frame 147 (C14orf147)
B20R08C11	20-11-8	Hs~Ref:NM_021158.1~uORF:IOH14340	1972	1382	1997	1019	988	1521	1499	947	5560	859	tribbles homolog 3 (Drosophila) (TRIB3)
B20R08C12	20-12-8	Hs~Ref:NM_021158.1~uORF:IOH14340	2088	1333	2150	1079	995	1493	1411	899	5689	881	tribbles homolog 3 (Drosophila) (TRIB3)
B20R08C13	20-13-8	Hs~MGC:BC029167.1~uORF:IOH22650	644	423	871	561	449	626	812	455	1568	371	CD177 molecule (CD177)
B20R08C14	20-14-8	Hs~MGC:BC029167.1~uORF:IOH22650	778	406	1018	504	520	610	883	477	1663	414	CD177 molecule (CD177)
B20R08C15	20-15-8	Hs~MGC:BC012493.1~uORF:IOH11147	1291	850	1855	771	780	890	2449	793	2976	440	KIAA1147 (KIAA1147)
B20R08C16	20-16-8	Hs~MGC:BC012493.1~uORF:IOH11147	1188	745	1751	810	723	942	2497	753	2896	399	KIAA1147 (KIAA1147)
B20R08C17	20-17-8	Hs~MGC:BC010426.1~uORF:IOH12487	207	316	652	526	464	886	1017	545	1348	163	cDNA clone MGC:15478 IMAGE:2967661, complete cds
B20R08C18	20-18-8	Hs~MGC:BC010426.1~uORF:IOH12487	509	451	631	536	517	902	1061	566	1239	95	cDNA clone MGC:15478 IMAGE:2967661, complete cds
B20R08C19	20-19-8	Hs~Ref:NM_005239.2~uORF:IOH10422	2320	860	1922	1679	1287	1846	17938	1123	3329	541	v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) (ETS2)
B20R08C20	20-20-8	Hs~Ref:NM_005239.2~uORF:IOH10422	2021	854	1878	1580	1270	2115	18176	1146	3350	518	v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) (ETS2)
B20R08C21	20-21-8	Hs~Ref:NM_012473.2~uORF:IOH11093	2144	758	1229	768	911	1166	1644	1963	2521	623	thioredoxin 2 (TXN2), nuclear gene encoding mitochondrial protein
B20R08C22	20-22-8	Hs~Ref:NM_012473.2~uORF:IOH11093	1950	819	1253	734	788	1219	1560	1711	2546	614	thioredoxin 2 (TXN2), nuclear gene encoding mitochondrial protein
B20R09C01	20-1-9	Hs~Ref:NM_012191.2~uORF:IOH40594	1085	3708	2896	895	1214	1355	1841	941	2234	606	N-acetyltransferase 6 (NAT6)
B20R09C02	20-2-9	Hs~Ref:NM_012191.2~uORF:IOH40594	1076	3904	2726	937	1268	1464	1789	1100	2246	623	N-acetyltransferase 6 (NAT6)
B20R09C03	20-3-9	Hs~Ref:NM_033201.1~uORF:IOH40574	1120	1326	861	912	500	657	1855	3506	1322	339	chromosome 16 open reading frame 45 (C16orf45)
B20R09C04	20-4-9	Hs~Ref:NM_033201.1~uORF:IOH40574	1204	1346	864	961	517	688	1881	3467	1116	323	chromosome 16 open reading frame 45 (C16orf45)
B20R09C05	20-5-9	Hs~Ref:NM_016606.2~uORF:IOH40596	1329	674	1076	4556	531	4621	3122	966	1843	309	receptor accessory protein 2 (REEP2)
B20R09C06	20-6-9	Hs~Ref:NM_016606.2~uORF:IOH40596	1306	679	993	4687	580	4993	3284	967	1791	330	receptor accessory protein 2 (REEP2)
B20R09C07	20-7-9	Hs~Ref:NM_019005.2~uORF:IOH40538	762	474	747	648	496	558	1191	603	1909	233	WD repeat-containing protein mio
B20R09C08	20-8-9	Hs~Ref:NM_019005.2~uORF:IOH40538	778	485	721	645	506	539	1160	610	1915	253	WD repeat-containing protein mio
B20R09C09	20-9-9	Hs~MGC:NM_177424.1~uORF:IOH26548	619	1195	816	351	504	935	630	624	2545	317	syntaxin 12 (STX12)
B20R09C10	20-10-9	Hs~MGC:NM_177424.1~uORF:IOH26548	572	1131	780	371	469	917	606	660	2501	368	syntaxin 12 (STX12)
B20R09C11	20-11-9	Hs~Ref:NM_005207.1~uORF:IOH26401	1309	819	1016	1899	873	3264	1238	515	1542	637	v-crk sarcoma virus CT10 oncogene homolog (avian)-like (CRKL)
B20R09C12	20-12-9	Hs~Ref:NM_005207.1~uORF:IOH26401	1340	772	1008	1995	844	3203	1272	508	1566	665	v-crk sarcoma virus CT10 oncogene homolog (avian)-like (CRKL)
B20R09C13	20-13-9	Hs~MGC:BC050688.1~uORF:IOH27002	1001	634	489	618	284	2096	606	624	1546	404	ribosomal protein SA (RPSA)
B20R09C14	20-14-9	Hs~MGC:BC050688.1~uORF:IOH27002	979	652	446	633	444	2013	748	617	1502	377	ribosomal protein SA (RPSA)
B20R09C15	20-15-9	Hs~Ref:NM_014012.2~uORF:IOH26198	1583	728	1420	862	594	909	1892	877	2545	492	RAS (RAD and GEM)-like GTP-binding 1 (REM1)
B20R09C16	20-16-9	Hs~Ref:NM_014012.2~uORF:IOH26198	1693	788	1432	864	621	1050	1535	977	2541	485	RAS (RAD and GEM)-like GTP-binding 1 (REM1)
B20R09C17	20-17-9	Hs~Ref:NM_013375.2~uORF:IOH1920	4722	1859	2617	2298	1383	2294	16212	2471	5378	1281	activator of basal transcription 1 (ABT1)
B20R09C18	20-18-9	Hs~Ref:NM_013375.2~uORF:IOH1920	4706	1882	2606	2294	1417	2282	16249	2568	5200	1169	activator of basal transcription 1 (ABT1)
B20R09C19	20-19-9	Hs~Ref:NM_005086.3~uORF:IOH1877	2028	1224	2482	1279	1144	1672	2670	1454	3199	793	sarcospan (Kras oncogene-associated gene) (SSPN)
B20R09C20	20-20-9	Hs~Ref:NM_005086.3~uORF:IOH1877	1907	1321	2318	1380	1007	2092	2654	1343	3352	889	sarcospan (Kras oncogene-associated gene) (SSPN)
B20R09C21	20-21-9	Hs~Ref:NM_001975.2~uORF:IOH2253	1327	849	1223	830	977	1319	1391	842	2149	586	enolase 2 (gamma, neuronal) (ENO2)
B20R09C22	20-22-9	Hs~Ref:NM_001975.2~uORF:IOH2253	1224	914	1233	932	1021	1205	1801	929	2321	531	enolase 2 (gamma, neuronal) (ENO2)
B20R10C01	20-1-10	Hs~MGC:BC013393.2~uORF:IOH13082	571	867	1776	222	525	472	1383	574	1744	1071	adducin 1 (alpha) (ADD1)
B20R10C02	20-2-10	Hs~MGC:BC013393.2~uORF:IOH13082	341	849	1636	316	602	530	1541	700	1671	1023	adducin 1 (alpha) (ADD1)
B20R10C03	20-3-10	Hs~MGC:BC059358.1~uORF:IOH29286	917	985	814	437	308	554	1658	458	944	369	RAB3A interacting protein (rabin3) (RAB3IP)
B20R10C04	20-4-10	Hs~MGC:BC059358.1~uORF:IOH29286	845	1100	711	376	333	513	911	415	936	328	RAB3A interacting protein (rabin3) (RAB3IP)
B20R10C05	20-5-10	Hs~MGC:BC041787.1~uORF:IOH27976	548	596	684	409	330	504	751	741	711	273	solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 (SLC11A1)
B20R10C06	20-6-10	Hs~MGC:BC041787.1~uORF:IOH27976	517	616	668	391	341	527	701	752	757	294	solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 (SLC11A1)
B20R10C07	20-7-10	Hs~MGC:BC058886.1~uORF:IOH29125	134	1420	432	242	384	417	378	1323	638	301	hypothetical protein FLJ11506 (FLJ11506)
B20R10C08	20-8-10	Hs~MGC:BC058886.1~uORF:IOH29125	208	1425	445	204	372	370	405	1340	684	283	hypothetical protein FLJ11506 (FLJ11506)
B20R10C09	20-9-10	Hs~MGC:BC057838.1~uORF:IOH29209	649	1392	1732	1187	597	1414	1061	2437	3700	461	sterile alpha motif domain containing 4A (SAMD4A)
B20R10C10	20-10-10	Hs~MGC:BC057838.1~uORF:IOH29209	631	1269	1722	1179	614	1403	1048	2386	3693	442	sterile alpha motif domain containing 4A (SAMD4A)
B20R11C21	20-21-11	Hs~MGC:BC011952.1~uORF:IOH10475	2302	984	623	374	135	726	2224	407	545	138	family with sequence similarity 18, member B2 (FAM18B2)
B20R11C22	20-22-11	Hs~MGC:BC011952.1~uORF:IOH10475	588	965	635	430	142	666	1562	423	565	310	family with sequence similarity 18, member B2 (FAM18B2)
B20R12C01	20-1-12	Hs~MGC:BC018137.1~uORF:IOH10369	4498	2793	1926	2005	1239	2805	12502	1567	3694	983	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa (TAF1B)
B20R12C02	20-2-12	Hs~MGC:BC018137.1~uORF:IOH10369	4373	2835	1952	1987	1249	2928	12134	1479	3713	1062	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa (TAF1B)
B20R12C03	20-3-12	Hs~MGC:BC000877.1~uORF:IOH3268	2398	1274	1351	847	580	1180	10693	1070	2238	516	arginine vasopressin-induced 1 (AVPI1)
B20R12C04	20-4-12	Hs~MGC:BC000877.1~uORF:IOH3268	2297	1304	1384	947	578	1235	9876	830	2210	452	arginine vasopressin-induced 1 (AVPI1)
B20R12C05	20-5-12	Hs~MGC:BC001259.1~uORF:IOH3096	398	417	432	234	261	456	672	362	589	346	adaptor-related protein complex 4, sigma 1 subunit (AP4S1)
B20R12C06	20-6-12	Hs~MGC:BC001259.1~uORF:IOH3096	467	379	483	3219	274	520	715	441	618	379	adaptor-related protein complex 4, sigma 1 subunit (AP4S1)
B20R12C07	20-7-12	Hs~MGC:BC047455.1~uORF:IOH26531	6815	1322	2972	833	1578	1189	2024	1886	3623	533	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 (DDX4)
B20R12C08	20-8-12	Hs~MGC:BC047455.1~uORF:IOH26531	6914	1305	2905	865	1568	1311	1982	2068	4122	521	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 (DDX4)
B20R12C09	20-9-12	Hs~MGC:BC035256.1~uORF:IOH27660	1045	2286	963	3182	1134	1214	4586	711	4208	392	Putative adenylate kinase 7
B20R12C10	20-10-12	Hs~MGC:BC035256.1~uORF:IOH27660	1024	2392	971	3236	1184	1316	4557	716	4363	377	Putative adenylate kinase 7
B20R12C11	20-11-12	Hs~MGC:BC035040.1~uORF:IOH27116	1074	1407	1095	742	779	1483	2300	820	2613	617	GRAM domain containing 1C (GRAMD1C)
B20R12C12	20-12-12	Hs~MGC:BC035040.1~uORF:IOH27116	1118	1528	1120	812	819	1439	2569	807	2590	666	GRAM domain containing 1C (GRAMD1C)
B20R12C13	20-13-12	Hs~Ref:NM_153687.1~uORF:IOH29079	1161	1007	1100	1008	801	1210	1898	913	2646	673	IKK interacting protein (IKIP), transcript variant 1
B20R12C14	20-14-12	Hs~Ref:NM_153687.1~uORF:IOH29079	1092	1150	1365	918	787	1224	1733	1038	2582	666	IKK interacting protein (IKIP), transcript variant 1
B20R12C15	20-15-12	Hs~MGC:BC103864.1~uORF:IOH63430	397	241	755	273	223	308	466	507	663	93	synovial sarcoma, X breakpoint 4, mRNA (cDNA clone MGC:119056 IMAGE:40003338), complete cds
B20R12C16	20-16-12	Hs~MGC:BC103864.1~uORF:IOH63430	334	215	679	273	161	358	509	339	577	93	synovial sarcoma, X breakpoint 4, mRNA (cDNA clone MGC:119056 IMAGE:40003338), complete cds
B20R12C17	20-17-12	Hs~MGC:BC098269.1~uORF:IOH63293	157	102	171	479	184	332	945	337	430	77	Rap1 GTPase-GDP dissociation stimulator 1
B20R12C18	20-18-12	Hs~MGC:BC098269.1~uORF:IOH63293	157	104	146	461	186	283	924	273	419	82	Rap1 GTPase-GDP dissociation stimulator 1
B20R12C19	20-19-12	Hs~MGC:BC100926.1~uORF:IOH63370	873	545	1395	587	512	1761	4371	718	8361	278	D-tyrosyl-tRNA(Tyr) deacylase 1
B20R12C20	20-20-12	Hs~MGC:BC100926.1~uORF:IOH63370	893	568	1424	619	566	1932	4267	719	7914	368	D-tyrosyl-tRNA(Tyr) deacylase 1
B20R12C21	20-21-12	Hs~MGC:BC101938.1~uORF:IOH63321	1098	1067	819	618	487	590	793	8018	1106	322	Epidermis-type lipoxygenase 3
B20R12C22	20-22-12	Hs~MGC:BC101938.1~uORF:IOH63321	1017	1088	738	561	610	563	734	7406	1098	268	Epidermis-type lipoxygenase 3
B20R13C01	20-1-13	Hs~Ref:NM_198044.1~uORF:IOH23224	1186	671	1601	5195	1111	1088	1867	1152	2170	656	zinc finger, DHHC-type containing 16 (ZDHHC16), transcript variant 3
B20R13C02	20-2-13	Hs~Ref:NM_198044.1~uORF:IOH23224	1105	676	1657	5177	1138	1146	1920	1094	2209	698	zinc finger, DHHC-type containing 16 (ZDHHC16), transcript variant 3
B20R13C03	20-3-13	Hs~MGC:BC033159.1~uORF:IOH23223	3122	4174	5028	3500	3339	5036	19414	8100	9125	2546	DnaJ (Hsp40) homolog, subfamily C, member 8 (DNAJC8)
B20R13C04	20-4-13	Hs~MGC:BC033159.1~uORF:IOH23223	3065	4110	4952	3582	3439	4945	19320	9190	9163	2615	DnaJ (Hsp40) homolog, subfamily C, member 8 (DNAJC8)
B20R13C05	20-5-13	Hs~Ref:NM_021627.2~uORF:IOH26311	7035	3068	6501	65451	2727	3324	2882	1659	4472	817	SUMO1/sentrin/SMT3 specific peptidase 2 (SENP2)
B20R13C06	20-6-13	Hs~Ref:NM_021627.2~uORF:IOH26311	7060	3053	6142	65462	2739	3567	2727	1831	4151	830	SUMO1/sentrin/SMT3 specific peptidase 2 (SENP2)
B20R13C07	20-7-13	Hs~MGC:BC020719.1~uORF:IOH12903	40	345	473	352	304	472	490	1270	792	210	hemoglobin, gamma A (HBG1)
B20R13C08	20-8-13	Hs~MGC:BC020719.1~uORF:IOH12903	318	322	452	216	315	500	497	1270	766	139	hemoglobin, gamma A (HBG1)
B20R13C09	20-9-13	Hs~Ref:NM_020958.2~uORF:IOH44465	574	743	853	360	396	494	506	306	1174	328	Serine/threonine-protein phosphatase 4 regulatory subunit 4
B20R13C10	20-10-13	Hs~Ref:NM_020958.2~uORF:IOH44465	531	739	848	357	435	550	510	293	1202	284	Serine/threonine-protein phosphatase 4 regulatory subunit 4
B20R13C13	20-13-13	Hs~Ref:NM_138331.1~uORF:IOH35122	808	380	1392	521	666	591	934	527	1374	364	ribonuclease, RNase A family, 8 (RNASE8)
B20R13C14	20-14-13	Hs~Ref:NM_138331.1~uORF:IOH35122	811	383	1456	522	652	568	882	767	1344	323	ribonuclease, RNase A family, 8 (RNASE8)
B20R13C15	20-15-13	Hs~Ref:NM_004763.2~uORF:IOH40963	1697	328	660	551	1422	496	644	1811	1275	272	integrin beta 1 binding protein 1 (ITGB1BP1), transcript variant 1
B20R13C16	20-16-13	Hs~Ref:NM_004763.2~uORF:IOH40963	1744	406	571	563	1447	497	645	1887	1271	218	integrin beta 1 binding protein 1 (ITGB1BP1), transcript variant 1
B20R13C17	20-17-13	Hs~MGC:BC017085.1~uORF:IOH10382	776	693	982	607	727	951	1170	572	1367	396	serine incorporator 2 (SERINC2)
B20R13C18	20-18-13	Hs~MGC:BC017085.1~uORF:IOH10382	759	684	1069	600	728	930	1124	498	1430	360	serine incorporator 2 (SERINC2)
B20R13C19	20-19-13	Hs~MGC:NM_152471.1~uORF:IOH10190	1266	360	638	293	144	741	558	286	693	72	hypothetical protein MGC17515 (MGC17515)
B20R13C20	20-20-13	Hs~MGC:NM_152471.1~uORF:IOH10190	1266	348	587	350	132	582	605	309	696	217	hypothetical protein MGC17515 (MGC17515)
B20R13C21	20-21-13	Hs~MGC:BC012131.1~uORF:IOH13142	29907	4669	5439	9795	3580	14761	4386	5937	7327	2744	chromosome 14 open reading frame 149 (C14orf149)
B20R13C22	20-22-13	Hs~MGC:BC012131.1~uORF:IOH13142	29303	4572	5392	9993	3496	15005	4160	5741	7431	2834	chromosome 14 open reading frame 149 (C14orf149)
B20R14C01	20-1-14	Hs~MGC:BC018206.1~uORF:IOH10533	406	260	365	297	206	404	1128	368	601	263	family with sequence similarity 128, member A (FAM128A)
B20R14C02	20-2-14	Hs~MGC:BC018206.1~uORF:IOH10533	519	293	415	300	205	422	868	336	662	312	family with sequence similarity 128, member A (FAM128A)
B20R14C05	20-5-14	Hs~Ref:NM_172208.1~uORF:IOH59271	523	456	840	325	368	521	1307	814	711	209	Tapasin
B20R14C06	20-6-14	Hs~Ref:NM_172208.1~uORF:IOH59271	555	406	848	588	307	493	1282	487	687	209	Tapasin
B20R14C07	20-7-14	Hs~Ref:NM_007005.3~uORF:IOH52787	1516	1276	1706	1740	1218	1272	2219	854	18737	1108	Transducin-like enhancer protein 4
B20R14C08	20-8-14	Hs~Ref:NM_007005.3~uORF:IOH52787	1486	1316	1719	1916	1215	1265	2302	846	18430	1134	Transducin-like enhancer protein 4
B20R14C09	20-9-14	Hs~Ref:NM_002495.1~uORF:IOH54701	635	569	697	529	348	908	1098	388	861	339	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial
B20R14C10	20-10-14	Hs~Ref:NM_002495.1~uORF:IOH54701	677	566	717	571	381	878	1143	398	867	335	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial
B20R14C11	20-11-14	Hs~MGC:BC009458.1~uORF:IOH13468	2783	2779	2308	1641	4281	3347	4579	3674	5164	2592	Homeobox protein BarH-like 1
B20R14C12	20-12-14	Hs~MGC:BC009458.1~uORF:IOH13468	3244	2786	2360	1558	4229	3397	5071	3862	5222	2471	Homeobox protein BarH-like 1
B20R14C13	20-13-14	Hs~Ref:NM_014370.2~uORF:IOH60262	1481	814	2641	1163	578	1270	3183	1195	2657	617	SFRS protein kinase 3 (SRPK3)
B20R14C14	20-14-14	Hs~Ref:NM_014370.2~uORF:IOH60262	1359	881	2638	1158	564	1240	3190	1190	2682	634	SFRS protein kinase 3 (SRPK3)
B20R14C15	20-15-14	Hs~MGC:BC104469.1~uORF:IOH63631	2524	1546	1836	1896	585	2684	5962	1847	2185	1600	Outer dense fiber protein 3-like protein 2
B20R14C16	20-16-14	Hs~MGC:BC104469.1~uORF:IOH63631	2600	1475	1854	1949	613	2662	5663	1811	2283	1670	Outer dense fiber protein 3-like protein 2
B20R14C17	20-17-14	Hs~Ref:NM_030754.2~uORF:IOH12636	344	303	533	228	307	520	532	360	558	220	serum amyloid A2, mRNA (cDNA clone MGC:23693 IMAGE:4767650), complete cds
B20R14C18	20-18-14	Hs~Ref:NM_030754.2~uORF:IOH12636	356	293	541	231	243	842	582	331	573	121	serum amyloid A2, mRNA (cDNA clone MGC:23693 IMAGE:4767650), complete cds
B20R14C19	20-19-14	Hs~Ref:NM_004162.2~uORF:IOH10188	2076	981	1671	941	1166	1155	1924	1255	3353	555	Ras-related protein Rab-5A
B20R14C20	20-20-14	Hs~Ref:NM_004162.2~uORF:IOH10188	1811	937	1626	971	1163	1186	2338	1239	3251	555	Ras-related protein Rab-5A
B20R15C05	20-5-15	Hs~Ref:NM_000566.1~uORF:IOH21921	780	498	725	499	344	607	734	660	1119	536	Fc fragment of IgG, high affinity Ia, receptor (CD64) (FCGR1A)
B20R15C06	20-6-15	Hs~Ref:NM_000566.1~uORF:IOH21921	2114	511	669	646	294	484	778	475	1009	523	Fc fragment of IgG, high affinity Ia, receptor (CD64) (FCGR1A)
B20R15C07	20-7-15	Hs~MGC:BC032838.2~uORF:IOH26853	1904	426	919	470	334	891	2862	509	1090	348	IQ and ubiquitin-like domain-containing protein
B20R15C08	20-8-15	Hs~MGC:BC032838.2~uORF:IOH26853	2038	476	898	481	395	637	2363	535	1078	350	IQ and ubiquitin-like domain-containing protein
B20R15C09	20-9-15	Hs~MGC:BC043193.2~uORF:IOH25850	709	391	721	275	272	609	1327	476	658	300	chromosome 4 open reading frame 18 (C4orf18)
B20R15C10	20-10-15	Hs~MGC:BC043193.2~uORF:IOH25850	1434	340	767	289	364	533	1199	373	794	291	chromosome 4 open reading frame 18 (C4orf18)
B20R15C11	20-11-15	Hs~MGC:NM_153208.1~uORF:IOH22871	2325	948	901	509	434	565	1320	650	1207	358	IQ motif containing K (IQCK)
B20R15C12	20-12-15	Hs~MGC:NM_153208.1~uORF:IOH22871	777	1491	878	517	467	552	927	585	1174	324	IQ motif containing K (IQCK)
B20R15C13	20-13-15	Hs~Ref:NM_001006665.1~CAT:PV3680	1143	1579	1902	920	543	2413	1191	3466	1823	426	ribosomal protein S6 kinase, 90kDa, polypeptide 1 (RPS6KA1), transcript variant 2
B20R15C14	20-14-15	Hs~Ref:NM_001006665.1~CAT:PV3680	1138	1138	1743	843	574	2477	1385	3410	1821	410	ribosomal protein S6 kinase, 90kDa, polypeptide 1 (RPS6KA1), transcript variant 2
B20R15C15	20-15-15	Hs~Ref:NM_003161.1~CAT:PV3815	372	248	633	424	425	459	578	370	882	207	ribosomal protein S6 kinase, 70kDa, polypeptide 1 (RPS6KB1)
B20R15C16	20-16-15	Hs~Ref:NM_003161.1~CAT:PV3815	425	169	148	444	405	463	549	357	868	92	ribosomal protein S6 kinase, 70kDa, polypeptide 1 (RPS6KB1)
B20R15C17	20-17-15	Hs~Ref:NM_031417.1~CAT:PV3851	9624	2148	2345	2572	2652	2419	3934	2164	4126	2675	MAP/microtubule affinity-regulating kinase 4
B20R15C18	20-18-15	Hs~Ref:NM_031417.1~CAT:PV3851	9771	2195	2357	2721	2629	2025	3837	2546	3954	2633	MAP/microtubule affinity-regulating kinase 4
B20R15C19	20-19-15	Hs~Ref:NM_002741.1~CAT:PV3790	1269	498	1185	361	468	461	1691	832	2030	318	Serine/threonine-protein kinase N1
B20R15C20	20-20-15	Hs~Ref:NM_002741.1~CAT:PV3790	1044	486	1150	363	448	482	1731	879	2008	327	Serine/threonine-protein kinase N1
B20R15C21	20-21-15	Hs~Ref:NM_014370.1~CAT:PV3880	1182	382	950	948	416	592	574	741	807	384	SFRS protein kinase 3 (SRPK3)
B20R15C22	20-22-15	Hs~Ref:NM_014370.1~CAT:PV3880	457	415	1010	795	444	562	554	721	784	384	SFRS protein kinase 3 (SRPK3)
B20R16C01	20-1-16	Hs~Ref:NM_000600.1~CAT_PHC0066	15	7	12	11	3	17	38	14	19	39	Interleukin-6
B20R16C02	20-2-16	Hs~Ref:NM_000600.1~CAT_PHC0066	14	7	15	11	4	18	48	14	19	55	Interleukin-6
B20R16C07	20-7-16	Hs~Ref:NM_001002755.1~uORF:IOH59825	1594	427	1085	402	529	799	883	377	838	362	NFU1 iron-sulfur cluster scaffold homolog, mitochondrial
B20R16C08	20-8-16	Hs~Ref:NM_001002755.1~uORF:IOH59825	1455	466	1067	416	527	794	852	362	781	348	NFU1 iron-sulfur cluster scaffold homolog, mitochondrial
B20R16C09	20-9-16	Hs~Ref:NM_175072.1~uORF:IOH59828	6867	2231	3043	2832	2448	4870	5536	2329	3287	2196	Aprataxin
B20R16C10	20-10-16	Hs~Ref:NM_175072.1~uORF:IOH59828	7134	2055	2877	2938	2549	4664	5442	2505	3199	2268	Aprataxin
B20R16C11	20-11-16	Hs~Ref:NM_145322.1~uORF:IOH53553	1496	1374	1448	1092	640	969	2008	1034	1840	501	oxysterol binding protein-like 3 (OSBPL3), transcript variant 4, mRNA.
B20R16C12	20-12-16	Hs~Ref:NM_145322.1~uORF:IOH53553	1143	1508	1472	1123	629	985	2098	1087	1865	481	oxysterol binding protein-like 3 (OSBPL3), transcript variant 4, mRNA.
B20R16C13	20-13-16	Hs~Ref:NM_006254.3~uORF:IOH26352	2053	7874	8447	1519	1858	1596	8611	1002	3770	756	protein kinase C, delta (PRKCD), transcript variant 1
B20R16C14	20-14-16	Hs~Ref:NM_006254.3~uORF:IOH26352	1912	7344	8302	1478	1967	1600	8725	1121	3795	777	protein kinase C, delta (PRKCD), transcript variant 1
B20R16C15	20-15-16	Hs~Ref:NM_005896.2~uORF:IOH11942	2	-1	-11	-6	6	-2	-4	0	-7	-1	Isocitrate dehydrogenase [NADP] cytoplasmic
B20R16C16	20-16-16	Hs~Ref:NM_005896.2~uORF:IOH11942	3	-1	123	-1	1	1	-1	-3	1	-3	Isocitrate dehydrogenase [NADP] cytoplasmic
B20R16C17	20-17-16	Hs~Ref:NM_017425.2~uORF:IOH21671	1139	789	1759	690	676	669	5494	980	2330	295	Sperm surface protein Sp17
B20R16C18	20-18-16	Hs~Ref:NM_017425.2~uORF:IOH21671	1111	787	1731	664	653	583	5647	959	2273	299	Sperm surface protein Sp17
B20R16C19	20-19-16	Hs~Ref:NM_019846.3~uORF:IOH40714	504	451	772	342	163	964	1269	497	814	344	chemokine (C-C motif) ligand 28 (CCL28), transcript variant 1
B20R16C20	20-20-16	Hs~Ref:NM_019846.3~uORF:IOH40714	918	432	744	417	252	771	1246	525	788	259	chemokine (C-C motif) ligand 28 (CCL28), transcript variant 1
B20R17C01	20-1-17	Hs~Ref:NM_033547.1~uORF:IOH14845	49	300	272	208	138	291	308	210	184	162	integrator complex subunit 4 (INTS4)
B20R17C02	20-2-17	Hs~Ref:NM_033547.1~uORF:IOH14845	210	73	294	206	154	290	288	229	224	202	integrator complex subunit 4 (INTS4)
B20R17C03	20-3-17	Hs~Ref:NM_001924.2~uORF:IOH13873	338	92	336	337	134	270	309	258	523	1	growth arrest and DNA-damage-inducible, alpha (GADD45A)
B20R17C04	20-4-17	Hs~Ref:NM_001924.2~uORF:IOH13873	333	199	347	240	107	336	318	298	475	38	growth arrest and DNA-damage-inducible, alpha (GADD45A)
B20R17C05	20-5-17	Hs~Ref:NM_002916.1~uORF:IOH13786	1017	515	490	462	490	996	849	1120	3648	602	replication factor C (activator 1) 4, 37kDa (RFC4), transcript variant 1
B20R17C06	20-6-17	Hs~Ref:NM_002916.1~uORF:IOH13786	1197	491	492	439	503	960	1016	1010	3472	632	replication factor C (activator 1) 4, 37kDa (RFC4), transcript variant 1
B20R17C07	20-7-17	Hs~Ref:NM_001450.2~uORF:IOH14447	940	268	457	283	250	627	449	332	545	234	four and a half LIM domains 2 (FHL2), transcript variant 1
B20R17C08	20-8-17	Hs~Ref:NM_001450.2~uORF:IOH14447	165	329	450	252	237	376	567	444	555	145	four and a half LIM domains 2 (FHL2), transcript variant 1
B20R17C09	20-9-17	Hs~Ref:NM_138403.3~uORF:IOH40584	561	420	627	299	282	420	1047	524	694	303	myosin light chain 2, precursor lymphocyte-specific (MYLC2PL)
B20R17C10	20-10-17	Hs~Ref:NM_138403.3~uORF:IOH40584	529	457	652	322	346	433	691	524	753	299	myosin light chain 2, precursor lymphocyte-specific (MYLC2PL)
B20R17C11	20-11-17	Hs~Ref:NM_015698.2~uORF:IOH3563	1701	455	368	484	839	752	2216	1012	1616	652	G patch domain and KOW motifs (GPKOW)
B20R17C12	20-12-17	Hs~Ref:NM_015698.2~uORF:IOH3563	1768	327	225	552	837	783	2317	957	1733	594	G patch domain and KOW motifs (GPKOW)
B20R17C13	20-13-17	Hs~MGC:BC021090.1~uORF:IOH13218	887	1266	179	198	456	607	1290	438	1047	149	scinderin (SCIN)
B20R17C14	20-14-17	Hs~MGC:BC021090.1~uORF:IOH13218	742	130	165	121	478	655	1285	460	1031	141	scinderin (SCIN)
B20R17C15	20-15-17	Hs~MGC:BC024590.1~uORF:IOH11674	251	42	576	200	186	197	255	772	344	44	dynamin 1-like (DNM1L)
B20R17C16	20-16-17	Hs~MGC:BC024590.1~uORF:IOH11674	494	47	576	181	100	212	282	833	295	71	dynamin 1-like (DNM1L)
B20R17C17	20-17-17	Hs~Ref:NM_138717.1~uORF:IOH42435	489	513	798	422	414	769	975	566	912	345	palmitoyl-protein thioesterase 2 (PPT2), transcript variant 2
B20R17C18	20-18-17	Hs~Ref:NM_138717.1~uORF:IOH42435	651	482	785	429	454	806	1420	574	930	410	palmitoyl-protein thioesterase 2 (PPT2), transcript variant 2
B20R17C19	20-19-17	Hs~Ref:NM_005513.1~uORF:IOH41075	636	138	588	360	305	923	3700	470	1054	1344	general transcription factor IIE, polypeptide 1, alpha 56kDa (GTF2E1)
B20R17C20	20-20-17	Hs~Ref:NM_005513.1~uORF:IOH41075	628	185	536	405	149	990	3794	478	1008	1365	general transcription factor IIE, polypeptide 1, alpha 56kDa (GTF2E1)
B20R17C21	20-21-17	Hs~Ref:NM_145202.3~uORF:IOH42472	7565	774	4400	626	754	1817	1115	536	1589	324	proline-rich acidic protein 1 (PRAP1)
B20R17C22	20-22-17	Hs~Ref:NM_145202.3~uORF:IOH42472	7760	768	4331	639	818	1965	1142	511	1505	341	proline-rich acidic protein 1 (PRAP1)
B20R18C01	20-1-18	Hs~Ref:XM_371901.1~uORF:IOH41658	600	606	591	358	357	625	1023	439	1302	317	DNA-binding protein Ikaros
B20R18C02	20-2-18	Hs~Ref:XM_371901.1~uORF:IOH41658	582	758	618	377	338	590	991	565	1101	338	DNA-binding protein Ikaros
B20R18C03	20-3-18	Hs~Ref:NM_004580.2~uORF:IOH29589	235	165	267	188	361	269	266	1504	-147	96	RAB27A, member RAS oncogene family (RAB27A), transcript variant 1
B20R18C04	20-4-18	Hs~Ref:NM_004580.2~uORF:IOH29589	228	234	259	254	336	296	290	1439	-86	91	RAB27A, member RAS oncogene family (RAB27A), transcript variant 1
B20R18C05	20-5-18	Hs~MGC:BC063629.1~uORF:IOH61519	293	252	332	289	198	280	564	276	329	170	HSPB (heat shock 27kDa) associated protein 1, mRNA (cDNA clone IMAGE:3892258), complete cds.
B20R18C06	20-6-18	Hs~MGC:BC063629.1~uORF:IOH61519	243	261	391	264	200	276	561	302	342	222	HSPB (heat shock 27kDa) associated protein 1, mRNA (cDNA clone IMAGE:3892258), complete cds.
B20R18C07	20-7-18	Hs~MGC:BC091489.1~uORF:IOH62570	520	511	797	1186	408	1609	1110	452	930	314	zinc finger, MYND domain containing 11, mRNA (cDNA clone MGC:111056 IMAGE:6186814), complete cds
B20R18C08	20-8-18	Hs~MGC:BC091489.1~uORF:IOH62570	503	465	826	1084	364	1309	1104	452	836	282	zinc finger, MYND domain containing 11, mRNA (cDNA clone MGC:111056 IMAGE:6186814), complete cds
B20R18C11	20-11-18	Hs~MGC:BC071659.1~uORF:IOH61780	792	828	1042	445	545	1211	1130	442	1010	328	HLA class II histocompatibility antigen, DR alpha chain
B20R18C12	20-12-18	Hs~MGC:BC071659.1~uORF:IOH61780	819	897	1061	514	539	1086	1231	556	1092	321	HLA class II histocompatibility antigen, DR alpha chain
B20R18C13	20-13-18	Hs~MGC:BC015505.1~uORF:IOH9981	7422	17295	10129	9340	10202	10174	11497	11447	9960	4740	DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 (DDX42)
B20R18C14	20-14-18	Hs~MGC:BC015505.1~uORF:IOH9981	7303	18289	10089	9358	10489	10840	11687	11295	9953	4874	DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 (DDX42)
B20R18C15	20-15-18	Hs~Ref:NM_020944.2~uORF:IOH9687	745	786	1325	663	551	848	1286	786	1588	436	glucosidase, beta (bile acid) 2 (GBA2)
B20R18C16	20-16-18	Hs~Ref:NM_020944.2~uORF:IOH9687	879	811	1366	678	581	755	1675	803	1664	433	glucosidase, beta (bile acid) 2 (GBA2)
B20R18C17	20-17-18	Hs~Ref:NM_020854.2~uORF:IOH9686	1083	929	1408	916	672	1084	2333	999	2043	656	KIAA1468 (KIAA1468)
B20R18C18	20-18-18	Hs~Ref:NM_020854.2~uORF:IOH9686	1133	850	1326	846	715	1094	1877	1070	2096	638	KIAA1468 (KIAA1468)
B20R18C19	20-19-18	Hs~MGC:BC040521.1~uORF:IOH27477	1013	525	967	519	870	881	1204	571	1205	392	testis expressed 2 (TEX2)
B20R18C20	20-20-18	Hs~MGC:BC040521.1~uORF:IOH27477	912	579	875	630	859	840	1120	605	1102	390	testis expressed 2 (TEX2)
B20R18C21	20-21-18	Hs~Ref:NM_017836.2~uORF:IOH26055	680	570	742	787	515	645	885	502	1036	347	Solute carrier family 41 member 3
B20R18C22	20-22-18	Hs~Ref:NM_017836.2~uORF:IOH26055	594	352	709	512	619	634	817	485	1036	341	Solute carrier family 41 member 3
B20R19C01	20-1-19	Hs~MGC:BC039856.1~uORF:IOH26187	1004	652	1135	887	617	871	2939	1016	3634	482	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 (ARHGEF6)
B20R19C02	20-2-19	Hs~MGC:BC039856.1~uORF:IOH26187	993	561	1153	911	601	672	2839	1109	3709	448	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 (ARHGEF6)
B20R19C03	20-3-19	Hs~MGC:BC009250.1~uORF:IOH27775	4277	1894	1713	1093	1037	2137	8295	1033	4062	926	guanine nucleotide binding protein-like 2 (nucleolar) (GNL2)
B20R19C04	20-4-19	Hs~MGC:BC009250.1~uORF:IOH27775	4274	1850	1730	1131	1033	2109	8478	1157	4254	1075	guanine nucleotide binding protein-like 2 (nucleolar) (GNL2)
B20R19C07	20-7-19	Hs~MGC:BC010875.2~uORF:IOH61497	274	247	372	162	173	216	379	318	28	121	Cell division cycle protein 16 homolog
B20R19C08	20-8-19	Hs~MGC:BC010875.2~uORF:IOH61497	167	153	363	151	76	201	1893	219	111	295	Cell division cycle protein 16 homolog
B20R19C09	20-9-19	Hs~MGC:BC063001.1~uORF:IOH61528	92	67	345	66	74	192	314	189	143	4	Signal recognition particle receptor subunit beta
B20R19C10	20-10-19	Hs~MGC:BC063001.1~uORF:IOH61528	92	70	312	70	68	218	213	203	125	18	Signal recognition particle receptor subunit beta
B20R19C11	20-11-19	Hs~MGC:BC028919.1~uORF:IOH61721	792	345	934	996	5928	739	836	348	700	214	Protein Tob2
B20R19C12	20-12-19	Hs~MGC:BC028919.1~uORF:IOH61721	743	1155	879	1021	6011	724	747	363	778	144	Protein Tob2
B20R19C13	20-13-19	Hs~MGC:BC035350.1~uORF:IOH27327	421	278	689	412	354	994	735	404	1604	385	cytochrome P450, family 4, subfamily F, polypeptide 12 (CYP4F12)
B20R19C14	20-14-19	Hs~MGC:BC035350.1~uORF:IOH27327	490	605	664	375	432	961	727	385	1798	283	cytochrome P450, family 4, subfamily F, polypeptide 12 (CYP4F12)
B20R19C15	20-15-19	Hs~Ref:NM_152453.2~uORF:IOH40202	958	787	1102	998	620	639	1958	595	1337	466	transmembrane and coiled-coil domains 5 (TMCO5)
B20R19C16	20-16-19	Hs~Ref:NM_152453.2~uORF:IOH40202	1016	852	1113	946	538	738	2225	605	1389	422	transmembrane and coiled-coil domains 5 (TMCO5)
B20R19C17	20-17-19	Hs~MGC:BC066938.1~uORF:IOH40083	4171	13897	4020	4937	9423	6898	6764	9296	4514	4583	DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 (DDX43)
B20R19C18	20-18-19	Hs~MGC:BC066938.1~uORF:IOH40083	4178	14347	4118	4794	9061	5329	6722	9118	4769	4748	DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 (DDX43)
B20R19C19	20-19-19	Hs~Ref:NM_000331.2~uORF:IOH58953	503	447	803	356	550	861	981	511	1119	293	Serum amyloid A protein
B20R19C20	20-20-19	Hs~Ref:NM_000331.2~uORF:IOH58953	579	519	776	379	530	772	902	474	1178	259	Serum amyloid A protein
B20R19C21	20-21-19	Hs~Ref:NM_024055.2~uORF:IOH3071	664	463	508	287	301	486	698	387	886	299	solute carrier family 30 (zinc transporter), member 5 (SLC30A5), transcript variant 2
B20R19C22	20-22-19	Hs~Ref:NM_024055.2~uORF:IOH3071	486	549	491	298	108	462	679	398	779	8	solute carrier family 30 (zinc transporter), member 5 (SLC30A5), transcript variant 2
B20R20C01	20-1-20	Hs~MGC:BC000535.1~uORF:IOH4145	1724	930	1120	755	396	1932	5237	793	1567	376	Suppressor of SWI4 1 homolog
B20R20C02	20-2-20	Hs~MGC:BC000535.1~uORF:IOH4145	1859	984	1087	679	434	2428	4943	721	-159	407	Suppressor of SWI4 1 homolog
B20R20C03	20-3-20	Hs~MGC:BC001001.2~uORF:IOH2958	366	459	491	520	410	649	813	337	89	314	vacuolar protein sorting 8 homolog (S. cerevisiae) (VPS8)
B20R20C04	20-4-20	Hs~MGC:BC001001.2~uORF:IOH2958	339	396	545	530	434	651	795	349	51	344	vacuolar protein sorting 8 homolog (S. cerevisiae) (VPS8)
B20R20C05	20-5-20	Hs~Ref:NM_017668.1~uORF:IOH4081	1134	1125	1168	5402	1613	1857	2326	1995	2220	755	nudE nuclear distribution gene E homolog 1 (A. nidulans) (NDE1)
B20R20C06	20-6-20	Hs~Ref:NM_017668.1~uORF:IOH4081	1115	1054	1192	5583	1598	1956	2270	2127	2283	788	nudE nuclear distribution gene E homolog 1 (A. nidulans) (NDE1)
B20R20C07	20-7-20	Hs~Ref:NM_144736.3~uORF:IOH40597	2403	3548	3314	3331	2916	4113	3628	3103	4040	1626	Protein midA homolog, mitochondrial
B20R20C08	20-8-20	Hs~Ref:NM_144736.3~uORF:IOH40597	2346	3490	3203	3233	2940	4103	3772	3155	4482	1676	Protein midA homolog, mitochondrial
B20R20C09	20-9-20	Hs~Ref:NM_012474.3~uORF:IOH40599	1096	2836	1736	844	1065	-2	-7	-9	-3	-1	uridine-cytidine kinase 2 (UCK2)
B20R20C10	20-10-20	Hs~Ref:NM_012474.3~uORF:IOH40599	1059	2705	1738	859	998	0	-3	-6	-11	-1	uridine-cytidine kinase 2 (UCK2)
B20R20C11	20-11-20	Hs~Ref:NM_000075.2~uORF:IOH5192	560	2249	737	545	320	383	812	479	292	337	cyclin D1 and cyclin-dependent kinase 4 (CDK4): cyclin D1 and CDK4 sequences are seperated by -- (in the protein list file).
B20R20C12	20-12-20	Hs~Ref:NM_000075.2~uORF:IOH5192	561	2352	773	535	311	377	831	469	275	335	cyclin D1 and cyclin-dependent kinase 4 (CDK4): cyclin D1 and CDK4 sequences are seperated by -- (in the protein list file).
B20R20C13	20-13-20	Hs~Ref:NM_001028.2~uORF:IOH5471	866	542	1068	646	713	1188	1296	650	1591	314	ribosomal protein S25 (RPS25)
B20R20C14	20-14-20	Hs~Ref:NM_001028.2~uORF:IOH5471	862	575	1063	637	690	1176	1342	632	1323	285	ribosomal protein S25 (RPS25)
B21R02C11	21-11-2	Hs~Ref:NM_001006634.1~uORF:IOH44197	1543	3587	65452	6136	4351	13343	4602	1697	3688	1924	Rho GTPase activating protein 17 (ARHGAP17), transcript variant 1
B21R02C12	21-12-2	Hs~Ref:NM_001006634.1~uORF:IOH44197	1402	3848	65477	6365	4508	13466	4723	1807	3691	1842	Rho GTPase activating protein 17 (ARHGAP17), transcript variant 1
B21R02C13	21-13-2	Hs~MGC:NM_153236.2~uORF:IOH11863	2469	254	968	436	642	320	689	271	842	289	GTPase, IMAP family member 7 (GIMAP7)
B21R02C14	21-14-2	Hs~MGC:NM_153236.2~uORF:IOH11863	2895	252	1365	682	370	327	838	172	824	251	GTPase, IMAP family member 7 (GIMAP7)
B21R02C15	21-15-2	Hs~Ref:NM_145010.1~uORF:IOH10871	56366	7175	12687	21056	19098	8416	9566	18456	10528	6987	chromosome 10 open reading frame 63 (C10orf63)
B21R02C16	21-16-2	Hs~Ref:NM_145010.1~uORF:IOH10871	57979	7169	13406	24611	21328	8062	9947	21079	10817	6952	chromosome 10 open reading frame 63 (C10orf63)
B21R02C17	21-17-2	Hs~MGC:BC011603.1~uORF:IOH13717	1361	683	1917	1895	2077	3825	2000	1443	2120	393	v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) (RELA)
B21R02C18	21-18-2	Hs~MGC:BC011603.1~uORF:IOH13717	1242	707	1861	1881	2389	3906	2083	1512	2159	379	v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) (RELA)
B21R02C19	21-19-2	Hs~Ref:NM_182480.1~uORF:IOH41665	540	340	835	364	346	395	536	329	508	210	coenzyme Q6 homolog, monooxygenase (S. cerevisiae) (COQ6), transcript variant 2
B21R02C20	21-20-2	Hs~Ref:NM_182480.1~uORF:IOH41665	588	341	673	342	319	443	536	340	670	220	coenzyme Q6 homolog, monooxygenase (S. cerevisiae) (COQ6), transcript variant 2
B21R02C21	21-21-2	Hs~Ref:XM_088679.2~uORF:IOH43003	7327	1399	2884	1457	707	2327	21772	1210	3590	565	Spermatid nuclear transition protein 4
B21R02C22	21-22-2	Hs~Ref:XM_088679.2~uORF:IOH43003	7105	1459	2579	1364	729	2308	21925	1203	3163	555	Spermatid nuclear transition protein 4
B21R03C01	21-1-3	Hs~Ref:NM_182492.1~uORF:IOH43816	2235	99	614	275	432	514	629	368	615	52	low density lipoprotein receptor-related protein 5-like (LRP5L)
B21R03C02	21-2-3	Hs~Ref:NM_182492.1~uORF:IOH43816	1131	1330	639	314	364	552	637	393	514	113	low density lipoprotein receptor-related protein 5-like (LRP5L)
B21R03C03	21-3-3	Hs~MGC:NM_198157.1~uORF:IOH42269	1326	1483	711	290	297	406	594	383	482	141	ubiquitin-conjugating enzyme E2L 3 (UBE2L3), transcript variant 2
B21R03C04	21-4-3	Hs~MGC:NM_198157.1~uORF:IOH42269	494	431	730	326	283	303	614	370	529	82	ubiquitin-conjugating enzyme E2L 3 (UBE2L3), transcript variant 2
B21R03C05	21-5-3	Hs~Ref:NM_003221.1~uORF:IOH25803	1038	945	1205	941	582	1099	2913	4176	892	407	transcription factor AP-2 beta (activating enhancer binding protein 2 beta) (TFAP2B)
B21R03C06	21-6-3	Hs~Ref:NM_003221.1~uORF:IOH25803	946	936	1062	1017	633	996	3120	3234	928	394	transcription factor AP-2 beta (activating enhancer binding protein 2 beta) (TFAP2B)
B21R03C07	21-7-3	Hs~MGC:NM_198276.1~uORF:IOH26511	273	312	464	463	274	284	266	854	1358	153	transmembrane protein 17 (TMEM17)
B21R03C08	21-8-3	Hs~MGC:NM_198276.1~uORF:IOH26511	284	295	437	1369	910	275	329	533	1319	171	transmembrane protein 17 (TMEM17)
B21R03C09	21-9-3	Hs~Ref:NM_018990.1~uORF:IOH27033	1199	1166	8085	716	484	1103	1703	460	1464	493	chromosome X open reading frame 9 (CXorf9)
B21R03C10	21-10-3	Hs~Ref:NM_018990.1~uORF:IOH27033	1151	1270	7973	790	447	1086	1704	461	1462	472	chromosome X open reading frame 9 (CXorf9)
B21R03C11	21-11-3	Hs~MGC:BC014029.1~uORF:IOH14050	500	223	344	373	259	251	325	231	429	122	ubiquitin protein ligase E3C (UBE3C)
B21R03C12	21-12-3	Hs~MGC:BC014029.1~uORF:IOH14050	719	206	315	400	326	238	327	265	390	199	ubiquitin protein ligase E3C (UBE3C)
B21R03C13	21-13-3	Hs~Ref:NM_015610.1~uORF:IOH5656	625	3591	1479	1414	1176	607	1044	997	1196	270	WD repeat domain, phosphoinositide interacting 2 (WIPI2), transcript variant 1
B21R03C14	21-14-3	Hs~Ref:NM_015610.1~uORF:IOH5656	625	3634	1434	1565	818	611	1015	842	1168	233	WD repeat domain, phosphoinositide interacting 2 (WIPI2), transcript variant 1
B21R03C15	21-15-3	Hs~Ref:NM_016058.1~uORF:IOH10494	631	403	491	301	2214	312	524	199	944	184	TP53RK binding protein (TPRKB)
B21R03C16	21-16-3	Hs~Ref:NM_016058.1~uORF:IOH10494	601	356	497	308	2322	259	613	410	942	84	TP53RK binding protein (TPRKB)
B21R03C17	21-17-3	Hs~Ref:NM_024061.1~uORF:IOH5510	713	493	1111	487	716	629	1000	827	1262	342	zinc finger protein 655 (ZNF655), transcript variant 2
B21R03C18	21-18-3	Hs~Ref:NM_024061.1~uORF:IOH5510	903	487	1044	528	618	798	1019	617	1215	330	zinc finger protein 655 (ZNF655), transcript variant 2
B21R03C19	21-19-3	Hs~MGC:BC011928.2~uORF:IOH14723	525	355	723	538	487	631	712	489	1119	257	JmjC domain-containing protein 4
B21R03C20	21-20-3	Hs~MGC:BC011928.2~uORF:IOH14723	443	347	730	541	501	588	732	492	320	242	JmjC domain-containing protein 4
B21R03C21	21-21-3	Hs~Ref:NM_138785.1~uORF:IOH12456	465	323	611	359	419	398	668	416	699	229	chromosome 6 open reading frame 72 (C6orf72)
B21R03C22	21-22-3	Hs~Ref:NM_138785.1~uORF:IOH12456	452	321	575	370	468	392	673	381	682	239	chromosome 6 open reading frame 72 (C6orf72)
B21R04C01	21-1-4	Hs~MGC:BC030702.1~uORF:IOH22356	1772	1662	2657	2056	1562	1238	6870	964	2929	661	microcephaly, primary autosomal recessive 1 (MCPH1)
B21R04C02	21-2-4	Hs~MGC:BC030702.1~uORF:IOH22356	2101	2152	2699	2205	1467	1365	6831	997	2678	574	microcephaly, primary autosomal recessive 1 (MCPH1)
B21R04C03	21-3-4	Hs~MGC:BC022988.1~uORF:IOH22366	1902	1245	2059	919	1382	3996	9513	2600	2812	799	chromosome 6 open reading frame 65 (C6orf65)
B21R04C04	21-4-4	Hs~MGC:BC022988.1~uORF:IOH22366	1889	983	1978	1001	1370	4034	9820	2661	3038	832	chromosome 6 open reading frame 65 (C6orf65)
B21R04C05	21-5-4	Hs~MGC:BC022957.1~uORF:IOH22373	1377	654	956	642	935	681	1189	1512	1924	371	chromosome 9 open reading frame 102 (C9orf102)
B21R04C06	21-6-4	Hs~MGC:BC022957.1~uORF:IOH22373	1274	686	1069	685	974	655	1077	1198	1946	368	chromosome 9 open reading frame 102 (C9orf102)
B21R04C07	21-7-4	Hs~Ref:NM_144697.1~uORF:IOH11412	1023	529	1123	490	242	1530	1148	504	893	454	chromosome 1 open reading frame 51 (C1orf51)
B21R04C08	21-8-4	Hs~Ref:NM_144697.1~uORF:IOH11412	1031	567	1016	2767	340	1650	1144	514	900	475	chromosome 1 open reading frame 51 (C1orf51)
B21R04C09	21-9-4	Hs~MGC:BC005373.1~uORF:IOH7181	11037	853	948	611	630	541	833	443	980	432	mitochondrial ribosomal protein S18B (MRPS18B)
B21R04C10	21-10-4	Hs~MGC:BC005373.1~uORF:IOH7181	10985	889	993	578	565	586	767	432	904	446	mitochondrial ribosomal protein S18B (MRPS18B)
B21R04C11	21-11-4	Hs~Ref:NM_032930.1~uORF:IOH6595	614	250	695	363	402	399	678	393	575	161	chromosome 11 open reading frame 70 (C11orf70)
B21R04C12	21-12-4	Hs~Ref:NM_032930.1~uORF:IOH6595	680	259	808	408	433	427	693	573	782	182	chromosome 11 open reading frame 70 (C11orf70)
B21R04C13	21-13-4	Hs~Ref:NM_020661.1~uORF:IOH6382	2131	1255	1687	1520	1230	1207	4789	1288	2080	741	activation-induced cytidine deaminase (AICDA)
B21R04C14	21-14-4	Hs~Ref:NM_020661.1~uORF:IOH6382	2190	1208	1682	1793	1153	1168	4499	1183	2089	695	activation-induced cytidine deaminase (AICDA)
B21R04C15	21-15-4	Hs~MGC:BC017789.1~uORF:IOH13662	1962	1078	2365	1154	1397	1272	2347	2342	1995	418	cysteine and histidine-rich domain (CHORD)-containing 1 (CHORDC1)
B21R04C16	21-16-4	Hs~MGC:BC017789.1~uORF:IOH13662	1979	1069	2501	1240	1390	1373	2382	1455	1901	423	cysteine and histidine-rich domain (CHORD)-containing 1 (CHORDC1)
B21R04C17	21-17-4	Hs~MGC:BC064700.1~uORF:IOH39815	1164	661	3433	854	1020	2012	1828	1332	1193	603	estrogen-related receptor gamma (ESRRG)
B21R04C18	21-18-4	Hs~MGC:BC064700.1~uORF:IOH39815	1220	674	3570	816	1359	2148	1773	1308	1172	585	estrogen-related receptor gamma (ESRRG)
B21R04C19	21-19-4	Hs~Ref:NM_199133.1~uORF:IOH39868	581	404	635	380	367	481	682	502	738	223	hypothetical protein LOC134145 (LOC134145)
B21R04C20	21-20-4	Hs~Ref:NM_199133.1~uORF:IOH39868	412	347	621	381	374	397	668	508	849	194	hypothetical protein LOC134145 (LOC134145)
B21R04C21	21-21-4	Hs~Ref:NM_032517.3~uORF:IOH10985	409	303	608	273	337	424	673	480	1150	170	lysozyme-like 1 (LYZL1)
B21R04C22	21-22-4	Hs~Ref:NM_032517.3~uORF:IOH10985	428	307	631	298	299	409	600	445	574	173	lysozyme-like 1 (LYZL1)
B21R05C01	21-1-5	Hs~MGC:BC010907.1~uORF:IOH12088	2259	2106	3134	1359	2224	3163	8523	2810	4243	1016	PAK1 interacting protein 1 (PAK1IP1)
B21R05C02	21-2-5	Hs~MGC:BC010907.1~uORF:IOH12088	2211	2049	3439	1438	2254	3155	8853	2962	4061	898	PAK1 interacting protein 1 (PAK1IP1)
B21R05C03	21-3-5	Hs~MGC:BC010935.1~uORF:IOH12932	1325	1181	2452	960	803	1832	1366	1099	1899	704	casein kappa (CSN3)
B21R05C04	21-4-5	Hs~MGC:BC010935.1~uORF:IOH12932	1338	1226	2495	944	836	1909	1466	1138	1918	727	casein kappa (CSN3)
B21R05C05	21-5-5	Hs~MGC:BC014539.1~uORF:IOH12145	1159	1181	4306	535	965	1316	2246	2018	5902	4382	secretogranin III (SCG3)
B21R05C06	21-6-5	Hs~MGC:BC014539.1~uORF:IOH12145	1181	1169	4087	606	1198	1410	2482	2251	6056	4152	secretogranin III (SCG3)
B21R05C07	21-7-5	Hs~Ref:NM_016940.1~uORF:IOH12821	2534	1773	3509	2121	2547	2508	10182	2665	3963	1038	RWD domain containing 2B (RWDD2B)
B21R05C08	21-8-5	Hs~Ref:NM_016940.1~uORF:IOH12821	2619	1788	3503	1822	2505	2555	10112	2570	4045	1008	RWD domain containing 2B (RWDD2B)
B21R05C09	21-9-5	Hs~MGC:NM_178543.3~uORF:IOH26296	604	221	525	1684	244	480	405	459	880	167	ectonucleotide pyrophosphatase/phosphodiesterase 7 (ENPP7)
B21R05C10	21-10-5	Hs~MGC:NM_178543.3~uORF:IOH26296	632	229	518	1224	286	460	402	417	861	93	ectonucleotide pyrophosphatase/phosphodiesterase 7 (ENPP7)
B21R05C11	21-11-5	Hs~MGC:BC050723.1~uORF:IOH27003	1580	766	1445	2469	2673	2784	1426	1914	4182	1042	zinc finger and BTB domain containing 44 (ZBTB44)
B21R05C12	21-12-5	Hs~MGC:BC050723.1~uORF:IOH27003	1667	690	1599	2516	2672	2790	1469	2068	4148	1005	zinc finger and BTB domain containing 44 (ZBTB44)
B21R05C13	21-13-5	Hs~Ref:NM_012472.1~uORF:IOH26570	9814	2635	2620	12871	14508	6226	2815	6135	15188	1774	leucine rich repeat containing 6 (LRRC6)
B21R05C14	21-14-5	Hs~Ref:NM_012472.1~uORF:IOH26570	10629	2603	2783	13547	12076	6093	2902	5527	15784	1841	leucine rich repeat containing 6 (LRRC6)
B21R05C15	21-15-5	Hs~MGC:BC040141.1~uORF:IOH26192	466	128	542	264	383	333	445	299	476	143	nuclear receptor subfamily 2, group C, member 1 (NR2C1)
B21R05C16	21-16-5	Hs~MGC:BC040141.1~uORF:IOH26192	409	288	460	200	238	362	451	382	437	187	nuclear receptor subfamily 2, group C, member 1 (NR2C1)
B21R05C17	21-17-5	Hs~Ref:NM_024754.2~uORF:IOH12500	1471	772	1941	934	1513	867	1667	853	1610	390	pentatricopeptide repeat domain 2 (PTCD2)
B21R05C18	21-18-5	Hs~Ref:NM_024754.2~uORF:IOH12500	1577	775	1936	935	1267	1022	1706	869	1554	448	pentatricopeptide repeat domain 2 (PTCD2)
B21R05C19	21-19-5	Hs~Ref:NM_030968.1~uORF:IOH13365	549	484	759	620	655	627	850	471	789	281	C1q and tumor necrosis factor related protein 1 (C1QTNF1), transcript variant 1
B21R05C20	21-20-5	Hs~Ref:NM_030968.1~uORF:IOH13365	568	442	789	652	604	552	820	484	1058	314	C1q and tumor necrosis factor related protein 1 (C1QTNF1), transcript variant 1
B21R05C21	21-21-5	Hs~Ref:NM_031446.2~uORF:IOH12400	781	512	748	462	575	751	1681	546	855	300	Uncharacterized protein C18orf21
B21R05C22	21-22-5	Hs~Ref:NM_031446.2~uORF:IOH12400	748	459	836	480	464	687	1523	512	978	298	Uncharacterized protein C18orf21
B21R06C01	21-1-6	Hs~Ref:NM_012163.1~uORF:IOH12859	544	400	732	455	445	518	584	381	1058	162	leucine rich repeat containing 29 (LRRC29), transcript variant 1
B21R06C02	21-2-6	Hs~Ref:NM_012163.1~uORF:IOH12859	1301	481	683	512	332	482	578	434	1030	153	leucine rich repeat containing 29 (LRRC29), transcript variant 1
B21R06C03	21-3-6	Hs~Ref:NM_182688.1~uORF:IOH45834	545	355	581	235	245	468	459	336	609	208	ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast) (UBE2G2), transcript variant 2
B21R06C04	21-4-6	Hs~Ref:NM_182688.1~uORF:IOH45834	435	361	566	234	230	427	461	319	608	156	ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast) (UBE2G2), transcript variant 2
B21R06C05	21-5-6	Hs~Ref:NM_145042.2~uORF:IOH45811	421	391	746	293	273	379	425	336	730	282	tubulin, alpha pseudogene (MGC16703) on chromosome 22
B21R06C06	21-6-6	Hs~Ref:NM_145042.2~uORF:IOH45811	461	391	786	292	298	339	480	371	659	229	tubulin, alpha pseudogene (MGC16703) on chromosome 22
B21R06C07	21-7-6	Hs~Ref:NM_005978.3~uORF:IOH45852	279	286	382	259	386	323	360	291	499	169	S100 calcium binding protein A2 (S100A2)
B21R06C08	21-8-6	Hs~Ref:NM_005978.3~uORF:IOH45852	292	307	393	402	373	333	383	291	552	154	S100 calcium binding protein A2 (S100A2)
B21R06C09	21-9-6	Hs~MGC:BC064940.1~uORF:IOH39946	1368	1654	1242	1600	924	1719	3274	1235	1911	427	Nuclear protein NP60
B21R06C10	21-10-6	Hs~MGC:BC064940.1~uORF:IOH39946	1347	1773	1213	1393	915	1529	3393	1167	1861	408	Nuclear protein NP60
B21R06C11	21-11-6	Hs~Ref:NM_213645.1~uORF:IOH45767	1537	907	1643	605	1318	1195	2381	1197	1059	327	tryptophanyl-tRNA synthetase (WARS), transcript variant 3
B21R06C12	21-12-6	Hs~Ref:NM_213645.1~uORF:IOH45767	1609	938	1728	620	1318	1250	2447	1238	1058	312	tryptophanyl-tRNA synthetase (WARS), transcript variant 3
B21R06C13	21-13-6	Hs~Ref:NM_033128.1~uORF:IOH45789	1460	1296	409	302	1094	1087	2042	701	496	178	scinderin (SCIN)
B21R06C14	21-14-6	Hs~Ref:NM_033128.1~uORF:IOH45789	1521	1355	415	343	813	1089	2104	649	347	78	scinderin (SCIN)
B21R06C15	21-15-6	Hs~Ref:NM_032955.1~uORF:IOH45766	271	144	585	521	492	286	286	277	838	149	allograft inflammatory factor 1 (AIF1), transcript variant 1
B21R06C16	21-16-6	Hs~Ref:NM_032955.1~uORF:IOH45766	271	137	561	444	531	308	296	320	840	92	allograft inflammatory factor 1 (AIF1), transcript variant 1
B21R06C17	21-17-6	Hs~Ref:NM_006306.2~uORF:IOH44953	1391	1573	4448	1145	945	1565	5493	3163	1196	834	structural maintenance of chromosomes 1A (SMC1A)
B21R06C18	21-18-6	Hs~Ref:NM_006306.2~uORF:IOH44953	1329	1591	4132	1195	1124	1601	5407	3139	1176	789	structural maintenance of chromosomes 1A (SMC1A)
B21R06C19	21-19-6	Hs~Ref:NM_006340.1~uORF:IOH52178	4140	3200	1608	3200	4761	2408	2530	802	9702	1059	Brain-specific angiogenesis inhibitor 1-associated protein 2
B21R06C20	21-20-6	Hs~Ref:NM_006340.1~uORF:IOH52178	4341	3490	1648	3261	4761	2206	2505	829	10192	1072	Brain-specific angiogenesis inhibitor 1-associated protein 2
B21R06C21	21-21-6	Hs~Ref:NM_006736.4~uORF:IOH57131	422	280	402	271	378	340	335	274	718	175	DnaJ homolog subfamily B member 2
B21R06C22	21-22-6	Hs~Ref:NM_006736.4~uORF:IOH57131	363	277	371	252	353	332	301	263	749	242	DnaJ homolog subfamily B member 2
B21R07C01	21-1-7	Hs~MGC:BC027591.1~uORF:IOH56061	303	687	444	389	404	368	413	392	1060	114	T-complex protein 1 subunit zeta-2
B21R07C02	21-2-7	Hs~MGC:BC027591.1~uORF:IOH56061	1671	676	328	396	309	380	448	406	992	99	T-complex protein 1 subunit zeta-2
B21R07C03	21-3-7	Hs~Ref:NM_032907.3~uORF:IOH56973	1058	180	468	244	100	344	364	636	632	75	Ubiquitin-like protein 7
B21R07C04	21-4-7	Hs~Ref:NM_032907.3~uORF:IOH56973	378	1321	415	239	88	352	400	610	588	44	Ubiquitin-like protein 7
B21R07C05	21-5-7	Hs~Ref:NM_003831.1~uORF:IOH20968	536	201	676	439	426	503	731	885	772	282	RIO kinase 3 (yeast) (RIOK3)
B21R07C06	21-6-7	Hs~Ref:NM_003831.1~uORF:IOH20968	555	447	658	462	386	483	730	823	819	289	RIO kinase 3 (yeast) (RIOK3)
B21R07C07	21-7-7	Hs~Ref:NM_001800.2~uORF:IOH5163	588	616	549	318	613	489	999	457	1473	356	cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) (CDKN2D), transcript variant 1
B21R07C08	21-8-7	Hs~Ref:NM_001800.2~uORF:IOH5163	583	672	522	340	611	481	977	455	1724	296	cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) (CDKN2D), transcript variant 1
B21R07C09	21-9-7	Hs~Ref:NM_006504.2~uORF:IOH20996	447	3069	944	478	496	448	573	941	1615	279	protein tyrosine phosphatase, receptor type, E (PTPRE), transcript variant 1
B21R07C10	21-10-7	Hs~Ref:NM_006504.2~uORF:IOH20996	415	180	602	352	407	473	621	914	1453	297	protein tyrosine phosphatase, receptor type, E (PTPRE), transcript variant 1
B21R07C11	21-11-7	Hs~Ref:NM_004090.1~uORF:IOH5237	553	613	611	622	690	792	953	667	4305	438	dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related) (DUSP3)
B21R07C12	21-12-7	Hs~Ref:NM_004090.1~uORF:IOH5237	607	555	633	596	792	801	931	681	4137	444	dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related) (DUSP3)
B21R07C13	21-13-7	Hs~Ref:NM_018273.2~uORF:IOH11850	615	452	616	339	716	477	739	397	708	264	transmembrane protein 143 (TMEM143)
B21R07C14	21-14-7	Hs~Ref:NM_018273.2~uORF:IOH11850	595	480	556	354	444	494	688	426	782	299	transmembrane protein 143 (TMEM143)
B21R07C15	21-15-7	Hs~Ref:NM_005299.1~uORF:IOH39404	487	409	615	1696	452	394	762	436	541	319	G protein-coupled receptor 31 (GPR31)
B21R07C16	21-16-7	Hs~Ref:NM_005299.1~uORF:IOH39404	500	402	628	389	391	485	765	467	597	285	G protein-coupled receptor 31 (GPR31)
B21R07C17	21-17-7	Hs~Ref:NM_001094.4~uORF:IOH39422	479	399	724	344	342	583	603	635	1752	330	amiloride-sensitive cation channel 1, neuronal (degenerin) (ACCN1), transcript variant 2
B21R07C18	21-18-7	Hs~Ref:NM_001094.4~uORF:IOH39422	461	396	744	367	352	693	599	482	1852	322	amiloride-sensitive cation channel 1, neuronal (degenerin) (ACCN1), transcript variant 2
B21R07C19	21-19-7	Hs~MGC:BC024746.1~uORF:IOH11988	808	729	967	714	2137	1516	888	2654	2107	362	DEP domain containing 6 (DEPDC6)
B21R07C20	21-20-7	Hs~MGC:BC024746.1~uORF:IOH11988	752	736	938	696	2029	1452	839	2682	2287	359	DEP domain containing 6 (DEPDC6)
B21R08C01	21-1-8	Hs~Ref:NM_001211.3~N/A	743	822	967	463	1153	608	1089	950	2112	282	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta
B21R08C02	21-2-8	Hs~Ref:NM_001211.3~N/A	686	798	1086	577	1103	597	1172	862	1898	299	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta
B21R08C03	21-3-8	Hs~Ref:NM_005990.1~N/A	702	733	1262	597	851	601	1082	1043	2700	317	Serine/threonine-protein kinase 10
B21R08C04	21-4-8	Hs~Ref:NM_005990.1~N/A	775	985	1262	595	827	586	1080	1076	2073	425	Serine/threonine-protein kinase 10
B21R08C05	21-5-8	Hs~Ref:NM_013233.1~N/A	739	965	1471	685	960	679	977	1706	2644	600	STE20/SPS1-related proline-alanine-rich protein kinase
B21R08C06	21-6-8	Hs~Ref:NM_013233.1~N/A	750	931	1577	656	966	639	1042	1757	2467	627	STE20/SPS1-related proline-alanine-rich protein kinase
B21R08C07	21-7-8	Hs~MGC:BC019300.1~uORF:IOH22880	605	603	965	461	492	747	1526	886	1152	370	Protein FAM127B
B21R08C08	21-8-8	Hs~MGC:BC019300.1~uORF:IOH22880	598	642	981	472	1191	706	1516	901	1208	340	Protein FAM127B
B21R08C09	21-9-8	Hs~Ref:NM_021019.2~uORF:IOH22891	463	3092	783	5630	755	911	851	566	767	104	myosin, light chain 6, alkali, smooth muscle and non-muscle (MYL6), transcript variant 1
B21R08C10	21-10-8	Hs~Ref:NM_021019.2~uORF:IOH22891	461	3002	662	396	471	857	854	573	733	256	myosin, light chain 6, alkali, smooth muscle and non-muscle (MYL6), transcript variant 1
B21R08C11	21-11-8	Hs~Ref:NM_032892.1~uORF:IOH22926	583	611	1330	532	585	1157	1489	801	1458	310	FERM domain containing 5 (FRMD5), transcript variant 2
B21R08C12	21-12-8	Hs~Ref:NM_032892.1~uORF:IOH22926	757	672	1401	526	1073	1301	1448	753	1427	313	FERM domain containing 5 (FRMD5), transcript variant 2
B21R08C13	21-13-8	Hs~MGC:NM_152362.1~uORF:IOH10838	870	761	1832	516	1780	7106	2700	2901	2027	343	tumor necrosis factor, alpha-induced protein 8-like 1 (TNFAIP8L1)
B21R08C14	21-14-8	Hs~MGC:NM_152362.1~uORF:IOH10838	791	773	1944	547	1180	6700	2741	2966	2002	352	tumor necrosis factor, alpha-induced protein 8-like 1 (TNFAIP8L1)
B21R08C15	21-15-8	Hs~Ref:NM_145012.3~uORF:IOH36789	2019	991	976	2017	1382	1340	2248	1535	7709	551	Cyclin-Y
B21R08C16	21-16-8	Hs~Ref:NM_145012.3~uORF:IOH36789	2139	1013	983	2145	1658	1209	2352	1567	7557	559	Cyclin-Y
B21R08C17	21-17-8	Hs~Ref:NM_001783.1~uORF:IOH44544	1386	956	2134	1077	1484	1449	1542	3630	2431	504	B-cell antigen receptor complex-associated protein alpha-chain
B21R08C18	21-18-8	Hs~Ref:NM_001783.1~uORF:IOH44544	1164	961	2232	1076	1485	1531	1560	3815	2449	491	B-cell antigen receptor complex-associated protein alpha-chain
B21R08C19	21-19-8	Hs~Ref:NM_005016.3~uORF:IOH44672	1238	717	1364	611	1587	917	3581	1446	1883	400	Poly(rC)-binding protein 2
B21R08C20	21-20-8	Hs~Ref:NM_005016.3~uORF:IOH44672	1275	747	1457	615	1371	821	3663	1378	1787	406	Poly(rC)-binding protein 2
B21R08C21	21-21-8	Hs~Ref:NM_198195.1~uORF:IOH44596	2044	640	1822	484	700	778	1160	612	1708	379	NEDD8-activating enzyme E1 catalytic subunit
B21R08C22	21-22-8	Hs~Ref:NM_198195.1~uORF:IOH44596	1649	536	1727	462	807	787	1154	585	1634	381	NEDD8-activating enzyme E1 catalytic subunit
B21R09C01	21-1-9	Hs~Ref:NM_016338.3~uORF:IOH21768	326	404	424	229	250	286	443	227	458	109	importin 11 (IPO11)
B21R09C02	21-2-9	Hs~Ref:NM_016338.3~uORF:IOH21768	394	357	840	242	279	283	502	250	282	64	importin 11 (IPO11)
B21R09C03	21-3-9	Hs~Ref:NM_017491.3~uORF:IOH3975	994	208	543	281	292	553	524	308	491	475	WD repeat domain 1 (WDR1), transcript variant 1
B21R09C04	21-4-9	Hs~Ref:NM_017491.3~uORF:IOH3975	439	168	560	280	259	507	542	307	703	455	WD repeat domain 1 (WDR1), transcript variant 1
B21R09C05	21-5-9	Hs~MGC:BC003610.2~uORF:IOH3899	513	513	784	403	281	447	632	426	630	284	milk fat globule-EGF factor 8 protein (MFGE8)
B21R09C06	21-6-9	Hs~MGC:BC003610.2~uORF:IOH3899	514	273	788	407	318	391	664	439	558	274	milk fat globule-EGF factor 8 protein (MFGE8)
B21R09C07	21-7-9	Hs~Ref:NM_023935.1~uORF:IOH4217	638	640	3064	631	787	852	2472	928	928	336	chromosome 20 open reading frame 116 (C20orf116)
B21R09C08	21-8-9	Hs~Ref:NM_023935.1~uORF:IOH4217	664	666	2997	614	2530	831	2462	948	933	345	chromosome 20 open reading frame 116 (C20orf116)
B21R09C09	21-9-9	Hs~Ref:NM_170676.2~uORF:IOH26710	3097	4353	9949	22798	5697	28129	6977	5198	6355	2468	Meis homeobox 2 (MEIS2), transcript variant d
B21R09C10	21-10-9	Hs~Ref:NM_170676.2~uORF:IOH26710	3165	4286	10119	23498	5698	28550	7151	5237	6567	2335	Meis homeobox 2 (MEIS2), transcript variant d
B21R09C11	21-11-9	Hs~MGC:BC014413.1~uORF:IOH13994	446	269	703	383	439	544	562	443	525	242	serine/threonine kinase 10 (STK10)
B21R09C12	21-12-9	Hs~MGC:BC014413.1~uORF:IOH13994	473	284	624	353	518	535	610	342	494	267	serine/threonine kinase 10 (STK10)
B21R09C13	21-13-9	Hs~Ref:NM_021073.2~uORF:IOH27302	615	502	554	392	702	479	752	426	536	303	bone morphogenetic protein 5 (BMP5)
B21R09C14	21-14-9	Hs~Ref:NM_021073.2~uORF:IOH27302	457	677	580	409	427	450	775	440	494	252	bone morphogenetic protein 5 (BMP5)
B21R09C15	21-15-9	Hs~MGC:BC056253.1~uORF:IOH29437	721	419	508	1078	431	378	901	445	802	280	iodotyrosine deiodinase (IYD)
B21R09C16	21-16-9	Hs~MGC:BC056253.1~uORF:IOH29437	673	489	509	172	380	397	858	444	885	259	iodotyrosine deiodinase (IYD)
B21R09C17	21-17-9	Hs~Ref:NM_032496.1~uORF:IOH6543	1055	865	778	558	500	826	925	516	1008	1915	Rho GTPase activating protein 9 (ARHGAP9), transcript variant 1
B21R09C18	21-18-9	Hs~Ref:NM_032496.1~uORF:IOH6543	955	800	802	590	431	838	948	487	949	1991	Rho GTPase activating protein 9 (ARHGAP9), transcript variant 1
B21R09C19	21-19-9	Hs~MGC:BC004564.2~uORF:IOH46115	733	2853	623	509	489	630	654	762	768	294	docking protein 3 (DOK3)
B21R09C20	21-20-9	Hs~MGC:BC004564.2~uORF:IOH46115	897	2685	655	518	424	535	672	820	739	278	docking protein 3 (DOK3)
B21R09C21	21-21-9	Hs~MGC:BC005840.2~uORF:IOH46093	2192	952	2194	1530	914	1186	4393	806	1789	501	selenoprotein S (SELS)
B21R09C22	21-22-9	Hs~MGC:BC005840.2~uORF:IOH46093	2106	895	2153	1526	955	1205	4245	754	2124	532	selenoprotein S (SELS)
B21R10C01	21-1-10	Hs~Ref:NM_020170.3~uORF:IOH46155	278	150	368	389	125	330	397	302	281	7	nicalin homolog (zebrafish) (NCLN)
B21R10C02	21-2-10	Hs~Ref:NM_020170.3~uORF:IOH46155	162	132	487	501	136	360	428	345	284	32	nicalin homolog (zebrafish) (NCLN)
B21R10C03	21-3-10	Hs~MGC:BC065370.1~uORF:IOH40687	1560	269	1607	3230	408	840	720	445	2381	288	chromosome 20 open reading frame 112 (C20orf112)
B21R10C04	21-4-10	Hs~MGC:BC065370.1~uORF:IOH40687	1538	585	1475	3386	404	854	712	414	2263	263	chromosome 20 open reading frame 112 (C20orf112)
B21R10C05	21-5-10	Hs~MGC:BC065738.1~uORF:IOH40732	485	723	278	157	272	290	423	331	570	72	zinc finger protein 483 (ZNF483)
B21R10C06	21-6-10	Hs~MGC:BC065738.1~uORF:IOH40732	506	702	316	177	330	275	418	298	587	109	zinc finger protein 483 (ZNF483)
B21R10C07	21-7-10	Hs~Ref:NM_052935.2~uORF:IOH40639	402	418	856	460	523	525	1055	572	890	305	5'-nucleotidase, cytosolic III-like (NT5C3L)
B21R10C08	21-8-10	Hs~Ref:NM_052935.2~uORF:IOH40639	421	407	839	474	714	502	1073	621	874	304	5'-nucleotidase, cytosolic III-like (NT5C3L)
B21R10C09	21-9-10	Hs~Ref:NM_080574.2~uORF:IOH40713	467	464	671	726	326	465	1192	355	814	636	chromosome 20 open reading frame 70 (C20orf70)
B21R10C10	21-10-10	Hs~Ref:NM_080574.2~uORF:IOH40713	486	570	782	684	423	434	1239	378	826	570	chromosome 20 open reading frame 70 (C20orf70)
B21R11C21	21-21-11	Hs~MGC:BC020803.1~uORF:IOH14817	3607	1654	2351	2415	1636	4009	3694	3292	2663	1080	developmentally regulated GTP binding protein 1 (DRG1)
B21R11C22	21-22-11	Hs~MGC:BC020803.1~uORF:IOH14817	3693	2067	2147	2374	1545	4306	3499	3094	2487	1102	developmentally regulated GTP binding protein 1 (DRG1)
B21R12C01	21-1-12	Hs~Ref:NM_016946.3~uORF:IOH12781	105	165	319	288	98	336	315	188	172	32	F11 receptor (F11R), transcript variant 1
B21R12C02	21-2-12	Hs~Ref:NM_016946.3~uORF:IOH12781	179	171	369	471	130	326	439	198	292	90	F11 receptor (F11R), transcript variant 1
B21R12C03	21-3-12	Hs~MGC:BC056673.1~uORF:IOH29479	542	1151	2187	735	770	1474	2954	1166	1716	395	protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9 (PPP1R2P9)
B21R12C04	21-4-12	Hs~MGC:BC056673.1~uORF:IOH29479	578	1171	2534	825	1631	1452	3023	1195	1587	398	protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9 (PPP1R2P9)
B21R12C05	21-5-12	Hs~MGC:BC002921.2~uORF:IOH6311	7650	14162	5438	12756	19143	10443	12991	16074	28122	6590	p21(CDKN1A)-activated kinase 4 (PAK4)
B21R12C06	21-6-12	Hs~MGC:BC002921.2~uORF:IOH6311	8025	12912	5363	12912	21344	10181	13179	14126	27646	6586	p21(CDKN1A)-activated kinase 4 (PAK4)
B21R12C07	21-7-12	Hs~MGC:BC000091.1~uORF:IOH4587	722	736	754	393	480	596	864	524	1731	319	ATG7 autophagy related 7 homolog (S. cerevisiae) (ATG7)
B21R12C08	21-8-12	Hs~MGC:BC000091.1~uORF:IOH4587	804	767	778	436	611	566	866	509	1736	276	ATG7 autophagy related 7 homolog (S. cerevisiae) (ATG7)
B21R12C09	21-9-12	Hs~MGC:BC013171.1~uORF:IOH22121	1005	879	1365	1248	690	1595	1703	1285	2587	518	cDNA clone IMAGE:4344401, **** WARNING: chimeric clone ****
B21R12C10	21-10-12	Hs~MGC:BC013171.1~uORF:IOH22121	978	908	1386	1190	752	1711	1624	1332	2578	509	cDNA clone IMAGE:4344401, **** WARNING: chimeric clone ****
B21R12C11	21-11-12	Hs~MGC:BC027465.1~uORF:IOH22829	1213	3073	1948	2010	1571	2339	1842	2358	3065	872	cDNA clone IMAGE:4155919, complete cds
B21R12C12	21-12-12	Hs~MGC:BC027465.1~uORF:IOH22829	1294	2937	1672	1232	1972	2400	1904	2468	3015	839	cDNA clone IMAGE:4155919, complete cds
B21R12C13	21-13-12	Hs~Ref:NM_020185.2~uORF:IOH21099	1052	3324	690	462	2174	1016	1034	562	1939	317	dual specificity phosphatase 22 (DUSP22)
B21R12C14	21-14-12	Hs~Ref:NM_020185.2~uORF:IOH21099	543	3350	683	483	1502	978	1051	536	1919	324	dual specificity phosphatase 22 (DUSP22)
B21R12C15	21-15-12	Hs~Ref:NM_014240.1~uORF:IOH41830	6070	1787	2958	1430	2516	1509	2462	1080	13939	511	LIM domains containing 1 (LIMD1)
B21R12C16	21-16-12	Hs~Ref:NM_014240.1~uORF:IOH41830	4724	1799	2989	1514	2512	1487	2417	1087	13981	505	LIM domains containing 1 (LIMD1)
B21R12C17	21-17-12	Hs~Ref:NM_001571.2~uORF:IOH45678	1317	1230	2230	1607	1437	24128	2435	1800	3931	895	interferon regulatory factor 3 (IRF3)
B21R12C18	21-18-12	Hs~Ref:NM_001571.2~uORF:IOH45678	1256	1273	2121	1651	1587	24292	2301	1547	4061	847	interferon regulatory factor 3 (IRF3)
B21R12C19	21-19-12	Hs~Ref:NM_001182.2~uORF:IOH45681	2538	5021	4879	2885	4729	5785	6392	3561	10156	1829	aldehyde dehydrogenase 7 family, member A1 (ALDH7A1)
B21R12C20	21-20-12	Hs~Ref:NM_001182.2~uORF:IOH45681	2534	5139	5543	2803	4962	5381	5837	3202	10728	1882	aldehyde dehydrogenase 7 family, member A1 (ALDH7A1)
B21R12C21	21-21-12	Hs~Ref:NM_024948.2~uORF:IOH45694	1041	773	1360	829	679	1157	2195	921	2275	519	chromosome 10 open reading frame 97 (C10orf97)
B21R12C22	21-22-12	Hs~Ref:NM_024948.2~uORF:IOH45694	1039	1049	1295	860	676	1146	2285	976	2198	521	chromosome 10 open reading frame 97 (C10orf97)
B21R13C03	21-3-13	Hs~Ref:NM_000800.2~uORF:IOH21917	618	1243	1080	435	889	524	647	579	1535	383	fibroblast growth factor 1 (acidic) (FGF1), transcript variant 1
B21R13C04	21-4-13	Hs~Ref:NM_000800.2~uORF:IOH21917	1780	1420	789	453	749	536	625	663	1721	371	fibroblast growth factor 1 (acidic) (FGF1), transcript variant 1
B21R13C05	21-5-13	Hs~MGC:NM_007189.1~uORF:IOH3871	190	111	1035	253	105	414	326	627	2018	201	ATP-binding cassette, sub-family F (GCN20), member 2 (ABCF2), nuclear gene encoding mitochondrial protein, transcript variant 1
B21R13C06	21-6-13	Hs~MGC:NM_007189.1~uORF:IOH3871	250	117	1061	201	116	394	372	628	1664	192	ATP-binding cassette, sub-family F (GCN20), member 2 (ABCF2), nuclear gene encoding mitochondrial protein, transcript variant 1
B21R13C07	21-7-13	Hs~Ref:NM_138432.1~uORF:IOH12304	365	955	336	100	64	185	203	168	295	35	serine dehydratase-like (SDSL)
B21R13C08	21-8-13	Hs~Ref:NM_138432.1~uORF:IOH12304	371	53	144	102	77	120	219	145	258	31	serine dehydratase-like (SDSL)
B21R13C11	21-11-13	Hs~Ref:NM_016215.3~uORF:IOH54905	419	613	560	472	369	287	410	367	1306	326	EGF-like domain-containing protein 7
B21R13C12	21-12-13	Hs~Ref:NM_016215.3~uORF:IOH54905	451	344	660	400	447	278	434	406	1342	306	EGF-like domain-containing protein 7
B21R13C15	21-15-13	Hs~Ref:NM_014716.2~uORF:IOH60017	662	670	681	701	680	471	536	1318	1275	395	ARFGAP with coiled-coil, ANK repeat and PH domain-containing protein 1
B21R13C16	21-16-13	Hs~Ref:NM_014716.2~uORF:IOH60017	488	639	614	738	459	436	568	1264	1360	368	ARFGAP with coiled-coil, ANK repeat and PH domain-containing protein 1
B21R13C17	21-17-13	Hs~Ref:NM_001125.2~uORF:IOH40024	435	448	671	378	348	605	974	457	755	255	ADP-ribosylarginine hydrolase (ADPRH)
B21R13C18	21-18-13	Hs~Ref:NM_001125.2~uORF:IOH40024	459	429	686	325	325	580	981	520	634	268	ADP-ribosylarginine hydrolase (ADPRH)
B21R13C19	21-19-13	Hs~MGC:BC064145.1~uORF:IOH40031	761	710	1060	666	998	1095	5911	935	1562	485	CDK5 regulatory subunit associated protein 1-like 1 (CDKAL1)
B21R13C20	21-20-13	Hs~MGC:BC064145.1~uORF:IOH40031	897	678	1128	673	807	1006	5583	910	1408	502	CDK5 regulatory subunit associated protein 1-like 1 (CDKAL1)
B21R13C21	21-21-13	Hs~MGC:BC067299.1~uORF:IOH40040	738	756	1073	666	621	1272	1314	861	1849	554	Mdm4, transformed 3T3 cell double minute 4, p53 binding protein (mouse) (MDM4)
B21R13C22	21-22-13	Hs~MGC:BC067299.1~uORF:IOH40040	1892	795	1118	698	622	1203	1291	866	2012	597	Mdm4, transformed 3T3 cell double minute 4, p53 binding protein (mouse) (MDM4)
B21R14C01	21-1-14	Hs~MGC:BC062471.1~uORF:IOH40049	2225	1384	2091	1477	1250	2646	3280	1212	3474	748	chromosome 15 open reading frame 26 (C15orf26)
B21R14C02	21-2-14	Hs~MGC:BC062471.1~uORF:IOH40049	2384	1368	2016	1279	1237	2765	3200	1209	3345	749	chromosome 15 open reading frame 26 (C15orf26)
B21R14C07	21-7-14	Hs~Ref:NM_005711.3~uORF:IOH54017	258	534	415	210	206	236	347	751	674	201	EGF-like repeat and discoidin I-like domain-containing protein 3
B21R14C08	21-8-14	Hs~Ref:NM_005711.3~uORF:IOH54017	280	119	380	238	311	276	379	637	688	196	EGF-like repeat and discoidin I-like domain-containing protein 3
B21R14C09	21-9-14	Hs~MGC:BC040376.1~uORF:IOH28629	735	399	1298	378	280	443	791	479	451	187	isoleucyl-tRNA synthetase 2, mitochondrial (IARS2)
B21R14C10	21-10-14	Hs~MGC:BC040376.1~uORF:IOH28629	682	232	1347	1166	249	474	818	472	448	151	isoleucyl-tRNA synthetase 2, mitochondrial (IARS2)
B21R14C11	21-11-14	Hs~Ref:NM_004869.2~uORF:IOH2268	294	31	467	622	730	1035	1222	369	550	261	vacuolar protein sorting 4 homolog B (S. cerevisiae) (VPS4B)
B21R14C12	21-12-14	Hs~Ref:NM_004869.2~uORF:IOH2268	311	180	582	420	943	997	1213	404	520	275	vacuolar protein sorting 4 homolog B (S. cerevisiae) (VPS4B)
B21R14C13	21-13-14	Hs~Ref:NM_005500.1~uORF:IOH3882	392	207	366	226	798	244	988	312	538	269	SUMO1 activating enzyme subunit 1 (SAE1)
B21R14C14	21-14-14	Hs~Ref:NM_005500.1~uORF:IOH3882	418	184	278	199	910	250	1008	316	575	182	SUMO1 activating enzyme subunit 1 (SAE1)
B21R14C15	21-15-14	Hs~Ref:NM_004804.1~uORF:IOH3935	659	302	714	667	-33	525	761	499	928	260	cytosolic iron-sulfur protein assembly 1 homolog (S. cerevisiae) (CIAO1)
B21R14C16	21-16-14	Hs~Ref:NM_004804.1~uORF:IOH3935	624	388	716	697	410	497	727	509	962	266	cytosolic iron-sulfur protein assembly 1 homolog (S. cerevisiae) (CIAO1)
B21R14C17	21-17-14	Hs~Ref:NM_000454.1~uORF:IOH4089	303	448	476	468	260	775	477	361	589	216	superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) (SOD1)
B21R14C18	21-18-14	Hs~Ref:NM_000454.1~uORF:IOH4089	267	349	452	325	303	865	491	359	597	220	superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) (SOD1)
B21R15C01	21-1-15	Hs~MGC:BC051731.1~uORF:IOH62375	648	266	482	317	116	290	523	1242	529	266	Mitogen-activated protein kinase 10
B21R15C02	21-2-15	Hs~MGC:BC051731.1~uORF:IOH62375	613	542	616	326	251	383	549	1196	470	200	Mitogen-activated protein kinase 10
B21R15C05	21-5-15	Hs~MGC:BC017357.1~uORF:IOH29348	394	221	731	315	253	445	626	444	680	261	zinc finger protein 765 (ZNF765)
B21R15C06	21-6-15	Hs~MGC:BC017357.1~uORF:IOH29348	1017	373	430	286	258	407	621	323	649	268	zinc finger protein 765 (ZNF765)
B21R15C07	21-7-15	Hs~MGC:BC055096.1~uORF:IOH29497	309	2066	471	210	82	268	466	347	388	206	zinc finger protein 695 (ZNF695)
B21R15C08	21-8-15	Hs~MGC:BC055096.1~uORF:IOH29497	253	60	529	236	215	266	420	391	424	52	zinc finger protein 695 (ZNF695)
B21R15C09	21-9-15	Hs~MGC:BC056508.1~uORF:IOH29456	786	631	8252	1163	488	1097	7707	935	1634	360	variable charge, Y-linked 1B (VCY)
B21R15C10	21-10-15	Hs~MGC:BC056508.1~uORF:IOH29456	804	720	8302	1192	563	1105	7939	885	1685	354	variable charge, Y-linked 1B (VCY)
B21R15C11	21-11-15	Hs~MGC:BC054021.1~uORF:IOH29457	354	174	444	441	188	302	472	272	475	87	pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 (PCBD2)
B21R15C12	21-12-15	Hs~MGC:BC054021.1~uORF:IOH29457	359	580	647	2207	223	302	425	365	466	82	pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 (PCBD2)
B21R15C17	21-17-15	Hs~Ref:NM_004441.3~CAT:PV3786	603	354	1515	619	344	1088	955	2062	1661	350	Ephrin receptor B1 (EPHB1)
B21R15C18	21-18-15	Hs~Ref:NM_004441.3~CAT:PV3786	602	340	1389	394	329	1156	942	1852	1639	335	Ephrin receptor B1 (EPHB1)
B21R15C19	21-19-15	Hs~Ref:NM_002738.5~CAT:P2251	2489	2178	5168	2164	490	1419	4216	738	931	512	protein kinase C, beta 1 (PRKCB1), transcript variant 2
B21R15C20	21-20-15	Hs~Ref:NM_002738.5~CAT:P2251	2170	2196	5415	2178	442	1287	4225	689	2343	491	protein kinase C, beta 1 (PRKCB1), transcript variant 2
B21R16C01	21-1-16	Hs~Ref:NM_005308.2~CAT:PV3824	1642	494	1111	1216	495	767	1505	1753	593	308	G protein-coupled receptor kinase 5 (GRK5)
B21R16C02	21-2-16	Hs~Ref:NM_005308.2~CAT:PV3824	1752	158	1192	1181	467	754	1579	1746	618	318	G protein-coupled receptor kinase 5 (GRK5)
B21R16C03	21-3-16	Hs~Ref:NM_000176.1~CAT:PV4690	3245	535	1531	399	350	504	1328	670	232	237	Glucocorticoid receptor
B21R16C04	21-4-16	Hs~Ref:NM_000176.1~CAT:PV4690	3176	500	1716	497	368	491	1328	774	931	240	Glucocorticoid receptor
B21R16C05	21-5-16	Hs~MGC:NM_199334.2~CAT:PV4762	526	193	333	247	208	444	552	927	622	248	thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) (THRA), transcript variant 1
B21R16C06	21-6-16	Hs~MGC:NM_199334.2~CAT:PV4762	500	211	361	248	236	450	557	811	625	260	thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) (THRA), transcript variant 1
B21R16C07	21-7-16	Hs~MGC:BC088364.1~uORF:IOH62598	619	768	1026	504	1706	1062	1104	844	1270	330	UV excision repair protein RAD23 homolog A
B21R16C08	21-8-16	Hs~MGC:BC088364.1~uORF:IOH62598	558	784	985	511	2063	984	1056	807	1309	309	UV excision repair protein RAD23 homolog A
B21R16C09	21-9-16	Hs~MGC:BC067823.1~uORF:IOH61674	1342	875	1068	1769	3827	1541	1457	1710	1424	841	Calcyclin-binding protein
B21R16C10	21-10-16	Hs~MGC:BC067823.1~uORF:IOH61674	1430	920	1119	1819	3944	1479	1422	1894	1487	877	Calcyclin-binding protein
B21R16C11	21-11-16	Hs~MGC:BC072419.1~uORF:IOH62555	33873	25276	24166	35385	36994	17656	13208	25011	27093	28136	Ig gamma-1 chain C region
B21R16C12	21-12-16	Hs~MGC:BC072419.1~uORF:IOH62555	32685	23852	23025	26681	41744	15254	14569	23872	26021	28320	Ig gamma-1 chain C region
B21R16C13	21-13-16	Hs~MGC:BC091500.1~uORF:IOH62588	1778	7055	2468	1304	2225	1415	3679	2352	2365	837	Outer dense fiber protein 2
B21R16C14	21-14-16	Hs~MGC:BC091500.1~uORF:IOH62588	1581	6640	1982	1255	2152	1463	3791	2521	2286	761	Outer dense fiber protein 2
B21R16C15	21-15-16	Hs~MGC:BC006155.1~uORF:IOH6598	712	609	617	320	290	538	874	711	708	311	adaptor-related protein complex 2, alpha 2 subunit (AP2A2)
B21R16C16	21-16-16	Hs~MGC:BC006155.1~uORF:IOH6598	497	382	555	340	373	546	971	684	737	317	adaptor-related protein complex 2, alpha 2 subunit (AP2A2)
B21R16C19	21-19-16	Hs~Ref:NM_002983.1~uORF:IOH29648	391	350	525	306	354	572	633	364	668	226	chemokine (C-C motif) ligand 3 (CCL3)
B21R16C20	21-20-16	Hs~Ref:NM_002983.1~uORF:IOH29648	423	357	576	321	369	529	617	350	878	232	chemokine (C-C motif) ligand 3 (CCL3)
B21R16C21	21-21-16	Hs~MGC:BC060852.1~uORF:IOH29264	1269	401	2168	1221	810	1086	801	757	2489	309	CCR4-NOT transcription complex, subunit 7 (CNOT7)
B21R16C22	21-22-16	Hs~MGC:BC060852.1~uORF:IOH29264	1203	384	2279	1183	762	1125	947	690	2649	312	CCR4-NOT transcription complex, subunit 7 (CNOT7)
B21R17C01	21-1-17	Hs~MGC:BC020691.1~uORF:IOH12187	877	808	1016	1045	1001	1337	1503	928	2847	527	pre-B-cell colony enhancing factor 1 (PBEF1)
B21R17C02	21-2-17	Hs~MGC:BC020691.1~uORF:IOH12187	768	858	1052	738	1059	1309	1578	882	1954	590	pre-B-cell colony enhancing factor 1 (PBEF1)
B21R17C03	21-3-17	Hs~MGC:BC022248.1~uORF:IOH12822	1896	1774	3016	944	1288	1484	4346	1183	3125	794	DnaJ (Hsp40) homolog, subfamily B, member 14 (DNAJB14)
B21R17C04	21-4-17	Hs~MGC:BC022248.1~uORF:IOH12822	1887	1604	2955	920	1286	1550	4500	1215	2924	771	DnaJ (Hsp40) homolog, subfamily B, member 14 (DNAJB14)
B21R17C05	21-5-17	Hs~Ref:NM_138326.1~uORF:IOH12970	806	759	1116	613	917	1338	1603	1321	2031	568	aminocarboxymuconate semialdehyde decarboxylase (ACMSD)
B21R17C06	21-6-17	Hs~Ref:NM_138326.1~uORF:IOH12970	847	706	1032	647	906	1258	1605	1255	1849	559	aminocarboxymuconate semialdehyde decarboxylase (ACMSD)
B21R17C07	21-7-17	Hs~MGC:BC009764.1~uORF:IOH12737	1234	1121	1208	707	1131	1628	1884	1042	2362	584	mitochondrial ribosomal protein L48 (MRPL48)
B21R17C08	21-8-17	Hs~MGC:BC009764.1~uORF:IOH12737	1149	1101	1286	622	1330	1655	1893	1062	2429	595	mitochondrial ribosomal protein L48 (MRPL48)
B21R17C09	21-9-17	Hs~Ref:NM_024585.2~uORF:IOH12995	454	386	1639	272	370	17856	247	355	661	82	armadillo repeat containing 7 (ARMC7)
B21R17C10	21-10-17	Hs~Ref:NM_024585.2~uORF:IOH12995	497	385	1677	272	365	17678	242	352	679	191	armadillo repeat containing 7 (ARMC7)
B21R17C11	21-11-17	Hs~Ref:NM_032413.1~uORF:IOH11314	638	1139	771	852	838	756	1718	559	1087	389	chromosome 15 open reading frame 48 (C15orf48), transcript variant 2
B21R17C12	21-12-17	Hs~Ref:NM_032413.1~uORF:IOH11314	638	1088	808	647	1183	740	1667	543	1106	386	chromosome 15 open reading frame 48 (C15orf48), transcript variant 2
B21R17C13	21-13-17	Hs~MGC:BC029375.1~uORF:IOH23125	1055	102	749	551	1637	4883	1000	667	1100	314	chromosome 11 open reading frame 30 (C11orf30)
B21R17C14	21-14-17	Hs~MGC:BC029375.1~uORF:IOH23125	1187	116	665	569	1083	5240	1024	731	1105	278	chromosome 11 open reading frame 30 (C11orf30)
B21R17C17	21-17-17	Hs~MGC:BC013158.1~uORF:IOH9772	334	395	369	273	259	409	487	349	515	280	amyloid beta (A4) precursor protein-binding, family B, member 3 (APBB3)
B21R17C18	21-18-17	Hs~MGC:BC013158.1~uORF:IOH9772	300	370	342	186	300	399	519	301	562	293	amyloid beta (A4) precursor protein-binding, family B, member 3 (APBB3)
B21R17C19	21-19-17	Hs~Ref:NM_018439.1~uORF:IOH23069	494	2325	1118	303	750	5901	938	1535	758	220	Impact homolog (mouse) (IMPACT)
B21R17C20	21-20-17	Hs~Ref:NM_018439.1~uORF:IOH23069	453	2386	1181	339	696	5437	904	1604	1007	257	Impact homolog (mouse) (IMPACT)
B21R17C21	21-21-17	Hs~Ref:NM_033003.1~uORF:IOH5665	1378	208	1571	558	213	18562	6126	242	594	305	general transcription factor II, i (GTF2I), transcript variant 4
B21R17C22	21-22-17	Hs~Ref:NM_033003.1~uORF:IOH5665	1436	211	1546	565	204	19429	6629	239	596	291	general transcription factor II, i (GTF2I), transcript variant 4
B21R18C01	21-1-18	Hs~Ref:NM_031361.1~uORF:IOH4674	579	1239	1081	847	445	880	2674	537	2033	345	collagen, type IV, alpha 3 (Goodpasture antigen) binding protein (COL4A3BP), transcript variant 2
B21R18C02	21-2-18	Hs~Ref:NM_031361.1~uORF:IOH4674	513	1217	1147	547	384	863	2633	561	2046	342	collagen, type IV, alpha 3 (Goodpasture antigen) binding protein (COL4A3BP), transcript variant 2
B21R18C03	21-3-18	Hs~MGC:BC001394.1~uORF:IOH3978	0	0	-4	-1	198	-1	-2	2	0	0	serpin peptidase inhibitor, clade B (ovalbumin), member 6 (SERPINB6)
B21R18C04	21-4-18	Hs~MGC:BC001394.1~uORF:IOH3978	-1	-1	-3	0	30	-2	2	2	-1	0	serpin peptidase inhibitor, clade B (ovalbumin), member 6 (SERPINB6)
B21R18C07	21-7-18	Hs~MGC:BC041366.2~uORF:IOH27747	2360	1308	2202	2672	1249	5902	4759	10791	3740	1318	ubiquitin specific peptidase 2 (USP2)
B21R18C08	21-8-18	Hs~MGC:BC041366.2~uORF:IOH27747	2006	1569	2016	2716	1605	5961	4981	10895	3748	1376	ubiquitin specific peptidase 2 (USP2)
B21R18C09	21-9-18	Hs~Ref:NM_004549.2~uORF:IOH5873	568	573	693	436	694	610	837	583	1375	382	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa (NDUFC2)
B21R18C10	21-10-18	Hs~Ref:NM_004549.2~uORF:IOH5873	610	605	686	481	655	645	876	760	1344	382	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa (NDUFC2)
B21R18C17	21-17-18	Hs~Ref:NM_005672.3~uORF:IOH57253	963	127	374	168	199	264	762	418	21	146	Prostate stem cell antigen
B21R18C18	21-18-18	Hs~Ref:NM_005672.3~uORF:IOH57253	250	141	362	259	234	281	744	363	418	94	Prostate stem cell antigen
B21R18C21	21-21-18	Hs~Ref:NM_000075.2~N/A	516	516	599	573	651	725	800	699	2227	318	cyclin D1 and cyclin-dependent kinase 4 (CDK4): cyclin D1 and CDK4 sequences are seperated by -- (in the protein list file).
B21R18C22	21-22-18	Hs~Ref:NM_000075.2~N/A	485	539	687	498	705	744	791	771	2127	317	cyclin D1 and cyclin-dependent kinase 4 (CDK4): cyclin D1 and CDK4 sequences are seperated by -- (in the protein list file).
B21R19C03	21-3-19	Hs~Ref:NM_000245.1~N/A	408	365	751	332	650	369	581	449	1074	252	Hepatocyte growth factor receptor
B21R19C04	21-4-19	Hs~Ref:NM_000245.1~N/A	368	570	786	315	615	391	632	472	998	231	Hepatocyte growth factor receptor
B21R19C05	21-5-19	Hs~Ref:NM_001004708.1~uORF:IOH28245	574	278	578	296	272	488	899	658	738	250	olfactory receptor, family 4, subfamily D, member 6 (OR4D6)
B21R19C06	21-6-19	Hs~Ref:NM_001004708.1~uORF:IOH28245	585	468	681	326	279	443	879	696	628	290	olfactory receptor, family 4, subfamily D, member 6 (OR4D6)
B21R19C07	21-7-19	Hs~MGC:BC041414.1~uORF:IOH25837	682	496	551	302	1288	602	1385	455	632	255	chromosome 10 open reading frame 72 (C10orf72)
B21R19C08	21-8-19	Hs~MGC:BC041414.1~uORF:IOH25837	631	443	582	312	1716	630	1436	439	698	256	chromosome 10 open reading frame 72 (C10orf72)
B21R19C09	21-9-19	Hs~MGC:BC050622.1~uORF:IOH27083	428	1655	516	296	208	458	830	404	434	213	receptor accessory protein 4 (REEP4)
B21R19C10	21-10-19	Hs~MGC:BC050622.1~uORF:IOH27083	413	207	603	307	241	453	840	406	438	165	receptor accessory protein 4 (REEP4)
B21R19C11	21-11-19	Hs~Ref:NM_080416.1~uORF:IOH10603	695	310	6601	1116	639	859	1503	616	3061	287	septin 4 (SEPT4), transcript variant 3
B21R19C12	21-12-19	Hs~Ref:NM_080416.1~uORF:IOH10603	704	613	6367	1066	933	838	1539	580	3128	268	septin 4 (SEPT4), transcript variant 3
B21R19C13	21-13-19	Hs~MGC:NM_183247.1~uORF:IOH44636	401	284	605	334	1281	469	799	462	817	392	transmembrane protease, serine 4 (TMPRSS4), transcript variant 2
B21R19C14	21-14-19	Hs~MGC:NM_183247.1~uORF:IOH44636	400	357	550	346	1202	506	789	465	815	271	transmembrane protease, serine 4 (TMPRSS4), transcript variant 2
B21R19C15	21-15-19	Hs~Ref:NM_144767.3~uORF:IOH44040	671	944	773	944	609	728	1685	704	1210	1721	A kinase (PRKA) anchor protein 13 (AKAP13), transcript variant 3
B21R19C16	21-16-19	Hs~Ref:NM_144767.3~uORF:IOH44040	679	873	779	864	831	719	1449	567	1218	1685	A kinase (PRKA) anchor protein 13 (AKAP13), transcript variant 3
B21R19C17	21-17-19	Hs~Ref:NM_006674.2~uORF:IOH42052	715	326	646	299	333	468	1381	373	745	293	HLA complex P5 (HCP5)
B21R19C18	21-18-19	Hs~Ref:NM_006674.2~uORF:IOH42052	514	359	617	472	389	605	1396	397	637	174	HLA complex P5 (HCP5)
B21R19C19	21-19-19	Hs~Ref:NM_198309.2~uORF:IOH42038	565	327	515	311	397	823	1436	375	812	315	tetratricopeptide repeat domain 8 (TTC8), transcript variant 2
B21R19C20	21-20-19	Hs~Ref:NM_198309.2~uORF:IOH42038	604	362	658	291	401	537	1458	345	767	290	tetratricopeptide repeat domain 8 (TTC8), transcript variant 2
B21R19C21	21-21-19	Hs~MGC:BC013069.1~uORF:IOH10251	757	577	1091	479	506	574	956	621	1902	526	cysteine conjugate-beta lyase; cytoplasmic (glutamine transaminase K, kyneurenine aminotransferase) (CCBL1)
B21R19C22	21-22-19	Hs~MGC:BC013069.1~uORF:IOH10251	767	640	1167	510	556	677	1030	649	1870	567	cysteine conjugate-beta lyase; cytoplasmic (glutamine transaminase K, kyneurenine aminotransferase) (CCBL1)
B21R20C01	21-1-20	Hs~Ref:NM_003358.1~uORF:IOH27248	640	603	799	580	482	588	849	533	1440	369	UDP-glucose ceramide glucosyltransferase (UGCG)
B21R20C02	21-2-20	Hs~Ref:NM_003358.1~uORF:IOH27248	655	635	859	596	486	572	782	492	1551	350	UDP-glucose ceramide glucosyltransferase (UGCG)
B21R20C03	21-3-20	Hs~Ref:NM_003692.1~uORF:IOH27690	840	591	940	481	435	844	1128	688	1626	381	transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1)
B21R20C04	21-4-20	Hs~Ref:NM_003692.1~uORF:IOH27690	877	568	930	543	437	831	1251	691	1586	398	transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1)
B21R20C05	21-5-20	Hs~Ref:NM_015488.1~uORF:IOH22386	811	682	874	578	661	905	1190	1044	2152	497	paroxysmal nonkinesigenic dyskinesia (PNKD), transcript variant 1
B21R20C06	21-6-20	Hs~Ref:NM_015488.1~uORF:IOH22386	858	772	1115	629	637	882	1233	1148	2114	494	paroxysmal nonkinesigenic dyskinesia (PNKD), transcript variant 1
B21R20C07	21-7-20	Hs~Ref:NM_030935.1~uORF:IOH3133	1526	742	1089	429	804	712	2901	570	1172	248	TSC22 domain family, member 4 (TSC22D4)
B21R20C08	21-8-20	Hs~Ref:NM_030935.1~uORF:IOH3133	1238	711	1014	431	1045	734	2966	570	1066	224	TSC22 domain family, member 4 (TSC22D4)
B21R20C09	21-9-20	Hs~MGC:NM_020801.1~uORF:IOH10036	870	899	1015	627	722	714	786	611	1165	334	arrestin domain containing 3 (ARRDC3)
B21R20C10	21-10-20	Hs~MGC:NM_020801.1~uORF:IOH10036	846	800	1057	587	698	737	885	669	1119	351	arrestin domain containing 3 (ARRDC3)
B21R20C11	21-11-20	Hs~Ref:NM_006791.1~uORF:IOH3901	4401	1905	1681	1704	1488	2420	6098	1992	2323	1036	mortality factor 4 like 1 (MORF4L1), transcript variant 1
B21R20C12	21-12-20	Hs~Ref:NM_006791.1~uORF:IOH3901	4593	1937	1694	1447	1777	2336	6219	1929	2369	974	mortality factor 4 like 1 (MORF4L1), transcript variant 1
B21R20C13	21-13-20	Hs~Ref:NM_018326.1~uORF:IOH14251	617	551	731	348	888	533	3187	545	2881	3392	GTPase, IMAP family member 4 (GIMAP4)
B21R20C14	21-14-20	Hs~Ref:NM_018326.1~uORF:IOH14251	606	553	703	351	717	515	3180	551	2831	3392	GTPase, IMAP family member 4 (GIMAP4)
B22R02C11	22-11-2	Hs~MGC:BC005944.1~uORF:IOH7504	1093	885	1208	824	962	831	1265	1293	2648	619	Eukaryotic translation initiation factor 3 subunit E
B22R02C12	22-12-2	Hs~MGC:BC005944.1~uORF:IOH7504	1054	912	1318	810	973	870	1231	2729	2617	642	Eukaryotic translation initiation factor 3 subunit E
B22R02C13	22-13-2	Hs~Ref:NM_018047.1~uORF:IOH3012	2509	3302	3142	1633	1636	5787	4270	9436	3474	894	Pre-mRNA-splicing factor RBM22
B22R02C14	22-14-2	Hs~Ref:NM_018047.1~uORF:IOH3012	2759	3045	3051	1672	1638	5555	4333	7280	3769	877	Pre-mRNA-splicing factor RBM22
B22R02C15	22-15-2	Hs~MGC:BC013116.1~uORF:IOH28618	4730	3029	3798	3064	6075	3224	10593	2784	7003	1807	CAP-Gly domain-containing linker protein 3
B22R02C16	22-16-2	Hs~MGC:BC013116.1~uORF:IOH28618	4786	2902	3730	3734	6139	3111	10546	2776	6998	1657	CAP-Gly domain-containing linker protein 3
B22R02C17	22-17-2	Hs~Ref:NM_012316.2~uORF:IOH10787	2759	1940	3472	3930	2250	1532	4528	2358	5477	1576	Importin subunit alpha-7
B22R02C18	22-18-2	Hs~Ref:NM_012316.2~uORF:IOH10787	2766	1972	3424	3806	2269	1501	4534	2324	5775	1556	Importin subunit alpha-7
B22R02C19	22-19-2	Hs~MGC:BC012341.1~uORF:IOH12496	628	399	1015	460	394	441	1472	816	1064	212	chromosome 3 open reading frame 1 (C3orf1)
B22R02C20	22-20-2	Hs~MGC:BC012341.1~uORF:IOH12496	646	456	962	435	427	439	1467	784	980	246	chromosome 3 open reading frame 1 (C3orf1)
B22R02C21	22-21-2	Hs~Ref:NM_014876.1~uORF:IOH10136	1720	973	1450	825	822	1112	2000	1207	3283	789	Josephin-1
B22R02C22	22-22-2	Hs~Ref:NM_014876.1~uORF:IOH10136	1665	999	1488	889	803	1172	2128	1362	3324	710	Josephin-1
B22R03C01	22-1-3	Hs~MGC:BC025383.2~uORF:IOH11203	1024	1007	1319	1116	975	1181	1527	1408	3554	720	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2
B22R03C02	22-2-3	Hs~MGC:BC025383.2~uORF:IOH11203	1183	943	1645	1127	971	1173	1554	1286	3262	734	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2
B22R03C03	22-3-3	Hs~Ref:NM_025193.2~uORF:IOH5538	1129	886	1945	870	1083	1575	1963	1199	3507	625	3 beta-hydroxysteroid dehydrogenase type 7
B22R03C04	22-4-3	Hs~Ref:NM_025193.2~uORF:IOH5538	1060	968	1625	933	929	1477	1803	1154	3328	752	3 beta-hydroxysteroid dehydrogenase type 7
B22R03C05	22-5-3	Hs~MGC:BC067521.1~uORF:IOH40152	366	522	831	280	292	360	519	393	733	239	grainyhead-like 1 (Drosophila) (GRHL1)
B22R03C06	22-6-3	Hs~MGC:BC067521.1~uORF:IOH40152	375	377	827	291	366	325	505	358	905	233	grainyhead-like 1 (Drosophila) (GRHL1)
B22R03C07	22-7-3	Hs~Ref:NM_018697.3~uORF:IOH37734	679	2293	1411	627	1384	1212	1189	1085	2800	429	LanC lantibiotic synthetase component C-like 2 (bacterial) (LANCL2)
B22R03C08	22-8-3	Hs~Ref:NM_018697.3~uORF:IOH37734	900	2374	1346	637	1527	1137	1062	1016	2977	464	LanC lantibiotic synthetase component C-like 2 (bacterial) (LANCL2)
B22R03C09	22-9-3	Hs~Ref:NM_000412.2~uORF:IOH40314	306	284	461	268	258	294	362	255	192	94	histidine-rich glycoprotein (HRG)
B22R03C10	22-10-3	Hs~Ref:NM_000412.2~uORF:IOH40314	323	375	425	277	234	296	415	260	885	98	histidine-rich glycoprotein (HRG)
B22R03C11	22-11-3	Hs~Ref:NM_198151.1~uORF:IOH37735	357	326	464	280	331	323	389	324	447	235	hypothetical protein LOC253012 (LOC253012), transcript variant 2
B22R03C12	22-12-3	Hs~Ref:NM_198151.1~uORF:IOH37735	390	343	523	260	296	880	429	329	218	282	hypothetical protein LOC253012 (LOC253012), transcript variant 2
B22R03C13	22-13-3	Hs~Ref:NM_130844.1~uORF:IOH41300	1152	1132	1940	942	479	1984	1682	1016	1368	354	WW domain containing oxidoreductase (WWOX), transcript variant 3
B22R03C14	22-14-3	Hs~Ref:NM_130844.1~uORF:IOH41300	1156	1232	1823	957	488	1747	1760	841	1432	533	WW domain containing oxidoreductase (WWOX), transcript variant 3
B22R03C15	22-15-3	Hs~Ref:NM_002624.2~uORF:IOH45929	335	1777	3180	402	752	23413	1210	584	1202	3746	prefoldin subunit 5 (PFDN5), transcript variant 1
B22R03C16	22-16-3	Hs~Ref:NM_002624.2~uORF:IOH45929	356	2000	2948	466	808	23085	1216	567	1278	3793	prefoldin subunit 5 (PFDN5), transcript variant 1
B22R03C17	22-17-3	Hs~Ref:NM_178850.1~uORF:IOH35720	473	608	641	406	1469	490	612	1199	933	282	hepatocyte nuclear factor 4, alpha (HNF4A), transcript variant 3
B22R03C18	22-18-3	Hs~Ref:NM_178850.1~uORF:IOH35720	502	599	669	422	1360	574	649	1500	923	313	hepatocyte nuclear factor 4, alpha (HNF4A), transcript variant 3
B22R03C19	22-19-3	Hs~Ref:NM_153752.1~uORF:IOH34931	3042	1212	984	580	607	627	448	793	1369	253	chromosome 21 open reading frame 84 (C21orf84)
B22R03C20	22-20-3	Hs~Ref:NM_153752.1~uORF:IOH34931	3199	1303	956	557	675	670	475	740	1491	287	chromosome 21 open reading frame 84 (C21orf84)
B22R03C21	22-21-3	Hs~Ref:NM_012419.3~uORF:IOH11052	691	504	1514	394	683	1398	1521	647	1270	202	regulator of G-protein signaling 17 (RGS17)
B22R03C22	22-22-3	Hs~Ref:NM_012419.3~uORF:IOH11052	675	533	1408	396	768	1448	1631	650	1361	132	regulator of G-protein signaling 17 (RGS17)
B22R04C01	22-1-4	Hs~MGC:BC015667.2~uORF:IOH14654	542	472	1863	565	476	1207	947	820	1706	380	kelch-like 29 (Drosophila) (KLHL29)
B22R04C02	22-2-4	Hs~MGC:BC015667.2~uORF:IOH14654	652	471	1983	578	612	1255	975	834	1862	357	kelch-like 29 (Drosophila) (KLHL29)
B22R04C03	22-3-4	Hs~Ref:NM_002963.2~uORF:IOH22174	466	370	1285	419	459	2192	1842	627	941	233	S100 calcium binding protein A7 (S100A7)
B22R04C04	22-4-4	Hs~Ref:NM_002963.2~uORF:IOH22174	482	412	1218	439	499	2188	1972	648	1021	228	S100 calcium binding protein A7 (S100A7)
B22R04C05	22-5-4	Hs~MGC:NM_182615.1~uORF:IOH21533	399	373	582	426	379	505	690	549	1523	254	hypothetical protein MGC40069 (MGC40069)
B22R04C06	22-6-4	Hs~MGC:NM_182615.1~uORF:IOH21533	397	371	609	444	344	544	715	535	1592	378	hypothetical protein MGC40069 (MGC40069)
B22R04C07	22-7-4	Hs~Ref:NM_016305.1~uORF:IOH12915	1375	1347	650	263	422	1345	1664	676	1556	147	synovial sarcoma translocation gene on chromosome 18-like 2 (SS18L2)
B22R04C08	22-8-4	Hs~Ref:NM_016305.1~uORF:IOH12915	1504	1395	664	264	517	1338	1124	663	1557	252	synovial sarcoma translocation gene on chromosome 18-like 2 (SS18L2)
B22R04C09	22-9-4	Hs~Ref:NM_002194.2~uORF:IOH10347	549	660	524	750	444	1119	26432	702	1839	110	inositol polyphosphate-1-phosphatase (INPP1)
B22R04C10	22-10-4	Hs~Ref:NM_002194.2~uORF:IOH10347	549	694	498	830	453	1126	30137	818	1760	119	inositol polyphosphate-1-phosphatase (INPP1)
B22R04C11	22-11-4	Hs~MGC:BC001964.1~uORF:IOH3201	632	459	765	425	552	514	1065	764	1789	532	acyl-Coenzyme A dehydrogenase family, member 8 (ACAD8)
B22R04C12	22-12-4	Hs~MGC:BC001964.1~uORF:IOH3201	654	492	830	418	429	565	1009	547	1577	422	acyl-Coenzyme A dehydrogenase family, member 8 (ACAD8)
B22R04C13	22-13-4	Hs~MGC:BC016614.1~uORF:IOH9750	562	438	756	395	415	480	724	472	1245	445	PCI domain containing 2 (PCID2)
B22R04C14	22-14-4	Hs~MGC:BC016614.1~uORF:IOH9750	562	483	814	383	501	420	812	493	1110	502	PCI domain containing 2 (PCID2)
B22R04C15	22-15-4	Hs~MGC:BC036123.1~uORF:IOH27289	2656	1183	3043	2587	3074	2137	7424	4909	3818	888	stromal membrane-associated protein 1 (SMAP1)
B22R04C16	22-16-4	Hs~MGC:BC036123.1~uORF:IOH27289	2803	1133	2860	3130	3241	2017	7074	4902	4094	856	stromal membrane-associated protein 1 (SMAP1)
B22R04C17	22-17-4	Hs~Ref:NM_014011.4~uORF:IOH37917	1063	710	1058	678	639	1000	1768	612	1207	432	suppressor of cytokine signaling 5 (SOCS5), transcript variant 1
B22R04C18	22-18-4	Hs~Ref:NM_014011.4~uORF:IOH37917	1114	727	975	682	583	833	1810	576	1263	410	suppressor of cytokine signaling 5 (SOCS5), transcript variant 1
B22R04C19	22-19-4	Hs~Ref:NM_052910.1~uORF:IOH38183	741	445	729	500	429	640	1072	530	866	283	SLIT and NTRK-like family, member 1 (SLITRK1)
B22R04C20	22-20-4	Hs~Ref:NM_052910.1~uORF:IOH38183	726	518	752	504	475	649	1036	527	915	342	SLIT and NTRK-like family, member 1 (SLITRK1)
B22R04C21	22-21-4	Hs~Ref:NM_174912.2~uORF:IOH37910	905	655	990	642	503	581	2582	544	1711	204	fatty acid amide hydrolase 2 (FAAH2)
B22R04C22	22-22-4	Hs~Ref:NM_174912.2~uORF:IOH37910	949	577	952	639	532	632	2546	544	1673	365	fatty acid amide hydrolase 2 (FAAH2)
B22R05C01	22-1-5	Hs~MGC:BC017786.1~uORF:IOH12194	882	622	965	652	752	606	995	1067	1475	393	zinc finger protein 226 (ZNF226)
B22R05C02	22-2-5	Hs~MGC:BC017786.1~uORF:IOH12194	945	601	1126	623	705	672	1079	1111	1448	435	zinc finger protein 226 (ZNF226)
B22R05C03	22-3-5	Hs~MGC:BC017780.1~uORF:IOH12140	967	350	933	605	543	537	569	605	1154	167	pleckstrin homology, Sec7 and coiled-coil domains 4 (PSCD4)
B22R05C04	22-4-5	Hs~MGC:BC017780.1~uORF:IOH12140	662	325	729	601	481	522	638	607	1119	267	pleckstrin homology, Sec7 and coiled-coil domains 4 (PSCD4)
B22R05C05	22-5-5	Hs~MGC:BC020630.1~uORF:IOH12113	729	619	2181	511	870	2588	2376	1299	1665	328	calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1)
B22R05C06	22-6-5	Hs~MGC:BC020630.1~uORF:IOH12113	739	687	2091	511	875	2647	2418	1300	1764	368	calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1)
B22R05C07	22-7-5	Hs~MGC:BC022405.1~uORF:IOH13019	615	499	816	581	532	569	946	643	1048	281	transmembrane protein 185A (TMEM185A)
B22R05C08	22-8-5	Hs~MGC:BC022405.1~uORF:IOH13019	670	509	814	480	525	543	929	621	1069	423	transmembrane protein 185A (TMEM185A)
B22R05C09	22-9-5	Hs~Ref:NM_004721.2~N/A	800	612	1283	525	533	680	1352	783	1461	266	Mitogen-activated protein kinase kinase kinase 13
B22R05C10	22-10-5	Hs~Ref:NM_004721.2~N/A	809	539	1363	727	530	695	1475	937	1506	393	Mitogen-activated protein kinase kinase kinase 13
B22R05C11	22-11-5	Hs~Ref:NM_006852.1~N/A	911	685	2988	753	924	1782	1792	765	7172	502	Serine/threonine-protein kinase tousled-like 2
B22R05C12	22-12-5	Hs~Ref:NM_006852.1~N/A	928	761	2938	721	916	1880	1655	831	6812	526	Serine/threonine-protein kinase tousled-like 2
B22R05C13	22-13-5	Hs~Ref:NM_006035.2~N/A	1161	653	1557	643	735	956	1550	861	1695	378	Serine/threonine-protein kinase MRCK beta
B22R05C14	22-14-5	Hs~Ref:NM_006035.2~N/A	1166	694	1635	617	663	928	1458	833	1757	362	Serine/threonine-protein kinase MRCK beta
B22R05C15	22-15-5	Hs~Ref:NM_003821.2~N/A	929	787	1391	617	835	1225	1450	692	1521	340	receptor-interacting serine-threonine kinase 2 (RIPK2)
B22R05C16	22-16-5	Hs~Ref:NM_003821.2~N/A	903	764	1410	739	858	1356	1426	671	1765	351	receptor-interacting serine-threonine kinase 2 (RIPK2)
B22R05C17	22-17-5	Hs~Ref:NM_207330.1~uORF:IOH40144	1216	1007	1571	872	988	1195	1979	913	1894	584	NIPA-like domain containing 1 (NPAL1)
B22R05C18	22-18-5	Hs~Ref:NM_207330.1~uORF:IOH40144	1300	1023	1529	854	995	1177	2054	889	1778	577	NIPA-like domain containing 1 (NPAL1)
B22R05C19	22-19-5	Hs~Ref:NM_002288.3~uORF:IOH40239	1114	514	877	380	734	817	784	470	1171	294	leukocyte-associated immunoglobulin-like receptor 2 (LAIR2), transcript variant 1
B22R05C20	22-20-5	Hs~Ref:NM_002288.3~uORF:IOH40239	1125	535	884	388	758	726	817	507	1219	287	leukocyte-associated immunoglobulin-like receptor 2 (LAIR2), transcript variant 1
B22R05C21	22-21-5	Hs~Ref:NM_004040.2~uORF:IOH40092	857	610	1008	575	694	609	1052	710	1288	127	ras homolog gene family, member B (RHOB)
B22R05C22	22-22-5	Hs~Ref:NM_004040.2~uORF:IOH40092	972	610	979	519	730	620	960	697	1301	255	ras homolog gene family, member B (RHOB)
B22R06C01	22-1-6	Hs~MGC:NM_152596.2~uORF:IOH40199	16860	1212	1815	1048	1283	1296	5534	1465	3684	1053	exonuclease 3'-5' domain-like 1 (EXDL1)
B22R06C02	22-2-6	Hs~MGC:NM_152596.2~uORF:IOH40199	16882	1245	1654	1064	1370	1275	6093	1494	3723	1091	exonuclease 3'-5' domain-like 1 (EXDL1)
B22R06C03	22-3-6	Hs~MGC:BC017344.1~uORF:IOH13180	1911	5060	2884	1680	1428	2508	3775	4569	3175	1175	isochorismatase domain containing 2 (ISOC2)
B22R06C04	22-4-6	Hs~MGC:BC017344.1~uORF:IOH13180	1981	5219	2814	1595	1293	2589	3846	4525	3270	1111	isochorismatase domain containing 2 (ISOC2)
B22R06C05	22-5-6	Hs~MGC:BC029424.1~uORF:IOH23140	1956	1879	3646	1719	1816	4396	4639	1901	4761	1327	Probable glutathione peroxidase 8
B22R06C06	22-6-6	Hs~MGC:BC029424.1~uORF:IOH23140	1948	2032	3559	1721	1722	4604	4941	1954	4489	1490	Probable glutathione peroxidase 8
B22R06C07	22-7-6	Hs~Ref:NM_019067.1~uORF:IOH13693	4595	2229	5290	2296	3542	2677	10429	2237	5326	1424	guanine nucleotide binding protein-like 3 (nucleolar)-like (GNL3L)
B22R06C08	22-8-6	Hs~Ref:NM_019067.1~uORF:IOH13693	4675	2232	5267	2277	3684	2464	9977	2199	5534	1610	guanine nucleotide binding protein-like 3 (nucleolar)-like (GNL3L)
B22R06C09	22-9-6	Hs~MGC:BC006104.1~uORF:IOH6588	2016	1480	1753	1938	2334	1644	2870	2589	2727	804	RIO kinase 1 (yeast) (RIOK1)
B22R06C10	22-10-6	Hs~MGC:BC006104.1~uORF:IOH6588	2076	1402	1843	2069	2170	1821	2963	2539	2629	764	RIO kinase 1 (yeast) (RIOK1)
B22R06C11	22-11-6	Hs~Ref:NM_003179.2~uORF:IOH54998	872	561	1042	467	523	1251	962	764	1211	403	Synaptophysin
B22R06C12	22-12-6	Hs~Ref:NM_003179.2~uORF:IOH54998	888	579	1089	459	500	1179	952	710	1250	352	Synaptophysin
B22R06C13	22-13-6	Hs~MGC:BC035582.1~uORF:IOH27620	1160	1261	1816	1246	3568	1076	1845	965	2119	704	Tripartite motif-containing protein 22
B22R06C14	22-14-6	Hs~MGC:BC035582.1~uORF:IOH27620	1249	1392	1727	1238	3796	1093	1857	1083	2064	685	Tripartite motif-containing protein 22
B22R06C15	22-15-6	Hs~Ref:NM_001009922.1~uORF:IOH54862	1047	903	1343	1194	866	2646	2529	1062	2214	396	RING finger and CHY zinc finger domain-containing protein 1
B22R06C16	22-16-6	Hs~Ref:NM_001009922.1~uORF:IOH54862	1076	1015	1253	1250	909	2726	2480	1139	2316	368	RING finger and CHY zinc finger domain-containing protein 1
B22R06C17	22-17-6	Hs~Ref:NM_138960.3~uORF:IOH59763	1593	8708	2391	4741	1829	1937	2049	6435	1892	521	Homeobox protein TGIF2LX
B22R06C18	22-18-6	Hs~Ref:NM_138960.3~uORF:IOH59763	1770	10454	2295	4772	2048	2023	1953	5794	2033	488	Homeobox protein TGIF2LX
B22R06C19	22-19-6	Hs~Ref:NM_024638.2~uORF:IOH22191	1769	1661	947	401	1000	602	1115	1101	1180	428	queuine tRNA-ribosyltransferase domain containing 1 (QTRTD1)
B22R06C20	22-20-6	Hs~Ref:NM_024638.2~uORF:IOH22191	1600	1756	938	391	1021	641	1158	1155	1208	409	queuine tRNA-ribosyltransferase domain containing 1 (QTRTD1)
B22R06C21	22-21-6	Hs~MGC:BC007767.2~uORF:IOH6486	1068	466	1060	824	937	1121	1227	877	1618	357	G patch domain containing 3 (GPATCH3)
B22R06C22	22-22-6	Hs~MGC:BC007767.2~uORF:IOH6486	1086	459	1047	832	1008	1134	1228	851	1701	226	G patch domain containing 3 (GPATCH3)
B22R07C01	22-1-7	Hs~Ref:NM_173487.1~uORF:IOH21933	675	608	965	491	601	772	1047	568	1705	362	chromosome 4 open reading frame 33 (C4orf33), transcript variant 1
B22R07C02	22-2-7	Hs~Ref:NM_173487.1~uORF:IOH21933	714	644	918	492	537	748	1156	555	1711	372	chromosome 4 open reading frame 33 (C4orf33), transcript variant 1
B22R07C03	22-3-7	Hs~Ref:NM_004001.3~uORF:IOH22175	768	546	939	712	1019	1089	2275	549	1395	430	Fc fragment of IgG, low affinity IIb, receptor (CD32) (FCGR2B), transcript variant 1
B22R07C04	22-4-7	Hs~Ref:NM_004001.3~uORF:IOH22175	789	570	927	718	906	1033	2324	569	1349	342	Fc fragment of IgG, low affinity IIb, receptor (CD32) (FCGR2B), transcript variant 1
B22R07C05	22-5-7	Hs~MGC:BC005932.1~uORF:IOH7557	965	1534	3092	706	1063	2357	6175	1913	2815	1033	Proteasome subunit alpha type-1
B22R07C06	22-6-7	Hs~MGC:BC005932.1~uORF:IOH7557	1013	1610	2979	664	1209	2246	6013	1971	2841	1040	Proteasome subunit alpha type-1
B22R07C07	22-7-7	Hs~Ref:NM_015922.1~uORF:IOH4468	664	552	615	858	493	457	1190	689	2997	794	Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating
B22R07C08	22-8-7	Hs~Ref:NM_015922.1~uORF:IOH4468	749	499	605	863	488	446	1253	706	2944	49	Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating
B22R07C09	22-9-7	Hs~MGC:BC000682.1~uORF:IOH4327	588	451	1663	1093	2745	648	775	824	3833	267	Protein DGCR6L
B22R07C10	22-10-7	Hs~MGC:BC000682.1~uORF:IOH4327	619	460	1582	1210	2653	764	784	802	3950	231	Protein DGCR6L
B22R07C11	22-11-7	Hs~Ref:NM_003893.2~uORF:IOH3707	17205	1021	1995	1541	3036	1684	2846	1576	2665	443	LIM domain-binding protein 1
B22R07C12	22-12-7	Hs~Ref:NM_003893.2~uORF:IOH3707	18301	1115	1977	1498	3290	1737	2778	1565	2678	461	LIM domain-binding protein 1
B22R07C13	22-13-7	Hs~Ref:NM_025106.2~uORF:IOH10100	1883	1207	3070	3496	1256	1941	4387	2103	8667	715	splA/ryanodine receptor domain and SOCS box containing 1 (SPSB1)
B22R07C14	22-14-7	Hs~Ref:NM_025106.2~uORF:IOH10100	1961	1213	2794	3573	1297	1883	4371	1854	8383	698	splA/ryanodine receptor domain and SOCS box containing 1 (SPSB1)
B22R07C15	22-15-7	Hs~MGC:BC015467.1~uORF:IOH10437	1027	817	1249	767	960	905	1572	973	2087	585	Palmitoyltransferase ZDHHC3
B22R07C16	22-16-7	Hs~MGC:BC015467.1~uORF:IOH10437	948	1076	1249	801	955	867	1515	869	2218	571	Palmitoyltransferase ZDHHC3
B22R07C17	22-17-7	Hs~Ref:NM_005727.2~uORF:IOH6907	662	468	944	450	492	543	875	540	1235	314	tetraspanin 1 (TSPAN1)
B22R07C18	22-18-7	Hs~Ref:NM_005727.2~uORF:IOH6907	721	556	943	475	441	507	935	603	1349	381	tetraspanin 1 (TSPAN1)
B22R07C19	22-19-7	Hs~MGC:BC012377.1~uORF:IOH10489	508	314	594	311	240	299	655	396	1235	495	EGF-like-domain, multiple 7 (EGFL7)
B22R07C20	22-20-7	Hs~MGC:BC012377.1~uORF:IOH10489	462	310	570	328	217	425	823	386	1294	381	EGF-like-domain, multiple 7 (EGFL7)
B22R07C21	22-21-7	Hs~MGC:BC035687.1~uORF:IOH26040	980	486	881	504	452	547	1589	716	988	225	flavin containing monooxygenase 5 (FMO5)
B22R07C22	22-22-7	Hs~MGC:BC035687.1~uORF:IOH26040	962	523	898	475	471	634	1596	684	1152	197	flavin containing monooxygenase 5 (FMO5)
B22R08C01	22-1-8	Hs~Ref:NM_025126.2~uORF:IOH6675	593	630	438	310	387	404	544	582	785	188	ring finger protein 34 (RNF34), transcript variant 2
B22R08C02	22-2-8	Hs~Ref:NM_025126.2~uORF:IOH6675	627	653	483	314	361	385	600	536	857	136	ring finger protein 34 (RNF34), transcript variant 2
B22R08C03	22-3-8	Hs~MGC:BC000879.1~uORF:IOH3208	1962	524	2206	648	925	1055	1372	873	1851	331	kynureninase (L-kynurenine hydrolase) (KYNU)
B22R08C04	22-4-8	Hs~MGC:BC000879.1~uORF:IOH3208	1897	513	2150	623	814	1058	1484	892	1907	257	kynureninase (L-kynurenine hydrolase) (KYNU)
B22R08C05	22-5-8	Hs~Ref:NM_000198.2~uORF:IOH27459	434	530	620	395	473	1163	2144	447	939	211	hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (HSD3B2)
B22R08C06	22-6-8	Hs~Ref:NM_000198.2~uORF:IOH27459	447	545	647	447	538	1076	2096	473	1205	180	hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (HSD3B2)
B22R08C07	22-7-8	Hs~Ref:NM_014790.3~uORF:IOH14698	1467	1857	1903	1572	6305	1537	2077	3213	3854	1738	janus kinase and microtubule interacting protein 2 (JAKMIP2)
B22R08C08	22-8-8	Hs~Ref:NM_014790.3~uORF:IOH14698	1547	1808	1890	1534	6502	1505	2192	3199	3475	1671	janus kinase and microtubule interacting protein 2 (JAKMIP2)
B22R08C09	22-9-8	Hs~MGC:BC017180.2~uORF:IOH12250	1701	811	1249	728	2996	1527	2169	945	2333	693	Staphylococcal nuclease domain-containing protein 1
B22R08C10	22-10-8	Hs~MGC:BC017180.2~uORF:IOH12250	1864	887	1248	820	3087	1574	2173	1031	2232	666	Staphylococcal nuclease domain-containing protein 1
B22R08C11	22-11-8	Hs~Ref:NM_012138.2~uORF:IOH4275	827	592	989	765	657	532	1439	581	1876	361	apoptosis antagonizing transcription factor (AATF)
B22R08C12	22-12-8	Hs~Ref:NM_012138.2~uORF:IOH4275	858	622	958	689	620	531	1359	541	1818	195	apoptosis antagonizing transcription factor (AATF)
B22R08C13	22-13-8	Hs~Ref:NM_003334.2~uORF:IOH22897	696	486	1753	453	761	1235	5117	432	1198	390	ubiquitin-activating enzyme E1 (UBE1), transcript variant 1
B22R08C14	22-14-8	Hs~Ref:NM_003334.2~uORF:IOH22897	756	506	1664	473	785	1127	5026	464	1452	299	ubiquitin-activating enzyme E1 (UBE1), transcript variant 1
B22R08C15	22-15-8	Hs~Ref:NM_181531.1~uORF:IOH44638	1074	1074	1480	834	767	1406	1892	1155	2541	686	Butyrophilin subfamily 2 member A2
B22R08C16	22-16-8	Hs~Ref:NM_181531.1~uORF:IOH44638	1161	1095	1462	820	767	1391	1895	1278	2447	645	Butyrophilin subfamily 2 member A2
B22R08C17	22-17-8	Hs~Ref:NM_144664.3~uORF:IOH45592	3330	2946	4346	3477	2721	4780	10750	3591	6435	2176	Protein FAM76B
B22R08C18	22-18-8	Hs~Ref:NM_144664.3~uORF:IOH45592	3336	2595	4158	3514	2732	4950	10747	3873	6495	2099	Protein FAM76B
B22R08C19	22-19-8	Hs~Ref:NM_014249.2~uORF:IOH34779	1409	1103	1521	842	897	1267	1862	1284	2401	699	Photoreceptor-specific nuclear receptor
B22R08C20	22-20-8	Hs~Ref:NM_014249.2~uORF:IOH34779	1474	1087	1527	889	847	1266	1842	1260	2513	691	Photoreceptor-specific nuclear receptor
B22R08C21	22-21-8	Hs~Ref:NM_152392.1~uORF:IOH42004	1151	908	1284	841	725	1250	1512	1162	2106	576	Activator of 90 kDa heat shock protein ATPase homolog 2
B22R08C22	22-22-8	Hs~Ref:NM_152392.1~uORF:IOH42004	1130	863	1161	824	730	1465	1353	900	2081	621	Activator of 90 kDa heat shock protein ATPase homolog 2
B22R09C01	22-1-9	Hs~Ref:NM_006949.1~uORF:IOH52408	3515	2201	891	1586	667	846	1998	408	1123	414	Syntaxin-binding protein 2
B22R09C02	22-2-9	Hs~Ref:NM_006949.1~uORF:IOH52408	3740	2443	869	1572	549	836	2052	485	1032	383	Syntaxin-binding protein 2
B22R09C03	22-3-9	Hs~Ref:NM_002628.3~uORF:IOH58968	4649	4262	8120	3643	8150	3711	3415	4112	12273	2417	profilin 2 (PFN2), transcript variant 2, mRNA.
B22R09C04	22-4-9	Hs~Ref:NM_002628.3~uORF:IOH58968	4400	4332	7999	3598	8506	3692	3612	4172	12061	2533	profilin 2 (PFN2), transcript variant 2, mRNA.
B22R09C07	22-7-9	Hs~Ref:NM_001003701.1~uORF:IOH58645	465	711	873	409	659	636	1351	442	1083	220	ATP synthase-coupling factor 6, mitochondrial
B22R09C08	22-8-9	Hs~Ref:NM_001003701.1~uORF:IOH58645	468	754	863	423	588	638	1189	414	1083	163	ATP synthase-coupling factor 6, mitochondrial
B22R09C09	22-9-9	Hs~Ref:NM_005277.3~uORF:IOH55974	329	403	388	343	665	291	340	261	717	145	Neuronal membrane glycoprotein M6-a
B22R09C10	22-10-9	Hs~Ref:NM_005277.3~uORF:IOH55974	278	476	417	421	676	264	361	245	418	419	Neuronal membrane glycoprotein M6-a
B22R09C11	22-11-9	Hs~Ref:NM_001003683.1~uORF:IOH52231	716	683	11478	3163	570	1253	1277	552	1716	942	phosphodiesterase 1A, calmodulin-dependent (PDE1A), transcript variant 2, mRNA.
B22R09C12	22-12-9	Hs~Ref:NM_001003683.1~uORF:IOH52231	1064	657	12366	3159	565	1439	1294	593	1679	995	phosphodiesterase 1A, calmodulin-dependent (PDE1A), transcript variant 2, mRNA.
B22R09C13	22-13-9	Hs~Ref:NM_005431.1~uORF:IOH57264	1107	348	871	385	342	576	882	654	1023	165	DNA repair protein XRCC2
B22R09C14	22-14-9	Hs~Ref:NM_005431.1~uORF:IOH57264	922	377	852	376	328	567	889	529	1099	158	DNA repair protein XRCC2
B22R09C15	22-15-9	Hs~Ref:NM_015599.1~uORF:IOH55441	587	953	784	566	479	1064	775	606	1421	441	Phosphoacetylglucosamine mutase
B22R09C16	22-16-9	Hs~Ref:NM_015599.1~uORF:IOH55441	609	1094	765	588	489	1044	741	574	1444	466	Phosphoacetylglucosamine mutase
B22R09C17	22-17-9	Hs~MGC:BC009009.1~uORF:IOH3263	1253	636	556	480	326	353	559	412	684	236	phospholipase C, beta 2 (PLCB2)
B22R09C18	22-18-9	Hs~MGC:BC009009.1~uORF:IOH3263	1296	341	577	467	282	431	535	417	668	256	phospholipase C, beta 2 (PLCB2)
B22R09C19	22-19-9	Hs~MGC:BC009025.1~uORF:IOH3311	463	361	588	366	266	399	641	332	612	285	chromosome 17 open reading frame 42 (C17orf42)
B22R09C20	22-20-9	Hs~MGC:BC009025.1~uORF:IOH3311	432	368	617	362	294	412	572	427	547	194	chromosome 17 open reading frame 42 (C17orf42)
B22R09C21	22-21-9	Hs~Ref:NM_015449.1~uORF:IOH3953	909	386	656	342	338	423	595	478	637	126	chromosome 1 open reading frame 43 (C1orf43), transcript variant 1
B22R09C22	22-22-9	Hs~Ref:NM_015449.1~uORF:IOH3953	905	416	663	365	325	472	643	477	720	186	chromosome 1 open reading frame 43 (C1orf43), transcript variant 1
B22R10C01	22-1-10	Hs~Ref:NM_001757.1~uORF:IOH3944	357	301	599	347	264	466	453	410	1078	364	carbonyl reductase 1 (CBR1)
B22R10C02	22-2-10	Hs~Ref:NM_001757.1~uORF:IOH3944	441	329	634	336	316	428	473	406	177	375	carbonyl reductase 1 (CBR1)
B22R10C03	22-3-10	Hs~Ref:NM_022157.2~uORF:IOH11175	1170	713	1311	660	858	700	1039	1245	2132	980	Ras-related GTP binding C (RRAGC)
B22R10C04	22-4-10	Hs~Ref:NM_022157.2~uORF:IOH11175	1186	697	1526	640	790	699	1122	1268	2054	928	Ras-related GTP binding C (RRAGC)
B22R10C05	22-5-10	Hs~MGC:BC032400.1~uORF:IOH21693	823	726	1243	633	1033	921	2252	839	1540	446	chromosome 16 open reading frame 44 (C16orf44)
B22R10C06	22-6-10	Hs~MGC:BC032400.1~uORF:IOH21693	805	771	1126	597	1030	810	2167	946	1715	475	chromosome 16 open reading frame 44 (C16orf44)
B22R10C07	22-7-10	Hs~MGC:BC033731.1~uORF:IOH21804	534	478	797	412	573	601	947	6918	1615	342	adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 (APPL2)
B22R10C08	22-8-10	Hs~MGC:BC033731.1~uORF:IOH21804	542	511	791	391	483	572	924	6941	1711	108	adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 (APPL2)
B22R10C09	22-9-10	Hs~Ref:NM_133375.2~uORF:IOH13442	1561	820	1254	673	841	735	1972	1050	1623	675	DIS3-like exonuclease 1
B22R10C10	22-10-10	Hs~Ref:NM_133375.2~uORF:IOH13442	1708	834	1218	779	825	863	1837	1028	1760	587	DIS3-like exonuclease 1
B22R11C21	22-21-11	Hs~Ref:NM_006827.2~uORF:IOH5148	915	775	1176	729	910	887	1597	807	1560	456	transmembrane emp24-like trafficking protein 10 (yeast) (TMED10)
B22R11C22	22-22-11	Hs~Ref:NM_006827.2~uORF:IOH5148	883	836	1242	731	896	1006	1711	815	1798	514	transmembrane emp24-like trafficking protein 10 (yeast) (TMED10)
B22R12C01	22-1-12	Hs~Ref:NM_015640.1~uORF:IOH22934	9261	4708	8355	5676	2263	3251	28166	2402	7484	7681	SERPINE1 mRNA binding protein 1 (SERBP1), transcript variant 4
B22R12C02	22-2-12	Hs~Ref:NM_015640.1~uORF:IOH22934	9664	4492	8157	5778	2770	3015	29513	2425	7501	7022	SERPINE1 mRNA binding protein 1 (SERBP1), transcript variant 4
B22R12C03	22-3-12	Hs~MGC:NM_152238.1~uORF:IOH10394	1104	767	1224	2818	974	945	2329	859	1429	518	sorting nexin 7 (SNX7), transcript variant 2
B22R12C04	22-4-12	Hs~MGC:NM_152238.1~uORF:IOH10394	1095	776	1235	2802	1079	972	2232	902	1423	527	sorting nexin 7 (SNX7), transcript variant 2
B22R12C05	22-5-12	Hs~Ref:NM_031311.2~uORF:IOH10663	926	790	1666	783	1007	902	1458	925	1780	641	carboxypeptidase, vitellogenic-like (CPVL), transcript variant 1
B22R12C06	22-6-12	Hs~Ref:NM_031311.2~uORF:IOH10663	882	786	1756	813	1048	956	1562	797	1808	638	carboxypeptidase, vitellogenic-like (CPVL), transcript variant 1
B22R12C07	22-7-12	Hs~Ref:NM_005792.1~uORF:IOH7199	1366	977	1488	986	1285	1203	2180	1845	3070	828	M-phase phosphoprotein 6 (MPHOSPH6)
B22R12C08	22-8-12	Hs~Ref:NM_005792.1~uORF:IOH7199	1389	1711	1474	1019	1164	1051	2130	1918	3504	931	M-phase phosphoprotein 6 (MPHOSPH6)
B22R12C09	22-9-12	Hs~MGC:BC014146.2~uORF:IOH12774	840	1664	1336	667	671	752	1493	640	1698	543	adaptor-related protein complex 4, beta 1 subunit (AP4B1)
B22R12C10	22-10-12	Hs~MGC:BC014146.2~uORF:IOH12774	824	821	1385	653	658	767	1558	664	1542	527	adaptor-related protein complex 4, beta 1 subunit (AP4B1)
B22R12C11	22-11-12	Hs~MGC:BC007003.1~uORF:IOH7198	1203	2923	1791	1803	919	1232	2031	888	3411	634	transglutaminase 4 (prostate) (TGM4)
B22R12C12	22-12-12	Hs~MGC:BC007003.1~uORF:IOH7198	1265	3222	1702	1864	910	1267	2215	944	3515	643	transglutaminase 4 (prostate) (TGM4)
B22R12C13	22-13-12	Hs~Ref:NM_020375.1~uORF:IOH13360	1011	1228	1304	860	1189	1107	1860	1719	1949	538	chromosome 12 open reading frame 5 (C12orf5)
B22R12C14	22-14-12	Hs~Ref:NM_020375.1~uORF:IOH13360	1090	1226	1362	814	1204	1122	1921	1736	2002	584	chromosome 12 open reading frame 5 (C12orf5)
B22R12C15	22-15-12	Hs~Ref:NM_032407.1~uORF:IOH36224	384	269	369	224	120	261	273	241	2016	1097	protocadherin gamma subfamily C, 5 (PCDHGC5), transcript variant 2
B22R12C16	22-16-12	Hs~Ref:NM_032407.1~uORF:IOH36224	1608	252	297	234	169	227	307	203	1577	1000	protocadherin gamma subfamily C, 5 (PCDHGC5), transcript variant 2
B22R12C17	22-17-12	Hs~Ref:NM_024587.2~uORF:IOH39908	937	198	281	171	148	202	241	343	208	49	transmembrane protein 53 (TMEM53)
B22R12C18	22-18-12	Hs~Ref:NM_024587.2~uORF:IOH39908	261	177	279	403	103	188	253	270	282	55	transmembrane protein 53 (TMEM53)
B22R12C19	22-19-12	Hs~Ref:NM_080870.2~uORF:IOH40303	3643	417	1055	333	405	724	2165	460	2776	177	diffuse panbronchiolitis critical region 1 (DPCR1)
B22R12C20	22-20-12	Hs~Ref:NM_080870.2~uORF:IOH40303	3816	476	967	361	442	755	2195	448	2890	149	diffuse panbronchiolitis critical region 1 (DPCR1)
B22R12C21	22-21-12	Hs~Ref:NM_017873.2~uORF:IOH39877	287	213	332	237	112	244	254	218	380	66	ankyrin repeat and SOCS box-containing 6 (ASB6), transcript variant 1
B22R12C22	22-22-12	Hs~Ref:NM_017873.2~uORF:IOH39877	274	200	344	199	217	247	247	190	445	112	ankyrin repeat and SOCS box-containing 6 (ASB6), transcript variant 1
B22R13C01	22-1-13	Hs~Ref:NM_030572.1~uORF:IOH5547	10050	479	779	510	462	529	889	886	1877	350	chromosome 12 open reading frame 39 (C12orf39)
B22R13C02	22-2-13	Hs~Ref:NM_030572.1~uORF:IOH5547	10445	476	766	525	486	554	907	669	1805	380	chromosome 12 open reading frame 39 (C12orf39)
B22R13C05	22-5-13	Hs~Ref:NM_021974.2~uORF:IOH4971	569	1145	836	354	670	226	445	334	1477	141	polymerase (RNA) II (DNA directed) polypeptide F (POLR2F)
B22R13C06	22-6-13	Hs~Ref:NM_021974.2~uORF:IOH4971	573	1220	881	333	705	273	421	345	1541	125	polymerase (RNA) II (DNA directed) polypeptide F (POLR2F)
B22R13C07	22-7-13	Hs~MGC:BC011680.1~uORF:IOH14815	585	726	841	538	663	627	1278	541	734	253	kelch domain containing 4 (KLHDC4)
B22R13C08	22-8-13	Hs~MGC:BC011680.1~uORF:IOH14815	643	1554	1069	570	663	656	1329	541	2028	200	kelch domain containing 4 (KLHDC4)
B22R13C09	22-9-13	Hs~MGC:BC033792.1~uORF:IOH21794	9247	10511	6402	12909	8596	5117	6419	9411	5963	8024	tumor protein D52-like 3 (TPD52L3)
B22R13C10	22-10-13	Hs~MGC:BC033792.1~uORF:IOH21794	9404	9081	6873	12462	9625	5488	6721	9665	5975	7828	tumor protein D52-like 3 (TPD52L3)
B22R13C11	22-11-13	Hs~MGC:BC008819.1~uORF:IOH6323	980	695	1246	779	672	3538	1275	650	2047	501	nuclear receptor subfamily 1, group H, member 3 (NR1H3)
B22R13C12	22-12-13	Hs~MGC:BC008819.1~uORF:IOH6323	1105	709	1063	771	690	3521	1156	640	1938	486	nuclear receptor subfamily 1, group H, member 3 (NR1H3)
B22R13C13	22-13-13	Hs~Ref:NM_004794.1~uORF:IOH4780	4404	562	729	495	544	824	825	499	1036	285	RAB33A, member RAS oncogene family (RAB33A)
B22R13C14	22-14-13	Hs~Ref:NM_004794.1~uORF:IOH4780	4664	577	756	462	558	823	797	497	1047	271	RAB33A, member RAS oncogene family (RAB33A)
B22R13C15	22-15-13	Hs~Ref:NM_001136.2~uORF:IOH12890	1577	699	1225	698	714	879	3057	842	1734	366	advanced glycosylation end product-specific receptor (AGER), transcript variant 1
B22R13C16	22-16-13	Hs~Ref:NM_001136.2~uORF:IOH12890	1977	716	1205	679	754	840	3203	836	1650	206	advanced glycosylation end product-specific receptor (AGER), transcript variant 1
B22R13C17	22-17-13	Hs~MGC:BC041769.1~uORF:IOH28631	1171	1357	2183	4714	1419	1215	1738	4720	1747	589	Double C2-like domain-containing protein alpha
B22R13C18	22-18-13	Hs~MGC:BC041769.1~uORF:IOH28631	1082	1466	2076	4771	1507	1186	1733	4939	1890	546	Double C2-like domain-containing protein alpha
B22R13C19	22-19-13	Hs~Ref:NM_004732.1~uORF:IOH29581	490	762	730	351	330	541	1707	473	1418	179	potassium voltage-gated channel, shaker-related subfamily, beta member 3 (KCNAB3)
B22R13C20	22-20-13	Hs~Ref:NM_004732.1~uORF:IOH29581	481	791	704	324	340	519	1761	532	1607	179	potassium voltage-gated channel, shaker-related subfamily, beta member 3 (KCNAB3)
B22R13C21	22-21-13	Hs~Ref:NM_002753.2~uORF:IOH29657	479	358	565	255	316	420	736	347	586	141	mitogen-activated protein kinase 10 (MAPK10), transcript variant 1
B22R13C22	22-22-13	Hs~Ref:NM_002753.2~uORF:IOH29657	450	346	532	235	299	412	727	308	580	246	mitogen-activated protein kinase 10 (MAPK10), transcript variant 1
B22R14C01	22-1-14	Hs~MGC:BC053320.1~uORF:IOH29401	792	301	518	262	275	415	909	648	725	239	C-terminal binding protein 1 (CTBP1)
B22R14C02	22-2-14	Hs~MGC:BC053320.1~uORF:IOH29401	483	316	591	285	257	494	835	376	597	204	C-terminal binding protein 1 (CTBP1)
B22R14C03	22-3-14	Hs~Ref:NM_006601.4~uORF:IOH5048	692	592	944	689	785	1500	1836	572	1797	465	prostaglandin E synthase 3 (cytosolic) (PTGES3)
B22R14C04	22-4-14	Hs~Ref:NM_006601.4~uORF:IOH5048	686	640	939	671	751	1545	1781	570	1804	527	prostaglandin E synthase 3 (cytosolic) (PTGES3)
B22R14C05	22-5-14	Hs~Ref:NM_018357.2~uORF:IOH6558	2204	3219	6308	2746	3680	39372	13407	1683	4151	878	La ribonucleoprotein domain family, member 6 (LARP6), transcript variant 1
B22R14C06	22-6-14	Hs~Ref:NM_018357.2~uORF:IOH6558	2254	3143	6620	2741	4238	38463	11460	1604	4254	769	La ribonucleoprotein domain family, member 6 (LARP6), transcript variant 1
B22R14C07	22-7-14	Hs~Ref:NM_018297.2~uORF:IOH6809	2248	2502	8944	2708	4923	4652	4247	3220	4209	1448	N-glycanase 1 (NGLY1)
B22R14C08	22-8-14	Hs~Ref:NM_018297.2~uORF:IOH6809	2304	3044	8405	2793	4918	5112	4263	3397	4245	1784	N-glycanase 1 (NGLY1)
B22R14C09	22-9-14	Hs~Ref:NM_031429.1~uORF:IOH6550	1490	2081	1782	1147	958	2623	1915	974	2545	699	retbindin (RTBDN), transcript variant 2
B22R14C10	22-10-14	Hs~Ref:NM_031429.1~uORF:IOH6550	1489	1999	1995	1137	1005	2439	1808	1046	2542	692	retbindin (RTBDN), transcript variant 2
B22R14C11	22-11-14	Hs~Ref:NM_002623.2~uORF:IOH12205	352	406	-19	255	237	330	1083	271	997	111	prefoldin subunit 4 (PFDN4)
B22R14C12	22-12-14	Hs~Ref:NM_002623.2~uORF:IOH12205	384	255	446	266	234	336	1157	265	79	202	prefoldin subunit 4 (PFDN4)
B22R14C13	22-13-14	Hs~Ref:NM_017838.2~uORF:IOH4642	2925	1527	2331	1397	1495	1798	13062	1536	3248	716	nucleolar protein family A, member 2 (H/ACA small nucleolar RNPs) (NOLA2), transcript variant 1
B22R14C14	22-14-14	Hs~Ref:NM_017838.2~uORF:IOH4642	3137	1525	2363	1271	1539	1783	12194	1506	3338	757	nucleolar protein family A, member 2 (H/ACA small nucleolar RNPs) (NOLA2), transcript variant 1
B22R14C15	22-15-14	Hs~Ref:NM_006319.2~uORF:IOH4047	693	518	1205	319	437	851	1057	486	907	167	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase) (CDIPT)
B22R14C16	22-16-14	Hs~Ref:NM_006319.2~uORF:IOH4047	790	536	1178	312	450	899	1103	433	926	148	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase) (CDIPT)
B22R14C17	22-17-14	Hs~MGC:BC030280.1~uORF:IOH21522	667	427	553	304	216	568	1044	426	2078	216	KIAA0513 (KIAA0513)
B22R14C18	22-18-14	Hs~MGC:BC030280.1~uORF:IOH21522	492	416	582	367	227	586	875	446	2214	269	KIAA0513 (KIAA0513)
B22R14C19	22-19-14	Hs~MGC:BC053840.1~uORF:IOH29362	773	617	1006	535	571	601	890	896	1998	354	killer cell lectin-like receptor subfamily C, member 1 (KLRC1)
B22R14C20	22-20-14	Hs~MGC:BC053840.1~uORF:IOH29362	782	557	1014	503	621	590	949	885	2078	420	killer cell lectin-like receptor subfamily C, member 1 (KLRC1)
B22R14C21	22-21-14	Hs~Ref:NM_005536.2~uORF:IOH21098	994	561	918	556	695	811	921	765	1503	312	inositol(myo)-1(or 4)-monophosphatase 1 (IMPA1)
B22R14C22	22-22-14	Hs~Ref:NM_005536.2~uORF:IOH21098	951	517	886	537	741	878	843	627	1507	348	inositol(myo)-1(or 4)-monophosphatase 1 (IMPA1)
B22R15C01	22-1-15	Hs~MGC:BC010358.1~uORF:IOH14272	427	318	621	378	263	461	898	805	857	273	cytochrome P450, family 39, subfamily A, polypeptide 1 (CYP39A1)
B22R15C02	22-2-15	Hs~MGC:BC010358.1~uORF:IOH14272	512	340	629	360	405	484	924	796	800	238	cytochrome P450, family 39, subfamily A, polypeptide 1 (CYP39A1)
B22R15C03	22-3-15	Hs~MGC:BC025703.1~uORF:IOH11991	1721	593	940	596	578	912	1086	618	1048	335	CD247 molecule (CD247)
B22R15C04	22-4-15	Hs~MGC:BC025703.1~uORF:IOH11991	1625	601	991	599	654	955	1137	553	1067	393	CD247 molecule (CD247)
B22R15C05	22-5-15	Hs~Ref:NM_004571.3~uORF:IOH6384	669	1305	1138	1260	717	2641	2679	681	1054	2619	PBX/knotted 1 homeobox 1 (PKNOX1)
B22R15C06	22-6-15	Hs~Ref:NM_004571.3~uORF:IOH6384	736	1372	1242	1254	722	2576	2827	697	1182	2827	PBX/knotted 1 homeobox 1 (PKNOX1)
B22R15C07	22-7-15	Hs~Ref:NM_030768.2~uORF:IOH12865	2514	3513	2865	12041	3961	2690	2239	1904	2885	1050	integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP)
B22R15C08	22-8-15	Hs~Ref:NM_030768.2~uORF:IOH12865	2593	4127	2631	12028	4194	3206	2151	2100	2946	1112	integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP)
B22R15C09	22-9-15	Hs~Ref:NM_004064.2~uORF:IOH1795	721	2326	1019	736	1829	2044	5388	2321	2201	321	cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
B22R15C10	22-10-15	Hs~Ref:NM_004064.2~uORF:IOH1795	683	1820	1007	738	1952	1970	5624	2439	2232	334	cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
B22R15C11	22-11-15	Hs~MGC:BC016057.1~uORF:IOH12761	1027	5664	14473	595	1020	4012	15829	3321	2558	510	Usher syndrome 1C (autosomal recessive, severe) (USH1C)
B22R15C12	22-12-15	Hs~MGC:BC016057.1~uORF:IOH12761	1105	6054	10051	606	1073	4069	15575	3249	2758	484	Usher syndrome 1C (autosomal recessive, severe) (USH1C)
B22R15C15	22-15-15	Hs~Ref:NM_003668.2~CAT:PV3301	352	444	697	353	987	507	357	738	163	145	mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5), transcript variant 1
B22R15C16	22-16-15	Hs~Ref:NM_003668.2~CAT:PV3301	350	514	692	331	1040	534	398	764	174	120	mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5), transcript variant 1
B22R15C17	22-17-15	Hs~Ref:NM_002740.1~CAT:PV3186	1786	343	562	371	274	432	544	869	808	69	protein kinase C, iota (PRKCI)
B22R15C18	22-18-15	Hs~Ref:NM_002740.1~CAT:PV3186	1893	357	617	473	281	405	575	850	804	144	protein kinase C, iota (PRKCI)
B22R15C19	22-19-15	Hs~Ref:NM_016231.2~CAT:PV4309	316	843	978	756	4340	2044	1022	7686	3605	224	nemo-like kinase (NLK)
B22R15C20	22-20-15	Hs~Ref:NM_016231.2~CAT:PV4309	321	738	932	726	4573	2162	1075	6834	3672	149	nemo-like kinase (NLK)
B22R15C21	22-21-15	Hs~N/A:NM_006206.3~CAT:PV3847	396	264	437	244	1068	272	1450	409	1013	158	platelet-derived growth factor receptor, alpha polypeptide (PDGFRA); see catalog number for detailed information on wild-type or point mutant status
B22R15C22	22-22-15	Hs~N/A:NM_006206.3~CAT:PV3847	412	232	433	234	1100	311	1441	475	1073	288	platelet-derived growth factor receptor, alpha polypeptide (PDGFRA); see catalog number for detailed information on wild-type or point mutant status
B22R16C01	22-1-16	Hs~Ref:NM_030662.2~CAT:PV3615	1974	791	1123	434	825	491	713	1327	876	252	mitogen-activated protein kinase kinase 2 (MAP2K2)
B22R16C02	22-2-16	Hs~Ref:NM_030662.2~CAT:PV3615	1254	913	1111	434	1137	523	692	1369	838	260	mitogen-activated protein kinase kinase 2 (MAP2K2)
B22R16C03	22-3-16	Hs~Ref:NM_032960.2~CAT:PV3317	633	439	763	865	2081	1591	658	2055	590	226	MAP kinase-activated protein kinase 2
B22R16C04	22-4-16	Hs~Ref:NM_032960.2~CAT:PV3317	687	490	742	819	2151	1621	640	1531	574	200	MAP kinase-activated protein kinase 2
B22R16C07	22-7-16	Hs~MGC:BC062732.1~uORF:IOH62856	65490	65490	65470	65493	65488	65491	65481	65491	65457	65491	Ig kappa chain C region
B22R16C08	22-8-16	Hs~MGC:BC062732.1~uORF:IOH62856	65493	65485	65471	65493	65490	65492	65481	65491	65466	65478	Ig kappa chain C region
B22R16C15	22-15-16	Hs~Ref:NM_021630.4~uORF:IOH57204	1368	2230	1903	1565	1603	1586	4403	4730	4805	687	PDZ and LIM domain protein 2
B22R16C16	22-16-16	Hs~Ref:NM_021630.4~uORF:IOH57204	1562	2420	1804	1621	1714	1560	4737	4721	4843	681	PDZ and LIM domain protein 2
B22R16C17	22-17-16	Hs~Ref:NM_006917.3~uORF:IOH57197	5752	1350	1511	11859	3085	1819	2956	2050	4367	563	Retinoic acid receptor RXR-gamma
B22R16C18	22-18-16	Hs~Ref:NM_006917.3~uORF:IOH57197	5773	1419	1504	12187	3319	1821	3023	2105	4621	523	Retinoic acid receptor RXR-gamma
B22R16C21	22-21-16	Hs~Ref:NM_004044.4~uORF:IOH57030	365	1344	854	2318	371	1834	530	558	876	199	Bifunctional purine biosynthesis protein PURH
B22R16C22	22-22-16	Hs~Ref:NM_004044.4~uORF:IOH57030	396	1450	823	2291	410	1824	532	689	869	301	Bifunctional purine biosynthesis protein PURH
B22R17C05	22-5-17	Hs~MGC:BC037845.1~uORF:IOH62213	1177	626	1871	5456	389	7601	1150	726	1373	303	Multiple coagulation factor deficiency protein 2
B22R17C06	22-6-17	Hs~MGC:BC037845.1~uORF:IOH62213	1280	669	1724	5937	378	7527	1121	729	1432	366	Multiple coagulation factor deficiency protein 2
B22R17C07	22-7-17	Hs~Ref:NM_001004419.1~uORF:IOH59666	332	266	712	277	262	508	569	402	883	274	C-type lectin domain family 2 member D
B22R17C08	22-8-17	Hs~Ref:NM_001004419.1~uORF:IOH59666	317	312	581	309	247	470	573	373	601	294	C-type lectin domain family 2 member D
B22R17C09	22-9-17	Hs~MGC:BC005876.1~uORF:IOH6081	520	3301	811	399	367	516	941	514	1078	252	V-type proton ATPase 21 kDa proteolipid subunit
B22R17C10	22-10-17	Hs~MGC:BC005876.1~uORF:IOH6081	718	4158	786	393	359	534	958	507	1169	256	V-type proton ATPase 21 kDa proteolipid subunit
B22R17C11	22-11-17	Hs~MGC:BC006793.1~uORF:IOH3184	1085	627	808	495	595	676	1859	640	1186	448	Trans-acting T-cell-specific transcription factor GATA-3
B22R17C12	22-12-17	Hs~MGC:BC006793.1~uORF:IOH3184	1143	545	889	714	600	788	1797	704	1402	419	Trans-acting T-cell-specific transcription factor GATA-3
B22R17C13	22-13-17	Hs~MGC:BC014307.1~uORF:IOH12074	1285	519	922	1145	496	915	1606	766	3302	512	chromosome 9 open reading frame 11 (C9orf11)
B22R17C14	22-14-17	Hs~MGC:BC014307.1~uORF:IOH12074	1212	566	828	863	507	930	1586	797	3250	464	chromosome 9 open reading frame 11 (C9orf11)
B22R17C15	22-15-17	Hs~Ref:NM_145254.1~uORF:IOH10884	521	449	1021	425	663	545	901	1078	1071	331	transmembrane protein 170 (TMEM170)
B22R17C16	22-16-17	Hs~Ref:NM_145254.1~uORF:IOH10884	554	457	933	449	649	545	854	1034	1082	338	transmembrane protein 170 (TMEM170)
B22R17C17	22-17-17	Hs~Ref:NM_022046.3~uORF:IOH35361	882	468	888	396	409	695	1116	591	1086	313	Kallikrein-14
B22R17C18	22-18-17	Hs~Ref:NM_022046.3~uORF:IOH35361	828	481	897	464	401	638	1108	568	895	328	Kallikrein-14
B22R17C19	22-19-17	Hs~Ref:NM_177524.1~uORF:IOH45900	2380	1717	1990	1519	2099	2063	6538	1916	2341	1011	mesoderm specific transcript homolog (mouse) (MEST), transcript variant 2
B22R17C20	22-20-17	Hs~Ref:NM_177524.1~uORF:IOH45900	2381	1743	2033	1579	2092	2110	7116	2017	2396	1042	mesoderm specific transcript homolog (mouse) (MEST), transcript variant 2
B22R17C21	22-21-17	Hs~Ref:NM_013264.2~uORF:IOH45462	569	494	672	500	408	601	1078	541	1068	523	DEAD (Asp-Glu-Ala-Asp) box polypeptide 25 (DDX25)
B22R17C22	22-22-17	Hs~Ref:NM_013264.2~uORF:IOH45462	584	479	712	514	405	574	1072	552	1026	446	DEAD (Asp-Glu-Ala-Asp) box polypeptide 25 (DDX25)
B22R18C01	22-1-18	Hs~Ref:NM_182503.1~uORF:IOH45446	1286	689	1814	578	707	1099	1811	717	1708	477	adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae) (ADAT2)
B22R18C02	22-2-18	Hs~Ref:NM_182503.1~uORF:IOH45446	1177	729	1799	587	858	1066	1864	750	1619	502	adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae) (ADAT2)
B22R18C03	22-3-18	Hs~Ref:NM_005408.2~uORF:IOH3315	510	504	1166	303	510	568	726	425	1624	394	chemokine (C-C motif) ligand 13 (CCL13)
B22R18C04	22-4-18	Hs~Ref:NM_005408.2~uORF:IOH3315	546	522	1073	300	539	611	661	487	1748	391	chemokine (C-C motif) ligand 13 (CCL13)
B22R18C05	22-5-18	Hs~Ref:NM_006644.2~uORF:IOH27526	437	311	587	769	354	791	820	442	1258	1063	heat shock 105kDa/110kDa protein 1 (HSPH1)
B22R18C06	22-6-18	Hs~Ref:NM_006644.2~uORF:IOH27526	427	334	524	757	304	762	801	377	1365	1204	heat shock 105kDa/110kDa protein 1 (HSPH1)
B22R18C07	22-7-18	Hs~MGC:BC050329.1~uORF:IOH26431	387	290	676	280	265	367	695	668	364	199	neuropilin (NRP) and tolloid (TLL)-like 1 (NETO1)
B22R18C08	22-8-18	Hs~MGC:BC050329.1~uORF:IOH26431	401	342	716	288	274	399	711	678	190	127	neuropilin (NRP) and tolloid (TLL)-like 1 (NETO1)
B22R18C09	22-9-18	Hs~Ref:NM_033397.2~uORF:IOH27489	355	2390	1016	321	310	1273	658	751	972	31	KIAA1754 (KIAA1754)
B22R18C10	22-10-18	Hs~Ref:NM_033397.2~uORF:IOH27489	501	585	983	367	309	1334	666	760	1001	317	KIAA1754 (KIAA1754)
B22R18C11	22-11-18	Hs~MGC:BC037773.1~uORF:IOH25827	479	417	710	380	331	552	1041	491	1011	449	Probable histone acetyltransferase MYST1
B22R18C12	22-12-18	Hs~MGC:BC037773.1~uORF:IOH25827	540	444	742	372	305	641	1070	529	931	449	Probable histone acetyltransferase MYST1
B22R18C13	22-13-18	Hs~Ref:NM_002744.2~N/A	433	376	593	283	287	412	810	385	1478	481	protein kinase C, zeta (PRKCZ), transcript variant 1
B22R18C14	22-14-18	Hs~Ref:NM_002744.2~N/A	412	384	623	293	279	450	806	421	879	166	protein kinase C, zeta (PRKCZ), transcript variant 1
B22R18C15	22-15-18	Hs~MGC:BC037322.1~uORF:IOH28715	681	356	600	322	277	530	856	535	1092	145	Ligand-dependent nuclear receptor corepressor-like protein
B22R18C16	22-16-18	Hs~MGC:BC037322.1~uORF:IOH28715	669	369	594	318	282	515	814	546	1122	136	Ligand-dependent nuclear receptor corepressor-like protein
B22R18C17	22-17-18	Hs~MGC:BC053872.1~uORF:IOH28961	651	485	989	501	416	1440	2468	633	1196	221	copine V (CPNE5)
B22R18C18	22-18-18	Hs~MGC:BC053872.1~uORF:IOH28961	657	523	938	542	434	1404	2468	660	1318	225	copine V (CPNE5)
B22R18C19	22-19-18	Hs~Ref:NM_033506.1~uORF:IOH40035	724	584	1578	575	554	571	1466	746	945	376	F-box protein 24 (FBXO24), transcript variant 1
B22R18C20	22-20-18	Hs~Ref:NM_033506.1~uORF:IOH40035	741	732	1615	486	576	606	1402	727	983	193	F-box protein 24 (FBXO24), transcript variant 1
B22R18C21	22-21-18	Hs~Ref:NM_024569.3~uORF:IOH43374	508	547	740	392	443	504	808	510	1031	465	Myelin protein zero-like protein 1
B22R18C22	22-22-18	Hs~Ref:NM_024569.3~uORF:IOH43374	548	539	687	400	460	499	738	551	937	375	Myelin protein zero-like protein 1
B22R19C01	22-1-19	Hs~Ref:NM_033421.2~uORF:IOH43365	648	1164	2012	706	385	1088	1058	837	2937	336	sorting nexin family member 21 (SNX21), transcript variant 1
B22R19C02	22-2-19	Hs~Ref:NM_033421.2~uORF:IOH43365	655	1207	1919	701	516	1107	1028	837	3020	340	sorting nexin family member 21 (SNX21), transcript variant 1
B22R19C03	22-3-19	Hs~Ref:XM_378661.1~uORF:IOH41602	587	523	791	429	497	788	973	519	1216	402	PREDICTED: Homo sapiens chromosome 17 open reading frame 51 (C17orf51)
B22R19C04	22-4-19	Hs~Ref:XM_378661.1~uORF:IOH41602	567	489	785	420	482	964	1009	520	1099	380	PREDICTED: Homo sapiens chromosome 17 open reading frame 51 (C17orf51)
B22R19C05	22-5-19	Hs~Ref:NM_006875.1~N/A	604	223	801	238	374	557	623	451	746	257	Serine/threonine-protein kinase Pim-2
B22R19C06	22-6-19	Hs~Ref:NM_006875.1~N/A	552	237	782	234	322	455	611	489	583	297	Serine/threonine-protein kinase Pim-2
B22R19C07	22-7-19	Hs~MGC:BC016652.1~N/A	648	583	1343	820	434	822	877	798	2283	497	Cytoplasmic tyrosine-protein kinase BMX
B22R19C08	22-8-19	Hs~MGC:BC016652.1~N/A	684	667	1477	867	457	746	1011	820	2418	503	Cytoplasmic tyrosine-protein kinase BMX
B22R19C09	22-9-19	Hs~MGC:BC003178.1~uORF:IOH5124	331	239	416	246	200	310	467	348	264	30	mutY homolog (E. coli) (MUTYH)
B22R19C10	22-10-19	Hs~MGC:BC003178.1~uORF:IOH5124	856	364	418	227	161	297	473	365	407	822	mutY homolog (E. coli) (MUTYH)
B22R19C11	22-11-19	Hs~Ref:NM_003878.1~uORF:IOH25778	817	460	806	457	402	651	1183	573	1285	441	gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) (GGH)
B22R19C12	22-12-19	Hs~Ref:NM_003878.1~uORF:IOH25778	571	494	827	459	392	648	1182	611	1149	472	gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) (GGH)
B22R19C13	22-13-19	Hs~MGC:BC066958.1~uORF:IOH61486	3874	2453	4278	2783	2820	3047	8824	3119	4237	1499	splicing factor, arginine/serine-rich 2, mRNA (cDNA clone MGC:87440 IMAGE:4837392), complete cds
B22R19C14	22-14-19	Hs~MGC:BC066958.1~uORF:IOH61486	4038	2627	4001	2549	2837	3105	9461	3166	4118	1398	splicing factor, arginine/serine-rich 2, mRNA (cDNA clone MGC:87440 IMAGE:4837392), complete cds
B22R19C15	22-15-19	Hs~Ref:NM_007102.1~uORF:IOH40405	567	456	763	387	412	601	793	597	1331	353	Guanylate cyclase activator 2B
B22R19C16	22-16-19	Hs~Ref:NM_007102.1~uORF:IOH40405	518	445	808	375	429	607	843	613	847	201	Guanylate cyclase activator 2B
B22R19C17	22-17-19	Hs~Ref:NM_002357.1~uORF:IOH40302	841	733	1250	1067	594	718	1368	1031	1878	737	MAX dimerization protein 1 (MXD1)
B22R19C18	22-18-19	Hs~Ref:NM_002357.1~uORF:IOH40302	702	796	1360	1280	585	870	1251	1005	1904	632	MAX dimerization protein 1 (MXD1)
B22R19C19	22-19-19	Hs~Ref:NM_173622.2~uORF:IOH40872	1432	529	808	645	438	624	1397	548	1075	329	CMT1A duplicated region transcript 4 (CDRT4)
B22R19C20	22-20-19	Hs~Ref:NM_173622.2~uORF:IOH40872	1029	701	858	509	478	641	1328	523	1041	255	CMT1A duplicated region transcript 4 (CDRT4)
B22R19C21	22-21-19	Hs~Ref:NM_139164.1~uORF:IOH59717	638	573	1270	285	328	-3	-2	-3	-3	-4	StAR-related lipid transfer protein 4
B22R19C22	22-22-19	Hs~Ref:NM_139164.1~uORF:IOH59717	666	600	1186	272	388	196	-2	-2	-1	-1	StAR-related lipid transfer protein 4
B22R20C01	22-1-20	Hs~Ref:NM_000607.1~uORF:IOH54759	457	242	468	246	382	-2	-4	-9	8	-1	Alpha-1-acid glycoprotein 1
B22R20C02	22-2-20	Hs~Ref:NM_000607.1~uORF:IOH54759	464	223	440	238	408	-15	154	193	3	0	Alpha-1-acid glycoprotein 1
B22R20C03	22-3-20	Hs~MGC:BC001899.1~uORF:IOH4819	399	384	603	344	411	515	598	562	578	257	fucosyltransferase 2 (secretor status included) (FUT2)
B22R20C04	22-4-20	Hs~MGC:BC001899.1~uORF:IOH4819	406	344	671	305	448	564	582	490	628	318	fucosyltransferase 2 (secretor status included) (FUT2)
B22R20C05	22-5-20	Hs~Ref:NM_078473.1~uORF:IOH1833	455	320	669	329	324	491	531	501	883	106	TM2 domain containing 2 (TM2D2), transcript variant 1
B22R20C06	22-6-20	Hs~Ref:NM_078473.1~uORF:IOH1833	456	350	693	370	342	482	584	699	768	185	TM2 domain containing 2 (TM2D2), transcript variant 1
B22R20C07	22-7-20	Hs~Ref:NM_004729.3~uORF:IOH55626	682	910	647	797	923	623	781	582	1415	692	Zinc finger BED domain-containing protein 1
B22R20C08	22-8-20	Hs~Ref:NM_004729.3~uORF:IOH55626	694	964	2245	786	908	580	768	491	1372	230	Zinc finger BED domain-containing protein 1
B22R20C09	22-9-20	Hs~Ref:NM_005760.2~uORF:IOH22256	325	330	356	305	151	377	660	244	1345	36	CCAAT/enhancer binding protein zeta (CEBPZ)
B22R20C10	22-10-20	Hs~Ref:NM_005760.2~uORF:IOH22256	139	400	327	234	169	359	643	221	1178	348	CCAAT/enhancer binding protein zeta (CEBPZ)
B22R20C11	22-11-20	Hs~Ref:NM_032370.1~uORF:IOH6927	432	520	914	238	315	453	620	256	2231	59	Zinc finger protein 414
B22R20C12	22-12-20	Hs~Ref:NM_032370.1~uORF:IOH6927	326	593	856	241	324	418	549	296	2147	146	Zinc finger protein 414
B22R20C13	22-13-20	Hs~MGC:BC012172.1~uORF:IOH13314	243	344	440	193	259	271	622	236	1606	83	Acetyl-coenzyme A synthetase, cytoplasmic
B22R20C14	22-14-20	Hs~MGC:BC012172.1~uORF:IOH13314	248	363	450	177	271	272	718	239	1458	86	Acetyl-coenzyme A synthetase, cytoplasmic
B23R02C11	23-11-2	Hs~MGC:BC062354.1~uORF:IOH40674	587	476	810	392	339	419	629	434	664	192	mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B (MGAT5B)
B23R02C12	23-12-2	Hs~MGC:BC062354.1~uORF:IOH40674	620	466	801	391	297	397	617	489	670	166	mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B (MGAT5B)
B23R02C13	23-13-2	Hs~Ref:NM_138288.1~uORF:IOH13958	1926	688	1126	501	648	589	843	586	1360	363	chromosome 14 open reading frame 147 (C14orf147)
B23R02C14	23-14-2	Hs~Ref:NM_138288.1~uORF:IOH13958	2153	785	1132	494	638	529	790	575	1437	388	chromosome 14 open reading frame 147 (C14orf147)
B23R02C15	23-15-2	Hs~MGC:BC012602.1~uORF:IOH14457	743	441	825	404	455	418	832	446	956	310	signaling lymphocytic activation molecule family member 1 (SLAMF1)
B23R02C16	23-16-2	Hs~MGC:BC012602.1~uORF:IOH14457	775	404	796	483	455	482	1229	456	851	299	signaling lymphocytic activation molecule family member 1 (SLAMF1)
B23R02C17	23-17-2	Hs~Ref:NM_144714.1~uORF:IOH11221	1901	1124	1497	806	709	898	5813	778	1723	426	PP2C-like domain-containing protein C3orf48
B23R02C18	23-18-2	Hs~Ref:NM_144714.1~uORF:IOH11221	1859	1117	1511	796	690	899	4692	758	1915	418	PP2C-like domain-containing protein C3orf48
B23R02C21	23-21-2	Hs~Ref:NM_205853.1~uORF:IOH43061	1369	1046	36800	1195	2189	38090	3394	1421	4198	466	musculoskeletal, embryonic nuclear protein 1 (MUSTN1)
B23R02C22	23-22-2	Hs~Ref:NM_205853.1~uORF:IOH43061	1213	1024	35845	1135	2254	38091	3389	1295	4444	453	musculoskeletal, embryonic nuclear protein 1 (MUSTN1)
B23R03C01	23-1-3	Hs~Ref:NM_032507.2~uORF:IOH43962	556	601	802	690	589	439	564	542	1144	330	piggyBac transposable element derived 1 (PGBD1)
B23R03C02	23-2-3	Hs~Ref:NM_032507.2~uORF:IOH43962	555	570	825	719	654	479	606	867	1152	252	piggyBac transposable element derived 1 (PGBD1)
B23R03C03	23-3-3	Hs~Ref:NM_054035.1~uORF:IOH43630	633	595	1768	471	634	640	1209	882	1394	419	unc-119 homolog (C. elegans) (UNC119), transcript variant 2
B23R03C04	23-4-3	Hs~Ref:NM_054035.1~uORF:IOH43630	721	570	1676	677	699	659	1258	740	1465	348	unc-119 homolog (C. elegans) (UNC119), transcript variant 2
B23R03C05	23-5-3	Hs~MGC:BC030792.1~uORF:IOH27135	621	539	569	516	532	764	817	786	2857	400	cyclin-dependent kinase 5, regulatory subunit 1 (p35) (CDK5R1)
B23R03C06	23-6-3	Hs~MGC:BC030792.1~uORF:IOH27135	530	539	541	628	513	732	810	735	2900	385	cyclin-dependent kinase 5, regulatory subunit 1 (p35) (CDK5R1)
B23R03C07	23-7-3	Hs~MGC:NM_183353.1~uORF:IOH14364	406	719	665	302	410	674	448	415	564	311	E3 ubiquitin-protein ligase RNF12
B23R03C08	23-8-3	Hs~MGC:NM_183353.1~uORF:IOH14364	371	699	633	466	441	697	475	441	636	334	E3 ubiquitin-protein ligase RNF12
B23R03C09	23-9-3	Hs~MGC:BC048292.1~uORF:IOH26585	339	515	363	226	207	925	271	332	501	82	FK506 binding protein 11, 19 kDa (FKBP11)
B23R03C10	23-10-3	Hs~MGC:BC048292.1~uORF:IOH26585	300	523	360	205	299	875	245	302	530	79	FK506 binding protein 11, 19 kDa (FKBP11)
B23R03C11	23-11-3	Hs~Ref:NM_032780.1~uORF:IOH27361	214	212	347	260	200	1705	236	196	350	73	transmembrane protein 25 (TMEM25)
B23R03C12	23-12-3	Hs~Ref:NM_032780.1~uORF:IOH27361	241	195	344	280	189	1606	233	173	372	121	transmembrane protein 25 (TMEM25)
B23R03C13	23-13-3	Hs~MGC:BC001907.1~uORF:IOH4806	423	631	1202	244	486	425	617	327	1064	224	Trafficking protein particle complex subunit 6A
B23R03C14	23-14-3	Hs~MGC:BC001907.1~uORF:IOH4806	410	628	1135	286	523	487	625	395	1077	125	Trafficking protein particle complex subunit 6A
B23R03C15	23-15-3	Hs~Ref:NM_001660.2~uORF:IOH5952	463	39	1290	447	430	402	-45	71	496	61	ADP-ribosylation factor 4 (ARF4)
B23R03C16	23-16-3	Hs~Ref:NM_001660.2~uORF:IOH5952	414	225	1139	308	467	407	92	485	743	43	ADP-ribosylation factor 4 (ARF4)
B23R03C17	23-17-3	Hs~Ref:NM_006838.1~uORF:IOH11106	5397	2643	6268	2755	4778	1656	13981	2764	5819	2061	methionyl aminopeptidase 2 (METAP2)
B23R03C18	23-18-3	Hs~Ref:NM_006838.1~uORF:IOH11106	5322	2631	5929	2684	4441	1618	14552	2511	5433	2098	methionyl aminopeptidase 2 (METAP2)
B23R03C19	23-19-3	Hs~MGC:BC008037.2~uORF:IOH5889	894	712	2033	925	875	2086	2741	538	1499	399	protein kinase C and casein kinase substrate in neurons 2 (PACSIN2)
B23R03C20	23-20-3	Hs~MGC:BC008037.2~uORF:IOH5889	963	475	1918	921	884	2127	2867	528	1624	405	protein kinase C and casein kinase substrate in neurons 2 (PACSIN2)
B23R03C21	23-21-3	Hs~MGC:BC034497.2~uORF:IOH22342	1745	1750	10789	3334	5131	2631	2717	1181	2897	461	family with sequence similarity 124A (FAM124A)
B23R03C22	23-22-3	Hs~MGC:BC034497.2~uORF:IOH22342	1809	1720	10548	2912	5342	2534	2633	1150	2907	473	family with sequence similarity 124A (FAM124A)
B23R04C01	23-1-4	Hs~Ref:NM_005185.1~uORF:IOH22362	567	374	814	251	448	311	541	386	704	178	calmodulin-like 3 (CALML3)
B23R04C02	23-2-4	Hs~Ref:NM_005185.1~uORF:IOH22362	570	292	777	264	470	296	576	502	730	150	calmodulin-like 3 (CALML3)
B23R04C03	23-3-4	Hs~MGC:BC029662.1~uORF:IOH22367	519	484	802	307	502	569	874	534	994	399	chromosome 20 open reading frame 142 (C20orf142)
B23R04C04	23-4-4	Hs~MGC:BC029662.1~uORF:IOH22367	510	549	779	953	516	513	870	442	1018	315	chromosome 20 open reading frame 142 (C20orf142)
B23R04C05	23-5-4	Hs~MGC:BC030027.1~uORF:IOH22381	729	466	803	788	513	487	890	426	1253	299	Guanine nucleotide-binding protein G(o) subunit alpha
B23R04C06	23-6-4	Hs~MGC:BC030027.1~uORF:IOH22381	833	430	783	378	469	488	926	473	1418	273	Guanine nucleotide-binding protein G(o) subunit alpha
B23R04C07	23-7-4	Hs~MGC:BC005332.1~uORF:IOH7177	17460	16997	16683	16385	14535	13323	13124	12502	20856	15221	cDNA clone MGC:12418 IMAGE:3934658, complete cds
B23R04C08	23-8-4	Hs~MGC:BC005332.1~uORF:IOH7177	17046	16820	16483	16979	14581	13328	13083	13211	20764	15683	cDNA clone MGC:12418 IMAGE:3934658, complete cds
B23R04C09	23-9-4	Hs~Ref:NM_005738.1~uORF:IOH5077	1136	3212	1230	669	1227	1433	979	2347	1310	581	ADP-ribosylation factor-like 4A (ARL4A), transcript variant 1
B23R04C10	23-10-4	Hs~Ref:NM_005738.1~uORF:IOH5077	1127	3324	1186	634	1254	1606	1018	2224	1401	542	ADP-ribosylation factor-like 4A (ARL4A), transcript variant 1
B23R04C11	23-11-4	Hs~MGC:BC002951.1~uORF:IOH4779	402	350	582	301	221	291	416	348	490	116	Protein transport protein Sec61 subunit alpha isoform 1
B23R04C12	23-12-4	Hs~MGC:BC002951.1~uORF:IOH4779	454	301	536	261	209	254	410	346	335	48	Protein transport protein Sec61 subunit alpha isoform 1
B23R04C13	23-13-4	Hs~MGC:BC003690.1~uORF:IOH3064	435	374	545	314	305	306	369	541	786	83	Importin-4
B23R04C14	23-14-4	Hs~MGC:BC003690.1~uORF:IOH3064	474	439	524	364	314	284	380	527	792	131	Importin-4
B23R04C15	23-15-4	Hs~Ref:NM_017411.2~uORF:IOH10903	1706	2089	1735	993	976	1933	3139	1322	2725	543	survival of motor neuron 2, centromeric (SMN2), transcript variant d
B23R04C16	23-16-4	Hs~Ref:NM_017411.2~uORF:IOH10903	1732	1946	1642	977	972	1952	3154	1237	3069	581	survival of motor neuron 2, centromeric (SMN2), transcript variant d
B23R04C17	23-17-4	Hs~MGC:BC063666.1~uORF:IOH39829	671	392	904	1104	1812	662	533	321	857	164	cAMP responsive element binding protein 3-like 2 (CREB3L2)
B23R04C18	23-18-4	Hs~MGC:BC063666.1~uORF:IOH39829	675	452	898	1125	1810	850	530	331	851	226	cAMP responsive element binding protein 3-like 2 (CREB3L2)
B23R04C19	23-19-4	Hs~MGC:BC035137.1~uORF:IOH27698	1079	786	1679	1644	875	1060	1059	2923	2253	489	thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) (THRA)
B23R04C20	23-20-4	Hs~MGC:BC035137.1~uORF:IOH27698	1116	775	1654	1588	890	1109	1038	2878	2079	505	thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) (THRA)
B23R04C21	23-21-4	Hs~Ref:NM_022754.4~uORF:IOH39788	942	865	851	758	462	633	770	587	1203	430	sideroflexin 1 (SFXN1)
B23R04C22	23-22-4	Hs~Ref:NM_022754.4~uORF:IOH39788	787	910	864	778	469	535	891	626	36	413	sideroflexin 1 (SFXN1)
B23R05C01	23-1-5	Hs~Ref:NM_013338.2~uORF:IOH12723	479	624	690	422	470	545	653	427	712	306	asparagine-linked glycosylation 5 homolog (S. cerevisiae, dolichyl-phosphate beta-glucosyltransferase) (ALG5)
B23R05C02	23-2-5	Hs~Ref:NM_013338.2~uORF:IOH12723	515	522	796	404	486	543	658	533	775	389	asparagine-linked glycosylation 5 homolog (S. cerevisiae, dolichyl-phosphate beta-glucosyltransferase) (ALG5)
B23R05C03	23-3-5	Hs~Ref:NM_006834.2~uORF:IOH12811	513	558	2480	645	1216	1029	1720	847	1293	204	RAB32, member RAS oncogene family (RAB32)
B23R05C04	23-4-5	Hs~Ref:NM_006834.2~uORF:IOH12811	527	576	2292	947	1293	1137	1835	836	1350	215	RAB32, member RAS oncogene family (RAB32)
B23R05C05	23-5-5	Hs~MGC:BC011011.1~uORF:IOH12897	595	521	777	816	595	514	896	583	1075	432	UEV and lactate/malate dehyrogenase domains (UEVLD)
B23R05C06	23-6-5	Hs~MGC:BC011011.1~uORF:IOH12897	651	530	812	494	502	492	875	706	1038	556	UEV and lactate/malate dehyrogenase domains (UEVLD)
B23R05C07	23-7-5	Hs~MGC:BC010929.1~uORF:IOH12868	1736	1470	1742	865	1779	1448	4485	1274	2254	739	LIM domain binding 3 (LDB3)
B23R05C08	23-8-5	Hs~MGC:BC010929.1~uORF:IOH12868	1714	1509	1625	945	1814	1431	4504	1216	2376	656	LIM domain binding 3 (LDB3)
B23R05C09	23-9-5	Hs~MGC:BC048104.1~uORF:IOH26746	558	402	589	294	274	358	641	267	618	230	5'-3' exoribonuclease 1 (XRN1)
B23R05C10	23-10-5	Hs~MGC:BC048104.1~uORF:IOH26746	556	402	596	326	263	368	656	250	1493	122	5'-3' exoribonuclease 1 (XRN1)
B23R05C11	23-11-5	Hs~MGC:BC047583.1~uORF:IOH26438	394	297	430	350	140	269	938	223	218	14	SPARC related modular calcium binding 2 (SMOC2)
B23R05C12	23-12-5	Hs~MGC:BC047583.1~uORF:IOH26438	428	272	481	349	96	265	889	238	444	176	SPARC related modular calcium binding 2 (SMOC2)
B23R05C13	23-13-5	Hs~MGC:NM_178126.2~uORF:IOH26767	520	1052	990	455	556	507	662	1279	1433	96	family with sequence similarity 134, member C (FAM134C)
B23R05C14	23-14-5	Hs~MGC:NM_178126.2~uORF:IOH26767	510	1139	938	451	564	493	694	1209	1721	80	family with sequence similarity 134, member C (FAM134C)
B23R05C15	23-15-5	Hs~Ref:NM_019891.1~uORF:IOH26775	537	164	554	213	186	757	503	207	455	65	ERO1-like beta (S. cerevisiae) (ERO1LB)
B23R05C16	23-16-5	Hs~Ref:NM_019891.1~uORF:IOH26775	320	146	564	215	201	789	394	192	396	157	ERO1-like beta (S. cerevisiae) (ERO1LB)
B23R05C17	23-17-5	Hs~Ref:NM_022107.1~uORF:IOH12525	438	228	596	154	348	2848	350	599	759	194	G-protein signaling modulator 3 (AGS3-like, C. elegans) (GPSM3)
B23R05C18	23-18-5	Hs~Ref:NM_022107.1~uORF:IOH12525	480	238	577	108	356	-51	341	596	738	219	G-protein signaling modulator 3 (AGS3-like, C. elegans) (GPSM3)
B23R05C19	23-19-5	Hs~Ref:NM_015955.2~uORF:IOH12624	1726	2004	1310	1329	811	991	4224	1623	1527	708	mediator of cell motility 1 (MEMO1)
B23R05C20	23-20-5	Hs~Ref:NM_015955.2~uORF:IOH12624	1795	2006	1256	1449	793	1600	4184	1586	1495	720	mediator of cell motility 1 (MEMO1)
B23R05C21	23-21-5	Hs~Ref:NM_015944.2~uORF:IOH12631	1409	1269	2199	1310	943	6095	3486	762	2637	532	amidohydrolase domain containing 2 (AMDHD2)
B23R05C22	23-22-5	Hs~Ref:NM_015944.2~uORF:IOH12631	1350	1299	2265	995	953	6581	3213	749	2688	507	amidohydrolase domain containing 2 (AMDHD2)
B23R06C01	23-1-6	Hs~Ref:NM_144611.1~uORF:IOH12901	458	1820	617	331	383	420	550	412	955	297	Cytochrome b5 domain-containing protein 2
B23R06C02	23-2-6	Hs~Ref:NM_144611.1~uORF:IOH12901	543	1588	649	357	403	411	547	566	979	243	Cytochrome b5 domain-containing protein 2
B23R06C03	23-3-6	Hs~Ref:NM_020199.1~uORF:IOH45786	820	289	987	342	339	677	868	520	716	148	chromosome 5 open reading frame 15 (C5orf15)
B23R06C04	23-4-6	Hs~Ref:NM_020199.1~uORF:IOH45786	702	306	968	330	357	644	942	492	705	105	chromosome 5 open reading frame 15 (C5orf15)
B23R06C05	23-5-6	Hs~Ref:NM_002832.2~uORF:IOH45836	1737	1956	2308	1945	1033	3960	4614	2241	1399	618	protein tyrosine phosphatase, non-receptor type 7 (PTPN7), transcript variant 1
B23R06C06	23-6-6	Hs~Ref:NM_002832.2~uORF:IOH45836	1741	1905	2168	1986	1103	3909	4924	2220	1430	1616	protein tyrosine phosphatase, non-receptor type 7 (PTPN7), transcript variant 1
B23R06C07	23-7-6	Hs~MGC:BC063479.1~uORF:IOH39883	975	388	752	359	415	586	969	610	759	1205	La ribonucleoprotein domain family, member 4 (LARP4)
B23R06C08	23-8-6	Hs~MGC:BC063479.1~uORF:IOH39883	901	478	715	374	395	502	954	649	732	113	La ribonucleoprotein domain family, member 4 (LARP4)
B23R06C09	23-9-6	Hs~Ref:NM_207645.1~uORF:IOH40066	421	436	476	326	444	443	852	426	1024	264	similar to expressed sequence AI593442 (LOC399947)
B23R06C10	23-10-6	Hs~Ref:NM_207645.1~uORF:IOH40066	434	478	484	311	485	401	787	420	983	196	similar to expressed sequence AI593442 (LOC399947)
B23R06C11	23-11-6	Hs~Ref:NM_197972.1~uORF:IOH45886	827	668	4812	987	556	764	1474	760	1560	418	non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase) (NME7), transcript variant 2
B23R06C12	23-12-6	Hs~Ref:NM_197972.1~uORF:IOH45886	849	674	4469	1038	524	700	1674	758	1544	421	non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase) (NME7), transcript variant 2
B23R06C13	23-13-6	Hs~Ref:NM_183041.1~uORF:IOH45814	593	270	622	255	283	387	548	665	1425	327	dystrobrevin binding protein 1 (DTNBP1), transcript variant 3
B23R06C14	23-14-6	Hs~Ref:NM_183041.1~uORF:IOH45814	563	315	612	242	286	403	533	624	1457	347	dystrobrevin binding protein 1 (DTNBP1), transcript variant 3
B23R06C15	23-15-6	Hs~Ref:NM_006172.1~uORF:IOH45889	433	244	576	299	280	285	593	340	739	261	natriuretic peptide precursor A (NPPA)
B23R06C16	23-16-6	Hs~Ref:NM_006172.1~uORF:IOH45889	340	235	545	323	272	275	601	412	650	109	natriuretic peptide precursor A (NPPA)
B23R06C17	23-17-6	Hs~Ref:NM_198723.1~uORF:IOH45764	1280	701	934	1096	876	1203	1895	593	4531	1485	transcription elongation factor A (SII), 2 (TCEA2), transcript variant 2
B23R06C18	23-18-6	Hs~Ref:NM_198723.1~uORF:IOH45764	1285	654	897	1148	870	1031	1966	594	4759	1508	transcription elongation factor A (SII), 2 (TCEA2), transcript variant 2
B23R06C19	23-19-6	Hs~Ref:NM_005168.3~uORF:IOH55962	349	1982	631	527	532	927	723	367	1321	424	Rho-related GTP-binding protein RhoE
B23R06C20	23-20-6	Hs~Ref:NM_005168.3~uORF:IOH55962	109	1944	594	461	556	448	711	365	1234	433	Rho-related GTP-binding protein RhoE
B23R07C03	23-3-7	Hs~MGC:NM_152740.2~uORF:IOH21624	270	226	305	189	175	95	254	345	283	95	3-hydroxyisobutyrate dehydrogenase, mitochondrial
B23R07C04	23-4-7	Hs~MGC:NM_152740.2~uORF:IOH21624	259	242	312	407	173	157	284	417	327	75	3-hydroxyisobutyrate dehydrogenase, mitochondrial
B23R07C07	23-7-7	Hs~Ref:NM_001823.2~uORF:IOH5211	409	352	595	516	1358	521	1734	418	1490	133	creatine kinase, brain (CKB)
B23R07C08	23-8-7	Hs~Ref:NM_001823.2~uORF:IOH5211	416	591	599	566	1323	526	1733	411	1536	376	creatine kinase, brain (CKB)
B23R07C09	23-9-7	Hs~Ref:NM_024025.1~uORF:IOH21299	461	358	714	519	405	431	670	463	709	347	dual specificity phosphatase 26 (putative) (DUSP26)
B23R07C10	23-10-7	Hs~Ref:NM_024025.1~uORF:IOH21299	430	330	652	541	430	424	698	450	730	350	dual specificity phosphatase 26 (putative) (DUSP26)
B23R07C11	23-11-7	Hs~Ref:NM_005605.2~uORF:IOH5608	476	503	838	399	458	793	603	563	1021	302	protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (PPP3CC)
B23R07C12	23-12-7	Hs~Ref:NM_005605.2~uORF:IOH5608	509	534	782	400	458	451	714	590	993	387	protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (PPP3CC)
B23R07C13	23-13-7	Hs~Ref:NM_016541.1~uORF:IOH39579	501	387	805	351	695	623	1027	590	1331	219	guanine nucleotide binding protein (G protein), gamma 13 (GNG13)
B23R07C14	23-14-7	Hs~Ref:NM_016541.1~uORF:IOH39579	502	377	812	354	694	686	997	545	1260	169	guanine nucleotide binding protein (G protein), gamma 13 (GNG13)
B23R07C15	23-15-7	Hs~Ref:NM_016542.2~uORF:IOH39650	471	451	852	411	437	754	672	454	805	178	serine/threonine protein kinase MST4 (MST4), transcript variant 1
B23R07C16	23-16-7	Hs~Ref:NM_016542.2~uORF:IOH39650	488	483	820	379	446	781	725	476	775	103	serine/threonine protein kinase MST4 (MST4), transcript variant 1
B23R07C17	23-17-7	Hs~MGC:BC045535.1~uORF:IOH26895	2546	1543	3434	995	1104	1187	7590	1057	3019	510	TRM1-like protein
B23R07C18	23-18-7	Hs~MGC:BC045535.1~uORF:IOH26895	2667	1497	2962	963	1109	1061	8037	1019	131	522	TRM1-like protein
B23R07C19	23-19-7	Hs~MGC:BC040351.1~uORF:IOH25766	657	462	602	337	277	349	649	446	2682	355	FAD-dependent oxidoreductase domain containing 2 (FOXRED2)
B23R07C20	23-20-7	Hs~MGC:BC040351.1~uORF:IOH25766	346	307	601	358	289	858	654	438	795	393	FAD-dependent oxidoreductase domain containing 2 (FOXRED2)
B23R07C21	23-21-7	Hs~Ref:NM_003668.2~N/A	4150	2125	3578	2563	3137	1845	6011	2439	8386	1360	mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5), transcript variant 1
B23R07C22	23-22-7	Hs~Ref:NM_003668.2~N/A	3806	2090	3479	2644	3205	2212	5782	2443	8248	1405	mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5), transcript variant 1
B23R08C03	23-3-8	Hs~Ref:NM_017572.1~N/A	764	803	1339	656	1163	591	989	1027	2971	301	MAP kinase-interacting serine/threonine-protein kinase 2
B23R08C04	23-4-8	Hs~Ref:NM_017572.1~N/A	713	802	1305	812	1095	604	972	1173	2975	443	MAP kinase-interacting serine/threonine-protein kinase 2
B23R08C05	23-5-8	Hs~Ref:NM_017593.2~N/A	632	746	1329	812	1371	423	922	1457	2406	417	BMP-2-inducible protein kinase
B23R08C06	23-6-8	Hs~Ref:NM_017593.2~N/A	594	753	1353	625	1365	424	915	936	2379	381	BMP-2-inducible protein kinase
B23R08C07	23-7-8	Hs~MGC:BC000583.1~uORF:IOH22887	525	3306	1079	307	529	1046	1894	1224	1090	972	Thimet oligopeptidase
B23R08C08	23-8-8	Hs~MGC:BC000583.1~uORF:IOH22887	509	3245	1064	317	543	1051	1893	1190	1109	459	Thimet oligopeptidase
B23R08C09	23-9-8	Hs~MGC:BC015562.1~uORF:IOH22914	406	8551	2376	395	2205	3037	1971	2033	1346	391	AKT1 substrate 1 (proline-rich) (AKT1S1)
B23R08C10	23-10-8	Hs~MGC:BC015562.1~uORF:IOH22914	420	8656	2243	364	2251	3014	2002	1956	1450	286	AKT1 substrate 1 (proline-rich) (AKT1S1)
B23R08C11	23-11-8	Hs~Ref:NM_004699.1~uORF:IOH4655	4953	2317	7233	6448	8564	28686	10248	15419	12854	803	family with sequence similarity 50, member A (FAM50A)
B23R08C12	23-12-8	Hs~Ref:NM_004699.1~uORF:IOH4655	4949	2474	7027	6131	8960	29268	10244	14480	13728	756	family with sequence similarity 50, member A (FAM50A)
B23R08C13	23-13-8	Hs~MGC:BC014394.1~uORF:IOH22936	3114	3545	15712	15291	6020	3924	14749	10687	5819	2554	A.T hook DNA-binding motif-containing protein 1
B23R08C14	23-14-8	Hs~MGC:BC014394.1~uORF:IOH22936	3133	3610	15084	14743	6408	4016	15382	9777	5777	2586	A.T hook DNA-binding motif-containing protein 1
B23R08C15	23-15-8	Hs~Ref:NM_201259.1~uORF:IOH45586	6511	3006	4824	10635	3487	3424	7243	5178	4855	2114	Mitochondrial import inner membrane translocase subunit TIM14
B23R08C16	23-16-8	Hs~Ref:NM_201259.1~uORF:IOH45586	6669	2874	4688	10188	3601	3332	7248	5202	5119	2180	Mitochondrial import inner membrane translocase subunit TIM14
B23R08C17	23-17-8	Hs~Ref:NM_173522.1~uORF:IOH44595	3066	1318	2862	1197	1081	1219	1680	1401	2923	687	Uncharacterized protein CXorf42
B23R08C18	23-18-8	Hs~Ref:NM_173522.1~uORF:IOH44595	2861	1413	2661	1260	1043	1337	1636	1418	3191	675	Uncharacterized protein CXorf42
B23R08C19	23-19-8	Hs~Ref:NM_156036.1~uORF:IOH44550	2371	1014	1127	1245	1732	2271	1557	3594	2587	987	Homeobox protein Hox-B6
B23R08C20	23-20-8	Hs~Ref:NM_156036.1~uORF:IOH44550	2224	980	1089	1265	1915	2349	1454	3491	2722	1012	Homeobox protein Hox-B6
B23R08C21	23-21-8	Hs~Ref:NM_003798.1~uORF:IOH44444	6100	2262	2636	4591	1062	1185	3462	1624	3153	868	Alpha-catulin
B23R08C22	23-22-8	Hs~Ref:NM_003798.1~uORF:IOH44444	6144	2274	2639	4554	1044	1482	3372	1600	3231	743	Alpha-catulin
B23R09C01	23-1-9	Hs~MGC:BC002508.2~uORF:IOH3971	727	1007	1032	495	465	672	854	846	1646	243	acetylserotonin O-methyltransferase-like (ASMTL)
B23R09C02	23-2-9	Hs~MGC:BC002508.2~uORF:IOH3971	913	1019	639	457	482	819	926	822	1527	160	acetylserotonin O-methyltransferase-like (ASMTL)
B23R09C03	23-3-9	Hs~MGC:BC001371.2~uORF:IOH3977	434	374	428	263	216	262	544	289	588	146	ER degradation enhancer, mannosidase alpha-like 2 (EDEM2)
B23R09C04	23-4-9	Hs~MGC:BC001371.2~uORF:IOH3977	408	303	455	264	354	321	547	240	660	214	ER degradation enhancer, mannosidase alpha-like 2 (EDEM2)
B23R09C05	23-5-9	Hs~Ref:NM_001722.2~uORF:IOH4103	2548	868	1551	1802	588	840	3272	1153	1516	1711	polymerase (RNA) III (DNA directed) polypeptide D, 44kDa (POLR3D)
B23R09C06	23-6-9	Hs~Ref:NM_001722.2~uORF:IOH4103	2483	866	1566	1383	532	1157	3238	971	1485	1662	polymerase (RNA) III (DNA directed) polypeptide D, 44kDa (POLR3D)
B23R09C07	23-7-9	Hs~Ref:NM_004550.3~uORF:IOH4011	382	288	392	294	291	244	390	256	547	95	NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) (NDUFS2)
B23R09C08	23-8-9	Hs~Ref:NM_004550.3~uORF:IOH4011	496	283	386	424	275	295	484	371	679	1359	NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) (NDUFS2)
B23R09C09	23-9-9	Hs~MGC:BC050551.1~uORF:IOH26948	2452	1847	1558	1013	3667	2464	2220	1447	1298	3567	BCL2-associated athanogene 5 (BAG5)
B23R09C10	23-10-9	Hs~MGC:BC050551.1~uORF:IOH26948	2608	1818	1517	1017	3900	2410	2171	1398	1667	1460	BCL2-associated athanogene 5 (BAG5)
B23R09C11	23-11-9	Hs~Ref:NM_197964.1~uORF:IOH7576	883	710	922	621	468	737	1089	679	1062	479	chromosome 7 open reading frame 55 (C7orf55)
B23R09C12	23-12-9	Hs~Ref:NM_197964.1~uORF:IOH7576	855	737	906	591	483	640	1212	715	1067	535	chromosome 7 open reading frame 55 (C7orf55)
B23R09C13	23-13-9	Hs~MGC:BC011250.1~uORF:IOH10217	289	299	438	271	374	293	322	347	649	96	myotubularin related protein 1 (MTMR1)
B23R09C14	23-14-9	Hs~MGC:BC011250.1~uORF:IOH10217	273	296	450	297	366	285	297	349	615	11	myotubularin related protein 1 (MTMR1)
B23R09C15	23-15-9	Hs~MGC:BC007015.1~uORF:IOH29312	3376	8215	1639	1209	965	1478	2257	2842	2447	526	cyclin E2 (CCNE2)
B23R09C16	23-16-9	Hs~MGC:BC007015.1~uORF:IOH29312	3299	8247	1581	1093	994	1537	2327	2643	2228	555	cyclin E2 (CCNE2)
B23R09C17	23-17-9	Hs~MGC:BC000419.2~uORF:IOH46092	720	423	725	421	329	569	562	407	1030	223	catechol-O-methyltransferase (COMT)
B23R09C18	23-18-9	Hs~MGC:BC000419.2~uORF:IOH46092	711	463	697	484	338	548	562	408	863	235	catechol-O-methyltransferase (COMT)
B23R09C19	23-19-9	Hs~Ref:NM_152743.2~uORF:IOH46177	568	311	672	405	325	479	474	385	662	238	chromosome 7 open reading frame 27 (C7orf27)
B23R09C20	23-20-9	Hs~Ref:NM_152743.2~uORF:IOH46177	558	337	649	349	335	447	492	407	688	271	chromosome 7 open reading frame 27 (C7orf27)
B23R09C21	23-21-9	Hs~MGC:BC005830.2~uORF:IOH46117	283	127	562	1659	120	2362	294	699	608	1083	annexin A9 (ANXA9)
B23R09C22	23-22-9	Hs~MGC:BC005830.2~uORF:IOH46117	97	169	660	881	135	2479	1053	547	501	1196	annexin A9 (ANXA9)
B23R10C01	23-1-10	Hs~Ref:NM_005663.2~uORF:IOH46152	5531	2562	4848	4872	3018	8737	13440	11172	7268	1106	Wolf-Hirschhorn syndrome candidate 2 (WHSC2)
B23R10C02	23-2-10	Hs~Ref:NM_005663.2~uORF:IOH46152	5409	2805	4611	4795	3289	8752	14331	10498	7620	1029	Wolf-Hirschhorn syndrome candidate 2 (WHSC2)
B23R10C03	23-3-10	Hs~MGC:BC063107.1~uORF:IOH40711	718	655	784	1475	510	769	1146	443	975	266	thyroid peroxidase (TPO)
B23R10C04	23-4-10	Hs~MGC:BC063107.1~uORF:IOH40711	654	563	712	1803	524	781	1104	430	1042	304	thyroid peroxidase (TPO)
B23R10C05	23-5-10	Hs~Ref:NM_152230.2~uORF:IOH40760	1200	523	901	799	634	799	1514	787	1251	360	inositol polyphosphate multikinase (IPMK)
B23R10C06	23-6-10	Hs~Ref:NM_152230.2~uORF:IOH40760	1154	547	844	512	606	762	1550	888	1392	364	inositol polyphosphate multikinase (IPMK)
B23R10C07	23-7-10	Hs~Ref:NM_007135.1~uORF:IOH40671	665	438	686	490	559	705	1147	768	1098	376	zinc finger protein 79 (ZNF79)
B23R10C08	23-8-10	Hs~Ref:NM_007135.1~uORF:IOH40671	594	423	657	676	509	720	1156	715	1081	2844	zinc finger protein 79 (ZNF79)
B23R10C09	23-9-10	Hs~MGC:BC015665.2~uORF:IOH40642	2627	3448	2677	5306	5552	4390	4488	4535	5861	2696	LATS, large tumor suppressor, homolog 1 (Drosophila) (LATS1)
B23R10C10	23-10-10	Hs~MGC:BC015665.2~uORF:IOH40642	2773	3582	2540	5185	5805	4403	4506	4601	5933	2357	LATS, large tumor suppressor, homolog 1 (Drosophila) (LATS1)
B23R11C21	23-21-11	Hs~MGC:BC032008.1~uORF:IOH22169	166	110	326	264	84	215	737	215	370	124	mitochondrial ribosomal protein L50 (MRPL50)
B23R11C22	23-22-11	Hs~MGC:BC032008.1~uORF:IOH22169	1355	120	300	259	97	194	356	242	380	66	mitochondrial ribosomal protein L50 (MRPL50)
B23R12C01	23-1-12	Hs~Ref:NM_152737.1~uORF:IOH22453	500	414	593	249	185	342	395	276	598	82	ring finger protein 182 (RNF182)
B23R12C02	23-2-12	Hs~Ref:NM_152737.1~uORF:IOH22453	508	388	552	262	162	318	412	249	702	285	ring finger protein 182 (RNF182)
B23R12C03	23-3-12	Hs~MGC:BC009194.2~uORF:IOH13702	825	466	491	518	469	1061	735	638	798	679	polymerase (DNA directed), gamma 2, accessory subunit (POLG2)
B23R12C04	23-4-12	Hs~MGC:BC009194.2~uORF:IOH13702	597	449	467	487	460	922	664	548	822	685	polymerase (DNA directed), gamma 2, accessory subunit (POLG2)
B23R12C05	23-5-12	Hs~Ref:NM_005434.3~uORF:IOH5127	303	356	349	435	356	359	405	393	682	187	mal, T-cell differentiation protein-like (MALL)
B23R12C06	23-6-12	Hs~Ref:NM_005434.3~uORF:IOH5127	326	405	365	378	341	391	387	395	574	223	mal, T-cell differentiation protein-like (MALL)
B23R12C07	23-7-12	Hs~MGC:BC032347.1~uORF:IOH21704	22016	8842	8579	17057	7748	6008	18453	4505	16588	11784	chromosome 8 open reading frame 59 (C8orf59)
B23R12C08	23-8-12	Hs~MGC:BC032347.1~uORF:IOH21704	22353	8002	8305	16518	7398	5836	19037	4642	17266	14247	chromosome 8 open reading frame 59 (C8orf59)
B23R12C11	23-11-12	Hs~MGC:NM_178152.1~uORF:IOH20954	5866	6853	8978	7514	6476	4783	5996	3050	8053	1596	Neuronal migration protein doublecortin
B23R12C12	23-12-12	Hs~MGC:NM_178152.1~uORF:IOH20954	6013	7167	9018	7453	6822	4816	6120	2988	9154	1592	Neuronal migration protein doublecortin
B23R12C13	23-13-12	Hs~MGC:BC002769.1~uORF:IOH5310	4844	248	459	346	452	1092	1298	2293	876	351	UPF0549 protein C20orf43 homolog
B23R12C14	23-14-12	Hs~MGC:BC002769.1~uORF:IOH5310	4890	380	442	314	432	1005	1341	2129	958	352	UPF0549 protein C20orf43 homolog
B23R12C15	23-15-12	Hs~Ref:NM_001001683.1~uORF:IOH45938	991	736	1212	745	582	844	1177	765	2023	483	mediator complex subunit 11 (MED11)
B23R12C16	23-16-12	Hs~Ref:NM_001001683.1~uORF:IOH45938	1032	683	1136	744	629	808	1175	771	2103	462	mediator complex subunit 11 (MED11)
B23R12C17	23-17-12	Hs~Ref:NM_030781.2~uORF:IOH41873	1234	1093	1420	1009	798	1237	1855	1163	2719	1117	Collectin-12
B23R12C18	23-18-12	Hs~Ref:NM_030781.2~uORF:IOH41873	1324	973	1316	1005	854	1215	1725	1172	3420	1192	Collectin-12
B23R12C19	23-19-12	Hs~Ref:NM_014255.3~uORF:IOH45647	1180	985	1101	750	662	991	1311	889	2643	611	transmembrane protein 4 (TMEM4)
B23R12C20	23-20-12	Hs~Ref:NM_014255.3~uORF:IOH45647	1287	988	1068	726	625	981	1671	947	2198	671	transmembrane protein 4 (TMEM4)
B23R12C21	23-21-12	Hs~Ref:NM_007162.1~uORF:IOH21660	5410	4670	2474	1895	15028	3343	3134	2666	3459	1048	transcription factor EB (TFEB)
B23R12C22	23-22-12	Hs~Ref:NM_007162.1~uORF:IOH21660	4998	4400	2357	1750	15087	3317	3114	2553	3299	987	transcription factor EB (TFEB)
B23R13C01	23-1-13	Hs~MGC:BC042161.1~uORF:IOH28007	500	675	651	369	522	412	644	604	1581	187	Trafficking protein particle complex subunit 5
B23R13C02	23-2-13	Hs~MGC:BC042161.1~uORF:IOH28007	568	683	678	387	580	400	605	615	1538	250	Trafficking protein particle complex subunit 5
B23R13C03	23-3-13	Hs~Ref:NM_152663.2~uORF:IOH26530	401	479	390	207	261	231	396	208	1506	88	Ral GEF with PH domain and SH3 binding motif 2 (RALGPS2), transcript variant 2
B23R13C04	23-4-13	Hs~Ref:NM_152663.2~uORF:IOH26530	469	427	360	203	314	208	356	207	1505	89	Ral GEF with PH domain and SH3 binding motif 2 (RALGPS2), transcript variant 2
B23R13C05	23-5-13	Hs~Ref:NM_005180.1~uORF:IOH13688	176	153	284	193	65	164	372	211	496	160	BMI1 polycomb ring finger oncogene (BMI1)
B23R13C06	23-6-13	Hs~Ref:NM_005180.1~uORF:IOH13688	180	214	295	163	30	164	349	207	540	307	BMI1 polycomb ring finger oncogene (BMI1)
B23R13C07	23-7-13	Hs~Ref:NM_020139.1~uORF:IOH5065	41	86	213	19	115	148	154	179	160	12	3-hydroxybutyrate dehydrogenase, type 2 (BDH2)
B23R13C08	23-8-13	Hs~Ref:NM_020139.1~uORF:IOH5065	81	73	256	375	43	122	159	194	419	10	3-hydroxybutyrate dehydrogenase, type 2 (BDH2)
B23R13C09	23-9-13	Hs~Ref:NM_014719.1~uORF:IOH60025	666	642	943	612	528	786	990	694	1214	359	Protein FAM115A
B23R13C10	23-10-13	Hs~Ref:NM_014719.1~uORF:IOH60025	667	673	1011	646	541	807	980	600	1290	426	Protein FAM115A
B23R13C17	23-17-13	Hs~MGC:BC062592.1~uORF:IOH39886	3316	1310	2477	1050	1536	1312	2076	1163	3422	628	transmembrane protein 71 (TMEM71)
B23R13C18	23-18-13	Hs~MGC:BC062592.1~uORF:IOH39886	3400	1272	2229	1095	1535	1281	2109	1179	4116	651	transmembrane protein 71 (TMEM71)
B23R13C19	23-19-13	Hs~MGC:BC064144.1~uORF:IOH40037	1040	2081	1057	1010	670	1597	1738	1713	1890	501	spermatogenesis associated 1 (SPATA1)
B23R13C20	23-20-13	Hs~MGC:BC064144.1~uORF:IOH40037	949	2019	1109	934	637	1640	1472	1665	1655	526	spermatogenesis associated 1 (SPATA1)
B23R13C21	23-21-13	Hs~Ref:NM_000939.1~uORF:IOH40048	2139	1280	1997	1144	1338	1615	2590	1278	2898	911	proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin) (POMC), transcript variant 2
B23R13C22	23-22-13	Hs~Ref:NM_000939.1~uORF:IOH40048	2293	1261	1964	1221	1362	1564	2335	1301	2950	851	proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin) (POMC), transcript variant 2
B23R14C01	23-1-14	Hs~MGC:BC067735.1~uORF:IOH40060	1254	800	2255	1820	842	1261	5847	1304	2095	593	hypothetical protein DKFZp761B107 (DKFZp761B107)
B23R14C02	23-2-14	Hs~MGC:BC067735.1~uORF:IOH40060	1119	813	2292	1813	835	1258	5907	1321	2263	616	hypothetical protein DKFZp761B107 (DKFZp761B107)
B23R14C05	23-5-14	Hs~Ref:NM_006224.2~uORF:IOH57274	379	308	467	865	608	478	630	871	739	87	Phosphatidylinositol transfer protein alpha isoform
B23R14C06	23-6-14	Hs~Ref:NM_006224.2~uORF:IOH57274	357	293	448	824	615	484	639	851	689	107	Phosphatidylinositol transfer protein alpha isoform
B23R14C07	23-7-14	Hs~MGC:BC060841.1~uORF:IOH29167	338	296	499	269	283	427	798	419	664	263	integrator complex subunit 5 (INTS5)
B23R14C08	23-8-14	Hs~MGC:BC060841.1~uORF:IOH29167	624	293	484	398	191	387	779	449	625	240	integrator complex subunit 5 (INTS5)
B23R14C09	23-9-14	Hs~Ref:NM_002444.1~uORF:IOH2457	824	1219	1767	644	1017	2114	6915	658	959	393	moesin (MSN)
B23R14C10	23-10-14	Hs~Ref:NM_002444.1~uORF:IOH2457	918	1349	1216	605	1092	2078	5890	698	940	608	moesin (MSN)
B23R14C11	23-11-14	Hs~Ref:NM_032726.1~uORF:IOH21106	380	309	881	495	239	603	1520	664	934	607	phospholipase C, delta 4 (PLCD4)
B23R14C12	23-12-14	Hs~Ref:NM_032726.1~uORF:IOH21106	375	329	858	486	260	631	1570	620	885	480	phospholipase C, delta 4 (PLCD4)
B23R14C13	23-13-14	Hs~MGC:BC011707.1~uORF:IOH13976	1091	2887	736	1327	872	1519	3372	1981	3971	871	nuclear receptor binding factor 2 (NRBF2)
B23R14C14	23-14-14	Hs~MGC:BC011707.1~uORF:IOH13976	1054	3374	750	1265	918	1454	3355	1987	3854	817	nuclear receptor binding factor 2 (NRBF2)
B23R14C15	23-15-14	Hs~MGC:BC001396.1~uORF:IOH3939	1433	774	15312	482	588	753	2502	3522	3117	317	chromosome 9 open reading frame 32 (C9orf32)
B23R14C16	23-16-14	Hs~MGC:BC001396.1~uORF:IOH3939	1398	775	13955	457	581	747	2674	3262	3068	320	chromosome 9 open reading frame 32 (C9orf32)
B23R14C17	23-17-14	Hs~MGC:BC004190.1~uORF:IOH3910	433	387	582	343	362	413	648	477	739	287	calcium binding atopy-related autoantigen 1 (CBARA1)
B23R14C18	23-18-14	Hs~MGC:BC004190.1~uORF:IOH3910	397	339	471	357	381	415	847	446	657	319	calcium binding atopy-related autoantigen 1 (CBARA1)
B23R14C19	23-19-14	Hs~MGC:BC073866.1~uORF:IOH61756	333	288	1231	353	433	6505	1172	737	1076	321	Protein arginine N-methyltransferase 6
B23R14C20	23-20-14	Hs~MGC:BC073866.1~uORF:IOH61756	233	347	1183	331	277	5935	1187	730	926	290	Protein arginine N-methyltransferase 6
B23R14C21	23-21-14	Hs~MGC:BC069428.1~uORF:IOH61864	524	532	467	278	2	464	659	676	928	272	calcium and integrin binding family member 3, mRNA (cDNA clone MGC:96922 IMAGE:7262131), complete cds
B23R14C22	23-22-14	Hs~MGC:BC069428.1~uORF:IOH61864	373	418	451	271	-1	458	664	613	789	263	calcium and integrin binding family member 3, mRNA (cDNA clone MGC:96922 IMAGE:7262131), complete cds
B23R15C01	23-1-15	Hs~MGC:BC067760.1~uORF:IOH61701	457	226	443	229	295	295	457	581	640	186	mitogen-activated protein kinase kinase 2 pseudogene, mRNA (cDNA clone MGC:87051 IMAGE:5296643), complete cds.
B23R15C02	23-2-15	Hs~MGC:BC067760.1~uORF:IOH61701	493	248	484	282	274	280	477	579	657	98	mitogen-activated protein kinase kinase 2 pseudogene, mRNA (cDNA clone MGC:87051 IMAGE:5296643), complete cds.
B23R15C03	23-3-15	Hs~MGC:BC032540.1~uORF:IOH61730	288	224	352	228	331	235	547	374	536	218	F-box only protein 22
B23R15C04	23-4-15	Hs~MGC:BC032540.1~uORF:IOH61730	288	253	362	317	124	271	514	389	540	200	F-box only protein 22
B23R15C05	23-5-15	Hs~MGC:BC060319.1~uORF:IOH29295	1094	374	670	368	469	2058	2083	487	1000	330	chromosome 19 open reading frame 33 (C19orf33)
B23R15C06	23-6-15	Hs~MGC:BC060319.1~uORF:IOH29295	1111	409	672	392	488	2115	2096	472	1247	323	chromosome 19 open reading frame 33 (C19orf33)
B23R15C07	23-7-15	Hs~MGC:BC054022.1~uORF:IOH29469	343	1666	3032	255	128	241	280	292	299	121	P antigen family, member 2 (prostate associated) (PAGE2)
B23R15C08	23-8-15	Hs~MGC:BC054022.1~uORF:IOH29469	363	1536	2759	303	115	172	362	228	441	148	P antigen family, member 2 (prostate associated) (PAGE2)
B23R15C09	23-9-15	Hs~MGC:BC040177.2~uORF:IOH28709	328	308	562	259	408	356	505	337	897	290	protein phosphatase 1H (PP2C domain containing) (PPM1H)
B23R15C10	23-10-15	Hs~MGC:BC040177.2~uORF:IOH28709	317	321	520	269	388	323	527	413	750	351	protein phosphatase 1H (PP2C domain containing) (PPM1H)
B23R15C11	23-11-15	Hs~MGC:BC059950.1~uORF:IOH29294	697	308	437	423	319	568	544	505	930	2082	ribosomal protein L12 (RPL12)
B23R15C12	23-12-15	Hs~MGC:BC059950.1~uORF:IOH29294	742	322	437	392	330	548	590	457	904	2020	ribosomal protein L12 (RPL12)
B23R15C13	23-13-15	Hs~Ref:NM_016281.2~CAT:PV3652	368	383	2642	351	268	507	767	797	1441	280	TAO kinase 3 (TAOK3)
B23R15C14	23-14-15	Hs~Ref:NM_016281.2~CAT:PV3652	443	381	2657	351	310	500	703	773	1579	298	TAO kinase 3 (TAOK3)
B23R15C17	23-17-15	Hs~Ref:NM_005233.3~CAT:PV3359	2203	4642	1716	2477	3311	2378	5648	964	4598	1234	Ephrin receptor A3 (EPHA3), transcript variant 1
B23R15C18	23-18-15	Hs~Ref:NM_005233.3~CAT:PV3359	2007	4526	1562	2988	3471	2384	9299	898	4247	1309	Ephrin receptor A3 (EPHA3), transcript variant 1
B23R16C01	23-1-16	Hs~Ref:NM_004850.2~CAT:PV3759	89	953	223	244	101	189	231	358	235	105	Rho-associated protein kinase 2
B23R16C02	23-2-16	Hs~Ref:NM_004850.2~CAT:PV3759	83	962	240	215	111	188	250	199	252	83	Rho-associated protein kinase 2
B23R16C03	23-3-16	Hs~Ref:NM_002376.2~CAT:PV4819	1928	1121	1553	4376	2182	2881	5795	4882	2030	2930	MAP/microtubule affinity-regulating kinase 3 (MARK3)
B23R16C04	23-4-16	Hs~Ref:NM_002376.2~CAT:PV4819	1840	1137	1234	4400	2000	2653	6215	4203	2019	3012	MAP/microtubule affinity-regulating kinase 3 (MARK3)
B23R16C05	23-5-16	Hs~Ref:NM_002957.3~CAT:PV4799	306	282	259	246	131	578	352	194	2439	180	retinoid X receptor, alpha (RXRA)
B23R16C06	23-6-16	Hs~Ref:NM_002957.3~CAT:PV4799	302	270	292	198	131	596	344	208	2361	131	retinoid X receptor, alpha (RXRA)
B23R16C07	23-7-16	Hs~MGC:BC094800.1~uORF:IOH62619	2129	2110	2153	2451	2605	8124	5022	3500	10879	1312	Jouberin
B23R16C08	23-8-16	Hs~MGC:BC094800.1~uORF:IOH62619	1869	1902	2131	2451	2717	7682	5527	3554	11297	1190	Jouberin
B23R16C09	23-9-16	Hs~MGC:BC094687.1~uORF:IOH62581	611	390	740	490	446	710	1576	567	1321	365	Elongation factor 1-alpha 1
B23R16C10	23-10-16	Hs~MGC:BC094687.1~uORF:IOH62581	623	409	684	505	503	885	1711	686	1201	369	Elongation factor 1-alpha 1
B23R16C11	23-11-16	Hs~MGC:BC096312.2~uORF:IOH63282	444	272	412	1228	457	923	1440	1762	1556	1566	Butyrophilin subfamily 1 member A1
B23R16C12	23-12-16	Hs~MGC:BC096312.2~uORF:IOH63282	254	347	248	1135	271	832	1302	720	861	2219	Butyrophilin subfamily 1 member A1
B23R16C13	23-13-16	Hs~MGC:BC100290.1~uORF:IOH62780	2890	299	573	386	420	487	834	380	878	145	Nucleotide-binding protein 1
B23R16C14	23-14-16	Hs~MGC:BC100290.1~uORF:IOH62780	2980	366	582	345	360	458	712	357	919	141	Nucleotide-binding protein 1
B23R16C15	23-15-16	Hs~Ref:NM_001814.1~uORF:IOH29634	541	535	661	383	318	573	729	412	912	367	cathepsin C (CTSC), transcript variant 1
B23R16C16	23-16-16	Hs~Ref:NM_001814.1~uORF:IOH29634	504	512	630	343	340	533	752	396	864	306	cathepsin C (CTSC), transcript variant 1
B23R16C17	23-17-16	Hs~Ref:NM_000882.1~uORF:IOH29844	631	466	669	381	388	520	1048	736	996	270	interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) (IL12A)
B23R16C18	23-18-16	Hs~Ref:NM_000882.1~uORF:IOH29844	670	438	590	492	413	509	1287	727	964	291	interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) (IL12A)
B23R16C19	23-19-16	Hs~MGC:BC053898.1~uORF:IOH29029	1149	640	748	849	582	729	1169	596	1309	657	homeobox C8 (HOXC8)
B23R16C20	23-20-16	Hs~MGC:BC053898.1~uORF:IOH29029	979	700	666	813	603	709	1147	642	1460	666	homeobox C8 (HOXC8)
B23R16C21	23-21-16	Hs~Ref:NM_016656.1~uORF:IOH29784	1165	566	1434	751	589	714	1436	593	2579	325	Ras-related GTP binding B (RRAGB), transcript variant RAGBl
B23R16C22	23-22-16	Hs~Ref:NM_016656.1~uORF:IOH29784	1084	585	1369	741	577	767	1466	566	2000	311	Ras-related GTP binding B (RRAGB), transcript variant RAGBl
B23R17C01	23-1-17	Hs~MGC:BC014144.1~uORF:IOH12115	1162	938	1193	778	1293	1331	2362	1473	2212	703	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) (ELAVL3)
B23R17C02	23-2-17	Hs~MGC:BC014144.1~uORF:IOH12115	1168	822	1145	789	1293	1241	2280	1052	2377	855	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) (ELAVL3)
B23R17C03	23-3-17	Hs~Ref:NM_144590.1~uORF:IOH12404	1243	989	1380	825	1455	1031	1976	1213	1775	530	ankyrin repeat domain 22 (ANKRD22)
B23R17C04	23-4-17	Hs~Ref:NM_144590.1~uORF:IOH12404	1220	1020	1331	819	1500	1048	2033	1244	1824	503	ankyrin repeat domain 22 (ANKRD22)
B23R17C05	23-5-17	Hs~Ref:NM_000963.1~uORF:IOH11237	1069	780	1521	764	1072	1274	1662	1066	2348	511	prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (PTGS2)
B23R17C06	23-6-17	Hs~Ref:NM_000963.1~uORF:IOH11237	977	711	1490	765	1065	1256	1614	1071	2109	537	prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (PTGS2)
B23R17C07	23-7-17	Hs~Ref:NM_144710.1~uORF:IOH10821	1692	1374	3478	1437	1153	1828	1754	1647	4507	1360	septin 10 (SEPT10), transcript variant 1
B23R17C08	23-8-17	Hs~Ref:NM_144710.1~uORF:IOH10821	1772	1341	3251	1559	1203	1769	1822	1692	4475	1480	septin 10 (SEPT10), transcript variant 1
B23R17C11	23-11-17	Hs~Ref:NM_130807.1~uORF:IOH10112	3953	5598	2784	4786	5174	2555	4351	3483	4792	2746	MOB1, Mps One Binder kinase activator-like 2A (yeast) (MOBKL2A)
B23R17C12	23-12-17	Hs~Ref:NM_130807.1~uORF:IOH10112	3836	5149	2728	4864	5419	2473	5121	3214	5072	2124	MOB1, Mps One Binder kinase activator-like 2A (yeast) (MOBKL2A)
B23R17C13	23-13-17	Hs~MGC:BC042035.1~uORF:IOH62381	184	172	614	346	188	406	1152	771	1798	124	MGC72080 pseudogene, mRNA (cDNA clone MGC:48448 IMAGE:5266019), complete cds.
B23R17C14	23-14-17	Hs~MGC:BC042035.1~uORF:IOH62381	244	246	601	303	358	362	1119	624	650	112	MGC72080 pseudogene, mRNA (cDNA clone MGC:48448 IMAGE:5266019), complete cds.
B23R17C15	23-15-17	Hs~MGC:BC041172.1~uORF:IOH61509	352	420	1031	3849	576	2898	2868	1395	1250	314	Oxysterols receptor LXR-alpha
B23R17C16	23-16-17	Hs~MGC:BC041172.1~uORF:IOH61509	356	467	1008	3745	593	2730	3640	1404	1289	291	Oxysterols receptor LXR-alpha
B23R17C17	23-17-17	Hs~MGC:BC000503.1~uORF:IOH3515	1665	953	1696	590	422	1384	876	3179	1538	416	Rab9 effector protein with kelch motifs (RABEPK)
B23R17C18	23-18-17	Hs~MGC:BC000503.1~uORF:IOH3515	1659	921	1625	671	433	1373	845	3190	1574	431	Rab9 effector protein with kelch motifs (RABEPK)
B23R17C19	23-19-17	Hs~Ref:NM_002572.1~uORF:IOH3561	758	762	1990	312	369	19426	1582	868	1526	300	platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa (PAFAH1B2)
B23R17C20	23-20-17	Hs~Ref:NM_002572.1~uORF:IOH3561	781	775	1860	289	339	19221	1589	795	1927	266	platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa (PAFAH1B2)
B23R17C21	23-21-17	Hs~MGC:BC002906.2~uORF:IOH5684	1045	1214	345	354	366	474	505	865	323	307	Uridine-cytidine kinase 2
B23R17C22	23-22-17	Hs~MGC:BC002906.2~uORF:IOH5684	924	1192	334	366	326	457	578	826	1029	274	Uridine-cytidine kinase 2
B23R18C01	23-1-18	Hs~Ref:NM_000858.2~uORF:IOH6313	350	313	498	263	256	822	1928	478	657	132	guanylate kinase 1 (GUK1)
B23R18C02	23-2-18	Hs~Ref:NM_000858.2~uORF:IOH6313	358	318	539	289	341	774	1976	422	855	186	guanylate kinase 1 (GUK1)
B23R18C03	23-3-18	Hs~MGC:BC019239.1~uORF:IOH13580	659	713	5535	472	580	953	10286	3789	1563	336	Cation transport regulator-like protein 2
B23R18C04	23-4-18	Hs~MGC:BC019239.1~uORF:IOH13580	740	749	5379	449	591	935	10705	3720	1628	330	Cation transport regulator-like protein 2
B23R18C05	23-5-18	Hs~Ref:NM_002521.1~uORF:IOH22623	562	524	655	472	450	630	880	689	2012	408	natriuretic peptide precursor B (NPPB)
B23R18C06	23-6-18	Hs~Ref:NM_002521.1~uORF:IOH22623	526	515	673	490	498	642	999	623	1613	426	natriuretic peptide precursor B (NPPB)
B23R18C07	23-7-18	Hs~MGC:NM_152723.1~uORF:IOH27358	1339	1588	1602	7968	739	1269	2023	1953	2016	626	coiled-coil domain containing 89 (CCDC89)
B23R18C08	23-8-18	Hs~MGC:NM_152723.1~uORF:IOH27358	1235	1652	1604	8562	759	1213	2155	1858	2001	586	coiled-coil domain containing 89 (CCDC89)
B23R18C09	23-9-18	Hs~MGC:BC015734.1~uORF:IOH14771	572	490	732	438	476	575	750	574	1821	429	copine III (CPNE3)
B23R18C10	23-10-18	Hs~MGC:BC015734.1~uORF:IOH14771	583	435	675	476	479	560	853	642	1797	407	copine III (CPNE3)
B23R18C11	23-11-18	Hs~Ref:NM_012199.2~uORF:IOH55724	900	481	737	349	318	800	1638	635	981	453	Eukaryotic translation initiation factor 2C 1
B23R18C12	23-12-18	Hs~Ref:NM_012199.2~uORF:IOH55724	814	400	685	420	316	809	1550	548	1016	1813	Eukaryotic translation initiation factor 2C 1
B23R18C15	23-15-18	Hs~Ref:NM_001017926.1~uORF:IOH55729	2078	484	1137	364	510	714	3123	2097	4175	361	Zinc fingers and homeoboxes protein 1
B23R18C16	23-16-18	Hs~Ref:NM_001017926.1~uORF:IOH55729	2096	455	1084	407	484	778	3087	1866	4030	336	Zinc fingers and homeoboxes protein 1
B23R18C17	23-17-18	Hs~Ref:NM_198977.1~uORF:IOH57194	371	378	700	249	340	404	1437	710	831	258	Rho guanine nucleotide exchange factor 1
B23R18C18	23-18-18	Hs~Ref:NM_198977.1~uORF:IOH57194	402	422	654	469	363	436	1431	696	883	260	Rho guanine nucleotide exchange factor 1
B23R18C19	23-19-18	Hs~Ref:NM_016440.1~N/A	1142	1432	2130	921	1132	1770	1457	1666	4893	474	Serine/threonine-protein kinase VRK3
B23R18C20	23-20-18	Hs~Ref:NM_016440.1~N/A	1123	1405	1981	902	1161	1792	1527	1589	5628	455	Serine/threonine-protein kinase VRK3
B23R18C21	23-21-18	Hs~Ref:NM_004329.1~N/A	788	638	723	524	1041	596	743	573	2077	338	Bone morphogenetic protein receptor type-1A
B23R18C22	23-22-18	Hs~Ref:NM_004329.1~N/A	744	562	696	616	1053	586	679	535	1750	359	Bone morphogenetic protein receptor type-1A
B23R19C01	23-1-19	Hs~Ref:NM_001203.1~N/A	383	434	581	319	1264	423	535	514	1284	233	bone morphogenetic protein receptor, type IB (BMPR1B)
B23R19C02	23-2-19	Hs~Ref:NM_001203.1~N/A	346	415	558	334	1258	395	529	839	1468	328	bone morphogenetic protein receptor, type IB (BMPR1B)
B23R19C03	23-3-19	Hs~Ref:NM_005163.1~N/A	695	402	650	430	714	543	613	763	1546	277	RAC-alpha serine/threonine-protein kinase
B23R19C04	23-4-19	Hs~Ref:NM_005163.1~N/A	795	435	607	426	735	535	635	632	1478	266	RAC-alpha serine/threonine-protein kinase
B23R19C05	23-5-19	Hs~Ref:NM_173494.1~uORF:IOH27391	1265	1058	1785	1775	602	1192	4038	693	4968	379	chromosome X open reading frame 41 (CXorf41)
B23R19C06	23-6-19	Hs~Ref:NM_173494.1~uORF:IOH27391	1289	960	1754	1758	621	1166	4296	688	5634	356	chromosome X open reading frame 41 (CXorf41)
B23R19C07	23-7-19	Hs~Ref:NM_022059.1~uORF:IOH26382	450	643	653	382	347	463	645	645	776	247	chemokine (C-X-C motif) ligand 16 (CXCL16), transcript variant 1
B23R19C08	23-8-19	Hs~Ref:NM_022059.1~uORF:IOH26382	448	664	677	425	326	444	638	639	842	235	chemokine (C-X-C motif) ligand 16 (CXCL16), transcript variant 1
B23R19C09	23-9-19	Hs~Ref:NM_018492.2~uORF:IOH12390	578	1910	816	529	624	2986	1983	735	2300	647	PDZ binding kinase (PBK)
B23R19C10	23-10-19	Hs~Ref:NM_018492.2~uORF:IOH12390	556	1929	766	480	650	2725	2028	695	2458	616	PDZ binding kinase (PBK)
B23R19C11	23-11-19	Hs~Ref:NM_004629.1~uORF:IOH4715	405	267	432	249	248	314	589	294	543	226	Fanconi anemia, complementation group G (FANCG)
B23R19C12	23-12-19	Hs~Ref:NM_004629.1~uORF:IOH4715	366	250	440	281	231	311	594	298	518	632	Fanconi anemia, complementation group G (FANCG)
B23R19C13	23-13-19	Hs~Ref:NM_001655.3~uORF:IOH43520	850	798	706	1878	822	1023	1668	598	1092	563	archain 1 (ARCN1)
B23R19C14	23-14-19	Hs~Ref:NM_001655.3~uORF:IOH43520	779	774	672	1689	840	915	1959	625	1145	461	archain 1 (ARCN1)
B23R19C15	23-15-19	Hs~Ref:NM_053030.2~uORF:IOH44055	4199	1571	1256	910	2262	1884	3239	1161	1829	19455	myosin, light polypeptide kinase (MYLK), transcript variant 5
B23R19C16	23-16-19	Hs~Ref:NM_053030.2~uORF:IOH44055	4274	1522	1238	903	2280	1709	3097	1022	1873	19507	myosin, light polypeptide kinase (MYLK), transcript variant 5
B23R19C19	23-19-19	Hs~Ref:XM_209196.3~uORF:IOH43609	2547	2108	798	328	1627	832	758	387	4435	392	PREDICTED: Homo sapiens similar to HSPC323 (LOC284422)
B23R19C20	23-20-19	Hs~Ref:XM_209196.3~uORF:IOH43609	2539	2082	768	300	1601	810	782	390	4222	383	PREDICTED: Homo sapiens similar to HSPC323 (LOC284422)
B23R19C21	23-21-19	Hs~Ref:NM_138771.1~uORF:IOH10465	2695	4359	2279	2011	1127	1430	2646	4953	3798	508	Coiled-coil domain-containing protein 126
B23R19C22	23-22-19	Hs~Ref:NM_138771.1~uORF:IOH10465	2715	4268	2217	1990	1143	1344	2747	5023	3851	520	Coiled-coil domain-containing protein 126
B23R20C01	23-1-20	Hs~Ref:NM_022141.1~uORF:IOH22820	480	281	648	1524	359	450	539	346	1301	251	parvin, gamma (PARVG)
B23R20C02	23-2-20	Hs~Ref:NM_022141.1~uORF:IOH22820	482	308	597	1511	422	469	558	508	1314	257	parvin, gamma (PARVG)
B23R20C03	23-3-20	Hs~Ref:NM_002734.1~uORF:IOH25740	738	799	749	487	374	463	1096	966	1281	257	protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (PRKAR1A), transcript variant 1
B23R20C04	23-4-20	Hs~Ref:NM_002734.1~uORF:IOH25740	821	825	708	468	346	448	1089	657	1327	280	protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (PRKAR1A), transcript variant 1
B23R20C05	23-5-20	Hs~Ref:NM_080745.1~uORF:IOH27453	958	934	907	712	552	536	1026	953	1542	338	tripartite motif-containing 69 (TRIM69), transcript variant b
B23R20C06	23-6-20	Hs~Ref:NM_080745.1~uORF:IOH27453	967	847	864	771	532	525	1047	919	1424	321	tripartite motif-containing 69 (TRIM69), transcript variant b
B23R20C07	23-7-20	Hs~MGC:BC003502.1~uORF:IOH5490	1391	1372	1202	589	911	-5	3	-1	-2	5	REX2, RNA exonuclease 2 homolog (S. cerevisiae) (REXO2)
B23R20C08	23-8-20	Hs~MGC:BC003502.1~uORF:IOH5490	1311	1362	1189	636	887	-2	8	4	4	3	REX2, RNA exonuclease 2 homolog (S. cerevisiae) (REXO2)
B23R20C09	23-9-20	Hs~Ref:NM_006503.1~uORF:IOH3614	865	425	1088	737	475	845	1424	653	994	208	proteasome (prosome, macropain) 26S subunit, ATPase, 4 (PSMC4), transcript variant 1
B23R20C10	23-10-20	Hs~Ref:NM_006503.1~uORF:IOH3614	799	437	1070	584	476	791	1399	682	929	250	proteasome (prosome, macropain) 26S subunit, ATPase, 4 (PSMC4), transcript variant 1
B23R20C11	23-11-20	Hs~Ref:NM_013332.1~uORF:IOH4831	710	1184	1270	512	558	715	769	712	867	311	hypoxia-inducible protein 2 (HIG2), transcript variant 1
B23R20C12	23-12-20	Hs~Ref:NM_013332.1~uORF:IOH4831	714	1402	1222	547	566	685	763	701	964	286	hypoxia-inducible protein 2 (HIG2), transcript variant 1
B23R20C13	23-13-20	Hs~MGC:BC020646.1~uORF:IOH14210	667	347	1251	596	346	465	2676	983	1026	816	CD302 molecule (CD302)
B23R20C14	23-14-20	Hs~MGC:BC020646.1~uORF:IOH14210	692	363	1244	575	384	470	2660	947	1158	58	CD302 molecule (CD302)
B24R02C11	24-11-2	Hs~MGC:BC060758.1~uORF:IOH29250	1261	891	1325	1101	966	1579	1372	1265	3677	552	Mediator of RNA polymerase II transcription subunit 1
B24R02C12	24-12-2	Hs~MGC:BC060758.1~uORF:IOH29250	1280	1423	1326	1082	976	1561	1485	1241	3233	666	Mediator of RNA polymerase II transcription subunit 1
B24R02C13	24-13-2	Hs~Ref:NM_014764.1~uORF:IOH6730	1721	1787	2437	1058	1540	2095	3534	1716	5135	895	DAZ-associated protein 2
B24R02C14	24-14-2	Hs~Ref:NM_014764.1~uORF:IOH6730	1760	1407	2313	1073	1528	2021	2086	1722	5163	657	DAZ-associated protein 2
B24R02C15	24-15-2	Hs~Ref:NM_015201.3~uORF:IOH14400	1276	1158	1431	993	1470	1324	1381	1030	3568	463	Ribosome biogenesis protein BOP1
B24R02C16	24-16-2	Hs~Ref:NM_015201.3~uORF:IOH14400	1308	1188	1446	1046	1289	1331	1452	1121	3416	979	Ribosome biogenesis protein BOP1
B24R02C17	24-17-2	Hs~MGC:BC039576.1~uORF:IOH28775	1185	1319	1192	894	948	1253	1450	1443	3229	1164	Abhydrolase domain-containing protein 1
B24R02C18	24-18-2	Hs~MGC:BC039576.1~uORF:IOH28775	1133	1280	1344	921	5319	1223	1419	1056	3370	-1	Abhydrolase domain-containing protein 1
B24R02C19	24-19-2	Hs~MGC:BC011550.1~uORF:IOH12657	1041	1570	969	807	1442	842	1479	1528	910	286	RNA methyltransferase-like protein 1
B24R02C20	24-20-2	Hs~MGC:BC011550.1~uORF:IOH12657	1019	1802	970	772	443	1827	1439	1565	1202	258	RNA methyltransferase-like protein 1
B24R02C21	24-21-2	Hs~MGC:BC018847.1~uORF:IOH14862	1285	1324	1708	1103	2307	2488	2414	1406	9953	5502	Transaldolase
B24R02C22	24-22-2	Hs~MGC:BC018847.1~uORF:IOH14862	1224	1278	1704	1168	1305	2156	2397	1461	9853	4939	Transaldolase
B24R03C01	24-1-3	Hs~MGC:BC012876.1~uORF:IOH10177	30746	31215	31283	29914	22177	22787	24263	22521	21203	17863	Ig lambda chain C regions
B24R03C02	24-2-3	Hs~MGC:BC012876.1~uORF:IOH10177	31103	31541	31502	30586	22032	24875	27843	23778	21561	17860	Ig lambda chain C regions
B24R03C03	24-3-3	Hs~Ref:NM_003720.1~uORF:IOH3819	2101	1110	1416	579	917	2233	1256	760	1879	693	Proteasome assembly chaperone 1
B24R03C04	24-4-3	Hs~Ref:NM_003720.1~uORF:IOH3819	2115	1108	1366	603	922	2329	1328	791	2018	721	Proteasome assembly chaperone 1
B24R03C05	24-5-3	Hs~MGC:BC069505.1~uORF:IOH40261	416	263	498	3318	486	426	11413	570	659	237	Bcl2 modifying factor (BMF)
B24R03C06	24-6-3	Hs~MGC:BC069505.1~uORF:IOH40261	542	248	496	1138	483	488	11668	593	339	236	Bcl2 modifying factor (BMF)
B24R03C07	24-7-3	Hs~Ref:NM_139348.1~uORF:IOH37807	1107	888	681	243	370	736	584	478	1125	201	bridging integrator 1 (BIN1), transcript variant 6
B24R03C08	24-8-3	Hs~Ref:NM_139348.1~uORF:IOH37807	1186	963	690	278	372	731	784	494	1192	316	bridging integrator 1 (BIN1), transcript variant 6
B24R03C09	24-9-3	Hs~Ref:NM_002365.3~uORF:IOH40373	816	801	672	452	340	591	1658	761	280	354	Melanoma-associated antigen B3
B24R03C10	24-10-3	Hs~Ref:NM_002365.3~uORF:IOH40373	781	749	711	403	377	556	1850	692	608	320	Melanoma-associated antigen B3
B24R03C11	24-11-3	Hs~Ref:NM_201567.1~uORF:IOH37812	794	2058	2999	4026	986	2059	7756	735	3262	-80	cell division cycle 25 homolog A (S. pombe) (CDC25A), transcript variant 2
B24R03C12	24-12-3	Hs~Ref:NM_201567.1~uORF:IOH37812	791	1895	2427	3886	937	1854	8437	719	3299	575	cell division cycle 25 homolog A (S. pombe) (CDC25A), transcript variant 2
B24R03C13	24-13-3	Hs~Ref:NM_181578.1~uORF:IOH45838	485	321	455	390	235	401	405	284	14	531	replication factor C (activator 1) 5, 36.5kDa (RFC5), transcript variant 2
B24R03C14	24-14-3	Hs~Ref:NM_181578.1~uORF:IOH45838	481	435	554	286	313	388	357	302	2083	-12	replication factor C (activator 1) 5, 36.5kDa (RFC5), transcript variant 2
B24R03C15	24-15-3	Hs~Ref:NM_017847.3~uORF:IOH45570	812	404	747	477	401	704	1066	356	3182	1111	chromosome 1 open reading frame 27 (C1orf27)
B24R03C16	24-16-3	Hs~Ref:NM_017847.3~uORF:IOH45570	769	403	718	498	352	642	1095	430	3421	1245	chromosome 1 open reading frame 27 (C1orf27)
B24R03C17	24-17-3	Hs~Ref:NM_005469.2~uORF:IOH41012	3503	3232	3893	4360	2904	4656	4464	3507	5230	2902	acyl-CoA thioesterase 8 (ACOT8), transcript variant 1
B24R03C18	24-18-3	Hs~Ref:NM_005469.2~uORF:IOH41012	3621	3288	3989	4244	8187	4526	4242	3708	5179	2985	acyl-CoA thioesterase 8 (ACOT8), transcript variant 1
B24R03C19	24-19-3	Hs~Ref:NM_172160.1~uORF:IOH35727	18184	10589	10231	16760	12319	4673	6215	10838	10520	9835	potassium voltage-gated channel, shaker-related subfamily, beta member 1 (KCNAB1), transcript variant 1
B24R03C20	24-20-3	Hs~Ref:NM_172160.1~uORF:IOH35727	17155	10893	9772	16958	13040	4483	6354	10948	10869	9507	potassium voltage-gated channel, shaker-related subfamily, beta member 1 (KCNAB1), transcript variant 1
B24R03C21	24-21-3	Hs~MGC:BC018122.1~uORF:IOH10873	1244	1072	2167	537	1289	1234	2522	1370	2307	508	Thioredoxin reductase 1, cytoplasmic
B24R03C22	24-22-3	Hs~MGC:BC018122.1~uORF:IOH10873	1184	1045	2195	518	1148	1099	2459	1346	2248	138	Thioredoxin reductase 1, cytoplasmic
B24R04C01	24-1-4	Hs~MGC:BC027486.1~uORF:IOH22849	937	922	863	549	832	865	770	1706	2276	329	hCG2020170 (hCG_2020170)
B24R04C02	24-2-4	Hs~MGC:BC027486.1~uORF:IOH22849	931	828	911	504	833	892	798	1690	2274	356	hCG2020170 (hCG_2020170)
B24R04C03	24-3-4	Hs~Ref:NM_004291.1~uORF:IOH22771	375	462	629	1198	268	593	551	486	498	293	CART prepropeptide (CARTPT)
B24R04C04	24-4-4	Hs~Ref:NM_004291.1~uORF:IOH22771	368	508	618	1355	277	827	576	499	547	285	CART prepropeptide (CARTPT)
B24R04C05	24-5-4	Hs~MGC:BC029524.1~uORF:IOH22562	2056	5669	2616	6011	1702	3610	24125	4955	6265	1512	Coiled-coil domain-containing protein 46
B24R04C06	24-6-4	Hs~MGC:BC029524.1~uORF:IOH22562	2528	6077	2673	6271	1746	3628	25023	4955	6156	1463	Coiled-coil domain-containing protein 46
B24R04C07	24-7-4	Hs~MGC:BC008141.1~uORF:IOH10197	627	470	714	357	539	724	1187	586	1615	300	UCHL5 interacting protein (UCHL5IP)
B24R04C08	24-8-4	Hs~MGC:BC008141.1~uORF:IOH10197	669	408	706	337	536	681	1189	639	1506	299	UCHL5 interacting protein (UCHL5IP)
B24R04C09	24-9-4	Hs~Ref:NM_053285.1~uORF:IOH10741	923	826	829	587	592	660	1142	555	2022	491	tektin 1 (TEKT1)
B24R04C10	24-10-4	Hs~Ref:NM_053285.1~uORF:IOH10741	968	859	904	506	652	703	1139	683	2032	533	tektin 1 (TEKT1)
B24R04C11	24-11-4	Hs~MGC:BC012609.1~uORF:IOH12212	368	205	496	273	506	445	239	415	95	559	serpin peptidase inhibitor, clade B (ovalbumin), member 2 (SERPINB2)
B24R04C12	24-12-4	Hs~MGC:BC012609.1~uORF:IOH12212	351	336	270	45	558	372	223	396	357	587	serpin peptidase inhibitor, clade B (ovalbumin), member 2 (SERPINB2)
B24R04C13	24-13-4	Hs~Ref:NM_014372.1~uORF:IOH11235	1408	354	973	382	382	1490	1320	1031	1973	147	ring finger protein 11 (RNF11)
B24R04C14	24-14-4	Hs~Ref:NM_014372.1~uORF:IOH11235	1418	384	980	407	393	1484	1440	1069	1928	158	ring finger protein 11 (RNF11)
B24R04C15	24-15-4	Hs~MGC:BC022436.1~uORF:IOH29340	867	215	785	485	689	682	992	1015	1416	164	tumor protein, translationally-controlled 1 (TPT1)
B24R04C16	24-16-4	Hs~MGC:BC022436.1~uORF:IOH29340	885	252	766	366	660	689	1059	1031	1362	148	tumor protein, translationally-controlled 1 (TPT1)
B24R04C17	24-17-4	Hs~Ref:NM_022074.2~uORF:IOH38055	1751	880	1236	1098	453	2042	3846	625	1569	-16	family with sequence similarity 111, member A (FAM111A), transcript variant 1
B24R04C18	24-18-4	Hs~Ref:NM_022074.2~uORF:IOH38055	1858	964	1395	1355	1900	2126	4201	727	1611	-24	family with sequence similarity 111, member A (FAM111A), transcript variant 1
B24R04C19	24-19-4	Hs~Ref:NM_032943.2~uORF:IOH38478	18721	3320	14623	7252	5423	9032	16507	7885	9154	2964	synaptotagmin-like 2 (SYTL2), transcript variant a
B24R04C20	24-20-4	Hs~Ref:NM_032943.2~uORF:IOH38478	17850	3278	14232	7391	5998	6751	16429	8279	9267	2963	synaptotagmin-like 2 (SYTL2), transcript variant a
B24R04C21	24-21-4	Hs~Ref:NM_024915.1~uORF:IOH38073	1300	848	1154	1097	2801	1756	4021	659	1811	268	grainyhead-like 2 (Drosophila) (GRHL2)
B24R04C22	24-22-4	Hs~Ref:NM_024915.1~uORF:IOH38073	1126	770	1046	1097	3189	1784	3703	607	1743	-12	grainyhead-like 2 (Drosophila) (GRHL2)
B24R05C01	24-1-5	Hs~MGC:BC022407.1~uORF:IOH13027	800	723	1109	1097	840	995	897	728	1652	375	SH2 domain containing 1B (SH2D1B)
B24R05C02	24-2-5	Hs~MGC:BC022407.1~uORF:IOH13027	797	712	1375	1037	882	1025	996	711	1761	405	SH2 domain containing 1B (SH2D1B)
B24R05C03	24-3-5	Hs~MGC:BC020843.1~uORF:IOH12055	754	702	1168	598	554	3722	1221	653	1306	461	hepatitis A virus cellular receptor 2 (HAVCR2)
B24R05C04	24-4-5	Hs~MGC:BC020843.1~uORF:IOH12055	745	628	1135	574	567	3071	1205	610	1378	337	hepatitis A virus cellular receptor 2 (HAVCR2)
B24R05C05	24-5-5	Hs~Ref:NM_016186.1~uORF:IOH12195	817	679	1184	629	623	3076	1126	731	2872	459	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 (SERPINA10), transcript variant 1
B24R05C06	24-6-5	Hs~Ref:NM_016186.1~uORF:IOH12195	2070	638	1165	573	602	643	1099	702	2784	424	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 (SERPINA10), transcript variant 1
B24R05C07	24-7-5	Hs~Ref:NM_014485.1~uORF:IOH13026	687	701	983	1296	556	762	1099	564	1929	474	prostaglandin D2 synthase, hematopoietic (PGDS)
B24R05C08	24-8-5	Hs~Ref:NM_014485.1~uORF:IOH13026	659	649	947	1216	583	787	1113	572	1924	481	prostaglandin D2 synthase, hematopoietic (PGDS)
B24R05C09	24-9-5	Hs~Ref:NM_004586.1~N/A	1011	870	1059	681	654	925	1685	815	1440	508	ribosomal protein S6 kinase, 90kDa, polypeptide 3 (RPS6KA3)
B24R05C10	24-10-5	Hs~Ref:NM_004586.1~N/A	1105	922	1146	667	610	898	1667	748	1554	459	ribosomal protein S6 kinase, 90kDa, polypeptide 3 (RPS6KA3)
B24R05C11	24-11-5	Hs~Ref:NM_003952.1~N/A	857	691	889	560	428	1650	1250	607	1132	231	Ribosomal protein S6 kinase beta-2
B24R05C12	24-12-5	Hs~Ref:NM_003952.1~N/A	816	725	944	595	430	656	1357	619	1099	-3	Ribosomal protein S6 kinase beta-2
B24R05C13	24-13-5	Hs~Ref:NM_019884.1~N/A	913	1861	935	560	422	718	1466	606	1175	502	Glycogen synthase kinase-3 alpha
B24R05C14	24-14-5	Hs~Ref:NM_019884.1~N/A	954	720	1002	564	405	703	1342	625	1153	544	Glycogen synthase kinase-3 alpha
B24R05C15	24-15-5	Hs~Ref:NM_007064.1~N/A	1005	683	1419	686	576	907	1526	648	2227	330	Kalirin
B24R05C16	24-16-5	Hs~Ref:NM_007064.1~N/A	986	768	1466	615	586	918	1628	705	2164	308	Kalirin
B24R05C17	24-17-5	Hs~MGC:BC024244.1~uORF:IOH40194	1517	1017	1386	757	845	997	2523	824	1906	334	splA/ryanodine receptor domain and SOCS box containing 3 (SPSB3)
B24R05C18	24-18-5	Hs~MGC:BC024244.1~uORF:IOH40194	1661	970	1400	806	3763	964	2497	846	1837	494	splA/ryanodine receptor domain and SOCS box containing 3 (SPSB3)
B24R05C19	24-19-5	Hs~Ref:NM_004991.1~uORF:IOH40284	2195	1562	2131	1169	3512	2045	6470	1434	3090	730	myelodysplasia syndrome 1 (MDS1)
B24R05C20	24-20-5	Hs~Ref:NM_004991.1~uORF:IOH40284	1948	1531	2026	1338	3103	2106	6289	1277	3025	693	myelodysplasia syndrome 1 (MDS1)
B24R05C21	24-21-5	Hs~Ref:NM_170610.2~uORF:IOH40168	3480	1822	2714	1578	3127	2127	11102	1700	4011	843	histone cluster 1, H2ba (HIST1H2BA)
B24R05C22	24-22-5	Hs~Ref:NM_170610.2~uORF:IOH40168	3438	1945	2592	1565	3313	2140	11250	1644	3960	577	histone cluster 1, H2ba (HIST1H2BA)
B24R06C01	24-1-6	Hs~Ref:NM_000588.3~uORF:IOH40240	1272	1054	1252	960	778	1918	1767	959	1915	597	interleukin 3 (colony-stimulating factor, multiple) (IL3)
B24R06C02	24-2-6	Hs~Ref:NM_000588.3~uORF:IOH40240	1231	1021	1392	730	804	1193	1751	1004	1948	598	interleukin 3 (colony-stimulating factor, multiple) (IL3)
B24R06C03	24-3-6	Hs~MGC:BC017926.1~uORF:IOH13470	2814	1486	2541	1230	1619	4263	3776	1239	3156	507	hemochromatosis type 2 (juvenile) (HFE2)
B24R06C04	24-4-6	Hs~MGC:BC017926.1~uORF:IOH13470	2856	1439	2506	1264	1617	1822	3791	1337	3209	739	hemochromatosis type 2 (juvenile) (HFE2)
B24R06C05	24-5-6	Hs~Ref:NM_018457.1~uORF:IOH23026	32860	1403	2136	2122	1540	3338	7164	5150	3791	4153	proline rich 13 (PRR13), transcript variant 2
B24R06C06	24-6-6	Hs~Ref:NM_018457.1~uORF:IOH23026	30953	1463	1844	1977	1590	1476	7407	5120	3918	4146	proline rich 13 (PRR13), transcript variant 2
B24R06C07	24-7-6	Hs~MGC:BC022378.1~uORF:IOH13502	3446	2011	2471	1643	1825	2217	3712	1423	4546	890	zinc finger with KRAB and SCAN domains 1 (ZKSCAN1)
B24R06C08	24-8-6	Hs~MGC:BC022378.1~uORF:IOH13502	3403	2039	2479	1554	1903	2302	3756	1425	4442	829	zinc finger with KRAB and SCAN domains 1 (ZKSCAN1)
B24R06C09	24-9-6	Hs~MGC:BC006234.1~uORF:IOH6300	2442	5058	2831	1913	1908	2547	3270	3140	4243	967	rhomboid domain containing 2 (RHBDD2)
B24R06C10	24-10-6	Hs~MGC:BC006234.1~uORF:IOH6300	2537	5502	3043	1951	1919	2821	3392	3231	4451	986	rhomboid domain containing 2 (RHBDD2)
B24R06C11	24-11-6	Hs~Ref:NM_004987.3~uORF:IOH55033	65471	65477	65467	65483	34843	65475	65480	65483	65481	65488	LIM and senescent cell antigen-like-containing domain protein 1
B24R06C12	24-12-6	Hs~Ref:NM_004987.3~uORF:IOH55033	65458	65420	65465	65480	34741	65476	65476	65484	65480	65481	LIM and senescent cell antigen-like-containing domain protein 1
B24R06C13	24-13-6	Hs~Ref:NM_004184.3~uORF:IOH59105	1215	1034	1690	587	778	1212	2459	1050	1539	-37	Tryptophanyl-tRNA synthetase, cytoplasmic
B24R06C14	24-14-6	Hs~Ref:NM_004184.3~uORF:IOH59105	1193	1102	1682	587	763	1319	2107	999	1538	181	Tryptophanyl-tRNA synthetase, cytoplasmic
B24R06C15	24-15-6	Hs~Ref:NM_001006946.1~uORF:IOH54992	511	445	1421	1138	306	1955	1393	360	1215	618	Syndecan-1
B24R06C16	24-16-6	Hs~Ref:NM_001006946.1~uORF:IOH54992	476	451	1415	1076	296	1887	1400	355	1154	-89	Syndecan-1
B24R06C17	24-17-6	Hs~Ref:NM_020456.1~uORF:IOH59677	675	516	598	440	297	468	629	386	790	155	Chronic lymphocytic leukemia deletion region gene 6 protein
B24R06C18	24-18-6	Hs~Ref:NM_020456.1~uORF:IOH59677	703	545	614	491	208	405	639	374	778	-17	Chronic lymphocytic leukemia deletion region gene 6 protein
B24R06C19	24-19-6	Hs~MGC:BC030214.1~uORF:IOH22591	6298	395	740	960	4639	849	888	1663	987	413	symplekin (SYMPK)
B24R06C20	24-20-6	Hs~MGC:BC030214.1~uORF:IOH22591	5528	330	732	864	2597	882	892	1703	1014	-25	symplekin (SYMPK)
B24R06C21	24-21-6	Hs~Ref:NM_152572.2~uORF:IOH22800	1951	1017	1807	856	2566	1625	1795	1050	4232	485	chromosome 9 open reading frame 98 (C9orf98)
B24R06C22	24-22-6	Hs~Ref:NM_152572.2~uORF:IOH22800	2009	1088	1793	813	1965	1489	1897	928	4219	-162	chromosome 9 open reading frame 98 (C9orf98)
B24R07C01	24-1-7	Hs~Ref:NM_145691.3~uORF:IOH23101	12935	2164	4189	1424	2659	4477	3407	1413	2290	2444	ATP synthase mitochondrial F1 complex assembly factor 2 (ATPAF2), nuclear gene encoding mitochondrial protein
B24R07C02	24-2-7	Hs~Ref:NM_145691.3~uORF:IOH23101	12212	2238	4326	1303	2682	4573	3480	1350	2126	2387	ATP synthase mitochondrial F1 complex assembly factor 2 (ATPAF2), nuclear gene encoding mitochondrial protein
B24R07C03	24-3-7	Hs~MGC:BC032518.1~uORF:IOH21930	1687	1319	1291	883	620	1118	1717	643	1807	768	cyclin G2 (CCNG2)
B24R07C04	24-4-7	Hs~MGC:BC032518.1~uORF:IOH21930	1380	1164	1183	905	600	1913	1640	703	1837	863	cyclin G2 (CCNG2)
B24R07C05	24-5-7	Hs~MGC:BC014679.1~uORF:IOH10445	811	645	1207	1270	375	4054	843	445	963	450	F-box only protein 8
B24R07C06	24-6-7	Hs~MGC:BC014679.1~uORF:IOH10445	813	528	966	449	381	2981	946	460	1074	406	F-box only protein 8
B24R07C11	24-11-7	Hs~Ref:NM_005653.2~uORF:IOH5160	26506	657	1504	582	2088	2029	2215	1233	1950	935	Alpha-globin transcription factor CP2
B24R07C12	24-12-7	Hs~Ref:NM_005653.2~uORF:IOH5160	26047	1683	1493	584	2212	1710	2023	1210	2032	921	Alpha-globin transcription factor CP2
B24R07C13	24-13-7	Hs~MGC:BC010704.1~uORF:IOH9730	220	832	778	295	349	723	767	439	1442	456	SH2B adaptor protein 1 (SH2B1)
B24R07C14	24-14-7	Hs~MGC:BC010704.1~uORF:IOH9730	642	656	745	280	333	769	783	423	1435	375	SH2B adaptor protein 1 (SH2B1)
B24R07C15	24-15-7	Hs~MGC:BC015056.1~uORF:IOH10144	468	362	601	317	280	435	633	519	761	183	acyl-Coenzyme A dehydrogenase family, member 10 (ACAD10)
B24R07C16	24-16-7	Hs~MGC:BC015056.1~uORF:IOH10144	563	400	587	337	284	461	780	507	812	398	acyl-Coenzyme A dehydrogenase family, member 10 (ACAD10)
B24R07C17	24-17-7	Hs~Ref:NM_145265.1~uORF:IOH10426	1093	1026	1122	602	942	931	1379	751	1470	5	coiled-coil domain containing 127 (CCDC127)
B24R07C18	24-18-7	Hs~Ref:NM_145265.1~uORF:IOH10426	1014	997	1255	639	906	1026	1370	797	1925	100	coiled-coil domain containing 127 (CCDC127)
B24R07C19	24-19-7	Hs~MGC:BC015725.1~uORF:IOH10141	712	456	891	398	371	575	845	572	808	35	Folliculin
B24R07C20	24-20-7	Hs~MGC:BC015725.1~uORF:IOH10141	785	416	787	480	168	682	1060	550	705	160	Folliculin
B24R07C21	24-21-7	Hs~MGC:BC033748.1~uORF:IOH21858	587	415	688	511	2151	520	959	723	957	207	pyridoxal-dependent decarboxylase domain containing 1 (PDXDC1)
B24R07C22	24-22-7	Hs~MGC:BC033748.1~uORF:IOH21858	640	547	873	476	3793	483	902	503	910	46	pyridoxal-dependent decarboxylase domain containing 1 (PDXDC1)
B24R08C01	24-1-8	Hs~Ref:NM_148176.1~uORF:IOH4678	3150	2639	2919	2953	2166	4568	9162	4739	3478	957	peptidylprolyl isomerase (cyclophilin)-like 2 (PPIL2), transcript variant 3
B24R08C02	24-2-8	Hs~Ref:NM_148176.1~uORF:IOH4678	2631	2609	2812	2723	2250	4834	9537	4333	3479	930	peptidylprolyl isomerase (cyclophilin)-like 2 (PPIL2), transcript variant 3
B24R08C03	24-3-8	Hs~MGC:BC040053.1~uORF:IOH26397	1982	470	823	745	642	874	1235	757	1059	450	methionine sulfoxide reductase B3 (MSRB3)
B24R08C04	24-4-8	Hs~MGC:BC040053.1~uORF:IOH26397	1967	474	867	845	684	837	1203	770	891	454	methionine sulfoxide reductase B3 (MSRB3)
B24R08C05	24-5-8	Hs~MGC:BC047443.1~uORF:IOH26545	834	648	1939	533	637	541	1217	958	1346	252	adenosine deaminase, RNA-specific, B2 (RED2 homolog rat) (ADARB2)
B24R08C06	24-6-8	Hs~MGC:BC047443.1~uORF:IOH26545	855	638	1572	433	735	508	1140	882	1518	82	adenosine deaminase, RNA-specific, B2 (RED2 homolog rat) (ADARB2)
B24R08C07	24-7-8	Hs~Ref:NM_177996.1~uORF:IOH14498	1148	647	1385	665	1459	1672	1574	734	26898	381	erythrocyte membrane protein band 4.1-like 1 (EPB41L1), transcript variant 2
B24R08C08	24-8-8	Hs~Ref:NM_177996.1~uORF:IOH14498	1171	159	1296	712	1487	1640	614	714	26339	323	erythrocyte membrane protein band 4.1-like 1 (EPB41L1), transcript variant 2
B24R08C09	24-9-8	Hs~Ref:NM_032448.1~uORF:IOH13366	969	2942	1161	3602	642	4625	9540	818	2129	3066	family with sequence similarity 120B (FAM120B)
B24R08C10	24-10-8	Hs~Ref:NM_032448.1~uORF:IOH13366	1012	3430	1105	3320	643	4494	9967	808	2233	2872	family with sequence similarity 120B (FAM120B)
B24R08C11	24-11-8	Hs~Ref:NM_005733.1~uORF:IOH13299	2061	2299	3329	2160	1427	28850	6043	1635	3139	1717	kinesin family member 20A (KIF20A)
B24R08C12	24-12-8	Hs~Ref:NM_005733.1~uORF:IOH13299	2070	2167	3228	2186	1420	30635	6090	1734	3117	1793	kinesin family member 20A (KIF20A)
B24R08C13	24-13-8	Hs~MGC:BC012349.1~uORF:IOH12510	1376	732	1499	715	730	1204	1451	553	1868	436	cyclin F (CCNF)
B24R08C14	24-14-8	Hs~MGC:BC012349.1~uORF:IOH12510	1394	750	1533	703	724	1347	1512	547	1896	519	cyclin F (CCNF)
B24R08C15	24-15-8	Hs~Ref:NM_004683.4~uORF:IOH42883	1235	859	1351	828	714	1114	1633	1035	2242	316	Regucalcin
B24R08C16	24-16-8	Hs~Ref:NM_004683.4~uORF:IOH42883	1305	930	1529	920	824	1146	1806	1002	2319	605	Regucalcin
B24R08C17	24-17-8	Hs~Ref:NM_004397.3~uORF:IOH45655	6184	3111	4106	4634	3513	4420	32766	3598	6264	2506	Probable ATP-dependent RNA helicase DDX6
B24R08C18	24-18-8	Hs~Ref:NM_004397.3~uORF:IOH45655	6101	3126	4083	4128	3569	4409	31999	3851	6105	2575	Probable ATP-dependent RNA helicase DDX6
B24R08C19	24-19-8	Hs~Ref:NM_032472.3~uORF:IOH44558	7063	1213	1674	1111	1263	6612	2019	1318	3063	959	Peptidyl-prolyl cis-trans isomerase-like 3
B24R08C20	24-20-8	Hs~Ref:NM_032472.3~uORF:IOH44558	7639	1134	1625	1016	1298	6013	2218	1256	3177	980	Peptidyl-prolyl cis-trans isomerase-like 3
B24R08C21	24-21-8	Hs~Ref:NM_207459.1~uORF:IOH45617	2822	1403	2377	1639	1150	1747	2967	1511	4261	845	Testis-expressed sequence 19 protein
B24R08C22	24-22-8	Hs~Ref:NM_207459.1~uORF:IOH45617	2963	1517	2317	1585	1191	1685	2841	1415	4353	942	Testis-expressed sequence 19 protein
B24R09C01	24-1-9	Hs~Ref:NM_001445.1~uORF:IOH54608	238	205	339	227	215	219	293	198	425	138	Gastrotropin
B24R09C02	24-2-9	Hs~Ref:NM_001445.1~uORF:IOH54608	306	170	334	229	212	203	355	195	396	54	Gastrotropin
B24R09C03	24-3-9	Hs~Ref:NM_001007232.1~uORF:IOH58619	365	191	2157	215	342	472	503	617	602	30	Caspase-1 inhibitor INCA
B24R09C04	24-4-9	Hs~Ref:NM_001007232.1~uORF:IOH58619	363	196	2134	193	358	470	556	595	655	27	Caspase-1 inhibitor INCA
B24R09C05	24-5-9	Hs~Ref:NM_001031.4~uORF:IOH58930	2165	1406	3051	1013	1260	1775	4184	1091	2284	529	40S ribosomal protein S28
B24R09C06	24-6-9	Hs~Ref:NM_001031.4~uORF:IOH58930	2329	1385	2163	1009	1283	1550	3964	970	2335	568	40S ribosomal protein S28
B24R09C07	24-7-9	Hs~Ref:NM_015015.1~uORF:IOH53632	2899	981	1514	1366	590	812	1641	1511	2324	2920	JmjC domain-containing histone demethylation protein 3B
B24R09C08	24-8-9	Hs~Ref:NM_015015.1~uORF:IOH53632	2719	956	1538	1546	537	872	1607	1431	2279	2721	JmjC domain-containing histone demethylation protein 3B
B24R09C13	24-13-9	Hs~Ref:NM_003367.2~uORF:IOH57272	1890	770	2090	1365	962	7938	2527	3369	2270	582	Upstream stimulatory factor 2
B24R09C14	24-14-9	Hs~Ref:NM_003367.2~uORF:IOH57272	1888	784	2057	1396	978	7513	2609	3563	2274	584	Upstream stimulatory factor 2
B24R09C15	24-15-9	Hs~MGC:BC053836.1~uORF:IOH57277	479	513	754	564	528	579	664	1150	836	398	Vasohibin-2
B24R09C16	24-16-9	Hs~MGC:BC053836.1~uORF:IOH57277	463	520	921	591	530	583	623	1116	888	379	Vasohibin-2
B24R09C17	24-17-9	Hs~Ref:NM_006995.2~uORF:IOH14772	392	402	617	427	391	391	585	364	1011	394	butyrophilin, subfamily 2, member A2 (BTN2A2), transcript variant 1
B24R09C18	24-18-9	Hs~Ref:NM_006995.2~uORF:IOH14772	390	429	615	498	369	364	642	445	884	391	butyrophilin, subfamily 2, member A2 (BTN2A2), transcript variant 1
B24R09C19	24-19-9	Hs~Ref:NM_014077.1~uORF:IOH4219	1550	1274	1459	1590	661	1042	4398	729	1848	522	family with sequence similarity 32, member A (FAM32A)
B24R09C20	24-20-9	Hs~Ref:NM_014077.1~uORF:IOH4219	1890	1177	1448	1724	665	1014	4315	809	1877	516	family with sequence similarity 32, member A (FAM32A)
B24R09C21	24-21-9	Hs~Ref:NM_018948.2~uORF:IOH14139	2272	678	1533	1185	1037	1190	1262	1165	1789	776	ERBB receptor feedback inhibitor 1 (ERRFI1)
B24R09C22	24-22-9	Hs~Ref:NM_018948.2~uORF:IOH14139	2181	688	1560	1050	1063	1054	1159	1265	1720	15	ERBB receptor feedback inhibitor 1 (ERRFI1)
B24R10C01	24-1-10	Hs~MGC:BC002622.1~uORF:IOH4142	1498	789	858	1828	633	616	826	582	1198	515	SMA3 (SMA4)
B24R10C02	24-2-10	Hs~MGC:BC002622.1~uORF:IOH4142	1062	711	828	1732	589	591	837	604	1232	370	SMA3 (SMA4)
B24R10C03	24-3-10	Hs~Ref:NM_022480.2~uORF:IOH21555	1558	898	1176	976	907	848	1701	745	1704	493	kelch-like 25 (Drosophila) (KLHL25)
B24R10C04	24-4-10	Hs~Ref:NM_022480.2~uORF:IOH21555	1586	975	1607	1005	974	872	1736	779	1451	525	kelch-like 25 (Drosophila) (KLHL25)
B24R10C05	24-5-10	Hs~MGC:BC032485.1~uORF:IOH21724	1805	2606	8720	1714	1797	1494	3750	1410	2316	670	apoptosis-inducing factor, mitochondrion-associated, 3 (AIFM3)
B24R10C06	24-6-10	Hs~MGC:BC032485.1~uORF:IOH21724	1833	2573	5447	1882	1770	1477	3717	1328	2568	699	apoptosis-inducing factor, mitochondrion-associated, 3 (AIFM3)
B24R10C07	24-7-10	Hs~Ref:NM_022822.1~uORF:IOH22120	4599	10551	7248	48170	2552	2310	7446	3215	4122	5255	kinesin light chain 2 (KLC2)
B24R10C08	24-8-10	Hs~Ref:NM_022822.1~uORF:IOH22120	5058	10714	7055	47669	2630	2542	7335	3424	4488	5139	kinesin light chain 2 (KLC2)
B24R10C09	24-9-10	Hs~Ref:NM_012175.3~uORF:IOH26934	1792	1035	1318	1017	1544	879	2095	830	1872	582	F-box protein 3 (FBXO3), transcript variant 1
B24R10C10	24-10-10	Hs~Ref:NM_012175.3~uORF:IOH26934	1868	1049	1268	978	1558	908	2138	848	1743	554	F-box protein 3 (FBXO3), transcript variant 1
B24R11C21	24-21-11	Hs~Ref:NM_006854.2~uORF:IOH5849	1316	757	1211	630	820	1082	1913	739	1372	415	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 (KDELR2), transcript variant 1
B24R11C22	24-22-11	Hs~Ref:NM_006854.2~uORF:IOH5849	1426	868	1282	620	790	1042	1965	728	1375	455	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 (KDELR2), transcript variant 1
B24R12C01	24-1-12	Hs~Ref:NM_000154.1~uORF:IOH4535	1502	685	1112	628	790	805	1417	818	3042	583	galactokinase 1 (GALK1)
B24R12C02	24-2-12	Hs~Ref:NM_000154.1~uORF:IOH4535	2097	729	1089	610	797	798	1434	810	3242	589	galactokinase 1 (GALK1)
B24R12C03	24-3-12	Hs~Ref:NM_130439.1~uORF:IOH10857	1193	1563	1450	1188	4871	1418	2525	1098	3954	609	MAX interactor 1 (MXI1), transcript variant 2
B24R12C04	24-4-12	Hs~Ref:NM_130439.1~uORF:IOH10857	1186	1649	1479	2722	4938	1393	2397	1062	3695	615	MAX interactor 1 (MXI1), transcript variant 2
B24R12C05	24-5-12	Hs~Ref:NM_002503.2~uORF:IOH11051	1509	1149	41857	2878	1692	1450	1516	1424	2181	770	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (NFKBIB), transcript variant 1
B24R12C06	24-6-12	Hs~Ref:NM_002503.2~uORF:IOH11051	1699	1157	41367	5804	1718	1395	1471	1601	2201	784	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (NFKBIB), transcript variant 1
B24R12C07	24-7-12	Hs~Ref:NM_138415.1~uORF:IOH13483	3064	2867	3869	2451	1141	2191	5550	2270	3427	880	PHD finger protein 21B (PHF21B)
B24R12C08	24-8-12	Hs~Ref:NM_138415.1~uORF:IOH13483	1986	2901	2456	2200	1175	2400	5405	2558	3887	881	PHD finger protein 21B (PHF21B)
B24R12C09	24-9-12	Hs~MGC:NM_173501.1~uORF:IOH11653	1067	1053	1269	861	780	1101	2073	856	2721	636	Uncharacterized protein C16orf52
B24R12C10	24-10-12	Hs~MGC:NM_173501.1~uORF:IOH11653	1067	1173	1293	893	762	1130	2022	850	2390	716	Uncharacterized protein C16orf52
B24R12C11	24-11-12	Hs~Ref:NM_012200.2~uORF:IOH6746	1259	2196	1620	850	969	1520	2599	1427	3642	950	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) (B3GAT3)
B24R12C12	24-12-12	Hs~Ref:NM_012200.2~uORF:IOH6746	1240	2305	1572	880	960	1459	2682	1475	3517	655	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) (B3GAT3)
B24R12C13	24-13-12	Hs~MGC:BC012176.1~uORF:IOH13364	1171	1179	1760	1335	4518	1321	1497	1938	12606	593	naked cuticle homolog 2 (Drosophila) (NKD2)
B24R12C14	24-14-12	Hs~MGC:BC012176.1~uORF:IOH13364	1187	1050	1782	1310	4489	1238	1631	1962	11814	606	naked cuticle homolog 2 (Drosophila) (NKD2)
B24R12C15	24-15-12	Hs~MGC:BC062625.1~uORF:IOH39875	163	321	223	183	55	254	387	172	364	5	solute carrier family 39 (zinc transporter), member 4 (SLC39A4)
B24R12C16	24-16-12	Hs~MGC:BC062625.1~uORF:IOH39875	157	108	465	147	62	131	189	153	431	47	solute carrier family 39 (zinc transporter), member 4 (SLC39A4)
B24R12C17	24-17-12	Hs~Ref:NM_207356.1~uORF:IOH40044	949	1212	974	2391	1047	1604	2072	941	2596	549	chromosome 1 open reading frame 174 (C1orf174)
B24R12C18	24-18-12	Hs~Ref:NM_207356.1~uORF:IOH40044	933	1182	954	2325	1107	1642	1988	970	2589	188	chromosome 1 open reading frame 174 (C1orf174)
B24R12C19	24-19-12	Hs~Ref:NM_138698.2~uORF:IOH36253	432	310	349	368	3054	292	646	275	544	114	Uncharacterized protein FLJ44066
B24R12C20	24-20-12	Hs~Ref:NM_138698.2~uORF:IOH36253	356	342	21	292	3239	287	592	245	677	96	Uncharacterized protein FLJ44066
B24R12C21	24-21-12	Hs~MGC:BC064532.1~uORF:IOH39909	354	389	694	197	201	364	551	272	576	81	signal-regulatory protein gamma (SIRPG)
B24R12C22	24-22-12	Hs~MGC:BC064532.1~uORF:IOH39909	120	202	739	179	246	820	540	278	570	75	signal-regulatory protein gamma (SIRPG)
B24R13C03	24-3-13	Hs~MGC:BC033035.1~uORF:IOH22449	616	272	557	353	397	437	541	609	1284	2194	hypothetical locus FLJ25758 (FLJ25758)
B24R13C04	24-4-13	Hs~MGC:BC033035.1~uORF:IOH22449	685	348	537	803	384	444	531	602	1241	2156	hypothetical locus FLJ25758 (FLJ25758)
B24R13C05	24-5-13	Hs~MGC:BC027978.1~uORF:IOH11454	836	637	810	846	590	655	1183	558	2167	351	hypothetical LOC541472
B24R13C06	24-6-13	Hs~MGC:BC027978.1~uORF:IOH11454	1020	657	1033	505	508	628	1168	533	2064	386	hypothetical LOC541472
B24R13C07	24-7-13	Hs~Ref:NM_058199.1~uORF:IOH4375	604	829	710	465	500	530	1044	513	1579	453	olfactomedin 1 (OLFM1), transcript variant 3
B24R13C08	24-8-13	Hs~Ref:NM_058199.1~uORF:IOH4375	669	920	684	504	516	298	1085	498	1814	462	olfactomedin 1 (OLFM1), transcript variant 3
B24R13C09	24-9-13	Hs~MGC:BC033736.1~uORF:IOH21824	10082	7059	6767	21358	11604	53453	7462	6727	9134	8955	dermatopontin (DPT)
B24R13C10	24-10-13	Hs~MGC:BC033736.1~uORF:IOH21824	10053	7275	6863	20284	11817	54825	7539	6855	8194	8751	dermatopontin (DPT)
B24R13C11	24-11-13	Hs~Ref:NM_013431.1~uORF:IOH12166	1309	860	496	599	875	1189	2143	459	4105	2618	killer cell lectin-like receptor subfamily C, member 4 (KLRC4)
B24R13C12	24-12-13	Hs~Ref:NM_013431.1~uORF:IOH12166	1355	790	457	565	870	1190	2245	452	4325	2635	killer cell lectin-like receptor subfamily C, member 4 (KLRC4)
B24R13C13	24-13-13	Hs~MGC:BC022297.1~uORF:IOH12908	1899	846	1778	791	784	1523	1515	724	1329	499	Diacylglycerol kinase epsilon
B24R13C14	24-14-13	Hs~MGC:BC022297.1~uORF:IOH12908	1893	826	1763	768	780	1470	1487	728	1373	373	Diacylglycerol kinase epsilon
B24R13C15	24-15-13	Hs~MGC:BC012620.1~uORF:IOH12299	704	581	733	335	435	745	962	415	1053	235	golgi SNAP receptor complex member 1 (GOSR1)
B24R13C16	24-16-13	Hs~MGC:BC012620.1~uORF:IOH12299	637	560	828	369	485	664	891	424	1065	10	golgi SNAP receptor complex member 1 (GOSR1)
B24R13C17	24-17-13	Hs~MGC:BC035716.2~uORF:IOH28745	367	310	545	296	288	731	905	327	800	0	interferon regulatory factor 9 (ISGF3G)
B24R13C18	24-18-13	Hs~MGC:BC035716.2~uORF:IOH28745	55	294	518	325	343	735	963	348	751	117	interferon regulatory factor 9 (ISGF3G)
B24R13C19	24-19-13	Hs~MGC:BC053508.1~uORF:IOH29392	549	309	484	440	251	618	848	281	468	121	ADP-ribosylation factor-like 6 interacting protein 2 (ARL6IP2)
B24R13C20	24-20-13	Hs~MGC:BC053508.1~uORF:IOH29392	537	317	516	408	477	554	819	302	223	106	ADP-ribosylation factor-like 6 interacting protein 2 (ARL6IP2)
B24R13C21	24-21-13	Hs~MGC:BC056150.1~uORF:IOH29126	948	722	1047	493	952	2386	1381	796	2223	250	ELK1, member of ETS oncogene family (ELK1)
B24R13C22	24-22-13	Hs~MGC:BC056150.1~uORF:IOH29126	935	775	1017	463	954	2436	1284	759	2196	392	ELK1, member of ETS oncogene family (ELK1)
B24R14C01	24-1-14	Hs~MGC:BC058906.1~uORF:IOH29100	1436	472	636	341	374	4866	820	387	668	293	aarF domain containing kinase 1 (ADCK1)
B24R14C02	24-2-14	Hs~MGC:BC058906.1~uORF:IOH29100	1158	267	669	419	295	5009	808	452	714	291	aarF domain containing kinase 1 (ADCK1)
B24R14C03	24-3-14	Hs~MGC:BC006005.1~uORF:IOH7509	4385	6504	1645	945	2606	2362	1779	3557	1983	1029	unconventional SNARE in the ER 1 homolog (S. cerevisiae) (USE1)
B24R14C04	24-4-14	Hs~MGC:BC006005.1~uORF:IOH7509	4442	6812	1624	938	2794	2354	1766	3418	1949	1010	unconventional SNARE in the ER 1 homolog (S. cerevisiae) (USE1)
B24R14C05	24-5-14	Hs~Ref:NM_002865.1~uORF:IOH5825	683	649	1035	559	998	1114	949	587	1561	371	RAB2A, member RAS oncogene family (RAB2A)
B24R14C06	24-6-14	Hs~Ref:NM_002865.1~uORF:IOH5825	833	602	1073	517	1007	1100	923	588	1578	381	RAB2A, member RAS oncogene family (RAB2A)
B24R14C07	24-7-14	Hs~Ref:NM_015342.1~uORF:IOH10863	7162	3692	3885	3931	2819	4045	4424	3944	5865	2628	peptidylprolyl isomerase domain and WD repeat containing 1 (PPWD1)
B24R14C08	24-8-14	Hs~Ref:NM_015342.1~uORF:IOH10863	6975	3723	3753	4031	2974	4062	4505	4060	6093	2639	peptidylprolyl isomerase domain and WD repeat containing 1 (PPWD1)
B24R14C09	24-9-14	Hs~Ref:NM_032377.2~uORF:IOH6191	5075	2138	5177	1911	2828	1964	16720	1531	5340	1763	elongation factor 1 homolog (S. cerevisiae) (ELOF1)
B24R14C10	24-10-14	Hs~Ref:NM_032377.2~uORF:IOH6191	5013	2151	5099	2001	2747	2025	17183	1501	4508	1502	elongation factor 1 homolog (S. cerevisiae) (ELOF1)
B24R14C11	24-11-14	Hs~MGC:BC001728.1~uORF:IOH4430	2032	849	1350	15809	594	1218	4009	612	8410	400	TCF3 fusion partner
B24R14C12	24-12-14	Hs~MGC:BC001728.1~uORF:IOH4430	2029	815	1408	15113	596	1142	4081	594	8385	391	TCF3 fusion partner
B24R14C13	24-13-14	Hs~Ref:NM_006408.2~uORF:IOH10438	1920	3314	734	708	1103	2097	1525	461	1406	386	anterior gradient homolog 2 (Xenopus laevis) (AGR2)
B24R14C14	24-14-14	Hs~Ref:NM_006408.2~uORF:IOH10438	1934	3431	743	665	1074	1861	1574	486	1369	-16	anterior gradient homolog 2 (Xenopus laevis) (AGR2)
B24R14C15	24-15-14	Hs~Ref:NM_007006.1~uORF:IOH4064	4341	862	1334	1258	986	1678	3565	1117	2406	1037	nudix (nucleoside diphosphate linked moiety X)-type motif 21 (NUDT21)
B24R14C16	24-16-14	Hs~Ref:NM_007006.1~uORF:IOH4064	4187	822	1345	1228	980	1890	3296	1114	2533	844	nudix (nucleoside diphosphate linked moiety X)-type motif 21 (NUDT21)
B24R14C17	24-17-14	Hs~MGC:BC031074.1~uORF:IOH22532	425	401	612	359	455	519	758	404	1040	-10	poly (ADP-ribose) polymerase family, member 16 (PARP16)
B24R14C18	24-18-14	Hs~MGC:BC031074.1~uORF:IOH22532	361	484	613	372	439	514	799	387	1071	-4	poly (ADP-ribose) polymerase family, member 16 (PARP16)
B24R14C19	24-19-14	Hs~MGC:BC004174.1~uORF:IOH3773	936	727	974	688	752	727	999	698	1644	-10	Serine/threonine-protein kinase Nek6
B24R14C20	24-20-14	Hs~MGC:BC004174.1~uORF:IOH3773	834	717	859	620	702	634	950	724	1902	-10	Serine/threonine-protein kinase Nek6
B24R14C21	24-21-14	Hs~Ref:NM_005130.1~uORF:IOH3926	1063	555	830	523	1000	674	1563	427	303	-4	fibroblast growth factor binding protein 1 (FGFBP1)
B24R14C22	24-22-14	Hs~Ref:NM_005130.1~uORF:IOH3926	1005	658	819	488	943	771	1481	416	1148	202	fibroblast growth factor binding protein 1 (FGFBP1)
B24R15C01	24-1-15	Hs~MGC:BC025781.1~uORF:IOH11788	473	303	589	442	396	510	730	463	918	242	signal peptide peptidase 3 (UNQ1887)
B24R15C02	24-2-15	Hs~MGC:BC025781.1~uORF:IOH11788	436	534	591	442	288	520	754	483	946	274	signal peptide peptidase 3 (UNQ1887)
B24R15C03	24-3-15	Hs~MGC:NM_174891.2~uORF:IOH11682	978	528	713	939	435	534	1043	554	1143	296	chromosome 14 open reading frame 79 (C14orf79)
B24R15C04	24-4-15	Hs~MGC:NM_174891.2~uORF:IOH11682	880	542	708	1012	422	530	1012	566	1089	272	chromosome 14 open reading frame 79 (C14orf79)
B24R15C05	24-5-15	Hs~MGC:BC015417.2~uORF:IOH11018	866	799	1226	7701	1439	938	1882	3481	1904	575	MAM domain containing 2 (MAMDC2)
B24R15C06	24-6-15	Hs~MGC:BC015417.2~uORF:IOH11018	1240	764	1189	2014	1479	972	1835	3522	1974	589	MAM domain containing 2 (MAMDC2)
B24R15C07	24-7-15	Hs~MGC:BC032455.1~uORF:IOH21667	889	666	788	607	614	530	1124	599	1020	312	chromosome 20 open reading frame 160 (C20orf160)
B24R15C08	24-8-15	Hs~MGC:BC032455.1~uORF:IOH21667	870	695	821	600	626	597	1121	585	994	329	chromosome 20 open reading frame 160 (C20orf160)
B24R15C09	24-9-15	Hs~Ref:NM_006298.2~uORF:IOH34757	4664	2943	6439	4445	5448	4228	11470	7325	6818	3096	zinc finger protein 192 (ZNF192)
B24R15C10	24-10-15	Hs~Ref:NM_006298.2~uORF:IOH34757	4635	3057	6277	4511	5686	4333	11656	7654	6790	3166	zinc finger protein 192 (ZNF192)
B24R15C11	24-11-15	Hs~Ref:NM_004114.2~uORF:IOH13832	3727	1852	2471	1867	2083	1820	15003	1536	3614	703	fibroblast growth factor 13 (FGF13), transcript variant 1A
B24R15C12	24-12-15	Hs~Ref:NM_004114.2~uORF:IOH13832	3760	1858	2442	1860	2087	1892	15311	1363	3722	727	fibroblast growth factor 13 (FGF13), transcript variant 1A
B24R15C15	24-15-15	Hs~Ref:NM_001626.2~CAT:PV3184	95	19	77	94	29	872	238	20	45	-4	v-akt murine thymoma viral oncogene homolog 2 (AKT2)
B24R15C16	24-16-15	Hs~Ref:NM_001626.2~CAT:PV3184	93	31	75	21	60	494	199	41	53	-11	v-akt murine thymoma viral oncogene homolog 2 (AKT2)
B24R15C17	24-17-15	Hs~Ref:NM_001007097.1~CAT:PV3616	123	527	497	228	545	416	460	293	712	-8	neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant b
B24R15C18	24-18-15	Hs~Ref:NM_001007097.1~CAT:PV3616	130	507	471	277	513	365	474	295	657	-10	neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), transcript variant b
B24R15C19	24-19-15	Hs~Ref:NM_020666.2~CAT:PV3839	538	601	1121	502	525	1671	1685	510	1445	-14	CDC-like kinase 4 (CLK4)
B24R15C20	24-20-15	Hs~Ref:NM_020666.2~CAT:PV3839	619	693	1111	492	496	1563	1582	545	1381	-12	CDC-like kinase 4 (CLK4)
B24R15C21	24-21-15	Hs~Ref:NM_000222.1~CAT:PV4132	1901	1324	1957	1299	2487	2002	1583	1153	2131	7	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), transcript variant 1; see catalog number for detailed information on wild-type or point mutant status
B24R15C22	24-22-15	Hs~Ref:NM_000222.1~CAT:PV4132	1125	1349	1854	1209	2566	1755	1616	1039	2488	7	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), transcript variant 1; see catalog number for detailed information on wild-type or point mutant status
B24R16C03	24-3-16	Hs~Ref:NM_018650.1~CAT:PV4395	3800	2572	2644	6404	2975	9293	4656	3775	4793	3861	Serine/threonine-protein kinase MARK1
B24R16C04	24-4-16	Hs~Ref:NM_018650.1~CAT:PV4395	3777	2551	2566	9354	2998	9027	4654	3794	5074	3671	Serine/threonine-protein kinase MARK1
B24R16C05	24-5-16	Hs~N/A:NM_002745.2~CAT:PV3314	11268	11689	10906	18841	9116	14015	13948	17100	12533	12359	Mitogen-activated protein kinase 1; see catalog number for detailed information on wild-type or point mutant status
B24R16C06	24-6-16	Hs~N/A:NM_002745.2~CAT:PV3314	10195	11254	10860	18099	9361	14285	13470	17320	12661	12274	Mitogen-activated protein kinase 1; see catalog number for detailed information on wild-type or point mutant status
B24R16C07	24-7-16	Hs~Ref:NM_001039517.1~uORF:IOH63103	1195	534	826	925	465	642	873	596	1340	431	Uncharacterized protein C1orf104
B24R16C08	24-8-16	Hs~Ref:NM_001039517.1~uORF:IOH63103	865	565	835	915	473	852	852	539	1249	403	Uncharacterized protein C1orf104
B24R16C15	24-15-16	Hs~MGC:BC032749.1~uORF:IOH56253	490	879	571	282	465	588	1374	351	697	-11	Protein SET
B24R16C16	24-16-16	Hs~MGC:BC032749.1~uORF:IOH56253	562	704	553	268	457	545	1343	356	646	-25	Protein SET
B24R16C17	24-17-16	Hs~Ref:NM_005552.3~uORF:IOH57028	677	408	786	1541	484	730	896	713	1352	-16	Kinesin light chain 1
B24R16C18	24-18-16	Hs~Ref:NM_005552.3~uORF:IOH57028	636	405	789	1533	492	768	889	731	1372	-11	Kinesin light chain 1
B24R16C21	24-21-16	Hs~MGC:BC008874.2~uORF:IOH57034	924	599	1545	584	607	628	2443	697	6770	0	Homeobox protein SIX1
B24R16C22	24-22-16	Hs~MGC:BC008874.2~uORF:IOH57034	972	580	1565	584	554	873	2343	766	6913	32	Homeobox protein SIX1
B24R17C01	24-1-17	Hs~MGC:BC093745.1~uORF:IOH61986	164	109	382	256	184	297	547	326	525	179	hypothetical LOC441178, mRNA (cDNA clone MGC:120780 IMAGE:7939590), complete cds
B24R17C02	24-2-17	Hs~MGC:BC093745.1~uORF:IOH61986	168	68	415	378	260	395	449	352	301	193	hypothetical LOC441178, mRNA (cDNA clone MGC:120780 IMAGE:7939590), complete cds
B24R17C03	24-3-17	Hs~MGC:BC093990.1~uORF:IOH62017	13124	3546	5583	5559	2016	7616	36634	2331	15966	13354	Sin3 histone deacetylase corepressor complex component SDS3
B24R17C04	24-4-17	Hs~MGC:BC093990.1~uORF:IOH62017	12131	3489	4884	6550	1791	6944	37786	2343	15624	12379	Sin3 histone deacetylase corepressor complex component SDS3
B24R17C05	24-5-17	Hs~MGC:BC031258.1~uORF:IOH62179	1450	295	506	1116	250	448	1097	386	754	261	NudC domain-containing protein 1
B24R17C06	24-6-17	Hs~MGC:BC031258.1~uORF:IOH62179	1562	410	512	479	252	398	1000	345	782	262	NudC domain-containing protein 1
B24R17C09	24-9-17	Hs~MGC:BC013319.1~uORF:IOH12891	520	366	525	402	346	818	1016	512	940	404	FYVE, RhoGEF and PH domain containing 6 (FGD6)
B24R17C10	24-10-17	Hs~MGC:BC013319.1~uORF:IOH12891	584	420	530	413	324	547	1020	463	834	412	FYVE, RhoGEF and PH domain containing 6 (FGD6)
B24R17C11	24-11-17	Hs~MGC:BC022854.1~uORF:IOH12377	587	542	948	456	392	509	830	619	1116	355	membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A)
B24R17C12	24-12-17	Hs~MGC:BC022854.1~uORF:IOH12377	579	554	917	443	417	530	896	648	1056	396	membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A)
B24R17C13	24-13-17	Hs~MGC:BC012569.1~uORF:IOH12120	661	665	674	476	413	574	937	715	990	330	zinc finger protein 673 (ZNF673)
B24R17C14	24-14-17	Hs~MGC:BC012569.1~uORF:IOH12120	602	1048	678	466	431	634	892	715	959	-32	zinc finger protein 673 (ZNF673)
B24R17C15	24-15-17	Hs~MGC:BC020942.1~uORF:IOH11137	742	683	1209	498	521	734	1181	1501	1476	417	transmembrane protein 140 (TMEM140)
B24R17C16	24-16-17	Hs~MGC:BC020942.1~uORF:IOH11137	704	491	1238	470	571	644	1104	1426	1409	-53	transmembrane protein 140 (TMEM140)
B24R17C17	24-17-17	Hs~MGC:BC000201.1~uORF:IOH4385	543	424	542	300	442	555	548	453	688	51	WD repeat domain 1 (WDR1)
B24R17C18	24-18-17	Hs~MGC:BC000201.1~uORF:IOH4385	14	369	536	412	463	599	620	403	737	181	WD repeat domain 1 (WDR1)
B24R17C19	24-19-17	Hs~Ref:NM_005174.2~uORF:IOH45903	457	320	502	307	341	478	742	395	594	191	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 (ATP5C1), nuclear gene encoding mitochondrial protein, transcript variant 2
B24R17C20	24-20-17	Hs~Ref:NM_005174.2~uORF:IOH45903	515	384	515	284	333	439	742	407	575	-2	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 (ATP5C1), nuclear gene encoding mitochondrial protein, transcript variant 2
B24R17C21	24-21-17	Hs~Ref:NM_014678.3~uORF:IOH45905	839	477	800	545	371	734	1287	512	632	1270	SAPS domain family, member 2 (SAPS2)
B24R17C22	24-22-17	Hs~Ref:NM_014678.3~uORF:IOH45905	724	530	814	553	372	356	1196	522	1229	1225	SAPS domain family, member 2 (SAPS2)
B24R18C01	24-1-18	Hs~Ref:NM_012121.4~uORF:IOH45907	1653	1100	921	2268	848	770	2439	497	1750	2033	CDC42 effector protein (Rho GTPase binding) 4 (CDC42EP4)
B24R18C02	24-2-18	Hs~Ref:NM_012121.4~uORF:IOH45907	1602	1048	952	2297	802	733	2412	479	1643	2012	CDC42 effector protein (Rho GTPase binding) 4 (CDC42EP4)
B24R18C03	24-3-18	Hs~MGC:BC007646.1~uORF:IOH7001	1679	475	669	757	478	624	2033	684	1071	321	exonuclease NEF-sp (LOC81691)
B24R18C04	24-4-18	Hs~MGC:BC007646.1~uORF:IOH7001	1737	532	683	832	548	641	2033	756	1073	371	exonuclease NEF-sp (LOC81691)
B24R18C05	24-5-18	Hs~MGC:BC047536.1~uORF:IOH27737	17564	4357	7536	12284	18511	10191	29148	16174	10576	5714	sciellin (SCEL)
B24R18C06	24-6-18	Hs~MGC:BC047536.1~uORF:IOH27737	17762	4468	7591	12223	18667	9821	28786	16371	10961	5632	sciellin (SCEL)
B24R18C07	24-7-18	Hs~MGC:BC048988.1~uORF:IOH26773	1367	554	3263	768	1609	575	1953	745	1747	290	chromosome 13 open reading frame 3 (C13orf3)
B24R18C08	24-8-18	Hs~MGC:BC048988.1~uORF:IOH26773	1372	562	3377	858	1814	582	1948	793	1679	298	chromosome 13 open reading frame 3 (C13orf3)
B24R18C09	24-9-18	Hs~MGC:BC057237.1~uORF:IOH29417	825	279	366	268	270	497	466	299	590	276	actin related protein 2/3 complex, subunit 5, 16kDa (ARPC5)
B24R18C10	24-10-18	Hs~MGC:BC057237.1~uORF:IOH29417	859	377	338	287	237	572	418	309	704	260	actin related protein 2/3 complex, subunit 5, 16kDa (ARPC5)
B24R18C11	24-11-18	Hs~MGC:BC017016.1~uORF:IOH10367	773	504	638	476	416	668	1803	528	1169	337	Lck-interacting transmembrane adapter 1
B24R18C12	24-12-18	Hs~MGC:BC017016.1~uORF:IOH10367	980	454	611	475	391	645	1805	761	1162	339	Lck-interacting transmembrane adapter 1
B24R18C13	24-13-18	Hs~Ref:NM_012279.1~uORF:IOH6492	3062	1306	1794	1473	983	2004	10982	2076	3579	587	zinc finger protein 346 (ZNF346)
B24R18C14	24-14-18	Hs~Ref:NM_012279.1~uORF:IOH6492	3118	1448	1814	1471	932	1961	10900	1654	3677	610	zinc finger protein 346 (ZNF346)
B24R18C15	24-15-18	Hs~MGC:BC056870.1~uORF:IOH29112	658	282	525	342	369	603	1120	440	705	-6	voltage-dependent anion channel 3 (VDAC3)
B24R18C16	24-16-18	Hs~MGC:BC056870.1~uORF:IOH29112	513	443	507	332	238	602	1014	470	694	-15	voltage-dependent anion channel 3 (VDAC3)
B24R18C17	24-17-18	Hs~MGC:BC053617.1~uORF:IOH29004	467	355	496	282	201	1273	1093	965	1499	-6	B-cell CLL/lymphoma 10 (BCL10)
B24R18C18	24-18-18	Hs~MGC:BC053617.1~uORF:IOH29004	565	348	540	395	188	1088	1245	941	1711	166	B-cell CLL/lymphoma 10 (BCL10)
B24R18C19	24-19-18	Hs~Ref:NM_153344.1~uORF:IOH40885	811	2250	1026	665	653	914	1262	768	1915	322	chromosome 6 open reading frame 141 (C6orf141)
B24R18C20	24-20-18	Hs~Ref:NM_153344.1~uORF:IOH40885	851	2231	1106	574	717	948	1173	782	1338	167	chromosome 6 open reading frame 141 (C6orf141)
B24R18C21	24-21-18	Hs~Ref:NM_180976.1~uORF:IOH43173	1457	722	4099	547	817	2632	1698	1356	1171	661	protein phosphatase 2, regulatory subunit B', delta isoform (PPP2R5D), transcript variant 2
B24R18C22	24-22-18	Hs~Ref:NM_180976.1~uORF:IOH43173	1202	852	3827	549	889	2798	1644	1387	588	1044	protein phosphatase 2, regulatory subunit B', delta isoform (PPP2R5D), transcript variant 2
B24R19C01	24-1-19	Hs~Ref:NM_006315.4~uORF:IOH41174	1170	375	701	506	443	643	1315	529	1413	338	polycomb group ring finger 3 (PCGF3)
B24R19C02	24-2-19	Hs~Ref:NM_006315.4~uORF:IOH41174	1134	474	761	530	423	713	1303	534	1295	364	polycomb group ring finger 3 (PCGF3)
B24R19C05	24-5-19	Hs~MGC:BC002369.1~N/A	1105	732	7784	621	2586	714	2364	577	1376	280	Serine/threonine-protein kinase PLK1
B24R19C06	24-6-19	Hs~MGC:BC002369.1~N/A	1308	729	7835	594	2479	773	2423	588	1446	277	Serine/threonine-protein kinase PLK1
B24R19C07	24-7-19	Hs~Ref:NM_004517.1~N/A	483	110	336	232	195	261	447	237	474	156	Integrin-linked protein kinase
B24R19C08	24-8-19	Hs~Ref:NM_004517.1~N/A	304	128	363	233	175	269	471	263	452	113	Integrin-linked protein kinase
B24R19C09	24-9-19	Hs~MGC:XM_291436.1~uORF:IOH28529	485	375	443	298	379	547	650	349	608	181	Olfactory receptor 14K1
B24R19C10	24-10-19	Hs~MGC:XM_291436.1~uORF:IOH28529	513	260	437	286	346	492	669	356	632	269	Olfactory receptor 14K1
B24R19C11	24-11-19	Hs~MGC:BC040606.1~uORF:IOH27734	486	595	458	329	350	530	651	472	761	331	WD repeat-containing protein 27
B24R19C12	24-12-19	Hs~MGC:BC040606.1~uORF:IOH27734	519	538	537	346	368	499	649	466	807	336	WD repeat-containing protein 27
B24R19C13	24-13-19	Hs~Ref:NM_001008660.1~uORF:IOH39850	7615	2922	3529	2359	2565	4146	7252	7154	6336	660	phosphatidylinositol binding clathrin assembly protein (PICALM), transcript variant 2
B24R19C14	24-14-19	Hs~Ref:NM_001008660.1~uORF:IOH39850	7565	3188	3536	2287	2625	4054	7244	7114	6535	664	phosphatidylinositol binding clathrin assembly protein (PICALM), transcript variant 2
B24R19C15	24-15-19	Hs~MGC:BC065918.1~uORF:IOH40465	2653	9319	2719	2194	1748	657	2641	1735	5769	294	Zinc finger CCHC domain-containing protein 8
B24R19C16	24-16-19	Hs~MGC:BC065918.1~uORF:IOH40465	2807	9263	2712	1929	1863	650	2572	1724	5971	243	Zinc finger CCHC domain-containing protein 8
B24R19C17	24-17-19	Hs~Ref:NM_004707.2~uORF:IOH40867	243	396	471	344	271	385	646	412	765	57	ATG12 autophagy related 12 homolog (S. cerevisiae) (ATG12)
B24R19C18	24-18-19	Hs~Ref:NM_004707.2~uORF:IOH40867	290	426	562	416	278	408	712	450	483	59	ATG12 autophagy related 12 homolog (S. cerevisiae) (ATG12)
B24R19C19	24-19-19	Hs~MGC:BC021988.1~uORF:IOH14635	925	887	819	2358	637	892	1067	834	2558	474	Nedd4 family interacting protein 2 (NDFIP2)
B24R19C20	24-20-19	Hs~MGC:BC021988.1~uORF:IOH14635	911	902	851	2197	655	914	908	794	2524	593	Nedd4 family interacting protein 2 (NDFIP2)
B24R19C21	24-21-19	Hs~Ref:NM_031483.3~uORF:IOH52904	1199	1234	1496	912	1471	-1	147	3	98	-3	E3 ubiquitin-protein ligase Itchy homolog
B24R19C22	24-22-19	Hs~Ref:NM_031483.3~uORF:IOH52904	1140	1301	1450	899	1497	1	123	-3	-6	-3	E3 ubiquitin-protein ligase Itchy homolog
B24R20C01	24-1-20	Hs~Ref:NM_024306.1~uORF:IOH5298	411	310	700	358	367	721	1000	541	1313	262	Fatty acid 2-hydroxylase
B24R20C02	24-2-20	Hs~Ref:NM_024306.1~uORF:IOH5298	403	595	773	382	353	711	1057	565	1182	291	Fatty acid 2-hydroxylase
B24R20C03	24-3-20	Hs~MGC:BC003606.1~uORF:IOH4960	620	540	878	345	292	492	716	438	857	268	XK, Kell blood group complex subunit-related family, member 8 (XKR8)
B24R20C04	24-4-20	Hs~MGC:BC003606.1~uORF:IOH4960	617	554	833	369	309	453	683	433	796	284	XK, Kell blood group complex subunit-related family, member 8 (XKR8)
B24R20C05	24-5-20	Hs~MGC:BC001610.1~uORF:IOH4912	547	272	293	378	299	325	413	286	771	156	zinc finger protein 765 (ZNF765)
B24R20C06	24-6-20	Hs~MGC:BC001610.1~uORF:IOH4912	495	278	288	325	313	343	410	263	803	162	zinc finger protein 765 (ZNF765)
B24R20C07	24-7-20	Hs~MGC:BC005212.1~uORF:IOH7144	191	338	346	202	157	329	554	256	1252	84	Non-SMC element 4 homolog A
B24R20C08	24-8-20	Hs~MGC:BC005212.1~uORF:IOH7144	298	219	340	78	154	342	540	219	1214	83	Non-SMC element 4 homolog A
B24R20C09	24-9-20	Hs~Ref:NM_080660.2~uORF:IOH6727	628	757	908	391	615	606	807	390	2195	340	zinc finger CCCH-type, antiviral 1-like (ZC3HAV1L)
B24R20C10	24-10-20	Hs~Ref:NM_080660.2~uORF:IOH6727	565	751	912	424	636	544	957	362	2182	340	zinc finger CCCH-type, antiviral 1-like (ZC3HAV1L)
B24R20C11	24-11-20	Hs~Ref:NM_080862.1~uORF:IOH6956	523	594	1172	317	399	1614	770	439	2397	149	SPRY domain-containing SOCS box protein 4
B24R20C12	24-12-20	Hs~Ref:NM_080862.1~uORF:IOH6956	467	586	1173	306	419	1736	772	422	2204	154	SPRY domain-containing SOCS box protein 4
B24R20C13	24-13-20	Hs~Ref:NM_002789.2~uORF:IOH7299	236	367	544	201	806	305	457	160	1113	34	proteasome (prosome, macropain) subunit, alpha type, 4 (PSMA4), transcript variant 1
B24R20C14	24-14-20	Hs~Ref:NM_002789.2~uORF:IOH7299	304	750	499	207	790	309	522	190	1076	26	proteasome (prosome, macropain) subunit, alpha type, 4 (PSMA4), transcript variant 1
B25R02C11	25-11-2	Hs~MGC:BC002488.1~uORF:IOH3970	24084	16193	15822	19028	11452	9206	34623	13791	13585	10511	SERPINE1 mRNA binding protein 1 (SERBP1)
B25R02C12	25-12-2	Hs~MGC:BC002488.1~uORF:IOH3970	22013	15190	16718	22723	12387	9545	35028	14006	13967	10145	SERPINE1 mRNA binding protein 1 (SERBP1)
B25R02C13	25-13-2	Hs~MGC:BC004106.1~uORF:IOH5672	814	1246	2167	2342	2159	3597	5616	2733	1945	516	mediator complex subunit 6 (MED6)
B25R02C14	25-14-2	Hs~MGC:BC004106.1~uORF:IOH5672	1144	1307	2178	1019	1544	3593	5619	2752	1838	505	mediator complex subunit 6 (MED6)
B25R02C15	25-15-2	Hs~MGC:BC030957.1~uORF:IOH23131	1014	995	1444	620	759	2592	2690	1243	1359	425	ankyrin 1, erythrocytic (ANK1)
B25R02C16	25-16-2	Hs~MGC:BC030957.1~uORF:IOH23131	990	1080	1566	580	672	2717	2738	1315	1234	416	ankyrin 1, erythrocytic (ANK1)
B25R02C19	25-19-2	Hs~Ref:NM_052940.3~uORF:IOH10671	-2	-1	2	886	594	1110	1977	767	2063	432	leucine rich repeat containing 42 (LRRC42)
B25R02C20	25-20-2	Hs~Ref:NM_052940.3~uORF:IOH10671	-1	2	5	713	553	1019	1890	772	1909	472	leucine rich repeat containing 42 (LRRC42)
B25R02C21	25-21-2	Hs~MGC:BC031227.1~uORF:IOH21600	685	845	1142	564	625	756	1637	625	3720	943	WD repeat domain 88 (WDR88)
B25R02C22	25-22-2	Hs~MGC:BC031227.1~uORF:IOH21600	679	885	1144	536	647	769	1909	633	3777	944	WD repeat domain 88 (WDR88)
B25R03C01	25-1-3	Hs~MGC:BC030516.1~uORF:IOH21650	4566	3910	2990	3126	2907	2865	10358	2638	6170	1436	La ribonucleoprotein domain family, member 2 (LARP2)
B25R03C02	25-2-3	Hs~MGC:BC030516.1~uORF:IOH21650	4685	4148	3280	3261	3213	2773	11026	2717	6042	1440	La ribonucleoprotein domain family, member 2 (LARP2)
B25R03C03	25-3-3	Hs~Ref:NM_001325.1~uORF:IOH11230	2136	2215	65474	1319	4096	1675	5729	5894	4587	1127	cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa (CSTF2)
B25R03C04	25-4-3	Hs~Ref:NM_001325.1~uORF:IOH11230	2195	2276	65472	1406	4146	1711	5928	5974	4652	1168	cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa (CSTF2)
B25R03C05	25-5-3	Hs~Ref:NM_001207.2~uORF:IOH5823	1819	2757	1564	2418	892	1295	4733	11619	6266	518	basic transcription factor 3 (BTF3), transcript variant 2
B25R03C06	25-6-3	Hs~Ref:NM_001207.2~uORF:IOH5823	1899	2860	1312	2564	804	1296	4441	12603	6304	677	basic transcription factor 3 (BTF3), transcript variant 2
B25R03C07	25-7-3	Hs~Ref:NM_004355.1~uORF:IOH13998	160	119	180	355	195	750	704	189	551	114	CD74 molecule, major histocompatibility complex, class II invariant chain (CD74), transcript variant 2
B25R03C08	25-8-3	Hs~Ref:NM_004355.1~uORF:IOH13998	1136	115	258	360	361	737	724	206	553	121	CD74 molecule, major histocompatibility complex, class II invariant chain (CD74), transcript variant 2
B25R03C09	25-9-3	Hs~Ref:NM_019058.1~uORF:IOH6497	2323	1230	2614	2273	1606	2451	1529	1963	3045	810	DNA-damage-inducible transcript 4 protein
B25R03C10	25-10-3	Hs~Ref:NM_019058.1~uORF:IOH6497	1972	1250	2390	2208	1686	2438	1491	2010	3024	840	DNA-damage-inducible transcript 4 protein
B25R03C11	25-11-3	Hs~Ref:NM_054016.1~uORF:IOH6575	1347	3185	1985	1220	1053	1301	3808	2934	1937	2188	FUS interacting protein (serine/arginine-rich) 1 (FUSIP1), transcript variant 2
B25R03C12	25-12-3	Hs~Ref:NM_054016.1~uORF:IOH6575	1336	3878	2115	1237	1313	1254	3864	3016	1890	2004	FUS interacting protein (serine/arginine-rich) 1 (FUSIP1), transcript variant 2
B25R03C13	25-13-3	Hs~Ref:NM_004039.1~uORF:IOH3974	6180	1178	1720	5206	3112	1633	5697	7821	2050	1183	annexin A2 (ANXA2), transcript variant 3
B25R03C14	25-14-3	Hs~Ref:NM_004039.1~uORF:IOH3974	6984	1218	1633	3400	2196	1595	5689	8051	1984	1219	annexin A2 (ANXA2), transcript variant 3
B25R03C15	25-15-3	Hs~Ref:NM_004169.2~uORF:IOH25904	672	1386	700	1331	1510	1299	3419	1203	3596	458	serine hydroxymethyltransferase 1 (soluble) (SHMT1), transcript variant 1
B25R03C16	25-16-3	Hs~Ref:NM_004169.2~uORF:IOH25904	692	1388	765	1380	1295	1309	3511	1146	3787	444	serine hydroxymethyltransferase 1 (soluble) (SHMT1), transcript variant 1
B25R03C17	25-17-3	Hs~MGC:BC001918.1~uORF:IOH5019	537	284	723	204	74	232	696	438	597	53	acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) (ACAA2)
B25R03C18	25-18-3	Hs~MGC:BC001918.1~uORF:IOH5019	677	357	728	204	86	433	721	436	218	119	acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) (ACAA2)
B25R03C19	25-19-3	Hs~MGC:BC037900.2~uORF:IOH27758	783	840	2288	3546	1090	3728	3279	1897	1937	420	C-terminal binding protein 2 (CTBP2)
B25R03C20	25-20-3	Hs~MGC:BC037900.2~uORF:IOH27758	682	884	2341	3617	1080	3301	3253	1753	2272	414	C-terminal binding protein 2 (CTBP2)
B25R03C21	25-21-3	Hs~Ref:NM_007255.1~uORF:IOH5828	6842	5850	4758	7128	5076	4388	6290	6741	7268	7771	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) (B4GALT7)
B25R03C22	25-22-3	Hs~Ref:NM_007255.1~uORF:IOH5828	6861	5980	4699	7077	5942	4239	7273	6837	6726	7480	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) (B4GALT7)
B25R04C01	25-1-4	Hs~Ref:NM_015987.2~uORF:IOH9993	543	250	527	366	299	477	673	278	1039	189	heme binding protein 1 (HEBP1)
B25R04C02	25-2-4	Hs~Ref:NM_015987.2~uORF:IOH9993	561	130	526	382	294	447	661	293	1041	40	heme binding protein 1 (HEBP1)
B25R04C03	25-3-4	Hs~MGC:BC007414.2~uORF:IOH5824	1073	1200	1689	825	873	1304	1898	1052	2317	681	UBX domain-containing protein 6
B25R04C04	25-4-4	Hs~MGC:BC007414.2~uORF:IOH5824	1155	1203	1768	863	916	1228	1918	945	2396	702	UBX domain-containing protein 6
B25R04C05	25-5-4	Hs~Ref:NM_002648.1~uORF:IOH14704	2264	1465	3167	1776	4775	1957	2725	2449	2683	637	pim-1 oncogene (PIM1)
B25R04C06	25-6-4	Hs~Ref:NM_002648.1~uORF:IOH14704	2210	1501	3143	1696	4811	1967	2691	2533	2736	617	pim-1 oncogene (PIM1)
B25R04C07	25-7-4	Hs~MGC:BC030827.1~uORF:IOH22231	182	145	409	269	210	588	345	838	1587	60	hippocalcin like 4 (HPCAL4)
B25R04C08	25-8-4	Hs~MGC:BC030827.1~uORF:IOH22231	137	135	406	269	236	595	114	844	1542	56	hippocalcin like 4 (HPCAL4)
B25R04C09	25-9-4	Hs~MGC:BC030586.2~uORF:IOH22241	14381	450	1048	3615	2746	2195	16954	2353	3814	1400	signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 (STAM)
B25R04C10	25-10-4	Hs~MGC:BC030586.2~uORF:IOH22241	14349	466	1027	3604	3031	2121	16849	2326	3675	1410	signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 (STAM)
B25R04C11	25-11-4	Hs~MGC:BC030585.2~uORF:IOH22261	477	544	812	425	944	560	937	466	1224	266	sperm associated antigen 6 (SPAG6)
B25R04C12	25-12-4	Hs~MGC:BC030585.2~uORF:IOH22261	505	922	799	421	956	567	814	430	1220	290	sperm associated antigen 6 (SPAG6)
B25R04C13	25-13-4	Hs~Ref:NM_003498.2~uORF:IOH22278	598	617	777	504	1191	524	587	405	1452	168	stannin (SNN)
B25R04C14	25-14-4	Hs~Ref:NM_003498.2~uORF:IOH22278	617	417	758	344	636	523	589	385	1411	75	stannin (SNN)
B25R04C15	25-15-4	Hs~MGC:BC031682.1~uORF:IOH22859	2516	1655	2934	1579	1374	2018	9769	1580	3100	966	RNA-binding protein 42
B25R04C16	25-16-4	Hs~MGC:BC031682.1~uORF:IOH22859	2521	1537	2770	1578	1135	1898	10569	1574	2858	864	RNA-binding protein 42
B25R04C17	25-17-4	Hs~MGC:BC021118.1~uORF:IOH13386	698	967	992	403	392	798	1405	600	691	268	paroxysmal nonkinesigenic dyskinesia (PNKD)
B25R04C18	25-18-4	Hs~MGC:BC021118.1~uORF:IOH13386	698	1006	992	403	459	789	1407	535	887	282	paroxysmal nonkinesigenic dyskinesia (PNKD)
B25R04C19	25-19-4	Hs~MGC:BC045606.1~uORF:IOH27193	392	331	550	245	310	439	570	357	945	203	nidogen 1 (NID1)
B25R04C20	25-20-4	Hs~MGC:BC045606.1~uORF:IOH27193	356	302	505	336	198	348	598	342	467	184	nidogen 1 (NID1)
B25R04C21	25-21-4	Hs~Ref:NM_004252.1~uORF:IOH4025	430	3610	1016	1330	325	705	1595	2603	2002	345	solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 (SLC9A3R1)
B25R04C22	25-22-4	Hs~Ref:NM_004252.1~uORF:IOH4025	441	3851	998	1518	302	695	1598	2548	2070	345	solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 (SLC9A3R1)
B25R05C01	25-1-5	Hs~MGC:BC023990.1~uORF:IOH27874	6860	1472	2288	3913	2211	2238	6375	8570	2409	1473	annexin A2 (ANXA2)
B25R05C02	25-2-5	Hs~MGC:BC023990.1~uORF:IOH27874	7091	1512	2333	3913	2151	2191	6165	8303	2288	1447	annexin A2 (ANXA2)
B25R05C03	25-3-5	Hs~MGC:BC059366.1~uORF:IOH39823	460	529	775	411	431	550	716	641	827	23	BTB/POZ domain-containing protein KCTD18
B25R05C04	25-4-5	Hs~MGC:BC059366.1~uORF:IOH39823	498	513	780	467	429	546	714	577	820	182	BTB/POZ domain-containing protein KCTD18
B25R05C05	25-5-5	Hs~Ref:NM_016062.1~uORF:IOH4424	696	998	1024	737	939	894	1562	1884	1440	398	family with sequence similarity 96, member B (FAM96B)
B25R05C06	25-6-5	Hs~Ref:NM_016062.1~uORF:IOH4424	741	1026	1062	788	856	910	1548	1995	1446	401	family with sequence similarity 96, member B (FAM96B)
B25R05C07	25-7-5	Hs~Ref:NM_012232.2~uORF:IOH39825	4762	494	730	381	927	803	1462	684	790	256	polymerase I and transcript release factor (PTRF)
B25R05C08	25-8-5	Hs~Ref:NM_012232.2~uORF:IOH39825	5220	516	781	379	938	831	1438	660	799	284	polymerase I and transcript release factor (PTRF)
B25R05C09	25-9-5	Hs~Ref:NM_006705.2~uORF:IOH3588	1258	437	1104	473	587	770	1126	595	1090	124	growth arrest and DNA-damage-inducible, gamma (GADD45G)
B25R05C10	25-10-5	Hs~Ref:NM_006705.2~uORF:IOH3588	1228	433	1124	453	646	733	1160	627	1044	245	growth arrest and DNA-damage-inducible, gamma (GADD45G)
B25R05C11	25-11-5	Hs~MGC:BC030805.1~uORF:IOH23050	839	805	1228	769	1191	841	1172	850	1867	616	syndecan 4 (SDC4)
B25R05C12	25-12-5	Hs~MGC:BC030805.1~uORF:IOH23050	821	886	1276	820	1349	901	1135	812	1875	623	syndecan 4 (SDC4)
B25R05C13	25-13-5	Hs~MGC:BC001648.1~uORF:IOH3702	1078	1714	1422	1055	3066	1406	1633	995	3143	492	WD repeat domain 18 (WDR18)
B25R05C14	25-14-5	Hs~MGC:BC001648.1~uORF:IOH3702	1066	1761	1416	991	1663	1372	1591	1023	3186	479	WD repeat domain 18 (WDR18)
B25R05C15	25-15-5	Hs~MGC:BC009398.1~uORF:IOH14462	912	651	1004	990	905	2287	1404	1056	3485	393	minichromosome maintenance complex component 7 (MCM7)
B25R05C16	25-16-5	Hs~MGC:BC009398.1~uORF:IOH14462	897	676	1050	972	964	2261	1389	1090	3291	371	minichromosome maintenance complex component 7 (MCM7)
B25R05C17	25-17-5	Hs~MGC:BC046117.1~uORF:IOH26985	1039	1535	5235	1953	2694	2825	5251	3806	3064	1249	dynein, axonemal, light intermediate chain 1 (DNALI1)
B25R05C18	25-18-5	Hs~MGC:BC046117.1~uORF:IOH26985	1063	1677	4921	1950	2371	2984	5598	4073	3361	1214	dynein, axonemal, light intermediate chain 1 (DNALI1)
B25R05C19	25-19-5	Hs~MGC:BC045563.1~uORF:IOH26744	259	486	324	203	265	717	454	1991	891	297	hypothetical protein FLJ30934 (FLJ30934)
B25R05C20	25-20-5	Hs~MGC:BC045563.1~uORF:IOH26744	303	505	295	249	244	583	417	1890	341	285	hypothetical protein FLJ30934 (FLJ30934)
B25R05C21	25-21-5	Hs~MGC:BC047303.1~uORF:IOH26558	1055	849	745	728	652	1178	1573	729	2452	471	chromosome 6 open reading frame 134 (C6orf134)
B25R05C22	25-22-5	Hs~MGC:BC047303.1~uORF:IOH26558	950	844	730	717	575	1090	1741	718	2206	491	chromosome 6 open reading frame 134 (C6orf134)
B25R06C01	25-1-6	Hs~MGC:NM_175085.1~uORF:IOH26153	251	194	287	249	259	425	381	305	94	93	phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase (GART), transcript variant 2
B25R06C02	25-2-6	Hs~MGC:NM_175085.1~uORF:IOH26153	239	198	333	242	260	419	359	376	438	86	phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase (GART), transcript variant 2
B25R06C03	25-3-6	Hs~Ref:NM_018153.2~uORF:IOH12656	543	657	651	373	307	481	726	523	831	99	anthrax toxin receptor 1 (ANTXR1), transcript variant 3
B25R06C04	25-4-6	Hs~Ref:NM_018153.2~uORF:IOH12656	599	567	601	337	347	518	780	437	768	14	anthrax toxin receptor 1 (ANTXR1), transcript variant 3
B25R06C05	25-5-6	Hs~MGC:BC012098.1~uORF:IOH13158	834	684	1935	1627	1076	780	1546	752	1302	370	glucan (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV) (GBE1)
B25R06C06	25-6-6	Hs~MGC:BC012098.1~uORF:IOH13158	970	635	1948	1494	1113	785	1458	681	1261	335	glucan (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV) (GBE1)
B25R06C07	25-7-6	Hs~Ref:NM_022915.2~uORF:IOH13325	785	539	684	468	624	627	780	534	1104	387	mitochondrial ribosomal protein L44 (MRPL44), nuclear gene encoding mitochondrial protein
B25R06C08	25-8-6	Hs~Ref:NM_022915.2~uORF:IOH13325	782	523	768	416	632	594	878	495	1066	442	mitochondrial ribosomal protein L44 (MRPL44), nuclear gene encoding mitochondrial protein
B25R06C09	25-9-6	Hs~MGC:BC024002.2~uORF:IOH11100	493	463	863	324	1106	605	953	716	1453	323	fibronectin type III domain containing 8 (FNDC8)
B25R06C10	25-10-6	Hs~MGC:BC024002.2~uORF:IOH11100	478	443	893	324	1207	562	974	829	1469	298	fibronectin type III domain containing 8 (FNDC8)
B25R06C11	25-11-6	Hs~Ref:NM_002307.1~uORF:IOH40009	1204	1346	5694	3202	1631	2436	2295	8335	3105	845	lectin, galactoside-binding, soluble, 7 (galectin 7) (LGALS7)
B25R06C12	25-12-6	Hs~Ref:NM_002307.1~uORF:IOH40009	1321	1362	5921	3269	1740	2457	2218	8416	3024	847	lectin, galactoside-binding, soluble, 7 (galectin 7) (LGALS7)
B25R06C13	25-13-6	Hs~MGC:BC065290.1~uORF:IOH39961	398	429	575	1239	862	569	552	544	556	172	cytochrome b reductase 1 (CYBRD1)
B25R06C14	25-14-6	Hs~MGC:BC065290.1~uORF:IOH39961	387	331	537	901	571	545	578	528	598	133	cytochrome b reductase 1 (CYBRD1)
B25R06C15	25-15-6	Hs~Ref:NM_153043.3~uORF:IOH40012	1469	682	2177	1340	986	983	2599	1245	2158	343	hypothetical protein FLJ37078 (FLJ37078)
B25R06C16	25-16-6	Hs~Ref:NM_153043.3~uORF:IOH40012	1472	718	2406	1452	883	1050	2712	1256	2088	342	hypothetical protein FLJ37078 (FLJ37078)
B25R06C17	25-17-6	Hs~Ref:NM_133635.3~uORF:IOH39914	434	340	605	242	421	355	562	571	506	207	protein O-fucosyltransferase 2 (POFUT2), transcript variant 3
B25R06C18	25-18-6	Hs~Ref:NM_133635.3~uORF:IOH39914	442	309	606	294	426	388	600	566	573	125	protein O-fucosyltransferase 2 (POFUT2), transcript variant 3
B25R06C19	25-19-6	Hs~MGC:BC021983.1~uORF:IOH27884	3311	2178	2650	1249	884	2487	9967	1535	3251	532	nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1)
B25R06C20	25-20-6	Hs~MGC:BC021983.1~uORF:IOH27884	3288	2172	2558	1351	851	2333	10379	1623	3564	532	nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1)
B25R06C21	25-21-6	Hs~MGC:BC017570.1~uORF:IOH27880	9076	3061	2391	5250	4522	2978	3317	4145	3766	5585	chromosome 9 open reading frame 78 (C9orf78)
B25R06C22	25-22-6	Hs~MGC:BC017570.1~uORF:IOH27880	10346	3385	2340	5885	4611	2931	3350	4421	3495	5618	chromosome 9 open reading frame 78 (C9orf78)
B25R07C01	25-1-7	Hs~Ref:NM_012280.1~uORF:IOH27897	1238	463	1071	771	560	732	1544	568	2110	947	FtsJ homolog 1 (E. coli) (FTSJ1), transcript variant 1
B25R07C02	25-2-7	Hs~Ref:NM_012280.1~uORF:IOH27897	1269	466	1151	739	570	699	1596	592	2115	926	FtsJ homolog 1 (E. coli) (FTSJ1), transcript variant 1
B25R07C03	25-3-7	Hs~Ref:NM_014239.1~uORF:IOH27837	669	624	1543	560	675	864	779	746	992	264	eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa (EIF2B2)
B25R07C04	25-4-7	Hs~Ref:NM_014239.1~uORF:IOH27837	656	511	1549	550	729	856	740	692	1012	256	eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa (EIF2B2)
B25R07C05	25-5-7	Hs~MGC:BC000921.2~uORF:IOH2975	1076	672	1111	522	515	834	2249	493	1093	349	methyltransferase like 5 (METTL5)
B25R07C06	25-6-7	Hs~MGC:BC000921.2~uORF:IOH2975	1076	613	1138	471	578	788	2244	509	1048	314	methyltransferase like 5 (METTL5)
B25R07C07	25-7-7	Hs~MGC:BC003397.1~uORF:IOH3007	320	207	406	235	327	331	497	245	703	269	Protein odr-4 homolog
B25R07C08	25-8-7	Hs~MGC:BC003397.1~uORF:IOH3007	324	446	432	245	314	318	442	372	640	256	Protein odr-4 homolog
B25R07C09	25-9-7	Hs~MGC:BC048214.1~uORF:IOH28047	425	268	498	249	424	373	562	464	-1	232	chromosome 8 open reading frame 13 (C8orf13)
B25R07C10	25-10-7	Hs~MGC:BC048214.1~uORF:IOH28047	463	492	600	257	420	365	515	379	-1	229	chromosome 8 open reading frame 13 (C8orf13)
B25R07C11	25-11-7	Hs~MGC:BC000578.1~uORF:IOH4180	502	449	700	492	807	626	1917	658	1937	430	hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome) (HPRT1)
B25R07C12	25-12-7	Hs~MGC:BC000578.1~uORF:IOH4180	513	437	750	538	1013	743	1830	689	2008	376	hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome) (HPRT1)
B25R07C13	25-13-7	Hs~Ref:NM_030803.5~uORF:IOH43648	1833	1516	3852	1634	1386	2162	1814	4271	5645	908	ATG16 autophagy related 16-like 1 (S. cerevisiae) (ATG16L1), transcript variant 1
B25R07C14	25-14-7	Hs~Ref:NM_030803.5~uORF:IOH43648	1841	1417	3772	1542	1370	2092	1875	4158	5741	934	ATG16 autophagy related 16-like 1 (S. cerevisiae) (ATG16L1), transcript variant 1
B25R07C15	25-15-7	Hs~Ref:NM_005622.3~uORF:IOH42133	1522	941	1923	1305	1636	1888	2006	933	1994	952	acyl-CoA synthetase medium-chain family member 3 (ACSM3), transcript variant 1
B25R07C16	25-16-7	Hs~Ref:NM_005622.3~uORF:IOH42133	1501	1033	1881	1181	1686	1793	2158	936	2001	915	acyl-CoA synthetase medium-chain family member 3 (ACSM3), transcript variant 1
B25R07C17	25-17-7	Hs~Ref:NM_033194.1~uORF:IOH43657	1663	1509	2122	15026	1575	1846	2149	1237	3262	1036	heat shock protein, alpha-crystallin-related, B9 (HSPB9)
B25R07C18	25-18-7	Hs~Ref:NM_033194.1~uORF:IOH43657	1542	1503	2182	15031	1449	1850	2144	1215	3696	1020	heat shock protein, alpha-crystallin-related, B9 (HSPB9)
B25R07C19	25-19-7	Hs~Ref:NM_006156.1~uORF:IOH42171	1392	728	1490	700	1051	2838	966	1219	1831	436	neural precursor cell expressed, developmentally down-regulated 8 (NEDD8)
B25R07C20	25-20-7	Hs~Ref:NM_006156.1~uORF:IOH42171	1513	739	1532	822	942	2458	996	1249	1955	442	neural precursor cell expressed, developmentally down-regulated 8 (NEDD8)
B25R07C21	25-21-7	Hs~MGC:NM_138355.1~uORF:IOH14669	1146	901	1321	748	995	959	1547	803	2723	573	secernin 2 (SCRN2)
B25R07C22	25-22-7	Hs~MGC:NM_138355.1~uORF:IOH14669	1175	970	1415	758	879	957	1611	769	2635	578	secernin 2 (SCRN2)
B25R08C01	25-1-8	Hs~MGC:BC017262.1~uORF:IOH13986	3124	1237	1572	1623	893	1239	2139	983	2607	684	chromosome 1 open reading frame 2 (C1orf2)
B25R08C02	25-2-8	Hs~MGC:BC017262.1~uORF:IOH13986	3098	1234	1647	1588	986	1267	2019	1171	2550	670	chromosome 1 open reading frame 2 (C1orf2)
B25R08C03	25-3-8	Hs~MGC:BC021930.1~uORF:IOH13703	6808	4957	5422	3670	4303	3983	18031	3713	6973	3291	KIAA1530 protein (KIAA1530)
B25R08C04	25-4-8	Hs~MGC:BC021930.1~uORF:IOH13703	7034	5079	5474	3917	4600	4102	18397	3510	7009	3286	KIAA1530 protein (KIAA1530)
B25R08C05	25-5-8	Hs~Ref:NM_006332.1~uORF:IOH13656	2544	1812	2796	1431	1912	2183	7003	1511	4003	942	interferon, gamma-inducible protein 30 (IFI30)
B25R08C06	25-6-8	Hs~Ref:NM_006332.1~uORF:IOH13656	2886	1818	2910	1426	1908	2181	7077	1557	4059	882	interferon, gamma-inducible protein 30 (IFI30)
B25R08C07	25-7-8	Hs~MGC:BC028739.2~uORF:IOH11395	525	501	673	390	476	462	695	519	725	277	Potassium voltage-gated channel subfamily V member 1
B25R08C08	25-8-8	Hs~MGC:BC028739.2~uORF:IOH11395	461	334	683	400	583	415	774	446	729	282	Potassium voltage-gated channel subfamily V member 1
B25R08C09	25-9-8	Hs~MGC:NM_172016.1~uORF:IOH5913	2051	1532	850	624	815	2209	1528	1110	1199	1013	tripartite motif-containing 39 (TRIM39), transcript variant 2
B25R08C10	25-10-8	Hs~MGC:NM_172016.1~uORF:IOH5913	1267	1575	1000	639	869	2138	1564	941	1137	1020	tripartite motif-containing 39 (TRIM39), transcript variant 2
B25R08C11	25-11-8	Hs~Ref:NM_016301.2~uORF:IOH7464	1035	651	1144	736	975	771	1261	540	1662	385	ATP binding domain 1 family, member C (ATPBD1C)
B25R08C12	25-12-8	Hs~Ref:NM_016301.2~uORF:IOH7464	1161	602	1142	813	1044	841	1379	589	1715	366	ATP binding domain 1 family, member C (ATPBD1C)
B25R08C13	25-13-8	Hs~MGC:BC029220.1~uORF:IOH22755	1985	2945	5096	3318	2404	17884	3088	1059	2838	1118	Transcription factor SOX-5
B25R08C14	25-14-8	Hs~MGC:BC029220.1~uORF:IOH22755	1905	2816	4706	3412	2415	16848	2978	1080	2697	1172	Transcription factor SOX-5
B25R08C15	25-15-8	Hs~MGC:BC012536.1~uORF:IOH14192	545	600	623	279	691	428	673	408	696	330	hydroxysteroid (17-beta) dehydrogenase 12 (HSD17B12)
B25R08C16	25-16-8	Hs~MGC:BC012536.1~uORF:IOH14192	550	583	591	290	423	359	685	405	661	294	hydroxysteroid (17-beta) dehydrogenase 12 (HSD17B12)
B25R08C17	25-17-8	Hs~Ref:NM_031992.1~uORF:IOH13859	935	1008	1863	652	635	6466	3075	1170	1873	417	eukaryotic translation initiation factor 4H (EIF4H), transcript variant 2
B25R08C18	25-18-8	Hs~Ref:NM_031992.1~uORF:IOH13859	967	1035	1992	635	696	5015	3081	1150	1909	415	eukaryotic translation initiation factor 4H (EIF4H), transcript variant 2
B25R08C19	25-19-8	Hs~Ref:NM_030673.1~uORF:IOH5238	487	918	1015	696	502	1350	1854	569	1040	239	SEC13-like 1 (S. cerevisiae) (SEC13L1), transcript variant 1
B25R08C20	25-20-8	Hs~Ref:NM_030673.1~uORF:IOH5238	580	2223	963	1541	490	1208	1838	563	1045	258	SEC13-like 1 (S. cerevisiae) (SEC13L1), transcript variant 1
B25R08C21	25-21-8	Hs~MGC:BC003566.1~uORF:IOH4871	1056	681	1372	1417	3225	923	2029	640	1554	436	zinc finger protein 24 (ZNF24)
B25R08C22	25-22-8	Hs~MGC:BC003566.1~uORF:IOH4871	1033	621	1277	1062	3364	973	1922	580	1519	415	zinc finger protein 24 (ZNF24)
B25R09C01	25-1-9	Hs~Ref:NM_021032.2~uORF:IOH35339	4167	4047	5970	2259	3713	8799	16744	1694	4882	1967	fibroblast growth factor 12 (FGF12), transcript variant 1
B25R09C02	25-2-9	Hs~Ref:NM_021032.2~uORF:IOH35339	4481	4201	6313	2414	4049	8751	15880	1631	4662	1930	fibroblast growth factor 12 (FGF12), transcript variant 1
B25R09C03	25-3-9	Hs~Ref:NM_025091.2~uORF:IOH35195	4702	2801	5360	7441	2399	3896	4895	2301	3368	1556	chromosome X and Y open reading frame 2 (CXYorf2)
B25R09C04	25-4-9	Hs~Ref:NM_025091.2~uORF:IOH35195	4829	2797	5440	7609	2556	3913	5058	2060	3395	1458	chromosome X and Y open reading frame 2 (CXYorf2)
B25R09C05	25-5-9	Hs~Ref:NM_130848.1~uORF:IOH35344	2982	2109	2146	1666	2243	2210	5751	3692	3045	1802	chromosome 5 open reading frame 20 (C5orf20)
B25R09C06	25-6-9	Hs~Ref:NM_130848.1~uORF:IOH35344	3042	2282	2124	1675	2167	2114	5607	3039	3123	1787	chromosome 5 open reading frame 20 (C5orf20)
B25R09C07	25-7-9	Hs~Ref:NM_018467.2~uORF:IOH7563	5662	1133	1196	842	1016	1040	1281	1059	1442	574	unconventional SNARE in the ER 1 homolog (S. cerevisiae) (USE1)
B25R09C08	25-8-9	Hs~Ref:NM_018467.2~uORF:IOH7563	5801	1100	1311	812	1168	1036	1326	1045	1438	558	unconventional SNARE in the ER 1 homolog (S. cerevisiae) (USE1)
B25R09C09	25-9-9	Hs~MGC:BC005313.1~uORF:IOH7368	803	196	373	580	339	396	1117	338	815	180	kallikrein 1 (KLK1)
B25R09C10	25-10-9	Hs~MGC:BC005313.1~uORF:IOH7368	484	806	318	571	405	403	1183	346	776	116	kallikrein 1 (KLK1)
B25R09C11	25-11-9	Hs~MGC:NM_007041.1~uORF:IOH10743	578	442	705	355	717	753	737	708	610	274	Arginyl-tRNA--protein transferase 1
B25R09C12	25-12-9	Hs~MGC:NM_007041.1~uORF:IOH10743	555	743	718	338	893	803	743	626	631	273	Arginyl-tRNA--protein transferase 1
B25R09C13	25-13-9	Hs~Ref:NM_053004.1~uORF:IOH14758	332	130	362	197	701	307	303	284	349	234	guanine nucleotide binding protein (G protein), beta polypeptide 1-like (GNB1L)
B25R09C14	25-14-9	Hs~Ref:NM_053004.1~uORF:IOH14758	337	1510	415	697	601	321	356	282	446	132	guanine nucleotide binding protein (G protein), beta polypeptide 1-like (GNB1L)
B25R09C15	25-15-9	Hs~Ref:NM_054012.1~uORF:IOH14007	1283	1096	1797	1686	2914	1706	1512	2219	3683	806	argininosuccinate synthetase 1 (ASS1), transcript variant 2
B25R09C16	25-16-9	Hs~Ref:NM_054012.1~uORF:IOH14007	1235	941	1801	1004	3352	1795	1669	2178	3770	817	argininosuccinate synthetase 1 (ASS1), transcript variant 2
B25R09C17	25-17-9	Hs~Ref:NM_006829.1~uORF:IOH5620	426	300	714	21264	557	916	1000	470	1211	390	chromosome 10 open reading frame 116 (C10orf116)
B25R09C18	25-18-9	Hs~Ref:NM_006829.1~uORF:IOH5620	418	343	758	21825	524	1053	1012	471	1253	402	chromosome 10 open reading frame 116 (C10orf116)
B25R09C19	25-19-9	Hs~MGC:BC004876.1~uORF:IOH5626	6260	3943	7099	4292	47578	4728	10089	3821	5598	3236	Protein MCM10 homolog
B25R09C20	25-20-9	Hs~MGC:BC004876.1~uORF:IOH5626	6658	4094	6790	4187	48354	4715	10066	3626	5915	3347	Protein MCM10 homolog
B25R09C21	25-21-9	Hs~MGC:BC001817.1~uORF:IOH5174	576	338	463	812	315	661	585	360	844	131	Acyl-CoA dehydrogenase family member 9, mitochondrial
B25R09C22	25-22-9	Hs~MGC:BC001817.1~uORF:IOH5174	371	393	503	351	364	430	635	370	782	192	Acyl-CoA dehydrogenase family member 9, mitochondrial
B25R10C01	25-1-10	Hs~MGC:BC004902.1~uORF:IOH5223	536	297	503	315	288	421	583	465	629	157	Uncharacterized protein KIAA0947
B25R10C02	25-2-10	Hs~MGC:BC004902.1~uORF:IOH5223	381	403	525	451	296	392	558	342	626	139	Uncharacterized protein KIAA0947
B25R10C03	25-3-10	Hs~MGC:BC033710.2~uORF:IOH45968	2334	2078	1626	1099	1269	1618	1921	1543	3212	876	RAD54 homolog B (S. cerevisiae) (RAD54B)
B25R10C04	25-4-10	Hs~MGC:BC033710.2~uORF:IOH45968	2378	2090	1654	1016	1252	1549	1775	1484	3153	840	RAD54 homolog B (S. cerevisiae) (RAD54B)
B25R10C05	25-5-10	Hs~Ref:NM_017572.2~uORF:IOH53775	1377	886	1491	779	1049	1117	2004	1039	4051	431	MAP kinase-interacting serine/threonine-protein kinase 2
B25R10C06	25-6-10	Hs~Ref:NM_017572.2~uORF:IOH53775	1371	905	1508	852	1162	1099	1965	1178	3909	466	MAP kinase-interacting serine/threonine-protein kinase 2
B25R10C07	25-7-10	Hs~MGC:BC006106.1~uORF:IOH6536	2892	5660	5442	2595	5135	4773	6625	12390	3902	3123	ribosomal protein S6 kinase, 70kDa, polypeptide 2 (RPS6KB2)
B25R10C08	25-8-10	Hs~MGC:BC006106.1~uORF:IOH6536	2724	5633	5468	2625	5352	4874	6831	12524	3820	3092	ribosomal protein S6 kinase, 70kDa, polypeptide 2 (RPS6KB2)
B25R10C09	25-9-10	Hs~Ref:NM_032303.2~uORF:IOH57810	630	737	1612	1199	1861	794	1184	1320	1389	439	Hydroxysteroid dehydrogenase-like protein 2
B25R10C10	25-10-10	Hs~Ref:NM_032303.2~uORF:IOH57810	719	720	1560	1230	2045	747	1178	1303	1374	442	Hydroxysteroid dehydrogenase-like protein 2
B25R11C21	25-21-11	Hs~Ref:NM_000576.1~uORF:IOH9821	1037	612	1557	715	978	826	1556	1282	1830	308	interleukin 1, beta (IL1B)
B25R11C22	25-22-11	Hs~Ref:NM_000576.1~uORF:IOH9821	983	534	1421	765	1217	846	1691	1268	1973	318	interleukin 1, beta (IL1B)
B25R12C01	25-1-12	Hs~Ref:NM_017840.1~uORF:IOH3760	2780	999	1405	719	945	1331	4671	916	1973	567	mitochondrial ribosomal protein L16 (MRPL16), nuclear gene encoding mitochondrial protein
B25R12C02	25-2-12	Hs~Ref:NM_017840.1~uORF:IOH3760	1912	993	1278	1277	982	1251	4517	1026	1918	497	mitochondrial ribosomal protein L16 (MRPL16), nuclear gene encoding mitochondrial protein
B25R12C03	25-3-12	Hs~MGC:BC013945.1~uORF:IOH13217	835	752	979	1119	723	1011	1516	785	1293	430	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12) (GALNT12)
B25R12C04	25-4-12	Hs~MGC:BC013945.1~uORF:IOH13217	893	763	923	559	736	983	1515	855	1351	474	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12) (GALNT12)
B25R12C07	25-7-12	Hs~MGC:BC050351.1~uORF:IOH62378	696	269	537	338	803	442	749	895	1359	274	Phosphofurin acidic cluster sorting protein 2
B25R12C08	25-8-12	Hs~MGC:BC050351.1~uORF:IOH62378	730	146	516	331	841	447	778	853	1421	296	Phosphofurin acidic cluster sorting protein 2
B25R12C09	25-9-12	Hs~MGC:BC068602.1~uORF:IOH61659	320	215	375	216	135	275	497	209	450	73	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial
B25R12C10	25-10-12	Hs~MGC:BC068602.1~uORF:IOH61659	199	147	379	196	216	267	539	213	425	344	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial
B25R12C11	25-11-12	Hs~MGC:BC033905.1~uORF:IOH61608	1150	215	2604	257	550	370	442	258	651	318	Rho guanine nucleotide exchange factor (GEF) 7, mRNA (cDNA clone MGC:33815 IMAGE:5262912), complete cds
B25R12C12	25-12-12	Hs~MGC:BC033905.1~uORF:IOH61608	1492	77	2592	226	588	381	500	282	600	332	Rho guanine nucleotide exchange factor (GEF) 7, mRNA (cDNA clone MGC:33815 IMAGE:5262912), complete cds
B25R12C13	25-13-12	Hs~MGC:BC068496.1~uORF:IOH62478	101	56	343	116	614	261	322	177	317	49	TBC domain-containing protein kinase-like protein
B25R12C14	25-14-12	Hs~MGC:BC068496.1~uORF:IOH62478	200	132	260	1822	545	260	324	299	320	43	TBC domain-containing protein kinase-like protein
B25R12C15	25-15-12	Hs~Ref:NM_012198.2~uORF:IOH7201	441	2732	366	2186	692	432	388	384	543	118	grancalcin, EF-hand calcium binding protein (GCA)
B25R12C16	25-16-12	Hs~Ref:NM_012198.2~uORF:IOH7201	394	216	379	298	341	469	436	258	464	80	grancalcin, EF-hand calcium binding protein (GCA)
B25R12C17	25-17-12	Hs~Ref:NM_000989.2~uORF:IOH3809	2559	792	1288	716	430	1198	11323	1301	2356	365	ribosomal protein L30 (RPL30)
B25R12C18	25-18-12	Hs~Ref:NM_000989.2~uORF:IOH3809	2526	843	1399	715	429	1586	12003	1300	1906	369	ribosomal protein L30 (RPL30)
B25R12C19	25-19-12	Hs~Ref:NM_005326.2~uORF:IOH3130	378	259	297	209	241	559	318	202	696	150	hydroxyacylglutathione hydrolase (HAGH), transcript variant 1
B25R12C20	25-20-12	Hs~Ref:NM_005326.2~uORF:IOH3130	390	278	293	246	281	212	302	190	647	204	hydroxyacylglutathione hydrolase (HAGH), transcript variant 1
B25R12C21	25-21-12	Hs~MGC:BC015109.1~uORF:IOH14036	2072	441	683	677	501	884	757	557	1257	400	39S ribosomal protein L1, mitochondrial
B25R12C22	25-22-12	Hs~MGC:BC015109.1~uORF:IOH14036	2242	478	645	562	572	951	809	572	1325	380	39S ribosomal protein L1, mitochondrial
B25R13C01	25-1-13	Hs~Ref:NM_024330.1~uORF:IOH5056	995	643	916	449	390	647	1127	450	1302	485	Long-chain fatty acid transport protein 3
B25R13C02	25-2-13	Hs~Ref:NM_024330.1~uORF:IOH5056	920	652	1012	1103	412	620	1093	453	1303	434	Long-chain fatty acid transport protein 3
B25R13C03	25-3-13	Hs~MGC:BC002655.2~uORF:IOH5256	451	326	553	1156	286	460	619	335	626	286	cell cycle related kinase (CCRK)
B25R13C04	25-4-13	Hs~MGC:BC002655.2~uORF:IOH5256	482	552	550	269	322	414	584	384	616	296	cell cycle related kinase (CCRK)
B25R13C05	25-5-13	Hs~MGC:BC007022.1~uORF:IOH7234	296	190	382	195	249	299	450	211	347	57	serum amyloid A1 (SAA1)
B25R13C06	25-6-13	Hs~MGC:BC007022.1~uORF:IOH7234	328	170	392	194	173	297	403	220	347	91	serum amyloid A1 (SAA1)
B25R13C07	25-7-13	Hs~MGC:BC016283.1~uORF:IOH10041	736	508	746	398	408	626	1063	641	1116	342	ATP-binding cassette, sub-family E (OABP), member 1 (ABCE1)
B25R13C08	25-8-13	Hs~MGC:BC016283.1~uORF:IOH10041	718	610	760	396	483	657	1134	607	1083	338	ATP-binding cassette, sub-family E (OABP), member 1 (ABCE1)
B25R13C09	25-9-13	Hs~Ref:NM_001011669.1~uORF:IOH57339	464	454	678	730	394	472	600	356	676	295	Coiled-coil-helix-coiled-coil-helix domain-containing protein 7
B25R13C10	25-10-13	Hs~Ref:NM_001011669.1~uORF:IOH57339	194	232	216	734	361	467	668	408	698	276	Coiled-coil-helix-coiled-coil-helix domain-containing protein 7
B25R13C11	25-11-13	Hs~Ref:NM_147196.1~uORF:IOH42270	2568	11135	4298	1041	1875	1198	1663	3494	4353	2532	Transmembrane inner ear expressed protein
B25R13C12	25-12-13	Hs~Ref:NM_147196.1~uORF:IOH42270	2512	11460	3788	990	1734	1190	1679	3608	4440	2581	Transmembrane inner ear expressed protein
B25R13C13	25-13-13	Hs~Ref:NM_024515.1~uORF:IOH5172	852	881	1353	586	1444	2057	3253	1103	1395	1221	WD repeat domain 25 (WDR25)
B25R13C14	25-14-13	Hs~Ref:NM_024515.1~uORF:IOH5172	643	868	1229	686	1089	2053	3356	1109	1369	1132	WD repeat domain 25 (WDR25)
B25R13C15	25-15-13	Hs~MGC:NM_024511.3~uORF:IOH5198	861	393	4549	698	999	1906	1745	891	1217	443	chromosome 4 open reading frame 15 (C4orf15)
B25R13C16	25-16-13	Hs~MGC:NM_024511.3~uORF:IOH5198	838	486	4723	510	635	1955	1751	941	1120	423	chromosome 4 open reading frame 15 (C4orf15)
B25R13C17	25-17-13	Hs~MGC:BC017871.1~uORF:IOH13901	888	849	1330	645	1209	952	2217	966	1950	426	ribonuclease P/MRP 40kDa subunit (RPP40)
B25R13C18	25-18-13	Hs~MGC:BC017871.1~uORF:IOH13901	885	835	1438	631	989	1157	2225	881	1941	452	ribonuclease P/MRP 40kDa subunit (RPP40)
B25R13C19	25-19-13	Hs~Ref:NM_007220.1~uORF:IOH11664	587	612	958	505	655	836	1228	691	1324	356	carbonic anhydrase VB, mitochondrial (CA5B), nuclear gene encoding mitochondrial protein
B25R13C20	25-20-13	Hs~Ref:NM_007220.1~uORF:IOH11664	641	612	920	535	637	834	1099	640	1213	371	carbonic anhydrase VB, mitochondrial (CA5B), nuclear gene encoding mitochondrial protein
B25R13C21	25-21-13	Hs~MGC:BC011863.2~uORF:IOH14833	883	822	960	809	1465	937	1733	728	1809	677	DNA helicase HEL308 (HEL308)
B25R13C22	25-22-13	Hs~MGC:BC011863.2~uORF:IOH14833	1133	707	936	763	1421	913	1896	709	1721	679	DNA helicase HEL308 (HEL308)
B25R14C01	25-1-14	Hs~Ref:NM_024790.2~uORF:IOH13277	1076	616	1030	528	541	692	1255	501	1375	986	centrosome and spindle pole associated protein 1 (CSPP1), transcript variant 2
B25R14C02	25-2-14	Hs~Ref:NM_024790.2~uORF:IOH13277	856	650	1089	802	545	717	1189	592	1355	932	centrosome and spindle pole associated protein 1 (CSPP1), transcript variant 2
B25R14C03	25-3-14	Hs~MGC:BC008788.2~uORF:IOH6237	534	246	492	268	266	629	907	473	785	286	chromosome 1 open reading frame 159 (C1orf159)
B25R14C04	25-4-14	Hs~MGC:BC008788.2~uORF:IOH6237	566	495	553	350	323	650	915	531	790	301	chromosome 1 open reading frame 159 (C1orf159)
B25R14C05	25-5-14	Hs~Ref:NM_014475.2~uORF:IOH21985	315	450	560	249	357	494	556	446	705	298	Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase
B25R14C06	25-6-14	Hs~Ref:NM_014475.2~uORF:IOH21985	353	457	561	254	376	517	603	418	613	298	Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase
B25R14C07	25-7-14	Hs~MGC:BC036784.1~uORF:IOH22104	548	577	890	366	443	582	809	413	851	314	RasGEF domain family, member 1B (RASGEF1B)
B25R14C08	25-8-14	Hs~MGC:BC036784.1~uORF:IOH22104	568	671	817	367	516	603	847	410	904	310	RasGEF domain family, member 1B (RASGEF1B)
B25R14C09	25-9-14	Hs~MGC:BC033882.1~uORF:IOH22100	403	485	650	292	394	423	752	450	619	331	chromosome 17 open reading frame 83 (C17orf83)
B25R14C10	25-10-14	Hs~MGC:BC033882.1~uORF:IOH22100	431	352	620	336	362	519	784	453	537	285	chromosome 17 open reading frame 83 (C17orf83)
B25R14C11	25-11-14	Hs~Ref:NM_017724.1~uORF:IOH29011	1466	987	1518	1003	2762	17122	6295	1077	1321	387	leucine rich repeat (in FLII) interacting protein 2 (LRRFIP2), transcript variant 2
B25R14C12	25-12-14	Hs~Ref:NM_017724.1~uORF:IOH29011	1389	964	1529	991	2393	17192	6299	1117	1377	420	leucine rich repeat (in FLII) interacting protein 2 (LRRFIP2), transcript variant 2
B25R14C13	25-13-14	Hs~Ref:NM_032786.1~uORF:IOH13275	2739	4673	3277	623	839	4245	3508	2615	1993	2116	zinc finger CCCH-type containing 10 (ZC3H10)
B25R14C14	25-14-14	Hs~Ref:NM_032786.1~uORF:IOH13275	2919	4691	2975	639	786	4161	3634	2781	1939	2059	zinc finger CCCH-type containing 10 (ZC3H10)
B25R14C15	25-15-14	Hs~Ref:NM_052901.2~uORF:IOH42062	391	187	469	1668	722	374	505	423	563	306	Calcium-binding mitochondrial carrier protein SCaMC-2
B25R14C16	25-16-14	Hs~Ref:NM_052901.2~uORF:IOH42062	336	231	461	1161	189	369	516	549	600	235	Calcium-binding mitochondrial carrier protein SCaMC-2
B25R14C17	25-17-14	Hs~Ref:NM_014157.2~uORF:IOH42224	424	345	517	322	445	509	764	454	767	310	Coiled-coil domain-containing protein 113
B25R14C18	25-18-14	Hs~Ref:NM_014157.2~uORF:IOH42224	404	336	552	347	339	750	826	441	840	293	Coiled-coil domain-containing protein 113
B25R14C19	25-19-14	Hs~Ref:NM_004548.1~uORF:IOH5864	465	332	621	290	341	594	770	457	907	325	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa (NDUFB10)
B25R14C20	25-20-14	Hs~Ref:NM_004548.1~uORF:IOH5864	446	399	538	303	397	649	815	528	789	276	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa (NDUFB10)
B25R14C21	25-21-14	Hs~Ref:NM_015407.3~uORF:IOH4118	659	676	1094	482	621	1169	1576	778	1880	389	abhydrolase domain containing 14A (ABHD14A)
B25R14C22	25-22-14	Hs~Ref:NM_015407.3~uORF:IOH4118	683	684	1039	868	528	1091	1681	768	1668	409	abhydrolase domain containing 14A (ABHD14A)
B25R15C01	25-1-15	Hs~Ref:NM_005855.1~uORF:IOH4168	525	539	719	467	461	752	907	1145	800	288	receptor (G protein-coupled) activity modifying protein 1 (RAMP1)
B25R15C02	25-2-15	Hs~Ref:NM_005855.1~uORF:IOH4168	521	561	749	568	504	782	927	751	805	301	receptor (G protein-coupled) activity modifying protein 1 (RAMP1)
B25R15C03	25-3-15	Hs~MGC:BC033790.1~uORF:IOH21793	522	545	1287	729	358	1124	1099	936	2319	377	chromosome 1 open reading frame 92 (C1orf92)
B25R15C04	25-4-15	Hs~MGC:BC033790.1~uORF:IOH21793	549	663	1335	432	358	1039	1146	890	2179	386	chromosome 1 open reading frame 92 (C1orf92)
B25R15C05	25-5-15	Hs~Ref:NM_170750.1~uORF:IOH41229	487	2055	671	389	376	579	648	485	787	303	proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 (PSMD10), transcript variant 2
B25R15C06	25-6-15	Hs~Ref:NM_170750.1~uORF:IOH41229	496	2266	656	387	500	565	625	502	739	264	proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 (PSMD10), transcript variant 2
B25R15C07	25-7-15	Hs~Ref:NM_005440.3~uORF:IOH44761	1138	904	1348	591	1020	1926	1461	1196	1460	507	Rho family GTPase 2 (RND2)
B25R15C08	25-8-15	Hs~Ref:NM_005440.3~uORF:IOH44761	1126	950	1376	612	1112	1910	1517	1203	1437	506	Rho family GTPase 2 (RND2)
B25R15C09	25-9-15	Hs~Ref:XM_048235.2~uORF:IOH43018	396	108	920	255	554	647	673	603	1637	317	Huntingtin-interacting protein M
B25R15C10	25-10-15	Hs~Ref:XM_048235.2~uORF:IOH43018	404	394	949	248	610	588	691	601	1529	338	Huntingtin-interacting protein M
B25R15C11	25-11-15	Hs~Ref:NM_005776.2~uORF:IOH41416	460	246	461	278	364	424	686	471	506	238	cornichon homolog (Drosophila) (CNIH)
B25R15C12	25-12-15	Hs~Ref:NM_005776.2~uORF:IOH41416	386	371	436	248	747	469	732	541	519	186	cornichon homolog (Drosophila) (CNIH)
B25R15C15	25-15-15	Hs~Ref:NM_005465.3~CAT:PV3185	975	1027	206	2383	352	1929	199	217	406	16	v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (AKT3), transcript variant 1
B25R15C16	25-16-15	Hs~Ref:NM_005465.3~CAT:PV3185	963	639	212	361	118	1908	199	209	1015	126	v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (AKT3), transcript variant 1
B25R15C19	25-19-15	Hs~Ref:NM_001240.2~CAT:PV4131	841	320	691	302	630	579	559	414	341	170	cyclin T1 (CCNT1)
B25R15C20	25-20-15	Hs~Ref:NM_001240.2~CAT:PV4131	795	333	724	297	628	574	540	379	506	137	cyclin T1 (CCNT1)
B25R16C01	25-1-16	Hs~Ref:NM_003215.1~CAT:PV3269	734	1481	1500	2725	2161	1016	2554	1385	962	496	tec protein tyrosine kinase (TEC)
B25R16C02	25-2-16	Hs~Ref:NM_003215.1~CAT:PV3269	709	1350	1592	2984	2097	1041	2707	1080	1027	508	tec protein tyrosine kinase (TEC)
B25R16C03	25-3-16	Hs~MGC:NM_015191.1~CAT:PV4792	573	1702	1699	634	310	933	892	438	1676	656	SNF1-like kinase 2 (SNF1LK2)
B25R16C04	25-4-16	Hs~MGC:NM_015191.1~CAT:PV4792	612	1707	1810	628	340	872	891	439	1654	679	SNF1-like kinase 2 (SNF1LK2)
B25R16C05	25-5-16	Hs~Ref:NM_005163.1~CAT:PV3685	170	72	178	144	75	169	252	116	153	113	RAC-alpha serine/threonine-protein kinase
B25R16C06	25-6-16	Hs~Ref:NM_005163.1~CAT:PV3685	123	70	164	138	84	155	267	231	168	75	RAC-alpha serine/threonine-protein kinase
B25R16C07	25-7-16	Hs~MGC:BC009390.1~uORF:IOH27829	356	48	396	196	381	362	382	300	574	188	seryl-tRNA synthetase (SARS)
B25R16C08	25-8-16	Hs~MGC:BC009390.1~uORF:IOH27829	297	59	358	202	385	337	393	265	603	116	seryl-tRNA synthetase (SARS)
B25R16C09	25-9-16	Hs~MGC:BC042150.1~uORF:IOH27999	354	205	607	259	260	673	502	398	560	204	STEAP family member 3 (STEAP3)
B25R16C10	25-10-16	Hs~MGC:BC042150.1~uORF:IOH27999	400	173	643	260	447	625	523	430	589	264	STEAP family member 3 (STEAP3)
B25R16C11	25-11-16	Hs~MGC:BC050377.1~uORF:IOH26671	7834	412	532	366	748	9211	893	3682	761	301	Serine/threonine-protein kinase PAK 1
B25R16C12	25-12-16	Hs~MGC:BC050377.1~uORF:IOH26671	6688	445	516	344	922	8928	832	3621	760	324	Serine/threonine-protein kinase PAK 1
B25R16C13	25-13-16	Hs~Ref:NM_006214.2~uORF:IOH22535	529	678	723	846	1294	1157	616	435	1180	376	phytanoyl-CoA 2-hydroxylase (PHYH), transcript variant 1
B25R16C14	25-14-16	Hs~Ref:NM_006214.2~uORF:IOH22535	509	543	793	870	1165	1380	635	397	1219	397	phytanoyl-CoA 2-hydroxylase (PHYH), transcript variant 1
B25R16C15	25-15-16	Hs~Ref:NM_203488.1~uORF:IOH44619	759	554	737	547	1314	659	1015	697	1452	405	Acylphosphatase-1
B25R16C16	25-16-16	Hs~Ref:NM_203488.1~uORF:IOH44619	824	1767	752	528	919	670	1091	663	1664	380	Acylphosphatase-1
B25R16C17	25-17-16	Hs~Ref:NM_001011670.1~uORF:IOH57330	411	418	521	294	464	563	656	402	1035	345	Coiled-coil-helix-coiled-coil-helix domain-containing protein 7
B25R16C18	25-18-16	Hs~Ref:NM_001011670.1~uORF:IOH57330	487	408	605	299	423	660	703	472	1151	371	Coiled-coil-helix-coiled-coil-helix domain-containing protein 7
B25R16C19	25-19-16	Hs~MGC:BC038467.1~uORF:IOH25921	649	586	769	405	727	739	968	722	1481	333	Vitelline membrane outer layer protein 1 homolog
B25R16C20	25-20-16	Hs~MGC:BC038467.1~uORF:IOH25921	613	580	788	416	694	760	903	622	1551	360	Vitelline membrane outer layer protein 1 homolog
B25R16C21	25-21-16	Hs~MGC:BC069412.1~uORF:IOH40305	520	448	667	354	575	705	839	580	1394	401	Elastase-2B
B25R16C22	25-22-16	Hs~MGC:BC069412.1~uORF:IOH40305	529	475	656	367	513	653	855	596	1156	407	Elastase-2B
B25R17C01	25-1-17	Hs~MGC:BC028199.1~uORF:IOH11414	984	818	1076	505	615	956	1247	820	1239	454	CD300 molecule-like family member f (CD300LF)
B25R17C02	25-2-17	Hs~MGC:BC028199.1~uORF:IOH11414	937	798	1101	520	605	893	1367	725	1300	405	CD300 molecule-like family member f (CD300LF)
B25R17C03	25-3-17	Hs~Ref:NM_006597.3~uORF:IOH11329	803	514	2042	685	891	897	1739	1459	2186	313	heat shock 70kDa protein 8 (HSPA8), transcript variant 1
B25R17C04	25-4-17	Hs~Ref:NM_006597.3~uORF:IOH11329	805	514	2023	703	1019	912	1737	1468	2170	320	heat shock 70kDa protein 8 (HSPA8), transcript variant 1
B25R17C05	25-5-17	Hs~MGC:BC017594.2~uORF:IOH27762	891	826	1347	589	1949	1993	1585	1021	2274	395	APAF1 interacting protein (APIP)
B25R17C06	25-6-17	Hs~MGC:BC017594.2~uORF:IOH27762	934	839	1323	590	1898	1953	1516	965	2190	389	APAF1 interacting protein (APIP)
B25R17C07	25-7-17	Hs~Ref:NM_001889.2~uORF:IOH26287	889	792	1092	530	1602	1869	1972	1212	2281	414	crystallin, zeta (quinone reductase) (CRYZ)
B25R17C08	25-8-17	Hs~Ref:NM_001889.2~uORF:IOH26287	888	783	1136	540	1623	1784	1926	1324	2268	459	crystallin, zeta (quinone reductase) (CRYZ)
B25R17C09	25-9-17	Hs~MGC:BC027484.1~uORF:IOH27427	1514	1308	1360	1117	1160	1438	1734	1021	5819	667	tribbles homolog 3 (Drosophila) (TRIB3)
B25R17C10	25-10-17	Hs~MGC:BC027484.1~uORF:IOH27427	1431	1390	1400	1182	1549	1356	1644	1096	5793	648	tribbles homolog 3 (Drosophila) (TRIB3)
B25R17C11	25-11-17	Hs~Ref:NM_032023.3~uORF:IOH21970	1755	1576	1812	883	4113	1172	7105	2407	2434	1053	Ras association (RalGDS/AF-6) domain family 4 (RASSF4)
B25R17C12	25-12-17	Hs~Ref:NM_032023.3~uORF:IOH21970	1744	1555	1864	912	4334	1211	7045	2390	2434	1064	Ras association (RalGDS/AF-6) domain family 4 (RASSF4)
B25R17C15	25-15-17	Hs~MGC:BC008808.2~uORF:IOH6341	1266	5998	1140	5644	962	2284	1668	542	1434	576	excision repair cross-complementing rodent repair deficiency, complementation group 6-like (ERCC6L)
B25R17C16	25-16-17	Hs~MGC:BC008808.2~uORF:IOH6341	1330	6321	1179	5666	928	2318	2121	531	1384	571	excision repair cross-complementing rodent repair deficiency, complementation group 6-like (ERCC6L)
B25R17C19	25-19-17	Hs~MGC:BC015155.1~uORF:IOH10623	552	355	631	320	462	580	544	584	499	201	alkB, alkylation repair homolog 3 (E. coli) (ALKBH3)
B25R17C20	25-20-17	Hs~MGC:BC015155.1~uORF:IOH10623	517	333	650	303	421	539	569	572	1629	204	alkB, alkylation repair homolog 3 (E. coli) (ALKBH3)
B25R17C21	25-21-17	Hs~Ref:NM_016613.3~uORF:IOH11008	357	318	428	260	333	380	567	393	426	99	chromosome 4 open reading frame 18 (C4orf18), transcript variant 2
B25R17C22	25-22-17	Hs~Ref:NM_016613.3~uORF:IOH11008	295	274	390	263	330	404	592	291	439	72	chromosome 4 open reading frame 18 (C4orf18), transcript variant 2
B25R18C01	25-1-18	Hs~MGC:BC009710.1~uORF:IOH9854	1098	1054	1906	896	1685	2222	1919	1498	3135	669	golgi SNAP receptor complex member 2 (GOSR2)
B25R18C02	25-2-18	Hs~MGC:BC009710.1~uORF:IOH9854	1115	1028	1953	888	1770	2170	1989	1516	3090	628	golgi SNAP receptor complex member 2 (GOSR2)
B25R18C03	25-3-18	Hs~Ref:NM_002745.2~N/A	637	610	1003	521	488	807	1037	735	1975	420	Mitogen-activated protein kinase 1; see catalog number for detailed information on wild-type or point mutant status
B25R18C04	25-4-18	Hs~Ref:NM_002745.2~N/A	629	638	1103	816	606	776	1073	744	1877	503	Mitogen-activated protein kinase 1; see catalog number for detailed information on wild-type or point mutant status
B25R18C05	25-5-18	Hs~MGC:BC019064.1~uORF:IOH12760	755	501	662	403	559	555	1145	489	1185	312	family with sequence similarity 40, member B (FAM40B)
B25R18C06	25-6-18	Hs~MGC:BC019064.1~uORF:IOH12760	808	475	645	385	529	542	1070	470	1242	315	family with sequence similarity 40, member B (FAM40B)
B25R18C07	25-7-18	Hs~MGC:BC010360.1~uORF:IOH12880	863	834	1112	486	660	845	2194	665	1327	276	LMBR1 domain containing 1 (LMBRD1)
B25R18C08	25-8-18	Hs~MGC:BC010360.1~uORF:IOH12880	938	849	1087	486	638	876	2337	692	1267	447	LMBR1 domain containing 1 (LMBRD1)
B25R18C09	25-9-18	Hs~Ref:NM_017609.2~uORF:IOH27480	510	328	595	329	251	534	1534	703	867	335	chromosome 10 open reading frame 92 (C10orf92)
B25R18C10	25-10-18	Hs~Ref:NM_017609.2~uORF:IOH27480	638	361	612	376	100	514	1645	503	819	359	chromosome 10 open reading frame 92 (C10orf92)
B25R18C11	25-11-18	Hs~MGC:BC022362.1~uORF:IOH14191	65489	65487	65486	65492	65321	65485	65458	64141	65486	65491	cDNA clone MGC:23888 IMAGE:4704496, complete cds
B25R18C12	25-12-18	Hs~MGC:BC022362.1~uORF:IOH14191	65473	65491	65489	65492	65255	65480	65399	64354	65489	65495	cDNA clone MGC:23888 IMAGE:4704496, complete cds
B25R18C13	25-13-18	Hs~MGC:BC017356.1~uORF:IOH14096	1953	1304	1266	1090	2170	1162	1574	1117	1626	1210	Ig mu chain C region
B25R18C14	25-14-18	Hs~MGC:BC017356.1~uORF:IOH14096	1367	1252	1317	1123	1691	1187	1278	1067	1663	1168	Ig mu chain C region
B25R18C15	25-15-18	Hs~MGC:BC007524.1~uORF:IOH6913	1133	611	677	446	779	706	1071	598	1092	345	sperm associated antigen 9 (SPAG9)
B25R18C16	25-16-18	Hs~MGC:BC007524.1~uORF:IOH6913	1026	582	741	693	799	693	1056	567	1302	368	sperm associated antigen 9 (SPAG9)
B25R18C17	25-17-18	Hs~Ref:NM_152785.3~uORF:IOH21630	1039	1329	1464	1382	1570	1160	2477	1838	3127	543	germinal center expressed transcript 2 (GCET2), transcript variant 1
B25R18C18	25-18-18	Hs~Ref:NM_152785.3~uORF:IOH21630	958	1310	1450	974	1587	1350	2581	1837	3275	582	germinal center expressed transcript 2 (GCET2), transcript variant 1
B25R18C19	25-19-18	Hs~Ref:NM_015634.2~uORF:IOH14837	778	618	867	729	775	779	1282	729	2928	392	KIF1-binding protein
B25R18C20	25-20-18	Hs~Ref:NM_015634.2~uORF:IOH14837	807	631	827	731	774	755	1274	800	3076	386	KIF1-binding protein
B25R18C21	25-21-18	Hs~Ref:NM_032902.5~uORF:IOH27809	1005	1233	1104	623	919	1046	1412	1339	2879	598	Protein phosphatase 1 regulatory subunit 16A
B25R18C22	25-22-18	Hs~Ref:NM_032902.5~uORF:IOH27809	982	1137	1085	640	882	1110	1411	1315	2331	476	Protein phosphatase 1 regulatory subunit 16A
B25R19C01	25-1-19	Hs~Ref:NM_004409.2~uORF:IOH40696	1344	1038	953	576	798	990	1530	873	1947	563	dystrophia myotonica-protein kinase (DMPK), transcript variant 2
B25R19C02	25-2-19	Hs~Ref:NM_004409.2~uORF:IOH40696	1327	907	978	611	788	968	1442	1103	1978	558	dystrophia myotonica-protein kinase (DMPK), transcript variant 2
B25R19C03	25-3-19	Hs~MGC:BC062701.1~uORF:IOH40710	759	778	977	784	882	941	1070	1343	1499	701	aquaporin 7, mRNA (cDNA clone MGC:71981 IMAGE:30324263), complete cds
B25R19C04	25-4-19	Hs~MGC:BC062701.1~uORF:IOH40710	792	743	1002	1235	1034	942	1077	1020	1458	674	aquaporin 7, mRNA (cDNA clone MGC:71981 IMAGE:30324263), complete cds
B25R19C05	25-5-19	Hs~MGC:BC037207.1~uORF:IOH27659	859	724	829	565	609	688	1045	802	1624	705	KIAA1600 (KIAA1600)
B25R19C06	25-6-19	Hs~MGC:BC037207.1~uORF:IOH27659	910	668	820	541	602	736	1009	651	1688	733	KIAA1600 (KIAA1600)
B25R19C07	25-7-19	Hs~Ref:NM_006804.2~uORF:IOH27296	1245	1940	1735	1535	2266	1557	2142	1342	3185	1083	StAR-related lipid transfer (START) domain containing 3 (STARD3)
B25R19C08	25-8-19	Hs~Ref:NM_006804.2~uORF:IOH27296	1336	1949	1801	1364	2391	1581	2037	1497	3129	1041	StAR-related lipid transfer (START) domain containing 3 (STARD3)
B25R19C09	25-9-19	Hs~Ref:NM_145899.1~uORF:IOH6516	3069	1928	3157	1485	3507	2122	12094	2086	3883	886	high mobility group AT-hook 1 (HMGA1), transcript variant 1
B25R19C10	25-10-19	Hs~Ref:NM_145899.1~uORF:IOH6516	3216	1935	3303	1410	3971	2156	12515	2129	3858	891	high mobility group AT-hook 1 (HMGA1), transcript variant 1
B25R19C11	25-11-19	Hs~MGC:BC029827.1~uORF:IOH28674	907	660	1038	652	950	982	1599	1089	1481	461	Down syndrome critical region gene 9 (DSCR9)
B25R19C12	25-12-19	Hs~MGC:BC029827.1~uORF:IOH28674	760	815	1009	608	1247	977	1474	959	1459	504	Down syndrome critical region gene 9 (DSCR9)
B25R19C13	25-13-19	Hs~Ref:NM_014045.1~uORF:IOH3680	500	1184	815	229	824	338	462	292	493	126	Low-density lipoprotein receptor-related protein 10
B25R19C14	25-14-19	Hs~Ref:NM_014045.1~uORF:IOH3680	353	417	774	229	336	334	469	311	517	148	Low-density lipoprotein receptor-related protein 10
B25R19C15	25-15-19	Hs~MGC:BC016327.1~uORF:IOH13232	648	403	684	293	716	645	568	459	1068	243	nucleoporin 62kDa C-terminal like (NUP62CL)
B25R19C16	25-16-19	Hs~MGC:BC016327.1~uORF:IOH13232	590	411	698	409	352	652	610	464	1151	364	nucleoporin 62kDa C-terminal like (NUP62CL)
B25R19C17	25-17-19	Hs~MGC:BC018722.1~uORF:IOH13970	952	1113	2209	899	951	2304	1634	1948	2677	447	alveolar soft part sarcoma chromosome region, candidate 1 (ASPSCR1)
B25R19C18	25-18-19	Hs~MGC:BC018722.1~uORF:IOH13970	968	1155	2045	775	1094	2314	1735	1917	2821	408	alveolar soft part sarcoma chromosome region, candidate 1 (ASPSCR1)
B25R19C19	25-19-19	Hs~Ref:NM_182575.1~uORF:IOH27360	302	221	427	260	328	802	557	380	2034	255	izumo sperm-egg fusion 1 (IZUMO1)
B25R19C20	25-20-19	Hs~Ref:NM_182575.1~uORF:IOH27360	269	303	393	252	327	813	495	367	2153	131	izumo sperm-egg fusion 1 (IZUMO1)
B25R19C21	25-21-19	Hs~MGC:BC028728.1~uORF:IOH11804	370	331	513	268	342	444	660	345	326	230	cation channel, sperm associated 2 (CATSPER2)
B25R19C22	25-22-19	Hs~MGC:BC028728.1~uORF:IOH11804	331	292	536	303	302	444	709	563	633	243	cation channel, sperm associated 2 (CATSPER2)
B25R20C01	25-1-20	Hs~MGC:BC018426.1~uORF:IOH9673	319	1295	451	190	145	397	786	295	358	43	Protein URG4
B25R20C02	25-2-20	Hs~MGC:BC018426.1~uORF:IOH9673	805	153	475	198	146	391	790	1045	395	268	Protein URG4
B25R20C03	25-3-20	Hs~MGC:BC008305.1~uORF:IOH6986	360	380	468	262	282	432	700	1105	642	243	Uncharacterized protein C18orf8
B25R20C04	25-4-20	Hs~MGC:BC008305.1~uORF:IOH6986	340	358	496	742	352	448	755	387	600	250	Uncharacterized protein C18orf8
B25R20C05	25-5-20	Hs~Ref:NM_032848.1~uORF:IOH13466	3548	1605	2599	1979	1156	2054	13358	1671	2764	823	chromosome 12 open reading frame 52 (C12orf52)
B25R20C06	25-6-20	Hs~Ref:NM_032848.1~uORF:IOH13466	3593	1564	2522	1323	1161	2126	13178	1536	2743	788	chromosome 12 open reading frame 52 (C12orf52)
B25R20C07	25-7-20	Hs~MGC:BC037963.1~uORF:IOH25981	-4	1	5	0	2211	2	24	349	0	1	Beta-adrenergic receptor kinase 1
B25R20C08	25-8-20	Hs~MGC:BC037963.1~uORF:IOH25981	8	-3	-2	3	2309	0	286	6	0	7	Beta-adrenergic receptor kinase 1
B25R20C11	25-11-20	Hs~MGC:BC003065.1~N/A	22005	28682	22694	27682	22857	22691	12780	15036	18663	15238	Cell division protein kinase 2
B25R20C12	25-12-20	Hs~MGC:BC003065.1~N/A	23106	28941	23482	27874	21468	22227	13269	15249	17914	15090	Cell division protein kinase 2
B26R02C11	26-11-2	Hs~Ref:NM_023079.2~uORF:IOH10095	358	1007	538	513	3869	440	467	3400	1022	164	ubiquitin-conjugating enzyme E2Z (UBE2Z)
B26R02C12	26-12-2	Hs~Ref:NM_023079.2~uORF:IOH10095	349	1015	469	656	4009	425	489	3425	1082	598	ubiquitin-conjugating enzyme E2Z (UBE2Z)
B26R02C13	26-13-2	Hs~MGC:BC031427.1~uORF:IOH22113	350	284	514	527	321	298	639	331	408	168	phosphatidylinositol transfer protein, beta (PITPNB)
B26R02C14	26-14-2	Hs~MGC:BC031427.1~uORF:IOH22113	357	328	501	400	299	336	683	317	547	114	phosphatidylinositol transfer protein, beta (PITPNB)
B26R02C15	26-15-2	Hs~Ref:NM_002001.1~uORF:IOH7481	762	572	1407	493	569	1769	1198	628	1548	403	Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A)
B26R02C16	26-16-2	Hs~Ref:NM_002001.1~uORF:IOH7481	818	594	1491	456	595	1840	1274	627	1577	351	Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A)
B26R02C17	26-17-2	Hs~MGC:BC009623.1~uORF:IOH9844	963	940	1399	548	901	2468	2608	653	1363	273	nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1)
B26R02C18	26-18-2	Hs~MGC:BC009623.1~uORF:IOH9844	975	1037	1397	710	924	2476	2512	641	1446	200	nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1)
B26R02C19	26-19-2	Hs~Ref:NM_004809.3~uORF:IOH22671	1730	1243	2591	2772	1116	1544	1983	1281	3659	578	stomatin (EPB72)-like 1 (STOML1)
B26R02C20	26-20-2	Hs~Ref:NM_004809.3~uORF:IOH22671	1751	1228	2591	2694	1109	1474	2036	1255	3652	602	stomatin (EPB72)-like 1 (STOML1)
B26R02C21	26-21-2	Hs~Ref:NM_021103.2~uORF:IOH10060	1142	818	1897	823	1342	947	1525	2081	4171	324	thymosin, beta 10 (TMSB10)
B26R02C22	26-22-2	Hs~Ref:NM_021103.2~uORF:IOH10060	1170	826	1882	887	1330	930	1533	2096	4243	314	thymosin, beta 10 (TMSB10)
B26R03C01	26-1-3	Hs~Ref:NM_000909.4~uORF:IOH22474	1041	809	1630	1100	861	750	1165	1075	3401	229	neuropeptide Y receptor Y1 (NPY1R)
B26R03C02	26-2-3	Hs~Ref:NM_000909.4~uORF:IOH22474	1028	804	1713	1093	695	794	1136	1060	3374	231	neuropeptide Y receptor Y1 (NPY1R)
B26R03C03	26-3-3	Hs~Ref:NM_003827.2~uORF:IOH4804	998	354	850	447	713	787	991	652	1473	182	N-ethylmaleimide-sensitive factor attachment protein, alpha (NAPA)
B26R03C04	26-4-3	Hs~Ref:NM_003827.2~uORF:IOH4804	680	367	836	444	884	776	976	637	1445	155	N-ethylmaleimide-sensitive factor attachment protein, alpha (NAPA)
B26R03C05	26-5-3	Hs~Ref:NM_013313.3~uORF:IOH43282	729	1157	1022	844	1136	1114	1484	1169	1621	508	yippee-like 1 (Drosophila) (YPEL1)
B26R03C06	26-6-3	Hs~Ref:NM_013313.3~uORF:IOH43282	684	1139	1061	810	950	1122	1507	1181	1557	515	yippee-like 1 (Drosophila) (YPEL1)
B26R03C09	26-9-3	Hs~Ref:NM_182759.2~uORF:IOH42521	534	450	633	330	266	518	1124	546	628	142	family with sequence similarity 19 (chemokine (C-C motif)-like), member A3 (FAM19A3), transcript variant 1
B26R03C10	26-10-3	Hs~Ref:NM_182759.2~uORF:IOH42521	572	448	774	315	279	596	1078	550	282	72	family with sequence similarity 19 (chemokine (C-C motif)-like), member A3 (FAM19A3), transcript variant 1
B26R03C11	26-11-3	Hs~Ref:NM_007075.3~uORF:IOH45934	867	1430	1218	561	501	3299	1450	550	1520	247	WD repeat domain 45 (WDR45), transcript variant 1
B26R03C12	26-12-3	Hs~Ref:NM_007075.3~uORF:IOH45934	1016	1667	1095	999	508	3681	1383	1053	1390	227	WD repeat domain 45 (WDR45), transcript variant 1
B26R03C15	26-15-3	Hs~Ref:NM_018664.1~uORF:IOH44746	1734	4222	8970	4063	2588	40045	6949	5838	4264	1437	Jun dimerization protein p21SNFT (SNFT)
B26R03C16	26-16-3	Hs~Ref:NM_018664.1~uORF:IOH44746	1812	4717	8982	3339	2651	40284	6973	5927	4591	1506	Jun dimerization protein p21SNFT (SNFT)
B26R03C17	26-17-3	Hs~Ref:NM_017927.2~uORF:IOH43690	658	286	553	249	254	497	468	253	467	313	mitofusin 1 (MFN1), nuclear gene encoding mitochondrial protein, transcript variant 2
B26R03C18	26-18-3	Hs~Ref:NM_017927.2~uORF:IOH43690	370	312	610	296	251	551	513	232	606	62	mitofusin 1 (MFN1), nuclear gene encoding mitochondrial protein, transcript variant 2
B26R03C19	26-19-3	Hs~Ref:NM_016339.1~uORF:IOH42129	317	333	169	313	237	299	279	231	1059	413	Rap guanine nucleotide exchange factor (GEF)-like 1 (RAPGEFL1)
B26R03C20	26-20-3	Hs~Ref:NM_016339.1~uORF:IOH42129	214	335	414	306	242	213	158	232	1064	336	Rap guanine nucleotide exchange factor (GEF)-like 1 (RAPGEFL1)
B26R03C21	26-21-3	Hs~Ref:NM_018129.1~uORF:IOH5875	521	437	651	499	1065	772	1022	1442	1199	620	pyridoxamine 5'-phosphate oxidase (PNPO)
B26R03C22	26-22-3	Hs~Ref:NM_018129.1~uORF:IOH5875	520	461	638	489	1150	807	1023	1423	1236	566	pyridoxamine 5'-phosphate oxidase (PNPO)
B26R04C01	26-1-4	Hs~Ref:NM_007241.2~uORF:IOH3275	538	569	629	387	444	669	876	729	1413	301	SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae) (SNF8)
B26R04C02	26-2-4	Hs~Ref:NM_007241.2~uORF:IOH3275	537	632	714	413	400	593	927	576	1434	303	SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae) (SNF8)
B26R04C03	26-3-4	Hs~Ref:NM_015975.3~uORF:IOH14186	3859	713	1383	1330	625	1144	2651	928	2126	517	TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa (TAF9B)
B26R04C04	26-4-4	Hs~Ref:NM_015975.3~uORF:IOH14186	4009	760	1316	1326	700	1106	2578	913	2229	518	TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa (TAF9B)
B26R04C05	26-5-4	Hs~Ref:NM_024093.1~uORF:IOH3089	6184	7703	6591	4299	4879	4148	3224	4592	4907	1015	chromosome 2 open reading frame 49 (C2orf49)
B26R04C06	26-6-4	Hs~Ref:NM_024093.1~uORF:IOH3089	7315	8067	6633	4186	5232	4015	3328	4325	5169	789	chromosome 2 open reading frame 49 (C2orf49)
B26R04C09	26-9-4	Hs~MGC:BC033154.1~uORF:IOH23226	1680	1395	1588	1403	1091	1583	1460	1297	2246	1343	Centromere protein L
B26R04C10	26-10-4	Hs~MGC:BC033154.1~uORF:IOH23226	1700	1547	1876	1423	1176	1776	1830	1385	2371	1469	Centromere protein L
B26R04C11	26-11-4	Hs~MGC:BC017114.1~uORF:IOH9995	31486	20865	10521	25773	12679	5309	24553	6536	16644	40038	oligonucleotide/oligosaccharide-binding fold containing 2A (OBFC2A)
B26R04C12	26-12-4	Hs~MGC:BC017114.1~uORF:IOH9995	33244	20957	8309	24245	12114	5507	23814	4419	14530	37635	oligonucleotide/oligosaccharide-binding fold containing 2A (OBFC2A)
B26R04C13	26-13-4	Hs~MGC:BC011963.1~uORF:IOH10799	438	2522	807	625	411	534	962	1087	908	200	peroxisomal biogenesis factor 11B (PEX11B)
B26R04C14	26-14-4	Hs~MGC:BC011963.1~uORF:IOH10799	599	663	855	573	399	566	857	905	914	177	peroxisomal biogenesis factor 11B (PEX11B)
B26R04C15	26-15-4	Hs~MGC:BC004207.1~N/A	491	71	479	197	128	298	443	279	972	119	Serine/threonine-protein kinase Chk2
B26R04C16	26-16-4	Hs~MGC:BC004207.1~N/A	529	142	508	153	173	316	388	268	989	218	Serine/threonine-protein kinase Chk2
B26R04C17	26-17-4	Hs~Ref:NM_002750.2~N/A	1176	354	1341	436	319	603	1484	620	1663	152	mitogen-activated protein kinase 8 (MAPK8), transcript variant JNK1-a1
B26R04C18	26-18-4	Hs~Ref:NM_002750.2~N/A	902	384	1415	614	338	683	1950	645	1843	148	mitogen-activated protein kinase 8 (MAPK8), transcript variant JNK1-a1
B26R04C19	26-19-4	Hs~MGC:BC020555.1~uORF:IOH10305	27302	16156	14135	21227	10078	9858	37632	12151	9893	9536	SERPINE1 mRNA binding protein 1 (SERBP1)
B26R04C20	26-20-4	Hs~MGC:BC020555.1~uORF:IOH10305	28680	16324	14769	21706	11002	9711	38152	10399	9907	9165	SERPINE1 mRNA binding protein 1 (SERBP1)
B26R04C21	26-21-4	Hs~MGC:BC011519.1~uORF:IOH9674	615	711	953	634	674	558	1819	540	1069	336	angiotensinogen (serpin peptidase inhibitor, clade A, member 8) (AGT)
B26R04C22	26-22-4	Hs~MGC:BC011519.1~uORF:IOH9674	578	700	924	632	710	575	1812	553	1021	298	angiotensinogen (serpin peptidase inhibitor, clade A, member 8) (AGT)
B26R05C03	26-3-5	Hs~Ref:NM_198156.1~uORF:IOH43352	1059	931	805	585	715	619	1203	551	1231	270	von Hippel-Lindau tumor suppressor (VHL), transcript variant 2
B26R05C04	26-4-5	Hs~Ref:NM_198156.1~uORF:IOH43352	1793	1066	816	567	754	604	1060	523	1265	218	von Hippel-Lindau tumor suppressor (VHL), transcript variant 2
B26R05C05	26-5-5	Hs~Ref:NM_181678.1~uORF:IOH43154	1168	411	697	358	332	462	779	454	994	97	protein phosphatase 2 (formerly 2A), regulatory subunit B, beta isoform (PPP2R2B), transcript variant 6
B26R05C06	26-6-5	Hs~Ref:NM_181678.1~uORF:IOH43154	662	386	687	359	415	449	782	410	819	152	protein phosphatase 2 (formerly 2A), regulatory subunit B, beta isoform (PPP2R2B), transcript variant 6
B26R05C07	26-7-5	Hs~Ref:NM_030650.1~uORF:IOH43353	370	334	447	251	210	501	1771	404	758	269	KIAA1715 (KIAA1715)
B26R05C08	26-8-5	Hs~Ref:NM_030650.1~uORF:IOH43353	380	343	463	243	275	537	1671	439	842	-4	KIAA1715 (KIAA1715)
B26R05C09	26-9-5	Hs~Ref:NM_017822.2~uORF:IOH13333	739	689	957	1400	941	2090	911	2545	2251	3381	chromosome 12 open reading frame 41 (C12orf41)
B26R05C10	26-10-5	Hs~Ref:NM_017822.2~uORF:IOH13333	752	754	955	1322	1142	2205	975	2534	2422	3452	chromosome 12 open reading frame 41 (C12orf41)
B26R05C11	26-11-5	Hs~MGC:BC001871.1~uORF:IOH4982	485	400	1004	16485	319	514	1061	492	362	318	chromosome 20 open reading frame 24 (C20orf24)
B26R05C12	26-12-5	Hs~MGC:BC001871.1~uORF:IOH4982	596	456	995	18430	288	517	1655	592	843	296	chromosome 20 open reading frame 24 (C20orf24)
B26R05C13	26-13-5	Hs~MGC:BC003049.1~uORF:IOH4999	37614	27421	19899	36924	12668	17072	51294	23630	12546	21950	SERPINE1 mRNA binding protein 1 (SERBP1)
B26R05C14	26-14-5	Hs~MGC:BC003049.1~uORF:IOH4999	41328	25400	18898	37781	14140	21997	49726	24108	13424	23533	SERPINE1 mRNA binding protein 1 (SERBP1)
B26R05C15	26-15-5	Hs~Ref:NM_001859.2~uORF:IOH11517	490	461	621	566	390	916	585	751	789	221	solute carrier family 31 (copper transporters), member 1 (SLC31A1)
B26R05C16	26-16-5	Hs~Ref:NM_001859.2~uORF:IOH11517	430	408	543	491	371	751	650	793	857	545	solute carrier family 31 (copper transporters), member 1 (SLC31A1)
B26R05C17	26-17-5	Hs~Ref:NM_032405.1~uORF:IOH35575	398	323	493	212	208	297	480	346	568	281	transmembrane protease, serine 3 (TMPRSS3), transcript variant D
B26R05C18	26-18-5	Hs~Ref:NM_032405.1~uORF:IOH35575	335	348	470	238	231	342	481	330	487	86	transmembrane protease, serine 3 (TMPRSS3), transcript variant D
B26R05C19	26-19-5	Hs~Ref:NM_198460.1~uORF:IOH36042	421	975	612	311	311	439	728	439	606	157	guanylate binding protein family, member 6 (GBP6)
B26R05C20	26-20-5	Hs~Ref:NM_198460.1~uORF:IOH36042	409	907	591	335	317	414	757	431	580	235	guanylate binding protein family, member 6 (GBP6)
B26R05C21	26-21-5	Hs~Ref:NM_021155.2~uORF:IOH35696	394	333	491	266	311	330	527	372	565	76	CD209 molecule (CD209)
B26R05C22	26-22-5	Hs~Ref:NM_021155.2~uORF:IOH35696	413	334	483	338	362	359	464	329	576	80	CD209 molecule (CD209)
B26R06C01	26-1-6	Hs~Ref:NM_001821.2~uORF:IOH36065	1716	461	1226	490	414	3690	1945	713	997	271	choroideremia-like (Rab escort protein 2) (CHML)
B26R06C02	26-2-6	Hs~Ref:NM_001821.2~uORF:IOH36065	1618	479	1218	521	534	3677	2014	711	1005	239	choroideremia-like (Rab escort protein 2) (CHML)
B26R06C03	26-3-6	Hs~Ref:NM_003406.2~uORF:IOH3874	561	343	965	328	421	1787	1445	475	879	648	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ), transcript variant 1
B26R06C04	26-4-6	Hs~Ref:NM_003406.2~uORF:IOH3874	717	384	918	334	453	1715	1312	452	1003	673	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ), transcript variant 1
B26R06C07	26-7-6	Hs~Ref:NM_006808.2~uORF:IOH4539	427	469	1822	1470	416	282	966	784	1068	305	Protein transport protein Sec61 subunit beta
B26R06C08	26-8-6	Hs~Ref:NM_006808.2~uORF:IOH4539	474	462	1630	1446	435	282	923	772	1095	181	Protein transport protein Sec61 subunit beta
B26R06C09	26-9-6	Hs~MGC:BC025767.1~uORF:IOH11434	339	388	589	404	615	570	742	837	1664	272	Rhophilin-1
B26R06C10	26-10-6	Hs~MGC:BC025767.1~uORF:IOH11434	345	382	562	424	567	537	750	929	1624	370	Rhophilin-1
B26R06C11	26-11-6	Hs~MGC:NM_019010.1~uORF:IOH22697	2475	773	1336	618	602	820	1787	1069	2502	596	keratin 20 (KRT20)
B26R06C12	26-12-6	Hs~MGC:NM_019010.1~uORF:IOH22697	2590	792	972	708	619	951	1988	1084	2461	457	keratin 20 (KRT20)
B26R06C13	26-13-6	Hs~Ref:NM_002201.3~uORF:IOH6793	1201	1322	1605	1805	1576	1564	2480	2405	3142	673	interferon stimulated exonuclease gene 20kDa (ISG20)
B26R06C14	26-14-6	Hs~Ref:NM_002201.3~uORF:IOH6793	1274	1420	1593	1969	1663	1793	2379	2265	3212	692	interferon stimulated exonuclease gene 20kDa (ISG20)
B26R06C15	26-15-6	Hs~Ref:NM_018466.2~uORF:IOH7131	377	6035	790	400	622	1038	1957	591	1122	90	asparagine-linked glycosylation 13 homolog (S. cerevisiae) (ALG13)
B26R06C16	26-16-6	Hs~Ref:NM_018466.2~uORF:IOH7131	376	6668	782	418	639	1011	1988	615	1174	159	asparagine-linked glycosylation 13 homolog (S. cerevisiae) (ALG13)
B26R06C17	26-17-6	Hs~MGC:BC005187.1~uORF:IOH7207	830	907	1007	528	782	899	1142	1076	2601	415	ubiquitin-fold modifier conjugating enzyme 1 (UFC1)
B26R06C18	26-18-6	Hs~MGC:BC005187.1~uORF:IOH7207	927	836	1087	599	830	991	1197	813	2534	423	ubiquitin-fold modifier conjugating enzyme 1 (UFC1)
B26R06C19	26-19-6	Hs~MGC:BC096245.1~uORF:IOH63235	1428	22987	9247	15169	278	14199	751	906	631	2171	Activin receptor type-2B
B26R06C20	26-20-6	Hs~MGC:BC096245.1~uORF:IOH63235	1425	22105	8688	15944	257	13601	762	903	611	2116	Activin receptor type-2B
B26R06C21	26-21-6	Hs~Ref:NM_022438.1~uORF:IOH58625	400	408	758	318	347	514	544	401	730	76	Myelin and lymphocyte protein
B26R06C22	26-22-6	Hs~Ref:NM_022438.1~uORF:IOH58625	370	433	727	302	373	477	499	392	755	60	Myelin and lymphocyte protein
B26R07C01	26-1-7	Hs~MGC:BC092473.1~uORF:IOH62652	320	308	486	300	325	470	500	424	114	275	Porcine endogenous retrovirus A receptor 2
B26R07C02	26-2-7	Hs~MGC:BC092473.1~uORF:IOH62652	363	362	553	249	297	481	538	438	723	283	Porcine endogenous retrovirus A receptor 2
B26R07C03	26-3-7	Hs~Ref:NM_207002.1~uORF:IOH58626	724	1687	7398	731	1004	1418	1424	893	3083	445	BCL2-like 11 (apoptosis facilitator) (BCL2L11), transcript variant 9, mRNA.
B26R07C04	26-4-7	Hs~Ref:NM_207002.1~uORF:IOH58626	785	1673	6834	675	832	1341	1331	785	3318	420	BCL2-like 11 (apoptosis facilitator) (BCL2L11), transcript variant 9, mRNA.
B26R07C05	26-5-7	Hs~Ref:NM_022551.2~uORF:IOH41520	1507	974	2099	735	626	1079	4350	872	638	461	ribosomal protein S18 (RPS18)
B26R07C06	26-6-7	Hs~Ref:NM_022551.2~uORF:IOH41520	1407	984	2104	769	-4	1049	4352	879	1384	445	ribosomal protein S18 (RPS18)
B26R07C07	26-7-7	Hs~Ref:NM_004403.1~uORF:IOH41276	275	76	327	141	237	146	305	177	664	202	deafness, autosomal dominant 5 (DFNA5)
B26R07C08	26-8-7	Hs~Ref:NM_004403.1~uORF:IOH41276	250	194	350	155	35	183	311	154	309	111	deafness, autosomal dominant 5 (DFNA5)
B26R07C09	26-9-7	Hs~Ref:NM_005765.2~uORF:IOH42509	632	636	1056	473	3463	561	809	655	1017	590	ATPase, H+ transporting, lysosomal accessory protein 2 (ATP6AP2)
B26R07C10	26-10-7	Hs~Ref:NM_005765.2~uORF:IOH42509	635	633	960	470	3735	540	820	636	1125	496	ATPase, H+ transporting, lysosomal accessory protein 2 (ATP6AP2)
B26R07C11	26-11-7	Hs~Ref:NM_194457.1~uORF:IOH41277	354	312	718	247	121	380	775	270	744	544	ubiquitin-conjugating enzyme E2, J2 (UBC6 homolog, yeast) (UBE2J2), transcript variant 4
B26R07C12	26-12-7	Hs~Ref:NM_194457.1~uORF:IOH41277	597	353	506	300	194	409	762	252	487	575	ubiquitin-conjugating enzyme E2, J2 (UBC6 homolog, yeast) (UBE2J2), transcript variant 4
B26R07C13	26-13-7	Hs~Ref:NM_003576.2~N/A	247	533	750	232	221	479	662	245	1545	252	Serine/threonine-protein kinase 24
B26R07C14	26-14-7	Hs~Ref:NM_003576.2~N/A	322	376	745	277	239	449	678	230	1605	57	Serine/threonine-protein kinase 24
B26R07C17	26-17-7	Hs~MGC:BC015833.1~uORF:IOH14840	8459	8328	8484	6070	7674	7643	6364	8570	9354	8766	cDNA clone MGC:27152 IMAGE:4691630, complete cds
B26R07C18	26-18-7	Hs~MGC:BC015833.1~uORF:IOH14840	9037	8224	8477	6037	7621	7031	6263	7388	9107	8683	cDNA clone MGC:27152 IMAGE:4691630, complete cds
B26R07C19	26-19-7	Hs~MGC:BC019015.2~uORF:IOH12089	2609	281	997	282	294	707	756	856	1154	207	mediator complex subunit 29 (MED29)
B26R07C20	26-20-7	Hs~MGC:BC019015.2~uORF:IOH12089	3040	289	955	288	334	553	698	847	1157	145	mediator complex subunit 29 (MED29)
B26R08C07	26-7-8	Hs~Ref:NM_004990.2~uORF:IOH3655	1370	917	1408	3151	481	1761	1563	1947	1199	1338	methionyl-tRNA synthetase (MARS)
B26R08C08	26-8-8	Hs~Ref:NM_004990.2~uORF:IOH3655	1429	940	1385	3120	3398	1713	1598	1942	1219	1279	methionyl-tRNA synthetase (MARS)
B26R08C09	26-9-8	Hs~MGC:BC000525.1~uORF:IOH3627	3046	485	1303	853	2122	869	4731	1935	1450	381	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) (GOT2)
B26R08C10	26-10-8	Hs~MGC:BC000525.1~uORF:IOH3627	3175	507	1173	905	2834	880	4673	1897	1602	389	glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) (GOT2)
B26R08C11	26-11-8	Hs~MGC:BC000645.1~uORF:IOH4240	602	500	774	473	1500	691	791	604	1079	442	solute carrier family 39 (zinc transporter), member 7 (SLC39A7)
B26R08C12	26-12-8	Hs~MGC:BC000645.1~uORF:IOH4240	507	503	910	484	427	662	741	563	1244	420	solute carrier family 39 (zinc transporter), member 7 (SLC39A7)
B26R08C13	26-13-8	Hs~MGC:BC012824.1~uORF:IOH22892	514	410	604	444	389	714	727	553	828	305	Tubulin-specific chaperone D
B26R08C14	26-14-8	Hs~MGC:BC012824.1~uORF:IOH22892	435	522	743	439	426	733	738	566	861	349	Tubulin-specific chaperone D
B26R08C15	26-15-8	Hs~MGC:NM_006216.2~uORF:IOH12816	1954	894	2698	1208	1087	1083	4160	1272	1764	371	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 (SERPINE2)
B26R08C16	26-16-8	Hs~MGC:NM_006216.2~uORF:IOH12816	1937	901	2591	1130	1117	1107	4050	1288	1983	498	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 (SERPINE2)
B26R08C17	26-17-8	Hs~Ref:NM_144982.1~uORF:IOH12275	14356	9327	8624	6244	7466	4782	18428	9359	11041	4053	coiled-coil domain containing 131 (CCDC131)
B26R08C18	26-18-8	Hs~Ref:NM_144982.1~uORF:IOH12275	14588	9342	8454	6380	7830	4632	19157	9151	11086	4367	coiled-coil domain containing 131 (CCDC131)
B26R08C21	26-21-8	Hs~Ref:NM_002704.1~uORF:IOH12030	909	685	985	625	748	1169	1289	650	1474	294	pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) (PPBP)
B26R08C22	26-22-8	Hs~Ref:NM_002704.1~uORF:IOH12030	924	728	980	594	700	1094	1296	635	1442	415	pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) (PPBP)
B26R09C01	26-1-9	Hs~Ref:NM_005512.1~uORF:IOH40550	449	298	600	399	225	491	697	443	696	272	leucine rich repeat containing 32 (LRRC32)
B26R09C02	26-2-9	Hs~Ref:NM_005512.1~uORF:IOH40550	449	330	643	437	291	535	809	440	275	131	leucine rich repeat containing 32 (LRRC32)
B26R09C03	26-3-9	Hs~Ref:NM_006205.1~uORF:IOH40356	4149	2647	6220	2382	2522	3964	15022	2460	5053	1889	phosphodiesterase 6H, cGMP-specific, cone, gamma (PDE6H)
B26R09C04	26-4-9	Hs~Ref:NM_006205.1~uORF:IOH40356	4335	2574	6372	2453	2799	3978	13932	2449	5131	1933	phosphodiesterase 6H, cGMP-specific, cone, gamma (PDE6H)
B26R09C05	26-5-9	Hs~MGC:BC069285.1~uORF:IOH40391	949	490	1125	947	568	813	1054	783	1127	327	defensin, beta 4 (DEFB4)
B26R09C06	26-6-9	Hs~MGC:BC069285.1~uORF:IOH40391	936	436	1044	900	527	772	982	707	918	381	defensin, beta 4 (DEFB4)
B26R09C07	26-7-9	Hs~MGC:BC065030.1~uORF:IOH40478	557	1353	830	328	269	493	734	431	919	563	Hermansky-Pudlak syndrome 4 (HPS4)
B26R09C08	26-8-9	Hs~MGC:BC065030.1~uORF:IOH40478	561	1430	826	359	743	458	760	443	782	521	Hermansky-Pudlak syndrome 4 (HPS4)
B26R09C09	26-9-9	Hs~Ref:NM_014325.1~uORF:IOH3562	327	371	470	235	530	357	459	291	713	167	coronin, actin binding protein, 1C (CORO1C), transcript variant 1
B26R09C10	26-10-9	Hs~Ref:NM_014325.1~uORF:IOH3562	322	384	476	270	59	380	498	296	673	100	coronin, actin binding protein, 1C (CORO1C), transcript variant 1
B26R09C11	26-11-9	Hs~Ref:NM_002802.1~uORF:IOH3591	1037	488	1927	433	6599	10768	2109	542	1151	261	proteasome (prosome, macropain) 26S subunit, ATPase, 1 (PSMC1)
B26R09C12	26-12-9	Hs~Ref:NM_002802.1~uORF:IOH3591	920	442	2543	423	7049	10761	2046	550	1278	339	proteasome (prosome, macropain) 26S subunit, ATPase, 1 (PSMC1)
B26R09C13	26-13-9	Hs~Ref:NM_005566.1~uORF:IOH3797	640	515	1021	535	326	482	926	881	1079	238	lactate dehydrogenase A (LDHA)
B26R09C14	26-14-9	Hs~Ref:NM_005566.1~uORF:IOH3797	425	884	537	560	405	127	881	873	1040	14	lactate dehydrogenase A (LDHA)
B26R09C15	26-15-9	Hs~Ref:NM_032214.1~uORF:IOH26309	986	743	1548	504	595	2361	1064	472	2345	511	Src-like-adaptor 2 (SLA2), transcript variant 1
B26R09C16	26-16-9	Hs~Ref:NM_032214.1~uORF:IOH26309	1012	810	1484	467	599	2385	1061	456	2504	392	Src-like-adaptor 2 (SLA2), transcript variant 1
B26R09C17	26-17-9	Hs~Ref:NM_138810.1~uORF:IOH12231	947	680	1462	636	702	808	1511	818	1791	414	T-cell activation GTPase activating protein (TAGAP), transcript variant 3
B26R09C18	26-18-9	Hs~Ref:NM_138810.1~uORF:IOH12231	1235	743	1489	598	683	903	1570	783	1857	416	T-cell activation GTPase activating protein (TAGAP), transcript variant 3
B26R09C19	26-19-9	Hs~MGC:BC022043.1~uORF:IOH13409	-8	-3	387	-1	-1	-6	1	-3	0	-2	chromosome 7 open reading frame 36 (C7orf36)
B26R09C20	26-20-9	Hs~MGC:BC022043.1~uORF:IOH13409	9	-4	0	1	1	-4	-3	932	-2	2	chromosome 7 open reading frame 36 (C7orf36)
B26R09C21	26-21-9	Hs~MGC:BC017249.1~uORF:IOH12653	1208	1046	1546	990	1400	1093	1838	1094	2233	458	enolase 3 (beta, muscle) (ENO3)
B26R09C22	26-22-9	Hs~MGC:BC017249.1~uORF:IOH12653	1199	1041	1483	1036	1466	1015	1904	1127	2253	575	enolase 3 (beta, muscle) (ENO3)
B26R10C01	26-1-10	Hs~MGC:NM_173474.2~uORF:IOH13254	1072	927	1413	2419	1155	1135	2159	941	2379	1265	N-terminal asparagine amidase (NTAN1)
B26R10C02	26-2-10	Hs~MGC:NM_173474.2~uORF:IOH13254	1183	888	1412	2522	1203	1138	2171	873	2240	1360	N-terminal asparagine amidase (NTAN1)
B26R10C03	26-3-10	Hs~MGC:BC037219.1~uORF:IOH28669	431	377	541	343	253	418	722	336	743	265	epidermal retinal dehydrogenase 2 (RDHE2)
B26R10C04	26-4-10	Hs~MGC:BC037219.1~uORF:IOH28669	452	377	540	315	285	552	785	314	619	257	epidermal retinal dehydrogenase 2 (RDHE2)
B26R10C07	26-7-10	Hs~MGC:BC057774.1~uORF:IOH29168	2845	1455	2151	1448	851	1756	12339	1526	3386	1135	RNA (guanine-9-)-methyltransferase domain-containing protein 3
B26R10C08	26-8-10	Hs~MGC:BC057774.1~uORF:IOH29168	3009	1500	2142	1406	4733	1709	13171	1339	3551	1010	RNA (guanine-9-)-methyltransferase domain-containing protein 3
B26R10C09	26-9-10	Hs~MGC:BC051000.1~uORF:IOH28084	3523	2870	6936	2847	4038	2508	3362	2607	3434	1993	T-cell leukemia/lymphoma 1B (TCL1B)
B26R10C10	26-10-10	Hs~MGC:BC051000.1~uORF:IOH28084	3493	2797	6763	2786	4846	2580	3461	2632	3571	2009	T-cell leukemia/lymphoma 1B (TCL1B)
B26R11C21	26-21-11	Hs~MGC:BC027596.1~uORF:IOH11362	499	1947	563	313	225	209	740	661	675	777	protein phosphatase 2 (formerly 2A), regulatory subunit A, beta isoform (PPP2R1B)
B26R11C22	26-22-11	Hs~MGC:BC027596.1~uORF:IOH11362	558	2113	547	283	222	382	682	530	722	180	protein phosphatase 2 (formerly 2A), regulatory subunit A, beta isoform (PPP2R1B)
B26R12C01	26-1-12	Hs~MGC:BC040693.1~uORF:IOH26345	302	309	453	223	217	348	572	295	217	227	CD53 molecule (CD53)
B26R12C02	26-2-12	Hs~MGC:BC040693.1~uORF:IOH26345	269	311	370	248	309	364	546	349	207	275	CD53 molecule (CD53)
B26R12C03	26-3-12	Hs~MGC:BC041133.1~uORF:IOH26142	1119	845	1032	934	773	1031	1791	838	1634	600	RAS-like, family 10, member B (RASL10B)
B26R12C04	26-4-12	Hs~MGC:BC041133.1~uORF:IOH26142	1151	783	960	939	614	946	1742	845	1927	728	RAS-like, family 10, member B (RASL10B)
B26R12C07	26-7-12	Hs~Ref:NM_012148.1~uORF:IOH39321	2276	944	1369	901	994	1137	4798	1542	2073	715	double homeobox, 3 (DUX3)
B26R12C08	26-8-12	Hs~Ref:NM_012148.1~uORF:IOH39321	2033	1016	1387	883	950	1259	5036	1311	2119	650	double homeobox, 3 (DUX3)
B26R12C09	26-9-12	Hs~Ref:NM_144980.1~uORF:IOH12741	601	457	721	520	510	706	963	679	1426	281	chromosome 6 open reading frame 118 (C6orf118)
B26R12C10	26-10-12	Hs~Ref:NM_144980.1~uORF:IOH12741	562	495	749	517	2415	730	831	629	1781	401	chromosome 6 open reading frame 118 (C6orf118)
B26R12C11	26-11-12	Hs~MGC:NM_182661.1~uORF:IOH5501	995	828	1146	646	1189	1008	1717	940	2210	543	ceramide kinase (CERK), transcript variant 2
B26R12C12	26-12-12	Hs~MGC:NM_182661.1~uORF:IOH5501	966	798	1063	710	2136	1090	1589	944	2192	621	ceramide kinase (CERK), transcript variant 2
B26R12C13	26-13-12	Hs~MGC:BC036054.2~uORF:IOH27217	1174	815	1353	650	1802	962	1858	1092	2333	295	chromosome 18 open reading frame 54 (C18orf54)
B26R12C14	26-14-12	Hs~MGC:BC036054.2~uORF:IOH27217	1141	884	1221	728	1341	1174	1854	1119	2348	443	chromosome 18 open reading frame 54 (C18orf54)
B26R12C15	26-15-12	Hs~MGC:BC034762.1~uORF:IOH22673	655	692	1158	440	1588	1499	1354	860	1495	356	golgi SNAP receptor complex member 2 (GOSR2), transcript variant C, mRNA.
B26R12C16	26-16-12	Hs~MGC:BC034762.1~uORF:IOH22673	694	657	1188	449	3290	1508	1316	831	1718	365	golgi SNAP receptor complex member 2 (GOSR2), transcript variant C, mRNA.
B26R12C17	26-17-12	Hs~MGC:BC096281.2~uORF:IOH63276	351	267	534	531	2675	267	497	351	433	148	Type I inositol-1,4,5-trisphosphate 5-phosphatase
B26R12C18	26-18-12	Hs~MGC:BC096281.2~uORF:IOH63276	331	255	509	234	114	259	503	316	545	93	Type I inositol-1,4,5-trisphosphate 5-phosphatase
B26R12C19	26-19-12	Hs~Ref:NM_145293.1~uORF:IOH11848	363	220	390	217	146	222	663	312	529	89	Putative elongation factor 1-delta-like protein
B26R12C20	26-20-12	Hs~Ref:NM_145293.1~uORF:IOH11848	324	216	395	229	182	423	680	329	527	62	Putative elongation factor 1-delta-like protein
B26R12C21	26-21-12	Hs~Ref:NM_000232.1~uORF:IOH12316	671	526	841	449	422	31	866	531	1099	468	Beta-sarcoglycan
B26R12C22	26-22-12	Hs~Ref:NM_000232.1~uORF:IOH12316	661	582	755	456	390	271	886	651	1123	516	Beta-sarcoglycan
B26R13C01	26-1-13	Hs~Ref:NM_032853.2~uORF:IOH42561	1307	935	1326	617	835	877	2622	858	1483	369	melanoma associated antigen (mutated) 1 (MUM1)
B26R13C02	26-2-13	Hs~Ref:NM_032853.2~uORF:IOH42561	1031	956	1402	649	889	865	2706	876	1629	407	melanoma associated antigen (mutated) 1 (MUM1)
B26R13C03	26-3-13	Hs~Ref:NM_015554.1~uORF:IOH44553	1099	1600	1699	761	4414	1677	3081	1345	2414	416	glucuronic acid epimerase (GLCE)
B26R13C04	26-4-13	Hs~Ref:NM_015554.1~uORF:IOH44553	1170	1610	1765	727	4490	1630	2816	1347	2498	429	glucuronic acid epimerase (GLCE)
B26R13C05	26-5-13	Hs~Ref:NM_003592.2~uORF:IOH41991	866	654	1291	557	988	748	1893	788	1349	329	cullin 1 (CUL1)
B26R13C06	26-6-13	Hs~Ref:NM_003592.2~uORF:IOH41991	936	691	1300	591	990	721	1985	793	1295	603	cullin 1 (CUL1)
B26R13C07	26-7-13	Hs~Ref:NM_182800.2~uORF:IOH44806	895	308	567	447	1679	513	4162	909	2402	253	arsenate resistance protein 2 (ARS2), transcript variant 2
B26R13C08	26-8-13	Hs~Ref:NM_182800.2~uORF:IOH44806	871	345	562	432	1719	529	4778	870	2570	253	arsenate resistance protein 2 (ARS2), transcript variant 2
B26R13C09	26-9-13	Hs~Ref:NM_001894.2~uORF:IOH21160	5440	6154	2577	3576	1712	2223	11506	2485	3931	2967	casein kinase 1, epsilon (CSNK1E), transcript variant 2
B26R13C10	26-10-13	Hs~Ref:NM_001894.2~uORF:IOH21160	6230	6374	2445	3442	1423	2676	11864	2608	4089	5053	casein kinase 1, epsilon (CSNK1E), transcript variant 2
B26R13C11	26-11-13	Hs~MGC:BC005982.1~uORF:IOH7502	555	328	585	236	1907	446	956	461	736	123	peptidylprolyl isomerase A (cyclophilin A) (PPIA)
B26R13C12	26-12-13	Hs~MGC:BC005982.1~uORF:IOH7502	573	366	528	260	885	444	928	460	521	209	peptidylprolyl isomerase A (cyclophilin A) (PPIA)
B26R13C13	26-13-13	Hs~Ref:NM_000430.2~uORF:IOH39940	1600	599	791	657	1322	1291	1659	1376	1327	653	platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45kDa (PAFAH1B1)
B26R13C14	26-14-13	Hs~Ref:NM_000430.2~uORF:IOH39940	1789	605	943	716	1671	1293	1717	1399	1289	518	platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45kDa (PAFAH1B1)
B26R13C15	26-15-13	Hs~MGC:NM_198498.1~uORF:IOH26293	470	459	492	292	618	474	815	383	608	251	chromosome 11 open reading frame 53 (C11orf53)
B26R13C16	26-16-13	Hs~MGC:NM_198498.1~uORF:IOH26293	498	322	562	523	446	495	788	399	689	110	chromosome 11 open reading frame 53 (C11orf53)
B26R13C17	26-17-13	Hs~MGC:BC006456.1~uORF:IOH5963	9726	640	637	509	3136	592	680	1675	1535	344	family with sequence similarity 21, member C (FAM21C)
B26R13C18	26-18-13	Hs~MGC:BC006456.1~uORF:IOH5963	9062	651	626	556	3545	597	704	1666	1650	420	family with sequence similarity 21, member C (FAM21C)
B26R13C19	26-19-13	Hs~Ref:NM_004781.2~uORF:IOH4958	420	350	585	297	966	627	609	334	469	232	vesicle-associated membrane protein 3 (cellubrevin) (VAMP3)
B26R13C20	26-20-13	Hs~Ref:NM_004781.2~uORF:IOH4958	312	336	617	272	174	616	593	327	647	321	vesicle-associated membrane protein 3 (cellubrevin) (VAMP3)
B26R13C21	26-21-13	Hs~Ref:NM_138480.1~uORF:IOH10174	353	336	553	279	282	414	637	344	691	155	hypothetical protein BC010522 (LOC149267)
B26R13C22	26-22-13	Hs~Ref:NM_138480.1~uORF:IOH10174	382	329	532	281	276	186	1308	370	726	135	hypothetical protein BC010522 (LOC149267)
B26R14C05	26-5-14	Hs~Ref:NM_007087.1~uORF:IOH59514	254	238	659	185	251	484	468	320	713	134	Calretinin
B26R14C06	26-6-14	Hs~Ref:NM_007087.1~uORF:IOH59514	207	116	613	220	243	451	448	319	734	84	Calretinin
B26R14C11	26-11-14	Hs~MGC:BC002553.1~uORF:IOH4036	664	646	1188	487	981	1473	1460	1043	1361	592	Aldehyde dehydrogenase family 3 member B1
B26R14C12	26-12-14	Hs~MGC:BC002553.1~uORF:IOH4036	678	689	1199	505	1217	1575	1574	940	1315	225	Aldehyde dehydrogenase family 3 member B1
B26R14C13	26-13-14	Hs~Ref:NM_007051.2~uORF:IOH5135	352	314	396	199	2605	1393	1466	218	690	119	FAS-associated factor 1
B26R14C14	26-14-14	Hs~Ref:NM_007051.2~uORF:IOH5135	404	306	584	201	357	1339	1464	218	743	9	FAS-associated factor 1
B26R14C15	26-15-14	Hs~MGC:BC001904.1~uORF:IOH4832	405	366	950	229	428	489	717	277	1045	191	Phosphoglycerate mutase 2
B26R14C16	26-16-14	Hs~MGC:BC001904.1~uORF:IOH4832	456	613	503	330	578	461	712	307	863	134	Phosphoglycerate mutase 2
B26R14C17	26-17-14	Hs~Ref:NM_000291.2~uORF:IOH42151	390	300	563	436	755	335	531	377	763	280	Phosphoglycerate kinase 1
B26R14C18	26-18-14	Hs~Ref:NM_000291.2~uORF:IOH42151	422	316	592	437	699	365	561	393	863	239	Phosphoglycerate kinase 1
B26R14C19	26-19-14	Hs~Ref:NM_001025595.1~uORF:IOH60838	649	764	3681	499	1252	31789	1323	836	2016	268	Arfaptin-1
B26R14C20	26-20-14	Hs~Ref:NM_001025595.1~uORF:IOH60838	692	798	3452	430	3109	32700	1321	790	2105	249	Arfaptin-1
B26R15C01	26-1-15	Hs~MGC:BC102030.1~uORF:IOH63600	556	407	648	429	548	695	836	508	861	312	Egl nine homolog 3
B26R15C02	26-2-15	Hs~MGC:BC102030.1~uORF:IOH63600	556	439	696	440	579	605	848	477	805	299	Egl nine homolog 3
B26R15C05	26-5-15	Hs~MGC:NM_174930.2~uORF:IOH11024	565	494	738	487	337	607	1228	796	1561	314	postmeiotic segregation increased 2-like 5 (PMS2L5)
B26R15C06	26-6-15	Hs~MGC:NM_174930.2~uORF:IOH11024	536	492	739	489	334	558	1110	784	1339	375	postmeiotic segregation increased 2-like 5 (PMS2L5)
B26R15C07	26-7-15	Hs~Ref:NM_032564.1~uORF:IOH10833	666	502	734	441	325	550	985	566	790	318	diacylglycerol O-acyltransferase homolog 2 (mouse) (DGAT2)
B26R15C08	26-8-15	Hs~Ref:NM_032564.1~uORF:IOH10833	716	531	746	391	311	546	878	582	908	232	diacylglycerol O-acyltransferase homolog 2 (mouse) (DGAT2)
B26R15C09	26-9-15	Hs~MGC:BC029605.1~uORF:IOH21616	386	517	620	388	450	605	728	488	756	539	synaptotagmin IX (SYT9)
B26R15C10	26-10-15	Hs~MGC:BC029605.1~uORF:IOH21616	481	573	623	341	429	528	729	459	619	400	synaptotagmin IX (SYT9)
B26R15C11	26-11-15	Hs~Ref:NM_006869.1~uORF:IOH21856	1553	1508	2802	999	710	3119	4100	1309	1915	1783	centaurin, alpha 1 (CENTA1)
B26R15C12	26-12-15	Hs~Ref:NM_006869.1~uORF:IOH21856	1551	1586	2690	970	656	3171	4144	1269	1828	1851	centaurin, alpha 1 (CENTA1)
B26R15C15	26-15-15	Hs~Ref:NM_005030.2~CAT:PV3501	1228	1945	2087	1497	1530	2379	3899	1941	1771	1422	polo-like kinase 1 (Drosophila) (PLK1)
B26R15C16	26-16-15	Hs~Ref:NM_005030.2~CAT:PV3501	1509	2614	1789	1666	1475	2205	3930	1935	1863	1566	polo-like kinase 1 (Drosophila) (PLK1)
B26R15C19	26-19-15	Hs~Ref:NM_004635.2~CAT:PV3299	242	148	317	312	706	368	358	241	187	215	mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3)
B26R15C20	26-20-15	Hs~Ref:NM_004635.2~CAT:PV3299	250	130	396	289	565	346	358	227	28	63	mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3)
B26R15C21	26-21-15	Hs~Ref:NM_004431.1~CAT:PV3688	520	1688	415	560	4640	771	1604	590	838	455	Ephrin type-A receptor 2
B26R15C22	26-22-15	Hs~Ref:NM_004431.1~CAT:PV3688	462	1734	416	541	763	797	1621	558	910	452	Ephrin type-A receptor 2
B26R16C01	26-1-16	Hs~Ref:NM_004836.2~CAT:PV5106	298	233	243	396	233	351	608	432	570	225	Eukaryotic translation initiation factor 2-alpha kinase 3
B26R16C02	26-2-16	Hs~Ref:NM_004836.2~CAT:PV5106	305	235	269	418	261	315	592	399	451	230	Eukaryotic translation initiation factor 2-alpha kinase 3
B26R16C03	26-3-16	Hs~Ref:NM_018724.3~CAT_PHC0205	566	420	326	417	655	126	628	177	497	337	interleukin 20 (IL20)
B26R16C04	26-4-16	Hs~Ref:NM_018724.3~CAT_PHC0205	618	454	274	415	598	191	586	173	45	347	interleukin 20 (IL20)
B26R16C05	26-5-16	Hs~Ref:NM_006274.2~CAT_PHC1244	85	57	175	182	29	668	348	141	111	58	chemokine (C-C motif) ligand 19 (CCL19)
B26R16C06	26-6-16	Hs~Ref:NM_006274.2~CAT_PHC1244	84	74	156	143	68	669	342	155	95	48	chemokine (C-C motif) ligand 19 (CCL19)
B26R16C07	26-7-16	Hs~Ref:NM_004127.3~uORF:IOH2368	299	742	286	491	600	495	391	418	1150	401	COP9 signalosome complex subunit 1
B26R16C08	26-8-16	Hs~Ref:NM_004127.3~uORF:IOH2368	271	729	286	486	594	525	396	433	1275	446	COP9 signalosome complex subunit 1
B26R16C09	26-9-16	Hs~MGC:BC012362.1~uORF:IOH12046	195	49	116	137	38	103	139	558	208	43	RAP2B, member of RAS oncogene family (RAP2B)
B26R16C10	26-10-16	Hs~MGC:BC012362.1~uORF:IOH12046	374	38	100	72	110	29	134	570	181	48	RAP2B, member of RAS oncogene family (RAP2B)
B26R16C11	26-11-16	Hs~Ref:NM_007198.1~uORF:IOH12511	148	1238	328	195	83	1083	1157	686	530	1195	proline synthetase co-transcribed homolog (bacterial) (PROSC)
B26R16C12	26-12-16	Hs~Ref:NM_007198.1~uORF:IOH12511	230	1349	322	181	100	1076	1226	718	960	1266	proline synthetase co-transcribed homolog (bacterial) (PROSC)
B26R16C13	26-13-16	Hs~Ref:NM_024821.1~uORF:IOH10944	128	211	287	261	142	391	430	393	219	133	coiled-coil domain containing 134 (CCDC134)
B26R16C14	26-14-16	Hs~Ref:NM_024821.1~uORF:IOH10944	93	287	308	229	52	433	465	394	182	85	coiled-coil domain containing 134 (CCDC134)
B26R16C15	26-15-16	Hs~Ref:NM_153329.2~uORF:IOH21432	1079	715	2073	963	5029	888	1640	997	2180	401	Aldehyde dehydrogenase family 16 member A1
B26R16C16	26-16-16	Hs~Ref:NM_153329.2~uORF:IOH21432	1111	903	2130	924	3352	857	1660	967	2200	629	Aldehyde dehydrogenase family 16 member A1
B26R16C17	26-17-16	Hs~MGC:BC022534.1~uORF:IOH10832	935	929	1626	629	1278	892	1339	1028	2262	507	Uncharacterized protein C4orf32
B26R16C18	26-18-16	Hs~MGC:BC022534.1~uORF:IOH10832	908	790	1719	636	1408	937	1232	1077	2279	409	Uncharacterized protein C4orf32
B26R16C19	26-19-16	Hs~Ref:NM_001024631.1~uORF:IOH57349	2168	127	1304	285	1596	1188	811	1147	1288	280	Ataxin-3
B26R16C20	26-20-16	Hs~Ref:NM_001024631.1~uORF:IOH57349	2230	26	1240	242	1739	1198	842	1080	1305	177	Ataxin-3
B26R16C21	26-21-16	Hs~Ref:NM_152485.2~uORF:IOH26147	1035	706	1920	718	938	902	1366	802	2537	336	Uncharacterized protein C1orf74
B26R16C22	26-22-16	Hs~Ref:NM_152485.2~uORF:IOH26147	1022	684	1863	752	2917	878	1296	832	2569	307	Uncharacterized protein C1orf74
B26R17C01	26-1-17	Hs~Ref:NM_006695.2~uORF:IOH5798	398	372	683	276	345	607	1195	971	1094	255	RUN domain containing 3A (RUNDC3A)
B26R17C02	26-2-17	Hs~Ref:NM_006695.2~uORF:IOH5798	329	376	699	266	375	704	1101	929	1185	189	RUN domain containing 3A (RUNDC3A)
B26R17C03	26-3-17	Hs~MGC:BC010427.1~uORF:IOH14505	186	245	1098	199	294	8409	976	356	921	237	polymerase (RNA) II (DNA directed) polypeptide D (POLR2D)
B26R17C04	26-4-17	Hs~MGC:BC010427.1~uORF:IOH14505	255	257	1059	170	254	7641	1076	368	851	76	polymerase (RNA) II (DNA directed) polypeptide D (POLR2D)
B26R17C05	26-5-17	Hs~Ref:NM_006713.2~uORF:IOH14686	326	722	545	339	660	1594	815	1341	887	240	SUB1 homolog (S. cerevisiae) (SUB1)
B26R17C06	26-6-17	Hs~Ref:NM_006713.2~uORF:IOH14686	319	805	544	354	663	1585	718	1329	921	269	SUB1 homolog (S. cerevisiae) (SUB1)
B26R17C07	26-7-17	Hs~MGC:NM_138353.1~uORF:IOH13957	276	298	419	213	254	304	446	408	885	252	DDB1- and CUL4-associated factor 15
B26R17C08	26-8-17	Hs~MGC:NM_138353.1~uORF:IOH13957	332	298	502	199	259	296	420	378	856	431	DDB1- and CUL4-associated factor 15
B26R17C09	26-9-17	Hs~Ref:NM_001005176.1~uORF:IOH40807	93	98	458	218	164	3818	327	241	323	375	SP140 nuclear body protein (SP140), transcript variant 2
B26R17C10	26-10-17	Hs~Ref:NM_001005176.1~uORF:IOH40807	215	175	460	188	146	3454	270	240	193	112	SP140 nuclear body protein (SP140), transcript variant 2
B26R17C11	26-11-17	Hs~Ref:NM_007117.1~uORF:IOH40291	416	269	672	320	286	427	541	421	839	177	thyrotropin-releasing hormone (TRH)
B26R17C12	26-12-17	Hs~Ref:NM_007117.1~uORF:IOH40291	464	287	674	343	269	435	527	440	1081	768	thyrotropin-releasing hormone (TRH)
B26R17C15	26-15-17	Hs~Ref:NM_001412.2~uORF:IOH3055	4590	1274	5601	1203	666	1853	16732	1143	2929	753	eukaryotic translation initiation factor 1A, X-linked (EIF1AX)
B26R17C16	26-16-17	Hs~Ref:NM_001412.2~uORF:IOH3055	4947	1319	5535	1192	779	1844	16967	1092	3094	769	eukaryotic translation initiation factor 1A, X-linked (EIF1AX)
B26R17C17	26-17-17	Hs~Ref:NM_015509.2~uORF:IOH43513	2448	14501	6103	4664	7118	7979	1581	4488	2916	1109	NECAP endocytosis associated 1 (NECAP1)
B26R17C18	26-18-17	Hs~Ref:NM_015509.2~uORF:IOH43513	2614	15215	6394	4648	8310	7631	1582	4263	3096	977	NECAP endocytosis associated 1 (NECAP1)
B26R17C19	26-19-17	Hs~Ref:NM_031845.1~uORF:IOH37776	6044	22529	14470	4114	5843	8234	8499	9167	6557	1332	microtubule-associated protein 2 (MAP2), transcript variant 2
B26R17C20	26-20-17	Hs~Ref:NM_031845.1~uORF:IOH37776	6502	23886	13684	3947	5351	7763	9538	8869	7668	1437	microtubule-associated protein 2 (MAP2), transcript variant 2
B26R17C21	26-21-17	Hs~Ref:NM_001008723.1~uORF:IOH43999	988	1253	1638	733	2339	1356	3071	1094	1395	453	chromosome 10 open reading frame 80 (C10orf80)
B26R17C22	26-22-17	Hs~Ref:NM_001008723.1~uORF:IOH43999	1133	1098	1567	694	1980	1224	2514	994	1295	494	chromosome 10 open reading frame 80 (C10orf80)
B26R18C01	26-1-18	Hs~Ref:NM_018063.3~uORF:IOH44165	1038	740	1382	1129	515	1149	3920	729	656	354	helicase, lymphoid-specific (HELLS)
B26R18C02	26-2-18	Hs~Ref:NM_018063.3~uORF:IOH44165	1002	736	1316	965	505	1056	3849	824	449	358	helicase, lymphoid-specific (HELLS)
B26R18C03	26-3-18	Hs~Ref:NM_002984.1~uORF:IOH29652	164	167	352	198	116	263	220	201	121	181	chemokine (C-C motif) ligand 4 (CCL4), transcript variant 1
B26R18C04	26-4-18	Hs~Ref:NM_002984.1~uORF:IOH29652	219	194	259	150	71	304	362	208	305	35	chemokine (C-C motif) ligand 4 (CCL4), transcript variant 1
B26R18C05	26-5-18	Hs~Ref:NM_005114.1~uORF:IOH29561	255	162	302	200	231	261	389	208	231	222	heparan sulfate (glucosamine) 3-O-sulfotransferase 1 (HS3ST1)
B26R18C06	26-6-18	Hs~Ref:NM_005114.1~uORF:IOH29561	253	225	303	188	164	269	342	210	297	300	heparan sulfate (glucosamine) 3-O-sulfotransferase 1 (HS3ST1)
B26R18C07	26-7-18	Hs~Ref:NM_004583.1~uORF:IOH29836	301	294	1022	362	449	521	422	715	757	305	RAB5C, member RAS oncogene family (RAB5C), transcript variant 2
B26R18C08	26-8-18	Hs~Ref:NM_004583.1~uORF:IOH29836	346	332	992	368	429	528	407	677	309	105	RAB5C, member RAS oncogene family (RAB5C), transcript variant 2
B26R18C09	26-9-18	Hs~Ref:NM_080391.1~uORF:IOH29576	596	456	662	658	614	724	1228	831	1184	247	protein tyrosine phosphatase type IVA, member 2 (PTP4A2), transcript variant 1
B26R18C10	26-10-18	Hs~Ref:NM_080391.1~uORF:IOH29576	553	447	684	672	628	736	1331	867	1261	590	protein tyrosine phosphatase type IVA, member 2 (PTP4A2), transcript variant 1
B26R18C11	26-11-18	Hs~MGC:BC047223.1~uORF:IOH62429	1048	797	968	615	510	913	3086	792	1483	290	Nuclear protein NP60
B26R18C12	26-12-18	Hs~MGC:BC047223.1~uORF:IOH62429	1044	802	996	667	507	1000	3267	837	1304	89	Nuclear protein NP60
B26R18C13	26-13-18	Hs~MGC:BC072461.1~uORF:IOH62565	11803	2410	18852	26007	3287	1563	10530	2186	1892	1849	Cysteine and histidine-rich domain-containing protein 1
B26R18C14	26-14-18	Hs~MGC:BC072461.1~uORF:IOH62565	12332	2431	16189	26081	3175	1525	10239	2110	2019	1818	Cysteine and histidine-rich domain-containing protein 1
B26R18C15	26-15-18	Hs~MGC:BC065533.1~uORF:IOH61590	1722	1273	1345	1502	564	2127	1748	1110	3173	1030	Inositol hexakisphosphate kinase 2
B26R18C16	26-16-18	Hs~MGC:BC065533.1~uORF:IOH61590	1964	1312	1291	1468	618	2163	1850	1054	3321	980	Inositol hexakisphosphate kinase 2
B26R18C17	26-17-18	Hs~MGC:BC070091.1~uORF:IOH62493	536	1178	977	891	558	1569	4578	1287	1117	469	Caspase recruitment domain-containing protein 9
B26R18C18	26-18-18	Hs~MGC:BC070091.1~uORF:IOH62493	584	1137	1087	843	3474	1541	4426	1224	1182	366	Caspase recruitment domain-containing protein 9
B26R19C01	26-1-19	Hs~Ref:NM_024770.1~uORF:IOH12447	665	443	713	426	551	695	943	634	976	316	methyltransferase like 8 (METTL8)
B26R19C02	26-2-19	Hs~Ref:NM_024770.1~uORF:IOH12447	655	425	674	411	515	576	966	591	965	321	methyltransferase like 8 (METTL8)
B26R19C03	26-3-19	Hs~MGC:BC003360.1~uORF:IOH2892	1245	865	1298	698	715	1210	4014	1041	1357	588	DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 (DDX18)
B26R19C04	26-4-19	Hs~MGC:BC003360.1~uORF:IOH2892	1274	816	1252	705	632	1256	3756	1126	1377	643	DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 (DDX18)
B26R19C05	26-5-19	Hs~Ref:NM_032016.1~uORF:IOH4681	494	486	580	378	282	826	561	426	1820	240	STARD3 N-terminal like (STARD3NL)
B26R19C06	26-6-19	Hs~Ref:NM_032016.1~uORF:IOH4681	430	596	595	384	284	882	546	480	1777	527	STARD3 N-terminal like (STARD3NL)
B26R19C07	26-7-19	Hs~Ref:NM_021107.1~uORF:IOH6073	391	416	528	297	270	420	514	397	1451	254	mitochondrial ribosomal protein S12 (MRPS12), nuclear gene encoding mitochondrial protein, transcript variant 1
B26R19C08	26-8-19	Hs~Ref:NM_021107.1~uORF:IOH6073	541	359	536	282	239	447	498	401	720	309	mitochondrial ribosomal protein S12 (MRPS12), nuclear gene encoding mitochondrial protein, transcript variant 1
B26R19C13	26-13-19	Hs~MGC:BC039826.1~uORF:IOH26225	598	486	798	338	517	558	932	437	976	380	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 (DDX6)
B26R19C14	26-14-19	Hs~MGC:BC039826.1~uORF:IOH26225	674	515	801	374	539	569	875	468	934	413	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 (DDX6)
B26R19C15	26-15-19	Hs~Ref:NM_201432.1~uORF:IOH40915	2152	1239	1024	537	1305	826	1741	734	1747	512	growth arrest-specific 7 (GAS7), transcript variant b
B26R19C16	26-16-19	Hs~Ref:NM_201432.1~uORF:IOH40915	2455	1361	1598	509	1018	838	1778	770	1768	492	growth arrest-specific 7 (GAS7), transcript variant b
B26R19C17	26-17-19	Hs~Ref:NM_030971.3~uORF:IOH40819	559	737	2213	382	420	588	1115	495	998	306	sideroflexin 3 (SFXN3)
B26R19C18	26-18-19	Hs~Ref:NM_030971.3~uORF:IOH40819	556	555	729	342	573	631	1088	476	943	216	sideroflexin 3 (SFXN3)
B26R19C19	26-19-19	Hs~Ref:NM_030570.2~uORF:IOH5529	463	396	674	361	349	533	1009	433	880	331	uroplakin 3B (UPK3B), transcript variant 1
B26R19C20	26-20-19	Hs~Ref:NM_030570.2~uORF:IOH5529	687	439	630	312	166	526	1269	422	800	174	uroplakin 3B (UPK3B), transcript variant 1
B26R19C21	26-21-19	Hs~MGC:BC008145.1~uORF:IOH3304	466	390	746	362	2701	704	1362	516	811	237	APEX nuclease (multifunctional DNA repair enzyme) 1 (APEX1)
B26R19C22	26-22-19	Hs~MGC:BC008145.1~uORF:IOH3304	446	358	600	383	348	707	786	667	748	108	APEX nuclease (multifunctional DNA repair enzyme) 1 (APEX1)
B26R20C01	26-1-20	Hs~Ref:NM_021159.2~uORF:IOH3912	248	195	315	356	261	315	597	388	521	164	RAP1, GTP-GDP dissociation stimulator 1 (RAP1GDS1), transcript variant 2
B26R20C02	26-2-20	Hs~Ref:NM_021159.2~uORF:IOH3912	320	256	343	301	189	310	573	328	590	154	RAP1, GTP-GDP dissociation stimulator 1 (RAP1GDS1), transcript variant 2
B26R20C03	26-3-20	Hs~Ref:NM_016049.1~uORF:IOH3959	329	539	523	293	341	396	497	628	700	260	chromosome 14 open reading frame 122 (C14orf122)
B26R20C04	26-4-20	Hs~Ref:NM_016049.1~uORF:IOH3959	353	608	543	284	297	437	458	640	690	187	chromosome 14 open reading frame 122 (C14orf122)
B26R20C05	26-5-20	Hs~MGC:BC015684.2~uORF:IOH14516	383	389	545	366	243	773	613	467	561	234	tripartite motif family-like 1 (TRIML1)
B26R20C06	26-6-20	Hs~MGC:BC015684.2~uORF:IOH14516	411	406	600	349	262	788	642	458	735	569	tripartite motif family-like 1 (TRIML1)
B26R20C07	26-7-20	Hs~Ref:NM_138369.1~uORF:IOH40571	756	351	660	300	478	929	878	877	1809	77	family with sequence similarity 44, member B (FAM44B)
B26R20C08	26-8-20	Hs~Ref:NM_138369.1~uORF:IOH40571	872	369	618	305	485	866	852	838	1883	296	family with sequence similarity 44, member B (FAM44B)
B26R20C09	26-9-20	Hs~Ref:NM_032017.1~uORF:IOH40615	6046	6338	6723	10982	6352	9344	8731	11007	9098	5817	serine/threonine kinase 40 (STK40)
B26R20C10	26-10-20	Hs~Ref:NM_032017.1~uORF:IOH40615	6094	6153	6463	10519	6355	9275	8763	10940	9649	6092	serine/threonine kinase 40 (STK40)
B26R20C11	26-11-20	Hs~Ref:NM_006611.1~uORF:IOH40369	1379	1135	1818	916	996	0	-3	-3	-1	264	killer cell lectin-like receptor subfamily A, member 1 (KLRA1)
B26R20C12	26-12-20	Hs~Ref:NM_006611.1~uORF:IOH40369	1575	1159	1767	905	1005	-4	18	2	0	0	killer cell lectin-like receptor subfamily A, member 1 (KLRA1)
B26R20C13	26-13-20	Hs~Ref:NM_033345.1~uORF:IOH40371	3663	2928	1749	7103	5511	3721	3954	8714	4186	2211	regulator of G-protein signaling 8 (RGS8), transcript variant 1
B26R20C14	26-14-20	Hs~Ref:NM_033345.1~uORF:IOH40371	3948	3024	1681	6759	5794	3690	4106	8796	4496	2133	regulator of G-protein signaling 8 (RGS8), transcript variant 1
B27R02C11	27-11-2	Hs~MGC:BC000942.2~uORF:IOH2983	364	295	951	1925	378	599	1419	595	709	1102	tetratricopeptide repeat domain 1 (TTC1)
B27R02C12	27-12-2	Hs~MGC:BC000942.2~uORF:IOH2983	356	326	900	1839	339	565	1241	590	721	1058	tetratricopeptide repeat domain 1 (TTC1)
B27R02C13	27-13-2	Hs~Ref:NM_003251.1~uORF:IOH22149	804	457	940	511	462	512	1124	726	1379	332	thyroid hormone responsive (SPOT14 homolog, rat) (THRSP)
B27R02C14	27-14-2	Hs~Ref:NM_003251.1~uORF:IOH22149	789	423	885	556	496	496	1110	764	1341	323	thyroid hormone responsive (SPOT14 homolog, rat) (THRSP)
B27R02C15	27-15-2	Hs~MGC:BC030237.1~uORF:IOH21507	559	507	1075	518	534	530	1482	896	1734	572	solute carrier family 22 (organic cation transporter), member 18 antisense (SLC22A18AS)
B27R02C16	27-16-2	Hs~MGC:BC030237.1~uORF:IOH21507	558	549	1074	519	454	569	1460	916	2180	703	solute carrier family 22 (organic cation transporter), member 18 antisense (SLC22A18AS)
B27R02C17	27-17-2	Hs~MGC:NM_148179.1~uORF:IOH23094	1133	622	1336	659	1197	676	2120	952	2223	475	chromosome 9 open reading frame 23 (C9orf23), transcript variant 2
B27R02C18	27-18-2	Hs~MGC:NM_148179.1~uORF:IOH23094	1040	630	1210	830	1154	668	2186	931	1883	441	chromosome 9 open reading frame 23 (C9orf23), transcript variant 2
B27R02C21	27-21-2	Hs~MGC:BC032379.1~uORF:IOH21649	1419	1291	1389	1284	982	1290	1590	1333	2772	922	transmembrane protein 18 (TMEM18)
B27R02C22	27-22-2	Hs~MGC:BC032379.1~uORF:IOH21649	1453	1247	1330	1886	969	1188	1526	1183	2755	924	transmembrane protein 18 (TMEM18)
B27R03C01	27-1-3	Hs~Ref:NM_016102.1~uORF:IOH21790	886	716	1201	666	688	868	2366	804	2321	684	tripartite motif-containing 17 (TRIM17), transcript variant 1
B27R03C02	27-2-3	Hs~Ref:NM_016102.1~uORF:IOH21790	921	736	1282	756	683	1041	2379	830	2289	685	tripartite motif-containing 17 (TRIM17), transcript variant 1
B27R03C03	27-3-3	Hs~Ref:NM_152318.1~uORF:IOH21631	1329	1429	2705	1302	4189	2862	9217	2599	2072	663	chromosome 12 open reading frame 45 (C12orf45)
B27R03C04	27-4-3	Hs~Ref:NM_152318.1~uORF:IOH21631	1309	1473	2627	1300	4369	2876	9671	2529	2095	618	chromosome 12 open reading frame 45 (C12orf45)
B27R03C05	27-5-3	Hs~Ref:NM_016009.2~uORF:IOH5827	767	2674	829	464	665	800	2153	1055	1450	113	SH3-domain GRB2-like endophilin B1 (SH3GLB1)
B27R03C06	27-6-3	Hs~Ref:NM_016009.2~uORF:IOH5827	697	2832	820	442	684	761	2066	1049	1480	203	SH3-domain GRB2-like endophilin B1 (SH3GLB1)
B27R03C07	27-7-3	Hs~MGC:BC005969.1~uORF:IOH7578	629	942	658	398	897	1928	690	543	1325	475	tubulin folding cofactor B (TBCB)
B27R03C08	27-8-3	Hs~MGC:BC005969.1~uORF:IOH7578	619	982	658	401	909	1872	727	537	1315	434	tubulin folding cofactor B (TBCB)
B27R03C09	27-9-3	Hs~Ref:NM_032403.1~uORF:IOH6540	2915	1500	4052	6108	3129	7271	4039	3209	3102	1311	protocadherin gamma subfamily C, 3 (PCDHGC3), transcript variant 3
B27R03C10	27-10-3	Hs~Ref:NM_032403.1~uORF:IOH6540	3080	1442	3846	5784	3314	7094	3746	3294	3171	1279	protocadherin gamma subfamily C, 3 (PCDHGC3), transcript variant 3
B27R03C11	27-11-3	Hs~Ref:NM_006360.1~uORF:IOH14618	433	407	586	218	336	483	657	774	1053	342	eukaryotic translation initiation factor 3, subunit M (EIF3M)
B27R03C12	27-12-3	Hs~Ref:NM_006360.1~uORF:IOH14618	422	391	591	460	359	508	735	708	1046	364	eukaryotic translation initiation factor 3, subunit M (EIF3M)
B27R03C13	27-13-3	Hs~Ref:NM_006038.1~uORF:IOH14383	6184	2886	2241	4376	7944	3715	2279	2746	6934	1481	spermatogenesis associated 2 (SPATA2)
B27R03C14	27-14-3	Hs~Ref:NM_006038.1~uORF:IOH14383	6134	2843	2143	4840	8390	3475	2404	2670	7041	1450	spermatogenesis associated 2 (SPATA2)
B27R03C15	27-15-3	Hs~MGC:BC047776.2~uORF:IOH26688	822	903	1347	6632	739	1129	1769	609	1308	512	coiled-coil domain containing 43 (CCDC43)
B27R03C16	27-16-3	Hs~MGC:BC047776.2~uORF:IOH26688	812	917	1320	6147	772	1112	1796	586	1281	441	coiled-coil domain containing 43 (CCDC43)
B27R03C17	27-17-3	Hs~Ref:NM_004236.1~uORF:IOH13834	763	607	2831	1330	808	754	824	1036	1420	497	COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis) (COPS2)
B27R03C18	27-18-3	Hs~Ref:NM_004236.1~uORF:IOH13834	766	694	2742	1312	833	745	878	1024	1368	488	COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis) (COPS2)
B27R03C19	27-19-3	Hs~MGC:BC046349.1~uORF:IOH26611	545	333	1165	389	1004	623	2008	3726	2851	91	RPA interacting protein (RPAIN)
B27R03C20	27-20-3	Hs~MGC:BC046349.1~uORF:IOH26611	577	348	1151	828	1011	592	1968	3567	2963	117	RPA interacting protein (RPAIN)
B27R03C21	27-21-3	Hs~Ref:NM_006333.1~uORF:IOH9978	1354	1355	2641	1136	1460	1412	2000	1150	3352	615	Nuclear nucleic acid-binding protein C1D
B27R03C22	27-22-3	Hs~Ref:NM_006333.1~uORF:IOH9978	1242	1376	2487	1785	1472	1354	2064	1143	3290	627	Nuclear nucleic acid-binding protein C1D
B27R04C01	27-1-4	Hs~Ref:NM_004649.1~uORF:IOH5054	792	4412	688	410	2049	899	1111	503	1545	302	chromosome 21 open reading frame 33 (C21orf33), nuclear gene encoding mitochondrial protein, transcript variant 1
B27R04C02	27-2-4	Hs~Ref:NM_004649.1~uORF:IOH5054	831	5328	658	397	2173	874	1116	471	1630	166	chromosome 21 open reading frame 33 (C21orf33), nuclear gene encoding mitochondrial protein, transcript variant 1
B27R04C03	27-3-4	Hs~MGC:BC005055.1~uORF:IOH6528	1475	1745	2492	909	1117	23095	880	2253	1964	293	forkhead box P1 (FOXP1)
B27R04C04	27-4-4	Hs~MGC:BC005055.1~uORF:IOH6528	1478	1782	2300	867	1145	22481	901	2124	2002	218	forkhead box P1 (FOXP1)
B27R04C05	27-5-4	Hs~MGC:BC007110.1~uORF:IOH7547	1651	1351	1717	1518	1369	1329	2407	1294	3446	904	Ester hydrolase C11orf54
B27R04C06	27-6-4	Hs~MGC:BC007110.1~uORF:IOH7547	1605	1291	1717	1508	1280	1348	2370	1268	3432	990	Ester hydrolase C11orf54
B27R04C07	27-7-4	Hs~MGC:NM_016544.1~uORF:IOH22234	904	1193	1665	1040	1256	2606	1683	2963	4428	478	rab and DnaJ domain containing (RBJ)
B27R04C08	27-8-4	Hs~MGC:NM_016544.1~uORF:IOH22234	950	1174	1566	986	1279	2541	1681	2699	4602	430	rab and DnaJ domain containing (RBJ)
B27R04C09	27-9-4	Hs~Ref:NM_024893.1~uORF:IOH22245	2696	705	1615	852	811	888	1152	952	2036	455	chromosome 20 open reading frame 39 (C20orf39)
B27R04C10	27-10-4	Hs~Ref:NM_024893.1~uORF:IOH22245	2805	653	1578	751	817	939	1105	706	2109	423	chromosome 20 open reading frame 39 (C20orf39)
B27R04C11	27-11-4	Hs~MGC:NM_152510.1~uORF:IOH22269	2376	2157	2137	1425	2093	3505	2571	1837	2313	542	HORMA domain containing 2 (HORMAD2)
B27R04C12	27-12-4	Hs~MGC:NM_152510.1~uORF:IOH22269	2523	2233	2041	1690	2226	3251	2594	1751	2345	562	HORMA domain containing 2 (HORMAD2)
B27R04C13	27-13-4	Hs~MGC:BC030602.2~uORF:IOH22288	657	456	731	363	515	460	764	430	1360	345	myosin ID (MYO1D)
B27R04C14	27-14-4	Hs~MGC:BC030602.2~uORF:IOH22288	545	460	662	408	488	429	731	388	1329	339	myosin ID (MYO1D)
B27R04C17	27-17-4	Hs~MGC:BC014260.2~uORF:IOH14850	2030	517	2223	1750	2630	1040	1230	1136	1561	455	poly (ADP-ribose) polymerase family, member 3 (PARP3)
B27R04C18	27-18-4	Hs~MGC:BC014260.2~uORF:IOH14850	2080	602	2150	1830	2748	1044	1224	1166	1604	373	poly (ADP-ribose) polymerase family, member 3 (PARP3)
B27R04C21	27-21-4	Hs~MGC:BC031964.1~uORF:IOH27669	2403	3076	4554	2191	1100	1734	6859	6210	2879	1101	glutamate-ammonia ligase (glutamine synthetase) (GLUL)
B27R04C22	27-22-4	Hs~MGC:BC031964.1~uORF:IOH27669	2411	3090	4438	2127	1202	1686	6713	5449	2991	1077	glutamate-ammonia ligase (glutamine synthetase) (GLUL)
B27R05C01	27-1-5	Hs~Ref:NM_000197.1~uORF:IOH21502	351	343	498	227	286	378	694	465	465	112	Testosterone 17-beta-dehydrogenase 3
B27R05C02	27-2-5	Hs~Ref:NM_000197.1~uORF:IOH21502	346	346	517	244	262	370	525	433	501	182	Testosterone 17-beta-dehydrogenase 3
B27R05C03	27-3-5	Hs~Ref:NM_006754.2~uORF:IOH39858	400	372	624	337	270	439	603	448	811	118	synaptophysin-like 1 (SYPL1), transcript variant 1
B27R05C04	27-4-5	Hs~Ref:NM_006754.2~uORF:IOH39858	397	360	666	408	278	518	696	475	719	191	synaptophysin-like 1 (SYPL1), transcript variant 1
B27R05C05	27-5-5	Hs~MGC:BC013918.1~uORF:IOH27878	903	504	830	650	489	1510	911	816	833	125	eukaryotic translation elongation factor 1 gamma (EEF1G)
B27R05C06	27-6-5	Hs~MGC:BC013918.1~uORF:IOH27878	856	508	813	595	514	1532	1018	854	826	69	eukaryotic translation elongation factor 1 gamma (EEF1G)
B27R05C07	27-7-5	Hs~Ref:NM_001007098.1~uORF:IOH39860	381	435	494	310	230	333	496	405	565	78	sterol carrier protein 2 (SCP2), transcript variant 2
B27R05C08	27-8-5	Hs~Ref:NM_001007098.1~uORF:IOH39860	372	415	497	367	230	322	538	442	516	130	sterol carrier protein 2 (SCP2), transcript variant 2
B27R05C09	27-9-5	Hs~Ref:NM_032354.1~uORF:IOH6348	1570	1493	1687	1202	1283	1069	1211	1150	3604	749	Transmembrane protein 107
B27R05C10	27-10-5	Hs~Ref:NM_032354.1~uORF:IOH6348	1577	1551	1644	1108	1323	1056	1113	1398	3607	678	Transmembrane protein 107
B27R05C11	27-11-5	Hs~MGC:NM_174896.2~uORF:IOH23052	1120	879	1230	1047	1056	1817	1240	1007	2900	594	chromosome 1 open reading frame 162 (C1orf162)
B27R05C12	27-12-5	Hs~MGC:NM_174896.2~uORF:IOH23052	1097	878	1132	1047	1074	1695	1171	1008	2911	599	chromosome 1 open reading frame 162 (C1orf162)
B27R05C13	27-13-5	Hs~Ref:NM_032735.1~uORF:IOH6549	1221	949	1501	637	1262	1243	1683	1418	2268	637	bestrophin 3 (BEST3), transcript variant 1
B27R05C14	27-14-5	Hs~Ref:NM_032735.1~uORF:IOH6549	1224	1001	1453	699	1156	1350	1585	1298	2256	611	bestrophin 3 (BEST3), transcript variant 1
B27R05C15	27-15-5	Hs~MGC:BC011554.1~uORF:IOH12718	2125	2105	3334	1190	1784	1862	2518	1516	3955	981	N-6 adenine-specific DNA methyltransferase 1 (putative) (N6AMT1)
B27R05C16	27-16-5	Hs~MGC:BC011554.1~uORF:IOH12718	2092	2003	3222	1176	1798	1726	2556	1508	4061	976	N-6 adenine-specific DNA methyltransferase 1 (putative) (N6AMT1)
B27R05C17	27-17-5	Hs~MGC:BC050401.1~uORF:IOH26650	1858	733	4324	1649	958	1127	1203	781	2383	6216	Protein FAM71D
B27R05C18	27-18-5	Hs~MGC:BC050401.1~uORF:IOH26650	1862	738	3874	1586	980	1049	1272	768	2281	6471	Protein FAM71D
B27R05C19	27-19-5	Hs~Ref:NM_005061.2~uORF:IOH26731	485	332	401	223	99	309	954	231	564	153	ribosomal protein L3-like (RPL3L)
B27R05C20	27-20-5	Hs~Ref:NM_005061.2~uORF:IOH26731	555	329	397	255	88	331	978	217	456	155	ribosomal protein L3-like (RPL3L)
B27R05C21	27-21-5	Hs~MGC:NM_173850.2~uORF:IOH26319	1064	370	819	477	440	532	643	673	825	236	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 (SERPINA12)
B27R05C22	27-22-5	Hs~MGC:NM_173850.2~uORF:IOH26319	1063	408	737	442	419	500	644	671	855	192	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 (SERPINA12)
B27R06C01	27-1-6	Hs~Ref:NM_033642.1~uORF:IOH36760	284	202	444	125	200	186	802	358	938	209	fibroblast growth factor 13 (FGF13), transcript variant 1B
B27R06C02	27-2-6	Hs~Ref:NM_033642.1~uORF:IOH36760	297	212	458	93	174	212	738	368	985	19	fibroblast growth factor 13 (FGF13), transcript variant 1B
B27R06C03	27-3-6	Hs~Ref:NM_004896.2~uORF:IOH10674	1622	1681	1396	1127	2377	1282	2251	793	1960	366	vacuolar protein sorting 26 homolog A (S. pombe) (VPS26A), transcript variant 1
B27R06C04	27-4-6	Hs~Ref:NM_004896.2~uORF:IOH10674	1251	1759	1339	1128	2576	1291	2328	741	1880	303	vacuolar protein sorting 26 homolog A (S. pombe) (VPS26A), transcript variant 1
B27R06C05	27-5-6	Hs~MGC:BC012094.1~uORF:IOH13126	832	459	656	337	321	512	848	470	683	234	RAB GTPase activating protein 1-like (RABGAP1L)
B27R06C06	27-6-6	Hs~MGC:BC012094.1~uORF:IOH13126	864	398	638	495	358	523	825	451	662	263	RAB GTPase activating protein 1-like (RABGAP1L)
B27R06C07	27-7-6	Hs~Ref:NM_019863.1~uORF:IOH10704	905	824	849	625	515	738	897	712	1392	760	coagulation factor VIII, procoagulant component (hemophilia A) (F8), transcript variant 2
B27R06C08	27-8-6	Hs~Ref:NM_019863.1~uORF:IOH10704	873	649	874	629	535	731	1152	721	1424	761	coagulation factor VIII, procoagulant component (hemophilia A) (F8), transcript variant 2
B27R06C09	27-9-6	Hs~MGC:BC014602.2~uORF:IOH10869	452	421	574	299	287	345	550	399	775	379	hypothetical protein BC014602 (LOC130951)
B27R06C10	27-10-6	Hs~MGC:BC014602.2~uORF:IOH10869	496	344	605	261	308	442	561	362	863	346	hypothetical protein BC014602 (LOC130951)
B27R06C11	27-11-6	Hs~Ref:NM_014460.2~uORF:IOH39936	3505	3255	3080	720	6387	1632	2171	1429	2058	1192	cold shock domain containing C2, RNA binding (CSDC2)
B27R06C12	27-12-6	Hs~Ref:NM_014460.2~uORF:IOH39936	3694	2776	2918	754	6570	1490	2268	1534	2086	1132	cold shock domain containing C2, RNA binding (CSDC2)
B27R06C13	27-13-6	Hs~Ref:NM_172251.1~uORF:IOH39983	925	442	861	364	327	603	1800	483	942	254	mitochondrial ribosomal protein L54 (MRPL54), nuclear gene encoding mitochondrial protein
B27R06C14	27-14-6	Hs~Ref:NM_172251.1~uORF:IOH39983	909	515	926	358	378	661	1854	554	948	253	mitochondrial ribosomal protein L54 (MRPL54), nuclear gene encoding mitochondrial protein
B27R06C15	27-15-6	Hs~Ref:NM_178833.3~uORF:IOH40887	398	347	567	381	407	459	681	880	926	236	Na+/H+ exchanger domain containing 2 (NHEDC2)
B27R06C16	27-16-6	Hs~Ref:NM_178833.3~uORF:IOH40887	399	354	518	465	366	472	747	813	959	200	Na+/H+ exchanger domain containing 2 (NHEDC2)
B27R06C17	27-17-6	Hs~Ref:NM_006388.2~uORF:IOH39963	5488	3440	3010	6810	2256	2603	4708	2123	5713	2225	HIV-1 Tat interacting protein, 60kDa (HTATIP), transcript variant 2
B27R06C18	27-18-6	Hs~Ref:NM_006388.2~uORF:IOH39963	5800	3211	2976	6346	2112	2475	4908	2177	5688	1817	HIV-1 Tat interacting protein, 60kDa (HTATIP), transcript variant 2
B27R06C19	27-19-6	Hs~MGC:NM_177553.1~uORF:IOH27961	8367	2611	2427	1713	910	1221	1281	3821	4624	1070	growth arrest-specific 2 (GAS2), transcript variant 2
B27R06C20	27-20-6	Hs~MGC:NM_177553.1~uORF:IOH27961	8364	2691	2364	1163	894	1168	1269	3453	4496	1049	growth arrest-specific 2 (GAS2), transcript variant 2
B27R06C21	27-21-6	Hs~Ref:NM_007122.1~uORF:IOH27901	1678	625	876	468	509	582	1081	583	1286	302	upstream transcription factor 1 (USF1), transcript variant 1
B27R06C22	27-22-6	Hs~Ref:NM_007122.1~uORF:IOH27901	1677	617	842	469	547	627	1097	582	1364	325	upstream transcription factor 1 (USF1), transcript variant 1
B27R07C01	27-1-7	Hs~MGC:BC041626.1~uORF:IOH27997	1150	2687	1797	1317	699	1359	1338	3655	1617	758	Dixin
B27R07C02	27-2-7	Hs~MGC:BC041626.1~uORF:IOH27997	1256	2780	1697	1313	711	1311	1274	3505	1623	649	Dixin
B27R07C03	27-3-7	Hs~Ref:NM_001633.1~uORF:IOH28015	583	424	708	394	476	474	594	372	810	255	alpha-1-microglobulin/bikunin precursor (AMBP)
B27R07C04	27-4-7	Hs~Ref:NM_001633.1~uORF:IOH28015	568	429	715	373	475	463	697	336	816	248	alpha-1-microglobulin/bikunin precursor (AMBP)
B27R07C05	27-5-7	Hs~MGC:BC047471.1~uORF:IOH26529	596	398	625	327	360	666	713	375	1004	309	dpy-19-like 2 pseudogene 4 (C. elegans) (DPY19L2P4)
B27R07C06	27-6-7	Hs~MGC:BC047471.1~uORF:IOH26529	676	408	652	537	237	663	745	442	1203	152	dpy-19-like 2 pseudogene 4 (C. elegans) (DPY19L2P4)
B27R07C07	27-7-7	Hs~MGC:BC042101.1~uORF:IOH26308	721	335	600	306	707	417	1032	407	1654	79	dual specificity phosphatase 16 (DUSP16)
B27R07C08	27-8-7	Hs~MGC:BC042101.1~uORF:IOH26308	712	340	628	317	708	464	1330	381	1474	547	dual specificity phosphatase 16 (DUSP16)
B27R07C09	27-9-7	Hs~Ref:NM_002157.1~uORF:IOH27794	1197	3181	2252	1738	1256	2915	13925	2698	2387	537	heat shock 10kDa protein 1 (chaperonin 10) (HSPE1)
B27R07C10	27-10-7	Hs~Ref:NM_002157.1~uORF:IOH27794	1222	3328	2152	1909	1371	2829	13498	2693	2511	531	heat shock 10kDa protein 1 (chaperonin 10) (HSPE1)
B27R07C11	27-11-7	Hs~MGC:BC046129.1~uORF:IOH26911	348	315	570	241	226	355	649	304	1832	536	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) (GALNT7)
B27R07C12	27-12-7	Hs~MGC:BC046129.1~uORF:IOH26911	423	296	608	318	258	480	693	349	1868	487	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) (GALNT7)
B27R07C13	27-13-7	Hs~Ref:NM_002767.2~uORF:IOH42120	1162	937	2450	910	2774	2596	1253	2052	1832	422	phosphoribosyl pyrophosphate synthetase-associated protein 2 (PRPSAP2)
B27R07C14	27-14-7	Hs~Ref:NM_002767.2~uORF:IOH42120	1256	925	2396	843	2831	2445	1353	1905	1776	421	phosphoribosyl pyrophosphate synthetase-associated protein 2 (PRPSAP2)
B27R07C17	27-17-7	Hs~Ref:NM_001008737.1~uORF:IOH42047	12532	10767	8161	19331	7967	5171	6433	8360	13919	8869	hypothetical LOC401052 (LOC401052)
B27R07C18	27-18-7	Hs~Ref:NM_001008737.1~uORF:IOH42047	12841	9309	7972	21849	7931	5143	6709	8497	14503	8381	hypothetical LOC401052 (LOC401052)
B27R07C19	27-19-7	Hs~Ref:XM_376658.1~uORF:IOH44528	1030	822	1369	1074	839	1429	1409	729	1551	548	Putative zinc-alpha-2-glycoprotein-like 1
B27R07C20	27-20-7	Hs~Ref:XM_376658.1~uORF:IOH44528	1063	855	1397	797	826	1440	1398	716	1599	488	Putative zinc-alpha-2-glycoprotein-like 1
B27R07C21	27-21-7	Hs~MGC:BC021263.1~uORF:IOH14642	2032	5361	3897	1370	1742	2746	4345	1542	3403	687	RAB24, member RAS oncogene family (RAB24)
B27R07C22	27-22-7	Hs~MGC:BC021263.1~uORF:IOH14642	2015	5292	3873	1301	1808	2725	4371	1562	3527	665	RAB24, member RAS oncogene family (RAB24)
B27R08C01	27-1-8	Hs~Ref:NM_016093.2~uORF:IOH14674	3896	2481	2891	2434	2697	2561	9524	2105	4219	1586	ribosomal protein L26-like 1 (RPL26L1)
B27R08C02	27-2-8	Hs~Ref:NM_016093.2~uORF:IOH14674	3805	2531	2856	2439	2676	2573	9654	2182	4158	1833	ribosomal protein L26-like 1 (RPL26L1)
B27R08C05	27-5-8	Hs~MGC:BC021551.1~uORF:IOH14682	1908	1018	1722	1279	1231	2773	1726	890	2735	642	nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein (NFATC2IP)
B27R08C06	27-6-8	Hs~MGC:BC021551.1~uORF:IOH14682	1646	1041	1722	1162	1250	2727	1666	868	2910	597	nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein (NFATC2IP)
B27R08C07	27-7-8	Hs~Ref:NM_054033.1~uORF:IOH4141	2974	3989	1733	3077	3467	2583	2481	6157	3530	783	FK506 binding protein 1B, 12.6 kDa (FKBP1B), transcript variant 2
B27R08C08	27-8-8	Hs~Ref:NM_054033.1~uORF:IOH4141	2628	3592	1537	3001	3607	2573	2452	5792	3488	938	FK506 binding protein 1B, 12.6 kDa (FKBP1B), transcript variant 2
B27R08C09	27-9-8	Hs~Ref:NM_006790.1~uORF:IOH7249	9324	6831	9855	12793	5512	6912	11348	9210	10931	5791	myotilin (MYOT)
B27R08C10	27-10-8	Hs~Ref:NM_006790.1~uORF:IOH7249	8353	7212	10248	12851	5164	8171	12517	9319	11862	5822	myotilin (MYOT)
B27R08C11	27-11-8	Hs~Ref:NM_145109.1~uORF:IOH21715	1201	1943	2588	2170	1983	5712	1873	1134	2372	758	mitogen-activated protein kinase kinase 3 (MAP2K3), transcript variant B
B27R08C12	27-12-8	Hs~Ref:NM_145109.1~uORF:IOH21715	995	1950	2487	2116	2010	5600	1965	1129	2577	359	mitogen-activated protein kinase kinase 3 (MAP2K3), transcript variant B
B27R08C13	27-13-8	Hs~Ref:NM_014305.1~uORF:IOH21821	2130	1071	1052	557	955	857	1740	841	2802	450	TDP-glucose 4,6-dehydratase (TGDS)
B27R08C14	27-14-8	Hs~Ref:NM_014305.1~uORF:IOH21821	2675	1039	1034	542	1001	845	1742	778	2716	205	TDP-glucose 4,6-dehydratase (TGDS)
B27R08C15	27-15-8	Hs~Ref:NM_018090.2~uORF:IOH14317	1071	1028	3132	1864	843	1600	2079	1349	1386	933	NECAP endocytosis associated 2 (NECAP2)
B27R08C16	27-16-8	Hs~Ref:NM_018090.2~uORF:IOH14317	1062	1001	3045	1785	889	1541	2112	1227	1386	927	NECAP endocytosis associated 2 (NECAP2)
B27R08C17	27-17-8	Hs~Ref:NM_003732.1~uORF:IOH14774	830	577	2025	3067	313	502	900	399	1233	570	eukaryotic translation initiation factor 4E binding protein 3 (EIF4EBP3)
B27R08C18	27-18-8	Hs~Ref:NM_003732.1~uORF:IOH14774	841	633	1932	3073	309	472	898	383	1291	286	eukaryotic translation initiation factor 4E binding protein 3 (EIF4EBP3)
B27R08C19	27-19-8	Hs~MGC:BC033856.1~uORF:IOH21797	6847	4443	7350	3349	2033	3613	13640	2486	7569	23452	La ribonucleoprotein domain family, member 1 (LARP1)
B27R08C20	27-20-8	Hs~MGC:BC033856.1~uORF:IOH21797	6555	4380	7033	3506	1934	3424	13545	2396	7380	23205	La ribonucleoprotein domain family, member 1 (LARP1)
B27R08C21	27-21-8	Hs~Ref:NM_007080.1~uORF:IOH10074	1831	1021	1375	874	4824	1045	4277	4399	2083	470	LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM6)
B27R08C22	27-22-8	Hs~Ref:NM_007080.1~uORF:IOH10074	1901	1039	1356	898	4995	1101	4379	4292	2095	422	LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM6)
B27R09C01	27-1-9	Hs~MGC:BC059363.1~uORF:IOH29178	900	936	1308	649	732	711	1602	823	1786	419	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
B27R09C02	27-2-9	Hs~MGC:BC059363.1~uORF:IOH29178	891	773	1315	674	707	821	1480	919	1814	472	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
B27R09C03	27-3-9	Hs~Ref:NM_145208.1~uORF:IOH35247	1516	2565	1896	994	1525	1382	1843	1205	2284	786	methyl-CpG binding domain protein 3-like 1 (MBD3L1)
B27R09C04	27-4-9	Hs~Ref:NM_145208.1~uORF:IOH35247	1504	2559	1986	1098	1524	1355	2204	1211	2436	816	methyl-CpG binding domain protein 3-like 1 (MBD3L1)
B27R09C05	27-5-9	Hs~Ref:NM_171830.1~uORF:IOH35405	1172	1145	2113	1242	702	1206	2409	922	1784	558	Calcium-activated potassium channel subunit beta-3
B27R09C06	27-6-9	Hs~Ref:NM_171830.1~uORF:IOH35405	1190	1197	2007	1127	737	1189	1548	853	1847	561	Calcium-activated potassium channel subunit beta-3
B27R09C07	27-7-9	Hs~Ref:NM_173859.1~uORF:IOH35196	1069	1006	1153	726	679	837	1309	679	1569	-3	breast cancer and salivary gland expression gene (RP11-49G10.8)
B27R09C08	27-8-9	Hs~Ref:NM_173859.1~uORF:IOH35196	939	962	1092	716	680	843	1146	710	1505	375	breast cancer and salivary gland expression gene (RP11-49G10.8)
B27R09C09	27-9-9	Hs~Ref:NM_004542.1~uORF:IOH14726	817	445	581	443	262	523	519	358	694	190	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa (NDUFA3)
B27R09C10	27-10-9	Hs~Ref:NM_004542.1~uORF:IOH14726	789	424	636	508	306	232	599	323	660	158	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa (NDUFA3)
B27R09C11	27-11-9	Hs~Ref:NM_144971.1~uORF:IOH10719	709	472	690	377	296	553	1375	404	772	226	hypothetical protein MGC26641 (MGC26641)
B27R09C12	27-12-9	Hs~Ref:NM_144971.1~uORF:IOH10719	815	448	635	425	384	515	1476	390	733	210	hypothetical protein MGC26641 (MGC26641)
B27R09C13	27-13-9	Hs~MGC:BC016341.1~uORF:IOH13791	392	338	587	306	364	409	575	369	980	125	interferon stimulated exonuclease gene 20kDa (ISG20)
B27R09C14	27-14-9	Hs~MGC:BC016341.1~uORF:IOH13791	389	305	570	277	288	382	552	630	979	154	interferon stimulated exonuclease gene 20kDa (ISG20)
B27R09C15	27-15-9	Hs~MGC:BC005249.1~uORF:IOH7355	1665	610	1123	625	737	750	2018	970	1190	308	estrogen receptor binding site associated, antigen, 9 (EBAG9)
B27R09C16	27-16-9	Hs~MGC:BC005249.1~uORF:IOH7355	1585	635	1041	636	762	729	2070	1024	1273	321	estrogen receptor binding site associated, antigen, 9 (EBAG9)
B27R09C17	27-17-9	Hs~Ref:NM_003357.2~uORF:IOH5625	209	126	264	255	258	227	234	210	379	1948	secretoglobin, family 1A, member 1 (uteroglobin) (SCGB1A1)
B27R09C18	27-18-9	Hs~Ref:NM_003357.2~uORF:IOH5625	223	255	303	195	242	214	195	196	365	2125	secretoglobin, family 1A, member 1 (uteroglobin) (SCGB1A1)
B27R09C19	27-19-9	Hs~MGC:BC003545.1~uORF:IOH5488	455	300	578	1866	281	579	612	352	555	2282	Transmembrane protein 165
B27R09C20	27-20-9	Hs~MGC:BC003545.1~uORF:IOH5488	473	312	519	2006	273	534	594	320	641	134	Transmembrane protein 165
B27R09C21	27-21-9	Hs~Ref:NM_024112.1~uORF:IOH5161	798	333	703	533	301	412	1195	618	1042	157	chromosome 9 open reading frame 16 (C9orf16)
B27R09C22	27-22-9	Hs~Ref:NM_024112.1~uORF:IOH5161	817	357	663	496	321	419	1175	570	887	159	chromosome 9 open reading frame 16 (C9orf16)
B27R10C01	27-1-10	Hs~MGC:BC002804.1~uORF:IOH5414	624	910	641	268	290	379	535	562	640	176	Mannosyl-oligosaccharide glucosidase
B27R10C02	27-2-10	Hs~MGC:BC002804.1~uORF:IOH5414	1296	420	574	290	326	268	516	468	615	6084	Mannosyl-oligosaccharide glucosidase
B27R10C03	27-3-10	Hs~Ref:NM_006476.4~uORF:IOH53833	1312	855	1188	716	787	1191	1354	963	2243	681	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G (ATP5L), nuclear gene encoding mitochondrial protein
B27R10C04	27-4-10	Hs~Ref:NM_006476.4~uORF:IOH53833	921	868	1276	743	736	1214	1696	1013	2355	671	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G (ATP5L), nuclear gene encoding mitochondrial protein
B27R10C05	27-5-10	Hs~MGC:BC009416.1~uORF:IOH46085	1072	652	1222	1170	728	1434	1462	741	2262	528	mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae) (MRM1)
B27R10C06	27-6-10	Hs~MGC:BC009416.1~uORF:IOH46085	1057	616	1238	1078	766	1341	1197	723	2349	536	mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae) (MRM1)
B27R10C07	27-7-10	Hs~Ref:NM_021945.4~uORF:IOH57770	983	756	1308	783	2611	916	1386	813	2036	188	chromosome 6 open reading frame 85 (C6orf85)
B27R10C08	27-8-10	Hs~Ref:NM_021945.4~uORF:IOH57770	897	1020	1226	591	2517	944	1218	787	2178	-5	chromosome 6 open reading frame 85 (C6orf85)
B27R10C09	27-9-10	Hs~MGC:NM_152329.3~uORF:IOH57797	1168	830	1273	729	686	1128	2118	1028	2369	670	Peptidylprolyl isomerase-like 5
B27R10C10	27-10-10	Hs~MGC:NM_152329.3~uORF:IOH57797	1116	827	1283	835	715	1120	2216	976	2518	876	Peptidylprolyl isomerase-like 5
B27R11C21	27-21-11	Hs~MGC:BC009294.1~uORF:IOH14145	2187	1310	1863	1473	1535	2048	5336	1303	3581	834	ribosomal protein L14 (RPL14)
B27R11C22	27-22-11	Hs~MGC:BC009294.1~uORF:IOH14145	2143	1235	1654	1290	1484	1903	5724	1407	3708	787	ribosomal protein L14 (RPL14)
B27R12C01	27-1-12	Hs~Ref:NM_000365.2~uORF:IOH7523	1157	963	4497	1172	1101	1623	4048	1642	2650	410	triosephosphate isomerase 1 (TPI1)
B27R12C02	27-2-12	Hs~Ref:NM_000365.2~uORF:IOH7523	1208	1020	4415	1172	1132	1665	4040	1673	2656	559	triosephosphate isomerase 1 (TPI1)
B27R12C05	27-5-12	Hs~Ref:NM_031268.3~uORF:IOH27406	954	689	1282	679	666	989	1326	753	1989	586	3-phosphoinositide dependent protein kinase-1 (PDPK1), transcript variant 2
B27R12C06	27-6-12	Hs~Ref:NM_031268.3~uORF:IOH27406	1765	673	1229	655	705	1197	1413	744	1891	623	3-phosphoinositide dependent protein kinase-1 (PDPK1), transcript variant 2
B27R12C07	27-7-12	Hs~MGC:BC082990.1~uORF:IOH62547	370	483	416	688	512	364	448	566	626	22	Melanoregulin
B27R12C08	27-8-12	Hs~MGC:BC082990.1~uORF:IOH62547	684	534	393	140	443	304	418	512	626	-26	Melanoregulin
B27R12C11	27-11-12	Hs~MGC:BC068458.1~uORF:IOH61629	347	1344	3071	471	893	1313	1658	4453	853	375	Ezrin
B27R12C12	27-12-12	Hs~MGC:BC068458.1~uORF:IOH61629	460	1351	2886	450	969	1257	1660	4149	861	377	Ezrin
B27R12C15	27-15-12	Hs~MGC:BC009739.1~uORF:IOH14525	97	60	229	57	73	383	272	155	278	50	homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 (HERPUD1)
B27R12C16	27-16-12	Hs~MGC:BC009739.1~uORF:IOH14525	1016	43	199	63	70	505	261	186	274	47	homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 (HERPUD1)
B27R12C17	27-17-12	Hs~Ref:NM_003168.1~uORF:IOH5411	4281	559	1005	468	408	514	600	726	683	37	suppressor of Ty 4 homolog 1 (S. cerevisiae) (SUPT4H1)
B27R12C18	27-18-12	Hs~Ref:NM_003168.1~uORF:IOH5411	4325	573	965	459	411	519	646	606	729	120	suppressor of Ty 4 homolog 1 (S. cerevisiae) (SUPT4H1)
B27R12C19	27-19-12	Hs~MGC:NM_012478.2~uORF:IOH6080	966	533	1057	590	2124	842	1326	3135	1098	354	WW domain binding protein 2 (WBP2)
B27R12C20	27-20-12	Hs~MGC:NM_012478.2~uORF:IOH6080	934	341	993	591	2198	906	1316	2814	1114	346	WW domain binding protein 2 (WBP2)
B27R12C21	27-21-12	Hs~Ref:NM_014673.2~uORF:IOH13932	639	282	310	352	135	146	869	293	507	195	tetratricopeptide repeat domain 35 (TTC35)
B27R12C22	27-22-12	Hs~Ref:NM_014673.2~uORF:IOH13932	678	265	312	330	127	126	859	335	650	92	tetratricopeptide repeat domain 35 (TTC35)
B27R13C01	27-1-13	Hs~Ref:NM_000359.1~uORF:IOH22155	1559	1274	2648	1713	1525	5466	9971	4827	3705	880	transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) (TGM1)
B27R13C02	27-2-13	Hs~Ref:NM_000359.1~uORF:IOH22155	1652	1297	2468	1599	1754	5447	7688	4730	3631	733	transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) (TGM1)
B27R13C03	27-3-13	Hs~Ref:NM_007107.2~uORF:IOH13133	1079	712	1146	768	552	1075	1139	732	1229	286	signal sequence receptor, gamma (translocon-associated protein gamma) (SSR3)
B27R13C04	27-4-13	Hs~Ref:NM_007107.2~uORF:IOH13133	1121	720	1106	740	583	1017	1173	689	1211	366	signal sequence receptor, gamma (translocon-associated protein gamma) (SSR3)
B27R13C05	27-5-13	Hs~MGC:BC002670.2~uORF:IOH5294	1692	652	1514	913	1836	1411	1353	672	3453	411	SERTA domain containing 1 (SERTAD1)
B27R13C06	27-6-13	Hs~MGC:BC002670.2~uORF:IOH5294	1713	643	1438	895	1880	1352	1440	679	3485	407	SERTA domain containing 1 (SERTAD1)
B27R13C07	27-7-13	Hs~MGC:BC012379.2~uORF:IOH10443	613	415	619	360	391	507	616	412	797	-23	chromosome 8 open reading frame 76 (C8orf76)
B27R13C08	27-8-13	Hs~MGC:BC012379.2~uORF:IOH10443	544	414	614	411	426	590	700	404	803	-23	chromosome 8 open reading frame 76 (C8orf76)
B27R13C09	27-9-13	Hs~Ref:NM_001005210.1~uORF:IOH37495	987	498	910	1151	674	751	1333	1088	1345	-17	Leucine-rich repeat-containing protein 55
B27R13C10	27-10-13	Hs~Ref:NM_001005210.1~uORF:IOH37495	960	489	887	1167	744	525	1343	1061	1403	88	Leucine-rich repeat-containing protein 55
B27R13C11	27-11-13	Hs~Ref:NM_001010899.1~uORF:IOH57359	1432	1120	2725	2452	1059	3474	3019	883	2224	2402	Putative uncharacterized protein C1orf120
B27R13C12	27-12-13	Hs~Ref:NM_001010899.1~uORF:IOH57359	1514	1089	2578	2398	1092	3351	3089	830	2161	2360	Putative uncharacterized protein C1orf120
B27R13C13	27-13-13	Hs~MGC:BC031637.1~uORF:IOH22785	7751	6832	7415	13455	6295	7186	9806	10831	6901	12759	ubiquitin-activating enzyme E1-like 2 (UBE1L2)
B27R13C14	27-14-13	Hs~MGC:BC031637.1~uORF:IOH22785	4656	6345	7805	14084	6587	7026	9665	10609	6740	12641	ubiquitin-activating enzyme E1-like 2 (UBE1L2)
B27R13C15	27-15-13	Hs~Ref:NM_006571.2~uORF:IOH21488	962	1418	1195	1395	656	1195	1286	879	2139	645	dynactin 6 (DCTN6)
B27R13C16	27-16-13	Hs~Ref:NM_006571.2~uORF:IOH21488	898	1457	1108	1075	658	1155	1309	816	2302	554	dynactin 6 (DCTN6)
B27R13C17	27-17-13	Hs~MGC:BC015742.1~uORF:IOH12050	703	564	862	548	426	825	838	610	1321	845	polymerase (DNA directed), eta (POLH)
B27R13C18	27-18-13	Hs~MGC:BC015742.1~uORF:IOH12050	677	956	800	551	435	907	957	703	1265	183	polymerase (DNA directed), eta (POLH)
B27R13C19	27-19-13	Hs~MGC:BC020885.1~uORF:IOH14357	11397	1961	3821	877	1116	21078	1281	1166	2265	490	Uncharacterized protein C12orf65
B27R13C20	27-20-13	Hs~MGC:BC020885.1~uORF:IOH14357	11569	2288	3574	856	1120	20466	1298	1126	2316	476	Uncharacterized protein C12orf65
B27R13C21	27-21-13	Hs~Ref:NM_014392.1~uORF:IOH4792	971	1797	1132	1780	918	2261	1819	749	1667	446	DNA segment on chromosome 4 (unique) 234 expressed sequence (D4S234E), transcript variant 1
B27R13C22	27-22-13	Hs~Ref:NM_014392.1~uORF:IOH4792	946	1276	1094	1876	978	2026	1759	767	1619	326	DNA segment on chromosome 4 (unique) 234 expressed sequence (D4S234E), transcript variant 1
B27R14C01	27-1-14	Hs~Ref:NM_001697.1~uORF:IOH13236	844	658	1197	658	732	906	2085	1065	1767	392	ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein) (ATP5O), nuclear gene encoding mitochondrial protein
B27R14C02	27-2-14	Hs~Ref:NM_001697.1~uORF:IOH13236	963	688	1118	656	755	879	1381	1118	1622	291	ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein) (ATP5O), nuclear gene encoding mitochondrial protein
B27R14C03	27-3-14	Hs~MGC:BC032663.1~uORF:IOH21987	408	333	601	324	378	430	579	530	1081	166	phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1)
B27R14C04	27-4-14	Hs~MGC:BC032663.1~uORF:IOH21987	356	333	605	300	468	455	628	502	1039	392	phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1)
B27R14C05	27-5-14	Hs~MGC:BC040844.1~uORF:IOH26310	2583	880	1159	755	621	3982	3618	1071	1362	680	synaptotagmin binding, cytoplasmic RNA interacting protein (SYNCRIP)
B27R14C06	27-6-14	Hs~MGC:BC040844.1~uORF:IOH26310	1292	835	1062	784	616	3564	2596	1044	1270	694	synaptotagmin binding, cytoplasmic RNA interacting protein (SYNCRIP)
B27R14C07	27-7-14	Hs~Ref:NM_144685.3~uORF:IOH22267	848	2224	633	403	481	901	901	1016	928	263	homeodomain interacting protein kinase 4 (HIPK4)
B27R14C08	27-8-14	Hs~Ref:NM_144685.3~uORF:IOH22267	950	2254	667	419	385	858	852	896	928	235	homeodomain interacting protein kinase 4 (HIPK4)
B27R14C09	27-9-14	Hs~Ref:NM_173571.1~uORF:IOH22557	639	454	1286	472	619	600	1515	1525	990	133	cancer/testis CT47 family, member 11 (CT47.11)
B27R14C10	27-10-14	Hs~Ref:NM_173571.1~uORF:IOH22557	667	455	1241	493	663	576	1471	1522	1027	171	cancer/testis CT47 family, member 11 (CT47.11)
B27R14C11	27-11-14	Hs~MGC:BC031300.1~uORF:IOH23207	609	920	1111	574	621	1516	1259	651	1992	509	chromosome 21 open reading frame 2 (C21orf2)
B27R14C12	27-12-14	Hs~MGC:BC031300.1~uORF:IOH23207	701	893	1094	589	604	1353	1273	613	2097	-22	chromosome 21 open reading frame 2 (C21orf2)
B27R14C13	27-13-14	Hs~MGC:BC033872.1~uORF:IOH21882	962	906	2298	657	448	2089	1189	619	1011	275	Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide (FCER1G)
B27R14C14	27-14-14	Hs~MGC:BC033872.1~uORF:IOH21882	905	881	2202	623	448	1852	1174	625	1043	95	Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide (FCER1G)
B27R14C15	27-15-14	Hs~Ref:NM_176869.1~uORF:IOH42167	476	490	938	442	350	791	739	1511	1305	382	Inorganic pyrophosphatase 2, mitochondrial
B27R14C16	27-16-14	Hs~Ref:NM_176869.1~uORF:IOH42167	482	531	825	476	335	882	704	1421	1373	393	Inorganic pyrophosphatase 2, mitochondrial
B27R14C17	27-17-14	Hs~Ref:NM_004231.2~uORF:IOH42330	408	357	510	253	358	738	538	429	789	432	V-type proton ATPase subunit F
B27R14C18	27-18-14	Hs~Ref:NM_004231.2~uORF:IOH42330	408	834	499	273	330	719	481	400	818	430	V-type proton ATPase subunit F
B27R14C19	27-19-14	Hs~Ref:NM_012179.2~uORF:IOH7010	682	561	1736	852	786	748	1169	1056	1569	411	F-box protein 7 (FBXO7), transcript variant 1
B27R14C20	27-20-14	Hs~Ref:NM_012179.2~uORF:IOH7010	692	571	1695	960	733	84	1078	1008	1580	428	F-box protein 7 (FBXO7), transcript variant 1
B27R14C21	27-21-14	Hs~Ref:NM_172236.1~uORF:IOH4155	575	524	804	455	452	580	983	620	907	478	protein O-fucosyltransferase 1 (POFUT1), transcript variant 2
B27R14C22	27-22-14	Hs~Ref:NM_172236.1~uORF:IOH4155	566	498	667	448	522	592	1005	615	970	265	protein O-fucosyltransferase 1 (POFUT1), transcript variant 2
B27R15C01	27-1-15	Hs~Ref:NM_173561.1~uORF:IOH27333	505	557	944	496	405	776	1765	830	971	264	UNC5C-like protein
B27R15C02	27-2-15	Hs~Ref:NM_173561.1~uORF:IOH27333	499	534	983	461	443	837	1447	1181	1003	384	UNC5C-like protein
B27R15C03	27-3-15	Hs~MGC:BC052303.1~uORF:IOH28113	2187	1965	2558	1078	1612	937	2317	1328	2011	556	Rho GTPase activating protein 4 (ARHGAP4)
B27R15C04	27-4-15	Hs~MGC:BC052303.1~uORF:IOH28113	2409	1955	2503	1054	1764	987	2626	1124	2255	508	Rho GTPase activating protein 4 (ARHGAP4)
B27R15C05	27-5-15	Hs~Ref:NM_003384.1~uORF:IOH41408	1991	1086	1643	1028	870	2187	4859	2415	2467	638	vaccinia related kinase 1 (VRK1)
B27R15C06	27-6-15	Hs~Ref:NM_003384.1~uORF:IOH41408	1711	1117	1658	1166	951	2173	4650	2311	2543	638	vaccinia related kinase 1 (VRK1)
B27R15C07	27-7-15	Hs~Ref:NM_198450.1~uORF:IOH42967	851	518	790	403	501	711	994	753	978	471	apolipoprotein O-like (APOOL)
B27R15C08	27-8-15	Hs~Ref:NM_198450.1~uORF:IOH42967	879	428	744	416	416	771	984	701	1045	518	apolipoprotein O-like (APOOL)
B27R15C09	27-9-15	Hs~Ref:NM_213566.1~uORF:IOH41232	447	951	461	331	238	565	992	1476	1841	116	DNA fragmentation factor, 45kDa, alpha polypeptide (DFFA), transcript variant 2
B27R15C10	27-10-15	Hs~Ref:NM_213566.1~uORF:IOH41232	503	892	441	356	197	550	1012	1358	1893	105	DNA fragmentation factor, 45kDa, alpha polypeptide (DFFA), transcript variant 2
B27R15C11	27-11-15	Hs~Ref:NM_182684.1~uORF:IOH44464	675	369	630	366	309	525	795	602	830	334	uroplakin 3B (UPK3B), transcript variant 2
B27R15C12	27-12-15	Hs~Ref:NM_182684.1~uORF:IOH44464	620	406	590	323	281	600	766	644	731	411	uroplakin 3B (UPK3B), transcript variant 2
B27R15C13	27-13-15	Hs~Ref:NM_002753.2~CAT:PV4563	587	332	921	910	462	1365	1467	351	778	1077	mitogen-activated protein kinase 10 (MAPK10), transcript variant 1
B27R15C14	27-14-15	Hs~Ref:NM_002753.2~CAT:PV4563	476	358	968	862	487	1355	1490	320	856	1046	mitogen-activated protein kinase 10 (MAPK10), transcript variant 1
B27R15C17	27-17-15	Hs~Ref:NM_001786.2~CAT:PV3292	945	1349	3389	937	1465	761	754	1058	1154	410	cell division cycle 2, G1 to S and G2 to M (CDC2), transcript variant 1
B27R15C18	27-18-15	Hs~Ref:NM_001786.2~CAT:PV3292	957	1234	3227	911	1464	682	705	1036	1122	406	cell division cycle 2, G1 to S and G2 to M (CDC2), transcript variant 1
B27R15C19	27-19-15	Hs~Ref:NM_018492.2~CAT:PV4130	316	735	582	388	364	1520	629	490	1499	146	PDZ binding kinase (PBK)
B27R15C20	27-20-15	Hs~Ref:NM_018492.2~CAT:PV4130	328	668	574	447	376	1486	686	481	1522	153	PDZ binding kinase (PBK)
B27R15C21	27-21-15	Hs~Ref:NM_005813.2~CAT:PV3692	702	760	849	12497	611	6973	2440	938	1713	649	Serine/threonine-protein kinase D3
B27R15C22	27-22-15	Hs~Ref:NM_005813.2~CAT:PV3692	734	721	821	11510	662	7249	2347	822	1771	365	Serine/threonine-protein kinase D3
B27R16C01	27-1-16	Hs~Ref:NM_004444.2~CAT:PV3251	107	322	834	960	41	449	214	252	381	96	ephrin receptor B4 (EPHB4)
B27R16C02	27-2-16	Hs~Ref:NM_004444.2~CAT:PV3251	102	335	725	878	48	468	218	276	377	80	ephrin receptor B4 (EPHB4)
B27R16C05	27-5-16	Hs~Ref:NM_002647.1~CAT:PV5126	595	1617	564	1326	383	532	920	1288	772	186	phosphoinositide-3-kinase, class 3 (PIK3C3)
B27R16C06	27-6-16	Hs~Ref:NM_002647.1~CAT:PV5126	582	1612	537	1678	441	526	903	1156	813	134	phosphoinositide-3-kinase, class 3 (PIK3C3)
B27R16C07	27-7-16	Hs~MGC:BC053557.1~uORF:IOH29019	788	488	435	263	108	1173	457	239	485	60	zinc finger protein 740 (ZNF740)
B27R16C08	27-8-16	Hs~MGC:BC053557.1~uORF:IOH29019	808	489	434	259	105	1329	497	240	511	187	zinc finger protein 740 (ZNF740)
B27R16C09	27-9-16	Hs~MGC:BC057837.1~uORF:IOH29210	315	1364	487	301	266	346	527	306	793	281	TR4 orphan receptor associated protein TRA16 (TRA16)
B27R16C10	27-10-16	Hs~MGC:BC057837.1~uORF:IOH29210	273	1272	436	313	144	354	512	338	794	249	TR4 orphan receptor associated protein TRA16 (TRA16)
B27R16C11	27-11-16	Hs~Ref:NM_007194.2~uORF:IOH21145	637	712	642	287	577	895	1807	384	911	284	CHK2 checkpoint homolog (S. pombe) (CHEK2), transcript variant 1
B27R16C12	27-12-16	Hs~Ref:NM_007194.2~uORF:IOH21145	642	677	625	310	608	891	1828	412	945	291	CHK2 checkpoint homolog (S. pombe) (CHEK2), transcript variant 1
B27R16C13	27-13-16	Hs~MGC:NM_199334.2~uORF:IOH6734	305	277	339	248	105	363	390	275	577	315	thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) (THRA), transcript variant 1
B27R16C14	27-14-16	Hs~MGC:NM_199334.2~uORF:IOH6734	332	142	331	261	107	330	424	295	580	410	thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) (THRA), transcript variant 1
B27R16C15	27-15-16	Hs~MGC:BC032382.1~uORF:IOH21661	1551	1705	3309	882	930	1560	2880	1324	5291	1553	similar to pleckstrin homology domain containing, family M (with RUN domain) member 1; adapter protein 162, mRNA, complete cds.
B27R16C16	27-16-16	Hs~MGC:BC032382.1~uORF:IOH21661	1513	1628	3135	831	871	1536	2951	1369	5120	1600	similar to pleckstrin homology domain containing, family M (with RUN domain) member 1; adapter protein 162, mRNA, complete cds.
B27R16C17	27-17-16	Hs~Ref:NM_002939.3~uORF:IOH25734	1065	560	720	509	364	748	1049	428	1338	371	Ribonuclease inhibitor
B27R16C18	27-18-16	Hs~Ref:NM_002939.3~uORF:IOH25734	1103	533	700	494	385	744	975	423	1308	363	Ribonuclease inhibitor
B27R16C19	27-19-16	Hs~Ref:NM_144675.1~uORF:IOH11144	466	374	495	289	387	551	723	328	819	286	GSG1-like (GSG1L), transcript variant 2, mRNA.
B27R16C20	27-20-16	Hs~Ref:NM_144675.1~uORF:IOH11144	426	390	531	444	381	428	748	354	805	294	GSG1-like (GSG1L), transcript variant 2, mRNA.
B27R16C21	27-21-16	Hs~Ref:NM_002102.2~uORF:IOH57347	576	425	633	428	510	557	778	513	1162	533	Glycophorin-E
B27R16C22	27-22-16	Hs~Ref:NM_002102.2~uORF:IOH57347	547	460	581	403	569	592	817	456	1173	574	Glycophorin-E
B27R17C01	27-1-17	Hs~MGC:BC015600.1~uORF:IOH12286	490	323	527	265	658	403	740	497	696	273	Sulfatase-modifying factor 2
B27R17C02	27-2-17	Hs~MGC:BC015600.1~uORF:IOH12286	495	318	573	280	300	438	699	475	713	191	Sulfatase-modifying factor 2
B27R17C03	27-3-17	Hs~MGC:BC012499.1~uORF:IOH11855	1048	1644	1891	1673	1411	2156	2227	1421	2971	702	NAD-dependent deacetylase sirtuin-1
B27R17C04	27-4-17	Hs~MGC:BC012499.1~uORF:IOH11855	1074	1571	1862	1889	1462	2236	2382	1504	2794	677	NAD-dependent deacetylase sirtuin-1
B27R17C05	27-5-17	Hs~MGC:BC042482.1~uORF:IOH27444	1180	970	1411	613	1938	2187	1798	1403	2713	546	potassium channel tetramerisation domain containing 7 (KCTD7)
B27R17C06	27-6-17	Hs~MGC:BC042482.1~uORF:IOH27444	1131	928	1432	624	1970	2186	1792	1329	2766	582	potassium channel tetramerisation domain containing 7 (KCTD7)
B27R17C07	27-7-17	Hs~Ref:NM_017903.2~uORF:IOH25956	926	739	1261	639	1374	1261	1376	972	2371	504	taurine upregulated gene 1 (TUG1)
B27R17C08	27-8-17	Hs~Ref:NM_017903.2~uORF:IOH25956	850	735	1255	609	1305	1266	1443	936	2485	423	taurine upregulated gene 1 (TUG1)
B27R17C09	27-9-17	Hs~Ref:NM_016466.4~uORF:IOH22083	591	542	1148	496	626	656	948	768	1366	272	ankyrin repeat domain 39 (ANKRD39)
B27R17C10	27-10-17	Hs~Ref:NM_016466.4~uORF:IOH22083	572	590	1100	566	616	643	930	747	1397	209	ankyrin repeat domain 39 (ANKRD39)
B27R17C11	27-11-17	Hs~Ref:NM_153364.1~uORF:IOH27498	1078	1083	1597	1035	951	1925	1816	1362	2634	568	family with sequence similarity 71, member C (FAM71C)
B27R17C12	27-12-17	Hs~Ref:NM_153364.1~uORF:IOH27498	1076	1083	1534	885	969	1915	1754	1382	2572	556	family with sequence similarity 71, member C (FAM71C)
B27R17C13	27-13-17	Hs~MGC:BC007519.2~uORF:IOH6177	879	739	968	814	540	916	1271	680	2067	483	OTU domain, ubiquitin aldehyde binding 1 (OTUB1)
B27R17C14	27-14-17	Hs~MGC:BC007519.2~uORF:IOH6177	791	759	1068	843	516	874	1231	649	2033	522	OTU domain, ubiquitin aldehyde binding 1 (OTUB1)
B27R17C15	27-15-17	Hs~MGC:BC033777.2~uORF:IOH21769	504	1632	33957	12505	983	8746	2009	1193	19311	10182	amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8 (ALS2CR8)
B27R17C16	27-16-17	Hs~MGC:BC033777.2~uORF:IOH21769	511	1651	33124	11888	1003	8611	2006	1208	19584	10146	amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8 (ALS2CR8)
B27R17C17	27-17-17	Hs~Ref:NM_053045.1~uORF:IOH14287	365	341	673	326	253	426	494	378	563	164	Transmembrane protein 203
B27R17C18	27-18-17	Hs~Ref:NM_053045.1~uORF:IOH14287	397	296	496	269	342	456	537	343	516	193	Transmembrane protein 203
B27R17C19	27-19-17	Hs~Ref:NM_003447.1~uORF:IOH11880	1392	619	888	603	719	721	1693	546	1425	379	zinc finger protein 165 (ZNF165)
B27R17C20	27-20-17	Hs~Ref:NM_003447.1~uORF:IOH11880	1393	606	896	653	675	751	1769	470	1361	413	zinc finger protein 165 (ZNF165)
B27R17C21	27-21-17	Hs~MGC:BC010904.1~uORF:IOH12069	980	597	879	583	527	836	2420	671	1228	474	DEP domain containing 1B (DEPDC1B)
B27R17C22	27-22-17	Hs~MGC:BC010904.1~uORF:IOH12069	1030	578	832	568	513	840	2491	582	1176	406	DEP domain containing 1B (DEPDC1B)
B27R18C01	27-1-18	Hs~MGC:BC022520.1~uORF:IOH10749	1367	1226	1817	989	3906	2126	2051	1688	3180	816	RUN domain containing 3B (RPIB9)
B27R18C02	27-2-18	Hs~MGC:BC022520.1~uORF:IOH10749	1339	1176	1763	1052	5597	2099	2346	1614	3173	710	RUN domain containing 3B (RPIB9)
B27R18C03	27-3-18	Hs~Ref:NM_031417.1~N/A	714	617	976	734	2116	732	1367	669	1881	469	MAP/microtubule affinity-regulating kinase 4
B27R18C04	27-4-18	Hs~Ref:NM_031417.1~N/A	752	646	984	635	4893	692	885	759	1840	493	MAP/microtubule affinity-regulating kinase 4
B27R18C05	27-5-18	Hs~Ref:NM_020648.3~uORF:IOH10689	740	601	1023	488	591	819	1526	687	2303	420	twisted gastrulation homolog 1 (Drosophila) (TWSG1)
B27R18C06	27-6-18	Hs~Ref:NM_020648.3~uORF:IOH10689	741	576	986	501	609	829	1504	737	2396	145	twisted gastrulation homolog 1 (Drosophila) (TWSG1)
B27R18C07	27-7-18	Hs~Ref:NM_013237.1~uORF:IOH4636	573	452	767	419	625	1299	938	610	2259	483	PRELI domain containing 1 (PRELID1)
B27R18C08	27-8-18	Hs~Ref:NM_013237.1~uORF:IOH4636	624	487	748	443	618	1265	1014	627	2230	425	PRELI domain containing 1 (PRELID1)
B27R18C09	27-9-18	Hs~MGC:BC057787.1~uORF:IOH29198	578	450	605	733	337	794	845	477	1151	470	Transmembrane protein 180
B27R18C10	27-10-18	Hs~MGC:BC057787.1~uORF:IOH29198	503	442	625	758	331	779	893	501	1114	464	Transmembrane protein 180
B27R18C11	27-11-18	Hs~Ref:NM_018108.2~uORF:IOH10013	461	446	796	803	845	304	1084	387	611	157	chromosome 14 open reading frame 130 (C14orf130), transcript variant 2
B27R18C12	27-12-18	Hs~Ref:NM_018108.2~uORF:IOH10013	457	443	766	735	933	293	1066	371	618	226	chromosome 14 open reading frame 130 (C14orf130), transcript variant 2
B27R18C13	27-13-18	Hs~Ref:NM_138773.1~uORF:IOH10147	850	449	614	449	417	572	875	512	1079	397	solute carrier family 25, member 46 (SLC25A46)
B27R18C14	27-14-18	Hs~Ref:NM_138773.1~uORF:IOH10147	628	612	622	396	475	571	972	506	1131	481	solute carrier family 25, member 46 (SLC25A46)
B27R18C15	27-15-18	Hs~MGC:BC025406.1~uORF:IOH11226	1639	1579	2334	1885	1927	4483	22429	3402	3869	1286	phosphodiesterase 4D interacting protein (myomegalin) (PDE4DIP)
B27R18C16	27-16-18	Hs~MGC:BC025406.1~uORF:IOH11226	1738	1700	2127	1812	2039	4451	21316	3388	3724	1170	phosphodiesterase 4D interacting protein (myomegalin) (PDE4DIP)
B27R18C17	27-17-18	Hs~Ref:NM_152285.1~uORF:IOH21698	1151	893	2548	1671	792	4509	3693	865	2055	778	arrestin domain containing 1 (ARRDC1)
B27R18C18	27-18-18	Hs~Ref:NM_152285.1~uORF:IOH21698	1137	789	2390	1651	801	4289	3658	793	2074	694	arrestin domain containing 1 (ARRDC1)
B27R18C19	27-19-18	Hs~MGC:BC065266.1~uORF:IOH40484	748	611	829	563	610	820	924	802	2088	436	Neutral alpha-glucosidase AB
B27R18C20	27-20-18	Hs~MGC:BC065266.1~uORF:IOH40484	697	644	826	545	613	849	1088	799	2107	498	Neutral alpha-glucosidase AB
B27R18C21	27-21-18	Hs~MGC:BC009388.1~uORF:IOH29324	492	356	601	422	449	398	1110	433	1036	111	hypothetical LOC554174, mRNA (cDNA clone MGC:16743 IMAGE:4130428), complete cds
B27R18C22	27-22-18	Hs~MGC:BC009388.1~uORF:IOH29324	498	351	563	371	523	383	1079	434	1037	96	hypothetical LOC554174, mRNA (cDNA clone MGC:16743 IMAGE:4130428), complete cds
B27R19C01	27-1-19	Hs~Ref:NM_014266.3~uORF:IOH29342	640	822	872	521	1197	678	896	891	1331	480	Hematopoietic cell signal transducer
B27R19C02	27-2-19	Hs~Ref:NM_014266.3~uORF:IOH29342	710	885	901	558	1506	679	900	923	1475	423	Hematopoietic cell signal transducer
B27R19C03	27-3-19	Hs~MGC:BC064840.1~uORF:IOH40500	7424	2981	16272	4618	3524	5414	7441	2642	5612	5365	Histone deacetylase 7
B27R19C04	27-4-19	Hs~MGC:BC064840.1~uORF:IOH40500	7649	3030	15479	4619	6571	5312	6714	2625	5864	5333	Histone deacetylase 7
B27R19C05	27-5-19	Hs~Ref:NM_014836.3~uORF:IOH27118	903	622	912	738	2395	888	1499	751	1648	2065	Rho-related BTB domain containing 1 (RHOBTB1), transcript variant 1
B27R19C06	27-6-19	Hs~Ref:NM_014836.3~uORF:IOH27118	815	646	928	712	4083	837	1510	808	1693	2093	Rho-related BTB domain containing 1 (RHOBTB1), transcript variant 1
B27R19C07	27-7-19	Hs~Ref:NM_032318.1~uORF:IOH6525	556	544	828	442	533	635	870	770	923	360	hippocampus abundant gene transcript-like 2 (HIATL2)
B27R19C08	27-8-19	Hs~Ref:NM_032318.1~uORF:IOH6525	568	590	835	398	488	671	964	568	969	341	hippocampus abundant gene transcript-like 2 (HIATL2)
B27R19C09	27-9-19	Hs~MGC:BC009197.2~uORF:IOH27820	716	1037	1112	530	541	926	1023	617	1623	414	BH3 interacting domain death agonist (BID)
B27R19C10	27-10-19	Hs~MGC:BC009197.2~uORF:IOH27820	707	1187	1082	566	534	936	976	557	1628	422	BH3 interacting domain death agonist (BID)
B27R19C11	27-11-19	Hs~MGC:BC058027.1~uORF:IOH29431	706	594	831	603	513	820	1097	714	1665	529	LysM, putative peptidoglycan-binding, domain containing 3 (LYSMD3)
B27R19C12	27-12-19	Hs~MGC:BC058027.1~uORF:IOH29431	672	618	878	535	523	816	1161	701	1604	502	LysM, putative peptidoglycan-binding, domain containing 3 (LYSMD3)
B27R19C13	27-13-19	Hs~MGC:NM_174892.1~uORF:IOH11440	1099	677	1055	391	377	709	805	429	985	180	CD300 molecule-like family member b (CD300LB)
B27R19C14	27-14-19	Hs~MGC:NM_174892.1~uORF:IOH11440	1432	702	932	358	485	664	827	441	983	289	CD300 molecule-like family member b (CD300LB)
B27R19C15	27-15-19	Hs~MGC:BC017936.1~uORF:IOH13624	560	297	627	376	396	593	2776	433	618	256	guanidinoacetate N-methyltransferase (GAMT)
B27R19C16	27-16-19	Hs~MGC:BC017936.1~uORF:IOH13624	570	347	602	367	345	574	2701	433	665	436	guanidinoacetate N-methyltransferase (GAMT)
B27R19C17	27-17-19	Hs~MGC:BC019358.1~uORF:IOH14809	583	428	674	380	315	472	670	532	880	364	Protein tweety homolog 1
B27R19C18	27-18-19	Hs~MGC:BC019358.1~uORF:IOH14809	572	396	727	410	369	465	729	482	928	410	Protein tweety homolog 1
B27R19C19	27-19-19	Hs~MGC:BC050563.1~uORF:IOH26951	2626	1186	1365	709	968	981	7124	1229	1934	580	hypothetical protein LOC202051 (LOC202051)
B27R19C20	27-20-19	Hs~MGC:BC050563.1~uORF:IOH26951	2687	1212	1300	722	918	963	7360	1219	1970	639	hypothetical protein LOC202051 (LOC202051)
B27R19C21	27-21-19	Hs~MGC:NM_178523.2~uORF:IOH21749	378	277	475	286	227	684	718	424	674	319	zinc finger protein 616 (ZNF616)
B27R19C22	27-22-19	Hs~MGC:NM_178523.2~uORF:IOH21749	371	271	451	284	216	608	640	431	750	131	zinc finger protein 616 (ZNF616)
B27R20C01	27-1-20	Hs~Ref:NM_052837.1~uORF:IOH10289	481	374	4170	346	1859	11792	904	728	1105	207	secretory carrier membrane protein 3 (SCAMP3), transcript variant 2
B27R20C02	27-2-20	Hs~Ref:NM_052837.1~uORF:IOH10289	517	343	3959	336	2176	11372	1710	599	1167	264	secretory carrier membrane protein 3 (SCAMP3), transcript variant 2
B27R20C03	27-3-20	Hs~MGC:BC022465.1~uORF:IOH11206	269	186	423	243	988	297	634	322	385	64	Lipid phosphate phosphatase-related protein type 1
B27R20C04	27-4-20	Hs~MGC:BC022465.1~uORF:IOH11206	180	625	428	220	149	288	660	320	346	39	Lipid phosphate phosphatase-related protein type 1
B27R20C05	27-5-20	Hs~MGC:BC015350.1~uORF:IOH10316	462	268	501	238	532	339	546	281	544	94	queuine tRNA-ribosyltransferase 1 (tRNA-guanine transglycosylase) (QTRT1)
B27R20C06	27-6-20	Hs~MGC:BC015350.1~uORF:IOH10316	372	278	455	255	1382	334	531	257	559	96	queuine tRNA-ribosyltransferase 1 (tRNA-guanine transglycosylase) (QTRT1)
B27R20C07	27-7-20	Hs~Ref:NM_001786.2~N/A	336	418	536	270	1230	373	503	313	1801	108	cell division cycle 2, G1 to S and G2 to M (CDC2), transcript variant 1
B27R20C08	27-8-20	Hs~Ref:NM_001786.2~N/A	338	416	539	269	380	344	563	410	1634	188	cell division cycle 2, G1 to S and G2 to M (CDC2), transcript variant 1
B27R20C09	27-9-20	Hs~MGC:BC001662.1~N/A	640	755	1367	1239	969	686	930	762	3704	437	MAP kinase-activated protein kinase 3
B27R20C10	27-10-20	Hs~MGC:BC001662.1~N/A	635	1170	1335	1274	984	720	766	771	3342	474	MAP kinase-activated protein kinase 3
B27R20C11	27-11-20	Hs~MGC:BC007852.1~N/A	759	677	1124	945	1726	642	1143	1087	2343	453	Serine/threonine-protein kinase 25
B27R20C12	27-12-20	Hs~MGC:BC007852.1~N/A	781	771	1110	852	4045	647	1173	1103	2184	444	Serine/threonine-protein kinase 25
B27R20C13	27-13-20	Hs~Ref:NM_052849.2~uORF:IOH45899	157	8	98	328	1819	166	345	226	56	78	coiled-coil domain containing 32 (CCDC32), transcript variant 2
B27R20C14	27-14-20	Hs~Ref:NM_052849.2~uORF:IOH45899	164	22	152	359	2633	149	324	197	49	247	coiled-coil domain containing 32 (CCDC32), transcript variant 2
B28R02C11	28-11-2	Hs~MGC:NM_173605.1~uORF:IOH21690	1472	3400	5203	18073	11773	2353	3010	3626	3314	1073	potassium channel regulator (KCNRG), transcript variant 1
B28R02C12	28-12-2	Hs~MGC:NM_173605.1~uORF:IOH21690	1817	3223	5035	17618	12365	2882	2994	3673	3298	1073	potassium channel regulator (KCNRG), transcript variant 1
B28R02C13	28-13-2	Hs~MGC:NM_152732.2~uORF:IOH22555	741	668	2735	1439	515	616	507	465	1510	1172	chromosome 6 open reading frame 206 (C6orf206)
B28R02C14	28-14-2	Hs~MGC:NM_152732.2~uORF:IOH22555	482	597	2677	1390	523	604	568	458	1505	1149	chromosome 6 open reading frame 206 (C6orf206)
B28R02C15	28-15-2	Hs~Ref:NM_032596.3~uORF:IOH11191	1033	2335	662	750	2578	560	940	410	4857	1272	chromosome 9 open reading frame 24 (C9orf24), transcript variant 1
B28R02C16	28-16-2	Hs~Ref:NM_032596.3~uORF:IOH11191	1034	1804	678	883	2372	625	1013	544	4925	1369	chromosome 9 open reading frame 24 (C9orf24), transcript variant 1
B28R02C17	28-17-2	Hs~Ref:NM_145027.1~uORF:IOH10936	1092	1111	604	2026	807	953	2410	1169	6154	1499	kinesin family member 6 (KIF6)
B28R02C18	28-18-2	Hs~Ref:NM_145027.1~uORF:IOH10936	920	1338	610	2250	832	924	2393	1098	5983	1496	kinesin family member 6 (KIF6)
B28R02C19	28-19-2	Hs~MGC:BC030815.1~uORF:IOH23044	3914	1364	1992	2042	1569	2648	3653	1950	4269	688	phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) (PIK3R1)
B28R02C20	28-20-2	Hs~MGC:BC030815.1~uORF:IOH23044	3590	1396	1968	1954	1538	2668	3593	1848	4201	427	phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) (PIK3R1)
B28R02C21	28-21-2	Hs~Ref:NM_014047.1~uORF:IOH11187	2046	1907	3952	1638	4057	16837	1972	1483	5856	928	chromosome 19 open reading frame 53 (C19orf53)
B28R02C22	28-22-2	Hs~Ref:NM_014047.1~uORF:IOH11187	2049	2287	3755	1855	3990	17149	1957	1434	5555	856	chromosome 19 open reading frame 53 (C19orf53)
B28R03C01	28-1-3	Hs~Ref:NM_002629.2~uORF:IOH13682	1880	1294	3327	858	1612	2072	3431	1349	5037	739	phosphoglycerate mutase 1 (brain) (PGAM1)
B28R03C02	28-2-3	Hs~Ref:NM_002629.2~uORF:IOH13682	1949	1330	3310	857	1655	2072	3321	1292	5332	747	phosphoglycerate mutase 1 (brain) (PGAM1)
B28R03C03	28-3-3	Hs~Ref:NM_004779.4~uORF:IOH27767	2538	1027	4224	1750	1900	1806	1812	1451	4472	409	CCR4-NOT transcription complex, subunit 8 (CNOT8)
B28R03C04	28-4-3	Hs~Ref:NM_004779.4~uORF:IOH27767	2508	1053	4153	2170	1945	1773	1809	1444	4465	408	CCR4-NOT transcription complex, subunit 8 (CNOT8)
B28R03C05	28-5-3	Hs~Ref:NM_015621.2~uORF:IOH43603	2395	2615	11249	1219	4840	2040	2279	5621	4130	1993	coiled-coil domain containing 69 (CCDC69)
B28R03C06	28-6-3	Hs~Ref:NM_015621.2~uORF:IOH43603	2666	2654	10783	1033	4994	1987	2214	5378	4097	1995	coiled-coil domain containing 69 (CCDC69)
B28R03C07	28-7-3	Hs~Ref:NM_181689.1~uORF:IOH41368	796	831	869	427	497	650	878	532	1250	289	Neuronatin
B28R03C08	28-8-3	Hs~Ref:NM_181689.1~uORF:IOH41368	759	813	809	388	485	690	982	541	1255	268	Neuronatin
B28R03C09	28-9-3	Hs~Ref:NM_005678.3~uORF:IOH45840	1738	1985	1869	1436	1897	7373	2694	2376	4747	942	SNRPN upstream reading frame (SNURF), transcript variant 1
B28R03C10	28-10-3	Hs~Ref:NM_005678.3~uORF:IOH45840	1655	1998	1924	1358	1929	7384	2785	2428	4668	944	SNRPN upstream reading frame (SNURF), transcript variant 1
B28R03C13	28-13-3	Hs~Ref:NM_201377.1~uORF:IOH43396	499	591	461	445	509	545	596	451	2949	383	cancer susceptibility candidate 2 (CASC2), transcript variant 2
B28R03C14	28-14-3	Hs~Ref:NM_201377.1~uORF:IOH43396	511	633	524	466	521	627	725	494	2839	390	cancer susceptibility candidate 2 (CASC2), transcript variant 2
B28R03C15	28-15-3	Hs~Ref:NM_033137.1~uORF:IOH43469	1253	1865	1530	1126	3030	2961	2550	2788	3179	447	fibroblast growth factor 1 (acidic) (FGF1), transcript variant 3
B28R03C16	28-16-3	Hs~Ref:NM_033137.1~uORF:IOH43469	1234	1865	1480	1150	3012	2922	2649	2710	3211	435	fibroblast growth factor 1 (acidic) (FGF1), transcript variant 3
B28R03C17	28-17-3	Hs~Ref:NM_004116.2~uORF:IOH43717	718	372	564	480	661	1334	652	632	1155	206	FK506 binding protein 1B, 12.6 kDa (FKBP1B), transcript variant 1
B28R03C18	28-18-3	Hs~Ref:NM_004116.2~uORF:IOH43717	626	399	520	490	650	1308	627	660	1125	223	FK506 binding protein 1B, 12.6 kDa (FKBP1B), transcript variant 1
B28R03C19	28-19-3	Hs~Ref:NM_153477.1~uORF:IOH41013	685	1568	1102	483	351	628	455	1281	946	30	ubiquitously-expressed transcript (UXT), transcript variant 1
B28R03C20	28-20-3	Hs~Ref:NM_153477.1~uORF:IOH41013	584	1736	1195	410	347	616	418	930	1008	-10	ubiquitously-expressed transcript (UXT), transcript variant 1
B28R03C21	28-21-3	Hs~Ref:NM_138412.1~uORF:IOH12664	842	700	809	466	518	658	805	651	1599	466	retinol dehydrogenase 13 (all-trans/9-cis) (RDH13)
B28R03C22	28-22-3	Hs~Ref:NM_138412.1~uORF:IOH12664	767	914	737	464	592	626	802	603	2035	496	retinol dehydrogenase 13 (all-trans/9-cis) (RDH13)
B28R04C01	28-1-4	Hs~MGC:BC001244.1~uORF:IOH3256	2469	842	1094	557	968	700	1358	879	2012	358	ankyrin repeat and SOCS box-containing 9 (ASB9)
B28R04C02	28-2-4	Hs~MGC:BC001244.1~uORF:IOH3256	992	822	1155	511	973	733	1457	819	2014	355	ankyrin repeat and SOCS box-containing 9 (ASB9)
B28R04C03	28-3-4	Hs~MGC:NM_152667.1~uORF:IOH10850	717	1797	862	282	470	1115	940	789	1688	197	N-acetylneuraminic acid phosphatase (NANP)
B28R04C04	28-4-4	Hs~MGC:NM_152667.1~uORF:IOH10850	672	1785	857	265	475	1115	934	781	1613	303	N-acetylneuraminic acid phosphatase (NANP)
B28R04C05	28-5-4	Hs~Ref:NM_031227.1~uORF:IOH3028	1215	3912	1333	2193	672	2754	1708	2065	2693	410	chromosome 20 open reading frame 18 (C20orf18), transcript variant 4
B28R04C06	28-6-4	Hs~Ref:NM_031227.1~uORF:IOH3028	1126	4013	1345	2130	677	2795	1693	1969	2646	413	chromosome 20 open reading frame 18 (C20orf18), transcript variant 4
B28R04C07	28-7-4	Hs~MGC:BC034146.1~uORF:IOH23168	65490	65486	65483	65486	65489	65489	65480	65487	65489	65492	immunoglobulin kappa variable 1-5 (IGKV1-5)
B28R04C08	28-8-4	Hs~MGC:BC034146.1~uORF:IOH23168	65489	65479	65480	65481	65483	65480	65469	65478	65484	65489	immunoglobulin kappa variable 1-5 (IGKV1-5)
B28R04C09	28-9-4	Hs~MGC:BC020619.1~uORF:IOH12054	520	1535	878	894	545	2182	1107	941	2384	398	glutathione S-transferase A3 (GSTA3)
B28R04C10	28-10-4	Hs~MGC:BC020619.1~uORF:IOH12054	517	1542	743	841	549	2019	1135	912	2292	381	glutathione S-transferase A3 (GSTA3)
B28R04C11	28-11-4	Hs~Ref:NM_004216.2~uORF:IOH14789	1148	930	1090	722	769	869	2467	818	1518	456	death effector domain containing (DEDD), transcript variant 2
B28R04C12	28-12-4	Hs~Ref:NM_004216.2~uORF:IOH14789	1190	1058	1080	811	787	938	2804	816	1533	472	death effector domain containing (DEDD), transcript variant 2
B28R04C13	28-13-4	Hs~MGC:BC010537.1~uORF:IOH10170	1794	4059	1870	2946	7960	6103	3094	3657	4304	1082	SUB1 homolog (S. cerevisiae) (SUB1)
B28R04C14	28-14-4	Hs~MGC:BC010537.1~uORF:IOH10170	1836	4200	1930	2881	8055	6163	3160	3602	4245	1170	SUB1 homolog (S. cerevisiae) (SUB1)
B28R04C17	28-17-4	Hs~Ref:NM_052987.1~N/A	129	127	256	208	156	310	360	278	381	-1	Cell division protein kinase 10
B28R04C18	28-18-4	Hs~Ref:NM_052987.1~N/A	18	127	188	183	160	307	328	310	412	41	Cell division protein kinase 10
B28R04C19	28-19-4	Hs~MGC:BC011454.1~uORF:IOH9647	5105	7303	8366	65480	3607	3129	6247	8117	5366	2057	angiomotin like 2 (AMOTL2)
B28R04C20	28-20-4	Hs~MGC:BC011454.1~uORF:IOH9647	4969	7453	8202	65463	3708	3042	6114	7696	5466	2146	angiomotin like 2 (AMOTL2)
B28R04C21	28-21-4	Hs~MGC:BC011460.1~uORF:IOH9675	1057	899	997	1038	611	1170	931	640	1584	9	chitinase 3-like 2 (CHI3L2)
B28R04C22	28-22-4	Hs~MGC:BC011460.1~uORF:IOH9675	894	795	1031	877	621	892	949	575	1475	-10	chitinase 3-like 2 (CHI3L2)
B28R05C03	28-3-5	Hs~Ref:NM_007030.1~uORF:IOH43477	2715	2766	3461	4555	3261	4430	7449	5760	20080	788	tubulin polymerization promoting protein (TPPP)
B28R05C04	28-4-5	Hs~Ref:NM_007030.1~uORF:IOH43477	2945	3010	3157	4428	3365	4220	7449	5532	19536	748	tubulin polymerization promoting protein (TPPP)
B28R05C05	28-5-5	Hs~Ref:NM_174902.2~uORF:IOH43203	481	862	957	9545	267	934	647	780	680	212	low density lipoprotein receptor class A domain containing 3 (LDLRAD3)
B28R05C06	28-6-5	Hs~Ref:NM_174902.2~uORF:IOH43203	421	841	958	9193	284	915	701	748	738	183	low density lipoprotein receptor class A domain containing 3 (LDLRAD3)
B28R05C07	28-7-5	Hs~Ref:XM_375359.1~uORF:IOH43383	425	468	1244	273	465	1014	1525	1324	1280	127	Protein BEAN
B28R05C08	28-8-5	Hs~Ref:XM_375359.1~uORF:IOH43383	345	408	1203	317	497	1015	1527	1311	1263	120	Protein BEAN
B28R05C09	28-9-5	Hs~Ref:NM_015532.2~uORF:IOH12446	4105	2349	13249	3911	12424	2244	3333	2370	5001	1404	glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A (GRINL1A), transcript variant 1
B28R05C10	28-10-5	Hs~Ref:NM_015532.2~uORF:IOH12446	4266	2478	13690	3936	12228	2243	3404	2330	5146	1387	glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A (GRINL1A), transcript variant 1
B28R05C11	28-11-5	Hs~MGC:BC029811.1~uORF:IOH22776	703	275	711	427	530	448	1297	823	772	261	hypothetical protein FLJ32658 (FLJ32658)
B28R05C12	28-12-5	Hs~MGC:BC029811.1~uORF:IOH22776	690	301	706	360	513	495	1287	844	782	244	hypothetical protein FLJ32658 (FLJ32658)
B28R05C13	28-13-5	Hs~Ref:NM_004302.3~uORF:IOH4418	600	449	758	465	359	584	1061	616	720	256	activin A receptor, type IB (ACVR1B), transcript variant 1
B28R05C14	28-14-5	Hs~Ref:NM_004302.3~uORF:IOH4418	646	755	805	442	343	593	1051	639	721	283	activin A receptor, type IB (ACVR1B), transcript variant 1
B28R05C15	28-15-5	Hs~MGC:BC034145.1~uORF:IOH23165	424	778	723	490	384	447	664	512	659	275	transmembrane 4 L six family member 1 (TM4SF1)
B28R05C16	28-16-5	Hs~MGC:BC034145.1~uORF:IOH23165	556	424	695	458	329	419	634	554	727	249	transmembrane 4 L six family member 1 (TM4SF1)
B28R05C17	28-17-5	Hs~Ref:NM_031282.1~uORF:IOH35897	257	199	696	312	-2	323	1350	658	536	96	Fc receptor-like 4 (FCRL4)
B28R05C18	28-18-5	Hs~Ref:NM_031282.1~uORF:IOH35897	248	195	693	266	-1	351	1320	653	546	103	Fc receptor-like 4 (FCRL4)
B28R05C19	28-19-5	Hs~Ref:NM_145872.1~uORF:IOH35588	292	341	706	319	310	426	576	368	577	123	ankyrin repeat and SOCS box-containing 4 (ASB4), transcript variant 2
B28R05C20	28-20-5	Hs~Ref:NM_145872.1~uORF:IOH35588	44	399	620	293	302	422	545	497	518	121	ankyrin repeat and SOCS box-containing 4 (ASB4), transcript variant 2
B28R05C21	28-21-5	Hs~Ref:NM_004262.1~uORF:IOH35723	869	267	738	328	243	649	1269	1052	519	145	transmembrane protease, serine 11D (TMPRSS11D)
B28R05C22	28-22-5	Hs~Ref:NM_004262.1~uORF:IOH35723	354	250	822	334	271	373	1315	878	474	16	transmembrane protease, serine 11D (TMPRSS11D)
B28R06C01	28-1-6	Hs~Ref:NM_203286.1~uORF:IOH35592	1811	471	534	74	169	392	670	379	638	263	poliovirus receptor-related 1 (herpesvirus entry mediator C) (PVRL1), transcript variant 3
B28R06C02	28-2-6	Hs~Ref:NM_203286.1~uORF:IOH35592	1750	258	540	906	178	396	658	620	691	244	poliovirus receptor-related 1 (herpesvirus entry mediator C) (PVRL1), transcript variant 3
B28R06C03	28-3-6	Hs~Ref:NM_003332.1~uORF:IOH10176	314	418	954	265	440	500	841	461	881	224	TYRO protein tyrosine kinase binding protein (TYROBP), transcript variant 1
B28R06C04	28-4-6	Hs~Ref:NM_003332.1~uORF:IOH10176	490	541	951	275	465	499	874	433	904	162	TYRO protein tyrosine kinase binding protein (TYROBP), transcript variant 1
B28R06C07	28-7-6	Hs~Ref:NM_001938.1~uORF:IOH5390	372	50	670	42	215	114	212	168	187	167	Protein Dr1
B28R06C08	28-8-6	Hs~Ref:NM_001938.1~uORF:IOH5390	146	46	643	123	202	178	198	162	296	45	Protein Dr1
B28R06C11	28-11-6	Hs~Ref:NM_024331.1~uORF:IOH3905	796	956	946	2353	1883	721	979	827	2723	349	chromosome 20 open reading frame 121 (C20orf121), transcript variant 1
B28R06C12	28-12-6	Hs~Ref:NM_024331.1~uORF:IOH3905	783	924	977	2209	1897	712	972	868	2532	341	chromosome 20 open reading frame 121 (C20orf121), transcript variant 1
B28R06C13	28-13-6	Hs~Ref:NM_144716.1~uORF:IOH13356	2301	2691	64712	21399	32900	4228	4410	10600	7095	1051	coiled-coil domain containing 12 (CCDC12)
B28R06C14	28-14-6	Hs~Ref:NM_144716.1~uORF:IOH13356	2306	2614	62153	20942	32642	4189	4538	10510	6903	1085	coiled-coil domain containing 12 (CCDC12)
B28R06C15	28-15-6	Hs~Ref:NM_144646.1~uORF:IOH12964	1588	2212	953	1048	744	856	1509	705	2293	457	immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides (IGJ)
B28R06C16	28-16-6	Hs~Ref:NM_144646.1~uORF:IOH12964	1501	831	923	958	758	881	1479	756	2111	442	immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides (IGJ)
B28R06C17	28-17-6	Hs~MGC:BC017054.1~uORF:IOH10366	3809	2800	2817	2425	3282	3593	3517	4174	4699	1847	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase (MTHFD2)
B28R06C18	28-18-6	Hs~MGC:BC017054.1~uORF:IOH10366	3634	3112	2825	2347	3154	3507	3410	4095	4595	1864	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase (MTHFD2)
B28R06C19	28-19-6	Hs~MGC:BC098400.1~uORF:IOH62654	1341	507	743	1248	1071	1228	959	1025	1912	154	C-terminal-binding protein 1
B28R06C20	28-20-6	Hs~MGC:BC098400.1~uORF:IOH62654	1254	483	732	1184	1071	1178	898	973	1970	211	C-terminal-binding protein 1
B28R06C21	28-21-6	Hs~MGC:BC092474.1~uORF:IOH62679	3549	4989	65462	7184	4184	5917	8703	6294	18270	1743	Proline-rich protein 16
B28R06C22	28-22-6	Hs~MGC:BC092474.1~uORF:IOH62679	3970	4922	65442	6662	4307	6643	8485	6320	19186	1733	Proline-rich protein 16
B28R07C01	28-1-7	Hs~MGC:BC096303.1~uORF:IOH63248	1228	1385	5285	3510	2268	3298	2321	2445	5360	878	Ribosomal protein S6 kinase alpha-3
B28R07C02	28-2-7	Hs~MGC:BC096303.1~uORF:IOH63248	1169	1359	4934	3132	2224	3108	2330	2226	5302	876	Ribosomal protein S6 kinase alpha-3
B28R07C05	28-5-7	Hs~Ref:NM_004664.2~uORF:IOH42498	419	240	810	3395	257	497	784	318	1355	215	lin-7 homolog A (C. elegans) (LIN7A)
B28R07C06	28-6-7	Hs~Ref:NM_004664.2~uORF:IOH42498	477	206	814	817	247	478	828	295	1324	242	lin-7 homolog A (C. elegans) (LIN7A)
B28R07C09	28-9-7	Hs~Ref:NM_021637.1~uORF:IOH41185	841	753	1946	854	614	800	1423	1344	2707	292	transmembrane protein 35 (TMEM35)
B28R07C10	28-10-7	Hs~Ref:NM_021637.1~uORF:IOH41185	874	827	1940	830	635	798	1497	1380	2774	263	transmembrane protein 35 (TMEM35)
B28R07C11	28-11-7	Hs~Ref:NM_002938.2~uORF:IOH41414	583	610	733	422	313	679	1169	326	1894	263	ring finger protein 4 (RNF4)
B28R07C12	28-12-7	Hs~Ref:NM_002938.2~uORF:IOH41414	602	565	826	444	286	685	1110	294	1792	234	ring finger protein 4 (RNF4)
B28R07C15	28-15-7	Hs~MGC:BC024013.2~uORF:IOH10901	62	2314	186	30	33	418	89	228	620	31	HCG3 gene (HCG3)
B28R07C16	28-16-7	Hs~MGC:BC024013.2~uORF:IOH10901	70	189	208	107	170	477	103	79	628	53	HCG3 gene (HCG3)
B28R07C17	28-17-7	Hs~MGC:BC022958.1~uORF:IOH11908	414	487	642	242	307	766	1042	382	2233	201	chromosome 9 open reading frame 97 (C9orf97)
B28R07C18	28-18-7	Hs~MGC:BC022958.1~uORF:IOH11908	98	466	628	200	304	742	936	370	2083	157	chromosome 9 open reading frame 97 (C9orf97)
B28R07C19	28-19-7	Hs~MGC:BC033775.1~uORF:IOH21766	97	861	56	20	197	344	677	120	447	127	coiled-coil-helix-coiled-coil-helix domain containing 4 (CHCHD4)
B28R07C20	28-20-7	Hs~MGC:BC033775.1~uORF:IOH21766	97	897	407	26	195	307	710	55	482	-5	coiled-coil-helix-coiled-coil-helix domain containing 4 (CHCHD4)
B28R07C21	28-21-7	Hs~Ref:NM_139022.2~uORF:IOH59366	735	796	887	624	574	840	865	1356	1259	6	tetraspanin 32 (TSPAN32), transcript variant 1
B28R07C22	28-22-7	Hs~Ref:NM_139022.2~uORF:IOH59366	721	761	1002	715	522	876	810	1229	1155	7	tetraspanin 32 (TSPAN32), transcript variant 1
B28R08C01	28-1-8	Hs~Ref:NM_001002269.1~uORF:IOH59989	3144	3629	2166	2226	2004	4891	5020	4864	6214	1060	Exosome complex exonuclease RRP40
B28R08C02	28-2-8	Hs~Ref:NM_001002269.1~uORF:IOH59989	3086	3803	2066	2263	2061	4884	5050	4853	6032	1129	Exosome complex exonuclease RRP40
B28R08C07	28-7-8	Hs~Ref:NM_005371.2~uORF:IOH4172	8825	11754	4621	4280	3342	5995	10037	5343	9258	7315	methyltransferase like 1 (METTL1), transcript variant 1
B28R08C08	28-8-8	Hs~Ref:NM_005371.2~uORF:IOH4172	8212	11565	4458	3963	3119	6166	10350	5241	9056	7319	methyltransferase like 1 (METTL1), transcript variant 1
B28R08C09	28-9-8	Hs~MGC:BC017025.1~uORF:IOH9960	606	650	620	634	486	513	797	548	1074	351	parathymosin (PTMS)
B28R08C10	28-10-8	Hs~MGC:BC017025.1~uORF:IOH9960	578	678	640	603	540	474	833	579	1054	313	parathymosin (PTMS)
B28R08C11	28-11-8	Hs~Ref:NM_002810.1~uORF:IOH3462	779	381	980	542	881	322	2666	804	4312	114	proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 (PSMD4)
B28R08C12	28-12-8	Hs~Ref:NM_002810.1~uORF:IOH3462	792	516	928	531	871	330	2635	791	4275	275	proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 (PSMD4)
B28R08C13	28-13-8	Hs~MGC:BC004122.1~uORF:IOH22910	276	2995	403	2474	1253	1934	805	1134	1940	241	Pre-mRNA-splicing factor ISY1 homolog
B28R08C14	28-14-8	Hs~MGC:BC004122.1~uORF:IOH22910	277	2859	400	2427	1239	1964	811	1113	2028	207	Pre-mRNA-splicing factor ISY1 homolog
B28R08C15	28-15-8	Hs~MGC:NM_153645.1~uORF:IOH11663	3089	2099	1388	5243	2908	1569	19895	4780	4199	4646	nucleoporin 50kDa (NUP50), transcript variant 3
B28R08C16	28-16-8	Hs~MGC:NM_153645.1~uORF:IOH11663	3087	2040	1483	5475	2975	1711	20267	4510	4017	4798	nucleoporin 50kDa (NUP50), transcript variant 3
B28R08C17	28-17-8	Hs~Ref:NM_002621.1~uORF:IOH12225	716	660	776	467	487	613	1145	589	1336	378	complement factor properdin (CFP)
B28R08C18	28-18-8	Hs~Ref:NM_002621.1~uORF:IOH12225	816	731	871	461	514	611	1093	552	1198	397	complement factor properdin (CFP)
B28R08C19	28-19-8	Hs~MGC:BC012303.1~uORF:IOH11142	804	617	898	461	535	666	1043	735	1677	475	PDZK1 interacting protein 1 (PDZK1IP1)
B28R08C20	28-20-8	Hs~MGC:BC012303.1~uORF:IOH11142	788	667	859	517	556	681	1105	703	1806	558	PDZK1 interacting protein 1 (PDZK1IP1)
B28R08C21	28-21-8	Hs~Ref:NM_024561.1~uORF:IOH11647	2552	1835	1022	677	624	914	1654	803	1853	501	NMDA receptor regulated 1-like (NARG1L), transcript variant 1
B28R08C22	28-22-8	Hs~Ref:NM_024561.1~uORF:IOH11647	1148	2084	1063	656	629	899	1553	709	2577	86	NMDA receptor regulated 1-like (NARG1L), transcript variant 1
B28R09C01	28-1-9	Hs~MGC:BC018918.2~uORF:IOH40607	1384	596	906	453	399	924	665	467	899	571	hypothetical protein FLJ20699 (FLJ20699)
B28R09C02	28-2-9	Hs~MGC:BC018918.2~uORF:IOH40607	1344	678	911	451	363	820	613	473	919	355	hypothetical protein FLJ20699 (FLJ20699)
B28R09C03	28-3-9	Hs~Ref:NM_021010.1~uORF:IOH40358	702	511	644	470	355	512	776	532	696	206	Defensin-5
B28R09C04	28-4-9	Hs~Ref:NM_021010.1~uORF:IOH40358	809	522	681	480	374	537	812	608	721	195	Defensin-5
B28R09C05	28-5-9	Hs~MGC:BC065525.1~uORF:IOH40477	4963	982	1639	24472	887	4389	1636	1456	1480	512	adducin 2 (beta) (ADD2)
B28R09C06	28-6-9	Hs~MGC:BC065525.1~uORF:IOH40477	5054	1113	1586	23660	869	4372	1608	1387	1367	498	adducin 2 (beta) (ADD2)
B28R09C07	28-7-9	Hs~Ref:NM_007190.2~uORF:IOH40514	2834	500	827	965	210	445	1139	538	732	410	SEC23 interacting protein (SEC23IP)
B28R09C08	28-8-9	Hs~Ref:NM_007190.2~uORF:IOH40514	765	335	889	924	218	523	1026	531	712	323	SEC23 interacting protein (SEC23IP)
B28R09C09	28-9-9	Hs~Ref:NM_005572.1~uORF:IOH3580	1099	1559	1239	1613	664	1402	2260	1369	3192	510	lamin A/C (LMNA), transcript variant 2
B28R09C10	28-10-9	Hs~Ref:NM_005572.1~uORF:IOH3580	1095	1467	1278	1525	696	1341	2233	1303	3315	497	lamin A/C (LMNA), transcript variant 2
B28R09C11	28-11-9	Hs~Ref:NM_002140.2~uORF:IOH3670	677	6712	794	699	358	574	1320	547	1097	361	heterogeneous nuclear ribonucleoprotein K (HNRPK), transcript variant 1
B28R09C12	28-12-9	Hs~Ref:NM_002140.2~uORF:IOH3670	681	6696	841	680	399	477	1273	533	1092	335	heterogeneous nuclear ribonucleoprotein K (HNRPK), transcript variant 1
B28R09C13	28-13-9	Hs~Ref:NM_001970.2~uORF:IOH3811	360	492	328	238	290	611	429	317	600	238	eukaryotic translation initiation factor 5A (EIF5A)
B28R09C14	28-14-9	Hs~Ref:NM_001970.2~uORF:IOH3811	418	460	384	254	303	581	422	325	634	274	eukaryotic translation initiation factor 5A (EIF5A)
B28R09C15	28-15-9	Hs~MGC:BC047393.1~uORF:IOH26537	1011	733	1056	790	662	1342	1422	812	2041	326	ring finger and CHY zinc finger domain containing 1 (RCHY1)
B28R09C16	28-16-9	Hs~MGC:BC047393.1~uORF:IOH26537	990	665	1015	807	704	1271	1417	796	1998	307	ring finger and CHY zinc finger domain containing 1 (RCHY1)
B28R09C17	28-17-9	Hs~MGC:BC020658.1~uORF:IOH12831	1207	955	1036	780	807	1173	1765	814	2184	605	Transmembrane protein 40
B28R09C18	28-18-9	Hs~MGC:BC020658.1~uORF:IOH12831	1076	959	1041	726	847	1210	1942	854	2281	623	Transmembrane protein 40
B28R09C19	28-19-9	Hs~MGC:NM_005702.1~uORF:IOH13346	-7	-6	298	911	1583	1398	2963	1122	2874	740	Era G-protein-like 1 (E. coli) (ERAL1)
B28R09C20	28-20-9	Hs~MGC:NM_005702.1~uORF:IOH13346	-1	-13	182	912	1565	1397	3126	1110	2872	750	Era G-protein-like 1 (E. coli) (ERAL1)
B28R09C21	28-21-9	Hs~MGC:BC010993.2~uORF:IOH12098	1200	2714	1195	568	771	1322	2282	1163	2421	365	Calcium-binding protein 39-like
B28R09C22	28-22-9	Hs~MGC:BC010993.2~uORF:IOH12098	749	2696	1149	598	803	1283	2342	1055	2470	283	Calcium-binding protein 39-like
B28R10C01	28-1-10	Hs~Ref:NM_004929.2~uORF:IOH1903	699	542	674	339	601	814	496	472	998	849	calbindin 1, 28kDa (CALB1)
B28R10C02	28-2-10	Hs~Ref:NM_004929.2~uORF:IOH1903	694	584	700	326	612	808	502	463	1030	965	calbindin 1, 28kDa (CALB1)
B28R10C03	28-3-10	Hs~MGC:BC059411.1~uORF:IOH29280	730	578	589	339	586	473	670	452	795	692	chromosome 11 open reading frame 65 (C11orf65)
B28R10C04	28-4-10	Hs~MGC:BC059411.1~uORF:IOH29280	754	644	605	398	591	439	705	426	719	829	chromosome 11 open reading frame 65 (C11orf65)
B28R10C05	28-5-10	Hs~MGC:BC059393.1~uORF:IOH29208	669	373	478	400	228	425	649	413	629	474	oligophrenin 1 (OPHN1)
B28R10C06	28-6-10	Hs~MGC:BC059393.1~uORF:IOH29208	570	316	470	264	230	491	693	467	896	423	oligophrenin 1 (OPHN1)
B28R10C07	28-7-10	Hs~MGC:BC053733.1~uORF:IOH28787	844	677	783	437	530	1819	953	568	1655	241	chromosome 2 open reading frame 34 (C2orf34)
B28R10C08	28-8-10	Hs~MGC:BC053733.1~uORF:IOH28787	767	659	740	463	547	1726	963	548	1740	308	chromosome 2 open reading frame 34 (C2orf34)
B28R10C09	28-9-10	Hs~MGC:BC041638.1~uORF:IOH28004	867	837	899	893	499	990	1054	2945	1547	385	squamous cell carcinoma antigen recognized by T cells 3 (SART3)
B28R10C10	28-10-10	Hs~MGC:BC041638.1~uORF:IOH28004	879	847	906	855	483	949	1044	2924	1580	399	squamous cell carcinoma antigen recognized by T cells 3 (SART3)
B28R12C01	28-1-12	Hs~MGC:BC044593.1~uORF:IOH26878	1853	669	1255	696	550	1287	3864	582	1383	175	Bardet-Biedl syndrome 5 (BBS5)
B28R12C02	28-2-12	Hs~MGC:BC044593.1~uORF:IOH26878	1805	670	1282	640	523	1336	3780	626	1426	201	Bardet-Biedl syndrome 5 (BBS5)
B28R12C03	28-3-12	Hs~MGC:BC050375.1~uORF:IOH26654	1191	76	286	303	804	389	485	731	850	68	Kv channel interacting protein 1 (KCNIP1)
B28R12C04	28-4-12	Hs~MGC:BC050375.1~uORF:IOH26654	1603	367	211	3358	798	353	482	699	832	61	Kv channel interacting protein 1 (KCNIP1)
B28R12C07	28-7-12	Hs~MGC:BC011761.2~uORF:IOH13919	803	606	582	384	352	543	928	551	1132	290	ilvB (bacterial acetolactate synthase)-like (ILVBL)
B28R12C08	28-8-12	Hs~MGC:BC011761.2~uORF:IOH13919	558	719	564	369	329	550	896	582	982	285	ilvB (bacterial acetolactate synthase)-like (ILVBL)
B28R12C09	28-9-12	Hs~Ref:NM_004240.2~uORF:IOH12722	705	705	776	456	617	817	866	712	1680	433	thyroid hormone receptor interactor 10 (TRIP10)
B28R12C10	28-10-12	Hs~Ref:NM_004240.2~uORF:IOH12722	732	701	798	455	667	761	910	643	1703	391	thyroid hormone receptor interactor 10 (TRIP10)
B28R12C11	28-11-12	Hs~Ref:NM_016451.3~uORF:IOH27122	704	826	719	484	454	729	961	675	1642	562	coatomer protein complex, subunit beta 1 (COPB1)
B28R12C12	28-12-12	Hs~Ref:NM_016451.3~uORF:IOH27122	736	754	717	490	527	684	1020	659	1585	437	coatomer protein complex, subunit beta 1 (COPB1)
B28R12C13	28-13-12	Hs~Ref:NM_153332.2~uORF:IOH27323	-3	152	-4	-3	-1	1	3	1	0	131	three prime histone mRNA exonuclease 1 (THEX1)
B28R12C14	28-14-12	Hs~Ref:NM_153332.2~uORF:IOH27323	-2	-4	-3	-1	-2	1	-1	3	-1	178	three prime histone mRNA exonuclease 1 (THEX1)
B28R12C15	28-15-12	Hs~MGC:BC101007.1~uORF:IOH63458	827	523	694	368	364	673	1277	488	862	292	POTE ankyrin domain family, member B, mRNA (cDNA clone MGC:119373 IMAGE:40006489), complete cds
B28R12C16	28-16-12	Hs~MGC:BC101007.1~uORF:IOH63458	864	2515	700	394	431	667	1348	430	917	275	POTE ankyrin domain family, member B, mRNA (cDNA clone MGC:119373 IMAGE:40006489), complete cds
B28R12C17	28-17-12	Hs~MGC:BC096336.1~uORF:IOH63244	458	204	501	369	121	1250	580	386	525	147	Insulin-degrading enzyme
B28R12C18	28-18-12	Hs~MGC:BC096336.1~uORF:IOH63244	299	386	527	412	260	493	516	331	627	136	Insulin-degrading enzyme
B28R12C19	28-19-12	Hs~MGC:BC024241.2~uORF:IOH11711	490	1183	788	1679	559	871	522	607	1186	228	Cysteine dioxygenase type 1
B28R12C20	28-20-12	Hs~MGC:BC024241.2~uORF:IOH11711	682	1234	804	1617	712	849	526	582	1146	219	Cysteine dioxygenase type 1
B28R12C21	28-21-12	Hs~MGC:BC103921.1~uORF:IOH63385	682	174	432	214	92	269	451	328	362	117	Protein Wnt-3a
B28R12C22	28-22-12	Hs~MGC:BC103921.1~uORF:IOH63385	117	205	494	234	86	291	406	264	337	99	Protein Wnt-3a
B28R13C01	28-1-13	Hs~Ref:NM_019592.5~uORF:IOH42829	739	2183	1078	1072	733	1549	1391	756	2908	-1	ring finger protein 20 (RNF20)
B28R13C02	28-2-13	Hs~Ref:NM_019592.5~uORF:IOH42829	713	2269	1054	1016	712	1546	1418	737	2903	211	ring finger protein 20 (RNF20)
B28R13C03	28-3-13	Hs~Ref:NM_139181.1~uORF:IOH42674	821	1472	815	950	682	993	1684	668	2079	141	centaurin, delta 2 (CENTD2), transcript variant 1
B28R13C04	28-4-13	Hs~Ref:NM_139181.1~uORF:IOH42674	892	1349	823	1668	692	977	1677	688	2095	185	centaurin, delta 2 (CENTD2), transcript variant 1
B28R13C05	28-5-13	Hs~Ref:NM_033360.2~uORF:IOH44611	679	476	678	1761	382	669	893	-1	951	137	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant a
B28R13C06	28-6-13	Hs~Ref:NM_033360.2~uORF:IOH44611	657	582	685	394	354	704	936	72	870	91	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant a
B28R13C07	28-7-13	Hs~Ref:NM_018052.3~uORF:IOH41847	1046	734	1128	586	603	712	1674	612	1564	249	Vac14 homolog (S. cerevisiae) (VAC14)
B28R13C08	28-8-13	Hs~Ref:NM_018052.3~uORF:IOH41847	1003	781	1088	577	746	676	1661	725	1555	196	Vac14 homolog (S. cerevisiae) (VAC14)
B28R13C09	28-9-13	Hs~Ref:NM_002688.2~uORF:IOH12490	624	969	1530	317	502	11320	1733	519	1169	229	septin 5 (SEPT5)
B28R13C10	28-10-13	Hs~Ref:NM_002688.2~uORF:IOH12490	635	975	1470	347	444	10710	1734	472	1116	45	septin 5 (SEPT5)
B28R13C11	28-11-13	Hs~MGC:BC047620.1~uORF:IOH28815	715	777	570	393	287	504	1438	791	672	247	guanylate cyclase 1, soluble, beta 3 (GUCY1B3)
B28R13C12	28-12-13	Hs~MGC:BC047620.1~uORF:IOH28815	733	767	630	400	313	511	1378	771	685	174	guanylate cyclase 1, soluble, beta 3 (GUCY1B3)
B28R13C13	28-13-13	Hs~MGC:BC064945.1~uORF:IOH39953	2231	762	1422	1473	767	906	4436	638	1896	285	SCY1-like 1 binding protein 1 (SCYL1BP1)
B28R13C14	28-14-13	Hs~MGC:BC064945.1~uORF:IOH39953	2336	780	1392	1469	743	934	4507	693	1883	224	SCY1-like 1 binding protein 1 (SCYL1BP1)
B28R13C15	28-15-13	Hs~Ref:NM_172213.1~uORF:IOH35341	956	1919	584	508	477	774	1107	614	1177	339	CD8b molecule (CD8B), transcript variant 2
B28R13C16	28-16-13	Hs~Ref:NM_172213.1~uORF:IOH35341	1042	672	609	514	453	720	1137	650	1195	133	CD8b molecule (CD8B), transcript variant 2
B28R13C17	28-17-13	Hs~Ref:NM_006272.1~uORF:IOH4935	3882	1364	2979	4761	2800	3113	10708	1877	6122	666	S100 calcium binding protein B (S100B)
B28R13C18	28-18-13	Hs~Ref:NM_006272.1~uORF:IOH4935	3767	1498	3055	4548	2833	3049	10624	1853	6067	561	S100 calcium binding protein B (S100B)
B28R13C19	28-19-13	Hs~MGC:BC010369.1~uORF:IOH13610	620	619	851	592	867	667	893	628	1223	256	E3 ubiquitin-protein ligase Arkadia
B28R13C20	28-20-13	Hs~MGC:BC010369.1~uORF:IOH13610	635	671	869	529	897	660	844	519	1378	545	E3 ubiquitin-protein ligase Arkadia
B28R13C21	28-21-13	Hs~Ref:NM_138801.1~uORF:IOH10118	448	308	588	266	201	469	642	352	628	479	galactose mutarotase (aldose 1-epimerase) (GALM)
B28R13C22	28-22-13	Hs~Ref:NM_138801.1~uORF:IOH10118	501	294	597	275	290	400	562	346	146	111	galactose mutarotase (aldose 1-epimerase) (GALM)
B28R14C01	28-1-14	Hs~MGC:BC029520.1~uORF:IOH22574	283	385	384	242	136	396	533	254	669	179	WD repeat, SAM and U-box domain-containing protein 1
B28R14C02	28-2-14	Hs~MGC:BC029520.1~uORF:IOH22574	452	403	379	248	224	470	610	284	488	125	WD repeat, SAM and U-box domain-containing protein 1
B28R14C03	28-3-14	Hs~Ref:NM_138316.2~uORF:IOH59336	1806	791	1155	709	570	903	2373	2653	1313	185	Pantothenate kinase 1
B28R14C04	28-4-14	Hs~Ref:NM_138316.2~uORF:IOH59336	1748	783	1123	1060	583	933	2443	2443	1331	599	Pantothenate kinase 1
B28R14C07	28-7-14	Hs~Ref:NM_003926.5~uORF:IOH59233	2010	1921	1729	1290	1345	1181	5179	3165	2656	715	Methyl-CpG-binding domain protein 3
B28R14C08	28-8-14	Hs~Ref:NM_003926.5~uORF:IOH59233	2174	1983	1667	1349	1389	1200	5199	3186	2917	544	Methyl-CpG-binding domain protein 3
B28R14C09	28-9-14	Hs~Ref:NM_004300.2~uORF:IOH54659	733	553	627	1055	479	1624	6220	929	2997	807	Low molecular weight phosphotyrosine protein phosphatase
B28R14C10	28-10-14	Hs~Ref:NM_004300.2~uORF:IOH54659	697	569	631	987	521	1633	6033	912	3186	729	Low molecular weight phosphotyrosine protein phosphatase
B28R14C11	28-11-14	Hs~Ref:NM_178818.2~uORF:IOH36816	442	237	428	267	242	468	628	367	1053	300	CKLF-like MARVEL transmembrane domain-containing protein 4
B28R14C12	28-12-14	Hs~Ref:NM_178818.2~uORF:IOH36816	394	254	398	272	339	372	605	399	966	97	CKLF-like MARVEL transmembrane domain-containing protein 4
B28R14C13	28-13-14	Hs~MGC:BC014225.2~uORF:IOH12178	154	90	288	243	261	229	633	368	551	199	Homeodomain-only protein
B28R14C14	28-14-14	Hs~MGC:BC014225.2~uORF:IOH12178	113	80	269	269	281	219	662	361	596	68	Homeodomain-only protein
B28R14C15	28-15-14	Hs~Ref:NM_001153.2~uORF:IOH4387	504	642	805	291	655	3244	3484	393	1662	579	Annexin A4
B28R14C16	28-16-14	Hs~Ref:NM_001153.2~uORF:IOH4387	531	609	825	336	667	3163	3361	383	1684	498	Annexin A4
B28R14C17	28-17-14	Hs~MGC:BC022368.1~uORF:IOH14722	251	100	601	244	103	505	359	324	464	47	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial
B28R14C18	28-18-14	Hs~MGC:BC022368.1~uORF:IOH14722	235	171	583	269	97	374	345	335	522	45	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial
B28R14C19	28-19-14	Hs~MGC:BC102021.1~uORF:IOH63591	946	816	1390	1152	934	984	1138	879	3640	523	Beta-crystallin B3
B28R14C20	28-20-14	Hs~MGC:BC102021.1~uORF:IOH63591	2197	838	1373	1189	946	997	1114	859	3543	386	Beta-crystallin B3
B28R15C01	28-1-15	Hs~Ref:NM_153758.1~uORF:IOH35292	998	679	1028	491	575	669	1342	557	1771	319	Interleukin-19
B28R15C02	28-2-15	Hs~Ref:NM_153758.1~uORF:IOH35292	1029	789	1039	507	575	722	1425	561	2465	336	Interleukin-19
B28R15C03	28-3-15	Hs~Ref:NM_001037293.1~uORF:IOH60135	896	1443	905	337	456	809	1608	914	1629	146	Paralemmin-2
B28R15C04	28-4-15	Hs~Ref:NM_001037293.1~uORF:IOH60135	980	1230	842	426	293	913	1583	953	1462	134	Paralemmin-2
B28R15C05	28-5-15	Hs~Ref:NM_006579.1~uORF:IOH11243	674	738	922	2707	602	1594	1117	607	1183	506	emopamil binding protein (sterol isomerase) (EBP)
B28R15C06	28-6-15	Hs~Ref:NM_006579.1~uORF:IOH11243	698	749	935	424	518	1669	1082	638	1178	513	emopamil binding protein (sterol isomerase) (EBP)
B28R15C07	28-7-15	Hs~MGC:BC015468.1~uORF:IOH11236	598	315	484	385	318	650	735	438	873	169	chromosome 21 open reading frame 91 (C21orf91)
B28R15C08	28-8-15	Hs~MGC:BC015468.1~uORF:IOH11236	640	695	507	389	261	517	733	460	1019	141	chromosome 21 open reading frame 91 (C21orf91)
B28R15C09	28-9-15	Hs~MGC:BC039244.1~uORF:IOH27185	941	761	1519	453	552	1623	991	540	1393	478	Nuclear transcription factor Y subunit alpha
B28R15C10	28-10-15	Hs~MGC:BC039244.1~uORF:IOH27185	904	880	1424	446	646	1156	1007	636	1363	389	Nuclear transcription factor Y subunit alpha
B28R15C11	28-11-15	Hs~MGC:BC038422.1~uORF:IOH27448	807	670	678	533	373	2206	1518	589	1256	430	zinc finger protein 533 (ZNF533)
B28R15C12	28-12-15	Hs~MGC:BC038422.1~uORF:IOH27448	831	626	727	548	655	2765	1480	462	1186	472	zinc finger protein 533 (ZNF533)
B28R15C13	28-13-15	Hs~Ref:NM_005975.2~CAT:PV3291	18	28	187	25	27	107	122	107	52	1	PTK6 protein tyrosine kinase 6 (PTK6)
B28R15C14	28-14-15	Hs~Ref:NM_005975.2~CAT:PV3291	64	27	97	55	56	36	73	43	78	-8	PTK6 protein tyrosine kinase 6 (PTK6)
B28R15C15	28-15-15	Hs~Ref:NM_016457.3~CAT:PV3758	563	593	391	481	221	563	721	375	871	200	protein kinase D2 (PRKD2), transcript variant 1
B28R15C16	28-16-15	Hs~Ref:NM_016457.3~CAT:PV3758	249	170	423	485	200	551	664	361	986	17	protein kinase D2 (PRKD2), transcript variant 1
B28R15C19	28-19-15	Hs~Ref:NM_003845.1~CAT:PV3871	1095	304	977	427	662	1297	842	619	986	370	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 (DYRK4)
B28R15C20	28-20-15	Hs~Ref:NM_003845.1~CAT:PV3871	1216	402	1004	457	617	1251	852	612	969	196	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 (DYRK4)
B28R16C01	28-1-16	Hs~Ref:NM_000589.2~CAT_PHC0045	405	75	479	290	65	615	320	176	303	189	interleukin 4 (IL4), transcript variant 1
B28R16C02	28-2-16	Hs~Ref:NM_000589.2~CAT_PHC0045	588	81	507	265	65	289	323	170	412	187	interleukin 4 (IL4), transcript variant 1
B28R16C05	28-5-16	Hs~Ref:NM_002989.2~CAT_PHC1475	2171	1269	1344	2625	958	2246	5647	1556	2074	861	C-C motif chemokine 21
B28R16C06	28-6-16	Hs~Ref:NM_002989.2~CAT_PHC1475	2402	1317	1352	2074	934	2112	5602	1595	2175	976	C-C motif chemokine 21
B28R16C07	28-7-16	Hs~MGC:BC026229.1~uORF:IOH12750	95	64	206	172	78	92	196	189	355	78	surfactant, pulmonary-associated protein A1B (SFTPA1)
B28R16C08	28-8-16	Hs~MGC:BC026229.1~uORF:IOH12750	172	77	202	206	119	434	153	171	187	61	surfactant, pulmonary-associated protein A1B (SFTPA1)
B28R16C09	28-9-16	Hs~Ref:NM_024805.1~uORF:IOH13501	95	236	228	417	183	94	290	176	881	164	chromosome 18 open reading frame 22 (C18orf22)
B28R16C10	28-10-16	Hs~Ref:NM_024805.1~uORF:IOH13501	140	225	223	396	113	123	364	188	389	79	chromosome 18 open reading frame 22 (C18orf22)
B28R16C11	28-11-16	Hs~MGC:BC009478.1~uORF:IOH12273	262	136	262	190	166	313	440	461	539	200	DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) (DCUN1D1)
B28R16C12	28-12-16	Hs~MGC:BC009478.1~uORF:IOH12273	268	146	278	195	158	717	432	465	545	122	DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) (DCUN1D1)
B28R16C13	28-13-16	Hs~MGC:BC014774.1~uORF:IOH10280	2761	831	334	562	511	605	539	402	1068	415	BCL2-associated athanogene (BAG1)
B28R16C14	28-14-16	Hs~MGC:BC014774.1~uORF:IOH10280	2730	771	452	556	474	656	590	354	1074	415	BCL2-associated athanogene (BAG1)
B28R16C15	28-15-16	Hs~Ref:NM_001002255.1~uORF:IOH50186	1605	876	1874	885	1121	973	1715	1052	2519	469	Small ubiquitin-related modifier 4
B28R16C16	28-16-16	Hs~Ref:NM_001002255.1~uORF:IOH50186	1629	833	1845	868	1111	1002	1685	1075	2521	424	Small ubiquitin-related modifier 4
B28R16C17	28-17-16	Hs~Ref:NM_001011540.1~uORF:IOH57331	1750	1042	2175	844	983	1219	1531	1166	2677	550	KU-MEL-3, mRNA (cDNA clone MGC:163527 IMAGE:40146686), complete cds
B28R16C18	28-18-16	Hs~Ref:NM_001011540.1~uORF:IOH57331	1891	1142	2193	841	958	1159	1549	1197	2503	538	KU-MEL-3, mRNA (cDNA clone MGC:163527 IMAGE:40146686), complete cds
B28R16C19	28-19-16	Hs~Ref:NM_001014439.1~uORF:IOH57350	1333	1121	2498	1209	1191	1123	1507	1227	2836	598	Uncharacterized protein C8orf16
B28R16C20	28-20-16	Hs~Ref:NM_001014439.1~uORF:IOH57350	1435	1124	2488	1232	1170	1147	1448	1274	2899	660	Uncharacterized protein C8orf16
B28R16C21	28-21-16	Hs~Ref:NM_006105.3~uORF:IOH11287	6222	5348	5479	3738	2191	8354	4187	30933	7367	1990	Rap guanine nucleotide exchange factor 3
B28R16C22	28-22-16	Hs~Ref:NM_006105.3~uORF:IOH11287	6291	5273	5231	3681	2281	7820	4312	29397	7445	1795	Rap guanine nucleotide exchange factor 3
B28R17C01	28-1-17	Hs~MGC:NM_152682.1~uORF:IOH10053	376	402	461	285	343	703	2985	565	773	375	RWD domain containing 4A (RWDD4A)
B28R17C02	28-2-17	Hs~MGC:NM_152682.1~uORF:IOH10053	367	368	419	286	321	669	2840	476	828	398	RWD domain containing 4A (RWDD4A)
B28R17C03	28-3-17	Hs~Ref:NM_138394.2~uORF:IOH14812	244	486	427	312	163	1456	2224	706	502	115	heterogeneous nuclear ribonucleoprotein L-like (HNRPLL)
B28R17C04	28-4-17	Hs~Ref:NM_138394.2~uORF:IOH14812	254	468	382	1711	170	1415	2230	680	502	123	heterogeneous nuclear ribonucleoprotein L-like (HNRPLL)
B28R17C05	28-5-17	Hs~Ref:NM_006937.2~uORF:IOH13961	162	51	313	3216	292	1251	1311	619	453	254	SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) (SUMO2), transcript variant 1
B28R17C06	28-6-17	Hs~Ref:NM_006937.2~uORF:IOH13961	309	181	311	240	280	1216	1296	605	483	247	SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) (SUMO2), transcript variant 1
B28R17C07	28-7-17	Hs~MGC:BC009313.1~uORF:IOH14080	865	55	272	177	49	61	183	217	339	76	cDNA clone MGC:16614 IMAGE:4111344, complete cds
B28R17C08	28-8-17	Hs~MGC:BC009313.1~uORF:IOH14080	59	151	260	218	71	0	167	203	384	51	cDNA clone MGC:16614 IMAGE:4111344, complete cds
B28R17C09	28-9-17	Hs~MGC:BC067221.1~uORF:IOH40763	293	149	332	221	210	242	332	324	875	166	glutathione peroxidase 2 (gastrointestinal) (GPX2)
B28R17C10	28-10-17	Hs~MGC:BC067221.1~uORF:IOH40763	274	155	343	217	136	308	350	319	408	111	glutathione peroxidase 2 (gastrointestinal) (GPX2)
B28R17C11	28-11-17	Hs~Ref:NM_013442.1~uORF:IOH5037	136	120	322	194	135	337	303	304	351	163	stomatin (EPB72)-like 2 (STOML2)
B28R17C12	28-12-17	Hs~Ref:NM_013442.1~uORF:IOH5037	170	62	353	227	125	160	369	321	461	104	stomatin (EPB72)-like 2 (STOML2)
B28R17C13	28-13-17	Hs~Ref:NM_207168.1~uORF:IOH40772	500	271	884	254	220	5997	512	796	1478	263	endosulfine alpha (ENSA), transcript variant 8
B28R17C14	28-14-17	Hs~Ref:NM_207168.1~uORF:IOH40772	479	242	884	245	281	5709	491	577	1447	120	endosulfine alpha (ENSA), transcript variant 8
B28R17C15	28-15-17	Hs~Ref:NM_152997.2~uORF:IOH40712	813	1374	458	211	324	392	336	417	586	151	chromosome 4 open reading frame 7 (C4orf7)
B28R17C16	28-16-17	Hs~Ref:NM_152997.2~uORF:IOH40712	854	175	416	310	337	277	336	343	620	68	chromosome 4 open reading frame 7 (C4orf7)
B28R17C19	28-19-17	Hs~Ref:NM_004032.2~uORF:IOH43554	808	842	698	515	458	771	981	793	1114	394	D-aspartate oxidase (DDO), transcript variant 2
B28R17C20	28-20-17	Hs~Ref:NM_004032.2~uORF:IOH43554	766	799	752	499	414	725	912	787	1175	415	D-aspartate oxidase (DDO), transcript variant 2
B28R17C21	28-21-17	Hs~Ref:NM_057157.1~uORF:IOH41398	944	621	631	389	329	586	971	557	976	433	cytochrome P450, family 26, subfamily A, polypeptide 1 (CYP26A1), transcript variant 2
B28R17C22	28-22-17	Hs~Ref:NM_057157.1~uORF:IOH41398	868	557	567	474	390	582	923	565	640	355	cytochrome P450, family 26, subfamily A, polypeptide 1 (CYP26A1), transcript variant 2
B28R18C01	28-1-18	Hs~Ref:NM_004922.2~uORF:IOH38664	1499	1116	2432	1295	1053	4753	2128	2181	3491	822	SEC24 related gene family, member C (S. cerevisiae) (SEC24C), transcript variant 1
B28R18C02	28-2-18	Hs~Ref:NM_004922.2~uORF:IOH38664	1445	1089	2281	1297	1054	4619	2112	2242	3231	781	SEC24 related gene family, member C (S. cerevisiae) (SEC24C), transcript variant 1
B28R18C03	28-3-18	Hs~Ref:NM_030981.1~uORF:IOH29640	196	250	466	342	710	1253	441	385	1036	222	RAB1B, member RAS oncogene family (RAB1B)
B28R18C04	28-4-18	Hs~Ref:NM_030981.1~uORF:IOH29640	185	199	443	2397	631	1219	426	364	975	134	RAB1B, member RAS oncogene family (RAB1B)
B28R18C05	28-5-18	Hs~MGC:BC053578.1~uORF:IOH28934	863	481	515	749	303	1627	548	774	2306	355	glutathione S-transferase A1 (GSTA1)
B28R18C06	28-6-18	Hs~MGC:BC053578.1~uORF:IOH28934	463	449	502	417	330	1659	541	736	2327	325	glutathione S-transferase A1 (GSTA1)
B28R18C07	28-7-18	Hs~Ref:NM_000773.2~uORF:IOH29616	232	63	308	245	-5	282	213	204	392	127	cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1)
B28R18C08	28-8-18	Hs~Ref:NM_000773.2~uORF:IOH29616	55	62	263	174	26	246	229	157	363	152	cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1)
B28R18C09	28-9-18	Hs~Ref:NM_003224.1~uORF:IOH29617	96	31	174	218	255	54	191	140	226	126	ADP-ribosylation factor related protein 1 (ARFRP1)
B28R18C10	28-10-18	Hs~Ref:NM_003224.1~uORF:IOH29617	63	574	235	192	44	62	234	185	672	29	ADP-ribosylation factor related protein 1 (ARFRP1)
B28R18C11	28-11-18	Hs~MGC:BC064391.1~uORF:IOH61736	1930	1428	1536	2994	2519	18296	1781	5952	3998	521	Coiled-coil domain-containing protein 6
B28R18C12	28-12-18	Hs~MGC:BC064391.1~uORF:IOH61736	1921	1414	1524	2845	2532	17511	1832	5591	4135	535	Coiled-coil domain-containing protein 6
B28R18C15	28-15-18	Hs~MGC:BC015546.1~uORF:IOH61714	142	893	527	457	675	565	850	521	1515	173	Uncharacterized protein C12orf60
B28R18C16	28-16-18	Hs~MGC:BC015546.1~uORF:IOH61714	299	890	503	464	709	552	861	514	1551	174	Uncharacterized protein C12orf60
B28R18C17	28-17-18	Hs~MGC:BC071563.1~uORF:IOH61664	478	555	2078	719	3367	797	4078	1464	1400	247	UPF0667 protein C1orf55
B28R18C18	28-18-18	Hs~MGC:BC071563.1~uORF:IOH61664	509	539	2112	682	3325	928	3972	1399	1349	190	UPF0667 protein C1orf55
B28R18C21	28-21-18	Hs~Ref:NM_000799.2~uORF:IOH61961	159	76	371	311	358	209	377	321	357	266	erythropoietin (EPO)
B28R18C22	28-22-18	Hs~Ref:NM_000799.2~uORF:IOH61961	175	63	326	308	259	236	361	285	406	249	erythropoietin (EPO)
B28R19C01	28-1-19	Hs~MGC:BC017012.1~uORF:IOH11877	1010	541	679	444	507	673	2014	653	965	410	Protein IWS1 homolog
B28R19C02	28-2-19	Hs~MGC:BC017012.1~uORF:IOH11877	919	588	689	454	267	629	2103	594	1040	397	Protein IWS1 homolog
B28R19C03	28-3-19	Hs~MGC:BC047741.1~uORF:IOH26659	771	769	727	553	302	542	907	654	1164	341	spinster homolog 1 (Drosophila) (SPNS1)
B28R19C04	28-4-19	Hs~MGC:BC047741.1~uORF:IOH26659	831	941	683	1570	309	584	940	574	1044	360	spinster homolog 1 (Drosophila) (SPNS1)
B28R19C05	28-5-19	Hs~Ref:NM_005613.2~uORF:IOH4771	372	534	511	760	481	469	494	492	879	360	regulator of G-protein signaling 4 (RGS4), transcript variant 2
B28R19C06	28-6-19	Hs~Ref:NM_005613.2~uORF:IOH4771	344	570	531	406	391	570	500	482	947	380	regulator of G-protein signaling 4 (RGS4), transcript variant 2
B28R19C07	28-7-19	Hs~MGC:BC000784.1~uORF:IOH4711	1484	360	449	330	292	557	558	431	1071	254	baculoviral IAP repeat-containing 5 (survivin) (BIRC5)
B28R19C08	28-8-19	Hs~MGC:BC000784.1~uORF:IOH4711	1730	336	483	296	276	612	581	482	1061	283	baculoviral IAP repeat-containing 5 (survivin) (BIRC5)
B28R19C09	28-9-19	Hs~MGC:BC047486.1~uORF:IOH62402	316	192	241	258	82	3888	513	265	1589	97	JmjC domain-containing histone demethylation protein 1A
B28R19C10	28-10-19	Hs~MGC:BC047486.1~uORF:IOH62402	275	175	256	259	86	952	540	273	1590	15	JmjC domain-containing histone demethylation protein 1A
B28R19C13	28-13-19	Hs~Ref:NM_023934.2~uORF:IOH40818	880	985	643	618	665	693	843	784	2345	380	FUN14 domain containing 2 (FUNDC2)
B28R19C14	28-14-19	Hs~Ref:NM_023934.2~uORF:IOH40818	958	993	611	630	629	649	787	837	2400	377	FUN14 domain containing 2 (FUNDC2)
B28R19C15	28-15-19	Hs~Ref:NM_024928.3~uORF:IOH12386	606	1320	2182	2256	616	2941	813	1234	7770	331	oligonucleotide/oligosaccharide-binding fold containing 1 (OBFC1)
B28R19C16	28-16-19	Hs~Ref:NM_024928.3~uORF:IOH12386	607	1061	2166	2207	642	2918	790	1145	7950	153	oligonucleotide/oligosaccharide-binding fold containing 1 (OBFC1)
B28R19C17	28-17-19	Hs~Ref:NM_017952.4~uORF:IOH40917	692	598	762	396	364	790	948	544	2398	432	Pentatricopeptide repeat domain 3 (PTCD3)
B28R19C18	28-18-19	Hs~Ref:NM_017952.4~uORF:IOH40917	764	749	726	393	422	1284	948	553	2599	346	Pentatricopeptide repeat domain 3 (PTCD3)
B28R19C19	28-19-19	Hs~MGC:BC032866.2~uORF:IOH27132	1113	370	561	689	443	1115	598	1626	10302	232	eukaryotic translation initiation factor 5 (EIF5)
B28R19C20	28-20-19	Hs~MGC:BC032866.2~uORF:IOH27132	1197	485	541	668	448	593	605	1611	9662	237	eukaryotic translation initiation factor 5 (EIF5)
B28R19C21	28-21-19	Hs~Ref:NM_080651.1~uORF:IOH3372	488	109	570	327	370	543	512	315	1253	19	mediator complex subunit 30 (MED30)
B28R19C22	28-22-19	Hs~Ref:NM_080651.1~uORF:IOH3372	363	372	582	343	305	422	495	317	1029	70	mediator complex subunit 30 (MED30)
B28R20C01	28-1-20	Hs~Ref:NM_138390.1~uORF:IOH3301	352	360	445	257	282	604	553	1694	873	247	transmembrane protein 169 (TMEM169)
B28R20C02	28-2-20	Hs~Ref:NM_138390.1~uORF:IOH3301	313	430	434	274	218	561	642	1700	897	208	transmembrane protein 169 (TMEM169)
B28R20C05	28-5-20	Hs~Ref:NM_004146.3~uORF:IOH4112	622	643	575	408	176	529	1404	507	949	317	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa (NDUFB7), nuclear gene encoding mitochondrial protein
B28R20C06	28-6-20	Hs~Ref:NM_004146.3~uORF:IOH4112	859	929	649	381	1618	567	1452	537	976	338	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa (NDUFB7), nuclear gene encoding mitochondrial protein
B28R20C07	28-7-20	Hs~Ref:NM_181900.2~uORF:IOH40592	1032	710	1910	838	3872	3617	1458	784	1308	543	StAR-related lipid transfer (START) domain containing 5 (STARD5)
B28R20C08	28-8-20	Hs~Ref:NM_181900.2~uORF:IOH40592	783	746	1859	815	1904	3521	1365	760	1342	509	StAR-related lipid transfer (START) domain containing 5 (STARD5)
B28R20C09	28-9-20	Hs~Ref:NM_022171.1~uORF:IOH40573	-12	-13	0	700	1720	881	1583	788	2231	488	T-cell leukemia translocation altered gene (TCTA)
B28R20C10	28-10-20	Hs~Ref:NM_022171.1~uORF:IOH40573	-3	-5	0	695	1366	1117	1554	746	2475	498	T-cell leukemia translocation altered gene (TCTA)
B28R20C11	28-11-20	Hs~MGC:BC007811.2~uORF:IOH40618	14	-2	-2	-1	-1	-4	87	-7	1719	0	hypothetical protein FLJ22795 (FLJ22795)
B28R20C12	28-12-20	Hs~MGC:BC007811.2~uORF:IOH40618	3	2	0	0	0	55	7	0	-3	1	hypothetical protein FLJ22795 (FLJ22795)
B28R20C13	28-13-20	Hs~Ref:NM_015289.2~uORF:IOH40537	1528	1646	4511	1395	1080	1735	9259	3651	3530	759	vacuolar protein sorting 39 homolog (S. cerevisiae) (VPS39)
B28R20C14	28-14-20	Hs~Ref:NM_015289.2~uORF:IOH40537	1549	1605	4466	1413	1043	1661	9129	3531	3424	732	vacuolar protein sorting 39 homolog (S. cerevisiae) (VPS39)
B29R02C11	29-11-2	Hs~Ref:NM_152333.1~uORF:IOH41357	617	391	861	441	861	769	799	787	806	264	solute carrier family 25, member 29 (SLC25A29), transcript variant 2
B29R02C12	29-12-2	Hs~Ref:NM_152333.1~uORF:IOH41357	693	490	882	483	913	716	742	808	765	361	solute carrier family 25, member 29 (SLC25A29), transcript variant 2
B29R02C13	29-13-2	Hs~Ref:NM_017563.1~uORF:IOH43886	1668	651	721	475	871	760	882	465	778	295	Interleukin-17 receptor D
B29R02C14	29-14-2	Hs~Ref:NM_017563.1~uORF:IOH43886	1707	674	706	482	927	666	919	464	797	259	Interleukin-17 receptor D
B29R02C15	29-15-2	Hs~Ref:NM_014065.2~uORF:IOH43942	1040	695	913	736	527	906	3656	747	3297	349	Protein asteroid homolog 1
B29R02C16	29-16-2	Hs~Ref:NM_014065.2~uORF:IOH43942	869	712	983	753	468	1000	3729	840	1157	337	Protein asteroid homolog 1
B29R02C17	29-17-2	Hs~MGC:BC013883.1~uORF:IOH40593	676	460	990	2133	864	2532	1004	663	1000	211	transmembrane protein 134 (TMEM134)
B29R02C18	29-18-2	Hs~MGC:BC013883.1~uORF:IOH40593	665	494	1072	2373	762	2395	1076	574	382	221	transmembrane protein 134 (TMEM134)
B29R02C19	29-19-2	Hs~Ref:NM_016816.1~uORF:IOH41283	8090	6028	2274	10482	5340	8572	4416	3999	5481	3078	2',5'-oligoadenylate synthetase 1, 40/46kDa (OAS1), transcript variant 1
B29R02C20	29-20-2	Hs~Ref:NM_016816.1~uORF:IOH41283	9355	5738	2390	10524	5382	8736	4701	4003	5675	3061	2',5'-oligoadenylate synthetase 1, 40/46kDa (OAS1), transcript variant 1
B29R02C21	29-21-2	Hs~Ref:XM_209489.2~uORF:IOH44775	1431	519	1301	816	784	1130	936	855	1687	268	PREDICTED: Homo sapiens similar to CG14853-PB (LOC285141)
B29R02C22	29-22-2	Hs~Ref:XM_209489.2~uORF:IOH44775	1084	471	1297	831	680	1139	936	864	1751	301	PREDICTED: Homo sapiens similar to CG14853-PB (LOC285141)
B29R03C05	29-5-3	Hs~MGC:BC009182.1~uORF:IOH13497	462	354	479	802	399	404	545	494	852	56	chromosome 14 open reading frame 159 (C14orf159)
B29R03C06	29-6-3	Hs~MGC:BC009182.1~uORF:IOH13497	453	212	499	1065	444	409	510	425	898	82	chromosome 14 open reading frame 159 (C14orf159)
B29R03C07	29-7-3	Hs~MGC:BC015323.1~uORF:IOH11084	829	926	1060	517	698	641	803	1145	1365	495	polybromo 1 (PBRM1)
B29R03C08	29-8-3	Hs~MGC:BC015323.1~uORF:IOH11084	843	920	1048	503	912	697	928	933	1325	404	polybromo 1 (PBRM1)
B29R03C09	29-9-3	Hs~Ref:NM_017612.1~uORF:IOH11180	4083	16414	3453	2494	6899	680	5313	1977	5627	271	Zinc finger CCHC domain-containing protein 8
B29R03C10	29-10-3	Hs~Ref:NM_017612.1~uORF:IOH11180	4254	17220	3182	2655	8321	681	5438	1952	5853	128	Zinc finger CCHC domain-containing protein 8
B29R03C11	29-11-3	Hs~MGC:BC012945.1~uORF:IOH25802	5232	125	1621	287	736	2418	494	8771	2200	45	Uncharacterized protein C19orf57
B29R03C12	29-12-3	Hs~MGC:BC012945.1~uORF:IOH25802	5517	127	1528	285	558	2351	504	9174	2077	296	Uncharacterized protein C19orf57
B29R03C13	29-13-3	Hs~Ref:NM_031427.1~uORF:IOH7274	816	879	920	436	1026	628	921	565	1385	395	dynein, axonemal, light chain 1 (DNAL1)
B29R03C14	29-14-3	Hs~Ref:NM_031427.1~uORF:IOH7274	826	959	920	476	1185	657	968	599	1472	395	dynein, axonemal, light chain 1 (DNAL1)
B29R03C15	29-15-3	Hs~MGC:BC027866.1~uORF:IOH12025	724	866	761	831	664	614	816	604	3154	1059	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 (ST8SIA4)
B29R03C16	29-16-3	Hs~MGC:BC027866.1~uORF:IOH12025	742	823	821	803	727	877	812	630	3374	1040	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 (ST8SIA4)
B29R03C17	29-17-3	Hs~Ref:NM_007362.2~uORF:IOH3243	2949	7171	3342	3600	2799	5572	5663	2366	5089	1786	nuclear cap binding protein subunit 2, 20kDa (NCBP2), transcript variant 1
B29R03C18	29-18-3	Hs~Ref:NM_007362.2~uORF:IOH3243	3035	7660	3180	3553	2832	5182	5625	2256	5188	1818	nuclear cap binding protein subunit 2, 20kDa (NCBP2), transcript variant 1
B29R03C19	29-19-3	Hs~MGC:BC010900.1~uORF:IOH12898	711	477	863	458	753	709	818	718	1506	340	ubiquitin-conjugating enzyme E2W (putative) (UBE2W)
B29R03C20	29-20-3	Hs~MGC:BC010900.1~uORF:IOH12898	740	822	868	437	700	818	937	653	1398	356	ubiquitin-conjugating enzyme E2W (putative) (UBE2W)
B29R03C21	29-21-3	Hs~Ref:NM_005979.1~uORF:IOH1589	631	1465	2002	1196	1143	1372	2137	767	1700	399	S100 calcium binding protein A13 (S100A13), transcript variant 2
B29R03C22	29-22-3	Hs~Ref:NM_005979.1~uORF:IOH1589	676	1389	1881	1202	994	1389	2123	757	1780	391	S100 calcium binding protein A13 (S100A13), transcript variant 2
B29R04C01	29-1-4	Hs~Ref:NM_001997.2~uORF:IOH1655	3232	1251	1565	747	1303	1471	4766	2928	3037	757	Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (FAU)
B29R04C02	29-2-4	Hs~Ref:NM_001997.2~uORF:IOH1655	3042	1129	1530	742	1407	1404	4876	2823	3036	580	Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (FAU)
B29R04C03	29-3-4	Hs~Ref:NM_001662.2~uORF:IOH1744	2078	93	720	158	1150	493	839	16537	1555	210	ADP-ribosylation factor 5 (ARF5)
B29R04C04	29-4-4	Hs~Ref:NM_001662.2~uORF:IOH1744	2136	81	719	386	1164	261	638	15528	1899	65	ADP-ribosylation factor 5 (ARF5)
B29R04C05	29-5-4	Hs~Ref:NM_001321.1~uORF:IOH1779	1564	1544	1765	3763	2438	2494	1883	2263	1717	1693	cysteine and glycine-rich protein 2 (CSRP2)
B29R04C06	29-6-4	Hs~Ref:NM_001321.1~uORF:IOH1779	1567	1781	1815	2422	2491	2505	1871	2584	1621	1484	cysteine and glycine-rich protein 2 (CSRP2)
B29R04C07	29-7-4	Hs~Ref:NM_004837.2~uORF:IOH7323	533	740	714	393	756	1107	2059	646	1402	465	geranylgeranyl diphosphate synthase 1 (GGPS1), transcript variant 1
B29R04C08	29-8-4	Hs~Ref:NM_004837.2~uORF:IOH7323	589	687	787	354	817	1219	2016	648	1372	461	geranylgeranyl diphosphate synthase 1 (GGPS1), transcript variant 1
B29R04C09	29-9-4	Hs~MGC:BC018995.2~uORF:IOH14243	420	516	859	215	490	588	515	521	572	95	family with sequence similarity 70, member B (FAM70B)
B29R04C10	29-10-4	Hs~MGC:BC018995.2~uORF:IOH14243	455	187	1029	218	580	598	576	491	594	349	family with sequence similarity 70, member B (FAM70B)
B29R04C11	29-11-4	Hs~Ref:NM_013443.2~uORF:IOH6716	560	578	1023	404	519	646	722	568	614	359	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
B29R04C12	29-12-4	Hs~Ref:NM_013443.2~uORF:IOH6716	636	639	972	473	486	718	705	582	582	355	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
B29R04C13	29-13-4	Hs~MGC:BC016308.1~uORF:IOH12905	505	647	616	295	638	377	579	526	506	93	chemokine (C-X-C motif) ligand 3 (CXCL3)
B29R04C14	29-14-4	Hs~MGC:BC016308.1~uORF:IOH12905	550	651	666	325	572	422	637	597	272	140	chemokine (C-X-C motif) ligand 3 (CXCL3)
B29R04C15	29-15-4	Hs~Ref:NM_012191.1~uORF:IOH5628	2250	5127	11056	1712	2921	2632	2528	2183	3086	1342	N-acetyltransferase 6 (NAT6)
B29R04C16	29-16-4	Hs~Ref:NM_012191.1~uORF:IOH5628	2259	5440	10726	1819	2983	2571	2556	2319	3020	1349	N-acetyltransferase 6 (NAT6)
B29R04C17	29-17-4	Hs~Ref:NM_001799.2~uORF:IOH3121	2382	1092	4459	1077	1326	1682	5084	1459	2059	402	cyclin-dependent kinase 7
B29R04C18	29-18-4	Hs~Ref:NM_001799.2~uORF:IOH3121	2435	1100	4208	1088	1350	1605	4911	1433	2047	412	cyclin-dependent kinase 7
B29R04C19	29-19-4	Hs~Ref:NM_014734.2~uORF:IOH39813	680	510	914	1828	865	633	1357	519	1332	252	KIAA0247 (KIAA0247)
B29R04C20	29-20-4	Hs~Ref:NM_014734.2~uORF:IOH39813	703	577	931	1983	806	648	1390	487	1352	160	KIAA0247 (KIAA0247)
B29R04C21	29-21-4	Hs~Ref:NM_016074.1~uORF:IOH39867	897	722	847	5699	973	1164	1667	2057	1994	393	bolA homolog 1 (E. coli) (BOLA1)
B29R04C22	29-22-4	Hs~Ref:NM_016074.1~uORF:IOH39867	935	690	789	5548	980	1151	1590	2014	2149	367	bolA homolog 1 (E. coli) (BOLA1)
B29R05C01	29-1-5	Hs~MGC:BC014532.1~uORF:IOH12798	6104	4454	4375	3756	4270	7619	4609	3582	4799	3794	decapping enzyme, scavenger (DCPS)
B29R05C02	29-2-5	Hs~MGC:BC014532.1~uORF:IOH12798	5780	4490	4566	4004	4349	7687	4754	3720	4830	3786	decapping enzyme, scavenger (DCPS)
B29R05C03	29-3-5	Hs~Ref:NM_016487.1~uORF:IOH12876	1606	2127	2414	2220	1699	1708	3372	1230	1851	811	chromosome 6 open reading frame 203 (C6orf203)
B29R05C04	29-4-5	Hs~Ref:NM_016487.1~uORF:IOH12876	1601	2168	2417	2096	1792	1640	3425	1162	1812	814	chromosome 6 open reading frame 203 (C6orf203)
B29R05C05	29-5-5	Hs~Ref:NM_005368.1~uORF:IOH12916	1358	433	45428	383	729	534	4040	286	1317	144	myoglobin (MB), transcript variant 1
B29R05C06	29-6-5	Hs~Ref:NM_005368.1~uORF:IOH12916	1378	402	45519	396	707	508	4088	310	1379	129	myoglobin (MB), transcript variant 1
B29R05C07	29-7-5	Hs~Ref:NM_014596.3~uORF:IOH12855	1272	1109	1281	1340	1282	833	911	908	1851	935	zinc ribbon domain containing 1 (ZNRD1), transcript variant b
B29R05C08	29-8-5	Hs~Ref:NM_014596.3~uORF:IOH12855	1181	1201	1283	1368	1207	859	904	888	1677	859	zinc ribbon domain containing 1 (ZNRD1), transcript variant b
B29R05C09	29-9-5	Hs~MGC:BC051688.1~uORF:IOH26513	1202	45	581	393	385	378	582	313	517	14	PNMA-like protein 1
B29R05C10	29-10-5	Hs~MGC:BC051688.1~uORF:IOH26513	1222	297	571	401	423	437	607	432	564	145	PNMA-like protein 1
B29R05C11	29-11-5	Hs~MGC:BC050645.1~uORF:IOH27032	1545	1720	1698	1884	2690	2119	6993	1739	5440	823	bystin-like (BYSL)
B29R05C12	29-12-5	Hs~MGC:BC050645.1~uORF:IOH27032	1594	1798	1673	1894	2594	2181	7178	1692	5934	792	bystin-like (BYSL)
B29R05C13	29-13-5	Hs~MGC:BC043391.1~uORF:IOH26414	716	513	1302	714	716	855	1306	4789	1135	3851	Transcription initiation factor TFIID subunit 7-like
B29R05C14	29-14-5	Hs~MGC:BC043391.1~uORF:IOH26414	720	490	1366	724	660	891	1312	4884	1288	3748	Transcription initiation factor TFIID subunit 7-like
B29R05C15	29-15-5	Hs~MGC:BC041158.1~uORF:IOH26191	389	391	442	1529	296	395	329	296	343	205	cytochrome P450, family 4, subfamily A, polypeptide 11 (CYP4A11)
B29R05C16	29-16-5	Hs~MGC:BC041158.1~uORF:IOH26191	405	369	421	1657	789	438	309	244	442	211	cytochrome P450, family 4, subfamily A, polypeptide 11 (CYP4A11)
B29R05C17	29-17-5	Hs~MGC:BC001108.1~uORF:IOH3845	774	571	876	920	2525	731	944	675	1556	688	PIH1 domain-containing protein 1
B29R05C18	29-18-5	Hs~MGC:BC001108.1~uORF:IOH3845	793	634	815	909	2285	664	947	684	1609	723	PIH1 domain-containing protein 1
B29R05C19	29-19-5	Hs~MGC:BC001697.1~uORF:IOH3864	1679	932	1489	689	1118	1330	5041	900	2726	414	ribosomal protein S15a (RPS15A)
B29R05C20	29-20-5	Hs~MGC:BC001697.1~uORF:IOH3864	1792	897	1484	652	1222	1330	5328	832	2731	412	ribosomal protein S15a (RPS15A)
B29R05C21	29-21-5	Hs~MGC:BC021093.1~uORF:IOH13303	531	608	603	323	474	432	564	369	907	172	Hippocampus abundant transcript-like protein 1
B29R05C22	29-22-5	Hs~MGC:BC021093.1~uORF:IOH13303	513	483	596	311	382	416	525	344	840	232	Hippocampus abundant transcript-like protein 1
B29R06C01	29-1-6	Hs~MGC:BC021927.1~uORF:IOH13479	2758	1485	1073	854	526	1183	1443	899	1653	1223	hypothetical protein LOC652968 (LOC652968)
B29R06C02	29-2-6	Hs~MGC:BC021927.1~uORF:IOH13479	2680	1500	1099	949	525	1176	1471	896	1697	1217	hypothetical protein LOC652968 (LOC652968)
B29R06C03	29-3-6	Hs~Ref:NM_147162.1~uORF:IOH45830	330	320	435	209	251	269	363	335	475	176	interleukin 11 receptor, alpha (IL11RA), transcript variant 2
B29R06C04	29-4-6	Hs~Ref:NM_147162.1~uORF:IOH45830	355	936	419	201	263	305	372	328	465	72	interleukin 11 receptor, alpha (IL11RA), transcript variant 2
B29R06C05	29-5-6	Hs~Ref:NM_024307.1~uORF:IOH45847	457	364	582	240	374	1988	496	347	513	106	glycerophosphodiester phosphodiesterase domain containing 3 (GDPD3)
B29R06C06	29-6-6	Hs~Ref:NM_024307.1~uORF:IOH45847	471	302	696	269	324	1983	473	348	469	97	glycerophosphodiester phosphodiesterase domain containing 3 (GDPD3)
B29R06C07	29-7-6	Hs~Ref:NM_198041.1~uORF:IOH45807	524	63	138	421	400	483	562	395	747	123	nudix (nucleoside diphosphate linked moiety X)-type motif 6 (NUDT6), transcript variant 2
B29R06C08	29-8-6	Hs~Ref:NM_198041.1~uORF:IOH45807	564	190	731	308	385	423	566	367	775	114	nudix (nucleoside diphosphate linked moiety X)-type motif 6 (NUDT6), transcript variant 2
B29R06C09	29-9-6	Hs~Ref:NM_182776.1~uORF:IOH45809	372	160	474	217	206	292	422	294	515	309	minichromosome maintenance complex component 7 (MCM7), transcript variant 2
B29R06C10	29-10-6	Hs~Ref:NM_182776.1~uORF:IOH45809	406	114	401	213	320	290	447	237	567	64	minichromosome maintenance complex component 7 (MCM7), transcript variant 2
B29R06C11	29-11-6	Hs~MGC:BC020726.1~uORF:IOH12969	12889	3527	5113	4577	4950	4965	10738	6617	5763	2886	sciellin (SCEL)
B29R06C12	29-12-6	Hs~MGC:BC020726.1~uORF:IOH12969	13715	3604	5056	4787	5347	4694	10463	7045	5867	3071	sciellin (SCEL)
B29R06C13	29-13-6	Hs~Ref:NM_005046.2~uORF:IOH22164	597	618	1093	412	627	634	1960	1084	1426	382	kallikrein-related peptidase 7 (KLK7), transcript variant 1
B29R06C14	29-14-6	Hs~Ref:NM_005046.2~uORF:IOH22164	590	543	1097	425	577	635	1913	1098	1991	336	kallikrein-related peptidase 7 (KLK7), transcript variant 1
B29R06C15	29-15-6	Hs~MGC:BC034696.1~uORF:IOH22151	787	738	1497	888	1053	1247	2415	1402	4528	435	syntaxin 19 (STX19)
B29R06C16	29-16-6	Hs~MGC:BC034696.1~uORF:IOH22151	823	733	1472	872	1492	1400	2413	1423	4443	435	syntaxin 19 (STX19)
B29R06C17	29-17-6	Hs~Ref:NM_005887.1~uORF:IOH45761	452	320	626	271	566	540	458	389	813	107	Leukemia-associated protein 1
B29R06C18	29-18-6	Hs~Ref:NM_005887.1~uORF:IOH45761	411	318	565	2516	499	498	468	380	928	50	Leukemia-associated protein 1
B29R06C19	29-19-6	Hs~Ref:NM_152618.2~uORF:IOH55646	298	196	350	106	223	237	372	230	77	92	Bardet-Biedl syndrome 12 protein
B29R06C20	29-20-6	Hs~Ref:NM_152618.2~uORF:IOH55646	317	131	337	202	308	142	425	308	275	35	Bardet-Biedl syndrome 12 protein
B29R07C01	29-1-7	Hs~Ref:NM_001888.2~uORF:IOH56006	255	19	196	162	56	168	174	460	57	29	Mu-crystallin homolog
B29R07C02	29-2-7	Hs~Ref:NM_001888.2~uORF:IOH56006	247	15	245	206	56	176	177	490	153	22	Mu-crystallin homolog
B29R07C03	29-3-7	Hs~Ref:NM_002601.2~uORF:IOH56967	2847	98	848	156	122	281	218	207	535	79	phosphodiesterase 6D, cGMP-specific, rod, delta (PDE6D), mRNA.
B29R07C04	29-4-7	Hs~Ref:NM_002601.2~uORF:IOH56967	2752	1401	818	168	196	286	214	182	509	70	phosphodiesterase 6D, cGMP-specific, rod, delta (PDE6D), mRNA.
B29R07C05	29-5-7	Hs~Ref:NM_024779.2~uORF:IOH11402	776	829	740	498	391	439	733	784	553	214	phosphatidylinositol-5-phosphate 4-kinase, type II, gamma (PIP4K2C)
B29R07C06	29-6-7	Hs~Ref:NM_024779.2~uORF:IOH11402	559	739	771	475	413	633	857	754	563	197	phosphatidylinositol-5-phosphate 4-kinase, type II, gamma (PIP4K2C)
B29R07C07	29-7-7	Hs~MGC:BC021278.1~uORF:IOH14591	288	179	822	263	352	331	390	342	426	89	hexokinase domain containing 1 (HKDC1)
B29R07C08	29-8-7	Hs~MGC:BC021278.1~uORF:IOH14591	324	98	699	239	172	234	363	285	465	71	hexokinase domain containing 1 (HKDC1)
B29R07C09	29-9-7	Hs~Ref:NM_144624.1~uORF:IOH14193	460	148	526	219	412	366	409	359	513	101	kinase interacting with leukemia-associated gene (stathmin) (KIS)
B29R07C10	29-10-7	Hs~Ref:NM_144624.1~uORF:IOH14193	480	149	596	208	370	396	446	365	483	128	kinase interacting with leukemia-associated gene (stathmin) (KIS)
B29R07C13	29-13-7	Hs~MGC:BC036327.1~uORF:IOH27334	512	603	861	366	568	731	674	715	864	324	phospholipase D family, member 3 (PLD3)
B29R07C14	29-14-7	Hs~MGC:BC036327.1~uORF:IOH27334	521	568	827	410	527	736	711	569	1135	346	phospholipase D family, member 3 (PLD3)
B29R07C15	29-15-7	Hs~Ref:NM_152255.1~uORF:IOH39607	473	500	696	348	89	668	602	551	683	247	proteasome (prosome, macropain) subunit, alpha type, 7 (PSMA7), transcript variant 2
B29R07C16	29-16-7	Hs~Ref:NM_152255.1~uORF:IOH39607	484	476	668	314	907	590	615	546	623	242	proteasome (prosome, macropain) subunit, alpha type, 7 (PSMA7), transcript variant 2
B29R07C17	29-17-7	Hs~Ref:NM_006931.1~uORF:IOH25795	385	340	490	289	294	699	529	485	381	189	solute carrier family 2 (facilitated glucose transporter), member 3 (SLC2A3)
B29R07C18	29-18-7	Hs~Ref:NM_006931.1~uORF:IOH25795	355	323	497	1478	397	904	495	482	283	261	solute carrier family 2 (facilitated glucose transporter), member 3 (SLC2A3)
B29R07C19	29-19-7	Hs~Ref:NM_004512.3~uORF:IOH39599	404	365	561	1337	378	845	498	564	635	232	interleukin 11 receptor, alpha (IL11RA), transcript variant 1
B29R07C20	29-20-7	Hs~Ref:NM_004512.3~uORF:IOH39599	701	400	571	311	493	841	508	555	721	164	interleukin 11 receptor, alpha (IL11RA), transcript variant 1
B29R08C01	29-1-8	Hs~Ref:NM_004443.2~N/A	670	891	1284	1032	940	1096	1889	1401	2810	512	Ephrin type-B receptor 3
B29R08C02	29-2-8	Hs~Ref:NM_004443.2~N/A	665	934	1542	1092	997	1114	2145	1466	2915	478	Ephrin type-B receptor 3
B29R08C03	29-3-8	Hs~Ref:NM_004560.2~N/A	861	2530	2664	2489	1449	1758	1759	1368	5142	963	Tyrosine-protein kinase transmembrane receptor ROR2
B29R08C04	29-4-8	Hs~Ref:NM_004560.2~N/A	935	2845	2675	2710	1508	1726	1680	1435	5301	985	Tyrosine-protein kinase transmembrane receptor ROR2
B29R08C05	29-5-8	Hs~Ref:NM_001106.2~N/A	2058	27618	10031	16195	1190	25984	990	1388	2386	2147	Activin receptor type-2B
B29R08C06	29-6-8	Hs~Ref:NM_001106.2~N/A	3747	26897	10288	16470	1091	24992	997	1317	2408	2128	Activin receptor type-2B
B29R08C07	29-7-8	Hs~MGC:BC036098.1~uORF:IOH27221	2425	347	230	1526	290	1479	304	574	538	59	neurocalcin delta (NCALD)
B29R08C08	29-8-8	Hs~MGC:BC036098.1~uORF:IOH27221	51	341	355	1122	288	1464	301	570	523	62	neurocalcin delta (NCALD)
B29R08C09	29-9-8	Hs~MGC:BC037547.1~uORF:IOH27538	749	803	989	477	863	626	1169	822	1310	299	cell division cycle 20 homolog B (S. cerevisiae) (CDC20B)
B29R08C10	29-10-8	Hs~MGC:BC037547.1~uORF:IOH27538	696	805	946	449	1056	606	1282	745	1243	393	cell division cycle 20 homolog B (S. cerevisiae) (CDC20B)
B29R08C11	29-11-8	Hs~Ref:NM_018441.2~uORF:IOH4050	1294	1405	1547	2180	1446	1937	1896	1323	2222	858	peroxisomal trans-2-enoyl-CoA reductase (PECR)
B29R08C12	29-12-8	Hs~Ref:NM_018441.2~uORF:IOH4050	1295	1468	1679	2126	1607	1879	1930	1788	2135	752	peroxisomal trans-2-enoyl-CoA reductase (PECR)
B29R08C13	29-13-8	Hs~Ref:NM_006429.1~uORF:IOH14430	647	3478	2196	19864	762	963	1897	1427	1746	279	chaperonin containing TCP1, subunit 7 (eta) (CCT7), transcript variant 1
B29R08C14	29-14-8	Hs~Ref:NM_006429.1~uORF:IOH14430	648	3775	2131	20191	736	978	1881	1519	1638	260	chaperonin containing TCP1, subunit 7 (eta) (CCT7), transcript variant 1
B29R08C15	29-15-8	Hs~Ref:NM_001890.1~uORF:IOH44412	1038	858	1449	648	1162	974	1007	862	2078	421	Alpha-S1-casein
B29R08C16	29-16-8	Hs~Ref:NM_001890.1~uORF:IOH44412	1099	852	1386	706	1837	945	1018	897	2057	441	Alpha-S1-casein
B29R08C17	29-17-8	Hs~Ref:NM_007221.1~uORF:IOH45646	848	942	1375	807	1554	892	1099	944	1868	441	Polyamine-modulated factor 1
B29R08C18	29-18-8	Hs~Ref:NM_007221.1~uORF:IOH45646	863	942	1522	1410	1534	984	1157	959	1879	428	Polyamine-modulated factor 1
B29R08C19	29-19-8	Hs~Ref:NM_203429.1~uORF:IOH44588	1185	1442	1761	1299	1230	872	986	969	2977	465	Down syndrome critical region protein 8
B29R08C20	29-20-8	Hs~Ref:NM_203429.1~uORF:IOH44588	1199	1383	1816	1066	1215	901	995	947	2955	466	Down syndrome critical region protein 8
B29R08C21	29-21-8	Hs~Ref:NM_181339.1~uORF:IOH45583	902	1047	1542	651	801	820	1040	766	1584	387	Interleukin-24
B29R08C22	29-22-8	Hs~Ref:NM_181339.1~uORF:IOH45583	849	984	1609	662	815	856	1113	814	1638	389	Interleukin-24
B29R09C01	29-1-9	Hs~MGC:BC004818.2~uORF:IOH3016	400	292	422	718	152	908	1082	199	646	61	chromosome 14 open reading frame 129 (C14orf129)
B29R09C02	29-2-9	Hs~MGC:BC004818.2~uORF:IOH3016	379	214	465	759	258	895	1099	219	645	161	chromosome 14 open reading frame 129 (C14orf129)
B29R09C03	29-3-9	Hs~MGC:BC011951.1~uORF:IOH10439	276	312	392	192	199	431	373	312	466	88	serine peptidase inhibitor, Kunitz type, 2 (SPINT2)
B29R09C04	29-4-9	Hs~MGC:BC011951.1~uORF:IOH10439	351	104	400	222	299	439	383	238	612	97	serine peptidase inhibitor, Kunitz type, 2 (SPINT2)
B29R09C05	29-5-9	Hs~Ref:NM_000403.3~uORF:IOH3262	374	576	1219	408	562	648	582	544	1226	268	UDP-galactose-4-epimerase (GALE), transcript variant 1
B29R09C06	29-6-9	Hs~Ref:NM_000403.3~uORF:IOH3262	2040	438	1239	403	517	583	589	479	1235	255	UDP-galactose-4-epimerase (GALE), transcript variant 1
B29R09C07	29-7-9	Hs~MGC:BC031870.2~uORF:IOH22046	837	1052	659	981	693	537	652	569	1168	189	diacylglycerol kinase, alpha 80kDa (DGKA)
B29R09C08	29-8-9	Hs~MGC:BC031870.2~uORF:IOH22046	712	1094	683	917	710	554	734	582	1198	203	diacylglycerol kinase, alpha 80kDa (DGKA)
B29R09C09	29-9-9	Hs~Ref:NM_016576.2~uORF:IOH6998	764	678	2042	459	521	1071	1505	665	1636	196	guanosine monophosphate reductase 2 (GMPR2), transcript variant 1
B29R09C10	29-10-9	Hs~Ref:NM_016576.2~uORF:IOH6998	766	806	2074	423	559	1098	1567	691	1575	251	guanosine monophosphate reductase 2 (GMPR2), transcript variant 1
B29R09C11	29-11-9	Hs~Ref:NM_014066.2~uORF:IOH4943	375	568	769	350	552	373	696	664	782	129	COMM domain containing 5 (COMMD5), transcript variant 1
B29R09C12	29-12-9	Hs~Ref:NM_014066.2~uORF:IOH4943	408	519	795	302	529	353	702	691	715	92	COMM domain containing 5 (COMMD5), transcript variant 1
B29R09C13	29-13-9	Hs~MGC:BC006470.1~uORF:IOH6015	491	508	741	279	386	414	829	445	593	160	macrophage erythroblast attacher (MAEA)
B29R09C14	29-14-9	Hs~MGC:BC006470.1~uORF:IOH6015	507	416	742	313	499	457	830	565	576	296	macrophage erythroblast attacher (MAEA)
B29R09C15	29-15-9	Hs~MGC:BC040276.1~uORF:IOH27380	1336	428	1188	639	1009	1473	920	540	1620	192	leucine rich repeat containing 48 (LRRC48)
B29R09C16	29-16-9	Hs~MGC:BC040276.1~uORF:IOH27380	1231	457	1700	594	278	1533	1012	588	1423	203	leucine rich repeat containing 48 (LRRC48)
B29R09C17	29-17-9	Hs~MGC:BC001121.2~uORF:IOH46072	352	286	745	655	431	311	453	278	805	91	deoxyguanosine kinase (DGUOK)
B29R09C18	29-18-9	Hs~MGC:BC001121.2~uORF:IOH46072	365	301	713	677	369	408	431	323	346	165	deoxyguanosine kinase (DGUOK)
B29R09C19	29-19-9	Hs~Ref:NM_001005910.1~uORF:IOH46074	528	594	773	2453	497	997	490	348	1028	192	inositol hexaphosphate kinase 2 (IHPK2), transcript variant 3
B29R09C20	29-20-9	Hs~Ref:NM_001005910.1~uORF:IOH46074	519	621	918	2491	619	933	644	447	864	109	inositol hexaphosphate kinase 2 (IHPK2), transcript variant 3
B29R09C21	29-21-9	Hs~MGC:BC019039.2~uORF:IOH46089	4103	7551	7340	5166	4706	2351	9549	5809	6446	2826	Regulator of G-protein signaling 3
B29R09C22	29-22-9	Hs~MGC:BC019039.2~uORF:IOH46089	3951	7508	7732	5178	4770	2422	9913	5610	6718	2725	Regulator of G-protein signaling 3
B29R10C01	29-1-10	Hs~MGC:BC022199.2~uORF:IOH46088	305	2620	372	205	244	115	0	-2	485	141	chromosome 18 open reading frame 10 (C18orf10)
B29R10C02	29-2-10	Hs~MGC:BC022199.2~uORF:IOH46088	295	83	449	211	290	15	5	-5	588	127	chromosome 18 open reading frame 10 (C18orf10)
B29R10C03	29-3-10	Hs~Ref:NM_014613.1~uORF:IOH40633	873	219	1038	353	631	1667	1361	659	1455	165	UBX domain containing 8 (UBXD8)
B29R10C04	29-4-10	Hs~Ref:NM_014613.1~uORF:IOH40633	846	601	1069	344	685	1693	1416	646	1476	159	UBX domain containing 8 (UBXD8)
B29R10C05	29-5-10	Hs~Ref:NM_002297.2~uORF:IOH40729	271	440	300	171	205	413	463	198	410	62	lipocalin 1 (tear prealbumin) (LCN1)
B29R10C06	29-6-10	Hs~Ref:NM_002297.2~uORF:IOH40729	360	386	301	194	337	362	474	200	399	60	lipocalin 1 (tear prealbumin) (LCN1)
B29R10C07	29-7-10	Hs~MGC:BC064512.1~uORF:IOH40668	1740	530	1479	1051	927	1763	1630	809	1606	368	ubiquitin protein ligase E3 component n-recognin 2 (UBR2)
B29R10C08	29-8-10	Hs~MGC:BC064512.1~uORF:IOH40668	928	499	1449	995	951	1834	1683	815	1632	244	ubiquitin protein ligase E3 component n-recognin 2 (UBR2)
B29R10C09	29-9-10	Hs~Ref:NM_153694.3~uORF:IOH40756	1741	823	946	1359	620	884	12081	898	2527	268	synaptonemal complex protein 3 (SYCP3)
B29R10C10	29-10-10	Hs~Ref:NM_153694.3~uORF:IOH40756	1827	818	930	1139	767	880	13205	898	2521	341	synaptonemal complex protein 3 (SYCP3)
B29R11C21	29-21-11	Hs~Ref:NM_014038.1~uORF:IOH7437	478	408	526	1221	405	2114	1291	581	1417	266	basic leucine zipper and W2 domains 2 (BZW2)
B29R11C22	29-22-11	Hs~Ref:NM_014038.1~uORF:IOH7437	452	468	545	846	358	2109	1288	576	1577	159	basic leucine zipper and W2 domains 2 (BZW2)
B29R12C01	29-1-12	Hs~MGC:BC005359.1~uORF:IOH7294	346	1258	293	235	243	774	304	248	609	102	glia maturation factor, beta (GMFB)
B29R12C02	29-2-12	Hs~MGC:BC005359.1~uORF:IOH7294	353	128	347	254	294	735	318	346	606	108	glia maturation factor, beta (GMFB)
B29R12C03	29-3-12	Hs~MGC:BC007460.1~uORF:IOH7350	224	130	228	468	220	246	219	230	347	31	acid phosphatase, prostate (ACPP)
B29R12C04	29-4-12	Hs~MGC:BC007460.1~uORF:IOH7350	270	94	281	447	189	271	226	210	411	84	acid phosphatase, prostate (ACPP)
B29R12C05	29-5-12	Hs~MGC:BC033728.1~uORF:IOH21800	359	266	480	1062	2038	457	691	387	858	143	Transcription initiation factor TFIID subunit 8
B29R12C06	29-6-12	Hs~MGC:BC033728.1~uORF:IOH21800	381	1763	483	1078	2062	472	771	409	841	138	Transcription initiation factor TFIID subunit 8
B29R12C07	29-7-12	Hs~Ref:NM_004567.2~uORF:IOH10913	1268	1108	863	723	1224	1708	1746	1578	3536	785	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4)
B29R12C08	29-8-12	Hs~Ref:NM_004567.2~uORF:IOH10913	1160	998	864	1004	1204	1710	1785	1621	3604	791	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4)
B29R12C09	29-9-12	Hs~Ref:NM_002197.1~uORF:IOH11817	1335	576	981	729	981	727	1103	474	1262	251	aconitase 1, soluble (ACO1)
B29R12C10	29-10-12	Hs~Ref:NM_002197.1~uORF:IOH11817	1273	611	1007	748	1072	692	1122	445	1256	264	aconitase 1, soluble (ACO1)
B29R12C11	29-11-12	Hs~MGC:NM_152576.1~uORF:IOH23047	453	652	487	520	751	293	467	301	679	132	hypothetical protein MGC24103 (MGC24103)
B29R12C12	29-12-12	Hs~MGC:NM_152576.1~uORF:IOH23047	454	673	480	529	709	241	487	315	698	118	hypothetical protein MGC24103 (MGC24103)
B29R12C13	29-13-12	Hs~Ref:NM_006831.1~uORF:IOH3500	1770	1117	3569	979	1088	1377	2630	1071	2312	474	CLP1, cleavage and polyadenylation factor I subunit, homolog (S. cerevisiae) (CLP1)
B29R12C14	29-14-12	Hs~Ref:NM_006831.1~uORF:IOH3500	1652	1134	3576	1005	1136	1613	2626	1060	2220	479	CLP1, cleavage and polyadenylation factor I subunit, homolog (S. cerevisiae) (CLP1)
B29R12C15	29-15-12	Hs~Ref:NM_001003938.2~uORF:IOH45603	872	858	1084	720	1090	948	834	1292	2464	693	Hemoglobin subunit mu
B29R12C16	29-16-12	Hs~Ref:NM_001003938.2~uORF:IOH45603	932	842	1018	715	1326	974	901	939	2303	737	Hemoglobin subunit mu
B29R12C17	29-17-12	Hs~Ref:NM_017592.1~uORF:IOH44564	13604	1288	12877	3979	2019	1974	3834	4973	2072	6255	Mediator of RNA polymerase II transcription subunit 29
B29R12C18	29-18-12	Hs~Ref:NM_017592.1~uORF:IOH44564	13525	1338	12929	4035	2210	2034	3497	4908	2105	6443	Mediator of RNA polymerase II transcription subunit 29
B29R12C19	29-19-12	Hs~Ref:NM_001001653.1~uORF:IOH45566	673	564	3360	819	575	14303	1546	575	2820	315	mediator of RNA polymerase II transcription, subunit 8 homolog (S. cerevisiae) (MED8), transcript variant 4
B29R12C20	29-20-12	Hs~Ref:NM_001001653.1~uORF:IOH45566	718	523	3552	976	625	13882	1581	589	2652	305	mediator of RNA polymerase II transcription, subunit 8 homolog (S. cerevisiae) (MED8), transcript variant 4
B29R12C21	29-21-12	Hs~Ref:NM_032385.1~uORF:IOH45875	2919	997	1579	1173	1123	1325	1944	1290	2516	722	chromosome 5 open reading frame 4 (C5orf4), transcript variant 2
B29R12C22	29-22-12	Hs~Ref:NM_032385.1~uORF:IOH45875	2158	1003	1517	940	1116	1275	1959	1294	2603	653	chromosome 5 open reading frame 4 (C5orf4), transcript variant 2
B29R13C01	29-1-13	Hs~Ref:NM_005651.1~uORF:IOH7291	1291	997	2034	1393	1164	2900	2050	2774	2633	660	tryptophan 2,3-dioxygenase (TDO2)
B29R13C02	29-2-13	Hs~Ref:NM_005651.1~uORF:IOH7291	1442	1028	2024	1475	1191	2822	2092	2820	2718	573	tryptophan 2,3-dioxygenase (TDO2)
B29R13C03	29-3-13	Hs~MGC:BC012616.1~uORF:IOH13744	1045	1087	2478	1382	1679	3253	2693	3013	3695	519	betaine-homocysteine methyltransferase (BHMT)
B29R13C04	29-4-13	Hs~MGC:BC012616.1~uORF:IOH13744	1082	1069	2529	1416	1693	3326	2613	2871	3754	445	betaine-homocysteine methyltransferase (BHMT)
B29R13C05	29-5-13	Hs~MGC:BC005065.1~uORF:IOH6560	829	765	1086	579	616	893	2004	1137	1459	232	ELKS/RAB6-interacting/CAST family member 1 (ERC1)
B29R13C06	29-6-13	Hs~MGC:BC005065.1~uORF:IOH6560	837	626	1058	550	620	875	2037	1223	1351	494	ELKS/RAB6-interacting/CAST family member 1 (ERC1)
B29R13C07	29-7-13	Hs~MGC:BC034014.1~uORF:IOH22132	233	82	330	126	246	184	262	150	870	16	F-box and leucine-rich repeat protein 16 (FBXL16)
B29R13C08	29-8-13	Hs~MGC:BC034014.1~uORF:IOH22132	209	222	332	49	137	104	344	164	1078	58	F-box and leucine-rich repeat protein 16 (FBXL16)
B29R13C09	29-9-13	Hs~Ref:NM_020468.2~uORF:IOH45873	860	3157	599	731	201	440	383	423	1260	102	sorting nexin 14 (SNX14), transcript variant 2
B29R13C10	29-10-13	Hs~Ref:NM_020468.2~uORF:IOH45873	834	3167	603	727	518	447	407	429	1293	217	sorting nexin 14 (SNX14), transcript variant 2
B29R13C11	29-11-13	Hs~Ref:NM_020417.1~uORF:IOH46271	550	537	755	424	788	1067	2547	2758	1366	280	T-box transcription factor TBX20
B29R13C12	29-12-13	Hs~Ref:NM_020417.1~uORF:IOH46271	473	503	734	382	821	1050	3742	2845	1286	407	T-box transcription factor TBX20
B29R13C15	29-15-13	Hs~Ref:NM_002863.3~uORF:IOH61143	516	474	662	517	966	547	1083	495	1592	340	Glycogen phosphorylase, liver form
B29R13C16	29-16-13	Hs~Ref:NM_002863.3~uORF:IOH61143	438	458	608	509	1222	556	1048	500	1599	363	Glycogen phosphorylase, liver form
B29R13C17	29-17-13	Hs~Ref:NM_001646.1~uORF:IOH14363	2389	1436	1881	1190	1378	1118	3646	1216	2394	400	apolipoprotein C-IV (APOC4)
B29R13C18	29-18-13	Hs~Ref:NM_001646.1~uORF:IOH14363	2320	1484	1832	1112	1584	1196	3292	1278	2454	414	apolipoprotein C-IV (APOC4)
B29R13C19	29-19-13	Hs~MGC:BC007514.1~uORF:IOH6107	437	360	1005	425	580	904	1039	482	1063	267	v-raf murine sarcoma 3611 viral oncogene homolog (ARAF)
B29R13C20	29-20-13	Hs~MGC:BC007514.1~uORF:IOH6107	457	345	1064	456	572	722	1069	509	1031	159	v-raf murine sarcoma 3611 viral oncogene homolog (ARAF)
B29R13C21	29-21-13	Hs~Ref:NM_002647.1~uORF:IOH21022	1530	425	750	420	400	636	838	465	939	395	phosphoinositide-3-kinase, class 3 (PIK3C3)
B29R13C22	29-22-13	Hs~Ref:NM_002647.1~uORF:IOH21022	836	407	732	401	333	713	790	454	806	368	phosphoinositide-3-kinase, class 3 (PIK3C3)
B29R14C01	29-1-14	Hs~Ref:NM_006496.1~uORF:IOH14567	578	561	683	435	418	588	1039	758	1142	231	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 (GNAI3)
B29R14C02	29-2-14	Hs~Ref:NM_006496.1~uORF:IOH14567	615	666	791	437	411	611	1029	795	1199	412	guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 (GNAI3)
B29R14C03	29-3-14	Hs~Ref:NM_139049.1~uORF:IOH53990	626	536	531	210	389	296	876	549	772	123	Mitogen-activated protein kinase 8
B29R14C04	29-4-14	Hs~Ref:NM_139049.1~uORF:IOH53990	705	313	569	211	402	293	900	353	760	144	Mitogen-activated protein kinase 8
B29R14C09	29-9-14	Hs~Ref:NM_005870.3~uORF:IOH53845	3803	1319	2952	1479	1256	1903	14774	1458	3374	704	Histone deacetylase complex subunit SAP18
B29R14C10	29-10-14	Hs~Ref:NM_005870.3~uORF:IOH53845	3483	1336	3139	1466	1126	1948	14985	1509	3434	729	Histone deacetylase complex subunit SAP18
B29R14C11	29-11-14	Hs~Ref:NM_006570.2~uORF:IOH6617	796	581	1674	540	611	580	668	606	1085	389	Ras-related GTP binding A (RRAGA)
B29R14C12	29-12-14	Hs~Ref:NM_006570.2~uORF:IOH6617	698	586	1645	539	722	590	660	605	1049	396	Ras-related GTP binding A (RRAGA)
B29R14C13	29-13-14	Hs~MGC:BC009012.1~uORF:IOH3329	530	535	884	918	647	3534	802	874	1609	670	phosphoribosyl pyrophosphate synthetase-associated protein 1 (PRPSAP1)
B29R14C14	29-14-14	Hs~MGC:BC009012.1~uORF:IOH3329	492	582	944	911	707	3920	866	932	1499	633	phosphoribosyl pyrophosphate synthetase-associated protein 1 (PRPSAP1)
B29R14C15	29-15-14	Hs~Ref:NM_018184.1~uORF:IOH11083	1719	1572	2334	1466	2372	1801	1743	1760	2474	1765	ADP-ribosylation factor-like 8B (ARL8B)
B29R14C16	29-16-14	Hs~Ref:NM_018184.1~uORF:IOH11083	1669	1633	2199	1446	2554	2089	1652	2098	2831	1592	ADP-ribosylation factor-like 8B (ARL8B)
B29R14C17	29-17-14	Hs~Ref:NM_024619.2~uORF:IOH6899	348	292	530	226	314	501	789	494	183	158	fructosamine-3-kinase-related protein (FN3KRP)
B29R14C18	29-18-14	Hs~Ref:NM_024619.2~uORF:IOH6899	344	319	683	263	298	442	731	688	9	235	fructosamine-3-kinase-related protein (FN3KRP)
B29R14C19	29-19-14	Hs~MGC:BC012760.2~uORF:IOH62834	2898	3770	3155	2893	1987	2726	3731	3145	385	1098	Glycogen synthase kinase-3 beta
B29R14C20	29-20-14	Hs~MGC:BC012760.2~uORF:IOH62834	2948	4094	2791	3664	2153	2530	3805	2849	3268	1093	Glycogen synthase kinase-3 beta
B29R15C01	29-1-15	Hs~MGC:BC068536.1~uORF:IOH61685	226	173	455	216	259	504	813	468	479	-1	KH domain-containing, RNA-binding, signal transduction-associated protein 3
B29R15C02	29-2-15	Hs~MGC:BC068536.1~uORF:IOH61685	278	156	433	216	270	491	821	491	542	12	KH domain-containing, RNA-binding, signal transduction-associated protein 3
B29R15C03	29-3-15	Hs~MGC:BC074501.1~uORF:IOH61735	420	363	479	243	386	388	486	328	623	131	Protein yippee-like 1
B29R15C04	29-4-15	Hs~MGC:BC074501.1~uORF:IOH61735	431	243	468	242	397	401	505	521	602	107	Protein yippee-like 1
B29R15C05	29-5-15	Hs~MGC:BC058833.1~uORF:IOH29475	253	175	310	204	182	269	352	380	501	93	Sperm-associated antigen 11
B29R15C06	29-6-15	Hs~MGC:BC058833.1~uORF:IOH29475	268	251	346	219	271	272	370	322	502	-11	Sperm-associated antigen 11
B29R15C07	29-7-15	Hs~MGC:BC059396.1~uORF:IOH29258	562	354	334	221	316	261	238	207	486	78	family with sequence similarity 92, member A3 (FAM92A3)
B29R15C08	29-8-15	Hs~MGC:BC059396.1~uORF:IOH29258	974	487	331	256	279	268	239	230	475	77	family with sequence similarity 92, member A3 (FAM92A3)
B29R15C09	29-9-15	Hs~MGC:BC046449.1~uORF:IOH28670	828	427	417	344	552	518	509	442	1224	68	Zinc finger protein 845
B29R15C10	29-10-15	Hs~MGC:BC046449.1~uORF:IOH28670	421	479	439	254	497	510	511	446	1148	85	Zinc finger protein 845
B29R15C11	29-11-15	Hs~MGC:BC054023.1~uORF:IOH29482	388	200	462	261	491	254	319	353	807	26	SPANX family, member C (SPANXC)
B29R15C12	29-12-15	Hs~MGC:BC054023.1~uORF:IOH29482	356	210	449	268	528	263	325	354	664	88	SPANX family, member C (SPANXC)
B29R15C17	29-17-15	Hs~Ref:NM_000222.1~CAT:PV3869	672	548	1113	459	669	809	946	497	973	334	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), transcript variant 1; see catalog number for detailed information on wild-type or point mutant status
B29R15C18	29-18-15	Hs~Ref:NM_000222.1~CAT:PV3869	725	541	1355	589	579	808	1000	761	715	324	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), transcript variant 1; see catalog number for detailed information on wild-type or point mutant status
B29R15C21	29-21-15	Hs~Ref:NM_005246.1~CAT:PV3806	8998	1062	486	122	256	1175	509	915	211	164	Proto-oncogene tyrosine-protein kinase FER
B29R15C22	29-22-15	Hs~Ref:NM_005246.1~CAT:PV3806	9673	1115	503	184	188	1267	462	942	203	130	Proto-oncogene tyrosine-protein kinase FER
B29R16C01	29-1-16	Hs~Ref:NM_005157.2~CAT:PV3864	541	971	618	317	189	435	647	355	567	128	v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), transcript variant a; see catalog number for detailed information on wild-type or point mutant status
B29R16C02	29-2-16	Hs~Ref:NM_005157.2~CAT:PV3864	560	536	702	366	222	455	732	344	493	124	v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), transcript variant a; see catalog number for detailed information on wild-type or point mutant status
B29R16C07	29-7-16	Hs~MGC:BC050543.1~uORF:IOH26964	1397	593	4678	1076	1319	923	979	786	2067	459	Protein FAM131B
B29R16C08	29-8-16	Hs~MGC:BC050543.1~uORF:IOH26964	1471	630	4542	1108	1332	996	1001	819	2044	453	Protein FAM131B
B29R16C11	29-11-16	Hs~MGC:BC071703.1~uORF:IOH61781	472	464	696	380	563	405	791	473	624	271	Gap junction beta-2 protein
B29R16C12	29-12-16	Hs~MGC:BC071703.1~uORF:IOH61781	422	498	673	389	624	434	810	485	651	236	Gap junction beta-2 protein
B29R16C13	29-13-16	Hs~MGC:BC063439.1~uORF:IOH61534	532	278	279	289	487	391	266	227	444	94	Glutathione S-transferase A4
B29R16C14	29-14-16	Hs~MGC:BC063439.1~uORF:IOH61534	508	134	270	269	571	396	279	232	459	81	Glutathione S-transferase A4
B29R16C15	29-15-16	Hs~Ref:NM_139208.1~uORF:IOH29573	1036	410	610	506	569	461	790	633	812	276	mannan-binding lectin serine peptidase 2 (MASP2), transcript variant 2
B29R16C16	29-16-16	Hs~Ref:NM_139208.1~uORF:IOH29573	1090	343	603	486	585	587	807	627	803	349	mannan-binding lectin serine peptidase 2 (MASP2), transcript variant 2
B29R16C17	29-17-16	Hs~Ref:NM_016563.1~uORF:IOH29600	2085	1658	2254	1566	2214	1787	2240	1959	3216	1120	RAS-like, family 12 (RASL12)
B29R16C18	29-18-16	Hs~Ref:NM_016563.1~uORF:IOH29600	2103	1695	2134	1652	2599	1848	2329	1876	3548	1142	RAS-like, family 12 (RASL12)
B29R16C19	29-19-16	Hs~MGC:BC054501.1~uORF:IOH28879	2655	4045	3171	7260	1350	4138	4816	887	2509	831	dynamin 2 (DNM2)
B29R16C20	29-20-16	Hs~MGC:BC054501.1~uORF:IOH28879	2690	4185	3185	7273	1384	3876	5089	827	2591	774	dynamin 2 (DNM2)
B29R16C21	29-21-16	Hs~Ref:NM_003955.2~uORF:IOH29563	15708	825	1089	8755	1117	2528	1182	1155	19178	18424	suppressor of cytokine signaling 3 (SOCS3)
B29R16C22	29-22-16	Hs~Ref:NM_003955.2~uORF:IOH29563	17165	851	1100	8508	1056	2496	1215	1118	19859	18138	suppressor of cytokine signaling 3 (SOCS3)
B29R17C01	29-1-17	Hs~Ref:NM_002443.2~uORF:IOH7298	1005	1026	1323	711	1257	1264	2169	1088	2140	304	microseminoprotein, beta- (MSMB), transcript variant PSP94
B29R17C02	29-2-17	Hs~Ref:NM_002443.2~uORF:IOH7298	1049	1069	1281	699	1288	1266	2129	1064	2134	1109	microseminoprotein, beta- (MSMB), transcript variant PSP94
B29R17C03	29-3-17	Hs~Ref:NM_144706.1~uORF:IOH12734	1294	1017	1276	773	2113	1621	2314	1168	2963	621	chromosome 2 open reading frame 15 (C2orf15)
B29R17C04	29-4-17	Hs~Ref:NM_144706.1~uORF:IOH12734	1353	963	1319	742	2112	1540	2308	1191	2912	467	chromosome 2 open reading frame 15 (C2orf15)
B29R17C05	29-5-17	Hs~MGC:BC022483.1~uORF:IOH11130	1143	1015	1374	798	1562	1386	1920	1180	2307	935	Rho GTPase-activating protein 29
B29R17C06	29-6-17	Hs~MGC:BC022483.1~uORF:IOH11130	1156	1092	1392	810	1598	1429	2073	1324	2225	873	Rho GTPase-activating protein 29
B29R17C07	29-7-17	Hs~MGC:NM_005533.2~uORF:IOH3930	982	2100	1410	745	1689	1883	2012	1545	2758	645	interferon-induced protein 35 (IFI35)
B29R17C08	29-8-17	Hs~MGC:NM_005533.2~uORF:IOH3930	1012	2705	1387	943	1790	1788	1839	1329	2584	717	interferon-induced protein 35 (IFI35)
B29R17C09	29-9-17	Hs~Ref:NM_000978.2~uORF:IOH13951	456	77	398	1634	159	243	208	209	357	66	ribosomal protein L23 (RPL23)
B29R17C10	29-10-17	Hs~Ref:NM_000978.2~uORF:IOH13951	434	195	313	2574	215	246	214	209	368	76	ribosomal protein L23 (RPL23)
B29R17C11	29-11-17	Hs~Ref:NM_031286.1~uORF:IOH22976	138	77	282	264	468	912	318	172	325	69	SH3 domain binding glutamic acid-rich protein like 3 (SH3BGRL3)
B29R17C12	29-12-17	Hs~Ref:NM_031286.1~uORF:IOH22976	162	79	290	262	531	959	317	149	349	57	SH3 domain binding glutamic acid-rich protein like 3 (SH3BGRL3)
B29R17C13	29-13-17	Hs~MGC:BC007815.1~uORF:IOH6757	652	370	712	712	730	465	462	420	2428	52	ATP binding domain 1 family, member B (ATPBD1B)
B29R17C14	29-14-17	Hs~MGC:BC007815.1~uORF:IOH6757	668	361	671	603	736	510	539	457	2642	81	ATP binding domain 1 family, member B (ATPBD1B)
B29R17C15	29-15-17	Hs~Ref:NM_002013.2~uORF:IOH14109	1793	2164	1444	708	898	1109	2512	1014	11560	353	FK506 binding protein 3, 25kDa (FKBP3)
B29R17C16	29-16-17	Hs~Ref:NM_002013.2~uORF:IOH14109	1911	2328	1457	716	927	1147	2671	975	11225	365	FK506 binding protein 3, 25kDa (FKBP3)
B29R17C17	29-17-17	Hs~Ref:NM_024348.2~uORF:IOH3523	402	920	601	288	539	637	518	503	1176	237	dynactin 3 (p22) (DCTN3), transcript variant 2
B29R17C18	29-18-17	Hs~Ref:NM_024348.2~uORF:IOH3523	414	943	526	277	588	606	644	465	612	286	dynactin 3 (p22) (DCTN3), transcript variant 2
B29R17C19	29-19-17	Hs~MGC:BC000884.1~uORF:IOH3230	390	399	712	340	673	500	581	355	800	267	signal peptidase complex subunit 1 homolog (S. cerevisiae) (SPCS1)
B29R17C20	29-20-17	Hs~MGC:BC000884.1~uORF:IOH3230	424	407	694	338	669	484	645	373	978	263	signal peptidase complex subunit 1 homolog (S. cerevisiae) (SPCS1)
B29R17C21	29-21-17	Hs~MGC:BC001426.1~uORF:IOH4083	514	747	789	1036	885	919	1047	569	617	159	ubiquinol-cytochrome c reductase hinge protein (UQCRH)
B29R17C22	29-22-17	Hs~MGC:BC001426.1~uORF:IOH4083	516	787	788	967	918	874	1087	386	723	248	ubiquinol-cytochrome c reductase hinge protein (UQCRH)
B29R18C01	29-1-18	Hs~MGC:BC016582.1~uORF:IOH9793	964	398	931	402	903	867	1357	573	2146	128	polypyrimidine tract binding protein 2 (PTBP2)
B29R18C02	29-2-18	Hs~MGC:BC016582.1~uORF:IOH9793	1085	595	948	386	943	971	1425	637	2210	207	polypyrimidine tract binding protein 2 (PTBP2)
B29R18C03	29-3-18	Hs~Ref:NM_006232.2~uORF:IOH4626	457	534	1513	404	538	598	3405	1680	1233	198	polymerase (RNA) II (DNA directed) polypeptide H (POLR2H)
B29R18C04	29-4-18	Hs~Ref:NM_006232.2~uORF:IOH4626	494	464	1593	422	520	600	3374	1689	1291	247	polymerase (RNA) II (DNA directed) polypeptide H (POLR2H)
B29R18C05	29-5-18	Hs~MGC:NM_152715.1~uORF:IOH21462	576	569	1964	381	521	697	2504	1519	1208	281	Tubulin-specific chaperone cofactor E-like protein
B29R18C06	29-6-18	Hs~MGC:NM_152715.1~uORF:IOH21462	571	587	2091	358	518	689	2450	1594	1172	282	Tubulin-specific chaperone cofactor E-like protein
B29R18C07	29-7-18	Hs~MGC:BC016486.1~uORF:IOH21471	791	919	2745	1201	764	1277	2668	3520	1839	552	lectin, galactoside-binding, soluble, 8 (galectin 8) (LGALS8)
B29R18C08	29-8-18	Hs~MGC:BC016486.1~uORF:IOH21471	821	1057	2722	2270	724	1320	2668	3419	1756	571	lectin, galactoside-binding, soluble, 8 (galectin 8) (LGALS8)
B29R18C09	29-9-18	Hs~MGC:BC001671.1~uORF:IOH3723	421	690	1326	688	510	572	2494	1307	1009	300	HD domain containing 2 (HDDC2)
B29R18C10	29-10-18	Hs~MGC:BC001671.1~uORF:IOH3723	871	567	1342	803	490	562	2411	1319	1001	252	HD domain containing 2 (HDDC2)
B29R18C11	29-11-18	Hs~MGC:BC056147.1~uORF:IOH29115	784	522	662	1026	656	444	853	535	813	301	F-box protein 38 (FBXO38)
B29R18C12	29-12-18	Hs~MGC:BC056147.1~uORF:IOH29115	734	553	715	426	948	475	849	560	882	336	F-box protein 38 (FBXO38)
B29R18C13	29-13-18	Hs~Ref:NM_181714.1~uORF:IOH26433	1613	2594	5821	1723	1516	1297	1304	1220	1761	884	Leber congenital amaurosis 5 (LCA5)
B29R18C14	29-14-18	Hs~Ref:NM_181714.1~uORF:IOH26433	1639	2813	6024	1635	1539	1027	1308	1406	1635	844	Leber congenital amaurosis 5 (LCA5)
B29R18C15	29-15-18	Hs~MGC:BC056911.1~uORF:IOH29120	1982	4296	1884	1218	1273	1571	3059	5899	2338	3790	dual specificity phosphatase 15 (DUSP15)
B29R18C16	29-16-18	Hs~MGC:BC056911.1~uORF:IOH29120	2234	4368	2112	1311	1326	1693	2892	5817	2436	3739	dual specificity phosphatase 15 (DUSP15)
B29R18C17	29-17-18	Hs~Ref:NM_001715.2~uORF:IOH57009	856	535	1390	730	6157	3511	3814	2744	2221	474	B lymphoid tyrosine kinase (BLK)
B29R18C18	29-18-18	Hs~Ref:NM_001715.2~uORF:IOH57009	829	515	1323	729	6381	3343	3899	2767	2453	482	B lymphoid tyrosine kinase (BLK)
B29R18C19	29-19-18	Hs~Ref:NM_022156.3~uORF:IOH39856	4817	1491	2048	1514	1847	3796	3160	1302	4066	914	dihydrouridine synthase 1-like (S. cerevisiae) (DUS1L)
B29R18C20	29-20-18	Hs~Ref:NM_022156.3~uORF:IOH39856	4749	1451	1966	1475	1884	3632	3088	1213	4231	883	dihydrouridine synthase 1-like (S. cerevisiae) (DUS1L)
B29R18C21	29-21-18	Hs~Ref:NM_080388.1~uORF:IOH10271	1458	874	1507	1093	1190	782	1225	1091	1683	465	S100 calcium binding protein A16 (S100A16)
B29R18C22	29-22-18	Hs~Ref:NM_080388.1~uORF:IOH10271	1530	882	1592	1021	1194	774	1232	906	1794	427	S100 calcium binding protein A16 (S100A16)
B29R19C01	29-1-19	Hs~MGC:BC031262.1~uORF:IOH21607	1064	817	3499	1093	1552	1239	1317	2509	2108	1802	catenin (cadherin-associated protein), alpha 1, 102kDa (CTNNA1)
B29R19C02	29-2-19	Hs~MGC:BC031262.1~uORF:IOH21607	903	849	3509	1140	1632	1242	1356	2371	2118	1781	catenin (cadherin-associated protein), alpha 1, 102kDa (CTNNA1)
B29R19C03	29-3-19	Hs~Ref:NM_003981.2~uORF:IOH5138	-3	852	1	290	0	292	8	0	1	21	protein regulator of cytokinesis 1 (PRC1), transcript variant 1
B29R19C04	29-4-19	Hs~Ref:NM_003981.2~uORF:IOH5138	-1	1039	-3	-2	-2	-2	-7	-4	-1	-1	protein regulator of cytokinesis 1 (PRC1), transcript variant 1
B29R19C07	29-7-19	Hs~Ref:NM_000910.1~uORF:IOH28389	564	513	737	411	521	550	959	645	1025	457	neuropeptide Y receptor Y2 (NPY2R)
B29R19C08	29-8-19	Hs~Ref:NM_000910.1~uORF:IOH28389	680	548	673	1290	496	562	960	1041	951	249	neuropeptide Y receptor Y2 (NPY2R)
B29R19C09	29-9-19	Hs~Ref:NM_052819.1~uORF:IOH3124	870	799	794	903	654	706	1363	986	1169	311	caspase recruitment domain family, member 14 (CARD14), transcript variant 2
B29R19C10	29-10-19	Hs~Ref:NM_052819.1~uORF:IOH3124	1082	736	824	1057	723	736	1289	783	1251	391	caspase recruitment domain family, member 14 (CARD14), transcript variant 2
B29R19C11	29-11-19	Hs~Ref:NM_022788.2~uORF:IOH12543	809	624	776	672	732	591	798	631	945	442	purinergic receptor P2Y, G-protein coupled, 12 (P2RY12), transcript variant 1
B29R19C12	29-12-19	Hs~Ref:NM_022788.2~uORF:IOH12543	776	590	741	593	983	681	773	638	1024	411	purinergic receptor P2Y, G-protein coupled, 12 (P2RY12), transcript variant 1
B29R19C13	29-13-19	Hs~MGC:BC002510.2~uORF:IOH3936	1498	583	898	754	1953	773	7035	573	1709	351	RAB6B, member RAS oncogene family (RAB6B)
B29R19C14	29-14-19	Hs~MGC:BC002510.2~uORF:IOH3936	1492	581	938	630	2034	650	7118	558	1846	364	RAB6B, member RAS oncogene family (RAB6B)
B29R19C15	29-15-19	Hs~MGC:BC036364.1~uORF:IOH45976	797	700	1121	1387	772	637	838	588	1640	334	BH3 interacting domain death agonist (BID)
B29R19C16	29-16-19	Hs~MGC:BC036364.1~uORF:IOH45976	796	686	1076	1398	840	702	788	578	1583	337	BH3 interacting domain death agonist (BID)
B29R19C17	29-17-19	Hs~Ref:NM_018132.3~uORF:IOH45979	1353	2680	1698	3465	953	2027	2128	1062	2150	563	centromere protein Q (CENPQ)
B29R19C18	29-18-19	Hs~Ref:NM_018132.3~uORF:IOH45979	1305	2883	1672	3377	915	2039	2074	1093	2639	536	centromere protein Q (CENPQ)
B29R19C19	29-19-19	Hs~Ref:NM_018276.2~uORF:IOH43518	865	361	669	592	766	713	705	501	907	324	Protein phosphatase Slingshot homolog 3
B29R19C20	29-20-19	Hs~Ref:NM_018276.2~uORF:IOH43518	823	347	837	553	630	773	691	508	857	313	Protein phosphatase Slingshot homolog 3
B29R19C21	29-21-19	Hs~Ref:NM_004545.1~uORF:IOH9964	515	998	722	415	738	642	613	389	1497	5814	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa (NDUFB1)
B29R19C22	29-22-19	Hs~Ref:NM_004545.1~uORF:IOH9964	489	1068	631	430	977	637	621	448	1484	5725	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa (NDUFB1)
B29R20C01	29-1-20	Hs~MGC:BC008624.1~uORF:IOH9639	1793	2188	608	547	705	962	5890	1099	1692	8553	cDNA clone MGC:18299 IMAGE:4179890, complete cds
B29R20C02	29-2-20	Hs~MGC:BC008624.1~uORF:IOH9639	1745	2357	552	572	762	1042	6226	1099	1717	8474	cDNA clone MGC:18299 IMAGE:4179890, complete cds
B29R20C03	29-3-20	Hs~MGC:BC010498.1~uORF:IOH10180	374	458	770	267	499	611	380	323	919	239	paxillin (PXN)
B29R20C04	29-4-20	Hs~MGC:BC010498.1~uORF:IOH10180	344	527	558	273	538	585	370	357	921	332	paxillin (PXN)
B29R20C05	29-5-20	Hs~MGC:BC016464.1~uORF:IOH10216	572	583	660	469	615	593	940	612	1582	395	ER degradation enhancer, mannosidase alpha-like 3 (EDEM3)
B29R20C06	29-6-20	Hs~MGC:BC016464.1~uORF:IOH10216	642	583	720	454	617	613	950	680	1457	692	ER degradation enhancer, mannosidase alpha-like 3 (EDEM3)
B29R20C07	29-7-20	Hs~Ref:NM_012394.2~uORF:IOH10683	303	401	423	420	367	365	380	305	1703	171	prefoldin subunit 2 (PFDN2)
B29R20C08	29-8-20	Hs~Ref:NM_012394.2~uORF:IOH10683	312	394	441	442	398	377	375	309	1718	148	prefoldin subunit 2 (PFDN2)
B29R20C09	29-9-20	Hs~Ref:NM_032353.1~uORF:IOH6304	381	338	430	1036	487	443	395	518	6337	202	vacuolar protein sorting 25 homolog (S. cerevisiae) (VPS25)
B29R20C10	29-10-20	Hs~Ref:NM_032353.1~uORF:IOH6304	478	534	426	1023	629	444	424	539	6584	185	vacuolar protein sorting 25 homolog (S. cerevisiae) (VPS25)
B29R20C11	29-11-20	Hs~Ref:NM_013230.1~uORF:IOH5911	642	392	579	356	526	530	561	750	678	1270	CD24 molecule (CD24)
B29R20C12	29-12-20	Hs~Ref:NM_013230.1~uORF:IOH5911	549	407	578	366	570	546	576	705	634	1249	CD24 molecule (CD24)
B29R20C13	29-13-20	Hs~MGC:BC015207.1~uORF:IOH11738	889	498	689	383	624	698	624	470	790	2888	ARP3 actin-related protein 3 homolog B (yeast) (ACTR3B)
B29R20C14	29-14-20	Hs~MGC:BC015207.1~uORF:IOH11738	796	489	717	319	442	709	623	454	956	2988	ARP3 actin-related protein 3 homolog B (yeast) (ACTR3B)
B30R02C11	30-11-2	Hs~MGC:BC004242.1~uORF:IOH5508	1874	2002	2434	1995	2060	1817	1596	2595	4832	1281	heterogeneous nuclear ribonucleoprotein U-like 1, mRNA (cDNA clone IMAGE:3619753), complete cds.
B30R02C12	30-12-2	Hs~MGC:BC004242.1~uORF:IOH5508	1802	2080	2471	1996	2110	1913	1654	2485	5601	1373	heterogeneous nuclear ribonucleoprotein U-like 1, mRNA (cDNA clone IMAGE:3619753), complete cds.
B30R02C13	30-13-2	Hs~MGC:BC013795.1~uORF:IOH11405	1500	938	1465	862	1028	1191	1699	1118	2671	760	Bardet-Biedl syndrome 10 protein
B30R02C14	30-14-2	Hs~MGC:BC013795.1~uORF:IOH11405	1432	974	1626	795	1258	1279	1752	1161	2767	721	Bardet-Biedl syndrome 10 protein
B30R02C15	30-15-2	Hs~MGC:NM_174942.1~uORF:IOH26291	4719	2632	4768	2384	6902	2789	14174	2266	7624	1413	GAS2-like protein 3
B30R02C16	30-16-2	Hs~MGC:NM_174942.1~uORF:IOH26291	4924	2773	4759	2650	5756	2731	14130	2304	7928	1313	GAS2-like protein 3
B30R02C17	30-17-2	Hs~MGC:BC025714.1~uORF:IOH11342	1685	1423	1886	1436	2044	2022	2855	1714	4103	687	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform
B30R02C18	30-18-2	Hs~MGC:BC025714.1~uORF:IOH11342	1714	1282	1927	1207	2181	1965	2803	1683	4129	676	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform
B30R02C19	30-19-2	Hs~MGC:BC011563.1~uORF:IOH12467	418	319	447	257	804	436	2566	322	781	17	Linker for activation of T-cells family member 1
B30R02C20	30-20-2	Hs~MGC:BC011563.1~uORF:IOH12467	352	297	434	266	1088	415	2546	329	753	280	Linker for activation of T-cells family member 1
B30R02C21	30-21-2	Hs~Ref:NM_004214.3~uORF:IOH2103	1152	829	1482	613	1491	818	2852	709	1090	540	fibroblast growth factor (acidic) intracellular binding protein (FIBP), transcript variant 2
B30R02C22	30-22-2	Hs~Ref:NM_004214.3~uORF:IOH2103	1118	843	1440	649	1131	829	3269	667	1057	495	fibroblast growth factor (acidic) intracellular binding protein (FIBP), transcript variant 2
B30R03C01	30-1-3	Hs~Ref:NM_006463.2~uORF:IOH2225	615	1474	1101	434	756	1324	605	1656	1119	603	STAM binding protein (STAMBP), transcript variant 1
B30R03C02	30-2-3	Hs~Ref:NM_006463.2~uORF:IOH2225	589	1569	1140	459	821	1339	623	1622	1139	592	STAM binding protein (STAMBP), transcript variant 1
B30R03C03	30-3-3	Hs~MGC:BC020647.1~uORF:IOH12765	976	623	990	901	851	820	2604	806	2094	387	coiled-coil domain containing 59 (CCDC59)
B30R03C04	30-4-3	Hs~MGC:BC020647.1~uORF:IOH12765	1010	595	978	951	831	798	2441	829	1931	291	coiled-coil domain containing 59 (CCDC59)
B30R03C05	30-5-3	Hs~Ref:NM_032602.1~uORF:IOH35940	348	390	511	246	242	479	369	233	407	131	Gap junction alpha-10 protein
B30R03C06	30-6-3	Hs~Ref:NM_032602.1~uORF:IOH35940	229	329	458	265	180	308	386	296	524	332	Gap junction alpha-10 protein
B30R03C07	30-7-3	Hs~Ref:NM_030911.1~uORF:IOH41011	644	4028	1019	408	428	1299	2293	2241	888	229	cytidine and dCMP deaminase domain containing 1 (CDADC1)
B30R03C08	30-8-3	Hs~Ref:NM_030911.1~uORF:IOH41011	600	4547	999	466	423	1337	2248	1786	820	256	cytidine and dCMP deaminase domain containing 1 (CDADC1)
B30R03C09	30-9-3	Hs~Ref:NM_020662.1~uORF:IOH37719	120	324	356	215	130	305	234	220	491	138	MRS2-like, magnesium homeostasis factor (S. cerevisiae) (MRS2L)
B30R03C10	30-10-3	Hs~Ref:NM_020662.1~uORF:IOH37719	353	280	364	213	126	225	251	231	275	112	MRS2-like, magnesium homeostasis factor (S. cerevisiae) (MRS2L)
B30R03C11	30-11-3	Hs~Ref:NM_000879.2~uORF:IOH40150	327	319	437	228	376	282	281	327	537	74	interleukin 5 (colony-stimulating factor, eosinophil) (IL5)
B30R03C12	30-12-3	Hs~Ref:NM_000879.2~uORF:IOH40150	222	338	387	232	338	304	323	326	797	77	interleukin 5 (colony-stimulating factor, eosinophil) (IL5)
B30R03C13	30-13-3	Hs~Ref:NM_021947.1~uORF:IOH41603	525	571	501	1411	2042	783	591	384	1161	492	serine racemase (SRR)
B30R03C14	30-14-3	Hs~Ref:NM_021947.1~uORF:IOH41603	505	582	500	1376	637	777	582	375	1119	418	serine racemase (SRR)
B30R03C15	30-15-3	Hs~Ref:NM_006902.3~uORF:IOH36664	2075	1195	2097	1546	3342	2355	2545	966	3747	512	paired related homeobox 1 (PRRX1), transcript variant pmx-1a
B30R03C16	30-16-3	Hs~Ref:NM_006902.3~uORF:IOH36664	2151	1149	2033	1624	2735	2317	2706	1071	3742	535	paired related homeobox 1 (PRRX1), transcript variant pmx-1a
B30R03C17	30-17-3	Hs~Ref:NM_207035.1~uORF:IOH41684	1205	744	1062	959	1863	887	1130	1253	1719	633	UPF0471 protein C1orf63 homolog
B30R03C18	30-18-3	Hs~Ref:NM_207035.1~uORF:IOH41684	1267	748	1146	980	1831	978	1140	1237	1739	644	UPF0471 protein C1orf63 homolog
B30R03C19	30-19-3	Hs~Ref:NM_201613.1~uORF:IOH45918	902	1181	1081	1217	1247	3023	1489	1144	2660	649	IKK interacting protein (IKIP), transcript variant 3.1
B30R03C20	30-20-3	Hs~Ref:NM_201613.1~uORF:IOH45918	909	1157	835	1167	1199	3049	1469	1120	2751	623	IKK interacting protein (IKIP), transcript variant 3.1
B30R03C21	30-21-3	Hs~MGC:BC020962.1~uORF:IOH10372	858	634	846	465	1139	719	1921	555	1149	318	sulfatase 2 (SULF2)
B30R03C22	30-22-3	Hs~MGC:BC020962.1~uORF:IOH10372	945	635	837	477	622	671	1830	526	1012	288	sulfatase 2 (SULF2)
B30R04C01	30-1-4	Hs~Ref:NM_020424.2~uORF:IOH10391	568	552	700	546	349	500	975	497	905	523	LYR motif containing 1 (LYRM1)
B30R04C02	30-2-4	Hs~Ref:NM_020424.2~uORF:IOH10391	596	543	735	554	389	566	1177	535	968	513	LYR motif containing 1 (LYRM1)
B30R04C03	30-3-4	Hs~Ref:NM_014061.3~uORF:IOH10824	4430	2762	3453	4041	1969	2413	14274	1688	5436	3003	melanoma antigen family H, 1 (MAGEH1)
B30R04C04	30-4-4	Hs~Ref:NM_014061.3~uORF:IOH10824	4615	2589	3343	4090	2019	2285	15590	1645	5663	2684	melanoma antigen family H, 1 (MAGEH1)
B30R04C05	30-5-4	Hs~MGC:BC016395.1~uORF:IOH11318	648	648	1847	489	1164	2686	2286	1082	2331	498	family with sequence similarity 119, member B (FAM119B)
B30R04C06	30-6-4	Hs~MGC:BC016395.1~uORF:IOH11318	696	700	1902	481	1074	2598	2227	1045	2346	543	family with sequence similarity 119, member B (FAM119B)
B30R04C07	30-7-4	Hs~MGC:BC017227.1~uORF:IOH12094	1015	1021	3221	1308	1504	1725	1104	1494	14476	1065	phosducin-like (PDCL)
B30R04C08	30-8-4	Hs~MGC:BC017227.1~uORF:IOH12094	1047	1058	3228	1320	1558	1742	1052	1502	15407	1072	phosducin-like (PDCL)
B30R04C09	30-9-4	Hs~MGC:BC014665.1~uORF:IOH14248	987	1407	926	917	537	967	2091	1415	2719	435	alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5)
B30R04C10	30-10-4	Hs~MGC:BC014665.1~uORF:IOH14248	1133	1560	861	884	558	1018	2068	1306	3121	391	alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5)
B30R04C11	30-11-4	Hs~MGC:NM_172341.1~uORF:IOH14527	667	716	808	457	732	649	666	738	1732	195	presenilin enhancer 2 homolog (C. elegans) (PSENEN)
B30R04C12	30-12-4	Hs~MGC:NM_172341.1~uORF:IOH14527	611	732	807	490	808	691	663	766	1692	419	presenilin enhancer 2 homolog (C. elegans) (PSENEN)
B30R04C13	30-13-4	Hs~MGC:BC010504.1~uORF:IOH10186	572	418	941	371	2732	464	733	508	2031	184	Phospholipase DDHD2
B30R04C14	30-14-4	Hs~MGC:BC010504.1~uORF:IOH10186	571	422	941	366	1161	441	709	508	1906	215	Phospholipase DDHD2
B30R04C15	30-15-4	Hs~Ref:NM_133265.2~uORF:IOH38152	6337	11060	13010	15990	6207	6759	7238	5746	9633	2205	angiomotin (AMOT)
B30R04C16	30-16-4	Hs~Ref:NM_133265.2~uORF:IOH38152	7048	12015	12500	16193	5836	6680	7325	5482	9993	2043	angiomotin (AMOT)
B30R04C17	30-17-4	Hs~Ref:NM_004398.2~uORF:IOH38427	1120	741	907	572	916	930	3001	714	1429	350	DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 (DDX10)
B30R04C18	30-18-4	Hs~Ref:NM_004398.2~uORF:IOH38427	1224	691	869	521	757	894	2838	732	1385	404	DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 (DDX10)
B30R04C19	30-19-4	Hs~MGC:BC058836.1~uORF:IOH29500	794	568	875	422	837	630	914	525	855	293	WD repeat domain 3 (WDR3)
B30R04C20	30-20-4	Hs~MGC:BC058836.1~uORF:IOH29500	824	637	747	424	103	683	943	596	919	362	WD repeat domain 3 (WDR3)
B30R04C21	30-21-4	Hs~Ref:NM_004798.2~uORF:IOH38253	2987	2092	2507	2389	3854	3236	3594	13033	2717	942	kinesin family member 3B (KIF3B)
B30R04C22	30-22-4	Hs~Ref:NM_004798.2~uORF:IOH38253	3113	2235	2368	2397	3824	3277	3610	13120	2712	1044	kinesin family member 3B (KIF3B)
B30R05C01	30-1-5	Hs~MGC:BC020688.1~uORF:IOH12152	305	935	513	304	454	637	1794	286	1190	400	ubiquitin specific peptidase 15 (USP15)
B30R05C02	30-2-5	Hs~MGC:BC020688.1~uORF:IOH12152	223	1037	556	340	434	660	1752	297	1142	440	ubiquitin specific peptidase 15 (USP15)
B30R05C03	30-3-5	Hs~Ref:NM_138818.1~uORF:IOH13380	1254	729	1325	863	950	925	1621	773	2232	452	prune homolog 2 (Drosophila) (PRUNE2)
B30R05C04	30-4-5	Hs~Ref:NM_138818.1~uORF:IOH13380	1307	713	1204	959	968	915	1537	801	2277	569	prune homolog 2 (Drosophila) (PRUNE2)
B30R05C05	30-5-5	Hs~MGC:BC017873.1~uORF:IOH12434	1518	1715	1696	1419	1387	1109	1514	1398	2632	911	family with sequence similarity 33, member A (FAM33A)
B30R05C06	30-6-5	Hs~MGC:BC017873.1~uORF:IOH12434	1587	1657	2221	1520	1515	1096	1589	1355	2528	924	family with sequence similarity 33, member A (FAM33A)
B30R05C07	30-7-5	Hs~Ref:NM_005797.2~uORF:IOH12078	825	754	1500	7701	1094	1289	1144	772	1518	556	myelin protein zero-like 2 (MPZL2), transcript variant 1
B30R05C08	30-8-5	Hs~Ref:NM_005797.2~uORF:IOH12078	536	811	1404	6969	924	1219	1122	799	1573	366	myelin protein zero-like 2 (MPZL2), transcript variant 1
B30R05C09	30-9-5	Hs~Ref:NM_003607.1~N/A	647	614	1547	496	1011	1049	1106	913	2422	166	Serine/threonine-protein kinase MRCK alpha
B30R05C10	30-10-5	Hs~Ref:NM_003607.1~N/A	614	651	1494	487	739	1062	1129	953	2520	120	Serine/threonine-protein kinase MRCK alpha
B30R05C11	30-11-5	Hs~Ref:NM_018650.1~N/A	1234	793	2032	1692	2007	993	1656	888	2893	264	Serine/threonine-protein kinase MARK1
B30R05C12	30-12-5	Hs~Ref:NM_018650.1~N/A	1271	735	2007	1729	1865	995	1758	802	2917	444	Serine/threonine-protein kinase MARK1
B30R05C13	30-13-5	Hs~Ref:NM_004954.2~N/A	1198	813	2565	1400	2760	1500	2341	910	3713	645	Serine/threonine-protein kinase MARK2
B30R05C14	30-14-5	Hs~Ref:NM_004954.2~N/A	1133	860	2403	1309	1636	1474	2504	873	3447	612	Serine/threonine-protein kinase MARK2
B30R05C15	30-15-5	Hs~Ref:NM_006281.1~N/A	1066	747	1857	623	1465	1119	2024	990	2177	471	serine/threonine kinase 3 (STE20 homolog, yeast) (STK3)
B30R05C16	30-16-5	Hs~Ref:NM_006281.1~N/A	1104	767	1795	617	1505	1049	2048	1060	2217	528	serine/threonine kinase 3 (STE20 homolog, yeast) (STK3)
B30R05C17	30-17-5	Hs~Ref:NM_003865.1~uORF:IOH40237	2512	1418	1964	1300	2836	1594	2854	1262	3531	1034	HESX homeobox 1 (HESX1)
B30R05C18	30-18-5	Hs~Ref:NM_003865.1~uORF:IOH40237	3068	1487	1748	1336	2793	1541	2783	1210	3151	898	HESX homeobox 1 (HESX1)
B30R05C19	30-19-5	Hs~MGC:BC068446.1~uORF:IOH40110	1337	1273	2155	881	1605	1210	2301	1027	2052	653	UDP glycosyltransferase 3 family, polypeptide A1 (UGT3A1)
B30R05C20	30-20-5	Hs~MGC:BC068446.1~uORF:IOH40110	1296	1440	1995	819	1713	1130	2699	1036	2100	762	UDP glycosyltransferase 3 family, polypeptide A1 (UGT3A1)
B30R05C21	30-21-5	Hs~Ref:NM_018402.1~uORF:IOH40165	1668	1083	1565	816	1658	1182	4505	1005	1900	569	interleukin 26 (IL26)
B30R05C22	30-22-5	Hs~Ref:NM_018402.1~uORF:IOH40165	1707	1117	1533	865	1658	1119	3787	1064	1827	626	interleukin 26 (IL26)
B30R06C01	30-1-6	Hs~Ref:NM_018724.3~uORF:IOH40238	1225	1006	1535	908	1267	1260	2410	990	2240	617	interleukin 20 (IL20)
B30R06C02	30-2-6	Hs~Ref:NM_018724.3~uORF:IOH40238	1227	1053	1609	1014	1260	1311	2457	966	2211	664	interleukin 20 (IL20)
B30R06C03	30-3-6	Hs~MGC:BC033794.1~uORF:IOH21798	2418	3146	2922	1126	1493	2158	2479	1058	3137	812	HD domain containing 3 (HDDC3)
B30R06C04	30-4-6	Hs~MGC:BC033794.1~uORF:IOH21798	2584	3196	2832	1136	1645	2005	2492	1062	3075	864	HD domain containing 3 (HDDC3)
B30R06C05	30-5-6	Hs~MGC:NM_173470.1~uORF:IOH21527	4905	4289	3870	2538	4060	3176	4070	2847	4865	3584	transmembrane protein 32 (TMEM32)
B30R06C06	30-6-6	Hs~MGC:NM_173470.1~uORF:IOH21527	5087	4471	3830	2524	3283	3107	4058	2964	4792	3376	transmembrane protein 32 (TMEM32)
B30R06C07	30-7-6	Hs~MGC:BC018782.1~uORF:IOH23121	15243	2329	1352	619	1762	1097	1118	867	1586	538	interleukin 32 (IL32)
B30R06C08	30-8-6	Hs~MGC:BC018782.1~uORF:IOH23121	16298	2609	1258	648	1743	1099	1141	849	1533	686	interleukin 32 (IL32)
B30R06C09	30-9-6	Hs~Ref:NM_138448.2~uORF:IOH10544	1791	1247	2196	1095	1650	2509	3054	1182	3680	716	acylphosphatase 2, muscle type (ACYP2)
B30R06C10	30-10-6	Hs~Ref:NM_138448.2~uORF:IOH10544	1782	1133	2184	1122	1696	2520	3162	1319	3679	751	acylphosphatase 2, muscle type (ACYP2)
B30R06C11	30-11-6	Hs~Ref:NM_003274.3~uORF:IOH53207	914	442	804	407	2119	666	1327	871	1669	84	Trafficking protein particle complex subunit 10
B30R06C12	30-12-6	Hs~Ref:NM_003274.3~uORF:IOH53207	863	451	798	423	2593	585	1405	744	1580	117	Trafficking protein particle complex subunit 10
B30R06C13	30-13-6	Hs~Ref:NM_003820.2~uORF:IOH59060	549	2022	933	665	887	1189	1109	1696	1310	670	Tumor necrosis factor receptor superfamily member 14
B30R06C14	30-14-6	Hs~Ref:NM_003820.2~uORF:IOH59060	525	2178	925	646	478	1343	1121	1713	1429	614	Tumor necrosis factor receptor superfamily member 14
B30R06C15	30-15-6	Hs~Ref:NM_001024732.1~uORF:IOH54967	708	431	622	556	3115	906	786	516	1326	310	Trans-2-enoyl-CoA reductase, mitochondrial
B30R06C16	30-16-6	Hs~Ref:NM_001024732.1~uORF:IOH54967	745	392	668	563	2266	1013	768	550	1391	267	Trans-2-enoyl-CoA reductase, mitochondrial
B30R06C17	30-17-6	Hs~Ref:NM_001001391.1~uORF:IOH53593	496	1314	702	486	2007	502	1427	765	1158	169	CD44 antigen
B30R06C18	30-18-6	Hs~Ref:NM_001001391.1~uORF:IOH53593	558	1329	620	494	1563	511	1297	742	1120	229	CD44 antigen
B30R06C19	30-19-6	Hs~Ref:NM_001746.2~uORF:IOH4977	489	351	517	385	999	448	932	360	801	288	calnexin (CANX), transcript variant 1
B30R06C20	30-20-6	Hs~Ref:NM_001746.2~uORF:IOH4977	495	500	514	411	958	466	950	361	865	172	calnexin (CANX), transcript variant 1
B30R06C21	30-21-6	Hs~Ref:NM_017704.2~uORF:IOH12866	491	357	514	1612	419	618	347	981	1070	446	ankyrin repeat domain 49 (ANKRD49)
B30R06C22	30-22-6	Hs~Ref:NM_017704.2~uORF:IOH12866	514	373	509	1566	386	570	344	950	1065	614	ankyrin repeat domain 49 (ANKRD49)
B30R07C01	30-1-7	Hs~Ref:NM_014406.4~uORF:IOH21813	809	504	956	531	631	1180	1209	492	999	342	chaperonin containing TCP1, subunit 8 (theta)-like 2 (CCT8L2)
B30R07C02	30-2-7	Hs~Ref:NM_014406.4~uORF:IOH21813	851	482	998	663	596	1188	1158	529	1373	363	chaperonin containing TCP1, subunit 8 (theta)-like 2 (CCT8L2)
B30R07C03	30-3-7	Hs~Ref:NM_032036.2~uORF:IOH21906	1188	836	1158	753	1012	1874	3463	687	1293	338	family with sequence similarity 14, member A (FAM14A)
B30R07C04	30-4-7	Hs~Ref:NM_032036.2~uORF:IOH21906	1264	854	1173	681	1048	1957	3371	679	1274	480	family with sequence similarity 14, member A (FAM14A)
B30R07C05	30-5-7	Hs~MGC:BC004897.1~uORF:IOH5182	485	371	501	338	513	680	720	272	1150	215	Carbonic anhydrase 3
B30R07C06	30-6-7	Hs~MGC:BC004897.1~uORF:IOH5182	473	389	499	337	542	674	704	273	1131	264	Carbonic anhydrase 3
B30R07C07	30-7-7	Hs~Ref:NM_003250.2~uORF:IOH5349	1559	749	2226	1439	1287	1115	1399	2875	2492	484	Thyroid hormone receptor alpha
B30R07C08	30-8-7	Hs~Ref:NM_003250.2~uORF:IOH5349	1564	804	2131	1486	1269	1113	1389	2879	2396	131	Thyroid hormone receptor alpha
B30R07C09	30-9-7	Hs~Ref:NM_001628.1~uORF:IOH4505	492	420	781	479	1700	616	638	972	1208	413	Aldose reductase
B30R07C10	30-10-7	Hs~Ref:NM_001628.1~uORF:IOH4505	701	410	811	507	1630	619	659	989	1319	140	Aldose reductase
B30R07C11	30-11-7	Hs~MGC:NM_152329.3~uORF:IOH23002	1280	760	1079	641	899	872	2369	904	1310	79	Peptidylprolyl isomerase-like 5
B30R07C12	30-12-7	Hs~MGC:NM_152329.3~uORF:IOH23002	1140	722	1139	670	883	832	2426	852	1381	112	Peptidylprolyl isomerase-like 5
B30R07C13	30-13-7	Hs~Ref:NM_005813.2~N/A	990	612	1437	605	851	708	2776	814	1657	487	Serine/threonine-protein kinase D3
B30R07C14	30-14-7	Hs~Ref:NM_005813.2~N/A	980	599	1829	563	913	868	2992	748	1609	362	Serine/threonine-protein kinase D3
B30R07C15	30-15-7	Hs~Ref:NM_004938.1~N/A	6591	1221	1850	1010	1057	5060	3122	1084	2145	564	Death-associated protein kinase 1
B30R07C16	30-16-7	Hs~Ref:NM_004938.1~N/A	6856	1249	1837	960	1070	5445	3183	1102	2197	548	Death-associated protein kinase 1
B30R07C17	30-17-7	Hs~MGC:BC008708.1~uORF:IOH6868	662	318	598	323	274	475	736	422	1194	401	hydroxysteroid (17-beta) dehydrogenase 10 (HSD17B10)
B30R07C18	30-18-7	Hs~MGC:BC008708.1~uORF:IOH6868	747	353	578	348	273	438	798	461	613	37	hydroxysteroid (17-beta) dehydrogenase 10 (HSD17B10)
B30R07C19	30-19-7	Hs~Ref:NM_014039.2~uORF:IOH9689	1118	1034	1117	613	681	991	1700	636	1737	376	Ester hydrolase C11orf54
B30R07C20	30-20-7	Hs~Ref:NM_014039.2~uORF:IOH9689	1098	1278	1106	594	712	878	1562	676	1576	468	Ester hydrolase C11orf54
B30R07C21	30-21-7	Hs~Ref:NM_014774.1~uORF:IOH4054	1896	699	1482	599	793	690	1179	2358	1107	194	KIAA0494 (KIAA0494)
B30R07C22	30-22-7	Hs~Ref:NM_014774.1~uORF:IOH4054	1714	581	1472	608	802	727	1044	2196	1163	265	KIAA0494 (KIAA0494)
B30R08C01	30-1-8	Hs~Ref:NM_031465.2~uORF:IOH6623	1434	698	1140	656	538	1064	3536	889	1424	382	chromosome 12 open reading frame 32 (C12orf32)
B30R08C02	30-2-8	Hs~Ref:NM_031465.2~uORF:IOH6623	1509	639	1225	1082	508	1088	3715	905	1343	430	chromosome 12 open reading frame 32 (C12orf32)
B30R08C03	30-3-8	Hs~Ref:NM_006779.2~uORF:IOH14061	1777	871	2522	735	1023	934	7939	930	1631	316	CDC42 effector protein (Rho GTPase binding) 2 (CDC42EP2)
B30R08C04	30-4-8	Hs~Ref:NM_006779.2~uORF:IOH14061	1824	855	2553	630	1076	912	7802	916	1649	487	CDC42 effector protein (Rho GTPase binding) 2 (CDC42EP2)
B30R08C05	30-5-8	Hs~MGC:BC000807.1~uORF:IOH3072	755	362	720	396	426	563	1510	486	868	157	zinc finger protein 160 (ZNF160)
B30R08C06	30-6-8	Hs~MGC:BC000807.1~uORF:IOH3072	751	391	671	394	397	539	1497	488	859	157	zinc finger protein 160 (ZNF160)
B30R08C07	30-7-8	Hs~Ref:NM_032673.1~uORF:IOH5517	1181	666	978	524	884	750	1468	580	1243	347	polycomb group ring finger 1 (PCGF1)
B30R08C08	30-8-8	Hs~Ref:NM_032673.1~uORF:IOH5517	1153	661	941	563	1110	755	1392	610	1072	335	polycomb group ring finger 1 (PCGF1)
B30R08C09	30-9-8	Hs~MGC:BC003555.1~uORF:IOH4980	1885	556	1292	1225	979	1027	872	478	5413	234	nucleolar complex associated 2 homolog (S. cerevisiae) (NOC2L)
B30R08C10	30-10-8	Hs~MGC:BC003555.1~uORF:IOH4980	1994	583	1281	1197	886	1039	904	450	5785	241	nucleolar complex associated 2 homolog (S. cerevisiae) (NOC2L)
B30R08C11	30-11-8	Hs~Ref:NM_032873.3~uORF:IOH6812	1044	1786	2137	810	895	20549	2349	593	5418	423	Cbl-interacting protein Sts-1 (STS-1)
B30R08C12	30-12-8	Hs~Ref:NM_032873.3~uORF:IOH6812	1003	1756	2166	848	959	19066	2369	741	4644	411	Cbl-interacting protein Sts-1 (STS-1)
B30R08C13	30-13-8	Hs~MGC:BC033233.1~uORF:IOH23273	878	894	2002	2492	742	920	5508	1640	1660	622	SNAP25-interacting protein (SNIP)
B30R08C14	30-14-8	Hs~MGC:BC033233.1~uORF:IOH23273	785	876	1690	2390	651	1086	5691	1374	1576	579	SNAP25-interacting protein (SNIP)
B30R08C15	30-15-8	Hs~Ref:NM_017523.2~uORF:IOH45706	1129	586	3215	566	464	803	2096	625	1309	657	XIAP associated factor-1 (XAF1), transcript variant 1
B30R08C16	30-16-8	Hs~Ref:NM_017523.2~uORF:IOH45706	1086	594	2920	587	454	720	2089	651	1341	675	XIAP associated factor-1 (XAF1), transcript variant 1
B30R08C17	30-17-8	Hs~MGC:NM_175609.1~uORF:IOH11575	946	673	1333	577	1111	1206	1608	672	1769	4713	ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1), transcript variant 2
B30R08C18	30-18-8	Hs~MGC:NM_175609.1~uORF:IOH11575	1045	704	1242	602	1088	1251	2154	748	1589	4393	ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1), transcript variant 2
B30R08C19	30-19-8	Hs~MGC:BC035359.1~uORF:IOH27405	1029	869	1102	660	588	1141	2035	913	1821	574	sialic acid binding Ig-like lectin 6 (SIGLEC6)
B30R08C20	30-20-8	Hs~MGC:BC035359.1~uORF:IOH27405	1081	943	1319	796	625	1162	1528	894	1775	625	sialic acid binding Ig-like lectin 6 (SIGLEC6)
B30R08C21	30-21-8	Hs~MGC:BC042608.1~uORF:IOH27462	4032	2271	2841	2706	1519	3663	7063	2115	4984	1887	family with sequence similarity 90, member A1 (FAM90A1)
B30R08C22	30-22-8	Hs~MGC:BC042608.1~uORF:IOH27462	3805	1674	3115	2780	1450	3614	6554	2185	5315	1199	family with sequence similarity 90, member A1 (FAM90A1)
B30R09C01	30-1-9	Hs~Ref:NM_145008.1~uORF:IOH58718	1408	643	1436	667	1024	906	1341	879	1624	415	Protein yippee-like 4
B30R09C02	30-2-9	Hs~Ref:NM_145008.1~uORF:IOH58718	1489	625	1467	1122	925	1048	1397	907	1640	418	Protein yippee-like 4
B30R09C03	30-3-9	Hs~Ref:NM_000755.2~uORF:IOH52480	922	895	1178	1880	585	995	2303	752	1677	467	Carnitine O-acetyltransferase
B30R09C04	30-4-9	Hs~Ref:NM_000755.2~uORF:IOH52480	926	953	1149	1340	623	972	2277	716	1778	583	Carnitine O-acetyltransferase
B30R09C05	30-5-9	Hs~MGC:NM_000483.3~uORF:IOH54561	257	248	382	222	366	278	247	193	221	75	apolipoprotein C-II (APOC2)
B30R09C06	30-6-9	Hs~MGC:NM_000483.3~uORF:IOH54561	317	281	364	229	464	316	252	189	397	73	apolipoprotein C-II (APOC2)
B30R09C07	30-7-9	Hs~Ref:NM_005022.2~uORF:IOH58967	3964	6972	8465	2705	7362	4145	3784	4174	10648	2441	Profilin-1
B30R09C08	30-8-9	Hs~Ref:NM_005022.2~uORF:IOH58967	4143	7355	8342	2838	7267	3989	3706	4143	10849	2329	Profilin-1
B30R09C09	30-9-9	Hs~MGC:BC007501.2~uORF:IOH56901	931	628	945	487	802	949	650	1154	4132	295	Protein-L-isoaspartate(D-aspartate) O-methyltransferase
B30R09C10	30-10-9	Hs~MGC:BC007501.2~uORF:IOH56901	876	653	888	478	801	943	730	1115	4205	283	Protein-L-isoaspartate(D-aspartate) O-methyltransferase
B30R09C11	30-11-9	Hs~MGC:BC006558.2~uORF:IOH57072	274	261	381	218	278	342	551	290	240	116	Host cell factor 2
B30R09C12	30-12-9	Hs~MGC:BC006558.2~uORF:IOH57072	157	238	438	214	132	349	557	399	944	89	Host cell factor 2
B30R09C13	30-13-9	Hs~Ref:NM_006998.3~uORF:IOH56717	456	383	427	370	309	1467	573	1870	824	159	Secretagogin
B30R09C14	30-14-9	Hs~Ref:NM_006998.3~uORF:IOH56717	465	409	449	372	304	1413	504	1813	891	295	Secretagogin
B30R09C17	30-17-9	Hs~Ref:NM_003583.2~uORF:IOH2412	3805	2442	3697	2549	1618	1787	4868	1553	3562	935	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2), transcript variant 1
B30R09C18	30-18-9	Hs~Ref:NM_003583.2~uORF:IOH2412	4154	2602	3198	2771	1724	1682	6113	1438	3140	1031	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2), transcript variant 1
B30R09C19	30-19-9	Hs~MGC:BC000566.1~uORF:IOH4164	1113	405	709	459	329	1186	499	360	689	113	RAB, member of RAS oncogene family-like 4 (RABL4)
B30R09C20	30-20-9	Hs~MGC:BC000566.1~uORF:IOH4164	1158	372	848	413	329	376	499	373	654	136	RAB, member of RAS oncogene family-like 4 (RABL4)
B30R09C21	30-21-9	Hs~MGC:BC018942.1~uORF:IOH12834	1411	923	1745	654	622	934	921	612	1440	548	Rho GTPase-activating protein SYDE1
B30R09C22	30-22-9	Hs~MGC:BC018942.1~uORF:IOH12834	1386	628	1115	603	578	974	929	581	1567	384	Rho GTPase-activating protein SYDE1
B30R10C01	30-1-10	Hs~MGC:BC022454.2~uORF:IOH10977	1366	410	725	395	448	667	721	2682	3744	243	Transient receptor potential cation channel subfamily M member 3
B30R10C02	30-2-10	Hs~MGC:BC022454.2~uORF:IOH10977	1261	383	746	457	383	547	717	2715	3817	130	Transient receptor potential cation channel subfamily M member 3
B30R10C03	30-3-10	Hs~Ref:NM_016404.1~uORF:IOH12070	1196	695	1135	1325	1241	901	1597	817	1605	487	hypothetical protein HSPC152 (HSPC152)
B30R10C04	30-4-10	Hs~Ref:NM_016404.1~uORF:IOH12070	1230	755	1115	660	1164	857	1591	828	1553	409	hypothetical protein HSPC152 (HSPC152)
B30R10C07	30-7-10	Hs~Ref:NM_006251.4~uORF:IOH27141	1450	1130	2359	887	1849	1231	3228	1418	3318	762	AMP-activated protein_kinase A1/B1/G1: PRKAA1/B1/G1 sequences are seperated by -- (in protein list file).
B30R10C08	30-8-10	Hs~Ref:NM_006251.4~uORF:IOH27141	1492	1161	2282	908	1738	1246	3226	1486	3207	740	AMP-activated protein_kinase A1/B1/G1: PRKAA1/B1/G1 sequences are seperated by -- (in protein list file).
B30R10C09	30-9-10	Hs~MGC:BC015497.1~uORF:IOH11495	1739	1424	1738	970	1530	1046	2573	1077	2006	883	Transcriptional enhancer factor TEF-3
B30R10C10	30-10-10	Hs~MGC:BC015497.1~uORF:IOH11495	2076	1344	1892	1000	1564	1037	2766	1049	2186	672	Transcriptional enhancer factor TEF-3
B30R11C21	30-21-11	Hs~Ref:NM_005165.1~uORF:IOH3879	897	1796	1510	942	1029	805	1114	783	1925	513	aldolase C, fructose-bisphosphate (ALDOC)
B30R11C22	30-22-11	Hs~Ref:NM_005165.1~uORF:IOH3879	898	1919	1171	889	1029	807	1144	772	1772	566	aldolase C, fructose-bisphosphate (ALDOC)
B30R12C01	30-1-12	Hs~Ref:NM_016146.1~uORF:IOH9822	1019	1320	1003	497	990	1058	1583	651	1171	391	trafficking protein particle complex 4 (TRAPPC4)
B30R12C02	30-2-12	Hs~Ref:NM_016146.1~uORF:IOH9822	908	739	999	567	996	1161	1668	633	1178	415	trafficking protein particle complex 4 (TRAPPC4)
B30R12C03	30-3-12	Hs~MGC:BC000504.1~uORF:IOH3510	930	461	823	1034	595	809	1644	559	1214	371	Succinyl-CoA ligase [GDP-forming] subunit alpha, mitochondrial
B30R12C04	30-4-12	Hs~MGC:BC000504.1~uORF:IOH3510	1069	480	822	690	723	821	1752	586	1248	172	Succinyl-CoA ligase [GDP-forming] subunit alpha, mitochondrial
B30R12C05	30-5-12	Hs~Ref:NM_001930.2~uORF:IOH3570	1052	864	1591	998	1215	1083	2630	1648	2020	860	deoxyhypusine synthase (DHPS), transcript variant 1
B30R12C06	30-6-12	Hs~Ref:NM_001930.2~uORF:IOH3570	910	957	1632	968	1361	970	2684	1452	2111	887	deoxyhypusine synthase (DHPS), transcript variant 1
B30R12C07	30-7-12	Hs~Ref:NM_018423.1~N/A	1125	1020	1510	755	1167	1071	2024	969	2683	769	serine/threonine/tyrosine kinase 1 (STYK1)
B30R12C08	30-8-12	Hs~Ref:NM_018423.1~N/A	1221	1018	1410	764	943	1014	1954	1014	2756	728	serine/threonine/tyrosine kinase 1 (STYK1)
B30R12C09	30-9-12	Hs~Ref:NM_001084.2~uORF:IOH12981	1288	1056	1597	1191	994	1528	2108	944	2204	740	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3)
B30R12C10	30-10-12	Hs~Ref:NM_001084.2~uORF:IOH12981	2032	1076	1566	1238	977	1407	2112	996	2476	724	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3)
B30R12C11	30-11-12	Hs~MGC:NM_178858.3~uORF:IOH13450	1536	774	1259	676	782	875	1781	804	1783	271	sideroflexin 2 (SFXN2)
B30R12C12	30-12-12	Hs~MGC:NM_178858.3~uORF:IOH13450	1912	774	1308	707	714	896	1786	856	1834	605	sideroflexin 2 (SFXN2)
B30R12C13	30-13-12	Hs~MGC:BC014658.1~uORF:IOH13361	1594	617	4364	1010	800	851	1857	1027	3321	103	chromosome 9 open reading frame 82 (C9orf82)
B30R12C14	30-14-12	Hs~MGC:BC014658.1~uORF:IOH13361	1089	629	4200	1009	830	851	2013	1009	3372	79	chromosome 9 open reading frame 82 (C9orf82)
B30R12C15	30-15-12	Hs~Ref:NM_014548.2~uORF:IOH39971	741	984	1339	1745	770	1377	1509	1144	1549	414	tropomodulin 2 (neuronal) (TMOD2)
B30R12C16	30-16-12	Hs~Ref:NM_014548.2~uORF:IOH39971	766	1050	1293	1676	790	1253	1559	1119	1652	424	tropomodulin 2 (neuronal) (TMOD2)
B30R12C17	30-17-12	Hs~MGC:BC067120.1~uORF:IOH40451	1097	767	14755	2322	6303	1473	3870	1305	1882	405	protein tyrosine phosphatase domain containing 1, mRNA (cDNA clone MGC:70358 IMAGE:5539182), complete cds
B30R12C18	30-18-12	Hs~MGC:BC067120.1~uORF:IOH40451	1146	765	14056	2382	6337	1430	3890	1197	1837	469	protein tyrosine phosphatase domain containing 1, mRNA (cDNA clone MGC:70358 IMAGE:5539182), complete cds
B30R12C19	30-19-12	Hs~Ref:NM_138458.1~uORF:IOH39984	247	238	310	213	127	184	520	221	294	83	WD repeat domain 92 (WDR92)
B30R12C20	30-20-12	Hs~Ref:NM_138458.1~uORF:IOH39984	228	227	494	172	227	265	569	271	229	110	WD repeat domain 92 (WDR92)
B30R12C21	30-21-12	Hs~Ref:NM_032368.3~uORF:IOH39898	565	667	2312	840	544	1252	881	1217	2377	346	leucine zipper and CTNNBIP1 domain containing (LZIC)
B30R12C22	30-22-12	Hs~Ref:NM_032368.3~uORF:IOH39898	557	718	2197	772	575	1258	856	1154	2519	178	leucine zipper and CTNNBIP1 domain containing (LZIC)
B30R13C01	30-1-13	Hs~Ref:NM_030755.1~uORF:IOH22397	643	989	1342	523	560	921	1013	713	2674	484	thioredoxin domain containing 1 (TXNDC1)
B30R13C02	30-2-13	Hs~Ref:NM_030755.1~uORF:IOH22397	706	833	1245	565	606	945	1081	739	2591	410	thioredoxin domain containing 1 (TXNDC1)
B30R13C03	30-3-13	Hs~MGC:BC030711.2~uORF:IOH22414	2110	1171	4138	1372	1913	31002	5905	1501	3421	430	Aprataxin and PNK-like factor
B30R13C04	30-4-13	Hs~MGC:BC030711.2~uORF:IOH22414	2150	1261	3981	1405	2031	31045	5889	1444	3542	376	Aprataxin and PNK-like factor
B30R13C07	30-7-13	Hs~MGC:BC036540.2~uORF:IOH22457	613	588	862	504	561	543	739	764	2534	412	hypothetical LOC400120 (LOC400120)
B30R13C08	30-8-13	Hs~MGC:BC036540.2~uORF:IOH22457	636	566	767	518	633	608	841	796	2678	450	hypothetical LOC400120 (LOC400120)
B30R13C09	30-9-13	Hs~Ref:NM_080876.2~uORF:IOH27172	674	549	943	453	437	495	978	584	2029	365	dual specificity phosphatase 19 (DUSP19)
B30R13C10	30-10-13	Hs~Ref:NM_080876.2~uORF:IOH27172	1220	594	907	495	409	508	914	529	727	153	dual specificity phosphatase 19 (DUSP19)
B30R13C11	30-11-13	Hs~Ref:NM_031954.2~uORF:IOH25947	3176	1216	1032	1068	1007	1093	1695	1145	2399	1054	potassium channel tetramerisation domain containing 10 (KCTD10)
B30R13C12	30-12-13	Hs~Ref:NM_031954.2~uORF:IOH25947	2253	1218	1014	1061	956	980	1558	1145	2243	1016	potassium channel tetramerisation domain containing 10 (KCTD10)
B30R13C13	30-13-13	Hs~MGC:BC040183.2~uORF:IOH27627	718	528	738	436	797	586	1032	532	1670	368	Rap guanine nucleotide exchange factor (GEF) 4 (RAPGEF4)
B30R13C14	30-14-13	Hs~MGC:BC040183.2~uORF:IOH27627	740	500	777	464	831	575	1107	522	1426	293	Rap guanine nucleotide exchange factor (GEF) 4 (RAPGEF4)
B30R13C15	30-15-13	Hs~MGC:BC029495.1~uORF:IOH22527	841	499	1085	531	425	707	1232	397	866	1198	Ubiquitin carboxyl-terminal hydrolase 6
B30R13C16	30-16-13	Hs~MGC:BC029495.1~uORF:IOH22527	835	471	1048	546	447	715	1311	455	917	1170	Ubiquitin carboxyl-terminal hydrolase 6
B30R13C17	30-17-13	Hs~MGC:BC025787.1~uORF:IOH12000	2737	1456	2258	2683	989	1911	12007	1548	3302	760	alkB, alkylation repair homolog 1 (E. coli) (ALKBH1)
B30R13C18	30-18-13	Hs~MGC:BC025787.1~uORF:IOH12000	2950	1510	2214	2606	1003	1903	12249	1636	3339	650	alkB, alkylation repair homolog 1 (E. coli) (ALKBH1)
B30R13C19	30-19-13	Hs~MGC:BC053347.1~uORF:IOH28937	540	435	593	507	1252	641	665	408	726	288	myelin associated glycoprotein (MAG)
B30R13C20	30-20-13	Hs~MGC:BC053347.1~uORF:IOH28937	520	448	623	491	1208	595	701	314	628	154	myelin associated glycoprotein (MAG)
B30R13C21	30-21-13	Hs~MGC:BC001048.1~uORF:IOH4605	1285	671	1363	775	759	1137	1324	753	1331	283	PCTAIRE protein kinase 1 (PCTK1)
B30R13C22	30-22-13	Hs~MGC:BC001048.1~uORF:IOH4605	1199	697	1283	754	750	1130	1330	720	1407	415	PCTAIRE protein kinase 1 (PCTK1)
B30R14C01	30-1-14	Hs~Ref:NM_003073.1~uORF:IOH29630	1056	825	1987	890	827	13496	3033	752	1803	405	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 (SMARCB1), transcript variant 1
B30R14C02	30-2-14	Hs~Ref:NM_003073.1~uORF:IOH29630	1093	832	1878	1009	606	13337	3057	775	1763	43	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 (SMARCB1), transcript variant 1
B30R14C03	30-3-14	Hs~Ref:NM_032361.1~uORF:IOH3160	1032	818	1211	823	1163	1057	1339	834	2246	811	THO complex 3 (THOC3)
B30R14C04	30-4-14	Hs~Ref:NM_032361.1~uORF:IOH3160	1003	767	1300	801	1032	977	1276	820	2244	415	THO complex 3 (THOC3)
B30R14C05	30-5-14	Hs~Ref:NM_004552.1~uORF:IOH4963	798	552	944	3919	680	844	1323	672	1279	699	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) (NDUFS5)
B30R14C06	30-6-14	Hs~Ref:NM_004552.1~uORF:IOH4963	707	617	1055	4201	625	833	1651	667	1379	620	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) (NDUFS5)
B30R14C07	30-7-14	Hs~Ref:NM_004016.1~uORF:IOH11698	843	1006	1047	1442	1045	1410	4122	610	1816	315	dystrophin (muscular dystrophy, Duchenne and Becker types) (DMD), transcript variant Dp71b
B30R14C08	30-8-14	Hs~Ref:NM_004016.1~uORF:IOH11698	865	1079	942	1414	1042	1325	3905	608	1864	258	dystrophin (muscular dystrophy, Duchenne and Becker types) (DMD), transcript variant Dp71b
B30R14C09	30-9-14	Hs~Ref:NM_001896.2~uORF:IOH6369	4869	2585	4593	2251	3134	2322	15885	1960	5745	2662	casein kinase 2, alpha prime polypeptide (CSNK2A2)
B30R14C10	30-10-14	Hs~Ref:NM_001896.2~uORF:IOH6369	4745	2646	4503	2338	3140	2320	16528	1923	5765	2769	casein kinase 2, alpha prime polypeptide (CSNK2A2)
B30R14C11	30-11-14	Hs~Ref:NM_207506.1~uORF:IOH59695	1139	614	1310	635	1738	981	978	538	1376	222	Sterile alpha motif domain-containing protein 12
B30R14C12	30-12-14	Hs~Ref:NM_207506.1~uORF:IOH59695	1270	617	1309	633	1818	982	898	587	1388	226	Sterile alpha motif domain-containing protein 12
B30R14C13	30-13-14	Hs~Ref:NM_005042.2~uORF:IOH53437	585	294	4021	627	451	1497	788	541	877	159	Salivary acidic proline-rich phosphoprotein 1/2
B30R14C14	30-14-14	Hs~Ref:NM_005042.2~uORF:IOH53437	549	294	3744	604	483	1467	835	521	882	197	Salivary acidic proline-rich phosphoprotein 1/2
B30R14C17	30-17-14	Hs~Ref:NM_015966.1~uORF:IOH13352	799	370	957	445	520	1047	663	363	931	125	ERGIC and golgi 3 (ERGIC3), transcript variant 2
B30R14C18	30-18-14	Hs~Ref:NM_015966.1~uORF:IOH13352	762	368	936	496	513	960	718	450	930	158	ERGIC and golgi 3 (ERGIC3), transcript variant 2
B30R14C19	30-19-14	Hs~MGC:BC058904.1~uORF:IOH29071	853	529	630	396	419	752	1330	588	737	169	armadillo repeat containing, X-linked 5 (ARMCX5)
B30R14C20	30-20-14	Hs~MGC:BC058904.1~uORF:IOH29071	829	525	625	396	415	686	1429	516	769	262	armadillo repeat containing, X-linked 5 (ARMCX5)
B30R14C21	30-21-14	Hs~MGC:BC054888.1~uORF:IOH29471	426	345	716	324	345	546	550	450	600	193	LSM14B, SCD6 homolog B (S. cerevisiae) (LSM14B)
B30R14C22	30-22-14	Hs~MGC:BC054888.1~uORF:IOH29471	430	395	663	348	359	605	513	427	598	219	LSM14B, SCD6 homolog B (S. cerevisiae) (LSM14B)
B30R15C01	30-1-15	Hs~MGC:BC052806.1~uORF:IOH28971	1264	641	1133	540	964	1125	3163	656	1191	595	mitochondrial ribosomal protein L55 (MRPL55)
B30R15C02	30-2-15	Hs~MGC:BC052806.1~uORF:IOH28971	1217	659	1100	575	530	1122	3162	649	1327	283	mitochondrial ribosomal protein L55 (MRPL55)
B30R15C03	30-3-15	Hs~MGC:BC056246.1~uORF:IOH29419	518	445	736	623	648	482	636	488	1101	488	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) (GALNT3)
B30R15C04	30-4-15	Hs~MGC:BC056246.1~uORF:IOH29419	556	466	728	383	630	474	774	493	1074	147	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) (GALNT3)
B30R15C05	30-5-15	Hs~Ref:NM_018216.1~uORF:IOH26341	1274	1190	1241	1589	907	1703	2680	6054	2807	1441	pantothenate kinase 4 (PANK4)
B30R15C06	30-6-15	Hs~Ref:NM_018216.1~uORF:IOH26341	1342	1213	1183	1574	888	1623	2756	5970	2863	1370	pantothenate kinase 4 (PANK4)
B30R15C07	30-7-15	Hs~MGC:BC061514.1~uORF:IOH29303	649	504	866	463	401	683	1081	547	910	275	MPV17 mitochondrial membrane protein-like (MPV17L)
B30R15C08	30-8-15	Hs~MGC:BC061514.1~uORF:IOH29303	706	488	856	520	446	782	1311	642	744	262	MPV17 mitochondrial membrane protein-like (MPV17L)
B30R15C09	30-9-15	Hs~MGC:BC060828.1~uORF:IOH29183	913	1532	1715	1262	1993	797	1721	721	2002	1132	AT rich interactive domain 3A (BRIGHT-like) (ARID3A)
B30R15C10	30-10-15	Hs~MGC:BC060828.1~uORF:IOH29183	972	1613	1628	1274	2164	825	1719	765	2123	182	AT rich interactive domain 3A (BRIGHT-like) (ARID3A)
B30R15C11	30-11-15	Hs~Ref:NM_014805.2~uORF:IOH39814	1031	1417	2501	1602	1056	1482	1753	3054	2094	667	EPM2A (laforin) interacting protein 1 (EPM2AIP1)
B30R15C12	30-12-15	Hs~Ref:NM_014805.2~uORF:IOH39814	944	1478	2464	1603	1094	1509	1715	3081	2230	747	EPM2A (laforin) interacting protein 1 (EPM2AIP1)
B30R15C15	30-15-15	Hs~Ref:NM_006256.1~CAT:PV3879	1824	559	1434	952	800	1299	1671	1195	2082	1865	Serine/threonine-protein kinase N2
B30R15C16	30-16-15	Hs~Ref:NM_006256.1~CAT:PV3879	1853	543	1415	906	778	1317	1578	1104	2199	1732	Serine/threonine-protein kinase N2
B30R15C17	30-17-15	Hs~Ref:NM_003177.3~CAT:PV3857	1357	446	779	589	542	911	2938	612	1244	163	spleen tyrosine kinase (SYK)
B30R15C18	30-18-15	Hs~Ref:NM_003177.3~CAT:PV3857	1242	430	782	556	562	939	2884	649	1191	186	spleen tyrosine kinase (SYK)
B30R15C19	30-19-15	Hs~Ref:NM_006622.1~CAT:PV4204	1474	3041	1750	702	1160	694	2094	988	1147	357	Serine/threonine-protein kinase PLK2
B30R15C20	30-20-15	Hs~Ref:NM_006622.1~CAT:PV4204	1442	3237	1597	672	1137	681	2006	1081	1173	384	Serine/threonine-protein kinase PLK2
B30R15C21	30-21-15	Hs~Ref:NM_004442.3~CAT:PV3625	250	229	2424	219	77	826	548	891	319	399	Ephrin type-B receptor 2
B30R15C22	30-22-15	Hs~Ref:NM_004442.3~CAT:PV3625	259	186	2171	206	105	613	477	569	291	374	Ephrin type-B receptor 2
B30R16C01	30-1-16	Hs~Ref:NM_001894.2~CAT:PV3500	1393	1559	4026	2766	1529	2196	14300	2882	3899	2494	casein kinase 1, epsilon (CSNK1E), transcript variant 2
B30R16C02	30-2-16	Hs~Ref:NM_001894.2~CAT:PV3500	1401	1991	3929	2734	1547	2478	14310	2772	3960	2670	casein kinase 1, epsilon (CSNK1E), transcript variant 2
B30R16C03	30-3-16	Hs~Ref:NM_004071.1~CAT:PV3315	47	235	239	272	181	683	414	151	593	72	Dual specificity protein kinase CLK1
B30R16C04	30-4-16	Hs~Ref:NM_004071.1~CAT:PV3315	147	250	243	164	203	652	440	156	548	81	Dual specificity protein kinase CLK1
B30R16C07	30-7-16	Hs~Ref:NM_001004286.1~uORF:IOH58640	1007	1227	1422	1039	1024	1875	2368	1882	3584	792	DNA fragmentation factor subunit beta
B30R16C08	30-8-16	Hs~Ref:NM_001004286.1~uORF:IOH58640	1061	1196	1377	1087	1185	1819	2207	1860	3656	759	DNA fragmentation factor subunit beta
B30R16C09	30-9-16	Hs~Ref:XM_936115.1~uORF:IOH3340	404	301	503	340	505	494	584	774	476	123	HLA class II histocompatibility antigen, DQ(3) alpha chain
B30R16C10	30-10-16	Hs~Ref:XM_936115.1~uORF:IOH3340	432	289	540	312	823	446	623	674	567	83	HLA class II histocompatibility antigen, DQ(3) alpha chain
B30R16C15	30-15-16	Hs~Ref:NM_014281.3~uORF:IOH57033	635	516	673	1563	311	1444	2330	1371	580	1887	Poly(U)-binding-splicing factor PUF60
B30R16C16	30-16-16	Hs~Ref:NM_014281.3~uORF:IOH57033	615	529	640	1534	310	1252	2138	1301	619	1829	Poly(U)-binding-splicing factor PUF60
B30R16C17	30-17-16	Hs~Ref:NM_012086.1~uORF:IOH55731	15160	347	731	571	334	646	812	614	798	3611	General transcription factor 3C polypeptide 3
B30R16C18	30-18-16	Hs~Ref:NM_012086.1~uORF:IOH55731	14245	341	689	605	346	635	849	642	822	3314	General transcription factor 3C polypeptide 3
B30R16C19	30-19-16	Hs~Ref:NM_000156.4~uORF:IOH57091	426	241	748	413	459	525	2186	404	558	297	Guanidinoacetate N-methyltransferase
B30R16C20	30-20-16	Hs~Ref:NM_000156.4~uORF:IOH57091	444	286	736	402	492	480	2154	484	582	213	Guanidinoacetate N-methyltransferase
B30R17C01	30-1-17	Hs~Ref:NM_001493.1~uORF:IOH3509	749	812	1434	640	899	1253	1822	1186	2262	469	GDP dissociation inhibitor 1 (GDI1)
B30R17C02	30-2-17	Hs~Ref:NM_001493.1~uORF:IOH3509	764	848	1383	667	887	1220	1880	1262	2257	84	GDP dissociation inhibitor 1 (GDI1)
B30R17C03	30-3-17	Hs~Ref:NM_000122.1~uORF:IOH6320	2192	1264	2048	1896	1553	1893	7183	1491	4003	1069	excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) (ERCC3)
B30R17C04	30-4-17	Hs~Ref:NM_000122.1~uORF:IOH6320	2184	1338	2049	2166	1492	1817	6756	1448	3989	1303	excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) (ERCC3)
B30R17C05	30-5-17	Hs~Ref:NM_032259.1~uORF:IOH6995	814	610	1008	638	610	864	1079	900	2195	513	WD repeat domain 24 (WDR24)
B30R17C06	30-6-17	Hs~Ref:NM_032259.1~uORF:IOH6995	816	657	995	611	674	785	1135	834	1755	576	WD repeat domain 24 (WDR24)
B30R17C07	30-7-17	Hs~MGC:BC026083.1~uORF:IOH62071	266	251	386	202	260	305	386	355	18	121	ADAM metallopeptidase domain 5 pseudogene, mRNA (cDNA clone MGC:26894 IMAGE:4828475), complete cds.
B30R17C08	30-8-17	Hs~MGC:BC026083.1~uORF:IOH62071	280	238	420	198	165	340	385	371	308	87	ADAM metallopeptidase domain 5 pseudogene, mRNA (cDNA clone MGC:26894 IMAGE:4828475), complete cds.
B30R17C09	30-9-17	Hs~Ref:NM_024786.1~uORF:IOH22166	644	548	841	750	563	1654	1270	710	1692	212	zinc finger, DHHC-type containing 11 (ZDHHC11)
B30R17C10	30-10-17	Hs~Ref:NM_024786.1~uORF:IOH22166	691	557	837	739	478	1518	1307	699	1774	273	zinc finger, DHHC-type containing 11 (ZDHHC11)
B30R17C13	30-13-17	Hs~MGC:BC006393.1~uORF:IOH6460	714	466	645	442	194	602	1063	517	939	370	Carboxypeptidase Z
B30R17C14	30-14-17	Hs~MGC:BC006393.1~uORF:IOH6460	655	467	719	437	430	599	2043	510	921	429	Carboxypeptidase Z
B30R17C15	30-15-17	Hs~Ref:NM_005040.1~uORF:IOH13548	608	467	700	357	370	36	799	501	776	220	prolylcarboxypeptidase (angiotensinase C) (PRCP), transcript variant 1
B30R17C16	30-16-17	Hs~Ref:NM_005040.1~uORF:IOH13548	556	453	675	344	370	597	834	501	835	235	prolylcarboxypeptidase (angiotensinase C) (PRCP), transcript variant 1
B30R17C17	30-17-17	Hs~Ref:NM_023946.1~uORF:IOH45530	296	338	668	284	329	493	641	468	773	192	Ly6/neurotoxin 1 (LYNX1), transcript variant 1
B30R17C18	30-18-17	Hs~Ref:NM_023946.1~uORF:IOH45530	1309	348	625	270	350	514	646	483	727	151	Ly6/neurotoxin 1 (LYNX1), transcript variant 1
B30R17C19	30-19-17	Hs~Ref:NM_022039.3~uORF:IOH39881	392	358	515	305	440	577	958	459	784	214	F-box and WD repeat domain containing 4 (FBXW4)
B30R17C20	30-20-17	Hs~Ref:NM_022039.3~uORF:IOH39881	447	419	517	352	426	528	989	451	909	98	F-box and WD repeat domain containing 4 (FBXW4)
B30R17C21	30-21-17	Hs~Ref:NM_000410.2~uORF:IOH35337	525	468	624	373	361	354	349	169	1009	385	Hereditary hemochromatosis protein
B30R17C22	30-22-17	Hs~Ref:NM_000410.2~uORF:IOH35337	524	430	620	388	345	179	308	145	1086	416	Hereditary hemochromatosis protein
B30R18C01	30-1-18	Hs~MGC:BC058899.1~uORF:IOH29087	1066	526	2492	778	719	926	4721	1329	1498	349	DSN1, MIND kinetochore complex component, homolog (S. cerevisiae) (DSN1)
B30R18C02	30-2-18	Hs~MGC:BC058899.1~uORF:IOH29087	1102	598	2503	798	661	944	4722	1294	1520	489	DSN1, MIND kinetochore complex component, homolog (S. cerevisiae) (DSN1)
B30R18C03	30-3-18	Hs~Ref:NM_173623.1~uORF:IOH27653	987	287	758	1823	318	448	705	392	1137	1710	tubulin tyrosine ligase-like family, member 6 (TTLL6)
B30R18C04	30-4-18	Hs~Ref:NM_173623.1~uORF:IOH27653	1068	290	772	1928	372	250	695	423	1115	577	tubulin tyrosine ligase-like family, member 6 (TTLL6)
B30R18C05	30-5-18	Hs~MGC:BC001380.2~uORF:IOH3984	360	225	322	232	246	937	381	303	630	-25	succinate dehydrogenase complex, subunit A, flavoprotein (Fp) (SDHA)
B30R18C06	30-6-18	Hs~MGC:BC001380.2~uORF:IOH3984	331	256	352	260	247	856	509	320	454	172	succinate dehydrogenase complex, subunit A, flavoprotein (Fp) (SDHA)
B30R18C07	30-7-18	Hs~MGC:BC020748.1~uORF:IOH13116	365	297	499	232	317	388	442	368	630	198	glycosylphosphatidylinositol specific phospholipase D1 (GPLD1)
B30R18C08	30-8-18	Hs~MGC:BC020748.1~uORF:IOH13116	355	304	503	231	-1	368	423	340	419	196	glycosylphosphatidylinositol specific phospholipase D1 (GPLD1)
B30R18C09	30-9-18	Hs~MGC:BC007218.1~uORF:IOH6864	411	268	367	232	70	909	450	258	482	103	FYVE and coiled-coil domain containing 1 (FYCO1)
B30R18C10	30-10-18	Hs~MGC:BC007218.1~uORF:IOH6864	439	277	398	232	141	1021	497	282	496	64	FYVE and coiled-coil domain containing 1 (FYCO1)
B30R18C11	30-11-18	Hs~MGC:BC040075.1~uORF:IOH28765	807	290	557	2069	168	560	817	583	701	307	selenoprotein P, plasma, 1 (SEPP1)
B30R18C12	30-12-18	Hs~MGC:BC040075.1~uORF:IOH28765	515	294	555	2126	451	590	798	573	713	226	selenoprotein P, plasma, 1 (SEPP1)
B30R18C13	30-13-18	Hs~MGC:BC047368.1~uORF:IOH26503	1179	678	1059	711	626	1023	3853	4582	1673	685	outer dense fiber of sperm tails 2-like (ODF2L)
B30R18C14	30-14-18	Hs~MGC:BC047368.1~uORF:IOH26503	1224	656	1078	630	628	980	3371	3578	1610	605	outer dense fiber of sperm tails 2-like (ODF2L)
B30R18C15	30-15-18	Hs~MGC:BC055088.1~uORF:IOH29459	730	423	699	424	425	646	1459	512	932	236	39S ribosomal protein L21, mitochondrial
B30R18C16	30-16-18	Hs~MGC:BC055088.1~uORF:IOH29459	672	444	698	461	407	625	1457	534	842	267	39S ribosomal protein L21, mitochondrial
B30R18C17	30-17-18	Hs~MGC:BC035975.1~uORF:IOH27963	644	420	706	408	382	836	962	496	1034	425	Uromodulin
B30R18C18	30-18-18	Hs~MGC:BC035975.1~uORF:IOH27963	628	409	686	416	405	888	1028	481	969	338	Uromodulin
B30R18C19	30-19-18	Hs~MGC:BC010464.1~uORF:IOH9638	433	501	545	381	460	433	539	465	817	511	mitogen-activated protein kinase kinase kinase 3 (MAP3K3)
B30R18C20	30-20-18	Hs~MGC:BC010464.1~uORF:IOH9638	467	525	612	342	428	536	538	447	774	662	mitogen-activated protein kinase kinase kinase 3 (MAP3K3)
B30R18C21	30-21-18	Hs~MGC:BC008383.1~uORF:IOH7227	461	457	644	440	385	535	661	506	821	406	elastase 3A, pancreatic (ELA3A)
B30R18C22	30-22-18	Hs~MGC:BC008383.1~uORF:IOH7227	485	431	600	424	383	507	599	852	805	400	elastase 3A, pancreatic (ELA3A)
B30R19C01	30-1-19	Hs~Ref:NM_020750.1~uORF:IOH40446	390	333	574	280	335	458	623	1548	660	172	exportin 5 (XPO5)
B30R19C02	30-2-19	Hs~Ref:NM_020750.1~uORF:IOH40446	451	315	586	318	321	518	668	598	668	416	exportin 5 (XPO5)
B30R19C03	30-3-19	Hs~MGC:BC063275.1~uORF:IOH40423	2254	1175	1815	1072	705	1958	8382	1212	2597	530	eukaryotic translation initiation factor 2C, 1 (EIF2C1)
B30R19C04	30-4-19	Hs~MGC:BC063275.1~uORF:IOH40423	2304	1096	1778	1288	670	1892	7752	1149	2593	703	eukaryotic translation initiation factor 2C, 1 (EIF2C1)
B30R19C05	30-5-19	Hs~MGC:BC021143.1~uORF:IOH23118	670	355	698	314	362	224	1028	394	931	372	transmembrane protein 112B (TMEM112B)
B30R19C06	30-6-19	Hs~MGC:BC021143.1~uORF:IOH23118	600	372	691	354	403	563	961	420	836	350	transmembrane protein 112B (TMEM112B)
B30R19C07	30-7-19	Hs~Ref:NM_004119.1~N/A	680	477	802	451	508	695	1233	566	1295	387	fms-related tyrosine kinase 3 (FLT3); see catalog number for detailed information on wild-type or point mutant status
B30R19C08	30-8-19	Hs~Ref:NM_004119.1~N/A	664	522	778	459	437	662	1241	579	1286	343	fms-related tyrosine kinase 3 (FLT3); see catalog number for detailed information on wild-type or point mutant status
B30R19C11	30-11-19	Hs~MGC:BC014037.1~N/A	398	199	1104	222	178	369	433	277	894	756	Serine/threonine-protein kinase Sgk2
B30R19C12	30-12-19	Hs~MGC:BC014037.1~N/A	558	221	1033	221	6	345	479	462	984	59	Serine/threonine-protein kinase Sgk2
B30R19C13	30-13-19	Hs~MGC:BC066917.1~uORF:IOH61482	584	488	562	320	477	403	717	702	716	184	Ubiquitin-conjugating enzyme E2 D3
B30R19C14	30-14-19	Hs~MGC:BC066917.1~uORF:IOH61482	556	510	564	301	503	424	492	590	750	226	Ubiquitin-conjugating enzyme E2 D3
B30R19C17	30-17-19	Hs~Ref:NM_001025248.1~uORF:IOH62874	211	251	522	221	281	356	532	331	418	181	deoxyuridine triphosphatase (DUT), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA.
B30R19C18	30-18-19	Hs~Ref:NM_001025248.1~uORF:IOH62874	240	286	532	243	282	387	514	349	479	82	deoxyuridine triphosphatase (DUT), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA.
B30R19C19	30-19-19	Hs~MGC:BC070374.1~uORF:IOH62870	362	265	363	280	301	328	510	266	462	253	Serum paraoxonase/lactonase 3
B30R19C20	30-20-19	Hs~MGC:BC070374.1~uORF:IOH62870	316	285	436	295	274	318	484	317	486	199	Serum paraoxonase/lactonase 3
B30R20C03	30-3-20	Hs~Ref:NM_001007534.1~uORF:IOH59764	538	636	587	377	418	0	-1	0	0	-14	Putative uncharacterized protein C3orf56
B30R20C04	30-4-20	Hs~Ref:NM_001007534.1~uORF:IOH59764	492	508	658	556	339	-1	22	-2	3	-4	Putative uncharacterized protein C3orf56
B30R20C05	30-5-20	Hs~Ref:NM_005917.2~uORF:IOH59077	692	438	1227	376	369	0	-6	1	-7	-1	Malate dehydrogenase, cytoplasmic
B30R20C06	30-6-20	Hs~Ref:NM_005917.2~uORF:IOH59077	671	436	1215	324	371	1	-5	-1	-3	-2	Malate dehydrogenase, cytoplasmic
B30R20C07	30-7-20	Hs~Ref:NM_032797.4~uORF:IOH56964	543	465	688	509	595	0	-3	-1	1083	548	Apoptosis-inducing factor 2
B30R20C08	30-8-20	Hs~Ref:NM_032797.4~uORF:IOH56964	684	446	674	491	567	-1	-3	0	970	621	Apoptosis-inducing factor 2
B30R20C09	30-9-20	Hs~Ref:NM_001005158.1~uORF:IOH57124	783	482	1366	1042	416	2751	1145	888	1196	537	Scm-like with four MBT domains protein 1
B30R20C10	30-10-20	Hs~Ref:NM_001005158.1~uORF:IOH57124	923	453	1421	1148	426	2612	1168	880	1133	572	Scm-like with four MBT domains protein 1
B30R20C11	30-11-20	Hs~Ref:NM_002907.2~uORF:IOH55572	335	317	473	246	316	993	521	334	865	884	ATP-dependent DNA helicase Q1
B30R20C12	30-12-20	Hs~Ref:NM_002907.2~uORF:IOH55572	411	325	441	229	353	592	615	335	925	182	ATP-dependent DNA helicase Q1
B30R20C13	30-13-20	Hs~Ref:NM_005985.2~uORF:IOH56124	898	475	2256	670	538	1448	841	681	1516	371	Zinc finger protein SNAI1
B30R20C14	30-14-20	Hs~Ref:NM_005985.2~uORF:IOH56124	827	520	2067	608	612	1327	870	460	1485	342	Zinc finger protein SNAI1
B31R02C11	31-11-2	Hs~MGC:BC066294.1~uORF:IOH40058	538	890	766	750	758	352	536	502	623	239	lysozyme-like 2 (LYZL2)
B31R02C12	31-12-2	Hs~MGC:BC066294.1~uORF:IOH40058	519	878	721	493	652	342	532	552	675	203	lysozyme-like 2 (LYZL2)
B31R02C13	31-13-2	Hs~Ref:NM_031463.3~uORF:IOH43565	506	365	714	433	755	342	988	545	566	197	Hydroxysteroid dehydrogenase-like protein 1
B31R02C14	31-14-2	Hs~Ref:NM_031463.3~uORF:IOH43565	535	374	777	477	622	361	906	529	590	116	Hydroxysteroid dehydrogenase-like protein 1
B31R02C15	31-15-2	Hs~Ref:NM_015002.2~uORF:IOH42260	1351	2208	3928	1790	910	2016	2980	1129	1922	621	F-box protein 21 (FBXO21), transcript variant 2
B31R02C16	31-16-2	Hs~Ref:NM_015002.2~uORF:IOH42260	1452	2214	3661	1772	1085	1962	2962	1099	1919	622	F-box protein 21 (FBXO21), transcript variant 2
B31R02C17	31-17-2	Hs~Ref:NM_002925.3~uORF:IOH41439	10246	2686	2086	3204	546	3272	920	912	1331	188	regulator of G-protein signaling 10 (RGS10), transcript variant 2
B31R02C18	31-18-2	Hs~Ref:NM_002925.3~uORF:IOH41439	10340	2668	1944	3168	384	3105	941	868	1323	112	regulator of G-protein signaling 10 (RGS10), transcript variant 2
B31R02C19	31-19-2	Hs~Ref:NM_000713.1~uORF:IOH41586	1135	939	2611	3425	1601	9270	6361	1299	2416	628	biliverdin reductase B (flavin reductase (NADPH)) (BLVRB)
B31R02C20	31-20-2	Hs~Ref:NM_000713.1~uORF:IOH41586	1073	878	2628	3052	1201	9189	6448	1228	2549	649	biliverdin reductase B (flavin reductase (NADPH)) (BLVRB)
B31R02C21	31-21-2	Hs~Ref:NM_021571.2~uORF:IOH42984	388	1515	582	321	860	412	662	338	617	360	ICEBERG caspase-1 inhibitor (ICEBERG)
B31R02C22	31-22-2	Hs~Ref:NM_021571.2~uORF:IOH42984	402	1331	538	269	632	449	712	370	732	348	ICEBERG caspase-1 inhibitor (ICEBERG)
B31R03C01	31-1-3	Hs~Ref:NM_199139.1~uORF:IOH44783	974	873	40029	718	1741	1496	1995	926	2207	1284	XIAP associated factor-1 (XAF1), transcript variant 2
B31R03C02	31-2-3	Hs~Ref:NM_199139.1~uORF:IOH44783	1061	851	38949	699	1280	1478	2092	947	2273	1227	XIAP associated factor-1 (XAF1), transcript variant 2
B31R03C03	31-3-3	Hs~Ref:NM_001008740.2~uORF:IOH41285	434	291	416	237	980	245	583	364	571	176	transmembrane and coiled-coil domains 2 (TMCO2)
B31R03C04	31-4-3	Hs~Ref:NM_001008740.2~uORF:IOH41285	393	359	418	295	1219	316	574	361	529	86	transmembrane and coiled-coil domains 2 (TMCO2)
B31R03C05	31-5-3	Hs~Ref:NM_021255.1~uORF:IOH12192	939	1178	826	801	3993	2103	1992	1193	1796	345	pellino homolog 2 (Drosophila) (PELI2)
B31R03C06	31-6-3	Hs~Ref:NM_021255.1~uORF:IOH12192	1004	1283	813	732	4514	1917	1892	1144	1764	373	pellino homolog 2 (Drosophila) (PELI2)
B31R03C07	31-7-3	Hs~Ref:NM_016289.2~uORF:IOH10730	610	1256	960	1888	1332	2668	1670	1753	4154	474	calcium binding protein 39 (CAB39)
B31R03C08	31-8-3	Hs~Ref:NM_016289.2~uORF:IOH10730	632	1296	922	1676	1397	2502	1636	1641	4197	435	calcium binding protein 39 (CAB39)
B31R03C09	31-9-3	Hs~Ref:NM_021079.2~uORF:IOH14141	1296	1808	2990	1982	1960	5397	4308	2065	1765	1815	N-myristoyltransferase 1 (NMT1)
B31R03C10	31-10-3	Hs~Ref:NM_021079.2~uORF:IOH14141	1337	1806	2862	2092	1821	5321	3929	2024	1796	1759	N-myristoyltransferase 1 (NMT1)
B31R03C11	31-11-3	Hs~MGC:BC020946.1~uORF:IOH26800	1385	502	424	659	922	369	318	830	970	150	tubulin, beta (TUBB)
B31R03C12	31-12-3	Hs~MGC:BC020946.1~uORF:IOH26800	1410	319	402	672	425	404	352	1183	975	191	tubulin, beta (TUBB)
B31R03C13	31-13-3	Hs~MGC:BC007407.1~uORF:IOH5830	921	728	1418	547	831	582	965	691	1512	350	neuromedin B (NMB)
B31R03C14	31-14-3	Hs~MGC:BC007407.1~uORF:IOH5830	898	703	1444	585	1722	596	979	549	1527	354	neuromedin B (NMB)
B31R03C15	31-15-3	Hs~Ref:NM_145792.1~uORF:IOH7456	647	565	771	801	897	585	883	567	1653	395	microsomal glutathione S-transferase 1 (MGST1), transcript variant 1a
B31R03C16	31-16-3	Hs~Ref:NM_145792.1~uORF:IOH7456	609	636	751	650	912	616	1029	480	1618	318	microsomal glutathione S-transferase 1 (MGST1), transcript variant 1a
B31R03C17	31-17-3	Hs~MGC:NM_173362.2~uORF:IOH12123	713	4186	771	2570	1430	613	4433	656	1497	204	Rieske domain-containing protein
B31R03C18	31-18-3	Hs~MGC:NM_173362.2~uORF:IOH12123	691	4179	733	2461	1548	577	4306	634	1554	208	Rieske domain-containing protein
B31R03C19	31-19-3	Hs~MGC:BC015059.1~uORF:IOH13646	4940	1681	3582	1995	1180	3385	3815	1437	4761	481	cutC copper transporter homolog (E. coli) (CUTC)
B31R03C20	31-20-3	Hs~MGC:BC015059.1~uORF:IOH13646	5098	1669	3377	1929	1150	3252	3722	1495	4766	487	cutC copper transporter homolog (E. coli) (CUTC)
B31R03C21	31-21-3	Hs~Ref:NM_003509.2~uORF:IOH1642	1783	1017	1236	763	902	991	5020	722	2033	385	histone cluster 1, H2ai (HIST1H2AI)
B31R03C22	31-22-3	Hs~Ref:NM_003509.2~uORF:IOH1642	1776	949	1258	679	1408	1017	5410	653	2029	385	histone cluster 1, H2ai (HIST1H2AI)
B31R04C01	31-1-4	Hs~Ref:NM_022497.2~uORF:IOH1725	1377	501	807	531	672	490	1173	1396	1660	276	mitochondrial ribosomal protein S25 (MRPS25), nuclear gene encoding mitochondrial protein
B31R04C02	31-2-4	Hs~Ref:NM_022497.2~uORF:IOH1725	1422	513	883	582	825	505	1216	1116	1721	260	mitochondrial ribosomal protein S25 (MRPS25), nuclear gene encoding mitochondrial protein
B31R04C03	31-3-4	Hs~Ref:NM_014286.2~uORF:IOH1769	265	345	207	194	372	229	330	1082	515	-5	frequenin homolog (Drosophila) (FREQ)
B31R04C04	31-4-4	Hs~Ref:NM_014286.2~uORF:IOH1769	224	359	227	246	515	231	300	1061	590	91	frequenin homolog (Drosophila) (FREQ)
B31R04C05	31-5-4	Hs~Ref:NM_022839.2~uORF:IOH1783	3134	1730	2466	1306	1840	1589	9425	1225	2715	1012	mitochondrial ribosomal protein S11 (MRPS11), nuclear gene encoding mitochondrial protein, transcript variant 1
B31R04C06	31-6-4	Hs~Ref:NM_022839.2~uORF:IOH1783	3227	1751	2438	1221	1335	1558	8998	1212	2709	1011	mitochondrial ribosomal protein S11 (MRPS11), nuclear gene encoding mitochondrial protein, transcript variant 1
B31R04C07	31-7-4	Hs~MGC:BC005974.1~uORF:IOH7463	725	1154	807	1587	1528	2001	1986	5747	2459	420	vesicle-associated membrane protein 4 (VAMP4)
B31R04C08	31-8-4	Hs~MGC:BC005974.1~uORF:IOH7463	733	1186	780	1523	1586	1862	1869	5471	2554	429	vesicle-associated membrane protein 4 (VAMP4)
B31R04C09	31-9-4	Hs~Ref:NM_015948.2~uORF:IOH7165	899	648	1000	581	973	528	1326	649	1215	274	solute carrier family 35, member B3 (SLC35B3)
B31R04C10	31-10-4	Hs~Ref:NM_015948.2~uORF:IOH7165	902	617	1016	581	2779	568	1232	641	1080	279	solute carrier family 35, member B3 (SLC35B3)
B31R04C11	31-11-4	Hs~MGC:BC014457.1~uORF:IOH12101	328	129	433	1292	1153	322	391	487	402	42	glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase) (GCAT)
B31R04C12	31-12-4	Hs~MGC:BC014457.1~uORF:IOH12101	391	124	451	1285	2112	300	440	529	397	35	glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase) (GCAT)
B31R04C13	31-13-4	Hs~MGC:BC007019.1~uORF:IOH7241	602	1027	664	1372	2741	1136	1784	4858	2484	379	vesicle-associated membrane protein 4 (VAMP4)
B31R04C14	31-14-4	Hs~MGC:BC007019.1~uORF:IOH7241	583	1055	665	1409	1535	1073	1718	4498	2479	371	vesicle-associated membrane protein 4 (VAMP4)
B31R04C15	31-15-4	Hs~Ref:NM_006303.2~uORF:IOH5395	1635	2275	2068	1182	2226	1858	1965	1433	2648	664	JTV1 gene (JTV1)
B31R04C16	31-16-4	Hs~Ref:NM_006303.2~uORF:IOH5395	1634	2490	2058	991	2097	1867	2003	1368	2688	620	JTV1 gene (JTV1)
B31R04C17	31-17-4	Hs~Ref:NM_199326.1~uORF:IOH3323	1418	685	1251	827	1351	983	871	828	1116	559	protein phosphatase 2 (formerly 2A), regulatory subunit B'', beta (PPP2R3B), transcript variant 2
B31R04C18	31-18-4	Hs~Ref:NM_199326.1~uORF:IOH3323	1397	689	1251	837	1375	979	864	831	1080	554	protein phosphatase 2 (formerly 2A), regulatory subunit B'', beta (PPP2R3B), transcript variant 2
B31R04C19	31-19-4	Hs~Ref:NM_004577.3~uORF:IOH39828	5707	980	1072	893	1833	2243	1525	1559	1259	443	phosphoserine phosphatase (PSPH)
B31R04C20	31-20-4	Hs~Ref:NM_004577.3~uORF:IOH39828	5689	965	1033	841	1658	2160	1475	1537	1317	430	phosphoserine phosphatase (PSPH)
B31R04C21	31-21-4	Hs~Ref:NM_005181.2~uORF:IOH1901	547	539	487	390	785	1052	801	431	883	169	carbonic anhydrase III, muscle specific (CA3)
B31R04C22	31-22-4	Hs~Ref:NM_005181.2~uORF:IOH1901	523	484	456	369	2203	1082	864	384	863	60	carbonic anhydrase III, muscle specific (CA3)
B31R05C01	31-1-5	Hs~Ref:NM_020466.3~uORF:IOH12271	9896	6143	6475	5382	9067	4542	6710	5234	5954	5662	LYR motif-containing protein 2
B31R05C02	31-2-5	Hs~Ref:NM_020466.3~uORF:IOH12271	10142	6048	6397	5323	8998	4485	6521	5254	5911	5677	LYR motif-containing protein 2
B31R05C03	31-3-5	Hs~Ref:NM_052822.1~uORF:IOH12952	1205	892	1260	3596	2467	832	1283	914	1561	651	secretory carrier membrane protein 1 (SCAMP1), transcript variant 2
B31R05C04	31-4-5	Hs~Ref:NM_052822.1~uORF:IOH12952	1080	818	1265	3384	2364	963	1270	844	1587	617	secretory carrier membrane protein 1 (SCAMP1), transcript variant 2
B31R05C05	31-5-5	Hs~Ref:NM_006299.2~uORF:IOH12838	5767	5184	4888	5005	7614	4492	4827	5227	6110	5206	zinc finger protein 193 (ZNF193)
B31R05C06	31-6-5	Hs~Ref:NM_006299.2~uORF:IOH12838	5702	5450	5027	4788	6462	4568	5176	5113	5918	5222	zinc finger protein 193 (ZNF193)
B31R05C07	31-7-5	Hs~Ref:NM_006984.1~uORF:IOH12270	743	864	1292	837	700	595	642	606	1521	400	claudin 10 (CLDN10), transcript variant 2
B31R05C08	31-8-5	Hs~Ref:NM_006984.1~uORF:IOH12270	681	880	1274	878	673	636	626	578	1519	425	claudin 10 (CLDN10), transcript variant 2
B31R05C09	31-9-5	Hs~MGC:BC039831.1~uORF:IOH26290	833	504	826	363	274	483	886	380	974	120	intraflagellar transport 52 homolog (Chlamydomonas) (IFT52)
B31R05C10	31-10-5	Hs~MGC:BC039831.1~uORF:IOH26290	913	541	831	429	268	531	888	433	892	154	intraflagellar transport 52 homolog (Chlamydomonas) (IFT52)
B31R05C11	31-11-5	Hs~MGC:BC038953.1~uORF:IOH26135	802	756	2684	1086	449	2914	1011	1732	1673	1171	component of oligomeric golgi complex 3 (COG3)
B31R05C12	31-12-5	Hs~MGC:BC038953.1~uORF:IOH26135	801	776	2633	1035	455	3056	1075	2165	1647	1139	component of oligomeric golgi complex 3 (COG3)
B31R05C13	31-13-5	Hs~Ref:NM_006977.1~uORF:IOH26026	324	423	352	344	489	226	265	205	620	178	zinc finger and BTB domain containing 25 (ZBTB25)
B31R05C14	31-14-5	Hs~Ref:NM_006977.1~uORF:IOH26026	365	226	354	372	248	220	256	332	599	213	zinc finger and BTB domain containing 25 (ZBTB25)
B31R05C15	31-15-5	Hs~MGC:BC039825.1~uORF:IOH26189	526	685	1713	1157	187	450	905	293	534	264	male germ cell-associated kinase (MAK)
B31R05C16	31-16-5	Hs~MGC:BC039825.1~uORF:IOH26189	534	551	1761	1243	182	508	957	221	644	263	male germ cell-associated kinase (MAK)
B31R05C17	31-17-5	Hs~Ref:NM_002305.2~uORF:IOH3861	3978	1679	2773	2254	790	1873	2255	1725	2398	1033	lectin, galactoside-binding, soluble, 1 (galectin 1) (LGALS1)
B31R05C18	31-18-5	Hs~Ref:NM_002305.2~uORF:IOH3861	4188	1658	2802	2174	540	1898	2238	1707	2261	1016	lectin, galactoside-binding, soluble, 1 (galectin 1) (LGALS1)
B31R05C19	31-19-5	Hs~MGC:BC020197.1~uORF:IOH13293	4190	1217	1586	5521	706	1383	2513	997	1548	635	1-aminocyclopropane-1-carboxylate synthase-like protein 1
B31R05C20	31-20-5	Hs~MGC:BC020197.1~uORF:IOH13293	4123	1229	1504	4840	711	1295	2355	939	1571	581	1-aminocyclopropane-1-carboxylate synthase-like protein 1
B31R05C21	31-21-5	Hs~Ref:NM_031468.1~uORF:IOH13340	1085	651	1188	619	517	769	830	687	1791	287	calneuron 1 (CALN1), transcript variant 1
B31R05C22	31-22-5	Hs~Ref:NM_031468.1~uORF:IOH13340	991	621	1305	518	586	792	713	612	1753	302	calneuron 1 (CALN1), transcript variant 1
B31R06C01	31-1-6	Hs~Ref:NM_017495.3~uORF:IOH13305	349	334	472	329	142	356	430	318	827	306	RNA binding motif protein 38 (RBM38), transcript variant 1
B31R06C02	31-2-6	Hs~Ref:NM_017495.3~uORF:IOH13305	421	354	435	268	237	417	444	281	823	206	RNA binding motif protein 38 (RBM38), transcript variant 1
B31R06C03	31-3-6	Hs~Ref:NM_206917.1~uORF:IOH45829	572	319	789	366	180	1163	491	340	653	173	nerve growth factor receptor (TNFRSF16) associated protein 1 (NGFRAP1), transcript variant 1
B31R06C04	31-4-6	Hs~Ref:NM_206917.1~uORF:IOH45829	567	315	824	382	92	1140	501	366	674	75	nerve growth factor receptor (TNFRSF16) associated protein 1 (NGFRAP1), transcript variant 1
B31R06C05	31-5-6	Hs~Ref:NM_198197.1~uORF:IOH45782	777	431	999	417	381	476	666	463	747	167	ubiquitin-activating enzyme E1C (UBA3 homolog, yeast) (UBE1C), transcript variant 3
B31R06C06	31-6-6	Hs~Ref:NM_198197.1~uORF:IOH45782	809	408	1059	387	380	432	707	475	776	146	ubiquitin-activating enzyme E1C (UBA3 homolog, yeast) (UBE1C), transcript variant 3
B31R06C07	31-7-6	Hs~Ref:NM_172002.3~uORF:IOH45832	591	412	667	300	295	561	663	378	1211	249	HscB iron-sulfur cluster co-chaperone homolog (E. coli) (HSCB)
B31R06C08	31-8-6	Hs~Ref:NM_172002.3~uORF:IOH45832	568	361	672	324	277	467	698	356	1297	236	HscB iron-sulfur cluster co-chaperone homolog (E. coli) (HSCB)
B31R06C09	31-9-6	Hs~Ref:NM_201516.1~uORF:IOH45833	1134	748	1029	717	371	639	2156	479	1159	347	H2A histone family, member V (H2AFV), transcript variant 4
B31R06C10	31-10-6	Hs~Ref:NM_201516.1~uORF:IOH45833	1164	770	1038	798	419	659	2222	526	1161	348	H2A histone family, member V (H2AFV), transcript variant 4
B31R06C11	31-11-6	Hs~Ref:NM_080675.2~uORF:IOH10614	981	1346	1167	1369	895	1040	1663	912	2555	700	sperm associated antigen 4-like (SPAG4L)
B31R06C12	31-12-6	Hs~Ref:NM_080675.2~uORF:IOH10614	1052	1492	1119	1334	917	1015	1680	916	2511	728	sperm associated antigen 4-like (SPAG4L)
B31R06C13	31-13-6	Hs~MGC:BC021250.1~uORF:IOH23082	1418	968	1010	828	927	1319	1232	908	4032	447	TPR repeat-containing protein LOC90826
B31R06C14	31-14-6	Hs~MGC:BC021250.1~uORF:IOH23082	1522	783	1233	819	1017	1282	1256	941	4042	404	TPR repeat-containing protein LOC90826
B31R06C15	31-15-6	Hs~MGC:BC020868.1~uORF:IOH12287	1075	827	4110	858	851	1023	1603	1393	2975	464	signal transducer and activator of transcription 5B (STAT5B)
B31R06C16	31-16-6	Hs~MGC:BC020868.1~uORF:IOH12287	1078	878	3783	717	845	1047	1714	1400	3040	456	signal transducer and activator of transcription 5B (STAT5B)
B31R06C17	31-17-6	Hs~Ref:NM_017863.2~uORF:IOH45788	727	1017	2042	432	264	727	864	473	1149	338	chromosome X open reading frame 48 (CXorf48), transcript variant 2
B31R06C18	31-18-6	Hs~Ref:NM_017863.2~uORF:IOH45788	720	1030	1913	409	299	707	872	466	1152	325	chromosome X open reading frame 48 (CXorf48), transcript variant 2
B31R06C21	31-21-6	Hs~Ref:NM_018290.2~uORF:IOH55528	117	48	178	89	54	268	1096	351	661	36	Phosphoglucomutase-2
B31R06C22	31-22-6	Hs~Ref:NM_018290.2~uORF:IOH55528	49	50	166	79	96	49	1031	505	657	5	Phosphoglucomutase-2
B31R07C01	31-1-7	Hs~MGC:BC022494.1~uORF:IOH56010	331	271	460	260	333	266	423	312	591	140	Amine oxidase [flavin-containing] B
B31R07C02	31-2-7	Hs~MGC:BC022494.1~uORF:IOH56010	377	320	477	261	345	296	438	284	728	23	Amine oxidase [flavin-containing] B
B31R07C05	31-5-7	Hs~Ref:NM_001744.2~uORF:IOH13877	525	1954	564	3936	277	859	563	612	1101	304	calcium/calmodulin-dependent protein kinase IV (CAMK4)
B31R07C06	31-6-7	Hs~Ref:NM_001744.2~uORF:IOH13877	645	2013	523	3515	272	997	557	596	1349	142	calcium/calmodulin-dependent protein kinase IV (CAMK4)
B31R07C07	31-7-7	Hs~MGC:BC024291.1~uORF:IOH14775	644	707	953	1553	284	452	530	477	858	182	BR serine/threonine kinase 2 (BRSK2)
B31R07C08	31-8-7	Hs~MGC:BC024291.1~uORF:IOH14775	597	598	887	1525	277	421	514	458	913	181	BR serine/threonine kinase 2 (BRSK2)
B31R07C09	31-9-7	Hs~MGC:BC017236.1~uORF:IOH14401	290	152	399	265	237	262	420	266	574	80	Casein kinase I isoform gamma-1
B31R07C10	31-10-7	Hs~MGC:BC017236.1~uORF:IOH14401	330	214	386	308	394	237	349	267	562	164	Casein kinase I isoform gamma-1
B31R07C11	31-11-7	Hs~Ref:NM_003656.3~uORF:IOH21059	345	355	500	266	253	287	374	686	610	236	Calcium/calmodulin-dependent protein kinase type 1
B31R07C12	31-12-7	Hs~Ref:NM_003656.3~uORF:IOH21059	334	560	468	255	255	313	357	659	666	310	Calcium/calmodulin-dependent protein kinase type 1
B31R07C13	31-13-7	Hs~Ref:NM_006930.2~uORF:IOH11897	378	408	519	287	205	510	724	434	3140	118	S-phase kinase-associated protein 1A (p19A) (SKP1A), transcript variant 1
B31R07C14	31-14-7	Hs~Ref:NM_006930.2~uORF:IOH11897	483	555	618	305	225	482	750	434	3154	145	S-phase kinase-associated protein 1A (p19A) (SKP1A), transcript variant 1
B31R07C15	31-15-7	Hs~MGC:BC040272.1~uORF:IOH27314	1955	2782	3751	2399	2476	2720	5701	2933	3341	904	interleukin 16 (lymphocyte chemoattractant factor) (IL16)
B31R07C16	31-16-7	Hs~MGC:BC040272.1~uORF:IOH27314	2152	2694	3576	2458	2562	2638	5627	2764	3265	844	interleukin 16 (lymphocyte chemoattractant factor) (IL16)
B31R07C17	31-17-7	Hs~Ref:NM_002987.2~uORF:IOH39735	631	483	711	440	267	518	876	683	619	129	chemokine (C-C motif) ligand 17 (CCL17)
B31R07C18	31-18-7	Hs~Ref:NM_002987.2~uORF:IOH39735	606	499	626	395	323	475	931	535	665	236	chemokine (C-C motif) ligand 17 (CCL17)
B31R07C19	31-19-7	Hs~MGC:BC029529.1~uORF:IOH27222	3113	878	534	327	309	367	689	385	790	309	tubulin, beta 2C (TUBB2C)
B31R07C20	31-20-7	Hs~MGC:BC029529.1~uORF:IOH27222	3195	565	635	372	314	367	672	384	771	264	tubulin, beta 2C (TUBB2C)
B31R07C21	31-21-7	Hs~Ref:NM_000459.1~N/A	1300	3346	2362	943	1196	882	1402	1185	2576	551	Angiopoietin-1 receptor
B31R07C22	31-22-7	Hs~Ref:NM_000459.1~N/A	1280	3392	2248	859	1123	852	1366	1156	2641	534	Angiopoietin-1 receptor
B31R08C01	31-1-8	Hs~Ref:NM_002577.1~N/A	2621	1330	1293	1129	960	1112	1676	808	2942	364	Serine/threonine-protein kinase PAK 2
B31R08C02	31-2-8	Hs~Ref:NM_002577.1~N/A	2917	1334	1253	1069	1193	1055	1606	817	2952	422	Serine/threonine-protein kinase PAK 2
B31R08C05	31-5-8	Hs~Ref:NM_006254.1~N/A	880	2155	2714	1018	1218	735	1069	1656	3291	439	Protein kinase C delta type
B31R08C06	31-6-8	Hs~Ref:NM_006254.1~N/A	967	2208	2806	837	1239	698	996	1553	3346	429	Protein kinase C delta type
B31R08C07	31-7-8	Hs~MGC:BC032370.1~uORF:IOH21637	467	848	1060	313	505	833	1040	1330	2485	205	nicotinamide nucleotide transhydrogenase (NNT)
B31R08C08	31-8-8	Hs~MGC:BC032370.1~uORF:IOH21637	412	760	1013	303	527	761	1036	1224	2427	191	nicotinamide nucleotide transhydrogenase (NNT)
B31R08C09	31-9-8	Hs~MGC:BC012926.1~uORF:IOH9695	2499	2068	2352	1266	1196	2052	4030	1799	2781	1566	EPS8-like 3 (EPS8L3)
B31R08C10	31-10-8	Hs~MGC:BC012926.1~uORF:IOH9695	2442	2137	2274	1258	1258	1913	4027	1710	2879	1420	EPS8-like 3 (EPS8L3)
B31R08C11	31-11-8	Hs~MGC:BC031663.1~uORF:IOH27378	202	164	907	207	271	470	553	490	594	46	guanylate cyclase activator 1A (retina) (GUCA1A)
B31R08C12	31-12-8	Hs~MGC:BC031663.1~uORF:IOH27378	196	158	850	179	267	436	551	502	579	53	guanylate cyclase activator 1A (retina) (GUCA1A)
B31R08C13	31-13-8	Hs~MGC:BC015182.1~uORF:IOH11570	498	584	854	449	295	859	724	552	1072	294	cytochrome b5 type A (microsomal) (CYB5A)
B31R08C14	31-14-8	Hs~MGC:BC015182.1~uORF:IOH11570	624	672	921	489	341	874	752	502	1061	409	cytochrome b5 type A (microsomal) (CYB5A)
B31R08C15	31-15-8	Hs~Ref:NM_180699.1~uORF:IOH44651	4813	5622	11192	5491	2565	3263	3289	2946	4218	4573	small nuclear ribonucleoprotein 35kDa (U11/U12) (SNRNP35), transcript variant 3, mRNA.
B31R08C16	31-16-8	Hs~Ref:NM_180699.1~uORF:IOH44651	5562	5173	10609	4827	2619	3182	3175	3385	4400	4091	small nuclear ribonucleoprotein 35kDa (U11/U12) (SNRNP35), transcript variant 3, mRNA.
B31R08C17	31-17-8	Hs~Ref:NM_016430.2~uORF:IOH44539	1060	1152	1949	2916	813	974	1217	1283	2045	653	Phosphatidylinositol N-acetylglucosaminyltransferase subunit P
B31R08C18	31-18-8	Hs~Ref:NM_016430.2~uORF:IOH44539	1011	1203	1876	2789	878	1002	1193	1318	1958	723	Phosphatidylinositol N-acetylglucosaminyltransferase subunit P
B31R08C19	31-19-8	Hs~Ref:NM_005125.1~uORF:IOH44423	1170	1023	1986	2715	898	1453	1887	1136	3063	817	Copper chaperone for superoxide dismutase
B31R08C20	31-20-8	Hs~Ref:NM_005125.1~uORF:IOH44423	1157	988	1871	2714	848	1365	1841	1102	3079	851	Copper chaperone for superoxide dismutase
B31R08C21	31-21-8	Hs~Ref:NM_005669.3~uORF:IOH45648	632	2793	1215	623	541	772	774	774	1392	446	Receptor expression-enhancing protein 5
B31R08C22	31-22-8	Hs~Ref:NM_005669.3~uORF:IOH45648	615	2850	1110	560	549	723	744	719	1477	363	Receptor expression-enhancing protein 5
B31R09C01	31-1-9	Hs~Ref:NM_017830.1~uORF:IOH3035	2272	1583	2828	1198	1272	1159	5871	1673	13054	553	OCIA domain containing 1 (OCIAD1), transcript variant 1
B31R09C02	31-2-9	Hs~Ref:NM_017830.1~uORF:IOH3035	2713	1642	2772	1221	1330	1247	5823	1657	13303	525	OCIA domain containing 1 (OCIAD1), transcript variant 1
B31R09C03	31-3-9	Hs~MGC:BC013737.1~uORF:IOH11914	464	315	624	849	366	556	956	311	1123	280	histone deacetylase 6 (HDAC6)
B31R09C04	31-4-9	Hs~MGC:BC013737.1~uORF:IOH11914	485	346	600	862	353	494	920	276	1049	166	histone deacetylase 6 (HDAC6)
B31R09C05	31-5-9	Hs~Ref:NM_021165.1~uORF:IOH21556	519	303	557	299	222	348	545	265	575	61	family with sequence similarity 5, member B (FAM5B)
B31R09C06	31-6-9	Hs~Ref:NM_021165.1~uORF:IOH21556	544	356	543	335	206	329	699	292	639	79	family with sequence similarity 5, member B (FAM5B)
B31R09C07	31-7-9	Hs~MGC:BC033621.2~uORF:IOH21688	3683	1852	4623	2344	1435	2141	13174	1545	5638	974	Pseudouridylate synthase 7 homolog-like protein
B31R09C08	31-8-9	Hs~MGC:BC033621.2~uORF:IOH21688	3649	1857	4558	2170	1359	2103	13054	1511	5419	960	Pseudouridylate synthase 7 homolog-like protein
B31R09C09	31-9-9	Hs~MGC:BC008353.1~uORF:IOH6984	535	425	632	368	324	412	683	368	683	243	glycine-N-acyltransferase-like 1 (GLYATL1)
B31R09C10	31-10-9	Hs~MGC:BC008353.1~uORF:IOH6984	551	381	582	395	295	370	638	364	651	226	glycine-N-acyltransferase-like 1 (GLYATL1)
B31R09C11	31-11-9	Hs~MGC:BC037982.1~uORF:IOH25936	424	526	588	457	287	364	839	452	703	317	leucine rich repeat containing 49 (LRRC49)
B31R09C12	31-12-9	Hs~MGC:BC037982.1~uORF:IOH25936	449	540	631	451	259	349	871	463	691	334	leucine rich repeat containing 49 (LRRC49)
B31R09C13	31-13-9	Hs~Ref:NM_005879.2~uORF:IOH3484	1923	1192	1163	724	785	976	4245	740	1415	381	TRAF interacting protein (TRAIP)
B31R09C14	31-14-9	Hs~Ref:NM_005879.2~uORF:IOH3484	2312	1087	1109	814	773	934	4241	695	1368	398	TRAF interacting protein (TRAIP)
B31R09C15	31-15-9	Hs~Ref:NM_005084.2~uORF:IOH25919	776	640	888	501	342	529	921	475	1088	429	phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (PLA2G7)
B31R09C16	31-16-9	Hs~Ref:NM_005084.2~uORF:IOH25919	777	580	873	501	298	526	921	456	1026	330	phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (PLA2G7)
B31R09C17	31-17-9	Hs~MGC:BC008919.2~uORF:IOH46149	788	345	1109	543	199	1589	1424	395	671	207	TBC1 domain family, member 9B (with GRAM domain) (TBC1D9B)
B31R09C18	31-18-9	Hs~MGC:BC008919.2~uORF:IOH46149	775	351	1036	543	231	1566	1447	545	679	234	TBC1 domain family, member 9B (with GRAM domain) (TBC1D9B)
B31R09C19	31-19-9	Hs~Ref:NM_033115.2~uORF:IOH46178	376	228	468	313	480	291	597	535	539	412	hypothetical protein MGC16169 (MGC16169)
B31R09C20	31-20-9	Hs~Ref:NM_033115.2~uORF:IOH46178	381	181	484	446	322	320	602	277	515	327	hypothetical protein MGC16169 (MGC16169)
B31R09C21	31-21-9	Hs~Ref:NM_001010905.1~uORF:IOH46114	353	409	488	326	280	326	517	317	541	299	chromosome 6 open reading frame 58 (C6orf58)
B31R09C22	31-22-9	Hs~Ref:NM_001010905.1~uORF:IOH46114	336	423	458	294	286	306	491	310	493	44	chromosome 6 open reading frame 58 (C6orf58)
B31R10C01	31-1-10	Hs~MGC:BC017258.2~uORF:IOH46181	489	1654	1011	295	360	394	1449	552	1165	132	minichromosome maintenance complex component 2 (MCM2)
B31R10C02	31-2-10	Hs~MGC:BC017258.2~uORF:IOH46181	496	1716	993	311	361	184	1405	539	1197	124	minichromosome maintenance complex component 2 (MCM2)
B31R10C03	31-3-10	Hs~MGC:BC064485.1~uORF:IOH40682	797	530	843	495	479	765	1156	541	1134	292	lymphocyte antigen 9 (LY9)
B31R10C04	31-4-10	Hs~MGC:BC064485.1~uORF:IOH40682	801	534	815	494	469	741	1040	521	1098	205	lymphocyte antigen 9 (LY9)
B31R10C05	31-5-10	Hs~Ref:NM_014519.2~uORF:IOH40635	1071	1230	1206	974	674	2386	909	1397	1498	398	zinc finger protein 232 (ZNF232)
B31R10C06	31-6-10	Hs~Ref:NM_014519.2~uORF:IOH40635	1056	1286	1203	879	685	2292	957	1381	1453	397	zinc finger protein 232 (ZNF232)
B31R10C07	31-7-10	Hs~Ref:NM_198949.1~uORF:IOH40684	371	540	580	249	252	651	387	495	544	91	nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 2B
B31R10C08	31-8-10	Hs~Ref:NM_198949.1~uORF:IOH40684	363	332	567	253	253	624	348	442	528	73	nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 2B
B31R10C09	31-9-10	Hs~MGC:BC064515.1~uORF:IOH40670	560	552	710	472	452	431	910	412	1015	249	raptor (raptor)
B31R10C10	31-10-10	Hs~MGC:BC064515.1~uORF:IOH40670	531	435	748	447	465	668	999	441	970	310	raptor (raptor)
B31R11C21	31-21-11	Hs~Ref:NM_001156.2~uORF:IOH5300	1374	2554	4819	1427	1532	4604	4116	2261	3177	880	annexin A7 (ANXA7), transcript variant 1
B31R11C22	31-22-11	Hs~Ref:NM_001156.2~uORF:IOH5300	1390	2537	4503	1222	1554	4261	3881	2187	3093	732	annexin A7 (ANXA7), transcript variant 1
B31R12C01	31-1-12	Hs~Ref:NM_001001974.1~uORF:IOH3868	2487	11473	2127	2157	854	2568	5662	9420	1714	641	pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 (PLEKHA1), transcript variant 2
B31R12C02	31-2-12	Hs~Ref:NM_001001974.1~uORF:IOH3868	2501	12547	2268	2117	836	2450	5767	9140	1661	607	pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 (PLEKHA1), transcript variant 2
B31R12C03	31-3-12	Hs~Ref:NM_017677.2~uORF:IOH10557	938	627	731	511	624	697	483	485	1038	358	myotubularin related protein 8 (MTMR8)
B31R12C04	31-4-12	Hs~Ref:NM_017677.2~uORF:IOH10557	867	629	663	570	677	727	546	450	1147	344	myotubularin related protein 8 (MTMR8)
B31R12C05	31-5-12	Hs~Ref:NM_006745.2~uORF:IOH9727	355	359	374	444	318	362	525	325	635	224	sterol-C4-methyl oxidase-like (SC4MOL), transcript variant 1
B31R12C06	31-6-12	Hs~Ref:NM_006745.2~uORF:IOH9727	382	357	335	439	273	214	495	310	566	268	sterol-C4-methyl oxidase-like (SC4MOL), transcript variant 1
B31R12C07	31-7-12	Hs~MGC:BC017046.1~uORF:IOH11667	621	643	829	561	378	732	920	446	1346	268	annexin A6 (ANXA6)
B31R12C08	31-8-12	Hs~MGC:BC017046.1~uORF:IOH11667	637	680	835	555	390	735	908	470	1374	282	annexin A6 (ANXA6)
B31R12C09	31-9-12	Hs~Ref:NM_005550.2~uORF:IOH22889	1648	2290	2796	1692	1596	1139	3494	1658	3880	819	kinesin family member C3 (KIFC3)
B31R12C10	31-10-12	Hs~Ref:NM_005550.2~uORF:IOH22889	1606	2218	2747	1636	1570	1185	3879	1540	3808	814	kinesin family member C3 (KIFC3)
B31R12C11	31-11-12	Hs~Ref:NM_001819.1~uORF:IOH3444	1405	641	1922	1416	841	3699	7060	2300	1895	636	chromogranin B (secretogranin 1) (CHGB)
B31R12C12	31-12-12	Hs~Ref:NM_001819.1~uORF:IOH3444	1410	230	1902	1346	798	3415	6787	2101	1880	606	chromogranin B (secretogranin 1) (CHGB)
B31R12C13	31-13-12	Hs~MGC:BC000712.1~uORF:IOH4703	7866	9058	3696	6648	4252	2767	8061	4363	5469	3792	kinesin family member C1 (KIFC1)
B31R12C14	31-14-12	Hs~MGC:BC000712.1~uORF:IOH4703	7885	9089	3580	6826	4448	2619	7847	4132	5549	3610	kinesin family member C1 (KIFC1)
B31R12C15	31-15-12	Hs~Ref:NM_005967.2~uORF:IOH45658	4030	1179	1437	908	732	2823	1362	1188	3238	868	NGFI-A-binding protein 2
B31R12C16	31-16-12	Hs~Ref:NM_005967.2~uORF:IOH45658	4141	1084	1380	775	807	2642	1194	1091	3501	788	NGFI-A-binding protein 2
B31R12C17	31-17-12	Hs~Ref:NM_000897.2~uORF:IOH45547	1853	1652	3350	1577	1040	2853	1909	1451	3399	850	Leukotriene C4 synthase
B31R12C18	31-18-12	Hs~Ref:NM_000897.2~uORF:IOH45547	1693	1590	3090	1477	2941	2846	1893	1498	3579	849	Leukotriene C4 synthase
B31R12C19	31-19-12	Hs~Ref:NM_003928.1~uORF:IOH45869	1204	1283	1449	779	2106	1314	1579	1233	2755	687	CAAX box 1 (CXX1)
B31R12C20	31-20-12	Hs~Ref:NM_003928.1~uORF:IOH45869	1238	1386	1382	901	2087	1336	1481	1216	2576	690	CAAX box 1 (CXX1)
B31R12C21	31-21-12	Hs~Ref:NM_004074.2~uORF:IOH45641	1348	1126	1463	882	706	1285	1617	1211	2625	640	cytochrome c oxidase subunit 8A (ubiquitous) (COX8A)
B31R12C22	31-22-12	Hs~Ref:NM_004074.2~uORF:IOH45641	1259	1094	1602	813	737	1279	1542	1159	2718	592	cytochrome c oxidase subunit 8A (ubiquitous) (COX8A)
B31R13C01	31-1-13	Hs~MGC:BC038713.1~uORF:IOH27724	1029	1014	2013	1108	952	1718	2091	2427	2615	434	pleckstrin homology, Sec7 and coiled-coil domains 2 (cytohesin-2) (PSCD2)
B31R13C02	31-2-13	Hs~MGC:BC038713.1~uORF:IOH27724	995	1024	1987	1182	973	1570	2098	2344	2564	430	pleckstrin homology, Sec7 and coiled-coil domains 2 (cytohesin-2) (PSCD2)
B31R13C03	31-3-13	Hs~MGC:BC016609.1~uORF:IOH11216	910	3261	5523	1236	2044	2644	1632	2521	3138	835	cytidine monophosphate N-acetylneuraminic acid synthetase (CMAS)
B31R13C04	31-4-13	Hs~MGC:BC016609.1~uORF:IOH11216	968	3276	5175	1278	2048	2624	1664	2088	3130	796	cytidine monophosphate N-acetylneuraminic acid synthetase (CMAS)
B31R13C05	31-5-13	Hs~Ref:NM_003845.1~uORF:IOH21591	371	458	657	371	338	698	848	300	1441	72	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 (DYRK4)
B31R13C06	31-6-13	Hs~Ref:NM_003845.1~uORF:IOH21591	347	454	656	309	309	601	887	342	1435	81	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 (DYRK4)
B31R13C09	31-9-13	Hs~Ref:NM_001008572.1~uORF:IOH45757	941	921	1063	905	569	751	1177	956	1885	835	tubulin tyrosine ligase-like family, member 1 (TTLL1), transcript variant 2
B31R13C10	31-10-13	Hs~Ref:NM_001008572.1~uORF:IOH45757	936	883	1114	854	571	718	1159	966	1918	703	tubulin tyrosine ligase-like family, member 1 (TTLL1), transcript variant 2
B31R13C11	31-11-13	Hs~Ref:NM_006313.1~uORF:IOH60028	917	767	1375	2572	546	820	2881	802	2708	459	Ubiquitin carboxyl-terminal hydrolase 15
B31R13C12	31-12-13	Hs~Ref:NM_006313.1~uORF:IOH60028	889	740	1377	2473	542	801	2943	835	2720	413	Ubiquitin carboxyl-terminal hydrolase 15
B31R13C17	31-17-13	Hs~MGC:BC016842.1~uORF:IOH10739	536	432	775	354	349	453	1011	415	779	205	LSM14A, SCD6 homolog A (S. cerevisiae) (LSM14A)
B31R13C18	31-18-13	Hs~MGC:BC016842.1~uORF:IOH10739	557	505	708	338	2429	513	1002	402	798	216	LSM14A, SCD6 homolog A (S. cerevisiae) (LSM14A)
B31R13C19	31-19-13	Hs~Ref:NM_006117.1~uORF:IOH21097	537	353	738	387	724	521	779	435	872	262	peroxisomal D3,D2-enoyl-CoA isomerase (PECI), transcript variant 1
B31R13C20	31-20-13	Hs~Ref:NM_006117.1~uORF:IOH21097	581	419	680	341	1115	550	797	414	890	292	peroxisomal D3,D2-enoyl-CoA isomerase (PECI), transcript variant 1
B31R14C01	31-1-14	Hs~Ref:NM_001218.2~uORF:IOH14010	1024	564	1475	654	728	913	1281	708	2362	441	carbonic anhydrase XII (CA12), transcript variant 1
B31R14C02	31-2-14	Hs~Ref:NM_001218.2~uORF:IOH14010	995	585	1570	675	719	899	1276	709	2221	394	carbonic anhydrase XII (CA12), transcript variant 1
B31R14C03	31-3-14	Hs~Ref:NM_001006624.1~uORF:IOH58664	340	241	937	264	236	367	1473	775	649	113	Podoplanin
B31R14C04	31-4-14	Hs~Ref:NM_001006624.1~uORF:IOH58664	356	248	899	270	233	371	1396	755	631	102	Podoplanin
B31R14C07	31-7-14	Hs~Ref:NM_003935.3~uORF:IOH54164	1309	810	1352	2785	490	1866	2251	2346	1296	1215	DNA topoisomerase 3-beta-1
B31R14C08	31-8-14	Hs~Ref:NM_003935.3~uORF:IOH54164	1125	790	1346	2569	455	1984	2182	2316	1461	1221	DNA topoisomerase 3-beta-1
B31R14C11	31-11-14	Hs~Ref:NM_004436.1~uORF:IOH3457	1437	1284	3023	1210	2563	24105	2769	1334	6115	2722	endosulfine alpha (ENSA), transcript variant 3
B31R14C12	31-12-14	Hs~Ref:NM_004436.1~uORF:IOH3457	1434	1261	2840	1171	2685	22246	2809	1254	6257	2620	endosulfine alpha (ENSA), transcript variant 3
B31R14C13	31-13-14	Hs~MGC:BC013957.1~uORF:IOH13899	4426	2469	10205	5977	2144	3238	5269	3184	17486	14221	family with sequence similarity 62 (C2 domain containing) member B (FAM62B)
B31R14C14	31-14-14	Hs~MGC:BC013957.1~uORF:IOH13899	4182	2400	10033	5744	2109	3092	5223	3151	18355	14300	family with sequence similarity 62 (C2 domain containing) member B (FAM62B)
B31R14C15	31-15-14	Hs~Ref:NM_003141.2~uORF:IOH9948	65488	64053	64350	64537	64607	61563	60049	65491	65487	65493	tripartite motif-containing 21 (TRIM21)
B31R14C16	31-16-14	Hs~Ref:NM_003141.2~uORF:IOH9948	65488	62301	62242	65487	64621	62831	57892	65490	65490	65492	tripartite motif-containing 21 (TRIM21)
B31R14C17	31-17-14	Hs~Ref:NM_002149.2~uORF:IOH13481	217	344	696	257	209	1025	322	588	4216	102	hippocalcin-like 1 (HPCAL1), transcript variant 1
B31R14C18	31-18-14	Hs~Ref:NM_002149.2~uORF:IOH13481	303	260	595	266	255	967	337	569	4221	395	hippocalcin-like 1 (HPCAL1), transcript variant 1
B31R14C19	31-19-14	Hs~MGC:BC068599.1~uORF:IOH60376	500	1385	527	405	1925	480	625	1633	963	285	pleckstrin homology domain containing, family M (with RUN domain) member 2, mRNA (cDNA clone IMAGE:5263629), complete cds.
B31R14C20	31-20-14	Hs~MGC:BC068599.1~uORF:IOH60376	513	1388	517	415	1010	432	617	1598	952	317	pleckstrin homology domain containing, family M (with RUN domain) member 2, mRNA (cDNA clone IMAGE:5263629), complete cds.
B31R15C03	31-3-15	Hs~MGC:BC064521.1~uORF:IOH61569	349	270	342	318	388	98	250	242	492	224	Cytoplasmic dynein 1 heavy chain 1
B31R15C04	31-4-15	Hs~MGC:BC064521.1~uORF:IOH61569	353	244	363	332	358	193	264	234	466	112	Cytoplasmic dynein 1 heavy chain 1
B31R15C05	31-5-15	Hs~MGC:BC057831.1~uORF:IOH29174	7638	328	374	297	388	768	369	437	2105	68	Zinc finger protein 799
B31R15C06	31-6-15	Hs~MGC:BC057831.1~uORF:IOH29174	7157	314	394	287	385	749	367	420	2054	81	Zinc finger protein 799
B31R15C07	31-7-15	Hs~MGC:BC060317.1~uORF:IOH29297	241	309	346	249	207	1073	263	261	431	69	general transcription factor IIH, polypeptide 5 (GTF2H5)
B31R15C08	31-8-15	Hs~MGC:BC060317.1~uORF:IOH29297	209	273	365	272	246	121	223	264	401	69	general transcription factor IIH, polypeptide 5 (GTF2H5)
B31R15C09	31-9-15	Hs~MGC:BC057848.1~uORF:IOH29211	289	372	437	286	263	47	470	333	474	80	similar to Asparagine synthetase [glutamine-hydrolyzing] (Glutamine-dependent asparagine synthetase) (TS11 cell cycle control protein) (FLJ43315)
B31R15C10	31-10-15	Hs~MGC:BC057848.1~uORF:IOH29211	335	159	386	262	255	174	437	342	439	141	similar to Asparagine synthetase [glutamine-hydrolyzing] (Glutamine-dependent asparagine synthetase) (TS11 cell cycle control protein) (FLJ43315)
B31R15C11	31-11-15	Hs~MGC:BC058819.1~uORF:IOH29418	226	106	306	211	180	286	364	268	403	34	zinc finger-like (LOC400713)
B31R15C12	31-12-15	Hs~MGC:BC058819.1~uORF:IOH29418	277	187	306	203	77	206	420	214	328	50	zinc finger-like (LOC400713)
B31R15C17	31-17-15	Hs~Ref:NM_006343.1~CAT:PV3627	38	634	407	138	62	206	223	398	1355	26	Proto-oncogene tyrosine-protein kinase MER
B31R15C18	31-18-15	Hs~Ref:NM_006343.1~CAT:PV3627	45	784	389	163	55	204	226	413	1305	27	Proto-oncogene tyrosine-protein kinase MER
B31R15C19	31-19-15	Hs~Ref:NM_014496.1~CAT:PV4557	902	211	695	2220	321	811	562	565	1033	3863	ribosomal protein S6 kinase, 90kDa, polypeptide 6 (RPS6KA6)
B31R15C20	31-20-15	Hs~Ref:NM_014496.1~CAT:PV4557	973	223	715	2002	334	783	561	555	991	3828	ribosomal protein S6 kinase, 90kDa, polypeptide 6 (RPS6KA6)
B31R15C21	31-21-15	Hs~Ref:NM_001007156.1~CAT:PV3617	629	1673	1535	679	929	839	1739	1220	1464	358	neurotrophic tyrosine kinase, receptor, type 3 (NTRK3), transcript variant 3
B31R15C22	31-22-15	Hs~Ref:NM_001007156.1~CAT:PV3617	577	1767	1533	682	944	835	1647	1161	1478	380	neurotrophic tyrosine kinase, receptor, type 3 (NTRK3), transcript variant 3
B31R16C01	31-1-16	Hs~Ref:NM_001715.2~CAT:PV3683	250	297	426	802	913	1383	828	539	393	58	B lymphoid tyrosine kinase (BLK)
B31R16C02	31-2-16	Hs~Ref:NM_001715.2~CAT:PV3683	243	308	397	843	929	1410	898	580	396	79	B lymphoid tyrosine kinase (BLK)
B31R16C09	31-9-16	Hs~Ref:NM_001040663.1~uORF:IOH61866	408	386	1033	470	894	769	1164	240	873	270	G antigen 4
B31R16C10	31-10-16	Hs~Ref:NM_001040663.1~uORF:IOH61866	453	254	972	435	872	765	1148	236	870	253	G antigen 4
B31R16C11	31-11-16	Hs~MGC:BC094747.1~uORF:IOH62638	1323	652	1030	1332	637	1440	1047	586	1379	349	SET and MYND domain-containing protein 2
B31R16C12	31-12-16	Hs~MGC:BC094747.1~uORF:IOH62638	1269	610	1110	1196	607	1173	1034	664	1316	360	SET and MYND domain-containing protein 2
B31R16C13	31-13-16	Hs~MGC:BC088370.1~uORF:IOH62603	420	473	684	424	429	579	613	416	5926	230	Prolactin
B31R16C14	31-14-16	Hs~MGC:BC088370.1~uORF:IOH62603	511	536	700	481	444	619	628	417	5999	274	Prolactin
B31R16C15	31-15-16	Hs~MGC:BC022244.1~uORF:IOH28623	652	1161	908	639	431	712	1019	518	1002	278	pyrroline-5-carboxylate reductase 1 (PYCR1)
B31R16C16	31-16-16	Hs~MGC:BC022244.1~uORF:IOH28623	560	1136	941	621	402	727	951	505	1026	244	pyrroline-5-carboxylate reductase 1 (PYCR1)
B31R16C17	31-17-16	Hs~MGC:BC053594.1~uORF:IOH28968	4773	12598	49943	4318	540	1781	2498	3094	3254	322	proline-rich transmembrane protein 2 (PRRT2)
B31R16C18	31-18-16	Hs~MGC:BC053594.1~uORF:IOH28968	4673	12747	47486	4037	491	1522	2486	2866	3322	311	proline-rich transmembrane protein 2 (PRRT2)
B31R16C19	31-19-16	Hs~MGC:BC037571.1~uORF:IOH28701	363	294	510	283	204	443	646	397	727	320	cholinergic receptor, nicotinic, alpha 7 (CHRFAM7A)
B31R16C20	31-20-16	Hs~MGC:BC037571.1~uORF:IOH28701	415	295	537	332	2576	455	632	394	682	273	cholinergic receptor, nicotinic, alpha 7 (CHRFAM7A)
B31R16C21	31-21-16	Hs~MGC:BC056682.1~uORF:IOH29473	517	540	581	323	1942	513	691	430	1030	381	zuotin related factor 1 (ZRF1)
B31R16C22	31-22-16	Hs~MGC:BC056682.1~uORF:IOH29473	469	721	553	375	1569	538	782	412	1070	397	zuotin related factor 1 (ZRF1)
B31R17C01	31-1-17	Hs~MGC:BC026238.1~uORF:IOH13560	958	836	1103	656	918	1149	1000	770	1467	448	orosomucoid 1 (ORM1)
B31R17C02	31-2-17	Hs~MGC:BC026238.1~uORF:IOH13560	923	704	1033	660	915	1126	1022	741	1468	445	orosomucoid 1 (ORM1)
B31R17C03	31-3-17	Hs~MGC:NM_152448.1~uORF:IOH22571	1115	886	1224	785	1897	1912	2127	1323	3772	604	chromosome 15 open reading frame 43 (C15orf43)
B31R17C04	31-4-17	Hs~MGC:NM_152448.1~uORF:IOH22571	1176	919	1222	859	1902	1925	2050	1333	4000	631	chromosome 15 open reading frame 43 (C15orf43)
B31R17C05	31-5-17	Hs~MGC:BC021266.1~uORF:IOH14195	1077	822	1176	1010	1156	1118	1834	1013	1998	631	Sodium channel subunit beta-1
B31R17C06	31-6-17	Hs~MGC:BC021266.1~uORF:IOH14195	1074	823	1183	918	1139	1132	1778	1006	2076	701	Sodium channel subunit beta-1
B31R17C07	31-7-17	Hs~Ref:NM_004617.2~uORF:IOH3961	729	668	918	608	691	824	1091	821	1416	508	transmembrane 4 L six family member 4 (TM4SF4)
B31R17C08	31-8-17	Hs~Ref:NM_004617.2~uORF:IOH3961	715	605	890	656	697	889	1219	791	1527	447	transmembrane 4 L six family member 4 (TM4SF4)
B31R17C09	31-9-17	Hs~Ref:NM_004888.2~uORF:IOH7535	1430	10691	2185	10672	12625	3003	8588	1187	2009	1082	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 (ATP6V1G1)
B31R17C10	31-10-17	Hs~Ref:NM_004888.2~uORF:IOH7535	1401	10750	2076	10047	12349	2933	8345	1168	1917	984	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 (ATP6V1G1)
B31R17C11	31-11-17	Hs~Ref:NM_019087.1~uORF:IOH14821	386	386	513	358	347	893	1335	680	791	46	ADP-ribosylation factor-like 15 (ARL15)
B31R17C12	31-12-17	Hs~Ref:NM_019087.1~uORF:IOH14821	367	418	498	328	344	829	1339	687	793	51	ADP-ribosylation factor-like 15 (ARL15)
B31R17C13	31-13-17	Hs~MGC:BC004955.1~uORF:IOH5528	4935	449	579	1034	540	1108	2776	2698	1732	297	ATPase inhibitory factor 1 (ATPIF1)
B31R17C14	31-14-17	Hs~MGC:BC004955.1~uORF:IOH5528	5160	491	588	1242	560	1078	2652	2360	1833	292	ATPase inhibitory factor 1 (ATPIF1)
B31R17C15	31-15-17	Hs~Ref:NM_022747.1~uORF:IOH22152	642	482	509	342	464	538	724	400	909	190	chromosome 14 open reading frame 136 (C14orf136)
B31R17C16	31-16-17	Hs~Ref:NM_022747.1~uORF:IOH22152	565	523	521	327	475	560	695	377	868	140	chromosome 14 open reading frame 136 (C14orf136)
B31R17C17	31-17-17	Hs~MGC:BC000395.1~uORF:IOH3542	446	637	492	285	261	507	517	333	638	246	LETM1 domain-containing protein 1
B31R17C18	31-18-17	Hs~MGC:BC000395.1~uORF:IOH3542	381	780	547	331	314	445	491	345	620	298	LETM1 domain-containing protein 1
B31R17C19	31-19-17	Hs~Ref:NM_080658.1~uORF:IOH3352	814	15529	3513	515	2241	867	837	854	1623	288	aspartoacylase (aminocyclase) 3 (ACY3)
B31R17C20	31-20-17	Hs~Ref:NM_080658.1~uORF:IOH3352	841	15637	3742	485	886	865	825	841	1664	289	aspartoacylase (aminocyclase) 3 (ACY3)
B31R17C21	31-21-17	Hs~MGC:BC008031.1~uORF:IOH7008	423	245	690	310	605	492	1117	644	1919	93	zinc finger protein 3 (ZNF3)
B31R17C22	31-22-17	Hs~MGC:BC008031.1~uORF:IOH7008	390	239	642	293	701	486	1156	638	1940	100	zinc finger protein 3 (ZNF3)
B31R18C01	31-1-18	Hs~MGC:BC009696.1~uORF:IOH9811	474	489	699	1426	593	490	769	839	1040	328	interferon induced transmembrane protein 2 (1-8D) (IFITM2)
B31R18C02	31-2-18	Hs~MGC:BC009696.1~uORF:IOH9811	441	462	712	1391	598	463	761	474	935	370	interferon induced transmembrane protein 2 (1-8D) (IFITM2)
B31R18C03	31-3-18	Hs~Ref:NM_002402.1~uORF:IOH3706	538	538	1496	507	817	606	2998	1588	1059	396	mesoderm specific transcript homolog (mouse) (MEST), transcript variant 1
B31R18C04	31-4-18	Hs~Ref:NM_002402.1~uORF:IOH3706	537	467	1451	469	808	613	3083	1494	1149	380	mesoderm specific transcript homolog (mouse) (MEST), transcript variant 1
B31R18C05	31-5-18	Hs~MGC:BC024939.1~uORF:IOH21470	405	394	1746	479	424	534	3693	1877	1031	299	ganglioside-induced differentiation-associated protein 1 (GDAP1)
B31R18C06	31-6-18	Hs~MGC:BC024939.1~uORF:IOH21470	453	397	1740	397	429	583	3621	1838	1074	361	ganglioside-induced differentiation-associated protein 1 (GDAP1)
B31R18C07	31-7-18	Hs~MGC:BC000120.1~uORF:IOH4407	1107	689	2730	2456	1023	3570	5571	2325	1953	291	general transcription factor IIF, polypeptide 1, 74kDa (GTF2F1)
B31R18C08	31-8-18	Hs~MGC:BC000120.1~uORF:IOH4407	961	649	2716	2332	1007	3233	5404	2334	1995	310	general transcription factor IIF, polypeptide 1, 74kDa (GTF2F1)
B31R18C09	31-9-18	Hs~Ref:NM_020239.2~uORF:IOH21482	-2	-1	0	4	797	926	0	355	2	-2	CDC42 small effector 1 (CDC42SE1), transcript variant 2
B31R18C10	31-10-18	Hs~Ref:NM_020239.2~uORF:IOH21482	-6	17	4	3	774	-2	-3	3	20	-3	CDC42 small effector 1 (CDC42SE1), transcript variant 2
B31R18C11	31-11-18	Hs~MGC:BC060814.1~uORF:IOH39802	-4	15	0	0	1	-2	-6	-1	-2	-2	centaurin, gamma 2 (CENTG2)
B31R18C12	31-12-18	Hs~MGC:BC060814.1~uORF:IOH39802	7	-6	-2	386	-2	154	59	221	-5	-3	centaurin, gamma 2 (CENTG2)
B31R18C13	31-13-18	Hs~MGC:BC036056.1~uORF:IOH27184	6050	3529	3900	6778	3139	6220	8707	10938	5396	7821	Fanconi anemia, complementation group M (FANCM)
B31R18C14	31-14-18	Hs~MGC:BC036056.1~uORF:IOH27184	6041	3558	3697	7275	3174	6003	8254	10435	5206	7517	Fanconi anemia, complementation group M (FANCM)
B31R18C15	31-15-18	Hs~Ref:XM_498434.1~uORF:IOH57016	1199	687	908	551	693	4347	1317	1021	1793	413	hypothetical protein MGC16075, mRNA (cDNA clone MGC:16075 IMAGE:3616854), complete cds
B31R18C16	31-16-18	Hs~Ref:XM_498434.1~uORF:IOH57016	951	714	873	527	731	4094	1313	944	1717	389	hypothetical protein MGC16075, mRNA (cDNA clone MGC:16075 IMAGE:3616854), complete cds
B31R18C17	31-17-18	Hs~Ref:NM_182481.1~uORF:IOH58617	360	465	761	307	273	465	1860	874	568	341	B melanoma antigen 3
B31R18C18	31-18-18	Hs~Ref:NM_182481.1~uORF:IOH58617	373	483	804	375	335	511	1753	893	626	294	B melanoma antigen 3
B31R18C19	31-19-18	Hs~Ref:NM_017839.3~uORF:IOH40661	955	916	1694	884	2609	861	1355	882	1954	409	acyltransferase like 1 (AYTL1)
B31R18C20	31-20-18	Hs~Ref:NM_017839.3~uORF:IOH40661	951	909	1699	900	598	854	1383	845	1998	374	acyltransferase like 1 (AYTL1)
B31R18C21	31-21-18	Hs~Ref:NM_005034.2~uORF:IOH10479	1076	1168	1855	1477	1923	1030	1439	1192	2489	537	polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa (POLR2K)
B31R18C22	31-22-18	Hs~Ref:NM_005034.2~uORF:IOH10479	1028	1206	1808	1358	1518	1031	1389	1160	2505	503	polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa (POLR2K)
B31R19C01	31-1-19	Hs~Ref:NM_014763.2~uORF:IOH23003	4021	3851	5015	7240	6415	15589	10125	8686	8695	3316	mitochondrial ribosomal protein L19 (MRPL19), nuclear gene encoding mitochondrial protein
B31R19C02	31-2-19	Hs~Ref:NM_014763.2~uORF:IOH23003	4076	3703	4865	7062	6549	15539	10117	8525	8849	3214	mitochondrial ribosomal protein L19 (MRPL19), nuclear gene encoding mitochondrial protein
B31R19C03	31-3-19	Hs~Ref:NM_003992.1~N/A	450	445	646	929	606	520	676	647	1083	360	Dual specificity protein kinase CLK3
B31R19C04	31-4-19	Hs~Ref:NM_003992.1~N/A	421	473	609	885	576	483	737	667	954	291	Dual specificity protein kinase CLK3
B31R19C05	31-5-19	Hs~Ref:NM_004887.2~uORF:IOH5492	781	656	800	1022	513	701	1700	703	1264	241	chemokine (C-X-C motif) ligand 14 (CXCL14)
B31R19C06	31-6-19	Hs~Ref:NM_004887.2~uORF:IOH5492	795	644	807	643	449	719	1641	723	1301	572	chemokine (C-X-C motif) ligand 14 (CXCL14)
B31R19C07	31-7-19	Hs~Ref:NM_016511.1~uORF:IOH27414	1050	1844	976	608	1293	975	1488	883	1551	463	C-type lectin domain family 1, member A (CLEC1A)
B31R19C08	31-8-19	Hs~Ref:NM_016511.1~uORF:IOH27414	915	1726	989	665	1222	1081	1444	799	1632	506	C-type lectin domain family 1, member A (CLEC1A)
B31R19C09	31-9-19	Hs~MGC:BC029869.1~uORF:IOH22797	576	479	676	560	356	689	999	586	1220	417	ectonucleoside triphosphate diphosphohydrolase 3 (ENTPD3)
B31R19C10	31-10-19	Hs~MGC:BC029869.1~uORF:IOH22797	590	461	1460	522	383	666	992	678	1209	397	ectonucleoside triphosphate diphosphohydrolase 3 (ENTPD3)
B31R19C11	31-11-19	Hs~Ref:NM_013342.1~uORF:IOH5505	1468	1479	1551	10463	669	1148	2807	697	7149	417	TCF3 (E2A) fusion partner (in childhood Leukemia) (TFPT)
B31R19C12	31-12-19	Hs~Ref:NM_013342.1~uORF:IOH5505	1381	1196	1593	5891	679	1145	2739	715	7002	400	TCF3 (E2A) fusion partner (in childhood Leukemia) (TFPT)
B31R19C13	31-13-19	Hs~MGC:BC001304.1~uORF:IOH45994	33041	22502	33337	65467	14673	23803	30286	13523	23410	13565	piccolo (presynaptic cytomatrix protein) (PCLO)
B31R19C14	31-14-19	Hs~MGC:BC001304.1~uORF:IOH45994	32692	22825	34139	65471	14640	26051	28616	14113	23556	15567	piccolo (presynaptic cytomatrix protein) (PCLO)
B31R19C15	31-15-19	Hs~Ref:NM_004755.2~uORF:IOH45179	1376	733	1986	1504	1187	1079	2612	1083	3920	443	ribosomal protein S6 kinase, 90kDa, polypeptide 5 (RPS6KA5), transcript variant 1
B31R19C16	31-16-19	Hs~Ref:NM_004755.2~uORF:IOH45179	1360	836	1970	1567	1197	1049	2612	975	4002	485	ribosomal protein S6 kinase, 90kDa, polypeptide 5 (RPS6KA5), transcript variant 1
B31R19C19	31-19-19	Hs~Ref:NM_207013.1~uORF:IOH42170	402	561	593	405	275	483	467	520	1939	412	transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) (TCEB2), transcript variant 2
B31R19C20	31-20-19	Hs~Ref:NM_207013.1~uORF:IOH42170	405	481	593	424	2942	468	457	478	2007	305	transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) (TCEB2), transcript variant 2
B31R19C21	31-21-19	Hs~MGC:BC017117.1~uORF:IOH10010	1482	776	1366	2596	4476	1014	1461	834	2822	761	cAMP responsive element modulator (CREM)
B31R19C22	31-22-19	Hs~MGC:BC017117.1~uORF:IOH10010	1356	876	1197	2649	1139	981	1555	796	2663	687	cAMP responsive element modulator (CREM)
B31R20C01	31-1-20	Hs~MGC:BC011400.1~uORF:IOH9691	1295	561	1215	2307	610	679	1159	3091	2265	809	Uncharacterized protein C14orf104
B31R20C02	31-2-20	Hs~MGC:BC011400.1~uORF:IOH9691	1333	596	1171	2366	614	664	1160	3187	2436	792	Uncharacterized protein C14orf104
B31R20C03	31-3-20	Hs~MGC:BC010518.1~uORF:IOH10184	1644	790	973	3568	602	846	1209	772	2343	1232	megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1)
B31R20C04	31-4-20	Hs~MGC:BC010518.1~uORF:IOH10184	1688	807	975	3703	666	873	1382	661	2303	1152	megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1)
B31R20C05	31-5-20	Hs~Ref:NM_033414.1~uORF:IOH10240	5919	1789	2834	15145	1463	1528	5528	1201	5142	893	zinc finger protein 622 (ZNF622)
B31R20C06	31-6-20	Hs~Ref:NM_033414.1~uORF:IOH10240	6156	1809	2758	14405	1538	1522	5464	1205	5502	889	zinc finger protein 622 (ZNF622)
B31R20C07	31-7-20	Hs~Ref:NM_012437.2~uORF:IOH3724	1646	2505	1671	2202	949	356	25	0	0	-2	SNAP-associated protein (SNAPAP)
B31R20C08	31-8-20	Hs~Ref:NM_012437.2~uORF:IOH3724	1654	2549	1803	2174	880	-1	29	-2	-4	-1	SNAP-associated protein (SNAPAP)
B31R20C09	31-9-20	Hs~MGC:BC015738.1~uORF:IOH14824	1219	1464	1051	1193	510	3365	3306	1730	17490	312	Zinc finger FYVE domain-containing protein 19
B31R20C10	31-10-20	Hs~MGC:BC015738.1~uORF:IOH14824	1275	1371	1153	1147	502	3055	3389	1614	17553	52	Zinc finger FYVE domain-containing protein 19
B31R20C11	31-11-20	Hs~MGC:BC001780.1~uORF:IOH4955	1800	1099	1718	1241	426	1352	6102	871	1611	473	Uncharacterized methyltransferase WBSCR22
B31R20C12	31-12-20	Hs~MGC:BC001780.1~uORF:IOH4955	1746	986	1537	1028	405	1395	5901	843	1583	445	Uncharacterized methyltransferase WBSCR22
B31R20C13	31-13-20	Hs~MGC:BC002737.1~uORF:IOH5347	1172	595	814	1272	469	1759	3643	686	1283	229	vesicle-associated membrane protein 2 (synaptobrevin 2) (VAMP2)
B31R20C14	31-14-20	Hs~MGC:BC002737.1~uORF:IOH5347	1128	590	701	1320	451	1683	3457	655	1338	172	vesicle-associated membrane protein 2 (synaptobrevin 2) (VAMP2)
B32R02C11	32-11-2	Hs~Ref:NM_053056.1~uORF:IOH1962	1066	946	1106	713	760	920	1299	927	2928	592	G1/S-specific cyclin-D1
B32R02C12	32-12-2	Hs~Ref:NM_053056.1~uORF:IOH1962	1064	1147	1130	1086	1239	979	1347	974	2800	662	G1/S-specific cyclin-D1
B32R02C13	32-13-2	Hs~MGC:BC006410.1~uORF:IOH6249	418	443	585	671	737	587	590	369	1168	262	Ubiquilin-4
B32R02C14	32-14-2	Hs~MGC:BC006410.1~uORF:IOH6249	252	289	597	681	661	576	581	369	1300	264	Ubiquilin-4
B32R02C15	32-15-2	Hs~MGC:BC029611.1~uORF:IOH28688	2057	1697	2224	2069	2963	3416	2666	3177	3950	1532	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein
B32R02C16	32-16-2	Hs~MGC:BC029611.1~uORF:IOH28688	2004	1630	2237	2038	7517	3419	2878	3018	3905	2814	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein
B32R02C17	32-17-2	Hs~Ref:NM_007176.1~uORF:IOH4267	1312	1109	1303	883	3771	1152	1416	1116	2824	1210	Probable ergosterol biosynthetic protein 28
B32R02C18	32-18-2	Hs~Ref:NM_007176.1~uORF:IOH4267	1346	1142	1247	799	1953	1246	1335	1395	2715	968	Probable ergosterol biosynthetic protein 28
B32R02C19	32-19-2	Hs~MGC:BC032350.1~uORF:IOH21707	721	572	683	488	2492	616	826	618	1403	128	major histocompatibility complex, class II, DR alpha (HLA-DRA)
B32R02C20	32-20-2	Hs~MGC:BC032350.1~uORF:IOH21707	847	538	697	483	3067	619	809	646	1432	20	major histocompatibility complex, class II, DR alpha (HLA-DRA)
B32R02C21	32-21-2	Hs~Ref:NM_001756.2~uORF:IOH2195	459	311	518	316	222	471	1185	380	1019	137	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 (SERPINA6)
B32R02C22	32-22-2	Hs~Ref:NM_001756.2~uORF:IOH2195	587	274	547	323	195	423	977	354	1032	126	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 (SERPINA6)
B32R03C01	32-1-3	Hs~Ref:NM_016188.3~uORF:IOH2230	441	338	495	385	444	370	598	380	1113	547	actin-like 6B (ACTL6B)
B32R03C02	32-2-3	Hs~Ref:NM_016188.3~uORF:IOH2230	568	355	509	336	1068	385	579	348	1181	465	actin-like 6B (ACTL6B)
B32R03C03	32-3-3	Hs~Ref:NM_012095.2~uORF:IOH12776	1023	913	818	926	1076	793	1029	547	1653	689	adaptor-related protein complex 3, mu 1 subunit (AP3M1), transcript variant 2
B32R03C04	32-4-3	Hs~Ref:NM_012095.2~uORF:IOH12776	949	909	814	1102	947	732	915	613	1701	693	adaptor-related protein complex 3, mu 1 subunit (AP3M1), transcript variant 2
B32R03C05	32-5-3	Hs~Ref:NM_006427.2~uORF:IOH40965	578	551	535	386	250	449	613	400	1285	201	SIVA1, apoptosis-inducing factor (SIVA1), transcript variant 1
B32R03C06	32-6-3	Hs~Ref:NM_006427.2~uORF:IOH40965	485	418	572	364	353	436	623	393	1205	146	SIVA1, apoptosis-inducing factor (SIVA1), transcript variant 1
B32R03C07	32-7-3	Hs~Ref:NM_022170.1~uORF:IOH44460	568	927	1512	493	381	12464	2064	838	2622	459	eukaryotic translation initiation factor 4H (EIF4H), transcript variant 1
B32R03C08	32-8-3	Hs~Ref:NM_022170.1~uORF:IOH44460	1987	939	1562	534	650	11886	2049	850	2580	390	eukaryotic translation initiation factor 4H (EIF4H), transcript variant 1
B32R03C09	32-9-3	Hs~Ref:NM_019885.2~uORF:IOH37861	174	122	333	199	99	198	245	215	359	60	cytochrome P450, family 26, subfamily B, polypeptide 1 (CYP26B1)
B32R03C10	32-10-3	Hs~Ref:NM_019885.2~uORF:IOH37861	142	116	309	204	70	209	215	227	214	47	cytochrome P450, family 26, subfamily B, polypeptide 1 (CYP26B1)
B32R03C11	32-11-3	Hs~MGC:BC066974.1~uORF:IOH40056	570	574	1747	1739	406	1525	704	4900	3276	268	EP400 N-terminal like (EP400NL)
B32R03C12	32-12-3	Hs~MGC:BC066974.1~uORF:IOH40056	578	586	1637	1699	744	1544	725	4856	3249	263	EP400 N-terminal like (EP400NL)
B32R03C13	32-13-3	Hs~Ref:NM_138348.3~uORF:IOH45908	699	-18	1158	369	281	4987	692	398	3019	485	family with sequence similarity 105, member B (FAM105B)
B32R03C14	32-14-3	Hs~Ref:NM_138348.3~uORF:IOH45908	713	320	1155	380	262	5658	791	422	3260	487	family with sequence similarity 105, member B (FAM105B)
B32R03C15	32-15-3	Hs~Ref:NM_001752.2~uORF:IOH41295	1136	1060	2455	2653	3893	6446	8930	1980	5280	752	catalase (CAT)
B32R03C16	32-16-3	Hs~Ref:NM_001752.2~uORF:IOH41295	1148	1064	2395	2494	4037	6116	8975	1874	5112	999	catalase (CAT)
B32R03C19	32-19-3	Hs~Ref:NM_194358.1~uORF:IOH45538	1036	960	1040	1722	2285	1571	1524	1464	1662	-16	ring finger protein 41 (RNF41), transcript variant 2
B32R03C20	32-20-3	Hs~Ref:NM_194358.1~uORF:IOH45538	1188	1053	1016	1706	746	1566	1474	1480	1719	1	ring finger protein 41 (RNF41), transcript variant 2
B32R03C21	32-21-3	Hs~MGC:BC016857.1~uORF:IOH10375	1239	3691	1995	958	1002	1267	2594	1955	3352	-34	ferritin, heavy polypeptide 1 (FTH1)
B32R03C22	32-22-3	Hs~MGC:BC016857.1~uORF:IOH10375	1344	3782	2047	1005	1092	1249	2038	1849	3321	-29	ferritin, heavy polypeptide 1 (FTH1)
B32R04C01	32-1-4	Hs~MGC:NM_177403.3~uORF:IOH10406	558	729	668	809	1765	746	691	687	1380	324	RAB7B, member RAS oncogene family (RAB7B)
B32R04C02	32-2-4	Hs~MGC:NM_177403.3~uORF:IOH10406	624	739	663	817	1443	734	689	690	1385	61	RAB7B, member RAS oncogene family (RAB7B)
B32R04C03	32-3-4	Hs~Ref:NM_017853.1~uORF:IOH10793	950	438	476	478	838	1074	564	736	1194	365	thioredoxin-like 4B (TXNL4B)
B32R04C04	32-4-4	Hs~Ref:NM_017853.1~uORF:IOH10793	927	451	466	568	499	1016	581	723	1223	52	thioredoxin-like 4B (TXNL4B)
B32R04C05	32-5-4	Hs~Ref:NM_138777.1~uORF:IOH10791	1113	659	912	495	602	1104	2055	788	1503	387	mitochondrial ribosome recycling factor (MRRF), nuclear gene encoding mitochondrial protein, transcript variant 1
B32R04C06	32-6-4	Hs~Ref:NM_138777.1~uORF:IOH10791	981	669	1005	516	555	985	2008	623	1459	308	mitochondrial ribosome recycling factor (MRRF), nuclear gene encoding mitochondrial protein, transcript variant 1
B32R04C07	32-7-4	Hs~Ref:NM_005272.2~uORF:IOH4363	1422	636	1029	672	1312	1020	1404	736	2472	298	guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 (GNAT2)
B32R04C08	32-8-4	Hs~Ref:NM_005272.2~uORF:IOH4363	1262	670	999	665	1292	1073	1354	693	1742	316	guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 (GNAT2)
B32R04C09	32-9-4	Hs~MGC:NM_182488.1~uORF:IOH10698	1398	762	1079	920	963	740	1397	566	2678	403	ubiquitin specific peptidase 12 (USP12)
B32R04C10	32-10-4	Hs~MGC:NM_182488.1~uORF:IOH10698	2502	815	1093	842	1046	813	1406	631	2895	348	ubiquitin specific peptidase 12 (USP12)
B32R04C11	32-11-4	Hs~Ref:NM_138379.1~uORF:IOH3316	672	606	957	427	379	539	1341	736	1818	395	T-cell immunoglobulin and mucin domain containing 4 (TIMD4)
B32R04C12	32-12-4	Hs~Ref:NM_138379.1~uORF:IOH3316	618	555	922	438	346	507	1366	713	1671	371	T-cell immunoglobulin and mucin domain containing 4 (TIMD4)
B32R04C13	32-13-4	Hs~Ref:NM_003666.1~uORF:IOH13812	1399	991	890	898	1160	1238	1433	906	3542	561	basic leucine zipper nuclear factor 1 (JEM-1) (BLZF1)
B32R04C14	32-14-4	Hs~Ref:NM_003666.1~uORF:IOH13812	1501	1065	891	989	1229	1207	1357	808	3654	613	basic leucine zipper nuclear factor 1 (JEM-1) (BLZF1)
B32R04C15	32-15-4	Hs~Ref:NM_018180.2~uORF:IOH38247	1558	1427	1688	1075	605	1623	3415	955	2150	404	DEAH (Asp-Glu-Ala-His) box polypeptide 32 (DHX32)
B32R04C16	32-16-4	Hs~Ref:NM_018180.2~uORF:IOH38247	1565	1266	1640	1022	374	1638	3054	915	2090	401	DEAH (Asp-Glu-Ala-His) box polypeptide 32 (DHX32)
B32R04C17	32-17-4	Hs~MGC:BC060886.1~uORF:IOH29219	1515	993	860	721	428	822	1424	677	1541	-10	myosin IXA (MYO9A)
B32R04C18	32-18-4	Hs~MGC:BC060886.1~uORF:IOH29219	2507	1004	867	774	415	824	1291	636	1506	106	myosin IXA (MYO9A)
B32R04C19	32-19-4	Hs~Ref:NM_152570.1~uORF:IOH38048	1776	625	923	459	289	745	1676	533	955	243	leucine rich repeat and Ig domain containing 2 (LINGO2)
B32R04C20	32-20-4	Hs~Ref:NM_152570.1~uORF:IOH38048	983	640	752	449	324	841	2020	2422	887	-61	leucine rich repeat and Ig domain containing 2 (LINGO2)
B32R04C21	32-21-4	Hs~Ref:NM_016457.3~uORF:IOH38433	1339	735	1255	1300	803	1321	1703	806	3327	333	protein kinase D2 (PRKD2), transcript variant 1
B32R04C22	32-22-4	Hs~Ref:NM_016457.3~uORF:IOH38433	1295	707	1228	1271	873	1353	1640	647	3387	336	protein kinase D2 (PRKD2), transcript variant 1
B32R05C01	32-1-5	Hs~Ref:NM_002198.1~uORF:IOH2022	1342	558	1158	612	657	787	1382	758	1429	452	interferon regulatory factor 1 (IRF1)
B32R05C02	32-2-5	Hs~Ref:NM_002198.1~uORF:IOH2022	1396	560	1126	644	681	786	1437	750	1467	312	interferon regulatory factor 1 (IRF1)
B32R05C03	32-3-5	Hs~MGC:BC022258.1~uORF:IOH12079	6713	6536	5915	6700	4624	5912	5969	5721	8191	5420	von Willebrand factor (VWF)
B32R05C04	32-4-5	Hs~MGC:BC022258.1~uORF:IOH12079	7094	6263	5698	6235	4110	6026	5803	6281	8098	5072	von Willebrand factor (VWF)
B32R05C05	32-5-5	Hs~MGC:BC017864.1~uORF:IOH12322	1142	1070	1037	887	824	821	1172	911	2377	833	glycophorin E (GYPE)
B32R05C06	32-6-5	Hs~MGC:BC017864.1~uORF:IOH12322	1126	1126	1221	909	860	845	1228	1025	2409	899	glycophorin E (GYPE)
B32R05C07	32-7-5	Hs~MGC:NM_152396.1~uORF:IOH12966	1262	924	1438	766	806	973	1227	844	2201	-73	methyltransferase like 6 (METTL6)
B32R05C08	32-8-5	Hs~MGC:NM_152396.1~uORF:IOH12966	1294	971	1278	794	805	957	1224	906	2237	510	methyltransferase like 6 (METTL6)
B32R05C09	32-9-5	Hs~Ref:NM_006575.2~N/A	1219	663	961	595	406	699	1592	605	1432	344	Mitogen-activated protein kinase kinase kinase kinase 5
B32R05C10	32-10-5	Hs~Ref:NM_006575.2~N/A	1278	769	987	582	426	731	1536	607	1162	522	Mitogen-activated protein kinase kinase kinase kinase 5
B32R05C11	32-11-5	Hs~Ref:NM_005465.2~N/A	1067	886	887	619	481	735	1255	961	1478	421	RAC-gamma serine/threonine-protein kinase
B32R05C12	32-12-5	Hs~Ref:NM_005465.2~N/A	903	753	901	605	446	719	1331	970	1335	386	RAC-gamma serine/threonine-protein kinase
B32R05C13	32-13-5	Hs~Ref:NM_003718.2~N/A	900	566	896	554	414	664	1780	914	1255	398	Cell division cycle 2-like protein kinase 5
B32R05C14	32-14-5	Hs~Ref:NM_003718.2~N/A	960	777	914	605	710	706	1693	790	1533	390	Cell division cycle 2-like protein kinase 5
B32R05C15	32-15-5	Hs~Ref:NM_021643.1~N/A	1019	614	1762	717	478	880	1227	763	3255	435	tribbles homolog 2 (Drosophila) (TRIB2)
B32R05C16	32-16-5	Hs~Ref:NM_021643.1~N/A	995	600	1705	710	292	901	1181	733	3238	392	tribbles homolog 2 (Drosophila) (TRIB2)
B32R05C17	32-17-5	Hs~Ref:NM_000496.1~uORF:IOH40269	1314	1300	1639	1171	1694	1268	2302	947	3109	665	crystallin, beta B2 (CRYBB2)
B32R05C18	32-18-5	Hs~Ref:NM_000496.1~uORF:IOH40269	1389	1282	1659	1126	1694	1255	2360	930	3135	602	crystallin, beta B2 (CRYBB2)
B32R05C19	32-19-5	Hs~Ref:NM_138499.2~uORF:IOH40143	3397	2310	3749	9450	5283	2786	3743	6851	5643	1707	PWWP domain-containing protein 2B
B32R05C20	32-20-5	Hs~Ref:NM_138499.2~uORF:IOH40143	3505	2406	3649	9747	5281	2734	3918	7092	5694	1613	PWWP domain-containing protein 2B
B32R05C21	32-21-5	Hs~Ref:NM_003089.4~uORF:IOH40192	4634	1931	2691	2098	1320	2214	17426	1569	5580	751	small nuclear ribonucleoprotein 70kDa polypeptide (RNP antigen) (SNRP70)
B32R05C22	32-22-5	Hs~Ref:NM_003089.4~uORF:IOH40192	4666	1812	2657	2108	1549	2226	18086	1581	5614	666	small nuclear ribonucleoprotein 70kDa polypeptide (RNP antigen) (SNRP70)
B32R06C01	32-1-6	Hs~Ref:NM_032847.1~uORF:IOH40091	836	727	1255	643	620	800	1307	1604	1494	451	chromosome 8 open reading frame 76 (C8orf76)
B32R06C02	32-2-6	Hs~Ref:NM_032847.1~uORF:IOH40091	843	739	1243	618	520	819	1364	1414	1506	329	chromosome 8 open reading frame 76 (C8orf76)
B32R06C03	32-3-6	Hs~Ref:NM_080590.1~uORF:IOH13252	499	596	488	407	357	716	542	516	1103	124	calcyphosine (CAPS), transcript variant 2
B32R06C04	32-4-6	Hs~Ref:NM_080590.1~uORF:IOH13252	549	619	502	448	350	687	567	540	1078	126	calcyphosine (CAPS), transcript variant 2
B32R06C05	32-5-6	Hs~MGC:NM_173652.1~uORF:IOH22733	1623	985	1597	3126	1084	1163	2154	875	2422	344	Uncharacterized protein C2orf58
B32R06C06	32-6-6	Hs~MGC:NM_173652.1~uORF:IOH22733	1365	1399	1703	3430	1123	1232	2584	1182	1701	137	Uncharacterized protein C2orf58
B32R06C07	32-7-6	Hs~Ref:NM_144594.1~uORF:IOH10942	2942	1677	3840	8048	2256	3401	3035	1729	3729	596	family with sequence similarity 112, member B (FAM112B)
B32R06C08	32-8-6	Hs~Ref:NM_144594.1~uORF:IOH10942	2793	1686	3747	7932	2322	3155	2981	1760	3911	628	family with sequence similarity 112, member B (FAM112B)
B32R06C09	32-9-6	Hs~Ref:NM_003975.1~uORF:IOH13203	11109	8223	65422	31000	16600	21453	16676	12304	13800	20489	SH2 domain protein 2A (SH2D2A)
B32R06C10	32-10-6	Hs~Ref:NM_003975.1~uORF:IOH13203	11153	8334	65417	30343	16467	20649	17098	12211	12779	20717	SH2 domain protein 2A (SH2D2A)
B32R06C11	32-11-6	Hs~Ref:NM_002421.2~uORF:IOH59103	778	579	637	660	277	1307	1068	1036	1259	29	Interstitial collagenase
B32R06C12	32-12-6	Hs~Ref:NM_002421.2~uORF:IOH59103	776	537	605	665	283	1354	1097	735	1236	289	Interstitial collagenase
B32R06C13	32-13-6	Hs~Ref:NM_013310.3~uORF:IOH59703	1065	706	795	737	447	1196	926	808	1890	298	Uncharacterized protein C2orf27
B32R06C14	32-14-6	Hs~Ref:NM_013310.3~uORF:IOH59703	1072	683	797	783	537	1238	888	727	1825	127	Uncharacterized protein C2orf27
B32R06C15	32-15-6	Hs~Ref:NM_198217.1~uORF:IOH59743	6018	2569	1844	1531	1042	3220	9931	1932	3502	881	Inhibitor of growth protein 1
B32R06C16	32-16-6	Hs~Ref:NM_198217.1~uORF:IOH59743	5846	2455	1804	1460	1089	3117	12540	1821	3257	855	Inhibitor of growth protein 1
B32R06C17	32-17-6	Hs~Ref:NM_001543.3~uORF:IOH52925	747	573	702	575	284	1042	1145	658	933	112	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1
B32R06C18	32-18-6	Hs~Ref:NM_001543.3~uORF:IOH52925	727	583	695	576	278	1100	873	648	911	-11	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1
B32R06C19	32-19-6	Hs~Ref:NM_006759.3~uORF:IOH26550	671	733	1380	964	672	1433	1064	589	2056	-83	UDP-glucose pyrophosphorylase 2 (UGP2), transcript variant 1
B32R06C20	32-20-6	Hs~Ref:NM_006759.3~uORF:IOH26550	719	688	1309	811	584	1427	983	595	2023	210	UDP-glucose pyrophosphorylase 2 (UGP2), transcript variant 1
B32R06C21	32-21-6	Hs~Ref:NM_016302.2~uORF:IOH23076	1076	641	1000	722	1403	902	1890	700	1740	-73	cereblon (CRBN)
B32R06C22	32-22-6	Hs~Ref:NM_016302.2~uORF:IOH23076	1103	554	1001	731	1764	820	1840	724	1802	-4	cereblon (CRBN)
B32R07C01	32-1-7	Hs~Ref:NM_020320.2~uORF:IOH14861	577	467	617	454	319	557	1062	454	798	273	arginyl-tRNA synthetase 2, mitochondrial (RARS2)
B32R07C02	32-2-7	Hs~Ref:NM_020320.2~uORF:IOH14861	567	399	597	407	398	488	1004	440	857	10	arginyl-tRNA synthetase 2, mitochondrial (RARS2)
B32R07C03	32-3-7	Hs~Ref:NM_006919.1~uORF:IOH7262	1345	737	692	540	482	589	773	350	941	291	serpin peptidase inhibitor, clade B (ovalbumin), member 3 (SERPINB3)
B32R07C04	32-4-7	Hs~Ref:NM_006919.1~uORF:IOH7262	1334	737	692	569	674	534	743	363	963	251	serpin peptidase inhibitor, clade B (ovalbumin), member 3 (SERPINB3)
B32R07C05	32-5-7	Hs~Ref:NM_005362.2~uORF:IOH3602	382	282	1036	815	366	894	501	287	1067	39	Melanoma-associated antigen 3
B32R07C06	32-6-7	Hs~Ref:NM_005362.2~uORF:IOH3602	274	273	475	1073	97	888	654	531	1705	40	Melanoma-associated antigen 3
B32R07C07	32-7-7	Hs~Ref:NM_007177.1~uORF:IOH10203	14271	18233	8030	55056	5133	16180	5006	14107	7577	3413	Protein FAM107A
B32R07C08	32-8-7	Hs~Ref:NM_007177.1~uORF:IOH10203	14207	16048	7728	54472	5098	15375	5192	13226	7383	3617	Protein FAM107A
B32R07C09	32-9-7	Hs~Ref:NM_001500.1~uORF:IOH4377	1211	1088	1314	927	1151	1627	2075	820	2119	241	GDP-mannose 4,6 dehydratase
B32R07C10	32-10-7	Hs~Ref:NM_001500.1~uORF:IOH4377	1217	1062	1217	892	1165	1580	2227	737	2096	483	GDP-mannose 4,6 dehydratase
B32R07C13	32-13-7	Hs~Ref:NM_018401.1~N/A	1017	862	1022	23468	801	658	1213	740	1648	440	Serine/threonine-protein kinase 32B
B32R07C14	32-14-7	Hs~Ref:NM_018401.1~N/A	1034	712	1004	22456	546	845	1334	838	1733	251	Serine/threonine-protein kinase 32B
B32R07C15	32-15-7	Hs~Ref:NM_003081.2~uORF:IOH9748	2418	1886	2903	65473	14991	2291	17326	8040	3964	800	synaptosomal-associated protein, 25kDa (SNAP25), transcript variant 1
B32R07C16	32-16-7	Hs~Ref:NM_003081.2~uORF:IOH9748	2438	1828	2789	65469	14920	2117	17537	7706	3968	790	synaptosomal-associated protein, 25kDa (SNAP25), transcript variant 1
B32R07C17	32-17-7	Hs~MGC:BC007610.1~uORF:IOH6911	3301	1237	2435	2587	2673	3558	10043	1321	8195	840	splicing factor 3b, subunit 2, 145kDa (SF3B2)
B32R07C18	32-18-7	Hs~MGC:BC007610.1~uORF:IOH6911	3254	1243	2485	2466	2663	3771	8517	1320	8457	546	splicing factor 3b, subunit 2, 145kDa (SF3B2)
B32R07C19	32-19-7	Hs~MGC:BC013781.1~uORF:IOH9733	675	919	655	557	310	874	752	666	2395	19	tubulin, gamma complex associated protein 3 (TUBGCP3)
B32R07C20	32-20-7	Hs~MGC:BC013781.1~uORF:IOH9733	713	905	639	579	339	892	733	651	2393	221	tubulin, gamma complex associated protein 3 (TUBGCP3)
B32R07C21	32-21-7	Hs~Ref:NM_016013.2~uORF:IOH4599	730	264	515	643	210	496	652	377	817	-15	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1 (NDUFAF1)
B32R07C22	32-22-7	Hs~Ref:NM_016013.2~uORF:IOH4599	690	351	554	620	505	475	580	437	855	530	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1 (NDUFAF1)
B32R08C01	32-1-8	Hs~MGC:BC028124.1~uORF:IOH11563	1269	1087	974	789	626	875	1209	824	1809	581	chromosome 17 open reading frame 46 (C17orf46)
B32R08C02	32-2-8	Hs~MGC:BC028124.1~uORF:IOH11563	1316	1066	995	787	660	895	1222	828	1854	-9	chromosome 17 open reading frame 46 (C17orf46)
B32R08C03	32-3-8	Hs~Ref:NM_016271.3~uORF:IOH11194	1699	831	1967	720	695	925	3879	1161	1915	-33	ring finger protein 138 (RNF138), transcript variant 1
B32R08C04	32-4-8	Hs~Ref:NM_016271.3~uORF:IOH11194	1780	819	1921	810	722	898	3943	1054	1856	-35	ring finger protein 138 (RNF138), transcript variant 1
B32R08C05	32-5-8	Hs~MGC:BC035054.2~uORF:IOH27693	1852	696	1343	550	519	858	1232	590	1605	-113	RAB28, member RAS oncogene family (RAB28)
B32R08C06	32-6-8	Hs~MGC:BC035054.2~uORF:IOH27693	1931	665	1375	597	521	839	1239	600	1534	-73	RAB28, member RAS oncogene family (RAB28)
B32R08C07	32-7-8	Hs~Ref:NM_001008657.1~uORF:IOH13916	1248	957	18111	1371	1964	2030	7005	1426	3558	874	Treacher Collins-Franceschetti syndrome 1 (TCOF1), transcript variant 3
B32R08C08	32-8-8	Hs~Ref:NM_001008657.1~uORF:IOH13916	1250	969	17064	1308	1826	2070	7104	1319	3614	825	Treacher Collins-Franceschetti syndrome 1 (TCOF1), transcript variant 3
B32R08C09	32-9-8	Hs~MGC:BC007957.1~uORF:IOH6766	1613	1219	3949	1048	865	1333	4117	1458	1826	264	chromosome 20 open reading frame 116 (C20orf116)
B32R08C10	32-10-8	Hs~MGC:BC007957.1~uORF:IOH6766	1716	1187	3736	1127	874	1342	4026	1400	1758	357	chromosome 20 open reading frame 116 (C20orf116)
B32R08C11	32-11-8	Hs~Ref:NM_182801.1~uORF:IOH23237	1233	1376	1485	1014	1037	1049	1750	999	1780	524	EGF-like, fibronectin type III and laminin G domains (EGFLAM), transcript variant 4
B32R08C12	32-12-8	Hs~Ref:NM_182801.1~uORF:IOH23237	1290	1360	1455	1098	1085	1005	1660	944	1650	713	EGF-like, fibronectin type III and laminin G domains (EGFLAM), transcript variant 4
B32R08C13	32-13-8	Hs~Ref:NM_005567.2~uORF:IOH3566	651	238	623	436	265	490	961	406	865	212	lectin, galactoside-binding, soluble, 3 binding protein (LGALS3BP)
B32R08C14	32-14-8	Hs~Ref:NM_005567.2~uORF:IOH3566	657	212	603	422	275	472	1027	533	793	140	lectin, galactoside-binding, soluble, 3 binding protein (LGALS3BP)
B32R08C15	32-15-8	Hs~MGC:BC021573.1~uORF:IOH14848	1454	721	858	593	345	1042	3211	1108	1363	742	GTP-binding protein 10
B32R08C16	32-16-8	Hs~MGC:BC021573.1~uORF:IOH14848	1521	708	852	568	258	923	1000	1020	1851	758	GTP-binding protein 10
B32R08C17	32-17-8	Hs~MGC:BC010349.1~uORF:IOH14182	612	772	423	562	112	367	694	401	468	-7	sorting nexin 7 (SNX7)
B32R08C18	32-18-8	Hs~MGC:BC010349.1~uORF:IOH14182	569	1325	400	567	134	434	619	348	621	13	sorting nexin 7 (SNX7)
B32R08C19	32-19-8	Hs~Ref:NM_032858.1~uORF:IOH12001	737	963	735	505	323	681	960	699	1171	24	maelstrom homolog (Drosophila) (MAEL)
B32R08C20	32-20-8	Hs~Ref:NM_032858.1~uORF:IOH12001	803	617	724	555	308	673	952	626	1314	335	maelstrom homolog (Drosophila) (MAEL)
B32R08C21	32-21-8	Hs~Ref:NM_198965.1~uORF:IOH44500	2376	2318	2025	1764	1525	1978	6016	1419	4386	1003	Parathyroid hormone-related protein
B32R08C22	32-22-8	Hs~Ref:NM_198965.1~uORF:IOH44500	2364	2131	2038	1767	2123	1960	5669	1630	4424	1362	Parathyroid hormone-related protein
B32R09C01	32-1-9	Hs~Ref:NM_001003704.1~uORF:IOH58771	392	404	566	272	259	409	513	360	785	-7	Mitochondrial 18 kDa protein
B32R09C02	32-2-9	Hs~Ref:NM_001003704.1~uORF:IOH58771	486	437	594	356	270	395	536	290	751	-21	Mitochondrial 18 kDa protein
B32R09C03	32-3-9	Hs~Ref:NM_021100.3~uORF:IOH39970	5796	1923	900	1743	487	905	1248	557	1142	282	Cysteine desulfurase, mitochondrial
B32R09C04	32-4-9	Hs~Ref:NM_021100.3~uORF:IOH39970	6341	1895	921	1852	480	965	1243	508	1073	-24	Cysteine desulfurase, mitochondrial
B32R09C05	32-5-9	Hs~Ref:NM_001487.1~uORF:IOH58705	2305	928	1045	870	727	838	1244	810	1880	541	Biogenesis of lysosome-related organelles complex 1 subunit 1
B32R09C06	32-6-9	Hs~Ref:NM_001487.1~uORF:IOH58705	2164	905	1041	869	703	792	1322	802	2017	559	Biogenesis of lysosome-related organelles complex 1 subunit 1
B32R09C07	32-7-9	Hs~Ref:NM_207440.1~uORF:IOH58673	1116	549	777	480	344	602	1221	444	1057	60	Putative uncharacterized protein C13orf35
B32R09C08	32-8-9	Hs~Ref:NM_207440.1~uORF:IOH58673	1087	648	742	458	414	626	1327	413	1025	42	Putative uncharacterized protein C13orf35
B32R09C09	32-9-9	Hs~Ref:NM_017703.1~uORF:IOH57088	979	1089	950	1850	563	853	1354	794	1331	750	F-box/LRR-repeat protein 12
B32R09C10	32-10-9	Hs~Ref:NM_017703.1~uORF:IOH57088	936	1147	936	1721	620	827	1457	894	1383	742	F-box/LRR-repeat protein 12
B32R09C11	32-11-9	Hs~MGC:BC067085.1~uORF:IOH57304	2056	10040	2124	2240	1881	2532	3134	5009	3815	1532	Huntingtin-interacting protein 1-related protein
B32R09C12	32-12-9	Hs~MGC:BC067085.1~uORF:IOH57304	2014	10010	2084	2031	1936	2541	2957	4501	3732	1456	Huntingtin-interacting protein 1-related protein
B32R09C13	32-13-9	Hs~Ref:NM_001030002.1~uORF:IOH55430	14445	9986	10404	16603	6826	8325	11750	21161	15031	10651	Growth factor receptor-bound protein 7
B32R09C14	32-14-9	Hs~Ref:NM_001030002.1~uORF:IOH55430	13784	10091	10482	16774	6869	8402	13704	22457	15194	10668	Growth factor receptor-bound protein 7
B32R09C15	32-15-9	Hs~Ref:NM_014470.2~uORF:IOH55981	1936	4275	1542	1030	845	1464	1874	1077	1903	778	Rho-related GTP-binding protein Rho6
B32R09C16	32-16-9	Hs~Ref:NM_014470.2~uORF:IOH55981	1839	4160	1462	941	1008	1481	1371	1045	2001	841	Rho-related GTP-binding protein Rho6
B32R09C17	32-17-9	Hs~MGC:BC007324.1~uORF:IOH7013	634	757	669	386	221	877	371	328	642	226	Phospholysine phosphohistidine inorganic pyrophosphate phosphatase
B32R09C18	32-18-9	Hs~MGC:BC007324.1~uORF:IOH7013	594	1015	656	403	227	847	431	312	1020	115	Phospholysine phosphohistidine inorganic pyrophosphate phosphatase
B32R09C19	32-19-9	Hs~MGC:BC020495.1~uORF:IOH10734	547	274	485	569	240	377	408	280	1033	47	RAB, member of RAS oncogene family-like 2B (RABL2B)
B32R09C20	32-20-9	Hs~MGC:BC020495.1~uORF:IOH10734	590	303	530	567	255	339	387	347	1046	26	RAB, member of RAS oncogene family-like 2B (RABL2B)
B32R09C21	32-21-9	Hs~Ref:NM_014310.3~uORF:IOH12833	3577	1323	2112	1499	1332	1891	1901	1226	2873	589	RASD family, member 2 (RASD2)
B32R09C22	32-22-9	Hs~Ref:NM_014310.3~uORF:IOH12833	3678	1263	2148	1323	1828	1532	1842	1168	2691	651	RASD family, member 2 (RASD2)
B32R10C01	32-1-10	Hs~Ref:NM_001803.1~uORF:IOH4221	614	541	698	436	483	682	751	609	800	266	CD52 molecule (CD52)
B32R10C02	32-2-10	Hs~Ref:NM_001803.1~uORF:IOH4221	635	473	726	471	455	713	735	601	850	-23	CD52 molecule (CD52)
B32R10C03	32-3-10	Hs~Ref:NM_017846.3~uORF:IOH4319	1579	1073	1528	2275	1135	1107	2149	922	1928	265	tRNA selenocysteine associated protein 1 (TRSPAP1), transcript variant 1
B32R10C04	32-4-10	Hs~Ref:NM_017846.3~uORF:IOH4319	1792	1040	1461	2123	1051	1100	2191	920	1979	92	tRNA selenocysteine associated protein 1 (TRSPAP1), transcript variant 1
B32R10C05	32-5-10	Hs~MGC:BC050718.1~uORF:IOH27017	974	3933	2502	3965	617	870	1415	741	1622	1244	polymerase (DNA directed) kappa (POLK)
B32R10C06	32-6-10	Hs~MGC:BC050718.1~uORF:IOH27017	988	3948	2388	3836	575	878	1384	678	1604	139	polymerase (DNA directed) kappa (POLK)
B32R10C07	32-7-10	Hs~MGC:BC036107.1~uORF:IOH27227	882	724	1746	672	676	911	1934	971	1842	2042	heat shock 70kDa protein 2 (HSPA2)
B32R10C08	32-8-10	Hs~MGC:BC036107.1~uORF:IOH27227	968	780	1715	590	601	923	1947	994	1845	833	heat shock 70kDa protein 2 (HSPA2)
B32R10C09	32-9-10	Hs~Ref:NM_004055.3~uORF:IOH10878	910	838	942	594	924	1021	1510	742	1688	498	calpain 5 (CAPN5)
B32R10C10	32-10-10	Hs~Ref:NM_004055.3~uORF:IOH10878	786	999	911	610	986	1012	1366	869	1661	16	calpain 5 (CAPN5)
B32R11C21	32-21-11	Hs~MGC:BC010697.1~uORF:IOH9799	1849	1863	1771	1530	6370	1375	4518	1135	2843	692	RNA-binding protein 40
B32R11C22	32-22-11	Hs~MGC:BC010697.1~uORF:IOH9799	1764	1899	1699	1457	5679	1201	4218	1064	2675	667	RNA-binding protein 40
B32R12C01	32-1-12	Hs~Ref:NM_016525.3~uORF:IOH10415	1628	3456	1837	838	1469	1018	9156	2319	2418	517	ubiquitin associated protein 1 (UBAP1)
B32R12C02	32-2-12	Hs~Ref:NM_016525.3~uORF:IOH10415	1617	3399	1804	820	1445	964	8996	2223	2371	-19	ubiquitin associated protein 1 (UBAP1)
B32R12C03	32-3-12	Hs~Ref:NM_012402.1~uORF:IOH3521	657	439	799	763	494	715	1513	614	1469	36	ADP-ribosylation factor interacting protein 2 (arfaptin 2) (ARFIP2)
B32R12C04	32-4-12	Hs~Ref:NM_012402.1~uORF:IOH3521	850	444	763	709	412	723	1603	623	1406	-19	ADP-ribosylation factor interacting protein 2 (arfaptin 2) (ARFIP2)
B32R12C05	32-5-12	Hs~MGC:BC017070.1~uORF:IOH11214	1898	2261	2087	1514	1055	2833	1770	1221	1970	792	clusterin associated protein 1 (CLUAP1)
B32R12C06	32-6-12	Hs~MGC:BC017070.1~uORF:IOH11214	2078	2274	2073	1494	962	2725	1712	1205	1996	287	clusterin associated protein 1 (CLUAP1)
B32R12C07	32-7-12	Hs~Ref:NM_138392.1~uORF:IOH13855	1115	1160	1242	1533	3237	1338	2042	1015	2532	225	SH3KBP1-binding protein 1
B32R12C08	32-8-12	Hs~Ref:NM_138392.1~uORF:IOH13855	1186	1124	1310	1465	1943	1176	1999	957	2532	2567	SH3KBP1-binding protein 1
B32R12C09	32-9-12	Hs~Ref:NM_138812.1~uORF:IOH10642	563	730	930	459	1891	2476	3145	1140	1378	530	DPY30 domain containing 1 (DYDC1)
B32R12C10	32-10-12	Hs~Ref:NM_138812.1~uORF:IOH10642	553	629	887	503	3013	2395	3714	1316	1393	-228	DPY30 domain containing 1 (DYDC1)
B32R12C11	32-11-12	Hs~Ref:NM_145041.1~uORF:IOH13199	1433	1275	2039	1034	990	2398	3473	1082	3903	-172	transmembrane protein 106A (TMEM106A)
B32R12C12	32-12-12	Hs~Ref:NM_145041.1~uORF:IOH13199	1504	1236	2008	1027	826	2390	3953	1220	3898	-18	transmembrane protein 106A (TMEM106A)
B32R12C13	32-13-12	Hs~Ref:NM_022755.2~uORF:IOH10937	2272	2146	1782	1121	1419	1860	6541	1221	3403	-233	inositol 1,3,4,5,6-pentakisphosphate 2-kinase (IPPK)
B32R12C14	32-14-12	Hs~Ref:NM_022755.2~uORF:IOH10937	2345	2121	1778	1120	1386	1825	6179	1133	3414	-27	inositol 1,3,4,5,6-pentakisphosphate 2-kinase (IPPK)
B32R12C15	32-15-12	Hs~Ref:NM_014582.1~uORF:IOH40248	525	1369	485	741	1256	702	1034	568	984	63	odorant binding protein 2A (OBP2A)
B32R12C16	32-16-12	Hs~Ref:NM_014582.1~uORF:IOH40248	378	1905	501	753	1234	691	972	560	1009	-11	odorant binding protein 2A (OBP2A)
B32R12C17	32-17-12	Hs~MGC:BC063451.1~uORF:IOH39854	1260	1470	936	847	805	2377	3747	719	3153	3752	t-complex 10 (mouse) (TCP10)
B32R12C18	32-18-12	Hs~MGC:BC063451.1~uORF:IOH39854	1370	451	841	869	774	2235	3748	624	3330	981	t-complex 10 (mouse) (TCP10)
B32R12C19	32-19-12	Hs~Ref:NM_194463.1~uORF:IOH39866	377	507	1133	248	229	404	623	405	839	29	ring finger protein 128 (RNF128), transcript variant 1
B32R12C20	32-20-12	Hs~Ref:NM_194463.1~uORF:IOH39866	309	656	1085	262	265	446	692	388	620	15	ring finger protein 128 (RNF128), transcript variant 1
B32R12C21	32-21-12	Hs~Ref:NM_002662.2~uORF:IOH40471	135	602	506	270	282	103	228	339	282	73	Phospholipase D1
B32R12C22	32-22-12	Hs~Ref:NM_002662.2~uORF:IOH40471	247	68	196	414	212	449	360	326	30	8	Phospholipase D1
B32R13C01	32-1-13	Hs~MGC:BC022077.1~uORF:IOH22412	665	607	736	450	446	695	1242	648	1849	406	kelch domain containing 9 (KARCA1)
B32R13C02	32-2-13	Hs~MGC:BC022077.1~uORF:IOH22412	681	555	782	464	478	305	1250	703	1954	594	kelch domain containing 9 (KARCA1)
B32R13C03	32-3-13	Hs~MGC:BC032957.1~uORF:IOH22428	599	468	748	448	386	1051	789	1273	1628	364	chromosome 1 open reading frame 111 (C1orf111)
B32R13C04	32-4-13	Hs~MGC:BC032957.1~uORF:IOH22428	812	474	784	460	364	1445	824	1202	1633	-83	chromosome 1 open reading frame 111 (C1orf111)
B32R13C05	32-5-13	Hs~MGC:BC001741.1~uORF:IOH4415	763	387	558	343	303	422	306	345	1277	-152	glyoxalase I (GLO1)
B32R13C06	32-6-13	Hs~MGC:BC001741.1~uORF:IOH4415	727	382	574	339	294	291	331	347	1371	-165	glyoxalase I (GLO1)
B32R13C07	32-7-13	Hs~Ref:NM_144588.2~uORF:IOH22403	1291	595	892	654	2387	915	976	918	2678	334	Zinc finger FYVE domain-containing protein 27
B32R13C08	32-8-13	Hs~Ref:NM_144588.2~uORF:IOH22403	1267	654	950	666	908	872	1117	966	2940	9	Zinc finger FYVE domain-containing protein 27
B32R13C09	32-9-13	Hs~Ref:NM_012239.3~uORF:IOH3763	5136	1015	1249	643	1769	1652	2314	2606	6532	106	sirtuin (silent mating type information regulation 2 homolog) 3 (S. cerevisiae) (SIRT3), transcript variant 1
B32R13C10	32-10-13	Hs~Ref:NM_012239.3~uORF:IOH3763	5182	1028	1164	665	1723	1658	2459	2476	6402	-132	sirtuin (silent mating type information regulation 2 homolog) 3 (S. cerevisiae) (SIRT3), transcript variant 1
B32R13C11	32-11-13	Hs~MGC:BC038509.1~uORF:IOH27674	515	651	739	368	2091	470	808	482	924	-31	regulator of calcineurin 2 (DSCR1L1)
B32R13C12	32-12-13	Hs~MGC:BC038509.1~uORF:IOH27674	557	584	781	406	323	475	822	536	904	-48	regulator of calcineurin 2 (DSCR1L1)
B32R13C13	32-13-13	Hs~Ref:NM_005834.1~uORF:IOH12331	927	1465	710	497	514	660	2190	1423	1320	57	translocase of inner mitochondrial membrane 17 homolog B (yeast) (TIMM17B)
B32R13C14	32-14-13	Hs~Ref:NM_005834.1~uORF:IOH12331	815	3217	658	501	592	761	2824	1642	1232	-2	translocase of inner mitochondrial membrane 17 homolog B (yeast) (TIMM17B)
B32R13C15	32-15-13	Hs~MGC:NM_182522.2~uORF:IOH22723	-4	2132	-1	421	325	4	1	-37	-4	0	family with sequence similarity 19 (chemokine (C-C motif)-like), member A4 (FAM19A4), transcript variant 1
B32R13C16	32-16-13	Hs~MGC:NM_182522.2~uORF:IOH22723	-4	2889	-6	498	-1	0	2	-1	-5	-9	family with sequence similarity 19 (chemokine (C-C motif)-like), member A4 (FAM19A4), transcript variant 1
B32R13C17	32-17-13	Hs~MGC:BC010089.1~uORF:IOH27833	1530	2901	1751	1332	3229	2051	3384	1920	2536	-211	acetylserotonin O-methyltransferase-like (ASMTL)
B32R13C18	32-18-13	Hs~MGC:BC010089.1~uORF:IOH27833	1712	3176	1704	1319	3239	2123	3657	1810	2599	-401	acetylserotonin O-methyltransferase-like (ASMTL)
B32R13C19	32-19-13	Hs~MGC:BC032646.1~uORF:IOH28703	440	1787	498	622	165	438	463	316	1363	-61	oxysterol binding protein-like 5 (OSBPL5)
B32R13C20	32-20-13	Hs~MGC:BC032646.1~uORF:IOH28703	467	295	504	582	382	429	493	379	1369	8	oxysterol binding protein-like 5 (OSBPL5)
B32R13C21	32-21-13	Hs~MGC:BC047664.1~uORF:IOH28841	3104	1328	1556	1749	1742	1516	4362	1545	3371	-39	ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)
B32R13C22	32-22-13	Hs~MGC:BC047664.1~uORF:IOH28841	3042	1347	1522	1645	1718	1354	4509	1439	3550	-56	ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)
B32R14C01	32-1-14	Hs~MGC:BC052750.1~uORF:IOH28795	1009	440	383	320	292	573	663	759	1638	476	Uncharacterized protein C2orf62
B32R14C02	32-2-14	Hs~MGC:BC052750.1~uORF:IOH28795	1005	372	414	341	331	600	653	725	1613	373	Uncharacterized protein C2orf62
B32R14C03	32-3-14	Hs~MGC:BC006222.2~uORF:IOH6310	119	385	672	763	380	580	1675	1789	1421	189	chromosome 14 open reading frame 131 (C14orf131)
B32R14C04	32-4-14	Hs~MGC:BC006222.2~uORF:IOH6310	266	378	657	710	385	771	1633	1662	1383	75	chromosome 14 open reading frame 131 (C14orf131)
B32R14C05	32-5-14	Hs~Ref:NM_203370.1~uORF:IOH40905	1049	560	888	1028	541	1218	733	557	1525	-181	chromosome 3 open reading frame 54 (C3orf54)
B32R14C06	32-6-14	Hs~Ref:NM_203370.1~uORF:IOH40905	1003	544	897	1066	543	1248	709	547	1552	-72	chromosome 3 open reading frame 54 (C3orf54)
B32R14C07	32-7-14	Hs~Ref:NM_012097.2~uORF:IOH3083	4924	483	781	660	1727	477	501	388	1001	-118	ADP-ribosylation factor-like 5A (ARL5A), transcript variant 1
B32R14C08	32-8-14	Hs~Ref:NM_012097.2~uORF:IOH3083	5483	490	841	613	868	427	602	374	1039	28	ADP-ribosylation factor-like 5A (ARL5A), transcript variant 1
B32R14C09	32-9-14	Hs~MGC:BC005984.1~uORF:IOH7476	1205	945	1948	676	1205	2298	1428	712	1814	464	chromosome 20 open reading frame 7 (C20orf7)
B32R14C10	32-10-14	Hs~MGC:BC005984.1~uORF:IOH7476	1124	934	1742	753	1349	2088	1397	724	1837	-122	chromosome 20 open reading frame 7 (C20orf7)
B32R14C15	32-15-14	Hs~Ref:NM_001033059.1~uORF:IOH59012	1512	508	3110	319	597	1292	1108	1335	3257	1	S-adenosylmethionine decarboxylase proenzyme
B32R14C16	32-16-14	Hs~Ref:NM_001033059.1~uORF:IOH59012	1537	413	3084	362	562	1245	1077	544	3494	-24	S-adenosylmethionine decarboxylase proenzyme
B32R14C17	32-17-14	Hs~Ref:NM_145802.1~uORF:IOH14040	2392	1066	605	599	481	648	807	748	1057	628	septin 6 (SEPT6), transcript variant V
B32R14C18	32-18-14	Hs~Ref:NM_145802.1~uORF:IOH14040	1459	1222	623	555	479	593	870	665	962	-3	septin 6 (SEPT6), transcript variant V
B32R14C19	32-19-14	Hs~MGC:BC038583.1~uORF:IOH28700	382	1275	415	251	286	294	403	280	1544	73	Protein FAM178B
B32R14C20	32-20-14	Hs~MGC:BC038583.1~uORF:IOH28700	375	244	399	262	390	691	536	352	1118	-3	Protein FAM178B
B32R14C21	32-21-14	Hs~MGC:BC058861.1~uORF:IOH28672	1971	768	1335	911	1031	1122	3545	1624	1870	-101	sulfotransferase family, cytosolic, 1C, member 4 (SULT1C4)
B32R14C22	32-22-14	Hs~MGC:BC058861.1~uORF:IOH28672	1970	743	1286	925	1024	1098	3299	1563	1962	-259	sulfotransferase family, cytosolic, 1C, member 4 (SULT1C4)
B32R15C01	32-1-15	Hs~MGC:BC054031.2~uORF:IOH29106	1334	893	1658	828	564	1730	2327	1039	1440	488	mitochondrial ribosomal protein S17 (MRPS17)
B32R15C02	32-2-15	Hs~MGC:BC054031.2~uORF:IOH29106	1363	769	1613	879	635	1591	2382	1032	1451	534	mitochondrial ribosomal protein S17 (MRPS17)
B32R15C03	32-3-15	Hs~MGC:BC007888.1~uORF:IOH29315	1370	728	1161	728	503	1127	3828	694	1943	465	eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa (EIF2S2)
B32R15C04	32-4-15	Hs~MGC:BC007888.1~uORF:IOH29315	1736	773	1157	660	514	1017	3924	643	1922	495	eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa (EIF2S2)
B32R15C05	32-5-15	Hs~Ref:NM_005639.1~uORF:IOH29114	3183	3069	2879	1869	1129	2286	13026	1882	4121	2167	synaptotagmin I (SYT1)
B32R15C06	32-6-15	Hs~Ref:NM_005639.1~uORF:IOH29114	3165	3117	2840	1844	1175	2252	13351	1906	4223	2017	synaptotagmin I (SYT1)
B32R15C07	32-7-15	Hs~Ref:NM_015327.1~uORF:IOH27102	1003	659	1799	1685	918	9696	1643	914	1689	379	Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans) (SMG5)
B32R15C08	32-8-15	Hs~Ref:NM_015327.1~uORF:IOH27102	1062	650	1779	1690	3124	9982	1074	964	1642	344	Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans) (SMG5)
B32R15C09	32-9-15	Hs~Ref:NM_145796.2~uORF:IOH29191	1241	773	2136	2779	2642	1391	2310	1142	2647	311	pogo transposable element with ZNF domain (POGZ), transcript variant 3
B32R15C10	32-10-15	Hs~Ref:NM_145796.2~uORF:IOH29191	1278	762	2053	2735	2759	1363	2494	1089	2622	725	pogo transposable element with ZNF domain (POGZ), transcript variant 3
B32R15C11	32-11-15	Hs~MGC:BC041831.1~uORF:IOH27713	1635	1453	2045	3320	943	1490	4096	3507	5363	877	transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) (TLE3)
B32R15C12	32-12-15	Hs~MGC:BC041831.1~uORF:IOH27713	1633	1421	1915	3199	800	1680	3740	3153	5502	942	transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) (TLE3)
B32R15C15	32-15-15	Hs~Ref:NM_006575.2~CAT:PV3682	646	187	388	739	2728	1649	664	-269	1276	777	Mitogen-activated protein kinase kinase kinase kinase 5
B32R15C16	32-16-15	Hs~Ref:NM_006575.2~CAT:PV3682	533	247	394	64	3277	826	675	589	3772	-26	Mitogen-activated protein kinase kinase kinase kinase 5
B32R15C19	32-19-15	Hs~Ref:NM_005157.2~CAT:PV3863	800	969	929	606	385	495	1017	429	1276	277	v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), transcript variant a; see catalog number for detailed information on wild-type or point mutant status
B32R15C20	32-20-15	Hs~Ref:NM_005157.2~CAT:PV3863	682	297	926	638	351	416	1117	449	1340	316	v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), transcript variant a; see catalog number for detailed information on wild-type or point mutant status
B32R15C21	32-21-15	Hs~Ref:NM_006549.2~CAT:PV4206	389	140	514	397	363	523	604	419	1678	55	Calcium/calmodulin-dependent protein kinase kinase 2
B32R15C22	32-22-15	Hs~Ref:NM_006549.2~CAT:PV4206	357	150	504	378	366	498	522	437	1523	-64	Calcium/calmodulin-dependent protein kinase kinase 2
B32R16C01	32-1-16	Hs~Ref:NM_000758.2~CAT_PHC2015	859	270	142	215	142	314	321	356	383	345	Granulocyte-macrophage colony-stimulating factor
B32R16C02	32-2-16	Hs~Ref:NM_000758.2~CAT_PHC2015	866	269	161	236	208	312	293	416	394	327	Granulocyte-macrophage colony-stimulating factor
B32R16C05	32-5-16	Hs~Ref:NM_002752.3~CAT:PV3620	1299	317	-1	172	119	177	412	136	402	-3	mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a2
B32R16C06	32-6-16	Hs~Ref:NM_002752.3~CAT:PV3620	1316	285	-18	189	105	107	750	177	686	6	mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a2
B32R16C07	32-7-16	Hs~Ref:NM_014166.2~uORF:IOH53881	1145	2638	2033	1707	1078	1912	1430	1615	4682	919	Mediator of RNA polymerase II transcription subunit 4
B32R16C08	32-8-16	Hs~Ref:NM_014166.2~uORF:IOH53881	1213	2601	2051	1716	1043	1866	1182	1496	4505	851	Mediator of RNA polymerase II transcription subunit 4
B32R16C11	32-11-16	Hs~MGC:BC093070.1~uORF:IOH63176	491	647	580	549	635	1382	2114	1608	1336	264	L-asparaginase
B32R16C12	32-12-16	Hs~MGC:BC093070.1~uORF:IOH63176	496	748	599	508	666	1292	2110	1562	1372	272	L-asparaginase
B32R16C15	32-15-16	Hs~Ref:NM_001005373.1~uORF:IOH55653	5928	2287	3670	2439	134	1730	2808	1473	5318	231	E3 ubiquitin-protein ligase LRSAM1
B32R16C16	32-16-16	Hs~Ref:NM_001005373.1~uORF:IOH55653	5931	2437	3439	2418	981	1883	2886	1150	5109	75	E3 ubiquitin-protein ligase LRSAM1
B32R16C17	32-17-16	Hs~Ref:NM_016216.2~uORF:IOH57112	454	3249	880	838	523	725	2300	6997	857	326	Lariat debranching enzyme
B32R16C18	32-18-16	Hs~Ref:NM_016216.2~uORF:IOH57112	863	3170	904	813	607	2952	2273	6470	834	344	Lariat debranching enzyme
B32R16C19	32-19-16	Hs~Ref:NM_004691.3~uORF:IOH57018	300	136	339	275	350	458	285	258	532	67	V-type proton ATPase subunit d 1
B32R16C20	32-20-16	Hs~Ref:NM_004691.3~uORF:IOH57018	377	577	301	282	194	470	357	242	736	56	V-type proton ATPase subunit d 1
B32R16C21	32-21-16	Hs~MGC:BC008042.2~uORF:IOH57013	812	582	766	607	339	491	1165	572	1682	479	Tumor necrosis factor ligand superfamily member 13
B32R16C22	32-22-16	Hs~MGC:BC008042.2~uORF:IOH57013	746	580	720	628	360	592	1002	465	1607	569	Tumor necrosis factor ligand superfamily member 13
B32R17C01	32-1-17	Hs~Ref:NM_020961.2~uORF:IOH6104	1611	1283	1955	3798	1813	1638	4472	9297	3052	797	KIAA1627 protein (KIAA1627)
B32R17C02	32-2-17	Hs~Ref:NM_020961.2~uORF:IOH6104	1650	1306	2022	4185	895	1590	4468	8488	3174	771	KIAA1627 protein (KIAA1627)
B32R17C03	32-3-17	Hs~Ref:NM_000420.2~uORF:IOH5088	741	866	1020	1030	528	827	1143	874	1713	578	Kell blood group, metallo-endopeptidase (KEL)
B32R17C04	32-4-17	Hs~Ref:NM_000420.2~uORF:IOH5088	873	735	1021	1628	568	887	1054	908	1639	35	Kell blood group, metallo-endopeptidase (KEL)
B32R17C07	32-7-17	Hs~Ref:NM_001064.1~uORF:IOH61026	4342	1048	1390	1158	472	1133	2064	6215	2429	865	Transketolase
B32R17C08	32-8-17	Hs~Ref:NM_001064.1~uORF:IOH61026	4516	1048	1340	1118	490	1100	2147	5740	2294	801	Transketolase
B32R17C09	32-9-17	Hs~MGC:NM_152690.1~uORF:IOH10343	727	673	796	521	406	762	1049	603	1307	229	dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit (DPM2), transcript variant 2
B32R17C10	32-10-17	Hs~MGC:NM_152690.1~uORF:IOH10343	728	771	793	545	405	783	1133	648	1285	916	dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit (DPM2), transcript variant 2
B32R17C11	32-11-17	Hs~Ref:NM_032146.2~uORF:IOH10608	951	1161	1673	760	523	1459	1455	888	2698	583	ADP-ribosylation factor-like 6 (ARL6), transcript variant 1
B32R17C12	32-12-17	Hs~Ref:NM_032146.2~uORF:IOH10608	910	1092	1586	826	483	1511	1448	921	2712	754	ADP-ribosylation factor-like 6 (ARL6), transcript variant 1
B32R17C13	32-13-17	Hs~Ref:NM_002994.2~uORF:IOH7295	1607	565	639	633	445	696	757	882	1197	424	chemokine (C-X-C motif) ligand 5 (CXCL5)
B32R17C14	32-14-17	Hs~Ref:NM_002994.2~uORF:IOH7295	1608	569	574	629	449	487	781	989	1159	1	chemokine (C-X-C motif) ligand 5 (CXCL5)
B32R17C17	32-17-17	Hs~Ref:NM_013409.1~uORF:IOH5621	470	247	691	464	506	298	699	523	1079	81	follistatin (FST), transcript variant FST344
B32R17C18	32-18-17	Hs~Ref:NM_013409.1~uORF:IOH5621	3549	1489	598	410	728	96	796	519	1039	-16	follistatin (FST), transcript variant FST344
B32R17C19	32-19-17	Hs~Ref:NM_020124.1~uORF:IOH35273	634	322	549	340	479	1105	1064	374	864	-10	interferon, kappa (IFNK)
B32R17C20	32-20-17	Hs~Ref:NM_020124.1~uORF:IOH35273	546	336	527	349	310	966	1012	352	1089	15	interferon, kappa (IFNK)
B32R17C21	32-21-17	Hs~Ref:NM_173624.1~uORF:IOH35387	586	653	631	381	159	649	827	464	-6	-6	hypothetical protein FLJ40504 (FLJ40504)
B32R17C22	32-22-17	Hs~Ref:NM_173624.1~uORF:IOH35387	584	507	609	443	332	648	693	407	11	-3	hypothetical protein FLJ40504 (FLJ40504)
B32R18C01	32-1-18	Hs~Ref:NM_015370.1~uORF:IOH35430	839	648	947	480	612	852	2493	526	1167	370	chromosome 22 open reading frame 31 (C22orf31)
B32R18C02	32-2-18	Hs~Ref:NM_015370.1~uORF:IOH35430	831	595	865	487	2698	799	2565	565	1187	348	chromosome 22 open reading frame 31 (C22orf31)
B32R18C03	32-3-18	Hs~MGC:BC044580.1~uORF:IOH26748	508	393	662	761	144	488	732	450	714	235	KIAA0391 (KIAA0391)
B32R18C04	32-4-18	Hs~MGC:BC044580.1~uORF:IOH26748	709	649	639	1089	198	539	1105	514	745	21	KIAA0391 (KIAA0391)
B32R18C05	32-5-18	Hs~MGC:BC021664.1~uORF:IOH12244	617	311	401	269	363	255	592	357	612	-11	solute carrier family 16, member 4 (monocarboxylic acid transporter 5) (SLC16A4)
B32R18C06	32-6-18	Hs~MGC:BC021664.1~uORF:IOH12244	828	381	405	242	246	260	408	490	659	92	solute carrier family 16, member 4 (monocarboxylic acid transporter 5) (SLC16A4)
B32R18C07	32-7-18	Hs~MGC:BC026241.1~uORF:IOH12763	355	391	379	255	358	418	353	313	575	122	ubiquitin protein ligase E3C (UBE3C)
B32R18C08	32-8-18	Hs~MGC:BC026241.1~uORF:IOH12763	377	264	372	273	287	456	303	314	627	104	ubiquitin protein ligase E3C (UBE3C)
B32R18C09	32-9-18	Hs~MGC:BC008390.1~uORF:IOH7426	797	545	1182	395	337	7397	633	452	1114	354	phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) (PDE4D)
B32R18C10	32-10-18	Hs~MGC:BC008390.1~uORF:IOH7426	765	665	1148	331	318	7808	697	500	1198	439	phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) (PDE4D)
B32R18C11	32-11-18	Hs~MGC:BC039256.1~uORF:IOH27247	641	424	701	543	209	564	1194	428	951	151	PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) (APRIN)
B32R18C12	32-12-18	Hs~MGC:BC039256.1~uORF:IOH27247	688	330	664	399	222	509	1218	454	912	179	PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) (APRIN)
B32R18C13	32-13-18	Hs~MGC:BC053576.1~uORF:IOH28927	470	409	520	483	242	500	794	354	791	5	UDP glucuronosyltransferase 1 family, polypeptide A10 (UGT1A10)
B32R18C14	32-14-18	Hs~MGC:BC053576.1~uORF:IOH28927	526	256	488	497	284	560	745	395	660	309	UDP glucuronosyltransferase 1 family, polypeptide A10 (UGT1A10)
B32R18C15	32-15-18	Hs~Ref:NM_181712.2~uORF:IOH29203	3140	1014	2491	793	1128	2731	1390	4715	1732	281	KN motif and ankyrin repeat domain-containing protein 4
B32R18C16	32-16-18	Hs~Ref:NM_181712.2~uORF:IOH29203	2979	985	2576	787	1097	2543	1350	4495	1765	298	KN motif and ankyrin repeat domain-containing protein 4
B32R18C17	32-17-18	Hs~Ref:NM_016848.2~uORF:IOH11138	60717	3471	10190	2991	3380	8566	5171	3852	9759	3833	SHC-transforming protein 3
B32R18C18	32-18-18	Hs~Ref:NM_016848.2~uORF:IOH11138	63725	3168	10103	2824	3991	8281	5198	3778	10166	3741	SHC-transforming protein 3
B32R18C19	32-19-18	Hs~MGC:BC020960.1~uORF:IOH10418	484	1190	735	495	462	286	898	456	1328	126	sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G (SEMA4G)
B32R18C20	32-20-18	Hs~MGC:BC020960.1~uORF:IOH10418	594	579	619	431	482	253	843	443	1608	-19	sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G (SEMA4G)
B32R18C21	32-21-18	Hs~Ref:NM_016204.1~uORF:IOH40347	415	167	398	296	80	67	525	299	1015	-7	growth differentiation factor 2 (GDF2)
B32R18C22	32-22-18	Hs~Ref:NM_016204.1~uORF:IOH40347	290	700	349	1125	75	439	496	278	252	-7	growth differentiation factor 2 (GDF2)
B32R19C01	32-1-19	Hs~Ref:NM_024678.3~uORF:IOH40617	504	525	737	420	585	584	968	488	792	339	asparaginyl-tRNA synthetase 2, mitochondrial (putative) (NARS2)
B32R19C02	32-2-19	Hs~Ref:NM_024678.3~uORF:IOH40617	500	539	608	465	553	592	1032	382	855	369	asparaginyl-tRNA synthetase 2, mitochondrial (putative) (NARS2)
B32R19C03	32-3-19	Hs~MGC:BC068031.1~uORF:IOH40029	967	757	961	627	2088	833	1892	537	1637	320	Cell cycle checkpoint control protein RAD9B homolog
B32R19C04	32-4-19	Hs~MGC:BC068031.1~uORF:IOH40029	996	714	941	591	456	804	1736	574	1569	333	Cell cycle checkpoint control protein RAD9B homolog
B32R19C07	32-7-19	Hs~Ref:NM_002011.2~N/A	733	564	576	318	328	121	798	516	894	92	Fibroblast growth factor receptor 4
B32R19C08	32-8-19	Hs~Ref:NM_002011.2~N/A	661	592	538	340	330	353	771	465	854	43	Fibroblast growth factor receptor 4
B32R19C09	32-9-19	Hs~MGC:BC000251.1~N/A	548	195	376	272	169	400	500	290	1047	-11	Glycogen synthase kinase-3 beta
B32R19C10	32-10-19	Hs~MGC:BC000251.1~N/A	479	202	342	261	176	126	387	273	1052	115	Glycogen synthase kinase-3 beta
B32R19C11	32-11-19	Hs~MGC:BC002541.1~N/A	369	103	306	302	146	209	346	225	424	-3	Phosphorylase b kinase gamma catalytic chain, testis/liver isoform
B32R19C12	32-12-19	Hs~MGC:BC002541.1~N/A	397	106	313	271	136	275	382	222	409	5	Phosphorylase b kinase gamma catalytic chain, testis/liver isoform
B32R19C13	32-13-19	Hs~MGC:BC001096.2~uORF:IOH62830	369	321	2557	300	215	417	319	257	836	130	Protein NOXP20
B32R19C14	32-14-19	Hs~MGC:BC001096.2~uORF:IOH62830	366	177	2605	288	224	450	286	226	808	133	Protein NOXP20
B32R19C15	32-15-19	Hs~MGC:BC080631.1~uORF:IOH63128	373	450	412	652	100	79	481	352	605	142	tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase, mRNA (cDNA clone MGC:99627 IMAGE:6536541), complete cds.
B32R19C16	32-16-19	Hs~MGC:BC080631.1~uORF:IOH63128	211	403	370	604	65	389	513	327	531	108	tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase, mRNA (cDNA clone MGC:99627 IMAGE:6536541), complete cds.
B32R19C17	32-17-19	Hs~MGC:BC070154.1~uORF:IOH63011	3032	1395	1762	1739	981	1671	9391	1353	2656	2279	Non-histone chromosomal protein HMG-14
B32R19C18	32-18-19	Hs~MGC:BC070154.1~uORF:IOH63011	3112	1326	1733	1674	857	1531	9356	1329	2677	2279	Non-histone chromosomal protein HMG-14
B32R19C19	32-19-19	Hs~MGC:BC071844.1~uORF:IOH63093	242	657	414	328	145	228	537	412	547	228	Claudin-7
B32R19C20	32-20-19	Hs~MGC:BC071844.1~uORF:IOH63093	227	176	413	334	131	199	551	406	569	179	Claudin-7
B32R19C21	32-21-19	Hs~Ref:NM_014314.3~uORF:IOH52971	495	857	699	1583	496	9	1	-11	860	-2	Probable ATP-dependent RNA helicase DDX58
B32R19C22	32-22-19	Hs~Ref:NM_014314.3~uORF:IOH52971	522	842	683	1572	449	0	2	1	39	-1	Probable ATP-dependent RNA helicase DDX58
B32R20C01	32-1-20	Hs~Ref:NM_012215.1~uORF:IOH52962	1133	1768	944	1128	378	-15	268	162	7	1	Bifunctional protein NCOAT
B32R20C02	32-2-20	Hs~Ref:NM_012215.1~uORF:IOH52962	1125	1776	934	1194	483	430	329	3	10	1	Bifunctional protein NCOAT
B32R20C03	32-3-20	Hs~Ref:NM_014382.2~uORF:IOH52964	635	337	593	441	2807	347	3969	-7	-3	-2	Calcium-transporting ATPase type 2C member 1
B32R20C04	32-4-20	Hs~Ref:NM_014382.2~uORF:IOH52964	716	217	520	300	71	-3	8	-3	-3	-2	Calcium-transporting ATPase type 2C member 1
B32R20C09	32-9-20	Hs~Ref:NM_001694.2~uORF:IOH56918	2	2	-1	202	223	108	342	233	541	79	V-type proton ATPase 16 kDa proteolipid subunit
B32R20C10	32-10-20	Hs~Ref:NM_001694.2~uORF:IOH56918	-4	0	-2	198	210	286	357	216	478	54	V-type proton ATPase 16 kDa proteolipid subunit
B32R20C11	32-11-20	Hs~Ref:NM_001948.3~uORF:IOH56236	597	856	2655	746	785	892	2273	801	1792	584	deoxyuridine triphosphatase (DUT), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA.
B32R20C12	32-12-20	Hs~Ref:NM_001948.3~uORF:IOH56236	604	895	2626	615	789	914	2057	819	1782	498	deoxyuridine triphosphatase (DUT), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA.
B33R02C11	33-11-2	Hs~Ref:NM_003930.2~uORF:IOH5696	1127	743	1671	785	533	1215	1052	656	1356	420	src kinase associated phosphoprotein 2 (SKAP2)
B33R02C12	33-12-2	Hs~Ref:NM_003930.2~uORF:IOH5696	733	771	1397	671	657	1073	1042	701	1487	450	src kinase associated phosphoprotein 2 (SKAP2)
B33R02C13	33-13-2	Hs~MGC:BC008741.1~uORF:IOH5919	1296	738	46566	800	2351	1154	2416	1839	25372	630	PDZ and LIM domain 5 (PDLIM5)
B33R02C14	33-14-2	Hs~MGC:BC008741.1~uORF:IOH5919	1146	799	33407	766	2325	1300	2411	1728	18590	660	PDZ and LIM domain 5 (PDLIM5)
B33R02C15	33-15-2	Hs~Ref:NM_022128.1~uORF:IOH14265	568	715	1020	618	540	951	1551	849	1689	414	ribokinase (RBKS)
B33R02C16	33-16-2	Hs~Ref:NM_022128.1~uORF:IOH14265	565	674	1022	548	560	969	1305	790	1876	359	ribokinase (RBKS)
B33R02C17	33-17-2	Hs~Ref:NM_033313.1~uORF:IOH20983	1143	1076	1257	1169	1188	1450	1867	2055	2628	581	CDC14 cell division cycle 14 homolog A (S. cerevisiae) (CDC14A), transcript variant 3
B33R02C18	33-18-2	Hs~Ref:NM_033313.1~uORF:IOH20983	1410	1081	1307	1218	1185	1397	1869	2113	2859	570	CDC14 cell division cycle 14 homolog A (S. cerevisiae) (CDC14A), transcript variant 3
B33R02C19	33-19-2	Hs~MGC:BC020747.1~uORF:IOH14518	3	1	-2	596	855	800	1315	643	1284	292	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 (SERPINA7)
B33R02C20	33-20-2	Hs~MGC:BC020747.1~uORF:IOH14518	3	14	0	690	601	741	1238	672	1089	298	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 (SERPINA7)
B33R02C21	33-21-2	Hs~MGC:BC028206.1~uORF:IOH11618	533	489	1089	2284	502	640	893	478	1332	337	killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 (KIR3DL1)
B33R02C22	33-22-2	Hs~MGC:BC028206.1~uORF:IOH11618	575	476	1317	2740	290	546	914	473	1345	196	killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 (KIR3DL1)
B33R03C01	33-1-3	Hs~Ref:NM_001612.3~uORF:IOH11009	743	485	1193	6414	409	1413	974	600	1491	251	acrosomal vesicle protein 1 (ACRV1), transcript variant 1
B33R03C02	33-2-3	Hs~Ref:NM_001612.3~uORF:IOH11009	803	580	1163	6397	410	1446	1002	574	1561	227	acrosomal vesicle protein 1 (ACRV1), transcript variant 1
B33R03C03	33-3-3	Hs~Ref:NM_025055.2~uORF:IOH11794	769	667	783	499	399	474	1134	464	889	175	coiled-coil domain containing 33 (CCDC33), transcript variant 1
B33R03C04	33-4-3	Hs~Ref:NM_025055.2~uORF:IOH11794	837	671	734	475	477	473	1085	472	825	160	coiled-coil domain containing 33 (CCDC33), transcript variant 1
B33R03C05	33-5-3	Hs~Ref:NM_015484.1~uORF:IOH9828	2293	2215	1617	1595	1578	2690	3059	1347	7069	995	SYF2 homolog, RNA splicing factor (S. cerevisiae) (SYF2), transcript variant 1
B33R03C06	33-6-3	Hs~Ref:NM_015484.1~uORF:IOH9828	2407	2017	1337	1454	1566	2738	2952	1301	7272	993	SYF2 homolog, RNA splicing factor (S. cerevisiae) (SYF2), transcript variant 1
B33R03C07	33-7-3	Hs~Ref:NM_017824.2~uORF:IOH9985	511	2095	630	598	474	511	768	511	843	98	membrane-associated ring finger (C3HC4) 5 (MARCH5)
B33R03C08	33-8-3	Hs~Ref:NM_017824.2~uORF:IOH9985	507	679	580	797	487	536	862	508	797	294	membrane-associated ring finger (C3HC4) 5 (MARCH5)
B33R03C09	33-9-3	Hs~Ref:NM_003795.1~uORF:IOH7529	1338	1686	852	762	1075	3029	3951	2104	1648	389	sorting nexin 3 (SNX3)
B33R03C10	33-10-3	Hs~Ref:NM_003795.1~uORF:IOH7529	1286	1789	907	768	1122	2828	3914	2059	1584	488	sorting nexin 3 (SNX3)
B33R03C11	33-11-3	Hs~MGC:BC009614.1~uORF:IOH9949	1299	442	1465	577	564	1046	632	478	1046	127	sperm associated antigen 16 (SPAG16)
B33R03C12	33-12-3	Hs~MGC:BC009614.1~uORF:IOH9949	772	473	1291	563	467	872	616	483	1035	146	sperm associated antigen 16 (SPAG16)
B33R03C13	33-13-3	Hs~MGC:BC044576.1~uORF:IOH26888	2487	516	1111	257	645	1658	12716	501	2574	358	family with sequence similarity 108, member B1 (FAM108B1)
B33R03C14	33-14-3	Hs~MGC:BC044576.1~uORF:IOH26888	2538	515	948	284	569	1640	12597	477	1294	339	family with sequence similarity 108, member B1 (FAM108B1)
B33R03C15	33-15-3	Hs~Ref:NM_032593.1~uORF:IOH26687	1352	948	830	1873	636	829	1375	818	7197	758	histidine triad nucleotide binding protein 2 (HINT2)
B33R03C16	33-16-3	Hs~Ref:NM_032593.1~uORF:IOH26687	1282	981	827	1748	678	801	1430	821	7317	690	histidine triad nucleotide binding protein 2 (HINT2)
B33R03C17	33-17-3	Hs~MGC:BC040106.1~uORF:IOH26285	4232	2489	2148	3587	1106	6872	15590	1623	3382	3961	hypothetical protein HSPC111 (HSPC111)
B33R03C18	33-18-3	Hs~MGC:BC040106.1~uORF:IOH26285	4764	2501	1958	3517	1297	6050	15775	1610	3397	4379	hypothetical protein HSPC111 (HSPC111)
B33R03C19	33-19-3	Hs~Ref:NM_012176.1~uORF:IOH26750	2048	484	499	383	644	170	531	335	2760	362	F-box protein 4 (FBXO4), transcript variant 1
B33R03C20	33-20-3	Hs~Ref:NM_012176.1~uORF:IOH26750	2448	503	548	520	709	292	535	330	2697	334	F-box protein 4 (FBXO4), transcript variant 1
B33R03C21	33-21-3	Hs~MGC:BC008440.1~uORF:IOH7416	1270	1069	1534	1018	1464	1329	1910	1152	3839	655	APAF1 interacting protein (APIP)
B33R03C22	33-22-3	Hs~MGC:BC008440.1~uORF:IOH7416	1407	1114	1735	997	1381	1376	1782	1138	3978	847	APAF1 interacting protein (APIP)
B33R04C01	33-1-4	Hs~Ref:NM_145306.1~uORF:IOH9906	2385	2002	2418	1597	2330	4237	3888	2214	5167	1704	chromosome 10 open reading frame 35 (C10orf35)
B33R04C02	33-2-4	Hs~Ref:NM_145306.1~uORF:IOH9906	2584	1995	2435	1619	2425	4193	4278	2273	5327	1687	chromosome 10 open reading frame 35 (C10orf35)
B33R04C03	33-3-4	Hs~Ref:NM_032359.1~uORF:IOH5762	2156	1295	19015	1541	2175	1927	6444	1695	3016	857	chromosome 3 open reading frame 26 (C3orf26)
B33R04C04	33-4-4	Hs~Ref:NM_032359.1~uORF:IOH5762	2284	1237	19393	1582	2338	1938	6451	1722	3107	811	chromosome 3 open reading frame 26 (C3orf26)
B33R04C05	33-5-4	Hs~Ref:NM_004782.2~uORF:IOH9957	2092	5756	1652	868	1433	1364	2753	1114	2332	606	synaptosomal-associated protein, 29kDa (SNAP29)
B33R04C06	33-6-4	Hs~Ref:NM_004782.2~uORF:IOH9957	2194	6158	1901	919	1511	1519	2585	1112	2281	653	synaptosomal-associated protein, 29kDa (SNAP29)
B33R04C07	33-7-4	Hs~Ref:NM_016040.2~uORF:IOH11975	896	725	1352	505	1172	869	1344	646	1184	250	transmembrane emp24 protein transport domain containing 5 (TMED5)
B33R04C08	33-8-4	Hs~Ref:NM_016040.2~uORF:IOH11975	884	738	1400	514	1191	1501	1333	671	1247	1887	transmembrane emp24 protein transport domain containing 5 (TMED5)
B33R04C09	33-9-4	Hs~MGC:BC000977.2~uORF:IOH2923	408	563	423	861	826	1318	692	539	1150	217	aminolevulinate, delta-, dehydratase (ALAD)
B33R04C10	33-10-4	Hs~MGC:BC000977.2~uORF:IOH2923	416	582	443	864	869	1395	713	579	1182	44	aminolevulinate, delta-, dehydratase (ALAD)
B33R04C11	33-11-4	Hs~Ref:NM_002412.1~uORF:IOH3104	877	1492	516	2696	922	3757	1094	11368	1428	125	O-6-methylguanine-DNA methyltransferase (MGMT)
B33R04C12	33-12-4	Hs~Ref:NM_002412.1~uORF:IOH3104	875	1614	572	2715	874	3830	1093	11467	1369	201	O-6-methylguanine-DNA methyltransferase (MGMT)
B33R04C13	33-13-4	Hs~Ref:NM_005574.2~uORF:IOH22221	719	505	748	487	885	833	950	614	1414	350	LIM domain only 2 (rhombotin-like 1) (LMO2)
B33R04C14	33-14-4	Hs~Ref:NM_005574.2~uORF:IOH22221	688	533	689	451	717	797	985	540	1648	333	LIM domain only 2 (rhombotin-like 1) (LMO2)
B33R04C15	33-15-4	Hs~Ref:NM_020376.2~uORF:IOH14746	462	563	599	424	508	972	971	563	772	264	patatin-like phospholipase domain containing 2 (PNPLA2)
B33R04C16	33-16-4	Hs~Ref:NM_020376.2~uORF:IOH14746	609	570	788	422	743	1048	855	613	771	293	patatin-like phospholipase domain containing 2 (PNPLA2)
B33R04C17	33-17-4	Hs~MGC:BC050387.1~uORF:IOH26653	2507	868	1139	733	1013	1219	1156	867	1653	1507	ankyrin repeat and sterile alpha motif domain containing 3 (ANKS3)
B33R04C18	33-18-4	Hs~MGC:BC050387.1~uORF:IOH26653	2761	858	1268	782	1176	1300	1315	801	1527	1422	ankyrin repeat and sterile alpha motif domain containing 3 (ANKS3)
B33R04C19	33-19-4	Hs~Ref:NM_198517.2~uORF:IOH25922	3761	4668	7545	7645	4396	33908	5899	2744	3267	2475	TBC1 domain family, member 10C (TBC1D10C)
B33R04C20	33-20-4	Hs~Ref:NM_198517.2~uORF:IOH25922	3935	4815	7558	7591	4536	34205	6075	2943	3318	2100	TBC1 domain family, member 10C (TBC1D10C)
B33R04C21	33-21-4	Hs~MGC:BC044851.1~uORF:IOH27643	629	620	705	523	484	682	1392	471	834	246	vacuolar protein sorting 41 homolog (S. cerevisiae) (VPS41)
B33R04C22	33-22-4	Hs~MGC:BC044851.1~uORF:IOH27643	642	646	643	463	500	613	1381	456	764	162	vacuolar protein sorting 41 homolog (S. cerevisiae) (VPS41)
B33R05C01	33-1-5	Hs~MGC:BC063392.1~uORF:IOH39855	448	802	494	980	363	575	655	706	569	199	WD repeat domain 73 (WDR73)
B33R05C02	33-2-5	Hs~MGC:BC063392.1~uORF:IOH39855	465	784	520	994	397	551	658	516	623	152	WD repeat domain 73 (WDR73)
B33R05C03	33-3-5	Hs~MGC:BC000381.2~uORF:IOH3454	3574	1675	2758	1962	1184	2520	22144	1831	3187	648	TBP-like 1 (TBPL1)
B33R05C04	33-4-5	Hs~MGC:BC000381.2~uORF:IOH3454	3788	1646	2739	1970	1315	2491	22433	1829	3359	647	TBP-like 1 (TBPL1)
B33R05C05	33-5-5	Hs~Ref:NM_032498.1~uORF:IOH11289	464	304	499	783	350	654	703	566	1015	145	Rhox homeobox family, member 2 (RHOXF2)
B33R05C06	33-6-5	Hs~Ref:NM_032498.1~uORF:IOH11289	465	341	589	735	413	648	727	539	1120	167	Rhox homeobox family, member 2 (RHOXF2)
B33R05C07	33-7-5	Hs~Ref:NM_018246.1~uORF:IOH40864	2787	807	1013	1333	1171	1355	14497	1366	1739	636	coiled-coil domain containing 25 (CCDC25)
B33R05C08	33-8-5	Hs~Ref:NM_018246.1~uORF:IOH40864	2863	823	1034	1188	1145	1307	14882	1418	1831	648	coiled-coil domain containing 25 (CCDC25)
B33R05C09	33-9-5	Hs~Ref:NM_024563.1~uORF:IOH23059	2254	1305	1550	1364	2001	1413	2191	1147	2858	1105	chromosome 5 open reading frame 23 (C5orf23)
B33R05C10	33-10-5	Hs~Ref:NM_024563.1~uORF:IOH23059	2533	1294	1653	1484	1977	1496	2261	1105	2983	1091	chromosome 5 open reading frame 23 (C5orf23)
B33R05C11	33-11-5	Hs~MGC:BC030813.1~uORF:IOH23055	48140	44348	44256	33525	53630	57049	45171	38258	53767	41523	cDNA clone MGC:22645 IMAGE:4700961, complete cds
B33R05C12	33-12-5	Hs~MGC:BC030813.1~uORF:IOH23055	52109	47097	44000	34253	59687	56457	42889	38512	56331	41027	cDNA clone MGC:22645 IMAGE:4700961, complete cds
B33R05C13	33-13-5	Hs~Ref:NM_001290.1~uORF:IOH23054	13848	1942	3877	1625	4589	3408	5464	3966	4890	954	LIM domain binding 2 (LDB2)
B33R05C14	33-14-5	Hs~Ref:NM_001290.1~uORF:IOH23054	13988	1881	3702	1566	4443	3465	5171	4176	4472	882	LIM domain binding 2 (LDB2)
B33R05C15	33-15-5	Hs~MGC:BC002373.1~uORF:IOH3593	166	53	331	1520	751	871	445	790	1285	81	hsp70-interacting protein (HSPBP1)
B33R05C16	33-16-5	Hs~MGC:BC002373.1~uORF:IOH3593	614	128	610	1574	1107	991	453	681	1785	230	hsp70-interacting protein (HSPBP1)
B33R05C17	33-17-5	Hs~MGC:BC050721.1~uORF:IOH27058	1000	1036	1049	1007	1308	1553	1597	1126	1947	925	KIAA0562 (KIAA0562)
B33R05C18	33-18-5	Hs~MGC:BC050721.1~uORF:IOH27058	982	1043	1064	909	1162	1568	1620	1046	2004	904	KIAA0562 (KIAA0562)
B33R05C19	33-19-5	Hs~MGC:BC047918.1~uORF:IOH26981	466	450	1167	816	874	721	750	952	1390	405	Rho GTPase activating protein 24 (ARHGAP24)
B33R05C20	33-20-5	Hs~MGC:BC047918.1~uORF:IOH26981	591	475	1136	791	772	653	764	943	1414	407	Rho GTPase activating protein 24 (ARHGAP24)
B33R05C21	33-21-5	Hs~Ref:NM_002788.1~uORF:IOH26156	1371	307	718	1731	759	1124	1604	596	985	216	proteasome (prosome, macropain) subunit, alpha type, 3 (PSMA3), transcript variant 1
B33R05C22	33-22-5	Hs~Ref:NM_002788.1~uORF:IOH26156	1291	276	708	1667	746	1099	1608	631	989	158	proteasome (prosome, macropain) subunit, alpha type, 3 (PSMA3), transcript variant 1
B33R06C01	33-1-6	Hs~Ref:NM_032373.1~uORF:IOH27011	330	673	330	262	264	250	321	292	344	103	polycomb group ring finger 5 (PCGF5)
B33R06C02	33-2-6	Hs~Ref:NM_032373.1~uORF:IOH27011	348	163	287	261	273	251	294	339	339	98	polycomb group ring finger 5 (PCGF5)
B33R06C03	33-3-6	Hs~Ref:NM_015894.2~uORF:IOH1745	647	1025	586	320	254	438	829	410	977	115	stathmin-like 3 (STMN3)
B33R06C04	33-4-6	Hs~Ref:NM_015894.2~uORF:IOH1745	656	1149	544	331	297	431	955	415	1006	103	stathmin-like 3 (STMN3)
B33R06C05	33-5-6	Hs~Ref:NM_002694.2~uORF:IOH1927	1078	640	1049	758	1148	1120	1190	834	1595	340	polymerase (RNA) II (DNA directed) polypeptide C, 33kDa (POLR2C), transcript variant alpha
B33R06C06	33-6-6	Hs~Ref:NM_002694.2~uORF:IOH1927	1035	638	992	765	1164	1165	1146	852	1621	479	polymerase (RNA) II (DNA directed) polypeptide C, 33kDa (POLR2C), transcript variant alpha
B33R06C07	33-7-6	Hs~MGC:BC022251.1~uORF:IOH12839	787	586	1412	606	1409	1098	1079	2224	2677	253	zinc finger, AN1-type domain 1 (ZFAND1)
B33R06C08	33-8-6	Hs~MGC:BC022251.1~uORF:IOH12839	793	693	1380	605	1443	991	1174	2311	2664	235	zinc finger, AN1-type domain 1 (ZFAND1)
B33R06C09	33-9-6	Hs~MGC:BC012814.1~uORF:IOH13051	668	541	1016	335	456	582	2081	536	917	196	zinc finger protein-like 1 (ZFPL1)
B33R06C10	33-10-6	Hs~MGC:BC012814.1~uORF:IOH13051	932	639	1058	336	460	587	2278	533	987	181	zinc finger protein-like 1 (ZFPL1)
B33R06C11	33-11-6	Hs~Ref:NM_032111.2~uORF:IOH39958	1239	263	1416	459	348	583	858	549	796	180	mitochondrial ribosomal protein L14 (MRPL14), nuclear gene encoding mitochondrial protein
B33R06C12	33-12-6	Hs~Ref:NM_032111.2~uORF:IOH39958	1143	287	1399	436	345	537	837	541	923	165	mitochondrial ribosomal protein L14 (MRPL14), nuclear gene encoding mitochondrial protein
B33R06C13	33-13-6	Hs~Ref:NM_001002018.1~uORF:IOH40008	868	449	1195	449	679	664	978	1162	2886	503	host cell factor C1 regulator 1 (XPO1 dependent) (HCFC1R1), transcript variant 3
B33R06C14	33-14-6	Hs~Ref:NM_001002018.1~uORF:IOH40008	912	434	1167	464	692	674	997	1195	3050	497	host cell factor C1 regulator 1 (XPO1 dependent) (HCFC1R1), transcript variant 3
B33R06C15	33-15-6	Hs~MGC:BC064367.1~uORF:IOH39904	1056	1298	1470	1097	731	2419	1938	5699	1850	2281	ankyrin repeat and sterile alpha motif domain containing 6 (ANKS6)
B33R06C16	33-16-6	Hs~MGC:BC064367.1~uORF:IOH39904	1097	1263	1568	1226	782	2474	2017	5893	1963	2184	ankyrin repeat and sterile alpha motif domain containing 6 (ANKS6)
B33R06C17	33-17-6	Hs~MGC:BC066654.1~uORF:IOH39960	1444	1038	1985	2419	1301	2038	1644	2233	2890	1104	jumonji domain containing 6 (JMJD6)
B33R06C18	33-18-6	Hs~MGC:BC066654.1~uORF:IOH39960	1373	1036	1993	2477	1244	2099	1623	2227	2916	1148	jumonji domain containing 6 (JMJD6)
B33R06C19	33-19-6	Hs~Ref:NM_032193.1~uORF:IOH27907	1116	474	1381	427	706	744	838	950	1385	302	ribonuclease H2, subunit C (RNASEH2C)
B33R06C20	33-20-6	Hs~Ref:NM_032193.1~uORF:IOH27907	1197	494	1408	444	629	741	815	899	1389	317	ribonuclease H2, subunit C (RNASEH2C)
B33R06C21	33-21-6	Hs~MGC:BC038105.2~uORF:IOH27173	2364	1230	3235	3213	2003	1203	5113	1189	2235	746	membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) (MPP7)
B33R06C22	33-22-6	Hs~MGC:BC038105.2~uORF:IOH27173	2571	1257	3205	2788	2219	1255	5002	1357	2268	705	membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) (MPP7)
B33R07C01	33-1-7	Hs~MGC:BC043269.2~uORF:IOH25865	911	517	772	390	451	688	948	512	860	317	chromosome 7 open reading frame 31 (C7orf31)
B33R07C02	33-2-7	Hs~MGC:BC043269.2~uORF:IOH25865	1004	671	816	402	443	707	960	547	908	151	chromosome 7 open reading frame 31 (C7orf31)
B33R07C03	33-3-7	Hs~MGC:BC018671.1~uORF:IOH27933	556	960	1990	369	347	820	617	449	7021	186	annexin A5 (ANXA5)
B33R07C04	33-4-7	Hs~MGC:BC018671.1~uORF:IOH27933	594	956	1938	354	364	837	652	457	7144	67	annexin A5 (ANXA5)
B33R07C05	33-5-7	Hs~MGC:BC051366.1~uORF:IOH28071	1684	1516	1559	678	1180	1070	1421	869	1778	602	cDNA clone MGC:59959 IMAGE:4137660, complete cds
B33R07C06	33-6-7	Hs~MGC:BC051366.1~uORF:IOH28071	1715	1502	1242	649	1211	1368	1402	867	1819	623	cDNA clone MGC:59959 IMAGE:4137660, complete cds
B33R07C07	33-7-7	Hs~Ref:NM_000997.2~uORF:IOH1585	1458	767	970	502	490	1025	4386	554	4768	1213	ribosomal protein L37 (RPL37)
B33R07C08	33-8-7	Hs~Ref:NM_000997.2~uORF:IOH1585	1563	892	1507	508	486	1036	4273	566	4464	1222	ribosomal protein L37 (RPL37)
B33R07C09	33-9-7	Hs~MGC:BC008058.1~uORF:IOH5838	15117	14639	2338	676	842	1148	1490	753	7110	3033	protein kinase C, zeta (PRKCZ)
B33R07C10	33-10-7	Hs~MGC:BC008058.1~uORF:IOH5838	14417	15547	1892	655	858	1212	1541	756	7385	3045	protein kinase C, zeta (PRKCZ)
B33R07C11	33-11-7	Hs~MGC:BC000980.1~uORF:IOH2952	407	143	364	256	262	387	436	333	719	143	interleukin 17 receptor B (IL17RB)
B33R07C12	33-12-7	Hs~MGC:BC000980.1~uORF:IOH2952	366	463	355	244	235	345	461	310	735	271	interleukin 17 receptor B (IL17RB)
B33R07C13	33-13-7	Hs~MGC:NM_183397.1~uORF:IOH44678	1597	1303	2526	1029	2000	1464	3091	1547	2311	755	peroxisomal membrane protein 4, 24kDa (PXMP4), transcript variant 2
B33R07C14	33-14-7	Hs~MGC:NM_183397.1~uORF:IOH44678	1545	1365	2460	1017	2050	1472	3111	1553	2233	749	peroxisomal membrane protein 4, 24kDa (PXMP4), transcript variant 2
B33R07C15	33-15-7	Hs~Ref:NM_182534.1~uORF:IOH40992	2505	2057	4657	1376	2080	9468	3380	1385	2903	816	chromosome 1 open reading frame 126 (C1orf126)
B33R07C16	33-16-7	Hs~Ref:NM_182534.1~uORF:IOH40992	2724	2147	4691	1362	2080	9407	3452	1302	3174	836	chromosome 1 open reading frame 126 (C1orf126)
B33R07C17	33-17-7	Hs~Ref:NM_199123.1~uORF:IOH42083	2087	1377	4196	1122	1439	1512	2869	1323	2399	611	SET domain containing 3 (SETD3), transcript variant 2
B33R07C18	33-18-7	Hs~Ref:NM_199123.1~uORF:IOH42083	1928	1434	4193	1067	1432	1545	2789	1260	2567	611	SET domain containing 3 (SETD3), transcript variant 2
B33R07C19	33-19-7	Hs~Ref:NM_025041.2~uORF:IOH44711	2238	1078	1983	836	2792	2580	1566	1107	2490	484	chromosome 3 open reading frame 36 (C3orf36)
B33R07C20	33-20-7	Hs~Ref:NM_025041.2~uORF:IOH44711	2670	1091	1912	847	3092	2597	1552	1097	2450	485	chromosome 3 open reading frame 36 (C3orf36)
B33R07C21	33-21-7	Hs~Ref:NM_033317.1~uORF:IOH14207	1051	847	1165	2788	1202	1215	1684	943	2010	617	dermokine (DMKN), transcript variant 2
B33R07C22	33-22-7	Hs~Ref:NM_033317.1~uORF:IOH14207	990	836	1160	2843	1205	1210	1763	880	1884	754	dermokine (DMKN), transcript variant 2
B33R08C01	33-1-8	Hs~Ref:NM_005435.2~uORF:IOH14526	4732	4674	4962	9086	2620	8610	6876	6417	8774	2359	Rho guanine nucleotide exchange factor (GEF) 5 (ARHGEF5)
B33R08C02	33-2-8	Hs~Ref:NM_005435.2~uORF:IOH14526	5280	5086	5112	9733	2731	9289	7354	6446	8976	2279	Rho guanine nucleotide exchange factor (GEF) 5 (ARHGEF5)
B33R08C03	33-3-8	Hs~Ref:NM_017952.2~uORF:IOH14124	2241	2121	2918	4121	3873	1695	2299	1373	3163	1358	Pentatricopeptide repeat-containing protein 3, mitochondrial
B33R08C04	33-4-8	Hs~Ref:NM_017952.2~uORF:IOH14124	2433	2082	2945	4252	3746	2075	2194	1544	3134	1365	Pentatricopeptide repeat-containing protein 3, mitochondrial
B33R08C05	33-5-8	Hs~MGC:BC016381.1~uORF:IOH13653	65500	65498	65488	65498	65481	65429	65486	65481	65495	65494	immunoglobulin heavy constant mu (IGHM)
B33R08C06	33-6-8	Hs~MGC:BC016381.1~uORF:IOH13653	65499	65495	65484	65497	65456	65438	65485	65493	65496	65494	immunoglobulin heavy constant mu (IGHM)
B33R08C07	33-7-8	Hs~Ref:NM_001400.2~uORF:IOH14201	639	443	691	427	871	580	1109	443	978	239	endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 (EDG1)
B33R08C08	33-8-8	Hs~Ref:NM_001400.2~uORF:IOH14201	652	517	1098	430	878	557	1215	434	912	271	endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 (EDG1)
B33R08C09	33-9-8	Hs~Ref:NM_020677.1~uORF:IOH5739	958	2610	1134	343	786	707	1174	963	1008	245	NmrA-like family domain containing 1 (NMRAL1)
B33R08C10	33-10-8	Hs~Ref:NM_020677.1~uORF:IOH5739	926	2695	930	343	782	739	1213	983	1009	240	NmrA-like family domain containing 1 (NMRAL1)
B33R08C11	33-11-8	Hs~MGC:BC015947.1~uORF:IOH10114	781	577	688	1065	595	528	1112	502	800	150	potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 (KCNS3)
B33R08C12	33-12-8	Hs~MGC:BC015947.1~uORF:IOH10114	799	527	692	1027	2020	546	1313	507	968	324	potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 (KCNS3)
B33R08C13	33-13-8	Hs~MGC:BC009961.1~uORF:IOH12967	725	630	1739	1941	859	2001	3045	956	1418	408	BTB/POZ domain-containing protein KCTD17
B33R08C14	33-14-8	Hs~MGC:BC009961.1~uORF:IOH12967	795	714	1762	1822	864	2012	3423	990	1391	382	BTB/POZ domain-containing protein KCTD17
B33R08C15	33-15-8	Hs~Ref:NM_001688.2~uORF:IOH7382	398	274	503	284	446	447	697	405	473	306	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1 (ATP5F1), nuclear gene encoding mitochondrial protein
B33R08C16	33-16-8	Hs~Ref:NM_001688.2~uORF:IOH7382	381	279	495	338	412	453	666	434	533	187	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1 (ATP5F1), nuclear gene encoding mitochondrial protein
B33R08C17	33-17-8	Hs~Ref:NM_005872.1~uORF:IOH7255	557	559	597	532	1077	730	717	624	846	279	breast carcinoma amplified sequence 2 (BCAS2)
B33R08C18	33-18-8	Hs~Ref:NM_005872.1~uORF:IOH7255	603	576	593	526	1091	695	756	582	1055	293	breast carcinoma amplified sequence 2 (BCAS2)
B33R08C19	33-19-8	Hs~Ref:NM_012108.1~uORF:IOH13463	837	910	1298	539	681	1055	1206	570	2499	285	signal transducing adaptor family member 1 (STAP1)
B33R08C20	33-20-8	Hs~Ref:NM_012108.1~uORF:IOH13463	827	971	1337	574	653	1080	1234	588	2289	247	signal transducing adaptor family member 1 (STAP1)
B33R08C21	33-21-8	Hs~MGC:BC022340.1~uORF:IOH14764	1035	560	823	486	709	2636	2410	1239	1226	378	SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) (SUMO2)
B33R08C22	33-22-8	Hs~MGC:BC022340.1~uORF:IOH14764	946	590	833	572	703	2567	2592	1096	1171	303	SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) (SUMO2)
B33R09C01	33-1-9	Hs~Ref:NM_181532.2~uORF:IOH35326	684	913	1100	668	991	925	861	1044	2564	309	ES cell expressed Ras (ERAS)
B33R09C02	33-2-9	Hs~Ref:NM_181532.2~uORF:IOH35326	703	920	1080	652	1001	905	843	1096	2572	283	ES cell expressed Ras (ERAS)
B33R09C03	33-3-9	Hs~Ref:NM_000572.2~uORF:IOH29878	874	964	1133	673	749	897	1232	816	1501	715	Interleukin-10
B33R09C04	33-4-9	Hs~Ref:NM_000572.2~uORF:IOH29878	872	948	1153	645	710	1251	1270	764	1544	653	Interleukin-10
B33R09C05	33-5-9	Hs~Ref:NM_181622.1~uORF:IOH35176	944	897	1064	652	729	1294	1534	869	1292	635	Keratin-associated protein 13-3
B33R09C06	33-6-9	Hs~Ref:NM_181622.1~uORF:IOH35176	995	976	1053	631	817	1324	1468	791	1384	612	Keratin-associated protein 13-3
B33R09C07	33-7-9	Hs~Ref:NM_176895.1~uORF:IOH29729	861	900	1010	1281	731	1271	1564	868	1338	435	Lipid phosphate phosphohydrolase 1
B33R09C08	33-8-9	Hs~Ref:NM_176895.1~uORF:IOH29729	827	1243	1253	1253	786	1399	1493	899	1288	667	Lipid phosphate phosphohydrolase 1
B33R09C09	33-9-9	Hs~MGC:BC005364.1~uORF:IOH7240	252	126	338	185	193	341	335	251	361	74	chromosome 10 open reading frame 59 (C10orf59)
B33R09C10	33-10-9	Hs~MGC:BC005364.1~uORF:IOH7240	272	283	340	195	216	340	348	263	337	64	chromosome 10 open reading frame 59 (C10orf59)
B33R09C11	33-11-9	Hs~MGC:BC016764.1~uORF:IOH13805	599	807	1438	323	700	1448	1891	773	1003	326	ribulose-5-phosphate-3-epimerase (RPE)
B33R09C12	33-12-9	Hs~MGC:BC016764.1~uORF:IOH13805	559	804	1555	286	902	1454	1929	760	1127	307	ribulose-5-phosphate-3-epimerase (RPE)
B33R09C13	33-13-9	Hs~Ref:NM_018327.1~uORF:IOH14250	521	388	727	305	529	551	1200	410	918	225	serine palmitoyltransferase, long chain base subunit 3 (SPTLC3)
B33R09C14	33-14-9	Hs~Ref:NM_018327.1~uORF:IOH14250	578	535	688	324	516	518	1199	433	898	249	serine palmitoyltransferase, long chain base subunit 3 (SPTLC3)
B33R09C15	33-15-9	Hs~Ref:NM_001225.2~uORF:IOH14345	301	595	373	312	348	382	547	226	377	178	caspase 4, apoptosis-related cysteine peptidase (CASP4), transcript variant alpha
B33R09C16	33-16-9	Hs~Ref:NM_001225.2~uORF:IOH14345	312	248	364	273	336	356	554	257	569	176	caspase 4, apoptosis-related cysteine peptidase (CASP4), transcript variant alpha
B33R09C17	33-17-9	Hs~Ref:NM_014448.2~uORF:IOH5304	958	541	3614	467	1233	960	4164	1291	1629	338	Rho guanine exchange factor (GEF) 16 (ARHGEF16)
B33R09C18	33-18-9	Hs~Ref:NM_014448.2~uORF:IOH5304	974	519	3739	472	935	1067	4296	1304	1480	342	Rho guanine exchange factor (GEF) 16 (ARHGEF16)
B33R09C19	33-19-9	Hs~Ref:NM_001864.2~uORF:IOH5372	992	446	887	669	444	651	960	528	1001	239	cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) (COX7A1)
B33R09C20	33-20-9	Hs~Ref:NM_001864.2~uORF:IOH5372	1148	498	913	667	443	677	994	590	815	220	cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) (COX7A1)
B33R09C21	33-21-9	Hs~MGC:BC002859.1~uORF:IOH5428	1631	1911	2410	1557	1940	3151	2926	1273	3963	1303	zinc finger protein 434 (ZNF434)
B33R09C22	33-22-9	Hs~MGC:BC002859.1~uORF:IOH5428	1608	1969	2540	1701	2114	3158	3021	1297	4038	1556	zinc finger protein 434 (ZNF434)
B33R10C01	33-1-10	Hs~Ref:NM_030577.1~uORF:IOH5575	1146	122	408	224	197	285	426	314	380	997	transmembrane protein 177 (TMEM177), transcript variant 2
B33R10C02	33-2-10	Hs~Ref:NM_030577.1~uORF:IOH5575	839	117	404	219	198	280	402	235	357	81	transmembrane protein 177 (TMEM177), transcript variant 2
B33R10C03	33-3-10	Hs~Ref:NM_032648.1~uORF:IOH5485	803	844	942	578	683	882	1070	856	1994	701	chromosome 1 open reading frame 90 (C1orf90)
B33R10C04	33-4-10	Hs~Ref:NM_032648.1~uORF:IOH5485	914	812	1022	577	693	898	1061	873	1920	637	chromosome 1 open reading frame 90 (C1orf90)
B33R10C05	33-5-10	Hs~Ref:NM_032321.1~uORF:IOH6608	2263	503	870	1584	593	801	3052	796	2050	82	hypothetical protein MGC13057 (MGC13057), transcript variant 4
B33R10C06	33-6-10	Hs~Ref:NM_032321.1~uORF:IOH6608	2225	511	826	1583	733	750	3047	816	2128	219	hypothetical protein MGC13057 (MGC13057), transcript variant 4
B33R10C07	33-7-10	Hs~MGC:BC005043.1~uORF:IOH6656	6444	4969	3658	3155	9319	3263	11862	5056	6167	4038	hypothetical protein MGC31957 (MGC31957)
B33R10C08	33-8-10	Hs~MGC:BC005043.1~uORF:IOH6656	6500	5104	3591	3214	8853	3268	12338	5046	5993	3807	hypothetical protein MGC31957 (MGC31957)
B33R10C09	33-9-10	Hs~Ref:NM_138779.2~uORF:IOH45970	956	1101	1537	678	785	1399	1331	934	2114	841	chromosome 13 open reading frame 27 (C13orf27)
B33R10C10	33-10-10	Hs~Ref:NM_138779.2~uORF:IOH45970	1122	825	1520	675	774	1108	1297	977	1968	760	chromosome 13 open reading frame 27 (C13orf27)
B33R11C21	33-21-11	Hs~Ref:NM_005981.2~uORF:IOH14295	1334	791	1249	729	1327	1121	2069	1000	1852	579	tetraspanin 31 (TSPAN31)
B33R11C22	33-22-11	Hs~Ref:NM_005981.2~uORF:IOH14295	1138	814	1198	667	1148	1096	1562	1135	1879	498	tetraspanin 31 (TSPAN31)
B33R12C01	33-1-12	Hs~Ref:NM_002136.1~uORF:IOH3526	3695	1722	3491	1142	2473	2595	15718	2023	3894	1007	heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), transcript variant 1
B33R12C02	33-2-12	Hs~Ref:NM_002136.1~uORF:IOH3526	4112	1807	3411	1145	2478	2503	15402	1846	3998	1136	heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), transcript variant 1
B33R12C03	33-3-12	Hs~Ref:NM_016079.1~uORF:IOH5607	1138	409	471	845	806	993	724	1025	743	239	vacuolar protein sorting 24 homolog (S. cerevisiae) (VPS24), transcript variant 1
B33R12C04	33-4-12	Hs~Ref:NM_016079.1~uORF:IOH5607	1167	497	462	826	839	960	723	1044	761	237	vacuolar protein sorting 24 homolog (S. cerevisiae) (VPS24), transcript variant 1
B33R12C05	33-5-12	Hs~MGC:BC011804.2~uORF:IOH14438	2965	2305	7529	2031	2607	11192	6225	3137	3404	968	chromosome 1 open reading frame 165 (C1orf165)
B33R12C06	33-6-12	Hs~MGC:BC011804.2~uORF:IOH14438	2854	2251	7471	2020	2826	10278	6310	3274	3548	920	chromosome 1 open reading frame 165 (C1orf165)
B33R12C07	33-7-12	Hs~MGC:BC007067.1~uORF:IOH57055	427	382	604	348	373	690	1257	596	882	46	Kinetochore-associated protein NSL1 homolog
B33R12C08	33-8-12	Hs~MGC:BC007067.1~uORF:IOH57055	377	370	643	331	380	649	1212	625	913	1	Kinetochore-associated protein NSL1 homolog
B33R12C11	33-11-12	Hs~MGC:BC075800.1~uORF:IOH62474	2055	360	448	200	325	470	513	584	547	104	cAMP-dependent protein kinase type II-beta regulatory subunit
B33R12C12	33-12-12	Hs~MGC:BC075800.1~uORF:IOH62474	313	391	596	175	328	454	475	612	583	98	cAMP-dependent protein kinase type II-beta regulatory subunit
B33R12C15	33-15-12	Hs~Ref:NM_023039.2~uORF:IOH11016	307	52	423	335	331	404	228	314	370	23	ankyrin repeat, family A (RFXANK-like), 2 (ANKRA2)
B33R12C16	33-16-12	Hs~Ref:NM_023039.2~uORF:IOH11016	285	156	261	150	293	363	232	323	400	30	ankyrin repeat, family A (RFXANK-like), 2 (ANKRA2)
B33R12C17	33-17-12	Hs~Ref:NM_031412.1~uORF:IOH14808	423	359	800	530	790	682	775	457	2407	223	GABA(A) receptor-associated protein like 1 (GABARAPL1)
B33R12C18	33-18-12	Hs~Ref:NM_031412.1~uORF:IOH14808	415	405	813	578	783	682	865	419	2535	229	GABA(A) receptor-associated protein like 1 (GABARAPL1)
B33R12C19	33-19-12	Hs~Ref:NM_012241.2~uORF:IOH4405	687	661	518	2091	845	944	772	766	945	1135	sirtuin (silent mating type information regulation 2 homolog) 5 (S. cerevisiae) (SIRT5), transcript variant 1
B33R12C20	33-20-12	Hs~Ref:NM_012241.2~uORF:IOH4405	759	727	584	1785	695	910	746	946	839	1186	sirtuin (silent mating type information regulation 2 homolog) 5 (S. cerevisiae) (SIRT5), transcript variant 1
B33R12C21	33-21-12	Hs~MGC:BC008437.1~uORF:IOH7418	186	239	250	193	347	294	518	203	310	53	calmodulin 2 (phosphorylase kinase, delta) (CALM2)
B33R12C22	33-22-12	Hs~MGC:BC008437.1~uORF:IOH7418	114	230	285	205	15	224	463	229	300	319	calmodulin 2 (phosphorylase kinase, delta) (CALM2)
B33R13C01	33-1-13	Hs~Ref:NM_000528.2~uORF:IOH4607	486	324	575	344	313	442	724	484	1599	752	mannosidase, alpha, class 2B, member 1 (MAN2B1)
B33R13C02	33-2-13	Hs~Ref:NM_000528.2~uORF:IOH4607	557	298	544	395	327	437	704	548	1646	693	mannosidase, alpha, class 2B, member 1 (MAN2B1)
B33R13C03	33-3-13	Hs~MGC:BC040107.1~uORF:IOH26226	2396	483	562	365	629	1839	898	456	1469	729	calcitonin gene-related peptide-receptor component protein (RCP9)
B33R13C04	33-4-13	Hs~MGC:BC040107.1~uORF:IOH26226	2492	432	564	349	651	2125	944	454	1518	703	calcitonin gene-related peptide-receptor component protein (RCP9)
B33R13C05	33-5-13	Hs~MGC:BC041143.1~uORF:IOH26146	518	447	471	294	369	465	536	397	772	246	Acyl-CoA-binding domain-containing protein 4
B33R13C06	33-6-13	Hs~MGC:BC041143.1~uORF:IOH26146	450	467	443	309	508	625	534	383	726	186	Acyl-CoA-binding domain-containing protein 4
B33R13C07	33-7-13	Hs~MGC:BC047030.1~uORF:IOH26622	649	459	592	429	488	607	890	392	950	198	uridine phosphorylase 1 (UPP1)
B33R13C08	33-8-13	Hs~MGC:BC047030.1~uORF:IOH26622	670	383	536	443	477	569	858	360	919	211	uridine phosphorylase 1 (UPP1)
B33R13C09	33-9-13	Hs~Ref:NM_001017973.1~uORF:IOH26049	1591	1140	1494	804	1298	1084	1470	751	1803	378	Prolyl 4-hydroxylase subunit alpha-2
B33R13C10	33-10-13	Hs~Ref:NM_001017973.1~uORF:IOH26049	1411	1192	1489	791	1275	1038	1523	805	1774	166	Prolyl 4-hydroxylase subunit alpha-2
B33R13C11	33-11-13	Hs~Ref:NM_001001325.1~uORF:IOH50193	689	658	753	541	443	880	1457	483	874	286	Putative serine protease inhibitor Kazal-type 5-like 2
B33R13C12	33-12-13	Hs~Ref:NM_001001325.1~uORF:IOH50193	713	775	957	550	487	929	1452	520	797	295	Putative serine protease inhibitor Kazal-type 5-like 2
B33R13C13	33-13-13	Hs~Ref:NM_148910.1~uORF:IOH42286	3848	2117	8772	8164	744	3435	4774	1646	1539	864	Toll/interleukin-1 receptor domain-containing adapter protein
B33R13C14	33-14-13	Hs~Ref:NM_148910.1~uORF:IOH42286	3866	2366	8343	8038	779	3543	4835	1744	1839	859	Toll/interleukin-1 receptor domain-containing adapter protein
B33R13C15	33-15-13	Hs~Ref:NM_207499.1~uORF:IOH37385	970	721	695	560	623	5265	632	1610	1149	319	Patched domain-containing protein C6orf138
B33R13C16	33-16-13	Hs~Ref:NM_207499.1~uORF:IOH37385	989	829	703	568	643	5083	647	1579	1102	290	Patched domain-containing protein C6orf138
B33R13C21	33-21-13	Hs~Ref:NM_002055.1~uORF:IOH9657	1394	1279	1499	2622	2421	1099	4208	939	3076	1118	glial fibrillary acidic protein (GFAP)
B33R13C22	33-22-13	Hs~Ref:NM_002055.1~uORF:IOH9657	1361	1182	1546	2302	2296	1178	4205	936	3304	975	glial fibrillary acidic protein (GFAP)
B33R14C01	33-1-14	Hs~Ref:NM_001629.2~uORF:IOH11710	1488	1189	2116	922	1453	1449	7532	1028	1974	571	arachidonate 5-lipoxygenase-activating protein (ALOX5AP)
B33R14C02	33-2-14	Hs~Ref:NM_001629.2~uORF:IOH11710	1669	1222	2182	888	1401	1370	7351	1043	1953	814	arachidonate 5-lipoxygenase-activating protein (ALOX5AP)
B33R14C03	33-3-14	Hs~Ref:NM_021244.2~uORF:IOH41163	776	570	1959	521	603	22801	1483	689	1563	450	Ras-related GTP-binding protein D
B33R14C04	33-4-14	Hs~Ref:NM_021244.2~uORF:IOH41163	780	512	1958	524	587	24082	1533	609	1640	195	Ras-related GTP-binding protein D
B33R14C05	33-5-14	Hs~Ref:NM_024979.2~uORF:IOH23111	1091	2300	1195	648	527	1936	2508	529	1283	764	Guanine nucleotide exchange factor DBS
B33R14C06	33-6-14	Hs~Ref:NM_024979.2~uORF:IOH23111	1115	2443	1155	674	622	2172	2429	568	1291	691	Guanine nucleotide exchange factor DBS
B33R14C07	33-7-14	Hs~Ref:NM_002279.3~uORF:IOH13096	549	326	406	305	564	638	611	455	568	18	keratin 33B (KRT33B)
B33R14C08	33-8-14	Hs~Ref:NM_002279.3~uORF:IOH13096	519	342	364	299	422	617	624	441	580	116	keratin 33B (KRT33B)
B33R14C09	33-9-14	Hs~Ref:NM_182563.2~uORF:IOH25780	377	388	479	287	377	535	739	433	754	55	BRICHOS domain-containing protein C16orf79
B33R14C10	33-10-14	Hs~Ref:NM_182563.2~uORF:IOH25780	360	994	453	298	336	606	883	425	690	66	BRICHOS domain-containing protein C16orf79
B33R14C11	33-11-14	Hs~MGC:BC029444.1~uORF:IOH23178	9599	9509	7359	10024	14458	13309	9062	8082	16064	12629	immunoglobulin kappa constant (IGKC)
B33R14C12	33-12-14	Hs~MGC:BC029444.1~uORF:IOH23178	9517	8971	7879	9923	13468	13602	9661	7877	17928	13358	immunoglobulin kappa constant (IGKC)
B33R14C13	33-13-14	Hs~MGC:BC034142.1~uORF:IOH23177	25900	25645	22992	25567	27387	31222	23624	19589	32894	25480	immunoglobulin kappa variable 1-5 (IGKV1-5)
B33R14C14	33-14-14	Hs~MGC:BC034142.1~uORF:IOH23177	25656	26208	23427	26095	28400	30789	23799	20058	33565	25589	immunoglobulin kappa variable 1-5 (IGKV1-5)
B33R14C15	33-15-14	Hs~Ref:NM_005522.3~uORF:IOH21992	31887	35081	14410	42504	26585	26010	18253	50097	21732	55526	homeobox A1 (HOXA1), transcript variant 1
B33R14C16	33-16-14	Hs~Ref:NM_005522.3~uORF:IOH21992	34555	34342	14785	43084	25272	26471	17295	47969	21765	53322	homeobox A1 (HOXA1), transcript variant 1
B33R14C17	33-17-14	Hs~Ref:NM_005047.2~uORF:IOH12867	402	406	733	322	712	919	1159	322	798	311	proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 (PSMD5)
B33R14C18	33-18-14	Hs~Ref:NM_005047.2~uORF:IOH12867	415	424	735	281	805	918	1144	323	788	318	proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 (PSMD5)
B33R14C19	33-19-14	Hs~Ref:NM_182835.1~uORF:IOH45521	822	887	1088	634	957	1084	2139	1104	1718	514	sec1 family domain containing 1 (SCFD1), transcript variant 2
B33R14C20	33-20-14	Hs~Ref:NM_182835.1~uORF:IOH45521	902	961	1135	689	844	961	2358	1116	1724	594	sec1 family domain containing 1 (SCFD1), transcript variant 2
B33R14C21	33-21-14	Hs~Ref:NM_134427.1~uORF:IOH45474	4042	2677	8194	5175	4734	2929	9417	5830	4303	3155	regulator of G-protein signaling 3 (RGS3), transcript variant 4
B33R14C22	33-22-14	Hs~Ref:NM_134427.1~uORF:IOH45474	3924	2598	7994	5060	4980	2934	8685	5791	4420	2553	regulator of G-protein signaling 3 (RGS3), transcript variant 4
B33R15C01	33-1-15	Hs~Ref:NM_004706.3~uORF:IOH45526	633	1268	922	773	817	815	1845	1206	1443	273	Rho guanine nucleotide exchange factor (GEF) 1 (ARHGEF1), transcript variant 2
B33R15C02	33-2-15	Hs~Ref:NM_004706.3~uORF:IOH45526	643	1380	844	793	829	805	1732	1151	1392	407	Rho guanine nucleotide exchange factor (GEF) 1 (ARHGEF1), transcript variant 2
B33R15C03	33-3-15	Hs~MGC:BC027994.1~uORF:IOH11366	749	634	946	811	517	766	2073	761	917	236	beta-transducin repeat containing (BTRC)
B33R15C04	33-4-15	Hs~MGC:BC027994.1~uORF:IOH11366	828	563	871	783	540	793	2047	870	936	381	beta-transducin repeat containing (BTRC)
B33R15C07	33-7-15	Hs~MGC:NM_153032.1~uORF:IOH43325	540	521	541	421	1223	568	854	536	749	162	hypothetical protein FLJ32065 (FLJ32065)
B33R15C08	33-8-15	Hs~MGC:NM_153032.1~uORF:IOH43325	593	458	521	393	479	626	872	538	739	215	hypothetical protein FLJ32065 (FLJ32065)
B33R15C09	33-9-15	Hs~Ref:NM_198489.1~uORF:IOH43342	2120	5026	1953	688	1315	1489	3918	1264	2051	1361	coiled-coil domain containing 84 (CCDC84)
B33R15C10	33-10-15	Hs~Ref:NM_198489.1~uORF:IOH43342	2087	5854	1963	773	1186	1644	4168	1237	2107	1163	coiled-coil domain containing 84 (CCDC84)
B33R15C11	33-11-15	Hs~Ref:NM_001008237.1~uORF:IOH43157	1084	619	639	491	3592	1143	1475	1832	2108	1961	tetratricopeptide repeat domain 32 (TTC32)
B33R15C12	33-12-15	Hs~Ref:NM_001008237.1~uORF:IOH43157	1125	581	671	490	3050	1138	1465	1816	2132	2016	tetratricopeptide repeat domain 32 (TTC32)
B33R15C15	33-15-15	Hs~Ref:NM_001274.2~CAT:P3040	235	91	414	189	72	642	519	392	1026	16	CHK1 checkpoint homolog (S. pombe) (CHEK1)
B33R15C16	33-16-15	Hs~Ref:NM_001274.2~CAT:P3040	210	178	377	205	18	618	493	379	92	18	CHK1 checkpoint homolog (S. pombe) (CHEK1)
B33R15C17	33-17-15	Hs~Ref:NM_014326.2~CAT:PV3614	1093	1192	1525	591	1284	1014	1079	1049	1268	370	Death-associated protein kinase 2
B33R15C18	33-18-15	Hs~Ref:NM_014326.2~CAT:PV3614	1104	1060	1459	586	1436	1058	1153	982	1406	399	Death-associated protein kinase 2
B33R16C01	33-1-16	Hs~Ref:NM_004579.2~CAT:PV4211	1853	12	366	243	166	455	511	526	366	58	mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)
B33R16C02	33-2-16	Hs~Ref:NM_004579.2~CAT:PV4211	1808	110	363	240	185	429	538	534	389	58	mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)
B33R16C03	33-3-16	Hs~Ref:NM_004451.3~CAT:PV4665	524	121	227	221	262	1816	556	337	415	73	estrogen-related receptor alpha (ESRRA)
B33R16C04	33-4-16	Hs~Ref:NM_004451.3~CAT:PV4665	542	110	226	224	247	2193	539	326	411	80	estrogen-related receptor alpha (ESRRA)
B33R16C05	33-5-16	Hs~Ref:NM_000594.2~CAT_PHC3015L	5	9	8	221	5	-1	83	103	2	1	tumor necrosis factor (TNF superfamily, member 2) (TNF); see catalog number for detailed information on wild-type or point mutant status
B33R16C06	33-6-16	Hs~Ref:NM_000594.2~CAT_PHC3015L	22	2	6	185	9	12	18	645	2	32	tumor necrosis factor (TNF superfamily, member 2) (TNF); see catalog number for detailed information on wild-type or point mutant status
B33R16C07	33-7-16	Hs~MGC:BC060786.1~uORF:IOH29290	1925	1067	1657	2494	2441	2065	3012	1153	4656	291	development and differentiation enhancing factor-like 1 (DDEFL1)
B33R16C08	33-8-16	Hs~MGC:BC060786.1~uORF:IOH29290	1948	1008	1672	2507	2318	2118	2997	1164	4533	436	development and differentiation enhancing factor-like 1 (DDEFL1)
B33R16C09	33-9-16	Hs~MGC:BC036651.2~uORF:IOH28634	1561	1355	1770	1376	2855	2841	2674	1548	3143	810	PTK2B protein tyrosine kinase 2 beta (PTK2B)
B33R16C10	33-10-16	Hs~MGC:BC036651.2~uORF:IOH28634	1589	1329	1745	1374	2932	2882	2707	1525	3180	725	PTK2B protein tyrosine kinase 2 beta (PTK2B)
B33R16C11	33-11-16	Hs~MGC:BC002704.1~uORF:IOH5332	1001	1308	1538	772	2671	2772	2187	1581	2719	517	signal transducer and activator of transcription 1, 91kDa (STAT1)
B33R16C12	33-12-16	Hs~MGC:BC002704.1~uORF:IOH5332	997	1281	1543	801	2299	2675	2082	1427	2706	599	signal transducer and activator of transcription 1, 91kDa (STAT1)
B33R16C13	33-13-16	Hs~MGC:BC001274.1~uORF:IOH3095	1421	1297	1763	874	2793	2617	2616	1539	3309	685	cell division cycle 2-like 5 (cholinesterase-related cell division controller) (CDC2L5)
B33R16C14	33-14-16	Hs~MGC:BC001274.1~uORF:IOH3095	1333	1403	1808	903	3144	2679	2526	1503	3105	632	cell division cycle 2-like 5 (cholinesterase-related cell division controller) (CDC2L5)
B33R16C15	33-15-16	Hs~Ref:XM_167152.4~uORF:IOH43549	834	595	685	481	2992	827	970	581	1621	401	Zinc finger protein 192
B33R16C16	33-16-16	Hs~Ref:XM_167152.4~uORF:IOH43549	751	588	691	442	3011	776	1096	699	1834	361	Zinc finger protein 192
B33R16C17	33-17-16	Hs~MGC:BC041876.1~uORF:IOH27738	1042	607	1090	671	1406	1462	2486	736	2729	550	tau tubulin kinase 2 (TTBK2)
B33R16C18	33-18-16	Hs~MGC:BC041876.1~uORF:IOH27738	1077	644	1141	704	1707	1532	3222	711	2893	514	tau tubulin kinase 2 (TTBK2)
B33R16C19	33-19-16	Hs~Ref:NM_001009554.1~uORF:IOH45685	2132	361	1005	353	740	828	1437	583	1610	366	microfibrillar-associated protein 3-like (MFAP3L), transcript variant 2
B33R16C20	33-20-16	Hs~Ref:NM_001009554.1~uORF:IOH45685	2137	344	945	377	531	796	1411	595	1606	388	microfibrillar-associated protein 3-like (MFAP3L), transcript variant 2
B33R16C21	33-21-16	Hs~MGC:BC017475.1~uORF:IOH14365	605	542	714	483	709	624	873	528	1572	238	Tetratricopeptide repeat protein 15
B33R16C22	33-22-16	Hs~MGC:BC017475.1~uORF:IOH14365	716	515	717	407	703	574	892	513	1197	577	Tetratricopeptide repeat protein 15
B33R17C01	33-1-17	Hs~MGC:BC007080.1~uORF:IOH7467	665	685	889	398	598	679	851	648	996	289	transmembrane protein 14B (TMEM14B)
B33R17C02	33-2-17	Hs~MGC:BC007080.1~uORF:IOH7467	669	706	886	415	593	670	842	664	1002	271	transmembrane protein 14B (TMEM14B)
B33R17C03	33-3-17	Hs~Ref:NM_023926.2~uORF:IOH22949	950	472	722	855	405	1071	2449	270	898	200	zinc finger and SCAN domain containing 18 (ZSCAN18)
B33R17C04	33-4-17	Hs~Ref:NM_023926.2~uORF:IOH22949	952	487	708	861	403	1126	2490	278	924	189	zinc finger and SCAN domain containing 18 (ZSCAN18)
B33R17C05	33-5-17	Hs~Ref:NM_016267.1~uORF:IOH2890	1168	1076	1114	900	569	709	1196	726	1338	1705	vestigial like 1 (Drosophila) (VGLL1)
B33R17C06	33-6-17	Hs~Ref:NM_016267.1~uORF:IOH2890	1166	1107	1141	915	715	804	1256	893	1281	1666	vestigial like 1 (Drosophila) (VGLL1)
B33R17C07	33-7-17	Hs~Ref:NM_003891.1~uORF:IOH29585	403	381	435	299	344	516	587	356	562	408	protein Z, vitamin K-dependent plasma glycoprotein (PROZ)
B33R17C08	33-8-17	Hs~Ref:NM_003891.1~uORF:IOH29585	368	400	370	280	302	514	591	368	780	134	protein Z, vitamin K-dependent plasma glycoprotein (PROZ)
B33R17C09	33-9-17	Hs~MGC:BC032598.1~uORF:IOH21976	2104	706	951	621	968	1462	2988	2662	1468	451	NHL repeat containing 2 (NHLRC2)
B33R17C10	33-10-17	Hs~MGC:BC032598.1~uORF:IOH21976	2100	704	988	647	915	1378	3067	2864	1477	427	NHL repeat containing 2 (NHLRC2)
B33R17C11	33-11-17	Hs~MGC:BC032587.1~uORF:IOH21953	1059	888	1363	2466	1433	8898	1555	1041	2401	766	tubby like protein 3 (TULP3)
B33R17C12	33-12-17	Hs~MGC:BC032587.1~uORF:IOH21953	1062	921	1321	2480	1208	9134	1533	1010	2381	697	tubby like protein 3 (TULP3)
B33R17C13	33-13-17	Hs~Ref:NM_053046.2~uORF:IOH27186	1403	1143	2099	3708	2570	3895	2537	1240	3766	659	egl nine homolog 2 (C. elegans) (EGLN2), transcript variant 1
B33R17C14	33-14-17	Hs~Ref:NM_053046.2~uORF:IOH27186	1581	1173	2367	3755	2535	3872	2440	1218	3737	627	egl nine homolog 2 (C. elegans) (EGLN2), transcript variant 1
B33R17C15	33-15-17	Hs~MGC:BC033881.1~uORF:IOH22099	1224	683	1512	2602	1161	1012	2044	1212	2405	488	XRCC6 binding protein 1 (XRCC6BP1)
B33R17C16	33-16-17	Hs~MGC:BC033881.1~uORF:IOH22099	1282	688	1495	2639	1117	987	2118	1226	2535	475	XRCC6 binding protein 1 (XRCC6BP1)
B33R17C17	33-17-17	Hs~Ref:NM_022142.3~uORF:IOH13085	628	453	635	321	747	710	1426	460	760	261	Epididymal sperm-binding protein 1
B33R17C18	33-18-17	Hs~Ref:NM_022142.3~uORF:IOH13085	591	475	617	280	561	703	1375	467	933	266	Epididymal sperm-binding protein 1
B33R17C19	33-19-17	Hs~Ref:NM_000200.1~uORF:IOH12986	497	376	604	317	965	668	904	584	729	235	histatin 3 (HTN3)
B33R17C20	33-20-17	Hs~Ref:NM_000200.1~uORF:IOH12986	510	421	627	327	516	682	885	575	811	368	histatin 3 (HTN3)
B33R18C01	33-1-18	Hs~MGC:NM_152394.2~uORF:IOH21592	375	309	437	411	271	423	734	395	550	435	chromosome 3 open reading frame 44 (C3orf44)
B33R18C02	33-2-18	Hs~MGC:NM_152394.2~uORF:IOH21592	335	272	459	407	266	421	707	381	680	255	chromosome 3 open reading frame 44 (C3orf44)
B33R18C03	33-3-18	Hs~Ref:NM_017719.2~N/A	742	859	1195	610	680	885	1267	763	2204	582	SNF-related serine/threonine-protein kinase
B33R18C04	33-4-18	Hs~Ref:NM_017719.2~N/A	744	860	1248	594	655	999	1225	764	2197	607	SNF-related serine/threonine-protein kinase
B33R18C05	33-5-18	Hs~Ref:NM_021158.1~N/A	1114	1079	2100	841	946	1254	1587	993	6694	781	tribbles homolog 3 (Drosophila) (TRIB3)
B33R18C06	33-6-18	Hs~Ref:NM_021158.1~N/A	1098	1091	2118	870	1162	1214	1532	987	6570	761	tribbles homolog 3 (Drosophila) (TRIB3)
B33R18C07	33-7-18	Hs~Ref:NM_032409.1~N/A	545	621	767	449	631	754	878	968	1443	258	Serine/threonine-protein kinase PINK1, mitochondrial
B33R18C08	33-8-18	Hs~Ref:NM_032409.1~N/A	600	659	759	457	607	798	921	759	1514	121	Serine/threonine-protein kinase PINK1, mitochondrial
B33R18C11	33-11-18	Hs~Ref:NM_207327.4~uORF:IOH40136	1137	1663	3141	781	1258	1231	2469	3399	2351	814	similar to RIKEN cDNA 2210021J22 (LOC150383)
B33R18C12	33-12-18	Hs~Ref:NM_207327.4~uORF:IOH40136	1068	1917	2990	767	1150	1199	2426	3400	2342	799	similar to RIKEN cDNA 2210021J22 (LOC150383)
B33R18C13	33-13-18	Hs~Ref:NM_018145.1~uORF:IOH40027	0	-1	-1	9	-16	-5	-3	1	-1	11	family with sequence similarity 82, member C (FAM82C)
B33R18C14	33-14-18	Hs~Ref:NM_018145.1~uORF:IOH40027	4	-1	0	8	977	1	-3	-2	586	1	family with sequence similarity 82, member C (FAM82C)
B33R18C15	33-15-18	Hs~Ref:NM_001692.2~uORF:IOH39878	1206	461	918	455	499	709	718	516	1399	303	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 (Renal tubular acidosis with deafness) (ATP6V1B1)
B33R18C16	33-16-18	Hs~Ref:NM_001692.2~uORF:IOH39878	934	465	830	492	520	769	861	490	1411	337	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 (Renal tubular acidosis with deafness) (ATP6V1B1)
B33R18C17	33-17-18	Hs~Ref:NM_001926.2~uORF:IOH40361	567	482	746	482	658	746	988	565	1415	347	defensin, alpha 6, Paneth cell-specific (DEFA6)
B33R18C18	33-18-18	Hs~Ref:NM_001926.2~uORF:IOH40361	554	1409	714	481	698	741	785	561	1381	345	defensin, alpha 6, Paneth cell-specific (DEFA6)
B33R18C21	33-21-18	Hs~MGC:BC017408.1~uORF:IOH27934	1209	1012	1043	753	1084	991	1168	961	1816	2205	Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial
B33R18C22	33-22-18	Hs~MGC:BC017408.1~uORF:IOH27934	1080	953	1026	732	1046	973	1216	1014	1797	1221	Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial
B33R19C01	33-1-19	Hs~Ref:NM_012244.2~uORF:IOH28096	529	860	729	615	713	798	1152	997	1384	335	Large neutral amino acids transporter small subunit 2
B33R19C02	33-2-19	Hs~Ref:NM_012244.2~uORF:IOH28096	533	925	805	642	717	809	1137	985	1394	314	Large neutral amino acids transporter small subunit 2
B33R19C03	33-3-19	Hs~Ref:NM_052874.1~uORF:IOH40693	465	1011	906	445	534	755	1067	880	1541	357	Syntaxin-1B
B33R19C04	33-4-19	Hs~Ref:NM_052874.1~uORF:IOH40693	517	1119	942	440	578	827	1194	807	1574	444	Syntaxin-1B
B33R19C05	33-5-19	Hs~Ref:NM_080617.4~uORF:IOH40259	1266	1605	1387	1001	1560	3119	1923	1888	2924	626	Cerebellin-4
B33R19C06	33-6-19	Hs~Ref:NM_080617.4~uORF:IOH40259	1256	1572	1351	982	1770	3139	1968	1844	2975	676	Cerebellin-4
B33R19C07	33-7-19	Hs~Ref:NM_017817.1~uORF:IOH12515	2844	1024	2438	1031	2816	1892	1713	1172	3063	543	RAB20, member RAS oncogene family (RAB20)
B33R19C08	33-8-19	Hs~Ref:NM_017817.1~uORF:IOH12515	2728	1024	2237	1022	2829	2044	1751	1255	2906	446	RAB20, member RAS oncogene family (RAB20)
B33R19C09	33-9-19	Hs~MGC:BC018048.1~uORF:IOH10610	954	453	843	373	914	935	937	559	1216	341	pro-melanin-concentrating hormone (PMCH)
B33R19C10	33-10-19	Hs~MGC:BC018048.1~uORF:IOH10610	927	413	898	399	938	1127	953	588	1249	324	pro-melanin-concentrating hormone (PMCH)
B33R19C11	33-11-19	Hs~MGC:BC017066.1~uORF:IOH11186	842	263	853	259	572	1323	1791	931	1015	105	Protein PPRC1
B33R19C12	33-12-19	Hs~MGC:BC017066.1~uORF:IOH11186	870	349	908	248	565	1335	1764	963	1049	100	Protein PPRC1
B33R19C13	33-13-19	Hs~Ref:NM_152322.2~uORF:IOH44718	-2	1	1	704	574	802	873	743	1922	494	BTB (POZ) domain containing 11 (BTBD11), transcript variant 1
B33R19C14	33-14-19	Hs~Ref:NM_152322.2~uORF:IOH44718	1	-3	1591	614	596	819	900	815	1749	456	BTB (POZ) domain containing 11 (BTBD11), transcript variant 1
B33R19C15	33-15-19	Hs~Ref:NM_002795.1~uORF:IOH14510	854	501	919	397	666	652	696	483	1016	216	proteasome (prosome, macropain) subunit, beta type, 3 (PSMB3)
B33R19C16	33-16-19	Hs~Ref:NM_002795.1~uORF:IOH14510	719	490	912	397	625	632	801	453	1176	108	proteasome (prosome, macropain) subunit, beta type, 3 (PSMB3)
B33R19C17	33-17-19	Hs~Ref:NM_152706.2~uORF:IOH11478	568	526	598	385	461	526	780	374	539	269	hypothetical protein MGC26647 (MGC26647)
B33R19C18	33-18-19	Hs~Ref:NM_152706.2~uORF:IOH11478	612	1043	623	424	466	621	940	379	853	263	hypothetical protein MGC26647 (MGC26647)
B33R19C19	33-19-19	Hs~MGC:BC010629.1~uORF:IOH9802	1618	10166	2189	1580	2563	2580	4869	4868	3255	982	outer dense fiber of sperm tails 2 (ODF2)
B33R19C20	33-20-19	Hs~MGC:BC010629.1~uORF:IOH9802	1705	10412	2111	1556	2442	2449	4949	5644	3284	999	outer dense fiber of sperm tails 2 (ODF2)
B33R19C21	33-21-19	Hs~MGC:BC003182.1~uORF:IOH5146	889	619	782	692	1229	611	952	690	1692	256	glycogen synthase 1 (muscle) (GYS1)
B33R19C22	33-22-19	Hs~MGC:BC003182.1~uORF:IOH5146	941	584	820	667	1187	686	1027	662	1531	736	glycogen synthase 1 (muscle) (GYS1)
B33R20C01	33-1-20	Hs~Ref:NM_004448.1~N/A	411	517	502	286	452	387	411	320	480	129	Receptor tyrosine-protein kinase erbB-2
B33R20C02	33-2-20	Hs~Ref:NM_004448.1~N/A	441	484	482	266	445	409	426	328	503	115	Receptor tyrosine-protein kinase erbB-2
B33R20C03	33-3-20	Hs~Ref:NM_002031.1~N/A	466	356	514	335	266	473	546	388	544	203	Tyrosine-protein kinase FRK
B33R20C04	33-4-20	Hs~Ref:NM_002031.1~N/A	449	663	505	358	284	495	592	380	616	319	Tyrosine-protein kinase FRK
B33R20C05	33-5-20	Hs~Ref:NM_001619.2~N/A	342	400	618	265	266	374	447	353	523	123	adrenergic, beta, receptor kinase 1 (ADRBK1)
B33R20C06	33-6-20	Hs~Ref:NM_001619.2~N/A	374	356	626	249	298	354	416	302	512	105	adrenergic, beta, receptor kinase 1 (ADRBK1)
B33R20C07	33-7-20	Hs~MGC:BC009797.1~uORF:IOH13683	691	345	513	304	452	542	667	544	753	151	GATA binding protein 1 (globin transcription factor 1) (GATA1)
B33R20C08	33-8-20	Hs~MGC:BC009797.1~uORF:IOH13683	689	434	528	296	444	550	778	521	726	19	GATA binding protein 1 (globin transcription factor 1) (GATA1)
B33R20C09	33-9-20	Hs~MGC:NM_139156.1~uORF:IOH6401	515	318	356	222	303	408	754	415	717	-2	adenosine monophosphate deaminase 2 (isoform L) (AMPD2), transcript variant 2
B33R20C10	33-10-20	Hs~MGC:NM_139156.1~uORF:IOH6401	356	381	389	236	295	471	823	767	721	103	adenosine monophosphate deaminase 2 (isoform L) (AMPD2), transcript variant 2
B33R20C13	33-13-20	Hs~Ref:NM_022343.2~uORF:IOH59950	755	1091	1562	918	1316	16442	-1	1442	-2	12	Golgi-associated plant pathogenesis-related protein 1
B33R20C14	33-14-20	Hs~Ref:NM_022343.2~uORF:IOH59950	906	1019	1939	1017	1317	32	1	-2	8	27	Golgi-associated plant pathogenesis-related protein 1
B34R02C11	34-11-2	Hs~Ref:NM_032343.1~uORF:IOH6589	6875	1804	6712	4918	2485	3243	8413	3723	5209	752	coiled-coil-helix-coiled-coil-helix domain containing 6 (CHCHD6)
B34R02C12	34-12-2	Hs~Ref:NM_032343.1~uORF:IOH6589	6036	1836	6514	4583	1960	3219	9414	3572	5465	707	coiled-coil-helix-coiled-coil-helix domain containing 6 (CHCHD6)
B34R02C13	34-13-2	Hs~Ref:NM_032369.1~uORF:IOH6885	912	547	904	568	496	700	1036	680	1170	304	hydrogen voltage-gated channel 1 (HVCN1), transcript variant 2
B34R02C14	34-14-2	Hs~Ref:NM_032369.1~uORF:IOH6885	1048	536	838	574	355	674	991	662	1173	271	hydrogen voltage-gated channel 1 (HVCN1), transcript variant 2
B34R02C15	34-15-2	Hs~Ref:NM_138455.1~uORF:IOH14338	427	390	536	652	296	465	500	579	1063	228	collagen triple helix repeat containing 1 (CTHRC1)
B34R02C16	34-16-2	Hs~Ref:NM_138455.1~uORF:IOH14338	400	351	562	647	409	440	511	562	1091	182	collagen triple helix repeat containing 1 (CTHRC1)
B34R02C17	34-17-2	Hs~MGC:BC020788.1~uORF:IOH12612	1017	546	992	1481	347	797	2632	942	1273	777	numb homolog (Drosophila) (NUMB)
B34R02C18	34-18-2	Hs~MGC:BC020788.1~uORF:IOH12612	1017	591	964	1530	319	841	2587	926	1243	654	numb homolog (Drosophila) (NUMB)
B34R02C19	34-19-2	Hs~MGC:BC030642.2~uORF:IOH22273	1140	1007	1634	847	799	1088	1643	1134	3261	605	Parkin coregulated gene protein
B34R02C20	34-20-2	Hs~MGC:BC030642.2~uORF:IOH22273	1185	954	1611	795	818	1027	1631	1067	3532	585	Parkin coregulated gene protein
B34R02C21	34-21-2	Hs~Ref:NM_000206.1~uORF:IOH14230	1359	1030	2787	941	1086	1332	1640	1204	2684	598	interleukin 2 receptor, gamma (severe combined immunodeficiency) (IL2RG)
B34R02C22	34-22-2	Hs~Ref:NM_000206.1~uORF:IOH14230	1332	1096	2704	992	1033	1242	1658	1220	2553	561	interleukin 2 receptor, gamma (severe combined immunodeficiency) (IL2RG)
B34R03C01	34-1-3	Hs~MGC:BC022082.1~uORF:IOH22416	1590	1097	2198	1239	1363	1258	1569	1473	2790	722	Putative DAP-2 like protein C8orf68
B34R03C02	34-2-3	Hs~MGC:BC022082.1~uORF:IOH22416	1666	1125	2187	1295	1327	1233	1635	1532	2754	533	Putative DAP-2 like protein C8orf68
B34R03C03	34-3-3	Hs~Ref:NM_003256.2~uORF:IOH10243	1446	1518	2557	1090	1204	1189	1847	1297	3163	762	TIMP metallopeptidase inhibitor 4 (TIMP4)
B34R03C04	34-4-3	Hs~Ref:NM_003256.2~uORF:IOH10243	1480	1402	2629	1119	1300	1252	1997	1270	3162	737	TIMP metallopeptidase inhibitor 4 (TIMP4)
B34R03C07	34-7-3	Hs~MGC:NM_004545.3~uORF:IOH43540	235	224	275	395	236	154	242	1829	198	42	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa (NDUFB1)
B34R03C08	34-8-3	Hs~MGC:NM_004545.3~uORF:IOH43540	244	202	281	522	213	271	279	308	260	40	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa (NDUFB1)
B34R03C09	34-9-3	Hs~Ref:NM_198493.1~uORF:IOH43276	268	1116	475	3101	400	20429	988	267	421	1561	ankyrin repeat domain 45 (ANKRD45)
B34R03C10	34-10-3	Hs~Ref:NM_198493.1~uORF:IOH43276	112	1225	487	3024	403	19125	1018	483	384	1464	ankyrin repeat domain 45 (ANKRD45)
B34R03C11	34-11-3	Hs~Ref:NM_152340.1~uORF:IOH42183	689	520	317	330	737	697	1106	1171	202	236	hypothetical protein FLJ39075 (FLJ39075)
B34R03C12	34-12-3	Hs~Ref:NM_152340.1~uORF:IOH42183	434	515	922	494	555	1011	1074	915	1645	245	hypothetical protein FLJ39075 (FLJ39075)
B34R03C13	34-13-3	Hs~Ref:NM_152382.1~uORF:IOH39899	207	373	309	294	131	363	282	260	379	62	JmjC domain-containing protein C2orf60
B34R03C14	34-14-3	Hs~Ref:NM_152382.1~uORF:IOH39899	302	323	309	254	126	356	260	240	496	100	JmjC domain-containing protein C2orf60
B34R03C15	34-15-3	Hs~Ref:NM_020125.1~uORF:IOH41018	321	255	389	636	129	955	448	216	450	163	SLAM family member 8 (SLAMF8)
B34R03C16	34-16-3	Hs~Ref:NM_020125.1~uORF:IOH41018	302	258	399	634	120	986	465	230	439	116	SLAM family member 8 (SLAMF8)
B34R03C17	34-17-3	Hs~Ref:NM_018396.1~uORF:IOH43688	479	362	604	867	779	834	906	351	1104	212	methyltransferase like 2B (METTL2B)
B34R03C18	34-18-3	Hs~Ref:NM_018396.1~uORF:IOH43688	504	378	577	869	5595	836	907	347	1051	215	methyltransferase like 2B (METTL2B)
B34R03C19	34-19-3	Hs~Ref:NM_018430.1~uORF:IOH44089	1121	307	961	4772	2897	940	938	655	1350	487	translin-associated factor X interacting protein 1 (TSNAXIP1)
B34R03C20	34-20-3	Hs~Ref:NM_018430.1~uORF:IOH44089	1243	292	871	5135	722	919	868	619	1362	386	translin-associated factor X interacting protein 1 (TSNAXIP1)
B34R03C21	34-21-3	Hs~MGC:BC020203.1~uORF:IOH14766	2159	2264	65464	1291	2362	1593	1860	1742	2112	428	glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5)
B34R03C22	34-22-3	Hs~MGC:BC020203.1~uORF:IOH14766	2157	2319	65478	1421	2488	1438	1796	1595	2070	474	glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5)
B34R04C01	34-1-4	Hs~Ref:NM_145273.1~uORF:IOH10923	931	1134	1085	725	1052	888	1093	809	1758	410	CD300 molecule-like family member g (CD300LG)
B34R04C02	34-2-4	Hs~Ref:NM_145273.1~uORF:IOH10923	910	1147	900	748	1168	971	1074	810	1819	278	CD300 molecule-like family member g (CD300LG)
B34R04C03	34-3-4	Hs~MGC:BC012542.1~uORF:IOH14219	709	501	785	558	561	848	815	677	983	283	GINS complex subunit 1 (Psf1 homolog) (GINS1)
B34R04C04	34-4-4	Hs~MGC:BC012542.1~uORF:IOH14219	663	484	707	562	608	841	876	697	1109	380	GINS complex subunit 1 (Psf1 homolog) (GINS1)
B34R04C05	34-5-4	Hs~MGC:NM_153207.2~uORF:IOH14301	3313	1568	3017	1553	1458	2102	9846	1555	3280	1227	AE binding protein 2 (AEBP2)
B34R04C06	34-6-4	Hs~MGC:NM_153207.2~uORF:IOH14301	3445	1668	3397	1455	1207	2233	9085	1609	3246	1263	AE binding protein 2 (AEBP2)
B34R04C07	34-7-4	Hs~Ref:NM_030814.4~uORF:IOH23215	2143	1896	2241	13390	1134	1496	1938	2026	2288	1365	chromosome 9 open reading frame 45 (C9orf45)
B34R04C08	34-8-4	Hs~Ref:NM_030814.4~uORF:IOH23215	2299	1840	2306	13435	1121	1444	1808	1463	2175	1494	chromosome 9 open reading frame 45 (C9orf45)
B34R04C09	34-9-4	Hs~MGC:BC017959.1~uORF:IOH12310	6761	6335	6542	34409	3559	3186	2772	3840	5079	4534	chromosome 2 open reading frame 47 (C2orf47)
B34R04C10	34-10-4	Hs~MGC:BC017959.1~uORF:IOH12310	6974	6564	6488	34609	3573	3548	3546	4520	5135	4595	chromosome 2 open reading frame 47 (C2orf47)
B34R04C11	34-11-4	Hs~MGC:BC030983.1~uORF:IOH23183	64070	60031	52661	58554	48666	48622	41988	41371	60510	64413	immunoglobulin lambda locus (IGL@)
B34R04C12	34-12-4	Hs~MGC:BC030983.1~uORF:IOH23183	62003	58210	52556	57718	35291	40569	40247	41441	59190	62391	immunoglobulin lambda locus (IGL@)
B34R04C13	34-13-4	Hs~MGC:BC029406.1~uORF:IOH23195	1148	803	1597	788	940	1027	1594	890	1665	639	angiopoietin 1 (ANGPT1)
B34R04C14	34-14-4	Hs~MGC:BC029406.1~uORF:IOH23195	1056	857	1582	716	596	987	1637	872	1644	575	angiopoietin 1 (ANGPT1)
B34R04C15	34-15-4	Hs~Ref:NM_016233.1~uORF:IOH44889	842	1925	859	608	470	1554	1250	699	1061	478	peptidyl arginine deiminase, type III (PADI3)
B34R04C16	34-16-4	Hs~Ref:NM_016233.1~uORF:IOH44889	805	2022	833	585	456	1482	1250	683	1021	428	peptidyl arginine deiminase, type III (PADI3)
B34R04C17	34-17-4	Hs~Ref:NM_021912.2~uORF:IOH43073	491	463	473	394	1814	336	608	366	502	97	gamma-aminobutyric acid (GABA) A receptor, beta 3 (GABRB3), transcript variant 2
B34R04C18	34-18-4	Hs~Ref:NM_021912.2~uORF:IOH43073	442	480	474	411	293	304	642	351	508	61	gamma-aminobutyric acid (GABA) A receptor, beta 3 (GABRB3), transcript variant 2
B34R04C19	34-19-4	Hs~Ref:NM_001302.3~uORF:IOH42947	1181	609	898	1054	1840	613	884	835	893	474	cortistatin (CORT)
B34R04C20	34-20-4	Hs~Ref:NM_001302.3~uORF:IOH42947	1155	644	968	1110	3039	604	923	917	931	437	cortistatin (CORT)
B34R04C21	34-21-4	Hs~Ref:NM_024800.1~N/A	56	166	350	563	118	70	253	185	316	308	Serine/threonine-protein kinase Nek11
B34R04C22	34-22-4	Hs~Ref:NM_024800.1~N/A	235	188	292	392	151	95	230	202	320	478	Serine/threonine-protein kinase Nek11
B34R05C05	34-5-5	Hs~Ref:NM_177457.2~uORF:IOH43474	486	457	698	571	529	613	614	453	810	205	Ly6/neurotoxin 1 (LYNX1), transcript variant 3
B34R05C06	34-6-5	Hs~Ref:NM_177457.2~uORF:IOH43474	487	536	692	638	438	587	598	525	745	155	Ly6/neurotoxin 1 (LYNX1), transcript variant 3
B34R05C07	34-7-5	Hs~Ref:NM_172193.1~uORF:IOH43476	502	310	609	541	265	642	692	502	803	227	kelch domain containing 1 (KLHDC1)
B34R05C08	34-8-5	Hs~Ref:NM_172193.1~uORF:IOH43476	505	344	584	541	240	677	596	448	729	-8	kelch domain containing 1 (KLHDC1)
B34R05C09	34-9-5	Hs~MGC:BC034435.1~uORF:IOH21500	2810	1315	1836	1615	1118	2112	9317	3458	2577	713	zinc finger CCCH-type containing 3 (ZC3H3)
B34R05C10	34-10-5	Hs~MGC:BC034435.1~uORF:IOH21500	2929	1342	1846	1615	1106	2230	8793	4638	2686	735	zinc finger CCCH-type containing 3 (ZC3H3)
B34R05C11	34-11-5	Hs~MGC:BC008765.2~uORF:IOH5957	425	428	996	664	294	1061	1148	411	798	395	syndecan 1 (SDC1)
B34R05C12	34-12-5	Hs~MGC:BC008765.2~uORF:IOH5957	448	353	989	611	287	1003	1163	408	791	411	syndecan 1 (SDC1)
B34R05C13	34-13-5	Hs~Ref:NM_005526.1~uORF:IOH13558	630	518	756	713	190	433	1925	574	938	118	heat shock transcription factor 1 (HSF1)
B34R05C14	34-14-5	Hs~Ref:NM_005526.1~uORF:IOH13558	648	475	730	677	203	429	1914	548	990	117	heat shock transcription factor 1 (HSF1)
B34R05C15	34-15-5	Hs~MGC:BC021180.2~uORF:IOH11041	2201	837	1319	822	460	1089	6230	1135	1212	643	high-mobility group box 4 (HMGB4)
B34R05C16	34-16-5	Hs~MGC:BC021180.2~uORF:IOH11041	4047	889	1370	797	457	1158	6349	1141	1249	596	high-mobility group box 4 (HMGB4)
B34R05C17	34-17-5	Hs~Ref:NM_002716.3~uORF:IOH42140	991	2498	359	294	1983	347	493	343	537	212	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform
B34R05C18	34-18-5	Hs~Ref:NM_002716.3~uORF:IOH42140	695	2574	370	265	543	356	504	334	465	245	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform
B34R05C19	34-19-5	Hs~Ref:NM_018988.1~uORF:IOH42390	435	1168	784	1207	2636	2462	870	1377	1054	1105	Glucose-fructose oxidoreductase domain-containing protein 1
B34R05C20	34-20-5	Hs~Ref:NM_018988.1~uORF:IOH42390	446	1198	757	1164	2923	2346	818	1297	1126	1028	Glucose-fructose oxidoreductase domain-containing protein 1
B34R05C21	34-21-5	Hs~Ref:NM_148976.1~uORF:IOH41126	1509	2564	4565	1049	4608	3146	10066	6761	3421	1558	Proteasome subunit alpha type-1
B34R05C22	34-22-5	Hs~Ref:NM_148976.1~uORF:IOH41126	1585	2316	4259	1011	3956	2830	9219	6740	3493	1407	Proteasome subunit alpha type-1
B34R06C01	34-1-6	Hs~Ref:NM_003605.3~uORF:IOH42213	286	782	692	508	459	470	1180	2484	922	149	O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) (OGT), transcript variant 3, mRNA.
B34R06C02	34-2-6	Hs~Ref:NM_003605.3~uORF:IOH42213	290	834	768	481	177	510	1211	2518	942	115	O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) (OGT), transcript variant 3, mRNA.
B34R06C03	34-3-6	Hs~MGC:BC011888.1~uORF:IOH14513	412	285	494	308	387	421	688	458	564	103	solute carrier family 35, member B1 (SLC35B1)
B34R06C04	34-4-6	Hs~MGC:BC011888.1~uORF:IOH14513	410	277	480	277	327	400	659	453	546	77	solute carrier family 35, member B1 (SLC35B1)
B34R06C05	34-5-6	Hs~Ref:NM_004331.1~uORF:IOH10961	319	589	400	645	396	633	382	954	779	114	BCL2/adenovirus E1B 19kDa interacting protein 3-like (BNIP3L)
B34R06C06	34-6-6	Hs~Ref:NM_004331.1~uORF:IOH10961	343	564	400	665	416	641	421	923	778	158	BCL2/adenovirus E1B 19kDa interacting protein 3-like (BNIP3L)
B34R06C07	34-7-6	Hs~Ref:NM_006184.2~uORF:IOH3531	114	51	530	577	71	35	1925	350	315	1	nucleobindin 1 (NUCB1)
B34R06C08	34-8-6	Hs~Ref:NM_006184.2~uORF:IOH3531	116	59	626	68	2214	70	402	344	114	-5	nucleobindin 1 (NUCB1)
B34R06C09	34-9-6	Hs~Ref:NM_199294.1~uORF:IOH23127	145	45	30	40	3723	-6	8	9	119	3	apoptosis-inducing, TAF9-like domain 1 (APITD1), transcript variant A
B34R06C10	34-10-6	Hs~Ref:NM_199294.1~uORF:IOH23127	176	48	38	254	8154	13	25	6	67	2	apoptosis-inducing, TAF9-like domain 1 (APITD1), transcript variant A
B34R06C11	34-11-6	Hs~Ref:NM_002275.1~uORF:IOH5303	965	1039	785	996	1423	899	1403	747	1786	426	keratin 15 (KRT15)
B34R06C12	34-12-6	Hs~Ref:NM_002275.1~uORF:IOH5303	920	1106	797	973	639	936	1256	773	1901	489	keratin 15 (KRT15)
B34R06C13	34-13-6	Hs~Ref:NM_006479.2~uORF:IOH7384	10239	14818	7126	2343	3034	3801	14478	3537	5125	2282	RAD51 associated protein 1 (RAD51AP1)
B34R06C14	34-14-6	Hs~Ref:NM_006479.2~uORF:IOH7384	10201	14880	7098	2210	2747	3753	14836	3422	5369	2154	RAD51 associated protein 1 (RAD51AP1)
B34R06C15	34-15-6	Hs~MGC:NM_152443.1~uORF:IOH10746	976	674	853	673	495	973	1543	805	1793	525	retinol dehydrogenase 12 (all-trans/9-cis/11-cis) (RDH12)
B34R06C16	34-16-6	Hs~MGC:NM_152443.1~uORF:IOH10746	2264	670	854	722	599	1056	1515	759	1796	497	retinol dehydrogenase 12 (all-trans/9-cis/11-cis) (RDH12)
B34R06C17	34-17-6	Hs~MGC:BC017168.1~uORF:IOH10008	2394	810	1229	1173	4358	1049	3881	1162	2617	401	leucine rich repeat containing 59 (LRRC59)
B34R06C18	34-18-6	Hs~MGC:BC017168.1~uORF:IOH10008	1492	860	1255	1186	2272	1066	3698	1228	2259	333	leucine rich repeat containing 59 (LRRC59)
B34R06C21	34-21-6	Hs~MGC:BC095485.1~uORF:IOH62662	1637	643	1385	1731	2348	1269	5470	1628	1187	334	MAGUK p55 subfamily member 5
B34R06C22	34-22-6	Hs~MGC:BC095485.1~uORF:IOH62662	1713	663	1367	1819	1004	1240	5200	1458	1186	306	MAGUK p55 subfamily member 5
B34R07C01	34-1-7	Hs~MGC:BC085613.1~uORF:IOH62733	1503	1742	1234	935	2286	1862	3634	1314	1630	446	SH3 domain protein D19, mRNA (cDNA clone MGC:105136 IMAGE:30707975), complete cds.
B34R07C02	34-2-7	Hs~MGC:BC085613.1~uORF:IOH62733	1544	1774	1322	900	1874	1857	3660	1273	1709	441	SH3 domain protein D19, mRNA (cDNA clone MGC:105136 IMAGE:30707975), complete cds.
B34R07C05	34-5-7	Hs~Ref:NM_178010.1~uORF:IOH43581	517	813	2127	2040	497	1741	733	304	723	306	SRY (sex determining region Y)-box 5 (SOX5), transcript variant 3
B34R07C06	34-6-7	Hs~Ref:NM_178010.1~uORF:IOH43581	562	678	2292	1913	510	2421	924	311	839	296	SRY (sex determining region Y)-box 5 (SOX5), transcript variant 3
B34R07C07	34-7-7	Hs~Ref:NM_002690.1~uORF:IOH41443	5157	2306	7341	2325	1351	1880	18793	1095	3285	1518	polymerase (DNA directed), beta (POLB)
B34R07C08	34-8-7	Hs~Ref:NM_002690.1~uORF:IOH41443	5406	2315	7161	2191	1041	1877	17224	1051	3217	1619	polymerase (DNA directed), beta (POLB)
B34R07C09	34-9-7	Hs~Ref:NM_022474.2~uORF:IOH44175	2947	1421	3561	4657	4875	1997	6830	3141	5313	894	membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) (MPP5)
B34R07C10	34-10-7	Hs~Ref:NM_022474.2~uORF:IOH44175	3001	1435	3488	4584	5153	1995	6686	3283	4479	870	membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) (MPP5)
B34R07C11	34-11-7	Hs~Ref:NM_000485.1~uORF:IOH41274	207	318	378	791	593	415	565	875	759	149	adenine phosphoribosyltransferase (APRT), transcript variant 1
B34R07C12	34-12-7	Hs~Ref:NM_000485.1~uORF:IOH41274	315	298	402	846	189	417	544	582	772	82	adenine phosphoribosyltransferase (APRT), transcript variant 1
B34R07C17	34-17-7	Hs~Ref:NM_144601.2~uORF:IOH26681	25	182	220	341	113	984	347	259	357	37	CKLF-like MARVEL transmembrane domain containing 3 (CMTM3), transcript variant 1
B34R07C18	34-18-7	Hs~Ref:NM_144601.2~uORF:IOH26681	1172	147	241	345	100	585	347	285	286	9	CKLF-like MARVEL transmembrane domain containing 3 (CMTM3), transcript variant 1
B34R07C19	34-19-7	Hs~MGC:BC031063.1~uORF:IOH28655	33	120	157	825	2540	12	89	152	36	4	immunoglobulin superfamily, member 10 (IGSF10)
B34R07C20	34-20-7	Hs~MGC:BC031063.1~uORF:IOH28655	35	76	103	816	647	228	100	170	72	5	immunoglobulin superfamily, member 10 (IGSF10)
B34R07C21	34-21-7	Hs~MGC:BC002660.1~uORF:IOH5287	46	174	480	182	454	258	403	404	119	8	tropomodulin 1 (TMOD1)
B34R07C22	34-22-7	Hs~MGC:BC002660.1~uORF:IOH5287	44	186	480	185	1213	229	397	356	159	104	tropomodulin 1 (TMOD1)
B34R08C01	34-1-8	Hs~Ref:NM_016520.1~uORF:IOH5899	536	200	258	456	173	664	318	462	225	337	chromosome 9 open reading frame 78 (C9orf78)
B34R08C02	34-2-8	Hs~Ref:NM_016520.1~uORF:IOH5899	486	186	242	414	166	678	348	508	306	254	chromosome 9 open reading frame 78 (C9orf78)
B34R08C03	34-3-8	Hs~Ref:NM_002550.1~uORF:IOH28412	563	304	848	278	403	577	851	418	525	-1	Olfactory receptor 3A1
B34R08C04	34-4-8	Hs~Ref:NM_002550.1~uORF:IOH28412	612	310	541	280	340	585	894	422	581	-6	Olfactory receptor 3A1
B34R08C05	34-5-8	Hs~Ref:NM_015560.1~uORF:IOH38530	404	307	448	304	443	515	651	383	696	105	optic atrophy 1 (autosomal dominant) (OPA1), nuclear gene encoding mitochondrial protein, transcript variant 1
B34R08C06	34-6-8	Hs~Ref:NM_015560.1~uORF:IOH38530	419	317	462	393	462	504	787	394	691	102	optic atrophy 1 (autosomal dominant) (OPA1), nuclear gene encoding mitochondrial protein, transcript variant 1
B34R08C07	34-7-8	Hs~MGC:BC000116.1~uORF:IOH4364	1264	2041	3016	1286	1473	1354	2911	1462	2636	967	KIAA0174 (KIAA0174)
B34R08C08	34-8-8	Hs~MGC:BC000116.1~uORF:IOH4364	1298	2308	2851	1219	1532	1338	3096	1420	2565	855	KIAA0174 (KIAA0174)
B34R08C09	34-9-8	Hs~Ref:NM_003908.1~uORF:IOH3554	847	592	1362	644	1214	873	3187	852	1583	357	eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa (EIF2S2)
B34R08C10	34-10-8	Hs~Ref:NM_003908.1~uORF:IOH3554	874	562	1331	669	1160	856	3389	895	1860	403	eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa (EIF2S2)
B34R08C11	34-11-8	Hs~MGC:BC000463.1~uORF:IOH3592	988	300	607	1121	1111	627	1026	583	910	222	splicing factor 3b, subunit 3, 130kDa (SF3B3)
B34R08C12	34-12-8	Hs~MGC:BC000463.1~uORF:IOH3592	1021	281	584	1026	769	634	1082	542	1163	73	splicing factor 3b, subunit 3, 130kDa (SF3B3)
B34R08C13	34-13-8	Hs~Ref:NM_017727.2~uORF:IOH4312	406	376	577	472	472	611	561	1033	720	227	Transmembrane protein 214
B34R08C14	34-14-8	Hs~Ref:NM_017727.2~uORF:IOH4312	407	354	578	414	480	641	553	508	760	277	Transmembrane protein 214
B34R08C15	34-15-8	Hs~MGC:BC012881.1~uORF:IOH10296	281	243	365	213	386	380	351	253	441	57	cDNA clone MGC:17553 IMAGE:3463076, complete cds
B34R08C16	34-16-8	Hs~MGC:BC012881.1~uORF:IOH10296	1026	301	313	224	219	78	393	271	512	266	cDNA clone MGC:17553 IMAGE:3463076, complete cds
B34R08C17	34-17-8	Hs~MGC:BC021682.1~uORF:IOH12127	1040	519	709	558	377	1901	1027	742	1709	235	glycine-N-acyltransferase-like 2 (GLYATL2)
B34R08C18	34-18-8	Hs~MGC:BC021682.1~uORF:IOH12127	789	513	660	556	391	822	1042	747	1758	261	glycine-N-acyltransferase-like 2 (GLYATL2)
B34R08C19	34-19-8	Hs~Ref:NM_145303.1~uORF:IOH13071	455	406	537	554	393	553	559	496	669	91	similar to RIKEN cDNA 2310008M10 (LOC202459)
B34R08C20	34-20-8	Hs~Ref:NM_145303.1~uORF:IOH13071	424	383	537	545	3084	550	590	464	778	88	similar to RIKEN cDNA 2310008M10 (LOC202459)
B34R08C21	34-21-8	Hs~Ref:NM_005726.2~uORF:IOH12647	787	838	1027	1113	1583	763	1578	748	1367	57	Ts translation elongation factor, mitochondrial (TSFM)
B34R08C22	34-22-8	Hs~Ref:NM_005726.2~uORF:IOH12647	842	810	1040	1089	1465	736	1603	698	1459	12	Ts translation elongation factor, mitochondrial (TSFM)
B34R09C01	34-1-9	Hs~MGC:BC068514.1~uORF:IOH40543	3182	1445	2234	1206	1419	1886	16107	1436	2552	386	NF-kappaB repressing factor (NKRF)
B34R09C02	34-2-9	Hs~MGC:BC068514.1~uORF:IOH40543	3321	1504	2158	1235	994	2068	15262	1481	2693	378	NF-kappaB repressing factor (NKRF)
B34R09C03	34-3-9	Hs~Ref:NM_000899.3~uORF:IOH40380	428	398	692	409	328	538	810	452	1447	377	KIT ligand (KITLG), transcript variant b
B34R09C04	34-4-9	Hs~Ref:NM_000899.3~uORF:IOH40380	458	404	596	339	382	520	822	448	1269	1	KIT ligand (KITLG), transcript variant b
B34R09C05	34-5-9	Hs~MGC:BC068555.1~uORF:IOH40548	1483	1679	661	434	549	703	1149	417	743	279	Rho GTPase activating protein 26 (ARHGAP26)
B34R09C06	34-6-9	Hs~MGC:BC068555.1~uORF:IOH40548	1516	1822	661	1078	536	743	1347	395	729	271	Rho GTPase activating protein 26 (ARHGAP26)
B34R09C07	34-7-9	Hs~Ref:NM_138416.1~uORF:IOH40625	663	533	758	600	417	703	1055	669	738	284	hypothetical protein BC011001 (LOC112937)
B34R09C08	34-8-9	Hs~Ref:NM_138416.1~uORF:IOH40625	675	564	814	479	404	813	1149	761	682	128	hypothetical protein BC011001 (LOC112937)
B34R09C09	34-9-9	Hs~Ref:NM_024053.1~uORF:IOH4348	906	437	475	845	756	866	436	694	9124	279	centromere protein M (CENPM), transcript variant 1
B34R09C10	34-10-9	Hs~Ref:NM_024053.1~uORF:IOH4348	947	440	439	804	696	828	451	639	3755	184	centromere protein M (CENPM), transcript variant 1
B34R09C11	34-11-9	Hs~Ref:NM_014765.1~uORF:IOH3218	497	687	930	1529	400	2388	1027	503	774	462	translocase of outer mitochondrial membrane 20 homolog (yeast) (TOMM20)
B34R09C12	34-12-9	Hs~Ref:NM_014765.1~uORF:IOH3218	499	718	935	1602	388	2330	1006	502	911	443	translocase of outer mitochondrial membrane 20 homolog (yeast) (TOMM20)
B34R09C13	34-13-9	Hs~Ref:NM_021178.1~uORF:IOH3409	578	748	727	15708	1120	1473	2149	1709	1207	786	cyclin B1 interacting protein 1 (CCNB1IP1), transcript variant 1
B34R09C14	34-14-9	Hs~Ref:NM_021178.1~uORF:IOH3409	615	731	699	16304	930	1297	2055	1503	1286	723	cyclin B1 interacting protein 1 (CCNB1IP1), transcript variant 1
B34R09C15	34-15-9	Hs~Ref:NM_006802.1~uORF:IOH3503	453	387	702	411	674	611	685	702	739	161	splicing factor 3a, subunit 3, 60kDa (SF3A3)
B34R09C16	34-16-9	Hs~Ref:NM_006802.1~uORF:IOH3503	461	365	668	397	683	717	716	597	745	-1	splicing factor 3a, subunit 3, 60kDa (SF3A3)
B34R09C17	34-17-9	Hs~MGC:BC008069.2~uORF:IOH5756	1908	1310	2375	1240	1092	2172	2832	1173	3318	676	SH3 and cysteine rich domain 3 (STAC3)
B34R09C18	34-18-9	Hs~MGC:BC008069.2~uORF:IOH5756	1859	1317	2205	1195	1105	2075	2722	1233	3374	629	SH3 and cysteine rich domain 3 (STAC3)
B34R09C19	34-19-9	Hs~Ref:NM_032601.2~uORF:IOH12757	1127	1131	1438	1017	719	1449	2237	926	1758	495	methylmalonyl CoA epimerase (MCEE)
B34R09C20	34-20-9	Hs~Ref:NM_032601.2~uORF:IOH12757	1139	1131	1345	1063	695	1168	2332	883	1857	496	methylmalonyl CoA epimerase (MCEE)
B34R09C21	34-21-9	Hs~MGC:BC020711.1~uORF:IOH12325	1251	972	1366	987	4440	1268	2306	966	1948	559	pregnancy specific beta-1-glycoprotein 11 (PSG11)
B34R09C22	34-22-9	Hs~MGC:BC020711.1~uORF:IOH12325	1504	957	1290	971	2925	1294	2213	914	1855	535	pregnancy specific beta-1-glycoprotein 11 (PSG11)
B34R10C01	34-1-10	Hs~MGC:NM_173825.1~uORF:IOH13382	1210	1308	1760	972	1594	1019	1225	1155	3261	554	Rab-like protein 3
B34R10C02	34-2-10	Hs~MGC:NM_173825.1~uORF:IOH13382	1318	1344	1631	955	1598	1053	1071	921	3296	557	Rab-like protein 3
B34R10C03	34-3-10	Hs~MGC:BC053595.1~uORF:IOH28970	1941	1195	2424	6057	1567	5921	2875	1233	3100	760	chromosome 22 open reading frame 9 (C22orf9)
B34R10C04	34-4-10	Hs~MGC:BC053595.1~uORF:IOH28970	2247	1190	2385	6101	1627	5507	3749	1229	3016	688	chromosome 22 open reading frame 9 (C22orf9)
B34R10C05	34-5-10	Hs~MGC:BC058285.1~uORF:IOH29450	319	260	483	253	266	370	1090	298	390	153	pregnancy specific beta-1-glycoprotein 1 (PSG1)
B34R10C06	34-6-10	Hs~MGC:BC058285.1~uORF:IOH29450	384	517	467	360	264	411	525	310	502	200	pregnancy specific beta-1-glycoprotein 1 (PSG1)
B34R10C09	34-9-10	Hs~MGC:BC027475.1~uORF:IOH28681	467	361	685	331	409	506	891	406	820	156	Leucine-rich repeat and fibronectin type-III domain-containing protein 4
B34R10C10	34-10-10	Hs~MGC:BC027475.1~uORF:IOH28681	478	355	651	330	403	560	865	416	2378	110	Leucine-rich repeat and fibronectin type-III domain-containing protein 4
B34R11C21	34-21-11	Hs~MGC:BC051888.1~uORF:IOH27068	6917	2478	1811	784	819	1105	4975	829	2621	723	tRNA-yW synthesizing protein 1 homolog (S. cerevisiae) (TYW1)
B34R11C22	34-22-11	Hs~MGC:BC051888.1~uORF:IOH27068	7088	2534	1625	784	610	1111	4832	915	2528	629	tRNA-yW synthesizing protein 1 homolog (S. cerevisiae) (TYW1)
B34R12C01	34-1-12	Hs~MGC:BC012901.1~uORF:IOH10497	660	422	671	653	709	588	581	942	771	263	Protein rogdi homolog
B34R12C02	34-2-12	Hs~MGC:BC012901.1~uORF:IOH10497	485	502	705	623	528	632	568	893	1013	528	Protein rogdi homolog
B34R12C03	34-3-12	Hs~MGC:NM_152646.2~uORF:IOH28001	699	1258	1473	1083	4251	7814	2535	2469	4720	886	hypothetical protein MGC23270 (MGC23270)
B34R12C04	34-4-12	Hs~MGC:NM_152646.2~uORF:IOH28001	755	1344	1678	1066	4474	7728	3057	2227	4839	838	hypothetical protein MGC23270 (MGC23270)
B34R12C05	34-5-12	Hs~MGC:BC001294.1~uORF:IOH3067	545	455	613	1192	525	620	602	536	755	392	chromosome 17 open reading frame 48 (C17orf48)
B34R12C06	34-6-12	Hs~MGC:BC001294.1~uORF:IOH3067	560	468	550	1211	498	576	608	506	774	406	chromosome 17 open reading frame 48 (C17orf48)
B34R12C07	34-7-12	Hs~Ref:NM_007067.3~uORF:IOH21942	260	741	617	244	271	648	501	261	902	69	MYST histone acetyltransferase 2 (MYST2)
B34R12C08	34-8-12	Hs~Ref:NM_007067.3~uORF:IOH21942	254	867	573	209	151	453	527	284	991	37	MYST histone acetyltransferase 2 (MYST2)
B34R12C09	34-9-12	Hs~MGC:BC008405.1~uORF:IOH7536	297	338	550	317	284	1192	1316	279	1293	116	pregnancy specific beta-1-glycoprotein 4 (PSG4)
B34R12C10	34-10-12	Hs~MGC:BC008405.1~uORF:IOH7536	291	322	551	305	239	1143	1343	292	1436	66	pregnancy specific beta-1-glycoprotein 4 (PSG4)
B34R12C11	34-11-12	Hs~Ref:NM_001021.2~uORF:IOH27847	198	250	413	156	197	571	770	243	1348	27	ribosomal protein S17 (RPS17)
B34R12C12	34-12-12	Hs~Ref:NM_001021.2~uORF:IOH27847	267	250	405	222	193	520	810	279	1096	46	ribosomal protein S17 (RPS17)
B34R12C13	34-13-12	Hs~Ref:NM_006899.2~uORF:IOH4853	661	459	673	548	438	611	1036	598	1313	392	isocitrate dehydrogenase 3 (NAD+) beta (IDH3B), nuclear gene encoding mitochondrial protein, transcript variant 1
B34R12C14	34-14-12	Hs~Ref:NM_006899.2~uORF:IOH4853	569	543	621	562	505	654	1073	625	1489	373	isocitrate dehydrogenase 3 (NAD+) beta (IDH3B), nuclear gene encoding mitochondrial protein, transcript variant 1
B34R12C15	34-15-12	Hs~MGC:BC098161.1~uORF:IOH63328	635	325	635	488	290	431	1229	574	457	60	Somatoliberin
B34R12C16	34-16-12	Hs~MGC:BC098161.1~uORF:IOH63328	635	316	589	487	229	480	1203	572	466	135	Somatoliberin
B34R12C17	34-17-12	Hs~MGC:BC098318.1~uORF:IOH63345	1518	531	545	2407	338	409	560	1057	543	83	chromosome 7 open reading frame 10, mRNA (cDNA clone MGC:120367 IMAGE:40024555), complete cds
B34R12C18	34-18-12	Hs~MGC:BC098318.1~uORF:IOH63345	1306	503	544	2345	283	339	561	575	574	75	chromosome 7 open reading frame 10, mRNA (cDNA clone MGC:120367 IMAGE:40024555), complete cds
B34R12C19	34-19-12	Hs~MGC:BC098302.1~uORF:IOH63362	10010	577	1137	4595	1364	929	10662	764	3439	318	Kanadaptin
B34R12C20	34-20-12	Hs~MGC:BC098302.1~uORF:IOH63362	10074	545	1087	4340	1360	911	9199	765	3574	170	Kanadaptin
B34R12C21	34-21-12	Hs~MGC:BC099845.1~uORF:IOH63294	565	90	267	529	121	201	990	309	288	51	RAP1, GTP-GDP dissociation stimulator 1 (RAP1GDS1), transcript variant 4, mRNA.
B34R12C22	34-22-12	Hs~MGC:BC099845.1~uORF:IOH63294	521	55	304	497	89	237	1063	293	309	89	RAP1, GTP-GDP dissociation stimulator 1 (RAP1GDS1), transcript variant 4, mRNA.
B34R13C01	34-1-13	Hs~Ref:NM_005259.1~uORF:IOH44374	5867	5103	6465	4230	3070	3607	24308	7213	7602	2283	myostatin (MSTN)
B34R13C02	34-2-13	Hs~Ref:NM_005259.1~uORF:IOH44374	6205	5403	6386	4110	2843	3569	24612	7811	7654	2587	myostatin (MSTN)
B34R13C03	34-3-13	Hs~Ref:XM_374803.1~uORF:IOH42807	4073	1250	1468	2567	1860	1826	3274	6192	2040	546	LINE-1 reverse transcriptase homolog
B34R13C04	34-4-13	Hs~Ref:XM_374803.1~uORF:IOH42807	4550	1227	1279	2542	2041	1796	3353	5222	2030	512	LINE-1 reverse transcriptase homolog
B34R13C05	34-5-13	Hs~Ref:NM_003994.4~uORF:IOH44526	898	650	1703	644	666	863	1360	797	1383	366	KIT ligand (KITLG), transcript variant a
B34R13C06	34-6-13	Hs~Ref:NM_003994.4~uORF:IOH44526	855	941	1783	672	632	881	1424	779	1338	374	KIT ligand (KITLG), transcript variant a
B34R13C07	34-7-13	Hs~Ref:NM_022749.4~uORF:IOH42659	599	517	927	573	429	573	756	549	1108	303	retinoic acid induced 16 (RAI16)
B34R13C08	34-8-13	Hs~Ref:NM_022749.4~uORF:IOH42659	640	532	854	455	423	571	726	546	1116	73	retinoic acid induced 16 (RAI16)
B34R13C09	34-9-13	Hs~MGC:BC012084.1~uORF:IOH13025	1008	719	943	520	418	971	1876	913	773	250	phosphatidylcholine transfer protein (PCTP)
B34R13C10	34-10-13	Hs~MGC:BC012084.1~uORF:IOH13025	1022	659	907	605	371	833	1809	903	821	253	phosphatidylcholine transfer protein (PCTP)
B34R13C11	34-11-13	Hs~Ref:NM_015068.1~uORF:IOH27074	903	640	891	1038	508	871	2175	2090	979	226	paternally expressed 10 (PEG10), transcript variant 1
B34R13C12	34-12-13	Hs~Ref:NM_015068.1~uORF:IOH27074	924	681	920	1051	523	781	2371	2001	1251	344	paternally expressed 10 (PEG10), transcript variant 1
B34R13C13	34-13-13	Hs~MGC:BC036099.1~uORF:IOH27225	10728	7181	7519	7253	5462	2969	21117	2879	6158	9894	aryl-hydrocarbon receptor nuclear translocator 2 (ARNT2)
B34R13C14	34-14-13	Hs~MGC:BC036099.1~uORF:IOH27225	10267	7208	7501	7263	5168	2910	21357	2679	6377	10108	aryl-hydrocarbon receptor nuclear translocator 2 (ARNT2)
B34R13C15	34-15-13	Hs~MGC:BC060042.1~uORF:IOH29484	1011	586	756	1749	482	700	1584	774	914	318	ribosomal protein L23a pseudogene (LOC649946)
B34R13C16	34-16-13	Hs~MGC:BC060042.1~uORF:IOH29484	932	534	735	1722	512	668	1508	815	889	288	ribosomal protein L23a pseudogene (LOC649946)
B34R13C17	34-17-13	Hs~MGC:BC009621.1~uORF:IOH9897	663	11967	4067	1372	1110	948	2259	1333	2294	354	recombination activating gene 1 activating protein 1 (RAG1AP1)
B34R13C18	34-18-13	Hs~MGC:BC009621.1~uORF:IOH9897	631	12484	3997	1334	1124	931	2185	1198	2217	351	recombination activating gene 1 activating protein 1 (RAG1AP1)
B34R13C19	34-19-13	Hs~MGC:BC033622.1~uORF:IOH21694	338	414	430	307	309	555	935	335	662	210	IMP (inosine monophosphate) dehydrogenase 1 (IMPDH1)
B34R13C20	34-20-13	Hs~MGC:BC033622.1~uORF:IOH21694	376	342	402	257	333	429	1038	316	524	300	IMP (inosine monophosphate) dehydrogenase 1 (IMPDH1)
B34R14C01	34-1-14	Hs~MGC:NM_181671.1~uORF:IOH6747	384	340	539	274	275	497	566	340	506	143	phosphatidylinositol transfer protein, cytoplasmic 1 (PITPNC1), transcript variant 2
B34R14C02	34-2-14	Hs~MGC:NM_181671.1~uORF:IOH6747	344	312	489	499	360	408	595	347	637	287	phosphatidylinositol transfer protein, cytoplasmic 1 (PITPNC1), transcript variant 2
B34R14C05	34-5-14	Hs~Ref:NM_001387.2~uORF:IOH54070	1031	512	2501	3724	857	1067	1310	1405	4187	364	Dihydropyrimidinase-related protein 3
B34R14C06	34-6-14	Hs~Ref:NM_001387.2~uORF:IOH54070	1056	483	2501	3656	880	1020	1444	1382	4375	353	Dihydropyrimidinase-related protein 3
B34R14C11	34-11-14	Hs~Ref:NM_014288.2~uORF:IOH13691	2398	667	1422	469	2683	1788	2098	1792	1246	466	Centromere protein R
B34R14C12	34-12-14	Hs~Ref:NM_014288.2~uORF:IOH13691	2409	687	1359	481	2705	1620	2059	1685	1702	432	Centromere protein R
B34R14C13	34-13-14	Hs~MGC:BC001172.1~uORF:IOH4467	504	263	563	258	198	509	1165	489	429	103	Transcriptional adapter 2-alpha
B34R14C14	34-14-14	Hs~MGC:BC001172.1~uORF:IOH4467	560	272	579	246	218	497	1151	463	499	137	Transcriptional adapter 2-alpha
B34R14C15	34-15-14	Hs~Ref:NM_022488.2~uORF:IOH13623	4566	79	272	238	351	443	704	281	600	43	Autophagy-related protein 3
B34R14C16	34-16-14	Hs~Ref:NM_022488.2~uORF:IOH13623	4820	81	249	220	361	415	685	302	660	61	Autophagy-related protein 3
B34R14C17	34-17-14	Hs~Ref:NM_001638.1~uORF:IOH14362	283	223	326	337	141	351	366	251	342	54	Apolipoprotein F
B34R14C18	34-18-14	Hs~Ref:NM_001638.1~uORF:IOH14362	259	197	308	339	101	292	388	1186	386	52	Apolipoprotein F
B34R15C01	34-1-15	Hs~MGC:BC101461.1~uORF:IOH63596	1188	1049	1137	1280	1043	1231	1165	992	2250	304	Neurexophilin-2
B34R15C02	34-2-15	Hs~MGC:BC101461.1~uORF:IOH63596	989	1073	1099	1144	976	1281	1253	1013	2210	450	Neurexophilin-2
B34R15C03	34-3-15	Hs~Ref:NM_033199.1~uORF:IOH10099	501	395	1238	589	638	693	929	779	3725	555	Urocortin-2
B34R15C04	34-4-15	Hs~Ref:NM_033199.1~uORF:IOH10099	539	400	1207	579	641	706	874	845	3876	559	Urocortin-2
B34R15C05	34-5-15	Hs~Ref:NM_003193.2~uORF:IOH3395	248	275	392	240	366	595	591	419	1169	195	tubulin folding cofactor E (TBCE), transcript variant 2
B34R15C06	34-6-15	Hs~Ref:NM_003193.2~uORF:IOH3395	246	258	487	262	416	519	687	416	1136	156	tubulin folding cofactor E (TBCE), transcript variant 2
B34R15C07	34-7-15	Hs~Ref:NM_006807.2~uORF:IOH4111	579	321	447	1045	262	714	670	261	885	55	chromobox homolog 1 (HP1 beta homolog Drosophila ) (CBX1)
B34R15C08	34-8-15	Hs~Ref:NM_006807.2~uORF:IOH4111	607	334	456	887	236	630	708	283	1078	45	chromobox homolog 1 (HP1 beta homolog Drosophila ) (CBX1)
B34R15C09	34-9-15	Hs~MGC:BC010125.1~uORF:IOH13046	1230	668	1373	1031	932	2614	1955	1266	1403	545	chromosome 3 open reading frame 37 (C3orf37)
B34R15C10	34-10-15	Hs~MGC:BC010125.1~uORF:IOH13046	1260	674	1318	1046	929	2349	1889	1246	805	515	chromosome 3 open reading frame 37 (C3orf37)
B34R15C11	34-11-15	Hs~Ref:NM_003295.1~uORF:IOH25767	72	117	173	30	132	106	234	185	228	47	tumor protein, translationally-controlled 1 (TPT1)
B34R15C12	34-12-15	Hs~Ref:NM_003295.1~uORF:IOH25767	72	87	241	209	150	91	258	322	151	19	tumor protein, translationally-controlled 1 (TPT1)
B34R15C15	34-15-15	Hs~Ref:NM_006374.2~CAT:PV3657	440	527	325	906	2420	1068	1640	2079	1325	503	serine/threonine kinase 25 (STE20 homolog, yeast) (STK25)
B34R15C16	34-16-15	Hs~Ref:NM_006374.2~CAT:PV3657	441	552	302	969	2335	1017	1587	2044	1388	423	serine/threonine kinase 25 (STE20 homolog, yeast) (STK25)
B34R15C17	34-17-15	Hs~Ref:NM_006293.2~CAT:PV3828	8170	509	1782	408	578	695	2060	3109	615	123	TYRO3 protein tyrosine kinase (TYRO3)
B34R15C18	34-18-15	Hs~Ref:NM_006293.2~CAT:PV3828	8153	517	1763	379	587	655	2002	3110	629	198	TYRO3 protein tyrosine kinase (TYRO3)
B34R15C19	34-19-15	Hs~Ref:NM_001015878.1~CAT:PV3856	526	405	891	455	376	437	452	864	1154	39	aurora kinase C (AURKC), transcript variant 1
B34R15C20	34-20-15	Hs~Ref:NM_001015878.1~CAT:PV3856	481	395	801	490	339	457	501	434	1094	79	aurora kinase C (AURKC), transcript variant 1
B34R15C21	34-21-15	Hs~Ref:NM_002093.2~CAT:PV3365	665	1654	1261	638	954	3193	1435	1425	1090	478	glycogen synthase kinase 3 beta (GSK3B)
B34R15C22	34-22-15	Hs~Ref:NM_002093.2~CAT:PV3365	715	1797	1240	604	892	2982	1303	1378	1227	462	glycogen synthase kinase 3 beta (GSK3B)
B34R16C01	34-1-16	Hs~Ref:NM_005546.3~CAT:PV3875	323	328	548	529	387	782	1149	1327	935	212	IL2-inducible T-cell kinase (ITK)
B34R16C02	34-2-16	Hs~Ref:NM_005546.3~CAT:PV3875	331	345	552	502	386	785	1364	1326	871	950	IL2-inducible T-cell kinase (ITK)
B34R16C07	34-7-16	Hs~Ref:NM_153330.2~uORF:IOH22558	740	686	1480	663	842	1597	2783	904	1338	623	DnaJ (Hsp40) homolog, subfamily B, member 8 (DNAJB8)
B34R16C08	34-8-16	Hs~Ref:NM_153330.2~uORF:IOH22558	758	720	1394	697	861	1591	2892	928	1367	503	DnaJ (Hsp40) homolog, subfamily B, member 8 (DNAJB8)
B34R16C09	34-9-16	Hs~MGC:BC001028.1~uORF:IOH4227	150	204	191	239	183	319	182	150	6	81	Magnesium transporter MRS2 homolog, mitochondrial
B34R16C10	34-10-16	Hs~MGC:BC001028.1~uORF:IOH4227	129	178	217	241	130	84	198	194	100	121	Magnesium transporter MRS2 homolog, mitochondrial
B34R16C11	34-11-16	Hs~Ref:NM_012425.2~uORF:IOH3398	546	70	243	606	171	1083	550	219	354	58	Ras suppressor protein 1 (RSU1), transcript variant 1
B34R16C12	34-12-16	Hs~Ref:NM_012425.2~uORF:IOH3398	572	88	292	630	164	1100	173	269	334	45	Ras suppressor protein 1 (RSU1), transcript variant 1
B34R16C13	34-13-16	Hs~Ref:NM_004078.1~uORF:IOH1778	3965	2641	3062	2933	2902	3293	4877	6568	2931	4419	cysteine and glycine-rich protein 1 (CSRP1)
B34R16C14	34-14-16	Hs~Ref:NM_004078.1~uORF:IOH1778	3623	2716	2705	3035	2788	3290	4921	6216	2870	4278	cysteine and glycine-rich protein 1 (CSRP1)
B34R16C15	34-15-16	Hs~Ref:NM_001498.2~uORF:IOH26166	998	907	3430	1804	896	1991	1203	1013	1960	476	Glutamate--cysteine ligase catalytic subunit
B34R16C16	34-16-16	Hs~Ref:NM_001498.2~uORF:IOH26166	1048	916	3385	1731	881	1900	1146	1046	2057	431	Glutamate--cysteine ligase catalytic subunit
B34R16C17	34-17-16	Hs~Ref:NM_002990.3~uORF:IOH50179	1258	935	2281	926	1010	1023	1391	1130	2081	136	C-C motif chemokine 22
B34R16C18	34-18-16	Hs~Ref:NM_002990.3~uORF:IOH50179	1309	941	2228	897	1019	1115	1492	1100	2044	489	C-C motif chemokine 22
B34R16C19	34-19-16	Hs~Ref:NM_022912.1~uORF:IOH40034	1201	993	2468	982	1131	2211	3387	2468	2191	480	Receptor expression-enhancing protein 1
B34R16C20	34-20-16	Hs~Ref:NM_022912.1~uORF:IOH40034	1161	999	2405	912	1061	2259	3324	2501	2243	446	Receptor expression-enhancing protein 1
B34R16C21	34-21-16	Hs~Ref:NM_001008535.1~uORF:IOH50159	1097	220	524	239	464	1443	823	999	976	62	A-kinase anchor protein 14
B34R16C22	34-22-16	Hs~Ref:NM_001008535.1~uORF:IOH50159	1142	211	487	230	219	1313	749	947	1022	46	A-kinase anchor protein 14
B34R17C01	34-1-17	Hs~MGC:BC014888.1~uORF:IOH10012	333	228	401	179	152	528	472	345	472	177	nuclear transport factor 2-like export factor 2
B34R17C02	34-2-17	Hs~MGC:BC014888.1~uORF:IOH10012	257	190	352	727	252	503	437	353	461	23	nuclear transport factor 2-like export factor 2
B34R17C03	34-3-17	Hs~MGC:BC007289.1~uORF:IOH6909	190	167	350	235	156	249	616	427	196	55	actin related protein M1 (ARPM1)
B34R17C04	34-4-17	Hs~MGC:BC007289.1~uORF:IOH6909	223	147	329	230	171	279	597	405	249	160	actin related protein M1 (ARPM1)
B34R17C05	34-5-17	Hs~MGC:BC015047.1~uORF:IOH10054	324	187	356	234	248	364	590	402	491	81	hydrolethalus syndrome 1 (HYLS1)
B34R17C06	34-6-17	Hs~MGC:BC015047.1~uORF:IOH10054	322	226	304	247	330	360	608	413	353	130	hydrolethalus syndrome 1 (HYLS1)
B34R17C07	34-7-17	Hs~MGC:BC016854.1~uORF:IOH10430	421	453	496	474	438	360	741	723	817	135	chromosome 11 open reading frame 67 (C11orf67)
B34R17C08	34-8-17	Hs~MGC:BC016854.1~uORF:IOH10430	417	464	426	618	459	339	746	652	794	105	chromosome 11 open reading frame 67 (C11orf67)
B34R17C09	34-9-17	Hs~Ref:NM_031273.1~uORF:IOH35487	329	323	601	321	299	439	812	543	790	172	testis expressed 13B (TEX13B)
B34R17C10	34-10-17	Hs~Ref:NM_031273.1~uORF:IOH35487	351	304	613	350	300	519	862	510	1134	166	testis expressed 13B (TEX13B)
B34R17C11	34-11-17	Hs~Ref:NM_152615.1~uORF:IOH35770	383	284	671	294	270	389	890	436	430	52	poly (ADP-ribose) polymerase family, member 15 (PARP15)
B34R17C12	34-12-17	Hs~Ref:NM_152615.1~uORF:IOH35770	412	258	682	326	229	527	926	433	507	53	poly (ADP-ribose) polymerase family, member 15 (PARP15)
B34R17C13	34-13-17	Hs~Ref:NM_144670.1~uORF:IOH35128	215	186	394	275	222	311	384	451	353	71	Alpha-2-macroglobulin-like protein 1
B34R17C14	34-14-17	Hs~Ref:NM_144670.1~uORF:IOH35128	253	229	374	275	238	328	346	421	342	67	Alpha-2-macroglobulin-like protein 1
B34R17C15	34-15-17	Hs~Ref:NM_002407.1~uORF:IOH40725	249	257	325	238	257	305	295	280	321	65	secretoglobin, family 2A, member 1 (SCGB2A1)
B34R17C16	34-16-17	Hs~Ref:NM_002407.1~uORF:IOH40725	261	219	305	216	247	296	318	301	386	70	secretoglobin, family 2A, member 1 (SCGB2A1)
B34R17C17	34-17-17	Hs~MGC:BC052602.1~uORF:IOH29373	309	2803	201	152	261	722	412	1476	197	49	carbonic anhydrase XIII (CA13)
B34R17C18	34-18-17	Hs~MGC:BC052602.1~uORF:IOH29373	318	2804	202	147	250	703	450	1369	473	58	carbonic anhydrase XIII (CA13)
B34R17C19	34-19-17	Hs~Ref:NM_194270.1~uORF:IOH43471	752	1268	832	977	645	993	9928	659	948	216	MORN repeat containing 2 (MORN2)
B34R17C20	34-20-17	Hs~Ref:NM_194270.1~uORF:IOH43471	756	1274	814	924	630	963	9302	635	923	220	MORN repeat containing 2 (MORN2)
B34R17C21	34-21-17	Hs~Ref:NM_004895.3~uORF:IOH43835	695	526	766	560	439	705	1109	680	1419	487	NLR family, pyrin domain containing 3 (NLRP3), transcript variant 1
B34R17C22	34-22-17	Hs~Ref:NM_004895.3~uORF:IOH43835	727	478	716	527	426	611	1140	695	1350	475	NLR family, pyrin domain containing 3 (NLRP3), transcript variant 1
B34R18C03	34-3-18	Hs~MGC:BC058823.1~uORF:IOH29422	219	187	230	864	43	172	250	218	213	81	dynein, cytoplasmic 2, light intermediate chain 1 (DYNC2LI1)
B34R18C04	34-4-18	Hs~MGC:BC058823.1~uORF:IOH29422	193	167	254	199	107	267	247	221	136	88	dynein, cytoplasmic 2, light intermediate chain 1 (DYNC2LI1)
B34R18C05	34-5-18	Hs~MGC:NM_173195.2~uORF:IOH29635	443	523	590	191	91	260	168	243	152	23	Kv channel interacting protein 2 (KCNIP2), transcript variant 6
B34R18C06	34-6-18	Hs~MGC:NM_173195.2~uORF:IOH29635	470	574	525	85	87	94	83	217	110	18	Kv channel interacting protein 2 (KCNIP2), transcript variant 6
B34R18C07	34-7-18	Hs~MGC:BC040630.1~uORF:IOH28784	241	193	229	278	244	304	215	240	248	102	aquaporin 8 (AQP8)
B34R18C08	34-8-18	Hs~MGC:BC040630.1~uORF:IOH28784	208	263	238	623	245	297	202	208	166	110	aquaporin 8 (AQP8)
B34R18C09	34-9-18	Hs~MGC:BC053998.1~uORF:IOH28976	313	338	368	440	317	633	554	430	662	260	serine/threonine kinase 16 (STK16)
B34R18C10	34-10-18	Hs~MGC:BC053998.1~uORF:IOH28976	339	355	395	412	303	676	523	402	520	761	serine/threonine kinase 16 (STK16)
B34R18C13	34-13-18	Hs~MGC:BC078147.1~uORF:IOH61810	978	524	877	888	501	992	2377	709	6884	340	Protein DGCR8
B34R18C14	34-14-18	Hs~MGC:BC078147.1~uORF:IOH61810	1036	540	848	848	512	958	2436	717	6958	309	Protein DGCR8
B34R18C15	34-15-18	Hs~MGC:BC036636.2~uORF:IOH61621	984	807	824	839	516	753	1324	1219	1131	367	LEM domain-containing protein 1
B34R18C16	34-16-18	Hs~MGC:BC036636.2~uORF:IOH61621	875	830	876	861	547	747	1249	1242	1177	219	LEM domain-containing protein 1
B34R18C17	34-17-18	Hs~MGC:BC095453.1~uORF:IOH63185	817	906	1759	583	702	1420	2168	977	1034	451	Tryptophanyl-tRNA synthetase, cytoplasmic
B34R18C18	34-18-18	Hs~MGC:BC095453.1~uORF:IOH63185	818	906	1624	571	725	1379	2137	947	962	445	Tryptophanyl-tRNA synthetase, cytoplasmic
B34R18C21	34-21-18	Hs~MGC:BC074956.2~uORF:IOH61932	432	291	405	319	322	471	468	456	630	354	Interferon alpha-14
B34R18C22	34-22-18	Hs~MGC:BC074956.2~uORF:IOH61932	400	285	291	294	443	520	447	462	558	295	Interferon alpha-14
B34R19C03	34-3-19	Hs~Ref:NM_182638.1~uORF:IOH59668	216	207	238	464	36	205	273	241	119	104	Hermansky-Pudlak syndrome 1 protein
B34R19C04	34-4-19	Hs~Ref:NM_182638.1~uORF:IOH59668	229	225	315	456	109	331	314	270	604	83	Hermansky-Pudlak syndrome 1 protein
B34R19C05	34-5-19	Hs~MGC:BC051843.1~uORF:IOH27014	231	330	282	196	236	512	886	232	365	54	microtubule-associated protein 4 (MAP4)
B34R19C06	34-6-19	Hs~MGC:BC051843.1~uORF:IOH27014	260	362	270	190	257	504	874	244	434	29	microtubule-associated protein 4 (MAP4)
B34R19C07	34-7-19	Hs~MGC:BC002645.1~uORF:IOH5243	542	446	573	362	355	551	864	553	1072	15	syntaxin 5 (STX5)
B34R19C08	34-8-19	Hs~MGC:BC002645.1~uORF:IOH5243	564	376	924	596	336	589	826	590	112	86	syntaxin 5 (STX5)
B34R19C09	34-9-19	Hs~MGC:BC002897.1~uORF:IOH5695	249	262	443	456	290	356	535	357	69	143	zinc finger protein 343 (ZNF343)
B34R19C10	34-10-19	Hs~MGC:BC002897.1~uORF:IOH5695	256	280	454	205	308	372	555	361	519	89	zinc finger protein 343 (ZNF343)
B34R19C13	34-13-19	Hs~Ref:NM_000476.1~uORF:IOH53853	96	344	251	57	148	171	167	259	183	22	Adenylate kinase isoenzyme 1
B34R19C14	34-14-19	Hs~Ref:NM_000476.1~uORF:IOH53853	129	303	249	39	82	291	104	71	128	108	Adenylate kinase isoenzyme 1
B34R19C15	34-15-19	Hs~Ref:NM_181467.1~uORF:IOH58611	89	76	225	162	106	56	319	218	142	53	Eukaryotic translation initiation factor 6
B34R19C16	34-16-19	Hs~Ref:NM_181467.1~uORF:IOH58611	68	146	227	177	88	186	195	218	108	32	Eukaryotic translation initiation factor 6
B34R19C17	34-17-19	Hs~MGC:BC002869.2~uORF:IOH5705	766	445	549	374	357	621	662	478	779	322	syntaxin binding protein 2 (STXBP2)
B34R19C18	34-18-19	Hs~MGC:BC002869.2~uORF:IOH5705	737	416	564	399	388	543	636	482	821	292	syntaxin binding protein 2 (STXBP2)
B34R19C19	34-19-19	Hs~MGC:BC032954.2~uORF:IOH22415	541	568	567	604	442	576	961	508	1020	340	protein phosphatase 2 (formerly 2A), regulatory subunit B, gamma isoform (PPP2R2C)
B34R19C20	34-20-19	Hs~MGC:BC032954.2~uORF:IOH22415	574	524	605	597	440	586	936	544	911	378	protein phosphatase 2 (formerly 2A), regulatory subunit B, gamma isoform (PPP2R2C)
B34R19C21	34-21-19	Hs~MGC:BC002493.1~uORF:IOH3967	583	539	772	486	455	818	1021	708	1163	316	transcription factor 19 (SC1) (TCF19)
B34R19C22	34-22-19	Hs~MGC:BC002493.1~uORF:IOH3967	581	506	707	458	495	766	1070	660	1274	329	transcription factor 19 (SC1) (TCF19)
B34R20C01	34-1-20	Hs~Ref:NM_024051.1~uORF:IOH4274	416	219	421	305	45	333	499	304	816	92	chromosome 7 open reading frame 24 (C7orf24)
B34R20C02	34-2-20	Hs~Ref:NM_024051.1~uORF:IOH4274	210	214	377	289	-109	323	734	330	864	103	chromosome 7 open reading frame 24 (C7orf24)
B34R20C03	34-3-20	Hs~Ref:NM_014221.1~uORF:IOH4127	345	270	620	365	372	1438	649	535	1320	164	mature T-cell proliferation 1 (MTCP1), nuclear gene encoding mitochondrial protein, transcript variant B1
B34R20C04	34-4-20	Hs~Ref:NM_014221.1~uORF:IOH4127	363	286	631	324	515	1381	679	539	1285	165	mature T-cell proliferation 1 (MTCP1), nuclear gene encoding mitochondrial protein, transcript variant B1
B34R20C05	34-5-20	Hs~MGC:BC002616.1~uORF:IOH4117	694	358	569	1162	583	1461	1317	536	997	234	transgelin 2 (TAGLN2)
B34R20C06	34-6-20	Hs~MGC:BC002616.1~uORF:IOH4117	746	422	539	1037	388	1448	1407	534	995	202	transgelin 2 (TAGLN2)
B34R20C07	34-7-20	Hs~Ref:NM_001009584.1~uORF:IOH40585	1640	1534	8288	1381	1359	2363	17378	5307	3475	522	armadillo repeat containing, X-linked 6 (ARMCX6), transcript variant 2
B34R20C08	34-8-20	Hs~Ref:NM_001009584.1~uORF:IOH40585	1666	1458	8662	1625	1440	2311	17261	5120	3215	495	armadillo repeat containing, X-linked 6 (ARMCX6), transcript variant 2
B34R20C09	34-9-20	Hs~Ref:NM_017866.3~uORF:IOH40588	1284	1078	2212	1223	982	1207	1674	1175	1801	548	transmembrane protein 70 (TMEM70), transcript variant 1
B34R20C10	34-10-20	Hs~Ref:NM_017866.3~uORF:IOH40588	1307	1050	2125	946	1003	1284	1645	1234	2015	582	transmembrane protein 70 (TMEM70), transcript variant 1
B34R20C11	34-11-20	Hs~Ref:NM_004123.1~uORF:IOH40365	989	657	1431	648	929	884	1129	881	1451	334	gastric inhibitory polypeptide (GIP)
B34R20C12	34-12-20	Hs~Ref:NM_004123.1~uORF:IOH40365	990	673	1380	678	938	904	1110	888	1430	321	gastric inhibitory polypeptide (GIP)
B34R20C13	34-13-20	Hs~Ref:NM_006428.3~uORF:IOH40570	4829	5440	4334	5456	4481	7174	15702	5450	3410	2196	mitochondrial ribosomal protein L28 (MRPL28), nuclear gene encoding mitochondrial protein
B34R20C14	34-14-20	Hs~Ref:NM_006428.3~uORF:IOH40570	4732	5336	4224	5280	4411	6849	18825	5755	3268	2063	mitochondrial ribosomal protein L28 (MRPL28), nuclear gene encoding mitochondrial protein
B35R02C11	35-11-2	Hs~MGC:BC001454.1~uORF:IOH3989	650	663	1329	1220	1524	764	2300	1186	1708	408	phosphoenolpyruvate carboxykinase 2 (mitochondrial) (PCK2)
B35R02C12	35-12-2	Hs~MGC:BC001454.1~uORF:IOH3989	663	613	1363	1204	1492	778	2256	1133	1761	416	phosphoenolpyruvate carboxykinase 2 (mitochondrial) (PCK2)
B35R02C13	35-13-2	Hs~Ref:NM_005028.3~uORF:IOH11029	628	927	1528	587	612	636	3243	1084	1463	388	phosphatidylinositol-5-phosphate 4-kinase, type II, alpha (PIP4K2A)
B35R02C14	35-14-2	Hs~Ref:NM_005028.3~uORF:IOH11029	614	928	1496	626	629	666	2901	1076	1485	383	phosphatidylinositol-5-phosphate 4-kinase, type II, alpha (PIP4K2A)
B35R02C15	35-15-2	Hs~Ref:NM_021643.1~uORF:IOH21149	748	607	1026	623	468	897	1422	892	1726	412	tribbles homolog 2 (Drosophila) (TRIB2)
B35R02C16	35-16-2	Hs~Ref:NM_021643.1~uORF:IOH21149	771	615	1461	601	492	863	1410	898	1830	424	tribbles homolog 2 (Drosophila) (TRIB2)
B35R02C17	35-17-2	Hs~Ref:NM_024594.1~uORF:IOH10705	723	730	1150	739	370	1736	1361	831	1687	367	pantothenate kinase 3 (PANK3)
B35R02C18	35-18-2	Hs~Ref:NM_024594.1~uORF:IOH10705	678	812	1370	785	327	1647	1285	842	1573	432	pantothenate kinase 3 (PANK3)
B35R02C19	35-19-2	Hs~Ref:NM_030663.1~uORF:IOH11124	977	1210	1308	4839	1697	1497	2264	1968	1628	450	sperm mitochondria-associated cysteine-rich protein (SMCP), nuclear gene encoding mitochondrial protein
B35R02C20	35-20-2	Hs~Ref:NM_030663.1~uORF:IOH11124	980	1175	1933	4898	1749	1455	2858	1903	1660	432	sperm mitochondria-associated cysteine-rich protein (SMCP), nuclear gene encoding mitochondrial protein
B35R02C21	35-21-2	Hs~MGC:BC022004.2~uORF:IOH11222	1259	947	1620	971	1019	1016	1711	1093	2231	348	catenin (cadherin-associated protein), alpha 3 (CTNNA3)
B35R02C22	35-22-2	Hs~MGC:BC022004.2~uORF:IOH11222	1234	1026	1612	890	1058	1076	1454	992	2168	354	catenin (cadherin-associated protein), alpha 3 (CTNNA3)
B35R03C01	35-1-3	Hs~Ref:NM_000559.1~uORF:IOH13643	530	580	983	643	567	734	992	1514	1108	340	hemoglobin, gamma A (HBG1)
B35R03C02	35-2-3	Hs~Ref:NM_000559.1~uORF:IOH13643	505	620	1002	682	568	704	1001	1435	1175	322	hemoglobin, gamma A (HBG1)
B35R03C03	35-3-3	Hs~MGC:BC028672.1~uORF:IOH14574	4144	3012	5185	2126	4401	4039	11394	3445	2	1	chromosome 15 open reading frame 15 (C15orf15)
B35R03C04	35-4-3	Hs~MGC:BC028672.1~uORF:IOH14574	4446	2778	5085	2571	4483	3851	10939	3246	0	-1	chromosome 15 open reading frame 15 (C15orf15)
B35R03C05	35-5-3	Hs~MGC:BC009564.1~uORF:IOH9952	6761	1464	1962	4385	1881	1681	4631	8256	2415	1135	annexin A2 (ANXA2)
B35R03C06	35-6-3	Hs~MGC:BC009564.1~uORF:IOH9952	6733	1450	1889	3775	1961	1588	4421	7345	2433	1068	annexin A2 (ANXA2)
B35R03C07	35-7-3	Hs~Ref:NM_001613.1~uORF:IOH9991	760	478	839	592	465	527	1088	887	906	371	actin, alpha 2, smooth muscle, aorta (ACTA2)
B35R03C08	35-8-3	Hs~Ref:NM_001613.1~uORF:IOH9991	776	544	855	528	528	541	1096	762	926	248	actin, alpha 2, smooth muscle, aorta (ACTA2)
B35R03C09	35-9-3	Hs~Ref:NM_003345.1~uORF:IOH5997	2261	719	1835	1059	1073	2375	1826	990	1888	396	ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) (UBE2I), transcript variant 1
B35R03C10	35-10-3	Hs~Ref:NM_003345.1~uORF:IOH5997	2310	692	1695	1059	1055	2278	1772	840	1895	369	ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) (UBE2I), transcript variant 1
B35R03C11	35-11-3	Hs~Ref:NM_002614.2~uORF:IOH5807	790	704	1306	2488	681	1140	2681	925	2891	479	PDZ domain containing 1 (PDZK1)
B35R03C12	35-12-3	Hs~Ref:NM_002614.2~uORF:IOH5807	766	717	1212	2301	697	1073	2517	826	2957	497	PDZ domain containing 1 (PDZK1)
B35R03C13	35-13-3	Hs~MGC:BC046208.1~uORF:IOH26975	373	426	560	262	718	412	1341	256	1817	537	interferon induced with helicase C domain 1 (IFIH1)
B35R03C14	35-14-3	Hs~MGC:BC046208.1~uORF:IOH26975	363	365	513	260	697	391	1322	231	1827	523	interferon induced with helicase C domain 1 (IFIH1)
B35R03C15	35-15-3	Hs~MGC:NM_182556.1~uORF:IOH25901	164	270	341	193	136	152	181	163	265	29	solute carrier family 25, member 45 (SLC25A45), transcript variant 1
B35R03C16	35-16-3	Hs~MGC:NM_182556.1~uORF:IOH25901	226	120	119	193	182	112	147	163	242	35	solute carrier family 25, member 45 (SLC25A45), transcript variant 1
B35R03C17	35-17-3	Hs~MGC:BC050439.1~uORF:IOH26673	240	322	107	312	209	187	105	206	375	48	vacuolar protein sorting 36 homolog (S. cerevisiae) (VPS36)
B35R03C18	35-18-3	Hs~MGC:BC050439.1~uORF:IOH26673	213	108	856	317	102	198	1412	160	155	42	vacuolar protein sorting 36 homolog (S. cerevisiae) (VPS36)
B35R03C19	35-19-3	Hs~MGC:BC045783.1~uORF:IOH26422	369	1570	344	973	111	372	495	297	506	67	Uncharacterized protein KIAA1109
B35R03C20	35-20-3	Hs~MGC:BC045783.1~uORF:IOH26422	343	1567	2054	946	243	404	942	339	518	55	Uncharacterized protein KIAA1109
B35R03C21	35-21-3	Hs~MGC:BC008407.1~uORF:IOH7438	1402	2493	1260	1483	886	3489	4632	7393	2986	866	tropomyosin 3 (TPM3)
B35R03C22	35-22-3	Hs~MGC:BC008407.1~uORF:IOH7438	1384	2450	1180	1295	895	3259	4535	6717	2963	827	tropomyosin 3 (TPM3)
B35R04C01	35-1-4	Hs~Ref:NM_138793.1~uORF:IOH9933	1380	1378	1782	956	1104	1206	2022	1285	2504	828	calcium activated nucleotidase 1 (CANT1)
B35R04C02	35-2-4	Hs~Ref:NM_138793.1~uORF:IOH9933	1452	1369	1937	984	1117	1249	2034	1252	2532	810	calcium activated nucleotidase 1 (CANT1)
B35R04C03	35-3-4	Hs~MGC:BC005823.1~uORF:IOH5772	2242	1128	3199	1404	2114	1203	1615	1240	3886	672	Signal transducer and activator of transcription 6
B35R04C04	35-4-4	Hs~MGC:BC005823.1~uORF:IOH5772	2570	1020	3010	1717	2162	1172	1543	1225	3941	691	Signal transducer and activator of transcription 6
B35R04C05	35-5-4	Hs~MGC:BC005902.1~uORF:IOH7553	1702	1117	1964	845	1102	1232	1720	2346	2942	630	biliverdin reductase A (BLVRA)
B35R04C06	35-6-4	Hs~MGC:BC005902.1~uORF:IOH7553	1642	1095	1965	816	1066	1191	1578	2352	2977	612	biliverdin reductase A (BLVRA)
B35R04C07	35-7-4	Hs~MGC:BC022571.1~uORF:IOH22219	1391	3657	1593	508	1175	1594	4009	10073	2167	5865	prune homolog 2 (Drosophila) (PRUNE2)
B35R04C08	35-8-4	Hs~MGC:BC022571.1~uORF:IOH22219	1395	3679	1616	508	1184	1476	3874	9361	2023	5486	prune homolog 2 (Drosophila) (PRUNE2)
B35R04C09	35-9-4	Hs~Ref:NM_012388.1~uORF:IOH3029	1969	557	1416	400	528	830	2277	7350	1335	397	pallidin homolog (mouse) (PLDN)
B35R04C10	35-10-4	Hs~Ref:NM_012388.1~uORF:IOH3029	2145	557	1327	464	520	773	2187	6893	1344	229	pallidin homolog (mouse) (PLDN)
B35R04C11	35-11-4	Hs~MGC:BC030828.1~uORF:IOH22214	709	579	868	535	476	530	911	630	1093	364	EGF-like repeats and discoidin I-like domains 3 (EDIL3)
B35R04C12	35-12-4	Hs~MGC:BC030828.1~uORF:IOH22214	721	547	837	444	514	577	1009	555	1122	359	EGF-like repeats and discoidin I-like domains 3 (EDIL3)
B35R04C13	35-13-4	Hs~MGC:BC034052.1~uORF:IOH22224	402	446	1070	340	265	917	737	612	698	541	Dapper homolog 3
B35R04C14	35-14-4	Hs~MGC:BC034052.1~uORF:IOH22224	376	331	1025	373	277	875	723	595	715	491	Dapper homolog 3
B35R04C15	35-15-4	Hs~Ref:NM_000709.2~uORF:IOH6690	404	416	572	382	262	486	565	434	541	329	branched chain keto acid dehydrogenase E1, alpha polypeptide (BCKDHA)
B35R04C16	35-16-4	Hs~Ref:NM_000709.2~uORF:IOH6690	465	411	606	396	248	468	549	442	620	313	branched chain keto acid dehydrogenase E1, alpha polypeptide (BCKDHA)
B35R04C17	35-17-4	Hs~MGC:NM_173809.2~uORF:IOH9955	426	1742	735	418	489	954	1331	465	762	404	biogenesis of lysosome-related organelles complex-1, subunit 2 (BLOC1S2), transcript variant 1
B35R04C18	35-18-4	Hs~MGC:NM_173809.2~uORF:IOH9955	428	1646	857	321	497	915	1394	452	783	371	biogenesis of lysosome-related organelles complex-1, subunit 2 (BLOC1S2), transcript variant 1
B35R04C19	35-19-4	Hs~MGC:BC003106.1~uORF:IOH4523	1798	711	868	393	381	682	777	428	1242	185	transmembrane protein 59 (TMEM59)
B35R04C20	35-20-4	Hs~MGC:BC003106.1~uORF:IOH4523	1673	582	762	419	381	635	777	434	1167	198	transmembrane protein 59 (TMEM59)
B35R04C21	35-21-4	Hs~Ref:NM_000626.1~uORF:IOH21963	558	603	878	420	326	607	973	640	819	254	CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 1
B35R04C22	35-22-4	Hs~Ref:NM_000626.1~uORF:IOH21963	523	601	780	368	336	565	744	760	822	219	CD79b molecule, immunoglobulin-associated beta (CD79B), transcript variant 1
B35R05C01	35-1-5	Hs~Ref:NM_145702.1~uORF:IOH40861	1062	552	867	20765	289	1077	2239	696	1104	566	tigger transposable element derived 1 (TIGD1)
B35R05C02	35-2-5	Hs~Ref:NM_145702.1~uORF:IOH40861	1036	591	846	18816	300	935	2180	680	1109	718	tigger transposable element derived 1 (TIGD1)
B35R05C03	35-3-5	Hs~MGC:BC010919.1~uORF:IOH27800	1852	1118	1160	881	450	1044	6246	868	1412	638	ribosomal protein L35 (RPL35)
B35R05C04	35-4-5	Hs~MGC:BC010919.1~uORF:IOH27800	1893	1128	1135	828	486	1010	6462	821	1473	1370	ribosomal protein L35 (RPL35)
B35R05C05	35-5-5	Hs~Ref:NM_006699.3~uORF:IOH39822	600	430	542	1068	282	355	765	483	505	1275	mannosidase, alpha, class 1A, member 2 (MAN1A2)
B35R05C06	35-6-5	Hs~Ref:NM_006699.3~uORF:IOH39822	639	484	605	1029	326	410	690	585	583	1647	mannosidase, alpha, class 1A, member 2 (MAN1A2)
B35R05C07	35-7-5	Hs~Ref:NM_002815.2~uORF:IOH3459	1140	1380	1540	1192	1047	1616	1486	1212	2246	1508	proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 (PSMD11)
B35R05C08	35-8-5	Hs~Ref:NM_002815.2~uORF:IOH3459	1161	1349	1602	1182	1039	1536	1458	1100	2079	1269	proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 (PSMD11)
B35R05C09	35-9-5	Hs~Ref:NM_079422.1~uORF:IOH7150	1009	577	2236	789	508	455	1132	563	1184	1310	myosin, light chain 1, alkali; skeletal, fast (MYL1), transcript variant 3f
B35R05C10	35-10-5	Hs~Ref:NM_079422.1~uORF:IOH7150	994	587	2020	709	499	447	1121	688	1239	1646	myosin, light chain 1, alkali; skeletal, fast (MYL1), transcript variant 3f
B35R05C11	35-11-5	Hs~MGC:BC006199.1~uORF:IOH5745	843	814	1008	1022	871	1116	3794	1435	2810	1723	Cytosol aminopeptidase
B35R05C12	35-12-5	Hs~MGC:BC006199.1~uORF:IOH5745	842	794	942	1057	865	993	3583	811	2784	2192	Cytosol aminopeptidase
B35R05C13	35-13-5	Hs~Ref:NM_005716.1~uORF:IOH3617	1708	1940	1575	2041	1292	1498	2137	1477	2677	761	GIPC PDZ domain containing family, member 1 (GIPC1), transcript variant 1
B35R05C14	35-14-5	Hs~Ref:NM_005716.1~uORF:IOH3617	1731	1167	1515	2402	1247	1476	2055	1301	2717	719	GIPC PDZ domain containing family, member 1 (GIPC1), transcript variant 1
B35R05C15	35-15-5	Hs~MGC:BC013155.1~uORF:IOH9761	1518	1162	1443	4142	1340	1313	1593	960	2643	671	crystallin, zeta (quinone reductase)-like 1 (CRYZL1)
B35R05C16	35-16-5	Hs~MGC:BC013155.1~uORF:IOH9761	1551	1170	1529	4386	1281	1356	1762	1025	2654	636	crystallin, zeta (quinone reductase)-like 1 (CRYZL1)
B35R05C17	35-17-5	Hs~MGC:NM_178509.3~uORF:IOH26305	816	412	718	486	345	395	1004	423	751	99	syntaxin binding protein 4 (STXBP4)
B35R05C18	35-18-5	Hs~MGC:NM_178509.3~uORF:IOH26305	868	453	704	316	364	392	491	406	749	98	syntaxin binding protein 4 (STXBP4)
B35R05C19	35-19-5	Hs~MGC:BC047333.1~uORF:IOH26567	638	791	800	638	340	1098	982	480	1897	257	spermatogenesis associated 9 (SPATA9)
B35R05C20	35-20-5	Hs~MGC:BC047333.1~uORF:IOH26567	642	783	858	561	387	1176	981	498	1876	219	spermatogenesis associated 9 (SPATA9)
B35R05C21	35-21-5	Hs~MGC:BC044239.1~uORF:IOH26369	1301	1249	1431	487	587	1152	1671	1752	2114	224	ankyrin repeat domain 13 family, member D (ANKRD13D)
B35R05C22	35-22-5	Hs~MGC:BC044239.1~uORF:IOH26369	1312	1256	1363	473	635	1128	1625	1751	2121	194	ankyrin repeat domain 13 family, member D (ANKRD13D)
B35R06C01	35-1-6	Hs~MGC:BC039832.1~uORF:IOH26274	2442	976	1007	938	1142	906	1828	1193	1181	549	periphilin 1 (PPHLN1)
B35R06C02	35-2-6	Hs~MGC:BC039832.1~uORF:IOH26274	2823	1028	949	898	1164	827	1844	1097	1209	541	periphilin 1 (PPHLN1)
B35R06C03	35-3-6	Hs~Ref:NM_014046.2~uORF:IOH1899	8867	623	918	460	495	547	1122	403	952	267	mitochondrial ribosomal protein S18B (MRPS18B), nuclear gene encoding mitochondrial protein
B35R06C04	35-4-6	Hs~Ref:NM_014046.2~uORF:IOH1899	9164	898	939	454	504	547	1124	415	795	8	mitochondrial ribosomal protein S18B (MRPS18B), nuclear gene encoding mitochondrial protein
B35R06C05	35-5-6	Hs~Ref:NM_006118.2~uORF:IOH1939	603	544	666	755	402	443	678	526	648	173	HCLS1 associated protein X-1 (HAX1), transcript variant 1
B35R06C06	35-6-6	Hs~Ref:NM_006118.2~uORF:IOH1939	586	454	651	735	443	444	699	545	615	122	HCLS1 associated protein X-1 (HAX1), transcript variant 1
B35R06C07	35-7-6	Hs~MGC:NM_006857.1~uORF:IOH13197	1033	926	934	1635	1352	580	1023	574	1319	316	putative nucleic acid binding protein RY-1 (RY1)
B35R06C08	35-8-6	Hs~MGC:NM_006857.1~uORF:IOH13197	1178	932	1157	1612	1377	640	1042	602	1192	101	putative nucleic acid binding protein RY-1 (RY1)
B35R06C09	35-9-6	Hs~Ref:NM_133480.1~uORF:IOH13139	2656	2123	3502	3982	5609	3946	6313	2668	3190	1867	transcriptional adaptor 3 (NGG1 homolog, yeast)-like (TADA3L), transcript variant 2
B35R06C10	35-10-6	Hs~Ref:NM_133480.1~uORF:IOH13139	2606	1903	3171	3836	5278	3802	6090	2480	3208	1700	transcriptional adaptor 3 (NGG1 homolog, yeast)-like (TADA3L), transcript variant 2
B35R06C11	35-11-6	Hs~Ref:NM_033069.1~uORF:IOH39981	1389	4465	1373	1827	847	603	886	809	769	17	chromosome 6 open reading frame 114 (C6orf114)
B35R06C12	35-12-6	Hs~Ref:NM_033069.1~uORF:IOH39981	1295	5233	1394	2144	890	626	964	721	834	219	chromosome 6 open reading frame 114 (C6orf114)
B35R06C13	35-13-6	Hs~Ref:NM_002822.3~uORF:IOH40883	19692	40584	13241	41320	16791	23613	31007	24014	24271	12581	twinfilin, actin-binding protein, homolog 1 (Drosophila) (TWF1)
B35R06C14	35-14-6	Hs~Ref:NM_002822.3~uORF:IOH40883	19455	38615	12652	41836	16338	22859	31441	22903	24774	11618	twinfilin, actin-binding protein, homolog 1 (Drosophila) (TWF1)
B35R06C15	35-15-6	Hs~Ref:NM_030636.1~uORF:IOH39935	2613	7974	3836	4319	1909	4958	4014	2299	5971	1477	Endonuclease/exonuclease/phosphatase family domain-containing protein 1
B35R06C16	35-16-6	Hs~Ref:NM_030636.1~uORF:IOH39935	2702	7920	3614	4140	1857	4730	4428	2229	6113	1313	Endonuclease/exonuclease/phosphatase family domain-containing protein 1
B35R06C17	35-17-6	Hs~Ref:NM_138959.1~uORF:IOH39982	843	569	741	488	722	462	902	563	884	1411	vang-like 1 (van gogh, Drosophila) (VANGL1)
B35R06C18	35-18-6	Hs~Ref:NM_138959.1~uORF:IOH39982	748	646	669	510	759	472	715	583	938	248	vang-like 1 (van gogh, Drosophila) (VANGL1)
B35R06C19	35-19-6	Hs~Ref:NM_022101.1~uORF:IOH27781	8277	3199	4568	11471	15897	6563	5057	6212	10088	2027	chromosome X open reading frame 56 (CXorf56)
B35R06C20	35-20-6	Hs~Ref:NM_022101.1~uORF:IOH27781	7765	3294	4519	7890	14877	6282	5051	5380	9772	1831	chromosome X open reading frame 56 (CXorf56)
B35R06C21	35-21-6	Hs~MGC:BC040214.1~uORF:IOH27456	824	1022	802	495	360	609	1403	551	1023	846	chromosome 7 open reading frame 38 (C7orf38)
B35R06C22	35-22-6	Hs~MGC:BC040214.1~uORF:IOH27456	755	1158	673	506	407	645	1463	555	961	2252	chromosome 7 open reading frame 38 (C7orf38)
B35R07C01	35-1-7	Hs~MGC:BC010368.1~uORF:IOH27803	535	387	645	387	279	436	919	607	644	176	OTU domain, ubiquitin aldehyde binding 1 (OTUB1)
B35R07C02	35-2-7	Hs~MGC:BC010368.1~uORF:IOH27803	612	463	661	333	270	460	893	408	706	164	OTU domain, ubiquitin aldehyde binding 1 (OTUB1)
B35R07C03	35-3-7	Hs~MGC:BC012566.1~uORF:IOH27796	1339	1486	1269	972	505	1732	3083	762	1606	356	nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1)
B35R07C04	35-4-7	Hs~MGC:BC012566.1~uORF:IOH27796	1446	1594	1214	949	476	1737	2814	747	1569	250	nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1)
B35R07C05	35-5-7	Hs~MGC:BC003356.1~uORF:IOH2875	499	434	598	976	262	373	631	361	1894	275	glucosidase, beta; acid (includes glucosylceramidase) (GBA)
B35R07C06	35-6-7	Hs~MGC:BC003356.1~uORF:IOH2875	528	430	626	1006	294	389	632	381	1888	262	glucosidase, beta; acid (includes glucosylceramidase) (GBA)
B35R07C07	35-7-7	Hs~MGC:BC000166.2~uORF:IOH2928	5871	3634	3534	7850	2325	2552	6211	1764	6925	1340	HIV-1 Tat interacting protein, 60kDa (HTATIP)
B35R07C08	35-8-7	Hs~MGC:BC000166.2~uORF:IOH2928	5746	3665	3449	7456	2358	2481	6479	1661	6658	1243	HIV-1 Tat interacting protein, 60kDa (HTATIP)
B35R07C09	35-9-7	Hs~Ref:NM_016303.1~uORF:IOH27824	1866	6061	59494	24729	6527	1977	1895	1634	3290	2128	WW domain binding protein 5 (WBP5), transcript variant 1
B35R07C10	35-10-7	Hs~Ref:NM_016303.1~uORF:IOH27824	2025	5975	57150	24591	6296	1856	1844	1617	3286	2046	WW domain binding protein 5 (WBP5), transcript variant 1
B35R07C11	35-11-7	Hs~MGC:BC003403.1~uORF:IOH3013	712	442	650	913	504	535	520	402	1009	148	RAP2C, member of RAS oncogene family (RAP2C)
B35R07C12	35-12-7	Hs~MGC:BC003403.1~uORF:IOH3013	753	432	628	962	463	572	568	438	1107	161	RAP2C, member of RAS oncogene family (RAP2C)
B35R07C13	35-13-7	Hs~Ref:NM_057749.1~uORF:IOH43526	3384	6087	4320	4074	1906	2405	6184	1728	3092	778	cyclin E2 (CCNE2)
B35R07C14	35-14-7	Hs~Ref:NM_057749.1~uORF:IOH43526	3278	6093	4417	4580	1964	2280	7734	1598	3072	458	cyclin E2 (CCNE2)
B35R07C15	35-15-7	Hs~Ref:NM_006756.2~uORF:IOH42106	5750	3345	6540	3007	2414	2278	14823	1825	4883	1688	transcription elongation factor A (SII), 1 (TCEA1), transcript variant 1
B35R07C16	35-16-7	Hs~Ref:NM_006756.2~uORF:IOH42106	5427	3231	6243	3061	2313	2269	15268	1774	4926	1669	transcription elongation factor A (SII), 1 (TCEA1), transcript variant 1
B35R07C17	35-17-7	Hs~Ref:XM_114355.2~uORF:IOH44495	1195	1018	1729	928	852	1048	1812	793	1712	399	Arylacetamide deacetylase
B35R07C18	35-18-7	Hs~Ref:XM_114355.2~uORF:IOH44495	1216	1085	1609	920	826	1094	1824	793	1612	398	Arylacetamide deacetylase
B35R07C21	35-21-7	Hs~Ref:NM_003315.1~uORF:IOH14566	2247	4388	2585	2515	988	1567	4643	2305	4991	573	DnaJ (Hsp40) homolog, subfamily C, member 7 (DNAJC7)
B35R07C22	35-22-7	Hs~Ref:NM_003315.1~uORF:IOH14566	2212	4557	2451	2239	1011	1506	4314	2125	5100	603	DnaJ (Hsp40) homolog, subfamily C, member 7 (DNAJC7)
B35R08C01	35-1-8	Hs~Ref:NM_052845.1~uORF:IOH13544	1816	1980	2310	2983	2315	1950	3573	1876	3143	619	methylmalonic aciduria (cobalamin deficiency) cblB type (MMAB), nuclear gene encoding mitochondrial protein
B35R08C02	35-2-8	Hs~Ref:NM_052845.1~uORF:IOH13544	1811	1968	2172	2900	3931	1917	3260	1723	3141	583	methylmalonic aciduria (cobalamin deficiency) cblB type (MMAB), nuclear gene encoding mitochondrial protein
B35R08C03	35-3-8	Hs~MGC:BC018667.1~uORF:IOH14819	1727	1379	1660	1197	1963	1395	2672	2224	2818	669	ankyrin repeat domain 1 (cardiac muscle) (ANKRD1)
B35R08C04	35-4-8	Hs~MGC:BC018667.1~uORF:IOH14819	1935	1373	1526	1183	2141	1340	2618	2095	2767	524	ankyrin repeat domain 1 (cardiac muscle) (ANKRD1)
B35R08C05	35-5-8	Hs~MGC:BC021253.2~uORF:IOH14624	2443	1351	935	1632	890	1113	896	890	2008	98	chromosome 9 open reading frame 58 (C9orf58)
B35R08C06	35-6-8	Hs~MGC:BC021253.2~uORF:IOH14624	2651	1349	895	1569	826	1065	853	845	1997	75	chromosome 9 open reading frame 58 (C9orf58)
B35R08C07	35-7-8	Hs~Ref:NM_031436.1~uORF:IOH5698	752	986	757	684	1413	854	1111	978	1379	120	aldo-keto reductase family 1, member C-like 2 (AKR1CL2)
B35R08C08	35-8-8	Hs~Ref:NM_031436.1~uORF:IOH5698	807	957	733	692	1405	832	1075	943	1314	147	aldo-keto reductase family 1, member C-like 2 (AKR1CL2)
B35R08C09	35-9-8	Hs~Ref:NM_020299.2~uORF:IOH6697	2012	539	2634	388	1246	410	977	366	1281	176	aldo-keto reductase family 1, member B10 (aldose reductase) (AKR1B10)
B35R08C10	35-10-8	Hs~Ref:NM_020299.2~uORF:IOH6697	2028	550	2491	382	1207	388	889	353	1299	175	aldo-keto reductase family 1, member B10 (aldose reductase) (AKR1B10)
B35R08C11	35-11-8	Hs~Ref:NM_003130.1~uORF:IOH13042	4578	2560	3917	3961	1542	2491	2745	6877	4618	1241	sorcin (SRI), transcript variant 1
B35R08C12	35-12-8	Hs~Ref:NM_003130.1~uORF:IOH13042	4722	2425	3901	3717	1547	2544	2783	6003	4878	1005	sorcin (SRI), transcript variant 1
B35R08C13	35-13-8	Hs~MGC:BC022305.1~uORF:IOH14446	1265	1150	1632	21288	539	1168	1305	569	1219	244	chloride intracellular channel 2 (CLIC2)
B35R08C14	35-14-8	Hs~MGC:BC022305.1~uORF:IOH14446	1175	1075	1586	19757	537	1136	1391	502	1264	386	chloride intracellular channel 2 (CLIC2)
B35R08C15	35-15-8	Hs~MGC:BC005253.1~uORF:IOH7296	828	1051	3219	581	585	646	746	848	1540	306	kelch-like 20 (Drosophila) (KLHL20)
B35R08C16	35-16-8	Hs~MGC:BC005253.1~uORF:IOH7296	791	1018	3055	536	560	661	741	844	1585	340	kelch-like 20 (Drosophila) (KLHL20)
B35R08C17	35-17-8	Hs~Ref:NM_000318.1~uORF:IOH7247	665	533	676	456	426	527	869	462	868	372	peroxisomal membrane protein 3, 35kDa (Zellweger syndrome) (PXMP3), transcript variant 1
B35R08C18	35-18-8	Hs~Ref:NM_000318.1~uORF:IOH7247	556	711	643	477	452	488	774	483	763	201	peroxisomal membrane protein 3, 35kDa (Zellweger syndrome) (PXMP3), transcript variant 1
B35R08C19	35-19-8	Hs~Ref:NM_003495.2~uORF:IOH12149	509	447	465	496	258	388	886	405	558	88	histone cluster 1, H4i (HIST1H4I)
B35R08C20	35-20-8	Hs~Ref:NM_003495.2~uORF:IOH12149	569	480	488	504	245	370	906	371	1292	103	histone cluster 1, H4i (HIST1H4I)
B35R08C21	35-21-8	Hs~MGC:BC017770.1~uORF:IOH14871	1441	1592	1352	824	842	1162	1759	764	2231	467	RNA binding motif protein 8A (RBM8A)
B35R08C22	35-22-8	Hs~MGC:BC017770.1~uORF:IOH14871	1386	1596	1303	800	861	1122	1868	748	2288	499	RNA binding motif protein 8A (RBM8A)
B35R09C01	35-1-9	Hs~Ref:NM_153007.3~uORF:IOH35383	1035	961	1182	2274	1824	808	1575	1310	1360	277	outer dense fiber of sperm tails 4 (ODF4)
B35R09C02	35-2-9	Hs~Ref:NM_153007.3~uORF:IOH35383	1202	941	1309	2460	1672	819	1628	1285	1455	214	outer dense fiber of sperm tails 4 (ODF4)
B35R09C03	35-3-9	Hs~MGC:BC059174.1~uORF:IOH28851	14335	8733	6104	11128	6005	3802	21115	6629	4047	2323	TRAF3-interacting protein 1
B35R09C04	35-4-9	Hs~MGC:BC059174.1~uORF:IOH28851	15027	7809	5792	10502	6848	3875	20794	6407	4070	1997	TRAF3-interacting protein 1
B35R09C05	35-5-9	Hs~Ref:NM_175735.3~uORF:IOH35282	1265	666	1030	622	955	6043	1050	644	1342	414	lysozyme G-like 2 (LYG2)
B35R09C06	35-6-9	Hs~Ref:NM_175735.3~uORF:IOH35282	1354	589	1022	634	941	5850	1011	620	1388	196	lysozyme G-like 2 (LYG2)
B35R09C07	35-7-9	Hs~Ref:NM_005208.3~uORF:IOH35287	1512	1040	2342	1164	990	2065	1257	1463	3566	249	crystallin, beta A1 (CRYBA1)
B35R09C08	35-8-9	Hs~Ref:NM_005208.3~uORF:IOH35287	1568	1050	2247	1099	1040	2010	1258	1445	3638	9	crystallin, beta A1 (CRYBA1)
B35R09C09	35-9-9	Hs~MGC:BC005395.1~uORF:IOH7260	657	414	662	448	275	652	488	294	637	69	hemopexin (HPX)
B35R09C10	35-10-9	Hs~MGC:BC005395.1~uORF:IOH7260	556	403	653	514	284	617	475	263	698	229	hemopexin (HPX)
B35R09C11	35-11-9	Hs~Ref:NM_004507.1~uORF:IOH7302	723	361	699	2382	271	505	681	374	620	112	HUS1 checkpoint homolog (S. pombe) (HUS1)
B35R09C12	35-12-9	Hs~Ref:NM_004507.1~uORF:IOH7302	786	362	676	2902	257	497	1190	397	692	83	HUS1 checkpoint homolog (S. pombe) (HUS1)
B35R09C13	35-13-9	Hs~Ref:NM_016464.1~uORF:IOH7268	14316	1046	960	4734	1297	1051	10559	780	3358	220	transmembrane protein 138 (TMEM138)
B35R09C14	35-14-9	Hs~Ref:NM_016464.1~uORF:IOH7268	13898	1036	905	4457	1291	989	5286	847	3589	162	transmembrane protein 138 (TMEM138)
B35R09C15	35-15-9	Hs~MGC:BC005248.1~uORF:IOH7358	1833	1305	2078	990	513	1300	6611	873	1802	360	eukaryotic translation initiation factor 1A, Y-linked (EIF1AY)
B35R09C16	35-16-9	Hs~MGC:BC005248.1~uORF:IOH7358	1922	1317	2052	880	499	1266	6948	693	1752	284	eukaryotic translation initiation factor 1A, Y-linked (EIF1AY)
B35R09C17	35-17-9	Hs~MGC:BC002827.1~uORF:IOH5413	764	867	697	808	551	1392	2300	2484	1165	685	tropomyosin 4 (TPM4)
B35R09C18	35-18-9	Hs~MGC:BC002827.1~uORF:IOH5413	636	926	650	833	546	1298	2074	2213	1146	603	tropomyosin 4 (TPM4)
B35R09C19	35-19-9	Hs~MGC:BC002863.2~uORF:IOH5708	1669	1129	1983	1007	610	9651	2689	925	3150	301	chromosome 9 open reading frame 156 (C9orf156)
B35R09C20	35-20-9	Hs~MGC:BC002863.2~uORF:IOH5708	1752	1040	1798	893	601	9165	2650	873	3075	264	chromosome 9 open reading frame 156 (C9orf156)
B35R09C21	35-21-9	Hs~Ref:NM_003085.2~uORF:IOH5707	500	459	369	1224	379	1337	508	2561	586	427	synuclein, beta (SNCB), transcript variant 2
B35R09C22	35-22-9	Hs~Ref:NM_003085.2~uORF:IOH5707	431	459	358	1096	383	1268	510	2331	580	-92	synuclein, beta (SNCB), transcript variant 2
B35R10C01	35-1-10	Hs~MGC:BC004341.1~uORF:IOH5560	562	810	609	554	1772	468	695	458	1100	135	Coiled-coil domain-containing protein 51
B35R10C02	35-2-10	Hs~MGC:BC004341.1~uORF:IOH5560	520	807	604	602	1950	618	702	522	996	93	Coiled-coil domain-containing protein 51
B35R10C03	35-3-10	Hs~MGC:BC001497.2~uORF:IOH12354	866	773	1047	712	2278	929	1598	872	1854	638	RAN binding protein 5 (RANBP5)
B35R10C04	35-4-10	Hs~MGC:BC001497.2~uORF:IOH12354	887	828	1010	654	656	843	1603	888	1905	849	RAN binding protein 5 (RANBP5)
B35R10C05	35-5-10	Hs~Ref:NM_016069.8~uORF:IOH6645	897	6063	976	972	659	1060	1875	1470	2235	504	mitochondria-associated protein involved in granulocyte-macrophage colony-stimulating factor signal transduction (Magmas), nuclear gene encoding mitochondrial protein
B35R10C06	35-6-10	Hs~Ref:NM_016069.8~uORF:IOH6645	957	5928	957	927	677	1047	1810	1348	2263	303	mitochondria-associated protein involved in granulocyte-macrophage colony-stimulating factor signal transduction (Magmas), nuclear gene encoding mitochondrial protein
B35R10C07	35-7-10	Hs~MGC:BC007847.2~uORF:IOH6718	1719	1159	4628	1035	819	1366	3030	1148	2793	938	eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) (EEF1D)
B35R10C08	35-8-10	Hs~MGC:BC007847.2~uORF:IOH6718	1749	1189	4714	993	828	1373	3100	1093	2912	1135	eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) (EEF1D)
B35R10C09	35-9-10	Hs~Ref:NM_002732.2~uORF:IOH45130	1463	946	1586	834	701	1007	2200	1252	1686	572	protein kinase, cAMP-dependent, catalytic, gamma (PRKACG)
B35R10C10	35-10-10	Hs~Ref:NM_002732.2~uORF:IOH45130	1361	1013	1688	854	698	1011	2225	1230	1735	354	protein kinase, cAMP-dependent, catalytic, gamma (PRKACG)
B35R11C21	35-21-11	Hs~MGC:BC000979.2~uORF:IOH2932	1041	1098	1220	944	1032	1649	1701	1252	2541	801	Probable ATP-dependent RNA helicase DDX49
B35R11C22	35-22-11	Hs~MGC:BC000979.2~uORF:IOH2932	999	1063	1269	936	992	1520	1759	1257	2621	682	Probable ATP-dependent RNA helicase DDX49
B35R12C01	35-1-12	Hs~Ref:NM_006694.1~uORF:IOH2941	993	843	1119	1178	5534	1005	1867	928	1478	522	jumping translocation breakpoint (JTB)
B35R12C02	35-2-12	Hs~Ref:NM_006694.1~uORF:IOH2941	983	845	1115	1220	3262	949	1799	995	1480	503	jumping translocation breakpoint (JTB)
B35R12C03	35-3-12	Hs~Ref:NM_005900.1~uORF:IOH4970	873	2013	2309	2593	4238	1231	1708	1412	2791	997	SMAD family member 1 (SMAD1), transcript variant 1
B35R12C04	35-4-12	Hs~Ref:NM_005900.1~uORF:IOH4970	852	1831	2128	2508	3557	1233	1577	1291	2834	935	SMAD family member 1 (SMAD1), transcript variant 1
B35R12C05	35-5-12	Hs~Ref:NM_006253.2~uORF:IOH3634	1321	1187	2661	1630	2612	4189	2298	1101	2200	625	protein kinase, AMP-activated, beta 1 non-catalytic subunit (PRKAB1)
B35R12C06	35-6-12	Hs~Ref:NM_006253.2~uORF:IOH3634	1443	1092	2630	1583	4341	4265	2322	1062	2085	672	protein kinase, AMP-activated, beta 1 non-catalytic subunit (PRKAB1)
B35R12C11	35-11-12	Hs~MGC:BC073163.1~uORF:IOH62548	482	557	411	231	198	577	1165	497	641	313	Interferon-induced guanylate-binding protein 2
B35R12C12	35-12-12	Hs~MGC:BC073163.1~uORF:IOH62548	457	515	399	229	171	522	538	460	654	275	Interferon-induced guanylate-binding protein 2
B35R12C13	35-13-12	Hs~MGC:BC080187.1~uORF:IOH62553	4379	2831	6569	5627	2939	7863	4207	4344	7293	1622	Leiomodin-1
B35R12C14	35-14-12	Hs~MGC:BC080187.1~uORF:IOH62553	4308	2932	6079	5520	2919	7305	4172	3967	7292	1573	Leiomodin-1
B35R12C15	35-15-12	Hs~Ref:NM_133484.1~uORF:IOH2979	326	802	381	305	196	390	1157	206	477	316	TRAF family member-associated NFKB activator (TANK), transcript variant 2
B35R12C16	35-16-12	Hs~Ref:NM_133484.1~uORF:IOH2979	320	715	337	298	162	402	1089	200	484	332	TRAF family member-associated NFKB activator (TANK), transcript variant 2
B35R12C17	35-17-12	Hs~Ref:NM_017924.2~uORF:IOH10782	270	75	205	362	83	92	285	235	348	105	chromosome 14 open reading frame 119 (C14orf119)
B35R12C18	35-18-12	Hs~Ref:NM_017924.2~uORF:IOH10782	268	142	238	317	95	101	98	217	347	86	chromosome 14 open reading frame 119 (C14orf119)
B35R12C19	35-19-12	Hs~Ref:NM_002922.2~uORF:IOH10963	482	493	293	923	82	228	286	342	418	138	regulator of G-protein signaling 1 (RGS1)
B35R12C20	35-20-12	Hs~Ref:NM_002922.2~uORF:IOH10963	511	449	291	870	77	226	344	302	462	43	regulator of G-protein signaling 1 (RGS1)
B35R12C21	35-21-12	Hs~Ref:NM_007019.1~uORF:IOH10068	258	84	268	4292	82	352	241	169	407	62	ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 1
B35R12C22	35-22-12	Hs~Ref:NM_007019.1~uORF:IOH10068	237	91	304	3711	48	17	221	166	394	51	ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 1
B35R13C01	35-1-13	Hs~Ref:NM_015184.2~uORF:IOH22060	2273	2657	1805	1122	2592	1414	2647	2434	2216	1653	phospholipase C-like 2 (PLCL2)
B35R13C02	35-2-13	Hs~Ref:NM_015184.2~uORF:IOH22060	2157	2633	1663	1115	6312	1528	2550	2282	2267	1634	phospholipase C-like 2 (PLCL2)
B35R13C03	35-3-13	Hs~MGC:BC045768.1~uORF:IOH26324	639	516	762	730	1426	560	767	624	1387	648	kelch-like 17 (Drosophila) (KLHL17)
B35R13C04	35-4-13	Hs~MGC:BC045768.1~uORF:IOH26324	602	594	804	739	835	602	705	607	1498	678	kelch-like 17 (Drosophila) (KLHL17)
B35R13C05	35-5-13	Hs~MGC:BC007424.2~uORF:IOH6160	1406	1786	2794	3317	8276	4932	3046	2169	6204	1455	PRP4 pre-mRNA processing factor 4 homolog (yeast) (PRPF4)
B35R13C06	35-6-13	Hs~MGC:BC007424.2~uORF:IOH6160	1457	1812	2638	3291	8925	4814	2847	2092	5950	1340	PRP4 pre-mRNA processing factor 4 homolog (yeast) (PRPF4)
B35R13C07	35-7-13	Hs~Ref:NM_002018.2~uORF:IOH14719	693	533	661	415	387	650	1059	448	801	329	flightless I homolog (Drosophila) (FLII)
B35R13C08	35-8-13	Hs~Ref:NM_002018.2~uORF:IOH14719	798	498	644	431	322	878	976	408	807	287	flightless I homolog (Drosophila) (FLII)
B35R13C09	35-9-13	Hs~MGC:BC038960.1~uORF:IOH26165	608	420	659	534	288	674	845	401	815	274	Probable E3 ubiquitin-protein ligase HERC3
B35R13C10	35-10-13	Hs~MGC:BC038960.1~uORF:IOH26165	542	450	713	548	303	708	1310	388	812	277	Probable E3 ubiquitin-protein ligase HERC3
B35R13C11	35-11-13	Hs~Ref:NM_170707.1~uORF:IOH41769	1704	2123	6069	1330	1129	1640	1826	1069	2982	523	Lamin-A/C
B35R13C12	35-12-13	Hs~Ref:NM_170707.1~uORF:IOH41769	1677	2132	5837	1288	1026	1592	1802	1015	2986	512	Lamin-A/C
B35R13C13	35-13-13	Hs~Ref:NM_207480.1~uORF:IOH50189	2210	3563	4100	956	613	2737	3635	925	2273	505	Putative uncharacterized protein UNQ5830/PRO19650/PRO19816
B35R13C14	35-14-13	Hs~Ref:NM_207480.1~uORF:IOH50189	2202	3489	3888	926	573	3007	3556	886	2382	554	Putative uncharacterized protein UNQ5830/PRO19650/PRO19816
B35R13C15	35-15-13	Hs~Ref:NM_004591.1~uORF:IOH50190	561	368	586	492	1660	556	480	273	620	106	C-C motif chemokine 20
B35R13C16	35-16-13	Hs~Ref:NM_004591.1~uORF:IOH50190	566	353	589	472	1402	500	530	288	593	25	C-C motif chemokine 20
B35R13C19	35-19-13	Hs~Ref:NM_013411.3~uORF:IOH59040	1692	1270	1420	1436	3494	983	5948	1353	2142	524	Adenylate kinase isoenzyme 2, mitochondrial
B35R13C20	35-20-13	Hs~Ref:NM_013411.3~uORF:IOH59040	1744	1164	1442	1583	3052	1019	5715	1324	2157	518	Adenylate kinase isoenzyme 2, mitochondrial
B35R13C21	35-21-13	Hs~MGC:NM_178814.2~uORF:IOH11915	1016	854	1253	786	556	1104	1317	796	1706	425	adaptor-related protein complex 1, sigma 3 subunit (AP1S3)
B35R13C22	35-22-13	Hs~MGC:NM_178814.2~uORF:IOH11915	1013	901	1402	741	552	1023	1308	830	1559	380	adaptor-related protein complex 1, sigma 3 subunit (AP1S3)
B35R14C03	35-3-14	Hs~Ref:NM_001001936.1~uORF:IOH23258	719	445	1086	447	4038	1315	1514	5926	1191	364	actin filament associated protein 1-like 2 (AFAP1L2), transcript variant 1
B35R14C04	35-4-14	Hs~Ref:NM_001001936.1~uORF:IOH23258	730	441	1050	427	1856	1190	1539	5958	1190	360	actin filament associated protein 1-like 2 (AFAP1L2), transcript variant 1
B35R14C05	35-5-14	Hs~Ref:NM_001945.1~uORF:IOH23272	637	1424	662	370	941	680	1500	1125	646	310	heparin-binding EGF-like growth factor (HBEGF)
B35R14C06	35-6-14	Hs~Ref:NM_001945.1~uORF:IOH23272	629	2084	638	386	337	681	1480	1515	693	335	heparin-binding EGF-like growth factor (HBEGF)
B35R14C07	35-7-14	Hs~Ref:NM_002011.3~uORF:IOH13371	872	731	589	412	1615	442	670	673	688	342	fibroblast growth factor receptor 4 (FGFR4), transcript variant 1
B35R14C08	35-8-14	Hs~Ref:NM_002011.3~uORF:IOH13371	805	360	555	432	341	471	906	562	768	248	fibroblast growth factor receptor 4 (FGFR4), transcript variant 1
B35R14C09	35-9-14	Hs~Ref:NM_006280.1~uORF:IOH2918	1717	378	656	430	383	798	783	450	869	266	signal sequence receptor, delta (translocon-associated protein delta) (SSR4)
B35R14C10	35-10-14	Hs~Ref:NM_006280.1~uORF:IOH2918	1847	417	632	430	355	884	748	440	799	304	signal sequence receptor, delta (translocon-associated protein delta) (SSR4)
B35R14C11	35-11-14	Hs~Ref:NM_018138.1~uORF:IOH11055	758	408	652	437	301	591	1064	472	771	338	TBCC domain containing 1 (TBCCD1)
B35R14C12	35-12-14	Hs~Ref:NM_018138.1~uORF:IOH11055	642	474	667	472	2640	613	1076	460	756	308	TBCC domain containing 1 (TBCCD1)
B35R14C13	35-13-14	Hs~Ref:NM_031206.2~uORF:IOH14284	359	421	501	510	1951	517	659	396	548	320	LAS1-like (S. cerevisiae) (LAS1L)
B35R14C14	35-14-14	Hs~Ref:NM_031206.2~uORF:IOH14284	359	359	535	490	906	826	655	408	556	308	LAS1-like (S. cerevisiae) (LAS1L)
B35R14C15	35-15-14	Hs~MGC:BC032656.1~uORF:IOH21979	792	664	744	554	1356	1000	1196	607	997	585	transcription factor 7-like 2 (T-cell specific, HMG-box) (TCF7L2)
B35R14C16	35-16-14	Hs~MGC:BC032656.1~uORF:IOH21979	831	716	729	540	190	1009	1164	624	954	586	transcription factor 7-like 2 (T-cell specific, HMG-box) (TCF7L2)
B35R14C17	35-17-14	Hs~MGC:BC030997.1~uORF:IOH23173	702	533	600	454	808	689	990	572	776	216	Putative S-adenosyl-L-methionine-dependent methyltransferase METT5D2
B35R14C18	35-18-14	Hs~MGC:BC030997.1~uORF:IOH23173	649	481	603	473	544	639	970	602	779	233	Putative S-adenosyl-L-methionine-dependent methyltransferase METT5D2
B35R14C19	35-19-14	Hs~Ref:NM_021173.2~uORF:IOH45937	1474	1154	2192	1594	1817	1447	1111	1199	2661	3	polymerase (DNA-directed), delta 4 (POLD4)
B35R14C20	35-20-14	Hs~Ref:NM_021173.2~uORF:IOH45937	1468	1182	2204	1595	1832	1407	1076	1098	2728	391	polymerase (DNA-directed), delta 4 (POLD4)
B35R14C21	35-21-14	Hs~Ref:NM_173455.1~uORF:IOH45492	828	733	1089	1455	2144	1117	1704	951	1486	493	High affinity cAMP-specific and IBMX-insensitive 3prime,5prime-cyclic phosphodiesterase 8A
B35R14C22	35-22-14	Hs~Ref:NM_173455.1~uORF:IOH45492	784	762	1208	1419	661	1098	1696	967	1555	470	High affinity cAMP-specific and IBMX-insensitive 3prime,5prime-cyclic phosphodiesterase 8A
B35R15C01	35-1-15	Hs~MGC:BC023549.2~uORF:IOH27821	1407	596	1282	1502	2714	1921	9024	916	5965	2686	Fas (TNFRSF6) binding factor 1 (FBF1)
B35R15C02	35-2-15	Hs~MGC:BC023549.2~uORF:IOH27821	1538	626	1249	1513	2868	2045	8696	843	6063	2499	Fas (TNFRSF6) binding factor 1 (FBF1)
B35R15C03	35-3-15	Hs~Ref:NM_080652.2~uORF:IOH7051	333	346	484	370	198	501	607	389	415	160	transmembrane protein 41A (TMEM41A)
B35R15C04	35-4-15	Hs~Ref:NM_080652.2~uORF:IOH7051	407	335	504	385	227	506	678	396	440	78	transmembrane protein 41A (TMEM41A)
B35R15C05	35-5-15	Hs~Ref:NM_021026.1~uORF:IOH43261	557	522	945	456	3318	780	1068	1198	1412	336	ret finger protein-like 1 (RFPL1)
B35R15C06	35-6-15	Hs~Ref:NM_021026.1~uORF:IOH43261	605	666	924	466	1563	709	1024	1077	1299	309	ret finger protein-like 1 (RFPL1)
B35R15C07	35-7-15	Hs~Ref:NM_001007529.1~uORF:IOH43417	610	989	614	408	132	646	952	804	734	299	cDNA FLJ40194 fis, clone TESTI2019481FLJ40194 protein ; [Source:UniProtKB/TrEMBL;Acc:Q8N7Z3]
B35R15C08	35-8-15	Hs~Ref:NM_001007529.1~uORF:IOH43417	1676	461	638	394	1433	621	957	752	864	303	cDNA FLJ40194 fis, clone TESTI2019481FLJ40194 protein ; [Source:UniProtKB/TrEMBL;Acc:Q8N7Z3]
B35R15C09	35-9-15	Hs~Ref:NM_181297.1~uORF:IOH43436	912	449	712	465	1405	616	1022	768	735	289	CKLF-like MARVEL transmembrane domain containing 1 (CMTM1), transcript variant 19
B35R15C10	35-10-15	Hs~Ref:NM_181297.1~uORF:IOH43436	988	497	721	453	2489	602	985	770	830	207	CKLF-like MARVEL transmembrane domain containing 1 (CMTM1), transcript variant 19
B35R15C11	35-11-15	Hs~Ref:NM_022772.2~uORF:IOH44912	525	238	463	285	1606	1465	504	348	468	121	EPS8-like 2 (EPS8L2)
B35R15C12	35-12-15	Hs~Ref:NM_022772.2~uORF:IOH44912	378	250	492	279	854	1387	529	363	484	68	EPS8-like 2 (EPS8L2)
B35R15C15	35-15-15	Hs~Ref:NM_002401.2~CAT:PV3876	892	1082	1005	927	2428	1291	1403	917	1177	340	Mitogen-activated protein kinase kinase kinase 3
B35R15C16	35-16-15	Hs~Ref:NM_002401.2~CAT:PV3876	882	990	894	865	4843	1302	1428	913	1187	529	Mitogen-activated protein kinase kinase kinase 3
B35R15C17	35-17-15	Hs~Ref:NM_004119.1~CAT:PV3967	384	390	705	305	1074	619	497	383	502	70	fms-related tyrosine kinase 3 (FLT3); see catalog number for detailed information on wild-type or point mutant status
B35R15C18	35-18-15	Hs~Ref:NM_004119.1~CAT:PV3967	373	354	836	306	348	632	514	371	447	66	fms-related tyrosine kinase 3 (FLT3); see catalog number for detailed information on wild-type or point mutant status
B35R15C19	35-19-15	Hs~Ref:NM_002755.2~CAT:PV3303	415	269	659	222	315	175	493	232	599	55	mitogen-activated protein kinase kinase 1 (MAP2K1); see catalog number for detailed information on wild-type or point mutant status
B35R15C20	35-20-15	Hs~Ref:NM_002755.2~CAT:PV3303	448	344	717	222	476	1271	451	314	620	58	mitogen-activated protein kinase kinase 1 (MAP2K1); see catalog number for detailed information on wild-type or point mutant status
B35R16C01	35-1-16	Hs~Ref:NM_002754.3~CAT:PV3656	277	978	457	227	883	476	250	644	212	51	mitogen-activated protein kinase 13 (MAPK13)
B35R16C02	35-2-16	Hs~Ref:NM_002754.3~CAT:PV3656	139	1005	493	242	509	704	270	362	378	43	mitogen-activated protein kinase 13 (MAPK13)
B35R16C05	35-5-16	Hs~Ref:NM_000075.2~CAT:PV4400	63	230	186	261	85	355	282	187	454	32	cyclin D1 and cyclin-dependent kinase 4 (CDK4): cyclin D1 and CDK4 sequences are seperated by -- (in the protein list file).
B35R16C06	35-6-16	Hs~Ref:NM_000075.2~CAT:PV4400	131	291	166	250	3742	341	155	186	434	24	cyclin D1 and cyclin-dependent kinase 4 (CDK4): cyclin D1 and CDK4 sequences are seperated by -- (in the protein list file).
B35R16C07	35-7-16	Hs~MGC:BC047901.2~uORF:IOH28877	1758	2071	2050	1040	6805	2615	3421	1931	3078	669	actinin, alpha 2 (ACTN2)
B35R16C08	35-8-16	Hs~MGC:BC047901.2~uORF:IOH28877	1588	2129	1949	1004	4759	2345	3445	1919	3069	652	actinin, alpha 2 (ACTN2)
B35R16C09	35-9-16	Hs~MGC:BC039904.1~uORF:IOH28768	1781	1519	2431	1444	5381	1765	3526	2984	5061	1624	histone deacetylase 4 (HDAC4)
B35R16C10	35-10-16	Hs~MGC:BC039904.1~uORF:IOH28768	1821	1539	2363	1473	4719	1703	3615	2927	5107	1571	histone deacetylase 4 (HDAC4)
B35R16C11	35-11-16	Hs~MGC:BC015358.1~uORF:IOH10311	1565	1496	1987	1207	2751	1987	2195	1807	4692	986	HIV-1 Tat interactive protein 2, 30kDa (HTATIP2)
B35R16C12	35-12-16	Hs~MGC:BC015358.1~uORF:IOH10311	1753	1476	1971	1217	2415	1846	2127	1739	4784	1005	HIV-1 Tat interactive protein 2, 30kDa (HTATIP2)
B35R16C13	35-13-16	Hs~MGC:BC043346.2~uORF:IOH28804	181	86	289	286	-26	340	209	217	445	55	ubiquitin-like 4A (UBL4A)
B35R16C14	35-14-16	Hs~MGC:BC043346.2~uORF:IOH28804	306	88	482	237	75	342	319	238	291	36	ubiquitin-like 4A (UBL4A)
B35R16C15	35-15-16	Hs~Ref:NM_206833.1~uORF:IOH40736	778	691	1015	694	909	693	4237	906	2028	641	cortexin 1 (CTXN1)
B35R16C16	35-16-16	Hs~Ref:NM_206833.1~uORF:IOH40736	774	716	989	653	831	683	4241	879	2094	307	cortexin 1 (CTXN1)
B35R16C17	35-17-16	Hs~Ref:NM_007375.3~uORF:IOH45677	1181	918	1709	831	1502	4264	4251	1444	2237	343	TAR DNA binding protein (TARDBP)
B35R16C18	35-18-16	Hs~Ref:NM_007375.3~uORF:IOH45677	1127	933	1738	839	1040	3869	4141	1408	2222	408	TAR DNA binding protein (TARDBP)
B35R16C19	35-19-16	Hs~Ref:NM_032342.1~uORF:IOH6569	914	508	882	500	933	479	901	470	1011	413	chromosome 9 open reading frame 125 (C9orf125)
B35R16C20	35-20-16	Hs~Ref:NM_032342.1~uORF:IOH6569	995	848	941	494	917	143	810	517	1046	478	chromosome 9 open reading frame 125 (C9orf125)
B35R16C21	35-21-16	Hs~MGC:BC012887.1~uORF:IOH25768	9969	1872	2039	1697	1478	2169	13967	1401	4192	1170	Nucleolar and spindle-associated protein 1
B35R16C22	35-22-16	Hs~MGC:BC012887.1~uORF:IOH25768	9705	1808	1945	1692	4075	2229	14457	1259	4252	1216	Nucleolar and spindle-associated protein 1
B35R17C01	35-1-17	Hs~MGC:BC041590.1~uORF:IOH28013	1168	3130	2143	1958	1971	1032	2222	1002	3990	980	bromodomain containing 9 (BRD9)
B35R17C02	35-2-17	Hs~MGC:BC041590.1~uORF:IOH28013	1244	3134	1994	1919	1718	949	2189	895	3903	940	bromodomain containing 9 (BRD9)
B35R17C03	35-3-17	Hs~Ref:NM_138565.1~uORF:IOH6227	11235	11315	17018	14306	20220	14893	18988	11644	18692	4109	cortactin (CTTN), transcript variant 2
B35R17C04	35-4-17	Hs~Ref:NM_138565.1~uORF:IOH6227	11049	11416	16086	13311	14638	13877	20707	10773	19299	3976	cortactin (CTTN), transcript variant 2
B35R17C05	35-5-17	Hs~Ref:NM_002038.2~uORF:IOH14517	613	434	614	873	372	640	1079	391	1356	217	interferon, alpha-inducible protein 6 (IFI6), transcript variant 1
B35R17C06	35-6-17	Hs~Ref:NM_002038.2~uORF:IOH14517	589	469	610	715	109	608	1207	399	1329	239	interferon, alpha-inducible protein 6 (IFI6), transcript variant 1
B35R17C07	35-7-17	Hs~Ref:NM_030881.2~uORF:IOH1750	9200	9171	6266	6950	14429	8769	7566	12435	7032	7510	DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 (DDX17), transcript variant 2
B35R17C08	35-8-17	Hs~Ref:NM_030881.2~uORF:IOH1750	9287	8857	6100	7566	12304	7731	9194	12147	6838	6878	DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 (DDX17), transcript variant 2
B35R17C09	35-9-17	Hs~MGC:BC042179.1~uORF:IOH25923	1201	930	1268	961	1380	1101	1382	941	2082	782	similar to CG10671-like (LOC161247)
B35R17C10	35-10-17	Hs~MGC:BC042179.1~uORF:IOH25923	1200	1013	1406	924	1929	1058	1416	1111	2132	730	similar to CG10671-like (LOC161247)
B35R17C11	35-11-17	Hs~MGC:BC051820.1~uORF:IOH27009	897	656	1511	2183	1035	2463	2960	816	2305	450	Guanine nucleotide exchange factor for Rab3A
B35R17C12	35-12-17	Hs~MGC:BC051820.1~uORF:IOH27009	898	686	1448	2161	-198	2388	2833	750	2376	443	Guanine nucleotide exchange factor for Rab3A
B35R17C13	35-13-17	Hs~Ref:NM_020234.3~uORF:IOH21971	10018	3498	4396	3679	1965	1902	3277	2169	2971	888	DTW domain containing 1 (DTWD1)
B35R17C14	35-14-17	Hs~Ref:NM_020234.3~uORF:IOH21971	10771	3441	4008	3522	1949	1778	3593	2099	3073	902	DTW domain containing 1 (DTWD1)
B35R17C15	35-15-17	Hs~MGC:BC013791.1~uORF:IOH22123	1141	1437	1203	824	1539	1079	1000	1585	2134	414	Purkinje cell protein 4 (PCP4)
B35R17C16	35-16-17	Hs~MGC:BC013791.1~uORF:IOH22123	1071	1388	1179	741	1478	964	995	1453	2195	382	Purkinje cell protein 4 (PCP4)
B35R17C17	35-17-17	Hs~Ref:NM_032570.1~uORF:IOH12288	920	400	524	322	475	401	794	422	595	365	NPC-related protein NAG73 (NAG73)
B35R17C18	35-18-17	Hs~Ref:NM_032570.1~uORF:IOH12288	509	517	529	332	605	400	711	402	636	354	NPC-related protein NAG73 (NAG73)
B35R17C19	35-19-17	Hs~Ref:NM_144717.1~uORF:IOH10849	472	556	637	449	783	614	540	488	767	416	Interleukin-20 receptor beta chain
B35R17C20	35-20-17	Hs~Ref:NM_144717.1~uORF:IOH10849	453	1359	446	464	4910	1123	638	436	613	182	Interleukin-20 receptor beta chain
B35R17C21	35-21-17	Hs~MGC:BC013103.1~uORF:IOH22117	969	664	1137	1716	-341	1025	1000	793	1191	782	rhomboid, veinlet-like 2 (Drosophila) (RHBDL2)
B35R17C22	35-22-17	Hs~MGC:BC013103.1~uORF:IOH22117	892	627	1095	1547	131	1181	957	738	1251	59	rhomboid, veinlet-like 2 (Drosophila) (RHBDL2)
B35R18C01	35-1-18	Hs~MGC:BC030597.1~uORF:IOH22318	4069	885	1191	3126	1643	1305	1066	1154	2208	392	ATR interacting protein (TREX1)
B35R18C02	35-2-18	Hs~MGC:BC030597.1~uORF:IOH22318	4312	832	1249	2921	1509	1204	1094	1048	2194	395	ATR interacting protein (TREX1)
B35R18C03	35-3-18	Hs~Ref:NM_014002.1~N/A	1028	638	1018	632	719	860	1344	1075	2184	446	Inhibitor of nuclear factor kappa-B kinase subunit epsilon
B35R18C04	35-4-18	Hs~Ref:NM_014002.1~N/A	872	665	915	623	799	843	1263	1010	2060	459	Inhibitor of nuclear factor kappa-B kinase subunit epsilon
B35R18C07	35-7-18	Hs~Ref:NM_015112.1~N/A	951	840	1302	691	522	1044	1589	1220	2189	447	Microtubule-associated serine/threonine-protein kinase 2
B35R18C08	35-8-18	Hs~Ref:NM_015112.1~N/A	1150	761	1330	645	2977	991	1770	1221	2340	479	Microtubule-associated serine/threonine-protein kinase 2
B35R18C09	35-9-18	Hs~Ref:NM_007194.1~N/A	3416	1123	1317	997	2010	1235	778	5540	4070	425	Serine/threonine-protein kinase Chk2
B35R18C10	35-10-18	Hs~Ref:NM_007194.1~N/A	3622	1154	1458	1087	1408	1127	750	5517	4092	412	Serine/threonine-protein kinase Chk2
B35R18C11	35-11-18	Hs~Ref:NM_004465.1~uORF:IOH40262	2481	1211	3261	1045	1333	1638	10246	1407	2357	530	fibroblast growth factor 10 (FGF10)
B35R18C12	35-12-18	Hs~Ref:NM_004465.1~uORF:IOH40262	2459	1186	3264	957	1291	1495	9664	1418	2350	498	fibroblast growth factor 10 (FGF10)
B35R18C13	35-13-18	Hs~Ref:NM_000589.2~uORF:IOH40149	526	502	698	515	2075	563	647	491	904	293	interleukin 4 (IL4), transcript variant 1
B35R18C14	35-14-18	Hs~Ref:NM_000589.2~uORF:IOH40149	441	535	659	543	2390	598	713	532	900	292	interleukin 4 (IL4), transcript variant 1
B35R18C15	35-15-18	Hs~Ref:NM_000586.2~uORF:IOH40161	662	521	871	544	217	589	964	499	941	301	interleukin 2 (IL2)
B35R18C16	35-16-18	Hs~Ref:NM_000586.2~uORF:IOH40161	2482	608	799	491	1905	581	871	539	965	262	interleukin 2 (IL2)
B35R18C21	35-21-18	Hs~Ref:NM_019092.1~uORF:IOH29458	157	74	219	348	7310	356	242	530	730	68	Protein FAM63B
B35R18C22	35-22-18	Hs~Ref:NM_019092.1~uORF:IOH29458	197	61	190	318	101	136	210	497	721	74	Protein FAM63B
B35R19C01	35-1-19	Hs~Ref:NM_005817.3~uORF:IOH27786	275	523	609	1365	142	695	530	451	816	155	Mannose-6-phosphate receptor-binding protein 1
B35R19C02	35-2-19	Hs~Ref:NM_005817.3~uORF:IOH27786	243	417	266	1251	82	679	541	372	795	93	Mannose-6-phosphate receptor-binding protein 1
B35R19C03	35-3-19	Hs~MGC:BC044586.1~uORF:IOH28860	5210	2864	2926	1564	2542	3267	6362	3477	10866	2204	ATP-dependent RNA helicase DHX8
B35R19C04	35-4-19	Hs~MGC:BC044586.1~uORF:IOH28860	5462	2841	2762	1540	2704	3065	6431	2777	10803	1974	ATP-dependent RNA helicase DHX8
B35R19C05	35-5-19	Hs~Ref:NM_001017431.1~uORF:IOH57340	1251	1043	1576	1145	849	1068	1228	1165	2427	593	Putative RNA-binding protein 3
B35R19C06	35-6-19	Hs~Ref:NM_001017431.1~uORF:IOH57340	1362	992	1586	1089	810	1046	1012	1043	2384	591	Putative RNA-binding protein 3
B35R19C07	35-7-19	Hs~MGC:BC036089.1~uORF:IOH27267	3348	3350	2919	2604	3309	2093	2700	2565	3211	1315	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 (MLLT3)
B35R19C08	35-8-19	Hs~MGC:BC036089.1~uORF:IOH27267	3487	3189	2899	2556	2669	2026	2625	2522	3239	1371	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 (MLLT3)
B35R19C09	35-9-19	Hs~MGC:BC013186.1~uORF:IOH10890	669	518	758	1757	420	1701	1106	642	1074	389	RCSD domain containing 1 (RCSD1)
B35R19C10	35-10-19	Hs~MGC:BC013186.1~uORF:IOH10890	706	482	782	1795	422	1720	1090	641	1122	377	RCSD domain containing 1 (RCSD1)
B35R19C11	35-11-19	Hs~Ref:NM_003352.4~uORF:IOH5973	1853	1434	2081	1877	967	1763	1437	1199	1796	868	SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) (SUMO1), transcript variant 1
B35R19C12	35-12-19	Hs~Ref:NM_003352.4~uORF:IOH5973	1758	1425	1928	1894	917	1803	1430	1062	1923	861	SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) (SUMO1), transcript variant 1
B35R19C13	35-13-19	Hs~MGC:BC009793.1~uORF:IOH14418	423	581	696	443	388	902	724	592	795	297	excision repair cross-complementing rodent repair deficiency, complementation group 8 (ERCC8)
B35R19C14	35-14-19	Hs~MGC:BC009793.1~uORF:IOH14418	681	476	643	459	393	920	672	522	881	333	excision repair cross-complementing rodent repair deficiency, complementation group 8 (ERCC8)
B35R19C15	35-15-19	Hs~MGC:BC009106.1~uORF:IOH10263	696	572	534	447	258	563	641	434	732	356	SEC16 homolog B (S. cerevisiae) (LZTR2)
B35R19C16	35-16-19	Hs~MGC:BC009106.1~uORF:IOH10263	3074	676	512	430	668	585	619	465	742	372	SEC16 homolog B (S. cerevisiae) (LZTR2)
B35R19C17	35-17-19	Hs~Ref:NM_023076.2~uORF:IOH2885	608	403	396	326	153	564	429	562	724	317	RING finger protein unkempt-like
B35R19C18	35-18-19	Hs~Ref:NM_023076.2~uORF:IOH2885	7542	390	474	398	384	453	416	508	726	354	RING finger protein unkempt-like
B35R19C19	35-19-19	Hs~Ref:NM_014055.1~uORF:IOH23043	659	516	1985	1770	487	597	628	512	1824	525	intraflagellar transport 81 homolog (Chlamydomonas) (IFT81), transcript variant 1
B35R19C20	35-20-19	Hs~Ref:NM_014055.1~uORF:IOH23043	597	530	1717	1695	1766	622	646	501	1814	515	intraflagellar transport 81 homolog (Chlamydomonas) (IFT81), transcript variant 1
B35R20C01	35-1-20	Hs~Ref:NM_001570.2~N/A	662	503	929	502	367	499	690	789	980	296	Interleukin-1 receptor-associated kinase-like 2
B35R20C02	35-2-20	Hs~Ref:NM_001570.2~N/A	682	444	937	489	411	653	695	781	1039	275	Interleukin-1 receptor-associated kinase-like 2
B35R20C03	35-3-20	Hs~Ref:NM_000455.3~N/A	513	384	627	374	358	415	821	430	709	301	serine/threonine kinase 11 (STK11)
B35R20C04	35-4-20	Hs~Ref:NM_000455.3~N/A	589	352	564	371	248	440	765	397	618	277	serine/threonine kinase 11 (STK11)
B35R20C05	35-5-20	Hs~Ref:NM_006137.4~uORF:IOH14100	384	442	437	274	199	649	671	473	551	229	CD7 molecule (CD7)
B35R20C06	35-6-20	Hs~Ref:NM_006137.4~uORF:IOH14100	364	424	427	273	236	606	491	285	552	183	CD7 molecule (CD7)
B35R20C07	35-7-20	Hs~Ref:NM_015680.2~uORF:IOH3981	227	147	402	242	106	192	257	349	381	44	chromosome 2 open reading frame 24 (C2orf24)
B35R20C08	35-8-20	Hs~Ref:NM_015680.2~uORF:IOH3981	287	612	358	252	128	185	281	371	374	52	chromosome 2 open reading frame 24 (C2orf24)
B35R20C09	35-9-20	Hs~Ref:NM_000851.2~uORF:IOH54796	1057	852	5452	949	597	0	0	-3	-2	-2	Glutathione S-transferase Mu 5
B35R20C10	35-10-20	Hs~Ref:NM_000851.2~uORF:IOH54796	813	825	5480	1027	698	0	-1	802	-1	0	Glutathione S-transferase Mu 5
B35R20C11	35-11-20	Hs~Ref:NM_012205.1~uORF:IOH54935	793	711	3260	19939	680	813	794	1546	2257	309	3-hydroxyanthranilate 3,4-dioxygenase
B35R20C12	35-12-20	Hs~Ref:NM_012205.1~uORF:IOH54935	793	685	3035	18526	695	760	820	1538	2239	288	3-hydroxyanthranilate 3,4-dioxygenase
B36R02C11	36-11-2	Hs~Ref:NM_020679.1~uORF:IOH21880	585	733	791	798	576	303	675	570	1151	144	MIF4G domain containing (MIF4GD)
B36R02C12	36-12-2	Hs~Ref:NM_020679.1~uORF:IOH21880	563	642	768	520	476	540	679	470	1191	103	MIF4G domain containing (MIF4GD)
B36R02C13	36-13-2	Hs~MGC:BC014451.1~uORF:IOH13490	490	492	578	422	724	423	708	780	913	168	protein C receptor, endothelial (EPCR) (PROCR)
B36R02C14	36-14-2	Hs~MGC:BC014451.1~uORF:IOH13490	446	511	562	417	733	609	681	737	925	184	protein C receptor, endothelial (EPCR) (PROCR)
B36R02C15	36-15-2	Hs~Ref:NM_005182.1~uORF:IOH21843	402	435	543	353	1011	485	815	483	1628	93	carbonic anhydrase VII (CA7), transcript variant 1
B36R02C16	36-16-2	Hs~Ref:NM_005182.1~uORF:IOH21843	403	430	518	358	838	488	1103	453	1374	99	carbonic anhydrase VII (CA7), transcript variant 1
B36R02C17	36-17-2	Hs~MGC:NM_153212.1~uORF:IOH22179	439	523	508	1149	1003	377	1040	626	723	182	gap junction protein, beta 4 (GJB4)
B36R02C18	36-18-2	Hs~MGC:NM_153212.1~uORF:IOH22179	1259	454	535	1187	1034	132	897	672	759	113	gap junction protein, beta 4 (GJB4)
B36R02C19	36-19-2	Hs~MGC:BC001370.2~uORF:IOH3980	1404	1447	1636	1446	3810	2294	1430	1804	2832	1101	LIM and senescent cell antigen-like domains 2 (LIMS2)
B36R02C20	36-20-2	Hs~MGC:BC001370.2~uORF:IOH3980	1130	1505	1625	1413	3830	2312	1485	1662	2846	1912	LIM and senescent cell antigen-like domains 2 (LIMS2)
B36R02C21	36-21-2	Hs~MGC:BC002733.2~uORF:IOH5365	35109	23993	13318	25865	14037	18211	18075	65457	14145	17913	chromosome 1 open reading frame 77 (C1orf77)
B36R02C22	36-22-2	Hs~MGC:BC002733.2~uORF:IOH5365	33376	19833	12991	22111	13234	17606	17526	65464	13399	17399	chromosome 1 open reading frame 77 (C1orf77)
B36R03C01	36-1-3	Hs~Ref:NM_001003396.1~uORF:IOH3597	1297	1361	2458	1673	734	1070	1425	1594	4192	933	tumor protein D52-like 1 (TPD52L1), transcript variant 3
B36R03C02	36-2-3	Hs~Ref:NM_001003396.1~uORF:IOH3597	1310	1366	2342	1669	742	1092	1419	1603	4247	907	tumor protein D52-like 1 (TPD52L1), transcript variant 3
B36R03C03	36-3-3	Hs~MGC:BC019315.1~uORF:IOH27769	3875	3313	4154	3847	2285	2391	2824	11921	5147	1254	N-acetylneuraminic acid synthase (sialic acid synthase) (NANS)
B36R03C04	36-4-3	Hs~MGC:BC019315.1~uORF:IOH27769	4092	3305	4006	3811	2102	2359	2868	12471	5155	1251	N-acetylneuraminic acid synthase (sialic acid synthase) (NANS)
B36R03C07	36-7-3	Hs~Ref:NM_138930.2~uORF:IOH42210	793	1084	348	341	188	1075	621	2347	1196	117	diablo homolog (Drosophila) (DIABLO), nuclear gene encoding mitochondrial protein, transcript variant 2
B36R03C08	36-8-3	Hs~Ref:NM_138930.2~uORF:IOH42210	517	1128	359	464	185	1033	629	2146	1265	120	diablo homolog (Drosophila) (DIABLO), nuclear gene encoding mitochondrial protein, transcript variant 2
B36R03C09	36-9-3	Hs~Ref:NM_012416.2~uORF:IOH43766	321	107	334	114	-8	239	205	133	445	37	RAN binding protein 6 (RANBP6)
B36R03C10	36-10-3	Hs~Ref:NM_012416.2~uORF:IOH43766	296	133	217	4	74	254	235	155	319	-138	RAN binding protein 6 (RANBP6)
B36R03C11	36-11-3	Hs~Ref:NM_173799.2~uORF:IOH42215	461	516	522	706	273	362	473	346	890	126	V-set and transmembrane domain containing 3 (VSTM3)
B36R03C12	36-12-3	Hs~Ref:NM_173799.2~uORF:IOH42215	431	387	513	601	9	355	463	343	892	121	V-set and transmembrane domain containing 3 (VSTM3)
B36R03C13	36-13-3	Hs~Ref:XM_375456.2~uORF:IOH43380	1677	633	585	660	553	2311	1049	529	1058	287	Ataxin-7-like protein 3
B36R03C14	36-14-3	Hs~Ref:XM_375456.2~uORF:IOH43380	1698	645	635	679	420	2329	947	483	1011	307	Ataxin-7-like protein 3
B36R03C15	36-15-3	Hs~Ref:NM_133629.1~uORF:IOH43384	312	391	384	397	107	114	278	252	834	90	RAD51-like 3 (S. cerevisiae) (RAD51L3), transcript variant 4
B36R03C16	36-16-3	Hs~Ref:NM_133629.1~uORF:IOH43384	333	302	389	399	6732	242	380	291	879	70	RAD51-like 3 (S. cerevisiae) (RAD51L3), transcript variant 4
B36R03C17	36-17-3	Hs~Ref:XM_291016.2~uORF:IOH43715	923	440	942	647	8851	2386	1408	1303	1219	266	PREDICTED: Homo sapiens hypothetical gene supported by AK075484; BC014578 (LOC339804)
B36R03C18	36-18-3	Hs~Ref:XM_291016.2~uORF:IOH43715	1043	351	917	637	5059	2274	1397	1213	1340	238	PREDICTED: Homo sapiens hypothetical gene supported by AK075484; BC014578 (LOC339804)
B36R03C19	36-19-3	Hs~Ref:NM_004218.1~uORF:IOH42139	358	586	624	394	3655	1318	558	475	4695	331	RAB11B, member RAS oncogene family (RAB11B)
B36R03C20	36-20-3	Hs~Ref:NM_004218.1~uORF:IOH42139	369	549	653	314	2957	1288	563	464	4613	86	RAB11B, member RAS oncogene family (RAB11B)
B36R03C21	36-21-3	Hs~Ref:NM_006183.2~uORF:IOH13686	690	740	967	615	531	846	1025	701	1298	289	neurotensin (NTS)
B36R03C22	36-22-3	Hs~Ref:NM_006183.2~uORF:IOH13686	736	652	871	684	631	410	1008	769	1172	263	neurotensin (NTS)
B36R04C01	36-1-4	Hs~MGC:BC019861.1~uORF:IOH11354	566	867	1378	481	393	616	927	466	747	347	UDP glucuronosyltransferase 1 family, polypeptide A6 (UGT1A6)
B36R04C02	36-2-4	Hs~MGC:BC019861.1~uORF:IOH11354	635	935	1351	549	402	742	937	455	821	93	UDP glucuronosyltransferase 1 family, polypeptide A6 (UGT1A6)
B36R04C03	36-3-4	Hs~MGC:BC021723.2~uORF:IOH11630	3686	4648	24161	1827	1431	2073	6412	994	1634	2604	four and a half LIM domains 5 (FHL5)
B36R04C04	36-4-4	Hs~MGC:BC021723.2~uORF:IOH11630	3793	4576	24826	2038	1494	1940	6512	965	1621	2550	four and a half LIM domains 5 (FHL5)
B36R04C05	36-5-4	Hs~Ref:NM_002000.2~uORF:IOH11326	940	1026	1175	940	576	933	1191	696	1473	554	Fc fragment of IgA, receptor for (FCAR), transcript variant 1
B36R04C06	36-6-4	Hs~Ref:NM_002000.2~uORF:IOH11326	1071	1081	1048	1032	644	888	1224	649	1487	519	Fc fragment of IgA, receptor for (FCAR), transcript variant 1
B36R04C07	36-7-4	Hs~Ref:NM_199328.1~uORF:IOH12281	7942	6852	6802	53783	4557	3134	2932	2090	8421	6808	claudin 8 (CLDN8)
B36R04C08	36-8-4	Hs~Ref:NM_199328.1~uORF:IOH12281	7198	7102	7188	59900	6484	3763	3615	2463	8577	8816	claudin 8 (CLDN8)
B36R04C09	36-9-4	Hs~MGC:BC030984.1~uORF:IOH23182	60363	60857	59043	65365	39958	41699	43510	43879	50826	56798	cDNA clone MGC:32654 IMAGE:4701898, complete cds
B36R04C10	36-10-4	Hs~MGC:BC030984.1~uORF:IOH23182	58346	59408	57427	65414	40523	41888	43941	44889	49816	55376	cDNA clone MGC:32654 IMAGE:4701898, complete cds
B36R04C11	36-11-4	Hs~Ref:NM_000159.2~uORF:IOH4104	2875	2551	2659	2669	2278	2457	2573	2064	3408	3039	glutaryl-Coenzyme A dehydrogenase (GCDH), nuclear gene encoding mitochondrial protein, transcript variant 1
B36R04C12	36-12-4	Hs~Ref:NM_000159.2~uORF:IOH4104	2526	2621	2564	2575	3110	2598	2311	2094	3344	2819	glutaryl-Coenzyme A dehydrogenase (GCDH), nuclear gene encoding mitochondrial protein, transcript variant 1
B36R04C13	36-13-4	Hs~MGC:BC025266.1~uORF:IOH23199	3101	2096	3080	2043	3455	13095	8606	2077	4219	914	taspase, threonine aspartase, 1 (TASP1)
B36R04C14	36-14-4	Hs~MGC:BC025266.1~uORF:IOH23199	3096	2044	2974	2191	2347	11971	7607	2098	4100	1169	taspase, threonine aspartase, 1 (TASP1)
B36R04C15	36-15-4	Hs~Ref:NM_058173.1~uORF:IOH42944	633	1327	731	700	237	45	418	819	854	184	mucin-like 1 (MUCL1)
B36R04C16	36-16-4	Hs~Ref:NM_058173.1~uORF:IOH42944	643	1238	701	681	38	412	359	784	862	172	mucin-like 1 (MUCL1)
B36R04C17	36-17-4	Hs~Ref:NM_000631.3~uORF:IOH41405	4343	1335	1632	7286	1560	1817	1953	1559	2926	614	neutrophil cytosolic factor 4, 40kDa (NCF4), transcript variant 1
B36R04C18	36-18-4	Hs~Ref:NM_000631.3~uORF:IOH41405	4308	1364	1629	6993	1517	1732	1964	1473	2853	745	neutrophil cytosolic factor 4, 40kDa (NCF4), transcript variant 1
B36R04C19	36-19-4	Hs~Ref:NM_178483.2~uORF:IOH43017	1350	1577	1362	2503	824	1213	3774	1023	2701	667	chromosome 20 open reading frame 79 (C20orf79)
B36R04C20	36-20-4	Hs~Ref:NM_178483.2~uORF:IOH43017	1441	1525	1350	2298	933	1185	3574	949	2693	573	chromosome 20 open reading frame 79 (C20orf79)
B36R04C21	36-21-4	Hs~MGC:BC000442.1~N/A	511	552	599	1333	763	581	467	407	220	471	Serine/threonine-protein kinase 12
B36R04C22	36-22-4	Hs~MGC:BC000442.1~N/A	483	536	618	1492	738	391	423	377	679	356	Serine/threonine-protein kinase 12
B36R05C01	36-1-5	Hs~Ref:NM_152757.1~uORF:IOH43336	4038	3914	3379	3980	2194	3291	3285	3216	4898	4257	Putative uncharacterized protein C20orf200
B36R05C02	36-2-5	Hs~Ref:NM_152757.1~uORF:IOH43336	3757	3927	3369	4066	2048	4557	3834	3291	4871	5188	Putative uncharacterized protein C20orf200
B36R05C05	36-5-5	Hs~Ref:NM_025000.1~uORF:IOH43428	1314	701	1426	923	452	1384	1396	765	6694	572	chromosome 2 open reading frame 37 (C2orf37)
B36R05C06	36-6-5	Hs~Ref:NM_025000.1~uORF:IOH43428	1363	700	1401	1025	437	1276	1418	765	6603	216	chromosome 2 open reading frame 37 (C2orf37)
B36R05C07	36-7-5	Hs~Ref:NM_025261.1~uORF:IOH43145	541	470	594	728	241	398	631	358	650	442	lymphocyte antigen 6 complex, locus G6C (LY6G6C)
B36R05C08	36-8-5	Hs~Ref:NM_025261.1~uORF:IOH43145	523	529	618	739	310	516	703	429	759	148	lymphocyte antigen 6 complex, locus G6C (LY6G6C)
B36R05C09	36-9-5	Hs~Ref:NM_014424.3~uORF:IOH6462	1223	816	849	1215	298	1347	4072	1887	2216	382	heat shock 27kDa protein family, member 7 (cardiovascular) (HSPB7)
B36R05C10	36-10-5	Hs~Ref:NM_014424.3~uORF:IOH6462	1236	793	818	1200	622	1265	4001	1747	2156	348	heat shock 27kDa protein family, member 7 (cardiovascular) (HSPB7)
B36R05C11	36-11-5	Hs~Ref:NM_005499.2~uORF:IOH5085	471	332	502	1030	267	667	949	443	962	89	SUMO1 activating enzyme subunit 2 (SAE2)
B36R05C12	36-12-5	Hs~Ref:NM_005499.2~uORF:IOH5085	456	293	480	1064	386	645	959	438	974	74	SUMO1 activating enzyme subunit 2 (SAE2)
B36R05C13	36-13-5	Hs~Ref:NM_052937.1~uORF:IOH22000	806	591	1004	4558	968	529	780	495	907	155	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 (PCMTD1)
B36R05C14	36-14-5	Hs~Ref:NM_052937.1~uORF:IOH22000	857	461	1062	5420	753	400	815	559	900	110	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 (PCMTD1)
B36R05C15	36-15-5	Hs~MGC:BC026101.2~uORF:IOH10652	4884	3712	2723	20893	3353	4345	5639	7272	10033	4111	nudE nuclear distribution gene E homolog (A. nidulans)-like 1 (NDEL1)
B36R05C16	36-16-5	Hs~MGC:BC026101.2~uORF:IOH10652	4808	3197	2643	20919	3164	4063	5593	6754	10157	4120	nudE nuclear distribution gene E homolog (A. nidulans)-like 1 (NDEL1)
B36R05C19	36-19-5	Hs~Ref:NM_000270.1~uORF:IOH41122	282	1141	515	1012	346	2818	723	406	849	626	Purine nucleoside phosphorylase
B36R05C20	36-20-5	Hs~Ref:NM_000270.1~uORF:IOH41122	275	1142	513	960	126	2880	721	374	838	603	Purine nucleoside phosphorylase
B36R05C21	36-21-5	Hs~Ref:NM_178587.1~uORF:IOH42153	703	751	587	436	9071	462	360	874	2811	86	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform
B36R05C22	36-22-5	Hs~Ref:NM_178587.1~uORF:IOH42153	669	832	588	492	9533	246	308	757	2875	18	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform
B36R06C01	36-1-6	Hs~Ref:NM_014904.1~uORF:IOH35890	756	1410	1655	740	489	2614	2195	1408	1359	1249	RAB11 family interacting protein 2 (class I) (RAB11FIP2)
B36R06C02	36-2-6	Hs~Ref:NM_014904.1~uORF:IOH35890	806	990	1732	667	517	4645	2162	1273	1400	118	RAB11 family interacting protein 2 (class I) (RAB11FIP2)
B36R06C03	36-3-6	Hs~MGC:BC025345.1~uORF:IOH14194	1093	1277	1456	1103	998	1356	2050	1022	1728	560	mRNA similar to LOC149651 (cDNA clone MGC:39393 IMAGE:4862156), complete cds
B36R06C04	36-4-6	Hs~MGC:BC025345.1~uORF:IOH14194	1060	1251	1348	1022	780	1202	2126	1010	1720	523	mRNA similar to LOC149651 (cDNA clone MGC:39393 IMAGE:4862156), complete cds
B36R06C05	36-5-6	Hs~Ref:NM_022458.2~uORF:IOH10735	292	203	459	329	224	306	326	458	451	42	limb region 1 homolog (mouse) (LMBR1)
B36R06C06	36-6-6	Hs~Ref:NM_022458.2~uORF:IOH10735	47	26	17	388	321	341	280	295	1093	40	limb region 1 homolog (mouse) (LMBR1)
B36R06C07	36-7-6	Hs~MGC:BC007411.2~uORF:IOH5892	1270	1349	377	269	308	47	272	273	739	48	Protein diaphanous homolog 1
B36R06C08	36-8-6	Hs~MGC:BC007411.2~uORF:IOH5892	460	308	580	780	62	177	247	285	522	16	Protein diaphanous homolog 1
B36R06C09	36-9-6	Hs~Ref:NM_016144.2~uORF:IOH7226	729	109	303	146	93	145	219	210	578	24	COMM domain containing 10 (COMMD10)
B36R06C10	36-10-6	Hs~Ref:NM_016144.2~uORF:IOH7226	741	55	284	140	102	315	221	225	620	128	COMM domain containing 10 (COMMD10)
B36R06C11	36-11-6	Hs~Ref:NM_030773.1~uORF:IOH21834	743	801	741	613	1029	949	1468	854	2354	265	tubulin, beta 1 (TUBB1)
B36R06C12	36-12-6	Hs~Ref:NM_030773.1~uORF:IOH21834	776	1013	699	566	992	800	1418	882	2222	366	tubulin, beta 1 (TUBB1)
B36R06C13	36-13-6	Hs~MGC:BC001917.1~uORF:IOH5075	935	892	779	657	645	896	1688	751	2490	203	malate dehydrogenase 2, NAD (mitochondrial) (MDH2)
B36R06C14	36-14-6	Hs~MGC:BC001917.1~uORF:IOH5075	1040	779	837	653	601	844	1466	767	2577	152	malate dehydrogenase 2, NAD (mitochondrial) (MDH2)
B36R06C15	36-15-6	Hs~MGC:BC001873.1~uORF:IOH4800	695	814	671	589	599	633	1000	658	2166	173	hairy/enhancer-of-split related with YRPW motif 1 (HEY1)
B36R06C16	36-16-6	Hs~MGC:BC001873.1~uORF:IOH4800	681	758	720	612	567	780	960	749	2006	320	hairy/enhancer-of-split related with YRPW motif 1 (HEY1)
B36R06C17	36-17-6	Hs~MGC:BC022288.1~uORF:IOH12278	1052	883	886	764	601	920	1695	712	2505	427	calsequestrin 2 (cardiac muscle) (CASQ2)
B36R06C18	36-18-6	Hs~MGC:BC022288.1~uORF:IOH12278	1390	907	978	730	572	1001	1609	730	2417	433	calsequestrin 2 (cardiac muscle) (CASQ2)
B36R06C21	36-21-6	Hs~MGC:BC096113.3~uORF:IOH63206	455	589	1815	305	293	972	1088	726	1169	152	Parvalbumin alpha
B36R06C22	36-22-6	Hs~MGC:BC096113.3~uORF:IOH63206	473	587	1766	314	309	811	1070	703	1245	131	Parvalbumin alpha
B36R07C03	36-3-7	Hs~MGC:BC089438.1~uORF:IOH62729	946	1030	778	975	322	718	2866	403	1163	169	Heterogeneous nuclear ribonucleoproteins C
B36R07C04	36-4-7	Hs~MGC:BC089438.1~uORF:IOH62729	943	999	970	885	271	663	2722	343	1166	164	Heterogeneous nuclear ribonucleoproteins C
B36R07C05	36-5-7	Hs~Ref:NM_000462.2~uORF:IOH38426	1783	833	5563	18911	1481	1542	2112	6091	1953	905	ubiquitin protein ligase E3A (human papilloma virus E6-associated protein, Angelman syndrome) (UBE3A), transcript variant 2
B36R07C06	36-6-7	Hs~Ref:NM_000462.2~uORF:IOH38426	1798	879	5658	18667	2345	1460	2098	5993	1908	362	ubiquitin protein ligase E3A (human papilloma virus E6-associated protein, Angelman syndrome) (UBE3A), transcript variant 2
B36R07C07	36-7-7	Hs~Ref:NM_012443.2~uORF:IOH43583	332	533	607	441	534	2375	372	396	1120	84	sperm associated antigen 6 (SPAG6), transcript variant 1
B36R07C08	36-8-7	Hs~Ref:NM_012443.2~uORF:IOH43583	1565	493	622	439	128	2248	364	417	1146	82	sperm associated antigen 6 (SPAG6), transcript variant 1
B36R07C09	36-9-7	Hs~Ref:NM_015124.2~uORF:IOH42418	112	88	279	174	38	263	691	183	643	72	death-inducing-protein (DIP)
B36R07C10	36-10-7	Hs~Ref:NM_015124.2~uORF:IOH42418	128	94	251	173	68	213	669	166	398	66	death-inducing-protein (DIP)
B36R07C11	36-11-7	Hs~Ref:NM_205840.1~uORF:IOH41387	892	774	1384	679	972	859	2143	552	1767	254	leukocyte specific transcript 1 (LST1), transcript variant 5
B36R07C12	36-12-7	Hs~Ref:NM_205840.1~uORF:IOH41387	897	832	1419	659	776	701	2258	583	1632	235	leukocyte specific transcript 1 (LST1), transcript variant 5
B36R07C13	36-13-7	Hs~MGC:BC065725.1~uORF:IOH62824	1354	801	2044	559	354	912	958	6588	1332	64	Rab9 effector protein with Kelch motifs
B36R07C14	36-14-7	Hs~MGC:BC065725.1~uORF:IOH62824	1320	770	2040	559	332	888	978	6469	1083	132	Rab9 effector protein with Kelch motifs
B36R07C15	36-15-7	Hs~MGC:BC047673.1~uORF:IOH26656	84	1421	233	272	200	441	550	506	103	12	amyloid beta (A4) precursor protein-binding, family A, member 2 binding protein (APBA2BP)
B36R07C16	36-16-7	Hs~MGC:BC047673.1~uORF:IOH26656	82	29	233	309	67	876	625	511	82	33	amyloid beta (A4) precursor protein-binding, family A, member 2 binding protein (APBA2BP)
B36R07C17	36-17-7	Hs~Ref:NM_016417.2~uORF:IOH26709	373	583	457	659	604	4751	3195	2157	973	97	glutaredoxin 5 (GLRX5)
B36R07C18	36-18-7	Hs~Ref:NM_016417.2~uORF:IOH26709	660	1999	459	622	628	4222	3264	2157	886	86	glutaredoxin 5 (GLRX5)
B36R07C19	36-19-7	Hs~Ref:NM_017886.1~N/A	261	475	708	437	304	286	702	272	1942	76	Serine/threonine-protein kinase ULK4
B36R07C20	36-20-7	Hs~Ref:NM_017886.1~N/A	274	2768	655	414	113	275	625	276	1822	54	Serine/threonine-protein kinase ULK4
B36R07C21	36-21-7	Hs~Ref:NM_015939.2~uORF:IOH3137	83	44	427	204	18	785	265	381	131	522	tRNA methyltransferase 6 homolog (S. cerevisiae) (TRMT6)
B36R07C22	36-22-7	Hs~Ref:NM_015939.2~uORF:IOH3137	117	44	329	196	90	231	185	315	-23	473	tRNA methyltransferase 6 homolog (S. cerevisiae) (TRMT6)
B36R08C01	36-1-8	Hs~Ref:NM_144498.1~uORF:IOH6030	129	4597	169	175	27	174	128	255	196	24	oxysterol binding protein-like 2 (OSBPL2), transcript variant 2
B36R08C02	36-2-8	Hs~Ref:NM_144498.1~uORF:IOH6030	33	20	175	195	22	106	180	216	303	19	oxysterol binding protein-like 2 (OSBPL2), transcript variant 2
B36R08C03	36-3-8	Hs~Ref:NM_003041.1~uORF:IOH38149	608	623	888	492	341	5863	1489	538	814	936	Sodium/glucose cotransporter 2
B36R08C04	36-4-8	Hs~Ref:NM_003041.1~uORF:IOH38149	636	551	893	431	341	5189	1488	506	925	217	Sodium/glucose cotransporter 2
B36R08C05	36-5-8	Hs~MGC:BC031620.1~uORF:IOH27386	1076	643	867	831	3893	1087	1229	694	2205	240	sorting nexin 19 (SNX19)
B36R08C06	36-6-8	Hs~MGC:BC031620.1~uORF:IOH27386	1065	671	955	847	3080	1031	1285	706	2235	225	sorting nexin 19 (SNX19)
B36R08C07	36-7-8	Hs~MGC:BC000306.1~uORF:IOH3456	2593	2775	1514	1981	1303	1923	5630	4512	2149	424	hydroxyacyl-Coenzyme A dehydrogenase (HADH)
B36R08C08	36-8-8	Hs~MGC:BC000306.1~uORF:IOH3456	2720	2656	1293	1741	558	1830	5782	4220	2169	420	hydroxyacyl-Coenzyme A dehydrogenase (HADH)
B36R08C09	36-9-8	Hs~Ref:NM_004632.2~uORF:IOH3569	1108	949	1143	992	923	918	1049	843	2267	350	death associated protein 3 (DAP3), nuclear gene encoding mitochondrial protein, transcript variant 2
B36R08C10	36-10-8	Hs~Ref:NM_004632.2~uORF:IOH3569	1119	1034	1084	857	1259	1044	1176	880	2386	547	death associated protein 3 (DAP3), nuclear gene encoding mitochondrial protein, transcript variant 2
B36R08C11	36-11-8	Hs~MGC:BC000238.1~uORF:IOH4394	2986	994	1913	911	980	1434	2476	857	2144	4192	ankyrin repeat and zinc finger domain containing 1 (ANKZF1)
B36R08C12	36-12-8	Hs~MGC:BC000238.1~uORF:IOH4394	2867	1092	2030	896	1048	1393	2461	863	2460	3672	ankyrin repeat and zinc finger domain containing 1 (ANKZF1)
B36R08C13	36-13-8	Hs~Ref:NM_000284.1~uORF:IOH3633	761	876	1001	534	594	628	725	747	1667	399	pyruvate dehydrogenase (lipoamide) alpha 1 (PDHA1)
B36R08C14	36-14-8	Hs~Ref:NM_000284.1~uORF:IOH3633	794	883	920	560	553	624	797	706	1718	380	pyruvate dehydrogenase (lipoamide) alpha 1 (PDHA1)
B36R08C17	36-17-8	Hs~MGC:BC013935.1~uORF:IOH12458	692	640	726	7750	317	434	1091	610	1823	361	mRNA similar to hypothetical protein FLJ21394 (cDNA clone MGC:24280 IMAGE:3950761), complete cds
B36R08C18	36-18-8	Hs~MGC:BC013935.1~uORF:IOH12458	1009	1401	675	7423	311	781	1021	710	1754	280	mRNA similar to hypothetical protein FLJ21394 (cDNA clone MGC:24280 IMAGE:3950761), complete cds
B36R08C19	36-19-8	Hs~Ref:NM_138794.1~uORF:IOH13353	1171	4341	1234	13370	923	3463	10264	2848	4945	429	lysophospholipase-like 1 (LYPLAL1)
B36R08C20	36-20-8	Hs~Ref:NM_138794.1~uORF:IOH13353	1170	4052	1224	13011	706	3394	10055	2608	4820	241	lysophospholipase-like 1 (LYPLAL1)
B36R08C21	36-21-8	Hs~Ref:NM_138573.1~uORF:IOH13075	798	1836	891	540	729	1045	843	1324	2461	325	neuregulin 4 (NRG4)
B36R08C22	36-22-8	Hs~Ref:NM_138573.1~uORF:IOH13075	769	1872	859	597	699	868	862	1150	2112	478	neuregulin 4 (NRG4)
B36R09C01	36-1-9	Hs~Ref:NM_031473.2~uORF:IOH40581	627	458	645	450	176	774	1271	564	832	154	intraflagellar transport 81 homolog (Chlamydomonas) (IFT81), transcript variant 2
B36R09C02	36-2-9	Hs~Ref:NM_031473.2~uORF:IOH40581	564	456	644	528	254	670	1355	601	887	175	intraflagellar transport 81 homolog (Chlamydomonas) (IFT81), transcript variant 2
B36R09C03	36-3-9	Hs~Ref:NM_152850.2~uORF:IOH40494	372	253	825	303	136	363	682	503	538	295	phosphatidylinositol glycan anchor biosynthesis, class O (PIGO), transcript variant 2
B36R09C04	36-4-9	Hs~Ref:NM_152850.2~uORF:IOH40494	394	256	861	312	305	542	645	448	590	94	phosphatidylinositol glycan anchor biosynthesis, class O (PIGO), transcript variant 2
B36R09C05	36-5-9	Hs~MGC:BC002723.2~uORF:IOH40582	499	503	776	389	375	736	670	629	886	110	RAD51-like 3 (S. cerevisiae) (RAD51L3)
B36R09C06	36-6-9	Hs~MGC:BC002723.2~uORF:IOH40582	1945	472	4098	403	275	650	703	565	1009	237	RAD51-like 3 (S. cerevisiae) (RAD51L3)
B36R09C07	36-7-9	Hs~Ref:NM_001501.1~uORF:IOH40386	2201	689	1090	546	392	970	1138	637	1478	337	gonadotropin-releasing hormone 2 (GNRH2), transcript variant 1
B36R09C08	36-8-9	Hs~Ref:NM_001501.1~uORF:IOH40386	1281	655	953	567	371	970	1210	601	1530	-76	gonadotropin-releasing hormone 2 (GNRH2), transcript variant 1
B36R09C09	36-9-9	Hs~Ref:NM_014033.1~uORF:IOH3148	318	371	423	301	134	393	377	329	562	45	methyltransferase like 7A (METTL7A)
B36R09C10	36-10-9	Hs~Ref:NM_014033.1~uORF:IOH3148	339	326	379	297	488	439	390	340	619	79	methyltransferase like 7A (METTL7A)
B36R09C11	36-11-9	Hs~MGC:BC000314.1~uORF:IOH3485	375	441	459	336	156	632	454	425	743	161	Reticulon-1
B36R09C12	36-12-9	Hs~MGC:BC000314.1~uORF:IOH3485	362	576	455	334	273	585	452	432	859	211	Reticulon-1
B36R09C13	36-13-9	Hs~Ref:NM_002857.1~uORF:IOH3467	514	370	475	294	317	496	561	261	723	65	peroxisomal biogenesis factor 19 (PEX19)
B36R09C14	36-14-9	Hs~Ref:NM_002857.1~uORF:IOH3467	509	534	475	280	315	482	556	250	716	65	peroxisomal biogenesis factor 19 (PEX19)
B36R09C15	36-15-9	Hs~Ref:NM_012111.1~uORF:IOH3527	338	795	388	378	218	445	686	1486	912	223	AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast) (AHSA1)
B36R09C16	36-16-9	Hs~Ref:NM_012111.1~uORF:IOH3527	422	690	505	388	146	421	672	1425	902	107	AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast) (AHSA1)
B36R09C17	36-17-9	Hs~Ref:NM_130782.1~uORF:IOH12138	1707	1409	1912	1142	1348	1479	2147	1034	3495	663	regulator of G-protein signaling 18 (RGS18)
B36R09C18	36-18-9	Hs~Ref:NM_130782.1~uORF:IOH12138	1744	1386	1791	1100	1303	1481	2199	1025	3589	824	regulator of G-protein signaling 18 (RGS18)
B36R09C19	36-19-9	Hs~MGC:BC020620.1~uORF:IOH12057	1205	1231	1410	1348	1017	1554	2102	1013	3388	718	nitrilase family, member 2 (NIT2)
B36R09C20	36-20-9	Hs~MGC:BC020620.1~uORF:IOH12057	1316	1189	1474	1404	1010	1560	2087	1050	3431	407	nitrilase family, member 2 (NIT2)
B36R09C21	36-21-9	Hs~MGC:BC022257.1~uORF:IOH12061	8659	3869	3733	4839	4325	5828	14568	5827	6660	2714	lectin, galactoside-binding, soluble, 14 (LGALS14)
B36R09C22	36-22-9	Hs~MGC:BC022257.1~uORF:IOH12061	8467	3735	3643	5203	4227	5371	13408	5238	6933	2564	lectin, galactoside-binding, soluble, 14 (LGALS14)
B36R10C01	36-1-10	Hs~MGC:BC020835.1~uORF:IOH13388	1119	1307	1354	2296	976	1230	1680	1120	2805	606	transmembrane protein 68 (TMEM68)
B36R10C02	36-2-10	Hs~MGC:BC020835.1~uORF:IOH13388	1153	1371	1448	1043	1115	1130	1705	1127	2650	371	transmembrane protein 68 (TMEM68)
B36R10C03	36-3-10	Hs~MGC:BC008201.1~uORF:IOH3360	313	257	1158	3084	-22	400	1068	534	638	171	receptor accessory protein 6 (REEP6)
B36R10C04	36-4-10	Hs~MGC:BC008201.1~uORF:IOH3360	289	255	1098	284	56	539	1010	574	629	206	receptor accessory protein 6 (REEP6)
B36R10C05	36-5-10	Hs~MGC:BC060844.1~uORF:IOH29182	480	427	679	234	85	481	784	719	1092	365	KIAA1609 (KIAA1609)
B36R10C06	36-6-10	Hs~MGC:BC060844.1~uORF:IOH29182	1908	480	779	250	233	457	782	704	1147	221	KIAA1609 (KIAA1609)
B36R10C09	36-9-10	Hs~MGC:BC053664.1~uORF:IOH28996	500	498	842	364	624	619	838	410	1476	465	zinc finger, FYVE domain containing 28 (ZFYVE28)
B36R10C10	36-10-10	Hs~MGC:BC053664.1~uORF:IOH28996	545	467	663	390	383	581	900	469	1325	427	zinc finger, FYVE domain containing 28 (ZFYVE28)
B36R12C01	36-1-12	Hs~Ref:NM_002823.2~uORF:IOH27923	268	406	889	1597	428	1125	496	231	516	275	prothymosin, alpha (gene sequence 28) (PTMA), transcript variant 2
B36R12C02	36-2-12	Hs~Ref:NM_002823.2~uORF:IOH27923	317	257	940	1752	1495	1029	722	246	619	108	prothymosin, alpha (gene sequence 28) (PTMA), transcript variant 2
B36R12C03	36-3-12	Hs~MGC:BC000797.1~uORF:IOH3049	494	1052	759	1657	333	623	940	654	1821	337	chromosome 2 open reading frame 33 (C2orf33)
B36R12C04	36-4-12	Hs~MGC:BC000797.1~uORF:IOH3049	544	1019	653	1622	335	650	903	618	1718	164	chromosome 2 open reading frame 33 (C2orf33)
B36R12C05	36-5-12	Hs~MGC:BC012539.1~uORF:IOH12758	784	885	1775	1360	574	912	1501	888	1679	328	mediator complex subunit 31 (MED31)
B36R12C06	36-6-12	Hs~MGC:BC012539.1~uORF:IOH12758	733	877	1676	1221	576	909	1502	1255	1685	461	mediator complex subunit 31 (MED31)
B36R12C07	36-7-12	Hs~MGC:NM_182623.1~uORF:IOH27355	503	268	430	269	108	689	812	119	1311	27	family with sequence similarity 131, member C (FAM131C)
B36R12C08	36-8-12	Hs~MGC:NM_182623.1~uORF:IOH27355	176	205	436	294	313	760	827	839	1357	28	family with sequence similarity 131, member C (FAM131C)
B36R12C09	36-9-12	Hs~Ref:NM_002262.2~uORF:IOH11597	183	254	413	176	252	482	743	382	1183	21	killer cell lectin-like receptor subfamily D, member 1 (KLRD1), transcript variant 1
B36R12C10	36-10-12	Hs~Ref:NM_002262.2~uORF:IOH11597	117	250	423	194	98	538	751	271	1233	22	killer cell lectin-like receptor subfamily D, member 1 (KLRD1), transcript variant 1
B36R12C11	36-11-12	Hs~MGC:BC014140.2~uORF:IOH12771	608	627	673	513	244	799	878	734	1425	580	Bardet-Biedl syndrome 2 (BBS2)
B36R12C12	36-12-12	Hs~MGC:BC014140.2~uORF:IOH12771	586	606	697	588	389	683	924	750	1663	511	Bardet-Biedl syndrome 2 (BBS2)
B36R12C13	36-13-12	Hs~MGC:BC016470.2~uORF:IOH11948	2172	1175	1540	1543	1924	1392	3537	3415	3055	578	essential meiotic endonuclease 1 homolog 1 (S. pombe) (EME1)
B36R12C14	36-14-12	Hs~MGC:BC016470.2~uORF:IOH11948	2229	1167	1554	1534	1923	1344	3659	3100	3029	260	essential meiotic endonuclease 1 homolog 1 (S. pombe) (EME1)
B36R12C15	36-15-12	Hs~MGC:BC100767.1~uORF:IOH63423	441	501	2832	332	238	1421	1797	530	837	196	Glycoprotein Xg
B36R12C16	36-16-12	Hs~MGC:BC100767.1~uORF:IOH63423	493	3725	2793	344	175	1094	1742	519	841	187	Glycoprotein Xg
B36R12C17	36-17-12	Hs~MGC:BC098334.1~uORF:IOH63288	620	68	276	255	95	348	774	255	538	68	RAP1, GTP-GDP dissociation stimulator 1 (RAP1GDS1), transcript variant 5, mRNA.
B36R12C18	36-18-12	Hs~MGC:BC098334.1~uORF:IOH63288	670	2219	252	277	108	347	741	299	495	60	RAP1, GTP-GDP dissociation stimulator 1 (RAP1GDS1), transcript variant 5, mRNA.
B36R12C19	36-19-12	Hs~MGC:BC100932.1~uORF:IOH63371	497	115	451	265	90	557	422	251	332	42	Apolipoprotein A-I-binding protein
B36R12C20	36-20-12	Hs~MGC:BC100932.1~uORF:IOH63371	609	117	422	240	87	468	407	264	336	38	Apolipoprotein A-I-binding protein
B36R12C21	36-21-12	Hs~MGC:BC100879.2~uORF:IOH63368	390	256	1071	309	238	16354	493	1097	789	85	Gamma-crystallin N
B36R12C22	36-22-12	Hs~MGC:BC100879.2~uORF:IOH63368	578	252	1043	287	306	14192	511	583	934	81	Gamma-crystallin N
B36R13C01	36-1-13	Hs~Ref:NM_183060.1~uORF:IOH44379	550	500	1184	1427	525	804	838	702	1012	389	cAMP responsive element modulator (CREM), transcript variant 22
B36R13C02	36-2-13	Hs~Ref:NM_183060.1~uORF:IOH44379	617	526	1278	1202	551	758	976	689	1193	392	cAMP responsive element modulator (CREM), transcript variant 22
B36R13C03	36-3-13	Hs~Ref:NM_033111.2~uORF:IOH44850	882	556	1503	569	-21	661	924	623	1307	920	NEDD4-binding protein 2-like 2
B36R13C04	36-4-13	Hs~Ref:NM_033111.2~uORF:IOH44850	906	387	1435	577	-33	643	927	632	1298	572	NEDD4-binding protein 2-like 2
B36R13C05	36-5-13	Hs~Ref:NM_000698.2~uORF:IOH42560	1432	447	370	779	2184	724	8536	1309	3713	1801	arachidonate 5-lipoxygenase (ALOX5)
B36R13C06	36-6-13	Hs~Ref:NM_000698.2~uORF:IOH42560	1389	435	615	701	2286	718	8594	1248	3700	597	arachidonate 5-lipoxygenase (ALOX5)
B36R13C07	36-7-13	Hs~Ref:NM_018553.1~uORF:IOH44546	1320	1608	1333	3206	949	1178	2124	2493	2464	1145	Uncharacterized protein C17orf85
B36R13C08	36-8-13	Hs~Ref:NM_018553.1~uORF:IOH44546	1318	1585	1305	2840	1076	1304	2185	2471	2512	1175	Uncharacterized protein C17orf85
B36R13C09	36-9-13	Hs~MGC:NM_178014.2~uORF:IOH6917	1184	557	964	711	461	945	1625	688	1143	320	tubulin, beta (TUBB)
B36R13C10	36-10-13	Hs~MGC:NM_178014.2~uORF:IOH6917	1261	583	876	680	250	830	1604	692	1193	141	tubulin, beta (TUBB)
B36R13C11	36-11-13	Hs~MGC:BC031830.1~uORF:IOH25818	3496	1625	1920	1464	261	1946	12581	1562	3116	618	kelch-like 32 (Drosophila) (KLHL32)
B36R13C12	36-12-13	Hs~MGC:BC031830.1~uORF:IOH25818	3355	1535	1832	1393	3172	1880	12291	1588	3157	621	kelch-like 32 (Drosophila) (KLHL32)
B36R13C13	36-13-13	Hs~MGC:BC015848.1~uORF:IOH27935	708	630	730	448	2219	858	2264	685	1134	422	glyoxalase domain containing 4 (GLOD4)
B36R13C14	36-14-13	Hs~MGC:BC015848.1~uORF:IOH27935	698	464	685	484	204	768	2310	649	1073	246	glyoxalase domain containing 4 (GLOD4)
B36R13C15	36-15-13	Hs~MGC:BC052802.1~uORF:IOH29404	375	193	507	533	100	1227	753	361	533	68	KIAA0467 (KIAA0467)
B36R13C16	36-16-13	Hs~MGC:BC052802.1~uORF:IOH29404	425	589	509	489	235	1132	669	355	539	79	KIAA0467 (KIAA0467)
B36R13C17	36-17-13	Hs~Ref:NM_138446.1~uORF:IOH13334	230	302	433	325	303	391	685	321	-22	338	chromosome 7 open reading frame 30 (C7orf30)
B36R13C18	36-18-13	Hs~Ref:NM_138446.1~uORF:IOH13334	217	603	476	340	99	404	696	340	-37	90	chromosome 7 open reading frame 30 (C7orf30)
B36R13C21	36-21-13	Hs~MGC:BC000742.1~uORF:IOH4675	439	605	395	304	151	265	677	769	658	2	glutathione peroxidase 1 (GPX1)
B36R13C22	36-22-13	Hs~MGC:BC000742.1~uORF:IOH4675	359	221	393	299	148	483	511	638	658	-17	glutathione peroxidase 1 (GPX1)
B36R14C01	36-1-14	Hs~MGC:NM_031448.2~uORF:IOH5544	370	369	472	254	104	499	770	340	685	111	chromosome 19 open reading frame 12 (C19orf12), transcript variant 2
B36R14C02	36-2-14	Hs~MGC:NM_031448.2~uORF:IOH5544	369	399	396	285	118	483	779	363	744	576	chromosome 19 open reading frame 12 (C19orf12), transcript variant 2
B36R14C03	36-3-14	Hs~Ref:NM_173060.1~uORF:IOH52621	10462	5186	32804	6479	52	4143	24203	5037	12026	728	Calpastatin
B36R14C04	36-4-14	Hs~Ref:NM_173060.1~uORF:IOH52621	10473	5411	29723	6138	-413	3942	25346	4671	12204	572	Calpastatin
B36R14C05	36-5-14	Hs~Ref:NM_032207.1~uORF:IOH52563	1846	887	1260	17828	820	1242	2324	10012	4101	409	Uncharacterized protein C19orf44
B36R14C06	36-6-14	Hs~Ref:NM_032207.1~uORF:IOH52563	1719	912	1257	15873	799	1241	2342	8984	3936	430	Uncharacterized protein C19orf44
B36R14C07	36-7-14	Hs~Ref:NM_002930.1~uORF:IOH54792	7492	7239	3899	2469	2454	6864	6220	7456	5552	783	GTP-binding protein Rit2
B36R14C08	36-8-14	Hs~Ref:NM_002930.1~uORF:IOH54792	7450	7110	3891	2381	2599	6905	6258	6901	5437	754	GTP-binding protein Rit2
B36R14C11	36-11-14	Hs~Ref:NM_004944.1~uORF:IOH14823	513	302	606	320	117	526	1098	373	698	103	Deoxyribonuclease gamma
B36R14C12	36-12-14	Hs~Ref:NM_004944.1~uORF:IOH14823	528	281	643	321	2849	543	1123	362	731	96	Deoxyribonuclease gamma
B36R14C13	36-13-14	Hs~Ref:NM_006708.1~uORF:IOH10090	366	180	444	250	170	200	264	237	834	99	Lactoylglutathione lyase
B36R14C14	36-14-14	Hs~Ref:NM_006708.1~uORF:IOH10090	352	184	549	238	214	199	281	215	849	110	Lactoylglutathione lyase
B36R14C15	36-15-14	Hs~Ref:NM_016581.2~uORF:IOH4404	471	233	1199	266	3051	671	649	238	1005	160	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial
B36R14C16	36-16-14	Hs~Ref:NM_016581.2~uORF:IOH4404	497	253	1242	294	2409	514	610	268	1206	104	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial
B36R14C17	36-17-14	Hs~Ref:NM_031443.1~uORF:IOH5157	3259	2596	1059	1077	2086	605	817	835	4915	252	Malcavernin
B36R14C18	36-18-14	Hs~Ref:NM_031443.1~uORF:IOH5157	3361	2529	1047	1078	3958	581	798	774	4977	291	Malcavernin
B36R14C19	36-19-14	Hs~MGC:BC025776.1~uORF:IOH11913	1929	1055	1328	1737	669	1526	3264	1014	1549	1189	Urotensin-2
B36R14C20	36-20-14	Hs~MGC:BC025776.1~uORF:IOH11913	2073	1027	1345	1702	605	1465	3330	960	1678	1178	Urotensin-2
B36R14C21	36-21-14	Hs~Ref:NM_002651.1~uORF:IOH44432	855	858	553	504	336	1157	922	585	516	275	Phosphatidylinositol 4-kinase beta
B36R14C22	36-22-14	Hs~Ref:NM_002651.1~uORF:IOH44432	851	870	554	473	540	1271	757	675	447	251	Phosphatidylinositol 4-kinase beta
B36R15C03	36-3-15	Hs~MGC:BC101406.1~uORF:IOH63592	1683	917	1614	947	344	1354	4599	912	2029	485	heart and neural crest derivatives expressed 2, mRNA (cDNA clone MGC:125303 IMAGE:40003700), complete cds
B36R15C04	36-4-15	Hs~MGC:BC101406.1~uORF:IOH63592	1661	841	1541	931	492	1298	4694	916	2034	457	heart and neural crest derivatives expressed 2, mRNA (cDNA clone MGC:125303 IMAGE:40003700), complete cds
B36R15C05	36-5-15	Hs~MGC:BC004514.1~uORF:IOH5664	161	259	218	303	184	265	568	255	908	38	LisH domain-containing protein ARMC9
B36R15C06	36-6-15	Hs~MGC:BC004514.1~uORF:IOH5664	134	157	190	311	140	222	628	255	913	27	LisH domain-containing protein ARMC9
B36R15C07	36-7-15	Hs~Ref:NM_006819.1~uORF:IOH5061	1009	1766	201	1125	835	763	27606	1020	720	275	stress-induced-phosphoprotein 1 (Hsp70/Hsp90-organizing protein) (STIP1)
B36R15C08	36-8-15	Hs~Ref:NM_006819.1~uORF:IOH5061	1550	1828	195	1280	948	653	27897	997	707	343	stress-induced-phosphoprotein 1 (Hsp70/Hsp90-organizing protein) (STIP1)
B36R15C09	36-9-15	Hs~Ref:NM_024588.2~uORF:IOH6887	50	186	389	335	30	434	382	189	577	4	hypothetical protein FLJ23584 (FLJ23584)
B36R15C10	36-10-15	Hs~Ref:NM_024588.2~uORF:IOH6887	61	148	374	133	42	240	361	145	536	1	hypothetical protein FLJ23584 (FLJ23584)
B36R15C11	36-11-15	Hs~Ref:NM_014060.1~uORF:IOH4208	594	587	791	475	233	610	1025	496	1070	724	malignant T cell amplified sequence 1 (MCTS1)
B36R15C12	36-12-15	Hs~Ref:NM_014060.1~uORF:IOH4208	593	553	1219	496	3021	672	936	527	1083	449	malignant T cell amplified sequence 1 (MCTS1)
B36R15C17	36-17-15	Hs~Ref:NM_002005.2~CAT:PV3354	1032	1590	1703	558	530	1186	1175	826	1218	339	feline sarcoma oncogene (FES)
B36R15C18	36-18-15	Hs~Ref:NM_002005.2~CAT:PV3354	1048	1679	1627	534	1491	1111	1221	819	1233	313	feline sarcoma oncogene (FES)
B36R15C19	36-19-15	Hs~Ref:NM_002730.1~CAT:P2912	51	51	79	578	3	215	514	565	-2	155	protein kinase, cAMP-dependent, catalytic, alpha (PRKACA), transcript variant 1
B36R15C20	36-20-15	Hs~Ref:NM_002730.1~CAT:P2912	49	57	111	109	25	95	555	504	-40	19	protein kinase, cAMP-dependent, catalytic, alpha (PRKACA), transcript variant 1
B36R16C01	36-1-16	Hs~Ref:NM_000588.3~CAT_PHC0035	9	8	12	40	2349	261	54	1	31	5	interleukin 3 (colony-stimulating factor, multiple) (IL3)
B36R16C02	36-2-16	Hs~Ref:NM_000588.3~CAT_PHC0035	12	11	277	41	1614	118	85	24	31	19	interleukin 3 (colony-stimulating factor, multiple) (IL3)
B36R16C03	36-3-16	Hs~Ref:NM_002985.1~CAT_PHC1055	21	2	396	48	4767	24	211	19	113	4	C-C motif chemokine 5
B36R16C04	36-4-16	Hs~Ref:NM_002985.1~CAT_PHC1055	23	21	327	37	4049	16	211	12	78	13	C-C motif chemokine 5
B36R16C07	36-7-16	Hs~MGC:BC053878.1~uORF:IOH28978	2133	1885	2854	1526	3939	2678	3545	998	1556	429	zeta-chain (TCR) associated protein kinase 70kDa (ZAP70)
B36R16C08	36-8-16	Hs~MGC:BC053878.1~uORF:IOH28978	2105	1920	2834	1465	2650	2602	3537	957	1549	449	zeta-chain (TCR) associated protein kinase 70kDa (ZAP70)
B36R16C09	36-9-16	Hs~MGC:BC008212.1~uORF:IOH3386	54	45	582	525	37	3891	241	217	348	26	chromosome 9 open reading frame 46 (C9orf46)
B36R16C10	36-10-16	Hs~MGC:BC008212.1~uORF:IOH3386	70	41	89	597	97	237	186	175	226	25	chromosome 9 open reading frame 46 (C9orf46)
B36R16C11	36-11-16	Hs~Ref:NM_016065.2~uORF:IOH12629	253	113	113	7470	63	68	278	287	369	962	mitochondrial ribosomal protein S16 (MRPS16), nuclear gene encoding mitochondrial protein
B36R16C12	36-12-16	Hs~Ref:NM_016065.2~uORF:IOH12629	220	75	104	7676	1228	68	248	241	557	429	mitochondrial ribosomal protein S16 (MRPS16), nuclear gene encoding mitochondrial protein
B36R16C13	36-13-16	Hs~Ref:NM_002476.2~uORF:IOH1793	3539	682	22159	21558	1551	547	957	206	1709	68	myosin, light chain 4, alkali; atrial, embryonic (MYL4), transcript variant 2
B36R16C14	36-14-16	Hs~Ref:NM_002476.2~uORF:IOH1793	3392	761	22625	21050	1601	623	948	221	1705	193	myosin, light chain 4, alkali; atrial, embryonic (MYL4), transcript variant 2
B36R16C15	36-15-16	Hs~Ref:NM_003341.3~uORF:IOH43236	1221	1120	1904	1007	1331	1308	1835	1346	2911	444	Ubiquitin-conjugating enzyme E2 E1
B36R16C16	36-16-16	Hs~Ref:NM_003341.3~uORF:IOH43236	1171	1058	1736	973	1156	1263	1757	1317	2909	259	Ubiquitin-conjugating enzyme E2 E1
B36R16C17	36-17-16	Hs~Ref:NM_005950.1~uORF:IOH57335	855	694	1274	624	1136	812	968	903	2323	318	Metallothionein-1G
B36R16C18	36-18-16	Hs~Ref:NM_005950.1~uORF:IOH57335	798	617	1251	607	1407	819	894	848	2514	421	Metallothionein-1G
B36R16C19	36-19-16	Hs~Ref:NM_000614.2~uORF:IOH40046	1050	1515	1330	670	2605	1444	1617	2213	3771	421	Ciliary neurotrophic factor
B36R16C20	36-20-16	Hs~Ref:NM_000614.2~uORF:IOH40046	1094	1445	1349	663	279	1380	1622	2125	3812	222	Ciliary neurotrophic factor
B36R16C21	36-21-16	Hs~MGC:BC036899.1~uORF:IOH25951	1891	1940	2473	1490	956	1815	4055	2256	3104	724	Cytoplasmic polyadenylation element-binding protein 4
B36R16C22	36-22-16	Hs~MGC:BC036899.1~uORF:IOH25951	1830	1877	2416	1430	1251	1711	3972	2215	3225	693	Cytoplasmic polyadenylation element-binding protein 4
B36R17C01	36-1-17	Hs~MGC:BC017115.1~uORF:IOH10111	165	70	352	180	472	1541	421	332	271	68	DNA-directed RNA polymerase I subunit RPA1
B36R17C02	36-2-17	Hs~MGC:BC017115.1~uORF:IOH10111	214	78	219	180	509	675	444	301	336	68	DNA-directed RNA polymerase I subunit RPA1
B36R17C03	36-3-17	Hs~Ref:NM_014878.2~uORF:IOH10030	969	111	293	193	172	655	583	262	357	42	Pumilio domain-containing protein KIAA0020
B36R17C04	36-4-17	Hs~Ref:NM_014878.2~uORF:IOH10030	970	103	404	109	1053	498	573	2195	299	32	Pumilio domain-containing protein KIAA0020
B36R17C05	36-5-17	Hs~Ref:NM_001902.2~uORF:IOH10106	292	168	649	1261	1160	742	601	647	787	-10	cystathionase (cystathionine gamma-lyase) (CTH), transcript variant 1
B36R17C06	36-6-17	Hs~Ref:NM_001902.2~uORF:IOH10106	311	443	650	1894	1258	456	605	981	776	-3	cystathionase (cystathionine gamma-lyase) (CTH), transcript variant 1
B36R17C07	36-7-17	Hs~MGC:BC007224.1~uORF:IOH6896	86	313	438	315	3129	100	304	218	284	121	Polypeptide N-acetylgalactosaminyltransferase 10
B36R17C08	36-8-17	Hs~MGC:BC007224.1~uORF:IOH6896	260	81	388	368	753	99	301	650	194	235	Polypeptide N-acetylgalactosaminyltransferase 10
B36R17C09	36-9-17	Hs~Ref:NM_058244.1~uORF:IOH35591	289	143	413	246	3746	340	394	298	404	75	wingless-type MMTV integration site family, member 8A (WNT8A)
B36R17C10	36-10-17	Hs~Ref:NM_058244.1~uORF:IOH35591	84	140	591	289	65	310	355	322	535	83	wingless-type MMTV integration site family, member 8A (WNT8A)
B36R17C11	36-11-17	Hs~Ref:NM_014496.1~uORF:IOH36120	1362	389	982	2683	439	1347	811	1090	1671	4236	ribosomal protein S6 kinase, 90kDa, polypeptide 6 (RPS6KA6)
B36R17C12	36-12-17	Hs~Ref:NM_014496.1~uORF:IOH36120	1344	315	964	2483	3087	1287	851	1010	1655	4123	ribosomal protein S6 kinase, 90kDa, polypeptide 6 (RPS6KA6)
B36R17C13	36-13-17	Hs~Ref:NM_033277.1~uORF:IOH40715	137	91	467	284	362	191	320	301	548	58	lacritin (LACRT)
B36R17C14	36-14-17	Hs~Ref:NM_033277.1~uORF:IOH40715	142	182	339	299	216	292	339	383	333	76	lacritin (LACRT)
B36R17C15	36-15-17	Hs~Ref:NM_032357.2~uORF:IOH40902	275	288	418	231	882	436	306	332	642	194	coiled-coil domain containing 115 (CCDC115)
B36R17C16	36-16-17	Hs~Ref:NM_032357.2~uORF:IOH40902	185	188	373	95	567	287	287	289	670	62	coiled-coil domain containing 115 (CCDC115)
B36R17C17	36-17-17	Hs~Ref:NM_206824.1~uORF:IOH42079	968	552	723	489	851	879	1027	889	1111	143	vitamin K epoxide reductase complex, subunit 1 (VKORC1), transcript variant 2
B36R17C18	36-18-17	Hs~Ref:NM_206824.1~uORF:IOH42079	898	560	776	479	647	869	991	779	1126	323	vitamin K epoxide reductase complex, subunit 1 (VKORC1), transcript variant 2
B36R17C21	36-21-17	Hs~Ref:NM_080612.1~uORF:IOH42263	601	540	462	1368	238	521	885	546	500	103	GRB2-associated binding protein 3 (GAB3), transcript variant 2
B36R17C22	36-22-17	Hs~Ref:NM_080612.1~uORF:IOH42263	535	353	472	1301	217	514	990	499	372	-4	GRB2-associated binding protein 3 (GAB3), transcript variant 2
B36R18C01	36-1-18	Hs~Ref:NM_001008220.1~uORF:IOH42361	1014	3603	1174	4470	1279	1984	8540	1396	4649	1734	complexin 2 (CPLX2), transcript variant 2
B36R18C02	36-2-18	Hs~Ref:NM_001008220.1~uORF:IOH42361	973	3541	1130	4323	1595	1898	8211	1014	4651	1651	complexin 2 (CPLX2), transcript variant 2
B36R18C03	36-3-18	Hs~Ref:NM_145331.1~uORF:IOH29760	358	1269	493	280	-45	409	387	391	710	201	mitogen-activated protein kinase kinase kinase 7 (MAP3K7), transcript variant B
B36R18C04	36-4-18	Hs~Ref:NM_145331.1~uORF:IOH29760	349	1255	1494	1627	-180	469	411	870	683	79	mitogen-activated protein kinase kinase kinase 7 (MAP3K7), transcript variant B
B36R18C05	36-5-18	Hs~Ref:NM_000727.2~uORF:IOH29633	133	166	507	1337	869	162	411	705	590	-11	calcium channel, voltage-dependent, gamma subunit 1 (CACNG1)
B36R18C06	36-6-18	Hs~Ref:NM_000727.2~uORF:IOH29633	248	181	633	2448	-259	803	387	1180	539	25	calcium channel, voltage-dependent, gamma subunit 1 (CACNG1)
B36R18C07	36-7-18	Hs~MGC:BC056918.1~uORF:IOH29061	333	453	554	336	6098	715	315	352	966	206	glutathione S-transferase omega 2 (GSTO2)
B36R18C08	36-8-18	Hs~MGC:BC056918.1~uORF:IOH29061	386	153	568	307	404	1091	368	439	930	94	glutathione S-transferase omega 2 (GSTO2)
B36R18C09	36-9-18	Hs~MGC:BC021585.1~uORF:IOH29349	101	101	105	199	168	278	465	252	510	62	high-mobility group 20B (HMG20B)
B36R18C10	36-10-18	Hs~MGC:BC021585.1~uORF:IOH29349	84	107	342	218	212	137	459	205	450	63	high-mobility group 20B (HMG20B)
B36R18C11	36-11-18	Hs~MGC:BC067768.1~uORF:IOH61696	619	708	971	504	217	1086	2162	664	1322	351	Geranylgeranyl pyrophosphate synthetase
B36R18C12	36-12-18	Hs~MGC:BC067768.1~uORF:IOH61696	606	635	878	494	2954	1106	2128	619	1308	357	Geranylgeranyl pyrophosphate synthetase
B36R18C13	36-13-18	Hs~MGC:BC047316.1~uORF:IOH62412	549	507	868	343	2502	898	1143	873	1169	232	optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) (OPA3), transcript variant 1, mRNA.
B36R18C14	36-14-18	Hs~MGC:BC047316.1~uORF:IOH62412	556	599	896	377	3178	954	1191	900	1180	168	optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) (OPA3), transcript variant 1, mRNA.
B36R18C17	36-17-18	Hs~MGC:BC073949.1~uORF:IOH61794	15955	1137	1730	829	2116	1131	1487	1415	2624	268	Ornithine decarboxylase antizyme 3
B36R18C18	36-18-18	Hs~MGC:BC073949.1~uORF:IOH61794	15771	1098	1666	829	2925	1043	1522	1318	2582	519	Ornithine decarboxylase antizyme 3
B36R18C19	36-19-18	Hs~MGC:BC037778.1~uORF:IOH62207	127	333	253	235	171	517	356	269	400	79	Valacyclovir hydrolase
B36R18C20	36-20-18	Hs~MGC:BC037778.1~uORF:IOH62207	249	421	335	240	330	315	304	213	426	58	Valacyclovir hydrolase
B36R19C01	36-1-19	Hs~Ref:NM_014440.1~uORF:IOH35127	220	372	597	255	555	148	390	537	988	60	Interleukin-1 family member 6
B36R19C02	36-2-19	Hs~Ref:NM_014440.1~uORF:IOH35127	197	107	597	278	230	121	370	1130	997	54	Interleukin-1 family member 6
B36R19C03	36-3-19	Hs~MGC:BC036434.1~uORF:IOH62212	730	618	1085	632	2010	949	1163	1233	4740	445	Serine/threonine-protein kinase VRK2
B36R19C04	36-4-19	Hs~MGC:BC036434.1~uORF:IOH62212	796	796	1122	1693	1845	856	1234	2121	4382	290	Serine/threonine-protein kinase VRK2
B36R19C05	36-5-19	Hs~MGC:BC051698.1~uORF:IOH26805	982	859	1391	1394	3080	1267	978	1531	1868	34	inturned planar cell polarity effector homolog (Drosophila) (INTU)
B36R19C06	36-6-19	Hs~MGC:BC051698.1~uORF:IOH26805	1058	871	1492	1802	767	1326	1004	1030	1890	465	inturned planar cell polarity effector homolog (Drosophila) (INTU)
B36R19C07	36-7-19	Hs~MGC:BC002832.1~uORF:IOH5425	224	518	574	353	2931	539	658	868	1637	364	butyrophilin, subfamily 3, member A2 (BTN3A2)
B36R19C08	36-8-19	Hs~MGC:BC002832.1~uORF:IOH5425	245	547	715	489	398	584	653	809	1522	359	butyrophilin, subfamily 3, member A2 (BTN3A2)
B36R19C09	36-9-19	Hs~Ref:NM_004414.3~uORF:IOH5722	563	510	620	426	121	719	642	1399	778	523	regulator of calcineurin 1 (RCAN1), transcript variant 1
B36R19C10	36-10-19	Hs~Ref:NM_004414.3~uORF:IOH5722	419	501	707	431	431	652	890	1432	806	539	regulator of calcineurin 1 (RCAN1), transcript variant 1
B36R19C11	36-11-19	Hs~Ref:NM_020368.1~uORF:IOH6359	1022	693	924	416	656	914	1546	637	1864	399	UTP3, small subunit (SSU) processome component, homolog (S. cerevisiae) (UTP3)
B36R19C12	36-12-19	Hs~Ref:NM_020368.1~uORF:IOH6359	1029	608	761	413	159	961	1590	579	1893	412	UTP3, small subunit (SSU) processome component, homolog (S. cerevisiae) (UTP3)
B36R19C13	36-13-19	Hs~Ref:NM_206898.1~uORF:IOH58589	202	673	147	1462	116	298	279	223	485	68	Melanocortin-2 receptor accessory protein
B36R19C14	36-14-19	Hs~Ref:NM_206898.1~uORF:IOH58589	98	83	1912	1435	97	181	319	240	464	120	Melanocortin-2 receptor accessory protein
B36R19C15	36-15-19	Hs~MGC:BC070334.1~uORF:IOH40810	13525	13678	12304	14574	13638	15515	14313	12719	18248	15371	immunoglobulin kappa constant (IGKC)
B36R19C16	36-16-19	Hs~MGC:BC070334.1~uORF:IOH40810	13221	13480	12240	14540	23483	14863	12544	12669	18629	17823	immunoglobulin kappa constant (IGKC)
B36R19C21	36-21-19	Hs~Ref:NM_018124.2~uORF:IOH4130	339	417	405	319	115	208	4	1	-1	203	RING finger and WD repeat domain-containing protein 3
B36R19C22	36-22-19	Hs~Ref:NM_018124.2~uORF:IOH4130	386	390	409	297	100	210	10	4	1	-9	RING finger and WD repeat domain-containing protein 3
B36R20C01	36-1-20	Hs~MGC:BC000993.2~uORF:IOH3015	359	493	698	367	351	505	504	763	914	205	islet cell autoantigen 1, 69kDa-like (ICA1L)
B36R20C02	36-2-20	Hs~MGC:BC000993.2~uORF:IOH3015	408	511	679	352	1146	582	545	638	915	-7	islet cell autoantigen 1, 69kDa-like (ICA1L)
B36R20C03	36-3-20	Hs~MGC:BC001550.1~uORF:IOH11681	341	1001	850	166	1849	1014	279	300	729	73	14-3-3 protein sigma
B36R20C04	36-4-20	Hs~MGC:BC001550.1~uORF:IOH11681	353	968	838	132	1343	811	287	320	711	82	14-3-3 protein sigma
B36R20C07	36-7-20	Hs~Ref:NM_005517.2~uORF:IOH40568	2028	3214	65464	2699	8465	-9	14	-6	-4	-2	high-mobility group nucleosomal binding domain 2 (HMGN2)
B36R20C08	36-8-20	Hs~Ref:NM_005517.2~uORF:IOH40568	1982	3264	65464	2663	8607	925	0	1	-4	-3	high-mobility group nucleosomal binding domain 2 (HMGN2)
B36R20C09	36-9-20	Hs~MGC:BC012584.1~uORF:IOH40613	716	1288	692	787	362	760	1267	737	2316	361	chaperonin containing TCP1, subunit 8 (theta) (CCT8)
B36R20C10	36-10-20	Hs~MGC:BC012584.1~uORF:IOH40613	623	1347	720	796	590	686	1299	640	2382	412	chaperonin containing TCP1, subunit 8 (theta) (CCT8)
B36R20C11	36-11-20	Hs~MGC:BC069421.1~uORF:IOH40393	895	840	1443	726	879	745	986	885	2193	475	metallothionein 1B (MT1B)
B36R20C12	36-12-20	Hs~MGC:BC069421.1~uORF:IOH40393	916	851	1389	719	732	829	1016	893	2113	459	metallothionein 1B (MT1B)
B36R20C13	36-13-20	Hs~Ref:NM_032563.1~uORF:IOH40397	1259	1264	1868	1069	512	1114	1596	1269	2513	574	late cornified envelope 3D (LCE3D)
B36R20C14	36-14-20	Hs~Ref:NM_032563.1~uORF:IOH40397	1272	1240	2131	1080	729	1132	1618	1289	2576	672	late cornified envelope 3D (LCE3D)
B37R02C11	37-11-2	Hs~Ref:NM_012094.3~uORF:IOH42322	1370	1305	2475	1158	1391	1831	1073	1145	6805	333	peroxiredoxin 5 (PRDX5), nuclear gene encoding mitochondrial protein, transcript variant 1
B37R02C12	37-12-2	Hs~Ref:NM_012094.3~uORF:IOH42322	1435	1284	2531	1162	1583	1887	1287	1019	2905	389	peroxiredoxin 5 (PRDX5), nuclear gene encoding mitochondrial protein, transcript variant 1
B37R02C13	37-13-2	Hs~Ref:NM_080414.1~uORF:IOH42243	3787	850	2019	629	1866	3774	2370	1772	2044	507	vacuolar protein sorting 16 homolog (S. cerevisiae) (VPS16), transcript variant 2
B37R02C14	37-14-2	Hs~Ref:NM_080414.1~uORF:IOH42243	3663	781	2006	630	1752	3644	2292	1840	2150	468	vacuolar protein sorting 16 homolog (S. cerevisiae) (VPS16), transcript variant 2
B37R02C15	37-15-2	Hs~Ref:NM_002484.1~uORF:IOH41188	2827	244	441	311	464	531	655	389	831	162	nucleotide binding protein 1 (MinD homolog, E. coli) (NUBP1)
B37R02C16	37-16-2	Hs~Ref:NM_002484.1~uORF:IOH41188	2930	230	441	314	447	504	678	418	894	154	nucleotide binding protein 1 (MinD homolog, E. coli) (NUBP1)
B37R02C17	37-17-2	Hs~Ref:NM_032237.2~uORF:IOH42245	736	536	790	871	555	678	1172	591	1430	420	hypothetical protein FLJ23356 (FLJ23356)
B37R02C18	37-18-2	Hs~Ref:NM_032237.2~uORF:IOH42245	683	556	693	894	876	698	1172	594	1268	399	hypothetical protein FLJ23356 (FLJ23356)
B37R02C21	37-21-2	Hs~Ref:NM_001018116.1~uORF:IOH42980	4875	2805	866	921	1282	953	2468	744	2767	847	similar to RIKEN cDNA 2310039E09 (LOC347273)
B37R02C22	37-22-2	Hs~Ref:NM_001018116.1~uORF:IOH42980	5366	2488	933	935	790	867	2458	605	2554	773	similar to RIKEN cDNA 2310039E09 (LOC347273)
B37R03C03	37-3-3	Hs~Ref:NM_033671.1~uORF:IOH43039	8885	6259	4279	8740	10181	9877	15992	4835	7354	8370	cyclin B3 (CCNB3), transcript variant 2
B37R03C04	37-4-3	Hs~Ref:NM_033671.1~uORF:IOH43039	9124	6308	4384	9289	11673	9504	16563	5146	7601	8187	cyclin B3 (CCNB3), transcript variant 2
B37R03C05	37-5-3	Hs~MGC:BC018953.1~uORF:IOH13650	289	220	462	270	591	427	495	484	1149	533	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2
B37R03C06	37-6-3	Hs~MGC:BC018953.1~uORF:IOH13650	331	200	469	239	438	449	531	470	1239	208	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2
B37R03C07	37-7-3	Hs~MGC:BC013687.1~uORF:IOH10463	974	683	894	510	723	2279	1473	758	1275	332	cDNA clone IMAGE:3858231, **** WARNING: chimeric clone ****
B37R03C08	37-8-3	Hs~MGC:BC013687.1~uORF:IOH10463	1043	744	925	532	725	2197	1589	743	1276	605	cDNA clone IMAGE:3858231, **** WARNING: chimeric clone ****
B37R03C09	37-9-3	Hs~Ref:NM_004102.2~uORF:IOH7163	271	139	272	173	474	357	945	266	697	233	fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) (FABP3)
B37R03C10	37-10-3	Hs~Ref:NM_004102.2~uORF:IOH7163	267	139	293	192	628	316	779	264	88	219	fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) (FABP3)
B37R03C11	37-11-3	Hs~Ref:NM_015878.2~uORF:IOH12717	585	536	660	1509	1872	1781	1411	729	1426	1167	antizyme inhibitor 1 (AZIN1), transcript variant 1
B37R03C12	37-12-3	Hs~Ref:NM_015878.2~uORF:IOH12717	579	517	702	1479	1750	1785	1583	754	1409	1081	antizyme inhibitor 1 (AZIN1), transcript variant 1
B37R03C13	37-13-3	Hs~MGC:BC007639.1~uORF:IOH6968	702	518	733	438	719	985	1049	656	1891	401	ATG4 autophagy related 4 homolog D (S. cerevisiae) (ATG4D)
B37R03C14	37-14-3	Hs~MGC:BC007639.1~uORF:IOH6968	666	555	759	450	650	713	939	701	2104	374	ATG4 autophagy related 4 homolog D (S. cerevisiae) (ATG4D)
B37R03C15	37-15-3	Hs~MGC:NM_152773.2~uORF:IOH11669	1059	460	725	444	694	890	1431	552	1837	238	hypothetical protein MGC33212 (MGC33212)
B37R03C16	37-16-3	Hs~MGC:NM_152773.2~uORF:IOH11669	1094	474	759	449	732	854	1394	651	1653	165	hypothetical protein MGC33212 (MGC33212)
B37R03C17	37-17-3	Hs~Ref:NM_032308.1~uORF:IOH5031	564	433	1714	1230	2278	1177	553	1050	404	172	RPA interacting protein (RPAIN), transcript variant 2
B37R03C18	37-18-3	Hs~Ref:NM_032308.1~uORF:IOH5031	533	478	1755	1204	1928	1186	595	1092	937	179	RPA interacting protein (RPAIN), transcript variant 2
B37R03C21	37-21-3	Hs~MGC:BC004967.1~uORF:IOH4830	1235	369	1097	764	788	680	1432	2501	902	78	UBA domain containing 1 (UBADC1)
B37R03C22	37-22-3	Hs~MGC:BC004967.1~uORF:IOH4830	1365	457	1057	721	922	678	1308	2427	982	416	UBA domain containing 1 (UBADC1)
B37R04C01	37-1-4	Hs~MGC:BC007347.2~uORF:IOH5863	5283	1468	2761	2476	2465	5324	2031	2261	2508	1055	chromodomain helicase DNA binding protein 2 (CHD2)
B37R04C02	37-2-4	Hs~MGC:BC007347.2~uORF:IOH5863	5571	1492	2771	2405	2674	5314	1989	2274	2482	1033	chromodomain helicase DNA binding protein 2 (CHD2)
B37R04C03	37-3-4	Hs~MGC:BC008344.1~uORF:IOH6969	657	975	520	249	515	455	863	631	667	125	serine/threonine kinase 40 (STK40)
B37R04C04	37-4-4	Hs~MGC:BC008344.1~uORF:IOH6969	620	352	506	249	619	406	822	632	685	102	serine/threonine kinase 40 (STK40)
B37R04C05	37-5-4	Hs~Ref:NM_000483.2~uORF:IOH1565	48	786	236	60	372	317	378	108	399	51	Apolipoprotein C-II
B37R04C06	37-6-4	Hs~Ref:NM_000483.2~uORF:IOH1565	64	834	231	72	247	329	392	43	361	41	Apolipoprotein C-II
B37R04C07	37-7-4	Hs~MGC:BC020750.1~uORF:IOH14535	544	581	554	370	376	499	489	586	680	148	serine dehydratase (SDS)
B37R04C08	37-8-4	Hs~MGC:BC020750.1~uORF:IOH14535	576	618	541	363	257	512	572	570	634	87	serine dehydratase (SDS)
B37R04C09	37-9-4	Hs~Ref:NM_024736.2~uORF:IOH7017	795	794	792	410	1020	812	734	524	1020	263	gasdermin domain containing 1 (GSDMDC1)
B37R04C10	37-10-4	Hs~Ref:NM_024736.2~uORF:IOH7017	834	702	843	417	928	804	1062	498	1130	125	gasdermin domain containing 1 (GSDMDC1)
B37R04C11	37-11-4	Hs~MGC:BC017504.1~uORF:IOH12256	534	2868	722	867	3367	1127	2552	1855	1012	189	Differentially expressed in FDCP 6 homolog
B37R04C12	37-12-4	Hs~MGC:BC017504.1~uORF:IOH12256	550	2907	693	864	3286	1153	2309	1867	1049	358	Differentially expressed in FDCP 6 homolog
B37R04C13	37-13-4	Hs~MGC:BC005270.1~uORF:IOH7330	1103	1134	726	683	1066	1971	1676	692	1321	513	NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) (NDUFS4)
B37R04C14	37-14-4	Hs~MGC:BC005270.1~uORF:IOH7330	1032	1283	765	692	1115	2233	1735	686	318	533	NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) (NDUFS4)
B37R04C15	37-15-4	Hs~MGC:BC004888.2~uORF:IOH5668	498	580	654	476	783	755	704	590	1558	425	sushi domain containing 4 (SUSD4)
B37R04C16	37-16-4	Hs~MGC:BC004888.2~uORF:IOH5668	605	573	710	450	783	673	806	945	1467	379	sushi domain containing 4 (SUSD4)
B37R04C17	37-17-4	Hs~Ref:NM_024322.1~uORF:IOH5713	1338	652	2272	615	905	19348	1147	1139	2374	422	centromere protein O (CENPO)
B37R04C18	37-18-4	Hs~Ref:NM_024322.1~uORF:IOH5713	1299	643	2277	612	1016	19687	1115	1023	2286	419	centromere protein O (CENPO)
B37R04C19	37-19-4	Hs~Ref:NM_003801.2~uORF:IOH4597	404	410	452	265	437	514	580	539	1234	495	glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast) (GPAA1)
B37R04C20	37-20-4	Hs~Ref:NM_003801.2~uORF:IOH4597	323	441	478	360	447	515	642	495	607	205	glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast) (GPAA1)
B37R04C21	37-21-4	Hs~Ref:NM_032704.1~uORF:IOH5513	409	280	481	363	452	883	490	568	724	203	tubulin, alpha 1c (TUBA1C)
B37R04C22	37-22-4	Hs~Ref:NM_032704.1~uORF:IOH5513	412	258	540	350	758	888	468	479	775	292	tubulin, alpha 1c (TUBA1C)
B37R05C01	37-1-5	Hs~Ref:NM_013246.1~uORF:IOH11263	2033	2101	1506	2274	11757	1040	949	981	1611	1418	cardiotrophin-like cytokine factor 1 (CLCF1)
B37R05C02	37-2-5	Hs~Ref:NM_013246.1~uORF:IOH11263	2085	2053	1528	2271	11441	1153	950	959	1817	1387	cardiotrophin-like cytokine factor 1 (CLCF1)
B37R05C03	37-3-5	Hs~MGC:BC019337.1~uORF:IOH12297	61112	49216	43526	42411	65476	44428	27224	45068	57978	57902	immunoglobulin heavy constant gamma 1 (G1m marker) (IGHG1)
B37R05C04	37-4-5	Hs~MGC:BC019337.1~uORF:IOH12297	63324	51059	42434	43745	65459	50853	26507	42754	57393	58677	immunoglobulin heavy constant gamma 1 (G1m marker) (IGHG1)
B37R05C05	37-5-5	Hs~Ref:NM_003986.1~uORF:IOH12345	1058	892	854	768	1356	2303	1382	776	1714	643	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 (BBOX1)
B37R05C06	37-6-5	Hs~Ref:NM_003986.1~uORF:IOH12345	933	979	852	732	1188	2406	1432	735	1765	645	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 (BBOX1)
B37R05C07	37-7-5	Hs~MGC:BC010901.1~uORF:IOH13498	453	475	507	664	864	1066	1144	582	1913	225	cytoskeleton associated protein 2 (CKAP2)
B37R05C08	37-8-5	Hs~MGC:BC010901.1~uORF:IOH13498	455	477	536	696	1022	1153	1272	609	1853	206	cytoskeleton associated protein 2 (CKAP2)
B37R05C09	37-9-5	Hs~MGC:BC026362.1~uORF:IOH11217	650	214	647	448	617	585	720	605	1674	296	kinesin family member 19 (KIF19)
B37R05C10	37-10-5	Hs~MGC:BC026362.1~uORF:IOH11217	748	511	583	436	572	584	680	526	1835	426	kinesin family member 19 (KIF19)
B37R05C11	37-11-5	Hs~Ref:NM_018282.1~uORF:IOH12080	0	-3	342	555	1207	1	-4	17	340	2	Paraspeckle component 1
B37R05C12	37-12-5	Hs~Ref:NM_018282.1~uORF:IOH12080	-1	-5	351	610	1382	0	0	4	-3	26	Paraspeckle component 1
B37R05C13	37-13-5	Hs~MGC:BC050614.1~uORF:IOH27013	648	1302	582	347	652	422	494	1351	500	161	RNA methyltransferase-like protein 1
B37R05C14	37-14-5	Hs~MGC:BC050614.1~uORF:IOH27013	533	1355	560	459	610	797	475	1417	406	136	RNA methyltransferase-like protein 1
B37R05C15	37-15-5	Hs~MGC:BC047567.1~uORF:IOH26429	1080	977	857	1907	1664	1356	649	586	1440	492	casein kinase 1, gamma 3 (CSNK1G3)
B37R05C16	37-16-5	Hs~MGC:BC047567.1~uORF:IOH26429	1251	1770	1071	1980	1723	1139	635	1052	1285	507	casein kinase 1, gamma 3 (CSNK1G3)
B37R05C17	37-17-5	Hs~MGC:BC009308.1~uORF:IOH13455	678	571	537	420	642	472	526	539	1147	507	chromosome 16 open reading frame 58 (C16orf58)
B37R05C18	37-18-5	Hs~MGC:BC009308.1~uORF:IOH13455	534	423	580	460	701	507	508	690	1122	420	chromosome 16 open reading frame 58 (C16orf58)
B37R05C19	37-19-5	Hs~Ref:NM_005253.1~uORF:IOH13117	9652	1020	981	1299	597	1192	1070	4152	1852	253	FOS-like antigen 2 (FOSL2)
B37R05C20	37-20-5	Hs~Ref:NM_005253.1~uORF:IOH13117	10272	965	918	1275	664	1229	1649	3752	2001	6231	FOS-like antigen 2 (FOSL2)
B37R05C21	37-21-5	Hs~MGC:BC000526.1~uORF:IOH3637	507	153	328	240	776	476	436	418	436	52	transmembrane protein 98 (TMEM98)
B37R05C22	37-22-5	Hs~MGC:BC000526.1~uORF:IOH3637	524	147	346	228	915	490	435	361	440	63	transmembrane protein 98 (TMEM98)
B37R06C01	37-1-6	Hs~Ref:NM_006263.1~uORF:IOH3647	1985	230	486	583	15655	510	350	960	1021	211	proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) (PSME1), transcript variant 1
B37R06C02	37-2-6	Hs~Ref:NM_006263.1~uORF:IOH3647	2191	227	497	603	15773	509	403	959	1059	190	proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) (PSME1), transcript variant 1
B37R06C03	37-3-6	Hs~Ref:NM_203457.1~uORF:IOH45842	3237	1854	4434	3727	1603	2650	2182	3176	2500	1489	peptidylprolyl isomerase E (cyclophilin E) (PPIE), transcript variant 3
B37R06C04	37-4-6	Hs~Ref:NM_203457.1~uORF:IOH45842	3432	1882	4516	3680	1569	2406	2331	3192	2547	1498	peptidylprolyl isomerase E (cyclophilin E) (PPIE), transcript variant 3
B37R06C05	37-5-6	Hs~Ref:NM_001006615.1~uORF:IOH45776	381	109	354	254	279	351	462	345	507	100	WD repeat domain 31 (WDR31), transcript variant 2
B37R06C06	37-6-6	Hs~Ref:NM_001006615.1~uORF:IOH45776	318	172	463	224	343	361	396	271	522	79	WD repeat domain 31 (WDR31), transcript variant 2
B37R06C07	37-7-6	Hs~Ref:NM_177953.1~uORF:IOH45824	410	196	502	220	355	431	721	325	680	107	Dynein light chain roadblock-type 1
B37R06C08	37-8-6	Hs~Ref:NM_177953.1~uORF:IOH45824	374	440	424	265	371	429	722	285	626	85	Dynein light chain roadblock-type 1
B37R06C09	37-9-6	Hs~Ref:NM_006903.3~uORF:IOH45750	457	225	403	262	590	444	496	458	1447	194	pyrophosphatase (inorganic) 2 (PPA2), nuclear gene encoding mitochondrial protein, transcript variant 2
B37R06C10	37-10-6	Hs~Ref:NM_006903.3~uORF:IOH45750	456	209	391	273	597	457	534	525	1685	195	pyrophosphatase (inorganic) 2 (PPA2), nuclear gene encoding mitochondrial protein, transcript variant 2
B37R06C11	37-11-6	Hs~Ref:NM_004470.2~uORF:IOH2972	780	998	1195	540	718	733	2721	1165	1261	400	FK506 binding protein 2, 13kDa (FKBP2), transcript variant 1
B37R06C12	37-12-6	Hs~Ref:NM_004470.2~uORF:IOH2972	806	942	1122	569	798	789	2643	1201	1447	468	FK506 binding protein 2, 13kDa (FKBP2), transcript variant 1
B37R06C13	37-13-6	Hs~MGC:BC004226.1~uORF:IOH22896	1449	951	1155	585	845	1492	1856	898	2075	438	PDZ domain-containing protein GIPC1
B37R06C14	37-14-6	Hs~MGC:BC004226.1~uORF:IOH22896	1372	939	1069	630	768	1525	1761	859	2391	561	PDZ domain-containing protein GIPC1
B37R06C15	37-15-6	Hs~MGC:BC032466.1~uORF:IOH21695	654	534	1161	403	543	1247	2305	1147	2720	2566	nicotinate phosphoribosyltransferase domain containing 1 (NAPRT1)
B37R06C16	37-16-6	Hs~MGC:BC032466.1~uORF:IOH21695	745	1935	1416	407	540	817	2155	1203	2939	2886	nicotinate phosphoribosyltransferase domain containing 1 (NAPRT1)
B37R06C17	37-17-6	Hs~MGC:BC031650.1~uORF:IOH22742	17897	20902	21810	25432	23379	18775	16787	29131	16829	38712	Putative E3 ubiquitin-protein ligase SH3RF2
B37R06C18	37-18-6	Hs~MGC:BC031650.1~uORF:IOH22742	18453	19815	21163	24167	20814	19006	15096	29578	16189	38080	Putative E3 ubiquitin-protein ligase SH3RF2
B37R06C19	37-19-6	Hs~Ref:NM_001002756.1~uORF:IOH58634	591	154	476	336	322	317	734	306	373	173	NFU1 iron-sulfur cluster scaffold homolog, mitochondrial
B37R06C20	37-20-6	Hs~Ref:NM_001002756.1~uORF:IOH58634	591	237	498	324	368	367	366	402	437	147	NFU1 iron-sulfur cluster scaffold homolog, mitochondrial
B37R07C01	37-1-7	Hs~Ref:NM_001008211.1~uORF:IOH57143	26649	323	1104	236	2231	367	900	978	1269	241	Optineurin
B37R07C02	37-2-7	Hs~Ref:NM_001008211.1~uORF:IOH57143	28420	304	1174	258	2219	364	965	996	1390	217	Optineurin
B37R07C03	37-3-7	Hs~Ref:NM_000314.3~uORF:IOH56926	423	830	1681	561	4672	1045	682	461	3550	670	Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
B37R07C04	37-4-7	Hs~Ref:NM_000314.3~uORF:IOH56926	436	836	1684	552	5013	1003	667	460	3529	305	Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
B37R07C05	37-5-7	Hs~Ref:NM_016282.2~uORF:IOH11046	1064	395	627	374	524	495	1301	1037	1111	221	adenylate kinase 3 (AK3)
B37R07C06	37-6-7	Hs~Ref:NM_016282.2~uORF:IOH11046	1006	335	572	397	529	513	1349	944	1161	177	adenylate kinase 3 (AK3)
B37R07C07	37-7-7	Hs~Ref:NM_145025.1~uORF:IOH10918	1038	77	404	228	375	291	378	343	526	69	chromosome 6 open reading frame 199 (C6orf199)
B37R07C08	37-8-7	Hs~Ref:NM_145025.1~uORF:IOH10918	1079	95	384	319	338	343	363	349	518	155	chromosome 6 open reading frame 199 (C6orf199)
B37R07C09	37-9-7	Hs~MGC:BC020221.1~uORF:IOH13291	2297	820	1035	475	548	930	1802	814	920	297	SH3 and cysteine rich domain (STAC)
B37R07C10	37-10-7	Hs~MGC:BC020221.1~uORF:IOH13291	2234	853	877	513	565	816	1838	826	1026	290	SH3 and cysteine rich domain (STAC)
B37R07C11	37-11-7	Hs~Ref:NM_001625.1~uORF:IOH14360	2673	21	400	271	331	409	459	289	1329	166	adenylate kinase 2 (AK2), transcript variant AK2A
B37R07C12	37-12-7	Hs~Ref:NM_001625.1~uORF:IOH14360	2961	89	400	231	284	428	412	334	1391	126	adenylate kinase 2 (AK2), transcript variant AK2A
B37R07C13	37-13-7	Hs~Ref:NM_000723.3~uORF:IOH39502	6720	4474	4779	3880	1999	3413	17717	2565	5127	3162	calcium channel, voltage-dependent, beta 1 subunit (CACNB1), transcript variant 1
B37R07C14	37-14-7	Hs~Ref:NM_000723.3~uORF:IOH39502	6838	4710	4609	3955	1407	3491	17646	2793	5339	2991	calcium channel, voltage-dependent, beta 1 subunit (CACNB1), transcript variant 1
B37R07C15	37-15-7	Hs~Ref:NM_001686.3~uORF:IOH11843	1341	1126	1178	924	1973	1848	7832	930	1386	584	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B), nuclear gene encoding mitochondrial protein
B37R07C16	37-16-7	Hs~Ref:NM_001686.3~uORF:IOH11843	1438	1107	1419	905	1537	1588	8024	1026	1331	548	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B), nuclear gene encoding mitochondrial protein
B37R07C17	37-17-7	Hs~MGC:BC028301.1~uORF:IOH11759	2613	1436	1579	1118	839	1878	8457	1572	2373	625	chromosome 18 open reading frame 56 (C18orf56)
B37R07C18	37-18-7	Hs~MGC:BC028301.1~uORF:IOH11759	2669	1431	1467	1087	853	1893	7920	1463	2309	582	chromosome 18 open reading frame 56 (C18orf56)
B37R07C19	37-19-7	Hs~MGC:BC025784.2~uORF:IOH11964	826	408	467	353	345	535	536	445	749	305	pancreatic lipase-related protein 1 (PNLIPRP1)
B37R07C20	37-20-7	Hs~MGC:BC025784.2~uORF:IOH11964	826	414	480	332	379	475	532	441	209	15	pancreatic lipase-related protein 1 (PNLIPRP1)
B37R07C21	37-21-7	Hs~Ref:NM_002756.2~N/A	1422	1017	1533	1103	1648	1207	1392	1396	3398	519	Dual specificity mitogen-activated protein kinase kinase 3
B37R07C22	37-22-7	Hs~Ref:NM_002756.2~N/A	1477	924	1652	1110	1836	1189	1307	1354	3419	545	Dual specificity mitogen-activated protein kinase kinase 3
B37R08C01	37-1-8	Hs~Ref:NM_001204.3~N/A	879	1376	1614	544	892	826	1289	998	4986	681	Bone morphogenetic protein receptor type-2
B37R08C02	37-2-8	Hs~Ref:NM_001204.3~N/A	896	1469	1552	587	958	903	1316	1042	5257	750	Bone morphogenetic protein receptor type-2
B37R08C03	37-3-8	Hs~Ref:NM_001982.1~N/A	929	1019	1041	523	1384	583	981	1121	2259	390	Receptor tyrosine-protein kinase erbB-3
B37R08C04	37-4-8	Hs~Ref:NM_001982.1~N/A	873	448	1016	556	1297	563	950	1200	2340	434	Receptor tyrosine-protein kinase erbB-3
B37R08C05	37-5-8	Hs~Ref:NM_001259.2~N/A	985	985	1802	565	1027	2003	721	941	3699	422	Cell division protein kinase 6
B37R08C06	37-6-8	Hs~Ref:NM_001259.2~N/A	943	1047	1715	563	969	1991	718	950	3740	488	Cell division protein kinase 6
B37R08C07	37-7-8	Hs~MGC:NM_015381.1~uORF:IOH25888	725	714	740	709	783	1487	1402	842	1479	410	Protein FAM19A5
B37R08C08	37-8-8	Hs~MGC:NM_015381.1~uORF:IOH25888	717	731	833	805	586	1530	1309	766	1582	470	Protein FAM19A5
B37R08C09	37-9-8	Hs~MGC:BC018080.1~uORF:IOH26802	1149	447	1122	1316	498	4484	1578	781	1215	752	chromosome 11 open reading frame 73 (C11orf73)
B37R08C10	37-10-8	Hs~MGC:BC018080.1~uORF:IOH26802	1066	364	900	479	830	4564	1435	720	2648	723	chromosome 11 open reading frame 73 (C11orf73)
B37R08C11	37-11-8	Hs~MGC:BC039172.1~uORF:IOH25808	471	463	630	425	589	604	880	638	1567	309	calmodulin-like 5 (CALML5)
B37R08C12	37-12-8	Hs~MGC:BC039172.1~uORF:IOH25808	474	705	592	429	383	633	925	603	1238	223	calmodulin-like 5 (CALML5)
B37R08C13	37-13-8	Hs~MGC:NM_174889.2~uORF:IOH25846	1328	2060	1809	846	626	2001	2297	2106	1472	955	NDUFA12-like (NDUFA12L)
B37R08C14	37-14-8	Hs~MGC:NM_174889.2~uORF:IOH25846	1321	1999	1703	897	758	1851	2287	2197	1401	944	NDUFA12-like (NDUFA12L)
B37R08C15	37-15-8	Hs~Ref:NM_005024.1~uORF:IOH35680	1779	1364	2467	1717	1430	1433	2509	1459	3702	688	serpin peptidase inhibitor, clade B (ovalbumin), member 10 (SERPINB10)
B37R08C16	37-16-8	Hs~Ref:NM_005024.1~uORF:IOH35680	1699	1303	2471	1660	1349	1708	2518	1483	3575	686	serpin peptidase inhibitor, clade B (ovalbumin), member 10 (SERPINB10)
B37R08C17	37-17-8	Hs~Ref:NM_006217.2~uORF:IOH11838	1766	1495	3177	2950	1189	1443	2676	1450	2944	631	serpin peptidase inhibitor, clade I (pancpin), member 2 (SERPINI2)
B37R08C18	37-18-8	Hs~Ref:NM_006217.2~uORF:IOH11838	1832	1378	2881	2976	1072	1454	2412	1344	2958	617	serpin peptidase inhibitor, clade I (pancpin), member 2 (SERPINI2)
B37R08C19	37-19-8	Hs~Ref:NM_000987.2~uORF:IOH45675	4227	2760	4598	2505	2356	2562	7629	2385	5704	2946	ribosomal protein L26 (RPL26)
B37R08C20	37-20-8	Hs~Ref:NM_000987.2~uORF:IOH45675	4108	2594	4467	2540	2817	2639	8125	2347	5567	2952	ribosomal protein L26 (RPL26)
B37R08C21	37-21-8	Hs~MGC:NM_172159.2~uORF:IOH25842	24467	12279	12717	17265	14585	9940	8479	15506	13739	16925	potassium voltage-gated channel, shaker-related subfamily, beta member 1 (KCNAB1), transcript variant 3
B37R08C22	37-22-8	Hs~MGC:NM_172159.2~uORF:IOH25842	27408	11868	12454	17412	14390	9548	8443	15533	13470	18616	potassium voltage-gated channel, shaker-related subfamily, beta member 1 (KCNAB1), transcript variant 3
B37R09C01	37-1-9	Hs~Ref:NM_025243.2~uORF:IOH22813	233	34	347	157	62	217	332	173	441	20	solute carrier family 19, member 3 (SLC19A3)
B37R09C02	37-2-9	Hs~Ref:NM_025243.2~uORF:IOH22813	229	1706	329	86	71	278	365	172	454	89	solute carrier family 19, member 3 (SLC19A3)
B37R09C03	37-3-9	Hs~Ref:NM_138612.1~uORF:IOH11074	640	574	1064	5194	649	2402	1257	383	653	416	hyaluronan synthase 3 (HAS3), transcript variant 2
B37R09C04	37-4-9	Hs~Ref:NM_138612.1~uORF:IOH11074	621	133	1059	5178	591	2395	1307	415	633	449	hyaluronan synthase 3 (HAS3), transcript variant 2
B37R09C05	37-5-9	Hs~Ref:NM_016823.2~uORF:IOH3182	432	325	1144	6659	449	4261	1335	1961	830	180	v-crk sarcoma virus CT10 oncogene homolog (avian) (CRK), transcript variant II
B37R09C06	37-6-9	Hs~Ref:NM_016823.2~uORF:IOH3182	453	345	1149	6812	467	4318	1253	1916	840	171	v-crk sarcoma virus CT10 oncogene homolog (avian) (CRK), transcript variant II
B37R09C07	37-7-9	Hs~MGC:BC000132.2~uORF:IOH2877	1037	780	1012	399	877	639	773	970	1733	328	centrosomal protein 72kDa (CEP72)
B37R09C08	37-8-9	Hs~MGC:BC000132.2~uORF:IOH2877	1081	1156	1149	495	578	683	814	875	1986	443	centrosomal protein 72kDa (CEP72)
B37R09C09	37-9-9	Hs~MGC:BC001327.1~uORF:IOH3125	2126	1966	3795	340	3819	2059	3628	2550	5488	1619	interferon-related developmental regulator 2 (IFRD2)
B37R09C10	37-10-9	Hs~MGC:BC001327.1~uORF:IOH3125	2154	1941	3968	586	3489	1996	3668	2448	5307	1572	interferon-related developmental regulator 2 (IFRD2)
B37R09C13	37-13-9	Hs~MGC:BC003549.1~uORF:IOH4987	4619	5054	4531	4443	5615	8610	9397	7760	4927	2788	enoyl Coenzyme A hydratase domain containing 1 (ECHDC1)
B37R09C14	37-14-9	Hs~MGC:BC003549.1~uORF:IOH4987	4941	5209	4781	4398	6080	8571	9419	7675	5105	2783	enoyl Coenzyme A hydratase domain containing 1 (ECHDC1)
B37R09C15	37-15-9	Hs~MGC:BC004985.1~uORF:IOH6071	522	346	477	304	339	389	711	344	157	104	neurolysin (metallopeptidase M3 family) (NLN)
B37R09C16	37-16-9	Hs~MGC:BC004985.1~uORF:IOH6071	704	506	430	266	246	214	754	410	93	103	neurolysin (metallopeptidase M3 family) (NLN)
B37R09C17	37-17-9	Hs~Ref:NM_080588.1~uORF:IOH46132	3148	4591	3879	4175	4824	2911	7926	6037	3101	2847	protein tyrosine phosphatase, non-receptor type 7 (PTPN7), transcript variant 2
B37R09C18	37-18-9	Hs~Ref:NM_080588.1~uORF:IOH46132	3312	4551	3210	4220	4051	3052	7918	5126	3080	2781	protein tyrosine phosphatase, non-receptor type 7 (PTPN7), transcript variant 2
B37R09C19	37-19-9	Hs~MGC:BC028348.2~uORF:IOH46079	582	628	1382	659	813	648	768	702	2378	366	growth factor, augmenter of liver regeneration (ERV1 homolog, S. cerevisiae) (GFER)
B37R09C20	37-20-9	Hs~MGC:BC028348.2~uORF:IOH46079	606	592	1402	682	899	663	781	659	2275	193	growth factor, augmenter of liver regeneration (ERV1 homolog, S. cerevisiae) (GFER)
B37R09C21	37-21-9	Hs~Ref:NM_004728.2~uORF:IOH46173	3948	1550	2610	1612	948	2809	11619	1979	2486	6573	DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 (DDX21)
B37R09C22	37-22-9	Hs~Ref:NM_004728.2~uORF:IOH46173	4031	1489	2379	1640	894	2802	11399	1976	2217	6353	DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 (DDX21)
B37R10C01	37-1-10	Hs~Ref:NM_032284.2~uORF:IOH46080	608	780	894	551	494	1466	998	1750	1081	208	PRP38 pre-mRNA processing factor 38 (yeast) domain containing A (PRPF38A), transcript variant 1
B37R10C02	37-2-10	Hs~Ref:NM_032284.2~uORF:IOH46080	628	861	813	514	632	1791	1085	1716	1108	770	PRP38 pre-mRNA processing factor 38 (yeast) domain containing A (PRPF38A), transcript variant 1
B37R10C03	37-3-10	Hs~MGC:BC062688.1~uORF:IOH40726	1853	1452	1562	943	2035	1603	3467	1093	2453	432	protein kinase, cGMP-dependent, type I (PRKG1)
B37R10C04	37-4-10	Hs~MGC:BC062688.1~uORF:IOH40726	1770	1517	1515	927	2031	1560	3432	1313	2538	190	protein kinase, cGMP-dependent, type I (PRKG1)
B37R10C05	37-5-10	Hs~Ref:NM_053067.1~uORF:IOH40632	118	50	287	27	67	661	228	489	444	39	ubiquilin 1 (UBQLN1), transcript variant 2
B37R10C06	37-6-10	Hs~Ref:NM_053067.1~uORF:IOH40632	116	14132	267	34	37	725	203	481	429	51	ubiquilin 1 (UBQLN1), transcript variant 2
B37R10C07	37-7-10	Hs~Ref:NM_033293.1~uORF:IOH40681	469	430	431	353	152	538	605	400	602	153	caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (CASP1), transcript variant gamma
B37R10C08	37-8-10	Hs~Ref:NM_033293.1~uORF:IOH40681	433	332	486	313	286	513	665	798	617	373	caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (CASP1), transcript variant gamma
B37R10C09	37-9-10	Hs~Ref:NM_001322.2~uORF:IOH40727	760	822	874	541	572	811	1251	556	1389	591	cystatin SA (CST2)
B37R10C10	37-10-10	Hs~Ref:NM_001322.2~uORF:IOH40727	734	790	870	542	619	786	1238	500	1392	588	cystatin SA (CST2)
B37R11C21	37-21-11	Hs~Ref:NM_003348.3~uORF:IOH3538	641	346	888	1704	413	618	575	364	3073	277	ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast) (UBE2N)
B37R11C22	37-22-11	Hs~Ref:NM_003348.3~uORF:IOH3538	680	439	897	1661	323	572	591	358	2883	-144	ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast) (UBE2N)
B37R12C01	37-1-12	Hs~Ref:NM_024296.2~uORF:IOH4214	449	375	423	268	353	433	661	754	479	-11	coiled-coil domain containing 28B (CCDC28B)
B37R12C02	37-2-12	Hs~Ref:NM_024296.2~uORF:IOH4214	474	104	419	261	444	524	685	649	573	103	coiled-coil domain containing 28B (CCDC28B)
B37R12C03	37-3-12	Hs~Ref:NM_000712.3~uORF:IOH7401	637	929	567	566	622	2532	3239	2163	1212	420	biliverdin reductase A (BLVRA)
B37R12C04	37-4-12	Hs~Ref:NM_000712.3~uORF:IOH7401	658	907	547	564	654	2419	3212	2351	1202	408	biliverdin reductase A (BLVRA)
B37R12C05	37-5-12	Hs~Ref:NM_016059.3~uORF:IOH4932	2250	1140	1602	1347	1338	2565	2783	1462	2092	705	peptidylprolyl isomerase (cyclophilin)-like 1 (PPIL1)
B37R12C06	37-6-12	Hs~Ref:NM_016059.3~uORF:IOH4932	2345	1004	1684	1538	1235	2765	3037	1452	2087	735	peptidylprolyl isomerase (cyclophilin)-like 1 (PPIL1)
B37R12C07	37-7-12	Hs~MGC:NM_021218.1~uORF:IOH10009	2873	2656	1239	1835	2915	1436	2550	2674	3517	1068	chromosome 9 open reading frame 80 (C9orf80)
B37R12C08	37-8-12	Hs~MGC:NM_021218.1~uORF:IOH10009	2964	2754	1282	1996	2858	1534	2308	2599	3651	1122	chromosome 9 open reading frame 80 (C9orf80)
B37R12C09	37-9-12	Hs~Ref:NM_005423.1~uORF:IOH21844	744	294	576	2102	476	1549	2199	5985	1691	118	trefoil factor 2 (spasmolytic protein 1) (TFF2)
B37R12C10	37-10-12	Hs~Ref:NM_005423.1~uORF:IOH21844	734	808	578	2118	447	1571	2189	5808	1679	255	trefoil factor 2 (spasmolytic protein 1) (TFF2)
B37R12C11	37-11-12	Hs~Ref:NM_145028.1~uORF:IOH22492	671	1008	633	558	658	847	973	759	1630	347	Uncharacterized protein C6orf81
B37R12C12	37-12-12	Hs~Ref:NM_145028.1~uORF:IOH22492	612	965	662	534	759	803	1048	710	1839	384	Uncharacterized protein C6orf81
B37R12C13	37-13-12	Hs~Ref:NM_005641.2~uORF:IOH11381	2446	17500	2111	4254	1158	1864	4304	2305	3105	580	TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa (TAF6), transcript variant 1
B37R12C14	37-14-12	Hs~Ref:NM_005641.2~uORF:IOH11381	2411	17522	2063	4718	1295	1776	4320	2354	3079	609	TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa (TAF6), transcript variant 1
B37R12C15	37-15-12	Hs~Ref:NM_181294.1~uORF:IOH50058	1131	1457	1465	3429	4645	3373	2321	1467	3389	850	CKLF-like MARVEL transmembrane domain-containing protein 1
B37R12C16	37-16-12	Hs~Ref:NM_181294.1~uORF:IOH50058	1079	1443	1422	3297	4572	3320	2705	1466	3579	840	CKLF-like MARVEL transmembrane domain-containing protein 1
B37R12C17	37-17-12	Hs~Ref:NM_152724.2~uORF:IOH45576	1914	982	1433	1191	862	1472	4059	1287	2717	746	Ras suppressor protein 1
B37R12C18	37-18-12	Hs~Ref:NM_152724.2~uORF:IOH45576	1750	1870	2227	1171	893	1843	2326	1250	3062	774	Ras suppressor protein 1
B37R12C19	37-19-12	Hs~MGC:NM_174922.3~uORF:IOH44655	1009	1459	2263	843	1529	1470	1475	1090	2563	867	Uncharacterized aarF domain-containing protein kinase 5
B37R12C20	37-20-12	Hs~MGC:NM_174922.3~uORF:IOH44655	945	946	1104	856	1330	1589	1589	1109	2614	931	Uncharacterized aarF domain-containing protein kinase 5
B37R13C01	37-1-13	Hs~MGC:BC038976.1~uORF:IOH28763	334	156	440	2363	236	437	669	889	459	58	Rho GTPase-activating protein 15
B37R13C02	37-2-13	Hs~MGC:BC038976.1~uORF:IOH28763	333	196	429	2281	244	465	703	508	551	94	Rho GTPase-activating protein 15
B37R13C03	37-3-13	Hs~MGC:BC053582.1~uORF:IOH28938	288	208	347	240	246	407	498	1369	581	107	solute carrier family 32 (GABA vesicular transporter), member 1 (SLC32A1)
B37R13C04	37-4-13	Hs~MGC:BC053582.1~uORF:IOH28938	279	175	358	236	294	408	674	333	575	77	solute carrier family 32 (GABA vesicular transporter), member 1 (SLC32A1)
B37R13C05	37-5-13	Hs~MGC:BC040546.1~uORF:IOH28687	257	561	335	243	209	336	379	315	436	76	proprotein convertase subtilisin/kexin type 2 (PCSK2)
B37R13C06	37-6-13	Hs~MGC:BC040546.1~uORF:IOH28687	319	567	315	265	168	348	408	256	541	108	proprotein convertase subtilisin/kexin type 2 (PCSK2)
B37R13C07	37-7-13	Hs~Ref:NM_000367.1~uORF:IOH27812	882	2864	1768	1000	5161	1146	1969	2546	2563	490	thiopurine S-methyltransferase (TPMT)
B37R13C08	37-8-13	Hs~Ref:NM_000367.1~uORF:IOH27812	840	2534	1765	1067	4576	1158	1865	2580	2539	486	thiopurine S-methyltransferase (TPMT)
B37R13C09	37-9-13	Hs~MGC:BC009078.1~uORF:IOH3357	591	853	1067	602	470	784	788	641	1488	486	chromosome 16 open reading frame 74 (C16orf74)
B37R13C10	37-10-13	Hs~MGC:BC009078.1~uORF:IOH3357	536	742	1058	527	475	776	770	673	1965	561	chromosome 16 open reading frame 74 (C16orf74)
B37R13C11	37-11-13	Hs~Ref:NM_181801.1~uORF:IOH45863	475	787	687	463	527	590	941	0	1901	150	ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 4
B37R13C12	37-12-13	Hs~Ref:NM_181801.1~uORF:IOH45863	477	890	620	469	468	615	965	7	2136	355	ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 4
B37R13C13	37-13-13	Hs~Ref:NM_021824.2~uORF:IOH45864	565	516	603	549	453	628	765	564	2060	371	NIF3 NGG1 interacting factor 3-like 1 (S. pombe) (NIF3L1)
B37R13C14	37-14-13	Hs~Ref:NM_021824.2~uORF:IOH45864	575	543	596	491	462	569	757	600	2180	445	NIF3 NGG1 interacting factor 3-like 1 (S. pombe) (NIF3L1)
B37R13C15	37-15-13	Hs~Ref:NM_203430.1~uORF:IOH45825	1083	321	2058	583	319	1843	671	5182	12962	61	peptidylprolyl isomerase A (cyclophilin A) (PPIA), transcript variant 2
B37R13C16	37-16-13	Hs~Ref:NM_203430.1~uORF:IOH45825	1137	308	2009	573	364	1788	956	5164	13236	58	peptidylprolyl isomerase A (cyclophilin A) (PPIA), transcript variant 2
B37R13C19	37-19-13	Hs~MGC:BC018630.1~uORF:IOH12072	570	1680	1414	445	599	620	1480	812	789	618	RAB GTPase-activating protein 1-like
B37R13C20	37-20-13	Hs~MGC:BC018630.1~uORF:IOH12072	486	712	646	419	302	484	1460	761	787	114	RAB GTPase-activating protein 1-like
B37R13C21	37-21-13	Hs~MGC:BC016992.1~uORF:IOH11870	817	560	1043	714	621	880	1773	804	1278	248	Programmed cell death protein 7
B37R13C22	37-22-13	Hs~MGC:BC016992.1~uORF:IOH11870	830	564	1059	742	503	829	1730	1380	1277	368	Programmed cell death protein 7
B37R14C01	37-1-14	Hs~MGC:BC020712.1~uORF:IOH13788	6623	1719	1974	1110	2254	1276	1920	2531	3123	571	POU domain, class 5, transcription factor 1
B37R14C02	37-2-14	Hs~MGC:BC020712.1~uORF:IOH13788	7070	1803	1977	1054	2419	1273	1979	2631	2998	667	POU domain, class 5, transcription factor 1
B37R14C03	37-3-14	Hs~Ref:NM_016011.2~uORF:IOH53949	3073	3446	1870	5396	3000	3610	3964	7374	4858	6136	Trans-2-enoyl-CoA reductase, mitochondrial
B37R14C04	37-4-14	Hs~Ref:NM_016011.2~uORF:IOH53949	2999	3478	1894	5303	3162	3639	3729	6199	4736	6253	Trans-2-enoyl-CoA reductase, mitochondrial
B37R14C05	37-5-14	Hs~Ref:NM_006568.2~uORF:IOH53926	310	188	450	205	230	852	863	513	514	71	Cell growth regulator with RING finger domain protein 1
B37R14C06	37-6-14	Hs~Ref:NM_006568.2~uORF:IOH53926	277	194	452	193	147	772	829	411	545	154	Cell growth regulator with RING finger domain protein 1
B37R14C09	37-9-14	Hs~Ref:NM_001912.2~uORF:IOH53927	316	236	410	311	481	466	550	339	624	467	Cathepsin L1
B37R14C10	37-10-14	Hs~Ref:NM_001912.2~uORF:IOH53927	337	241	374	301	421	493	490	426	659	342	Cathepsin L1
B37R14C11	37-11-14	Hs~Ref:NM_005109.1~uORF:IOH21155	1796	669	542	480	1056	498	1684	442	1918	840	oxidative-stress responsive 1 (OXSR1)
B37R14C12	37-12-14	Hs~Ref:NM_005109.1~uORF:IOH21155	1851	565	515	490	982	496	1724	469	872	907	oxidative-stress responsive 1 (OXSR1)
B37R14C13	37-13-14	Hs~MGC:NM_178588.1~uORF:IOH13592	424	411	490	336	7432	6	825	597	2036	298	protein phosphatase 2, regulatory subunit B', gamma isoform (PPP2R5C), transcript variant 4
B37R14C14	37-14-14	Hs~MGC:NM_178588.1~uORF:IOH13592	390	411	496	344	7804	519	1339	659	1878	292	protein phosphatase 2, regulatory subunit B', gamma isoform (PPP2R5C), transcript variant 4
B37R14C15	37-15-14	Hs~Ref:NM_021131.1~uORF:IOH4040	354	489	2025	2341	444	1603	1503	618	1115	241	protein phosphatase 2A activator, regulatory subunit 4 (PPP2R4), transcript variant 3
B37R14C16	37-16-14	Hs~Ref:NM_021131.1~uORF:IOH4040	372	483	2062	2374	447	1683	1324	627	1101	300	protein phosphatase 2A activator, regulatory subunit 4 (PPP2R4), transcript variant 3
B37R14C17	37-17-14	Hs~Ref:NM_001791.2~uORF:IOH10262	340	297	569	353	382	455	547	463	688	114	cell division cycle 42 (GTP binding protein, 25kDa) (CDC42), transcript variant 1
B37R14C18	37-18-14	Hs~Ref:NM_001791.2~uORF:IOH10262	452	338	534	429	425	487	527	444	377	134	cell division cycle 42 (GTP binding protein, 25kDa) (CDC42), transcript variant 1
B37R14C21	37-21-14	Hs~MGC:BC036511.1~uORF:IOH62268	801	1189	3884	19189	1208	26587	1776	1837	4260	1018	Homeobox protein Meis1
B37R14C22	37-22-14	Hs~MGC:BC036511.1~uORF:IOH62268	855	1217	4321	18242	1213	24484	1749	1786	4218	981	Homeobox protein Meis1
B37R15C01	37-1-15	Hs~MGC:BC041345.1~uORF:IOH62289	530	252	1313	372	446	822	845	553	2214	185	S-adenosylmethionine decarboxylase proenzyme
B37R15C02	37-2-15	Hs~MGC:BC041345.1~uORF:IOH62289	492	216	1227	263	479	800	842	591	2224	174	S-adenosylmethionine decarboxylase proenzyme
B37R15C05	37-5-15	Hs~MGC:BC000177.2~uORF:IOH2886	-3	17	76	0	2260	556	572	842	1110	285	DnaJ (Hsp40) homolog, subfamily B, member 6 (DNAJB6)
B37R15C06	37-6-15	Hs~MGC:BC000177.2~uORF:IOH2886	1	0	7	126	1824	551	581	461	1075	279	DnaJ (Hsp40) homolog, subfamily B, member 6 (DNAJB6)
B37R15C07	37-7-15	Hs~MGC:BC016634.1~uORF:IOH28617	630	822	778	483	49312	679	572	573	1661	369	Glutaminyl-tRNA synthetase
B37R15C08	37-8-15	Hs~MGC:BC016634.1~uORF:IOH28617	633	859	846	530	50036	609	552	584	1807	388	Glutaminyl-tRNA synthetase
B37R15C09	37-9-15	Hs~MGC:BC060773.1~uORF:IOH29187	847	561	1839	1289	1859	2945	1057	1762	454	2873	SRY (sex determining region Y)-box 5 (SOX5)
B37R15C10	37-10-15	Hs~MGC:BC060773.1~uORF:IOH29187	731	946	1668	1280	1878	2919	1085	1677	1868	2827	SRY (sex determining region Y)-box 5 (SOX5)
B37R15C11	37-11-15	Hs~MGC:BC021739.1~uORF:IOH28646	893	774	724	634	1806	554	363	479	1468	594	hypothetical LOC554201
B37R15C12	37-12-15	Hs~MGC:BC021739.1~uORF:IOH28646	890	765	676	650	1797	546	379	489	1481	602	hypothetical LOC554201
B37R15C15	37-15-15	Hs~Ref:NM_001556.1~CAT:PV3836	301	379	286	348	431	274	861	209	312	219	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKBKB)
B37R15C16	37-16-15	Hs~Ref:NM_001556.1~CAT:PV3836	335	405	283	359	215	260	809	212	471	68	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKBKB)
B37R15C17	37-17-15	Hs~Ref:NM_013254.2~CAT:PV3504	778	785	1200	941	487	1446	700	2097	854	379	TANK-binding kinase 1 (TBK1)
B37R15C18	37-18-15	Hs~Ref:NM_013254.2~CAT:PV3504	822	704	1224	934	542	1471	682	2107	771	384	TANK-binding kinase 1 (TBK1)
B37R15C21	37-21-15	Hs~Ref:NM_005211.1~CAT:PV3249	513	814	994	472	367	1138	1027	2246	1322	452	colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog (CSF1R)
B37R15C22	37-22-15	Hs~Ref:NM_005211.1~CAT:PV3249	487	830	989	473	400	1090	975	2192	1247	436	colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog (CSF1R)
B37R16C01	37-1-16	Hs~Ref:NM_001396.2~CAT:PV3785	545	776	815	1695	424	876	1312	716	1381	1271	Dual specificity tyrosine-phosphorylation-regulated kinase 1A
B37R16C02	37-2-16	Hs~Ref:NM_001396.2~CAT:PV3785	533	569	761	1272	458	867	1433	772	1521	1141	Dual specificity tyrosine-phosphorylation-regulated kinase 1A
B37R16C03	37-3-16	Hs~Ref:NM_000376.1~CAT:PV4552	1454	52	140	322	766	496	166	457	544	66	vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR), transcript variant 1
B37R16C04	37-4-16	Hs~Ref:NM_000376.1~CAT:PV4552	1399	42	154	318	782	461	428	444	568	130	vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR), transcript variant 1
B37R16C05	37-5-16	Hs~Ref:NM_001105.2~CAT:PV4877	248	278	218	282	2663	335	396	4123	999	127	Activin receptor type-1
B37R16C06	37-6-16	Hs~Ref:NM_001105.2~CAT:PV4877	268	5	231	307	2222	373	378	3100	1817	190	Activin receptor type-1
B37R16C07	37-7-16	Hs~Ref:NM_022135.2~uORF:IOH26334	1082	954	1112	662	822	2183	1755	880	3104	455	popeye domain containing 2 (POPDC2)
B37R16C08	37-8-16	Hs~Ref:NM_022135.2~uORF:IOH26334	1062	1003	1105	647	933	1991	1637	822	3397	460	popeye domain containing 2 (POPDC2)
B37R16C09	37-9-16	Hs~Ref:NM_152328.3~uORF:IOH26952	945	1582	1614	1347	963	2575	2322	1499	2912	647	adenylosuccinate synthase like 1 (ADSSL1), transcript variant 2
B37R16C10	37-10-16	Hs~Ref:NM_152328.3~uORF:IOH26952	898	1577	1585	1334	953	2608	2411	1510	3059	697	adenylosuccinate synthase like 1 (ADSSL1), transcript variant 2
B37R16C11	37-11-16	Hs~MGC:BC046163.1~uORF:IOH28869	799	791	882	882	652	988	1621	771	1640	459	glutathione peroxidase 4 (phospholipid hydroperoxidase) (GPX4)
B37R16C12	37-12-16	Hs~MGC:BC046163.1~uORF:IOH28869	675	593	849	814	701	1037	1720	790	1540	433	glutathione peroxidase 4 (phospholipid hydroperoxidase) (GPX4)
B37R16C13	37-13-16	Hs~Ref:NM_021640.2~uORF:IOH28884	515	567	694	891	646	799	926	696	1164	372	chromosome 12 open reading frame 10 (C12orf10)
B37R16C14	37-14-16	Hs~Ref:NM_021640.2~uORF:IOH28884	588	578	677	927	656	808	1368	678	675	366	chromosome 12 open reading frame 10 (C12orf10)
B37R16C15	37-15-16	Hs~MGC:BC059384.1~uORF:IOH29284	538	546	643	429	544	636	1448	617	729	299	glutamate receptor, ionotropic, N-methyl D-aspartate 2C (GRIN2C)
B37R16C16	37-16-16	Hs~MGC:BC059384.1~uORF:IOH29284	547	568	640	414	576	753	845	609	1342	380	glutamate receptor, ionotropic, N-methyl D-aspartate 2C (GRIN2C)
B37R16C17	37-17-16	Hs~MGC:BC053901.1~uORF:IOH29032	1939	1038	2018	974	1056	2030	7216	992	2459	792	zinc finger protein 280A (SUHW1)
B37R16C18	37-18-16	Hs~MGC:BC053901.1~uORF:IOH29032	1915	900	1742	932	1002	1986	7358	1022	2515	806	zinc finger protein 280A (SUHW1)
B37R16C19	37-19-16	Hs~Ref:NM_002190.1~uORF:IOH29641	562	530	725	500	531	688	1054	530	1072	226	interleukin 17A (IL17A)
B37R16C20	37-20-16	Hs~Ref:NM_002190.1~uORF:IOH29641	530	2069	764	442	528	1229	1010	544	1138	313	interleukin 17A (IL17A)
B37R16C21	37-21-16	Hs~MGC:BC053675.1~uORF:IOH29030	1072	1534	881	1292	737	970	2131	727	1459	422	thymopoietin (TMPO)
B37R16C22	37-22-16	Hs~MGC:BC053675.1~uORF:IOH29030	940	1111	792	1371	657	849	2126	771	1837	364	thymopoietin (TMPO)
B37R17C03	37-3-17	Hs~MGC:BC016841.1~uORF:IOH10737	1112	1073	1067	690	1037	1236	1677	1002	1867	557	RAB34, member RAS oncogene family (RAB34)
B37R17C04	37-4-17	Hs~MGC:BC016841.1~uORF:IOH10737	1186	1077	1017	741	1019	1192	1328	916	1883	523	RAB34, member RAS oncogene family (RAB34)
B37R17C05	37-5-17	Hs~MGC:BC028935.1~uORF:IOH22836	1932	1284	1793	874	3219	2191	5787	1349	2689	623	chromosome 3 open reading frame 64 (C3orf64)
B37R17C06	37-6-17	Hs~MGC:BC028935.1~uORF:IOH22836	1935	1232	1766	878	3256	2172	5490	1710	3056	597	chromosome 3 open reading frame 64 (C3orf64)
B37R17C07	37-7-17	Hs~MGC:BC033734.1~uORF:IOH21809	759	748	910	551	1124	1362	1463	1309	2051	506	Uncharacterized protein C17orf66
B37R17C08	37-8-17	Hs~MGC:BC033734.1~uORF:IOH21809	779	936	827	603	1071	1361	1496	919	2156	528	Uncharacterized protein C17orf66
B37R17C09	37-9-17	Hs~MGC:BC010739.1~uORF:IOH9887	6872	4716	1134	2029	633	2025	1485	5115	2912	806	COP9 signalosome complex subunit 7b
B37R17C10	37-10-17	Hs~MGC:BC010739.1~uORF:IOH9887	7338	5030	1134	2072	457	2083	1494	5043	3250	799	COP9 signalosome complex subunit 7b
B37R17C11	37-11-17	Hs~Ref:NM_016096.1~uORF:IOH10050	1372	1019	1252	2658	3380	3275	8443	2368	3063	604	zinc finger protein 706 (ZNF706), transcript variant 2
B37R17C12	37-12-17	Hs~Ref:NM_016096.1~uORF:IOH10050	1435	1041	1275	2624	3495	3344	8493	2400	3006	575	zinc finger protein 706 (ZNF706), transcript variant 2
B37R17C13	37-13-17	Hs~Ref:NM_000266.1~uORF:IOH22822	214	291	275	231	784	385	324	345	393	126	Norrie disease (pseudoglioma) (NDP)
B37R17C14	37-14-17	Hs~Ref:NM_000266.1~uORF:IOH22822	260	169	304	293	784	359	384	366	223	139	Norrie disease (pseudoglioma) (NDP)
B37R17C15	37-15-17	Hs~Ref:NM_005901.2~uORF:IOH22138	645	1037	658	1446	926	1217	1668	1846	1083	149	SMAD family member 2 (SMAD2), transcript variant 1
B37R17C16	37-16-17	Hs~Ref:NM_005901.2~uORF:IOH22138	672	962	728	1466	1019	1271	1889	1893	1410	135	SMAD family member 2 (SMAD2), transcript variant 1
B37R17C17	37-17-17	Hs~Ref:NM_020954.1~uORF:IOH25742	915	519	1024	464	528	656	1629	493	1028	239	KIAA1618 (KIAA1618)
B37R17C18	37-18-17	Hs~Ref:NM_020954.1~uORF:IOH25742	917	519	986	445	554	685	1635	492	1092	33	KIAA1618 (KIAA1618)
B37R17C19	37-19-17	Hs~Ref:NM_003476.2~uORF:IOH7398	6676	2123	2318	21671	2589	2590	4658	1601	2903	754	cysteine and glycine-rich protein 3 (cardiac LIM protein) (CSRP3)
B37R17C20	37-20-17	Hs~Ref:NM_003476.2~uORF:IOH7398	7617	2605	3085	20939	2499	2705	4778	1513	2839	792	cysteine and glycine-rich protein 3 (cardiac LIM protein) (CSRP3)
B37R17C21	37-21-17	Hs~MGC:BC039014.1~uORF:IOH26125	1257	983	2610	1001	585	1055	1591	1112	1672	288	RNA polymerase II associated protein 2 (RPAP2)
B37R17C22	37-22-17	Hs~MGC:BC039014.1~uORF:IOH26125	1143	1751	1647	992	666	845	1561	1204	1788	370	RNA polymerase II associated protein 2 (RPAP2)
B37R18C01	37-1-18	Hs~Ref:NM_012321.1~uORF:IOH3488	16292	8391	65467	9588	5710	28259	9497	9834	29985	13594	LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM4)
B37R18C02	37-2-18	Hs~Ref:NM_012321.1~uORF:IOH3488	16028	8312	65478	8974	5684	22571	9518	10195	30503	14556	LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM4)
B37R18C03	37-3-18	Hs~Ref:NM_016319.1~uORF:IOH14433	1671	739	1449	754	621	1019	4370	1838	1874	462	COP9 constitutive photomorphogenic homolog subunit 7A (Arabidopsis) (COPS7A)
B37R18C04	37-4-18	Hs~Ref:NM_016319.1~uORF:IOH14433	1568	853	1384	800	645	1062	4010	1839	2056	436	COP9 constitutive photomorphogenic homolog subunit 7A (Arabidopsis) (COPS7A)
B37R18C05	37-5-18	Hs~Ref:NM_024760.1~uORF:IOH13956	702	602	1323	363	442	766	3074	1507	951	336	transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) (TLE6)
B37R18C06	37-6-18	Hs~Ref:NM_024760.1~uORF:IOH13956	646	689	1316	404	404	682	3172	1465	1134	311	transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) (TLE6)
B37R18C07	37-7-18	Hs~MGC:BC001433.1~uORF:IOH4012	506	297	1168	467	468	881	3530	1316	1316	370	centrosomal protein 250kDa (CEP250)
B37R18C08	37-8-18	Hs~MGC:BC001433.1~uORF:IOH4012	473	783	1138	473	473	842	3484	1617	1618	390	centrosomal protein 250kDa (CEP250)
B37R18C09	37-9-18	Hs~Ref:NM_021945.1~uORF:IOH21442	831	595	1718	418	730	874	3808	2569	1793	425	chromosome 6 open reading frame 85 (C6orf85)
B37R18C10	37-10-18	Hs~Ref:NM_021945.1~uORF:IOH21442	749	913	1714	457	691	811	3782	1926	1811	425	chromosome 6 open reading frame 85 (C6orf85)
B37R18C11	37-11-18	Hs~Ref:NM_001928.2~uORF:IOH29270	611	768	769	413	535	516	603	2000	781	186	Complement factor D
B37R18C12	37-12-18	Hs~Ref:NM_001928.2~uORF:IOH29270	620	567	806	394	477	521	576	1987	719	236	Complement factor D
B37R18C13	37-13-18	Hs~MGC:BC050546.1~uORF:IOH26928	812	499	723	489	-50	965	2146	549	876	409	MYB binding protein (P160) 1a (MYBBP1A)
B37R18C14	37-14-18	Hs~MGC:BC050546.1~uORF:IOH26928	769	464	711	455	236	893	2057	584	1527	334	MYB binding protein (P160) 1a (MYBBP1A)
B37R18C15	37-15-18	Hs~MGC:BC010634.1~uORF:IOH9775	532	498	548	411	495	620	1300	429	959	303	SLU7 splicing factor homolog (S. cerevisiae) (SLU7)
B37R18C16	37-16-18	Hs~MGC:BC010634.1~uORF:IOH9775	498	491	552	424	500	603	1405	405	1182	133	SLU7 splicing factor homolog (S. cerevisiae) (SLU7)
B37R18C17	37-17-18	Hs~Ref:NM_003590.2~uORF:IOH26262	868	1601	847	626	799	940	1895	812	1498	342	cullin 3 (CUL3)
B37R18C18	37-18-18	Hs~Ref:NM_003590.2~uORF:IOH26262	835	1385	843	655	601	943	1912	747	1375	142	cullin 3 (CUL3)
B37R18C19	37-19-18	Hs~Ref:NM_017588.1~uORF:IOH4895	1526	1191	2515	1218	1718	1506	4807	1710	3879	1128	WD repeat domain 5 (WDR5), transcript variant 1
B37R18C20	37-20-18	Hs~Ref:NM_017588.1~uORF:IOH4895	1476	1470	2811	1211	1843	1518	4634	1699	3890	1093	WD repeat domain 5 (WDR5), transcript variant 1
B37R18C21	37-21-18	Hs~MGC:BC010152.1~uORF:IOH27838	1181	1011	2345	833	992	1141	1118	830	2002	353	stomatin (EPB72)-like 2 (STOML2)
B37R18C22	37-22-18	Hs~MGC:BC010152.1~uORF:IOH27838	1202	796	2601	819	1005	919	1128	864	2132	524	stomatin (EPB72)-like 2 (STOML2)
B37R19C01	37-1-19	Hs~MGC:BC000758.1~uORF:IOH3735	1701	1273	2701	1476	2766	2555	2097	1488	2497	634	Coiled-coil domain-containing protein 28A
B37R19C02	37-2-19	Hs~MGC:BC000758.1~uORF:IOH3735	1811	1230	2764	1421	2794	2414	2122	1496	2452	630	Coiled-coil domain-containing protein 28A
B37R19C03	37-3-19	Hs~MGC:BC014385.1~uORF:IOH29333	6404	1151	3387	2119	31359	3957	2996	7122	4286	688	integrin beta 3 binding protein (beta3-endonexin) (ITGB3BP)
B37R19C04	37-4-19	Hs~MGC:BC014385.1~uORF:IOH29333	6782	1122	3360	1969	35260	4198	3128	6835	4459	685	integrin beta 3 binding protein (beta3-endonexin) (ITGB3BP)
B37R19C05	37-5-19	Hs~Ref:NM_032676.1~uORF:IOH5559	546	513	680	566	485	817	782	701	1844	320	hypothetical protein MGC10955 (MGC10955)
B37R19C06	37-6-19	Hs~Ref:NM_032676.1~uORF:IOH5559	557	606	665	573	438	930	854	725	1889	251	hypothetical protein MGC10955 (MGC10955)
B37R19C07	37-7-19	Hs~Ref:NM_001353.3~uORF:IOH14162	579	388	741	542	396	766	1129	599	942	293	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) (AKR1C1)
B37R19C08	37-8-19	Hs~Ref:NM_001353.3~uORF:IOH14162	536	370	785	566	405	857	1067	1224	901	357	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) (AKR1C1)
B37R19C09	37-9-19	Hs~MGC:BC023152.1~uORF:IOH21475	2169	669	1446	735	1601	6145	1216	1068	1829	210	glycogenin 2 (GYG2)
B37R19C10	37-10-19	Hs~MGC:BC023152.1~uORF:IOH21475	2192	658	1458	712	1406	6288	1202	669	2083	304	glycogenin 2 (GYG2)
B37R19C13	37-13-19	Hs~Ref:NM_005051.1~uORF:IOH3529	1235	1171	1206	1488	14171	2243	1403	697	2385	555	glutaminyl-tRNA synthetase (QARS)
B37R19C14	37-14-19	Hs~Ref:NM_005051.1~uORF:IOH3529	1254	1178	1265	1478	14340	2358	1510	707	2437	536	glutaminyl-tRNA synthetase (QARS)
B37R19C15	37-15-19	Hs~Ref:NM_014408.3~uORF:IOH5925	304	262	399	261	422	475	493	618	2270	67	trafficking protein particle complex 3 (TRAPPC3)
B37R19C16	37-16-19	Hs~Ref:NM_014408.3~uORF:IOH5925	285	337	419	255	401	453	504	624	2275	63	trafficking protein particle complex 3 (TRAPPC3)
B37R19C17	37-17-19	Hs~Ref:NM_022827.2~uORF:IOH12469	1774	1502	2229	1171	3229	3760	1976	50002	5914	2498	spermatogenesis associated 20 (SPATA20)
B37R19C18	37-18-19	Hs~Ref:NM_022827.2~uORF:IOH12469	1812	1585	2282	1180	2844	3688	1976	47774	6000	2357	spermatogenesis associated 20 (SPATA20)
B37R19C19	37-19-19	Hs~Ref:NM_014412.2~uORF:IOH7484	1044	686	1083	1010	2327	1281	1035	1938	1905	414	calcyclin binding protein (CACYBP), transcript variant 1
B37R19C20	37-20-19	Hs~Ref:NM_014412.2~uORF:IOH7484	1011	667	1052	1019	2497	1348	1160	1923	1782	424	calcyclin binding protein (CACYBP), transcript variant 1
B37R19C21	37-21-19	Hs~MGC:BC000772.1~uORF:IOH4704	486	525	608	484	539	865	672	433	1490	1188	Myosin light chain 2, lymphocyte-specific
B37R19C22	37-22-19	Hs~MGC:BC000772.1~uORF:IOH4704	501	662	1019	455	523	615	658	420	1746	1172	Myosin light chain 2, lymphocyte-specific
B37R20C01	37-1-20	Hs~Ref:NM_004965.3~uORF:IOH4772	3743	1690	3560	1947	1376	2321	17072	1479	3865	2098	high-mobility group nucleosome binding domain 1 (HMGN1)
B37R20C02	37-2-20	Hs~Ref:NM_004965.3~uORF:IOH4772	3889	1597	3486	1905	1355	2187	16809	1524	4063	2188	high-mobility group nucleosome binding domain 1 (HMGN1)
B37R20C03	37-3-20	Hs~MGC:BC001132.1~uORF:IOH3853	3695	1667	2404	1592	1616	3042	18676	1938	3703	1967	DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 (DDX54)
B37R20C04	37-4-20	Hs~MGC:BC001132.1~uORF:IOH3853	3801	1689	2374	1459	1749	3073	18296	1976	3780	1957	DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 (DDX54)
B37R20C05	37-5-20	Hs~MGC:BC003604.1~uORF:IOH4978	669	930	881	575	3360	720	950	659	1769	1094	Importin-9
B37R20C06	37-6-20	Hs~MGC:BC003604.1~uORF:IOH4978	679	733	819	555	3415	769	992	715	2895	1127	Importin-9
B37R20C07	37-7-20	Hs~Ref:NM_005694.1~uORF:IOH12906	766	982	562	237	671	1630	3808	679	1064	154	COX17 cytochrome c oxidase assembly homolog (S. cerevisiae) (COX17), nuclear gene encoding mitochondrial protein
B37R20C08	37-8-20	Hs~Ref:NM_005694.1~uORF:IOH12906	781	1375	609	194	706	1686	4042	1158	184	92	COX17 cytochrome c oxidase assembly homolog (S. cerevisiae) (COX17), nuclear gene encoding mitochondrial protein
B37R20C09	37-9-20	Hs~MGC:BC014298.1~uORF:IOH13449	12107	19256	5091	5955	5915	9862	10762	13888	16274	10208	PRKR interacting protein 1 (IL11 inducible) (PRKRIP1)
B37R20C10	37-10-20	Hs~MGC:BC014298.1~uORF:IOH13449	12447	19450	5099	6348	5960	10447	10855	12265	16780	9879	PRKR interacting protein 1 (IL11 inducible) (PRKRIP1)
B37R20C11	37-11-20	Hs~Ref:NM_005097.1~uORF:IOH10604	538	3471	575	305	284	516	610	674	765	297	leucine-rich, glioma inactivated 1 (LGI1)
B37R20C12	37-12-20	Hs~Ref:NM_005097.1~uORF:IOH10604	494	25	506	297	225	444	570	428	696	285	leucine-rich, glioma inactivated 1 (LGI1)
B37R20C13	37-13-20	Hs~MGC:BC004239.1~uORF:IOH5526	316	356	439	241	913	467	607	342	1049	524	jumping translocation breakpoint (JTB)
B37R20C14	37-14-20	Hs~MGC:BC004239.1~uORF:IOH5526	331	283	448	229	216	405	452	342	1011	513	jumping translocation breakpoint (JTB)
B38R02C13	38-13-2	Hs~Ref:NM_004892.2~uORF:IOH3957	1255	2052	1651	1467	1077	1184	1827	1820	2580	587	Vesicle-trafficking protein SEC22b
B38R02C14	38-14-2	Hs~Ref:NM_004892.2~uORF:IOH3957	1224	2013	1658	1317	1085	1190	1781	1211	2579	564	Vesicle-trafficking protein SEC22b
B38R02C15	38-15-2	Hs~MGC:BC058920.1~uORF:IOH29109	1116	891	1258	785	774	782	1330	887	2480	571	Acyl carrier protein, mitochondrial
B38R02C16	38-16-2	Hs~MGC:BC058920.1~uORF:IOH29109	1086	944	1213	783	775	766	1311	909	2327	619	Acyl carrier protein, mitochondrial
B38R02C17	38-17-2	Hs~MGC:BC013990.1~uORF:IOH14082	1445	1194	1438	1465	865	1429	2097	1232	2270	1085	WD repeat-containing protein 33
B38R02C18	38-18-2	Hs~MGC:BC013990.1~uORF:IOH14082	1501	1281	1392	1496	893	1375	2002	1272	2375	1034	WD repeat-containing protein 33
B38R02C19	38-19-2	Hs~MGC:NM_176826.1~uORF:IOH4631	781	904	659	367	375	475	759	470	666	267	ilvB (bacterial acetolactate synthase)-like (ILVBL), transcript variant 2
B38R02C20	38-20-2	Hs~MGC:NM_176826.1~uORF:IOH4631	790	847	692	383	379	489	743	446	728	290	ilvB (bacterial acetolactate synthase)-like (ILVBL), transcript variant 2
B38R02C21	38-21-2	Hs~Ref:NM_015991.1~uORF:IOH23091	1101	724	1276	759	1403	1191	1684	678	1436	442	complement component 1, q subcomponent, A chain (C1QA)
B38R02C22	38-22-2	Hs~Ref:NM_015991.1~uORF:IOH23091	1091	735	1238	729	1384	1152	2130	796	1391	420	complement component 1, q subcomponent, A chain (C1QA)
B38R03C01	38-1-3	Hs~Ref:NM_033261.2~uORF:IOH12134	4867	399	827	623	698	3356	2096	627	1804	427	isopentenyl-diphosphate delta isomerase 2 (IDI2)
B38R03C02	38-2-3	Hs~Ref:NM_033261.2~uORF:IOH12134	5107	444	837	637	723	3280	2176	623	1774	397	isopentenyl-diphosphate delta isomerase 2 (IDI2)
B38R03C05	38-5-3	Hs~Ref:NM_153612.2~uORF:IOH35580	335	303	377	286	353	348	482	351	375	120	heparan sulfate (glucosamine) 3-O-sulfotransferase 5 (HS3ST5)
B38R03C06	38-6-3	Hs~Ref:NM_153612.2~uORF:IOH35580	344	258	424	284	170	348	466	318	161	282	heparan sulfate (glucosamine) 3-O-sulfotransferase 5 (HS3ST5)
B38R03C07	38-7-3	Hs~Ref:NM_173065.1~uORF:IOH40989	429	332	460	1011	396	334	452	354	644	240	interleukin 28 receptor, alpha (interferon, lambda receptor) (IL28RA), transcript variant 3
B38R03C08	38-8-3	Hs~Ref:NM_173065.1~uORF:IOH40989	425	527	529	702	413	344	467	394	647	262	interleukin 28 receptor, alpha (interferon, lambda receptor) (IL28RA), transcript variant 3
B38R03C09	38-9-3	Hs~Ref:NM_153031.1~uORF:IOH40991	327	522	399	859	375	358	341	409	688	233	hypothetical protein LOC150538 (FLJ32063)
B38R03C10	38-10-3	Hs~Ref:NM_153031.1~uORF:IOH40991	383	380	418	789	402	378	336	364	457	259	hypothetical protein LOC150538 (FLJ32063)
B38R03C11	38-11-3	Hs~Ref:NM_178176.2~uORF:IOH40964	332	397	519	407	395	417	490	364	774	309	monoacylglycerol O-acyltransferase 3 (MOGAT3)
B38R03C12	38-12-3	Hs~Ref:NM_178176.2~uORF:IOH40964	362	416	518	387	364	428	476	416	849	161	monoacylglycerol O-acyltransferase 3 (MOGAT3)
B38R03C13	38-13-3	Hs~Ref:NM_002309.2~uORF:IOH34705	2270	1335	4796	1033	1212	1078	4402	1096	1649	1171	leukemia inhibitory factor (cholinergic differentiation factor) (LIF)
B38R03C14	38-14-3	Hs~Ref:NM_002309.2~uORF:IOH34705	2225	1358	4988	998	1231	1111	4462	1027	1546	1067	leukemia inhibitory factor (cholinergic differentiation factor) (LIF)
B38R03C15	38-15-3	Hs~Ref:NM_000139.2~uORF:IOH44387	778	444	895	437	429	613	929	485	2330	158	membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide) (MS4A2)
B38R03C16	38-16-3	Hs~Ref:NM_000139.2~uORF:IOH44387	814	436	877	436	465	601	964	482	2101	220	membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide) (MS4A2)
B38R03C17	38-17-3	Hs~Ref:NM_202467.1~uORF:IOH45902	1253	707	744	407	486	1035	1492	570	933	237	GIPC PDZ domain containing family, member 1 (GIPC1), transcript variant 2
B38R03C18	38-18-3	Hs~Ref:NM_202467.1~uORF:IOH45902	1374	722	765	399	481	1005	1511	592	833	192	GIPC PDZ domain containing family, member 1 (GIPC1), transcript variant 2
B38R03C19	38-19-3	Hs~Ref:NM_000606.1~uORF:IOH44341	589	441	549	354	326	452	572	325	654	274	complement component 8, gamma polypeptide (C8G)
B38R03C20	38-20-3	Hs~Ref:NM_000606.1~uORF:IOH44341	558	466	561	412	349	480	604	401	715	202	complement component 8, gamma polypeptide (C8G)
B38R03C21	38-21-3	Hs~MGC:BC016942.1~uORF:IOH10309	1558	1229	2690	1544	1227	2880	1863	2153	3475	1281	Putative adenosylhomocysteinase 2
B38R03C22	38-22-3	Hs~MGC:BC016942.1~uORF:IOH10309	1548	1225	2662	1465	1243	2811	1828	2237	3468	1253	Putative adenosylhomocysteinase 2
B38R04C01	38-1-4	Hs~MGC:BC017724.1~uORF:IOH10317	770	1510	765	351	784	1128	8915	1365	1922	576	FIP1 like 1 (S. cerevisiae) (FIP1L1)
B38R04C02	38-2-4	Hs~MGC:BC017724.1~uORF:IOH10317	854	1636	743	369	815	1084	8719	1283	1963	618	FIP1 like 1 (S. cerevisiae) (FIP1L1)
B38R04C03	38-3-4	Hs~MGC:BC015329.1~uORF:IOH10328	1259	1348	1525	845	691	1626	1460	702	2018	230	transgelin 3 (TAGLN3)
B38R04C04	38-4-4	Hs~MGC:BC015329.1~uORF:IOH10328	1437	1426	1565	860	699	1542	1451	722	2027	340	transgelin 3 (TAGLN3)
B38R04C05	38-5-4	Hs~Ref:NM_007260.2~uORF:IOH10346	398	325	393	354	590	793	587	611	1406	313	lysophospholipase II (LYPLA2)
B38R04C06	38-6-4	Hs~Ref:NM_007260.2~uORF:IOH10346	114	314	388	343	591	769	577	571	1336	262	lysophospholipase II (LYPLA2)
B38R04C07	38-7-4	Hs~Ref:NM_005155.5~uORF:IOH3929	3069	495	631	505	489	638	1159	602	973	343	palmitoyl-protein thioesterase 2 (PPT2), transcript variant 1
B38R04C08	38-8-4	Hs~Ref:NM_005155.5~uORF:IOH3929	657	434	664	474	495	703	1157	590	946	379	palmitoyl-protein thioesterase 2 (PPT2), transcript variant 1
B38R04C09	38-9-4	Hs~MGC:NM_152587.2~uORF:IOH22568	873	582	703	552	671	733	1192	696	1984	445	chromosome 11 open reading frame 65 (C11orf65)
B38R04C10	38-10-4	Hs~MGC:NM_152587.2~uORF:IOH22568	846	581	734	600	626	647	1197	650	1766	466	chromosome 11 open reading frame 65 (C11orf65)
B38R04C11	38-11-4	Hs~MGC:BC007047.1~uORF:IOH7319	935	590	1254	689	648	805	1107	666	1761	451	fibrinogen-like 1 (FGL1)
B38R04C12	38-12-4	Hs~MGC:BC007047.1~uORF:IOH7319	938	577	1083	687	621	774	1071	635	1736	519	fibrinogen-like 1 (FGL1)
B38R04C13	38-13-4	Hs~Ref:NM_144654.1~uORF:IOH12733	1393	719	1453	789	908	830	1861	796	2064	490	chromosome 9 open reading frame 116 (C9orf116), transcript variant 2
B38R04C14	38-14-4	Hs~Ref:NM_144654.1~uORF:IOH12733	1338	749	1465	788	915	925	1823	744	1917	535	chromosome 9 open reading frame 116 (C9orf116), transcript variant 2
B38R04C15	38-15-4	Hs~MGC:BC021934.1~uORF:IOH27957	1216	651	975	720	747	848	1667	512	959	307	proline rich 14 (PRR14)
B38R04C16	38-16-4	Hs~MGC:BC021934.1~uORF:IOH27957	1268	668	1023	798	716	809	1767	486	962	316	proline rich 14 (PRR14)
B38R04C17	38-17-4	Hs~Ref:NM_017629.2~uORF:IOH38411	1941	953	1396	1343	680	1270	5203	917	1634	576	eukaryotic translation initiation factor 2C, 4 (EIF2C4)
B38R04C18	38-18-4	Hs~Ref:NM_017629.2~uORF:IOH38411	1945	1014	1409	1391	681	1378	5296	924	1694	591	eukaryotic translation initiation factor 2C, 4 (EIF2C4)
B38R04C19	38-19-4	Hs~Ref:NM_001098.2~uORF:IOH22985	1343	1590	1058	3532	1076	3255	4847	1774	985	511	aconitase 2, mitochondrial (ACO2), nuclear gene encoding mitochondrial protein
B38R04C20	38-20-4	Hs~Ref:NM_001098.2~uORF:IOH22985	1385	1559	1019	3335	1066	3085	4221	1573	1007	494	aconitase 2, mitochondrial (ACO2), nuclear gene encoding mitochondrial protein
B38R04C21	38-21-4	Hs~Ref:NM_002235.2~uORF:IOH37901	1211	782	1539	797	977	887	1637	713	3102	497	potassium voltage-gated channel, shaker-related subfamily, member 6 (KCNA6)
B38R04C22	38-22-4	Hs~Ref:NM_002235.2~uORF:IOH37901	1167	753	1454	817	968	818	1601	747	2937	523	potassium voltage-gated channel, shaker-related subfamily, member 6 (KCNA6)
B38R05C01	38-1-5	Hs~MGC:BC013031.1~uORF:IOH13433	902	2371	1192	792	1083	1110	1071	1034	4270	376	Pleckstrin homology-like domain family B member 1
B38R05C02	38-2-5	Hs~MGC:BC013031.1~uORF:IOH13433	944	2601	1153	850	1269	1164	1123	998	4227	421	Pleckstrin homology-like domain family B member 1
B38R05C03	38-3-5	Hs~MGC:BC007199.1~uORF:IOH6547	957	697	1022	719	816	861	978	752	1469	587	Metal transporter CNNM3
B38R05C04	38-4-5	Hs~MGC:BC007199.1~uORF:IOH6547	1305	696	1066	834	751	905	1032	643	1221	453	Metal transporter CNNM3
B38R05C05	38-5-5	Hs~MGC:BC031079.1~uORF:IOH22556	3001	892	1211	1096	1100	867	4018	969	1406	915	CUG triplet repeat, RNA binding protein 1 (CUGBP1)
B38R05C06	38-6-5	Hs~MGC:BC031079.1~uORF:IOH22556	2000	939	1169	1139	1155	916	4130	986	1613	930	CUG triplet repeat, RNA binding protein 1 (CUGBP1)
B38R05C09	38-9-5	Hs~Ref:NM_013392.1~N/A	1767	448	1085	1007	616	728	929	990	2552	256	Nuclear receptor-binding protein
B38R05C10	38-10-5	Hs~Ref:NM_013392.1~N/A	1889	439	1007	964	600	652	909	992	2302	147	Nuclear receptor-binding protein
B38R05C11	38-11-5	Hs~Ref:NM_003674.1~N/A	795	586	1399	736	586	668	793	931	1237	497	Cell division protein kinase 10
B38R05C12	38-12-5	Hs~Ref:NM_003674.1~N/A	776	646	1302	684	585	625	766	861	1224	558	Cell division protein kinase 10
B38R05C13	38-13-5	Hs~Ref:NM_006374.2~N/A	1228	744	1724	822	781	874	1600	973	1803	426	serine/threonine kinase 25 (STE20 homolog, yeast) (STK25)
B38R05C14	38-14-5	Hs~Ref:NM_006374.2~N/A	1260	767	1777	893	782	1050	1646	992	1891	463	serine/threonine kinase 25 (STE20 homolog, yeast) (STK25)
B38R05C15	38-15-5	Hs~Ref:NM_005044.1~N/A	835	694	880	821	677	787	1497	628	919	392	protein kinase, X-linked (PRKX)
B38R05C16	38-16-5	Hs~Ref:NM_005044.1~N/A	879	735	890	868	738	832	1478	639	1055	419	protein kinase, X-linked (PRKX)
B38R05C17	38-17-5	Hs~MGC:BC068460.1~uORF:IOH40106	927	1210	1434	1339	1039	1261	1673	2054	2526	437	thiamin pyrophosphokinase 1 (TPK1)
B38R05C18	38-18-5	Hs~MGC:BC068460.1~uORF:IOH40106	928	1236	1359	1304	1021	1212	1624	1885	2504	461	thiamin pyrophosphokinase 1 (TPK1)
B38R05C19	38-19-5	Hs~Ref:NM_021803.1~uORF:IOH40163	2170	1211	2170	2940	1501	1315	3313	956	2295	1220	interleukin 21 (IL21)
B38R05C20	38-20-5	Hs~Ref:NM_021803.1~uORF:IOH40163	2217	1300	2214	2817	1518	1301	3145	985	2277	1072	interleukin 21 (IL21)
B38R05C21	38-21-5	Hs~Ref:NM_000519.2~uORF:IOH40232	624	844	989	535	773	713	789	549	982	1347	hemoglobin, delta (HBD)
B38R05C22	38-22-5	Hs~Ref:NM_000519.2~uORF:IOH40232	628	830	1003	529	734	677	812	614	1178	1372	hemoglobin, delta (HBD)
B38R06C01	38-1-6	Hs~Ref:NM_178813.5~uORF:IOH40109	2744	883	1773	1124	1300	2174	2644	1763	3065	543	A kinase (PRKA) anchor protein 14 (AKAP14), transcript variant 1
B38R06C02	38-2-6	Hs~Ref:NM_178813.5~uORF:IOH40109	2509	907	1774	1104	1424	2147	2709	1763	2932	585	A kinase (PRKA) anchor protein 14 (AKAP14), transcript variant 1
B38R06C03	38-3-6	Hs~MGC:BC017956.1~uORF:IOH12293	3332	1815	2698	3198	1826	1951	3277	1539	4979	1212	phospholipase A2, group IVC (cytosolic, calcium-independent) (PLA2G4C)
B38R06C04	38-4-6	Hs~MGC:BC017956.1~uORF:IOH12293	3405	1873	2790	3014	1879	1998	3244	1662	4464	1132	phospholipase A2, group IVC (cytosolic, calcium-independent) (PLA2G4C)
B38R06C05	38-5-6	Hs~Ref:NM_031491.1~uORF:IOH23163	2896	1164	1348	860	1106	955	1436	1135	2052	363	retinol binding protein 5, cellular (RBP5)
B38R06C06	38-6-6	Hs~Ref:NM_031491.1~uORF:IOH23163	865	1130	1366	978	1088	957	1370	1383	2016	389	retinol binding protein 5, cellular (RBP5)
B38R06C07	38-7-6	Hs~MGC:BC031799.1~uORF:IOH22193	2269	1271	1827	1317	1317	1487	2592	2385	2795	879	Acyl-coenzyme A thioesterase 4
B38R06C08	38-8-6	Hs~MGC:BC031799.1~uORF:IOH22193	1708	1234	1867	1247	1405	1457	2477	1483	2796	738	Acyl-coenzyme A thioesterase 4
B38R06C09	38-9-6	Hs~MGC:NM_175870.3~uORF:IOH5318	1463	1093	1771	936	1157	1254	1968	1185	2536	697	hypothetical protein LOC90925 (LOC90925)
B38R06C10	38-10-6	Hs~MGC:NM_175870.3~uORF:IOH5318	1443	1068	1743	1037	1166	1228	2223	1202	2421	732	hypothetical protein LOC90925 (LOC90925)
B38R06C11	38-11-6	Hs~Ref:NM_001015509.1~uORF:IOH54713	1200	1103	2999	1116	1416	23012	4835	1348	1784	609	Peptidyl-tRNA hydrolase 2, mitochondrial
B38R06C12	38-12-6	Hs~Ref:NM_001015509.1~uORF:IOH54713	1221	1129	2910	1132	1443	21859	4701	2937	1616	619	Peptidyl-tRNA hydrolase 2, mitochondrial
B38R06C13	38-13-6	Hs~Ref:NM_020137.3~uORF:IOH52884	1474	2136	5001	1421	2414	2445	4387	3202	2048	799	GRIP1-associated protein 1
B38R06C14	38-14-6	Hs~Ref:NM_020137.3~uORF:IOH52884	1554	2263	5077	1284	2483	2613	4008	2170	2069	768	GRIP1-associated protein 1
B38R06C15	38-15-6	Hs~Ref:NM_002154.3~uORF:IOH52882	631	486	726	3102	665	965	1322	717	991	208	Heat shock 70 kDa protein 4
B38R06C16	38-16-6	Hs~Ref:NM_002154.3~uORF:IOH52882	634	483	762	3399	659	888	1273	672	830	195	Heat shock 70 kDa protein 4
B38R06C17	38-17-6	Hs~Ref:NM_013393.1~uORF:IOH59783	2753	1535	3031	1786	1302	6802	2991	1321	1722	681	Putative ribosomal RNA methyltransferase 2
B38R06C18	38-18-6	Hs~Ref:NM_013393.1~uORF:IOH59783	2916	1603	2872	1744	1280	6650	3086	1332	1757	681	Putative ribosomal RNA methyltransferase 2
B38R06C19	38-19-6	Hs~Ref:NM_152324.1~uORF:IOH22764	1009	547	1059	769	1574	881	1175	542	1352	449	chromosome 13 open reading frame 16 (C13orf16)
B38R06C20	38-20-6	Hs~Ref:NM_152324.1~uORF:IOH22764	1048	518	1042	823	1631	890	1086	556	1348	309	chromosome 13 open reading frame 16 (C13orf16)
B38R06C21	38-21-6	Hs~Ref:NM_152772.1~uORF:IOH21739	1952	1218	2700	3146	1519	1849	1575	2492	2889	1332	T-complex protein 11-like protein 2
B38R06C22	38-22-6	Hs~Ref:NM_152772.1~uORF:IOH21739	1899	1190	2739	3187	1530	1854	1574	2391	2851	1361	T-complex protein 11-like protein 2
B38R07C01	38-1-7	Hs~Ref:NM_032509.2~uORF:IOH26995	722	709	685	523	889	766	702	667	1404	267	RNA binding motif protein 13 (RBM13)
B38R07C02	38-2-7	Hs~Ref:NM_032509.2~uORF:IOH26995	735	675	693	562	795	778	674	617	1249	487	RNA binding motif protein 13 (RBM13)
B38R07C03	38-3-7	Hs~Ref:NM_006337.3~uORF:IOH12378	3165	1807	2343	1490	1789	4857	9309	1163	2698	720	microspherule protein 1 (MCRS1), transcript variant 1
B38R07C04	38-4-7	Hs~Ref:NM_006337.3~uORF:IOH12378	3337	1864	2368	1397	1968	4803	10124	1182	2604	796	microspherule protein 1 (MCRS1), transcript variant 1
B38R07C05	38-5-7	Hs~MGC:BC026038.1~uORF:IOH13982	65451	65496	65486	65489	65438	65469	65482	65491	65473	65469	Ig gamma-1 chain C region
B38R07C06	38-6-7	Hs~MGC:BC026038.1~uORF:IOH13982	65331	65494	65486	65487	65466	65475	65484	65489	65475	65473	Ig gamma-1 chain C region
B38R07C09	38-9-7	Hs~MGC:NM_181526.1~uORF:IOH5278	1238	1580	1342	2935	2985	1065	5531	1114	1414	259	myosin, light chain 9, regulatory (MYL9), transcript variant 2, mRNA.
B38R07C10	38-10-7	Hs~MGC:NM_181526.1~uORF:IOH5278	1248	1652	1250	2798	2712	1018	5479	1099	1371	219	myosin, light chain 9, regulatory (MYL9), transcript variant 2, mRNA.
B38R07C11	38-11-7	Hs~MGC:BC000044.1~uORF:IOH4604	4907	2551	4558	2622	4914	2224	16574	2620	4909	1649	Spindlin-2B
B38R07C12	38-12-7	Hs~MGC:BC000044.1~uORF:IOH4604	5007	2456	4768	2569	4769	2144	16373	2102	4694	1672	Spindlin-2B
B38R07C13	38-13-7	Hs~Ref:NM_002737.1~N/A	918	582	1023	1600	540	781	1065	1548	1038	480	protein kinase C, alpha (PRKCA); see catalog number for detailed information on wild-type or point mutant status
B38R07C14	38-14-7	Hs~Ref:NM_002737.1~N/A	883	634	1007	1692	566	802	1067	851	1285	386	protein kinase C, alpha (PRKCA); see catalog number for detailed information on wild-type or point mutant status
B38R07C15	38-15-7	Hs~Ref:NM_006206.2~N/A	889	770	1094	3779	865	901	1207	758	1695	549	Alpha-type platelet-derived growth factor receptor
B38R07C16	38-16-7	Hs~Ref:NM_006206.2~N/A	1019	833	984	3948	1029	941	1221	849	1630	444	Alpha-type platelet-derived growth factor receptor
B38R07C17	38-17-7	Hs~Ref:NM_000222.1~N/A	1577	1158	1673	11629	4642	902	1595	969	1887	1117	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), transcript variant 1; see catalog number for detailed information on wild-type or point mutant status
B38R07C18	38-18-7	Hs~Ref:NM_000222.1~N/A	1562	1299	1688	11641	4524	793	1551	863	1872	807	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), transcript variant 1; see catalog number for detailed information on wild-type or point mutant status
B38R07C19	38-19-7	Hs~Ref:NM_005734.1~N/A	3880	3450	3381	33257	15168	1101	1399	843	3675	3982	homeodomain interacting protein kinase 3 (HIPK3), transcript variant 1
B38R07C20	38-20-7	Hs~Ref:NM_005734.1~N/A	3793	3479	3224	33420	13914	1142	1355	1063	3688	3082	homeodomain interacting protein kinase 3 (HIPK3), transcript variant 1
B38R07C21	38-21-7	Hs~Ref:NM_017785.2~uORF:IOH12118	2060	2952	1818	3665	1637	1444	1411	1816	1924	3442	coiled-coil domain containing 99 (CCDC99)
B38R07C22	38-22-7	Hs~Ref:NM_017785.2~uORF:IOH12118	2083	2917	1717	3524	1618	1436	1418	1695	1898	3291	coiled-coil domain containing 99 (CCDC99)
B38R08C01	38-1-8	Hs~MGC:BC014428.1~uORF:IOH14661	764	706	743	3203	869	505	789	509	658	331	mitochondrial translational release factor 1-like (MTRF1L)
B38R08C02	38-2-8	Hs~MGC:BC014428.1~uORF:IOH14661	735	658	687	3496	1007	466	851	535	589	415	mitochondrial translational release factor 1-like (MTRF1L)
B38R08C03	38-3-8	Hs~MGC:BC016929.1~uORF:IOH11225	3724	3481	2921	11729	8351	631	957	605	1460	942	MHC class I polypeptide-related sequence A (MICA)
B38R08C04	38-4-8	Hs~MGC:BC016929.1~uORF:IOH11225	3802	3326	3154	13309	7754	673	966	625	1630	940	MHC class I polypeptide-related sequence A (MICA)
B38R08C05	38-5-8	Hs~MGC:BC041037.1~uORF:IOH28003	65485	52309	53005	52466	65451	43198	30068	39724	65476	65482	immunoglobulin heavy constant mu (IGHM)
B38R08C06	38-6-8	Hs~MGC:BC041037.1~uORF:IOH28003	65043	52883	53423	47008	63895	44701	29044	40952	65261	65483	immunoglobulin heavy constant mu (IGHM)
B38R08C07	38-7-8	Hs~MGC:BC033181.1~uORF:IOH23240	3713	4482	1235	1266	1158	1278	1349	744	2655	623	formin-like 3 (FMNL3)
B38R08C08	38-8-8	Hs~MGC:BC033181.1~uORF:IOH23240	3680	4662	1186	1223	1142	1154	1351	761	2518	608	formin-like 3 (FMNL3)
B38R08C09	38-9-8	Hs~Ref:NM_145701.1~uORF:IOH12253	959	697	1290	895	1003	745	1245	572	1785	382	cell division cycle associated 4 (CDCA4), transcript variant 14
B38R08C10	38-10-8	Hs~Ref:NM_145701.1~uORF:IOH12253	1014	740	1249	880	983	749	1289	613	1806	401	cell division cycle associated 4 (CDCA4), transcript variant 14
B38R08C11	38-11-8	Hs~Ref:NM_006586.2~uORF:IOH5802	681	644	1017	1210	680	711	1467	458	1145	165	Protein canopy homolog 3
B38R08C12	38-12-8	Hs~Ref:NM_006586.2~uORF:IOH5802	724	713	1238	1240	665	661	1414	214	1083	59	Protein canopy homolog 3
B38R08C13	38-13-8	Hs~MGC:BC010084.2~uORF:IOH13070	665	840	1071	3410	753	717	741	558	1967	225	family with sequence similarity 86, member A (FAM86A)
B38R08C14	38-14-8	Hs~MGC:BC010084.2~uORF:IOH13070	660	841	1006	3381	757	681	741	507	1929	219	family with sequence similarity 86, member A (FAM86A)
B38R08C15	38-15-8	Hs~Ref:NM_031899.2~uORF:IOH45679	563	495	779	522	429	799	1262	503	773	339	golgi reassembly stacking protein 1, 65kDa (GORASP1)
B38R08C16	38-16-8	Hs~Ref:NM_031899.2~uORF:IOH45679	572	442	783	500	439	890	1208	540	801	275	golgi reassembly stacking protein 1, 65kDa (GORASP1)
B38R08C17	38-17-8	Hs~Ref:NM_006877.1~uORF:IOH6246	651	591	660	577	497	888	1728	617	1489	421	guanosine monophosphate reductase (GMPR)
B38R08C18	38-18-8	Hs~Ref:NM_006877.1~uORF:IOH6246	743	597	725	591	539	763	1629	574	1444	438	guanosine monophosphate reductase (GMPR)
B38R08C19	38-19-8	Hs~Ref:NM_003153.3~uORF:IOH45683	1220	827	1638	974	673	946	1629	988	1403	710	signal transducer and activator of transcription 6, interleukin-4 induced (STAT6)
B38R08C20	38-20-8	Hs~Ref:NM_003153.3~uORF:IOH45683	1172	774	1641	1010	630	987	1588	912	1380	691	signal transducer and activator of transcription 6, interleukin-4 induced (STAT6)
B38R08C21	38-21-8	Hs~Ref:NM_018325.1~uORF:IOH45695	1128	760	913	760	613	813	1389	703	1379	431	chromosome 9 open reading frame 72 (C9orf72), transcript variant 1
B38R08C22	38-22-8	Hs~Ref:NM_018325.1~uORF:IOH45695	1170	760	978	701	596	849	1328	699	1262	400	chromosome 9 open reading frame 72 (C9orf72), transcript variant 1
B38R09C01	38-1-9	Hs~Ref:NM_000983.3~uORF:IOH58958	2858	1394	2397	1282	1123	2464	11494	1335	2529	597	60S ribosomal protein L22
B38R09C02	38-2-9	Hs~Ref:NM_000983.3~uORF:IOH58958	3011	1527	2327	1270	1170	2409	10472	1350	2385	549	60S ribosomal protein L22
B38R09C05	38-5-9	Hs~Ref:NM_024060.2~uORF:IOH54639	438	345	592	1350	548	2825	907	502	1558	130	AHNAK nucleoprotein (AHNAK), transcript variant 2
B38R09C06	38-6-9	Hs~Ref:NM_024060.2~uORF:IOH54639	483	327	631	1347	535	2765	964	507	1559	192	AHNAK nucleoprotein (AHNAK), transcript variant 2
B38R09C07	38-7-9	Hs~Ref:NM_007079.2~uORF:IOH4497	2011	1111	1690	1299	1761	1203	5576	1197	1946	811	Protein tyrosine phosphatase type IVA 3
B38R09C08	38-8-9	Hs~Ref:NM_007079.2~uORF:IOH4497	1888	1115	1799	1247	1647	1303	5318	1134	1776	716	Protein tyrosine phosphatase type IVA 3
B38R09C09	38-9-9	Hs~Ref:NM_006554.3~uORF:IOH56609	473	309	515	318	390	453	512	485	706	297	Metaxin-2
B38R09C10	38-10-9	Hs~Ref:NM_006554.3~uORF:IOH56609	486	414	493	403	403	452	500	490	730	194	Metaxin-2
B38R09C17	38-17-9	Hs~MGC:BC013172.1~uORF:IOH11965	410	310	943	358	898	9	414	361	561	273	ankyrin repeat and SOCS box-containing 9 (ASB9)
B38R09C18	38-18-9	Hs~MGC:BC013172.1~uORF:IOH11965	388	277	896	357	867	353	419	339	433	224	ankyrin repeat and SOCS box-containing 9 (ASB9)
B38R09C19	38-19-9	Hs~Ref:NM_013416.1~uORF:IOH5398	505	341	458	534	425	442	623	489	580	360	neutrophil cytosolic factor 4, 40kDa (NCF4), transcript variant 2
B38R09C20	38-20-9	Hs~Ref:NM_013416.1~uORF:IOH5398	503	348	465	519	374	420	630	467	571	426	neutrophil cytosolic factor 4, 40kDa (NCF4), transcript variant 2
B38R09C21	38-21-9	Hs~MGC:BC025708.1~uORF:IOH11251	472	325	906	379	242	421	1534	730	533	83	multiple C2 domains, transmembrane 2 (MCTP2)
B38R09C22	38-22-9	Hs~MGC:BC025708.1~uORF:IOH11251	448	286	922	446	295	409	1615	742	380	90	multiple C2 domains, transmembrane 2 (MCTP2)
B38R10C01	38-1-10	Hs~MGC:BC020225.1~uORF:IOH13323	347	198	575	283	372	466	461	283	655	115	Putative phosphatidylinositol 4-kinase alpha-like protein P2
B38R10C02	38-2-10	Hs~MGC:BC020225.1~uORF:IOH13323	331	1304	494	291	360	451	463	278	299	81	Putative phosphatidylinositol 4-kinase alpha-like protein P2
B38R10C03	38-3-10	Hs~Ref:NM_000714.3~uORF:IOH3897	733	856	930	640	1100	858	1487	738	927	402	translocator protein (18kDa) (TSPO), transcript variant PBR
B38R10C04	38-4-10	Hs~Ref:NM_000714.3~uORF:IOH3897	739	811	959	591	1072	889	1568	703	1336	424	translocator protein (18kDa) (TSPO), transcript variant PBR
B38R10C05	38-5-10	Hs~MGC:BC016715.1~uORF:IOH27895	773	840	1079	642	1430	891	1522	780	1637	359	ferritin, light polypeptide (FTL)
B38R10C06	38-6-10	Hs~MGC:BC016715.1~uORF:IOH27895	800	912	1123	654	1350	905	1449	756	1538	498	ferritin, light polypeptide (FTL)
B38R10C07	38-7-10	Hs~Ref:NM_003929.1~uORF:IOH4101	1464	1345	1639	1046	2670	913	1427	1064	2356	612	RAB7, member RAS oncogene family-like 1 (RAB7L1)
B38R10C08	38-8-10	Hs~Ref:NM_003929.1~uORF:IOH4101	1493	1371	1691	969	2534	875	1441	1063	2258	547	RAB7, member RAS oncogene family-like 1 (RAB7L1)
B38R10C09	38-9-10	Hs~Ref:NM_001029.2~uORF:IOH4114	1772	1090	1754	989	2143	1371	6108	1029	1887	504	ribosomal protein S26 (RPS26)
B38R10C10	38-10-10	Hs~Ref:NM_001029.2~uORF:IOH4114	1842	1180	1795	975	1983	1477	6222	1021	1902	556	ribosomal protein S26 (RPS26)
B38R11C21	38-21-11	Hs~MGC:BC000417.1~uORF:IOH3651	1500	1093	1552	765	1889	1260	1761	839	1434	664	single-strand-selective monofunctional uracil-DNA glycosylase 1 (SMUG1)
B38R11C22	38-22-11	Hs~MGC:BC000417.1~uORF:IOH3651	1525	1011	1582	748	1837	1270	1580	813	1623	619	single-strand-selective monofunctional uracil-DNA glycosylase 1 (SMUG1)
B38R12C01	38-1-12	Hs~Ref:NM_001023.2~uORF:IOH6083	4680	2293	3656	2913	2186	3180	23852	2054	4446	892	ribosomal protein S20 (RPS20)
B38R12C02	38-2-12	Hs~Ref:NM_001023.2~uORF:IOH6083	4942	2270	3617	2929	2241	3092	23544	2035	4458	872	ribosomal protein S20 (RPS20)
B38R12C03	38-3-12	Hs~Ref:NM_001537.1~uORF:IOH6103	953	1732	2646	790	1749	1369	1855	1052	2120	677	heat shock factor binding protein 1 (HSBP1)
B38R12C04	38-4-12	Hs~Ref:NM_001537.1~uORF:IOH6103	1017	1734	2608	812	1700	1394	1893	1039	2226	680	heat shock factor binding protein 1 (HSBP1)
B38R12C05	38-5-12	Hs~Ref:NM_020189.1~uORF:IOH6776	868	777	1321	1355	1237	807	7310	1077	1703	247	Enhancer of yellow 2 transcription factor homolog
B38R12C06	38-6-12	Hs~Ref:NM_020189.1~uORF:IOH6776	778	774	1302	2844	1234	820	7208	1073	1659	173	Enhancer of yellow 2 transcription factor homolog
B38R12C07	38-7-12	Hs~Ref:NM_004103.2~N/A	1239	1342	2745	1763	1297	1710	2796	1643	4851	698	Protein tyrosine kinase 2 beta
B38R12C08	38-8-12	Hs~Ref:NM_004103.2~N/A	1355	1341	2725	2153	1229	1672	2791	1589	4830	620	Protein tyrosine kinase 2 beta
B38R12C09	38-9-12	Hs~Ref:NM_013355.1~N/A	1208	962	1815	962	1038	1086	2036	966	2364	586	Serine/threonine-protein kinase N3
B38R12C10	38-10-12	Hs~Ref:NM_013355.1~N/A	1160	973	1886	871	1000	1062	2058	952	2472	537	Serine/threonine-protein kinase N3
B38R12C11	38-11-12	Hs~Ref:NM_001396.2~N/A	2344	2226	4372	2207	2897	2409	5246	1936	8786	1585	Dual specificity tyrosine-phosphorylation-regulated kinase 1A
B38R12C12	38-12-12	Hs~Ref:NM_001396.2~N/A	2355	2057	4251	2277	3011	2410	5274	1875	8618	1556	Dual specificity tyrosine-phosphorylation-regulated kinase 1A
B38R12C15	38-15-12	Hs~Ref:NM_005867.2~uORF:IOH40378	343	749	363	233	238	205	147	235	265	72	Down syndrome critical region gene 4 (DSCR4)
B38R12C16	38-16-12	Hs~Ref:NM_005867.2~uORF:IOH40378	224	754	278	597	260	280	5680	343	292	95	Down syndrome critical region gene 4 (DSCR4)
B38R12C17	38-17-12	Hs~Ref:NM_002854.2~uORF:IOH40404	212	380	418	273	238	837	241	301	699	69	parvalbumin (PVALB)
B38R12C18	38-18-12	Hs~Ref:NM_002854.2~uORF:IOH40404	209	381	394	282	251	631	226	278	675	66	parvalbumin (PVALB)
B38R12C19	38-19-12	Hs~Ref:NM_001002762.1~uORF:IOH39966	429	982	827	795	447	762	461	412	1030	311	DnaJ (Hsp40) homolog, subfamily B, member 12 (DNAJB12), transcript variant 1
B38R12C20	38-20-12	Hs~Ref:NM_001002762.1~uORF:IOH39966	460	859	798	766	455	915	421	382	847	361	DnaJ (Hsp40) homolog, subfamily B, member 12 (DNAJB12), transcript variant 1
B38R12C21	38-21-12	Hs~Ref:NM_001004307.1~uORF:IOH40197	428	355	606	496	93	169	721	178	203	197	hypothetical LOC339541 (MGC33556)
B38R12C22	38-22-12	Hs~Ref:NM_001004307.1~uORF:IOH40197	377	374	650	519	87	279	309	188	133	31	hypothetical LOC339541 (MGC33556)
B38R13C01	38-1-13	Hs~Ref:NM_020665.2~uORF:IOH12463	400	970	674	507	556	550	609	1160	784	162	transmembrane protein 27 (TMEM27)
B38R13C02	38-2-13	Hs~Ref:NM_020665.2~uORF:IOH12463	409	1047	665	512	415	566	649	444	851	155	transmembrane protein 27 (TMEM27)
B38R13C03	38-3-13	Hs~Ref:NM_024557.2~uORF:IOH10980	803	10440	711	1321	1009	3428	3617	2170	1904	213	resistance to inhibitors of cholinesterase 3 homolog (C. elegans) (RIC3)
B38R13C04	38-4-13	Hs~Ref:NM_024557.2~uORF:IOH10980	781	10628	725	1272	1075	3495	3706	2157	1884	45	resistance to inhibitors of cholinesterase 3 homolog (C. elegans) (RIC3)
B38R13C05	38-5-13	Hs~MGC:BC017572.1~uORF:IOH14665	2553	614	750	529	1596	596	5762	1138	2302	1654	poliovirus receptor-related 3 (PVRL3)
B38R13C06	38-6-13	Hs~MGC:BC017572.1~uORF:IOH14665	3018	564	815	614	1514	645	5654	1050	2288	102	poliovirus receptor-related 3 (PVRL3)
B38R13C07	38-7-13	Hs~Ref:NM_000801.2~uORF:IOH4623	1477	337	685	552	645	520	562	940	976	257	FK506 binding protein 1A, 12kDa (FKBP1A), transcript variant 12B
B38R13C08	38-8-13	Hs~Ref:NM_000801.2~uORF:IOH4623	1377	355	683	475	663	510	556	920	934	2951	FK506 binding protein 1A, 12kDa (FKBP1A), transcript variant 12B
B38R13C11	38-11-13	Hs~Ref:NM_002072.1~uORF:IOH29692	752	717	814	967	732	630	946	460	2042	352	guanine nucleotide binding protein (G protein), q polypeptide (GNAQ)
B38R13C12	38-12-13	Hs~Ref:NM_002072.1~uORF:IOH29692	733	720	808	944	803	596	930	477	1927	387	guanine nucleotide binding protein (G protein), q polypeptide (GNAQ)
B38R13C13	38-13-13	Hs~Ref:NM_003877.3~uORF:IOH13865	3833	3359	2482	1877	2763	866	1965	1257	1522	573	suppressor of cytokine signaling 2 (SOCS2)
B38R13C14	38-14-13	Hs~Ref:NM_003877.3~uORF:IOH13865	4070	3432	2790	1958	2960	848	2077	1251	1649	518	suppressor of cytokine signaling 2 (SOCS2)
B38R13C15	38-15-13	Hs~Ref:NM_000294.1~uORF:IOH4032	47905	57494	27900	65492	43485	24775	22610	61124	25250	64072	phosphorylase kinase, gamma 2 (testis)
B38R13C16	38-16-13	Hs~Ref:NM_000294.1~uORF:IOH4032	57125	53933	27168	65490	43433	23336	23026	56229	23985	58406	phosphorylase kinase, gamma 2 (testis)
B38R13C17	38-17-13	Hs~MGC:BC022045.1~uORF:IOH14841	1163	873	994	1004	759	1048	2236	1202	1188	1172	mitochondrial ribosomal protein S31 (MRPS31)
B38R13C18	38-18-13	Hs~MGC:BC022045.1~uORF:IOH14841	1244	847	912	977	803	916	2264	1222	1304	1126	mitochondrial ribosomal protein S31 (MRPS31)
B38R13C19	38-19-13	Hs~MGC:BC020975.1~uORF:IOH10376	8385	1172	3442	3474	1963	2867	2207	1658	4640	677	tsukushin (TSKU)
B38R13C20	38-20-13	Hs~MGC:BC020975.1~uORF:IOH10376	8662	1168	3459	3415	1911	2914	2461	1800	4586	635	tsukushin (TSKU)
B38R13C21	38-21-13	Hs~MGC:BC020662.1~uORF:IOH12844	487	446	528	481	423	855	1059	514	760	246	chromosome X open reading frame 48 (CXorf48)
B38R13C22	38-22-13	Hs~MGC:BC020662.1~uORF:IOH12844	488	448	553	432	439	640	794	477	713	327	chromosome X open reading frame 48 (CXorf48)
B38R14C01	38-1-14	Hs~Ref:NM_002737.1~uORF:IOH29644	577	683	731	582	564	764	754	1010	678	108	protein kinase C, alpha (PRKCA); see catalog number for detailed information on wild-type or point mutant status
B38R14C02	38-2-14	Hs~Ref:NM_002737.1~uORF:IOH29644	568	704	748	542	453	754	725	403	851	54	protein kinase C, alpha (PRKCA); see catalog number for detailed information on wild-type or point mutant status
B38R14C05	38-5-14	Hs~MGC:BC047733.1~uORF:IOH26736	7059	4780	986	3433	1063	701	2791	821	1811	357	tRNA aspartic acid methyltransferase 1 (TRDMT1)
B38R14C06	38-6-14	Hs~MGC:BC047733.1~uORF:IOH26736	7469	5221	1019	3423	1029	758	2764	824	1758	212	tRNA aspartic acid methyltransferase 1 (TRDMT1)
B38R14C07	38-7-14	Hs~Ref:NM_206852.1~uORF:IOH40898	1157	1153	1599	1179	1266	1554	1625	1232	2310	996	reticulon 1 (RTN1), transcript variant 3
B38R14C08	38-8-14	Hs~Ref:NM_206852.1~uORF:IOH40898	1089	1207	1582	1142	1235	1493	1609	1288	2227	1014	reticulon 1 (RTN1), transcript variant 3
B38R14C09	38-9-14	Hs~Ref:NM_030673.2~uORF:IOH40899	647	665	1461	1026	1156	2132	2645	1073	1409	264	SEC13-like 1 (S. cerevisiae) (SEC13L1), transcript variant 1
B38R14C10	38-10-14	Hs~Ref:NM_030673.2~uORF:IOH40899	692	671	1404	961	1166	2028	2534	1050	1319	145	SEC13-like 1 (S. cerevisiae) (SEC13L1), transcript variant 1
B38R14C11	38-11-14	Hs~Ref:NM_198560.1~uORF:IOH59787	225	346	531	485	367	369	571	319	757	109	Lipoma HMGIC fusion partner-like 4 protein
B38R14C12	38-12-14	Hs~Ref:NM_198560.1~uORF:IOH59787	413	310	474	457	356	387	586	335	743	145	Lipoma HMGIC fusion partner-like 4 protein
B38R14C19	38-19-14	Hs~Ref:NM_015246.1~uORF:IOH26658	786	977	932	428	769	566	865	619	1113	489	mahogunin, ring finger 1 (MGRN1)
B38R14C20	38-20-14	Hs~Ref:NM_015246.1~uORF:IOH26658	824	983	913	427	764	624	868	627	1102	459	mahogunin, ring finger 1 (MGRN1)
B38R14C21	38-21-14	Hs~MGC:BC026270.1~uORF:IOH14666	680	473	698	728	3283	1118	2880	921	850	378	phosphodiesterase 4D interacting protein (myomegalin) (PDE4DIP)
B38R14C22	38-22-14	Hs~MGC:BC026270.1~uORF:IOH14666	719	432	701	683	3276	983	2235	890	805	370	phosphodiesterase 4D interacting protein (myomegalin) (PDE4DIP)
B38R15C01	38-1-15	Hs~MGC:BC011234.1~uORF:IOH10261	5039	1821	2519	2103	10428	2515	8950	9501	2900	816	survival motor neuron domain containing 1 (SMNDC1)
B38R15C02	38-2-15	Hs~MGC:BC011234.1~uORF:IOH10261	5023	1841	2638	2044	11144	2456	8989	9473	2713	820	survival motor neuron domain containing 1 (SMNDC1)
B38R15C03	38-3-15	Hs~MGC:BC052955.1~uORF:IOH28816	980	552	1784	995	835	3141	1327	1017	1539	397	Wiskott-Aldrich syndrome-like (WASL)
B38R15C04	38-4-15	Hs~MGC:BC052955.1~uORF:IOH28816	1035	603	1882	1014	841	3145	1340	1000	1427	318	Wiskott-Aldrich syndrome-like (WASL)
B38R15C05	38-5-15	Hs~Ref:NM_006715.2~uORF:IOH26932	603	534	765	479	569	690	1165	573	1045	242	mannosidase, alpha, class 2C, member 1 (MAN2C1)
B38R15C06	38-6-15	Hs~Ref:NM_006715.2~uORF:IOH26932	663	609	742	489	505	719	1212	590	1112	222	mannosidase, alpha, class 2C, member 1 (MAN2C1)
B38R15C07	38-7-15	Hs~Ref:NM_001932.2~uORF:IOH29065	1092	783	1148	2185	1946	1383	2134	732	2321	981	membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) (MPP3), transcript variant 1
B38R15C08	38-8-15	Hs~Ref:NM_001932.2~uORF:IOH29065	1110	826	1115	2063	2048	1325	2163	698	2121	906	membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) (MPP3), transcript variant 1
B38R15C09	38-9-15	Hs~Ref:NM_007106.2~uORF:IOH29272	783	1538	915	1014	845	11204	1729	888	1426	513	ubiquitin-like 3 (UBL3)
B38R15C10	38-10-15	Hs~Ref:NM_007106.2~uORF:IOH29272	853	1608	949	955	855	10532	1703	855	1372	8	ubiquitin-like 3 (UBL3)
B38R15C11	38-11-15	Hs~MGC:BC060825.1~uORF:IOH29162	818	556	884	520	665	722	1633	521	998	533	Endothelial lipase
B38R15C12	38-12-15	Hs~MGC:BC060825.1~uORF:IOH29162	816	587	923	511	637	710	1654	547	987	1032	Endothelial lipase
B38R15C17	38-17-15	Hs~Ref:NM_006206.3~CAT:PV3811	201	169	333	182	287	198	864	376	231	96	platelet-derived growth factor receptor, alpha polypeptide (PDGFRA); see catalog number for detailed information on wild-type or point mutant status
B38R15C18	38-18-15	Hs~Ref:NM_006206.3~CAT:PV3811	202	188	288	162	287	214	834	338	145	81	platelet-derived growth factor receptor, alpha polypeptide (PDGFRA); see catalog number for detailed information on wild-type or point mutant status
B38R15C21	38-21-15	Hs~Ref:NM_182691.1~CAT:PV3829	708	946	1004	18061	474	1628	822	1185	913	265	SFRS protein kinase 2 (SRPK2), transcript variant 2
B38R15C22	38-22-15	Hs~Ref:NM_182691.1~CAT:PV3829	699	919	1015	16933	473	1522	757	1189	890	276	SFRS protein kinase 2 (SRPK2), transcript variant 2
B38R16C01	38-1-16	Hs~Ref:NM_003600.1~CAT:PV3612	953	1218	1463	17217	1871	2811	1638	1957	2358	1129	aurora kinase A (AURKA), transcript variant 2
B38R16C02	38-2-16	Hs~Ref:NM_003600.1~CAT:PV3612	1091	1225	1633	15492	1770	2647	1796	2106	2104	1123	aurora kinase A (AURKA), transcript variant 2
B38R16C03	38-3-16	Hs~Ref:NM_002745.2~CAT:PV3313	416	448	590	748	428	805	1295	1609	972	805	Mitogen-activated protein kinase 1; see catalog number for detailed information on wild-type or point mutant status
B38R16C04	38-4-16	Hs~Ref:NM_002745.2~CAT:PV3313	378	482	587	750	432	820	1235	1675	1012	317	Mitogen-activated protein kinase 1; see catalog number for detailed information on wild-type or point mutant status
B38R16C07	38-7-16	Hs~Ref:NM_182724.1~uORF:IOH58633	700	3532	809	1476	719	1216	1167	1993	1878	327	cAMP responsive element modulator (CREM), transcript variant 11, mRNA.
B38R16C08	38-8-16	Hs~Ref:NM_182724.1~uORF:IOH58633	686	3544	786	1268	777	1169	1133	1885	1728	42	cAMP responsive element modulator (CREM), transcript variant 11, mRNA.
B38R16C11	38-11-16	Hs~Ref:NM_016281.2~uORF:IOH54175	686	392	1448	591	445	542	868	755	704	401	TAO kinase 3 (TAOK3)
B38R16C12	38-12-16	Hs~Ref:NM_016281.2~uORF:IOH54175	487	392	1391	549	448	614	869	712	719	308	TAO kinase 3 (TAOK3)
B38R16C13	38-13-16	Hs~Ref:NM_181270.1~uORF:IOH58636	674	642	1258	2449	3480	599	1333	1302	1683	501	CKLF-like MARVEL transmembrane domain-containing protein 1
B38R16C14	38-14-16	Hs~Ref:NM_181270.1~uORF:IOH58636	697	646	1227	2482	3463	847	1383	1288	1611	492	CKLF-like MARVEL transmembrane domain-containing protein 1
B38R16C15	38-15-16	Hs~MGC:BC058074.1~uORF:IOH56524	496	375	770	393	391	560	641	460	563	221	WNT1 inducible signaling pathway protein 2, mRNA (cDNA clone MGC:64884 IMAGE:5194313), complete cds
B38R16C16	38-16-16	Hs~MGC:BC058074.1~uORF:IOH56524	465	332	550	408	402	524	587	455	547	162	WNT1 inducible signaling pathway protein 2, mRNA (cDNA clone MGC:64884 IMAGE:5194313), complete cds
B38R16C17	38-17-16	Hs~Ref:NM_012144.2~uORF:IOH55631	1149	2354	1047	939	460	1197	2195	895	1178	1663	Dynein intermediate chain 1, axonemal
B38R16C18	38-18-16	Hs~Ref:NM_012144.2~uORF:IOH55631	1161	2342	935	1014	457	1084	2084	811	1167	1655	Dynein intermediate chain 1, axonemal
B38R16C21	38-21-16	Hs~Ref:NM_138285.3~uORF:IOH56483	1400	673	1243	765	2576	987	4359	3887	2532	369	Nucleoporin NUP53
B38R16C22	38-22-16	Hs~Ref:NM_138285.3~uORF:IOH56483	1377	643	1188	752	2458	964	4286	3902	2568	340	Nucleoporin NUP53
B38R17C01	38-1-17	Hs~MGC:BC011753.2~uORF:IOH12350	1286	1388	1654	1138	9579	1582	2525	1536	3133	943	transcriptional adaptor 2 (ADA2 homolog, yeast)-like (TADA2L)
B38R17C02	38-2-17	Hs~MGC:BC011753.2~uORF:IOH12350	1357	1401	1694	1162	1850	1771	2620	1474	3480	780	transcriptional adaptor 2 (ADA2 homolog, yeast)-like (TADA2L)
B38R17C03	38-3-17	Hs~Ref:NM_020345.3~uORF:IOH12650	1483	1076	2091	1066	1288	1057	1115	1271	2218	633	NFKB inhibitor interacting Ras-like 1 (NKIRAS1)
B38R17C04	38-4-17	Hs~Ref:NM_020345.3~uORF:IOH12650	1508	1128	2015	1036	1633	986	1111	1207	2350	347	NFKB inhibitor interacting Ras-like 1 (NKIRAS1)
B38R17C05	38-5-17	Hs~Ref:NM_024333.1~uORF:IOH4546	1552	1621	3034	1564	2553	3307	2290	2473	4616	898	Fibronectin type III and SPRY domain-containing protein 1
B38R17C06	38-6-17	Hs~Ref:NM_024333.1~uORF:IOH4546	1538	1668	2970	1449	2283	2888	2477	2372	4405	783	Fibronectin type III and SPRY domain-containing protein 1
B38R17C07	38-7-17	Hs~MGC:BC011735.2~uORF:IOH13045	1081	1079	1541	932	1096	1271	1627	1243	3602	1482	phospholipid scramblase 3 (PLSCR3)
B38R17C08	38-8-17	Hs~MGC:BC011735.2~uORF:IOH13045	1114	1084	1641	949	1104	1280	1535	1217	3410	1597	phospholipid scramblase 3 (PLSCR3)
B38R17C09	38-9-17	Hs~MGC:BC008200.1~uORF:IOH3147	418	2358	536	294	450	754	540	498	1178	338	keratin 8 (KRT8)
B38R17C10	38-10-17	Hs~MGC:BC008200.1~uORF:IOH3147	432	2507	508	409	352	723	536	490	1125	316	keratin 8 (KRT8)
B38R17C11	38-11-17	Hs~Ref:NM_014685.1~uORF:IOH4612	656	264	373	269	291	415	511	343	651	213	homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 (HERPUD1), transcript variant 1
B38R17C12	38-12-17	Hs~Ref:NM_014685.1~uORF:IOH4612	204	270	349	286	303	410	482	324	815	222	homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 (HERPUD1), transcript variant 1
B38R17C13	38-13-17	Hs~Ref:NM_020898.1~uORF:IOH5116	780	799	626	491	618	728	488	739	711	234	calcium binding and coiled-coil domain 1 (CALCOCO1)
B38R17C14	38-14-17	Hs~Ref:NM_020898.1~uORF:IOH5116	731	842	627	469	642	711	539	721	844	393	calcium binding and coiled-coil domain 1 (CALCOCO1)
B38R17C15	38-15-17	Hs~MGC:BC009046.1~uORF:IOH3394	3774	1039	2709	1379	1243	1665	3033	4333	2834	563	neurogenic differentiation 1 (NEUROD1)
B38R17C16	38-16-17	Hs~MGC:BC009046.1~uORF:IOH3394	3448	1056	2666	1295	1213	1600	3040	3920	2645	549	neurogenic differentiation 1 (NEUROD1)
B38R17C17	38-17-17	Hs~Ref:NM_018410.2~uORF:IOH5020	919	611	1014	676	594	1193	2240	791	1652	508	Holliday junction recognition protein
B38R17C18	38-18-17	Hs~Ref:NM_018410.2~uORF:IOH5020	907	788	998	694	648	1169	2031	798	1705	503	Holliday junction recognition protein
B38R17C19	38-19-17	Hs~MGC:BC051285.1~uORF:IOH28125	681	1125	1008	1676	1514	753	922	720	2217	316	coiled-coil domain containing 107 (CCDC107)
B38R17C20	38-20-17	Hs~MGC:BC051285.1~uORF:IOH28125	657	1121	979	1728	1500	805	902	716	2079	201	coiled-coil domain containing 107 (CCDC107)
B38R17C21	38-21-17	Hs~MGC:BC014649.1~uORF:IOH14550	505	503	737	486	400	728	750	543	897	447	galactose-3-O-sulfotransferase 1 (GAL3ST1)
B38R17C22	38-22-17	Hs~MGC:BC014649.1~uORF:IOH14550	537	555	720	490	402	681	765	462	859	405	galactose-3-O-sulfotransferase 1 (GAL3ST1)
B38R18C01	38-1-18	Hs~MGC:BC009074.1~uORF:IOH3371	670	732	713	3025	333	1084	1044	940	438	1630	chromosome 8 open reading frame 70 (C8orf70)
B38R18C02	38-2-18	Hs~MGC:BC009074.1~uORF:IOH3371	670	806	695	3284	232	1141	1255	1060	897	1233	chromosome 8 open reading frame 70 (C8orf70)
B38R18C03	38-3-18	Hs~Ref:NM_174901.3~uORF:IOH35161	395	1424	631	447	160	538	693	497	974	456	family with sequence similarity 9, member C (FAM9C)
B38R18C04	38-4-18	Hs~Ref:NM_174901.3~uORF:IOH35161	481	438	587	481	508	525	692	553	727	364	family with sequence similarity 9, member C (FAM9C)
B38R18C07	38-7-18	Hs~Ref:NM_004546.1~uORF:IOH4818	737	608	580	534	912	923	714	786	1082	479	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa (NDUFB2), nuclear gene encoding mitochondrial protein
B38R18C08	38-8-18	Hs~Ref:NM_004546.1~uORF:IOH4818	761	597	590	578	852	887	695	760	966	469	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa (NDUFB2), nuclear gene encoding mitochondrial protein
B38R18C09	38-9-18	Hs~MGC:BC049366.1~uORF:IOH26745	330	377	355	367	371	339	400	315	594	159	dystrobrevin, beta (DTNB)
B38R18C10	38-10-18	Hs~MGC:BC049366.1~uORF:IOH26745	375	359	368	578	364	306	433	323	465	316	dystrobrevin, beta (DTNB)
B38R18C11	38-11-18	Hs~Ref:NM_182838.1~uORF:IOH43111	517	366	546	367	365	518	628	426	707	284	Solute carrier family 35 member E2
B38R18C12	38-12-18	Hs~Ref:NM_182838.1~uORF:IOH43111	543	369	542	402	349	525	594	449	640	186	Solute carrier family 35 member E2
B38R18C13	38-13-18	Hs~MGC:BC033886.2~uORF:IOH27178	-3	4	3	535	0	0	-3	1	0	-5	germ cell-less homolog 1 (Drosophila)-like (GMCL1L)
B38R18C14	38-14-18	Hs~MGC:BC033886.2~uORF:IOH27178	31	16	-1	533	2	1	-2	-1	1	1	germ cell-less homolog 1 (Drosophila)-like (GMCL1L)
B38R18C15	38-15-18	Hs~MGC:BC044227.1~uORF:IOH26333	718	962	854	542	546	773	1451	650	1307	338	Parkin coregulated gene protein homolog
B38R18C16	38-16-18	Hs~MGC:BC044227.1~uORF:IOH26333	704	949	1020	518	529	709	1420	657	1472	357	Parkin coregulated gene protein homolog
B38R18C17	38-17-18	Hs~MGC:BC036846.1~uORF:IOH28739	771	475	853	496	408	761	1585	1229	926	433	protease, serine, 33 (PRSS33)
B38R18C18	38-18-18	Hs~MGC:BC036846.1~uORF:IOH28739	810	608	849	517	437	771	1654	1204	933	466	protease, serine, 33 (PRSS33)
B38R18C19	38-19-18	Hs~Ref:NM_006449.2~uORF:IOH12552	3357	2203	7470	2683	3078	6533	6765	5378	3671	865	CDC42 effector protein (Rho GTPase binding) 3 (CDC42EP3)
B38R18C20	38-20-18	Hs~Ref:NM_006449.2~uORF:IOH12552	3394	2179	6914	2602	2925	7188	6738	4999	3488	788	CDC42 effector protein (Rho GTPase binding) 3 (CDC42EP3)
B38R18C21	38-21-18	Hs~MGC:BC033582.1~uORF:IOH22594	564	691	767	503	476	772	903	737	960	451	mRNA similar to LOC166173 (cDNA clone MGC:34832 IMAGE:5203730), complete cds
B38R18C22	38-22-18	Hs~MGC:BC033582.1~uORF:IOH22594	622	679	770	495	531	747	858	625	924	359	mRNA similar to LOC166173 (cDNA clone MGC:34832 IMAGE:5203730), complete cds
B38R19C01	38-1-19	Hs~MGC:BC025742.1~uORF:IOH11762	1527	952	1711	701	498	927	920	548	1271	378	Integral membrane protein 2C
B38R19C02	38-2-19	Hs~MGC:BC025742.1~uORF:IOH11762	1383	829	1216	623	1021	1014	958	523	1165	444	Integral membrane protein 2C
B38R19C03	38-3-19	Hs~Ref:NM_006275.2~uORF:IOH3168	3870	1407	3108	1807	715	2212	18709	1458	2780	758	splicing factor, arginine/serine-rich 6 (SFRS6)
B38R19C04	38-4-19	Hs~Ref:NM_006275.2~uORF:IOH3168	2039	1467	3127	1790	774	2164	18235	1530	2751	971	splicing factor, arginine/serine-rich 6 (SFRS6)
B38R19C05	38-5-19	Hs~Ref:NM_003318.3~uORF:IOH4197	894	606	1500	588	906	1545	1960	952	1394	203	TTK protein kinase (TTK)
B38R19C06	38-6-19	Hs~Ref:NM_003318.3~uORF:IOH4197	861	604	1387	603	924	1599	1983	832	1519	389	TTK protein kinase (TTK)
B38R19C07	38-7-19	Hs~Ref:NM_022164.1~uORF:IOH39923	635	605	817	449	429	748	1143	642	1213	380	tubulointerstitial nephritis antigen-like 1 (TINAGL1)
B38R19C08	38-8-19	Hs~Ref:NM_022164.1~uORF:IOH39923	656	619	893	423	406	668	1124	588	1249	315	tubulointerstitial nephritis antigen-like 1 (TINAGL1)
B38R19C09	38-9-19	Hs~MGC:BC015202.2~uORF:IOH39942	1692	1382	1614	2844	1379	1272	3673	2196	1944	3199	centromere protein T (CENPT)
B38R19C10	38-10-19	Hs~MGC:BC015202.2~uORF:IOH39942	1819	1283	1593	2572	1172	1266	3391	2034	1936	2749	centromere protein T (CENPT)
B38R19C11	38-11-19	Hs~Ref:NM_020182.3~uORF:IOH41590	1172	781	1438	752	2010	3369	1359	1748	1986	902	transmembrane, prostate androgen induced RNA (TMEPAI), transcript variant 1
B38R19C12	38-12-19	Hs~Ref:NM_020182.3~uORF:IOH41590	1230	904	1424	794	2168	2919	1391	1729	1860	973	transmembrane, prostate androgen induced RNA (TMEPAI), transcript variant 1
B38R19C13	38-13-19	Hs~MGC:BC024254.1~uORF:IOH13735	2843	7556	2994	1900	10200	6641	2977	2641	5081	1440	abl-interactor 1 (ABI1)
B38R19C14	38-14-19	Hs~MGC:BC024254.1~uORF:IOH13735	2871	6716	2812	1666	9926	6310	2667	2554	5107	1386	abl-interactor 1 (ABI1)
B38R19C15	38-15-19	Hs~MGC:BC024030.2~uORF:IOH11924	659	783	868	460	358	671	1813	524	850	374	F-box protein 32 (FBXO32)
B38R19C16	38-16-19	Hs~MGC:BC024030.2~uORF:IOH11924	735	885	1015	441	373	668	1769	552	828	292	F-box protein 32 (FBXO32)
B38R19C17	38-17-19	Hs~Ref:NM_024096.1~uORF:IOH3203	507	4781	1265	1044	668	3272	855	1144	1846	527	XTP3-transactivated protein A (XTP3TPA)
B38R19C18	38-18-19	Hs~Ref:NM_024096.1~uORF:IOH3203	495	4650	1173	988	669	3029	820	1109	1877	353	XTP3-transactivated protein A (XTP3TPA)
B38R19C19	38-19-19	Hs~MGC:BC066915.1~uORF:IOH61470	481	656	586	758	233	756	1168	1487	1532	188	MARCKS-related protein
B38R19C20	38-20-19	Hs~MGC:BC066915.1~uORF:IOH61470	526	667	529	786	232	714	1115	1376	1523	371	MARCKS-related protein
B38R19C21	38-21-19	Hs~Ref:NM_003765.1~uORF:IOH59047	962	1822	6121	665	1411	1664	2064	2909	1827	406	Syntaxin-10
B38R19C22	38-22-19	Hs~Ref:NM_003765.1~uORF:IOH59047	1012	1748	5702	658	1385	1561	2059	2796	1726	373	Syntaxin-10
B38R20C01	38-1-20	Hs~Ref:NM_138452.1~uORF:IOH54999	358	1155	710	274	507	-2	-1	-1	703	217	Dehydrogenase/reductase SDR family member 1
B38R20C02	38-2-20	Hs~Ref:NM_138452.1~uORF:IOH54999	345	1061	472	253	497	1	-3	-5	773	107	Dehydrogenase/reductase SDR family member 1
B38R20C03	38-3-20	Hs~Ref:NM_002811.3~uORF:IOH59072	464	500	1368	471	902	7	-4	-1	2	-6	26S proteasome non-ATPase regulatory subunit 7
B38R20C04	38-4-20	Hs~Ref:NM_002811.3~uORF:IOH59072	519	509	1365	464	859	1	-8	0	1	0	26S proteasome non-ATPase regulatory subunit 7
B38R20C05	38-5-20	Hs~MGC:BC045626.1~uORF:IOH27484	2847	1301	1933	1692	1885	3	154	2	2	-1	Homeobox protein PKNOX2
B38R20C06	38-6-20	Hs~MGC:BC045626.1~uORF:IOH27484	2857	1359	1926	1650	1916	-1	-3	2	649	-3	Homeobox protein PKNOX2
B38R20C07	38-7-20	Hs~Ref:NM_012227.1~uORF:IOH57121	419	329	579	377	286	451	1058	973	555	364	Putative GTP-binding protein 6
B38R20C08	38-8-20	Hs~Ref:NM_012227.1~uORF:IOH57121	427	385	635	337	288	491	1060	532	658	325	Putative GTP-binding protein 6
B38R20C09	38-9-20	Hs~Ref:NM_007042.1~uORF:IOH56123	591	498	899	415	484	633	1796	1018	922	148	Ribonuclease P protein subunit p14
B38R20C10	38-10-20	Hs~Ref:NM_007042.1~uORF:IOH56123	550	488	929	1361	406	553	1727	932	903	284	Ribonuclease P protein subunit p14
B38R20C11	38-11-20	Hs~MGC:BC018029.1~uORF:IOH56012	570	995	574	1366	483	571	1048	851	1148	145	6-pyruvoyl tetrahydrobiopterin synthase
B38R20C12	38-12-20	Hs~MGC:BC018029.1~uORF:IOH56012	544	1023	561	534	517	566	973	870	1079	182	6-pyruvoyl tetrahydrobiopterin synthase
B38R20C13	38-13-20	Hs~Ref:NM_015474.2~uORF:IOH55544	381	311	538	459	346	430	848	523	1309	195	SAM domain and HD domain-containing protein 1
B38R20C14	38-14-20	Hs~Ref:NM_015474.2~uORF:IOH55544	353	323	509	396	319	433	854	509	1239	362	SAM domain and HD domain-containing protein 1
B39R02C11	39-11-2	Hs~Ref:NM_182970.2~uORF:IOH43687	1866	893	9050	1892	1421	815	1617	1218	1292	435	regulating synaptic membrane exocytosis 4 (RIMS4)
B39R02C12	39-12-2	Hs~Ref:NM_182970.2~uORF:IOH43687	1750	861	10427	1876	1229	821	1721	773	1275	423	regulating synaptic membrane exocytosis 4 (RIMS4)
B39R02C13	39-13-2	Hs~Ref:NM_178582.1~uORF:IOH42341	1230	963	60953	600	5657	475	780	831	1036	159	histocompatibility (minor) 13 (HM13), transcript variant 4
B39R02C14	39-14-2	Hs~Ref:NM_178582.1~uORF:IOH42341	1189	938	56093	581	5161	474	792	791	1053	122	histocompatibility (minor) 13 (HM13), transcript variant 4
B39R02C15	39-15-2	Hs~Ref:NM_079420.1~uORF:IOH42932	1650	971	65465	600	610	660	1575	1045	1684	5439	myosin, light chain 1, alkali; skeletal, fast (MYL1), transcript variant 1f
B39R02C16	39-16-2	Hs~Ref:NM_079420.1~uORF:IOH42932	1710	973	65472	565	628	610	1567	934	1680	5219	myosin, light chain 1, alkali; skeletal, fast (MYL1), transcript variant 1f
B39R02C17	39-17-2	Hs~Ref:NM_025233.4~uORF:IOH40019	866	2099	1239	819	440	1254	1137	451	1593	747	Coenzyme A synthase (COASY), transcript variant 1
B39R02C18	39-18-2	Hs~Ref:NM_025233.4~uORF:IOH40019	932	2035	1277	805	430	1193	1142	464	1504	725	Coenzyme A synthase (COASY), transcript variant 1
B39R02C21	39-21-2	Hs~Ref:NM_178859.2~uORF:IOH43037	479	224	1732	268	1419	856	826	843	526	106	organic solute transporter beta (OSTbeta)
B39R02C22	39-22-2	Hs~Ref:NM_178859.2~uORF:IOH43037	353	476	1675	258	1425	825	844	831	608	98	organic solute transporter beta (OSTbeta)
B39R03C05	39-5-3	Hs~MGC:BC008651.1~uORF:IOH3382	762	643	850	956	778	668	1009	1260	3504	356	hypothetical protein MGC9913 (MGC9913)
B39R03C06	39-6-3	Hs~MGC:BC008651.1~uORF:IOH3382	770	694	882	1069	717	593	1022	964	3501	342	hypothetical protein MGC9913 (MGC9913)
B39R03C07	39-7-3	Hs~MGC:BC002656.1~uORF:IOH5254	309	318	433	265	371	288	338	1641	718	271	Thyroid receptor-interacting protein 11
B39R03C08	39-8-3	Hs~MGC:BC002656.1~uORF:IOH5254	307	282	440	254	517	318	346	1566	701	277	Thyroid receptor-interacting protein 11
B39R03C09	39-9-3	Hs~Ref:NM_032213.2~uORF:IOH13135	524	603	802	1122	3235	1104	783	1154	1175	930	RNA binding motif and ELMO/CED-12 domain 1 (RBED1)
B39R03C10	39-10-3	Hs~Ref:NM_032213.2~uORF:IOH13135	533	574	775	1113	1703	1040	708	920	1143	915	RNA binding motif and ELMO/CED-12 domain 1 (RBED1)
B39R03C11	39-11-3	Hs~Ref:NM_007083.2~uORF:IOH12334	781	874	1089	740	1448	624	624	753	1376	437	nudix (nucleoside diphosphate linked moiety X)-type motif 6 (NUDT6), transcript variant 1
B39R03C12	39-12-3	Hs~Ref:NM_007083.2~uORF:IOH12334	802	834	1462	740	1356	579	632	525	1316	422	nudix (nucleoside diphosphate linked moiety X)-type motif 6 (NUDT6), transcript variant 1
B39R03C13	39-13-3	Hs~MGC:BC008567.1~uORF:IOH3328	758	2643	35110	519	1057	912	955	582	1397	158	chromosome 21 open reading frame 7 (C21orf7)
B39R03C14	39-14-3	Hs~MGC:BC008567.1~uORF:IOH3328	704	2537	30350	487	2165	869	935	517	1388	151	chromosome 21 open reading frame 7 (C21orf7)
B39R03C15	39-15-3	Hs~MGC:BC010896.1~uORF:IOH14253	858	618	972	518	499	642	956	553	1151	430	chromosome 3 open reading frame 28 (C3orf28)
B39R03C16	39-16-3	Hs~MGC:BC010896.1~uORF:IOH14253	840	588	820	539	462	633	930	566	1189	406	chromosome 3 open reading frame 28 (C3orf28)
B39R03C17	39-17-3	Hs~MGC:BC003366.1~uORF:IOH2912	593	520	609	639	457	477	752	602	822	314	calcium regulated heat stable protein 1, 24kDa (CARHSP1)
B39R03C18	39-18-3	Hs~MGC:BC003366.1~uORF:IOH2912	645	429	624	621	474	534	829	588	834	311	calcium regulated heat stable protein 1, 24kDa (CARHSP1)
B39R03C19	39-19-3	Hs~MGC:BC017064.1~uORF:IOH11279	802	459	915	542	473	645	798	600	1531	290	chromosome 3 open reading frame 52 (C3orf52)
B39R03C20	39-20-3	Hs~MGC:BC017064.1~uORF:IOH11279	748	552	891	557	499	687	730	644	1577	309	chromosome 3 open reading frame 52 (C3orf52)
B39R03C21	39-21-3	Hs~Ref:NM_014481.2~uORF:IOH4887	59901	43040	22105	65478	11940	43540	44845	37196	49717	36418	APEX nuclease (apurinic/apyrimidinic endonuclease) 2 (APEX2), nuclear gene encoding mitochondrial protein
B39R03C22	39-22-3	Hs~Ref:NM_014481.2~uORF:IOH4887	51706	37269	20016	65477	10933	43413	45500	35676	46841	33827	APEX nuclease (apurinic/apyrimidinic endonuclease) 2 (APEX2), nuclear gene encoding mitochondrial protein
B39R04C01	39-1-4	Hs~MGC:BC005233.1~uORF:IOH7235	712	440	767	1147	734	547	1014	629	661	116	pancreatic lipase-related protein 1 (PNLIPRP1)
B39R04C02	39-2-4	Hs~MGC:BC005233.1~uORF:IOH7235	704	459	789	859	727	561	1925	628	696	49	pancreatic lipase-related protein 1 (PNLIPRP1)
B39R04C03	39-3-4	Hs~Ref:NM_145045.1~uORF:IOH13104	618	623	601	979	586	482	599	375	836	351	Coiled-coil domain-containing protein 151
B39R04C04	39-4-4	Hs~Ref:NM_145045.1~uORF:IOH13104	613	612	556	993	609	473	720	394	936	317	Coiled-coil domain-containing protein 151
B39R04C05	39-5-4	Hs~Ref:NM_005258.2~uORF:IOH1566	666	2069	1264	1377	1178	1538	2867	3552	2755	428	GTP cyclohydrolase I feedback regulator (GCHFR)
B39R04C06	39-6-4	Hs~Ref:NM_005258.2~uORF:IOH1566	660	1999	1197	1140	1148	1600	2733	3169	2685	380	GTP cyclohydrolase I feedback regulator (GCHFR)
B39R04C07	39-7-4	Hs~MGC:BC007874.2~uORF:IOH6696	946	463	632	578	358	868	1711	494	679	273	far upstream element (FUSE) binding protein 3 (FUBP3)
B39R04C08	39-8-4	Hs~MGC:BC007874.2~uORF:IOH6696	1031	444	691	588	337	911	1662	526	706	241	far upstream element (FUSE) binding protein 3 (FUBP3)
B39R04C09	39-9-4	Hs~MGC:BC015752.1~uORF:IOH12141	1529	786	1543	1286	3444	2305	2794	1054	2183	364	interferon regulatory factor 4 (IRF4)
B39R04C10	39-10-4	Hs~MGC:BC015752.1~uORF:IOH12141	1384	738	1519	1193	1858	2182	2746	812	2136	389	interferon regulatory factor 4 (IRF4)
B39R04C11	39-11-4	Hs~MGC:BC005254.1~uORF:IOH7277	650	619	701	403	1701	464	660	435	604	78	C-type lectin domain family 2, member B (CLEC2B)
B39R04C12	39-12-4	Hs~MGC:BC005254.1~uORF:IOH7277	681	603	704	434	1424	439	645	397	576	98	C-type lectin domain family 2, member B (CLEC2B)
B39R04C13	39-13-4	Hs~Ref:NM_024678.2~uORF:IOH6715	888	719	901	524	6525	580	678	605	1244	157	Probable asparaginyl-tRNA synthetase, mitochondrial
B39R04C14	39-14-4	Hs~Ref:NM_024678.2~uORF:IOH6715	885	696	883	561	9994	607	711	572	1301	12	Probable asparaginyl-tRNA synthetase, mitochondrial
B39R04C15	39-15-4	Hs~Ref:NM_013319.1~uORF:IOH5671	751	555	865	524	1244	544	891	669	1105	550	UbiA prenyltransferase domain containing 1 (UBIAD1)
B39R04C16	39-16-4	Hs~Ref:NM_013319.1~uORF:IOH5671	688	674	823	517	2322	620	891	646	1142	523	UbiA prenyltransferase domain containing 1 (UBIAD1)
B39R04C17	39-17-4	Hs~MGC:BC001258.1~uORF:IOH3053	752	1260	1050	980	3464	1254	551	596	1260	493	phosphoglucomutase 3 (PGM3)
B39R04C18	39-18-4	Hs~MGC:BC001258.1~uORF:IOH3053	795	1171	991	921	500	1244	564	549	1279	422	phosphoglucomutase 3 (PGM3)
B39R04C19	39-19-4	Hs~MGC:BC004248.1~uORF:IOH5475	789	1024	794	1071	3068	817	681	573	1001	379	bone morphogenetic protein 7 (osteogenic protein 1) (BMP7)
B39R04C20	39-20-4	Hs~MGC:BC004248.1~uORF:IOH5475	854	1176	853	1060	3592	799	667	591	673	365	bone morphogenetic protein 7 (osteogenic protein 1) (BMP7)
B39R04C21	39-21-4	Hs~Ref:NM_012289.2~uORF:IOH5732	21206	36162	9972	35589	15517	28769	18899	25061	21595	20797	Kelch-like ECH-associated protein 1
B39R04C22	39-22-4	Hs~Ref:NM_012289.2~uORF:IOH5732	16897	32827	8980	32620	15608	26972	18800	24500	21395	19150	Kelch-like ECH-associated protein 1
B39R05C01	39-1-5	Hs~MGC:BC014538.1~uORF:IOH12144	1486	652	1141	921	1142	934	1279	1039	1817	519	zinc finger protein 215 (ZNF215)
B39R05C02	39-2-5	Hs~MGC:BC014538.1~uORF:IOH12144	1436	598	1194	1194	1085	995	1378	981	1603	558	zinc finger protein 215 (ZNF215)
B39R05C03	39-3-5	Hs~MGC:BC010915.1~uORF:IOH12222	1240	1021	1171	1475	1026	1530	1369	858	1377	724	glutathione S-transferase pi (GSTP1)
B39R05C04	39-4-5	Hs~MGC:BC010915.1~uORF:IOH12222	1143	956	1158	1378	989	1445	863	832	1315	771	glutathione S-transferase pi (GSTP1)
B39R05C05	39-5-5	Hs~MGC:BC012573.1~uORF:IOH12159	1098	936	1287	1162	999	738	1450	847	1226	503	acyl-CoA thioesterase 9 (ACOT9)
B39R05C06	39-6-5	Hs~MGC:BC012573.1~uORF:IOH12159	1094	942	1313	1231	965	841	1423	699	1309	515	acyl-CoA thioesterase 9 (ACOT9)
B39R05C07	39-7-5	Hs~MGC:BC012626.1~uORF:IOH12346	1467	1278	1845	1436	1202	2108	2454	1313	2116	1042	N-acetyltransferase 8 (NAT8)
B39R05C08	39-8-5	Hs~MGC:BC012626.1~uORF:IOH12346	1451	1366	1846	1407	1054	2048	2425	1312	2117	1012	N-acetyltransferase 8 (NAT8)
B39R05C09	39-9-5	Hs~MGC:BC014244.1~uORF:IOH12917	1209	295	1620	2601	3718	9900	694	3229	2940	131	reticulon 2 (RTN2)
B39R05C10	39-10-5	Hs~MGC:BC014244.1~uORF:IOH12917	1131	396	1551	2299	2336	9506	670	3154	2915	151	reticulon 2 (RTN2)
B39R05C11	39-11-5	Hs~Ref:NM_004762.1~uORF:IOH26691	1136	3930	4367	785	3105	1265	1665	2726	2025	3109	pleckstrin homology, Sec7 and coiled-coil domains 1(cytohesin 1) (PSCD1), transcript variant 1
B39R05C12	39-12-5	Hs~Ref:NM_004762.1~uORF:IOH26691	1135	3985	4627	754	2044	1218	1595	2607	2001	2944	pleckstrin homology, Sec7 and coiled-coil domains 1(cytohesin 1) (PSCD1), transcript variant 1
B39R05C13	39-13-5	Hs~MGC:BC051838.1~uORF:IOH27071	725	796	1243	344	2536	456	371	526	656	248	Rho guanine nucleotide exchange factor 16
B39R05C14	39-14-5	Hs~MGC:BC051838.1~uORF:IOH27071	640	807	1235	348	2382	454	460	567	729	-33	Rho guanine nucleotide exchange factor 16
B39R05C15	39-15-5	Hs~Ref:NM_005902.1~uORF:IOH27044	674	1178	984	930	3436	1322	2336	1979	1650	62	SMAD family member 3 (SMAD3)
B39R05C16	39-16-5	Hs~Ref:NM_005902.1~uORF:IOH27044	634	1151	906	900	3045	1270	2332	1970	1709	230	SMAD family member 3 (SMAD3)
B39R05C17	39-17-5	Hs~Ref:NM_024552.1~uORF:IOH12136	453	1081	759	457	784	749	849	594	1182	375	LAG1 homolog, ceramide synthase 4 (LASS4)
B39R05C18	39-18-5	Hs~Ref:NM_024552.1~uORF:IOH12136	543	1064	786	466	2868	733	836	568	1189	335	LAG1 homolog, ceramide synthase 4 (LASS4)
B39R05C19	39-19-5	Hs~Ref:NM_004866.2~uORF:IOH12951	1110	1059	1466	690	495	6421	826	1069	2199	311	secretory carrier membrane protein 1 (SCAMP1)
B39R05C20	39-20-5	Hs~Ref:NM_004866.2~uORF:IOH12951	1060	1187	1360	683	644	6111	833	1027	2191	351	secretory carrier membrane protein 1 (SCAMP1)
B39R05C21	39-21-5	Hs~Ref:NM_002300.2~uORF:IOH3646	632	658	811	433	342	2578	620	552	1206	-13	lactate dehydrogenase B (LDHB)
B39R05C22	39-22-5	Hs~Ref:NM_002300.2~uORF:IOH3646	599	655	821	437	434	2476	608	527	1410	-42	lactate dehydrogenase B (LDHB)
B39R06C01	39-1-6	Hs~Ref:NM_006321.1~uORF:IOH3683	715	639	1229	2055	581	791	592	1091	1333	253	ariadne homolog 2 (Drosophila) (ARIH2)
B39R06C02	39-2-6	Hs~Ref:NM_006321.1~uORF:IOH3683	675	600	1173	2016	577	748	647	1041	1192	302	ariadne homolog 2 (Drosophila) (ARIH2)
B39R06C03	39-3-6	Hs~Ref:NM_182728.1~uORF:IOH45748	387	488	613	568	574	549	1222	700	540	105	solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 (SLC7A8), transcript variant 2
B39R06C04	39-4-6	Hs~Ref:NM_182728.1~uORF:IOH45748	334	430	613	498	679	590	1255	722	516	70	solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 (SLC7A8), transcript variant 2
B39R06C05	39-5-6	Hs~Ref:NM_175040.1~uORF:IOH45799	641	351	570	576	498	456	866	445	612	211	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 (ST6GALNAC4), transcript variant 2
B39R06C06	39-6-6	Hs~Ref:NM_175040.1~uORF:IOH45799	601	375	533	517	486	513	858	441	644	272	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 (ST6GALNAC4), transcript variant 2
B39R06C07	39-7-6	Hs~Ref:NM_206836.1~uORF:IOH45844	392	268	428	1038	1256	409	500	320	453	188	peroxisomal D3,D2-enoyl-CoA isomerase (PECI), transcript variant 2
B39R06C08	39-8-6	Hs~Ref:NM_206836.1~uORF:IOH45844	395	299	478	1039	1145	339	463	236	547	147	peroxisomal D3,D2-enoyl-CoA isomerase (PECI), transcript variant 2
B39R06C09	39-9-6	Hs~Ref:NM_016400.2~uORF:IOH45779	978	690	455	2891	3956	573	555	1138	1532	182	Huntingtin interacting protein K (HYPK)
B39R06C10	39-10-6	Hs~Ref:NM_016400.2~uORF:IOH45779	947	774	434	2863	3553	590	560	1122	1528	268	Huntingtin interacting protein K (HYPK)
B39R06C11	39-11-6	Hs~MGC:BC011975.1~uORF:IOH10480	865	1251	1214	778	611	817	1426	844	1659	408	syntaxin 7 (STX7)
B39R06C12	39-12-6	Hs~MGC:BC011975.1~uORF:IOH10480	970	921	1232	732	4367	809	1392	806	1744	396	syntaxin 7 (STX7)
B39R06C13	39-13-6	Hs~Ref:NM_002608.1~uORF:IOH22794	1189	822	1281	750	1781	897	2698	1035	1743	381	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) (PDGFB), transcript variant 1
B39R06C14	39-14-6	Hs~Ref:NM_002608.1~uORF:IOH22794	1208	732	1207	827	1300	954	2676	1059	1750	400	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) (PDGFB), transcript variant 1
B39R06C15	39-15-6	Hs~MGC:BC022341.1~uORF:IOH14769	676	576	1034	594	1173	696	1840	956	1393	417	Probable arginyl-tRNA synthetase, mitochondrial
B39R06C16	39-16-6	Hs~MGC:BC022341.1~uORF:IOH14769	731	660	1044	588	846	679	1779	1009	1315	401	Probable arginyl-tRNA synthetase, mitochondrial
B39R06C17	39-17-6	Hs~MGC:BC031592.1~uORF:IOH22703	581	708	891	659	894	672	1387	799	1514	456	serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 (SERPINF2)
B39R06C18	39-18-6	Hs~MGC:BC031592.1~uORF:IOH22703	596	698	879	685	988	618	1331	859	1401	400	serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 (SERPINF2)
B39R06C19	39-19-6	Hs~Ref:NM_003677.3~uORF:IOH56971	548	386	483	291	3451	637	1144	255	802	56	Density-regulated protein
B39R06C20	39-20-6	Hs~Ref:NM_003677.3~uORF:IOH56971	551	294	461	264	314	579	1171	242	790	57	Density-regulated protein
B39R06C21	39-21-6	Hs~Ref:NM_032730.3~uORF:IOH56958	483	397	434	326	355	514	426	374	1071	-24	Reticulon-4-interacting protein 1
B39R06C22	39-22-6	Hs~Ref:NM_032730.3~uORF:IOH56958	522	386	484	307	473	526	400	385	1214	-7	Reticulon-4-interacting protein 1
B39R07C05	39-5-7	Hs~MGC:BC015186.1~uORF:IOH12980	282	242	376	238	364	300	426	325	1278	219	platelet-derived growth factor receptor, alpha polypeptide (PDGFRA)
B39R07C06	39-6-7	Hs~MGC:BC015186.1~uORF:IOH12980	330	253	415	236	329	305	489	406	1320	195	platelet-derived growth factor receptor, alpha polypeptide (PDGFRA)
B39R07C07	39-7-7	Hs~Ref:NM_013410.1~uORF:IOH13992	402	251	392	647	806	497	582	697	2428	69	adenylate kinase 3-like 1 (AK3L1), nuclear gene encoding mitochondrial protein, transcript variant 6
B39R07C08	39-8-7	Hs~Ref:NM_013410.1~uORF:IOH13992	386	274	425	638	728	518	577	540	2337	181	adenylate kinase 3-like 1 (AK3L1), nuclear gene encoding mitochondrial protein, transcript variant 6
B39R07C09	39-9-7	Hs~Ref:NM_005565.2~uORF:IOH11014	2375	1306	1431	2434	2792	6703	3723	2682	25842	1040	lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) (LCP2)
B39R07C10	39-10-7	Hs~Ref:NM_005565.2~uORF:IOH11014	2198	1401	1373	2262	2401	6468	3586	2626	25517	959	lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) (LCP2)
B39R07C11	39-11-7	Hs~Ref:NM_001721.2~uORF:IOH11645	708	1243	829	701	624	719	911	812	1240	475	BMX non-receptor tyrosine kinase (BMX), transcript variant 2
B39R07C12	39-12-7	Hs~Ref:NM_001721.2~uORF:IOH11645	664	860	764	683	419	615	909	760	1158	426	BMX non-receptor tyrosine kinase (BMX), transcript variant 2
B39R07C13	39-13-7	Hs~Ref:NM_005002.3~uORF:IOH13734	809	945	964	749	3876	714	934	1095	958	587	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa (NDUFA9)
B39R07C14	39-14-7	Hs~Ref:NM_005002.3~uORF:IOH13734	982	938	793	961	1142	765	927	1130	997	582	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa (NDUFA9)
B39R07C15	39-15-7	Hs~MGC:BC027609.2~uORF:IOH11601	580	1243	689	671	1133	942	4344	708	1652	372	spermatid associated (SPERT)
B39R07C16	39-16-7	Hs~MGC:BC027609.2~uORF:IOH11601	587	1381	728	525	1385	886	4121	752	1575	370	spermatid associated (SPERT)
B39R07C17	39-17-7	Hs~Ref:NM_017868.2~uORF:IOH21721	375	414	857	364	243	415	580	399	556	96	tetratricopeptide repeat domain 12 (TTC12)
B39R07C18	39-18-7	Hs~Ref:NM_017868.2~uORF:IOH21721	179	395	931	353	719	424	623	418	570	82	tetratricopeptide repeat domain 12 (TTC12)
B39R07C19	39-19-7	Hs~Ref:NM_016584.2~uORF:IOH39400	386	389	536	404	4612	488	566	509	717	-7	interleukin 23, alpha subunit p19 (IL23A)
B39R07C20	39-20-7	Hs~Ref:NM_016584.2~uORF:IOH39400	506	440	558	416	316	488	521	435	734	-19	interleukin 23, alpha subunit p19 (IL23A)
B39R07C21	39-21-7	Hs~Ref:NM_021913.2~N/A	768	810	987	775	881	733	1059	938	2517	210	Tyrosine-protein kinase receptor UFO
B39R07C22	39-22-7	Hs~Ref:NM_021913.2~N/A	777	947	1086	741	1072	749	1068	1071	2718	417	Tyrosine-protein kinase receptor UFO
B39R08C01	39-1-8	Hs~Ref:NM_005211.1~N/A	682	872	1039	731	886	642	1273	826	1993	414	colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog (CSF1R)
B39R08C02	39-2-8	Hs~Ref:NM_005211.1~N/A	690	866	1026	753	850	652	953	845	2097	397	colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog (CSF1R)
B39R08C03	39-3-8	Hs~Ref:NM_006343.1~N/A	583	948	1146	2551	981	1184	1175	2239	4947	353	Proto-oncogene tyrosine-protein kinase MER
B39R08C04	39-4-8	Hs~Ref:NM_006343.1~N/A	647	861	1046	2495	924	1113	1167	2218	4676	350	Proto-oncogene tyrosine-protein kinase MER
B39R08C05	39-5-8	Hs~Ref:NM_002530.1~N/A	1131	1657	2533	2265	1205	1069	5617	2645	4243	520	NT-3 growth factor receptor
B39R08C06	39-6-8	Hs~Ref:NM_002530.1~N/A	1096	1589	2449	2173	1168	1085	5343	2572	4079	510	NT-3 growth factor receptor
B39R08C07	39-7-8	Hs~Ref:NM_032112.1~uORF:IOH25749	2750	1369	2375	943	1069	2220	2040	1776	2243	679	mitochondrial ribosomal protein L43 (MRPL43), nuclear gene encoding mitochondrial protein, transcript variant 1
B39R08C08	39-8-8	Hs~Ref:NM_032112.1~uORF:IOH25749	3077	1315	2295	894	932	2354	2024	1654	2223	655	mitochondrial ribosomal protein L43 (MRPL43), nuclear gene encoding mitochondrial protein, transcript variant 1
B39R08C09	39-9-8	Hs~MGC:BC036197.1~uORF:IOH27500	4061	2815	2160	1355	1151	50032	2345	1262	2962	4034	hypothetical protein LOC403312 (MGC39545)
B39R08C10	39-10-8	Hs~MGC:BC036197.1~uORF:IOH27500	3436	2710	2238	1374	991	52891	2307	1227	3047	4016	hypothetical protein LOC403312 (MGC39545)
B39R08C11	39-11-8	Hs~MGC:NM_178838.2~uORF:IOH23233	1021	1047	1255	1098	739	1333	1459	1602	2336	541	hypothetical protein LOC90768 (MGC45800)
B39R08C12	39-12-8	Hs~MGC:NM_178838.2~uORF:IOH23233	1203	1036	1171	1181	693	1269	1449	1602	2297	564	hypothetical protein LOC90768 (MGC45800)
B39R08C13	39-13-8	Hs~Ref:NM_016210.1~uORF:IOH22819	2542	725	1110	890	671	733	1967	1037	1610	408	chromosome 3 open reading frame 18 (C3orf18)
B39R08C14	39-14-8	Hs~Ref:NM_016210.1~uORF:IOH22819	2546	741	1075	947	3899	740	1894	1014	1661	403	chromosome 3 open reading frame 18 (C3orf18)
B39R08C15	39-15-8	Hs~Ref:NM_021268.1~uORF:IOH35234	965	959	2054	1328	2239	1022	1487	1275	2434	448	interferon, alpha 17 (IFNA17)
B39R08C16	39-16-8	Hs~Ref:NM_021268.1~uORF:IOH35234	941	971	2132	1198	2061	987	1556	1269	2443	451	interferon, alpha 17 (IFNA17)
B39R08C17	39-17-8	Hs~Ref:NM_006590.2~uORF:IOH45672	4095	2225	3974	3594	5475	6225	11711	3404	9859	1457	ubiquitin specific peptidase 39 (USP39)
B39R08C18	39-18-8	Hs~Ref:NM_006590.2~uORF:IOH45672	4382	2214	3966	3555	4298	5960	11874	3307	9744	1440	ubiquitin specific peptidase 39 (USP39)
B39R08C19	39-19-8	Hs~MGC:BC031687.1~uORF:IOH21501	5021	1202	3359	2759	7613	2674	3470	1683	17786	1551	drebrin-like (DBNL)
B39R08C20	39-20-8	Hs~MGC:BC031687.1~uORF:IOH21501	4920	1179	3352	2635	1280	2565	3469	1484	17417	1513	drebrin-like (DBNL)
B39R08C21	39-21-8	Hs~Ref:NM_007041.2~uORF:IOH45551	1288	954	1882	1140	994	1317	1900	1137	2122	555	arginyltransferase 1 (ATE1), transcript variant 2
B39R08C22	39-22-8	Hs~Ref:NM_007041.2~uORF:IOH45551	1210	1058	1999	1065	1087	1368	1883	1208	2152	501	arginyltransferase 1 (ATE1), transcript variant 2
B39R09C01	39-1-9	Hs~Ref:NM_152277.1~uORF:IOH11072	601	507	3925	1292	423	573	2987	486	1629	168	ubiquitin domain containing 2 (UBTD2)
B39R09C02	39-2-9	Hs~Ref:NM_152277.1~uORF:IOH11072	597	499	3895	1221	412	567	2596	442	1615	158	ubiquitin domain containing 2 (UBTD2)
B39R09C03	39-3-9	Hs~MGC:BC018302.1~uORF:IOH10233	474	506	592	538	501	732	697	378	800	220	TRM1 tRNA methyltransferase 1 homolog (S. cerevisiae) (TRMT1)
B39R09C04	39-4-9	Hs~MGC:BC018302.1~uORF:IOH10233	488	464	599	531	516	729	745	370	702	99	TRM1 tRNA methyltransferase 1 homolog (S. cerevisiae) (TRMT1)
B39R09C05	39-5-9	Hs~MGC:BC025682.1~uORF:IOH10827	567	1513	1994	510	524	644	783	622	584	4641	gasdermin-like (GSDML)
B39R09C06	39-6-9	Hs~MGC:BC025682.1~uORF:IOH10827	576	1551	1939	528	524	607	780	585	653	4420	gasdermin-like (GSDML)
B39R09C07	39-7-9	Hs~Ref:NM_013943.1~uORF:IOH10508	583	1873	1808	915	871	1247	1816	1957	1159	341	chloride intracellular channel 4 (CLIC4)
B39R09C08	39-8-9	Hs~Ref:NM_013943.1~uORF:IOH10508	599	1899	1790	859	770	1160	1759	1820	1156	365	chloride intracellular channel 4 (CLIC4)
B39R09C09	39-9-9	Hs~Ref:NM_000849.1~uORF:IOH4761	385	349	589	448	1887	408	657	973	669	106	glutathione S-transferase M3 (brain) (GSTM3)
B39R09C10	39-10-9	Hs~Ref:NM_000849.1~uORF:IOH4761	496	359	597	413	1982	431	661	886	664	123	glutathione S-transferase M3 (brain) (GSTM3)
B39R09C11	39-11-9	Hs~MGC:BC007633.1~uORF:IOH6965	720	857	928	601	579	540	801	732	848	317	eukaryotic translation initiation factor 2C, 2 (EIF2C2)
B39R09C12	39-12-9	Hs~MGC:BC007633.1~uORF:IOH6965	749	824	1004	651	532	565	788	809	855	272	eukaryotic translation initiation factor 2C, 2 (EIF2C2)
B39R09C13	39-13-9	Hs~MGC:BC007526.1~uORF:IOH6827	627	706	9184	683	617	431	899	557	573	213	chromosome X open reading frame 34 (CXorf34)
B39R09C14	39-14-9	Hs~MGC:BC007526.1~uORF:IOH6827	609	677	9607	811	640	425	946	529	546	184	chromosome X open reading frame 34 (CXorf34)
B39R09C15	39-15-9	Hs~Ref:NM_003574.2~uORF:IOH5040	642	1072	65485	1041	867	3876	1046	2324	1407	315	VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa (VAPA), transcript variant 1
B39R09C16	39-16-9	Hs~Ref:NM_003574.2~uORF:IOH5040	563	1040	65484	932	710	3734	1049	2462	1488	314	VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa (VAPA), transcript variant 1
B39R09C17	39-17-9	Hs~Ref:NM_201625.1~uORF:IOH41017	335	265	319	325	2826	450	313	506	6337	88	C-type lectin domain family 12 member A
B39R09C18	39-18-9	Hs~Ref:NM_201625.1~uORF:IOH41017	373	297	319	319	1889	434	315	488	6300	84	C-type lectin domain family 12 member A
B39R09C19	39-19-9	Hs~MGC:BC022812.1~uORF:IOH46102	560	343	681	538	282	388	564	423	865	-7	podoplanin (PDPN)
B39R09C20	39-20-9	Hs~MGC:BC022812.1~uORF:IOH46102	562	361	656	663	238	410	535	557	829	80	podoplanin (PDPN)
B39R09C21	39-21-9	Hs~Ref:NM_198175.1~uORF:IOH41255	2752	844	820	836	442	725	555	1061	1037	280	non-metastatic cells 1, protein (NM23A) expressed in (NME1), transcript variant 1
B39R09C22	39-22-9	Hs~Ref:NM_198175.1~uORF:IOH41255	2785	799	813	667	577	704	560	1012	1055	276	non-metastatic cells 1, protein (NM23A) expressed in (NME1), transcript variant 1
B39R10C01	39-1-10	Hs~MGC:BC001852.2~uORF:IOH46107	507	392	1923	513	456	737	843	399	842	250	tRNA-histidine guanylyltransferase 1-like (S. cerevisiae) (THG1L)
B39R10C02	39-2-10	Hs~MGC:BC001852.2~uORF:IOH46107	554	430	1886	489	437	749	768	397	752	209	tRNA-histidine guanylyltransferase 1-like (S. cerevisiae) (THG1L)
B39R10C03	39-3-10	Hs~Ref:NM_007172.2~uORF:IOH40805	1562	835	853	2927	1876	953	12612	2295	1425	3492	nucleoporin 50kDa (NUP50), transcript variant 2
B39R10C04	39-4-10	Hs~Ref:NM_007172.2~uORF:IOH40805	1513	849	876	2712	1770	891	12546	2073	1432	3454	nucleoporin 50kDa (NUP50), transcript variant 2
B39R10C07	39-7-10	Hs~MGC:BC062736.1~uORF:IOH40707	1574	439	792	449	536	712	1352	796	2577	721	basic transcription factor 3, pseudogene 9 (LOC503543)
B39R10C08	39-8-10	Hs~MGC:BC062736.1~uORF:IOH40707	1549	445	780	465	523	687	1328	840	2599	676	basic transcription factor 3, pseudogene 9 (LOC503543)
B39R10C09	39-9-10	Hs~Ref:NM_207350.1~uORF:IOH40748	21930	1364	1519	1985	1694	4557	26063	3565	2919	9306	similar to FRG1 protein (FSHD region gene 1 protein) (MGC72104)
B39R10C10	39-10-10	Hs~Ref:NM_207350.1~uORF:IOH40748	21606	1403	1486	2000	1265	4121	24558	3204	3168	9289	similar to FRG1 protein (FSHD region gene 1 protein) (MGC72104)
B39R11C21	39-21-11	Hs~MGC:BC011795.2~uORF:IOH13069	623	276	346	275	245	415	1440	324	588	108	NDRG family member 4 (NDRG4)
B39R11C22	39-22-11	Hs~MGC:BC011795.2~uORF:IOH13069	610	222	351	266	625	395	1199	296	601	143	NDRG family member 4 (NDRG4)
B39R12C01	39-1-12	Hs~Ref:NM_001190.2~uORF:IOH4883	230	234	208	391	300	269	392	267	286	117	branched chain aminotransferase 2, mitochondrial (BCAT2)
B39R12C02	39-2-12	Hs~Ref:NM_001190.2~uORF:IOH4883	230	238	245	410	131	233	351	239	319	70	branched chain aminotransferase 2, mitochondrial (BCAT2)
B39R12C03	39-3-12	Hs~Ref:NM_004725.2~uORF:IOH4613	312	295	342	480	191	358	629	387	239	83	BUB3 budding uninhibited by benzimidazoles 3 homolog (yeast) (BUB3), transcript variant 1
B39R12C04	39-4-12	Hs~Ref:NM_004725.2~uORF:IOH4613	334	335	373	445	328	432	672	445	390	155	BUB3 budding uninhibited by benzimidazoles 3 homolog (yeast) (BUB3), transcript variant 1
B39R12C05	39-5-12	Hs~MGC:BC000453.2~uORF:IOH3516	1350	1169	698	1389	1348	4347	29040	811	1537	296	pericentriolar material 1 (PCM1)
B39R12C06	39-6-12	Hs~MGC:BC000453.2~uORF:IOH3516	1291	1040	655	1293	1362	4195	28623	707	1621	258	pericentriolar material 1 (PCM1)
B39R12C07	39-7-12	Hs~MGC:BC007207.1~uORF:IOH6669	604	962	898	2231	616	518	1161	652	1114	269	chromosome 16 open reading frame 13 (C16orf13)
B39R12C08	39-8-12	Hs~MGC:BC007207.1~uORF:IOH6669	635	1028	842	2198	606	496	1149	635	1074	282	chromosome 16 open reading frame 13 (C16orf13)
B39R12C09	39-9-12	Hs~MGC:BC017943.1~uORF:IOH12235	1082	2099	754	2814	680	2096	3207	7957	1976	496	protein phosphatase 1, regulatory (inhibitor) subunit 1C (PPP1R1C)
B39R12C10	39-10-12	Hs~MGC:BC017943.1~uORF:IOH12235	1229	1916	719	2831	632	1981	3016	7444	2183	484	protein phosphatase 1, regulatory (inhibitor) subunit 1C (PPP1R1C)
B39R12C11	39-11-12	Hs~MGC:BC029032.1~uORF:IOH22628	668	449	739	503	498	452	540	491	1008	262	arachidonate 15-lipoxygenase (ALOX15)
B39R12C12	39-12-12	Hs~MGC:BC029032.1~uORF:IOH22628	652	510	778	537	463	452	531	486	1006	102	arachidonate 15-lipoxygenase (ALOX15)
B39R12C13	39-13-12	Hs~Ref:NM_024059.2~uORF:IOH2960	1292	938	1540	863	731	1018	2238	1108	2098	472	chromosome 20 open reading frame 195 (C20orf195)
B39R12C14	39-14-12	Hs~Ref:NM_024059.2~uORF:IOH2960	1311	917	1611	935	1609	1028	2297	967	2074	435	chromosome 20 open reading frame 195 (C20orf195)
B39R12C17	39-17-12	Hs~Ref:XM_375307.2~uORF:IOH44530	702	725	826	1010	897	980	1123	901	1424	534	Putative uncharacterized protein ENSP00000341502
B39R12C18	39-18-12	Hs~Ref:XM_375307.2~uORF:IOH44530	744	865	861	1045	742	1001	1070	781	1334	561	Putative uncharacterized protein ENSP00000341502
B39R12C19	39-19-12	Hs~Ref:NM_080918.1~uORF:IOH44424	1437	1438	1551	1765	969	1235	1755	1003	1949	59	Deoxyguanosine kinase, mitochondrial
B39R12C20	39-20-12	Hs~Ref:NM_080918.1~uORF:IOH44424	1420	1311	1550	1690	1064	1292	1762	1088	160	569	Deoxyguanosine kinase, mitochondrial
B39R12C21	39-21-12	Hs~Ref:NM_198216.1~uORF:IOH44674	3782	2123	3837	5502	1613	7808	5854	8363	5097	808	small nuclear ribonucleoprotein polypeptides B and B1 (SNRPB), transcript variant 1, mRNA.
B39R12C22	39-22-12	Hs~Ref:NM_198216.1~uORF:IOH44674	4349	2122	3973	5216	2108	7462	6297	7723	5235	797	small nuclear ribonucleoprotein polypeptides B and B1 (SNRPB), transcript variant 1, mRNA.
B39R13C01	39-1-13	Hs~Ref:NM_004574.2~uORF:IOH29562	921	1342	5085	1136	437	824	1766	622	2622	217	septin 4 (SEPT4), transcript variant 1
B39R13C02	39-2-13	Hs~Ref:NM_004574.2~uORF:IOH29562	946	938	4629	1194	430	814	1837	638	2594	202	septin 4 (SEPT4), transcript variant 1
B39R13C03	39-3-13	Hs~Ref:NM_032781.2~uORF:IOH29621	404	723	871	490	390	1025	806	698	707	187	protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) (PTPN5), transcript variant 2
B39R13C04	39-4-13	Hs~Ref:NM_032781.2~uORF:IOH29621	424	536	740	477	301	952	826	687	737	173	protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) (PTPN5), transcript variant 2
B39R13C05	39-5-13	Hs~MGC:BC000914.1~uORF:IOH2971	1166	1464	1043	822	876	926	1801	734	875	528	splicing factor, arginine/serine-rich 3 (SFRS3)
B39R13C06	39-6-13	Hs~MGC:BC000914.1~uORF:IOH2971	1068	1428	1134	1101	936	1022	1712	709	218	520	splicing factor, arginine/serine-rich 3 (SFRS3)
B39R13C07	39-7-13	Hs~MGC:BC039039.1~uORF:IOH27465	2648	3192	4139	1867	3034	7355	3698	2096	3239	637	zeta-chain (TCR) associated protein kinase 70kDa (ZAP70)
B39R13C08	39-8-13	Hs~MGC:BC039039.1~uORF:IOH27465	2582	2967	4043	1821	2947	7169	3822	1963	3230	655	zeta-chain (TCR) associated protein kinase 70kDa (ZAP70)
B39R13C09	39-9-13	Hs~Ref:NM_001005753.1~uORF:IOH45855	1096	931	1381	1348	888	949	1450	972	2216	296	vacuolar protein sorting 24 homolog (S. cerevisiae) (VPS24), transcript variant 2
B39R13C10	39-10-13	Hs~Ref:NM_001005753.1~uORF:IOH45855	1050	821	1272	1060	882	1081	1303	947	2189	304	vacuolar protein sorting 24 homolog (S. cerevisiae) (VPS24), transcript variant 2
B39R13C11	39-11-13	Hs~Ref:NM_197967.1~uORF:IOH45743	1030	566	661	653	411	531	922	496	1397	354	BH3 interacting domain death agonist (BID), transcript variant 3
B39R13C12	39-12-13	Hs~Ref:NM_197967.1~uORF:IOH45743	979	561	661	582	430	507	872	442	1271	279	BH3 interacting domain death agonist (BID), transcript variant 3
B39R13C13	39-13-13	Hs~Ref:NM_145863.1~uORF:IOH45865	9991	335	617	1493	606	613	1009	2258	937	365	ankyrin repeat and SOCS box-containing 3 (ASB3), transcript variant 2
B39R13C14	39-14-13	Hs~Ref:NM_145863.1~uORF:IOH45865	10015	321	618	1468	1549	556	931	2108	941	339	ankyrin repeat and SOCS box-containing 3 (ASB3), transcript variant 2
B39R13C15	39-15-13	Hs~Ref:NM_004178.3~uORF:IOH45867	575	478	521	412	1036	296	425	303	904	57	TAR (HIV-1) RNA binding protein 2 (TARBP2), transcript variant 3
B39R13C16	39-16-13	Hs~Ref:NM_004178.3~uORF:IOH45867	555	456	518	408	846	292	423	335	896	29	TAR (HIV-1) RNA binding protein 2 (TARBP2), transcript variant 3
B39R13C17	39-17-13	Hs~MGC:BC013385.1~uORF:IOH12422	688	607	698	505	448	600	1495	457	1355	403	C-type lectin domain family 7, member A (CLEC7A)
B39R13C18	39-18-13	Hs~MGC:BC013385.1~uORF:IOH12422	691	858	755	480	225	586	1560	630	1191	324	C-type lectin domain family 7, member A (CLEC7A)
B39R13C19	39-19-13	Hs~MGC:BC012933.1~uORF:IOH11173	981	941	1128	1950	734	765	1277	1653	1345	462	suppressor of variegation 4-20 homolog 1 (Drosophila) (SUV420H1)
B39R13C20	39-20-13	Hs~MGC:BC012933.1~uORF:IOH11173	941	743	1142	1814	584	730	1230	1331	1519	866	suppressor of variegation 4-20 homolog 1 (Drosophila) (SUV420H1)
B39R13C21	39-21-13	Hs~MGC:BC016996.1~uORF:IOH11935	635	404	829	483	396	630	1058	505	1105	256	Dedicator of cytokinesis protein 2
B39R13C22	39-22-13	Hs~MGC:BC016996.1~uORF:IOH11935	614	416	843	500	640	595	1303	445	1252	262	Dedicator of cytokinesis protein 2
B39R14C01	39-1-14	Hs~MGC:BC012865.1~uORF:IOH11604	1767	1264	1488	854	642	957	5484	916	1527	380	UPF0518 protein FAM160B2
B39R14C02	39-2-14	Hs~MGC:BC012865.1~uORF:IOH11604	1753	1007	1502	885	603	1034	5760	870	1565	358	UPF0518 protein FAM160B2
B39R14C03	39-3-14	Hs~Ref:NM_152387.2~uORF:IOH53987	8249	3842	4984	3679	4200	3161	13459	5855	6577	3197	BTB/POZ domain-containing protein KCTD18
B39R14C04	39-4-14	Hs~Ref:NM_152387.2~uORF:IOH53987	8557	3775	4712	3440	3970	3491	13794	5398	6671	3044	BTB/POZ domain-containing protein KCTD18
B39R14C05	39-5-14	Hs~Ref:NM_013367.2~uORF:IOH54154	308	997	345	2611	331	722	592	325	604	183	Anaphase-promoting complex subunit 4
B39R14C06	39-6-14	Hs~Ref:NM_013367.2~uORF:IOH54154	308	130	312	398	134	345	615	318	369	155	Anaphase-promoting complex subunit 4
B39R14C11	39-11-14	Hs~MGC:XM_376503.1~uORF:IOH11280	284	299	581	317	1303	437	560	517	651	186	ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function) (ENPP4)
B39R14C12	39-12-14	Hs~MGC:XM_376503.1~uORF:IOH11280	264	335	572	338	1455	364	484	390	670	201	ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function) (ENPP4)
B39R14C13	39-13-14	Hs~Ref:NM_005398.2~uORF:IOH13809	409	416	553	366	4125	444	636	684	1377	285	protein phosphatase 1, regulatory (inhibitor) subunit 3C (PPP1R3C)
B39R14C14	39-14-14	Hs~Ref:NM_005398.2~uORF:IOH13809	409	343	542	391	4315	412	664	630	1239	279	protein phosphatase 1, regulatory (inhibitor) subunit 3C (PPP1R3C)
B39R14C15	39-15-14	Hs~Ref:NM_016322.2~uORF:IOH6559	489	388	682	419	439	505	629	1014	779	265	RAB14, member RAS oncogene family (RAB14)
B39R14C16	39-16-14	Hs~Ref:NM_016322.2~uORF:IOH6559	492	445	679	404	410	505	637	1013	805	280	RAB14, member RAS oncogene family (RAB14)
B39R14C17	39-17-14	Hs~Ref:NM_002143.2~uORF:IOH4454	618	639	866	699	729	615	822	837	4251	383	hippocalcin (HPCA)
B39R14C18	39-18-14	Hs~Ref:NM_002143.2~uORF:IOH4454	584	1666	933	687	704	596	772	874	4318	347	hippocalcin (HPCA)
B39R14C19	39-19-14	Hs~Ref:NM_000673.3~uORF:IOH60854	1436	489	410	281	203	533	650	556	893	379	Alcohol dehydrogenase class 4 mu/sigma chain
B39R14C20	39-20-14	Hs~Ref:NM_000673.3~uORF:IOH60854	1298	910	392	290	299	542	576	535	913	377	Alcohol dehydrogenase class 4 mu/sigma chain
B39R15C01	39-1-15	Hs~MGC:BC036523.1~uORF:IOH62112	802	979	1110	560	577	752	1220	1619	1161	387	Mirror-image polydactyly gene 1 protein
B39R15C02	39-2-15	Hs~MGC:BC036523.1~uORF:IOH62112	3210	1039	1098	578	572	816	1161	1508	1229	415	Mirror-image polydactyly gene 1 protein
B39R15C05	39-5-15	Hs~MGC:BC012736.2~uORF:IOH14394	393	466	506	1294	1611	255	529	335	847	290	nuclear receptor coactivator 4 (NCOA4)
B39R15C06	39-6-15	Hs~MGC:BC012736.2~uORF:IOH14394	418	590	511	908	1790	571	516	386	828	334	nuclear receptor coactivator 4 (NCOA4)
B39R15C07	39-7-15	Hs~MGC:BC056148.1~uORF:IOH29121	677	729	1105	1701	5285	964	731	1148	1627	484	nuclear receptor subfamily 1, group D, member 1 (NR1D1)
B39R15C08	39-8-15	Hs~MGC:BC056148.1~uORF:IOH29121	628	732	1074	1120	5157	963	770	1180	1542	497	nuclear receptor subfamily 1, group D, member 1 (NR1D1)
B39R15C09	39-9-15	Hs~MGC:BC041632.1~uORF:IOH29353	455	2254	308	323	348	1003	663	403	559	150	hypothetical LOC339483 (LOC339483)
B39R15C10	39-10-15	Hs~MGC:BC041632.1~uORF:IOH29353	453	183	321	218	324	526	399	326	730	72	hypothetical LOC339483 (LOC339483)
B39R15C11	39-11-15	Hs~MGC:BC015596.1~uORF:IOH29335	371	1118	522	530	321	405	1407	1185	1383	168	chromosome 21 open reading frame 51 (C21orf51)
B39R15C12	39-12-15	Hs~MGC:BC015596.1~uORF:IOH29335	366	289	530	528	310	619	440	1035	1511	145	chromosome 21 open reading frame 51 (C21orf51)
B39R15C17	39-17-15	Hs~Ref:NM_006282.1~CAT:PV3854	286	490	691	365	373	315	2753	2086	1451	77	Serine/threonine-protein kinase 4
B39R15C18	39-18-15	Hs~Ref:NM_006282.1~CAT:PV3854	136	746	704	327	341	328	2585	1941	1446	156	Serine/threonine-protein kinase 4
B39R15C19	39-19-15	Hs~Ref:NM_000294.1~CAT:PV4555	264	408	392	436	550	324	387	324	480	32	phosphorylase kinase, gamma 2 (testis)
B39R15C20	39-20-15	Hs~Ref:NM_000294.1~CAT:PV4555	346	548	391	442	511	315	377	757	541	41	phosphorylase kinase, gamma 2 (testis)
B39R16C01	39-1-16	Hs~Ref:NM_001569.2~CAT:PV4403	5182	292	12583	792	995	594	504	14516	733	398	Interleukin-1 receptor-associated kinase 1
B39R16C02	39-2-16	Hs~Ref:NM_001569.2~CAT:PV4403	5984	299	12533	840	1062	494	510	13353	473	323	Interleukin-1 receptor-associated kinase 1
B39R16C05	39-5-16	Hs~Ref:NM_004935.1~CAT:PV4676	6093	90	272	1254	1382	982	718	467	1448	1177	cyclin-dependent kinase 5 (CDK5) and p25: CDK5 and p25 sequences are seperated by -- (in protein list file).
B39R16C06	39-6-16	Hs~Ref:NM_004935.1~CAT:PV4676	5775	84	273	1169	1353	947	748	406	1532	1154	cyclin-dependent kinase 5 (CDK5) and p25: CDK5 and p25 sequences are seperated by -- (in protein list file).
B39R16C07	39-7-16	Hs~Ref:NM_012282.2~uORF:IOH27351	746	606	970	1303	875	724	1207	917	1367	364	KCNE1-like (KCNE1L)
B39R16C08	39-8-16	Hs~Ref:NM_012282.2~uORF:IOH27351	705	623	1015	737	886	697	1201	869	1349	348	KCNE1-like (KCNE1L)
B39R16C09	39-9-16	Hs~MGC:BC016985.2~uORF:IOH28621	1261	1058	1732	1827	1674	1359	3231	1457	2274	784	ankyrin repeat domain 44 (ANKRD44)
B39R16C10	39-10-16	Hs~MGC:BC016985.2~uORF:IOH28621	1298	1239	1656	1880	1634	1259	3734	1403	2234	781	ankyrin repeat domain 44 (ANKRD44)
B39R16C11	39-11-16	Hs~Ref:NM_153486.2~uORF:IOH26957	779	906	1322	698	762	804	4159	675	1531	432	lactate dehydrogenase D (LDHD), nuclear gene encoding mitochondrial protein, transcript variant 1
B39R16C12	39-12-16	Hs~Ref:NM_153486.2~uORF:IOH26957	788	752	1289	679	695	950	1805	722	1398	436	lactate dehydrogenase D (LDHD), nuclear gene encoding mitochondrial protein, transcript variant 1
B39R16C13	39-13-16	Hs~MGC:BC047782.1~uORF:IOH26739	1104	993	1992	932	1339	2275	2915	924	2267	415	cDNA clone MGC:54300 IMAGE:6500495, complete cds
B39R16C14	39-14-16	Hs~MGC:BC047782.1~uORF:IOH26739	1113	1030	2008	948	1316	2183	3001	922	2420	416	cDNA clone MGC:54300 IMAGE:6500495, complete cds
B39R16C15	39-15-16	Hs~MGC:BC016442.1~uORF:IOH28612	662	813	803	608	865	1141	1051	754	1078	308	Fibronectin type III and SPRY domain-containing protein 1
B39R16C16	39-16-16	Hs~MGC:BC016442.1~uORF:IOH28612	647	698	800	634	976	1070	1076	779	1083	328	Fibronectin type III and SPRY domain-containing protein 1
B39R16C17	39-17-16	Hs~MGC:BC039323.1~uORF:IOH28719	2033	908	3281	1410	1277	1134	3501	1138	2254	634	zinc finger protein 8 (ZNF8)
B39R16C18	39-18-16	Hs~MGC:BC039323.1~uORF:IOH28719	2034	850	3187	1327	1236	1053	3460	981	2220	599	zinc finger protein 8 (ZNF8)
B39R16C19	39-19-16	Hs~MGC:BC060760.1~uORF:IOH29142	532	94	3516	473	757	553	505	851	1640	230	GTPase, IMAP family member 6 (GIMAP6)
B39R16C20	39-20-16	Hs~MGC:BC060760.1~uORF:IOH29142	573	261	3475	444	819	547	524	889	1617	238	GTPase, IMAP family member 6 (GIMAP6)
B39R16C21	39-21-16	Hs~MGC:BC053646.1~uORF:IOH28946	1088	827	2344	3072	1072	1665	3040	1304	36698	542	eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa (EIF2B5)
B39R16C22	39-22-16	Hs~MGC:BC053646.1~uORF:IOH28946	1051	987	2330	2885	1101	1490	3090	1218	36983	517	eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa (EIF2B5)
B39R17C01	39-1-17	Hs~MGC:BC060870.1~uORF:IOH62447	3428	237	686	242	552	233	1694	761	433	469	Receptor-interacting serine/threonine-protein kinase 5
B39R17C02	39-2-17	Hs~MGC:BC060870.1~uORF:IOH62447	2308	254	659	251	590	461	1764	760	345	315	Receptor-interacting serine/threonine-protein kinase 5
B39R17C03	39-3-17	Hs~Ref:NM_006144.2~uORF:IOH14828	1116	813	1185	726	1875	1070	1924	844	1131	448	granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) (GZMA)
B39R17C04	39-4-17	Hs~Ref:NM_006144.2~uORF:IOH14828	1266	809	1277	701	2021	1079	1919	889	758	430	granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) (GZMA)
B39R17C05	39-5-17	Hs~MGC:NM_152552.1~uORF:IOH22758	1791	1755	1795	1392	5411	2911	2794	2016	3089	624	sterile alpha motif domain containing 3 (SAMD3), transcript variant 2
B39R17C06	39-6-17	Hs~MGC:NM_152552.1~uORF:IOH22758	1473	1759	1836	1277	5348	2444	2912	1914	2972	606	sterile alpha motif domain containing 3 (SAMD3), transcript variant 2
B39R17C07	39-7-17	Hs~Ref:NM_145250.1~uORF:IOH11197	828	740	853	965	1301	1043	1875	936	1626	434	ribonuclease, RNase A family, 11 (non-active) (RNASE11)
B39R17C08	39-8-17	Hs~Ref:NM_145250.1~uORF:IOH11197	739	674	894	737	1215	1023	1668	1009	1659	413	ribonuclease, RNase A family, 11 (non-active) (RNASE11)
B39R17C09	39-9-17	Hs~Ref:NM_018384.1~uORF:IOH12230	444	711	612	776	784	467	1667	1114	1083	357	GTPase, IMAP family member 5 (GIMAP5)
B39R17C10	39-10-17	Hs~Ref:NM_018384.1~uORF:IOH12230	476	757	588	822	771	549	1847	1077	1208	308	GTPase, IMAP family member 5 (GIMAP5)
B39R17C11	39-11-17	Hs~Ref:NM_005105.2~uORF:IOH10383	716	1312	587	892	867	924	1914	2822	1012	322	RNA binding motif protein 8A (RBM8A)
B39R17C12	39-12-17	Hs~Ref:NM_005105.2~uORF:IOH10383	712	1281	554	825	881	836	1380	2156	1023	303	RNA binding motif protein 8A (RBM8A)
B39R17C13	39-13-17	Hs~Ref:NM_004049.2~uORF:IOH10128	179	150	216	165	423	92	221	214	110	30	BCL2-related protein A1 (BCL2A1)
B39R17C14	39-14-17	Hs~Ref:NM_004049.2~uORF:IOH10128	183	179	202	182	414	649	206	200	148	30	BCL2-related protein A1 (BCL2A1)
B39R17C15	39-15-17	Hs~Ref:NM_003342.2~uORF:IOH5319	65	254	549	478	424	1025	358	309	466	186	ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, yeast) (UBE2G1)
B39R17C16	39-16-17	Hs~Ref:NM_003342.2~uORF:IOH5319	233	258	553	577	416	539	363	635	452	136	ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, yeast) (UBE2G1)
B39R17C17	39-17-17	Hs~MGC:BC032851.2~uORF:IOH27168	1339	1162	3182	1294	1108	3697	9005	7356	4684	703	Cas-Br-M (murine) ecotropic retroviral transforming sequence b (CBLB)
B39R17C18	39-18-17	Hs~MGC:BC032851.2~uORF:IOH27168	1485	1203	3172	1154	770	4548	9510	7995	4568	645	Cas-Br-M (murine) ecotropic retroviral transforming sequence b (CBLB)
B39R17C19	39-19-17	Hs~Ref:NM_014899.2~uORF:IOH25836	458	62	239	241	42	207	344	225	101	136	Rho-related BTB domain containing 3 (RHOBTB3)
B39R17C20	39-20-17	Hs~Ref:NM_014899.2~uORF:IOH25836	79	65	235	187	58	-3	354	244	135	25	Rho-related BTB domain containing 3 (RHOBTB3)
B39R17C21	39-21-17	Hs~Ref:NM_058217.1~uORF:IOH4338	501	235	662	456	698	470	488	379	453	190	RAD51 homolog C (S. cerevisiae) (RAD51C), transcript variant 3
B39R17C22	39-22-17	Hs~Ref:NM_058217.1~uORF:IOH4338	435	770	667	405	403	362	483	748	594	101	RAD51 homolog C (S. cerevisiae) (RAD51C), transcript variant 3
B39R18C01	39-1-18	Hs~MGC:NM_174940.1~uORF:IOH3344	337	294	595	330	554	441	487	363	96	135	transmembrane protein 80 (TMEM80), transcript variant 1
B39R18C02	39-2-18	Hs~MGC:NM_174940.1~uORF:IOH3344	334	285	562	361	538	509	530	383	74	775	transmembrane protein 80 (TMEM80), transcript variant 1
B39R18C03	39-3-18	Hs~MGC:BC017337.1~uORF:IOH13947	5352	799	2022	728	1329	966	4880	2024	1324	532	general transcription factor IIIC, polypeptide 5, 63kDa (GTF3C5)
B39R18C04	39-4-18	Hs~MGC:BC017337.1~uORF:IOH13947	5520	821	1974	730	1325	1106	5012	1979	1290	447	general transcription factor IIIC, polypeptide 5, 63kDa (GTF3C5)
B39R18C05	39-5-18	Hs~Ref:NM_032459.1~uORF:IOH21413	36361	1152	2020	819	1543	1204	6522	1032	5331	1624	embryonal Fyn-associated substrate (EFS), transcript variant 2
B39R18C06	39-6-18	Hs~Ref:NM_032459.1~uORF:IOH21413	35026	1148	2044	829	1461	1095	6533	1045	5248	1449	embryonal Fyn-associated substrate (EFS), transcript variant 2
B39R18C07	39-7-18	Hs~MGC:BC021622.1~uORF:IOH21430	872	635	1676	993	523	1176	5079	1917	1587	284	phosphoinositide-3-kinase, regulatory subunit 3 (p55, gamma) (PIK3R3)
B39R18C08	39-8-18	Hs~MGC:BC021622.1~uORF:IOH21430	779	579	1671	1053	517	1221	5047	1944	1451	280	phosphoinositide-3-kinase, regulatory subunit 3 (p55, gamma) (PIK3R3)
B39R18C09	39-9-18	Hs~MGC:BC020979.1~uORF:IOH21444	816	469	1837	1787	468	776	4401	1914	993	358	ZW10 interactor (ZWINT)
B39R18C10	39-10-18	Hs~MGC:BC020979.1~uORF:IOH21444	862	425	1812	1700	474	699	4101	1862	1100	344	ZW10 interactor (ZWINT)
B39R18C11	39-11-18	Hs~Ref:NM_001008726.1~uORF:IOH9771	1030	1033	962	634	914	1893	1320	526	947	710	WD repeat domain 89 (WDR89), transcript variant 1
B39R18C12	39-12-18	Hs~Ref:NM_001008726.1~uORF:IOH9771	940	1001	945	609	971	2016	1372	497	983	635	WD repeat domain 89 (WDR89), transcript variant 1
B39R18C13	39-13-18	Hs~MGC:BC056401.1~uORF:IOH28794	609	757	1035	788	1292	554	1059	432	1357	257	centaurin, delta 2 (CENTD2)
B39R18C14	39-14-18	Hs~MGC:BC056401.1~uORF:IOH28794	692	839	1020	829	1295	565	1054	420	1462	49	centaurin, delta 2 (CENTD2)
B39R18C15	39-15-18	Hs~Ref:NM_021260.1~uORF:IOH28828	532	506	703	835	1409	583	2250	607	1186	208	zinc finger, FYVE domain containing 1 (ZFYVE1), transcript variant 1
B39R18C16	39-16-18	Hs~Ref:NM_021260.1~uORF:IOH28828	515	521	703	971	1586	845	2233	628	1160	391	zinc finger, FYVE domain containing 1 (ZFYVE1), transcript variant 1
B39R18C17	39-17-18	Hs~MGC:BC043394.1~uORF:IOH26350	1190	1147	1816	5773	1274	1715	1263	1579	3477	794	ankyrin repeat domain 17 (ANKRD17)
B39R18C18	39-18-18	Hs~MGC:BC043394.1~uORF:IOH26350	1202	1184	1798	5204	1133	1742	1258	1634	3528	793	ankyrin repeat domain 17 (ANKRD17)
B39R18C19	39-19-18	Hs~MGC:BC032120.1~uORF:IOH23083	818	805	1738	534	697	957	1626	757	1441	6	chromosome 20 open reading frame 11 (C20orf11)
B39R18C20	39-20-18	Hs~MGC:BC032120.1~uORF:IOH23083	1096	813	1705	541	876	944	1619	720	1486	252	chromosome 20 open reading frame 11 (C20orf11)
B39R18C21	39-21-18	Hs~Ref:NM_025136.1~uORF:IOH6524	1987	1742	3280	1487	2059	1937	3030	28553	2965	719	optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) (OPA3), transcript variant 2
B39R18C22	39-22-18	Hs~Ref:NM_025136.1~uORF:IOH6524	1328	1739	3226	1425	1802	1879	3000	29064	2902	777	optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) (OPA3), transcript variant 2
B39R19C01	39-1-19	Hs~MGC:BC051911.1~uORF:IOH27047	1441	2623	3695	4410	3278	5356	3703	2905	2427	1284	chromosome 13 open reading frame 24 (C13orf24)
B39R19C02	39-2-19	Hs~MGC:BC051911.1~uORF:IOH27047	1474	2585	3381	4151	3260	5444	3717	2749	2890	1239	chromosome 13 open reading frame 24 (C13orf24)
B39R19C03	39-3-19	Hs~Ref:NM_145275.1~uORF:IOH14017	902	923	1623	784	970	753	2226	1085	1962	430	kinesin light chain 3 (KLC3), transcript variant 2
B39R19C04	39-4-19	Hs~Ref:NM_145275.1~uORF:IOH14017	889	860	1612	717	940	765	2199	967	2043	407	kinesin light chain 3 (KLC3), transcript variant 2
B39R19C07	39-7-19	Hs~MGC:BC018771.1~uORF:IOH13629	597	492	713	514	411	657	975	514	680	305	glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5)
B39R19C08	39-8-19	Hs~MGC:BC018771.1~uORF:IOH13629	527	495	635	425	344	723	899	495	442	229	glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5)
B39R19C09	39-9-19	Hs~MGC:BC023982.1~uORF:IOH14039	601	588	1104	609	660	3079	1148	773	1036	382	chromosome 5 open reading frame 32 (C5orf32)
B39R19C10	39-10-19	Hs~MGC:BC023982.1~uORF:IOH14039	635	577	1198	710	619	2935	981	760	1350	358	chromosome 5 open reading frame 32 (C5orf32)
B39R19C13	39-13-19	Hs~Ref:NM_018206.3~uORF:IOH4148	1337	739	1913	1130	1204	913	1798	834	2498	362	vacuolar protein sorting 35 homolog (S. cerevisiae) (VPS35)
B39R19C14	39-14-19	Hs~Ref:NM_018206.3~uORF:IOH4148	1420	782	1962	1101	954	911	1808	842	2358	369	vacuolar protein sorting 35 homolog (S. cerevisiae) (VPS35)
B39R19C15	39-15-19	Hs~Ref:NM_032750.1~uORF:IOH6797	1900	1119	2786	1451	1177	1902	2522	1111	2292	1818	abhydrolase domain containing 14B (ABHD14B)
B39R19C16	39-16-19	Hs~Ref:NM_032750.1~uORF:IOH6797	1885	1049	2664	1477	1212	1865	2447	1242	2248	1800	abhydrolase domain containing 14B (ABHD14B)
B39R19C17	39-17-19	Hs~MGC:BC007072.1~uORF:IOH7380	2181	1422	2278	4570	3044	1931	3912	1478	4763	7587	hypothetical protein MGC12538
B39R19C18	39-18-19	Hs~MGC:BC007072.1~uORF:IOH7380	1955	1446	2201	3997	2698	1922	3782	1420	4756	7108	hypothetical protein MGC12538
B39R19C19	39-19-19	Hs~Ref:NM_003785.3~uORF:IOH5630	539	610	801	765	401	755	902	417	2365	150	P antigen family, member 1 (prostate associated) (PAGE1)
B39R19C20	39-20-19	Hs~Ref:NM_003785.3~uORF:IOH5630	592	593	804	716	83	724	906	375	2342	150	P antigen family, member 1 (prostate associated) (PAGE1)
B39R19C21	39-21-19	Hs~Ref:NM_080664.1~uORF:IOH9768	2007	1252	1586	2111	4011	3276	3533	1700	3147	1200	chromosome 14 open reading frame 126 (C14orf126)
B39R19C22	39-22-19	Hs~Ref:NM_080664.1~uORF:IOH9768	2031	1385	1573	1958	3433	3158	3372	1768	3271	1266	chromosome 14 open reading frame 126 (C14orf126)
B39R20C01	39-1-20	Hs~Ref:NM_020676.2~uORF:IOH3846	674	682	849	663	684	704	1063	747	1272	996	abhydrolase domain containing 6 (ABHD6)
B39R20C02	39-2-20	Hs~Ref:NM_020676.2~uORF:IOH3846	742	686	667	606	738	692	991	823	1869	1015	abhydrolase domain containing 6 (ABHD6)
B39R20C03	39-3-20	Hs~Ref:NM_014358.1~uORF:IOH4717	681	595	764	546	1032	718	1168	782	1529	2510	C-type lectin domain family 4, member E (CLEC4E)
B39R20C04	39-4-20	Hs~Ref:NM_014358.1~uORF:IOH4717	620	673	867	552	1135	700	1184	771	1403	3112	C-type lectin domain family 4, member E (CLEC4E)
B39R20C05	39-5-20	Hs~MGC:BC005004.1~uORF:IOH4814	3852	2689	2742	2992	2834	2383	6080	2600	3381	6089	family with sequence similarity 64, member A (FAM64A)
B39R20C06	39-6-20	Hs~MGC:BC005004.1~uORF:IOH4814	3773	2829	2705	2773	2861	2376	6079	2783	5134	3216	family with sequence similarity 64, member A (FAM64A)
B39R20C07	39-7-20	Hs~Ref:NM_016930.1~uORF:IOH13076	55	16	132	50	562	69	108	116	2	8	syntaxin 18 (STX18)
B39R20C08	39-8-20	Hs~Ref:NM_016930.1~uORF:IOH13076	71	37	176	5	30	189	122	26	36	7	syntaxin 18 (STX18)
B39R20C09	39-9-20	Hs~Ref:NM_003123.1~uORF:IOH12537	490	205	626	1616	372	579	568	413	459	218	sialophorin (leukosialin, CD43) (SPN), transcript variant 2
B39R20C10	39-10-20	Hs~Ref:NM_003123.1~uORF:IOH12537	472	249	613	1545	338	548	546	399	380	333	sialophorin (leukosialin, CD43) (SPN), transcript variant 2
B39R20C11	39-11-20	Hs~MGC:BC000924.2~uORF:IOH2992	490	496	520	450	553	430	481	528	445	318	ADP-ribosylation factor-like 17 (ARL17)
B39R20C12	39-12-20	Hs~MGC:BC000924.2~uORF:IOH2992	353	463	498	318	528	470	479	514	478	115	ADP-ribosylation factor-like 17 (ARL17)
B39R20C13	39-13-20	Hs~MGC:BC010665.1~uORF:IOH9756	264	335	375	230	829	352	467	238	189	-2	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa (NDUFB11)
B39R20C14	39-14-20	Hs~MGC:BC010665.1~uORF:IOH9756	243	514	388	249	844	327	468	243	859	-5	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa (NDUFB11)
B40R02C11	40-11-2	Hs~MGC:BC029660.1~uORF:IOH22374	957	856	1328	684	3045	1076	1839	1115	2356	410	Ubiquitin carboxyl-terminal hydrolase 24
B40R02C12	40-12-2	Hs~MGC:BC029660.1~uORF:IOH22374	974	810	1268	671	291	1086	1640	1132	2398	514	Ubiquitin carboxyl-terminal hydrolase 24
B40R02C13	40-13-2	Hs~MGC:BC034774.1~uORF:IOH22743	2202	980	1210	746	783	1567	2024	1227	2431	787	Uncharacterized protein C6orf10
B40R02C14	40-14-2	Hs~MGC:BC034774.1~uORF:IOH22743	2502	1003	1218	715	688	1586	1793	1072	2390	678	Uncharacterized protein C6orf10
B40R02C15	40-15-2	Hs~MGC:BC015814.1~uORF:IOH10105	1520	1611	1875	1140	5474	1462	2912	1068	3714	1047	EF-hand calcium binding domain 7, mRNA (cDNA clone MGC:9635 IMAGE:3915942), complete cds
B40R02C16	40-16-2	Hs~MGC:BC015814.1~uORF:IOH10105	1517	1600	2001	1285	2345	1581	2962	1109	3672	992	EF-hand calcium binding domain 7, mRNA (cDNA clone MGC:9635 IMAGE:3915942), complete cds
B40R02C17	40-17-2	Hs~Ref:NM_006012.2~uORF:IOH4910	1413	6979	2147	1334	1301	1867	4076	1035	3711	7384	Putative ATP-dependent Clp protease proteolytic subunit, mitochondrial
B40R02C18	40-18-2	Hs~Ref:NM_006012.2~uORF:IOH4910	1335	6772	2049	1268	1254	1746	4221	1106	3579	6955	Putative ATP-dependent Clp protease proteolytic subunit, mitochondrial
B40R02C19	40-19-2	Hs~Ref:NM_002479.2~uORF:IOH6403	1552	2224	954	762	1110	1267	2118	1658	2016	353	myogenin (myogenic factor 4) (MYOG)
B40R02C20	40-20-2	Hs~Ref:NM_002479.2~uORF:IOH6403	1554	2049	915	739	3590	1220	2138	1583	2026	322	myogenin (myogenic factor 4) (MYOG)
B40R02C21	40-21-2	Hs~Ref:NM_134442.2~uORF:IOH9797	665	656	680	871	227	733	602	477	670	153	cAMP responsive element binding protein 1 (CREB1), transcript variant B
B40R02C22	40-22-2	Hs~Ref:NM_134442.2~uORF:IOH9797	780	526	598	746	191	750	638	456	897	51	cAMP responsive element binding protein 1 (CREB1), transcript variant B
B40R03C01	40-1-3	Hs~MGC:NM_152323.1~uORF:IOH21727	829	493	644	316	310	853	1053	614	1345	269	Spi-C transcription factor (Spi-1/PU.1 related) (SPIC)
B40R03C02	40-2-3	Hs~MGC:NM_152323.1~uORF:IOH21727	841	620	702	355	499	779	1142	492	1393	387	Spi-C transcription factor (Spi-1/PU.1 related) (SPIC)
B40R03C05	40-5-3	Hs~Ref:NM_173695.1~uORF:IOH35866	329	249	391	218	337	136	430	221	243	79	chromosome X open reading frame 59 (CXorf59)
B40R03C06	40-6-3	Hs~Ref:NM_173695.1~uORF:IOH35866	368	1928	458	214	228	203	403	205	272	79	chromosome X open reading frame 59 (CXorf59)
B40R03C07	40-7-3	Hs~Ref:NM_178134.2~uORF:IOH35875	349	199	418	272	138	131	373	239	465	111	cytochrome P450, family 4, subfamily Z, polypeptide 1 (CYP4Z1)
B40R03C08	40-8-3	Hs~Ref:NM_178134.2~uORF:IOH35875	307	205	384	366	157	475	382	232	513	71	cytochrome P450, family 4, subfamily Z, polypeptide 1 (CYP4Z1)
B40R03C09	40-9-3	Hs~Ref:NM_006418.3~uORF:IOH35885	1181	222	435	297	160	240	271	352	602	108	Olfactomedin-4
B40R03C10	40-10-3	Hs~Ref:NM_006418.3~uORF:IOH35885	275	206	359	253	-3	298	259	346	467	80	Olfactomedin-4
B40R03C11	40-11-3	Hs~Ref:NM_145655.2~uORF:IOH35693	291	490	422	377	121	368	357	248	407	165	glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) (GCNT2), transcript variant 3
B40R03C12	40-12-3	Hs~Ref:NM_145655.2~uORF:IOH35693	308	468	492	393	193	337	357	250	503	158	glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) (GCNT2), transcript variant 3
B40R03C13	40-13-3	Hs~Ref:NM_005446.2~uORF:IOH44334	535	446	621	257	151	22	572	276	673	126	purinergic receptor P2X-like 1, orphan receptor (P2RXL1)
B40R03C14	40-14-3	Hs~Ref:NM_005446.2~uORF:IOH44334	546	472	631	356	138	272	829	319	699	62	purinergic receptor P2X-like 1, orphan receptor (P2RXL1)
B40R03C15	40-15-3	Hs~Ref:NM_006591.1~uORF:IOH41599	5471	1094	3507	6271	6434	2396	3511	2589	2942	1738	polymerase (DNA-directed), delta 3, accessory subunit (POLD3)
B40R03C16	40-16-3	Hs~Ref:NM_006591.1~uORF:IOH41599	6474	1090	3560	5354	2540	2744	3910	2421	2846	1437	polymerase (DNA-directed), delta 3, accessory subunit (POLD3)
B40R03C17	40-17-3	Hs~Ref:NM_054022.2~uORF:IOH36765	1897	922	1151	803	1553	171	710	486	1642	141	golgi SNAP receptor complex member 2 (GOSR2), transcript variant B
B40R03C18	40-18-3	Hs~Ref:NM_054022.2~uORF:IOH36765	801	847	1100	677	1955	251	654	523	1318	-17	golgi SNAP receptor complex member 2 (GOSR2), transcript variant B
B40R03C19	40-19-3	Hs~Ref:NM_182739.1~uORF:IOH44393	1446	4689	4096	2240	2399	1834	2236	2990	3241	1608	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa (NDUFB6), nuclear gene encoding mitochondrial protein, transcript variant 2
B40R03C20	40-20-3	Hs~Ref:NM_182739.1~uORF:IOH44393	1371	4389	4054	2242	2607	1695	2287	2822	3345	1266	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa (NDUFB6), nuclear gene encoding mitochondrial protein, transcript variant 2
B40R03C21	40-21-3	Hs~Ref:NM_031297.1~uORF:IOH10314	593	1232	667	639	2012	638	716	679	1016	10	ring finger protein 208 (RNF208)
B40R03C22	40-22-3	Hs~Ref:NM_031297.1~uORF:IOH10314	618	655	643	692	241	712	687	653	1559	-10	ring finger protein 208 (RNF208)
B40R04C01	40-1-4	Hs~Ref:NM_033046.1~uORF:IOH10325	1755	6487	7043	2043	1835	2544	2330	1195	4212	1913	rhotekin (RTKN), transcript variant 2
B40R04C02	40-2-4	Hs~Ref:NM_033046.1~uORF:IOH10325	1763	6459	6830	1928	1611	2489	2414	1162	4064	1799	rhotekin (RTKN), transcript variant 2
B40R04C03	40-3-4	Hs~MGC:BC016979.1~uORF:IOH10345	1978	2460	2197	2005	1527	2686	2267	1520	7194	969	N-terminal EF-hand calcium-binding protein 2
B40R04C04	40-4-4	Hs~MGC:BC016979.1~uORF:IOH10345	1906	2275	2054	2038	1419	2789	2231	1387	6985	1019	N-terminal EF-hand calcium-binding protein 2
B40R04C05	40-5-4	Hs~MGC:BC020955.1~uORF:IOH10359	450	2034	543	312	211	106	632	384	760	22	TBC1 domain family, member 23 (TBC1D23)
B40R04C06	40-6-4	Hs~MGC:BC020955.1~uORF:IOH10359	456	358	568	300	229	447	606	398	629	-10	TBC1 domain family, member 23 (TBC1D23)
B40R04C07	40-7-4	Hs~Ref:NM_032765.1~uORF:IOH7015	2238	1620	2557	707	1019	2053	2966	825	2809	368	tripartite motif-containing 52 (TRIM52)
B40R04C08	40-8-4	Hs~Ref:NM_032765.1~uORF:IOH7015	2551	1688	2558	740	686	1935	2820	885	2732	402	tripartite motif-containing 52 (TRIM52)
B40R04C09	40-9-4	Hs~MGC:BC010181.1~uORF:IOH12592	650	514	618	352	297	542	812	281	1173	120	DPH3, KTI11 homolog (S. cerevisiae) (DPH3)
B40R04C10	40-10-4	Hs~MGC:BC010181.1~uORF:IOH12592	511	559	552	350	247	552	823	266	1180	-24	DPH3, KTI11 homolog (S. cerevisiae) (DPH3)
B40R04C11	40-11-4	Hs~Ref:NM_007233.1~uORF:IOH5376	1348	1141	1570	861	699	1659	2179	895	2126	519	TP53 activated protein 1 (TP53AP1)
B40R04C12	40-12-4	Hs~Ref:NM_007233.1~uORF:IOH5376	1404	1117	1635	758	317	1627	2202	886	2246	472	TP53 activated protein 1 (TP53AP1)
B40R04C13	40-13-4	Hs~Ref:NM_033177.2~uORF:IOH6217	1395	860	1283	681	988	1108	2276	684	2143	528	HLA-B associated transcript 4 (BAT4)
B40R04C14	40-14-4	Hs~Ref:NM_033177.2~uORF:IOH6217	1580	1247	1370	814	1068	1175	2715	844	2381	456	HLA-B associated transcript 4 (BAT4)
B40R04C15	40-15-4	Hs~Ref:NM_022140.2~uORF:IOH38016	11942	8011	4398	12475	10247	6932	19045	4744	6824	4862	Band 4.1-like protein 4A
B40R04C16	40-16-4	Hs~Ref:NM_022140.2~uORF:IOH38016	11134	7955	4411	11836	5643	6911	20388	4348	6387	3690	Band 4.1-like protein 4A
B40R04C17	40-17-4	Hs~Ref:NM_015687.2~uORF:IOH38763	4799	2662	4670	14516	4198	2257	5064	1967	2843	4972	filamin A interacting protein 1 (FILIP1)
B40R04C18	40-18-4	Hs~Ref:NM_015687.2~uORF:IOH38763	4304	2293	4307	14379	5101	2275	4712	1982	2472	5336	filamin A interacting protein 1 (FILIP1)
B40R04C19	40-19-4	Hs~Ref:NM_018480.2~uORF:IOH28698	1331	972	1096	621	1451	837	1724	569	1367	26	transmembrane protein 126B (TMEM126B)
B40R04C20	40-20-4	Hs~Ref:NM_018480.2~uORF:IOH28698	1383	884	1055	616	1113	1218	1891	668	1629	100	transmembrane protein 126B (TMEM126B)
B40R04C21	40-21-4	Hs~Ref:NM_018133.2~uORF:IOH38005	6372	965	2067	933	6125	1874	5886	1565	2342	273	male-specific lethal 2-like 1 (Drosophila) (MSL2L1)
B40R04C22	40-22-4	Hs~Ref:NM_018133.2~uORF:IOH38005	6240	1036	1949	910	296	1574	5379	1531	2436	241	male-specific lethal 2-like 1 (Drosophila) (MSL2L1)
B40R05C01	40-1-5	Hs~MGC:BC010501.1~uORF:IOH10253	3099	2830	3713	3741	3246	3482	11266	1770	5738	2308	Catenin delta-1
B40R05C02	40-2-5	Hs~MGC:BC010501.1~uORF:IOH10253	3575	2823	3614	3415	2393	3261	12382	1680	5761	2251	Catenin delta-1
B40R05C03	40-3-5	Hs~MGC:BC002555.1~uORF:IOH4008	982	943	1191	1220	941	968	1071	850	1996	49	CDC-like kinase 3 (CLK3)
B40R05C04	40-4-5	Hs~MGC:BC002555.1~uORF:IOH4008	970	988	1207	1110	1066	1001	1054	854	1969	285	CDC-like kinase 3 (CLK3)
B40R05C05	40-5-5	Hs~Ref:NM_015971.2~uORF:IOH1875	1848	1172	1572	832	910	1340	4713	848	2811	-49	mitochondrial ribosomal protein S7 (MRPS7), nuclear gene encoding mitochondrial protein
B40R05C06	40-6-5	Hs~Ref:NM_015971.2~uORF:IOH1875	1773	1137	1537	933	955	1299	4696	800	2663	-28	mitochondrial ribosomal protein S7 (MRPS7), nuclear gene encoding mitochondrial protein
B40R05C07	40-7-5	Hs~MGC:BC022377.1~uORF:IOH13489	1200	129	729	1138	532	679	1049	598	1240	131	La ribonucleoprotein domain family, member 4 (LARP4)
B40R05C08	40-8-5	Hs~MGC:BC022377.1~uORF:IOH13489	1180	560	702	1106	456	683	1083	594	1122	116	La ribonucleoprotein domain family, member 4 (LARP4)
B40R05C09	40-9-5	Hs~Ref:NM_002742.1~N/A	1188	894	1132	516	1478	942	1291	636	1524	351	Serine/threonine-protein kinase D1
B40R05C10	40-10-5	Hs~Ref:NM_002742.1~N/A	1100	972	1229	714	1535	860	1544	639	1483	-7	Serine/threonine-protein kinase D1
B40R05C11	40-11-5	Hs~Ref:NM_003600.1~N/A	7797	4502	6443	4476	2320	2986	19806	2351	8425	5568	aurora kinase A (AURKA), transcript variant 2
B40R05C12	40-12-5	Hs~Ref:NM_003600.1~N/A	7890	4399	6683	4494	1762	2940	21294	2322	8646	5673	aurora kinase A (AURKA), transcript variant 2
B40R05C13	40-13-5	Hs~Ref:NM_018571.4~N/A	1022	887	1109	500	337	665	1072	514	937	350	amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2 (ALS2CR2)
B40R05C14	40-14-5	Hs~Ref:NM_018571.4~N/A	915	897	995	545	193	778	970	528	954	-21	amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2 (ALS2CR2)
B40R05C15	40-15-5	Hs~Ref:NM_004834.2~N/A	1495	1211	1305	1824	4623	1051	1805	635	1546	176	Mitogen-activated protein kinase kinase kinase kinase 4
B40R05C16	40-16-5	Hs~Ref:NM_004834.2~N/A	1457	1215	1304	1705	2223	1021	1932	609	1504	2079	Mitogen-activated protein kinase kinase kinase kinase 4
B40R05C17	40-17-5	Hs~Ref:NM_001001330.1~uORF:IOH40137	3481	2095	2165	1863	2140	2780	10333	1546	3591	1024	receptor accessory protein 3 (REEP3)
B40R05C18	40-18-5	Hs~Ref:NM_001001330.1~uORF:IOH40137	3531	2072	2069	1824	2285	3142	10502	1480	3438	556	receptor accessory protein 3 (REEP3)
B40R05C19	40-19-5	Hs~Ref:NM_144647.2~uORF:IOH40190	3913	1863	1147	1127	1956	1268	1586	1811	2080	36689	calcyphosine-like (CAPSL), transcript variant 1
B40R05C20	40-20-5	Hs~Ref:NM_144647.2~uORF:IOH40190	3865	1775	1070	1146	542	525	1739	1824	2159	34394	calcyphosine-like (CAPSL), transcript variant 1
B40R05C21	40-21-5	Hs~MGC:BC069451.1~uORF:IOH40263	1175	819	1218	725	3920	1177	1768	906	2091	379	progestagen-associated endometrial protein (placental protein 14, pregnancy-associated endometrial alpha-2-globulin, alpha uterine protein), transcript variant 2 (PAEP)
B40R05C22	40-22-5	Hs~MGC:BC069451.1~uORF:IOH40263	1212	787	1191	711	644	1235	1713	877	2087	344	progestagen-associated endometrial protein (placental protein 14, pregnancy-associated endometrial alpha-2-globulin, alpha uterine protein), transcript variant 2 (PAEP)
B40R06C01	40-1-6	Hs~Ref:NM_024057.2~uORF:IOH40191	1764	1249	3210	2346	2682	5045	5505	1253	9273	1733	nucleoporin 37kDa (NUP37)
B40R06C02	40-2-6	Hs~Ref:NM_024057.2~uORF:IOH40191	1764	1257	3100	2260	2278	5110	5747	1128	9419	1740	nucleoporin 37kDa (NUP37)
B40R06C03	40-3-6	Hs~Ref:NM_032345.1~uORF:IOH6625	4635	3088	11007	4359	3343	3637	9463	2349	6259	2318	within bgcn homolog (Drosophila) (WIBG)
B40R06C04	40-4-6	Hs~Ref:NM_032345.1~uORF:IOH6625	4704	2989	10620	4146	3330	3613	9431	2246	6310	2308	within bgcn homolog (Drosophila) (WIBG)
B40R06C05	40-5-6	Hs~Ref:NM_145204.1~uORF:IOH22722	661	2216	1276	462	5949	2291	2725	724	8185	172	SUMO/sentrin specific peptidase family member 8 (SENP8)
B40R06C06	40-6-6	Hs~Ref:NM_145204.1~uORF:IOH22722	674	2269	1313	453	5762	2091	2746	695	8248	175	SUMO/sentrin specific peptidase family member 8 (SENP8)
B40R06C07	40-7-6	Hs~Ref:NM_006498.1~uORF:IOH22699	1603	1298	2238	856	1069	1410	2431	1186	2733	820	lectin, galactoside-binding, soluble, 2 (LGALS2)
B40R06C08	40-8-6	Hs~Ref:NM_006498.1~uORF:IOH22699	1599	1297	2312	878	1072	1346	2450	1196	2713	844	lectin, galactoside-binding, soluble, 2 (LGALS2)
B40R06C09	40-9-6	Hs~Ref:NM_001175.1~uORF:IOH14469	4434	1664	2096	914	1874	2022	2366	1876	3359	820	Rho GDP dissociation inhibitor (GDI) beta (ARHGDIB)
B40R06C10	40-10-6	Hs~Ref:NM_001175.1~uORF:IOH14469	4455	1668	1949	925	1567	1927	2157	1782	3245	891	Rho GDP dissociation inhibitor (GDI) beta (ARHGDIB)
B40R06C11	40-11-6	Hs~Ref:NM_014396.2~uORF:IOH52895	1214	1075	1034	1031	446	1246	2050	606	1704	259	Vacuolar protein sorting-associated protein 41 homolog
B40R06C12	40-12-6	Hs~Ref:NM_014396.2~uORF:IOH52895	1194	1051	943	967	429	1354	2012	589	1779	329	Vacuolar protein sorting-associated protein 41 homolog
B40R06C13	40-13-6	Hs~Ref:NM_003826.1~uORF:IOH54997	584	467	699	298	213	777	646	609	748	110	Gamma-soluble NSF attachment protein
B40R06C14	40-14-6	Hs~Ref:NM_003826.1~uORF:IOH54997	561	314	693	306	196	914	655	646	752	-10	Gamma-soluble NSF attachment protein
B40R06C15	40-15-6	Hs~MGC:BC002371.2~uORF:IOH59061	744	784	840	674	7297	1903	1005	624	911	301	Protein NipSnap homolog 1
B40R06C16	40-16-6	Hs~MGC:BC002371.2~uORF:IOH59061	727	830	791	717	997	1793	1043	612	-5	2161	Protein NipSnap homolog 1
B40R06C17	40-17-6	Hs~Ref:NM_003314.1~uORF:IOH54949	630	840	771	2014	982	1120	427	241	570	1549	Tetratricopeptide repeat protein 1
B40R06C18	40-18-6	Hs~Ref:NM_003314.1~uORF:IOH54949	437	795	786	1877	516	1145	437	253	717	1757	Tetratricopeptide repeat protein 1
B40R06C19	40-19-6	Hs~MGC:BC006105.1~uORF:IOH5992	32356	31575	15540	39984	22364	21189	14608	36705	36339	30651	chromosome 6 open reading frame 134 (C6orf134)
B40R06C20	40-20-6	Hs~MGC:BC006105.1~uORF:IOH5992	30204	30418	14855	43006	21413	20559	16011	36014	36121	29877	chromosome 6 open reading frame 134 (C6orf134)
B40R06C21	40-21-6	Hs~Ref:NM_173852.3~uORF:IOH22704	606	447	642	442	6385	538	916	400	121	85	keratinocyte associated protein 2 (KRTCAP2)
B40R06C22	40-22-6	Hs~Ref:NM_173852.3~uORF:IOH22704	577	544	698	470	329	1514	872	381	-3	-12	keratinocyte associated protein 2 (KRTCAP2)
B40R07C01	40-1-7	Hs~Ref:NM_005171.2~uORF:IOH23136	401	399	704	636	1202	637	687	555	1222	265	activating transcription factor 1 (ATF1)
B40R07C02	40-2-7	Hs~Ref:NM_005171.2~uORF:IOH23136	416	393	702	632	1056	662	777	480	1234	317	activating transcription factor 1 (ATF1)
B40R07C03	40-3-7	Hs~Ref:NM_005309.1~uORF:IOH9641	1215	2574	1562	4070	2612	2012	6586	2122	3880	1212	glutamic-pyruvate transaminase (alanine aminotransferase) (GPT)
B40R07C04	40-4-7	Hs~Ref:NM_005309.1~uORF:IOH9641	1243	2512	1501	4007	2481	1958	6506	1968	3907	1138	glutamic-pyruvate transaminase (alanine aminotransferase) (GPT)
B40R07C05	40-5-7	Hs~MGC:NM_152992.1~uORF:IOH3431	1572	1023	1035	1727	1060	1021	827	1287	1939	642	POM121 and ZP3 fusion protein
B40R07C06	40-6-7	Hs~MGC:NM_152992.1~uORF:IOH3431	1590	1090	1038	1623	1081	1044	841	1225	1955	600	POM121 and ZP3 fusion protein
B40R07C07	40-7-7	Hs~Ref:NM_004328.2~uORF:IOH3650	743	714	658	492	564	674	796	575	12	281	Mitochondrial chaperone BCS1
B40R07C08	40-8-7	Hs~Ref:NM_004328.2~uORF:IOH3650	873	669	728	503	335	733	848	645	1384	254	Mitochondrial chaperone BCS1
B40R07C09	40-9-7	Hs~Ref:NM_002794.2~uORF:IOH4386	679	729	711	369	319	714	784	380	1666	231	Proteasome subunit beta type-2
B40R07C10	40-10-7	Hs~Ref:NM_002794.2~uORF:IOH4386	624	715	707	395	29	702	878	358	1668	-77	Proteasome subunit beta type-2
B40R07C11	40-11-7	Hs~MGC:NM_152301.3~uORF:IOH3274	1688	827	1742	590	666	3443	1242	3864	10521	1658	MORF4 family-associated protein 1-like 1
B40R07C12	40-12-7	Hs~MGC:NM_152301.3~uORF:IOH3274	1681	1105	1734	592	596	3370	1339	3774	10599	1656	MORF4 family-associated protein 1-like 1
B40R07C13	40-13-7	Hs~Ref:NM_002738.2~N/A	1022	903	1016	548	444	706	1202	750	1578	444	Protein kinase C beta type
B40R07C14	40-14-7	Hs~Ref:NM_002738.2~N/A	933	912	972	571	365	916	1212	690	1563	486	Protein kinase C beta type
B40R07C15	40-15-7	Hs~Ref:NM_006255.1~N/A	2737	1739	1907	3196	9923	3585	3715	1287	2985	1107	protein kinase C, eta
B40R07C16	40-16-7	Hs~Ref:NM_006255.1~N/A	2439	1676	1780	2982	4921	3289	3830	1349	3048	2475	protein kinase C, eta
B40R07C17	40-17-7	Hs~Ref:NM_004217.1~N/A	8994	5891	7485	5249	4980	4246	19492	4113	10985	7884	aurora kinase B (AURKB)
B40R07C18	40-18-7	Hs~Ref:NM_004217.1~N/A	8929	5877	7350	5267	6116	4271	19977	3983	10976	8223	aurora kinase B (AURKB)
B40R07C19	40-19-7	Hs~Ref:NM_007170.1~N/A	2179	753	1936	854	2153	1962	1111	829	4051	300	Dual specificity testis-specific protein kinase 2
B40R07C20	40-20-7	Hs~Ref:NM_007170.1~N/A	2131	704	1880	835	4528	1986	1147	794	4017	279	Dual specificity testis-specific protein kinase 2
B40R07C21	40-21-7	Hs~MGC:BC012105.1~uORF:IOH14609	2911	1646	1707	1862	673	3495	1632	1454	2527	1691	nuclear VCP-like (NVL)
B40R07C22	40-22-7	Hs~MGC:BC012105.1~uORF:IOH14609	2951	1576	1691	1714	795	2889	1596	1530	2528	1505	nuclear VCP-like (NVL)
B40R08C01	40-1-8	Hs~Ref:NM_017809.2~uORF:IOH10134	732	527	661	519	187	607	1365	537	1510	166	nuclear RNA export factor 2 (NXF2), transcript variant 1
B40R08C02	40-2-8	Hs~Ref:NM_017809.2~uORF:IOH10134	628	446	712	485	516	719	1472	552	1085	189	nuclear RNA export factor 2 (NXF2), transcript variant 1
B40R08C03	40-3-8	Hs~Ref:NM_021219.2~uORF:IOH12137	532	410	571	420	223	274	662	389	713	283	junctional adhesion molecule 2 (JAM2)
B40R08C04	40-4-8	Hs~Ref:NM_021219.2~uORF:IOH12137	538	434	524	424	208	1028	696	381	186	287	junctional adhesion molecule 2 (JAM2)
B40R08C05	40-5-8	Hs~Ref:NM_000700.1~uORF:IOH3222	7270	1938	4353	2590	1775	2921	4622	6917	2107	1743	annexin A1 (ANXA1)
B40R08C06	40-6-8	Hs~Ref:NM_000700.1~uORF:IOH3222	7215	1990	4240	2477	1754	2822	4559	6222	2109	1670	annexin A1 (ANXA1)
B40R08C07	40-7-8	Hs~Ref:NM_021783.2~uORF:IOH23275	4334	853	954	811	602	795	1481	870	1516	1433	ectodysplasin A2 receptor (EDA2R)
B40R08C08	40-8-8	Hs~Ref:NM_021783.2~uORF:IOH23275	4636	755	1010	793	497	908	1490	844	1438	1402	ectodysplasin A2 receptor (EDA2R)
B40R08C13	40-13-8	Hs~Ref:NM_002394.3~uORF:IOH4673	644	817	2194	1125	585	13810	1023	2594	1742	203	solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 (SLC3A2), transcript variant 3
B40R08C14	40-14-8	Hs~Ref:NM_002394.3~uORF:IOH4673	633	798	2067	1084	466	13629	1139	2670	1685	233	solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 (SLC3A2), transcript variant 3
B40R08C15	40-15-8	Hs~Ref:NM_002424.1~uORF:IOH45732	677	669	758	590	-46	814	1212	621	1269	254	matrix metallopeptidase 8 (neutrophil collagenase) (MMP8)
B40R08C16	40-16-8	Hs~Ref:NM_002424.1~uORF:IOH45732	1013	649	757	547	7466	785	914	688	688	272	matrix metallopeptidase 8 (neutrophil collagenase) (MMP8)
B40R08C17	40-17-8	Hs~MGC:BC040457.1~uORF:IOH26807	2011	1059	1015	883	6953	1568	1534	1936	2547	191	calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha (CAMK2A)
B40R08C18	40-18-8	Hs~MGC:BC040457.1~uORF:IOH26807	1402	1082	1124	841	6975	1575	1795	1763	2239	-111	calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha (CAMK2A)
B40R08C19	40-19-8	Hs~MGC:BC006986.1~uORF:IOH7170	3186	2248	2084	1619	2101	2186	11365	1805	3648	-169	RNA binding motif protein 41 (RBM41)
B40R08C20	40-20-8	Hs~MGC:BC006986.1~uORF:IOH7170	3209	2120	1946	1518	2130	1884	11350	1867	3839	-184	RNA binding motif protein 41 (RBM41)
B40R08C21	40-21-8	Hs~Ref:NM_021146.2~uORF:IOH4956	940	427	644	430	316	425	824	548	135	23	angiopoietin-like 7 (ANGPTL7)
B40R08C22	40-22-8	Hs~Ref:NM_021146.2~uORF:IOH4956	815	505	650	435	350	618	895	533	180	173	angiopoietin-like 7 (ANGPTL7)
B40R09C01	40-1-9	Hs~Ref:NM_002899.2~uORF:IOH58961	283	460	511	301	228	524	566	220	921	121	Retinol-binding protein 1
B40R09C02	40-2-9	Hs~Ref:NM_002899.2~uORF:IOH58961	276	355	481	290	248	505	583	219	835	108	Retinol-binding protein 1
B40R09C03	40-3-9	Hs~Ref:NM_002188.2~uORF:IOH35104	557	529	769	424	331	686	885	496	812	328	Interleukin-13
B40R09C04	40-4-9	Hs~Ref:NM_002188.2~uORF:IOH35104	609	729	749	464	301	435	841	440	753	322	Interleukin-13
B40R09C05	40-5-9	Hs~Ref:NM_003527.4~uORF:IOH58710	2382	1174	1844	911	941	1477	8405	973	2302	447	Histone H2B type 1-O
B40R09C06	40-6-9	Hs~Ref:NM_003527.4~uORF:IOH58710	2147	1238	1814	854	961	1418	8595	960	2153	390	Histone H2B type 1-O
B40R09C07	40-7-9	Hs~Ref:NM_153819.1~uORF:IOH52442	2246	2666	2775	3017	4587	2933	2575	2026	3197	1136	RAS guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), transcript variant 2, mRNA.
B40R09C08	40-8-9	Hs~Ref:NM_153819.1~uORF:IOH52442	2373	2955	2813	3044	4518	2939	2753	2059	3291	1101	RAS guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), transcript variant 2, mRNA.
B40R09C09	40-9-9	Hs~Ref:NM_001001711.1~uORF:IOH56024	7537	2602	3254	1745	974	5547	1885	3363	2577	2039	Protein DDI1 homolog 1
B40R09C10	40-10-9	Hs~Ref:NM_001001711.1~uORF:IOH56024	7447	2716	3270	1664	941	5358	2180	3099	2472	1959	Protein DDI1 homolog 1
B40R09C13	40-13-9	Hs~Ref:NM_003690.3~uORF:IOH57108	3332	1595	5992	1586	1121	31989	12770	2740	4268	-1	Interferon-inducible double stranded RNA-dependent protein kinase activator A
B40R09C14	40-14-9	Hs~Ref:NM_003690.3~uORF:IOH57108	3321	1649	5785	1553	890	30091	12287	2704	4188	1099	Interferon-inducible double stranded RNA-dependent protein kinase activator A
B40R09C17	40-17-9	Hs~MGC:BC002680.1~uORF:IOH5302	4414	1002	5095	3297	5695	3914	2929	1268	3529	831	thyroid hormone receptor interactor 6 (TRIP6)
B40R09C18	40-18-9	Hs~MGC:BC002680.1~uORF:IOH5302	3913	945	5066	3209	4865	3558	3046	1128	3358	-50	thyroid hormone receptor interactor 6 (TRIP6)
B40R09C19	40-19-9	Hs~MGC:BC014552.1~uORF:IOH12669	640	714	772	420	253	598	721	455	1093	-131	Thiamin pyrophosphokinase 1
B40R09C20	40-20-9	Hs~MGC:BC014552.1~uORF:IOH12669	686	771	799	416	350	12	721	446	1164	-48	Thiamin pyrophosphokinase 1
B40R09C21	40-21-9	Hs~Ref:NM_007202.2~uORF:IOH10972	1073	420	1043	475	386	488	648	441	204	33	A kinase (PRKA) anchor protein 10 (AKAP10), nuclear gene encoding mitochondrial protein
B40R09C22	40-22-9	Hs~Ref:NM_007202.2~uORF:IOH10972	918	372	958	483	460	61	621	438	421	42	A kinase (PRKA) anchor protein 10 (AKAP10), nuclear gene encoding mitochondrial protein
B40R10C01	40-1-10	Hs~Ref:NM_018291.2~uORF:IOH14716	357	443	413	240	142	317	414	221	615	91	hypothetical protein FLJ10986 (FLJ10986)
B40R10C02	40-2-10	Hs~Ref:NM_018291.2~uORF:IOH14716	386	368	463	263	120	311	363	282	337	87	hypothetical protein FLJ10986 (FLJ10986)
B40R10C03	40-3-10	Hs~Ref:NM_016139.2~uORF:IOH3869	2130	1670	5678	2906	2401	3382	4215	4310	3846	830	coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2)
B40R10C04	40-4-10	Hs~Ref:NM_016139.2~uORF:IOH3869	2133	1665	5541	2843	2346	3159	4135	4031	3882	788	coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2)
B40R10C05	40-5-10	Hs~Ref:NM_013974.1~uORF:IOH4021	742	746	1068	515	825	809	1274	738	1831	512	dimethylarginine dimethylaminohydrolase 2 (DDAH2)
B40R10C06	40-6-10	Hs~Ref:NM_013974.1~uORF:IOH4021	780	816	1070	573	820	787	1457	691	1684	480	dimethylarginine dimethylaminohydrolase 2 (DDAH2)
B40R10C07	40-7-10	Hs~Ref:NM_145870.1~uORF:IOH4046	660	1087	1013	1623	602	1160	1546	852	2978	490	glutathione transferase zeta 1 (maleylacetoacetate isomerase) (GSTZ1), transcript variant 1
B40R10C08	40-8-10	Hs~Ref:NM_145870.1~uORF:IOH4046	689	1103	1019	1642	564	1173	1397	850	2984	459	glutathione transferase zeta 1 (maleylacetoacetate isomerase) (GSTZ1), transcript variant 1
B40R10C09	40-9-10	Hs~Ref:NM_001349.2~uORF:IOH4209	1034	4712	1716	774	2184	1377	2922	1040	2239	621	aspartyl-tRNA synthetase (DARS)
B40R10C10	40-10-10	Hs~Ref:NM_001349.2~uORF:IOH4209	1013	4802	1706	807	2155	1372	3005	1016	2154	669	aspartyl-tRNA synthetase (DARS)
B40R11C21	40-21-11	Hs~Ref:NM_020141.2~uORF:IOH5923	1105	1206	1312	769	896	1084	2373	705	1784	74	chromosome 1 open reading frame 119 (C1orf119)
B40R11C22	40-22-11	Hs~Ref:NM_020141.2~uORF:IOH5923	1126	944	1274	794	953	1039	2331	745	1866	85	chromosome 1 open reading frame 119 (C1orf119)
B40R12C01	40-1-12	Hs~Ref:NM_004846.1~uORF:IOH6102	15748	28263	11307	11975	5252	12410	30596	11942	10322	8990	eukaryotic translation initiation factor 4E family member 2 (EIF4E2)
B40R12C02	40-2-12	Hs~Ref:NM_004846.1~uORF:IOH6102	14805	14569	11061	11214	5085	11857	27146	12016	10038	9073	eukaryotic translation initiation factor 4E family member 2 (EIF4E2)
B40R12C03	40-3-12	Hs~Ref:NM_001070.1~uORF:IOH4241	1176	3583	1128	886	703	1097	2451	776	1565	368	tubulin, gamma 1 (TUBG1)
B40R12C04	40-4-12	Hs~Ref:NM_001070.1~uORF:IOH4241	1159	3666	1201	874	3740	1099	2435	849	1556	447	tubulin, gamma 1 (TUBG1)
B40R12C05	40-5-12	Hs~Ref:NM_007285.5~uORF:IOH7450	5273	3211	7057	3091	4035	2167	19794	1442	4490	1398	GABA(A) receptor-associated protein-like 2 (GABARAPL2)
B40R12C06	40-6-12	Hs~Ref:NM_007285.5~uORF:IOH7450	5142	2106	7090	3012	4585	2104	20788	1363	4564	1119	GABA(A) receptor-associated protein-like 2 (GABARAPL2)
B40R12C07	40-7-12	Hs~Ref:NM_012424.2~N/A	4048	1535	2953	1538	3602	4273	13841	3673	4770	1053	Ribosomal protein S6 kinase delta-1
B40R12C08	40-8-12	Hs~Ref:NM_012424.2~N/A	3381	1586	2815	1435	1282	4215	12575	3456	5055	1006	Ribosomal protein S6 kinase delta-1
B40R12C09	40-9-12	Hs~Ref:NM_053006.1~N/A	3685	1747	4627	2049	1388	2792	4330	1674	5627	905	testis-specific serine kinase 2 (TSSK2)
B40R12C10	40-10-12	Hs~Ref:NM_053006.1~N/A	2835	1771	4609	2048	1415	2672	4058	1663	5407	645	testis-specific serine kinase 2 (TSSK2)
B40R12C11	40-11-12	Hs~Ref:NM_003503.2~N/A	2120	1348	2258	1263	963	1464	3865	1165	3050	723	Cell division cycle 7-related protein kinase
B40R12C12	40-12-12	Hs~Ref:NM_003503.2~N/A	2222	1371	2132	1008	898	1427	3854	1106	3079	483	Cell division cycle 7-related protein kinase
B40R12C13	40-13-12	Hs~Ref:NM_032844.1~N/A	1149	1326	1622	855	1017	1404	2030	971	2740	801	Microtubule-associated serine/threonine-protein kinase-like
B40R12C14	40-14-12	Hs~Ref:NM_032844.1~N/A	1202	1269	1598	779	972	1337	1973	965	2910	10144	Microtubule-associated serine/threonine-protein kinase-like
B40R12C15	40-15-12	Hs~Ref:NM_181710.2~uORF:IOH40189	113	995	365	399	55	509	369	260	129	301	zinc and ring finger 4 (ZNRF4)
B40R12C16	40-16-12	Hs~Ref:NM_181710.2~uORF:IOH40189	705	94	389	67	1285	32	357	223	415	53	zinc and ring finger 4 (ZNRF4)
B40R12C17	40-17-12	Hs~Ref:NM_018215.2~uORF:IOH40888	303	542	244	5883	219	54	242	174	104	133	hypothetical protein FLJ10781 (FLJ10781), transcript variant 1
B40R12C18	40-18-12	Hs~Ref:NM_018215.2~uORF:IOH40888	426	515	197	6155	75	291	210	211	118	21	hypothetical protein FLJ10781 (FLJ10781), transcript variant 1
B40R12C19	40-19-12	Hs~Ref:NM_017706.3~uORF:IOH40135	477	238	438	45	350	824	516	341	1002	90	WD repeat domain 55 (WDR55)
B40R12C20	40-20-12	Hs~Ref:NM_017706.3~uORF:IOH40135	528	245	528	497	1115	869	532	379	1055	69	WD repeat domain 55 (WDR55)
B40R12C21	40-21-12	Hs~Ref:NM_052960.1~uORF:IOH39885	96	232	324	275	124	285	568	319	648	45	Retinoid-binding protein 7
B40R12C22	40-22-12	Hs~Ref:NM_052960.1~uORF:IOH39885	145	251	187	249	148	199	570	276	652	-5	Retinoid-binding protein 7
B40R13C01	40-1-13	Hs~Ref:NM_016462.1~uORF:IOH3937	457	2670	721	414	548	547	790	592	936	251	transmembrane protein 14C (TMEM14C)
B40R13C02	40-2-13	Hs~Ref:NM_016462.1~uORF:IOH3937	439	1009	809	414	517	528	791	612	1085	277	transmembrane protein 14C (TMEM14C)
B40R13C03	40-3-13	Hs~MGC:BC000931.2~uORF:IOH2988	393	266	493	269	278	229	566	344	446	136	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 (ATP5C1)
B40R13C04	40-4-13	Hs~MGC:BC000931.2~uORF:IOH2988	372	270	473	270	1946	380	557	365	765	9	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 (ATP5C1)
B40R13C05	40-5-13	Hs~MGC:BC015569.1~uORF:IOH14802	1311	2379	1545	2278	1550	1766	2601	1346	2926	557	ADP-ribosylation factor-like protein 6-interacting protein 4
B40R13C06	40-6-13	Hs~MGC:BC015569.1~uORF:IOH14802	1275	1783	1510	2241	1400	1819	2643	1300	2960	425	ADP-ribosylation factor-like protein 6-interacting protein 4
B40R13C07	40-7-13	Hs~Ref:NM_145173.1~uORF:IOH22396	610	619	755	514	1511	497	694	641	1783	-49	DIRAS family, GTP-binding RAS-like 1 (DIRAS1)
B40R13C08	40-8-13	Hs~Ref:NM_145173.1~uORF:IOH22396	752	588	745	507	593	537	763	594	1851	-73	DIRAS family, GTP-binding RAS-like 1 (DIRAS1)
B40R13C09	40-9-13	Hs~MGC:BC052988.1~uORF:IOH28908	4636	2170	2292	5634	1005	2299	6687	1744	4556	1910	retinoic acid induced 14 (RAI14)
B40R13C10	40-10-13	Hs~MGC:BC052988.1~uORF:IOH28908	4163	2149	2128	5746	949	2236	6440	1577	3844	1787	retinoic acid induced 14 (RAI14)
B40R13C11	40-11-13	Hs~MGC:BC042637.1~uORF:IOH21048	627	567	896	3103	366	1059	1533	468	1184	-30	activin A receptor type II-like 1 (ACVRL1)
B40R13C12	40-12-13	Hs~MGC:BC042637.1~uORF:IOH21048	640	563	871	2939	529	1139	1607	493	1241	-14	activin A receptor type II-like 1 (ACVRL1)
B40R13C13	40-13-13	Hs~MGC:BC028006.1~uORF:IOH11573	44608	41017	21799	41562	21134	32582	33826	53997	31518	65465	inducible T-cell co-stimulator (ICOS)
B40R13C14	40-14-13	Hs~MGC:BC028006.1~uORF:IOH11573	44099	37544	21005	37846	27312	31872	34392	57134	29952	42965	inducible T-cell co-stimulator (ICOS)
B40R13C15	40-15-13	Hs~MGC:BC040966.1~uORF:IOH26250	640	723	854	390	303	685	973	490	-62	-60	sialic acid acetylesterase (SIAE)
B40R13C16	40-16-13	Hs~MGC:BC040966.1~uORF:IOH26250	647	711	808	465	1816	660	922	450	16	5	sialic acid acetylesterase (SIAE)
B40R13C17	40-17-13	Hs~MGC:BC031412.1~uORF:IOH22687	390	332	487	1127	331	197	703	253	524	3	hyaluronan binding protein 2 (HABP2)
B40R13C18	40-18-13	Hs~MGC:BC031412.1~uORF:IOH22687	396	216	442	826	198	276	658	330	-85	19	hyaluronan binding protein 2 (HABP2)
B40R13C19	40-19-13	Hs~MGC:BC011393.1~uORF:IOH9774	1359	1126	1454	2151	529	1339	1969	845	1447	302	chimerin (chimaerin) 1 (CHN1)
B40R13C20	40-20-13	Hs~MGC:BC011393.1~uORF:IOH9774	1313	1085	1404	876	590	1148	1927	809	984	11	chimerin (chimaerin) 1 (CHN1)
B40R13C21	40-21-13	Hs~Ref:NM_001841.1~uORF:IOH29591	723	444	951	605	432	-51	1325	572	570	-9	cannabinoid receptor 2 (macrophage) (CNR2)
B40R13C22	40-22-13	Hs~Ref:NM_001841.1~uORF:IOH29591	663	665	960	613	261	845	1218	552	853	84	cannabinoid receptor 2 (macrophage) (CNR2)
B40R14C01	40-1-14	Hs~MGC:BC056146.1~uORF:IOH29058	873	734	808	548	340	768	2611	512	447	360	hook homolog 3 (Drosophila) (HOOK3)
B40R14C02	40-2-14	Hs~MGC:BC056146.1~uORF:IOH29058	846	1458	854	480	356	754	2668	561	1437	320	hook homolog 3 (Drosophila) (HOOK3)
B40R14C03	40-3-14	Hs~Ref:NM_033083.1~uORF:IOH25830	813	3415	1879	7726	3060	2967	1660	4457	2821	530	ELL associated factor 1 (EAF1)
B40R14C04	40-4-14	Hs~Ref:NM_033083.1~uORF:IOH25830	807	3821	1893	7349	6682	2784	1575	4383	2697	475	ELL associated factor 1 (EAF1)
B40R14C05	40-5-14	Hs~MGC:NM_178127.2~uORF:IOH26886	468	885	600	418	1955	503	890	419	669	203	angiopoietin-like 5 (ANGPTL5)
B40R14C06	40-6-14	Hs~MGC:NM_178127.2~uORF:IOH26886	485	885	599	424	1962	507	872	466	693	-23	angiopoietin-like 5 (ANGPTL5)
B40R14C07	40-7-14	Hs~MGC:BC036242.1~uORF:IOH27520	3702	3174	3027	2842	3403	10008	4968	2435	3657	1109	copine III (CPNE3)
B40R14C08	40-8-14	Hs~MGC:BC036242.1~uORF:IOH27520	3688	3154	3209	2828	1521	9840	5140	2406	3849	1154	copine III (CPNE3)
B40R14C09	40-9-14	Hs~MGC:BC015521.1~uORF:IOH11702	1355	1125	666	741	442	8299	937	1281	2138	202	ubiquitin carboxyl-terminal hydrolase L5 (UCHL5)
B40R14C10	40-10-14	Hs~MGC:BC015521.1~uORF:IOH11702	1383	1177	644	697	285	8102	968	1227	1943	64	ubiquitin carboxyl-terminal hydrolase L5 (UCHL5)
B40R14C15	40-15-14	Hs~MGC:NM_173217.1~uORF:IOH59000	601	523	601	340	297	706	650	413	1043	-23	Beta-galactoside alpha-2,6-sialyltransferase 1
B40R14C16	40-16-14	Hs~MGC:NM_173217.1~uORF:IOH59000	629	640	625	404	1622	682	663	422	168	-22	Beta-galactoside alpha-2,6-sialyltransferase 1
B40R14C17	40-17-14	Hs~Ref:NM_001252.2~uORF:IOH59017	483	561	707	743	2023	673	766	506	903	107	CD70 antigen
B40R14C18	40-18-14	Hs~Ref:NM_001252.2~uORF:IOH59017	551	487	679	757	2305	942	859	478	969	-32	CD70 antigen
B40R14C19	40-19-14	Hs~Ref:NM_002738.5~uORF:IOH22061	1173	3777	7231	3592	1159	1318	6243	1078	2361	710	protein kinase C, beta 1 (PRKCB1), transcript variant 2
B40R14C20	40-20-14	Hs~Ref:NM_002738.5~uORF:IOH22061	1167	3728	6851	3405	1413	1301	6580	1024	2334	-35	protein kinase C, beta 1 (PRKCB1), transcript variant 2
B40R14C21	40-21-14	Hs~MGC:BC028629.1~uORF:IOH11485	422	274	533	427	147	477	618	368	326	18	gamma-aminobutyric acid (GABA) A receptor, alpha 3 (GABRA3)
B40R14C22	40-22-14	Hs~MGC:BC028629.1~uORF:IOH11485	510	292	495	400	170	750	651	359	150	773	gamma-aminobutyric acid (GABA) A receptor, alpha 3 (GABRA3)
B40R15C01	40-1-15	Hs~MGC:BC018359.1~uORF:IOH11786	530	1840	756	747	392	499	1374	627	1025	342	methionine adenosyltransferase I, alpha (MAT1A)
B40R15C02	40-2-15	Hs~MGC:BC018359.1~uORF:IOH11786	523	1923	769	713	131	472	1409	628	996	307	methionine adenosyltransferase I, alpha (MAT1A)
B40R15C03	40-3-15	Hs~MGC:BC058900.1~uORF:IOH29076	798	492	1158	584	223	1948	1939	826	148	357	rabaptin, RAB GTPase binding effector protein 2 (RABEP2)
B40R15C04	40-4-15	Hs~MGC:BC058900.1~uORF:IOH29076	803	482	1096	566	79	1854	1962	808	745	282	rabaptin, RAB GTPase binding effector protein 2 (RABEP2)
B40R15C05	40-5-15	Hs~Ref:NM_000466.1~uORF:IOH27596	1948	1324	1882	1475	866	1238	2689	1083	3988	711	peroxisome biogenesis factor 1 (PEX1)
B40R15C06	40-6-15	Hs~Ref:NM_000466.1~uORF:IOH27596	2023	1378	1834	1498	1078	1173	2869	1154	3925	344	peroxisome biogenesis factor 1 (PEX1)
B40R15C07	40-7-15	Hs~MGC:BC060785.1~uORF:IOH29158	1722	744	1884	820	462	960	1670	3463	1584	229	tripartite motif-containing 40 (TRIM40)
B40R15C08	40-8-15	Hs~MGC:BC060785.1~uORF:IOH29158	1829	783	1731	879	442	876	1667	3338	1599	444	tripartite motif-containing 40 (TRIM40)
B40R15C09	40-9-15	Hs~Ref:NM_017949.1~uORF:IOH29099	1147	4777	2857	3217	1220	2040	2289	1627	8623	766	CUE domain containing 1 (CUEDC1)
B40R15C10	40-10-15	Hs~Ref:NM_017949.1~uORF:IOH29099	1163	4762	2852	3677	1270	2018	2365	1701	8857	763	CUE domain containing 1 (CUEDC1)
B40R15C11	40-11-15	Hs~Ref:NM_003517.2~uORF:IOH29296	3272	1459	1707	1369	958	1628	12399	1047	2992	611	histone cluster 2, H2ac (HIST2H2AC)
B40R15C12	40-12-15	Hs~Ref:NM_003517.2~uORF:IOH29296	3342	1419	1710	1253	979	1610	12842	1039	3118	-156	histone cluster 2, H2ac (HIST2H2AC)
B40R15C13	40-13-15	Hs~Ref:NM_005157.2~CAT:PV3865	739	442	1253	614	204	941	1374	461	1023	-30	v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), transcript variant a; see catalog number for detailed information on wild-type or point mutant status
B40R15C14	40-14-15	Hs~Ref:NM_005157.2~CAT:PV3865	734	406	1149	570	228	944	1407	514	1039	299	v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), transcript variant a; see catalog number for detailed information on wild-type or point mutant status
B40R15C15	40-15-15	Hs~Ref:NM_020397.1~CAT:PV3663	776	1012	1550	442	813	1350	818	1451	1399	-26	calcium/calmodulin-dependent protein kinase ID (CAMK1D), transcript variant 1
B40R15C16	40-16-15	Hs~Ref:NM_020397.1~CAT:PV3663	950	1072	1563	415	546	1477	860	1351	1330	-16	calcium/calmodulin-dependent protein kinase ID (CAMK1D), transcript variant 1
B40R15C17	40-17-15	Hs~Ref:NM_001221.2~CAT:PV3373	751	2043	1166	744	420	4369	1599	3875	1537	242	calcium/calmodulin-dependent protein kinase (CaM kinase) II delta (CAMK2D), transcript variant 3
B40R15C18	40-18-15	Hs~Ref:NM_001221.2~CAT:PV3373	832	2197	1201	799	582	3959	1618	3601	1654	30	calcium/calmodulin-dependent protein kinase (CaM kinase) II delta (CAMK2D), transcript variant 3
B40R15C19	40-19-15	Hs~Ref:NM_002880.1~CAT:PV3805	525	184	422	275	373	87	1106	209	1635	1	v-raf-1 murine leukemia viral oncogene homolog 1 (RAF1)
B40R15C20	40-20-15	Hs~Ref:NM_002880.1~CAT:PV3805	502	178	401	287	1221	653	1120	216	1693	-11	v-raf-1 murine leukemia viral oncogene homolog 1 (RAF1)
B40R15C21	40-21-15	Hs~Ref:NM_001744.2~CAT:PV3310	460	1364	1782	2624	193	744	2542	372	105	76	calcium/calmodulin-dependent protein kinase IV (CAMK4)
B40R15C22	40-22-15	Hs~Ref:NM_001744.2~CAT:PV3310	470	1408	1770	2502	95	913	2348	344	33	-7	calcium/calmodulin-dependent protein kinase IV (CAMK4)
B40R16C15	40-15-16	Hs~Ref:NM_001354.4~uORF:IOH57036	322	457	609	282	192	710	1302	701	821	62	Aldo-keto reductase family 1 member C2
B40R16C16	40-16-16	Hs~Ref:NM_001354.4~uORF:IOH57036	347	467	567	354	175	651	1315	687	773	-40	Aldo-keto reductase family 1 member C2
B40R16C17	40-17-16	Hs~Ref:NM_001025247.1~uORF:IOH56427	413	166	428	287	218	534	517	294	639	31	TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L
B40R16C18	40-18-16	Hs~Ref:NM_001025247.1~uORF:IOH56427	472	164	463	297	819	695	443	290	40	4	TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L
B40R16C19	40-19-16	Hs~Ref:NM_004902.2~uORF:IOH52195	1907	2408	2243	1466	1830	2494	2842	1251	3397	2005	RNA-binding protein 39
B40R16C20	40-20-16	Hs~Ref:NM_004902.2~uORF:IOH52195	1853	2665	2152	1151	4300	2406	2884	1360	3327	461	RNA-binding protein 39
B40R16C21	40-21-16	Hs~Ref:NM_139124.1~uORF:IOH57251	2240	1139	1815	2142	639	1451	2203	1258	3309	552	C-jun-amino-terminal kinase-interacting protein 2
B40R16C22	40-22-16	Hs~Ref:NM_139124.1~uORF:IOH57251	2273	1141	1855	2058	703	1488	2196	1176	3307	490	C-jun-amino-terminal kinase-interacting protein 2
B40R17C01	40-1-17	Hs~Ref:NM_004541.2~uORF:IOH4389	705	652	722	454	778	870	923	702	1674	36	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa (NDUFA1), nuclear gene encoding mitochondrial protein
B40R17C02	40-2-17	Hs~Ref:NM_004541.2~uORF:IOH4389	665	636	783	472	714	834	1017	677	1815	480	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa (NDUFA1), nuclear gene encoding mitochondrial protein
B40R17C03	40-3-17	Hs~Ref:NM_004077.2~uORF:IOH12424	1346	1171	1324	688	736	1359	1528	1165	2716	458	citrate synthase (CS), nuclear gene encoding mitochondrial protein, transcript variant 1
B40R17C04	40-4-17	Hs~Ref:NM_004077.2~uORF:IOH12424	1286	1109	1164	697	806	1387	1612	1191	2714	545	citrate synthase (CS), nuclear gene encoding mitochondrial protein, transcript variant 1
B40R17C05	40-5-17	Hs~MGC:BC002763.2~uORF:IOH5342	1513	1529	1915	1563	1149	1494	2045	1819	2471	1029	protein kinase, cAMP-dependent, regulatory, type II, alpha (PRKAR2A)
B40R17C06	40-6-17	Hs~MGC:BC002763.2~uORF:IOH5342	1519	1592	1821	1523	1050	1513	2017	1758	2491	990	protein kinase, cAMP-dependent, regulatory, type II, alpha (PRKAR2A)
B40R17C07	40-7-17	Hs~MGC:BC003193.1~uORF:IOH4578	991	938	1328	1632	1504	1482	1326	1328	4341	783	leucine rich repeat containing 1 (LRRC1)
B40R17C08	40-8-17	Hs~MGC:BC003193.1~uORF:IOH4578	1078	915	1344	1570	1637	1425	1305	1353	4199	762	leucine rich repeat containing 1 (LRRC1)
B40R17C09	40-9-17	Hs~Ref:NM_021254.1~uORF:IOH4573	905	460	1563	315	961	770	550	703	2594	744	chromosome 21 open reading frame 59 (C21orf59)
B40R17C10	40-10-17	Hs~Ref:NM_021254.1~uORF:IOH4573	425	437	1584	339	952	877	559	609	2536	747	chromosome 21 open reading frame 59 (C21orf59)
B40R17C11	40-11-17	Hs~MGC:BC000733.1~uORF:IOH4627	910	696	872	729	690	1919	2811	726	2384	335	eukaryotic translation initiation factor 3, subunit G (EIF3S4)
B40R17C12	40-12-17	Hs~MGC:BC000733.1~uORF:IOH4627	901	745	906	756	746	1860	2892	708	2305	317	eukaryotic translation initiation factor 3, subunit G (EIF3S4)
B40R17C13	40-13-17	Hs~Ref:NM_032014.1~uORF:IOH13283	1027	784	1022	651	3225	979	2033	898	1277	2785	mitochondrial ribosomal protein S24 (MRPS24), nuclear gene encoding mitochondrial protein
B40R17C14	40-14-17	Hs~Ref:NM_032014.1~uORF:IOH13283	1112	745	1065	685	3223	1046	1957	860	1436	1934	mitochondrial ribosomal protein S24 (MRPS24), nuclear gene encoding mitochondrial protein
B40R17C15	40-15-17	Hs~MGC:BC009108.1~uORF:IOH10191	5816	3860	4546	4945	24537	9034	16177	5853	9521	4266	cDNA clone IMAGE:3451214 (MCM10)
B40R17C16	40-16-17	Hs~MGC:BC009108.1~uORF:IOH10191	5834	3989	4417	4832	23692	9012	16556	5701	9220	5305	cDNA clone IMAGE:3451214 (MCM10)
B40R17C17	40-17-17	Hs~MGC:BC060806.1~uORF:IOH29136	551	569	570	368	93	937	791	533	1081	62	reversion-inducing-cysteine-rich protein with kazal motifs (RECK)
B40R17C18	40-18-17	Hs~MGC:BC060806.1~uORF:IOH29136	549	609	684	397	1338	257	810	543	990	35	reversion-inducing-cysteine-rich protein with kazal motifs (RECK)
B40R17C19	40-19-17	Hs~MGC:BC058036.1~uORF:IOH29481	536	564	544	345	474	227	740	432	713	189	folate receptor 2 (fetal) (FOLR2)
B40R17C20	40-20-17	Hs~MGC:BC058036.1~uORF:IOH29481	524	375	490	340	722	27	743	367	730	-3	folate receptor 2 (fetal) (FOLR2)
B40R17C21	40-21-17	Hs~MGC:BC034417.1~uORF:IOH22867	483	337	596	396	284	122	693	432	9	44	yeast Sps1/Ste20-related kinase 4 (S. cerevisiae) (YSK4)
B40R17C22	40-22-17	Hs~MGC:BC034417.1~uORF:IOH22867	543	243	516	352	311	688	632	511	345	-17	yeast Sps1/Ste20-related kinase 4 (S. cerevisiae) (YSK4)
B40R18C01	40-1-18	Hs~Ref:NM_145247.4~uORF:IOH45440	543	376	370	302	298	538	1031	558	332	302	chromosome 10 open reading frame 78 (C10orf78), transcript variant 2
B40R18C02	40-2-18	Hs~Ref:NM_145247.4~uORF:IOH45440	552	370	390	287	264	687	1111	472	769	267	chromosome 10 open reading frame 78 (C10orf78), transcript variant 2
B40R18C07	40-7-18	Hs~MGC:BC039235.1~uORF:IOH27982	177	207	324	211	116	115	385	268	294	98	Serum albumin
B40R18C08	40-8-18	Hs~MGC:BC039235.1~uORF:IOH27982	881	201	380	481	140	154	427	258	368	41	Serum albumin
B40R18C09	40-9-18	Hs~Ref:NM_001165.3~uORF:IOH25952	1263	537	565	634	467	500	707	458	324	482	baculoviral IAP repeat-containing 3 (BIRC3), transcript variant 1
B40R18C10	40-10-18	Hs~Ref:NM_001165.3~uORF:IOH25952	488	477	531	550	618	248	699	532	330	328	baculoviral IAP repeat-containing 3 (BIRC3), transcript variant 1
B40R18C11	40-11-18	Hs~MGC:BC050716.1~uORF:IOH27065	336	598	485	288	308	203	691	442	908	-14	neurotrimin (HNT)
B40R18C12	40-12-18	Hs~MGC:BC050716.1~uORF:IOH27065	358	570	458	317	493	674	709	422	802	3	neurotrimin (HNT)
B40R18C13	40-13-18	Hs~MGC:BC033491.1~uORF:IOH27359	584	2844	832	347	249	1363	1064	407	968	1817	adenosine deaminase domain containing 2 (ADAD2)
B40R18C14	40-14-18	Hs~MGC:BC033491.1~uORF:IOH27359	651	2763	834	358	227	1414	991	428	918	-34	adenosine deaminase domain containing 2 (ADAD2)
B40R18C15	40-15-18	Hs~MGC:BC040290.1~uORF:IOH27654	639	402	524	321	459	707	925	410	865	204	ubiquitin-conjugating enzyme E2D N-terminal like (UBE2DNL)
B40R18C16	40-16-18	Hs~MGC:BC040290.1~uORF:IOH27654	660	458	561	300	314	546	965	421	865	-21	ubiquitin-conjugating enzyme E2D N-terminal like (UBE2DNL)
B40R18C17	40-17-18	Hs~MGC:BC045799.1~uORF:IOH26424	1173	1173	1659	1643	3837	1140	2663	1559	2229	521	Zinc finger protein 428
B40R18C18	40-18-18	Hs~MGC:BC045799.1~uORF:IOH26424	1121	1145	1696	1703	6255	1221	2708	1620	2326	546	Zinc finger protein 428
B40R18C19	40-19-18	Hs~Ref:NM_032860.2~uORF:IOH22948	1849	992	1001	762	780	1139	5835	834	2922	59	LTV1 homolog (S. cerevisiae) (LTV1)
B40R18C20	40-20-18	Hs~Ref:NM_032860.2~uORF:IOH22948	1872	919	984	746	760	1119	5732	819	2692	41	LTV1 homolog (S. cerevisiae) (LTV1)
B40R18C21	40-21-18	Hs~MGC:BC030210.1~uORF:IOH22603	557	533	525	354	1165	616	577	496	789	57	CD79b molecule, immunoglobulin-associated beta (CD79B)
B40R18C22	40-22-18	Hs~MGC:BC030210.1~uORF:IOH22603	461	297	540	353	124	339	522	439	92	-21	CD79b molecule, immunoglobulin-associated beta (CD79B)
B40R19C01	40-1-19	Hs~Ref:NM_001384.2~uORF:IOH5134	399	197	360	205	-6	3637	490	285	58	17	DPH2 homolog (S. cerevisiae) (DPH2), transcript variant 1
B40R19C02	40-2-19	Hs~Ref:NM_001384.2~uORF:IOH5134	187	156	308	222	798	1838	492	328	276	13	DPH2 homolog (S. cerevisiae) (DPH2), transcript variant 1
B40R19C03	40-3-19	Hs~Ref:NM_002287.2~uORF:IOH11793	881	1841	2932	248	163	1751	537	1202	549	925	leukocyte-associated immunoglobulin-like receptor 1 (LAIR1), transcript variant a
B40R19C04	40-4-19	Hs~Ref:NM_002287.2~uORF:IOH11793	713	1822	2880	254	185	922	577	1100	572	937	leukocyte-associated immunoglobulin-like receptor 1 (LAIR1), transcript variant a
B40R19C05	40-5-19	Hs~MGC:BC006012.1~uORF:IOH40621	418	447	540	333	335	647	708	407	703	180	Selenoprotein T
B40R19C06	40-6-19	Hs~MGC:BC006012.1~uORF:IOH40621	403	465	572	351	237	352	675	415	845	177	Selenoprotein T
B40R19C07	40-7-19	Hs~Ref:NM_005375.2~uORF:IOH39964	500	1071	552	308	218	479	954	405	543	128	v-myb myeloblastosis viral oncogene homolog (avian) (MYB)
B40R19C08	40-8-19	Hs~Ref:NM_005375.2~uORF:IOH39964	1367	280	562	433	94	476	948	397	607	121	v-myb myeloblastosis viral oncogene homolog (avian) (MYB)
B40R19C09	40-9-19	Hs~Ref:NM_007250.2~uORF:IOH43163	2912	1119	1660	925	650	1715	9470	1670	3496	450	Kruppel-like factor 8 (KLF8)
B40R19C10	40-10-19	Hs~Ref:NM_007250.2~uORF:IOH43163	2498	1056	1599	945	617	1523	9065	1691	3643	547	Kruppel-like factor 8 (KLF8)
B40R19C11	40-11-19	Hs~MGC:BC002552.2~uORF:IOH4031	413	431	530	316	461	518	765	373	206	376	high-mobility group 20B (HMG20B)
B40R19C12	40-12-19	Hs~MGC:BC002552.2~uORF:IOH4031	399	455	522	331	271	394	707	400	725	109	high-mobility group 20B (HMG20B)
B40R19C13	40-13-19	Hs~MGC:NM_152522.2~uORF:IOH11477	421	409	515	335	191	657	691	404	792	3088	ADP-ribosylation factor-like protein 6-interacting protein 6
B40R19C14	40-14-19	Hs~MGC:NM_152522.2~uORF:IOH11477	467	473	612	371	190	102	650	404	874	23	ADP-ribosylation factor-like protein 6-interacting protein 6
B40R19C15	40-15-19	Hs~MGC:BC028724.1~uORF:IOH11709	656	610	1149	523	317	786	912	696	979	127	Dual specificity protein phosphatase 18
B40R19C16	40-16-19	Hs~MGC:BC028724.1~uORF:IOH11709	1085	691	1146	513	298	698	962	755	997	134	Dual specificity protein phosphatase 18
B40R19C17	40-17-19	Hs~MGC:BC000288.1~uORF:IOH3404	2816	2269	2375	1556	846	2629	11730	62109	3984	14	CCHC-type zinc finger, nucleic acid binding protein (CNBP)
B40R19C18	40-18-19	Hs~MGC:BC000288.1~uORF:IOH3404	3058	2425	2349	1542	3329	2451	11850	58440	4017	30	CCHC-type zinc finger, nucleic acid binding protein (CNBP)
B40R19C19	40-19-19	Hs~MGC:BC000232.1~uORF:IOH62785	358	954	430	290	405	150	473	335	508	-55	Receptor expression-enhancing protein 5
B40R19C20	40-20-19	Hs~MGC:BC000232.1~uORF:IOH62785	238	995	409	286	444	286	442	336	459	-26	Receptor expression-enhancing protein 5
B40R20C01	40-1-20	Hs~Ref:NM_006398.2~uORF:IOH59996	4588	1828	2750	1899	1024	3250	-3	1	1	-3	Ubiquitin D
B40R20C02	40-2-20	Hs~Ref:NM_006398.2~uORF:IOH59996	4451	1801	2647	1817	987	312	-1	3	87	-1	Ubiquitin D
B40R20C03	40-3-20	Hs~Ref:NM_001012984.1~uORF:IOH54807	965	572	1304	385	512	365	0	-2	185	-3	Uncharacterized protein C16orf86
B40R20C04	40-4-20	Hs~Ref:NM_001012984.1~uORF:IOH54807	821	512	1470	421	516	98	-1	0	93	0	Uncharacterized protein C16orf86
B40R20C05	40-5-20	Hs~Ref:NM_002758.3~uORF:IOH59078	1486	507	3243	396	410	368	2	1	92	0	Dual specificity mitogen-activated protein kinase kinase 6
B40R20C06	40-6-20	Hs~Ref:NM_002758.3~uORF:IOH59078	1475	706	3212	400	433	-71	0	0	156	-1	Dual specificity mitogen-activated protein kinase kinase 6
B40R20C07	40-7-20	Hs~Ref:NM_016224.3~uORF:IOH55509	727	708	1147	2754	992	880	1910	1000	2385	401	Sorting nexin-9
B40R20C08	40-8-20	Hs~Ref:NM_016224.3~uORF:IOH55509	774	631	1135	2098	959	2492	1849	999	1779	367	Sorting nexin-9
B40R20C09	40-9-20	Hs~MGC:BC013098.1~uORF:IOH22115	1155	522	1128	448	530	356	1181	498	2047	435	Melanoma-associated antigen 2
B40R20C10	40-10-20	Hs~MGC:BC013098.1~uORF:IOH22115	908	535	1171	516	579	868	1234	496	2352	534	Melanoma-associated antigen 2
B40R20C11	40-11-20	Hs~MGC:BC017202.2~uORF:IOH57138	2835	4891	1979	3020	1074	4019	5418	5517	2684	18153	Isovaleryl-CoA dehydrogenase, mitochondrial
B40R20C12	40-12-20	Hs~MGC:BC017202.2~uORF:IOH57138	2747	4801	1965	3070	1280	4201	5715	5251	2494	17483	Isovaleryl-CoA dehydrogenase, mitochondrial
B40R20C13	40-13-20	Hs~Ref:NM_001010927.2~uORF:IOH55541	754	611	4214	1354	1488	1325	2083	1037	1429	47513	T-cell lymphoma invasion and metastasis 2 (TIAM2), transcript variant 2, mRNA.
B40R20C14	40-14-20	Hs~Ref:NM_001010927.2~uORF:IOH55541	759	585	4138	1229	1441	1351	2169	967	1471	45208	T-cell lymphoma invasion and metastasis 2 (TIAM2), transcript variant 2, mRNA.
B41R02C11	41-11-2	Hs~Ref:NM_001871.2~uORF:IOH11321	909	1913	1895	526	492	706	892	434	1009	305	carboxypeptidase B1 (tissue) (CPB1)
B41R02C12	41-12-2	Hs~Ref:NM_001871.2~uORF:IOH11321	892	1796	2182	550	469	768	1020	472	1044	316	carboxypeptidase B1 (tissue) (CPB1)
B41R02C13	41-13-2	Hs~MGC:BC029382.1~uORF:IOH23139	2096	3696	11714	2065	3490	4067	7190	3030	7733	2497	Angiogenic factor with G patch and FHA domains 1
B41R02C14	41-14-2	Hs~MGC:BC029382.1~uORF:IOH23139	2315	3885	10807	1934	3473	4295	7175	3929	7600	2336	Angiogenic factor with G patch and FHA domains 1
B41R02C15	41-15-2	Hs~MGC:BC009259.1~uORF:IOH13329	778	1087	932	580	2371	669	3026	12356	1590	332	Homeobox-containing protein 1
B41R02C16	41-16-2	Hs~MGC:BC009259.1~uORF:IOH13329	765	1140	900	575	2519	609	3143	11852	1613	369	Homeobox-containing protein 1
B41R02C17	41-17-2	Hs~MGC:BC001555.1~uORF:IOH10965	1012	832	1137	1025	1092	787	2921	937	1753	485	peptidylprolyl isomerase G (cyclophilin G) (PPIG)
B41R02C18	41-18-2	Hs~MGC:BC001555.1~uORF:IOH10965	942	1092	1128	1166	1004	724	1770	942	1488	314	peptidylprolyl isomerase G (cyclophilin G) (PPIG)
B41R02C19	41-19-2	Hs~Ref:NM_001898.2~uORF:IOH14329	1834	818	1406	0	862	5056	1447	789	2106	412	cystatin SN (CST1)
B41R02C20	41-20-2	Hs~Ref:NM_001898.2~uORF:IOH14329	1909	933	1430	2	800	4899	1400	790	2063	380	cystatin SN (CST1)
B41R02C21	41-21-2	Hs~MGC:BC024184.2~uORF:IOH10751	2478	996	1530	917	932	1359	6461	767	1747	344	germ cell-less homolog 1 (Drosophila)-like (GMCL1L)
B41R02C22	41-22-2	Hs~MGC:BC024184.2~uORF:IOH10751	2392	1029	1573	887	1004	1340	6564	751	1675	295	germ cell-less homolog 1 (Drosophila)-like (GMCL1L)
B41R03C01	41-1-3	Hs~MGC:BC016703.1~uORF:IOH13173	835	846	1216	699	864	758	1254	979	1123	280	hypothetical protein FLJ20581 (FLJ20581)
B41R03C02	41-2-3	Hs~MGC:BC016703.1~uORF:IOH13173	878	828	1230	843	888	798	1338	890	1226	331	hypothetical protein FLJ20581 (FLJ20581)
B41R03C03	41-3-3	Hs~MGC:BC010895.1~uORF:IOH14241	946	1081	1567	967	1182	2894	2578	756	1577	658	sulfotransferase family, cytosolic, 1B, member 1 (SULT1B1)
B41R03C04	41-4-3	Hs~MGC:BC010895.1~uORF:IOH14241	1559	1173	1590	972	1170	2980	2567	790	1432	342	sulfotransferase family, cytosolic, 1B, member 1 (SULT1B1)
B41R03C05	41-5-3	Hs~Ref:NM_001015.2~uORF:IOH6920	1770	993	868	527	551	1045	2163	551	1623	330	ribosomal protein S11 (RPS11)
B41R03C06	41-6-3	Hs~Ref:NM_001015.2~uORF:IOH6920	1468	856	859	563	560	989	2098	576	1414	383	ribosomal protein S11 (RPS11)
B41R03C07	41-7-3	Hs~MGC:BC007566.1~uORF:IOH6849	630	470	714	754	476	786	536	388	753	308	mannose-6-phosphate receptor binding protein 1 (M6PRBP1)
B41R03C08	41-8-3	Hs~MGC:BC007566.1~uORF:IOH6849	818	830	730	769	505	799	536	339	762	292	mannose-6-phosphate receptor binding protein 1 (M6PRBP1)
B41R03C09	41-9-3	Hs~MGC:NM_173473.2~uORF:IOH9870	1397	1314	1111	603	761	1046	1111	749	1724	390	chromosome 10 open reading frame 104 (C10orf104)
B41R03C10	41-10-3	Hs~MGC:NM_173473.2~uORF:IOH9870	1451	1350	1045	635	721	1028	1211	692	1694	383	chromosome 10 open reading frame 104 (C10orf104)
B41R03C11	41-11-3	Hs~MGC:BC009615.1~uORF:IOH9891	584	703	641	393	530	430	656	394	657	386	OTU domain, ubiquitin aldehyde binding 2 (OTUB2)
B41R03C12	41-12-3	Hs~MGC:BC009615.1~uORF:IOH9891	549	818	612	414	519	529	756	454	726	374	OTU domain, ubiquitin aldehyde binding 2 (OTUB2)
B41R03C13	41-13-3	Hs~MGC:BC030811.1~uORF:IOH23057	933	1228	1285	906	2080	881	793	2140	2543	532	Kruppel-like factor 4 (gut) (KLF4)
B41R03C14	41-14-3	Hs~MGC:BC030811.1~uORF:IOH23057	934	1163	1265	962	1951	846	830	2159	2465	520	Kruppel-like factor 4 (gut) (KLF4)
B41R03C15	41-15-3	Hs~MGC:NM_033387.2~uORF:IOH26402	3300	3726	2800	3818	3851	4022	6377	3528	16037	3024	family with sequence similarity 78, member A (FAM78A)
B41R03C16	41-16-3	Hs~MGC:NM_033387.2~uORF:IOH26402	3358	3856	2740	3765	4238	3842	6413	3445	15602	2926	family with sequence similarity 78, member A (FAM78A)
B41R03C17	41-17-3	Hs~MGC:NM_176791.2~uORF:IOH26363	1083	5845	1946	4543	5641	2600	5146	9872	2231	335	family with sequence similarity 112, member A (FAM112A), transcript variant 1
B41R03C18	41-18-3	Hs~MGC:NM_176791.2~uORF:IOH26363	1184	6124	1941	4368	5589	2468	4793	10530	2201	239	family with sequence similarity 112, member A (FAM112A), transcript variant 1
B41R03C19	41-19-3	Hs~Ref:NM_033014.1~uORF:IOH27143	333	352	490	169	304	344	373	262	436	96	osteoglycin (OGN), transcript variant 1
B41R03C20	41-20-3	Hs~Ref:NM_033014.1~uORF:IOH27143	363	349	473	189	305	333	353	266	455	111	osteoglycin (OGN), transcript variant 1
B41R03C21	41-21-3	Hs~MGC:BC024208.1~uORF:IOH12635	1103	1129	3915	2078	1936	3015	1310	1636	2671	694	RNA binding motif protein 23 (RBM23)
B41R03C22	41-22-3	Hs~MGC:BC024208.1~uORF:IOH12635	1116	1239	3915	1975	1728	2960	1319	1617	2632	675	RNA binding motif protein 23 (RBM23)
B41R04C01	41-1-4	Hs~Ref:NM_145043.1~uORF:IOH13260	2496	2315	2811	7755	4004	2050	4137	1793	4374	1345	nei like 2 (E. coli) (NEIL2)
B41R04C02	41-2-4	Hs~Ref:NM_145043.1~uORF:IOH13260	2436	2376	2745	8837	4264	2003	4436	1768	4469	1236	nei like 2 (E. coli) (NEIL2)
B41R04C03	41-3-4	Hs~Ref:NM_018696.1~uORF:IOH12628	1603	1355	2794	2538	2168	1925	3788	1125	2834	659	elaC homolog 1 (E. coli) (ELAC1)
B41R04C04	41-4-4	Hs~Ref:NM_018696.1~uORF:IOH12628	1679	1458	2911	2359	2165	1999	3881	1121	2702	711	elaC homolog 1 (E. coli) (ELAC1)
B41R04C05	41-5-4	Hs~MGC:BC015169.1~uORF:IOH9936	984	1754	1217	742	4504	1007	1212	837	2208	624	Ubiquitin-conjugating enzyme E2 Z
B41R04C06	41-6-4	Hs~MGC:BC015169.1~uORF:IOH9936	1248	1625	1189	761	4646	1015	1195	803	2352	598	Ubiquitin-conjugating enzyme E2 Z
B41R04C07	41-7-4	Hs~Ref:NM_001584.1~uORF:IOH22675	1004	1288	951	2061	905	1476	1980	2965	1518	563	metallophosphoesterase domain containing 2 (MPPED2)
B41R04C08	41-8-4	Hs~Ref:NM_001584.1~uORF:IOH22675	946	1363	951	2099	939	1486	1946	3091	1602	537	metallophosphoesterase domain containing 2 (MPPED2)
B41R04C09	41-9-4	Hs~Ref:NM_018659.1~uORF:IOH22679	660	582	710	400	465	476	655	417	1024	302	cytokine-like 1 (CYTL1)
B41R04C10	41-10-4	Hs~Ref:NM_018659.1~uORF:IOH22679	680	693	746	415	492	581	708	435	909	320	cytokine-like 1 (CYTL1)
B41R04C11	41-11-4	Hs~MGC:NM_152315.1~uORF:IOH22681	581	682	542	318	401	479	571	381	914	327	Protein FAM55A
B41R04C12	41-12-4	Hs~MGC:NM_152315.1~uORF:IOH22681	705	604	556	349	412	438	668	378	719	286	Protein FAM55A
B41R04C13	41-13-4	Hs~MGC:BC008217.1~uORF:IOH3169	1157	988	1481	612	1673	873	1820	665	1368	365	Heterogeneous nuclear ribonucleoprotein L-like
B41R04C14	41-14-4	Hs~MGC:BC008217.1~uORF:IOH3169	1155	802	1384	634	1615	877	1425	657	1232	414	Heterogeneous nuclear ribonucleoprotein L-like
B41R04C15	41-15-4	Hs~Ref:NM_002633.2~uORF:IOH26862	357	476	529	257	512	617	727	621	745	1487	phosphoglucomutase 1 (PGM1)
B41R04C16	41-16-4	Hs~Ref:NM_002633.2~uORF:IOH26862	357	336	531	275	566	582	743	619	736	1743	phosphoglucomutase 1 (PGM1)
B41R04C17	41-17-4	Hs~Ref:NM_001150.1~uORF:IOH39688	420	419	1080	522	410	1033	703	1427	677	151	alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150) (ANPEP)
B41R04C18	41-18-4	Hs~Ref:NM_001150.1~uORF:IOH39688	460	425	1061	542	402	1032	672	1395	698	158	alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150) (ANPEP)
B41R04C19	41-19-4	Hs~Ref:NM_176792.1~uORF:IOH26232	553	579	671	453	2790	543	680	607	843	307	mitochondrial ribosomal protein L43 (MRPL43), nuclear gene encoding mitochondrial protein, transcript variant 2
B41R04C20	41-20-4	Hs~Ref:NM_176792.1~uORF:IOH26232	555	580	715	417	2804	565	614	538	769	73	mitochondrial ribosomal protein L43 (MRPL43), nuclear gene encoding mitochondrial protein, transcript variant 2
B41R04C21	41-21-4	Hs~Ref:NM_005525.2~uORF:IOH12895	805	1391	1030	302	404	444	515	389	631	197	hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1), transcript variant 1
B41R04C22	41-22-4	Hs~Ref:NM_005525.2~uORF:IOH12895	813	1428	1052	360	363	402	536	453	386	86	hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1), transcript variant 1
B41R05C01	41-1-5	Hs~MGC:BC047411.1~uORF:IOH26516	1832	1567	1345	863	592	1187	15421	888	1331	737	tubulin tyrosine ligase-like family, member 2 (TTLL2)
B41R05C02	41-2-5	Hs~MGC:BC047411.1~uORF:IOH26516	1941	1512	1239	901	620	1225	15511	874	1350	585	tubulin tyrosine ligase-like family, member 2 (TTLL2)
B41R05C03	41-3-5	Hs~Ref:NM_014553.1~uORF:IOH39819	6735	703	616	518	422	661	896	583	981	256	transcription factor CP2-like 1 (TFCP2L1)
B41R05C04	41-4-5	Hs~Ref:NM_014553.1~uORF:IOH39819	7289	720	627	533	433	805	901	632	761	124	transcription factor CP2-like 1 (TFCP2L1)
B41R05C05	41-5-5	Hs~Ref:NM_006402.2~uORF:IOH40860	6171	741	511	472	422	1525	495	780	1207	164	hepatitis B virus x interacting protein (HBXIP)
B41R05C06	41-6-5	Hs~Ref:NM_006402.2~uORF:IOH40860	6194	777	519	476	463	1490	494	729	1240	173	hepatitis B virus x interacting protein (HBXIP)
B41R05C07	41-7-5	Hs~MGC:BC022895.1~uORF:IOH12258	700	680	809	319	593	959	970	483	921	275	membrane-spanning 4-domains, subfamily A, member 8B (MS4A8B)
B41R05C08	41-8-5	Hs~MGC:BC022895.1~uORF:IOH12258	672	598	822	344	588	980	917	749	1220	214	membrane-spanning 4-domains, subfamily A, member 8B (MS4A8B)
B41R05C09	41-9-5	Hs~Ref:NM_005868.3~uORF:IOH2876	1356	1431	1596	2329	1302	1646	1711	1448	3762	853	BET1 homolog (S. cerevisiae) (BET1)
B41R05C10	41-10-5	Hs~Ref:NM_005868.3~uORF:IOH2876	1340	1402	1519	2360	1478	1619	1932	1308	3859	841	BET1 homolog (S. cerevisiae) (BET1)
B41R05C11	41-11-5	Hs~Ref:NM_015993.1~uORF:IOH5384	2280	1398	1522	1004	834	1433	1525	1301	2845	596	plasma membrane proteolipid (plasmolipin) (PLLP)
B41R05C12	41-12-5	Hs~Ref:NM_015993.1~uORF:IOH5384	2354	1506	1576	1072	872	1444	1607	1357	3010	582	plasma membrane proteolipid (plasmolipin) (PLLP)
B41R05C13	41-13-5	Hs~Ref:NM_024819.2~uORF:IOH5768	1335	1412	5071	1045	839	1405	2245	1148	2609	730	Dephospho-CoA kinase domain-containing protein
B41R05C14	41-14-5	Hs~Ref:NM_024819.2~uORF:IOH5768	1522	1335	4942	1054	900	1263	2308	1190	2433	817	Dephospho-CoA kinase domain-containing protein
B41R05C15	41-15-5	Hs~Ref:NM_000995.2~uORF:IOH4459	1923	1674	2213	1251	1470	2519	4169	1750	3561	1126	ribosomal protein L34 (RPL34), transcript variant 1
B41R05C16	41-16-5	Hs~Ref:NM_000995.2~uORF:IOH4459	1920	1641	2117	1214	1429	2460	4171	1740	3319	1034	ribosomal protein L34 (RPL34), transcript variant 1
B41R05C17	41-17-5	Hs~Ref:NM_002269.1~uORF:IOH26522	297	381	327	307	309	317	354	197	466	115	karyopherin alpha 5 (importin alpha 6) (KPNA5)
B41R05C18	41-18-5	Hs~Ref:NM_002269.1~uORF:IOH26522	260	348	294	295	261	228	326	223	390	65	karyopherin alpha 5 (importin alpha 6) (KPNA5)
B41R05C19	41-19-5	Hs~MGC:BC050432.1~uORF:IOH26694	566	383	497	317	422	1337	646	428	86	380	staufen, RNA binding protein, homolog 1 (Drosophila) (STAU1)
B41R05C20	41-20-5	Hs~MGC:BC050432.1~uORF:IOH26694	464	321	497	340	416	1318	650	230	473	336	staufen, RNA binding protein, homolog 1 (Drosophila) (STAU1)
B41R05C21	41-21-5	Hs~Ref:NM_003724.1~uORF:IOH26418	968	858	733	624	573	1114	1257	494	1161	583	jerky homolog (mouse) (JRK), transcript variant 1
B41R05C22	41-22-5	Hs~Ref:NM_003724.1~uORF:IOH26418	907	857	746	645	556	1080	1201	474	1208	391	jerky homolog (mouse) (JRK), transcript variant 1
B41R06C01	41-1-6	Hs~MGC:BC035747.1~uORF:IOH26034	528	1391	628	372	625	538	626	673	810	169	solute carrier family 35 (UDP-galactose transporter), member A2 (SLC35A2)
B41R06C02	41-2-6	Hs~MGC:BC035747.1~uORF:IOH26034	556	1506	582	350	613	506	677	739	773	149	solute carrier family 35 (UDP-galactose transporter), member A2 (SLC35A2)
B41R06C03	41-3-6	Hs~Ref:NM_024071.2~uORF:IOH3850	7727	651	721	530	1290	920	1711	593	5343	448	zinc finger, FYVE domain containing 21 (ZFYVE21)
B41R06C04	41-4-6	Hs~Ref:NM_024071.2~uORF:IOH3850	7504	643	744	533	1280	861	1611	610	5333	408	zinc finger, FYVE domain containing 21 (ZFYVE21)
B41R06C05	41-5-6	Hs~Ref:NM_001680.2~uORF:IOH1555	672	756	717	1365	391	598	709	471	2632	295	FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant a
B41R06C06	41-6-6	Hs~Ref:NM_001680.2~uORF:IOH1555	634	736	700	395	399	583	660	405	3034	290	FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant a
B41R06C07	41-7-6	Hs~MGC:NM_178815.2~uORF:IOH12502	472	1066	615	299	377	483	438	250	748	256	ADP-ribosylation factor-like 5B (ARL5B)
B41R06C08	41-8-6	Hs~MGC:NM_178815.2~uORF:IOH12502	510	1026	583	301	375	513	506	326	605	280	ADP-ribosylation factor-like 5B (ARL5B)
B41R06C09	41-9-6	Hs~Ref:NM_001018.2~uORF:IOH1683	1212	949	1162	572	628	1042	2784	847	1173	408	ribosomal protein S15 (RPS15)
B41R06C10	41-10-6	Hs~Ref:NM_001018.2~uORF:IOH1683	1125	928	1105	581	677	982	3206	540	1532	384	ribosomal protein S15 (RPS15)
B41R06C11	41-11-6	Hs~Ref:NM_153686.4~uORF:IOH40880	1160	471	611	362	424	541	643	427	1135	172	Ligand-dependent nuclear receptor corepressor-like protein
B41R06C12	41-12-6	Hs~Ref:NM_153686.4~uORF:IOH40880	1160	540	653	368	386	532	615	449	1222	134	Ligand-dependent nuclear receptor corepressor-like protein
B41R06C13	41-13-6	Hs~Ref:NM_024647.4~uORF:IOH39956	683	261	611	328	341	623	667	251	803	55	nucleoporin 43kDa (NUP43), transcript variant 2
B41R06C14	41-14-6	Hs~Ref:NM_024647.4~uORF:IOH39956	727	263	627	362	412	615	649	321	766	38	nucleoporin 43kDa (NUP43), transcript variant 2
B41R06C15	41-15-6	Hs~MGC:BC062459.1~uORF:IOH40000	1012	443	635	1787	485	850	2266	500	713	656	butyrophilin-like 9 (BTNL9)
B41R06C16	41-16-6	Hs~MGC:BC062459.1~uORF:IOH40000	896	358	675	1672	444	876	2398	484	612	383	butyrophilin-like 9 (BTNL9)
B41R06C17	41-17-6	Hs~Ref:NM_004269.2~uORF:IOH39902	1860	488	615	287	543	488	479	308	502	105	mediator complex subunit 27 (MED27)
B41R06C18	41-18-6	Hs~Ref:NM_004269.2~uORF:IOH39902	1851	495	629	313	483	511	495	341	536	100	mediator complex subunit 27 (MED27)
B41R06C19	41-19-6	Hs~MGC:BC045532.1~uORF:IOH26774	648	471	636	346	447	538	767	524	593	148	LSM8 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM8)
B41R06C20	41-20-6	Hs~MGC:BC045532.1~uORF:IOH26774	616	513	678	358	434	502	843	1083	680	223	LSM8 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM8)
B41R06C21	41-21-6	Hs~MGC:BC023560.1~uORF:IOH27849	594	514	627	434	622	579	955	567	833	215	FERM domain containing 3 (FRMD3)
B41R06C22	41-22-6	Hs~MGC:BC023560.1~uORF:IOH27849	634	488	621	391	696	540	818	413	607	27	FERM domain containing 3 (FRMD3)
B41R07C01	41-1-7	Hs~Ref:NM_003564.1~uORF:IOH27832	1150	781	1004	1448	377	4	27	409	1592	138	transgelin 2 (TAGLN2)
B41R07C02	41-2-7	Hs~Ref:NM_003564.1~uORF:IOH27832	1219	872	978	1443	396	2	121	394	1618	307	transgelin 2 (TAGLN2)
B41R07C03	41-3-7	Hs~MGC:BC051362.1~uORF:IOH28072	680	286	507	203	235	463	634	363	262	112	hypothetical LOC554223 (LOC554223)
B41R07C04	41-4-7	Hs~MGC:BC051362.1~uORF:IOH28072	700	345	565	1208	240	462	622	337	615	107	hypothetical LOC554223 (LOC554223)
B41R07C05	41-5-7	Hs~Ref:NM_004765.2~uORF:IOH14041	3559	1164	1412	809	1013	1474	2174	1313	1591	77	B-cell CLL/lymphoma 7C (BCL7C)
B41R07C06	41-6-7	Hs~Ref:NM_004765.2~uORF:IOH14041	3839	1189	1398	588	1090	1481	2121	1293	1562	6	B-cell CLL/lymphoma 7C (BCL7C)
B41R07C07	41-7-7	Hs~MGC:BC009457.1~uORF:IOH14847	699	572	784	404	565	652	634	422	1127	238	guanine nucleotide binding protein (G protein) alpha 12 (GNA12)
B41R07C08	41-8-7	Hs~MGC:BC009457.1~uORF:IOH14847	690	524	797	417	566	533	610	419	1213	285	guanine nucleotide binding protein (G protein) alpha 12 (GNA12)
B41R07C09	41-9-7	Hs~MGC:BC035690.1~uORF:IOH26051	1051	1799	1863	674	953	797	1051	771	1751	416	myotubularin related protein 14 (MTMR14)
B41R07C10	41-10-7	Hs~MGC:BC035690.1~uORF:IOH26051	1171	1875	1804	663	989	764	1157	757	1746	419	myotubularin related protein 14 (MTMR14)
B41R07C11	41-11-7	Hs~MGC:BC000954.1~uORF:IOH3033	1389	1009	1144	871	1198	8718	1321	1001	2331	435	chromobox homolog 3 (HP1 gamma homolog, Drosophila) (CBX3)
B41R07C12	41-12-7	Hs~MGC:BC000954.1~uORF:IOH3033	1495	936	1129	859	1289	8877	1353	981	2338	440	chromobox homolog 3 (HP1 gamma homolog, Drosophila) (CBX3)
B41R07C13	41-13-7	Hs~Ref:NM_002142.3~uORF:IOH44625	975	960	1766	497	855	1254	2569	2594	2419	318	Homeobox protein Hox-A9
B41R07C14	41-14-7	Hs~Ref:NM_002142.3~uORF:IOH44625	980	921	1756	498	855	1209	2612	2478	2390	338	Homeobox protein Hox-A9
B41R07C15	41-15-7	Hs~Ref:NM_001244.2~uORF:IOH42084	1242	1140	2082	888	1244	1204	2086	854	2326	711	tumor necrosis factor (ligand) superfamily, member 8 (TNFSF8)
B41R07C16	41-16-7	Hs~Ref:NM_001244.2~uORF:IOH42084	1230	1208	2064	1107	1294	1146	1997	894	2433	672	tumor necrosis factor (ligand) superfamily, member 8 (TNFSF8)
B41R07C17	41-17-7	Hs~Ref:NM_144660.1~uORF:IOH43639	2142	1477	2702	889	1641	1192	2110	863	1890	671	sterile alpha motif domain containing 8 (SAMD8)
B41R07C18	41-18-7	Hs~Ref:NM_144660.1~uORF:IOH43639	2153	1467	2676	847	1543	1207	2309	862	2003	643	sterile alpha motif domain containing 8 (SAMD8)
B41R07C19	41-19-7	Hs~Ref:NM_006426.1~uORF:IOH42101	2792	1592	1903	1153	1695	1855	2600	3611	2617	770	dihydropyrimidinase-like 4 (DPYSL4)
B41R07C20	41-20-7	Hs~Ref:NM_006426.1~uORF:IOH42101	2870	1609	1991	1135	1968	1793	2361	3730	2667	737	dihydropyrimidinase-like 4 (DPYSL4)
B41R07C21	41-21-7	Hs~MGC:BC011739.2~uORF:IOH14463	3720	2226	3518	2263	3237	2846	18004	2984	5221	1010	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C (APOBEC3C)
B41R07C22	41-22-7	Hs~MGC:BC011739.2~uORF:IOH14463	3817	2225	3430	2253	3324	2760	16296	3092	4991	999	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C (APOBEC3C)
B41R08C01	41-1-8	Hs~Ref:NM_002622.3~uORF:IOH14625	975	933	3105	849	1230	3656	1233	633	1555	287	prefoldin subunit 1 (PFDN1)
B41R08C02	41-2-8	Hs~Ref:NM_002622.3~uORF:IOH14625	1081	977	3133	889	1248	3646	1242	662	1555	266	prefoldin subunit 1 (PFDN1)
B41R08C03	41-3-8	Hs~MGC:NM_007270.2~uORF:IOH14166	1735	740	1476	1102	913	1588	4420	1215	2266	295	FK506 binding protein 9, 63 kDa (FKBP9)
B41R08C04	41-4-8	Hs~MGC:NM_007270.2~uORF:IOH14166	1711	700	1534	682	884	1628	4533	1257	2485	545	FK506 binding protein 9, 63 kDa (FKBP9)
B41R08C05	41-5-8	Hs~MGC:NM_058163.1~uORF:IOH14811	597	1207	1444	909	435	1485	1182	3520	1303	585	TSR2, 20S rRNA accumulation, homolog (S. cerevisiae) (TSR2)
B41R08C06	41-6-8	Hs~MGC:NM_058163.1~uORF:IOH14811	598	1232	1468	709	458	1547	1158	3439	1251	523	TSR2, 20S rRNA accumulation, homolog (S. cerevisiae) (TSR2)
B41R08C07	41-7-8	Hs~Ref:NM_022777.1~uORF:IOH14797	431	687	795	262	1117	510	440	343	804	109	RAB, member RAS oncogene family-like 5 (RABL5)
B41R08C08	41-8-8	Hs~Ref:NM_022777.1~uORF:IOH14797	459	643	783	305	1121	530	460	337	491	95	RAB, member RAS oncogene family-like 5 (RABL5)
B41R08C09	41-9-8	Hs~Ref:NM_002436.2~uORF:IOH3460	806	1069	1246	890	2347	1600	2589	608	2809	333	membrane protein, palmitoylated 1, 55kDa (MPP1)
B41R08C10	41-10-8	Hs~Ref:NM_002436.2~uORF:IOH3460	829	1136	1238	862	2652	1564	2712	637	2701	302	membrane protein, palmitoylated 1, 55kDa (MPP1)
B41R08C11	41-11-8	Hs~MGC:BC008094.1~uORF:IOH3305	1703	2105	1796	4052	1931	521	695	500	793	271	retinal G protein coupled receptor (RGR)
B41R08C12	41-12-8	Hs~MGC:BC008094.1~uORF:IOH3305	1622	1962	1774	3897	2112	516	719	406	744	312	retinal G protein coupled receptor (RGR)
B41R08C13	41-13-8	Hs~Ref:NM_024046.1~uORF:IOH21132	2978	3591	3373	4028	2174	3038	2161	1942	4218	1642	CaM kinase-like vesicle-associated (CAMKV)
B41R08C14	41-14-8	Hs~Ref:NM_024046.1~uORF:IOH21132	3131	4070	3431	4106	1616	3030	2084	1888	4179	2022	CaM kinase-like vesicle-associated (CAMKV)
B41R08C15	41-15-8	Hs~MGC:BC003643.1~uORF:IOH5184	482	631	701	558	366	504	653	326	780	511	dehydrodolichyl diphosphate synthase (DHDDS)
B41R08C16	41-16-8	Hs~MGC:BC003643.1~uORF:IOH5184	438	670	744	446	510	503	629	346	929	603	dehydrodolichyl diphosphate synthase (DHDDS)
B41R08C17	41-17-8	Hs~MGC:NM_003848.1~uORF:IOH26605	1428	1426	1679	2960	1110	1264	1747	743	1857	377	succinate-CoA ligase, GDP-forming, beta subunit (SUCLG2)
B41R08C18	41-18-8	Hs~MGC:NM_003848.1~uORF:IOH26605	1533	1400	1632	2847	987	1245	1758	766	1804	492	succinate-CoA ligase, GDP-forming, beta subunit (SUCLG2)
B41R08C19	41-19-8	Hs~MGC:BC000162.2~uORF:IOH2911	728	630	769	587	712	1082	1034	428	1076	354	serine/threonine kinase receptor associated protein (STRAP)
B41R08C20	41-20-8	Hs~MGC:BC000162.2~uORF:IOH2911	734	623	771	584	524	1107	999	432	973	432	serine/threonine kinase receptor associated protein (STRAP)
B41R08C21	41-21-8	Hs~Ref:NM_004544.1~uORF:IOH3043	579	702	849	494	1477	638	896	557	1184	256	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa (NDUFA10), nuclear gene encoding mitochondrial protein
B41R08C22	41-22-8	Hs~Ref:NM_004544.1~uORF:IOH3043	581	716	858	509	1560	635	828	959	906	244	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa (NDUFA10), nuclear gene encoding mitochondrial protein
B41R09C01	41-1-9	Hs~Ref:NM_002170.2~uORF:IOH35228	1041	1199	1397	968	1211	982	1312	820	1622	812	interferon, alpha 8 (IFNA8)
B41R09C02	41-2-9	Hs~Ref:NM_002170.2~uORF:IOH35228	1064	1255	1455	977	1204	960	1228	867	1722	761	interferon, alpha 8 (IFNA8)
B41R09C03	41-3-9	Hs~Ref:NM_014943.3~uORF:IOH28064	2065	2575	1644	22591	1434	1677	10621	1387	1711	2662	zinc fingers and homeoboxes 2 (ZHX2)
B41R09C04	41-4-9	Hs~Ref:NM_014943.3~uORF:IOH28064	2277	2479	1656	24261	1502	1861	10617	1363	1749	2819	zinc fingers and homeoboxes 2 (ZHX2)
B41R09C05	41-5-9	Hs~Ref:NM_002173.1~uORF:IOH35231	693	812	823	779	687	881	855	693	1099	415	interferon, alpha 16 (IFNA16)
B41R09C06	41-6-9	Hs~Ref:NM_002173.1~uORF:IOH35231	702	733	918	664	694	894	891	663	1316	419	interferon, alpha 16 (IFNA16)
B41R09C07	41-7-9	Hs~Ref:NM_002626.4~uORF:IOH6888	1071	1394	1276	892	820	1316	1353	743	1777	491	phosphofructokinase, liver (PFKL), transcript variant 2
B41R09C08	41-8-9	Hs~Ref:NM_002626.4~uORF:IOH6888	1091	1513	1313	931	776	1228	1446	792	1784	509	phosphofructokinase, liver (PFKL), transcript variant 2
B41R09C09	41-9-9	Hs~Ref:NM_138779.1~uORF:IOH10711	4124	2226	2705	1769	1093	1023	1848	-2	3189	1740	chromosome 13 open reading frame 27 (C13orf27)
B41R09C10	41-10-9	Hs~Ref:NM_138779.1~uORF:IOH10711	3973	2241	2794	1798	1070	798	1265	0	3133	1668	chromosome 13 open reading frame 27 (C13orf27)
B41R09C11	41-11-9	Hs~MGC:BC008499.1~uORF:IOH7414	1793	1074	1041	801	867	1051	3254	579	1496	340	chromosome 15 open reading frame 15 (C15orf15)
B41R09C12	41-12-9	Hs~MGC:BC008499.1~uORF:IOH7414	1761	1068	1066	783	984	1077	3352	775	1406	377	chromosome 15 open reading frame 15 (C15orf15)
B41R09C13	41-13-9	Hs~Ref:NM_080743.2~uORF:IOH10836	853	698	825	630	528	826	1769	535	924	530	serine-arginine repressor protein (35 kDa) (SRrp35)
B41R09C14	41-14-9	Hs~Ref:NM_080743.2~uORF:IOH10836	869	694	840	607	518	792	1785	454	907	140	serine-arginine repressor protein (35 kDa) (SRrp35)
B41R09C15	41-15-9	Hs~MGC:NM_178861.3~uORF:IOH10760	1001	1021	1109	660	491	841	749	515	2516	358	ring finger protein 113B (RNF113B)
B41R09C16	41-16-9	Hs~MGC:NM_178861.3~uORF:IOH10760	962	940	1066	655	689	825	695	521	2988	368	ring finger protein 113B (RNF113B)
B41R09C17	41-17-9	Hs~Ref:NM_138381.1~uORF:IOH6954	640	657	679	523	608	670	800	446	735	150	oxidoreductase NAD-binding domain containing 1 (OXNAD1)
B41R09C18	41-18-9	Hs~Ref:NM_138381.1~uORF:IOH6954	647	469	697	478	535	348	824	452	722	385	oxidoreductase NAD-binding domain containing 1 (OXNAD1)
B41R09C19	41-19-9	Hs~MGC:BC008303.1~uORF:IOH6987	381	395	415	443	504	486	467	240	566	173	transmembrane protein 176A (TMEM176A)
B41R09C20	41-20-9	Hs~MGC:BC008303.1~uORF:IOH6987	375	431	425	450	484	395	483	303	501	40	transmembrane protein 176A (TMEM176A)
B41R09C21	41-21-9	Hs~Ref:NM_004966.2~uORF:IOH3987	1714	1225	8447	2024	1748	1267	4180	1246	1981	865	heterogeneous nuclear ribonucleoprotein F (HNRPF), transcript variant 3
B41R09C22	41-22-9	Hs~Ref:NM_004966.2~uORF:IOH3987	1819	1193	8860	1955	1808	1140	4301	1106	1848	800	heterogeneous nuclear ribonucleoprotein F (HNRPF), transcript variant 3
B41R10C01	41-1-10	Hs~MGC:BC002677.1~uORF:IOH5269	661	537	25670	563	1958	1644	5985	3367	1962	411	A.T hook DNA-binding motif-containing protein 1
B41R10C02	41-2-10	Hs~MGC:BC002677.1~uORF:IOH5269	688	634	28056	789	2003	1613	5930	2849	2066	395	A.T hook DNA-binding motif-containing protein 1
B41R10C03	41-3-10	Hs~Ref:NM_001001852.2~uORF:IOH39671	1198	785	1908	1292	2166	1524	1049	1841	1893	532	pim-3 oncogene (PIM3)
B41R10C04	41-4-10	Hs~Ref:NM_001001852.2~uORF:IOH39671	1213	706	1902	1226	2148	1611	1060	1843	2203	545	pim-3 oncogene (PIM3)
B41R10C05	41-5-10	Hs~Ref:NM_006397.2~uORF:IOH13113	1300	691	1228	813	735	1089	1053	840	2374	939	ribonuclease H2, subunit A (RNASEH2A)
B41R10C06	41-6-10	Hs~Ref:NM_006397.2~uORF:IOH13113	1337	695	1250	797	745	1068	1113	844	2348	926	ribonuclease H2, subunit A (RNASEH2A)
B41R10C07	41-7-10	Hs~Ref:NM_152857.1~uORF:IOH3479	730	721	943	1532	760	1562	921	1174	2098	454	Wilms tumor 1 associated protein (WTAP), transcript variant 2
B41R10C08	41-8-10	Hs~Ref:NM_152857.1~uORF:IOH3479	738	705	914	1541	755	1770	1090	1188	2100	464	Wilms tumor 1 associated protein (WTAP), transcript variant 2
B41R10C09	41-9-10	Hs~Ref:NM_014018.2~uORF:IOH12228	1792	934	1501	955	961	1394	1592	2930	3592	718	mitochondrial ribosomal protein S28 (MRPS28), nuclear gene encoding mitochondrial protein
B41R10C10	41-10-10	Hs~Ref:NM_014018.2~uORF:IOH12228	1782	921	1542	900	1022	1353	1494	2983	3628	710	mitochondrial ribosomal protein S28 (MRPS28), nuclear gene encoding mitochondrial protein
B41R11C21	41-21-11	Hs~Ref:NM_001728.1~uORF:IOH3378	1168	793	1100	686	1443	888	1180	860	1780	426	basigin (Ok blood group) (BSG), transcript variant 1
B41R11C22	41-22-11	Hs~Ref:NM_001728.1~uORF:IOH3378	1409	729	1129	676	1509	871	1189	825	1664	435	basigin (Ok blood group) (BSG), transcript variant 1
B41R12C01	41-1-12	Hs~Ref:NM_014570.2~uORF:IOH5693	2112	1659	2227	1919	3184	2807	2689	2191	3134	4169	ADP-ribosylation factor GTPase activating protein 3 (ARFGAP3)
B41R12C02	41-2-12	Hs~Ref:NM_014570.2~uORF:IOH5693	1955	1487	2358	2179	3220	2686	2790	1853	3206	4229	ADP-ribosylation factor GTPase activating protein 3 (ARFGAP3)
B41R12C03	41-3-12	Hs~MGC:BC034784.1~uORF:IOH22773	1856	1513	1926	9998	1598	2799	5324	1516	3651	704	zinc finger, MYND domain containing 11 (ZMYND11)
B41R12C04	41-4-12	Hs~MGC:BC034784.1~uORF:IOH22773	1858	1525	1893	10374	1580	2730	5286	1251	4264	672	zinc finger, MYND domain containing 11 (ZMYND11)
B41R12C05	41-5-12	Hs~MGC:NM_030645.1~uORF:IOH14805	1839	2253	1998	1504	1192	1906	4310	2045	2636	704	SH3-binding domain protein 5-like (SH3BP5L)
B41R12C06	41-6-12	Hs~MGC:NM_030645.1~uORF:IOH14805	1891	2298	2007	1409	1231	1787	4305	2143	2815	712	SH3-binding domain protein 5-like (SH3BP5L)
B41R12C07	41-7-12	Hs~Ref:NM_000507.2~uORF:IOH2056	604	624	877	584	392	2643	2541	314	843	228	fructose-1,6-bisphosphatase 1 (FBP1)
B41R12C08	41-8-12	Hs~Ref:NM_000507.2~uORF:IOH2056	598	706	880	539	387	2533	2518	302	823	282	fructose-1,6-bisphosphatase 1 (FBP1)
B41R12C09	41-9-12	Hs~Ref:NM_018719.2~uORF:IOH26280	1181	370	752	389	330	1113	550	311	917	186	cell division cycle associated 7-like (CDCA7L)
B41R12C10	41-10-12	Hs~Ref:NM_018719.2~uORF:IOH26280	1151	375	720	386	296	1162	551	377	1017	160	cell division cycle associated 7-like (CDCA7L)
B41R12C11	41-11-12	Hs~Ref:NM_015387.2~uORF:IOH57047	1853	658	1963	446	845	586	2050	740	12681	324	Mps one binder kinase activator-like 3
B41R12C12	41-12-12	Hs~Ref:NM_015387.2~uORF:IOH57047	2028	654	1976	460	907	556	2201	674	12718	943	Mps one binder kinase activator-like 3
B41R12C15	41-15-12	Hs~Ref:NM_000880.2~uORF:IOH26652	1239	1007	1023	728	879	1492	1418	1013	2283	770	interleukin 7 (IL7)
B41R12C16	41-16-12	Hs~Ref:NM_000880.2~uORF:IOH26652	1205	1111	1056	723	943	913	1324	777	2251	689	interleukin 7 (IL7)
B41R12C17	41-17-12	Hs~MGC:BC011786.1~uORF:IOH13185	862	918	1136	771	1060	1152	1214	736	2263	746	insulin-like growth factor 2 (somatomedin A) (IGF2)
B41R12C18	41-18-12	Hs~MGC:BC011786.1~uORF:IOH13185	828	1148	1165	836	974	921	1350	770	2141	697	insulin-like growth factor 2 (somatomedin A) (IGF2)
B41R12C19	41-19-12	Hs~Ref:NM_022787.2~uORF:IOH13215	540	1313	1350	683	612	760	1453	386	936	262	nicotinamide nucleotide adenylyltransferase 1 (NMNAT1)
B41R12C20	41-20-12	Hs~Ref:NM_022787.2~uORF:IOH13215	530	1329	1316	698	609	765	1355	390	1010	134	nicotinamide nucleotide adenylyltransferase 1 (NMNAT1)
B41R12C21	41-21-12	Hs~Ref:NM_016208.1~uORF:IOH5976	468	192	394	142	314	248	170	151	213	14	vacuolar protein sorting 28 homolog (S. cerevisiae) (VPS28), transcript variant 1
B41R12C22	41-22-12	Hs~Ref:NM_016208.1~uORF:IOH5976	443	340	397	137	330	216	195	156	31	4	vacuolar protein sorting 28 homolog (S. cerevisiae) (VPS28), transcript variant 1
B41R13C01	41-1-13	Hs~Ref:NM_002254.5~uORF:IOH42589	1931	1227	2124	873	936	1368	1620	1101	1420	665	kinesin family member 3C (KIF3C)
B41R13C02	41-2-13	Hs~Ref:NM_002254.5~uORF:IOH42589	1648	1195	2107	933	1016	1368	1685	997	1427	580	kinesin family member 3C (KIF3C)
B41R13C03	41-3-13	Hs~MGC:BC012021.1~uORF:IOH10818	1126	895	1004	574	644	1500	1826	1390	2232	520	E3 ubiquitin-protein ligase RNF125
B41R13C04	41-4-13	Hs~MGC:BC012021.1~uORF:IOH10818	1139	860	1049	576	623	1138	1819	1596	2699	507	E3 ubiquitin-protein ligase RNF125
B41R13C05	41-5-13	Hs~Ref:NM_015023.2~uORF:IOH21950	576	684	799	411	328	1083	839	435	917	345	WD and tetratricopeptide repeats 1 (WDTC1)
B41R13C06	41-6-13	Hs~Ref:NM_015023.2~uORF:IOH21950	623	593	785	460	369	1133	753	421	887	356	WD and tetratricopeptide repeats 1 (WDTC1)
B41R13C07	41-7-13	Hs~Ref:NM_031434.2~uORF:IOH3021	841	700	1262	614	656	1144	1036	766	2253	421	transmembrane and ubiquitin-like domain containing 1 (TMUB1)
B41R13C08	41-8-13	Hs~Ref:NM_031434.2~uORF:IOH3021	831	814	1234	633	658	1103	1090	754	2487	405	transmembrane and ubiquitin-like domain containing 1 (TMUB1)
B41R13C09	41-9-13	Hs~MGC:BC014484.1~uORF:IOH13585	609	612	629	341	363	825	750	386	907	282	torsin family 1, member A (torsin A) (TOR1A)
B41R13C10	41-10-13	Hs~MGC:BC014484.1~uORF:IOH13585	613	706	588	343	356	820	767	378	882	286	torsin family 1, member A (torsin A) (TOR1A)
B41R13C11	41-11-13	Hs~MGC:BC015626.2~uORF:IOH13367	1002	840	817	394	959	603	1128	443	794	371	par-6 partitioning defective 6 homolog alpha (C. elegans) (PARD6A)
B41R13C12	41-12-13	Hs~MGC:BC015626.2~uORF:IOH13367	1032	864	846	453	1089	635	1200	431	694	680	par-6 partitioning defective 6 homolog alpha (C. elegans) (PARD6A)
B41R13C13	41-13-13	Hs~MGC:BC015514.1~uORF:IOH11731	15980	12168	6624	13878	7697	4992	17940	5100	8288	11790	tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) (TFPI)
B41R13C14	41-14-13	Hs~MGC:BC015514.1~uORF:IOH11731	14807	12329	6691	13691	6926	5317	17491	5097	8136	10988	tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) (TFPI)
B41R13C15	41-15-13	Hs~Ref:NM_000149.1~uORF:IOH45728	4003	1858	1483	1134	1831	4942	3700	1144	1981	680	Galactoside 3(4)-L-fucosyltransferase
B41R13C16	41-16-13	Hs~Ref:NM_000149.1~uORF:IOH45728	4207	1953	1486	1142	1989	4837	3556	1177	1889	653	Galactoside 3(4)-L-fucosyltransferase
B41R13C17	41-17-13	Hs~MGC:BC000029.2~uORF:IOH4750	591	524	574	406	795	493	750	645	734	196	Phosphatidylinositol 4-kinase beta
B41R13C18	41-18-13	Hs~MGC:BC000029.2~uORF:IOH4750	480	498	640	421	570	536	734	452	783	365	Phosphatidylinositol 4-kinase beta
B41R14C01	41-1-14	Hs~Ref:NM_019110.3~uORF:IOH13427	1836	820	1271	640	812	1239	1051	826	1815	496	Zinc finger protein with KRAB and SCAN domains 4
B41R14C02	41-2-14	Hs~Ref:NM_019110.3~uORF:IOH13427	1598	862	1393	631	818	1258	1126	705	1805	449	Zinc finger protein with KRAB and SCAN domains 4
B41R14C03	41-3-14	Hs~Ref:NM_198331.1~uORF:IOH42150	504	326	501	341	315	668	955	388	671	272	Phosphatidylinositide phosphatase SAC2
B41R14C04	41-4-14	Hs~Ref:NM_198331.1~uORF:IOH42150	489	414	489	347	315	513	857	397	988	309	Phosphatidylinositide phosphatase SAC2
B41R14C05	41-5-14	Hs~Ref:NM_198890.1~uORF:IOH42393	467	404	619	367	503	593	571	434	791	363	Autophagy-related protein 16-1
B41R14C06	41-6-14	Hs~Ref:NM_198890.1~uORF:IOH42393	468	601	610	414	570	600	559	425	785	368	Autophagy-related protein 16-1
B41R14C07	41-7-14	Hs~Ref:NM_013240.2~uORF:IOH41150	826	1109	1792	375	920	882	869	770	1766	278	N(6)-adenine-specific DNA methyltransferase 1
B41R14C08	41-8-14	Hs~Ref:NM_013240.2~uORF:IOH41150	867	1027	1784	378	939	892	999	708	1867	280	N(6)-adenine-specific DNA methyltransferase 1
B41R14C09	41-9-14	Hs~Ref:NM_002893.2~uORF:IOH42163	551	681	632	485	2264	706	1181	479	834	247	Histone-binding protein RBBP7
B41R14C10	41-10-14	Hs~Ref:NM_002893.2~uORF:IOH42163	559	613	619	486	2163	744	1104	488	1042	342	Histone-binding protein RBBP7
B41R14C11	41-11-14	Hs~Ref:NM_002301.2~uORF:IOH10643	552	702	719	478	613	772	1351	616	1100	413	lactate dehydrogenase C (LDHC), transcript variant 1
B41R14C12	41-12-14	Hs~Ref:NM_002301.2~uORF:IOH10643	577	468	673	472	624	787	1263	568	1155	352	lactate dehydrogenase C (LDHC), transcript variant 1
B41R14C13	41-13-14	Hs~Ref:NM_006307.2~uORF:IOH13589	625	751	603	366	458	437	666	417	138	312	sushi-repeat-containing protein, X-linked (SRPX)
B41R14C14	41-14-14	Hs~Ref:NM_006307.2~uORF:IOH13589	618	725	624	366	583	483	656	390	527	152	sushi-repeat-containing protein, X-linked (SRPX)
B41R14C15	41-15-14	Hs~Ref:NM_130398.1~uORF:IOH5832	3530	3650	3682	3231	6510	2211	4208	2728	3800	1722	exonuclease 1 (EXO1), transcript variant 2
B41R14C16	41-16-14	Hs~Ref:NM_130398.1~uORF:IOH5832	3497	3503	3570	3180	6631	2071	3894	2577	3850	1675	exonuclease 1 (EXO1), transcript variant 2
B41R14C17	41-17-14	Hs~MGC:BC034141.1~uORF:IOH23179	40203	38300	31459	42061	42363	43129	36492	32784	53202	45108	immunoglobulin kappa constant (IGKC)
B41R14C18	41-18-14	Hs~MGC:BC034141.1~uORF:IOH23179	39341	37290	31529	41733	42119	43400	33019	33833	53576	46135	immunoglobulin kappa constant (IGKC)
B41R14C19	41-19-14	Hs~Ref:NM_001547.3~uORF:IOH45467	1278	970	1266	837	1252	2658	2670	878	1929	443	interferon-induced protein with tetratricopeptide repeats 2 (IFIT2)
B41R14C20	41-20-14	Hs~Ref:NM_001547.3~uORF:IOH45467	1342	852	1290	841	1068	2575	2646	836	1986	471	interferon-induced protein with tetratricopeptide repeats 2 (IFIT2)
B41R14C21	41-21-14	Hs~Ref:NM_153710.2~uORF:IOH45542	792	729	1023	629	955	736	775	745	1681	370	chromosome 9 open reading frame 96 (C9orf96)
B41R14C22	41-22-14	Hs~Ref:NM_153710.2~uORF:IOH45542	729	733	991	599	915	727	747	691	1411	361	chromosome 9 open reading frame 96 (C9orf96)
B41R15C01	41-1-15	Hs~Ref:NM_007169.2~uORF:IOH45469	867	743	807	558	805	978	1152	708	1215	572	phosphatidylethanolamine N-methyltransferase (PEMT), nuclear gene encoding mitochondrial protein, transcript variant 2
B41R15C02	41-2-15	Hs~Ref:NM_007169.2~uORF:IOH45469	824	694	793	544	852	984	1258	742	1299	582	phosphatidylethanolamine N-methyltransferase (PEMT), nuclear gene encoding mitochondrial protein, transcript variant 2
B41R15C03	41-3-15	Hs~Ref:NM_001001660.1~uORF:IOH45936	653	700	793	527	731	816	1188	661	1131	383	LYR motif containing 5 (LYRM5)
B41R15C04	41-4-15	Hs~Ref:NM_001001660.1~uORF:IOH45936	692	740	887	497	745	802	1177	612	1273	354	LYR motif containing 5 (LYRM5)
B41R15C05	41-5-15	Hs~MGC:BC048125.1~uORF:IOH26780	649	662	713	409	429	764	1135	618	961	350	Uncharacterized protein C15orf33
B41R15C06	41-6-15	Hs~MGC:BC048125.1~uORF:IOH26780	616	847	697	422	419	744	1037	705	961	317	Uncharacterized protein C15orf33
B41R15C07	41-7-15	Hs~Ref:NM_002730.1~uORF:IOH26286	680	936	805	418	529	560	772	962	932	255	protein kinase, cAMP-dependent, catalytic, alpha (PRKACA), transcript variant 1
B41R15C08	41-8-15	Hs~Ref:NM_002730.1~uORF:IOH26286	700	887	790	446	534	587	718	1032	939	223	protein kinase, cAMP-dependent, catalytic, alpha (PRKACA), transcript variant 1
B41R15C09	41-9-15	Hs~MGC:BC051762.1~uORF:IOH28838	1406	1680	1292	1278	1196	1748	1876	1245	2408	1593	Uncharacterized protein C20orf96
B41R15C10	41-10-15	Hs~MGC:BC051762.1~uORF:IOH28838	1421	1680	1343	1268	1211	1758	1960	1218	2387	1656	Uncharacterized protein C20orf96
B41R15C11	41-11-15	Hs~MGC:BC009189.1~uORF:IOH29320	837	866	928	462	637	827	1073	586	1170	463	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 (NDUFA13)
B41R15C12	41-12-15	Hs~MGC:BC009189.1~uORF:IOH29320	816	862	921	474	687	829	1108	587	901	385	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 (NDUFA13)
B41R15C15	41-15-15	Hs~Ref:NM_004438.1~CAT:PV3651	1186	624	478	738	902	1383	656	785	659	316	Ephrin type-A receptor 4
B41R15C16	41-16-15	Hs~Ref:NM_004438.1~CAT:PV3651	1191	574	468	755	954	1386	624	752	689	300	Ephrin type-A receptor 4
B41R15C19	41-19-15	Hs~Ref:NM_000875.2~CAT:PV3250	506	511	557	326	989	519	1632	572	704	1410	insulin-like growth factor 1 receptor (IGF1R)
B41R15C20	41-20-15	Hs~Ref:NM_000875.2~CAT:PV3250	485	511	578	320	534	550	1619	420	667	291	insulin-like growth factor 1 receptor (IGF1R)
B41R16C01	41-1-16	Hs~Ref:NM_004443.2~CAT:PV3658	73	63	292	46	607	276	229	132	193	24	Ephrin type-B receptor 3
B41R16C02	41-2-16	Hs~Ref:NM_004443.2~CAT:PV3658	470	622	282	142	45	318	242	166	89	16	Ephrin type-B receptor 3
B41R16C03	41-3-16	Hs~Ref:NM_006252.2~CAT:PV4674	252	124	1488	201	262	4424	481	222	4	131	AMP-activated protein_kinase A2/B1/G1: PRKAA2/B1/G1 sequences are seperated by -- (in protein list file).
B41R16C04	41-4-16	Hs~Ref:NM_006252.2~CAT:PV4674	253	144	1526	211	249	4301	520	224	692	150	AMP-activated protein_kinase A2/B1/G1: PRKAA2/B1/G1 sequences are seperated by -- (in protein list file).
B41R16C07	41-7-16	Hs~MGC:BC015244.1~uORF:IOH21465	1215	1317	1721	770	2567	2926	2129	2066	2961	554	MAD2 mitotic arrest deficient-like 2 (yeast) (MAD2L2)
B41R16C08	41-8-16	Hs~MGC:BC015244.1~uORF:IOH21465	1243	1290	1791	796	2737	2890	2156	1690	3101	537	MAD2 mitotic arrest deficient-like 2 (yeast) (MAD2L2)
B41R16C09	41-9-16	Hs~Ref:NM_025160.1~uORF:IOH21455	1115	1089	1602	844	1609	2350	1992	1278	2704	579	WD repeat-containing protein 26
B41R16C10	41-10-16	Hs~Ref:NM_025160.1~uORF:IOH21455	1102	1069	1594	818	1639	2354	2073	1254	2696	659	WD repeat-containing protein 26
B41R16C11	41-11-16	Hs~MGC:BC024223.2~uORF:IOH14706	1005	736	928	500	1187	1893	2653	3246	1099	413	thioredoxin domain containing 9 (TXNDC9)
B41R16C12	41-12-16	Hs~MGC:BC024223.2~uORF:IOH14706	1013	716	949	530	1162	1842	2693	3282	1108	363	thioredoxin domain containing 9 (TXNDC9)
B41R16C13	41-13-16	Hs~MGC:BC060767.1~uORF:IOH29188	2689	1332	4745	1274	1901	3020	2571	3430	3361	863	centaurin, beta 2 (CENTB2)
B41R16C14	41-14-16	Hs~MGC:BC060767.1~uORF:IOH29188	2767	1199	4370	1283	1856	3027	2534	3348	3462	780	centaurin, beta 2 (CENTB2)
B41R16C15	41-15-16	Hs~Ref:NM_004666.1~uORF:IOH37862	540	342	601	372	471	635	1106	480	1267	103	vanin 1 (VNN1)
B41R16C16	41-16-16	Hs~Ref:NM_004666.1~uORF:IOH37862	513	328	572	381	509	654	1117	500	1060	228	vanin 1 (VNN1)
B41R17C01	41-1-17	Hs~MGC:BC012445.1~uORF:IOH10448	496	641	661	1996	609	724	860	706	999	424	TraB domain containing (TRABD)
B41R17C02	41-2-17	Hs~MGC:BC012445.1~uORF:IOH10448	859	658	657	450	665	705	818	563	945	519	TraB domain containing (TRABD)
B41R17C03	41-3-17	Hs~MGC:BC050535.1~uORF:IOH26965	736	891	706	531	924	844	1039	447	1009	541	muscleblind-like (Drosophila) (MBNL1)
B41R17C04	41-4-17	Hs~MGC:BC050535.1~uORF:IOH26965	648	802	724	507	610	796	1024	499	1103	390	muscleblind-like (Drosophila) (MBNL1)
B41R17C05	41-5-17	Hs~MGC:BC031062.1~uORF:IOH27218	735	1503	1122	840	739	783	1474	578	906	280	DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 (DDX20)
B41R17C06	41-6-17	Hs~MGC:BC031062.1~uORF:IOH27218	748	1579	1106	827	731	765	1383	594	956	305	DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 (DDX20)
B41R17C07	41-7-17	Hs~MGC:BC035021.1~uORF:IOH27103	5000	4831	4485	8202	1409	4296	2520	3464	4071	5893	membrane-associated ring finger (C3HC4) 10 (RNF190)
B41R17C08	41-8-17	Hs~MGC:BC035021.1~uORF:IOH27103	5519	5475	4580	8357	1443	4186	2501	3571	4187	6075	membrane-associated ring finger (C3HC4) 10 (RNF190)
B41R17C09	41-9-17	Hs~MGC:BC042970.1~uORF:IOH25849	1042	1014	1263	726	934	1065	1529	864	2317	661	coactosin-like 1 (Dictyostelium) (COTL1)
B41R17C10	41-10-17	Hs~MGC:BC042970.1~uORF:IOH25849	1044	963	1236	706	949	1072	1681	856	2220	728	coactosin-like 1 (Dictyostelium) (COTL1)
B41R17C11	41-11-17	Hs~MGC:BC032645.1~uORF:IOH21959	1411	1852	1468	1867	1187	1499	1862	1836	2293	559	chromosome 10 open reading frame 88 (C10orf88)
B41R17C12	41-12-17	Hs~MGC:BC032645.1~uORF:IOH21959	1518	1944	1449	1943	1159	1389	1724	1824	2391	517	chromosome 10 open reading frame 88 (C10orf88)
B41R17C13	41-13-17	Hs~Ref:NM_014864.2~uORF:IOH27350	869	995	972	642	1138	881	1186	787	1879	444	family with sequence similarity 20, member B (FAM20B)
B41R17C14	41-14-17	Hs~Ref:NM_014864.2~uORF:IOH27350	928	971	999	692	1100	896	1137	793	1722	595	family with sequence similarity 20, member B (FAM20B)
B41R17C15	41-15-17	Hs~MGC:BC034692.1~uORF:IOH22176	3315	1871	1840	1538	2060	8964	2577	2496	4950	900	anillin, actin binding protein (ANLN)
B41R17C16	41-16-17	Hs~MGC:BC034692.1~uORF:IOH22176	3564	1993	1863	1473	2139	8858	2693	2445	4948	851	anillin, actin binding protein (ANLN)
B41R17C17	41-17-17	Hs~MGC:BC008054.1~uORF:IOH7016	387	174	387	305	437	459	682	433	669	122	Transmembrane protein 43
B41R17C18	41-18-17	Hs~MGC:BC008054.1~uORF:IOH7016	370	9	442	296	510	496	672	409	760	215	Transmembrane protein 43
B41R17C19	41-19-17	Hs~Ref:NM_032499.1~uORF:IOH6336	510	70	621	418	521	700	661	422	869	496	chromosome 15 open reading frame 41 (C15orf41)
B41R17C20	41-20-17	Hs~Ref:NM_032499.1~uORF:IOH6336	464	678	627	427	600	658	650	479	676	271	chromosome 15 open reading frame 41 (C15orf41)
B41R18C01	41-1-18	Hs~MGC:BC008365.1~uORF:IOH5958	579	744	751	1267	364	567	491	548	551	277	Transmembrane protein 205
B41R18C02	41-2-18	Hs~MGC:BC008365.1~uORF:IOH5958	1015	702	763	391	390	590	464	481	577	351	Transmembrane protein 205
B41R18C03	41-3-18	Hs~Ref:NM_003215.1~N/A	1595	1524	2214	8283	2309	1198	1907	984	2775	927	tec protein tyrosine kinase (TEC)
B41R18C04	41-4-18	Hs~Ref:NM_003215.1~N/A	1537	1516	2283	8855	2836	1138	2044	1054	3316	833	tec protein tyrosine kinase (TEC)
B41R18C05	41-5-18	Hs~MGC:BC002466.1~N/A	857	1350	4001	833	1288	1335	2091	1125	3199	1300	A-Raf proto-oncogene serine/threonine-protein kinase
B41R18C06	41-6-18	Hs~MGC:BC002466.1~N/A	2306	1295	4034	814	1304	1356	1914	1078	3501	1283	A-Raf proto-oncogene serine/threonine-protein kinase
B41R18C07	41-7-18	Hs~MGC:BC011668.1~N/A	3556	1535	3646	1165	1127	2133	11823	1464	6605	1393	Casein kinase II subunit alpha
B41R18C08	41-8-18	Hs~MGC:BC011668.1~N/A	3669	1543	3620	1174	1107	2061	12639	1390	6799	1354	Casein kinase II subunit alpha
B41R18C09	41-9-18	Hs~MGC:BC001968.1~N/A	1025	1146	1505	629	781	1099	1593	1310	2983	654	Cell division protein kinase 9
B41R18C10	41-10-18	Hs~MGC:BC001968.1~N/A	948	1081	1473	628	817	1124	1646	855	3113	542	Cell division protein kinase 9
B41R18C11	41-11-18	Hs~MGC:BC036096.2~uORF:IOH27280	1588	1098	1128	582	607	1147	5312	677	1521	371	zinc finger protein 18 (ZNF18)
B41R18C12	41-12-18	Hs~MGC:BC036096.2~uORF:IOH27280	1740	1035	1142	599	641	1013	4781	714	1537	335	zinc finger protein 18 (ZNF18)
B41R18C13	41-13-18	Hs~Ref:NM_002659.1~uORF:IOH5327	563	591	608	372	700	582	819	427	985	158	plasminogen activator, urokinase receptor (PLAUR), transcript variant 1
B41R18C14	41-14-18	Hs~Ref:NM_002659.1~uORF:IOH5327	602	448	608	358	592	641	801	422	1143	354	plasminogen activator, urokinase receptor (PLAUR), transcript variant 1
B41R18C15	41-15-18	Hs~MGC:BC063648.1~uORF:IOH39845	678	711	675	385	810	566	864	469	1033	546	Keratin, type II cytoskeletal 79
B41R18C16	41-16-18	Hs~MGC:BC063648.1~uORF:IOH39845	679	508	726	359	867	574	805	492	991	408	Keratin, type II cytoskeletal 79
B41R18C17	41-17-18	Hs~MGC:BC067819.1~uORF:IOH40128	1096	976	1135	688	2409	1831	1665	654	1520	268	transmembrane protein 29 (TMEM29)
B41R18C18	41-18-18	Hs~MGC:BC067819.1~uORF:IOH40128	1168	1475	1171	678	2613	1833	1750	721	1511	271	transmembrane protein 29 (TMEM29)
B41R18C21	41-21-18	Hs~Ref:NM_199183.1~uORF:IOH60515	9201	9256	6985	2221	13892	1205	1390	689	2394	1584	Putative testis serine protease 5
B41R18C22	41-22-18	Hs~Ref:NM_199183.1~uORF:IOH60515	9152	8866	7325	2247	15340	1187	1371	737	2009	2170	Putative testis serine protease 5
B41R19C01	41-1-19	Hs~MGC:BC092518.1~uORF:IOH62695	54909	42771	43670	57325	55750	42944	30029	38076	48217	47499	Ig gamma-1 chain C region
B41R19C02	41-2-19	Hs~MGC:BC092518.1~uORF:IOH62695	56401	45410	44260	59222	58129	40943	30609	40880	48203	50163	Ig gamma-1 chain C region
B41R19C03	41-3-19	Hs~Ref:NM_213593.3~uORF:IOH60449	739	424	658	241	595	442	1081	543	499	306	Type I iodothyronine deiodinase
B41R19C04	41-4-19	Hs~Ref:NM_213593.3~uORF:IOH60449	590	638	694	242	497	362	1077	509	668	3	Type I iodothyronine deiodinase
B41R19C05	41-5-19	Hs~MGC:BC035079.2~uORF:IOH27679	1194	1224	1264	758	1668	1091	1706	810	2306	681	zinc finger, ZZ-type containing 3 (ZZZ3)
B41R19C06	41-6-19	Hs~MGC:BC035079.2~uORF:IOH27679	1217	1332	1202	793	1459	1109	1463	796	2261	669	zinc finger, ZZ-type containing 3 (ZZZ3)
B41R19C07	41-7-19	Hs~MGC:NM_181703.1~uORF:IOH13936	1567	1991	1911	906	1901	1498	1510	1090	2948	776	gap junction protein, alpha 5, 40kDa (GJA5), transcript variant B
B41R19C08	41-8-19	Hs~MGC:NM_181703.1~uORF:IOH13936	1614	2492	1899	974	1958	1430	1523	993	3102	840	gap junction protein, alpha 5, 40kDa (GJA5), transcript variant B
B41R19C09	41-9-19	Hs~Ref:NM_152460.2~uORF:IOH35340	2001	2358	2045	752	1160	1172	1373	1000	2331	857	chromosome 17 open reading frame 77 (C17orf77)
B41R19C10	41-10-19	Hs~Ref:NM_152460.2~uORF:IOH35340	2089	2130	2042	751	1194	1210	1326	967	1983	753	chromosome 17 open reading frame 77 (C17orf77)
B41R19C11	41-11-19	Hs~Ref:NM_178497.2~uORF:IOH44607	2774	2604	2501	1231	1345	1218	1394	1148	2330	972	Uncharacterized protein C4orf26
B41R19C12	41-12-19	Hs~Ref:NM_178497.2~uORF:IOH44607	2860	2657	2507	1292	1356	1180	1422	957	2247	993	Uncharacterized protein C4orf26
B41R19C13	41-13-19	Hs~MGC:BC020713.1~uORF:IOH12329	1	4	7	313	1034	1011	1277	951	2700	688	serpin peptidase inhibitor, clade B (ovalbumin), member 5 (SERPINB5)
B41R19C14	41-14-19	Hs~MGC:BC020713.1~uORF:IOH12329	0	4	4	333	848	969	1403	967	2639	595	serpin peptidase inhibitor, clade B (ovalbumin), member 5 (SERPINB5)
B41R19C15	41-15-19	Hs~Ref:NM_203417.1~uORF:IOH45858	1406	1324	1306	1121	1184	1206	2072	3144	3082	1143	regulator of calcineurin 1 (RCAN1), transcript variant 2
B41R19C16	41-16-19	Hs~Ref:NM_203417.1~uORF:IOH45858	1458	1274	1363	1083	1249	1265	2108	3135	3053	1004	regulator of calcineurin 1 (RCAN1), transcript variant 2
B41R19C17	41-17-19	Hs~Ref:NM_212540.1~uORF:IOH45879	1093	944	1022	580	809	933	1209	770	2518	537	Transcription factor E2F6
B41R19C18	41-18-19	Hs~Ref:NM_212540.1~uORF:IOH45879	1079	973	1038	529	869	896	1267	802	2533	598	Transcription factor E2F6
B41R19C19	41-19-19	Hs~MGC:BC011857.2~uORF:IOH46160	1135	1376	1027	944	1416	1374	1356	1196	2651	1276	immunoglobulin heavy constant mu (IGHM)
B41R19C20	41-20-19	Hs~MGC:BC011857.2~uORF:IOH46160	1109	1320	1021	905	1595	1317	1371	1117	2636	1223	immunoglobulin heavy constant mu (IGHM)
B41R19C21	41-21-19	Hs~MGC:BC066942.1~uORF:IOH40062	738	600	551	477	1196	614	845	597	841	276	PR domain containing 5 (PRDM5)
B41R19C22	41-22-19	Hs~MGC:BC066942.1~uORF:IOH40062	731	418	499	462	975	593	820	709	880	342	PR domain containing 5 (PRDM5)
B41R20C05	41-5-20	Hs~Ref:NM_148571.1~uORF:IOH41376	642	888	614	404	808	1057	753	454	1099	334	mitochondrial ribosomal protein L27 (MRPL27), nuclear gene encoding mitochondrial protein, transcript variant 2
B41R20C06	41-6-20	Hs~Ref:NM_148571.1~uORF:IOH41376	586	939	600	442	819	1014	667	431	1083	348	mitochondrial ribosomal protein L27 (MRPL27), nuclear gene encoding mitochondrial protein, transcript variant 2
B41R20C07	41-7-20	Hs~Ref:NM_144595.1~uORF:IOH25832	1195	1443	1082	1024	1206	10	21	2	2753	876	SLAIN motif family, member 1 (SLAIN1), transcript variant 2
B41R20C08	41-8-20	Hs~Ref:NM_144595.1~uORF:IOH25832	1196	1545	1054	1066	1106	7	16	-1	2975	854	SLAIN motif family, member 1 (SLAIN1), transcript variant 2
B41R20C09	41-9-20	Hs~Ref:NM_005558.2~uORF:IOH13864	4054	2806	1058	2021	1138	1244	18653	1043	1678	328	ladinin 1 (LAD1)
B41R20C10	41-10-20	Hs~Ref:NM_005558.2~uORF:IOH13864	4272	3053	1062	2110	1159	1267	18787	1154	1812	364	ladinin 1 (LAD1)
B41R20C11	41-11-20	Hs~Ref:NM_024076.1~uORF:IOH4559	1355	1069	1085	561	1117	950	1265	3146	2067	446	potassium channel tetramerisation domain containing 15 (KCTD15)
B41R20C12	41-12-20	Hs~Ref:NM_024076.1~uORF:IOH4559	1309	1015	1157	525	1050	954	1094	2645	2091	439	potassium channel tetramerisation domain containing 15 (KCTD15)
B41R20C13	41-13-20	Hs~MGC:BC000103.1~uORF:IOH4659	5527	1676	3087	1451	2475	3290	2926	3130	6137	1492	NCK adaptor protein 2 (NCK2)
B41R20C14	41-14-20	Hs~MGC:BC000103.1~uORF:IOH4659	5754	1612	3070	1496	2499	3084	2877	3087	6008	1515	NCK adaptor protein 2 (NCK2)
B42R02C11	42-11-2	Hs~Ref:NM_006401.1~uORF:IOH3664	1752	9543	3393	1427	7613	907	1653	754	3139	284	acidic (leucine-rich) nuclear phosphoprotein 32 family, member B (ANP32B)
B42R02C12	42-12-2	Hs~Ref:NM_006401.1~uORF:IOH3664	1655	9768	3409	2167	7494	906	1664	4523	3344	1423	acidic (leucine-rich) nuclear phosphoprotein 32 family, member B (ANP32B)
B42R02C13	42-13-2	Hs~MGC:BC009055.1~uORF:IOH3376	746	9711	4097	9968	9574	4225	5286	8830	1558	1297	Protein FAM184A
B42R02C14	42-14-2	Hs~MGC:BC009055.1~uORF:IOH3376	844	9683	3948	9933	9113	4324	5138	8430	7814	195	Protein FAM184A
B42R02C15	42-15-2	Hs~MGC:BC000553.1~uORF:IOH4163	1645	1789	3321	54428	1637	835	1438	1813	3232	447	phospholipase D family, member 3 (PLD3)
B42R02C16	42-16-2	Hs~MGC:BC000553.1~uORF:IOH4163	1664	1671	3354	47128	1655	825	1433	1641	3004	361	phospholipase D family, member 3 (PLD3)
B42R02C17	42-17-2	Hs~Ref:NM_005390.1~uORF:IOH22280	2816	2445	2611	530	555	420	625	459	496	395	pyruvate dehydrogenase (lipoamide) alpha 2 (PDHA2)
B42R02C18	42-18-2	Hs~Ref:NM_005390.1~uORF:IOH22280	2814	2297	3307	443	632	454	611	450	648	318	pyruvate dehydrogenase (lipoamide) alpha 2 (PDHA2)
B42R02C19	42-19-2	Hs~Ref:NM_001016.2~uORF:IOH14179	925	848	1530	545	766	655	1221	784	827	369	ribosomal protein S12 (RPS12)
B42R02C20	42-20-2	Hs~Ref:NM_001016.2~uORF:IOH14179	972	891	1455	573	762	664	1150	795	948	361	ribosomal protein S12 (RPS12)
B42R02C21	42-21-2	Hs~MGC:BC016365.1~uORF:IOH27881	1853	1524	3321	1282	2807	1625	2037	1848	2139	613	transmembrane emp24 protein transport domain containing 5 (TMED5)
B42R02C22	42-22-2	Hs~MGC:BC016365.1~uORF:IOH27881	1497	1483	3263	1275	2858	1600	2071	1795	2636	595	transmembrane emp24 protein transport domain containing 5 (TMED5)
B42R03C01	42-1-3	Hs~Ref:NM_017856.1~uORF:IOH3877	1514	1243	2406	907	2644	1631	1922	2039	3242	579	gem (nuclear organelle) associated protein 8 (GEMIN8), transcript variant 3
B42R03C02	42-2-3	Hs~Ref:NM_017856.1~uORF:IOH3877	1545	1302	1950	895	2071	1440	1779	2037	3231	515	gem (nuclear organelle) associated protein 8 (GEMIN8), transcript variant 3
B42R03C03	42-3-3	Hs~MGC:BC000896.1~uORF:IOH3226	1481	4753	2711	1015	3829	996	2345	1027	2254	435	RAB10, member RAS oncogene family (RAB10)
B42R03C04	42-4-3	Hs~MGC:BC000896.1~uORF:IOH3226	1478	4857	2418	975	3357	982	2399	1104	2509	448	RAB10, member RAS oncogene family (RAB10)
B42R03C05	42-5-3	Hs~Ref:NM_016830.2~uORF:IOH43739	430	713	754	873	1171	1144	542	1070	1348	216	vesicle-associated membrane protein 1 (synaptobrevin 1) (VAMP1), transcript variant 3
B42R03C06	42-6-3	Hs~Ref:NM_016830.2~uORF:IOH43739	415	711	711	838	1276	1143	534	963	1229	252	vesicle-associated membrane protein 1 (synaptobrevin 1) (VAMP1), transcript variant 3
B42R03C07	42-7-3	Hs~Ref:NM_033484.1~uORF:IOH42196	2360	864	1105	295	3191	722	732	305	547	261	F-box protein 4 (FBXO4), transcript variant 2
B42R03C08	42-8-3	Hs~Ref:NM_033484.1~uORF:IOH42196	2461	972	1213	301	4211	758	669	340	624	250	F-box protein 4 (FBXO4), transcript variant 2
B42R03C09	42-9-3	Hs~MGC:NM_201280.1~uORF:IOH43536	2937	1185	1255	1083	12601	872	1562	9965	6880	1796	muted homolog (mouse) (MUTED)
B42R03C10	42-10-3	Hs~MGC:NM_201280.1~uORF:IOH43536	2653	1240	1289	1036	12553	913	1634	9726	6735	1622	muted homolog (mouse) (MUTED)
B42R03C11	42-11-3	Hs~Ref:NM_032141.1~uORF:IOH43707	23717	16474	10352	22798	21075	27628	39947	19511	13854	8059	coiled-coil domain containing 55 (CCDC55), transcript variant 1
B42R03C12	42-12-3	Hs~Ref:NM_032141.1~uORF:IOH43707	23518	15327	9858	21689	21838	29293	39286	15512	13337	7961	coiled-coil domain containing 55 (CCDC55), transcript variant 1
B42R03C13	42-13-3	Hs~Ref:NM_033259.1~uORF:IOH42049	2250	4621	10315	9452	5158	1482	2005	1954	2600	252	calcium/calmodulin-dependent protein kinase II inhibitor 2 (CAMK2N2)
B42R03C14	42-14-3	Hs~Ref:NM_033259.1~uORF:IOH42049	2047	4741	10194	6079	4922	1501	2029	1725	2723	336	calcium/calmodulin-dependent protein kinase II inhibitor 2 (CAMK2N2)
B42R03C15	42-15-3	Hs~Ref:NM_198501.1~uORF:IOH43320	5997	13605	15911	65461	7222	6524	11621	6249	10428	2347	Smoothelin-like protein 2
B42R03C16	42-16-3	Hs~Ref:NM_198501.1~uORF:IOH43320	6209	12953	15165	65481	6207	6210	10770	5899	10323	2176	Smoothelin-like protein 2
B42R03C19	42-19-3	Hs~Ref:NM_005089.1~uORF:IOH43714	436	694	750	630	697	836	276	295	776	174	zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2 (ZRSR2)
B42R03C20	42-20-3	Hs~Ref:NM_005089.1~uORF:IOH43714	411	662	750	611	817	860	267	315	800	90	zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2 (ZRSR2)
B42R03C21	42-21-3	Hs~Ref:NM_005506.1~uORF:IOH9776	664	609	1021	527	515	640	819	613	699	356	scavenger receptor class B, member 2 (SCARB2)
B42R03C22	42-22-3	Hs~Ref:NM_005506.1~uORF:IOH9776	652	609	1019	490	496	586	782	635	880	321	scavenger receptor class B, member 2 (SCARB2)
B42R04C01	42-1-4	Hs~Ref:NM_052852.1~uORF:IOH5816	1012	669	961	826	697	1066	2816	830	1132	334	zinc finger protein 486 (ZNF486)
B42R04C02	42-2-4	Hs~Ref:NM_052852.1~uORF:IOH5816	1023	689	1135	995	610	1150	2733	761	1394	570	zinc finger protein 486 (ZNF486)
B42R04C03	42-3-4	Hs~MGC:BC009464.1~uORF:IOH13699	739	827	996	900	573	709	1014	919	1149	452	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B
B42R04C04	42-4-4	Hs~MGC:BC009464.1~uORF:IOH13699	753	716	1036	938	864	732	926	906	1255	577	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B
B42R04C05	42-5-4	Hs~MGC:BC007523.1~uORF:IOH6889	1391	503	790	2207	493	798	775	922	1607	291	neuron navigator 1 (NAV1)
B42R04C06	42-6-4	Hs~MGC:BC007523.1~uORF:IOH6889	1457	519	801	2094	531	850	794	932	1548	267	neuron navigator 1 (NAV1)
B42R04C07	42-7-4	Hs~MGC:BC029378.1~uORF:IOH23186	5139	2510	3550	2673	2262	4468	15036	1579	5090	2345	telomeric repeat binding factor (NIMA-interacting) 1 (TERF1)
B42R04C08	42-8-4	Hs~MGC:BC029378.1~uORF:IOH23186	5359	2602	3579	2755	2269	4288	14668	1575	5040	2297	telomeric repeat binding factor (NIMA-interacting) 1 (TERF1)
B42R04C09	42-9-4	Hs~MGC:BC032708.1~uORF:IOH21938	754	1149	694	834	1086	1066	1180	1018	1285	1022	transducin (beta)-like 1X-linked (TBL1X)
B42R04C10	42-10-4	Hs~MGC:BC032708.1~uORF:IOH21938	808	1224	722	838	971	1025	1078	980	1296	956	transducin (beta)-like 1X-linked (TBL1X)
B42R04C11	42-11-4	Hs~Ref:NM_003617.2~uORF:IOH23200	2656	3860	1802	2178	3327	3263	6610	2212	4363	2153	regulator of G-protein signaling 5 (RGS5)
B42R04C12	42-12-4	Hs~Ref:NM_003617.2~uORF:IOH23200	2959	3986	1806	1965	3197	3500	6515	2293	4025	2054	regulator of G-protein signaling 5 (RGS5)
B42R04C13	42-13-4	Hs~MGC:BC014475.1~uORF:IOH12830	558	455	917	496	5432	1149	824	1519	2305	628	baculoviral IAP repeat-containing 7 (livin) (BIRC7)
B42R04C14	42-14-4	Hs~MGC:BC014475.1~uORF:IOH12830	459	439	921	496	4459	1177	881	1035	2275	510	baculoviral IAP repeat-containing 7 (livin) (BIRC7)
B42R04C15	42-15-4	Hs~Ref:NM_006817.2~uORF:IOH41199	751	330	598	769	382	384	594	425	658	165	endoplasmic reticulum protein 29 (ERP29), transcript variant 1
B42R04C16	42-16-4	Hs~Ref:NM_006817.2~uORF:IOH41199	800	316	561	706	297	371	606	433	680	62	endoplasmic reticulum protein 29 (ERP29), transcript variant 1
B42R04C17	42-17-4	Hs~Ref:NM_022575.2~uORF:IOH41705	5225	866	2710	760	636	1620	1748	835	1632	268	vacuolar protein sorting 16 homolog (S. cerevisiae) (VPS16), transcript variant 1
B42R04C18	42-18-4	Hs~Ref:NM_022575.2~uORF:IOH41705	5251	870	2459	828	920	1522	1676	833	1569	27	vacuolar protein sorting 16 homolog (S. cerevisiae) (VPS16), transcript variant 1
B42R04C19	42-19-4	Hs~Ref:NM_181690.1~uORF:IOH43070	7152	976	2084	1804	571	5897	3019	2094	1278	93	v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (AKT3), transcript variant 2
B42R04C20	42-20-4	Hs~Ref:NM_181690.1~uORF:IOH43070	6969	991	1546	1709	387	5246	2931	1928	1059	383	v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (AKT3), transcript variant 2
B42R04C21	42-21-4	Hs~Ref:NM_005794.2~uORF:IOH41302	2350	1501	2249	609	706	617	1244	688	911	626	dehydrogenase/reductase (SDR family) member 2 (DHRS2), transcript variant 2
B42R04C22	42-22-4	Hs~Ref:NM_005794.2~uORF:IOH41302	2362	1427	2412	567	671	404	1292	650	959	591	dehydrogenase/reductase (SDR family) member 2 (DHRS2), transcript variant 2
B42R05C01	42-1-5	Hs~Ref:NM_152418.2~uORF:IOH43407	775	355	541	354	367	357	481	720	749	139	WD repeat domain 21C (WDR21C)
B42R05C02	42-2-5	Hs~Ref:NM_152418.2~uORF:IOH43407	551	385	688	395	99	863	478	727	675	213	WD repeat domain 21C (WDR21C)
B42R05C03	42-3-5	Hs~Ref:NM_022333.1~uORF:IOH43130	1064	1312	808	505	564	586	1638	540	804	251	TIA1 cytotoxic granule-associated RNA binding protein-like 1 (TIAL1), transcript variant 2
B42R05C04	42-4-5	Hs~Ref:NM_022333.1~uORF:IOH43130	1086	1143	849	510	721	565	1709	549	821	229	TIA1 cytotoxic granule-associated RNA binding protein-like 1 (TIAL1), transcript variant 2
B42R05C05	42-5-5	Hs~Ref:NM_173700.1~uORF:IOH43271	1537	2041	855	750	528	807	1783	1107	1860	268	BCoR-like protein 2
B42R05C06	42-6-5	Hs~Ref:NM_173700.1~uORF:IOH43271	1549	2019	828	693	472	569	1870	1117	1849	317	BCoR-like protein 2
B42R05C09	42-9-5	Hs~MGC:BC068078.1~uORF:IOH40781	1835	4048	1517	1148	963	1383	3685	1621	1762	2265	nucleophosmin/nucleoplasmin, 2 (NPM2)
B42R05C10	42-10-5	Hs~MGC:BC068078.1~uORF:IOH40781	1792	3958	1600	1165	972	1315	3456	1695	1788	2358	nucleophosmin/nucleoplasmin, 2 (NPM2)
B42R05C11	42-11-5	Hs~MGC:BC012885.1~uORF:IOH10554	11295	6572	6951	1346	667	569	913	486	640	219	Plexin domain-containing protein 2
B42R05C12	42-12-5	Hs~MGC:BC012885.1~uORF:IOH10554	10820	6901	7166	1441	613	669	1037	554	803	192	Plexin domain-containing protein 2
B42R05C13	42-13-5	Hs~MGC:BC064612.1~uORF:IOH39905	26378	26646	23263	56600	3112	23960	11037	65437	6974	4609	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 (MLLT6)
B42R05C14	42-14-5	Hs~MGC:BC064612.1~uORF:IOH39905	25572	25488	22049	56265	3200	23051	12130	65478	6621	4426	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 (MLLT6)
B42R05C15	42-15-5	Hs~Ref:NM_145261.2~uORF:IOH9879	561	442	664	376	320	534	1011	507	478	222	DnaJ (Hsp40) homolog, subfamily C, member 19 (DNAJC19)
B42R05C16	42-16-5	Hs~Ref:NM_145261.2~uORF:IOH9879	470	365	600	365	384	469	1059	436	543	99	DnaJ (Hsp40) homolog, subfamily C, member 19 (DNAJC19)
B42R05C17	42-17-5	Hs~Ref:NM_016370.1~uORF:IOH42108	662	369	500	733	651	973	470	1206	6151	915	Ras-related protein Rab-9B
B42R05C18	42-18-5	Hs~Ref:NM_016370.1~uORF:IOH42108	659	371	418	719	614	901	220	1133	5787	151	Ras-related protein Rab-9B
B42R05C19	42-19-5	Hs~Ref:NM_020197.1~uORF:IOH42115	1538	2065	-1100	5075	4422	2777	1874	2045	710	571	SET and MYND domain-containing protein 2
B42R05C20	42-20-5	Hs~Ref:NM_020197.1~uORF:IOH42115	1421	1918	163	4652	4289	2534	2058	1777	304	614	SET and MYND domain-containing protein 2
B42R05C21	42-21-5	Hs~Ref:NM_001012337.1~uORF:IOH42173	125	196	1073	556	503	17529	637	630	996	276	Ropporin-1B
B42R05C22	42-22-5	Hs~Ref:NM_001012337.1~uORF:IOH42173	346	277	1244	537	482	16460	692	667	1125	119	Ropporin-1B
B42R06C01	42-1-6	Hs~Ref:NM_018201.2~uORF:IOH41097	909	363	818	417	1527	959	1137	1034	1182	166	TBC1 domain family member 13
B42R06C02	42-2-6	Hs~Ref:NM_018201.2~uORF:IOH41097	930	399	821	842	1450	1024	1227	991	1159	101	TBC1 domain family member 13
B42R06C03	42-3-6	Hs~MGC:BC009077.1~uORF:IOH9817	719	679	787	1060	628	759	1035	637	2326	371	APAF1 interacting protein (APIP)
B42R06C04	42-4-6	Hs~MGC:BC009077.1~uORF:IOH9817	705	750	857	1744	1201	682	1064	613	2403	268	APAF1 interacting protein (APIP)
B42R06C05	42-5-6	Hs~Ref:NM_016422.2~uORF:IOH11058	596	1542	2286	1556	932	13761	953	587	2219	303	ring finger protein 141 (RNF141)
B42R06C06	42-6-6	Hs~Ref:NM_016422.2~uORF:IOH11058	618	1629	2161	1483	780	14118	939	580	2088	322	ring finger protein 141 (RNF141)
B42R06C07	42-7-6	Hs~MGC:BC000557.1~uORF:IOH4154	701	507	651	438	664	1688	922	541	1692	597	phosphatidylethanolamine N-methyltransferase (PEMT)
B42R06C08	42-8-6	Hs~MGC:BC000557.1~uORF:IOH4154	671	493	695	411	799	979	1003	487	1568	369	phosphatidylethanolamine N-methyltransferase (PEMT)
B42R06C09	42-9-6	Hs~MGC:BC011916.1~uORF:IOH12850	816	398	1087	685	1188	898	879	978	1565	371	chromosome 10 open reading frame 65 (C10orf65)
B42R06C10	42-10-6	Hs~MGC:BC011916.1~uORF:IOH12850	833	397	1007	726	1339	878	824	958	1609	262	chromosome 10 open reading frame 65 (C10orf65)
B42R06C11	42-11-6	Hs~MGC:BC000412.1~uORF:IOH3631	3056	1239	1993	1066	3276	2737	6666	1266	3123	699	coiled-coil domain containing 106 (CCDC106)
B42R06C12	42-12-6	Hs~MGC:BC000412.1~uORF:IOH3631	2817	1265	1767	1416	3330	2713	6122	1434	3344	756	coiled-coil domain containing 106 (CCDC106)
B42R06C13	42-13-6	Hs~MGC:BC001606.1~uORF:IOH4901	2940	936	1560	6054	4075	1479	2006	982	1859	2949	neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2) (NCF2)
B42R06C14	42-14-6	Hs~MGC:BC001606.1~uORF:IOH4901	2982	960	1550	5473	2997	1392	2034	906	1732	2693	neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2) (NCF2)
B42R06C15	42-15-6	Hs~MGC:BC006306.1~uORF:IOH6404	697	733	790	587	791	801	1012	934	1970	481	Conserved oligomeric Golgi complex subunit 4
B42R06C16	42-16-6	Hs~MGC:BC006306.1~uORF:IOH6404	697	694	756	578	819	834	1066	863	1840	469	Conserved oligomeric Golgi complex subunit 4
B42R06C17	42-17-6	Hs~MGC:BC007750.2~uORF:IOH6405	812	558	960	805	831	730	1645	936	1975	113	Tripartite motif-containing protein 55
B42R06C18	42-18-6	Hs~MGC:BC007750.2~uORF:IOH6405	868	592	1008	846	519	750	1738	593	1996	357	Tripartite motif-containing protein 55
B42R06C19	42-19-6	Hs~Ref:NM_025241.1~uORF:IOH41143	6399	1486	65284	1177	2155	2727	1508	2517	1838	285	UBX domain containing 1 (UBXD1)
B42R06C20	42-20-6	Hs~Ref:NM_025241.1~uORF:IOH41143	6526	1316	65385	1057	2399	2869	1539	2359	1860	145	UBX domain containing 1 (UBXD1)
B42R06C21	42-21-6	Hs~Ref:NM_201592.1~uORF:IOH41375	2120	1421	5850	1897	3285	1626	4112	1041	1285	1052	glycoprotein M6A (GPM6A), transcript variant 3
B42R06C22	42-22-6	Hs~Ref:NM_201592.1~uORF:IOH41375	2296	1414	5951	1800	3241	1607	4415	1025	1185	1186	glycoprotein M6A (GPM6A), transcript variant 3
B42R07C01	42-1-7	Hs~Ref:NM_052988.2~uORF:IOH41508	825	632	7944	416	999	639	790	626	1143	294	cyclin-dependent kinase (CDC2-like) 10 (CDK10), transcript variant a
B42R07C02	42-2-7	Hs~Ref:NM_052988.2~uORF:IOH41508	880	618	7221	1625	1101	676	761	591	1064	334	cyclin-dependent kinase (CDC2-like) 10 (CDK10), transcript variant a
B42R07C03	42-3-7	Hs~MGC:BC093020.1~uORF:IOH62682	6297	3642	3471	4112	2703	3166	10326	3071	4496	1528	Isocitrate dehydrogenase [NADP] cytoplasmic
B42R07C04	42-4-7	Hs~MGC:BC093020.1~uORF:IOH62682	6272	3489	3393	3939	2414	2809	9861	3018	4561	1459	Isocitrate dehydrogenase [NADP] cytoplasmic
B42R07C05	42-5-7	Hs~MGC:BC070267.1~uORF:IOH40812	1030	328	940	758	603	232	960	192	857	128	phosphodiesterase 7B (PDE7B)
B42R07C06	42-6-7	Hs~MGC:BC070267.1~uORF:IOH40812	1058	327	868	203	570	1038	987	192	907	106	phosphodiesterase 7B (PDE7B)
B42R07C07	42-7-7	Hs~Ref:NM_025197.2~uORF:IOH42110	756	279	790	257	525	15	739	444	1089	95	CDK5 regulatory subunit-associated protein 3
B42R07C08	42-8-7	Hs~Ref:NM_025197.2~uORF:IOH42110	737	315	873	242	584	1258	700	427	1008	96	CDK5 regulatory subunit-associated protein 3
B42R07C09	42-9-7	Hs~Ref:NM_138559.1~uORF:IOH43559	7826	1392	7332	788	1611	1112	4233	892	4081	374	B-cell CLL/lymphoma 11A (zinc finger protein) (BCL11A), transcript variant 3
B42R07C10	42-10-7	Hs~Ref:NM_138559.1~uORF:IOH43559	8277	1377	6905	759	1504	1063	4052	964	4011	399	B-cell CLL/lymphoma 11A (zinc finger protein) (BCL11A), transcript variant 3
B42R07C11	42-11-7	Hs~Ref:XM_371664.3~uORF:IOH43574	1292	408	17637	235	1950	373	1007	242	344	57	Uncharacterized protein KIAA1257
B42R07C12	42-12-7	Hs~Ref:XM_371664.3~uORF:IOH43574	1322	409	18349	283	1914	362	480	435	247	46	Uncharacterized protein KIAA1257
B42R07C13	42-13-7	Hs~MGC:BC007340.2~uORF:IOH62790	830	677	1031	1314	839	1009	1765	1018	1856	496	bystin-like (BYSL)
B42R07C14	42-14-7	Hs~MGC:BC007340.2~uORF:IOH62790	801	695	958	999	774	907	1446	749	1755	217	bystin-like (BYSL)
B42R07C21	42-21-7	Hs~MGC:BC005958.1~uORF:IOH62812	614	399	924	1445	414	555	1687	902	1046	56	Coiled-coil domain-containing protein 5
B42R07C22	42-22-7	Hs~MGC:BC005958.1~uORF:IOH62812	619	371	855	1467	450	514	1561	879	1012	44	Coiled-coil domain-containing protein 5
B42R08C01	42-1-8	Hs~MGC:BC074965.2~uORF:IOH61950	667	315	386	261	556	360	470	341	410	272	Interferon alpha-4
B42R08C02	42-2-8	Hs~MGC:BC074965.2~uORF:IOH61950	685	294	431	317	397	387	471	365	309	62	Interferon alpha-4
B42R08C03	42-3-8	Hs~Ref:NM_016433.3~uORF:IOH57161	1637	222	431	1046	143	702	207	763	184	365	Glycolipid transfer protein
B42R08C04	42-4-8	Hs~Ref:NM_016433.3~uORF:IOH57161	1760	3013	435	690	372	88	190	762	191	49	Glycolipid transfer protein
B42R08C05	42-5-8	Hs~MGC:BC036804.1~uORF:IOH56311	417	1054	560	313	544	190	224	228	688	168	chromosome 9 open reading frame 95 (C9orf95), transcript variant 2, mRNA.
B42R08C06	42-6-8	Hs~MGC:BC036804.1~uORF:IOH56311	529	295	648	227	514	39	242	229	689	72	chromosome 9 open reading frame 95 (C9orf95), transcript variant 2, mRNA.
B42R08C07	42-7-8	Hs~MGC:BC029799.1~uORF:IOH22727	1279	383	1157	609	968	1217	1075	798	1905	211	DMRT-like family C1 (DMRTC1)
B42R08C08	42-8-8	Hs~MGC:BC029799.1~uORF:IOH22727	1329	392	1053	580	1027	1227	1053	767	1728	72	DMRT-like family C1 (DMRTC1)
B42R08C09	42-9-8	Hs~MGC:BC002751.1~uORF:IOH5335	1195	661	1027	501	678	21	861	679	942	432	transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) (TAP2)
B42R08C10	42-10-8	Hs~MGC:BC002751.1~uORF:IOH5335	1425	585	1063	575	646	629	913	749	907	492	transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) (TAP2)
B42R08C11	42-11-8	Hs~MGC:BC001250.1~uORF:IOH3221	4092	930	1684	1683	1087	978	3393	2072	1978	1892	breast carcinoma amplified sequence 3 (BCAS3)
B42R08C12	42-12-8	Hs~MGC:BC001250.1~uORF:IOH3221	3995	948	1702	1755	980	1035	3333	2007	2017	1883	breast carcinoma amplified sequence 3 (BCAS3)
B42R08C13	42-13-8	Hs~Ref:NM_016630.2~uORF:IOH4511	1115	1015	1486	844	1164	1133	1700	1489	1616	298	spastic paraplegia 21 (autosomal recessive, Mast syndrome) (SPG21)
B42R08C14	42-14-8	Hs~Ref:NM_016630.2~uORF:IOH4511	1052	1028	1273	841	1104	1110	1698	1464	1628	303	spastic paraplegia 21 (autosomal recessive, Mast syndrome) (SPG21)
B42R08C15	42-15-8	Hs~MGC:BC009779.1~uORF:IOH12227	1715	2268	1873	2060	2192	2578	3196	4551	6501	1548	outer dense fiber of sperm tails 2-like (ODF2L)
B42R08C16	42-16-8	Hs~MGC:BC009779.1~uORF:IOH12227	1613	2290	1918	1960	1609	2440	3087	4000	6370	1522	outer dense fiber of sperm tails 2-like (ODF2L)
B42R08C17	42-17-8	Hs~Ref:NM_033661.1~uORF:IOH6391	693	2260	1315	447	614	1032	1514	1138	710	263	WD repeat domain 4 (WDR4), transcript variant 2
B42R08C18	42-18-8	Hs~Ref:NM_033661.1~uORF:IOH6391	684	2135	1082	455	895	947	1496	782	668	77	WD repeat domain 4 (WDR4), transcript variant 2
B42R08C19	42-19-8	Hs~MGC:BC018445.1~uORF:IOH9764	597	673	1409	702	1117	1207	1857	867	1544	144	Lactation elevated protein 1
B42R08C20	42-20-8	Hs~MGC:BC018445.1~uORF:IOH9764	629	762	1630	690	652	1108	1814	800	1530	171	Lactation elevated protein 1
B42R08C21	42-21-8	Hs~MGC:BC008091.1~uORF:IOH3325	956	388	1071	2006	678	636	516	729	1071	115	mRNA similar to hypothetical protein FLJ20234
B42R08C22	42-22-8	Hs~MGC:BC008091.1~uORF:IOH3325	985	387	900	1999	654	587	507	740	1146	102	mRNA similar to hypothetical protein FLJ20234
B42R09C01	42-1-9	Hs~MGC:BC034926.1~uORF:IOH23229	881	554	815	475	665	1390	988	779	878	299	Cartilage intermediate layer protein 2
B42R09C02	42-2-9	Hs~MGC:BC034926.1~uORF:IOH23229	905	505	825	545	698	1576	1038	599	907	405	Cartilage intermediate layer protein 2
B42R09C03	42-3-9	Hs~Ref:NM_020126.3~uORF:IOH6613	1322	682	1098	1494	697	1182	3648	1102	2266	368	sphingosine kinase 2 (SPHK2)
B42R09C04	42-4-9	Hs~Ref:NM_020126.3~uORF:IOH6613	1284	944	1135	1567	479	1116	3567	1150	2286	169	sphingosine kinase 2 (SPHK2)
B42R09C05	42-5-9	Hs~Ref:NM_024036.3~uORF:IOH23019	708	878	654	290	575	455	731	400	574	245	leucine rich repeat and fibronectin type III domain containing 4 (LRFN4)
B42R09C06	42-6-9	Hs~Ref:NM_024036.3~uORF:IOH23019	776	766	1196	288	535	129	706	454	589	118	leucine rich repeat and fibronectin type III domain containing 4 (LRFN4)
B42R09C07	42-7-9	Hs~MGC:BC015008.1~uORF:IOH23029	2142	1890	1796	1011	1726	1557	6467	1205	1655	1832	Hydroxyacylglutathione hydrolase-like protein
B42R09C08	42-8-9	Hs~MGC:BC015008.1~uORF:IOH23029	2048	1939	1433	932	1631	1720	5987	1210	1915	2089	Hydroxyacylglutathione hydrolase-like protein
B42R09C09	42-9-9	Hs~Ref:NM_006666.1~uORF:IOH3426	376	370	406	398	352	408	552	456	648	198	RuvB-like 2 (E. coli) (RUVBL2)
B42R09C10	42-10-9	Hs~Ref:NM_006666.1~uORF:IOH3426	340	369	408	459	376	598	537	491	618	242	RuvB-like 2 (E. coli) (RUVBL2)
B42R09C11	42-11-9	Hs~Ref:NM_006145.1~uORF:IOH3496	570	543	1195	1729	1408	3790	1140	923	1319	564	DnaJ (Hsp40) homolog, subfamily B, member 1 (DNAJB1)
B42R09C12	42-12-9	Hs~Ref:NM_006145.1~uORF:IOH3496	540	589	1176	1699	1331	3498	1164	865	1309	556	DnaJ (Hsp40) homolog, subfamily B, member 1 (DNAJB1)
B42R09C13	42-13-9	Hs~Ref:NM_014176.1~uORF:IOH3736	1361	518	536	496	1256	1693	639	854	687	261	ubiquitin-conjugating enzyme E2T (putative) (UBE2T)
B42R09C14	42-14-9	Hs~Ref:NM_014176.1~uORF:IOH3736	1435	479	508	519	1171	1545	689	827	696	210	ubiquitin-conjugating enzyme E2T (putative) (UBE2T)
B42R09C15	42-15-9	Hs~Ref:NM_006169.1~uORF:IOH4357	482	357	432	380	796	813	325	356	384	182	nicotinamide N-methyltransferase (NNMT)
B42R09C16	42-16-9	Hs~Ref:NM_006169.1~uORF:IOH4357	376	381	458	365	862	780	310	322	440	88	nicotinamide N-methyltransferase (NNMT)
B42R09C17	42-17-9	Hs~MGC:BC053853.1~uORF:IOH28945	668	424	924	666	330	539	551	296	1067	185	Phytanoyl-CoA dioxygenase domain-containing protein 1
B42R09C18	42-18-9	Hs~MGC:BC053853.1~uORF:IOH28945	660	426	833	634	315	596	543	308	1040	115	Phytanoyl-CoA dioxygenase domain-containing protein 1
B42R09C19	42-19-9	Hs~MGC:BC046173.2~uORF:IOH28861	365	255	470	275	417	346	678	322	367	602	nudix (nucleoside diphosphate linked moiety X)-type motif 13 (NUDT13)
B42R09C20	42-20-9	Hs~MGC:BC046173.2~uORF:IOH28861	319	307	493	328	222	460	683	558	273	64	nudix (nucleoside diphosphate linked moiety X)-type motif 13 (NUDT13)
B42R09C21	42-21-9	Hs~MGC:BC052611.1~uORF:IOH29384	931	373	835	2326	473	800	905	692	1070	196	paxillin (PXN)
B42R09C22	42-22-9	Hs~MGC:BC052611.1~uORF:IOH29384	1017	370	669	2160	516	705	933	409	1081	153	paxillin (PXN)
B42R10C01	42-1-10	Hs~Ref:NM_002059.3~uORF:IOH12292	968	1143	1099	792	4055	963	1675	996	1975	507	growth hormone 2 (GH2), transcript variant 1
B42R10C02	42-2-10	Hs~Ref:NM_002059.3~uORF:IOH12292	937	1112	1115	747	1222	910	1691	889	2028	525	growth hormone 2 (GH2), transcript variant 1
B42R10C03	42-3-10	Hs~MGC:BC056408.1~uORF:IOH29086	898	667	1817	1126	1042	1302	3097	1475	2429	413	dihydropyrimidinase-like 2 (DPYSL2)
B42R10C04	42-4-10	Hs~MGC:BC056408.1~uORF:IOH29086	920	666	1659	1119	919	1535	3108	1660	2321	394	dihydropyrimidinase-like 2 (DPYSL2)
B42R10C05	42-5-10	Hs~MGC:BC051301.1~uORF:IOH29359	971	1002	476	331	591	397	552	398	1533	224	TEA domain family member 2 (TEAD2)
B42R10C06	42-6-10	Hs~MGC:BC051301.1~uORF:IOH29359	1076	1341	546	331	437	324	584	497	1508	265	TEA domain family member 2 (TEAD2)
B42R10C07	42-7-10	Hs~MGC:BC051716.1~uORF:IOH28817	11910	1514	1454	709	1344	1412	1264	4131	2626	328	RUN and FYVE domain containing 3 (RUFY3)
B42R10C08	42-8-10	Hs~MGC:BC051716.1~uORF:IOH28817	12362	1713	1342	686	1226	1430	1234	3680	2595	252	RUN and FYVE domain containing 3 (RUFY3)
B42R10C09	42-9-10	Hs~MGC:BC035198.1~uORF:IOH28613	604	474	621	3829	851	2499	1528	629	1142	309	pyruvate kinase, muscle (PKM2)
B42R10C10	42-10-10	Hs~MGC:BC035198.1~uORF:IOH28613	593	475	604	3999	800	2109	1925	725	1110	199	pyruvate kinase, muscle (PKM2)
B42R11C21	42-21-11	Hs~Ref:NM_020651.2~uORF:IOH26519	7528	2027	3863	1189	2222	1561	9718	4849	3861	646	pellino homolog 1 (Drosophila) (PELI1)
B42R11C22	42-22-11	Hs~Ref:NM_020651.2~uORF:IOH26519	7726	1946	3416	1140	1852	1488	9472	4561	3875	608	pellino homolog 1 (Drosophila) (PELI1)
B42R12C01	42-1-12	Hs~Ref:NM_006116.2~uORF:IOH26991	918	871	1026	904	932	965	3137	1388	1898	501	mitogen-activated protein kinase kinase kinase 7 interacting protein 1 (MAP3K7IP1), transcript variant alpha
B42R12C02	42-2-12	Hs~Ref:NM_006116.2~uORF:IOH26991	977	867	1044	875	1148	942	3080	1307	1908	532	mitogen-activated protein kinase kinase kinase 7 interacting protein 1 (MAP3K7IP1), transcript variant alpha
B42R12C03	42-3-12	Hs~Ref:NM_182539.1~uORF:IOH27104	997	838	1090	923	1520	927	1386	1606	1873	555	t-complex-associated-testis-expressed 1 (TCTE1)
B42R12C04	42-4-12	Hs~Ref:NM_182539.1~uORF:IOH27104	1037	849	1058	839	1482	1024	1425	1284	1776	466	t-complex-associated-testis-expressed 1 (TCTE1)
B42R12C05	42-5-12	Hs~MGC:BC039731.1~uORF:IOH26126	1036	824	1065	695	3268	1016	1201	862	1859	599	preferentially expressed antigen in melanoma (PRAME)
B42R12C06	42-6-12	Hs~MGC:BC039731.1~uORF:IOH26126	987	1133	1187	696	3464	942	1163	889	1785	492	preferentially expressed antigen in melanoma (PRAME)
B42R12C07	42-7-12	Hs~MGC:BC016768.1~uORF:IOH27892	290	320	421	307	293	396	337	522	407	413	nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1)
B42R12C08	42-8-12	Hs~MGC:BC016768.1~uORF:IOH27892	291	354	480	280	295	421	327	602	449	63	nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1)
B42R12C09	42-9-12	Hs~Ref:NM_006433.2~uORF:IOH27865	398	216	356	162	166	138	417	155	131	252	granulysin (GNLY), transcript variant NKG5
B42R12C10	42-10-12	Hs~Ref:NM_006433.2~uORF:IOH27865	330	255	347	436	191	178	436	217	305	45	granulysin (GNLY), transcript variant NKG5
B42R12C13	42-13-12	Hs~Ref:NM_003618.2~N/A	4559	968	1713	8170	1419	54	182	197	155	152	Mitogen-activated protein kinase kinase kinase kinase 3
B42R12C14	42-14-12	Hs~Ref:NM_003618.2~N/A	4547	919	1570	25	1295	449	185	140	74	5	Mitogen-activated protein kinase kinase kinase kinase 3
B42R12C15	42-15-12	Hs~MGC:BC104042.1~uORF:IOH63415	1262	490	658	466	522	575	594	471	713	134	UPF0484 protein FAM167A
B42R12C16	42-16-12	Hs~MGC:BC104042.1~uORF:IOH63415	1358	476	646	545	547	515	564	431	803	232	UPF0484 protein FAM167A
B42R12C17	42-17-12	Hs~MGC:BC099658.1~uORF:IOH63280	3746	955	964	3053	1144	902	3691	962	1763	210	Oral-facial-digital syndrome 1 protein (Protein 71-7A) [Source:UniProtKB/Swiss-Prot;Acc:O75665]
B42R12C18	42-18-12	Hs~MGC:BC099658.1~uORF:IOH63280	4176	970	1076	2859	972	886	3715	836	1745	217	Oral-facial-digital syndrome 1 protein (Protein 71-7A) [Source:UniProtKB/Swiss-Prot;Acc:O75665]
B42R12C19	42-19-12	Hs~MGC:BC011618.2~uORF:IOH13944	4599	6373	2261	510	2239	801	846	588	1058	344	Probetacellulin
B42R12C20	42-20-12	Hs~MGC:BC011618.2~uORF:IOH13944	4633	6287	2061	562	2699	917	898	624	1257	110	Probetacellulin
B42R12C21	42-21-12	Hs~MGC:BC103812.1~uORF:IOH63363	8566	8689	4405	12792	5321	8020	10576	9056	7975	2683	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3
B42R12C22	42-22-12	Hs~MGC:BC103812.1~uORF:IOH63363	8638	8622	3838	11265	5119	7313	9906	7495	7673	2699	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3
B42R13C03	42-3-13	Hs~Ref:NM_018847.1~uORF:IOH42536	2705	6524	2319	5117	2842	3823	4931	9931	5868	1505	kelch-like 9 (Drosophila) (KLHL9)
B42R13C04	42-4-13	Hs~Ref:NM_018847.1~uORF:IOH42536	3144	6726	2324	5017	2752	3802	4650	9631	5632	1414	kelch-like 9 (Drosophila) (KLHL9)
B42R13C05	42-5-13	Hs~Ref:NM_198266.1~uORF:IOH44502	2656	1718	873	1489	3460	2440	1468	1587	3302	741	inhibitor of growth family, member 3 (ING3), transcript variant 2
B42R13C06	42-6-13	Hs~Ref:NM_198266.1~uORF:IOH44502	2788	2229	916	1253	3621	2174	1463	1401	3175	640	inhibitor of growth family, member 3 (ING3), transcript variant 2
B42R13C07	42-7-13	Hs~Ref:NM_152434.1~uORF:IOH42646	3516	1710	2705	24736	1695	2250	2417	899	2242	427	CWF19-like 2, cell cycle control (S. pombe) (CWF19L2)
B42R13C08	42-8-13	Hs~Ref:NM_152434.1~uORF:IOH42646	3405	1624	2908	25150	1573	2278	2353	891	2347	392	CWF19-like 2, cell cycle control (S. pombe) (CWF19L2)
B42R13C09	42-9-13	Hs~MGC:BC025700.1~uORF:IOH11281	1183	1672	1332	988	860	1268	3414	1317	1569	668	AF4/FMR2 family, member 4 (AFF4)
B42R13C10	42-10-13	Hs~MGC:BC025700.1~uORF:IOH11281	1241	1746	1315	853	890	1245	3708	1335	1556	645	AF4/FMR2 family, member 4 (AFF4)
B42R13C11	42-11-13	Hs~MGC:BC021559.1~uORF:IOH14004	838	733	718	2824	661	910	1462	966	1262	577	polymerase (DNA directed), epsilon (POLE)
B42R13C12	42-12-13	Hs~MGC:BC021559.1~uORF:IOH14004	799	719	707	1885	608	920	1308	953	1239	561	polymerase (DNA directed), epsilon (POLE)
B42R13C13	42-13-13	Hs~Ref:NM_007111.2~uORF:IOH13752	991	983	930	4803	754	514	960	497	824	147	transcription factor Dp-1 (TFDP1)
B42R13C14	42-14-13	Hs~Ref:NM_007111.2~uORF:IOH13752	1155	1044	994	554	790	545	965	492	746	189	transcription factor Dp-1 (TFDP1)
B42R13C15	42-15-13	Hs~Ref:NM_002005.2~uORF:IOH21035	2529	1858	2023	864	1629	1139	3502	863	1477	430	feline sarcoma oncogene (FES)
B42R13C16	42-16-13	Hs~Ref:NM_002005.2~uORF:IOH21035	2460	1938	2043	773	1279	1076	3608	783	1445	405	feline sarcoma oncogene (FES)
B42R13C17	42-17-13	Hs~Ref:NM_006002.2~uORF:IOH11751	816	890	4541	1604	1036	1016	1897	616	1090	25	ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) (UCHL3)
B42R13C18	42-18-13	Hs~Ref:NM_006002.2~uORF:IOH11751	810	885	4341	1475	966	939	1874	603	1079	392	ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) (UCHL3)
B42R13C19	42-19-13	Hs~MGC:BC001743.1~uORF:IOH4884	5300	666	65486	1851	1251	3853	1155	1448	1528	257	cDNA clone IMAGE:3537461, **** WARNING: chimeric clone ****
B42R13C20	42-20-13	Hs~MGC:BC001743.1~uORF:IOH4884	5291	693	58516	1788	1448	3840	1100	1310	1498	468	cDNA clone IMAGE:3537461, **** WARNING: chimeric clone ****
B42R13C21	42-21-13	Hs~MGC:BC002778.1~uORF:IOH5313	1030	577	833	500	644	1168	2970	737	829	526	Myosin light chain 2, lymphocyte-specific
B42R13C22	42-22-13	Hs~MGC:BC002778.1~uORF:IOH5313	1040	615	967	556	884	1093	2917	735	918	458	Myosin light chain 2, lymphocyte-specific
B42R14C01	42-1-14	Hs~Ref:NM_004708.2~uORF:IOH11821	700	999	685	481	481	512	588	293	512	170	programmed cell death 5 (PDCD5)
B42R14C02	42-2-14	Hs~Ref:NM_004708.2~uORF:IOH11821	786	1111	744	482	526	526	619	308	488	336	programmed cell death 5 (PDCD5)
B42R14C07	42-7-14	Hs~Ref:NM_002266.2~uORF:IOH54048	1418	1929	1744	3566	2072	1117	4930	1311	1741	697	Importin subunit alpha-2
B42R14C08	42-8-14	Hs~Ref:NM_002266.2~uORF:IOH54048	1388	1229	1495	3362	1787	1202	5135	1314	1722	669	Importin subunit alpha-2
B42R14C09	42-9-14	Hs~Ref:NM_130791.1~uORF:IOH59559	494	559	870	368	657	667	933	509	764	308	WW domain-containing oxidoreductase
B42R14C10	42-10-14	Hs~Ref:NM_130791.1~uORF:IOH59559	571	557	858	405	726	736	931	498	795	264	WW domain-containing oxidoreductase
B42R14C11	42-11-14	Hs~Ref:NM_006905.2~uORF:IOH12639	529	257	499	5004	279	288	534	353	784	357	Pregnancy-specific beta-1-glycoprotein 1
B42R14C12	42-12-14	Hs~Ref:NM_006905.2~uORF:IOH12639	551	270	487	5264	298	382	544	334	709	111	Pregnancy-specific beta-1-glycoprotein 1
B42R14C13	42-13-14	Hs~Ref:NM_021237.3~uORF:IOH50183	618	304	565	5033	670	586	1021	401	1125	564	Selenoprotein K
B42R14C14	42-14-14	Hs~Ref:NM_021237.3~uORF:IOH50183	531	322	546	375	641	577	996	399	1035	124	Selenoprotein K
B42R14C15	42-15-14	Hs~Ref:NM_130897.1~uORF:IOH50191	451	267	506	320	970	339	893	534	1195	301	Dynein light chain roadblock-type 2
B42R14C16	42-16-14	Hs~Ref:NM_130897.1~uORF:IOH50191	437	271	527	277	955	356	851	542	1134	267	Dynein light chain roadblock-type 2
B42R14C17	42-17-14	Hs~MGC:BC101026.2~uORF:IOH63533	1724	2335	1959	1304	1813	3201	1965	2017	2399	639	Spindle assembly abnormal protein 6 homolog
B42R14C18	42-18-14	Hs~MGC:BC101026.2~uORF:IOH63533	1844	2245	1921	1199	2752	3041	1921	1924	2368	546	Spindle assembly abnormal protein 6 homolog
B42R14C19	42-19-14	Hs~MGC:NM_182607.2~uORF:IOH25853	486	488	1391	467	650	636	1076	579	778	340	V-set and immunoglobulin domain containing 1 (VSIG1)
B42R14C20	42-20-14	Hs~MGC:NM_182607.2~uORF:IOH25853	467	482	1300	437	686	622	1035	563	784	228	V-set and immunoglobulin domain containing 1 (VSIG1)
B42R14C21	42-21-14	Hs~MGC:BC030640.1~uORF:IOH26818	556	735	749	430	849	616	652	528	708	442	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 (ATP6V1B2)
B42R14C22	42-22-14	Hs~MGC:BC030640.1~uORF:IOH26818	498	712	965	406	1166	516	653	508	803	442	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 (ATP6V1B2)
B42R15C01	42-1-15	Hs~MGC:BC012924.1~uORF:IOH11017	3110	1753	1608	1171	1685	2542	4748	2349	3015	678	dual adaptor of phosphotyrosine and 3-phosphoinositides (DAPP1)
B42R15C02	42-2-15	Hs~MGC:BC012924.1~uORF:IOH11017	3314	1857	1630	1147	1568	2583	4790	2458	2881	671	dual adaptor of phosphotyrosine and 3-phosphoinositides (DAPP1)
B42R15C05	42-5-15	Hs~Ref:NM_019845.1~uORF:IOH5716	498	495	804	434	704	459	559	747	799	386	Protein reprimo
B42R15C06	42-6-15	Hs~Ref:NM_019845.1~uORF:IOH5716	450	492	829	407	609	869	624	605	749	119	Protein reprimo
B42R15C07	42-7-15	Hs~Ref:NM_024309.1~uORF:IOH5379	1181	2598	4590	1275	1347	1885	6642	1580	5748	607	TNFAIP3-interacting protein 2
B42R15C08	42-8-15	Hs~Ref:NM_024309.1~uORF:IOH5379	1252	1842	3414	1286	1226	1776	6169	1591	5886	582	TNFAIP3-interacting protein 2
B42R15C09	42-9-15	Hs~MGC:BC028064.1~uORF:IOH11593	566	666	808	383	543	679	888	536	1453	203	RAB39, member RAS oncogene family (RAB39)
B42R15C10	42-10-15	Hs~MGC:BC028064.1~uORF:IOH11593	597	672	852	454	538	711	876	574	1497	156	RAB39, member RAS oncogene family (RAB39)
B42R15C11	42-11-15	Hs~MGC:BC004410.1~uORF:IOH5586	542	1634	2442	1438	510	527	1362	294	1354	121	Zinc finger protein castor homolog 1
B42R15C12	42-12-15	Hs~MGC:BC004410.1~uORF:IOH5586	635	1630	2329	1691	536	509	1378	254	1286	105	Zinc finger protein castor homolog 1
B42R15C15	42-15-15	Hs~Ref:NM_021972.2~CAT:PV5214	99	601	222	2102	927	327	736	374	303	99	sphingosine kinase 1 (SPHK1), transcript variant 1
B42R15C16	42-16-15	Hs~Ref:NM_021972.2~CAT:PV5214	96	576	230	1925	827	348	725	369	171	81	sphingosine kinase 1 (SPHK1), transcript variant 1
B42R15C17	42-17-15	Hs~Ref:NM_000208.1~CAT:PV3781	81	144	227	260	243	476	292	542	298	41	Insulin receptor
B42R15C18	42-18-15	Hs~Ref:NM_000208.1~CAT:PV3781	83	155	231	243	222	446	276	522	313	110	Insulin receptor
B42R15C21	42-21-15	Hs~Ref:NM_004760.1~CAT:PV3783	22967	21511	19535	389	65468	1844	649	764	760	186	serine/threonine kinase 17a (STK17A)
B42R15C22	42-22-15	Hs~Ref:NM_004760.1~CAT:PV3783	24751	21592	20803	353	65479	1596	621	730	790	224	serine/threonine kinase 17a (STK17A)
B42R16C01	42-1-16	Hs~Ref:NM_002031.1~CAT:PV3874	65493	65497	65481	4234	65427	586	503	596	2010	1796	Tyrosine-protein kinase FRK
B42R16C02	42-2-16	Hs~Ref:NM_002031.1~CAT:PV3874	65482	65494	65463	4606	65428	626	530	643	2110	1833	Tyrosine-protein kinase FRK
B42R16C07	42-7-16	Hs~MGC:BC019254.1~uORF:IOH12801	2973	2079	2078	349	2646	726	992	574	802	494	Ecto-NOX disulfide-thiol exchanger 2
B42R16C08	42-8-16	Hs~MGC:BC019254.1~uORF:IOH12801	2681	2902	2873	471	2644	788	1320	510	785	360	Ecto-NOX disulfide-thiol exchanger 2
B42R16C09	42-9-16	Hs~MGC:BC029560.1~uORF:IOH21582	6696	5286	5001	368	2863	587	626	445	709	364	vacuolar protein sorting 53 homolog (S. cerevisiae) (VPS53)
B42R16C10	42-10-16	Hs~MGC:BC029560.1~uORF:IOH21582	6991	5642	5724	300	3088	543	594	407	682	240	vacuolar protein sorting 53 homolog (S. cerevisiae) (VPS53)
B42R16C11	42-11-16	Hs~MGC:BC031564.1~uORF:IOH22698	5399	4704	4806	398	1331	931	1194	464	701	367	chromosome 11 open reading frame 75 (C11orf75)
B42R16C12	42-12-16	Hs~MGC:BC031564.1~uORF:IOH22698	5662	4454	5077	410	1295	948	1234	406	707	245	chromosome 11 open reading frame 75 (C11orf75)
B42R16C13	42-13-16	Hs~Ref:NM_016449.2~uORF:IOH29060	3904	3603	4123	1705	20593	1328	1769	1487	1868	709	hypothetical protein LOC51233 (LOC51233)
B42R16C14	42-14-16	Hs~Ref:NM_016449.2~uORF:IOH29060	3845	4189	4188	1672	17001	1273	1744	1554	1802	735	hypothetical protein LOC51233 (LOC51233)
B42R16C15	42-15-16	Hs~Ref:NM_001014291.1~uORF:IOH57344	1000	845	1783	702	1317	1173	1458	865	2005	367	Small proline-rich protein 2G
B42R16C16	42-16-16	Hs~Ref:NM_001014291.1~uORF:IOH57344	975	813	1899	716	1314	1168	1488	819	2024	354	Small proline-rich protein 2G
B42R16C17	42-17-16	Hs~MGC:BC038585.1~uORF:IOH26053	1613	1255	2004	1025	1757	1313	1852	1871	2267	845	Tripartite motif-containing protein 15
B42R16C18	42-18-16	Hs~MGC:BC038585.1~uORF:IOH26053	1630	1263	1961	977	1514	1223	1834	1875	2221	791	Tripartite motif-containing protein 15
B42R16C19	42-19-16	Hs~Ref:NM_019025.2~uORF:IOH41563	1443	1032	3238	1489	1866	1153	3512	2855	2530	397	Spermine oxidase
B42R16C20	42-20-16	Hs~Ref:NM_019025.2~uORF:IOH41563	1507	1018	3222	1496	1798	1163	3424	2757	2579	377	Spermine oxidase
B42R16C21	42-21-16	Hs~Ref:NM_017974.2~uORF:IOH37886	1617	995	2932	1007	930	1877	1776	2341	4300	632	Autophagy-related protein 16-1
B42R16C22	42-22-16	Hs~Ref:NM_017974.2~uORF:IOH37886	1649	937	2840	1023	997	1857	1794	2169	3962	626	Autophagy-related protein 16-1
B42R17C01	42-1-17	Hs~Ref:NM_005720.1~uORF:IOH3992	473	387	521	446	482	716	623	466	720	303	actin related protein 2/3 complex, subunit 1B, 41kDa (ARPC1B)
B42R17C02	42-2-17	Hs~Ref:NM_005720.1~uORF:IOH3992	572	407	511	438	477	717	594	493	747	328	actin related protein 2/3 complex, subunit 1B, 41kDa (ARPC1B)
B42R17C03	42-3-17	Hs~Ref:NM_004635.2~uORF:IOH3889	834	431	677	2593	519	707	1738	844	858	303	mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3)
B42R17C04	42-4-17	Hs~Ref:NM_004635.2~uORF:IOH3889	857	427	684	2501	559	710	1796	789	866	231	mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3)
B42R17C05	42-5-17	Hs~MGC:BC009967.1~uORF:IOH12224	645	428	540	365	1331	564	449	406	846	295	N-terminal kinase-like protein
B42R17C06	42-6-17	Hs~MGC:BC009967.1~uORF:IOH12224	667	435	521	403	1100	600	515	644	842	281	N-terminal kinase-like protein
B42R17C07	42-7-17	Hs~MGC:BC007530.1~uORF:IOH6875	287	446	1371	-75	1017	157	559	422	362	-6	elastin microfibril interfacer 1 (EMILIN1)
B42R17C08	42-8-17	Hs~MGC:BC007530.1~uORF:IOH6875	387	1749	1321	-59	957	176	413	469	701	166	elastin microfibril interfacer 1 (EMILIN1)
B42R17C09	42-9-17	Hs~Ref:NM_001764.1~uORF:IOH35547	288	325	373	277	363	368	349	277	331	54	CD1b molecule (CD1B)
B42R17C10	42-10-17	Hs~Ref:NM_001764.1~uORF:IOH35547	248	279	416	292	319	334	321	254	290	69	CD1b molecule (CD1B)
B42R17C11	42-11-17	Hs~Ref:NM_021062.2~uORF:IOH35040	1543	675	1144	570	1127	1345	3281	671	1742	348	histone cluster 1, H2bb (HIST1H2BB)
B42R17C12	42-12-17	Hs~Ref:NM_021062.2~uORF:IOH35040	1399	592	1149	558	1011	1213	3253	690	1711	386	histone cluster 1, H2bb (HIST1H2BB)
B42R17C13	42-13-17	Hs~Ref:NM_175055.2~uORF:IOH35043	1166	612	986	628	510	1069	2628	631	1438	290	histone cluster 3, H2bb (HIST3H2BB)
B42R17C14	42-14-17	Hs~Ref:NM_175055.2~uORF:IOH35043	1126	587	1718	649	519	912	2719	617	1328	303	histone cluster 3, H2bb (HIST3H2BB)
B42R17C15	42-15-17	Hs~Ref:NM_173597.1~uORF:IOH35045	472	381	650	309	414	511	846	415	756	226	hypothetical protein FLJ37587 (FLJ37587)
B42R17C16	42-16-17	Hs~Ref:NM_173597.1~uORF:IOH35045	504	384	956	298	437	545	886	408	716	114	hypothetical protein FLJ37587 (FLJ37587)
B42R17C17	42-17-17	Hs~MGC:BC100026.1~uORF:IOH62766	468	337	433	248	232	545	859	505	561	257	protein arginine methyltransferase 2, mRNA (cDNA clone MGC:111373 IMAGE:30559810), complete cds
B42R17C18	42-18-17	Hs~MGC:BC100026.1~uORF:IOH62766	417	357	459	222	273	544	853	668	531	94	protein arginine methyltransferase 2, mRNA (cDNA clone MGC:111373 IMAGE:30559810), complete cds
B42R17C21	42-21-17	Hs~MGC:BC001277.1~uORF:IOH3254	130	72	214	186	233	322	400	124	749	131	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 (KDELR3)
B42R17C22	42-22-17	Hs~MGC:BC001277.1~uORF:IOH3254	153	315	221	151	128	166	435	230	672	26	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 (KDELR3)
B42R18C01	42-1-18	Hs~MGC:BC036364.1~uORF:IOH27636	93	54	120	36	94	165	99	107	404	74	BH3 interacting domain death agonist (BID)
B42R18C02	42-2-18	Hs~MGC:BC036364.1~uORF:IOH27636	66	64	157	34	174	166	139	126	463	59	BH3 interacting domain death agonist (BID)
B42R18C03	42-3-18	Hs~Ref:NM_005893.1~uORF:IOH2471	49	69	168	139	270	39	207	324	18	28	calicin (CCIN)
B42R18C04	42-4-18	Hs~Ref:NM_005893.1~uORF:IOH2471	540	58	154	200	307	0	253	375	-19	290	calicin (CCIN)
B42R18C05	42-5-18	Hs~Ref:NM_001622.1~uORF:IOH2128	275	308	349	386	716	412	203	7	395	380	alpha-2-HS-glycoprotein (AHSG)
B42R18C06	42-6-18	Hs~Ref:NM_001622.1~uORF:IOH2128	250	350	340	12	1223	29	522	432	515	58	alpha-2-HS-glycoprotein (AHSG)
B42R18C07	42-7-18	Hs~MGC:BC058000.1~uORF:IOH29426	121	268	375	245	1006	2079	516	857	577	106	tocopherol (alpha) transfer protein (TTPA)
B42R18C08	42-8-18	Hs~MGC:BC058000.1~uORF:IOH29426	192	2476	633	351	894	856	564	996	334	34	tocopherol (alpha) transfer protein (TTPA)
B42R18C09	42-9-18	Hs~MGC:BC058039.1~uORF:IOH29487	190	423	351	172	186	243	316	238	326	7	spermatogenesis associated 19 (SPATA19)
B42R18C10	42-10-18	Hs~MGC:BC058039.1~uORF:IOH29487	1488	297	304	457	190	284	324	205	324	1	spermatogenesis associated 19 (SPATA19)
B42R18C13	42-13-18	Hs~MGC:BC005403.1~uORF:IOH61712	2310	2377	2491	2429	1874	3403	6130	3513	2713	778	Uncharacterized protein C11orf57
B42R18C14	42-14-18	Hs~MGC:BC005403.1~uORF:IOH61712	2331	2463	2961	2497	1931	3165	6004	3429	2462	853	Uncharacterized protein C11orf57
B42R18C15	42-15-18	Hs~MGC:BC065819.1~uORF:IOH61742	1513	753	1958	710	1235	1357	1976	914	1445	431	Catenin alpha-3
B42R18C16	42-16-18	Hs~MGC:BC065819.1~uORF:IOH61742	1537	768	1387	755	1212	1370	2067	877	1351	597	Catenin alpha-3
B42R18C19	42-19-18	Hs~MGC:BC028573.1~uORF:IOH62077	741	3811	690	240	2235	756	407	1023	770	312	Dual specificity protein kinase CLK1
B42R18C20	42-20-18	Hs~MGC:BC028573.1~uORF:IOH62077	850	3538	727	300	2565	551	423	3758	715	415	Dual specificity protein kinase CLK1
B42R18C21	42-21-18	Hs~Ref:NM_018339.3~uORF:IOH57057	1026	4351	723	481	3145	1320	1676	4341	1375	539	Riboflavin kinase
B42R18C22	42-22-18	Hs~Ref:NM_018339.3~uORF:IOH57057	1043	4285	680	475	3031	1311	1603	3228	1299	467	Riboflavin kinase
B42R19C07	42-7-19	Hs~MGC:BC066941.1~uORF:IOH61467	867	434	383	603	414	3736	616	696	966	184	40S ribosomal protein SA
B42R19C08	42-8-19	Hs~MGC:BC066941.1~uORF:IOH61467	817	514	445	521	389	2939	613	1640	472	3	40S ribosomal protein SA
B42R19C11	42-11-19	Hs~MGC:BC048281.1~uORF:IOH26575	151	379	376	312	387	477	551	424	860	37	zinc finger, RAN-binding domain containing 1 (ZRANB1)
B42R19C12	42-12-19	Hs~MGC:BC048281.1~uORF:IOH26575	313	291	368	322	412	509	518	370	725	35	zinc finger, RAN-binding domain containing 1 (ZRANB1)
B42R19C13	42-13-19	Hs~Ref:NM_018111.1~uORF:IOH57283	511	267	332	225	361	431	533	262	626	181	Putative uncharacterized protein FLJ10490
B42R19C14	42-14-19	Hs~Ref:NM_018111.1~uORF:IOH57283	532	318	388	210	348	375	541	283	526	56	Putative uncharacterized protein FLJ10490
B42R19C15	42-15-19	Hs~Ref:NM_000366.5~uORF:IOH56864	336	294	372	399	350	1785	2601	1107	677	2078	tropomyosin 1 (alpha) (TPM1), transcript variant 5, mRNA.
B42R19C16	42-16-19	Hs~Ref:NM_000366.5~uORF:IOH56864	376	304	383	399	353	1612	2491	971	594	1844	tropomyosin 1 (alpha) (TPM1), transcript variant 5, mRNA.
B42R19C17	42-17-19	Hs~Ref:NM_033198.2~uORF:IOH57312	898	242	332	229	243	450	278	161	106	47	GPI transamidase component PIG-S
B42R19C18	42-18-19	Hs~Ref:NM_033198.2~uORF:IOH57312	1078	201	2970	256	257	338	282	225	68	33	GPI transamidase component PIG-S
B42R19C19	42-19-19	Hs~Ref:NM_001001552.3~uORF:IOH58612	5592	476	1040	409	1506	3228	4582	2059	238	567	LEM domain-containing protein 1
B42R19C20	42-20-19	Hs~Ref:NM_001001552.3~uORF:IOH58612	5829	471	698	361	1596	2671	4209	2679	786	602	LEM domain-containing protein 1
B42R19C21	42-21-19	Hs~Ref:NM_005697.3~uORF:IOH3933	563	442	668	328	569	451	611	1598	752	273	secretory carrier membrane protein 2 (SCAMP2)
B42R19C22	42-22-19	Hs~Ref:NM_005697.3~uORF:IOH3933	610	479	582	329	592	521	542	538	816	206	secretory carrier membrane protein 2 (SCAMP2)
B42R20C01	42-1-20	Hs~Ref:NM_024033.1~uORF:IOH2894	910	484	1686	571	1450	948	980	1026	1552	356	chromosome 7 open reading frame 49 (C7orf49)
B42R20C02	42-2-20	Hs~Ref:NM_024033.1~uORF:IOH2894	983	495	1793	603	1417	953	1089	980	1733	435	chromosome 7 open reading frame 49 (C7orf49)
B42R20C03	42-3-20	Hs~Ref:NM_007008.1~uORF:IOH4069	623	415	548	373	438	613	582	534	1017	402	reticulon 4 (RTN4), transcript variant 3
B42R20C04	42-4-20	Hs~Ref:NM_007008.1~uORF:IOH4069	656	406	582	339	422	575	706	622	1036	174	reticulon 4 (RTN4), transcript variant 3
B42R20C05	42-5-20	Hs~Ref:NM_006324.1~uORF:IOH3019	1134	647	885	1106	1014	1125	2968	1085	1312	784	craniofacial development protein 1 (CFDP1)
B42R20C06	42-6-20	Hs~Ref:NM_006324.1~uORF:IOH3019	1190	654	921	958	777	1579	2540	1137	1346	609	craniofacial development protein 1 (CFDP1)
B42R20C07	42-7-20	Hs~Ref:NM_020175.1~uORF:IOH13452	2709	2307	4202	1836	2205	2971	3234	1484	3057	826	dihydrouridine synthase 3-like (S. cerevisiae) (DUS3L)
B42R20C08	42-8-20	Hs~Ref:NM_020175.1~uORF:IOH13452	2842	2307	4082	1831	2157	2021	3444	1446	2454	756	dihydrouridine synthase 3-like (S. cerevisiae) (DUS3L)
B42R20C09	42-9-20	Hs~Ref:NM_018645.3~uORF:IOH6723	1874	6074	9579	1550	2290	2426	2846	5838	3585	436	Transcription cofactor HES-6
B42R20C10	42-10-20	Hs~Ref:NM_018645.3~uORF:IOH6723	1567	7053	6416	1653	2363	2539	2914	2202	3944	194	Transcription cofactor HES-6
B42R20C11	42-11-20	Hs~Ref:NM_007277.3~uORF:IOH40459	2072	2533	3050	1473	3526	1935	2869	1708	3109	605	exocyst complex component 3 (EXOC3)
B42R20C12	42-12-20	Hs~Ref:NM_007277.3~uORF:IOH40459	2127	2013	3031	1423	3207	1845	2843	1632	2952	612	exocyst complex component 3 (EXOC3)
B42R20C13	42-13-20	Hs~Ref:NM_004164.2~uORF:IOH40388	322	912	539	1	603	246	-3	0	-4	3	retinol binding protein 2, cellular (RBP2)
B42R20C14	42-14-20	Hs~Ref:NM_004164.2~uORF:IOH40388	355	2222	499	-2	556	16	7	2	-2	-1	retinol binding protein 2, cellular (RBP2)
B43R02C11	43-11-2	Hs~MGC:BC016922.2~uORF:IOH11182	1578	2298	853	502	349	522	1560	390	700	128	tolloid-like 1 (TLL1)
B43R02C12	43-12-2	Hs~MGC:BC016922.2~uORF:IOH11182	1794	391	802	711	413	523	1558	373	635	82	tolloid-like 1 (TLL1)
B43R02C13	43-13-2	Hs~MGC:BC013988.1~uORF:IOH13255	598	729	1577	892	523	716	1993	1416	1948	292	chromosome 11 open reading frame 49 (C11orf49)
B43R02C14	43-14-2	Hs~MGC:BC013988.1~uORF:IOH13255	625	579	1540	889	496	707	2004	1396	1902	4	chromosome 11 open reading frame 49 (C11orf49)
B43R02C15	43-15-2	Hs~MGC:BC021969.2~uORF:IOH13337	918	668	1348	613	537	717	2142	1109	1786	3512	Uncharacterized protein C1orf176
B43R02C16	43-16-2	Hs~MGC:BC021969.2~uORF:IOH13337	925	636	1279	645	606	735	2113	1120	1601	418	Uncharacterized protein C1orf176
B43R02C17	43-17-2	Hs~Ref:NM_139201.1~uORF:IOH3954	1908	1042	1082	1257	1150	1401	1380	814	2015	4436	G protein-coupled receptor kinase interactor 2 (GIT2), transcript variant 4
B43R02C18	43-18-2	Hs~Ref:NM_139201.1~uORF:IOH3954	1580	1087	967	1208	852	1529	1425	805	1879	356	G protein-coupled receptor kinase interactor 2 (GIT2), transcript variant 4
B43R02C19	43-19-2	Hs~MGC:BC010395.1~uORF:IOH13836	-12	-1	-1	798	1428	1120	2053	1085	2243	-6	ATPase, H+ transporting, lysosomal accessory protein 2 (ATP6AP2)
B43R02C20	43-20-2	Hs~MGC:BC010395.1~uORF:IOH13836	0	-1	1	816	964	1148	2007	1192	2157	-3	ATPase, H+ transporting, lysosomal accessory protein 2 (ATP6AP2)
B43R02C21	43-21-2	Hs~Ref:NM_012318.1~uORF:IOH13897	2396	1313	2369	813	746	1118	2656	1036	1547	-27	leucine zipper-EF-hand containing transmembrane protein 1 (LETM1)
B43R02C22	43-22-2	Hs~Ref:NM_012318.1~uORF:IOH13897	2221	1252	2283	805	1078	1214	2598	974	1560	-4	leucine zipper-EF-hand containing transmembrane protein 1 (LETM1)
B43R03C01	43-1-3	Hs~Ref:NM_001657.2~uORF:IOH13747	977	792	1379	822	541	753	2085	5331	1577	398	amphiregulin (schwannoma-derived growth factor) (AREG)
B43R03C02	43-2-3	Hs~Ref:NM_001657.2~uORF:IOH13747	966	816	1324	821	548	789	2053	4948	1293	235	amphiregulin (schwannoma-derived growth factor) (AREG)
B43R03C03	43-3-3	Hs~MGC:BC016745.2~uORF:IOH10673	1546	1098	1706	906	916	1287	2391	2090	1642	417	capping protein (actin filament) muscle Z-line, alpha 3 (CAPZA3)
B43R03C04	43-4-3	Hs~MGC:BC016745.2~uORF:IOH10673	1475	1049	1583	871	842	1313	2417	1030	1688	234	capping protein (actin filament) muscle Z-line, alpha 3 (CAPZA3)
B43R03C05	43-5-3	Hs~MGC:BC009680.1~uORF:IOH9934	782	661	814	549	492	697	1049	591	930	406	Transaldolase
B43R03C06	43-6-3	Hs~MGC:BC009680.1~uORF:IOH9934	675	698	851	569	492	620	1070	584	955	197	Transaldolase
B43R03C07	43-7-3	Hs~Ref:NM_003847.1~uORF:IOH9834	447	397	541	366	292	409	539	344	-22	97	peroxisomal biogenesis factor 11A (PEX11A)
B43R03C08	43-8-3	Hs~Ref:NM_003847.1~uORF:IOH9834	503	453	547	341	345	410	599	376	456	-9	peroxisomal biogenesis factor 11A (PEX11A)
B43R03C09	43-9-3	Hs~MGC:BC013424.1~uORF:IOH9880	1631	2138	1404	621	561	647	1016	726	1161	1	armadillo repeat containing 8 (ARMC8)
B43R03C10	43-10-3	Hs~MGC:BC013424.1~uORF:IOH9880	1586	2073	1535	581	489	680	1012	709	1127	-6	armadillo repeat containing 8 (ARMC8)
B43R03C11	43-11-3	Hs~MGC:BC013567.1~uORF:IOH9922	880	1200	1120	755	744	620	1015	1079	1183	1729	ubiquitin specific peptidase 48 (USP48)
B43R03C12	43-12-3	Hs~MGC:BC013567.1~uORF:IOH9922	855	1238	1047	645	815	637	932	1097	1166	324	ubiquitin specific peptidase 48 (USP48)
B43R03C13	43-13-3	Hs~MGC:BC027478.1~uORF:IOH22847	106	93	323	253	127	185	174	302	148	1922	ADAMTS-like 4 (ADAMTSL4)
B43R03C14	43-14-3	Hs~MGC:BC027478.1~uORF:IOH22847	175	93	334	284	666	113	170	636	449	74	ADAMTS-like 4 (ADAMTSL4)
B43R03C15	43-15-3	Hs~MGC:BC040924.1~uORF:IOH26332	5275	225	373	278	82	238	548	319	426	127	synaptotagmin XVI (SYT16)
B43R03C16	43-16-3	Hs~MGC:BC040924.1~uORF:IOH26332	102	165	975	287	99	211	569	296	-3	4528	synaptotagmin XVI (SYT16)
B43R03C17	43-17-3	Hs~MGC:BC036391.1~uORF:IOH22062	4797	2908	2395	3321	3618	1355	1942	2105	8	3863	CUG triplet repeat, RNA binding protein 2 (CUGBP2)
B43R03C18	43-18-3	Hs~MGC:BC036391.1~uORF:IOH22062	6198	3030	1870	3325	3476	1486	1877	1963	1991	2360	CUG triplet repeat, RNA binding protein 2 (CUGBP2)
B43R03C19	43-19-3	Hs~MGC:BC031101.1~uORF:IOH27268	2620	321	455	242	137	148	145	119	91	3468	tubulin, epsilon 1 (TUBE1)
B43R03C20	43-20-3	Hs~MGC:BC031101.1~uORF:IOH27268	289	455	375	244	2013	73	168	124	23	190	tubulin, epsilon 1 (TUBE1)
B43R03C21	43-21-3	Hs~Ref:NM_016484.1~uORF:IOH12355	2338	5874	1761	1263	4084	2158	1957	3792	2479	3951	PDZ domain containing 11 (PDZD11)
B43R03C22	43-22-3	Hs~Ref:NM_016484.1~uORF:IOH12355	2214	5922	1674	1163	2529	1916	1938	3290	2688	-19	PDZ domain containing 11 (PDZD11)
B43R04C01	43-1-4	Hs~MGC:BC009253.1~uORF:IOH13411	2165	4501	27453	3366	7700	2221	2155	4627	3771	664	ATP-binding cassette, sub-family F (GCN20), member 3 (ABCF3)
B43R04C02	43-2-4	Hs~MGC:BC009253.1~uORF:IOH13411	1974	4325	21889	3143	7664	2071	2126	3219	3890	665	ATP-binding cassette, sub-family F (GCN20), member 3 (ABCF3)
B43R04C03	43-3-4	Hs~Ref:NM_021809.2~uORF:IOH13079	2064	1615	3953	2719	2587	1465	4601	1972	2861	637	TGFB-induced factor homeobox 2 (TGIF2)
B43R04C04	43-4-4	Hs~Ref:NM_021809.2~uORF:IOH13079	2098	1651	3845	2543	2543	1417	4352	1855	2837	792	TGFB-induced factor homeobox 2 (TGIF2)
B43R04C05	43-5-4	Hs~Ref:NM_014267.2~uORF:IOH7554	1180	876	2214	1748	1918	1233	2209	2722	2758	820	chromosome 11 open reading frame 58 (C11orf58)
B43R04C06	43-6-4	Hs~Ref:NM_014267.2~uORF:IOH7554	1267	891	2122	1749	1866	1149	2116	2768	2720	711	chromosome 11 open reading frame 58 (C11orf58)
B43R04C07	43-7-4	Hs~Ref:NM_001956.1~uORF:IOH22678	1824	968	1448	803	713	1174	5034	843	1851	298	endothelin 2 (EDN2)
B43R04C08	43-8-4	Hs~Ref:NM_001956.1~uORF:IOH22678	1720	971	1351	870	739	1104	4916	820	1792	240	endothelin 2 (EDN2)
B43R04C09	43-9-4	Hs~MGC:BC000175.2~uORF:IOH2926	1004	585	1370	666	1090	736	1087	935	1669	237	Hermansky-Pudlak syndrome 1 (HPS1)
B43R04C10	43-10-4	Hs~MGC:BC000175.2~uORF:IOH2926	983	582	1547	664	1011	718	1165	878	1593	-31	Hermansky-Pudlak syndrome 1 (HPS1)
B43R04C11	43-11-4	Hs~Ref:NM_007262.1~uORF:IOH3149	871	421	869	641	360	435	441	379	904	78	Parkinson disease (autosomal recessive, early onset) 7 (PARK7)
B43R04C12	43-12-4	Hs~Ref:NM_007262.1~uORF:IOH3149	384	457	727	666	362	443	439	393	956	70	Parkinson disease (autosomal recessive, early onset) 7 (PARK7)
B43R04C13	43-13-4	Hs~Ref:NM_000398.3~uORF:IOH3023	1189	3705	3052	1611	1435	4669	2957	2257	1676	679	cytochrome b5 reductase 3 (CYB5R3), transcript variant M
B43R04C14	43-14-4	Hs~Ref:NM_000398.3~uORF:IOH3023	1172	3614	2941	1487	1397	4310	3014	2111	1769	627	cytochrome b5 reductase 3 (CYB5R3), transcript variant M
B43R04C15	43-15-4	Hs~MGC:BC042606.1~uORF:IOH26783	738	515	974	413	377	560	926	453	579	27	pleckstrin homology domain containing, family G (with RhoGef domain) member 5 (PLEKHG5)
B43R04C16	43-16-4	Hs~MGC:BC042606.1~uORF:IOH26783	420	455	1318	397	861	556	920	406	647	105	pleckstrin homology domain containing, family G (with RhoGef domain) member 5 (PLEKHG5)
B43R04C17	43-17-4	Hs~MGC:BC009289.2~uORF:IOH12925	3127	757	1155	1767	828	5073	2520	1655	2227	464	Long-chain-fatty-acid--CoA ligase ACSBG1
B43R04C18	43-18-4	Hs~MGC:BC009289.2~uORF:IOH12925	3019	737	1234	1407	814	4744	2619	1596	2174	630	Long-chain-fatty-acid--CoA ligase ACSBG1
B43R04C19	43-19-4	Hs~Ref:NM_014437.2~uORF:IOH4006	698	540	1339	257	366	412	508	412	405	83	solute carrier family 39 (zinc transporter), member 1 (SLC39A1)
B43R04C20	43-20-4	Hs~Ref:NM_014437.2~uORF:IOH4006	641	737	686	290	226	398	520	394	533	40	solute carrier family 39 (zinc transporter), member 1 (SLC39A1)
B43R04C21	43-21-4	Hs~MGC:BC026345.1~uORF:IOH10790	2913	1532	1213	5113	3453	1976	5193	1349	7144	811	Ermin
B43R04C22	43-22-4	Hs~MGC:BC026345.1~uORF:IOH10790	3220	1503	1162	4669	1669	1915	4934	1350	7850	696	Ermin
B43R05C01	43-1-5	Hs~Ref:NM_024613.2~uORF:IOH13017	582	677	583	402	665	886	767	1103	813	326	pleckstrin homology domain containing, family F (with FYVE domain) member 2 (PLEKHF2)
B43R05C02	43-2-5	Hs~Ref:NM_024613.2~uORF:IOH13017	570	657	537	408	660	840	757	1049	822	114	pleckstrin homology domain containing, family F (with FYVE domain) member 2 (PLEKHF2)
B43R05C03	43-3-5	Hs~Ref:NM_020548.4~uORF:IOH39853	1055	566	1034	1751	968	3070	3749	1217	1377	348	diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein) (DBI), transcript variant 1
B43R05C04	43-4-5	Hs~Ref:NM_020548.4~uORF:IOH39853	1049	558	964	1610	964	2868	3694	1109	1416	290	diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein) (DBI), transcript variant 1
B43R05C05	43-5-5	Hs~MGC:BC017212.2~uORF:IOH13041	2441	1369	1965	1611	1093	1696	9425	1388	2064	420	PHD finger protein 11 (PHF11)
B43R05C06	43-6-5	Hs~MGC:BC017212.2~uORF:IOH13041	2453	1302	1900	1539	1094	1717	8805	1313	2250	340	PHD finger protein 11 (PHF11)
B43R05C07	43-7-5	Hs~Ref:NM_203405.1~uORF:IOH39798	400	344	497	258	188	332	445	377	55	82	Keratin-associated protein 26-1
B43R05C08	43-8-5	Hs~Ref:NM_203405.1~uORF:IOH39798	413	375	502	263	341	362	437	400	684	-13	Keratin-associated protein 26-1
B43R05C09	43-9-5	Hs~Ref:NM_016057.1~uORF:IOH5427	694	491	3212	314	4144	1384	4763	703	1428	138	coatomer protein complex, subunit zeta 1 (COPZ1)
B43R05C10	43-10-5	Hs~Ref:NM_016057.1~uORF:IOH5427	717	478	3158	302	4036	1268	4635	635	1403	-20	coatomer protein complex, subunit zeta 1 (COPZ1)
B43R05C11	43-11-5	Hs~MGC:NM_138730.1~uORF:IOH9857	5582	3174	55230	2713	2357	2917	24725	1825	10519	2052	high mobility group nucleosomal binding domain 3 (HMGN3), transcript variant 2
B43R05C12	43-12-5	Hs~MGC:NM_138730.1~uORF:IOH9857	5675	3099	55446	2709	2189	2873	25284	1781	11022	2002	high mobility group nucleosomal binding domain 3 (HMGN3), transcript variant 2
B43R05C13	43-13-5	Hs~Ref:NM_002035.1~uORF:IOH6216	1231	1144	2498	1173	991	1170	1855	1136	2410	647	follicular lymphoma variant translocation 1 (FVT1)
B43R05C14	43-14-5	Hs~Ref:NM_002035.1~uORF:IOH6216	1295	1181	2264	1094	1005	1228	1955	1199	2323	608	follicular lymphoma variant translocation 1 (FVT1)
B43R05C15	43-15-5	Hs~Ref:NM_032933.1~uORF:IOH6290	2695	1713	2905	1296	2389	2307	3424	2077	3854	744	chromosome 18 open reading frame 45 (C18orf45)
B43R05C16	43-16-5	Hs~Ref:NM_032933.1~uORF:IOH6290	2714	1680	2918	1252	2617	2172	3434	1950	3713	939	chromosome 18 open reading frame 45 (C18orf45)
B43R05C19	43-19-5	Hs~MGC:BC044585.1~uORF:IOH26894	808	365	664	227	143	349	685	479	190	73	ROD1 regulator of differentiation 1 (S. pombe) (ROD1)
B43R05C20	43-20-5	Hs~MGC:BC044585.1~uORF:IOH26894	508	872	696	241	185	297	596	364	97	41	ROD1 regulator of differentiation 1 (S. pombe) (ROD1)
B43R05C21	43-21-5	Hs~MGC:NM_178450.2~uORF:IOH26430	686	395	2035	759	317	552	638	674	810	213	membrane-associated ring finger (C3HC4) 3 (MARCH3)
B43R05C22	43-22-5	Hs~MGC:NM_178450.2~uORF:IOH26430	692	482	2050	627	1563	594	625	612	1154	147	membrane-associated ring finger (C3HC4) 3 (MARCH3)
B43R06C01	43-1-6	Hs~MGC:NM_182756.1~uORF:IOH26877	713	456	5173	338	773	2752	2470	2802	3828	4301	speedy homolog A (Drosophila) (SPDYA), transcript variant 2
B43R06C02	43-2-6	Hs~MGC:NM_182756.1~uORF:IOH26877	756	475	4542	361	746	2982	2615	2632	3732	4470	speedy homolog A (Drosophila) (SPDYA), transcript variant 2
B43R06C03	43-3-6	Hs~Ref:NM_020133.1~uORF:IOH12573	743	6089	16258	541	2537	649	635	365	505	185	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) (AGPAT4)
B43R06C04	43-4-6	Hs~Ref:NM_020133.1~uORF:IOH12573	725	5911	15831	539	2643	637	669	357	516	126	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) (AGPAT4)
B43R06C05	43-5-6	Hs~Ref:NM_138462.1~uORF:IOH10685	617	796	1843	1263	814	769	1666	602	975	313	zinc finger, MYND-type containing 19 (ZMYND19)
B43R06C06	43-6-6	Hs~Ref:NM_138462.1~uORF:IOH10685	582	778	1735	1205	765	728	1600	569	1014	267	zinc finger, MYND-type containing 19 (ZMYND19)
B43R06C07	43-7-6	Hs~Ref:NM_001878.2~uORF:IOH1673	580	544	2185	1204	507	571	1213	489	1943	293	cellular retinoic acid binding protein 2 (CRABP2)
B43R06C08	43-8-6	Hs~Ref:NM_001878.2~uORF:IOH1673	605	559	2078	1157	502	575	1227	497	1900	-11	cellular retinoic acid binding protein 2 (CRABP2)
B43R06C09	43-9-6	Hs~Ref:NM_000975.2~uORF:IOH1740	2531	1265	2332	1033	524	3162	8973	877	1568	-38	ribosomal protein L11 (RPL11)
B43R06C10	43-10-6	Hs~Ref:NM_000975.2~uORF:IOH1740	2416	1207	2338	1033	500	3177	9606	859	1951	-24	ribosomal protein L11 (RPL11)
B43R06C11	43-11-6	Hs~MGC:BC064553.1~uORF:IOH39901	582	367	25471	842	599	1889	1057	713	923	18	proline-rich protein HaeIII subfamily 1 (PRH1)
B43R06C12	43-12-6	Hs~MGC:BC064553.1~uORF:IOH39901	568	383	22666	777	597	1768	1036	656	942	59	proline-rich protein HaeIII subfamily 1 (PRH1)
B43R06C13	43-13-6	Hs~Ref:NM_172037.2~uORF:IOH39980	485	374	611	768	303	682	593	1769	765	90	Retinol dehydrogenase 10
B43R06C14	43-14-6	Hs~Ref:NM_172037.2~uORF:IOH39980	460	340	553	760	296	670	604	1723	865	92	Retinol dehydrogenase 10
B43R06C15	43-15-6	Hs~MGC:BC066354.1~uORF:IOH40076	423	339	614	353	1007	336	470	423	615	9	chromosome 20 open reading frame 71 (C20orf71)
B43R06C16	43-16-6	Hs~MGC:BC066354.1~uORF:IOH40076	279	311	599	359	731	348	481	457	578	28	chromosome 20 open reading frame 71 (C20orf71)
B43R06C17	43-17-6	Hs~MGC:BC064593.1~uORF:IOH39933	994	905	1797	873	789	796	1659	1283	1549	259	mRNA-decapping enzyme 2
B43R06C18	43-18-6	Hs~MGC:BC064593.1~uORF:IOH39933	920	851	1829	908	1410	741	1547	1210	1607	213	mRNA-decapping enzyme 2
B43R06C19	43-19-6	Hs~MGC:BC042036.1~uORF:IOH26443	647	430	800	427	431	501	1119	636	915	172	BolA-like protein 3
B43R06C20	43-20-6	Hs~MGC:BC042036.1~uORF:IOH26443	771	455	784	370	416	549	1025	403	717	149	BolA-like protein 3
B43R06C21	43-21-6	Hs~MGC:BC023514.2~uORF:IOH27789	2388	719	1273	909	338	887	1158	485	327	177	neurensin 1 (NRSN1)
B43R06C22	43-22-6	Hs~MGC:BC023514.2~uORF:IOH27789	2300	646	1235	854	394	933	1137	485	725	690	neurensin 1 (NRSN1)
B43R07C01	43-1-7	Hs~MGC:BC014501.1~uORF:IOH27915	928	766	1410	571	893	786	834	502	1211	64	four and a half LIM domains 3 (FHL3)
B43R07C02	43-2-7	Hs~MGC:BC014501.1~uORF:IOH27915	966	786	1375	533	871	735	907	565	1140	-14	four and a half LIM domains 3 (FHL3)
B43R07C03	43-3-7	Hs~Ref:NM_022063.1~uORF:IOH27864	3011	1377	5843	1818	1137	1982	12836	1261	2565	474	chromosome 10 open reading frame 84 (C10orf84)
B43R07C04	43-4-7	Hs~Ref:NM_022063.1~uORF:IOH27864	2994	1340	5751	1707	1118	1877	12363	1210	2485	333	chromosome 10 open reading frame 84 (C10orf84)
B43R07C05	43-5-7	Hs~MGC:BC017299.1~uORF:IOH14780	353	384	635	299	288	394	797	292	679	51	tripartite motif-containing 47 (TRIM47)
B43R07C06	43-6-7	Hs~MGC:BC017299.1~uORF:IOH14780	392	368	626	276	297	366	787	265	722	73	tripartite motif-containing 47 (TRIM47)
B43R07C07	43-7-7	Hs~Ref:NM_005643.2~uORF:IOH13738	561	532	835	2127	716	495	837	330	650	110	TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa (TAF11)
B43R07C08	43-8-7	Hs~Ref:NM_005643.2~uORF:IOH13738	616	558	826	1971	668	508	860	348	664	140	TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa (TAF11)
B43R07C09	43-9-7	Hs~MGC:BC016790.1~uORF:IOH27885	1136	1712	2961	3246	6938	4376	6974	1362	3041	391	KIAA1143 (KIAA1143)
B43R07C10	43-10-7	Hs~MGC:BC016790.1~uORF:IOH27885	1114	1489	2982	3122	6732	4040	6648	1199	2863	368	KIAA1143 (KIAA1143)
B43R07C11	43-11-7	Hs~MGC:BC049215.1~uORF:IOH26613	779	2022	739	728	652	914	2468	712	1346	287	2'-5'-oligoadenylate synthetase 2, 69/71kDa (OAS2)
B43R07C12	43-12-7	Hs~MGC:BC049215.1~uORF:IOH26613	777	1959	741	720	663	939	2455	708	1317	322	2'-5'-oligoadenylate synthetase 2, 69/71kDa (OAS2)
B43R07C13	43-13-7	Hs~Ref:NM_177405.1~uORF:IOH40959	1116	994	1589	821	1200	956	1683	832	1625	600	cat eye syndrome chromosome region, candidate 1 (CECR1), transcript variant 2
B43R07C14	43-14-7	Hs~Ref:NM_177405.1~uORF:IOH40959	1158	965	1622	822	1188	922	1733	796	1565	215	cat eye syndrome chromosome region, candidate 1 (CECR1), transcript variant 2
B43R07C15	43-15-7	Hs~Ref:XM_372239.3~uORF:IOH44466	735	539	1670	873	1930	733	1259	730	1958	-24	Protein ripply1
B43R07C16	43-16-7	Hs~Ref:XM_372239.3~uORF:IOH44466	739	532	1675	874	1297	727	1227	693	2035	228	Protein ripply1
B43R07C17	43-17-7	Hs~Ref:NM_176783.1~uORF:IOH40962	2898	1077	3253	1156	15621	1089	2620	1574	2101	497	proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) (PSME1), transcript variant 2
B43R07C18	43-18-7	Hs~Ref:NM_176783.1~uORF:IOH40962	2940	1078	3214	1216	12769	1238	2573	1564	2129	506	proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) (PSME1), transcript variant 2
B43R07C19	43-19-7	Hs~Ref:NM_004449.3~uORF:IOH41014	7722	1379	3424	1308	1141	3174	5339	1678	2481	2227	v-ets erythroblastosis virus E26 oncogene homolog (avian) (ERG), transcript variant 2
B43R07C20	43-20-7	Hs~Ref:NM_004449.3~uORF:IOH41014	7357	1434	3292	1198	1145	3336	5190	1587	2428	2341	v-ets erythroblastosis virus E26 oncogene homolog (avian) (ERG), transcript variant 2
B43R07C21	43-21-7	Hs~Ref:NM_052844.1~uORF:IOH13517	1062	870	1631	745	1587	984	1193	746	1932	523	WD repeat domain 34 (WDR34)
B43R07C22	43-22-7	Hs~Ref:NM_052844.1~uORF:IOH13517	1059	829	1579	687	971	960	1187	725	1992	491	WD repeat domain 34 (WDR34)
B43R08C01	43-1-8	Hs~MGC:BC010176.1~uORF:IOH14168	1408	530	1173	685	782	998	1057	1945	1349	111	sarcoma antigen NY-SAR-48 (NY-SAR-48)
B43R08C02	43-2-8	Hs~MGC:BC010176.1~uORF:IOH14168	1419	549	1159	685	758	964	1026	1778	1285	104	sarcoma antigen NY-SAR-48 (NY-SAR-48)
B43R08C03	43-3-8	Hs~MGC:BC014001.1~uORF:IOH13543	2922	1127	2730	1212	1728	1425	4050	1138	3167	307	FAS-associated factor 2
B43R08C04	43-4-8	Hs~MGC:BC014001.1~uORF:IOH13543	2962	1125	2665	1190	1690	1381	3992	1082	3189	290	FAS-associated factor 2
B43R08C05	43-5-8	Hs~MGC:BC011885.1~uORF:IOH14206	6499	3961	5321	3860	4641	4163	18199	2737	7054	1856	eukaryotic translation initiation factor 2A, 65kDa (EIF2A)
B43R08C06	43-6-8	Hs~MGC:BC011885.1~uORF:IOH14206	6694	3879	5334	3728	4572	4193	17040	2595	6893	1987	eukaryotic translation initiation factor 2A, 65kDa (EIF2A)
B43R08C07	43-7-8	Hs~Ref:NM_004251.2~uORF:IOH14673	567	479	711	1703	1412	739	886	592	1031	10	RAB9A, member RAS oncogene family (RAB9A)
B43R08C08	43-8-8	Hs~Ref:NM_004251.2~uORF:IOH14673	576	476	704	1649	1363	714	882	573	1004	173	RAB9A, member RAS oncogene family (RAB9A)
B43R08C09	43-9-8	Hs~MGC:BC005153.1~uORF:IOH5158	1699	1171	2342	2148	1817	1525	1507	1647	2957	649	rabphilin 3A-like (without C2 domains) (RPH3AL)
B43R08C10	43-10-8	Hs~MGC:BC005153.1~uORF:IOH5158	1554	1160	2290	2176	1751	1485	1477	1745	2961	652	rabphilin 3A-like (without C2 domains) (RPH3AL)
B43R08C11	43-11-8	Hs~MGC:BC016964.1~uORF:IOH10344	932	858	1445	984	730	633	1241	645	895	368	MAS-related GPR, member F (MRGPRF)
B43R08C12	43-12-8	Hs~MGC:BC016964.1~uORF:IOH10344	991	881	1396	1005	683	643	1180	678	942	368	MAS-related GPR, member F (MRGPRF)
B43R08C13	43-13-8	Hs~MGC:BC009877.1~uORF:IOH12614	1299	8775	65472	1237	4227	2714	2846	1833	1903	500	P2Y purinoceptor 11
B43R08C14	43-14-8	Hs~MGC:BC009877.1~uORF:IOH12614	1386	8358	65472	1257	3872	2485	2801	1840	1896	517	P2Y purinoceptor 11
B43R08C15	43-15-8	Hs~MGC:BC001494.1~uORF:IOH14556	3541	4269	1775	2250	1840	3684	5496	7831	2048	689	WD repeat domain 57 (U5 snRNP specific) (WDR57)
B43R08C16	43-16-8	Hs~MGC:BC001494.1~uORF:IOH14556	3466	4193	1720	2161	989	3593	5594	6852	2146	658	WD repeat domain 57 (U5 snRNP specific) (WDR57)
B43R08C17	43-17-8	Hs~Ref:NM_013385.2~uORF:IOH26246	1398	1312	1567	1026	1007	7140	2241	962	2239	607	pleckstrin homology, Sec7 and coiled-coil domains 4 (PSCD4)
B43R08C18	43-18-8	Hs~Ref:NM_013385.2~uORF:IOH26246	1329	1369	1611	995	752	6919	2224	952	2337	543	pleckstrin homology, Sec7 and coiled-coil domains 4 (PSCD4)
B43R08C19	43-19-8	Hs~MGC:BC015557.2~uORF:IOH14423	681	593	846	1008	689	689	746	603	1427	191	CD68 molecule (CD68)
B43R08C20	43-20-8	Hs~MGC:BC015557.2~uORF:IOH14423	739	595	874	1058	652	612	762	547	1242	168	CD68 molecule (CD68)
B43R08C21	43-21-8	Hs~Ref:NM_000107.1~uORF:IOH4740	893	763	1084	1297	582	688	1694	561	1070	428	damage-specific DNA binding protein 2, 48kDa (DDB2)
B43R08C22	43-22-8	Hs~Ref:NM_000107.1~uORF:IOH4740	891	776	1080	1268	528	686	1718	784	-4	289	damage-specific DNA binding protein 2, 48kDa (DDB2)
B43R09C01	43-1-9	Hs~Ref:NM_138279.1~uORF:IOH35268	1507	1291	1714	1857	1584	1038	2509	1185	2138	40	BCL2/adenovirus E1B 19kD interacting protein like (BNIPL), transcript variant 2
B43R09C02	43-2-9	Hs~Ref:NM_138279.1~uORF:IOH35268	1520	1296	1708	1848	1644	1021	2568	1141	2112	616	BCL2/adenovirus E1B 19kD interacting protein like (BNIPL), transcript variant 2
B43R09C03	43-3-9	Hs~Ref:NM_006153.3~uORF:IOH6521	2961	1585	3021	1447	2018	1996	5481	4912	2589	578	NCK adaptor protein 1 (NCK1)
B43R09C04	43-4-9	Hs~Ref:NM_006153.3~uORF:IOH6521	2910	1587	3019	1400	1980	1892	5012	4526	2573	588	NCK adaptor protein 1 (NCK1)
B43R09C05	43-5-9	Hs~Ref:NM_175908.3~uORF:IOH35325	1042	1077	1364	826	868	1098	1685	997	1780	172	hypothetical protein LOC284296 (LOC284296)
B43R09C06	43-6-9	Hs~Ref:NM_175908.3~uORF:IOH35325	1045	1092	1370	850	865	1052	1548	1018	1903	38	hypothetical protein LOC284296 (LOC284296)
B43R09C07	43-7-9	Hs~Ref:NM_021002.1~uORF:IOH35232	797	802	1200	725	713	846	1608	675	1214	30	interferon, alpha 6 (IFNA6)
B43R09C08	43-8-9	Hs~Ref:NM_021002.1~uORF:IOH35232	796	815	1239	694	677	862	1592	652	1228	394	interferon, alpha 6 (IFNA6)
B43R09C09	43-9-9	Hs~Ref:NM_145269.1~uORF:IOH10713	6697	2342	1497	4849	1261	1674	9886	1238	3813	395	Protein FAM92A1
B43R09C10	43-10-9	Hs~Ref:NM_145269.1~uORF:IOH10713	6368	2229	1449	4705	1172	1579	9671	1259	3642	350	Protein FAM92A1
B43R09C11	43-11-9	Hs~MGC:NM_015464.1~uORF:IOH7434	673	448	567	405	366	486	1177	339	593	224	sclerostin domain containing 1 (SOSTDC1)
B43R09C12	43-12-9	Hs~MGC:NM_015464.1~uORF:IOH7434	658	413	562	400	310	453	1208	342	547	265	sclerostin domain containing 1 (SOSTDC1)
B43R09C13	43-13-9	Hs~MGC:BC014323.1~uORF:IOH13941	279	273	321	385	127	220	368	168	173	102	B-cell receptor-associated protein 31 (BCAP31)
B43R09C14	43-14-9	Hs~MGC:BC014323.1~uORF:IOH13941	241	159	308	377	103	239	338	172	101	161	B-cell receptor-associated protein 31 (BCAP31)
B43R09C15	43-15-9	Hs~Ref:NM_138289.1~uORF:IOH10781	689	1181	620	738	1424	609	720	524	689	556	actin-related protein T1 (ACTRT1)
B43R09C16	43-16-9	Hs~Ref:NM_138289.1~uORF:IOH10781	718	1162	616	720	798	605	730	540	641	542	actin-related protein T1 (ACTRT1)
B43R09C19	43-19-9	Hs~Ref:NM_006166.2~uORF:IOH7129	827	427	735	623	421	519	881	576	932	387	nuclear transcription factor Y, beta (NFYB)
B43R09C20	43-20-9	Hs~Ref:NM_006166.2~uORF:IOH7129	872	466	752	611	456	440	800	578	873	301	nuclear transcription factor Y, beta (NFYB)
B43R09C21	43-21-9	Hs~Ref:NM_014234.3~uORF:IOH3322	966	398	604	579	2308	659	651	463	1441	672	hydroxysteroid (17-beta) dehydrogenase 8 (HSD17B8)
B43R09C22	43-22-9	Hs~Ref:NM_014234.3~uORF:IOH3322	1050	376	632	450	2197	741	624	588	1539	308	hydroxysteroid (17-beta) dehydrogenase 8 (HSD17B8)
B43R10C01	43-1-10	Hs~MGC:BC002793.1~uORF:IOH5316	581	351	641	621	318	324	3053	438	421	25	interferon (alpha, beta and omega) receptor 2 (IFNAR2)
B43R10C02	43-2-10	Hs~MGC:BC002793.1~uORF:IOH5316	616	365	653	640	346	347	2889	460	432	72	interferon (alpha, beta and omega) receptor 2 (IFNAR2)
B43R10C03	43-3-10	Hs~Ref:NM_058192.2~uORF:IOH12988	1115	936	1333	826	860	933	4172	1109	2207	465	RNA pseudouridylate synthase domain containing 1 (RPUSD1)
B43R10C04	43-4-10	Hs~Ref:NM_058192.2~uORF:IOH12988	1118	936	1313	822	860	922	4015	1087	2273	439	RNA pseudouridylate synthase domain containing 1 (RPUSD1)
B43R10C05	43-5-10	Hs~Ref:NM_031989.2~uORF:IOH4487	1704	658	950	506	1318	812	5850	1437	1444	320	poly(rC) binding protein 2 (PCBP2), transcript variant 2
B43R10C06	43-6-10	Hs~Ref:NM_031989.2~uORF:IOH4487	1684	653	937	483	1281	791	5629	1351	1376	331	poly(rC) binding protein 2 (PCBP2), transcript variant 2
B43R10C07	43-7-10	Hs~Ref:NM_017907.1~uORF:IOH4941	857	721	942	612	671	722	1061	690	1943	621	chromosome 11 open reading frame 59 (C11orf59)
B43R10C08	43-8-10	Hs~Ref:NM_017907.1~uORF:IOH4941	846	681	873	672	640	880	1024	718	1845	530	chromosome 11 open reading frame 59 (C11orf59)
B43R10C09	43-9-10	Hs~Ref:NM_014747.2~uORF:IOH4568	4601	2336	2663	1221	1593	2837	4441	2163	3315	746	regulating synaptic membrane exocytosis 3 (RIMS3)
B43R10C10	43-10-10	Hs~Ref:NM_014747.2~uORF:IOH4568	4285	2260	2537	1193	1493	2640	4403	2136	3193	655	regulating synaptic membrane exocytosis 3 (RIMS3)
B43R11C21	43-21-11	Hs~MGC:BC010061.2~uORF:IOH12254	1123	979	1151	671	747	1166	1582	896	1913	535	Meckel syndrome, type 1 (MKS1)
B43R11C22	43-22-11	Hs~MGC:BC010061.2~uORF:IOH12254	974	993	1147	698	731	1141	1675	871	2164	539	Meckel syndrome, type 1 (MKS1)
B43R12C01	43-1-12	Hs~MGC:BC030833.1~uORF:IOH22239	1161	892	1493	1168	916	1133	1659	872	1244	367	NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) (NDUFS1)
B43R12C02	43-2-12	Hs~MGC:BC030833.1~uORF:IOH22239	1181	906	1523	1106	928	1269	1589	911	1289	184	NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) (NDUFS1)
B43R12C03	43-3-12	Hs~MGC:BC029886.1~uORF:IOH22823	1404	1522	1779	5536	824	1628	3834	2546	2124	710	occludin (OCLN)
B43R12C04	43-4-12	Hs~MGC:BC029886.1~uORF:IOH22823	1424	1557	1765	12588	778	1507	3659	2488	2066	737	occludin (OCLN)
B43R12C05	43-5-12	Hs~Ref:NM_006419.1~uORF:IOH14282	1184	892	1086	5007	1005	1163	1955	925	1480	491	chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) (CXCL13)
B43R12C06	43-6-12	Hs~Ref:NM_006419.1~uORF:IOH14282	1174	952	1133	4451	958	1089	2110	944	1442	496	chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) (CXCL13)
B43R12C07	43-7-12	Hs~Ref:NM_002488.2~uORF:IOH7216	643	456	475	2777	774	1066	2215	1206	1261	16	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa (NDUFA2)
B43R12C08	43-8-12	Hs~Ref:NM_002488.2~uORF:IOH7216	636	422	449	377	4156	996	2117	1131	1274	435	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa (NDUFA2)
B43R12C15	43-15-12	Hs~Ref:NM_021198.1~uORF:IOH12189	871	1445	1568	2163	778	966	1604	918	1429	468	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 (CTDSP1), transcript variant 1
B43R12C16	43-16-12	Hs~Ref:NM_021198.1~uORF:IOH12189	815	1213	1471	1299	662	990	1611	1850	1554	442	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 (CTDSP1), transcript variant 1
B43R12C17	43-17-12	Hs~MGC:BC027178.1~uORF:IOH10797	958	1211	1677	1683	899	1654	2456	2091	2308	498	PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) (PRPF40A)
B43R12C18	43-18-12	Hs~MGC:BC027178.1~uORF:IOH10797	1010	949	1579	2313	830	1597	2326	2612	2113	512	PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) (PRPF40A)
B43R12C19	43-19-12	Hs~Ref:NM_006573.2~uORF:IOH12947	823	1053	1259	2506	921	1593	1677	783	815	639	tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B)
B43R12C20	43-20-12	Hs~Ref:NM_006573.2~uORF:IOH12947	797	1059	1233	644	906	1708	1719	708	772	96	tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B)
B43R12C21	43-21-12	Hs~Ref:NM_004264.2~uORF:IOH7394	379	132	495	296	241	195	302	294	286	30	mediator complex subunit 21 (MED21)
B43R12C22	43-22-12	Hs~Ref:NM_004264.2~uORF:IOH7394	347	349	537	273	216	27	286	292	329	3	mediator complex subunit 21 (MED21)
B43R13C01	43-1-13	Hs~Ref:NM_016619.1~uORF:IOH10473	771	738	840	602	612	844	1076	931	1119	320	placenta-specific 8 (PLAC8)
B43R13C02	43-2-13	Hs~Ref:NM_016619.1~uORF:IOH10473	790	742	829	639	609	866	1140	765	1196	248	placenta-specific 8 (PLAC8)
B43R13C03	43-3-13	Hs~Ref:NM_152786.1~uORF:IOH11171	2061	969	1392	2144	1035	1546	3792	1466	2612	566	chromosome 9 open reading frame 43 (C9orf43)
B43R13C04	43-4-13	Hs~Ref:NM_152786.1~uORF:IOH11171	2062	980	1333	6673	1010	1499	3765	1434	2450	536	chromosome 9 open reading frame 43 (C9orf43)
B43R13C05	43-5-13	Hs~Ref:NM_006628.4~uORF:IOH3044	4321	1800	3405	2279	1969	10137	8411	3025	5479	792	cyclic AMP phosphoprotein, 19 kD (ARPP-19)
B43R13C06	43-6-13	Hs~Ref:NM_006628.4~uORF:IOH3044	4012	1762	3537	2221	1735	9477	8481	2858	5408	710	cyclic AMP phosphoprotein, 19 kD (ARPP-19)
B43R13C07	43-7-13	Hs~MGC:BC016389.1~uORF:IOH10478	678	607	962	2365	5350	763	2271	460	893	-13	chromosome 2 open reading frame 18 (C2orf18)
B43R13C08	43-8-13	Hs~MGC:BC016389.1~uORF:IOH10478	673	615	914	597	1080	767	2201	443	882	654	chromosome 2 open reading frame 18 (C2orf18)
B43R13C09	43-9-13	Hs~Ref:NM_144606.1~uORF:IOH12359	65487	61466	57572	65484	65286	35214	30702	42959	54967	54766	folliculin (FLCN), transcript variant 2
B43R13C10	43-10-13	Hs~Ref:NM_144606.1~uORF:IOH12359	65484	63359	56567	65482	64964	33919	33395	43343	54538	53339	folliculin (FLCN), transcript variant 2
B43R13C11	43-11-13	Hs~MGC:BC024300.1~uORF:IOH12700	668	3915	705	401	3244	535	531	211	438	195	follistatin-like 4 (FSTL4)
B43R13C12	43-12-13	Hs~MGC:BC024300.1~uORF:IOH12700	600	3883	720	444	466	490	545	254	445	209	follistatin-like 4 (FSTL4)
B43R13C13	43-13-13	Hs~MGC:BC017799.1~uORF:IOH14286	4441	2991	2715	3190	3070	2120	6950	3231	2380	1282	nucleoporin 62kDa C-terminal like (NUP62CL)
B43R13C14	43-14-13	Hs~MGC:BC017799.1~uORF:IOH14286	3628	2680	2645	6731	3002	2076	7038	3296	2400	1261	nucleoporin 62kDa C-terminal like (NUP62CL)
B43R13C15	43-15-13	Hs~Ref:NM_001668.2~uORF:IOH36815	13165	2371	5130	3755	2386	7927	7291	9224	9444	1843	Aryl hydrocarbon receptor nuclear translocator
B43R13C16	43-16-13	Hs~Ref:NM_001668.2~uORF:IOH36815	10681	2362	4982	3498	2265	7556	7375	9463	9632	1735	Aryl hydrocarbon receptor nuclear translocator
B43R13C19	43-19-13	Hs~Ref:NM_006395.1~uORF:IOH52654	974	832	917	3246	512	642	1081	659	1303	6	Autophagy-related protein 7
B43R13C20	43-20-13	Hs~Ref:NM_006395.1~uORF:IOH52654	958	848	875	2185	537	712	1087	629	1366	4	Autophagy-related protein 7
B43R14C03	43-3-14	Hs~Ref:NM_194290.1~uORF:IOH42276	5367	6848	3228	4453	3172	4657	21234	4261	6562	2467	cDNA FLJ42001 fis, clone SPLEN2029912 (LOC153684 protein)  [Source:UniProtKB/TrEMBL;Acc:Q6ZVW3]
B43R14C04	43-4-14	Hs~Ref:NM_194290.1~uORF:IOH42276	5446	6759	3084	4260	2976	4282	20295	4169	6396	2556	cDNA FLJ42001 fis, clone SPLEN2029912 (LOC153684 protein)  [Source:UniProtKB/TrEMBL;Acc:Q6ZVW3]
B43R14C05	43-5-14	Hs~Ref:NM_001013644.1~uORF:IOH42793	522	529	850	1615	425	531	910	739	1037	311	UPF0627 protein ENSP00000358171
B43R14C06	43-6-14	Hs~Ref:NM_001013644.1~uORF:IOH42793	536	490	815	1148	6161	553	934	717	997	354	UPF0627 protein ENSP00000358171
B43R14C07	43-7-14	Hs~Ref:NM_020152.2~uORF:IOH42211	651	391	810	542	909	675	1300	699	681	13	TAK1-like protein
B43R14C08	43-8-14	Hs~Ref:NM_020152.2~uORF:IOH42211	672	396	804	450	751	689	1285	636	614	168	TAK1-like protein
B43R14C09	43-9-14	Hs~Ref:NM_181481.2~uORF:IOH42514	548	352	498	587	582	803	587	534	729	129	Uncharacterized protein C18orf1
B43R14C10	43-10-14	Hs~Ref:NM_181481.2~uORF:IOH42514	706	443	535	558	448	815	602	568	691	147	Uncharacterized protein C18orf1
B43R14C11	43-11-14	Hs~MGC:BC019069.1~uORF:IOH14121	2295	1217	2412	983	1352	2159	5989	2358	2026	2091	ribosomal L1 domain containing 1 (RSL1D1)
B43R14C12	43-12-14	Hs~MGC:BC019069.1~uORF:IOH14121	1760	1220	2246	995	1145	2244	5984	2267	1998	1944	ribosomal L1 domain containing 1 (RSL1D1)
B43R14C13	43-13-14	Hs~Ref:NM_016006.1~uORF:IOH10127	2548	438	608	543	790	433	1727	435	635	199	abhydrolase domain containing 5 (ABHD5)
B43R14C14	43-14-14	Hs~Ref:NM_016006.1~uORF:IOH10127	2468	446	588	847	743	454	1724	445	672	185	abhydrolase domain containing 5 (ABHD5)
B43R14C15	43-15-14	Hs~MGC:NM_173517.2~uORF:IOH14095	865	512	728	2326	533	525	760	480	609	224	vitamin K epoxide reductase complex, subunit 1-like 1 (VKORC1L1)
B43R14C16	43-16-14	Hs~MGC:NM_173517.2~uORF:IOH14095	568	482	742	1961	472	556	700	1226	623	247	vitamin K epoxide reductase complex, subunit 1-like 1 (VKORC1L1)
B43R14C17	43-17-14	Hs~MGC:BC020622.1~uORF:IOH12066	1451	1411	1590	4231	1801	2098	1677	1326	1957	756	OTU domain containing 7B (OTUD7B)
B43R14C18	43-18-14	Hs~MGC:BC020622.1~uORF:IOH12066	1534	1306	1555	3069	3346	2063	1693	1157	1890	798	OTU domain containing 7B (OTUD7B)
B43R14C19	43-19-14	Hs~Ref:NM_006454.2~uORF:IOH45932	1200	1522	1703	2497	2057	1967	1954	1489	2128	866	MAX dimerization protein 4 (MXD4)
B43R14C20	43-20-14	Hs~Ref:NM_006454.2~uORF:IOH45932	1096	1592	1713	1740	2224	1777	1991	1424	2209	974	MAX dimerization protein 4 (MXD4)
B43R14C21	43-21-14	Hs~Ref:NM_023112.2~uORF:IOH45933	1333	4087	1838	1254	1487	1929	5266	2687	2126	363	OTU domain, ubiquitin aldehyde binding 2 (OTUB2)
B43R14C22	43-22-14	Hs~Ref:NM_023112.2~uORF:IOH45933	1307	4410	1766	1244	1540	1889	5331	2481	2066	359	OTU domain, ubiquitin aldehyde binding 2 (OTUB2)
B43R15C01	43-1-15	Hs~Ref:NM_014955.2~uORF:IOH45543	1587	1205	1743	2076	2131	2502	5382	1009	1636	479	KIAA0859 (KIAA0859), transcript variant 2
B43R15C02	43-2-15	Hs~Ref:NM_014955.2~uORF:IOH45543	1536	1214	1863	2013	2761	2389	5316	1045	1796	461	KIAA0859 (KIAA0859), transcript variant 2
B43R15C03	43-3-15	Hs~Ref:NM_018189.2~uORF:IOH45471	2253	1370	1844	1325	1688	1554	5749	1356	2594	976	Developmental pluripotency-associated protein 4
B43R15C04	43-4-15	Hs~Ref:NM_018189.2~uORF:IOH45471	2329	1397	1893	1368	1628	1576	5658	1314	2441	900	Developmental pluripotency-associated protein 4
B43R15C05	43-5-15	Hs~MGC:BC044575.1~uORF:IOH26889	701	545	663	485	354	618	1021	607	899	368	tryptophanyl tRNA synthetase 2, mitochondrial (WARS2)
B43R15C06	43-6-15	Hs~MGC:BC044575.1~uORF:IOH26889	631	524	673	512	617	617	1014	584	959	88	tryptophanyl tRNA synthetase 2, mitochondrial (WARS2)
B43R15C07	43-7-15	Hs~MGC:BC061699.1~uORF:IOH29429	722	514	698	434	844	660	1548	581	794	165	glycosyltransferase-like domain containing 1 (GTDC1)
B43R15C08	43-8-15	Hs~MGC:BC061699.1~uORF:IOH29429	884	539	640	441	528	647	1550	588	811	150	glycosyltransferase-like domain containing 1 (GTDC1)
B43R15C09	43-9-15	Hs~MGC:BC041615.1~uORF:IOH28053	862	840	1061	439	1047	621	1105	638	1007	-8	zinc finger protein 551 (ZNF551)
B43R15C10	43-10-15	Hs~MGC:BC041615.1~uORF:IOH28053	830	895	1053	486	1283	658	1064	621	969	-17	zinc finger protein 551 (ZNF551)
B43R15C11	43-11-15	Hs~MGC:BC056409.1~uORF:IOH29119	840	558	913	752	743	880	1179	851	2173	-10	cisplatin resistance-associated overexpressed protein (CROP)
B43R15C12	43-12-15	Hs~MGC:BC056409.1~uORF:IOH29119	842	561	871	699	698	848	1186	743	2289	172	cisplatin resistance-associated overexpressed protein (CROP)
B43R15C21	43-21-15	Hs~Ref:NM_000215.1~CAT:PV3855	283	1176	443	336	228	460	340	430	1237	24	Tyrosine-protein kinase JAK3
B43R15C22	43-22-15	Hs~Ref:NM_000215.1~CAT:PV3855	198	277	426	306	233	976	347	398	1123	48	Tyrosine-protein kinase JAK3
B43R16C01	43-1-16	Hs~Ref:NM_006255.1~CAT:P2634	757	715	587	513	794	2014	1150	547	874	370	protein kinase C, eta
B43R16C02	43-2-16	Hs~Ref:NM_006255.1~CAT:P2634	790	729	567	543	805	1915	824	517	707	360	protein kinase C, eta
B43R16C03	43-3-16	Hs~Ref:NM_006218.2~CAT:PV4788	465	177	254	300	92	295	642	380	516	50	PIK3CA is coexpressed and copurified with the regulatory subunit PI3KR1: PIK3CA and PI3KR1 sequences are seperated by -- (in protein list file).
B43R16C04	43-4-16	Hs~Ref:NM_006218.2~CAT:PV4788	439	169	246	299	128	281	606	342	531	46	PIK3CA is coexpressed and copurified with the regulatory subunit PI3KR1: PIK3CA and PI3KR1 sequences are seperated by -- (in protein list file).
B43R16C05	43-5-16	Hs~Ref:NM_006035.2~CAT:PV4399	269	134	217	11	290	131	118	68	104	27	Serine/threonine-protein kinase MRCK beta
B43R16C06	43-6-16	Hs~Ref:NM_006035.2~CAT:PV4399	237	91	216	112	546	138	160	75	103	0	Serine/threonine-protein kinase MRCK beta
B43R16C07	43-7-16	Hs~Ref:NM_021914.3~uORF:IOH14198	1566	1802	2483	1200	5211	2699	2442	1736	3243	1321	cofilin 2 (muscle) (CFL2), transcript variant 1
B43R16C08	43-8-16	Hs~Ref:NM_021914.3~uORF:IOH14198	1598	1874	2518	1161	4565	2594	2495	1625	3156	1000	cofilin 2 (muscle) (CFL2), transcript variant 1
B43R16C09	43-9-16	Hs~MGC:BC012289.1~uORF:IOH11447	1151	1482	1616	769	4373	2764	2537	1537	2216	731	KIAA0515 (KIAA0515)
B43R16C10	43-10-16	Hs~MGC:BC012289.1~uORF:IOH11447	1187	1439	1575	832	3632	2711	2519	1520	2374	596	KIAA0515 (KIAA0515)
B43R16C11	43-11-16	Hs~MGC:BC052803.1~uORF:IOH29397	1516	1404	2898	1131	2386	2206	2651	1469	3448	780	forkhead box P4 (FOXP4)
B43R16C12	43-12-16	Hs~MGC:BC052803.1~uORF:IOH29397	1489	1395	2883	1156	2476	2148	2639	1402	3459	757	forkhead box P4 (FOXP4)
B43R16C13	43-13-16	Hs~MGC:BC058926.1~uORF:IOH29101	1027	1035	1980	780	1920	1889	3216	1050	2133	535	catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1)
B43R16C14	43-14-16	Hs~MGC:BC058926.1~uORF:IOH29101	1050	990	1951	783	1596	1920	3191	1052	2337	480	catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1)
B43R16C15	43-15-16	Hs~Ref:NM_031919.1~uORF:IOH42936	796	681	1827	495	609	713	3706	1833	1205	451	fibronectin type III and SPRY domain containing 1-like (FSD1L), transcript variant 2
B43R16C16	43-16-16	Hs~Ref:NM_031919.1~uORF:IOH42936	722	688	1783	525	713	723	3656	1853	1365	447	fibronectin type III and SPRY domain containing 1-like (FSD1L), transcript variant 2
B43R16C17	43-17-16	Hs~Ref:NM_001012425.1~uORF:IOH44762	927	810	857	483	1028	634	947	497	1179	337	chromosome 1 open reading frame 146 (C1orf146)
B43R16C18	43-18-16	Hs~Ref:NM_001012425.1~uORF:IOH44762	936	802	858	472	10133	665	992	519	1196	376	chromosome 1 open reading frame 146 (C1orf146)
B43R16C19	43-19-16	Hs~Ref:NM_003769.2~uORF:IOH41184	3651	1734	2612	1928	1047	2521	20491	2532	3765	852	splicing factor, arginine/serine-rich 9 (SFRS9)
B43R16C20	43-20-16	Hs~Ref:NM_003769.2~uORF:IOH41184	3686	1716	2587	1902	1233	2449	20593	2398	3654	1051	splicing factor, arginine/serine-rich 9 (SFRS9)
B43R16C21	43-21-16	Hs~Ref:NM_018173.1~uORF:IOH43927	1069	730	739	449	840	864	980	624	1543	474	Pleckstrin homology domain-containing family G member 6
B43R16C22	43-22-16	Hs~Ref:NM_018173.1~uORF:IOH43927	1025	807	752	466	864	1041	923	575	1467	415	Pleckstrin homology domain-containing family G member 6
B43R17C01	43-1-17	Hs~Ref:NM_014741.2~uORF:IOH3624	1699	567	1118	696	769	2192	1443	728	1581	434	KIAA0652 (KIAA0652)
B43R17C02	43-2-17	Hs~Ref:NM_014741.2~uORF:IOH3624	1770	588	964	666	710	2052	1353	717	1572	452	KIAA0652 (KIAA0652)
B43R17C03	43-3-17	Hs~Ref:NM_018348.4~uORF:IOH27159	709	476	1110	454	394	618	1273	599	1200	288	hypothetical protein FLJ11171 (FLJ11171), transcript variant 1
B43R17C04	43-4-17	Hs~Ref:NM_018348.4~uORF:IOH27159	628	494	1005	468	381	659	1230	831	1146	285	hypothetical protein FLJ11171 (FLJ11171), transcript variant 1
B43R17C05	43-5-17	Hs~MGC:BC036062.1~uORF:IOH27284	460	342	505	330	437	467	745	476	527	239	protocadherin beta 16 (PCDHB16)
B43R17C06	43-6-17	Hs~MGC:BC036062.1~uORF:IOH27284	471	350	487	366	198	463	886	455	535	95	protocadherin beta 16 (PCDHB16)
B43R17C07	43-7-17	Hs~MGC:BC050424.1~uORF:IOH26735	680	442	544	352	6775	641	974	430	871	1242	F-box protein 38 (FBXO38)
B43R17C08	43-8-17	Hs~MGC:BC050424.1~uORF:IOH26735	710	440	576	347	156	645	956	465	883	88	F-box protein 38 (FBXO38)
B43R17C09	43-9-17	Hs~MGC:BC016879.1~uORF:IOH10754	2107	2528	2020	1852	3218	1770	3093	3666	14948	871	chromosome 6 open reading frame 113 (C6orf113)
B43R17C10	43-10-17	Hs~MGC:BC016879.1~uORF:IOH10754	1958	2521	1999	1647	2806	1710	3089	3457	14611	642	chromosome 6 open reading frame 113 (C6orf113)
B43R17C11	43-11-17	Hs~MGC:BC036492.2~uORF:IOH22068	1339	1275	1845	1230	3852	1405	2273	2829	2413	1942	Formin-like protein 2
B43R17C12	43-12-17	Hs~MGC:BC036492.2~uORF:IOH22068	1270	1174	1711	1185	3526	1347	2252	2581	2385	617	Formin-like protein 2
B43R17C13	43-13-17	Hs~Ref:NM_003092.3~uORF:IOH21977	7482	5032	2987	2180	2745	4460	8671	1987	4550	1338	small nuclear ribonucleoprotein polypeptide B'' (SNRPB2), transcript variant 1
B43R17C14	43-14-17	Hs~Ref:NM_003092.3~uORF:IOH21977	7706	4843	2913	2186	2551	4377	8882	1890	4860	1325	small nuclear ribonucleoprotein polypeptide B'' (SNRPB2), transcript variant 1
B43R17C15	43-15-17	Hs~Ref:NM_016388.2~uORF:IOH22617	1932	944	1294	1459	1905	1205	3613	808	2969	597	T cell receptor associated transmembrane adaptor 1 (TRAT1)
B43R17C16	43-16-17	Hs~Ref:NM_016388.2~uORF:IOH22617	1643	924	1266	1456	2503	1169	3611	765	3042	589	T cell receptor associated transmembrane adaptor 1 (TRAT1)
B43R17C17	43-17-17	Hs~Ref:NM_079834.1~uORF:IOH9634	503	577	533	320	774	476	644	504	789	225	secretory carrier membrane protein 4 (SCAMP4)
B43R17C18	43-18-17	Hs~Ref:NM_079834.1~uORF:IOH9634	440	620	535	321	772	477	649	461	808	231	secretory carrier membrane protein 4 (SCAMP4)
B43R17C19	43-19-17	Hs~MGC:BC007920.1~uORF:IOH6782	552	271	599	269	187	416	603	386	591	279	major histocompatibility complex, class II, DR beta 1 (HLA-DRB1)
B43R17C20	43-20-17	Hs~MGC:BC007920.1~uORF:IOH6782	341	491	512	301	278	441	666	363	619	18	major histocompatibility complex, class II, DR beta 1 (HLA-DRB1)
B43R17C21	43-21-17	Hs~Ref:NM_004357.2~uORF:IOH3965	551	512	660	341	362	711	743	410	806	201	CD151 molecule (Raph blood group) (CD151), transcript variant 1
B43R17C22	43-22-17	Hs~Ref:NM_004357.2~uORF:IOH3965	539	646	618	335	388	363	769	453	789	246	CD151 molecule (Raph blood group) (CD151), transcript variant 1
B43R18C01	43-1-18	Hs~Ref:NM_024058.1~uORF:IOH3251	475	370	992	326	312	510	676	398	550	137	hypothetical protein MGC5590 (MGC5590)
B43R18C02	43-2-18	Hs~Ref:NM_024058.1~uORF:IOH3251	479	408	1123	306	694	513	666	391	560	127	hypothetical protein MGC5590 (MGC5590)
B43R18C03	43-3-18	Hs~MGC:BC013879.1~N/A	1272	2729	2423	1034	1165	1196	1883	1008	1919	553	Serine/threonine-protein kinase PLK2
B43R18C04	43-4-18	Hs~MGC:BC013879.1~N/A	1394	2529	2359	1017	1362	1208	1874	1730	1980	541	Serine/threonine-protein kinase PLK2
B43R18C05	43-5-18	Hs~MGC:BC020972.1~N/A	4096	3907	4277	4493	3401	4741	17523	4972	7587	3290	Casein kinase I isoform gamma-2
B43R18C06	43-6-18	Hs~MGC:BC020972.1~N/A	4050	3857	4040	4078	3340	4419	17374	4807	7686	3018	Casein kinase I isoform gamma-2
B43R18C09	43-9-18	Hs~Ref:NM_024776.1~N/A	799	637	916	516	4620	917	1570	990	2211	314	Tyrosine-protein kinase SgK269
B43R18C10	43-10-18	Hs~Ref:NM_024776.1~N/A	810	619	976	551	4495	867	1606	946	2047	274	Tyrosine-protein kinase SgK269
B43R18C11	43-11-18	Hs~MGC:BC032822.2~uORF:IOH26849	2840	1134	1334	870	1308	1481	5175	922	2978	496	erythrocyte membrane protein band 4.1 like 5 (EPB41L5)
B43R18C12	43-12-18	Hs~MGC:BC032822.2~uORF:IOH26849	2883	1093	1377	790	1010	1340	4932	992	2956	527	erythrocyte membrane protein band 4.1 like 5 (EPB41L5)
B43R18C13	43-13-18	Hs~MGC:NM_020783.2~uORF:IOH22458	1054	682	758	543	1437	805	2999	631	1084	304	synaptotagmin IV (SYT4)
B43R18C14	43-14-18	Hs~MGC:NM_020783.2~uORF:IOH22458	1035	703	754	584	1200	760	3007	603	1086	250	synaptotagmin IV (SYT4)
B43R18C17	43-17-18	Hs~MGC:BC062564.1~uORF:IOH39851	1357	1086	1087	746	880	1009	3813	813	2272	502	dyslexia susceptibility 1 candidate 1 (DYX1C1)
B43R18C18	43-18-18	Hs~MGC:BC062564.1~uORF:IOH39851	1244	1239	1081	739	2124	962	3850	813	2331	523	dyslexia susceptibility 1 candidate 1 (DYX1C1)
B43R18C21	43-21-18	Hs~Ref:NM_144610.1~uORF:IOH60533	847	885	923	906	537	290	1394	697	908	114	Uncharacterized serine/threonine-protein kinase SgK494
B43R18C22	43-22-18	Hs~Ref:NM_144610.1~uORF:IOH60533	952	824	960	930	520	442	1384	758	794	265	Uncharacterized serine/threonine-protein kinase SgK494
B43R19C03	43-3-19	Hs~MGC:BC090938.1~uORF:IOH62696	49497	47676	41850	46484	54123	37469	30236	40947	45880	46504	Ig gamma-1 chain C region
B43R19C04	43-4-19	Hs~MGC:BC090938.1~uORF:IOH62696	48962	48704	44225	47477	52242	33433	32338	36977	46587	45783	Ig gamma-1 chain C region
B43R19C05	43-5-19	Hs~MGC:BC028682.2~uORF:IOH22322	2472	1060	1446	696	631	1076	1486	885	1497	507	coiled-coil domain containing 91 (CCDC91)
B43R19C06	43-6-19	Hs~MGC:BC028682.2~uORF:IOH22322	1011	1090	1365	670	587	1054	1486	968	1643	559	coiled-coil domain containing 91 (CCDC91)
B43R19C07	43-7-19	Hs~Ref:NM_018335.2~uORF:IOH45711	281	302	569	772	566	2164	650	1321	1063	204	chromosome 14 open reading frame 131 (C14orf131)
B43R19C08	43-8-19	Hs~Ref:NM_018335.2~uORF:IOH45711	330	320	567	722	488	2048	644	1232	1063	177	chromosome 14 open reading frame 131 (C14orf131)
B43R19C09	43-9-19	Hs~Ref:NM_152509.1~uORF:IOH44542	1134	920	962	605	778	1034	1288	816	1494	1205	Putative palmitoyltransferase ZDHHC8-like protein  [Source:UniProtKB/Swiss-Prot;Acc:Q3KR32]
B43R19C10	43-10-19	Hs~Ref:NM_152509.1~uORF:IOH44542	1156	992	1106	702	5771	968	1306	786	1484	661	Putative palmitoyltransferase ZDHHC8-like protein  [Source:UniProtKB/Swiss-Prot;Acc:Q3KR32]
B43R19C11	43-11-19	Hs~Ref:NM_001018061.1~uORF:IOH57329	2176	1854	1699	1377	3986	1775	3778	1596	2459	1175	UPF0544 protein C5orf45  [Source:UniProtKB/Swiss-Prot;Acc:Q6NTE8]
B43R19C12	43-12-19	Hs~Ref:NM_001018061.1~uORF:IOH57329	2161	1769	1766	1464	2141	1733	3573	1668	2473	1202	UPF0544 protein C5orf45  [Source:UniProtKB/Swiss-Prot;Acc:Q6NTE8]
B43R19C13	43-13-19	Hs~Ref:NM_181515.1~uORF:IOH45751	2016	1076	1368	973	917	1510	3020	1744	2385	476	mitochondrial ribosomal protein L21 (MRPL21), nuclear gene encoding mitochondrial protein, transcript variant 1
B43R19C14	43-14-19	Hs~Ref:NM_181515.1~uORF:IOH45751	1656	1097	1459	1044	1194	1426	3059	1672	2343	594	mitochondrial ribosomal protein L21 (MRPL21), nuclear gene encoding mitochondrial protein, transcript variant 1
B43R19C15	43-15-19	Hs~Ref:NM_001002244.1~uORF:IOH45898	760	865	1449	959	1369	1031	1304	1131	2489	619	Anaphase-promoting complex subunit 11
B43R19C16	43-16-19	Hs~Ref:NM_001002244.1~uORF:IOH45898	451	338	1356	950	984	1050	1342	1070	2432	575	Anaphase-promoting complex subunit 11
B43R19C17	43-17-19	Hs~Ref:NM_018485.1~uORF:IOH39439	732	711	952	567	914	829	1054	728	1874	498	G protein-coupled receptor 77 (GPR77)
B43R19C18	43-18-19	Hs~Ref:NM_018485.1~uORF:IOH39439	768	799	930	607	1826	763	1079	730	1773	472	G protein-coupled receptor 77 (GPR77)
B43R19C19	43-19-19	Hs~Ref:XM_370664.2~uORF:IOH44703	767	776	1451	1275	4510	1166	995	916	4185	449	Coiled-coil domain-containing protein 15
B43R19C20	43-20-19	Hs~Ref:XM_370664.2~uORF:IOH44703	680	807	1432	1329	482	1295	874	886	4460	420	Coiled-coil domain-containing protein 15
B43R19C21	43-21-19	Hs~Ref:NM_181608.1~uORF:IOH34903	442	500	431	340	251	553	459	408	732	242	keratin associated protein 19-2 (KRTAP19-2)
B43R19C22	43-22-19	Hs~Ref:NM_181608.1~uORF:IOH34903	471	435	449	312	260	327	435	376	689	174	keratin associated protein 19-2 (KRTAP19-2)
B43R20C01	43-1-20	Hs~Ref:NM_153750.1~uORF:IOH43458	2027	567	1106	605	531	1949	1145	637	1104	247	chromosome 21 open reading frame 81 (C21orf81)
B43R20C02	43-2-20	Hs~Ref:NM_153750.1~uORF:IOH43458	1985	612	1178	586	834	2580	1196	632	1071	234	chromosome 21 open reading frame 81 (C21orf81)
B43R20C03	43-3-20	Hs~Ref:NM_006763.2~uORF:IOH41569	348	395	436	263	250	1862	463	213	455	90	BTG family, member 2 (BTG2)
B43R20C04	43-4-20	Hs~Ref:NM_006763.2~uORF:IOH41569	368	386	429	251	116	240	469	282	502	54	BTG family, member 2 (BTG2)
B43R20C05	43-5-20	Hs~Ref:NM_133491.2~uORF:IOH12374	777	1275	1017	1150	810	973	848	903	1317	340	spermidine/spermine N1-acetyltransferase 2 (SAT2)
B43R20C06	43-6-20	Hs~Ref:NM_133491.2~uORF:IOH12374	799	1222	1049	1070	734	1079	836	959	1266	344	spermidine/spermine N1-acetyltransferase 2 (SAT2)
B43R20C07	43-7-20	Hs~MGC:BC005155.1~uORF:IOH5175	383	257	449	257	239	401	385	416	469	80	Rho guanine nucleotide exchange factor 1
B43R20C08	43-8-20	Hs~MGC:BC005155.1~uORF:IOH5175	447	287	473	264	256	403	376	337	521	91	Rho guanine nucleotide exchange factor 1
B43R20C09	43-9-20	Hs~MGC:BC017048.1~uORF:IOH10387	386	314	404	255	325	525	517	404	525	127	gap junction protein, beta 2, 26kDa (GJB2)
B43R20C10	43-10-20	Hs~MGC:BC017048.1~uORF:IOH10387	385	313	423	295	381	482	524	384	528	92	gap junction protein, beta 2, 26kDa (GJB2)
B43R20C11	43-11-20	Hs~Ref:NM_004530.1~uORF:IOH4128	760	573	1008	374	927	606	536	452	748	192	matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (MMP2)
B43R20C12	43-12-20	Hs~Ref:NM_004530.1~uORF:IOH4128	1502	570	964	403	3934	686	565	492	630	32	matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (MMP2)
B43R20C13	43-13-20	Hs~Ref:NM_002903.1~uORF:IOH4436	2013	1350	1286	2368	6011	831	4436	1397	1023	418	recoverin (RCVRN)
B43R20C14	43-14-20	Hs~Ref:NM_002903.1~uORF:IOH4436	1464	1332	1248	2299	5147	1170	4380	1504	1078	448	recoverin (RCVRN)
B44R02C11	44-11-2	Hs~Ref:NM_006651.2~uORF:IOH4343	-1	5	-3	3	2504	3399	15440	17217	10288	3796	complexin 1 (CPLX1)
B44R02C12	44-12-2	Hs~Ref:NM_006651.2~uORF:IOH4343	4	1	10	26	6725	3098	15471	15933	9666	3371	complexin 1 (CPLX1)
B44R02C13	44-13-2	Hs~MGC:BC002437.1~uORF:IOH4246	1561	948	2731	1069	4240	961	1783	2086	3327	-14	exosome component 3 (EXOSC3)
B44R02C14	44-14-2	Hs~MGC:BC002437.1~uORF:IOH4246	1455	931	2496	4953	74	782	1787	1937	2332	137	exosome component 3 (EXOSC3)
B44R02C15	44-15-2	Hs~MGC:BC006794.1~uORF:IOH3178	1527	1232	2201	1540	1097	1129	1680	1423	1497	517	interferon induced transmembrane protein 3 (1-8U) (IFITM3)
B44R02C16	44-16-2	Hs~MGC:BC006794.1~uORF:IOH3178	1662	1186	2198	1360	1310	1077	1659	1456	1437	-138	interferon induced transmembrane protein 3 (1-8U) (IFITM3)
B44R02C17	44-17-2	Hs~MGC:BC029402.1~uORF:IOH23135	1531	668	1093	2649	2212	171	1993	727	900	-59	proteasome (prosome, macropain) subunit, alpha type, 3 (PSMA3)
B44R02C18	44-18-2	Hs~MGC:BC029402.1~uORF:IOH23135	1658	655	1075	2501	3528	575	2016	735	1412	-208	proteasome (prosome, macropain) subunit, alpha type, 3 (PSMA3)
B44R02C19	44-19-2	Hs~Ref:NM_001448.2~uORF:IOH25750	1272	1360	2180	789	828	1088	1145	1130	4	336	glypican 4 (GPC4)
B44R02C20	44-20-2	Hs~Ref:NM_001448.2~uORF:IOH25750	1313	1380	2166	789	864	1110	1124	1014	598	443	glypican 4 (GPC4)
B44R02C21	44-21-2	Hs~Ref:NM_016046.2~uORF:IOH11580	1447	1717	2070	952	948	1306	1765	2249	3324	493	exosome component 1 (EXOSC1)
B44R02C22	44-22-2	Hs~Ref:NM_016046.2~uORF:IOH11580	1412	1584	2034	949	1249	1324	1760	2147	3393	507	exosome component 1 (EXOSC1)
B44R03C01	44-1-3	Hs~MGC:BC018823.2~uORF:IOH14860	3977	1687	3257	2652	3142	2162	4465	1922	14904	4937	splicing factor, arginine/serine-rich 5 (SFRS5)
B44R03C02	44-2-3	Hs~MGC:BC018823.2~uORF:IOH14860	3472	1658	3205	2613	4776	2160	4265	1856	14331	5280	splicing factor, arginine/serine-rich 5 (SFRS5)
B44R03C03	44-3-3	Hs~Ref:NM_012328.1~uORF:IOH22212	2188	1295	2458	1079	1476	1270	1944	1232	2602	5546	DnaJ (Hsp40) homolog, subfamily B, member 9 (DNAJB9)
B44R03C04	44-4-3	Hs~Ref:NM_012328.1~uORF:IOH22212	1456	1291	2338	1097	1550	1325	1907	1280	2295	467	DnaJ (Hsp40) homolog, subfamily B, member 9 (DNAJB9)
B44R03C05	44-5-3	Hs~Ref:NM_197957.2~uORF:IOH41003	448	750	375	1008	600	1296	748	569	1470	201	MYC associated factor X (MAX), transcript variant 6
B44R03C06	44-6-3	Hs~Ref:NM_197957.2~uORF:IOH41003	360	768	415	974	582	1223	700	464	1189	276	MYC associated factor X (MAX), transcript variant 6
B44R03C07	44-7-3	Hs~MGC:NM_201263.1~uORF:IOH43175	894	1706	2622	660	942	581	623	622	104	27	tryptophanyl tRNA synthetase 2, mitochondrial (WARS2), nuclear gene encoding mitochondrial protein, transcript variant 2
B44R03C08	44-8-3	Hs~MGC:NM_201263.1~uORF:IOH43175	916	1744	2570	808	902	678	730	768	36	100	tryptophanyl tRNA synthetase 2, mitochondrial (WARS2), nuclear gene encoding mitochondrial protein, transcript variant 2
B44R03C09	44-9-3	Hs~Ref:XM_371311.3~uORF:IOH42993	793	1705	2529	1647	769	2193	6786	8243	7428	371	PREDICTED: Homo sapiens hypothetical protein FLJ36032 (FLJ36032)
B44R03C10	44-10-3	Hs~Ref:XM_371311.3~uORF:IOH42993	813	1719	2494	1531	633	2064	6754	7769	7713	-101	PREDICTED: Homo sapiens hypothetical protein FLJ36032 (FLJ36032)
B44R03C11	44-11-3	Hs~Ref:NM_138623.2~uORF:IOH42179	828	3001	12494	599	609	2159	1497	806	3719	288	BCL2-like 11 (apoptosis facilitator) (BCL2L11), transcript variant 3
B44R03C12	44-12-3	Hs~Ref:NM_138623.2~uORF:IOH42179	802	3048	12079	756	3376	2064	1508	750	6631	131	BCL2-like 11 (apoptosis facilitator) (BCL2L11), transcript variant 3
B44R03C15	44-15-3	Hs~Ref:NM_198491.1~uORF:IOH41015	797	593	806	1051	874	432	733	453	1117	161	family with sequence similarity 92, member B (FAM92B)
B44R03C16	44-16-3	Hs~Ref:NM_198491.1~uORF:IOH41015	806	602	845	1256	924	410	912	484	813	-81	family with sequence similarity 92, member B (FAM92B)
B44R03C17	44-17-3	Hs~Ref:NM_139161.2~uORF:IOH43543	211	305	347	380	464	416	1495	324	142	18	crumbs homolog 3 (Drosophila) (CRB3), transcript variant 2
B44R03C18	44-18-3	Hs~Ref:NM_139161.2~uORF:IOH43543	268	282	313	183	1153	357	1534	351	344	-66	crumbs homolog 3 (Drosophila) (CRB3), transcript variant 2
B44R03C19	44-19-3	Hs~Ref:NM_004875.2~uORF:IOH42058	550	625	653	423	2398	654	536	428	1454	-40	polymerase (RNA) I polypeptide C, 30kDa (POLR1C), transcript variant 2
B44R03C20	44-20-3	Hs~Ref:NM_004875.2~uORF:IOH42058	535	571	589	409	320	715	571	428	1647	-31	polymerase (RNA) I polypeptide C, 30kDa (POLR1C), transcript variant 2
B44R03C21	44-21-3	Hs~MGC:BC011515.1~uORF:IOH9684	808	726	853	575	540	800	1010	668	1613	-34	tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) (TAZ)
B44R03C22	44-22-3	Hs~MGC:BC011515.1~uORF:IOH9684	845	741	827	557	535	209	1035	597	1102	-14	tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) (TAZ)
B44R04C01	44-1-4	Hs~MGC:BC007783.2~uORF:IOH6518	861	690	654	369	725	743	778	529	1068	146	chemokine (C-C motif) ligand 3-like 3 (CCL3L3)
B44R04C02	44-2-4	Hs~MGC:BC007783.2~uORF:IOH6518	813	707	663	371	2642	770	767	508	1100	126	chemokine (C-C motif) ligand 3-like 3 (CCL3L3)
B44R04C03	44-3-4	Hs~MGC:BC015799.1~uORF:IOH10121	808	793	402	449	404	495	482	456	18	509	caspase 7, apoptosis-related cysteine peptidase (CASP7)
B44R04C04	44-4-4	Hs~MGC:BC015799.1~uORF:IOH10121	758	804	395	474	369	674	569	584	345	178	caspase 7, apoptosis-related cysteine peptidase (CASP7)
B44R04C05	44-5-4	Hs~MGC:BC025369.1~uORF:IOH14349	790	868	362	517	430	7369	590	1144	231	103	ubiquitin carboxyl-terminal hydrolase L5 (UCHL5)
B44R04C06	44-6-4	Hs~MGC:BC025369.1~uORF:IOH14349	783	866	394	487	336	7137	604	1108	1073	97	ubiquitin carboxyl-terminal hydrolase L5 (UCHL5)
B44R04C07	44-7-4	Hs~MGC:BC033130.1~uORF:IOH23218	935	876	1129	704	532	711	996	695	1073	298	lysyl oxidase-like 3 (LOXL3)
B44R04C08	44-8-4	Hs~MGC:BC033130.1~uORF:IOH23218	1131	886	1098	766	752	699	896	648	1164	299	lysyl oxidase-like 3 (LOXL3)
B44R04C09	44-9-4	Hs~MGC:BC020873.1~uORF:IOH12323	1619	1340	1420	1014	978	1046	1475	930	1302	1225	chloride channel Kb (CLCNKB)
B44R04C10	44-10-4	Hs~MGC:BC020873.1~uORF:IOH12323	1179	1275	1375	1016	1603	1048	1532	890	1806	352	chloride channel Kb (CLCNKB)
B44R04C11	44-11-4	Hs~Ref:NM_018464.2~uORF:IOH7211	1348	1390	1436	1239	728	1393	1475	1164	2092	727	CDGSH iron sulfur domain 1 (CISD1)
B44R04C12	44-12-4	Hs~Ref:NM_018464.2~uORF:IOH7211	1337	1370	1431	1226	4978	1292	1477	1062	1957	1074	CDGSH iron sulfur domain 1 (CISD1)
B44R04C13	44-13-4	Hs~Ref:NM_001544.2~uORF:IOH23172	1525	1154	1412	1173	1708	1472	2130	1037	2007	962	intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) (ICAM4), transcript variant 1
B44R04C14	44-14-4	Hs~Ref:NM_001544.2~uORF:IOH23172	1649	1199	1465	1317	1697	1466	2282	1023	2071	887	intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) (ICAM4), transcript variant 1
B44R04C15	44-15-4	Hs~Ref:NM_016648.1~uORF:IOH41297	2898	2240	7120	12152	4258	12558	8631	2504	18711	1753	La ribonucleoprotein domain family, member 7 (LARP7), transcript variant 1
B44R04C16	44-16-4	Hs~Ref:NM_016648.1~uORF:IOH41297	2816	2119	6916	11316	3800	13615	8937	2423	18089	1483	La ribonucleoprotein domain family, member 7 (LARP7), transcript variant 1
B44R04C17	44-17-4	Hs~Ref:NM_206919.1~uORF:IOH43014	3543	2454	2712	1222	2070	1729	1944	472	831	115	ADP-ribosylation factor-like 9 (ARL9)
B44R04C18	44-18-4	Hs~Ref:NM_206919.1~uORF:IOH43014	3859	2181	2840	1177	2027	832	2025	479	880	112	ADP-ribosylation factor-like 9 (ARL9)
B44R04C19	44-19-4	Hs~Ref:NM_004701.2~uORF:IOH41218	7462	5160	4861	4077	8665	5045	5626	5427	6387	2527	cyclin B2 (CCNB2)
B44R04C20	44-20-4	Hs~Ref:NM_004701.2~uORF:IOH41218	7744	4646	5134	3979	17771	4908	5470	5221	6864	3145	cyclin B2 (CCNB2)
B44R04C21	44-21-4	Hs~Ref:NM_172178.1~uORF:IOH44756	662	579	707	331	477	178	570	299	37	6	mitochondrial ribosomal protein L42 (MRPL42), nuclear gene encoding mitochondrial protein, transcript variant 3
B44R04C22	44-22-4	Hs~Ref:NM_172178.1~uORF:IOH44756	766	589	689	317	386	429	592	306	11	22	mitochondrial ribosomal protein L42 (MRPL42), nuclear gene encoding mitochondrial protein, transcript variant 3
B44R05C01	44-1-5	Hs~MGC:NM_016533.4~uORF:IOH43470	651	754	769	625	1311	529	637	682	1383	105	ninjurin 2 (NINJ2)
B44R05C02	44-2-5	Hs~MGC:NM_016533.4~uORF:IOH43470	620	798	820	640	1762	572	645	691	1181	88	ninjurin 2 (NINJ2)
B44R05C03	44-3-5	Hs~Ref:NM_173084.1~uORF:IOH43187	816	503	776	315	87	165	594	283	278	241	Tripartite motif-containing protein 59
B44R05C04	44-4-5	Hs~Ref:NM_173084.1~uORF:IOH43187	499	445	710	318	278	197	544	283	313	39	Tripartite motif-containing protein 59
B44R05C07	44-7-5	Hs~Ref:NM_012451.2~uORF:IOH43189	791	868	1847	1561	620	523	896	614	56	176	synaptogyrin 4 (SYNGR4)
B44R05C08	44-8-5	Hs~Ref:NM_012451.2~uORF:IOH43189	913	932	1892	1470	482	508	949	590	1838	164	synaptogyrin 4 (SYNGR4)
B44R05C09	44-9-5	Hs~MGC:BC048980.1~uORF:IOH26755	888	575	745	387	248	504	1058	498	192	103	protein kinase, AMP-activated, alpha 1 catalytic subunit (PRKAA1)
B44R05C10	44-10-5	Hs~MGC:BC048980.1~uORF:IOH26755	678	567	762	420	494	548	1014	607	806	164	protein kinase, AMP-activated, alpha 1 catalytic subunit (PRKAA1)
B44R05C11	44-11-5	Hs~Ref:NM_001007545.1~uORF:IOH40706	1130	965	861	556	405	867	1048	575	760	235	HEAT repeat containing 1 (HEATR1)
B44R05C12	44-12-5	Hs~Ref:NM_001007545.1~uORF:IOH40706	1107	998	858	479	322	867	1063	527	798	259	HEAT repeat containing 1 (HEATR1)
B44R05C13	44-13-5	Hs~MGC:BC045655.1~uORF:IOH27726	1252	937	1496	501	2339	1029	1928	677	761	222	transmembrane protein 97 (TMEM97)
B44R05C14	44-14-5	Hs~MGC:BC045655.1~uORF:IOH27726	1231	924	1450	523	1444	1047	1971	670	1009	-18	transmembrane protein 97 (TMEM97)
B44R05C15	44-15-5	Hs~Ref:NM_016167.3~uORF:IOH40609	2993	1359	1511	1252	1195	2021	14419	1862	3419	609	nucleolar protein 7, 27kDa (NOL7)
B44R05C16	44-16-5	Hs~Ref:NM_016167.3~uORF:IOH40609	2941	1345	1523	1279	1433	1974	14549	1793	3284	673	nucleolar protein 7, 27kDa (NOL7)
B44R05C17	44-17-5	Hs~Ref:NM_133640.3~uORF:IOH42523	819	1738	3253	1873	1088	16586	1490	1608	1909	738	Mediator of RNA polymerase II transcription subunit 22
B44R05C18	44-18-5	Hs~Ref:NM_133640.3~uORF:IOH42523	902	1648	3205	1826	1044	16012	1509	1549	1909	705	Mediator of RNA polymerase II transcription subunit 22
B44R05C19	44-19-5	Hs~Ref:NM_173842.1~uORF:IOH42169	389	514	398	383	1921	339	1167	869	753	222	Interleukin-1 receptor antagonist protein
B44R05C20	44-20-5	Hs~Ref:NM_173842.1~uORF:IOH42169	407	481	389	330	460	650	1199	857	798	-112	Interleukin-1 receptor antagonist protein
B44R05C21	44-21-5	Hs~Ref:NM_007066.3~uORF:IOH42371	848	1060	883	65	1690	421	244	246	593	429	cAMP-dependent protein kinase inhibitor gamma
B44R05C22	44-22-5	Hs~Ref:NM_007066.3~uORF:IOH42371	879	1054	865	60	210	290	243	103	586	-34	cAMP-dependent protein kinase inhibitor gamma
B44R06C01	44-1-6	Hs~Ref:NM_002735.1~uORF:IOH42254	1030	1488	1336	1904	1145	1650	1662	3137	1107	128	cAMP-dependent protein kinase type I-beta regulatory subunit
B44R06C02	44-2-6	Hs~Ref:NM_002735.1~uORF:IOH42254	960	1479	1274	1409	824	1570	1690	3044	983	137	cAMP-dependent protein kinase type I-beta regulatory subunit
B44R06C03	44-3-6	Hs~MGC:BC004440.1~uORF:IOH5013	737	801	1296	1413	3030	934	1330	562	1483	802	ninjurin 1 (NINJ1)
B44R06C04	44-4-6	Hs~MGC:BC004440.1~uORF:IOH5013	473	695	1129	941	607	737	1233	593	1784	184	ninjurin 1 (NINJ1)
B44R06C05	44-5-6	Hs~Ref:NM_004738.1~uORF:IOH4934	1359	917	3266	3271	746	191	20	3	470	-1	VAMP (vesicle-associated membrane protein)-associated protein B and C (VAPB)
B44R06C06	44-6-6	Hs~Ref:NM_004738.1~uORF:IOH4934	1375	910	3204	2839	823	-21	-14	1	207	-3	VAMP (vesicle-associated membrane protein)-associated protein B and C (VAPB)
B44R06C07	44-7-6	Hs~MGC:BC009010.1~uORF:IOH3292	1328	963	3071	2839	854	2833	3290	1350	5211	550	Uncharacterized protein C6orf142 homolog
B44R06C08	44-8-6	Hs~MGC:BC009010.1~uORF:IOH3292	1347	973	3022	2676	49	2817	3277	1263	5299	488	Uncharacterized protein C6orf142 homolog
B44R06C09	44-9-6	Hs~Ref:NM_019103.1~uORF:IOH9858	755	671	808	465	356	467	827	401	130	5	zinc finger, matrin type 5 (ZMAT5), transcript variant 1
B44R06C10	44-10-6	Hs~Ref:NM_019103.1~uORF:IOH9858	699	658	820	611	581	467	702	371	774	112	zinc finger, matrin type 5 (ZMAT5), transcript variant 1
B44R06C11	44-11-6	Hs~Ref:NM_138278.1~uORF:IOH11810	947	940	1128	793	688	867	1227	1142	2880	436	BCL2/adenovirus E1B 19kD interacting protein like (BNIPL)
B44R06C12	44-12-6	Hs~Ref:NM_138278.1~uORF:IOH11810	934	918	1171	849	862	865	1274	1082	2274	302	BCL2/adenovirus E1B 19kD interacting protein like (BNIPL)
B44R06C13	44-13-6	Hs~MGC:BC033726.1~uORF:IOH21784	1141	1075	1312	1242	4254	1221	1970	1023	3288	1084	coiled-coil domain containing 82 (CCDC82)
B44R06C14	44-14-6	Hs~MGC:BC033726.1~uORF:IOH21784	1060	1001	1228	1293	2983	1179	1834	1039	3043	-10	coiled-coil domain containing 82 (CCDC82)
B44R06C15	44-15-6	Hs~MGC:BC033752.1~uORF:IOH21873	978	720	898	1112	1269	874	1023	537	1384	-12	cytochrome P450, family 20, subfamily A, polypeptide 1 (CYP20A1)
B44R06C16	44-16-6	Hs~MGC:BC033752.1~uORF:IOH21873	1030	693	916	1116	976	904	1008	508	1415	-10	cytochrome P450, family 20, subfamily A, polypeptide 1 (CYP20A1)
B44R06C17	44-17-6	Hs~MGC:BC029112.1~uORF:IOH22118	5593	924	1183	6438	1266	1626	3350	1012	3759	341	SAM domain, SH3 domain and nuclear localization signals 1 (SAMSN1)
B44R06C18	44-18-6	Hs~MGC:BC029112.1~uORF:IOH22118	6195	846	1194	5523	1209	1495	3407	958	3704	776	SAM domain, SH3 domain and nuclear localization signals 1 (SAMSN1)
B44R06C19	44-19-6	Hs~Ref:NM_201262.1~uORF:IOH41260	447	1269	5870	703	1851	10299	2545	424	1326	1206	DnaJ (Hsp40) homolog, subfamily C, member 12 (DNAJC12), transcript variant 2
B44R06C20	44-20-6	Hs~Ref:NM_201262.1~uORF:IOH41260	444	1247	5626	563	840	9970	2613	435	1347	1206	DnaJ (Hsp40) homolog, subfamily C, member 12 (DNAJC12), transcript variant 2
B44R06C21	44-21-6	Hs~Ref:NM_153045.2~uORF:IOH41169	274	193	311	154	2598	217	356	1199	149	16	chromosome 9 open reading frame 91 (C9orf91)
B44R06C22	44-22-6	Hs~Ref:NM_153045.2~uORF:IOH41169	182	218	332	166	89	61	370	96	87	20	chromosome 9 open reading frame 91 (C9orf91)
B44R07C01	44-1-7	Hs~Ref:NM_003996.2~uORF:IOH60395	648	2625	1367	1187	2843	660	1701	956	3608	191	glutathione peroxidase 5 (epididymal androgen-related protein) (GPX5), transcript variant 2, mRNA.
B44R07C02	44-2-7	Hs~Ref:NM_003996.2~uORF:IOH60395	696	2521	1471	761	2599	697	1723	941	1536	104	glutathione peroxidase 5 (epididymal androgen-related protein) (GPX5), transcript variant 2, mRNA.
B44R07C05	44-5-7	Hs~Ref:NM_005465.3~uORF:IOH37801	4685	788	983	1085	596	5279	2174	1557	1984	373	v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (AKT3), transcript variant 1
B44R07C06	44-6-7	Hs~Ref:NM_005465.3~uORF:IOH37801	4297	783	958	1022	-10	5011	2175	1470	1905	367	v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (AKT3), transcript variant 1
B44R07C07	44-7-7	Hs~Ref:NM_016369.3~uORF:IOH41005	778	712	1218	424	314	511	650	2788	541	169	claudin 18 (CLDN18), transcript variant 1
B44R07C08	44-8-7	Hs~Ref:NM_016369.3~uORF:IOH41005	776	738	1272	423	355	518	651	2693	250	-8	claudin 18 (CLDN18), transcript variant 1
B44R07C09	44-9-7	Hs~Ref:NM_000148.2~uORF:IOH41006	677	998	2080	290	567	331	452	324	1862	314	fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) (FUT1)
B44R07C10	44-10-7	Hs~Ref:NM_000148.2~uORF:IOH41006	728	1015	2177	435	589	336	485	374	1495	305	fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) (FUT1)
B44R07C11	44-11-7	Hs~Ref:NM_014445.2~uORF:IOH41298	1002	1501	3385	3710	841	2887	2021	1923	2719	756	stress-associated endoplasmic reticulum protein 1 (SERP1)
B44R07C12	44-12-7	Hs~Ref:NM_014445.2~uORF:IOH41298	954	1484	3361	1629	816	2889	2053	1922	2809	712	stress-associated endoplasmic reticulum protein 1 (SERP1)
B44R07C13	44-13-7	Hs~MGC:BC002519.2~uORF:IOH62827	1271	1652	1274	3476	1201	8842	6201	5788	3537	1423	Bifunctional polynucleotide phosphatase/kinase
B44R07C14	44-14-7	Hs~MGC:BC002519.2~uORF:IOH62827	1231	1584	1248	2169	1403	8411	6068	5776	3521	1538	Bifunctional polynucleotide phosphatase/kinase
B44R07C17	44-17-7	Hs~MGC:BC066341.1~uORF:IOH61487	615	1921	1077	564	2298	415	825	592	1526	156	Ferritin heavy chain
B44R07C18	44-18-7	Hs~MGC:BC066341.1~uORF:IOH61487	681	1917	1050	520	2410	825	778	473	1444	163	Ferritin heavy chain
B44R07C19	44-19-7	Hs~MGC:BC089041.1~uORF:IOH63113	5159	696	760	880	1628	1032	610	420	1854	185	Guanine nucleotide-binding protein subunit alpha-11
B44R07C20	44-20-7	Hs~MGC:BC089041.1~uORF:IOH63113	5041	705	756	855	639	330	569	471	1796	76	Guanine nucleotide-binding protein subunit alpha-11
B44R07C21	44-21-7	Hs~MGC:BC065731.1~uORF:IOH62864	432	469	657	532	2930	628	1011	1050	1628	3698	Neutrophil cytosol factor 1
B44R07C22	44-22-7	Hs~MGC:BC065731.1~uORF:IOH62864	469	482	624	549	1373	699	927	913	1781	3844	Neutrophil cytosol factor 1
B44R08C01	44-1-8	Hs~MGC:BC047476.1~uORF:IOH62399	379	449	606	598	450	231	425	321	1776	-27	N-terminal kinase-like-binding protein 1
B44R08C02	44-2-8	Hs~MGC:BC047476.1~uORF:IOH62399	468	411	590	528	421	157	452	343	181	-16	N-terminal kinase-like-binding protein 1
B44R08C03	44-3-8	Hs~Ref:NM_000577.3~uORF:IOH57147	687	280	371	604	313	191	600	419	459	61	Interleukin-1 receptor antagonist protein
B44R08C04	44-4-8	Hs~Ref:NM_000577.3~uORF:IOH57147	192	293	347	796	293	184	568	388	544	60	Interleukin-1 receptor antagonist protein
B44R08C05	44-5-8	Hs~Ref:NM_000689.3~uORF:IOH57094	604	753	749	263	540	327	224	192	296	40	Retinal dehydrogenase 1
B44R08C06	44-6-8	Hs~Ref:NM_000689.3~uORF:IOH57094	641	738	752	206	439	194	231	201	-12	28	Retinal dehydrogenase 1
B44R08C07	44-7-8	Hs~MGC:BC031655.1~uORF:IOH22760	686	393	1639	604	307	838	1051	769	2073	492	chromosome 1 open reading frame 38 (C1orf38)
B44R08C08	44-8-8	Hs~MGC:BC031655.1~uORF:IOH22760	686	400	1668	593	305	783	1087	768	2128	603	chromosome 1 open reading frame 38 (C1orf38)
B44R08C09	44-9-8	Hs~MGC:BC000788.1~uORF:IOH4609	2240	336	4521	319	228	486	1073	754	765	53	chromosome 19 open reading frame 62 (HSPC142)
B44R08C10	44-10-8	Hs~MGC:BC000788.1~uORF:IOH4609	527	351	4411	296	230	475	1075	719	976	78	chromosome 19 open reading frame 62 (HSPC142)
B44R08C11	44-11-8	Hs~Ref:NM_006623.1~uORF:IOH3438	1116	336	707	884	604	361	612	930	562	90	phosphoglycerate dehydrogenase (PHGDH)
B44R08C12	44-12-8	Hs~Ref:NM_006623.1~uORF:IOH3438	1132	366	721	788	583	363	611	890	561	95	phosphoglycerate dehydrogenase (PHGDH)
B44R08C13	44-13-8	Hs~MGC:BC004349.1~uORF:IOH4355	1907	1385	5481	977	905	1365	3985	1565	2628	495	RAN binding protein 3 (RANBP3)
B44R08C14	44-14-8	Hs~MGC:BC004349.1~uORF:IOH4355	1570	1324	5348	923	853	1376	3957	1288	2598	596	RAN binding protein 3 (RANBP3)
B44R08C15	44-15-8	Hs~Ref:NM_002243.2~uORF:IOH13007	831	801	1000	760	563	685	929	641	2469	55	potassium inwardly-rectifying channel, subfamily J, member 15 (KCNJ15), transcript variant 2
B44R08C16	44-16-8	Hs~Ref:NM_002243.2~uORF:IOH13007	889	727	993	786	619	794	983	667	2143	78	potassium inwardly-rectifying channel, subfamily J, member 15 (KCNJ15), transcript variant 2
B44R08C17	44-17-8	Hs~MGC:BC014095.2~uORF:IOH14089	826	866	1176	1472	750	2978	1837	1072	1768	151	v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) (RELA)
B44R08C18	44-18-8	Hs~MGC:BC014095.2~uORF:IOH14089	901	853	1145	1414	698	2734	1856	1015	1710	235	v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) (RELA)
B44R08C19	44-19-8	Hs~MGC:BC001709.1~uORF:IOH4911	994	990	838	2021	557	1486	6430	1269	3063	247	NAD kinase (NADK)
B44R08C20	44-20-8	Hs~MGC:BC001709.1~uORF:IOH4911	946	1010	796	2056	1133	1322	6511	1296	3220	253	NAD kinase (NADK)
B44R08C21	44-21-8	Hs~Ref:NM_003943.1~uORF:IOH14388	647	664	754	613	521	501	877	607	1746	248	starch binding domain 1 (STBD1)
B44R08C22	44-22-8	Hs~Ref:NM_003943.1~uORF:IOH14388	708	596	738	564	726	486	818	643	1904	92	starch binding domain 1 (STBD1)
B44R09C01	44-1-9	Hs~Ref:NM_153012.1~uORF:IOH12147	1469	1227	1211	905	504	1156	4174	1712	1647	319	Tumor necrosis factor ligand superfamily member 12
B44R09C02	44-2-9	Hs~Ref:NM_153012.1~uORF:IOH12147	1488	993	1181	877	489	1202	4166	1232	1562	368	Tumor necrosis factor ligand superfamily member 12
B44R09C03	44-3-9	Hs~MGC:BC006375.2~uORF:IOH6475	1808	1175	1545	1112	506	1250	3011	943	1615	145	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2)
B44R09C04	44-4-9	Hs~MGC:BC006375.2~uORF:IOH6475	1783	1137	1480	1127	599	1169	2896	782	1361	138	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2)
B44R09C05	44-5-9	Hs~MGC:BC001222.1~uORF:IOH4460	953	398	589	475	344	595	943	422	721	279	tripartite motif-containing 62 (TRIM62)
B44R09C06	44-6-9	Hs~MGC:BC001222.1~uORF:IOH4460	824	426	675	520	579	525	932	404	135	67	tripartite motif-containing 62 (TRIM62)
B44R09C07	44-7-9	Hs~Ref:NM_001183.3~uORF:IOH4722	607	537	721	2212	335	409	693	369	-40	66	ATPase, H+ transporting, lysosomal accessory protein 1 (ATP6AP1)
B44R09C08	44-8-9	Hs~Ref:NM_001183.3~uORF:IOH4722	1391	525	696	1608	352	519	675	370	317	50	ATPase, H+ transporting, lysosomal accessory protein 1 (ATP6AP1)
B44R09C09	44-9-9	Hs~Ref:NM_005804.2~uORF:IOH3477	1005	826	666	2100	303	1011	1225	805	998	199	DEAD (Asp-Glu-Ala-Asp) box polypeptide 39 (DDX39)
B44R09C10	44-10-9	Hs~Ref:NM_005804.2~uORF:IOH3477	661	819	642	484	332	1082	1164	753	1287	-26	DEAD (Asp-Glu-Ala-Asp) box polypeptide 39 (DDX39)
B44R09C11	44-11-9	Hs~MGC:BC001467.1~uORF:IOH4030	419	322	387	329	84	509	1629	420	348	-45	acireductone dioxygenase 1 (ADI1)
B44R09C12	44-12-9	Hs~MGC:BC001467.1~uORF:IOH4030	424	351	409	730	228	531	1609	372	600	33	acireductone dioxygenase 1 (ADI1)
B44R09C13	44-13-9	Hs~Ref:NM_006701.2~uORF:IOH3749	948	1243	1072	1233	1736	1193	3864	1081	1560	1284	thioredoxin-like 4A (TXNL4A)
B44R09C14	44-14-9	Hs~Ref:NM_006701.2~uORF:IOH3749	900	1274	1006	1094	1668	1165	3935	1129	1982	1689	thioredoxin-like 4A (TXNL4A)
B44R09C15	44-15-9	Hs~Ref:NM_021130.1~uORF:IOH4329	2170	1227	1446	1131	1079	1525	1609	945	3068	863	peptidylprolyl isomerase A (cyclophilin A) (PPIA)
B44R09C16	44-16-9	Hs~Ref:NM_021130.1~uORF:IOH4329	2216	1246	1458	1146	1085	1586	1592	1006	2743	724	peptidylprolyl isomerase A (cyclophilin A) (PPIA)
B44R09C17	44-17-9	Hs~MGC:BC057792.1~uORF:IOH29128	831	394	497	566	197	421	561	509	713	50	carbonic anhydrase IV (CA4)
B44R09C18	44-18-9	Hs~MGC:BC057792.1~uORF:IOH29128	830	360	494	594	195	443	592	498	719	-43	carbonic anhydrase IV (CA4)
B44R09C19	44-19-9	Hs~MGC:BC035721.1~uORF:IOH28747	1000	925	845	701	553	1147	1258	540	1281	-15	mitochondrial GTPase 1 homolog (S. cerevisiae) (MTG1)
B44R09C20	44-20-9	Hs~MGC:BC035721.1~uORF:IOH28747	1008	997	834	677	609	1277	1254	555	1241	-31	mitochondrial GTPase 1 homolog (S. cerevisiae) (MTG1)
B44R10C01	44-1-10	Hs~MGC:BC022319.1~uORF:IOH12335	1249	6274	1373	1072	757	1709	1962	1293	2883	572	alcohol dehydrogenase 4 (class II), pi polypeptide (ADH4)
B44R10C02	44-2-10	Hs~MGC:BC022319.1~uORF:IOH12335	1310	6022	1419	1044	676	1689	2035	1127	2928	521	alcohol dehydrogenase 4 (class II), pi polypeptide (ADH4)
B44R10C03	44-3-10	Hs~MGC:BC004368.1~uORF:IOH5600	-1	-2	453	-1	340	1306	519	629	1276	70	proteasome (prosome, macropain) activator subunit 2 (PA28 beta) (PSME2)
B44R10C04	44-4-10	Hs~MGC:BC004368.1~uORF:IOH5600	4	0	2	0	355	1193	539	605	1216	27	proteasome (prosome, macropain) activator subunit 2 (PA28 beta) (PSME2)
B44R10C05	44-5-10	Hs~MGC:BC053866.1~uORF:IOH28947	1562	1833	1992	1032	632	1893	6017	1530	2039	550	endothelin 3 (EDN3)
B44R10C06	44-6-10	Hs~MGC:BC053866.1~uORF:IOH28947	1592	1783	2000	1354	652	1817	6048	1535	2078	531	endothelin 3 (EDN3)
B44R10C07	44-7-10	Hs~MGC:BC053365.1~uORF:IOH29003	1219	1265	1353	1999	1032	1446	2145	2591	4226	670	ribosomal protein S6 kinase, 70kDa, polypeptide 1 (RPS6KB1)
B44R10C08	44-8-10	Hs~MGC:BC053365.1~uORF:IOH29003	1432	1272	1328	1516	162	1391	2136	2551	4398	582	ribosomal protein S6 kinase, 70kDa, polypeptide 1 (RPS6KB1)
B44R11C21	44-21-11	Hs~MGC:BC050419.1~uORF:IOH26677	2436	3265	2422	940	3495	5563	3595	982	3378	727	leucine rich repeat containing 48 (LRRC48)
B44R11C22	44-22-11	Hs~MGC:BC050419.1~uORF:IOH26677	2494	3254	2316	849	2565	5416	3270	936	3354	692	leucine rich repeat containing 48 (LRRC48)
B44R12C01	44-1-12	Hs~Ref:NM_003668.2~uORF:IOH28010	4234	9243	5093	10129	7775	6630	7982	6620	7993	1967	mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5), transcript variant 1
B44R12C02	44-2-12	Hs~Ref:NM_003668.2~uORF:IOH28010	4149	9227	5145	9215	8632	6423	8245	6789	7797	1795	mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5), transcript variant 1
B44R12C03	44-3-12	Hs~MGC:BC005072.1~uORF:IOH6573	1310	981	1462	833	1261	1219	1679	1536	2140	532	hypothetical protein MGC13008 (MGC13008)
B44R12C04	44-4-12	Hs~MGC:BC005072.1~uORF:IOH6573	1349	1027	1471	821	1218	1208	1805	1496	2150	438	hypothetical protein MGC13008 (MGC13008)
B44R12C05	44-5-12	Hs~Ref:NM_022006.1~uORF:IOH12523	855	821	1001	1046	1442	1256	3287	1653	2578	469	FXYD domain containing ion transport regulator 7 (FXYD7)
B44R12C06	44-6-12	Hs~Ref:NM_022006.1~uORF:IOH12523	814	782	915	965	1531	1265	3303	1555	2655	326	FXYD domain containing ion transport regulator 7 (FXYD7)
B44R12C07	44-7-12	Hs~Ref:NM_014551.3~uORF:IOH3660	438	572	502	26	329	119	102	1526	-55	11	non-SMC condensin II complex, subunit H2 (NCAPH2), transcript variant 1
B44R12C08	44-8-12	Hs~Ref:NM_014551.3~uORF:IOH3660	416	573	527	580	111	170	120	715	115	28	non-SMC condensin II complex, subunit H2 (NCAPH2), transcript variant 1
B44R12C09	44-9-12	Hs~Ref:NM_001130.5~uORF:IOH59679	700	897	844	999	619	1019	690	462	903	599	Amino-terminal enhancer of split
B44R12C10	44-10-12	Hs~Ref:NM_001130.5~uORF:IOH59679	600	810	877	1161	469	919	717	435	946	528	Amino-terminal enhancer of split
B44R12C11	44-11-12	Hs~MGC:BC103694.1~uORF:IOH63599	702	292	322	729	390	158	91	18	71	6	NKG2D ligand 4
B44R12C12	44-12-12	Hs~MGC:BC103694.1~uORF:IOH63599	183	360	354	1015	339	11	51	322	130	5	NKG2D ligand 4
B44R12C13	44-13-12	Hs~MGC:BC010852.1~uORF:IOH9927	1399	993	1122	1620	1440	867	1011	531	1431	63	Aflatoxin B1 aldehyde reductase member 2
B44R12C14	44-14-12	Hs~MGC:BC010852.1~uORF:IOH9927	1249	961	1123	1535	1416	835	1011	529	2555	297	Aflatoxin B1 aldehyde reductase member 2
B44R12C15	44-15-12	Hs~MGC:BC030665.1~uORF:IOH22451	822	402	831	1667	46	667	947	485	2202	194	Sulfotransferase 4A1
B44R12C16	44-16-12	Hs~MGC:BC030665.1~uORF:IOH22451	1027	386	794	2046	373	624	966	448	2221	90	Sulfotransferase 4A1
B44R12C17	44-17-12	Hs~MGC:BC027476.1~uORF:IOH11961	3904	346	781	401	657	512	567	402	615	7	CCR4-NOT transcription complex, subunit 6, mRNA (cDNA clone IMAGE:5000764), complete cds.
B44R12C18	44-18-12	Hs~MGC:BC027476.1~uORF:IOH11961	884	390	902	431	539	497	593	365	615	102	CCR4-NOT transcription complex, subunit 6, mRNA (cDNA clone IMAGE:5000764), complete cds.
B44R12C19	44-19-12	Hs~MGC:BC100766.2~uORF:IOH63422	1533	447	1814	519	1536	1238	1634	453	454	11	Glycoprotein Xg
B44R12C20	44-20-12	Hs~MGC:BC100766.2~uORF:IOH63422	1368	474	1820	534	1500	1492	1524	431	861	151	Glycoprotein Xg
B44R12C21	44-21-12	Hs~MGC:BC100813.1~uORF:IOH63506	321	277	413	325	173	244	578	272	631	91	Putative T-complex protein 1 subunit theta-like 2
B44R12C22	44-22-12	Hs~MGC:BC100813.1~uORF:IOH63506	912	231	404	317	172	654	547	279	648	20	Putative T-complex protein 1 subunit theta-like 2
B44R13C01	44-1-13	Hs~Ref:NM_024692.3~uORF:IOH42634	4564	1792	2045	2532	2334	2191	2962	2282	3393	1526	CAP-GLY domain containing linker protein family, member 4 (CLIP4)
B44R13C02	44-2-13	Hs~Ref:NM_024692.3~uORF:IOH42634	3874	1762	2185	2381	2072	2149	3154	2323	3214	1216	CAP-GLY domain containing linker protein family, member 4 (CLIP4)
B44R13C03	44-3-13	Hs~Ref:NM_014622.4~uORF:IOH41880	2067	1841	2389	2459	1189	1997	3270	2086	2881	666	loss of heterozygosity, 11, chromosomal region 2, gene A (LOH11CR2A), transcript variant 1
B44R13C04	44-4-13	Hs~Ref:NM_014622.4~uORF:IOH41880	1547	1908	2451	2620	1214	1945	3198	1861	2861	708	loss of heterozygosity, 11, chromosomal region 2, gene A (LOH11CR2A), transcript variant 1
B44R13C05	44-5-13	Hs~Ref:NM_023015.3~uORF:IOH41890	985	1670	1826	693	1432	615	1144	1723	1765	272	integrator complex subunit 3 (INTS3)
B44R13C06	44-6-13	Hs~Ref:NM_023015.3~uORF:IOH41890	1046	1647	1856	661	1176	651	1139	1623	1870	293	integrator complex subunit 3 (INTS3)
B44R13C07	44-7-13	Hs~Ref:NM_182597.1~uORF:IOH44503	1493	3714	2554	2879	2586	1162	2430	2536	7811	808	Coiled-coil domain-containing transmembrane protein C7orf53
B44R13C08	44-8-13	Hs~Ref:NM_182597.1~uORF:IOH44503	1515	3550	2466	2634	2304	1137	2451	2447	7592	818	Coiled-coil domain-containing transmembrane protein C7orf53
B44R13C09	44-9-13	Hs~Ref:NM_080650.1~uORF:IOH7567	1475	513	1267	515	429	1430	1229	639	1566	139	ATP binding domain 4 (ATPBD4)
B44R13C10	44-10-13	Hs~Ref:NM_080650.1~uORF:IOH7567	1494	511	1284	531	431	1364	1215	656	1654	138	ATP binding domain 4 (ATPBD4)
B44R13C11	44-11-13	Hs~MGC:BC017237.1~uORF:IOH14458	718	677	697	726	456	924	1433	1240	975	1	Syntaxin-10
B44R13C12	44-12-13	Hs~MGC:BC017237.1~uORF:IOH14458	699	741	718	727	397	953	1375	1168	975	753	Syntaxin-10
B44R13C13	44-13-13	Hs~MGC:NM_014346.1~uORF:IOH22792	947	602	762	1563	407	935	1788	393	976	166	TBC1 domain family, member 22A (TBC1D22A)
B44R13C14	44-14-13	Hs~MGC:NM_014346.1~uORF:IOH22792	910	583	704	1560	21	857	1811	379	1019	168	TBC1 domain family, member 22A (TBC1D22A)
B44R13C15	44-15-13	Hs~Ref:NM_001394.3~uORF:IOH21147	2	4	197	3456	1549	-2	-2	-4	-2	35	dual specificity phosphatase 4 (DUSP4), transcript variant 1
B44R13C16	44-16-13	Hs~Ref:NM_001394.3~uORF:IOH21147	8	-1	-6	4312	1896	0	-2	1	-2	-4	dual specificity phosphatase 4 (DUSP4), transcript variant 1
B44R13C17	44-17-13	Hs~MGC:BC015165.1~uORF:IOH9890	2017	465	1425	535	529	2542	1352	1010	5925	250	exocyst complex component 7 (EXOC7)
B44R13C18	44-18-13	Hs~MGC:BC015165.1~uORF:IOH9890	1925	397	1573	597	477	2540	1400	1011	5500	197	exocyst complex component 7 (EXOC7)
B44R13C19	44-19-13	Hs~MGC:BC022893.1~uORF:IOH13672	960	440	640	432	122	729	2262	440	1698	45	potassium channel tetramerisation domain containing 6 (KCTD6)
B44R13C20	44-20-13	Hs~MGC:BC022893.1~uORF:IOH13672	971	510	685	448	221	530	2262	381	1563	12	potassium channel tetramerisation domain containing 6 (KCTD6)
B44R13C21	44-21-13	Hs~MGC:BC004921.1~uORF:IOH5220	751	498	688	561	311	328	1904	1796	1000	-3	hypothetical protein BC004921 (LOC93349)
B44R13C22	44-22-13	Hs~MGC:BC004921.1~uORF:IOH5220	650	471	618	576	200	436	3168	1702	1016	40	hypothetical protein BC004921 (LOC93349)
B44R14C01	44-1-14	Hs~MGC:BC001430.1~uORF:IOH3991	1305	474	1081	378	263	544	741	376	761	208	processing of precursor 7, ribonuclease P/MRP subunit (S. cerevisiae) (POP7)
B44R14C02	44-2-14	Hs~MGC:BC001430.1~uORF:IOH3991	1169	585	1205	369	259	531	693	426	827	8	processing of precursor 7, ribonuclease P/MRP subunit (S. cerevisiae) (POP7)
B44R14C03	44-3-14	Hs~Ref:NM_001801.2~uORF:IOH54757	706	2030	1053	3944	585	998	778	843	941	236	Cysteine dioxygenase type 1
B44R14C04	44-4-14	Hs~Ref:NM_001801.2~uORF:IOH54757	540	2030	1051	3671	585	980	773	849	1011	235	Cysteine dioxygenase type 1
B44R14C09	44-9-14	Hs~Ref:NM_001012732.1~uORF:IOH54732	1298	1863	2363	1614	865	8493	3216	1264	2215	288	Deoxycytidylate deaminase
B44R14C10	44-10-14	Hs~Ref:NM_001012732.1~uORF:IOH54732	1144	1858	2312	1517	848	8435	3244	1183	2054	298	Deoxycytidylate deaminase
B44R14C11	44-11-14	Hs~MGC:BC016828.1~uORF:IOH23007	422	309	607	322	331	416	576	264	4	68	N-acylsphingosine amidohydrolase (acid ceramidase) 1, mRNA (cDNA clone MGC:24572 IMAGE:4109317), complete cds
B44R14C12	44-12-14	Hs~MGC:BC016828.1~uORF:IOH23007	476	310	581	391	889	474	553	377	423	-3	N-acylsphingosine amidohydrolase (acid ceramidase) 1, mRNA (cDNA clone MGC:24572 IMAGE:4109317), complete cds
B44R14C13	44-13-14	Hs~Ref:NM_000790.1~uORF:IOH3416	622	343	489	404	140	728	764	347	351	51	Aromatic-L-amino-acid decarboxylase
B44R14C14	44-14-14	Hs~Ref:NM_000790.1~uORF:IOH3416	660	348	473	163	127	805	783	307	371	49	Aromatic-L-amino-acid decarboxylase
B44R14C15	44-15-14	Hs~Ref:NM_002924.2~uORF:IOH11294	2554	683	1070	988	364	4668	2268	541	3157	113	Regulator of G-protein signaling 7
B44R14C16	44-16-14	Hs~Ref:NM_002924.2~uORF:IOH11294	2570	712	1022	983	47	4311	2191	568	2447	-23	Regulator of G-protein signaling 7
B44R14C17	44-17-14	Hs~MGC:BC103919.1~uORF:IOH63517	2061	363	580	381	370	359	829	512	5389	21	Vang-like protein 2
B44R14C18	44-18-14	Hs~MGC:BC103919.1~uORF:IOH63517	1984	400	577	360	688	601	869	436	5866	125	Vang-like protein 2
B44R14C19	44-19-14	Hs~MGC:BC036193.1~uORF:IOH27486	617	571	719	349	234	258	470	371	558	449	family with sequence similarity 26, member C (FAM26C)
B44R14C20	44-20-14	Hs~MGC:BC036193.1~uORF:IOH27486	560	488	684	377	239	328	528	334	516	216	family with sequence similarity 26, member C (FAM26C)
B44R14C21	44-21-14	Hs~Ref:NM_006225.1~uORF:IOH20956	717	617	769	607	540	1047	1607	609	1312	90	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1
B44R14C22	44-22-14	Hs~Ref:NM_006225.1~uORF:IOH20956	664	619	672	603	558	672	1101	565	1284	71	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1
B44R15C01	44-1-15	Hs~MGC:BC104468.1~uORF:IOH63630	445	788	589	623	1060	825	630	439	1134	373	Outer dense fiber protein 3-like protein 2
B44R15C02	44-2-15	Hs~MGC:BC104468.1~uORF:IOH63630	476	858	744	645	1061	872	620	411	1146	286	Outer dense fiber protein 3-like protein 2
B44R15C05	44-5-15	Hs~Ref:NM_024294.1~uORF:IOH5168	632	724	954	27971	565	2252	3245	1959	1147	509	chromosome 6 open reading frame 106 (C6orf106), transcript variant 1
B44R15C06	44-6-15	Hs~Ref:NM_024294.1~uORF:IOH5168	625	697	977	27769	521	2156	3180	1878	1155	511	chromosome 6 open reading frame 106 (C6orf106), transcript variant 1
B44R15C07	44-7-15	Hs~MGC:BC014441.1~uORF:IOH13328	782	500	697	438	522	824	1479	575	1347	-12	NOL1/NOP2/Sun domain family, member 4 (NSUN4)
B44R15C08	44-8-15	Hs~MGC:BC014441.1~uORF:IOH13328	797	503	725	371	519	751	1467	571	1260	-27	NOL1/NOP2/Sun domain family, member 4 (NSUN4)
B44R15C11	44-11-15	Hs~MGC:BC004376.1~uORF:IOH5584	36	401	416	50	72	515	398	220	785	14	annexin A8 (ANXA8L1)
B44R15C12	44-12-15	Hs~MGC:BC004376.1~uORF:IOH5584	45	204	299	44	73	1431	432	246	229	23	annexin A8 (ANXA8L1)
B44R15C13	44-13-15	Hs~Ref:NM_002576.2~CAT:PV3820	8509	398	314	931	534	20109	1281	7561	654	136	Serine/threonine-protein kinase PAK 1
B44R15C14	44-14-15	Hs~Ref:NM_002576.2~CAT:PV3820	8217	408	294	977	593	19724	1296	7018	728	69	Serine/threonine-protein kinase PAK 1
B44R15C17	44-17-15	Hs~Ref:NM_004834.2~CAT:PV3687	170	311	254	127	341	480	650	282	546	236	Mitogen-activated protein kinase kinase kinase kinase 4
B44R15C18	44-18-15	Hs~Ref:NM_004834.2~CAT:PV3687	169	193	304	245	285	389	1564	279	565	115	Mitogen-activated protein kinase kinase kinase kinase 4
B44R15C19	44-19-15	Hs~Ref:NM_133494.1~CAT:PV3833	288	546	520	492	53	702	1809	397	885	212	NIMA (never in mitosis gene a)- related kinase 7 (NEK7)
B44R15C20	44-20-15	Hs~Ref:NM_133494.1~CAT:PV3833	294	353	512	485	217	634	541	379	1369	-8	NIMA (never in mitosis gene a)- related kinase 7 (NEK7)
B44R15C21	44-21-15	Hs~Ref:NM_000141.2~CAT:PV3368	152	364	474	487	247	328	720	339	387	63	fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant 1
B44R15C22	44-22-15	Hs~Ref:NM_000141.2~CAT:PV3368	313	210	400	431	56	335	1401	346	523	76	fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant 1
B44R16C01	44-1-16	Hs~Ref:NM_000586.2~CAT_PHC0027	746	397	611	1176	386	222	420	216	671	330	interleukin 2 (IL2)
B44R16C02	44-2-16	Hs~Ref:NM_000586.2~CAT_PHC0027	742	447	618	1221	433	210	429	209	474	341	interleukin 2 (IL2)
B44R16C03	44-3-16	Hs~Ref:NM_002982.1~CAT_PHC1015	203	79	201	724	95	51	152	71	183	3	chemokine (C-C motif) ligand 2 (CCL2)
B44R16C04	44-4-16	Hs~Ref:NM_002982.1~CAT_PHC1015	218	80	63	10	74	108	125	51	136	11	chemokine (C-C motif) ligand 2 (CCL2)
B44R16C05	44-5-16	Hs~Ref:NM_002651.1~CAT:PV5277	2404	628	197	338	380	2326	756	471	925	363	Phosphatidylinositol 4-kinase beta
B44R16C06	44-6-16	Hs~Ref:NM_002651.1~CAT:PV5277	2442	615	261	275	251	2305	775	1661	1044	431	Phosphatidylinositol 4-kinase beta
B44R16C07	44-7-16	Hs~Ref:NM_032315.1~uORF:IOH5083	475	454	634	318	293	540	823	847	586	137	solute carrier family 25, member 33 (SLC25A33)
B44R16C08	44-8-16	Hs~Ref:NM_032315.1~uORF:IOH5083	526	485	586	307	384	436	813	603	554	119	solute carrier family 25, member 33 (SLC25A33)
B44R16C09	44-9-16	Hs~Ref:NM_006370.1~uORF:IOH5143	580	528	704	356	397	2024	648	552	1071	243	vesicle transport through interaction with t-SNAREs homolog 1B (yeast) (VTI1B)
B44R16C10	44-10-16	Hs~Ref:NM_006370.1~uORF:IOH5143	623	629	696	339	305	2269	707	577	19	146	vesicle transport through interaction with t-SNAREs homolog 1B (yeast) (VTI1B)
B44R16C11	44-11-16	Hs~Ref:NM_000628.3~uORF:IOH4959	198	520	894	300	112	1573	522	356	101	110	interleukin 10 receptor, beta (IL10RB)
B44R16C12	44-12-16	Hs~Ref:NM_000628.3~uORF:IOH4959	394	502	873	320	296	1953	543	303	176	98	interleukin 10 receptor, beta (IL10RB)
B44R16C13	44-13-16	Hs~Ref:NM_007263.3~uORF:IOH5090	2976	585	1030	358	199	1457	845	454	724	116	coatomer protein complex, subunit epsilon (COPE), transcript variant 1
B44R16C14	44-14-16	Hs~Ref:NM_007263.3~uORF:IOH5090	424	596	1035	338	566	1021	842	439	742	115	coatomer protein complex, subunit epsilon (COPE), transcript variant 1
B44R16C15	44-15-16	Hs~Ref:NM_199359.1~uORF:IOH41594	3775	1942	713	512	567	3803	1829	646	1535	432	tumor protein D52-like 2 (TPD52L2), transcript variant 6, mRNA.
B44R16C16	44-16-16	Hs~Ref:NM_199359.1~uORF:IOH41594	3734	1945	706	506	555	3420	1770	618	1506	372	tumor protein D52-like 2 (TPD52L2), transcript variant 6, mRNA.
B44R16C17	44-17-16	Hs~Ref:NM_181337.2~uORF:IOH50149	2523	925	1855	1074	808	790	1211	1406	1839	247	Kidney-associated antigen 1
B44R16C18	44-18-16	Hs~Ref:NM_181337.2~uORF:IOH50149	2474	924	1943	1089	797	768	1515	1301	1876	192	Kidney-associated antigen 1
B44R16C19	44-19-16	Hs~Ref:NM_181655.1~uORF:IOH50196	1684	1251	2514	1152	1113	1180	2755	1435	2827	894	UPF0450 protein C17orf58
B44R16C20	44-20-16	Hs~Ref:NM_181655.1~uORF:IOH50196	1658	1325	2516	1115	1134	1299	2129	1429	2781	818	UPF0450 protein C17orf58
B44R16C21	44-21-16	Hs~Ref:NM_152876.1~uORF:IOH50154	1317	982	2001	921	962	1762	2412	1117	3096	421	Tumor necrosis factor receptor superfamily member 6
B44R16C22	44-22-16	Hs~Ref:NM_152876.1~uORF:IOH50154	1239	930	1918	922	957	1679	2326	1063	2989	21	Tumor necrosis factor receptor superfamily member 6
B44R17C01	44-1-17	Hs~Ref:NM_002512.1~uORF:IOH4345	412	722	425	301	392	414	470	748	957	135	non-metastatic cells 2, protein (NM23B) expressed in (NME2), transcript variant 1
B44R17C02	44-2-17	Hs~Ref:NM_002512.1~uORF:IOH4345	336	751	424	330	408	973	477	740	930	152	non-metastatic cells 2, protein (NM23B) expressed in (NME2), transcript variant 1
B44R17C03	44-3-17	Hs~MGC:BC015547.1~uORF:IOH10337	490	468	565	290	339	934	827	881	729	471	uridine-cytidine kinase 1 (UCK1)
B44R17C04	44-4-17	Hs~MGC:BC015547.1~uORF:IOH10337	508	398	545	718	382	691	805	878	696	519	uridine-cytidine kinase 1 (UCK1)
B44R17C05	44-5-17	Hs~MGC:BC011365.1~uORF:IOH9656	2877	1562	1021	99	827	-4	3	8	2	-2	glyoxalase I (GLO1)
B44R17C06	44-6-17	Hs~MGC:BC011365.1~uORF:IOH9656	530	1628	1024	-6	806	1	-1	6	1	-1	glyoxalase I (GLO1)
B44R17C07	44-7-17	Hs~MGC:NM_015138.2~uORF:IOH10055	2956	1633	1127	594	924	1098	1889	1163	1144	362	Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) (RTF1)
B44R17C08	44-8-17	Hs~MGC:NM_015138.2~uORF:IOH10055	3285	1610	1157	472	869	1216	1749	1193	1256	329	Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) (RTF1)
B44R17C09	44-9-17	Hs~Ref:NM_016212.1~uORF:IOH35032	435	432	565	356	377	1746	511	643	1623	206	TP53TG3 protein (TP53TG3)
B44R17C10	44-10-17	Hs~Ref:NM_016212.1~uORF:IOH35032	282	464	542	353	362	1877	518	636	1452	106	TP53TG3 protein (TP53TG3)
B44R17C11	44-11-17	Hs~Ref:NM_019618.2~uORF:IOH35169	305	268	572	232	168	137	298	233	512	123	interleukin 1 family, member 9 (IL1F9)
B44R17C12	44-12-17	Hs~Ref:NM_019618.2~uORF:IOH35169	295	233	542	191	164	478	306	248	514	118	interleukin 1 family, member 9 (IL1F9)
B44R17C13	44-13-17	Hs~Ref:NM_013357.2~uORF:IOH35581	1133	703	911	565	654	1028	3190	802	831	2	purine-rich element binding protein G (PURG), transcript variant A
B44R17C14	44-14-17	Hs~Ref:NM_013357.2~uORF:IOH35581	1266	834	905	571	489	1057	3084	805	1040	203	purine-rich element binding protein G (PURG), transcript variant A
B44R17C15	44-15-17	Hs~Ref:NM_175065.2~uORF:IOH35055	1592	697	1069	623	553	1082	3493	611	2241	228	histone cluster 2, H2ab (HIST2H2AB)
B44R17C16	44-16-17	Hs~Ref:NM_175065.2~uORF:IOH35055	1568	660	1070	628	470	1106	3513	563	2211	105	histone cluster 2, H2ab (HIST2H2AB)
B44R17C17	44-17-17	Hs~MGC:BC090049.1~uORF:IOH62587	102	300	384	270	62	219	345	226	111	547	Mesoderm-specific transcript homolog protein
B44R17C18	44-18-17	Hs~MGC:BC090049.1~uORF:IOH62587	159	331	439	296	97	-5	343	235	149	39	Mesoderm-specific transcript homolog protein
B44R17C21	44-21-17	Hs~MGC:BC056414.1~uORF:IOH29116	63	47	330	412	39	542	342	966	340	11	plasmalemma vesicle associated protein (PLVAP)
B44R17C22	44-22-17	Hs~MGC:BC056414.1~uORF:IOH29116	46	52	255	110	30	390	340	235	408	91	plasmalemma vesicle associated protein (PLVAP)
B44R18C01	44-1-18	Hs~MGC:BC033537.1~uORF:IOH27639	363	125	319	66	141	3186	282	83	208	30	KIAA1576 protein (KIAA1576)
B44R18C02	44-2-18	Hs~MGC:BC033537.1~uORF:IOH27639	171	192	322	614	110	3006	271	93	52	30	KIAA1576 protein (KIAA1576)
B44R18C03	44-3-18	Hs~MGC:BC034528.1~uORF:IOH22201	467	693	1133	24	437	68	187	200	53	19	serpin peptidase inhibitor, clade B (ovalbumin), member 8 (SERPINB8)
B44R18C04	44-4-18	Hs~MGC:BC034528.1~uORF:IOH22201	448	622	1138	662	448	429	151	343	156	18	serpin peptidase inhibitor, clade B (ovalbumin), member 8 (SERPINB8)
B44R18C05	44-5-18	Hs~Ref:NM_002790.1~uORF:IOH29609	965	1264	2219	617	1047	1188	756	992	2117	230	proteasome (prosome, macropain) subunit, alpha type, 5 (PSMA5)
B44R18C06	44-6-18	Hs~Ref:NM_002790.1~uORF:IOH29609	1084	1110	2212	461	888	796	749	896	2100	251	proteasome (prosome, macropain) subunit, alpha type, 5 (PSMA5)
B44R18C07	44-7-18	Hs~Ref:NM_018400.1~uORF:IOH29595	511	127	908	1495	111	1196	408	583	974	125	sodium channel, voltage-gated, type III, beta (SCN3B), transcript variant 1
B44R18C08	44-8-18	Hs~Ref:NM_018400.1~uORF:IOH29595	1028	169	903	410	335	673	415	456	941	118	sodium channel, voltage-gated, type III, beta (SCN3B), transcript variant 1
B44R18C09	44-9-18	Hs~MGC:BC058031.1~uORF:IOH29444	78	104	403	365	191	227	352	249	243	46	haptoglobin (HP)
B44R18C10	44-10-18	Hs~MGC:BC058031.1~uORF:IOH29444	121	3	330	267	78	493	368	200	248	48	haptoglobin (HP)
B44R18C11	44-11-18	Hs~MGC:BC073841.1~uORF:IOH61759	891	1834	955	1304	876	1625	10136	5528	5992	1712	Kinesin light chain 3
B44R18C12	44-12-18	Hs~MGC:BC073841.1~uORF:IOH61759	951	1842	947	1247	827	1628	10180	5644	5748	1499	Kinesin light chain 3
B44R18C15	44-15-18	Hs~MGC:BC093068.1~uORF:IOH63191	1284	860	1121	922	530	972	4320	1189	1125	394	Elongation factor Ts, mitochondrial
B44R18C16	44-16-18	Hs~MGC:BC093068.1~uORF:IOH63191	1250	816	1087	862	497	922	4455	1120	1188	346	Elongation factor Ts, mitochondrial
B44R18C17	44-17-18	Hs~MGC:BC068456.1~uORF:IOH62464	726	607	1503	460	527	1627	2290	707	1202	219	14-3-3 protein zeta/delta
B44R18C18	44-18-18	Hs~MGC:BC068456.1~uORF:IOH62464	587	580	1444	436	577	1530	1938	691	1328	908	14-3-3 protein zeta/delta
B44R19C03	44-3-19	Hs~MGC:BC032842.1~uORF:IOH62113	602	898	660	606	521	386	461	273	528	201	family with sequence similarity 71, member F1, mRNA (cDNA clone MGC:32919 IMAGE:4829634), complete cds.
B44R19C04	44-4-19	Hs~MGC:BC032842.1~uORF:IOH62113	640	964	619	549	509	661	535	249	427	147	family with sequence similarity 71, member F1, mRNA (cDNA clone MGC:32919 IMAGE:4829634), complete cds.
B44R19C05	44-5-19	Hs~MGC:BC066948.1~uORF:IOH61473	11663	11093	10652	2534	9454	1290	767	772	2812	1464	Ubiquitin-conjugating enzyme E2 S
B44R19C06	44-6-19	Hs~MGC:BC066948.1~uORF:IOH61473	11466	11359	11302	2531	9662	1232	768	762	2596	1828	Ubiquitin-conjugating enzyme E2 S
B44R19C09	44-9-19	Hs~MGC:BC050696.1~uORF:IOH27004	321	935	635	582	578	1858	680	1866	1077	259	chromosome 12 open reading frame 48 (C12orf48)
B44R19C10	44-10-19	Hs~MGC:BC050696.1~uORF:IOH27004	316	914	621	576	602	1763	634	2232	1088	220	chromosome 12 open reading frame 48 (C12orf48)
B44R19C11	44-11-19	Hs~MGC:BC040152.1~uORF:IOH26252	463	575	583	463	376	1244	522	486	546	268	dolichyl pyrophosphate phosphatase 1 (DOLPP1)
B44R19C12	44-12-19	Hs~MGC:BC040152.1~uORF:IOH26252	445	484	603	482	1102	1318	684	450	691	359	dolichyl pyrophosphate phosphatase 1 (DOLPP1)
B44R19C13	44-13-19	Hs~Ref:NM_052965.1~uORF:IOH56031	117	146	543	328	210	831	469	111	412	40	tRNA-splicing endonuclease subunit Sen15
B44R19C14	44-14-19	Hs~Ref:NM_052965.1~uORF:IOH56031	102	150	583	47	202	783	580	130	392	29	tRNA-splicing endonuclease subunit Sen15
B44R19C15	44-15-19	Hs~Ref:NM_004595.2~uORF:IOH57117	536	530	639	52	484	495	1164	201	195	-10	Spermine synthase
B44R19C16	44-16-19	Hs~Ref:NM_004595.2~uORF:IOH57117	537	556	675	105	408	340	1327	184	1044	1	Spermine synthase
B44R19C17	44-17-19	Hs~Ref:NM_002575.1~uORF:IOH53975	831	740	796	206	663	919	479	191	401	184	Plasminogen activator inhibitor 2
B44R19C18	44-18-19	Hs~Ref:NM_002575.1~uORF:IOH53975	832	783	821	96	655	188	443	152	399	65	Plasminogen activator inhibitor 2
B44R19C19	44-19-19	Hs~Ref:NM_032958.3~uORF:IOH58649	2005	2204	1932	724	2143	576	848	847	3366	311	DNA directed RNA polymerase II polypeptide J-related  [Source:RefSeq peptide;Acc:NP_116581]
B44R19C20	44-20-19	Hs~Ref:NM_032958.3~uORF:IOH58649	2177	2162	1887	722	2177	681	840	845	3541	248	DNA directed RNA polymerase II polypeptide J-related  [Source:RefSeq peptide;Acc:NP_116581]
B44R19C21	44-21-19	Hs~Ref:NM_015492.2~uORF:IOH4170	289	466	1474	382	223	23550	565	615	1145	126	Uncharacterized protein C15orf39
B44R19C22	44-22-19	Hs~Ref:NM_015492.2~uORF:IOH4170	432	317	1421	334	197	21053	587	457	599	121	Uncharacterized protein C15orf39
B44R20C01	44-1-20	Hs~Ref:NM_002469.1~uORF:IOH13806	644	617	815	482	660	1212	1195	708	1523	234	myogenic factor 6 (herculin) (MYF6)
B44R20C02	44-2-20	Hs~Ref:NM_002469.1~uORF:IOH13806	645	647	799	489	718	1145	1209	725	1619	190	myogenic factor 6 (herculin) (MYF6)
B44R20C03	44-3-20	Hs~Ref:NM_005032.2~uORF:IOH2504	436	691	731	1120	582	683	1545	518	1865	186	plastin 3 (T isoform) (PLS3)
B44R20C04	44-4-20	Hs~Ref:NM_005032.2~uORF:IOH2504	591	579	838	1052	587	617	1541	483	2235	281	plastin 3 (T isoform) (PLS3)
B44R20C05	44-5-20	Hs~MGC:BC001120.1~uORF:IOH3920	1110	1310	5077	3294	906	2553	2370	8518	3304	566	lectin, galactoside-binding, soluble, 3 (LGALS3)
B44R20C06	44-6-20	Hs~MGC:BC001120.1~uORF:IOH3920	1085	1284	4998	3089	908	2505	2457	8177	3217	565	lectin, galactoside-binding, soluble, 3 (LGALS3)
B44R20C07	44-7-20	Hs~Ref:NM_138422.1~uORF:IOH13417	834	899	1641	2015	1854	2007	4284	2316	3345	913	tRNA-specific adenosine deaminase-like protein 3
B44R20C08	44-8-20	Hs~Ref:NM_138422.1~uORF:IOH13417	850	881	1600	2080	1955	1952	4191	2299	3389	949	tRNA-specific adenosine deaminase-like protein 3
B44R20C09	44-9-20	Hs~Ref:NM_001833.1~uORF:IOH13701	817	671	1431	587	447	830	1114	1270	2282	111	clathrin, light chain (Lca) (CLTA), transcript variant 1, mRNA.
B44R20C10	44-10-20	Hs~Ref:NM_001833.1~uORF:IOH13701	836	681	1423	598	529	863	1113	1427	2287	290	clathrin, light chain (Lca) (CLTA), transcript variant 1, mRNA.
B44R20C11	44-11-20	Hs~Ref:NM_004394.1~uORF:IOH40583	1660	1578	2677	3286	1378	2636	4478	1903	4692	543	death-associated protein (DAP)
B44R20C12	44-12-20	Hs~Ref:NM_004394.1~uORF:IOH40583	1798	1645	2704	3117	1213	2604	4407	1714	4593	563	death-associated protein (DAP)
B44R20C13	44-13-20	Hs~MGC:BC065552.1~uORF:IOH40470	1853	1527	2221	1166	733	609	124	-12	7	4	isoleucyl-tRNA synthetase (IARS)
B44R20C14	44-14-20	Hs~MGC:BC065552.1~uORF:IOH40470	1720	1410	2512	1220	790	-8	2642	-4	95	5	isoleucyl-tRNA synthetase (IARS)
B45R02C11	45-11-2	Hs~Ref:NM_024514.4~uORF:IOH41000	290	463	414	235	160	310	1015	282	411	582	cytochrome P450, family 2, subfamily R, polypeptide 1 (CYP2R1)
B45R02C12	45-12-2	Hs~Ref:NM_024514.4~uORF:IOH41000	301	241	383	248	65	624	712	276	609	114	cytochrome P450, family 2, subfamily R, polypeptide 1 (CYP2R1)
B45R02C13	45-13-2	Hs~Ref:NM_018039.2~uORF:IOH43857	1952	1243	1705	1374	962	2065	8309	3891	2768	1532	jumonji domain containing 2D (JMJD2D)
B45R02C14	45-14-2	Hs~Ref:NM_018039.2~uORF:IOH43857	1960	1402	1647	1872	944	2180	6620	5467	2493	1294	jumonji domain containing 2D (JMJD2D)
B45R02C21	45-21-2	Hs~Ref:NM_138395.2~uORF:IOH43092	699	4851	976	742	829	960	1285	1356	6321	457	methionyl-tRNA synthetase 2, mitochondrial (MARS2), nuclear gene encoding mitochondrial protein
B45R02C22	45-22-2	Hs~Ref:NM_138395.2~uORF:IOH43092	742	1068	945	724	735	1185	1150	1423	5765	443	methionyl-tRNA synthetase 2, mitochondrial (MARS2), nuclear gene encoding mitochondrial protein
B45R03C01	45-1-3	Hs~Ref:NM_145174.1~uORF:IOH44767	1229	937	991	728	478	1317	2176	536	1233	284	DnaJ (Hsp40) homolog, subfamily B, member 7 (DNAJB7)
B45R03C02	45-2-3	Hs~Ref:NM_145174.1~uORF:IOH44767	1254	968	1038	878	446	1377	2302	482	1382	258	DnaJ (Hsp40) homolog, subfamily B, member 7 (DNAJB7)
B45R03C03	45-3-3	Hs~Ref:NM_197958.1~uORF:IOH43099	649	3065	2087	375	523	36601	1628	626	1467	201	La ribonucleoprotein domain family, member 6 (LARP6), transcript variant 2
B45R03C04	45-4-3	Hs~Ref:NM_197958.1~uORF:IOH43099	721	2546	2117	460	579	35907	1602	649	1424	205	La ribonucleoprotein domain family, member 6 (LARP6), transcript variant 2
B45R03C05	45-5-3	Hs~MGC:BC004969.1~uORF:IOH5105	1469	2622	357	420	3476	1631	610	1105	970	271	cDNA clone IMAGE:2906290, complete cds
B45R03C06	45-6-3	Hs~MGC:BC004969.1~uORF:IOH5105	1616	1466	346	460	3682	1620	612	1142	1101	317	cDNA clone IMAGE:2906290, complete cds
B45R03C07	45-7-3	Hs~Ref:NM_032886.1~uORF:IOH6980	547	539	702	681	441	672	748	653	1047	444	transmembrane protein 137 (TMEM137)
B45R03C08	45-8-3	Hs~Ref:NM_032886.1~uORF:IOH6980	517	556	678	446	482	719	741	899	1202	448	transmembrane protein 137 (TMEM137)
B45R03C09	45-9-3	Hs~Ref:NM_000999.2~uORF:IOH4263	1872	1107	1566	853	1396	1366	5627	1165	1811	539	ribosomal protein L38 (RPL38), transcript variant 1
B45R03C10	45-10-3	Hs~Ref:NM_000999.2~uORF:IOH4263	1859	1131	1661	869	1432	1422	5660	1061	1876	337	ribosomal protein L38 (RPL38), transcript variant 1
B45R03C11	45-11-3	Hs~Ref:NM_052861.1~uORF:IOH21487	803	580	791	508	2473	696	913	782	1511	518	hypothetical protein MGC21675 (MGC21675)
B45R03C12	45-12-3	Hs~Ref:NM_052861.1~uORF:IOH21487	742	623	817	503	612	667	1091	674	1348	312	hypothetical protein MGC21675 (MGC21675)
B45R03C13	45-13-3	Hs~Ref:NM_015633.1~uORF:IOH59821	496	470	712	355	405	520	1273	467	1301	176	FGFR1 oncogene partner 2
B45R03C14	45-14-3	Hs~Ref:NM_015633.1~uORF:IOH59821	513	460	710	377	423	521	953	408	1181	203	FGFR1 oncogene partner 2
B45R03C15	45-15-3	Hs~Ref:NM_005340.1~uORF:IOH3136	453	574	502	415	540	632	660	514	1478	277	histidine triad nucleotide binding protein 1 (HINT1)
B45R03C16	45-16-3	Hs~Ref:NM_005340.1~uORF:IOH3136	475	604	534	418	550	660	656	540	1536	185	histidine triad nucleotide binding protein 1 (HINT1)
B45R03C17	45-17-3	Hs~Ref:NM_012396.1~uORF:IOH12626	2356	1284	3395	1944	3333	1727	6590	1221	2911	711	pleckstrin homology-like domain, family A, member 3 (PHLDA3)
B45R03C18	45-18-3	Hs~Ref:NM_012396.1~uORF:IOH12626	2382	1278	3534	1870	3532	1659	6694	1168	2918	646	pleckstrin homology-like domain, family A, member 3 (PHLDA3)
B45R03C19	45-19-3	Hs~Ref:NM_006022.1~uORF:IOH3511	1474	4258	2143	809	930	2078	1338	862	1489	393	TSC22 domain family, member 1 (TSC22D1), transcript variant 2
B45R03C20	45-20-3	Hs~Ref:NM_006022.1~uORF:IOH3511	1521	1340	2067	837	974	2042	1326	808	1489	362	TSC22 domain family, member 1 (TSC22D1), transcript variant 2
B45R03C21	45-21-3	Hs~Ref:NM_016491.1~uORF:IOH4665	600	2371	429	394	343	475	430	349	777	240	mitochondrial ribosomal protein L37 (MRPL37), nuclear gene encoding mitochondrial protein
B45R03C22	45-22-3	Hs~Ref:NM_016491.1~uORF:IOH4665	557	1092	428	384	337	451	477	368	751	61	mitochondrial ribosomal protein L37 (MRPL37), nuclear gene encoding mitochondrial protein
B45R04C01	45-1-4	Hs~Ref:NM_016638.1~uORF:IOH4953	1353	5154	2428	5796	1449	5880	1646	2275	2564	857	ADP-ribosylation factor-like protein 6-interacting protein 4
B45R04C02	45-2-4	Hs~Ref:NM_016638.1~uORF:IOH4953	1367	5308	2423	6635	1437	5978	1675	2426	2614	855	ADP-ribosylation factor-like protein 6-interacting protein 4
B45R04C03	45-3-4	Hs~Ref:NM_021048.2~uORF:IOH5670	1172	1921	1955	1239	1476	1769	800	530	2660	182	melanoma antigen family A, 10 (MAGEA10), transcript variant 2
B45R04C04	45-4-4	Hs~Ref:NM_021048.2~uORF:IOH5670	1170	780	1968	1299	1744	1801	795	526	2827	170	melanoma antigen family A, 10 (MAGEA10), transcript variant 2
B45R04C05	45-5-4	Hs~Ref:NM_004813.1~uORF:IOH5041	524	306	558	365	260	520	652	379	600	203	peroxisomal biogenesis factor 16 (PEX16), transcript variant 1
B45R04C06	45-6-4	Hs~Ref:NM_004813.1~uORF:IOH5041	607	643	567	420	278	569	686	386	474	96	peroxisomal biogenesis factor 16 (PEX16), transcript variant 1
B45R04C07	45-7-4	Hs~Ref:NM_014315.1~uORF:IOH4690	339	323	410	1028	360	400	488	312	409	472	kelch domain containing 2 (KLHDC2)
B45R04C08	45-8-4	Hs~Ref:NM_014315.1~uORF:IOH4690	362	169	415	1397	281	403	460	476	423	133	kelch domain containing 2 (KLHDC2)
B45R04C09	45-9-4	Hs~Ref:NM_000984.2~uORF:IOH13591	4960	2215	2327	1826	1414	3223	21807	1717	3583	1040	ribosomal protein L23a (RPL23A)
B45R04C10	45-10-4	Hs~Ref:NM_000984.2~uORF:IOH13591	4958	2272	2369	1821	1421	3178	22169	1628	3479	1065	ribosomal protein L23a (RPL23A)
B45R04C11	45-11-4	Hs~Ref:NM_016467.1~uORF:IOH7173	387	320	388	264	469	390	389	585	362	409	ORM1-like 1 (S. cerevisiae) (ORMDL1)
B45R04C12	45-12-4	Hs~Ref:NM_016467.1~uORF:IOH7173	350	128	350	253	466	404	409	421	126	239	ORM1-like 1 (S. cerevisiae) (ORMDL1)
B45R04C13	45-13-4	Hs~MGC:BC022302.1~uORF:IOH14393	474	328	320	252	300	412	498	321	761	138	cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) (CMAH)
B45R04C14	45-14-4	Hs~MGC:BC022302.1~uORF:IOH14393	450	296	354	264	294	414	552	312	952	73	cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) (CMAH)
B45R04C15	45-15-4	Hs~Ref:NM_001324.1~uORF:IOH6092	1131	1259	968	2556	605	3057	1870	889	1647	357	cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa (CSTF1), transcript variant 2
B45R04C16	45-16-4	Hs~Ref:NM_001324.1~uORF:IOH6092	1185	1308	969	2402	635	2961	1799	813	1659	173	cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa (CSTF1), transcript variant 2
B45R04C17	45-17-4	Hs~Ref:NM_020165.2~uORF:IOH3060	2027	981	854	778	1058	2312	1785	999	1609	637	RAD18 homolog (S. cerevisiae) (RAD18)
B45R04C18	45-18-4	Hs~Ref:NM_020165.2~uORF:IOH3060	2011	1070	938	825	1052	2225	1743	792	1610	579	RAD18 homolog (S. cerevisiae) (RAD18)
B45R04C19	45-19-4	Hs~MGC:BC001600.1~uORF:IOH4905	466	2978	544	311	607	921	613	562	920	145	cell division cycle 123 homolog (S. cerevisiae) (CDC123)
B45R04C20	45-20-4	Hs~MGC:BC001600.1~uORF:IOH4905	472	243	533	308	639	930	623	550	935	145	cell division cycle 123 homolog (S. cerevisiae) (CDC123)
B45R04C21	45-21-4	Hs~Ref:NM_016091.1~uORF:IOH4743	465	1544	412	368	601	526	489	391	843	343	eukaryotic translation initiation factor 3, subunit E interacting protein (EIF3EIP)
B45R04C22	45-22-4	Hs~Ref:NM_016091.1~uORF:IOH4743	383	537	437	384	448	485	454	349	910	128	eukaryotic translation initiation factor 3, subunit E interacting protein (EIF3EIP)
B45R05C01	45-1-5	Hs~MGC:BC005241.1~uORF:IOH7257	28	24	249	25	237	224	296	222	98	145	MRE11 meiotic recombination 11 homolog A (S. cerevisiae) (MRE11A)
B45R05C02	45-2-5	Hs~MGC:BC005241.1~uORF:IOH7257	27	398	325	23	46	125	361	219	106	176	MRE11 meiotic recombination 11 homolog A (S. cerevisiae) (MRE11A)
B45R05C03	45-3-5	Hs~Ref:NM_022165.1~uORF:IOH12041	-1	5	3	518	1	-6	-3	2	37	-1	lin-7 homolog B (C. elegans) (LIN7B)
B45R05C04	45-4-5	Hs~Ref:NM_022165.1~uORF:IOH12041	0	-4	455	644	-2	-5	-4	165	1050	-3	lin-7 homolog B (C. elegans) (LIN7B)
B45R05C05	45-5-5	Hs~MGC:NM_153217.1~uORF:IOH13241	756	653	1163	624	534	2763	738	584	2876	897	transmembrane protein 174 (TMEM174)
B45R05C06	45-6-5	Hs~MGC:NM_153217.1~uORF:IOH13241	651	587	1191	660	582	2660	771	669	2484	941	transmembrane protein 174 (TMEM174)
B45R05C07	45-7-5	Hs~MGC:BC016914.1~uORF:IOH10995	948	871	940	871	734	961	812	789	1446	677	zinc finger, CCHC domain containing 4 (ZCCHC4)
B45R05C08	45-8-5	Hs~MGC:BC016914.1~uORF:IOH10995	753	766	841	930	745	967	813	795	1415	646	zinc finger, CCHC domain containing 4 (ZCCHC4)
B45R05C09	45-9-5	Hs~Ref:NM_144977.1~uORF:IOH11157	451	451	492	483	323	482	680	460	1021	162	DENN domain-containing protein 1B
B45R05C10	45-10-5	Hs~Ref:NM_144977.1~uORF:IOH11157	484	493	484	379	549	516	659	756	1162	398	DENN domain-containing protein 1B
B45R05C11	45-11-5	Hs~Ref:NM_014172.1~uORF:IOH10635	295	548	403	243	284	647	7827	2318	474	875	phosphohistidine phosphatase 1 (PHPT1)
B45R05C12	45-12-5	Hs~Ref:NM_014172.1~uORF:IOH10635	276	511	377	241	3719	673	8451	282	342	71	phosphohistidine phosphatase 1 (PHPT1)
B45R05C13	45-13-5	Hs~Ref:NM_144642.1~uORF:IOH10744	419	445	458	570	978	475	657	371	881	206	synaptoporin (SYNPR)
B45R05C14	45-14-5	Hs~Ref:NM_144642.1~uORF:IOH10744	376	375	456	540	408	488	648	363	926	265	synaptoporin (SYNPR)
B45R05C15	45-15-5	Hs~MGC:BC026349.1~uORF:IOH10888	1100	730	1337	945	482	905	751	444	1023	223	glutamate decarboxylase 1 (brain, 67kDa) (GAD1)
B45R05C16	45-16-5	Hs~MGC:BC026349.1~uORF:IOH10888	1168	774	1365	948	502	948	657	449	1096	183	glutamate decarboxylase 1 (brain, 67kDa) (GAD1)
B45R05C17	45-17-5	Hs~MGC:BC014181.1~uORF:IOH12954	385	324	394	247	314	479	431	299	649	236	coenzyme Q6 homolog, monooxygenase (S. cerevisiae) (COQ6)
B45R05C18	45-18-5	Hs~MGC:BC014181.1~uORF:IOH12954	356	380	405	291	342	533	466	318	748	193	coenzyme Q6 homolog, monooxygenase (S. cerevisiae) (COQ6)
B45R05C19	45-19-5	Hs~Ref:NM_017825.1~uORF:IOH12841	296	728	407	447	587	1076	5336	243	618	18	ADP-ribosylhydrolase like 2 (ADPRHL2)
B45R05C20	45-20-5	Hs~Ref:NM_017825.1~uORF:IOH12841	320	505	396	426	650	1082	5581	258	653	102	ADP-ribosylhydrolase like 2 (ADPRHL2)
B45R05C21	45-21-5	Hs~MGC:BC019268.1~uORF:IOH13177	1852	896	3367	912	1113	1660	2000	750	1933	1674	Protein arginine N-methyltransferase 1
B45R05C22	45-22-5	Hs~MGC:BC019268.1~uORF:IOH13177	1975	860	3394	884	998	1618	1846	781	2007	1677	Protein arginine N-methyltransferase 1
B45R06C01	45-1-6	Hs~Ref:NM_001381.2~uORF:IOH2343	7441	2729	2503	1664	1509	8681	2845	1652	4852	8975	docking protein 1, 62kDa (downstream of tyrosine kinase 1) (DOK1)
B45R06C02	45-2-6	Hs~Ref:NM_001381.2~uORF:IOH2343	8136	2703	2612	1811	1587	8413	2996	1682	5320	9160	docking protein 1, 62kDa (downstream of tyrosine kinase 1) (DOK1)
B45R06C03	45-3-6	Hs~Ref:NM_207005.1~uORF:IOH45744	2079	2165	1078	1038	387	930	1376	738	1439	261	upstream transcription factor 1 (USF1), transcript variant 2
B45R06C04	45-4-6	Hs~Ref:NM_207005.1~uORF:IOH45744	2152	2168	1030	1055	381	909	1283	722	1502	245	upstream transcription factor 1 (USF1), transcript variant 2
B45R06C05	45-5-6	Hs~Ref:NM_001001713.1~uORF:IOH45822	335	46	264	175	147	1347	429	480	406	355	SH3 domain binding glutamic acid-rich protein (SH3BGR), transcript variant 2
B45R06C06	45-6-6	Hs~Ref:NM_001001713.1~uORF:IOH45822	377	57	140	191	210	1347	438	428	477	26	SH3 domain binding glutamic acid-rich protein (SH3BGR), transcript variant 2
B45R06C07	45-7-6	Hs~Ref:NM_033481.2~uORF:IOH45897	521	259	354	280	474	415	486	246	501	461	F-box protein 9 (FBXO9), transcript variant 3
B45R06C08	45-8-6	Hs~Ref:NM_033481.2~uORF:IOH45897	366	815	377	246	380	470	474	247	538	141	F-box protein 9 (FBXO9), transcript variant 3
B45R06C09	45-9-6	Hs~Ref:NM_007310.1~uORF:IOH45773	272	1166	284	207	266	544	242	210	371	316	catechol-O-methyltransferase (COMT), transcript variant S-COMT
B45R06C10	45-10-6	Hs~Ref:NM_007310.1~uORF:IOH45773	277	153	276	237	213	521	243	401	416	296	catechol-O-methyltransferase (COMT), transcript variant S-COMT
B45R06C11	45-11-6	Hs~MGC:BC001801.1~uORF:IOH4461	4554	849	1449	1653	1616	2210	2104	2904	2377	612	hypothetical gene supported by BC001801 (LOC284912)
B45R06C12	45-12-6	Hs~MGC:BC001801.1~uORF:IOH4461	4983	839	1399	1572	1755	2252	2110	2627	2344	569	hypothetical gene supported by BC001801 (LOC284912)
B45R06C13	45-13-6	Hs~Ref:NM_014487.2~uORF:IOH4416	751	562	685	532	799	784	1555	894	1764	299	zinc finger protein 330 (ZNF330)
B45R06C14	45-14-6	Hs~Ref:NM_014487.2~uORF:IOH4416	743	624	691	464	635	656	1369	871	1567	417	zinc finger protein 330 (ZNF330)
B45R06C15	45-15-6	Hs~MGC:BC000718.1~uORF:IOH4584	658	514	629	401	1377	774	1186	1153	1753	454	dynactin 2 (p50) (DCTN2)
B45R06C16	45-16-6	Hs~MGC:BC000718.1~uORF:IOH4584	695	483	640	402	1359	789	1008	1090	1826	438	dynactin 2 (p50) (DCTN2)
B45R06C17	45-17-6	Hs~MGC:BC015221.1~uORF:IOH11566	309	319	615	181	312	745	851	438	748	143	tescalcin (TESC)
B45R06C18	45-18-6	Hs~MGC:BC015221.1~uORF:IOH11566	316	308	624	186	316	747	909	486	721	158	tescalcin (TESC)
B45R06C19	45-19-6	Hs~Ref:NM_006861.2~uORF:IOH10011	333	379	462	376	382	451	499	401	679	103	RAB35, member RAS oncogene family (RAB35)
B45R06C20	45-20-6	Hs~Ref:NM_006861.2~uORF:IOH10011	369	402	437	400	353	502	517	394	687	225	RAB35, member RAS oncogene family (RAB35)
B45R06C21	45-21-6	Hs~Ref:NM_021252.2~uORF:IOH10139	401	722	446	313	692	540	1143	434	671	195	RAB18, member RAS oncogene family (RAB18)
B45R06C22	45-22-6	Hs~Ref:NM_021252.2~uORF:IOH10139	357	609	421	333	440	621	1151	365	740	113	RAB18, member RAS oncogene family (RAB18)
B45R07C01	45-1-7	Hs~Ref:NM_016530.1~uORF:IOH12810	544	517	537	351	625	570	676	412	1096	240	RAB8B, member RAS oncogene family (RAB8B)
B45R07C02	45-2-7	Hs~Ref:NM_016530.1~uORF:IOH12810	542	425	529	400	617	619	854	458	1071	301	RAB8B, member RAS oncogene family (RAB8B)
B45R07C03	45-3-7	Hs~MGC:BC008950.2~uORF:IOH56909	536	247	400	339	440	506	620	643	949	188	Prenylated Rab acceptor protein 1
B45R07C04	45-4-7	Hs~MGC:BC008950.2~uORF:IOH56909	538	294	398	349	438	480	571	621	1049	141	Prenylated Rab acceptor protein 1
B45R07C05	45-5-7	Hs~Ref:NM_020990.2~uORF:IOH5022	421	1630	755	467	821	722	751	697	950	716	creatine kinase, mitochondrial 1B (CKMT1B), nuclear gene encoding mitochondrial protein
B45R07C06	45-6-7	Hs~Ref:NM_020990.2~uORF:IOH5022	436	1622	805	497	821	719	710	620	1058	179	creatine kinase, mitochondrial 1B (CKMT1B), nuclear gene encoding mitochondrial protein
B45R07C07	45-7-7	Hs~MGC:BC007023.1~uORF:IOH7270	421	403	468	410	321	453	464	397	682	525	Serine-protein kinase ATM
B45R07C08	45-8-7	Hs~MGC:BC007023.1~uORF:IOH7270	392	2005	427	353	371	443	432	380	599	432	Serine-protein kinase ATM
B45R07C09	45-9-7	Hs~MGC:BC007462.1~uORF:IOH7287	298	552	439	315	463	340	465	372	508	425	creatine kinase, muscle (CKM)
B45R07C10	45-10-7	Hs~MGC:BC007462.1~uORF:IOH7287	298	1032	468	496	320	385	484	420	359	134	creatine kinase, muscle (CKM)
B45R07C11	45-11-7	Hs~Ref:NM_006374.2~uORF:IOH6735	1005	1219	980	1860	3769	1095	1848	2241	2963	750	serine/threonine kinase 25 (STE20 homolog, yeast) (STK25)
B45R07C12	45-12-7	Hs~Ref:NM_006374.2~uORF:IOH6735	1070	1242	948	1569	3655	1108	1820	2078	2361	747	serine/threonine kinase 25 (STE20 homolog, yeast) (STK25)
B45R07C13	45-13-7	Hs~MGC:BC016645.2~uORF:IOH25785	1122	615	1306	1575	602	960	1699	1032	1407	602	phosphoserine aminotransferase 1 (PSAT1)
B45R07C14	45-14-7	Hs~MGC:BC016645.2~uORF:IOH25785	1348	660	1275	1520	829	938	1734	1054	1434	544	phosphoserine aminotransferase 1 (PSAT1)
B45R07C15	45-15-7	Hs~MGC:BC022967.1~uORF:IOH11792	576	501	600	432	332	626	984	568	1060	374	WD repeat domain 22 (WDR22)
B45R07C16	45-16-7	Hs~MGC:BC022967.1~uORF:IOH11792	554	513	587	449	335	656	713	578	659	458	WD repeat domain 22 (WDR22)
B45R07C17	45-17-7	Hs~Ref:NM_030770.1~uORF:IOH39634	681	386	629	403	346	771	978	489	841	177	transmembrane protease, serine 5 (spinesin) (TMPRSS5)
B45R07C18	45-18-7	Hs~Ref:NM_030770.1~uORF:IOH39634	668	671	611	374	350	722	1116	503	852	47	transmembrane protease, serine 5 (spinesin) (TMPRSS5)
B45R07C19	45-19-7	Hs~Ref:NM_020444.2~uORF:IOH12012	11965	10293	8177	3638	7704	4617	18463	7937	7573	3873	UPF0498 protein KIAA1191
B45R07C20	45-20-7	Hs~Ref:NM_020444.2~uORF:IOH12012	12226	9888	8570	4053	7464	4565	18636	8105	7823	3558	UPF0498 protein KIAA1191
B45R07C21	45-21-7	Hs~Ref:NM_001616.2~N/A	1867	27350	8244	17105	995	27360	655	480	1735	1516	Activin receptor type-2A
B45R07C22	45-22-7	Hs~Ref:NM_001616.2~N/A	1884	27474	8220	16527	956	26860	681	441	1723	1499	Activin receptor type-2A
B45R08C03	45-3-8	Hs~Ref:NM_005235.1~N/A	776	698	951	660	1162	784	1257	816	3594	218	Receptor tyrosine-protein kinase erbB-4
B45R08C04	45-4-8	Hs~Ref:NM_005235.1~N/A	765	663	942	536	1179	730	1234	759	3361	490	Receptor tyrosine-protein kinase erbB-4
B45R08C05	45-5-8	Hs~Ref:NM_004444.2~N/A	1064	1238	1541	1135	1716	867	1236	2228	4912	541	ephrin receptor B4 (EPHB4)
B45R08C06	45-6-8	Hs~Ref:NM_004444.2~N/A	1143	1345	1554	1190	1777	937	1268	2266	4777	604	ephrin receptor B4 (EPHB4)
B45R08C07	45-7-8	Hs~MGC:BC011821.1~uORF:IOH14728	498	640	940	987	627	840	2456	804	1617	372	Synembryn-A
B45R08C08	45-8-8	Hs~MGC:BC011821.1~uORF:IOH14728	640	928	914	1043	711	867	2499	833	1478	462	Synembryn-A
B45R08C09	45-9-8	Hs~Ref:NM_002677.1~uORF:IOH27101	1480	1303	1953	1154	876	1506	5501	1413	1732	413	peripheral myelin protein 2 (PMP2)
B45R08C10	45-10-8	Hs~Ref:NM_002677.1~uORF:IOH27101	1540	1147	1884	2190	979	1478	5721	1359	1986	423	peripheral myelin protein 2 (PMP2)
B45R08C11	45-11-8	Hs~MGC:BC033824.1~uORF:IOH21887	289	1552	1155	3122	246	2250	1740	709	869	332	numb homolog (Drosophila) (NUMB)
B45R08C12	45-12-8	Hs~MGC:BC033824.1~uORF:IOH21887	350	1502	1312	1544	544	2132	1825	693	980	169	numb homolog (Drosophila) (NUMB)
B45R08C15	45-15-8	Hs~Ref:NM_002515.2~uORF:IOH45733	2750	2341	1807	1016	1306	2350	1943	1178	6106	905	neuro-oncological ventral antigen 1 (NOVA1), transcript variant 1
B45R08C16	45-16-8	Hs~Ref:NM_002515.2~uORF:IOH45733	2795	2656	1879	965	982	2383	1838	1201	6074	900	neuro-oncological ventral antigen 1 (NOVA1), transcript variant 1
B45R08C17	45-17-8	Hs~Ref:NM_021014.2~uORF:IOH43685	2922	1643	2863	3738	2239	1948	3380	1533	3803	860	synovial sarcoma, X breakpoint 3 (SSX3), transcript variant 1
B45R08C18	45-18-8	Hs~Ref:NM_021014.2~uORF:IOH43685	2963	1902	2892	3769	2318	1929	3316	1476	3766	825	synovial sarcoma, X breakpoint 3 (SSX3), transcript variant 1
B45R08C19	45-19-8	Hs~Ref:NM_018945.3~uORF:IOH45738	2176	1490	2581	1385	1438	1435	2255	1334	3033	722	phosphodiesterase 7B (PDE7B)
B45R08C20	45-20-8	Hs~Ref:NM_018945.3~uORF:IOH45738	2228	1227	2541	1403	1431	1517	2275	1385	3153	565	phosphodiesterase 7B (PDE7B)
B45R08C21	45-21-8	Hs~MGC:BC028295.1~uORF:IOH25815	2317	1033	1614	950	1081	1350	1391	1103	2471	446	peptidase D (PEPD)
B45R08C22	45-22-8	Hs~MGC:BC028295.1~uORF:IOH25815	2370	1023	1627	941	998	1292	1425	1038	2524	329	peptidase D (PEPD)
B45R09C01	45-1-9	Hs~MGC:BC009894.2~uORF:IOH14557	10305	7554	5426	15300	5392	7047	11773	7082	8068	4405	3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPSS2)
B45R09C02	45-2-9	Hs~MGC:BC009894.2~uORF:IOH14557	11511	8538	5442	18621	5882	7325	12414	7543	7550	4601	3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPSS2)
B45R09C03	45-3-9	Hs~MGC:BC031688.1~uORF:IOH22878	350	413	329	388	265	372	396	262	467	142	tektin 3 (TEKT3)
B45R09C04	45-4-9	Hs~MGC:BC031688.1~uORF:IOH22878	327	269	318	328	1341	327	401	250	692	162	tektin 3 (TEKT3)
B45R09C05	45-5-9	Hs~MGC:BC019883.1~uORF:IOH11101	505	381	737	371	454	939	624	476	1393	311	C-type lectin domain family 2 member D
B45R09C06	45-6-9	Hs~MGC:BC019883.1~uORF:IOH11101	562	308	751	370	378	898	643	475	1221	234	C-type lectin domain family 2 member D
B45R09C07	45-7-9	Hs~Ref:NM_000499.2~uORF:IOH10675	376	267	372	234	233	462	465	274	667	267	cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1)
B45R09C08	45-8-9	Hs~Ref:NM_000499.2~uORF:IOH10675	477	227	391	347	243	513	415	322	968	111	cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1)
B45R09C09	45-9-9	Hs~MGC:BC007693.1~uORF:IOH6315	3119	731	1411	874	5372	6012	980	615	2631	519	peptidylprolyl isomerase (cyclophilin)-like 3 (PPIL3)
B45R09C10	45-10-9	Hs~MGC:BC007693.1~uORF:IOH6315	3240	708	1330	162	6249	6061	1030	568	2569	557	peptidylprolyl isomerase (cyclophilin)-like 3 (PPIL3)
B45R09C11	45-11-9	Hs~MGC:BC001772.1~uORF:IOH4925	2075	2203	1563	3378	63384	2973	2227	1172	6027	1304	Glutaminyl-tRNA synthetase
B45R09C12	45-12-9	Hs~MGC:BC001772.1~uORF:IOH4925	2195	2159	1577	4133	65468	2920	2274	1152	6698	1388	Glutaminyl-tRNA synthetase
B45R09C13	45-13-9	Hs~MGC:BC008790.1~uORF:IOH6239	468	417	509	463	3030	549	616	665	939	232	glutathione S-transferase M3 (brain) (GSTM3)
B45R09C14	45-14-9	Hs~MGC:BC008790.1~uORF:IOH6239	487	430	504	443	2432	583	576	774	897	241	glutathione S-transferase M3 (brain) (GSTM3)
B45R09C15	45-15-9	Hs~MGC:BC005029.1~uORF:IOH6657	1095	532	916	833	907	1111	1112	780	1526	276	leprecan-like 1 (LEPREL1)
B45R09C16	45-16-9	Hs~MGC:BC005029.1~uORF:IOH6657	1078	479	882	852	768	1034	1204	593	1272	405	leprecan-like 1 (LEPREL1)
B45R09C17	45-17-9	Hs~MGC:BC068070.1~uORF:IOH40777	949	1343	3592	554	683	1423	1082	545	1299	432	mitochondrial ribosomal protein L52 (MRPL52)
B45R09C18	45-18-9	Hs~MGC:BC068070.1~uORF:IOH40777	982	1406	3755	604	732	1345	1196	536	1468	419	mitochondrial ribosomal protein L52 (MRPL52)
B45R09C19	45-19-9	Hs~Ref:NM_004669.2~uORF:IOH46100	516	489	496	398	612	1425	707	824	1115	185	chloride intracellular channel 3 (CLIC3)
B45R09C20	45-20-9	Hs~Ref:NM_004669.2~uORF:IOH46100	515	452	491	422	631	1616	623	910	1066	219	chloride intracellular channel 3 (CLIC3)
B45R09C21	45-21-9	Hs~Ref:NM_005898.4~uORF:IOH46168	7735	7797	6681	8303	6930	3589	7365	8760	2745	2291	cell cycle associated protein 1 (CAPRIN1), transcript variant 1
B45R09C22	45-22-9	Hs~Ref:NM_005898.4~uORF:IOH46168	8202	7516	6947	8108	4616	3536	7575	8277	2914	2250	cell cycle associated protein 1 (CAPRIN1), transcript variant 1
B45R10C01	45-1-10	Hs~MGC:BC022893.1~uORF:IOH46101	1831	3895	2560	1579	4107	4130	2166	2895	3210	1629	potassium channel tetramerisation domain containing 6 (KCTD6)
B45R10C02	45-2-10	Hs~MGC:BC022893.1~uORF:IOH46101	1974	4108	2688	1747	4635	4116	2334	3254	3233	1678	potassium channel tetramerisation domain containing 6 (KCTD6)
B45R10C03	45-3-10	Hs~MGC:BC020596.1~uORF:IOH12740	492	483	515	408	431	442	507	544	759	269	cytochrome P450, family 2, subfamily C, polypeptide 8 (CYP2C8)
B45R10C04	45-4-10	Hs~MGC:BC020596.1~uORF:IOH12740	500	573	540	420	386	453	488	552	739	279	cytochrome P450, family 2, subfamily C, polypeptide 8 (CYP2C8)
B45R10C05	45-5-10	Hs~MGC:BC062323.1~uORF:IOH40678	676	2593	557	487	431	902	728	927	2327	310	chromosome 21 open reading frame 25 (C21orf25)
B45R10C06	45-6-10	Hs~MGC:BC062323.1~uORF:IOH40678	656	2607	565	460	389	920	667	816	2521	387	chromosome 21 open reading frame 25 (C21orf25)
B45R10C07	45-7-10	Hs~Ref:NM_177938.1~uORF:IOH40630	1711	507	840	1400	456	878	670	577	1116	638	hypoxia-inducible factor prolyl 4-hydroxylase (PH-4), transcript variant 3
B45R10C08	45-8-10	Hs~Ref:NM_177938.1~uORF:IOH40630	1518	646	919	1503	439	1008	755	572	943	408	hypoxia-inducible factor prolyl 4-hydroxylase (PH-4), transcript variant 3
B45R10C09	45-9-10	Hs~Ref:NM_144679.1~uORF:IOH40679	4998	1685	1933	9579	2196	4031	3982	1716	2259	842	chromosome 17 open reading frame 56 (C17orf56)
B45R10C10	45-10-10	Hs~Ref:NM_144679.1~uORF:IOH40679	5335	1683	2030	9630	2401	4022	4189	1674	2339	850	chromosome 17 open reading frame 56 (C17orf56)
B45R11C21	45-21-11	Hs~MGC:BC033529.2~uORF:IOH27634	243	205	356	278	238	417	579	904	536	156	uridine phosphorylase 2 (UPP2)
B45R11C22	45-22-11	Hs~MGC:BC033529.2~uORF:IOH27634	272	222	363	301	199	518	401	184	479	81	uridine phosphorylase 2 (UPP2)
B45R12C01	45-1-12	Hs~MGC:BC053545.1~uORF:IOH28972	305	153	414	346	246	1186	489	658	833	872	tropomyosin 1 (alpha) (TPM1)
B45R12C02	45-2-12	Hs~MGC:BC053545.1~uORF:IOH28972	363	492	421	350	258	1253	511	757	2617	807	tropomyosin 1 (alpha) (TPM1)
B45R12C03	45-3-12	Hs~MGC:BC000870.1~uORF:IOH3246	348	158	449	318	2515	366	691	375	963	788	TIMELESS interacting protein (TIPIN)
B45R12C04	45-4-12	Hs~MGC:BC000870.1~uORF:IOH3246	376	147	457	337	118	312	709	367	724	72	TIMELESS interacting protein (TIPIN)
B45R12C05	45-5-12	Hs~Ref:NM_057089.1~uORF:IOH4579	352	662	309	1262	280	507	392	333	285	235	adaptor-related protein complex 1, sigma 1 subunit (AP1S1), transcript variant 2
B45R12C06	45-6-12	Hs~Ref:NM_057089.1~uORF:IOH4579	416	655	287	1288	312	534	396	342	391	220	adaptor-related protein complex 1, sigma 1 subunit (AP1S1), transcript variant 2
B45R12C07	45-7-12	Hs~Ref:NM_006519.1~uORF:IOH23129	1128	734	880	1087	766	872	1162	881	2008	337	dynein, light chain, Tctex-type 1 (DYNLT1)
B45R12C08	45-8-12	Hs~Ref:NM_006519.1~uORF:IOH23129	1052	758	926	1114	727	864	1173	893	2138	340	dynein, light chain, Tctex-type 1 (DYNLT1)
B45R12C09	45-9-12	Hs~MGC:BC033710.1~uORF:IOH21756	4055	1872	1624	6193	2128	1731	1223	4611	2886	949	DNA repair and recombination protein RAD54B
B45R12C10	45-10-12	Hs~MGC:BC033710.1~uORF:IOH21756	3980	1714	1561	6340	2158	1525	1174	4432	2764	943	DNA repair and recombination protein RAD54B
B45R12C11	45-11-12	Hs~MGC:BC010155.2~uORF:IOH12990	2118	2544	1812	1941	2998	1598	2208	3652	3051	1343	Adrenodoxin-like protein, mitochondrial
B45R12C12	45-12-12	Hs~MGC:BC010155.2~uORF:IOH12990	2278	2281	1967	1923	2798	1559	2157	3469	3117	1372	Adrenodoxin-like protein, mitochondrial
B45R12C13	45-13-12	Hs~Ref:NM_015973.1~uORF:IOH21513	443	626	512	564	663	582	535	527	3703	383	galanin prepropeptide (GAL)
B45R12C14	45-14-12	Hs~Ref:NM_015973.1~uORF:IOH21513	456	654	535	481	654	564	584	523	3608	382	galanin prepropeptide (GAL)
B45R12C15	45-15-12	Hs~Ref:NM_001092.3~uORF:IOH39490	15102	7413	1553	1141	1280	6463	8891	1149	3127	1190	active BCR-related gene (ABR), transcript variant 2
B45R12C16	45-16-12	Hs~Ref:NM_001092.3~uORF:IOH39490	15797	7721	1605	1030	1186	6451	8778	1140	3340	1204	active BCR-related gene (ABR), transcript variant 2
B45R12C17	45-17-12	Hs~Ref:NM_002714.2~uORF:IOH39632	14245	3960	4781	29133	4515	18610	5756	4485	4413	3538	protein phosphatase 1, regulatory (inhibitor) subunit 10 (PPP1R10)
B45R12C18	45-18-12	Hs~Ref:NM_002714.2~uORF:IOH39632	14483	3897	4742	29168	4444	20520	5728	4057	4579	3966	protein phosphatase 1, regulatory (inhibitor) subunit 10 (PPP1R10)
B45R12C19	45-19-12	Hs~Ref:NM_001002021.1~uORF:IOH6659	1134	1107	1198	811	871	1446	2092	1001	2465	737	phosphofructokinase, liver (PFKL), transcript variant 1
B45R12C20	45-20-12	Hs~Ref:NM_001002021.1~uORF:IOH6659	1159	1057	1226	895	892	1343	2153	986	2443	531	phosphofructokinase, liver (PFKL), transcript variant 1
B45R12C21	45-21-12	Hs~Ref:NM_005825.2~uORF:IOH39691	2835	2479	2937	2023	3508	2410	3427	1655	4508	779	RAS guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), transcript variant 1
B45R12C22	45-22-12	Hs~Ref:NM_005825.2~uORF:IOH39691	2921	2701	2987	2129	3550	2393	3250	889	4496	791	RAS guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), transcript variant 1
B45R13C01	45-1-13	Hs~Ref:NM_006110.1~uORF:IOH3469	635	1140	694	563	441	1102	1857	542	1575	463	CD2 (cytoplasmic tail) binding protein 2 (CD2BP2)
B45R13C02	45-2-13	Hs~Ref:NM_006110.1~uORF:IOH3469	592	1169	713	542	484	1160	1538	504	1656	151	CD2 (cytoplasmic tail) binding protein 2 (CD2BP2)
B45R13C03	45-3-13	Hs~MGC:BC007606.1~uORF:IOH6915	444	1325	1085	1529	739	728	918	1181	1409	285	cDNA clone IMAGE:3351130, complete cds
B45R13C04	45-4-13	Hs~MGC:BC007606.1~uORF:IOH6915	463	1337	1056	1554	692	734	892	1093	1358	370	cDNA clone IMAGE:3351130, complete cds
B45R13C05	45-5-13	Hs~Ref:NM_002044.1~uORF:IOH4633	319	654	475	341	303	393	6833	492	715	394	galactokinase 2 (GALK2), transcript variant 1
B45R13C06	45-6-13	Hs~Ref:NM_002044.1~uORF:IOH4633	420	745	388	352	442	353	6888	456	676	215	galactokinase 2 (GALK2), transcript variant 1
B45R13C07	45-7-13	Hs~Ref:NM_000269.1~uORF:IOH6979	533	845	525	392	578	731	576	710	1286	359	non-metastatic cells 1, protein (NM23A) expressed in (NME1), transcript variant 2
B45R13C08	45-8-13	Hs~Ref:NM_000269.1~uORF:IOH6979	599	882	501	424	555	699	607	723	1284	380	non-metastatic cells 1, protein (NM23A) expressed in (NME1), transcript variant 2
B45R13C09	45-9-13	Hs~Ref:NM_024104.1~uORF:IOH3754	1201	1168	2704	762	992	1680	1882	1264	3586	698	chromosome 19 open reading frame 42 (C19orf42)
B45R13C10	45-10-13	Hs~Ref:NM_024104.1~uORF:IOH3754	1146	1076	2711	760	1032	1686	1878	1126	3594	644	chromosome 19 open reading frame 42 (C19orf42)
B45R13C11	45-11-13	Hs~Ref:NM_004710.2~uORF:IOH3613	701	478	842	441	440	852	2880	516	965	308	synaptogyrin 2 (SYNGR2)
B45R13C12	45-12-13	Hs~Ref:NM_004710.2~uORF:IOH3613	627	549	744	520	421	924	2912	521	994	240	synaptogyrin 2 (SYNGR2)
B45R13C13	45-13-13	Hs~Ref:NM_004060.2~uORF:IOH4393	652	1958	964	518	508	857	2374	558	1193	329	cyclin G1 (CCNG1), transcript variant 1
B45R13C14	45-14-13	Hs~Ref:NM_004060.2~uORF:IOH4393	612	1965	940	457	594	917	1741	538	1065	352	cyclin G1 (CCNG1), transcript variant 1
B45R13C15	45-15-13	Hs~Ref:NM_003021.2~uORF:IOH3498	629	584	779	589	747	719	1478	529	1297	468	small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha (SGTA)
B45R13C16	45-16-13	Hs~Ref:NM_003021.2~uORF:IOH3498	634	526	671	664	606	820	818	529	1366	583	small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha (SGTA)
B45R13C17	45-17-13	Hs~MGC:BC020605.1~uORF:IOH12851	0	0	-2	461	668	752	1052	629	1488	203	Protein CARP
B45R13C18	45-18-13	Hs~MGC:BC020605.1~uORF:IOH12851	-2	-4	5	421	862	754	986	515	1401	205	Protein CARP
B45R13C19	45-19-13	Hs~Ref:NM_054023.2~uORF:IOH12827	1078	594	770	435	806	1075	713	457	941	198	secretoglobin, family 3A, member 2 (SCGB3A2)
B45R13C20	45-20-13	Hs~Ref:NM_054023.2~uORF:IOH12827	1101	477	774	463	831	1046	729	514	941	191	secretoglobin, family 3A, member 2 (SCGB3A2)
B45R13C21	45-21-13	Hs~MGC:BC017969.1~uORF:IOH12941	747	659	760	492	466	760	1316	550	1033	339	Radical S-adenosyl methionine domain-containing protein 2
B45R13C22	45-22-13	Hs~MGC:BC017969.1~uORF:IOH12941	696	619	747	474	462	752	1308	554	1095	203	Radical S-adenosyl methionine domain-containing protein 2
B45R14C01	45-1-14	Hs~MGC:BC012026.1~uORF:IOH10767	769	532	807	366	505	754	935	473	1002	595	cDNA clone IMAGE:4476475, complete cds
B45R14C02	45-2-14	Hs~MGC:BC012026.1~uORF:IOH10767	812	554	847	353	558	732	937	486	1007	1422	cDNA clone IMAGE:4476475, complete cds
B45R14C05	45-5-14	Hs~Ref:NM_001221.2~uORF:IOH54032	582	771	606	619	630	2123	1025	2252	1791	392	calcium/calmodulin-dependent protein kinase (CaM kinase) II delta (CAMK2D), transcript variant 3
B45R14C06	45-6-14	Hs~Ref:NM_001221.2~uORF:IOH54032	596	794	588	648	654	2053	1002	2196	1849	420	calcium/calmodulin-dependent protein kinase (CaM kinase) II delta (CAMK2D), transcript variant 3
B45R14C07	45-7-14	Hs~Ref:NM_003584.1~uORF:IOH53923	344	300	371	259	178	672	607	373	807	364	RNA/RNP complex-1-interacting phosphatase
B45R14C08	45-8-14	Hs~Ref:NM_003584.1~uORF:IOH53923	328	354	378	277	326	614	647	319	634	431	RNA/RNP complex-1-interacting phosphatase
B45R14C11	45-11-14	Hs~MGC:BC028954.1~uORF:IOH28639	574	547	516	441	389	672	738	480	928	433	piggyBac transposable element derived 3 (PGBD3)
B45R14C12	45-12-14	Hs~MGC:BC028954.1~uORF:IOH28639	478	502	486	407	418	677	767	463	888	470	piggyBac transposable element derived 3 (PGBD3)
B45R14C13	45-13-14	Hs~MGC:BC009195.2~uORF:IOH12344	751	415	445	447	386	483	944	406	808	282	heat shock protein 90kDa beta (Grp94), member 1 (HSP90B1)
B45R14C14	45-14-14	Hs~MGC:BC009195.2~uORF:IOH12344	743	296	474	386	370	489	648	389	761	321	heat shock protein 90kDa beta (Grp94), member 1 (HSP90B1)
B45R14C15	45-15-14	Hs~Ref:NM_004936.2~uORF:IOH12785	381	410	565	359	466	654	988	396	1147	228	cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 1
B45R14C16	45-16-14	Hs~Ref:NM_004936.2~uORF:IOH12785	400	421	545	422	439	614	852	384	1123	174	cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 1
B45R14C17	45-17-14	Hs~Ref:NM_030952.1~uORF:IOH21129	604	459	665	564	505	753	812	494	1292	885	NUAK family, SNF1-like kinase, 2 (NUAK2)
B45R14C18	45-18-14	Hs~Ref:NM_030952.1~uORF:IOH21129	610	537	715	604	723	925	739	509	1136	728	NUAK family, SNF1-like kinase, 2 (NUAK2)
B45R14C19	45-19-14	Hs~MGC:BC039337.1~uORF:IOH62273	4836	832	1518	10571	776	2187	3324	1438	2815	654	Polyadenylate-binding protein-interacting protein 2
B45R14C20	45-20-14	Hs~MGC:BC039337.1~uORF:IOH62273	5145	845	1572	10536	829	2152	3525	1303	2882	596	Polyadenylate-binding protein-interacting protein 2
B45R15C01	45-1-15	Hs~MGC:BC036064.1~uORF:IOH62147	661	791	65491	1148	946	2562	3603	728	23	92	Ras-related protein Rab-33B
B45R15C02	45-2-15	Hs~MGC:BC036064.1~uORF:IOH62147	699	755	65491	1255	960	2552	3724	708	-2	17	Ras-related protein Rab-33B
B45R15C03	45-3-15	Hs~MGC:BC093864.1~uORF:IOH62000	525	418	417	2180	557	1044	695	471	2619	347	Disks large homolog 3
B45R15C04	45-4-15	Hs~MGC:BC093864.1~uORF:IOH62000	506	460	369	2046	599	1128	642	480	2540	305	Disks large homolog 3
B45R15C05	45-5-15	Hs~MGC:BC039317.1~uORF:IOH28723	1	2	-3	1	449	393	520	371	538	280	coiled-coil domain containing 65 (CCDC65)
B45R15C06	45-6-15	Hs~MGC:BC039317.1~uORF:IOH28723	-1	-3	1	3	156	389	486	412	578	204	coiled-coil domain containing 65 (CCDC65)
B45R15C07	45-7-15	Hs~MGC:BC033034.2~uORF:IOH28643	428	466	2324	416	568	468	869	7	801	312	DIX domain containing 1 (DIXDC1)
B45R15C08	45-8-15	Hs~MGC:BC033034.2~uORF:IOH28643	483	532	2407	473	616	425	797	417	687	263	DIX domain containing 1 (DIXDC1)
B45R15C09	45-9-15	Hs~MGC:BC057770.1~uORF:IOH29234	269	10	224	183	318	345	191	243	379	344	solute carrier family 27 (fatty acid transporter), member 2 (SLC27A2)
B45R15C10	45-10-15	Hs~MGC:BC057770.1~uORF:IOH29234	159	48	224	193	288	279	199	247	389	225	solute carrier family 27 (fatty acid transporter), member 2 (SLC27A2)
B45R15C11	45-11-15	Hs~MGC:BC011776.1~uORF:IOH13876	438	504	349	371	220	1115	1129	316	475	364	tropomyosin 2 (beta) (TPM2)
B45R15C12	45-12-15	Hs~MGC:BC011776.1~uORF:IOH13876	345	368	351	362	233	1075	1090	325	433	338	tropomyosin 2 (beta) (TPM2)
B45R15C15	45-15-15	Hs~Ref:NM_001259.5~CAT:PV4401	404	35	146	159	20	981	1194	219	514	285	cyclin D1 and cyclin-dependent kinase 6 (CDK6): cyclin D1 and CDK6 sequences are seperated by -- (in the protein list file).
B45R15C16	45-16-15	Hs~Ref:NM_001259.5~CAT:PV4401	386	35	144	322	1144	1013	1363	234	515	282	cyclin D1 and cyclin-dependent kinase 6 (CDK6): cyclin D1 and CDK6 sequences are seperated by -- (in the protein list file).
B45R15C19	45-19-15	Hs~Ref:NM_003318.3~CAT:PV3792	534	649	1115	626	1523	1865	1183	794	1681	295	TTK protein kinase (TTK)
B45R15C20	45-20-15	Hs~Ref:NM_003318.3~CAT:PV3792	563	684	1104	552	1017	1845	1235	808	1684	272	TTK protein kinase (TTK)
B45R16C01	45-1-16	Hs~Ref:NM_005157.2~CAT:P3049	1281	875	2452	1833	670	1357	3738	2365	2731	1003	v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), transcript variant a; see catalog number for detailed information on wild-type or point mutant status
B45R16C02	45-2-16	Hs~Ref:NM_005157.2~CAT:P3049	1452	882	2662	1801	701	1404	3811	2285	2741	872	v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), transcript variant a; see catalog number for detailed information on wild-type or point mutant status
B45R16C07	45-7-16	Hs~MGC:BC048970.1~uORF:IOH26893	2831	1788	2379	1420	2764	2516	14176	1501	3384	861	tubulin tyrosine ligase-like family, member 7 (TTLL7)
B45R16C08	45-8-16	Hs~MGC:BC048970.1~uORF:IOH26893	2773	1795	2333	1452	2860	2442	13603	1358	3329	829	tubulin tyrosine ligase-like family, member 7 (TTLL7)
B45R16C09	45-9-16	Hs~MGC:BC036908.1~uORF:IOH28734	1134	874	919	1205	656	1302	1987	798	1815	813	hypothetical protein FLJ31438 (FLJ31438)
B45R16C10	45-10-16	Hs~MGC:BC036908.1~uORF:IOH28734	999	860	916	1190	623	1276	2116	834	1712	902	hypothetical protein FLJ31438 (FLJ31438)
B45R16C11	45-11-16	Hs~MGC:BC038241.1~uORF:IOH28735	790	659	737	730	745	1826	1548	759	1374	438	NFAT activation molecule 1
B45R16C12	45-12-16	Hs~MGC:BC038241.1~uORF:IOH28735	791	646	766	730	782	1780	1400	756	1467	401	NFAT activation molecule 1
B45R16C13	45-13-16	Hs~MGC:BC050538.1~uORF:IOH26922	988	768	848	655	943	1226	1447	716	1468	514	radical S-adenosyl methionine domain containing 1 (RSAD1)
B45R16C14	45-14-16	Hs~MGC:BC050538.1~uORF:IOH26922	876	740	867	630	873	1168	1380	700	1464	486	radical S-adenosyl methionine domain containing 1 (RSAD1)
B45R16C15	45-15-16	Hs~Ref:NM_003277.1~uORF:IOH3589	91	80	199	202	128	344	470	192	329	226	claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) (CLDN5)
B45R16C16	45-16-16	Hs~Ref:NM_003277.1~uORF:IOH3589	43	2	153	343	247	321	436	184	339	55	claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) (CLDN5)
B45R16C17	45-17-16	Hs~Ref:NM_001004.2~uORF:IOH6844	26	24	196	765	111	1579	321	198	80	25	ribosomal protein, large, P2 (RPLP2)
B45R16C18	45-18-16	Hs~Ref:NM_001004.2~uORF:IOH6844	24	40	105	269	22	44	25	185	76	26	ribosomal protein, large, P2 (RPLP2)
B45R16C19	45-19-16	Hs~MGC:BC057772.1~uORF:IOH29154	567	610	559	741	576	746	882	405	951	401	chromosome 18 open reading frame 22 (C18orf22)
B45R16C20	45-20-16	Hs~MGC:BC057772.1~uORF:IOH29154	575	619	616	638	581	847	880	403	1020	243	chromosome 18 open reading frame 22 (C18orf22)
B45R16C21	45-21-16	Hs~MGC:BC035875.2~uORF:IOH28741	815	497	870	636	594	1095	1326	465	1502	469	Zinc finger protein 131
B45R16C22	45-22-16	Hs~MGC:BC035875.2~uORF:IOH28741	832	492	898	646	543	1157	1301	484	1537	469	Zinc finger protein 131
B45R17C01	45-1-17	Hs~MGC:BC066256.1~uORF:IOH61852	148	103	310	216	224	307	824	365	522	353	Interleukin-2
B45R17C02	45-2-17	Hs~MGC:BC066256.1~uORF:IOH61852	166	92	258	203	154	338	935	357	510	691	Interleukin-2
B45R17C05	45-5-17	Hs~MGC:BC068518.1~uORF:IOH61668	244	223	634	320	1525	346	2228	749	704	287	BTB/POZ domain-containing protein KCTD9
B45R17C06	45-6-17	Hs~MGC:BC068518.1~uORF:IOH61668	118	250	633	412	59	412	2280	719	473	96	BTB/POZ domain-containing protein KCTD9
B45R17C07	45-7-17	Hs~Ref:NM_001040633.1~uORF:IOH61663	577	147	378	250	372	697	741	427	813	276	protein kinase, AMP-activated, gamma 2 non-catalytic subunit (PRKAG2), transcript variant c, mRNA.
B45R17C08	45-8-17	Hs~Ref:NM_001040633.1~uORF:IOH61663	573	490	396	248	388	707	765	415	805	330	protein kinase, AMP-activated, gamma 2 non-catalytic subunit (PRKAG2), transcript variant c, mRNA.
B45R17C09	45-9-17	Hs~Ref:NM_016050.1~uORF:IOH4903	1207	1518	999	978	1000	1613	1985	870	1761	458	mitochondrial ribosomal protein L11 (MRPL11), nuclear gene encoding mitochondrial protein, transcript variant 1
B45R17C10	45-10-17	Hs~Ref:NM_016050.1~uORF:IOH4903	1168	1611	995	921	1062	1721	2071	906	1742	458	mitochondrial ribosomal protein L11 (MRPL11), nuclear gene encoding mitochondrial protein, transcript variant 1
B45R17C13	45-13-17	Hs~Ref:NM_000345.2~uORF:IOH14008	643	207	173	209	594	585	172	3912	919	217	synuclein, alpha (non A4 component of amyloid precursor) (SNCA), transcript variant NACP140
B45R17C14	45-14-17	Hs~Ref:NM_000345.2~uORF:IOH14008	736	226	182	234	645	590	228	3955	981	259	synuclein, alpha (non A4 component of amyloid precursor) (SNCA), transcript variant NACP140
B45R17C15	45-15-17	Hs~Ref:NM_013242.1~uORF:IOH5166	3298	1613	1570	1437	1245	7963	10507	1871	2899	2111	chromosome 16 open reading frame 80 (C16orf80)
B45R17C16	45-16-17	Hs~Ref:NM_013242.1~uORF:IOH5166	3573	1717	1629	1470	1195	8103	10167	1876	2942	2081	chromosome 16 open reading frame 80 (C16orf80)
B45R17C17	45-17-17	Hs~Ref:NM_014667.1~uORF:IOH29305	3480	1132	20315	928	1102	1735	1193	1311	2411	1319	vestigial like 4 (Drosophila) (VGLL4)
B45R17C18	45-18-17	Hs~Ref:NM_014667.1~uORF:IOH29305	3572	1120	20932	952	1181	1788	1326	1346	2500	1392	vestigial like 4 (Drosophila) (VGLL4)
B45R17C19	45-19-17	Hs~MGC:BC040173.1~uORF:IOH27622	485	1020	759	376	587	3905	709	424	1078	265	WD repeat domain 85 (WDR85)
B45R17C20	45-20-17	Hs~MGC:BC040173.1~uORF:IOH27622	470	1023	790	455	527	3968	647	394	1049	142	WD repeat domain 85 (WDR85)
B45R17C21	45-21-17	Hs~MGC:BC047765.1~uORF:IOH26665	427	406	463	387	554	700	872	334	676	195	ATP-binding cassette, sub-family A (ABC1), member 8 (ABCA8)
B45R17C22	45-22-17	Hs~MGC:BC047765.1~uORF:IOH26665	540	449	526	352	351	678	825	365	659	107	ATP-binding cassette, sub-family A (ABC1), member 8 (ABCA8)
B45R18C01	45-1-18	Hs~MGC:BC021987.2~uORF:IOH27886	392	119	443	282	148	549	715	349	1031	309	N-myc (and STAT) interactor (NMI)
B45R18C02	45-2-18	Hs~MGC:BC021987.2~uORF:IOH27886	352	30	388	292	168	642	755	346	967	659	N-myc (and STAT) interactor (NMI)
B45R18C03	45-3-18	Hs~Ref:NM_030810.1~uORF:IOH4474	470	294	608	245	350	500	1332	886	1496	398	thioredoxin domain containing 5 (TXNDC5), transcript variant 1
B45R18C04	45-4-18	Hs~Ref:NM_030810.1~uORF:IOH4474	483	288	584	253	331	495	1202	904	905	282	thioredoxin domain containing 5 (TXNDC5), transcript variant 1
B45R18C05	45-5-18	Hs~Ref:NM_016286.1~uORF:IOH4017	452	599	900	313	477	554	2669	1241	992	194	dicarbonyl/L-xylulose reductase (DCXR)
B45R18C06	45-6-18	Hs~Ref:NM_016286.1~uORF:IOH4017	427	629	903	301	416	564	2593	1185	960	243	dicarbonyl/L-xylulose reductase (DCXR)
B45R18C07	45-7-18	Hs~Ref:NM_007108.1~uORF:IOH14150	1354	2099	1589	915	532	1035	4587	1759	1370	327	transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) (TCEB2), transcript variant 1
B45R18C08	45-8-18	Hs~Ref:NM_007108.1~uORF:IOH14150	1483	2809	1573	936	483	991	4480	1752	1343	189	transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) (TCEB2), transcript variant 1
B45R18C09	45-9-18	Hs~MGC:BC000190.1~uORF:IOH4410	1093	1258	1972	674	707	1653	7495	2529	2084	510	zinc finger, C3HC-type containing 1 (ZC3HC1)
B45R18C10	45-10-18	Hs~MGC:BC000190.1~uORF:IOH4410	1306	1377	1979	652	754	1492	7194	2477	2218	564	zinc finger, C3HC-type containing 1 (ZC3HC1)
B45R18C11	45-11-18	Hs~MGC:BC045640.1~uORF:IOH25879	356	105	229	233	319	377	484	212	836	349	RAN binding protein 5 (RANBP5)
B45R18C12	45-12-18	Hs~MGC:BC045640.1~uORF:IOH25879	136	725	240	222	176	409	465	223	412	214	RAN binding protein 5 (RANBP5)
B45R18C13	45-13-18	Hs~Ref:NM_178493.3~uORF:IOH29141	400	478	416	304	405	1507	605	353	595	118	notum pectinacetylesterase homolog (Drosophila) (NOTUM)
B45R18C14	45-14-18	Hs~Ref:NM_178493.3~uORF:IOH29141	436	423	438	275	512	1355	627	325	605	302	notum pectinacetylesterase homolog (Drosophila) (NOTUM)
B45R18C15	45-15-18	Hs~MGC:BC041132.1~uORF:IOH26140	1036	1926	1354	1123	1501	1514	2478	1947	4117	882	kinesin family member C3 (KIFC3)
B45R18C16	45-16-18	Hs~MGC:BC041132.1~uORF:IOH26140	1092	2095	1376	1165	1547	1699	2280	2051	4056	844	kinesin family member C3 (KIFC3)
B45R18C17	45-17-18	Hs~MGC:BC039583.2~uORF:IOH28773	1054	458	501	499	346	829	1593	661	891	157	Bifunctional protein NCOAT
B45R18C18	45-18-18	Hs~MGC:BC039583.2~uORF:IOH28773	1030	372	555	454	409	751	1664	697	948	146	Bifunctional protein NCOAT
B45R18C19	45-19-18	Hs~Ref:NM_182571.2~uORF:IOH57364	856	858	1244	805	851	1080	1461	880	1929	832	Scavenger receptor cysteine-rich domain-containing protein LOC284297
B45R18C20	45-20-18	Hs~Ref:NM_182571.2~uORF:IOH57364	835	877	1277	831	874	1103	1429	896	1891	756	Scavenger receptor cysteine-rich domain-containing protein LOC284297
B45R18C21	45-21-18	Hs~Ref:NM_052838.2~uORF:IOH12732	1322	863	2381	1308	1843	1443	1717	1164	2453	330	septin 1 (SEPT1)
B45R18C22	45-22-18	Hs~Ref:NM_052838.2~uORF:IOH12732	1343	849	2529	1365	2003	1579	1620	1184	2388	358	septin 1 (SEPT1)
B45R19C01	45-1-19	Hs~MGC:BC007014.1~uORF:IOH7141	849	484	749	1058	21308	1599	1657	1997	2377	361	tumor necrosis factor, alpha-induced protein 8 (TNFAIP8)
B45R19C02	45-2-19	Hs~MGC:BC007014.1~uORF:IOH7141	882	495	832	1079	22715	1653	1705	1919	2415	248	tumor necrosis factor, alpha-induced protein 8 (TNFAIP8)
B45R19C03	45-3-19	Hs~MGC:BC008902.2~uORF:IOH7022	-2	1	-4	1	5708	2	-5	-1	522	723	GRIP and coiled-coil domain-containing protein 1
B45R19C04	45-4-19	Hs~MGC:BC008902.2~uORF:IOH7022	-1	0	1	1	5715	1	-2	-2	599	-2	GRIP and coiled-coil domain-containing protein 1
B45R19C05	45-5-19	Hs~Ref:NM_021123.1~uORF:IOH27363	457	306	745	324	544	791	849	312	874	310	G antigen 7 (GAGE7)
B45R19C06	45-6-19	Hs~Ref:NM_021123.1~uORF:IOH27363	410	320	690	313	559	793	826	311	904	405	G antigen 7 (GAGE7)
B45R19C07	45-7-19	Hs~MGC:BC010124.2~uORF:IOH22972	332	1945	308	225	420	388	516	402	1346	227	neuroblastoma breakpoint family, member 1 (NBPF1)
B45R19C08	45-8-19	Hs~MGC:BC010124.2~uORF:IOH22972	332	1319	281	222	463	366	472	339	1309	220	neuroblastoma breakpoint family, member 1 (NBPF1)
B45R19C09	45-9-19	Hs~MGC:BC032101.1~uORF:IOH22993	469	781	472	377	554	641	799	454	1084	445	Protein jagunal homolog 1
B45R19C10	45-10-19	Hs~MGC:BC032101.1~uORF:IOH22993	587	872	492	387	577	671	842	503	1049	294	Protein jagunal homolog 1
B45R19C11	45-11-19	Hs~MGC:NM_152614.1~uORF:IOH22756	567	249	480	381	456	955	1025	418	1148	470	Uncharacterized protein C2orf57
B45R19C12	45-12-19	Hs~MGC:NM_152614.1~uORF:IOH22756	666	271	492	404	441	909	1104	390	1028	359	Uncharacterized protein C2orf57
B45R19C13	45-13-19	Hs~MGC:BC034222.1~uORF:IOH21594	-1	0	32	2	1019	4	2	2	1	1	HRAS-like suppressor family, member 5 (HRASLS5)
B45R19C14	45-14-19	Hs~MGC:BC034222.1~uORF:IOH21594	-2	-3	-1	0	140	4	255	-1	1	0	HRAS-like suppressor family, member 5 (HRASLS5)
B45R19C15	45-15-19	Hs~Ref:NM_177924.1~uORF:IOH21469	-1	0	1	182	190	296	245	193	460	353	N-acylsphingosine amidohydrolase (acid ceramidase) 1 (ASAH1), transcript variant 1
B45R19C16	45-16-19	Hs~Ref:NM_177924.1~uORF:IOH21469	-2	1	-1	216	177	549	265	233	439	113	N-acylsphingosine amidohydrolase (acid ceramidase) 1 (ASAH1), transcript variant 1
B45R19C17	45-17-19	Hs~Ref:NM_016588.2~uORF:IOH5242	793	696	1015	747	684	1026	1102	701	1889	485	neuritin 1 (NRN1)
B45R19C18	45-18-19	Hs~Ref:NM_016588.2~uORF:IOH5242	824	680	879	702	674	1030	1221	759	1707	354	neuritin 1 (NRN1)
B45R19C19	45-19-19	Hs~MGC:BC013878.2~uORF:IOH27784	1329	532	1346	1106	2333	884	4840	1474	2486	296	thimet oligopeptidase 1 (THOP1)
B45R19C20	45-20-19	Hs~MGC:BC013878.2~uORF:IOH27784	1371	519	1332	1093	2499	829	5229	1456	2722	182	thimet oligopeptidase 1 (THOP1)
B45R19C21	45-21-19	Hs~MGC:BC053509.1~uORF:IOH29394	1156	577	868	997	1039	1037	1442	874	42	5	5,10-methylenetetrahydrofolate reductase (NADPH) (MTHFR)
B45R19C22	45-22-19	Hs~MGC:BC053509.1~uORF:IOH29394	1203	618	873	1020	1099	986	1517	778	1548	739	5,10-methylenetetrahydrofolate reductase (NADPH) (MTHFR)
B45R20C01	45-1-20	Hs~MGC:BC000878.1~uORF:IOH3267	224	352	236	423	381	399	339	2526	713	299	lactamase, beta 2 (LACTB2)
B45R20C02	45-2-20	Hs~MGC:BC000878.1~uORF:IOH3267	231	264	249	473	397	420	335	2673	1480	249	lactamase, beta 2 (LACTB2)
B45R20C03	45-3-20	Hs~Ref:NM_000262.1~uORF:IOH4589	608	610	512	579	503	733	764	560	704	1147	N-acetylgalactosaminidase, alpha- (NAGA)
B45R20C04	45-4-20	Hs~Ref:NM_000262.1~uORF:IOH4589	538	689	577	508	469	736	835	554	1851	1016	N-acetylgalactosaminidase, alpha- (NAGA)
B45R20C05	45-5-20	Hs~Ref:NM_024314.1~uORF:IOH5409	460	486	439	456	448	812	694	496	1825	1400	hypothetical protein MGC4294 (MGC4294)
B45R20C06	45-6-20	Hs~Ref:NM_024314.1~uORF:IOH5409	386	478	414	414	510	750	724	501	1606	1368	hypothetical protein MGC4294 (MGC4294)
B45R20C07	45-7-20	Hs~Ref:NM_145050.1~uORF:IOH12883	451	-3	360	363	837	0	-1	-4	-2	-3	coiled-coil domain containing 26 (CCDC26)
B45R20C08	45-8-20	Hs~Ref:NM_145050.1~uORF:IOH12883	473	911	362	347	767	-1	-3	7	350	-3	coiled-coil domain containing 26 (CCDC26)
B45R20C09	45-9-20	Hs~MGC:NM_032550.1~uORF:IOH10814	742	352	709	281	891	1376	1200	4252	1335	355	actin filament associated protein 1-like 2 (AFAP1L2), transcript variant 2
B45R20C10	45-10-20	Hs~MGC:NM_032550.1~uORF:IOH10814	771	333	688	282	1045	1466	1240	4165	1342	298	actin filament associated protein 1-like 2 (AFAP1L2), transcript variant 2
B45R20C11	45-11-20	Hs~MGC:BC016755.1~uORF:IOH12873	229	0	403	455	421	660	714	548	780	383	complement factor H-related 1 (CFHR1)
B45R20C12	45-12-20	Hs~MGC:BC016755.1~uORF:IOH12873	707	325	403	441	513	720	692	569	860	245	complement factor H-related 1 (CFHR1)
B45R20C13	45-13-20	Hs~Ref:NM_003115.2~uORF:IOH13054	467	1075	555	519	776	907	1178	705	802	388	UDP-N-acteylglucosamine pyrophosphorylase 1 (UAP1)
B45R20C14	45-14-20	Hs~Ref:NM_003115.2~uORF:IOH13054	581	1062	567	539	631	890	1183	708	798	382	UDP-N-acteylglucosamine pyrophosphorylase 1 (UAP1)
B46R02C11	46-11-2	Hs~MGC:BC000440.1~uORF:IOH3468	1314	1270	2237	1025	1277	3372	2408	1433	3469	596	Cystathionine beta-synthase
B46R02C12	46-12-2	Hs~MGC:BC000440.1~uORF:IOH3468	1289	1558	2370	1047	1207	3187	2341	1400	3497	474	Cystathionine beta-synthase
B46R02C13	46-13-2	Hs~Ref:NM_006325.2~uORF:IOH10063	1759	1944	2543	1072	1083	1134	1674	889	2637	1036	GTP-binding nuclear protein Ran
B46R02C14	46-14-2	Hs~Ref:NM_006325.2~uORF:IOH10063	1732	1234	2261	1132	1051	1097	1842	969	2638	943	GTP-binding nuclear protein Ran
B46R02C15	46-15-2	Hs~MGC:BC057760.1~uORF:IOH29220	3324	2001	14407	2358	2524	2653	9299	2110	4900	1056	MORN repeat-containing protein 3
B46R02C16	46-16-2	Hs~MGC:BC057760.1~uORF:IOH29220	3623	2140	14954	2264	2455	2542	9375	2048	4914	1083	MORN repeat-containing protein 3
B46R02C17	46-17-2	Hs~Ref:NM_023942.1~uORF:IOH4176	2107	1047	61493	1041	1188	2424	1824	1050	2430	394	Leucine-rich repeat-containing protein 61
B46R02C18	46-18-2	Hs~Ref:NM_023942.1~uORF:IOH4176	2070	1038	55921	993	1159	2426	1804	975	2401	431	Leucine-rich repeat-containing protein 61
B46R02C19	46-19-2	Hs~MGC:BC020637.1~uORF:IOH12160	581	291	339	364	453	1051	2059	341	1006	2209	interleukin 1 family, member 7 (zeta) (IL1F7)
B46R02C20	46-20-2	Hs~MGC:BC020637.1~uORF:IOH12160	585	256	312	344	452	993	2004	361	1047	2068	interleukin 1 family, member 7 (zeta) (IL1F7)
B46R02C21	46-21-2	Hs~MGC:BC020838.1~uORF:IOH13454	720	502	582	344	488	754	2530	444	815	349	claudin 20 (CLDN20)
B46R02C22	46-22-2	Hs~MGC:BC020838.1~uORF:IOH13454	699	480	511	315	502	716	2422	436	816	279	claudin 20 (CLDN20)
B46R03C01	46-1-3	Hs~Ref:NM_001306.2~uORF:IOH13619	686	644	988	362	672	982	901	1031	840	342	claudin 3 (CLDN3)
B46R03C02	46-2-3	Hs~Ref:NM_001306.2~uORF:IOH13619	734	637	1075	382	631	857	902	1081	835	339	claudin 3 (CLDN3)
B46R03C03	46-3-3	Hs~MGC:BC029224.1~uORF:IOH22788	1059	908	1874	400	670	599	760	479	1458	330	Coiled-coil domain-containing protein 42A
B46R03C04	46-4-3	Hs~MGC:BC029224.1~uORF:IOH22788	1146	923	1806	354	664	588	785	449	1473	323	Coiled-coil domain-containing protein 42A
B46R03C05	46-5-3	Hs~Ref:NM_181618.1~uORF:IOH40951	603	597	575	343	570	591	419	601	895	519	chemokine-like factor superfamily 5 (CKLFSF5), transcript variant 2
B46R03C06	46-6-3	Hs~Ref:NM_181618.1~uORF:IOH40951	601	608	609	388	1473	580	438	1392	898	186	chemokine-like factor superfamily 5 (CKLFSF5), transcript variant 2
B46R03C07	46-7-3	Hs~Ref:NM_022568.2~uORF:IOH41048	425	2016	5386	649	1819	844	1112	3079	1142	248	Aldehyde dehydrogenase family 8 member A1
B46R03C08	46-8-3	Hs~Ref:NM_022568.2~uORF:IOH41048	652	2070	5470	634	848	835	1083	2075	1084	186	Aldehyde dehydrogenase family 8 member A1
B46R03C09	46-9-3	Hs~Ref:NM_024966.2~uORF:IOH35829	517	344	9011	199	548	281	281	302	408	92	sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D (SEMA6D), transcript variant 6
B46R03C10	46-10-3	Hs~Ref:NM_024966.2~uORF:IOH35829	406	702	7784	293	503	271	302	282	454	87	sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D (SEMA6D), transcript variant 6
B46R03C11	46-11-3	Hs~Ref:NM_020465.2~uORF:IOH40985	866	674	44049	3011	734	1063	1313	421	2122	4368	NDRG family member 4 (NDRG4)
B46R03C12	46-12-3	Hs~Ref:NM_020465.2~uORF:IOH40985	918	677	38454	3145	732	1034	1281	396	2047	4152	NDRG family member 4 (NDRG4)
B46R03C13	46-13-3	Hs~Ref:NM_002477.1~uORF:IOH44370	9768	419	670	857	1246	1501	996	614	1212	132	myosin, light chain 5, regulatory (MYL5)
B46R03C14	46-14-3	Hs~Ref:NM_002477.1~uORF:IOH44370	9843	368	679	821	1238	1489	972	525	1132	238	myosin, light chain 5, regulatory (MYL5)
B46R03C15	46-15-3	Hs~Ref:NM_001002232.1~uORF:IOH45883	1139	2132	2372	457	833	408	944	425	880	318	kallikrein-related peptidase 2 (KLK2), transcript variant 3
B46R03C16	46-16-3	Hs~Ref:NM_001002232.1~uORF:IOH45883	1120	2337	2840	503	791	722	862	335	407	144	kallikrein-related peptidase 2 (KLK2), transcript variant 3
B46R03C17	46-17-3	Hs~Ref:NM_004113.3~uORF:IOH34727	3182	2667	6164	1600	1168	1552	10881	1044	2222	1471	fibroblast growth factor 12 (FGF12), transcript variant 2
B46R03C18	46-18-3	Hs~Ref:NM_004113.3~uORF:IOH34727	3392	2756	6286	1521	1169	1545	10351	1032	2204	1498	fibroblast growth factor 12 (FGF12), transcript variant 2
B46R03C21	46-21-3	Hs~Ref:NM_052877.1~uORF:IOH10269	902	850	2226	653	871	7383	1942	806	1262	366	mediator complex subunit 8 (MED8), transcript variant 3
B46R03C22	46-22-3	Hs~Ref:NM_052877.1~uORF:IOH10269	883	911	2191	611	828	8129	1855	806	1267	369	mediator complex subunit 8 (MED8), transcript variant 3
B46R04C01	46-1-4	Hs~MGC:BC010555.1~uORF:IOH10297	899	1638	1014	878	1600	1356	1213	1466	2080	275	zinc finger protein 167 (ZNF167)
B46R04C02	46-2-4	Hs~MGC:BC010555.1~uORF:IOH10297	990	1708	1001	895	1300	1362	1227	1224	1927	358	zinc finger protein 167 (ZNF167)
B46R04C03	46-3-4	Hs~Ref:NM_031910.2~uORF:IOH10302	1398	712	1249	1049	995	885	1101	1250	2142	595	C1q and tumor necrosis factor related protein 6 (C1QTNF6), transcript variant 1
B46R04C04	46-4-4	Hs~Ref:NM_031910.2~uORF:IOH10302	1346	715	1235	1006	969	862	1059	801	2098	556	C1q and tumor necrosis factor related protein 6 (C1QTNF6), transcript variant 1
B46R04C05	46-5-4	Hs~Ref:NM_006978.1~uORF:IOH10306	2557	805	1428	781	5435	1197	990	1201	1527	220	ring finger protein 113A (RNF113A)
B46R04C06	46-6-4	Hs~Ref:NM_006978.1~uORF:IOH10306	3089	774	1417	768	5570	1236	1052	1245	1588	228	ring finger protein 113A (RNF113A)
B46R04C07	46-7-4	Hs~MGC:BC014991.1~uORF:IOH12177	65470	65479	65437	65485	65356	65474	65459	65476	65428	65468	N-methylpurine-DNA glycosylase (MPG)
B46R04C08	46-8-4	Hs~MGC:BC014991.1~uORF:IOH12177	65472	65472	65459	65488	65409	65483	65471	65477	65449	65471	N-methylpurine-DNA glycosylase (MPG)
B46R04C09	46-9-4	Hs~Ref:NM_033416.1~uORF:IOH12991	1260	925	1223	691	774	1036	3408	1178	1956	545	IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) (IMP4)
B46R04C10	46-10-4	Hs~Ref:NM_033416.1~uORF:IOH12991	1277	919	1219	770	898	1128	3353	852	1873	528	IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) (IMP4)
B46R04C11	46-11-4	Hs~Ref:NM_013328.2~uORF:IOH11728	729	1064	1363	734	873	1130	1235	930	2163	331	pyrroline-5-carboxylate reductase family, member 2 (PYCR2)
B46R04C12	46-12-4	Hs~Ref:NM_013328.2~uORF:IOH11728	746	1105	1308	707	848	1037	1175	954	2025	254	pyrroline-5-carboxylate reductase family, member 2 (PYCR2)
B46R04C13	46-13-4	Hs~MGC:BC004271.1~uORF:IOH5483	1013	660	1362	530	740	732	1277	556	1949	375	Beta-Ala-His dipeptidase
B46R04C14	46-14-4	Hs~MGC:BC004271.1~uORF:IOH5483	920	663	1291	608	752	881	1425	572	2117	417	Beta-Ala-His dipeptidase
B46R04C15	46-15-4	Hs~Ref:NM_172070.2~uORF:IOH38243	615	427	1247	1252	797	1524	2054	749	601	179	zinc finger protein 650 (ZNF650)
B46R04C16	46-16-4	Hs~Ref:NM_172070.2~uORF:IOH38243	600	357	1159	1260	923	1450	1915	669	2070	691	zinc finger protein 650 (ZNF650)
B46R04C17	46-17-4	Hs~MGC:BC040339.1~uORF:IOH25738	1923	2488	1410	626	1354	641	1240	428	922	104	nucleotide-binding oligomerization domain containing 1 (NOD1)
B46R04C18	46-18-4	Hs~MGC:BC040339.1~uORF:IOH25738	2264	2501	1371	534	1264	653	1163	472	930	204	nucleotide-binding oligomerization domain containing 1 (NOD1)
B46R04C19	46-19-4	Hs~Ref:NM_080600.1~uORF:IOH38014	5781	6349	2826	594	5093	3242	1912	881	1418	508	myelin associated glycoprotein (MAG), transcript variant 2
B46R04C20	46-20-4	Hs~Ref:NM_080600.1~uORF:IOH38014	5796	6090	2791	605	5225	3036	1902	965	1455	580	myelin associated glycoprotein (MAG), transcript variant 2
B46R04C21	46-21-4	Hs~Ref:NM_004912.3~uORF:IOH38232	65492	65491	50250	9007	62726	3843	3390	2741	2735	3281	KRIT1, ankyrin repeat containing (KRIT1), transcript variant 2
B46R04C22	46-22-4	Hs~Ref:NM_004912.3~uORF:IOH38232	65491	65490	44925	8796	61785	3611	3813	2460	3085	3738	KRIT1, ankyrin repeat containing (KRIT1), transcript variant 2
B46R05C01	46-1-5	Hs~Ref:NM_015959.1~uORF:IOH4346	805	882	1252	786	3557	1118	1614	1405	2139	620	Thioredoxin domain-containing protein 14
B46R05C02	46-2-5	Hs~Ref:NM_015959.1~uORF:IOH4346	889	878	1297	804	3046	1164	1596	1423	2086	563	Thioredoxin domain-containing protein 14
B46R05C03	46-3-5	Hs~Ref:NM_006439.3~uORF:IOH12221	1408	1065	2121	1833	7924	3092	2586	1620	3669	1320	Protein mab-21-like 2
B46R05C04	46-4-5	Hs~Ref:NM_006439.3~uORF:IOH12221	1427	980	2176	1786	9095	3131	2713	1678	3832	1388	Protein mab-21-like 2
B46R05C05	46-5-5	Hs~Ref:NM_001157.2~uORF:IOH6821	1259	467	1044	974	11152	1291	1206	700	1184	491	annexin A11 (ANXA11), transcript variant a
B46R05C06	46-6-5	Hs~Ref:NM_001157.2~uORF:IOH6821	1381	488	1011	929	12109	1334	1130	669	1178	564	annexin A11 (ANXA11), transcript variant a
B46R05C07	46-7-5	Hs~MGC:BC012895.1~uORF:IOH9632	1770	96	173	322	1054	307	204	738	2906	39	solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 (SLC7A1)
B46R05C08	46-8-5	Hs~MGC:BC012895.1~uORF:IOH9632	1851	78	179	312	1096	219	180	686	2795	40	solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 (SLC7A1)
B46R05C09	46-9-5	Hs~Ref:NM_003942.1~N/A	1111	771	1619	865	912	1148	2119	954	2713	475	Ribosomal protein S6 kinase alpha-4
B46R05C10	46-10-5	Hs~Ref:NM_003942.1~N/A	1185	815	1394	818	922	1239	2053	1105	2703	604	Ribosomal protein S6 kinase alpha-4
B46R05C11	46-11-5	Hs~Ref:NM_020421.1~N/A	769	559	723	605	493	833	1131	674	934	388	Uncharacterized aarF domain-containing protein kinase 1
B46R05C12	46-12-5	Hs~Ref:NM_020421.1~N/A	841	556	814	589	504	706	1173	646	1015	357	Uncharacterized aarF domain-containing protein kinase 1
B46R05C13	46-13-5	Hs~Ref:NM_002314.2~N/A	1094	656	852	571	754	924	1731	649	1157	255	LIM domain kinase 1
B46R05C14	46-14-5	Hs~Ref:NM_002314.2~N/A	1052	656	852	642	786	871	1621	754	1271	361	LIM domain kinase 1
B46R05C15	46-15-5	Hs~Ref:NM_002741.1~N/A	868	691	864	741	1828	798	1102	543	1074	135	Serine/threonine-protein kinase N1
B46R05C16	46-16-5	Hs~Ref:NM_002741.1~N/A	909	745	897	762	2236	803	1560	594	859	101	Serine/threonine-protein kinase N1
B46R05C17	46-17-5	Hs~MGC:BC069328.1~uORF:IOH40255	649	1499	630	667	725	821	12837	831	1368	182	Bcl2 modifying factor (BMF)
B46R05C18	46-18-5	Hs~MGC:BC069328.1~uORF:IOH40255	680	1508	598	634	694	763	12374	761	1320	74	Bcl2 modifying factor (BMF)
B46R05C19	46-19-5	Hs~Ref:NM_025029.2~uORF:IOH40105	1861	7308	1045	1834	1184	1269	2449	2544	1766	304	Protein FAM128B
B46R05C20	46-20-5	Hs~Ref:NM_025029.2~uORF:IOH40105	1951	7294	1039	1623	1110	1305	2394	2360	1710	438	Protein FAM128B
B46R05C21	46-21-5	Hs~MGC:BC067445.1~uORF:IOH40160	2709	1240	1965	5499	1596	2024	2461	897	3056	724	disabled homolog 1 (Drosophila) (DAB1)
B46R05C22	46-22-5	Hs~MGC:BC067445.1~uORF:IOH40160	2759	1175	1855	5075	1554	1914	2437	815	2949	638	disabled homolog 1 (Drosophila) (DAB1)
B46R06C01	46-1-6	Hs~Ref:NM_004527.2~uORF:IOH40231	16048	11756	7831	38932	19664	6555	8070	39730	11798	35635	mesenchyme homeobox 1 (MEOX1), transcript variant 1
B46R06C02	46-2-6	Hs~Ref:NM_004527.2~uORF:IOH40231	14102	11832	8195	34599	14383	5876	8174	35733	11359	32554	mesenchyme homeobox 1 (MEOX1), transcript variant 1
B46R06C03	46-3-6	Hs~MGC:BC015732.1~uORF:IOH13370	722	779	1017	1174	956	955	1144	761	1748	475	histidine triad nucleotide binding protein 3 (HINT3)
B46R06C04	46-4-6	Hs~MGC:BC015732.1~uORF:IOH13370	700	771	934	1172	1178	998	1096	747	1702	495	histidine triad nucleotide binding protein 3 (HINT3)
B46R06C05	46-5-6	Hs~Ref:NM_145280.1~uORF:IOH21779	2237	1594	4528	2366	2273	3745	2377	2242	3935	668	family with sequence similarity 119, member A (FAM119A)
B46R06C06	46-6-6	Hs~Ref:NM_145280.1~uORF:IOH21779	2364	1649	4343	2279	2061	3648	2253	2167	3801	756	family with sequence similarity 119, member A (FAM119A)
B46R06C07	46-7-6	Hs~Ref:NM_080387.1~uORF:IOH21717	1337	1116	1351	850	1363	1297	1931	1863	2709	608	C-type lectin domain family 4, member D (CLEC4D)
B46R06C08	46-8-6	Hs~Ref:NM_080387.1~uORF:IOH21717	1321	1087	1372	816	1412	1236	1860	1768	2533	638	C-type lectin domain family 4, member D (CLEC4D)
B46R06C09	46-9-6	Hs~Ref:NM_013290.1~uORF:IOH6212	1446	982	1073	1093	828	1669	2719	3340	1991	698	Homologous-pairing protein 2 homolog
B46R06C10	46-10-6	Hs~Ref:NM_013290.1~uORF:IOH6212	1403	981	958	1283	884	1622	2617	3135	1968	230	Homologous-pairing protein 2 homolog
B46R06C11	46-11-6	Hs~Ref:NM_002133.1~uORF:IOH54938	1298	975	1010	160	957	1404	2324	951	1778	275	Heme oxygenase 1
B46R06C12	46-12-6	Hs~Ref:NM_002133.1~uORF:IOH54938	1231	981	1045	2081	923	1190	2339	936	1788	117	Heme oxygenase 1
B46R06C13	46-13-6	Hs~Ref:NM_004092.2~uORF:IOH54943	1726	1803	1066	1470	1480	2010	2551	1355	2489	739	Enoyl-CoA hydratase, mitochondrial
B46R06C14	46-14-6	Hs~Ref:NM_004092.2~uORF:IOH54943	1582	1695	1035	1484	1568	1842	2448	1299	2486	711	Enoyl-CoA hydratase, mitochondrial
B46R06C15	46-15-6	Hs~Ref:NM_003011.1~uORF:IOH59459	588	796	582	425	981	632	1659	389	751	148	Protein SET
B46R06C16	46-16-6	Hs~Ref:NM_003011.1~uORF:IOH59459	594	831	583	390	868	656	1662	367	779	85	Protein SET
B46R06C17	46-17-6	Hs~Ref:NM_145014.1~uORF:IOH59272	1882	809	1057	590	1199	980	1571	660	1093	358	Hydrolethalus syndrome protein 1
B46R06C18	46-18-6	Hs~Ref:NM_145014.1~uORF:IOH59272	1861	780	1066	558	1213	927	1551	639	1165	331	Hydrolethalus syndrome protein 1
B46R06C19	46-19-6	Hs~MGC:BC016730.1~uORF:IOH27890	826	834	1034	747	1142	661	1088	1260	1284	590	HCLS1 associated protein X-1 (HAX1)
B46R06C20	46-20-6	Hs~MGC:BC016730.1~uORF:IOH27890	860	799	1030	719	1134	713	1028	1231	1220	405	HCLS1 associated protein X-1 (HAX1)
B46R06C21	46-21-6	Hs~MGC:BC050328.1~uORF:IOH26426	577	630	589	741	594	737	852	506	874	974	neuroblastoma breakpoint family, member 22 (pseudogene) (NBPF22P)
B46R06C22	46-22-6	Hs~MGC:BC050328.1~uORF:IOH26426	635	623	551	712	582	655	847	491	846	776	neuroblastoma breakpoint family, member 22 (pseudogene) (NBPF22P)
B46R07C01	46-1-7	Hs~MGC:BC031073.1~uORF:IOH22537	865	573	815	448	1035	734	1089	474	1137	338	poly (ADP-ribose) polymerase family, member 11 (PARP11)
B46R07C02	46-2-7	Hs~MGC:BC031073.1~uORF:IOH22537	868	584	856	419	827	717	1037	500	968	360	poly (ADP-ribose) polymerase family, member 11 (PARP11)
B46R07C03	46-3-7	Hs~MGC:BC048107.1~uORF:IOH26749	1172	664	940	1045	1074	662	905	1011	1433	377	zinc finger protein 333 (ZNF333)
B46R07C04	46-4-7	Hs~MGC:BC048107.1~uORF:IOH26749	1276	745	938	1049	1002	722	957	995	1339	290	zinc finger protein 333 (ZNF333)
B46R07C05	46-5-7	Hs~MGC:BC003096.1~uORF:IOH4534	2010	3230	2765	1442	1027	1827	2679	1539	2143	460	PDZ and LIM domain protein 4
B46R07C06	46-6-7	Hs~MGC:BC003096.1~uORF:IOH4534	2189	3272	2662	1435	1105	1746	2608	1473	2057	460	PDZ and LIM domain protein 4
B46R07C07	46-7-7	Hs~MGC:BC016821.1~uORF:IOH23009	1349	3056	2219	3734	794	2935	1957	854	2331	670	MAP3K12-binding inhibitory protein 1
B46R07C08	46-8-7	Hs~MGC:BC016821.1~uORF:IOH23009	1347	2923	2180	3786	886	2845	1984	991	2266	636	MAP3K12-binding inhibitory protein 1
B46R07C09	46-9-7	Hs~MGC:BC001375.1~uORF:IOH3976	1108	2242	1400	541	1864	1138	839	611	1866	718	Cytosolic non-specific dipeptidase
B46R07C10	46-10-7	Hs~MGC:BC001375.1~uORF:IOH3976	1001	2334	1397	462	1879	1140	894	594	1812	741	Cytosolic non-specific dipeptidase
B46R07C13	46-13-7	Hs~Ref:NM_000906.1~N/A	1377	1020	1702	842	660	954	1745	992	1918	520	Atrial natriuretic peptide receptor A
B46R07C14	46-14-7	Hs~Ref:NM_000906.1~N/A	1215	1138	1555	821	628	931	1735	934	1667	430	Atrial natriuretic peptide receptor A
B46R07C17	46-17-7	Hs~Ref:NM_004734.1~N/A	3449	4176	5801	6844	3028	2870	10087	2576	6788	1298	doublecortin-like kinase 1 (DCLK1)
B46R07C18	46-18-7	Hs~Ref:NM_004734.1~N/A	3620	4189	5887	5994	2995	2713	10018	2490	6570	1219	doublecortin-like kinase 1 (DCLK1)
B46R07C19	46-19-7	Hs~Ref:NM_001569.2~N/A	1784	1416	2435	519	1208	879	1144	657	1514	441	Interleukin-1 receptor-associated kinase 1
B46R07C20	46-20-7	Hs~Ref:NM_001569.2~N/A	1888	1380	2355	546	1184	772	1234	643	1355	412	Interleukin-1 receptor-associated kinase 1
B46R07C21	46-21-7	Hs~MGC:BC014271.2~uORF:IOH13908	13113	10152	8362	10377	9680	8535	7177	8041	13298	14385	endoglin (Osler-Rendu-Weber syndrome 1) (ENG)
B46R07C22	46-22-7	Hs~MGC:BC014271.2~uORF:IOH13908	12402	9795	8406	10354	9441	8078	6882	7983	12589	13582	endoglin (Osler-Rendu-Weber syndrome 1) (ENG)
B46R08C01	46-1-8	Hs~MGC:BC009993.2~uORF:IOH27830	3948	1492	1898	4699	2013	8013	4428	3021	2609	1159	chromosome 3 open reading frame 37 (C3orf37)
B46R08C02	46-2-8	Hs~MGC:BC009993.2~uORF:IOH27830	3946	1411	1857	4653	1967	7573	4319	3018	2598	1109	chromosome 3 open reading frame 37 (C3orf37)
B46R08C03	46-3-8	Hs~Ref:NM_005159.3~uORF:IOH14126	648	412	841	415	492	541	696	420	711	382	actin, alpha, cardiac muscle 1 (ACTC1)
B46R08C04	46-4-8	Hs~Ref:NM_005159.3~uORF:IOH14126	665	428	873	423	571	610	709	420	724	287	actin, alpha, cardiac muscle 1 (ACTC1)
B46R08C05	46-5-8	Hs~Ref:NM_006442.2~uORF:IOH14520	576	389	756	676	611	1430	1021	453	1150	672	DR1-associated protein 1 (negative cofactor 2 alpha) (DRAP1)
B46R08C06	46-6-8	Hs~Ref:NM_006442.2~uORF:IOH14520	633	411	754	686	556	1398	998	434	1135	666	DR1-associated protein 1 (negative cofactor 2 alpha) (DRAP1)
B46R08C07	46-7-8	Hs~Ref:NM_019601.3~uORF:IOH23286	779	556	827	334	569	465	705	405	696	174	sushi domain containing 2 (SUSD2)
B46R08C08	46-8-8	Hs~Ref:NM_019601.3~uORF:IOH23286	820	544	838	402	571	540	694	660	771	240	sushi domain containing 2 (SUSD2)
B46R08C09	46-9-8	Hs~Ref:NM_006480.4~uORF:IOH13081	1737	695	1337	4142	1133	2526	2873	6254	1723	312	regulator of G-protein signaling 14 (RGS14)
B46R08C10	46-10-8	Hs~Ref:NM_006480.4~uORF:IOH13081	1768	657	1310	3811	1135	2446	2711	5362	1622	167	regulator of G-protein signaling 14 (RGS14)
B46R08C11	46-11-8	Hs~Ref:NM_003335.2~uORF:IOH6479	1077	1372	1766	777	1635	978	959	647	1060	337	ubiquitin-activating enzyme E1-like (UBE1L)
B46R08C12	46-12-8	Hs~Ref:NM_003335.2~uORF:IOH6479	1044	1355	1785	804	1436	1043	914	672	1098	200	ubiquitin-activating enzyme E1-like (UBE1L)
B46R08C13	46-13-8	Hs~Ref:NM_003321.3~uORF:IOH4865	3701	4281	2592	1795	4950	1302	1802	985	2519	631	Tu translation elongation factor, mitochondrial (TUFM)
B46R08C14	46-14-8	Hs~Ref:NM_003321.3~uORF:IOH4865	3938	4282	2413	1832	4847	1353	1873	999	2559	646	Tu translation elongation factor, mitochondrial (TUFM)
B46R08C15	46-15-8	Hs~Ref:NM_003633.1~uORF:IOH3669	576	457	491	404	990	627	839	439	1026	337	ectodermal-neural cortex (with BTB-like domain) (ENC1)
B46R08C16	46-16-8	Hs~Ref:NM_003633.1~uORF:IOH3669	479	406	536	421	814	586	925	460	999	382	ectodermal-neural cortex (with BTB-like domain) (ENC1)
B46R08C17	46-17-8	Hs~Ref:NM_004401.1~uORF:IOH4671	459	389	574	302	1148	316	8852	267	762	105	DNA fragmentation factor, 45kDa, alpha polypeptide (DFFA), transcript variant 1
B46R08C18	46-18-8	Hs~Ref:NM_004401.1~uORF:IOH4671	455	394	567	257	1143	305	8467	262	734	61	DNA fragmentation factor, 45kDa, alpha polypeptide (DFFA), transcript variant 1
B46R08C19	46-19-8	Hs~MGC:BC037779.2~uORF:IOH27741	1572	840	1111	730	852	991	1430	726	2070	553	Zinc finger protein 165
B46R08C20	46-20-8	Hs~MGC:BC037779.2~uORF:IOH27741	1599	930	1108	767	858	1009	1445	720	1941	559	Zinc finger protein 165
B46R08C21	46-21-8	Hs~Ref:NM_004117.2~uORF:IOH27424	1969	748	1009	874	8388	937	2205	1397	3018	517	FK506 binding protein 5 (FKBP5)
B46R08C22	46-22-8	Hs~Ref:NM_004117.2~uORF:IOH27424	2105	745	991	795	8245	889	2197	1303	2984	485	FK506 binding protein 5 (FKBP5)
B46R09C01	46-1-9	Hs~Ref:NM_014478.3~uORF:IOH59924	1975	542	655	344	958	1699	843	517	1545	724	DNA-directed RNA polymerase III subunit RPC9
B46R09C02	46-2-9	Hs~Ref:NM_014478.3~uORF:IOH59924	2032	514	660	339	955	1795	804	552	1490	726	DNA-directed RNA polymerase III subunit RPC9
B46R09C03	46-3-9	Hs~Ref:NM_002416.1~uORF:IOH57247	884	574	1511	488	610	856	1598	627	977	310	C-X-C motif chemokine 9
B46R09C04	46-4-9	Hs~Ref:NM_002416.1~uORF:IOH57247	915	584	1457	535	640	891	1595	581	997	437	C-X-C motif chemokine 9
B46R09C05	46-5-9	Hs~Ref:NM_181893.1~uORF:IOH59929	1154	621	1807	556	647	984	811	777	1204	260	Ubiquitin-conjugating enzyme E2 D3
B46R09C06	46-6-9	Hs~Ref:NM_181893.1~uORF:IOH59929	1143	617	1799	550	596	886	808	730	1171	63	Ubiquitin-conjugating enzyme E2 D3
B46R09C07	46-7-9	Hs~MGC:BC035017.2~uORF:IOH28642	581	738	24029	345	676	830	1201	498	1480	446	Sodium channel subunit beta-4
B46R09C08	46-8-9	Hs~MGC:BC035017.2~uORF:IOH28642	568	737	23544	344	900	876	1137	508	1509	388	Sodium channel subunit beta-4
B46R09C09	46-9-9	Hs~MGC:BC008964.2~uORF:IOH56888	390	285	426	245	287	416	473	564	504	736	6-phosphofructokinase, liver type
B46R09C10	46-10-9	Hs~MGC:BC008964.2~uORF:IOH56888	412	289	446	235	261	439	462	356	502	171	6-phosphofructokinase, liver type
B46R09C11	46-11-9	Hs~Ref:NM_001937.3~uORF:IOH53854	714	709	906	245	318	601	477	288	515	73	Dermatopontin
B46R09C12	46-12-9	Hs~Ref:NM_001937.3~uORF:IOH53854	723	692	845	312	230	761	460	296	532	722	Dermatopontin
B46R09C13	46-13-9	Hs~Ref:NM_182729.1~uORF:IOH52112	936	1321	1718	610	1132	1467	2189	1284	1703	534	Thioredoxin reductase 1, cytoplasmic
B46R09C14	46-14-9	Hs~Ref:NM_182729.1~uORF:IOH52112	939	1315	1676	569	1104	1250	2190	1312	1625	502	Thioredoxin reductase 1, cytoplasmic
B46R09C15	46-15-9	Hs~Ref:NM_006294.2~uORF:IOH57049	920	1755	1749	733	1647	2397	1847	2465	1914	566	Cytochrome b-c1 complex subunit 7
B46R09C16	46-16-9	Hs~Ref:NM_006294.2~uORF:IOH57049	861	1719	1673	719	1792	2285	1799	2175	1872	470	Cytochrome b-c1 complex subunit 7
B46R09C17	46-17-9	Hs~Ref:NM_033316.2~uORF:IOH6835	784	700	963	762	877	932	1121	712	1609	484	antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 (MFI2), transcript variant 2
B46R09C18	46-18-9	Hs~Ref:NM_033316.2~uORF:IOH6835	841	686	989	600	863	985	1301	685	1542	487	antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 (MFI2), transcript variant 2
B46R09C19	46-19-9	Hs~Ref:NM_022483.2~uORF:IOH13312	792	392	632	381	291	575	536	325	600	102	chromosome 5 open reading frame 28 (C5orf28)
B46R09C20	46-20-9	Hs~Ref:NM_022483.2~uORF:IOH13312	841	422	642	375	275	443	569	379	628	356	chromosome 5 open reading frame 28 (C5orf28)
B46R09C21	46-21-9	Hs~MGC:BC000953.2~uORF:IOH3022	2011	870	1065	795	874	962	3972	572	1466	567	RIO kinase 2 (yeast) (RIOK2)
B46R09C22	46-22-9	Hs~MGC:BC000953.2~uORF:IOH3022	2056	878	1032	777	788	976	3963	554	1325	671	RIO kinase 2 (yeast) (RIOK2)
B46R10C01	46-1-10	Hs~Ref:NM_014702.1~uORF:IOH21412	3053	1536	1343	989	2071	1455	4423	1064	3146	581	KIAA0408 (KIAA0408)
B46R10C02	46-2-10	Hs~Ref:NM_014702.1~uORF:IOH21412	3028	1291	1422	1031	2061	1489	4572	1137	3057	612	KIAA0408 (KIAA0408)
B46R10C03	46-3-10	Hs~Ref:NM_000442.2~uORF:IOH10695	1117	866	1105	824	701	1369	1699	807	2559	562	platelet/endothelial cell adhesion molecule (CD31 antigen) (PECAM1)
B46R10C04	46-4-10	Hs~Ref:NM_000442.2~uORF:IOH10695	1131	875	1122	859	861	1416	1702	842	2560	586	platelet/endothelial cell adhesion molecule (CD31 antigen) (PECAM1)
B46R10C05	46-5-10	Hs~Ref:NM_024695.1~uORF:IOH10911	2129	384	533	2400	533	1101	996	4836	3617	455	lectin, mannose-binding, 1 like (LMAN1L)
B46R10C06	46-6-10	Hs~Ref:NM_024695.1~uORF:IOH10911	2327	395	519	2259	521	1073	952	4596	3426	227	lectin, mannose-binding, 1 like (LMAN1L)
B46R10C07	46-7-10	Hs~MGC:BC007382.1~uORF:IOH7027	733	522	627	382	471	661	1327	555	953	201	RAB7B, member RAS oncogene family (RAB7B)
B46R10C08	46-8-10	Hs~MGC:BC007382.1~uORF:IOH7027	674	492	667	390	538	912	1347	525	886	173	RAB7B, member RAS oncogene family (RAB7B)
B46R10C09	46-9-10	Hs~Ref:NM_017871.3~uORF:IOH7042	997	793	967	627	914	1075	1447	739	1562	548	cleavage and polyadenylation specific factor 3-like (CPSF3L)
B46R10C10	46-10-10	Hs~Ref:NM_017871.3~uORF:IOH7042	910	716	933	591	860	1097	1433	821	1613	534	cleavage and polyadenylation specific factor 3-like (CPSF3L)
B46R11C21	46-21-11	Hs~Ref:NM_002364.1~uORF:IOH11315	3243	2286	2522	3790	2479	2488	11401	8514	5277	1384	melanoma antigen family B, 2 (MAGEB2)
B46R11C22	46-22-11	Hs~Ref:NM_002364.1~uORF:IOH11315	3313	2356	2441	3487	2505	2427	11438	8001	5172	1384	melanoma antigen family B, 2 (MAGEB2)
B46R12C01	46-1-12	Hs~Ref:NM_032341.1~uORF:IOH7525	953	839	992	742	870	1542	1186	652	1429	432	DDI1, DNA-damage inducible 1, homolog 2 (S. cerevisiae) (DDI2)
B46R12C02	46-2-12	Hs~Ref:NM_032341.1~uORF:IOH7525	989	838	1022	751	889	1590	1086	750	1398	466	DDI1, DNA-damage inducible 1, homolog 2 (S. cerevisiae) (DDI2)
B46R12C03	46-3-12	Hs~Ref:NM_007217.2~uORF:IOH3934	1328	2525	5292	592	1018	915	921	780	1344	405	programmed cell death 10 (PDCD10), transcript variant 1
B46R12C04	46-4-12	Hs~Ref:NM_007217.2~uORF:IOH3934	1383	2706	5290	607	1047	951	595	767	1294	357	programmed cell death 10 (PDCD10), transcript variant 1
B46R12C05	46-5-12	Hs~Ref:NM_015933.1~uORF:IOH3769	4849	1988	3664	2850	3450	2677	22014	1889	3455	1007	coiled-coil domain containing 72 (CCDC72)
B46R12C06	46-6-12	Hs~Ref:NM_015933.1~uORF:IOH3769	5031	2111	3819	2787	3401	3038	21209	1825	3474	975	coiled-coil domain containing 72 (CCDC72)
B46R12C07	46-7-12	Hs~MGC:BC053989.1~uORF:IOH29368	688	705	610	417	403	708	955	434	1024	504	zinc finger protein 179 (ZNF179)
B46R12C08	46-8-12	Hs~MGC:BC053989.1~uORF:IOH29368	583	580	593	401	482	914	791	404	995	530	zinc finger protein 179 (ZNF179)
B46R12C09	46-9-12	Hs~MGC:BC059364.1~uORF:IOH29285	527	564	602	248	395	587	599	245	775	247	zinc binding alcohol dehydrogenase, domain containing 1 (ZADH1)
B46R12C10	46-10-12	Hs~MGC:BC059364.1~uORF:IOH29285	549	593	556	264	432	604	544	282	675	35	zinc binding alcohol dehydrogenase, domain containing 1 (ZADH1)
B46R12C11	46-11-12	Hs~MGC:BC054517.1~uORF:IOH28882	896	963	1032	340	662	1523	507	297	746	201	Fanconi anemia, complementation group L (FANCL)
B46R12C12	46-12-12	Hs~MGC:BC054517.1~uORF:IOH28882	891	992	1012	351	711	1447	480	312	849	64	Fanconi anemia, complementation group L (FANCL)
B46R12C13	46-13-12	Hs~Ref:NM_002447.1~N/A	1638	1228	1827	936	1624	1090	1796	838	2288	715	Macrophage-stimulating protein receptor
B46R12C14	46-14-12	Hs~Ref:NM_002447.1~N/A	1739	1217	1852	854	1567	1018	1776	788	2202	463	Macrophage-stimulating protein receptor
B46R12C15	46-15-12	Hs~MGC:BC016640.1~uORF:IOH21476	1675	1122	1047	1294	933	910	1829	742	2820	488	synovial sarcoma, X breakpoint 5 (SSX5)
B46R12C16	46-16-12	Hs~MGC:BC016640.1~uORF:IOH21476	1665	1391	1009	1322	963	921	1693	804	2690	457	synovial sarcoma, X breakpoint 5 (SSX5)
B46R12C17	46-17-12	Hs~MGC:NM_152634.1~uORF:IOH21490	2649	1732	955	678	1843	1113	1946	761	2218	545	TFS2-M domain-containing protein 1 (MGC17403)
B46R12C18	46-18-12	Hs~MGC:NM_152634.1~uORF:IOH21490	3018	1857	981	891	1703	1097	1935	867	2285	524	TFS2-M domain-containing protein 1 (MGC17403)
B46R12C19	46-19-12	Hs~Ref:NM_005038.1~uORF:IOH22406	3499	1876	830	1118	1070	1151	1357	1294	1215	223	peptidylprolyl isomerase D (cyclophilin D) (PPID)
B46R12C20	46-20-12	Hs~Ref:NM_005038.1~uORF:IOH22406	3664	1823	852	1111	1063	1067	1329	1125	1174	158	peptidylprolyl isomerase D (cyclophilin D) (PPID)
B46R13C01	46-1-13	Hs~MGC:BC009016.1~uORF:IOH3326	599	399	716	383	497	593	830	310	1173	279	complement component 1, q subcomponent, C chain (C1QC)
B46R13C02	46-2-13	Hs~MGC:BC009016.1~uORF:IOH3326	606	441	656	394	447	562	769	365	1243	249	complement component 1, q subcomponent, C chain (C1QC)
B46R13C03	46-3-13	Hs~MGC:BC017922.1~uORF:IOH12726	864	529	790	434	557	2200	726	399	1237	134	Immunoglobulin iota chain
B46R13C04	46-4-13	Hs~MGC:BC017922.1~uORF:IOH12726	772	492	779	439	570	724	755	374	1105	383	Immunoglobulin iota chain
B46R13C05	46-5-13	Hs~MGC:BC020729.1~uORF:IOH12978	1320	745	1041	1781	970	910	2377	586	1728	457	cyclin E2 (CCNE2)
B46R13C06	46-6-13	Hs~MGC:BC020729.1~uORF:IOH12978	1353	650	1042	1701	847	1030	2291	594	1734	466	cyclin E2 (CCNE2)
B46R13C07	46-7-13	Hs~MGC:BC015877.1~uORF:IOH13013	1321	886	1178	656	769	877	1000	696	2014	449	cadherin 19, type 2 (CDH19)
B46R13C08	46-8-13	Hs~MGC:BC015877.1~uORF:IOH13013	1278	728	1139	656	782	872	1322	714	1999	393	cadherin 19, type 2 (CDH19)
B46R13C09	46-9-13	Hs~MGC:BC051841.1~uORF:IOH28892	649	653	650	744	725	1195	801	689	1287	307	transmembrane protein 25 (TMEM25)
B46R13C10	46-10-13	Hs~MGC:BC051841.1~uORF:IOH28892	680	679	682	755	587	1030	788	639	1124	305	transmembrane protein 25 (TMEM25)
B46R13C11	46-11-13	Hs~MGC:BC060847.1~uORF:IOH29212	532	750	579	325	567	598	605	400	779	107	par-6 partitioning defective 6 homolog beta (C. elegans) (PARD6B)
B46R13C12	46-12-13	Hs~MGC:BC060847.1~uORF:IOH29212	506	773	589	314	515	616	586	410	698	148	par-6 partitioning defective 6 homolog beta (C. elegans) (PARD6B)
B46R13C13	46-13-13	Hs~MGC:BC053984.1~uORF:IOH29361	520	926	544	423	477	932	1472	478	1605	125	immunoglobulin heavy variable 4-31 (IGHV4-31)
B46R13C14	46-14-13	Hs~MGC:BC053984.1~uORF:IOH29361	582	979	518	364	475	838	1430	473	1543	83	immunoglobulin heavy variable 4-31 (IGHV4-31)
B46R13C15	46-15-13	Hs~MGC:BC053656.1~uORF:IOH28981	777	467	734	499	566	892	1146	567	1313	168	EGF-like repeats and discoidin I-like domains 3 (EDIL3)
B46R13C16	46-16-13	Hs~MGC:BC053656.1~uORF:IOH28981	773	964	712	510	530	890	1166	555	905	249	EGF-like repeats and discoidin I-like domains 3 (EDIL3)
B46R13C17	46-17-13	Hs~Ref:NM_023080.1~uORF:IOH13369	1248	1021	1770	3349	1485	2743	3078	4921	4512	528	chromosome 8 open reading frame 33 (C8orf33)
B46R13C18	46-18-13	Hs~Ref:NM_023080.1~uORF:IOH13369	1323	935	1742	3249	1360	2607	2997	4386	4365	536	chromosome 8 open reading frame 33 (C8orf33)
B46R13C19	46-19-13	Hs~MGC:BC056418.1~uORF:IOH29118	536	357	565	451	308	620	923	510	886	237	melanoma cell adhesion molecule (MCAM)
B46R13C20	46-20-13	Hs~MGC:BC056418.1~uORF:IOH29118	477	381	565	466	322	629	852	474	899	241	melanoma cell adhesion molecule (MCAM)
B46R13C21	46-21-13	Hs~Ref:NM_000484.1~uORF:IOH29583	439	302	467	265	253	588	624	362	561	121	amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease) (APP), transcript variant 1
B46R13C22	46-22-13	Hs~Ref:NM_000484.1~uORF:IOH29583	467	284	466	266	249	570	569	352	545	214	amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease) (APP), transcript variant 1
B46R14C01	46-1-14	Hs~MGC:BC028736.1~uORF:IOH28644	571	458	629	282	435	748	746	345	675	157	Glutamate receptor 2
B46R14C02	46-2-14	Hs~MGC:BC028736.1~uORF:IOH28644	587	455	597	276	393	851	740	376	751	272	Glutamate receptor 2
B46R14C03	46-3-14	Hs~MGC:BC017072.1~uORF:IOH10334	669	1044	784	820	539	1172	717	629	1548	298	BTB (POZ) domain containing 10 (BTBD10)
B46R14C04	46-4-14	Hs~MGC:BC017072.1~uORF:IOH10334	660	889	747	804	520	1250	685	647	1487	246	BTB (POZ) domain containing 10 (BTBD10)
B46R14C05	46-5-14	Hs~Ref:NM_001013.2~uORF:IOH5840	1560	3577	1302	871	976	1568	4930	763	1435	608	ribosomal protein S9 (RPS9)
B46R14C06	46-6-14	Hs~Ref:NM_001013.2~uORF:IOH5840	1608	3480	1286	922	962	1515	4875	724	1446	581	ribosomal protein S9 (RPS9)
B46R14C07	46-7-14	Hs~Ref:NM_020347.1~uORF:IOH27664	846	4053	732	3026	902	2648	970	1258	2628	399	leucine zipper transcription factor-like 1 (LZTFL1)
B46R14C08	46-8-14	Hs~Ref:NM_020347.1~uORF:IOH27664	840	4448	719	2810	802	2650	915	1238	2568	286	leucine zipper transcription factor-like 1 (LZTFL1)
B46R14C09	46-9-14	Hs~Ref:NM_002822.1~uORF:IOH25866	4461	18126	4095	21008	5536	13802	12484	13148	10334	3196	Twinfilin-1
B46R14C10	46-10-14	Hs~Ref:NM_002822.1~uORF:IOH25866	4634	19789	4092	20256	5162	12772	12340	12723	10322	3555	Twinfilin-1
B46R14C11	46-11-14	Hs~Ref:NM_183012.1~uORF:IOH53457	772	401	564	3327	464	791	643	600	1217	437	cAMP responsive element modulator (CREM), transcript variant 20, mRNA.
B46R14C12	46-12-14	Hs~Ref:NM_183012.1~uORF:IOH53457	679	375	530	3358	483	708	642	575	1136	417	cAMP responsive element modulator (CREM), transcript variant 20, mRNA.
B46R14C13	46-13-14	Hs~Ref:NM_001886.1~uORF:IOH59021	1686	1197	922	2127	740	1544	3173	857	1656	361	Beta-crystallin A4
B46R14C14	46-14-14	Hs~Ref:NM_001886.1~uORF:IOH59021	1517	1210	878	2125	738	1460	3179	873	1756	317	Beta-crystallin A4
B46R14C15	46-15-14	Hs~Ref:NM_001017367.1~uORF:IOH59815	466	347	478	1922	800	582	485	395	989	241	C4b-binding protein beta chain
B46R14C16	46-16-14	Hs~Ref:NM_001017367.1~uORF:IOH59815	195	350	470	2178	764	597	506	399	786	182	C4b-binding protein beta chain
B46R14C17	46-17-14	Hs~Ref:NM_005079.2~uORF:IOH59008	219	144	342	213	851	530	1155	567	694	177	Tumor protein D52
B46R14C18	46-18-14	Hs~Ref:NM_005079.2~uORF:IOH59008	303	115	338	198	798	505	1101	530	685	68	Tumor protein D52
B46R14C19	46-19-14	Hs~MGC:BC042820.1~uORF:IOH26481	744	795	1369	636	646	881	2132	806	5461	324	proteasome (prosome, macropain) subunit, alpha type, 8 (PSMA8)
B46R14C20	46-20-14	Hs~MGC:BC042820.1~uORF:IOH26481	746	816	1325	658	662	919	2078	835	5356	171	proteasome (prosome, macropain) subunit, alpha type, 8 (PSMA8)
B46R14C21	46-21-14	Hs~Ref:NM_173475.1~uORF:IOH26231	1004	379	1378	250	430	6634	525	430	659	87	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) (DCUN1D3)
B46R14C22	46-22-14	Hs~Ref:NM_173475.1~uORF:IOH26231	1038	417	1342	246	438	6084	528	375	617	86	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) (DCUN1D3)
B46R15C01	46-1-15	Hs~Ref:NM_005441.2~uORF:IOH13577	5495	1548	2480	1423	2030	4202	3563	2633	4320	495	chromatin assembly factor 1, subunit B (p60) (CHAF1B)
B46R15C02	46-2-15	Hs~Ref:NM_005441.2~uORF:IOH13577	5769	1590	2520	1409	1636	4032	3454	2626	4426	459	chromatin assembly factor 1, subunit B (p60) (CHAF1B)
B46R15C03	46-3-15	Hs~Ref:NM_173618.1~uORF:IOH26714	1492	1571	2036	1311	5500	2490	2203	1123	2611	883	coiled-coil domain containing 95 (CCDC95)
B46R15C04	46-4-15	Hs~Ref:NM_173618.1~uORF:IOH26714	1505	1441	2046	1260	5300	2275	2145	1156	2617	856	coiled-coil domain containing 95 (CCDC95)
B46R15C05	46-5-15	Hs~Ref:NM_203422.1~uORF:IOH29035	1399	568	1105	399	982	861	867	533	1227	384	LRRN4 C-terminal-like protein
B46R15C06	46-6-15	Hs~Ref:NM_203422.1~uORF:IOH29035	1448	524	1035	429	912	888	846	577	1172	327	LRRN4 C-terminal-like protein
B46R15C07	46-7-15	Hs~MGC:BC057767.1~uORF:IOH29267	2119	720	1122	897	1759	1203	1616	1140	2406	695	chromosome 20 open reading frame 132 (C20orf132)
B46R15C08	46-8-15	Hs~MGC:BC057767.1~uORF:IOH29267	2120	778	1125	936	1385	1232	1660	1189	2381	695	chromosome 20 open reading frame 132 (C20orf132)
B46R15C09	46-9-15	Hs~MGC:BC056907.1~uORF:IOH29059	2253	564	1579	707	1817	2323	5829	862	2860	697	cDNA clone MGC:65154 IMAGE:5122136, complete cds
B46R15C10	46-10-15	Hs~MGC:BC056907.1~uORF:IOH29059	2291	556	1546	715	1775	2291	5619	848	2782	160	cDNA clone MGC:65154 IMAGE:5122136, complete cds
B46R15C11	46-11-15	Hs~MGC:BC057783.1~uORF:IOH29271	2183	1522	2854	3751	3185	4959	4366	2611	4792	1439	splicing factor, arginine/serine-rich 2B (SFRS2B)
B46R15C12	46-12-15	Hs~MGC:BC057783.1~uORF:IOH29271	2292	1483	2856	3774	3023	4638	4331	2514	5049	1703	splicing factor, arginine/serine-rich 2B (SFRS2B)
B46R15C17	46-17-15	Hs~Ref:NM_001798.2~CAT:PV3267	553	539	377	661	1143	535	616	563	578	265	cyclin-dependent kinase 2 (CDK2), transcript variant 1
B46R15C18	46-18-15	Hs~Ref:NM_001798.2~CAT:PV3267	557	594	441	651	1117	535	593	534	695	223	cyclin-dependent kinase 2 (CDK2), transcript variant 1
B46R15C21	46-21-15	Hs~Ref:NM_006609.2~CAT:PV3822	738	771	1038	2079	854	2307	1485	1744	5689	806	Mitogen-activated protein kinase kinase kinase 2
B46R15C22	46-22-15	Hs~Ref:NM_006609.2~CAT:PV3822	709	762	1071	1949	860	2100	1482	1550	5547	807	Mitogen-activated protein kinase kinase kinase 2
B46R16C01	46-1-16	Hs~Ref:NM_020168.3~CAT:PV3502	1081	1438	5341	2533	3137	5089	4453	2232	1682	1602	p21(CDKN1A)-activated kinase 6 (PAK6)
B46R16C02	46-2-16	Hs~Ref:NM_020168.3~CAT:PV3502	1130	1426	5512	2424	3011	5134	4687	2148	1671	1526	p21(CDKN1A)-activated kinase 6 (PAK6)
B46R16C03	46-3-16	Hs~Ref:NM_000619.2~CAT_PHC4031	1221	342	802	702	184	1107	2394	235	1501	378	Interferon gamma
B46R16C04	46-4-16	Hs~Ref:NM_000619.2~CAT_PHC4031	1328	307	789	714	142	1113	2368	247	1469	407	Interferon gamma
B46R16C07	46-7-16	Hs~Ref:NM_001003806.1~uORF:IOH58623	616	531	711	448	523	741	1367	580	1250	457	TCR gamma alternate reading frame protein (TARP), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA.
B46R16C08	46-8-16	Hs~Ref:NM_001003806.1~uORF:IOH58623	667	536	762	471	515	826	1367	579	1280	410	TCR gamma alternate reading frame protein (TARP), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA.
B46R16C15	46-15-16	Hs~MGC:BC069677.1~uORF:IOH61907	879	750	805	495	2095	947	1701	989	1326	347	Regulator of G-protein signaling 8
B46R16C16	46-16-16	Hs~MGC:BC069677.1~uORF:IOH61907	934	766	782	531	1974	927	1695	1049	1154	532	Regulator of G-protein signaling 8
B46R16C17	46-17-16	Hs~Ref:NM_006148.1~uORF:IOH54875	1664	10053	20762	3870	2035	2216	4744	1483	2529	448	LIM and SH3 domain protein 1
B46R16C18	46-18-16	Hs~Ref:NM_006148.1~uORF:IOH54875	1777	10117	20110	3360	2027	2155	4507	1324	2449	528	LIM and SH3 domain protein 1
B46R16C19	46-19-16	Hs~MGC:BC040545.1~uORF:IOH62182	578	475	505	374	503	855	959	390	858	152	Fermitin family homolog 1
B46R16C20	46-20-16	Hs~MGC:BC040545.1~uORF:IOH62182	547	502	507	379	467	976	931	444	871	151	Fermitin family homolog 1
B46R16C21	46-21-16	Hs~Ref:NM_005861.2~uORF:IOH56981	505	505	656	484	587	1370	1046	2907	2229	75	STIP1 homology and U box-containing protein 1
B46R16C22	46-22-16	Hs~Ref:NM_005861.2~uORF:IOH56981	487	479	651	444	560	1381	988	3093	2033	497	STIP1 homology and U box-containing protein 1
B46R17C01	46-1-17	Hs~Ref:NM_003302.1~uORF:IOH5518	6573	1781	5620	4317	13312	7375	3753	2238	4947	1406	thyroid hormone receptor interactor 6 (TRIP6)
B46R17C02	46-2-17	Hs~Ref:NM_003302.1~uORF:IOH5518	6815	1770	5912	4202	12207	7462	3624	2181	4874	1442	thyroid hormone receptor interactor 6 (TRIP6)
B46R17C03	46-3-17	Hs~MGC:BC001874.1~uORF:IOH4836	1133	754	1138	597	1001	866	1203	686	1945	488	sequestosome 1 (SQSTM1)
B46R17C04	46-4-17	Hs~MGC:BC001874.1~uORF:IOH4836	1126	783	1082	642	869	930	1229	711	2006	507	sequestosome 1 (SQSTM1)
B46R17C05	46-5-17	Hs~MGC:BC000331.1~uORF:IOH3559	1875	1014	1722	895	1421	1975	1660	1229	2663	588	proteasome (prosome, macropain) subunit, beta type, 4 (PSMB4)
B46R17C06	46-6-17	Hs~MGC:BC000331.1~uORF:IOH3559	1782	938	1647	939	1504	2048	1594	1262	2824	571	proteasome (prosome, macropain) subunit, beta type, 4 (PSMB4)
B46R17C07	46-7-17	Hs~Ref:NM_015665.3~uORF:IOH4287	697	557	729	461	952	1438	1306	577	1409	377	achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple-A) (AAAS)
B46R17C08	46-8-17	Hs~Ref:NM_015665.3~uORF:IOH4287	650	619	665	481	891	1411	1143	581	1387	392	achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple-A) (AAAS)
B46R17C09	46-9-17	Hs~Ref:NM_003673.2~uORF:IOH13813	497	355	482	314	474	502	637	645	839	129	titin-cap (telethonin) (TCAP)
B46R17C10	46-10-17	Hs~Ref:NM_003673.2~uORF:IOH13813	561	296	455	322	382	478	575	634	793	199	titin-cap (telethonin) (TCAP)
B46R17C11	46-11-17	Hs~Ref:NM_025231.1~uORF:IOH5460	1114	796	701	525	840	1158	1626	596	1401	477	zinc finger and SCAN domain containing 16 (ZSCAN16)
B46R17C12	46-12-17	Hs~Ref:NM_025231.1~uORF:IOH5460	1199	736	691	511	872	1194	1509	587	1487	399	zinc finger and SCAN domain containing 16 (ZSCAN16)
B46R17C13	46-13-17	Hs~Ref:NM_005610.1~uORF:IOH4480	419	258	220	202	1354	738	455	235	206	71	retinoblastoma binding protein 4 (RBBP4)
B46R17C14	46-14-17	Hs~Ref:NM_005610.1~uORF:IOH4480	16	246	229	295	1347	671	441	227	331	65	retinoblastoma binding protein 4 (RBBP4)
B46R17C15	46-15-17	Hs~MGC:BC000247.1~uORF:IOH4476	526	251	332	307	2647	899	357	268	377	99	THAP domain containing 4 (THAP4)
B46R17C16	46-16-17	Hs~MGC:BC000247.1~uORF:IOH4476	402	241	316	304	2815	900	325	253	478	23	THAP domain containing 4 (THAP4)
B46R17C17	46-17-17	Hs~Ref:NM_025125.2~uORF:IOH12854	870	560	670	616	674	848	1093	626	1159	447	chromosome 10 open reading frame 57 (C10orf57)
B46R17C18	46-18-17	Hs~Ref:NM_025125.2~uORF:IOH12854	738	521	685	528	651	776	1027	637	1218	229	chromosome 10 open reading frame 57 (C10orf57)
B46R17C19	46-19-17	Hs~MGC:BC008386.1~uORF:IOH7171	577	393	509	365	528	664	793	400	851	82	zinc finger protein 273 (ZNF273)
B46R17C20	46-20-17	Hs~MGC:BC008386.1~uORF:IOH7171	573	380	519	376	527	751	840	419	844	129	zinc finger protein 273 (ZNF273)
B46R17C21	46-21-17	Hs~MGC:BC008720.2~uORF:IOH6530	992	629	733	607	997	972	840	719	1186	389	cysteine-rich with EGF-like domains 1 (CRELD1)
B46R17C22	46-22-17	Hs~MGC:BC008720.2~uORF:IOH6530	996	592	737	596	976	898	870	770	1139	455	cysteine-rich with EGF-like domains 1 (CRELD1)
B46R18C01	46-1-18	Hs~Ref:NM_033440.1~uORF:IOH7156	412	455	445	300	439	474	591	347	932	152	elastase 2A (ELA2A)
B46R18C02	46-2-18	Hs~Ref:NM_033440.1~uORF:IOH7156	381	423	466	262	529	437	539	359	873	283	elastase 2A (ELA2A)
B46R18C03	46-3-18	Hs~MGC:BC104226.1~uORF:IOH63629	479	321	451	315	551	363	845	421	632	208	C-C motif chemokine 4
B46R18C04	46-4-18	Hs~MGC:BC104226.1~uORF:IOH63629	524	359	456	299	478	417	882	445	664	265	C-C motif chemokine 4
B46R18C05	46-5-18	Hs~Ref:NM_018638.4~uORF:IOH60258	2339	727	1400	2466	1033	2589	2067	1041	1802	652	Ethanolamine kinase 1
B46R18C06	46-6-18	Hs~Ref:NM_018638.4~uORF:IOH60258	2087	678	1405	2410	1095	2565	2066	1068	1904	636	Ethanolamine kinase 1
B46R18C07	46-7-18	Hs~Ref:NM_148978.1~uORF:IOH35641	2254	523	872	473	474	4226	2056	1409	981	660	pantothenate kinase 1 (PANK1), transcript variant beta
B46R18C08	46-8-18	Hs~Ref:NM_148978.1~uORF:IOH35641	2310	590	901	473	503	4175	2136	1415	943	619	pantothenate kinase 1 (PANK1), transcript variant beta
B46R18C09	46-9-18	Hs~Ref:NM_173611.1~uORF:IOH35542	612	610	1185	370	467	777	3705	1497	902	142	family with sequence similarity 98, member B (FAM98B), transcript variant 1
B46R18C10	46-10-18	Hs~Ref:NM_173611.1~uORF:IOH35542	612	572	1176	389	499	735	3581	1458	968	301	family with sequence similarity 98, member B (FAM98B), transcript variant 1
B46R18C11	46-11-18	Hs~Ref:NM_024578.1~uORF:IOH23128	2160	1152	1165	928	945	1385	4020	1471	2177	827	occludin/ELL domain containing 1 (OCEL1)
B46R18C12	46-12-18	Hs~Ref:NM_024578.1~uORF:IOH23128	2103	1081	1168	981	1420	1386	3678	1435	2146	717	occludin/ELL domain containing 1 (OCEL1)
B46R18C13	46-13-18	Hs~MGC:BC062344.1~uORF:IOH40702	651	628	685	489	574	783	987	553	1283	583	patched domain containing 1 (PTCHD1)
B46R18C14	46-14-18	Hs~MGC:BC062344.1~uORF:IOH40702	664	705	676	561	533	883	945	546	1454	401	patched domain containing 1 (PTCHD1)
B46R18C15	46-15-18	Hs~MGC:BC070146.1~uORF:IOH40806	916	805	929	662	690	1050	1244	619	1760	563	zinc finger protein 28 (ZNF28)
B46R18C16	46-16-18	Hs~MGC:BC070146.1~uORF:IOH40806	888	807	1013	741	665	1054	1204	625	1700	596	zinc finger protein 28 (ZNF28)
B46R18C17	46-17-18	Hs~MGC:BC069185.1~uORF:IOH40766	1806	813	1362	1622	655	1106	1800	657	1722	625	Fc receptor-like 2 (FCRL2)
B46R18C18	46-18-18	Hs~MGC:BC069185.1~uORF:IOH40766	1938	804	1259	1546	678	1016	1688	622	1824	594	Fc receptor-like 2 (FCRL2)
B46R18C19	46-19-18	Hs~MGC:NM_152338.1~uORF:IOH22692	452	254	332	509	510	736	754	608	972	496	zymogen granule protein 16 (ZG16)
B46R18C20	46-20-18	Hs~MGC:NM_152338.1~uORF:IOH22692	306	272	397	515	543	768	799	642	1080	431	zymogen granule protein 16 (ZG16)
B46R18C21	46-21-18	Hs~Ref:NM_020685.1~uORF:IOH13506	396	308	414	312	392	824	472	350	692	135	chromosome 3 open reading frame 14 (C3orf14)
B46R18C22	46-22-18	Hs~Ref:NM_020685.1~uORF:IOH13506	360	299	355	240	395	512	419	346	642	129	chromosome 3 open reading frame 14 (C3orf14)
B46R19C01	46-1-19	Hs~Ref:NM_134428.1~uORF:IOH12663	729	604	868	472	608	669	1016	597	1389	284	regulatory factor X, 3 (influences HLA class II expression) (RFX3), transcript variant 2
B46R19C02	46-2-19	Hs~Ref:NM_134428.1~uORF:IOH12663	715	565	863	489	658	694	1015	646	1402	395	regulatory factor X, 3 (influences HLA class II expression) (RFX3), transcript variant 2
B46R19C03	46-3-19	Hs~MGC:BC033985.1~uORF:IOH25855	790	757	736	729	769	799	775	655	2700	473	hypothetical gene supported by BC033985 (MGC44328)
B46R19C04	46-4-19	Hs~MGC:BC033985.1~uORF:IOH25855	831	880	719	709	749	841	826	653	2318	425	hypothetical gene supported by BC033985 (MGC44328)
B46R19C05	46-5-19	Hs~MGC:BC008668.1~uORF:IOH9808	1971	1432	2177	1021	1070	1888	1058	2644	1564	505	cyclin G associated kinase (GAK)
B46R19C06	46-6-19	Hs~MGC:BC008668.1~uORF:IOH9808	2161	1407	2208	982	1127	1803	989	2478	1621	465	cyclin G associated kinase (GAK)
B46R19C07	46-7-19	Hs~Ref:NM_016932.2~uORF:IOH12464	564	469	518	353	788	700	1403	486	796	259	SIX homeobox 2 (SIX2)
B46R19C08	46-8-19	Hs~Ref:NM_016932.2~uORF:IOH12464	536	500	514	356	749	787	1453	507	800	147	SIX homeobox 2 (SIX2)
B46R19C09	46-9-19	Hs~Ref:NM_000387.2~uORF:IOH1973	354	296	342	273	309	407	440	390	524	67	solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (SLC25A20), nuclear gene encoding mitochondrial protein
B46R19C10	46-10-19	Hs~Ref:NM_000387.2~uORF:IOH1973	301	194	374	285	400	451	436	411	703	267	solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (SLC25A20), nuclear gene encoding mitochondrial protein
B46R19C11	46-11-19	Hs~Ref:NM_001296.3~uORF:IOH10320	407	477	426	415	453	695	753	443	1080	456	chemokine binding protein 2 (CCBP2)
B46R19C12	46-12-19	Hs~Ref:NM_001296.3~uORF:IOH10320	408	497	458	433	446	720	716	437	1159	250	chemokine binding protein 2 (CCBP2)
B46R19C13	46-13-19	Hs~MGC:BC056240.1~uORF:IOH29466	440	1953	460	330	870	1363	836	610	1255	159	small proline-rich protein 1B (cornifin) (SPRR1B)
B46R19C14	46-14-19	Hs~MGC:BC056240.1~uORF:IOH29466	420	1885	415	403	819	1362	736	583	1136	147	small proline-rich protein 1B (cornifin) (SPRR1B)
B46R19C15	46-15-19	Hs~Ref:NM_007026.1~uORF:IOH21130	1886	1535	1287	2796	1972	2541	2329	2957	4399	4117	dual specificity phosphatase 14 (DUSP14)
B46R19C16	46-16-19	Hs~Ref:NM_007026.1~uORF:IOH21130	2063	1735	1360	3068	1975	2584	2582	2917	4153	4074	dual specificity phosphatase 14 (DUSP14)
B46R19C17	46-17-19	Hs~Ref:NM_004811.1~uORF:IOH13601	700	363	602	572	1019	682	8759	499	1249	67	leupaxin (LPXN)
B46R19C18	46-18-19	Hs~Ref:NM_004811.1~uORF:IOH13601	734	300	575	568	958	639	8386	473	1232	159	leupaxin (LPXN)
B46R19C19	46-19-19	Hs~MGC:NM_181468.1~uORF:IOH3908	1259	773	1393	355	920	597	761	337	1081	154	eukaryotic translation initiation factor 6 (EIF6), transcript variant 2
B46R19C20	46-20-19	Hs~MGC:NM_181468.1~uORF:IOH3908	1232	749	1260	375	878	727	746	338	922	156	eukaryotic translation initiation factor 6 (EIF6), transcript variant 2
B46R19C21	46-21-19	Hs~MGC:BC095488.1~uORF:IOH63166	452	273	2276	534	443	1142	807	431	847	158	Salivary acidic proline-rich phosphoprotein 1/2
B46R19C22	46-22-19	Hs~MGC:BC095488.1~uORF:IOH63166	452	258	2194	491	437	1021	757	399	776	363	Salivary acidic proline-rich phosphoprotein 1/2
B46R20C03	46-3-20	Hs~Ref:NM_130389.2~uORF:IOH59768	597	453	452	330	423	49	28	241	0	0	Tripartite motif-containing protein 34
B46R20C04	46-4-20	Hs~Ref:NM_130389.2~uORF:IOH59768	575	476	500	333	422	1	6	-1	-2	0	Tripartite motif-containing protein 34
B46R20C07	46-7-20	Hs~Ref:NM_002491.1~uORF:IOH10805	345	1077	389	301	353	1086	609	873	1061	316	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa (NDUFB3)
B46R20C08	46-8-20	Hs~Ref:NM_002491.1~uORF:IOH10805	356	1260	467	362	387	1113	575	936	1419	615	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa (NDUFB3)
B46R20C09	46-9-20	Hs~MGC:BC018113.1~uORF:IOH11302	315	442	430	485	308	816	548	917	980	183	ubiquitin specific peptidase 3 (USP3)
B46R20C10	46-10-20	Hs~MGC:BC018113.1~uORF:IOH11302	293	269	447	467	354	803	576	959	959	252	ubiquitin specific peptidase 3 (USP3)
B46R20C11	46-11-20	Hs~Ref:NM_021114.1~uORF:IOH56004	278	226	343	201	298	396	635	376	524	62	Serine protease inhibitor Kazal-type 2
B46R20C12	46-12-20	Hs~Ref:NM_021114.1~uORF:IOH56004	246	236	328	197	315	373	590	350	424	83	Serine protease inhibitor Kazal-type 2
B46R20C13	46-13-20	Hs~Ref:NM_004297.1~uORF:IOH27303	302	262	748	232	361	404	1156	547	602	196	Guanine nucleotide-binding protein subunit alpha-14
B46R20C14	46-14-20	Hs~Ref:NM_004297.1~uORF:IOH27303	317	288	702	252	350	415	1144	551	626	31	Guanine nucleotide-binding protein subunit alpha-14
B47R02C11	47-11-2	Hs~Ref:NM_178557.2~uORF:IOH42501	748	505	614	410	1182	580	704	550	637	131	N-acetyltransferase 8-like (NAT8L)
B47R02C12	47-12-2	Hs~Ref:NM_178557.2~uORF:IOH42501	741	426	612	594	1050	576	636	498	665	158	N-acetyltransferase 8-like (NAT8L)
B47R02C13	47-13-2	Hs~Ref:NM_130390.1~uORF:IOH42237	1053	437	841	283	3064	972	799	473	904	158	tripartite motif-containing 34 (TRIM34), transcript variant 3
B47R02C14	47-14-2	Hs~Ref:NM_130390.1~uORF:IOH42237	1081	446	811	346	965	968	781	478	871	146	tripartite motif-containing 34 (TRIM34), transcript variant 3
B47R02C15	47-15-2	Hs~Ref:NM_002122.3~uORF:IOH41004	883	618	868	511	6228	588	765	1394	781	164	major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1)
B47R02C16	47-16-2	Hs~Ref:NM_002122.3~uORF:IOH41004	920	606	910	323	7956	585	798	1261	754	163	major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1)
B47R02C21	47-21-2	Hs~Ref:NM_003093.1~uORF:IOH41465	12272	17537	11947	42117	13889	16552	15995	25478	28271	5093	small nuclear ribonucleoprotein polypeptide C (SNRPC)
B47R02C22	47-22-2	Hs~Ref:NM_003093.1~uORF:IOH41465	11602	16209	11722	41806	16598	15948	14968	23425	28591	4732	small nuclear ribonucleoprotein polypeptide C (SNRPC)
B47R03C01	47-1-3	Hs~MGC:NM_181509.1~uORF:IOH42908	1328	465	725	411	597	874	1162	490	1028	137	microtubule-associated protein 1 light chain 3 alpha (MAP1LC3A), transcript variant 2
B47R03C02	47-2-3	Hs~MGC:NM_181509.1~uORF:IOH42908	1282	478	707	401	592	926	1148	516	1016	144	microtubule-associated protein 1 light chain 3 alpha (MAP1LC3A), transcript variant 2
B47R03C03	47-3-3	Hs~Ref:NM_182775.1~uORF:IOH41510	654	504	665	365	610	414	755	536	603	224	ALS2 C-terminal like (ALS2CL), transcript variant 3
B47R03C04	47-4-3	Hs~Ref:NM_182775.1~uORF:IOH41510	659	544	713	348	479	355	740	744	587	110	ALS2 C-terminal like (ALS2CL), transcript variant 3
B47R03C05	47-5-3	Hs~MGC:BC028039.1~uORF:IOH11511	1500	960	949	1313	2158	4344	1755	4578	2577	776	hypothetical protein MGC39900 (MGC39900)
B47R03C06	47-6-3	Hs~MGC:BC028039.1~uORF:IOH11511	1585	949	905	1239	2113	4160	1723	4252	2475	720	hypothetical protein MGC39900 (MGC39900)
B47R03C07	47-7-3	Hs~Ref:NM_005274.1~uORF:IOH4556	711	1158	998	838	2931	775	2343	2096	1438	389	guanine nucleotide binding protein (G protein), gamma 5 (GNG5)
B47R03C08	47-8-3	Hs~Ref:NM_005274.1~uORF:IOH4556	729	1122	1004	881	3863	736	2277	1973	3828	318	guanine nucleotide binding protein (G protein), gamma 5 (GNG5)
B47R03C09	47-9-3	Hs~MGC:BC002934.1~uORF:IOH5727	605	534	756	511	564	661	819	615	1005	328	family with sequence similarity 3, member A (FAM3A)
B47R03C10	47-10-3	Hs~MGC:BC002934.1~uORF:IOH5727	624	575	819	513	601	761	824	577	982	316	family with sequence similarity 3, member A (FAM3A)
B47R03C11	47-11-3	Hs~Ref:NM_024312.1~uORF:IOH5325	1008	1045	840	420	800	558	559	436	938	156	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits (GNPTAB)
B47R03C12	47-12-3	Hs~Ref:NM_024312.1~uORF:IOH5325	994	990	810	434	830	526	561	450	932	-19	N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits (GNPTAB)
B47R03C13	47-13-3	Hs~Ref:NM_013254.2~uORF:IOH21006	1699	1350	1362	668	1084	1549	1019	644	1227	426	TANK-binding kinase 1 (TBK1)
B47R03C14	47-14-3	Hs~Ref:NM_013254.2~uORF:IOH21006	1692	1234	1349	789	946	1666	1068	667	1259	302	TANK-binding kinase 1 (TBK1)
B47R03C15	47-15-3	Hs~MGC:BC001716.1~uORF:IOH4447	3983	1444	2043	13880	954	1438	3938	1336	2563	133	poly(A) binding protein interacting protein 2 (PAIP2)
B47R03C16	47-16-3	Hs~MGC:BC001716.1~uORF:IOH4447	3872	1234	2016	12654	926	1363	3915	1348	2594	536	poly(A) binding protein interacting protein 2 (PAIP2)
B47R03C19	47-19-3	Hs~MGC:BC004885.1~uORF:IOH5650	1707	933	899	484	1903	690	826	860	1507	305	UPF0546 membrane protein C1orf91
B47R03C20	47-20-3	Hs~MGC:BC004885.1~uORF:IOH5650	1713	968	912	514	1883	688	812	856	1533	497	UPF0546 membrane protein C1orf91
B47R03C21	47-21-3	Hs~Ref:NM_032284.1~uORF:IOH4769	1218	1784	996	1507	863	1670	882	494	936	131	Pre-mRNA-splicing factor 38A
B47R03C22	47-22-3	Hs~Ref:NM_032284.1~uORF:IOH4769	1226	1684	963	1403	883	1548	950	535	891	-8	Pre-mRNA-splicing factor 38A
B47R04C01	47-1-4	Hs~MGC:BC001726.1~uORF:IOH4820	1709	4832	1010	1822	1188	552	1060	750	1270	135	Nucleolar protein 11
B47R04C02	47-2-4	Hs~MGC:BC001726.1~uORF:IOH4820	1716	5010	975	1853	1205	529	1017	752	1220	123	Nucleolar protein 11
B47R04C03	47-3-4	Hs~MGC:BC007048.1~uORF:IOH7230	7057	13630	1999	7647	3313	10182	8596	28725	5428	3134	zinc finger, MYM-type 5 (ZMYM5)
B47R04C04	47-4-4	Hs~MGC:BC007048.1~uORF:IOH7230	7066	13258	1972	7267	2466	8999	8176	24439	5362	2760	zinc finger, MYM-type 5 (ZMYM5)
B47R04C05	47-5-4	Hs~MGC:BC003040.1~uORF:IOH5055	966	583	971	584	729	535	788	611	612	118	aspartyl aminopeptidase (DNPEP)
B47R04C06	47-6-4	Hs~MGC:BC003040.1~uORF:IOH5055	1012	608	993	613	769	508	713	521	618	156	aspartyl aminopeptidase (DNPEP)
B47R04C07	47-7-4	Hs~MGC:NM_153326.1~uORF:IOH4326	571	839	1896	1158	0	5023	4518	1150	1390	642	aldo-keto reductase family 1, member A1 (aldehyde reductase) (AKR1A1), transcript variant 2
B47R04C08	47-8-4	Hs~MGC:NM_153326.1~uORF:IOH4326	575	819	1856	1061	0	4490	4451	1096	1386	593	aldo-keto reductase family 1, member A1 (aldehyde reductase) (AKR1A1), transcript variant 2
B47R04C09	47-9-4	Hs~Ref:NM_144628.1~uORF:IOH12982	536	419	472	275	1	371	427	261	811	142	TBC1 domain family, member 20 (TBC1D20)
B47R04C10	47-10-4	Hs~Ref:NM_144628.1~uORF:IOH12982	538	463	437	264	-8	319	432	344	773	94	TBC1 domain family, member 20 (TBC1D20)
B47R04C11	47-11-4	Hs~MGC:BC007949.1~uORF:IOH6744	736	305	415	609	564	580	609	369	397	88	Elongation factor 1-gamma
B47R04C12	47-12-4	Hs~MGC:BC007949.1~uORF:IOH6744	761	313	387	582	509	566	621	344	389	65	Elongation factor 1-gamma
B47R04C13	47-13-4	Hs~MGC:BC011857.1~uORF:IOH14038	817	756	645	627	699	548	781	491	683	481	Ig mu chain C region
B47R04C14	47-14-4	Hs~MGC:BC011857.1~uORF:IOH14038	908	769	658	584	639	593	886	525	743	152	Ig mu chain C region
B47R04C15	47-15-4	Hs~Ref:NM_007065.2~uORF:IOH6219	2124	475	2432	2642	-8	942	6987	1226	1906	136	cell division cycle 37 homolog (S. cerevisiae) (CDC37)
B47R04C16	47-16-4	Hs~Ref:NM_007065.2~uORF:IOH6219	2061	491	2353	2474	38	866	6851	1173	1970	121	cell division cycle 37 homolog (S. cerevisiae) (CDC37)
B47R04C17	47-17-4	Hs~MGC:BC001889.1~uORF:IOH4855	1414	604	890	452	425	694	665	813	1121	195	N-ethylmaleimide-sensitive factor attachment protein, gamma (NAPG)
B47R04C18	47-18-4	Hs~MGC:BC001889.1~uORF:IOH4855	1427	589	929	444	-8	703	653	787	1061	179	N-ethylmaleimide-sensitive factor attachment protein, gamma (NAPG)
B47R04C19	47-19-4	Hs~Ref:NM_058179.1~uORF:IOH4946	4638	1690	1752	1024	2069	628	1757	762	1612	416	phosphoserine aminotransferase 1 (PSAT1), transcript variant 1
B47R04C20	47-20-4	Hs~Ref:NM_058179.1~uORF:IOH4946	4733	1736	1794	984	1987	578	1719	754	1619	424	phosphoserine aminotransferase 1 (PSAT1), transcript variant 1
B47R04C21	47-21-4	Hs~Ref:NM_005659.1~uORF:IOH4744	9170	4462	4661	5594	5162	2837	6484	5623	7594	2099	ubiquitin fusion degradation 1 like (yeast) (UFD1L), transcript variant 1, mRNA.
B47R04C22	47-22-4	Hs~Ref:NM_005659.1~uORF:IOH4744	8981	4206	4249	5172	4869	2499	6719	5129	7499	1950	ubiquitin fusion degradation 1 like (yeast) (UFD1L), transcript variant 1, mRNA.
B47R05C01	47-1-5	Hs~Ref:NM_145212.1~uORF:IOH13804	42	31	171	24	286	185	184	134	138	15	mitochondrial ribosomal protein L30 (MRPL30), nuclear gene encoding mitochondrial protein, transcript variant 1
B47R05C02	47-2-5	Hs~Ref:NM_145212.1~uORF:IOH13804	34	34	238	23	287	406	238	248	85	10	mitochondrial ribosomal protein L30 (MRPL30), nuclear gene encoding mitochondrial protein, transcript variant 1
B47R05C03	47-3-5	Hs~Ref:NM_000458.1~uORF:IOH11258	1103	914	1184	711	730	733	767	581	975	391	HNF1 homeobox B (HNF1B)
B47R05C04	47-4-5	Hs~Ref:NM_000458.1~uORF:IOH11258	1116	941	1097	660	802	788	767	569	1098	410	HNF1 homeobox B (HNF1B)
B47R05C05	47-5-5	Hs~MGC:BC026213.1~uORF:IOH11042	1470	1592	1713	2101	57	1463	1882	1388	2227	826	F-box/WD repeat-containing protein 11
B47R05C06	47-6-5	Hs~MGC:BC026213.1~uORF:IOH11042	1485	1502	1733	2082	-6	1415	1909	1362	2106	836	F-box/WD repeat-containing protein 11
B47R05C07	47-7-5	Hs~Ref:NM_145299.1~uORF:IOH11298	1537	483	1851	584	6	709	770	480	1010	381	Dynein heavy chain 6, axonemal
B47R05C08	47-8-5	Hs~Ref:NM_145299.1~uORF:IOH11298	1492	468	1788	554	0	656	763	493	1009	380	Dynein heavy chain 6, axonemal
B47R05C09	47-9-5	Hs~MGC:BC019598.1~uORF:IOH10613	924	1079	888	552	568	810	2983	672	1230	306	Zinc finger matrin-type protein 4
B47R05C10	47-10-5	Hs~MGC:BC019598.1~uORF:IOH10613	861	1046	899	558	568	874	2943	714	1372	432	Zinc finger matrin-type protein 4
B47R05C11	47-11-5	Hs~Ref:NM_007246.2~uORF:IOH10632	446	1004	619	581	618	522	1151	5953	1910	275	kelch-like 2, Mayven (Drosophila) (KLHL2)
B47R05C12	47-12-5	Hs~Ref:NM_007246.2~uORF:IOH10632	433	899	602	590	530	536	1109	5533	1830	314	kelch-like 2, Mayven (Drosophila) (KLHL2)
B47R05C13	47-13-5	Hs~Ref:NM_138454.1~uORF:IOH12871	292	311	552	287	397	375	1472	357	839	56	nucleoredoxin-like 1 (NXNL1)
B47R05C14	47-14-5	Hs~Ref:NM_138454.1~uORF:IOH12871	259	313	570	279	377	364	1480	364	820	151	nucleoredoxin-like 1 (NXNL1)
B47R05C15	47-15-5	Hs~MGC:BC022459.1~uORF:IOH11064	1410	436	984	626	475	805	1124	656	1757	200	sulfotransferase family 4A, member 1 (SULT4A1)
B47R05C16	47-16-5	Hs~MGC:BC022459.1~uORF:IOH11064	1442	441	961	605	496	774	1108	635	1757	187	sulfotransferase family 4A, member 1 (SULT4A1)
B47R05C17	47-17-5	Hs~Ref:NM_022476.1~uORF:IOH3844	9783	3380	2483	3338	10804	2184	2666	1704	2836	1545	AKT interacting protein (AKTIP), transcript variant 2
B47R05C18	47-18-5	Hs~Ref:NM_022476.1~uORF:IOH3844	9890	3265	2435	3096	10886	2036	2757	1715	2836	1423	AKT interacting protein (AKTIP), transcript variant 2
B47R05C19	47-19-5	Hs~MGC:BC014131.1~uORF:IOH12938	989	1495	1545	759	-23	834	3008	553	1100	-5	RNA pseudouridylate synthase domain containing 4 (RPUSD4)
B47R05C20	47-20-5	Hs~MGC:BC014131.1~uORF:IOH12938	1017	1565	1513	761	-12	893	3197	525	1119	250	RNA pseudouridylate synthase domain containing 4 (RPUSD4)
B47R05C21	47-21-5	Hs~MGC:BC012842.1~uORF:IOH10512	679	10339	2222	398	12	835	1718	466	1554	201	Obg-like ATPase 1 (GTPBP9)
B47R05C22	47-22-5	Hs~MGC:BC012842.1~uORF:IOH10512	668	9520	2236	415	353	723	1651	442	1557	182	Obg-like ATPase 1 (GTPBP9)
B47R06C01	47-1-6	Hs~MGC:BC025761.1~uORF:IOH11223	561	493	560	357	-3	562	619	398	863	525	Cytochrome P450 2W1
B47R06C02	47-2-6	Hs~MGC:BC025761.1~uORF:IOH11223	593	562	610	353	-2	608	623	394	883	579	Cytochrome P450 2W1
B47R06C03	47-3-6	Hs~Ref:NM_173843.1~uORF:IOH45793	453	462	443	376	419	420	968	545	496	103	interleukin 1 receptor antagonist (IL1RN), transcript variant 4
B47R06C04	47-4-6	Hs~Ref:NM_173843.1~uORF:IOH45793	492	428	448	322	427	425	972	488	502	97	interleukin 1 receptor antagonist (IL1RN), transcript variant 4
B47R06C05	47-5-6	Hs~Ref:NM_203379.1~uORF:IOH45817	833	1137	767	540	917	977	1351	501	649	75	acyl-CoA synthetase long-chain family member 5 (ACSL5), transcript variant 2
B47R06C06	47-6-6	Hs~Ref:NM_203379.1~uORF:IOH45817	910	1277	695	541	547	893	1305	499	638	171	acyl-CoA synthetase long-chain family member 5 (ACSL5), transcript variant 2
B47R06C07	47-7-6	Hs~Ref:NM_017819.1~uORF:IOH45746	1892	6956	2023	1838	2715	1647	5587	1250	2423	799	RNA (guanine-9-)-methyltransferase domain-containing protein 1, mitochondrial
B47R06C08	47-8-6	Hs~Ref:NM_017819.1~uORF:IOH45746	1878	6745	1982	1775	2500	1621	5835	1273	2420	811	RNA (guanine-9-)-methyltransferase domain-containing protein 1, mitochondrial
B47R06C09	47-9-6	Hs~Ref:NM_198938.1~uORF:IOH45795	1120	1809	388	281	526	410	316	1895	315	56	prostaglandin E synthase 2 (PTGES2), transcript variant 2
B47R06C10	47-10-6	Hs~Ref:NM_198938.1~uORF:IOH45795	1131	1801	312	276	627	531	380	1690	356	35	prostaglandin E synthase 2 (PTGES2), transcript variant 2
B47R06C11	47-11-6	Hs~Ref:NM_138419.1~uORF:IOH22975	2017	984	11641	1405	1359	1195	3567	1711	4264	1004	Protein FAM54A
B47R06C12	47-12-6	Hs~Ref:NM_138419.1~uORF:IOH22975	1904	988	11260	1377	1519	1133	3477	1740	4088	938	Protein FAM54A
B47R06C13	47-13-6	Hs~Ref:NM_016532.2~uORF:IOH4433	1070	794	1149	573	699	829	1513	825	1849	421	skeletal muscle and kidney enriched inositol phosphatase (SKIP), transcript variant 1
B47R06C14	47-14-6	Hs~Ref:NM_016532.2~uORF:IOH4433	1058	778	1211	630	683	861	1493	827	1877	425	skeletal muscle and kidney enriched inositol phosphatase (SKIP), transcript variant 1
B47R06C15	47-15-6	Hs~Ref:NM_002461.1~uORF:IOH4651	819	871	1002	598	622	1566	1868	1159	1684	458	mevalonate (diphospho) decarboxylase (MVD)
B47R06C16	47-16-6	Hs~Ref:NM_002461.1~uORF:IOH4651	859	821	1033	611	759	1517	1876	1106	1767	306	mevalonate (diphospho) decarboxylase (MVD)
B47R06C17	47-17-6	Hs~Ref:NM_024062.2~uORF:IOH2945	645	610	789	530	518	689	1275	736	1435	424	vang-like 1 (van gogh, Drosophila) (VANGL1)
B47R06C18	47-18-6	Hs~Ref:NM_024062.2~uORF:IOH2945	637	589	771	513	676	709	1300	706	1349	393	vang-like 1 (van gogh, Drosophila) (VANGL1)
B47R06C19	47-19-6	Hs~Ref:NM_022337.1~uORF:IOH10104	665	1199	968	1277	350	2586	653	479	653	150	RAB38, member RAS oncogene family (RAB38)
B47R06C20	47-20-6	Hs~Ref:NM_022337.1~uORF:IOH10104	662	1205	968	1264	333	2735	643	453	689	134	RAB38, member RAS oncogene family (RAB38)
B47R06C21	47-21-6	Hs~Ref:NM_004283.2~uORF:IOH10511	532	1002	1193	399	1073	458	604	533	3602	102	Ras-related protein Rab-3D
B47R06C22	47-22-6	Hs~Ref:NM_004283.2~uORF:IOH10511	504	754	1166	374	1021	383	613	527	3603	35	Ras-related protein Rab-3D
B47R07C01	47-1-7	Hs~Ref:NM_001667.1~uORF:IOH1753	372	3494	1746	375	456	1292	2037	485	583	165	ADP-ribosylation factor-like 2 (ARL2)
B47R07C02	47-2-7	Hs~Ref:NM_001667.1~uORF:IOH1753	384	3651	1691	385	481	1271	2049	486	573	748	ADP-ribosylation factor-like 2 (ARL2)
B47R07C05	47-5-7	Hs~Ref:NM_001239.2~uORF:IOH7258	509	432	631	443	479	1055	597	456	598	166	cyclin H (CCNH)
B47R07C06	47-6-7	Hs~Ref:NM_001239.2~uORF:IOH7258	424	365	674	480	473	1163	645	415	639	265	cyclin H (CCNH)
B47R07C07	47-7-7	Hs~MGC:BC005298.1~uORF:IOH7271	672	1482	732	401	359	527	1122	498	622	168	cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase) (CDK7)
B47R07C08	47-8-7	Hs~MGC:BC005298.1~uORF:IOH7271	665	523	826	416	489	520	1177	509	680	341	cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase) (CDK7)
B47R07C09	47-9-7	Hs~MGC:BC005371.1~uORF:IOH7357	577	472	727	445	489	462	742	494	651	91	N-acetylglucosamine kinase (NAGK)
B47R07C10	47-10-7	Hs~MGC:BC005371.1~uORF:IOH7357	498	410	798	466	471	527	740	469	678	256	N-acetylglucosamine kinase (NAGK)
B47R07C11	47-11-7	Hs~Ref:NM_005391.1~uORF:IOH10145	470	501	753	259	342	476	442	354	578	82	pyruvate dehydrogenase kinase, isozyme 3 (PDK3)
B47R07C12	47-12-7	Hs~Ref:NM_005391.1~uORF:IOH10145	471	590	774	293	317	490	370	402	472	89	pyruvate dehydrogenase kinase, isozyme 3 (PDK3)
B47R07C13	47-13-7	Hs~MGC:BC016987.1~uORF:IOH11787	2217	1315	1477	1947	969	1963	6534	1528	2360	462	family with sequence similarity 44, member A (FAM44A)
B47R07C14	47-14-7	Hs~MGC:BC016987.1~uORF:IOH11787	2327	1300	1422	1853	884	1863	6021	1344	2281	431	family with sequence similarity 44, member A (FAM44A)
B47R07C15	47-15-7	Hs~Ref:NM_004451.3~uORF:IOH39702	1829	1011	1128	826	744	2318	4032	796	1216	301	estrogen-related receptor alpha (ESRRA)
B47R07C16	47-16-7	Hs~Ref:NM_004451.3~uORF:IOH39702	1761	1048	1131	802	665	2356	4064	780	1222	249	estrogen-related receptor alpha (ESRRA)
B47R07C17	47-17-7	Hs~MGC:BC028040.1~uORF:IOH11532	1587	1512	1325	933	1086	1731	5900	1080	769	3017	2',3'-cyclic nucleotide 3' phosphodiesterase (CNP)
B47R07C18	47-18-7	Hs~MGC:BC028040.1~uORF:IOH11532	1428	1389	1396	1009	1307	1651	5897	815	1532	260	2',3'-cyclic nucleotide 3' phosphodiesterase (CNP)
B47R07C19	47-19-7	Hs~MGC:BC019823.1~uORF:IOH11439	433	1576	600	386	3270	713	641	825	893	138	sorting nexin family member 21 (SNX21)
B47R07C20	47-20-7	Hs~MGC:BC019823.1~uORF:IOH11439	446	1609	618	423	113	675	672	858	867	-10	sorting nexin family member 21 (SNX21)
B47R08C01	47-1-8	Hs~Ref:NM_007314.1~N/A	1285	984	1869	631	1463	634	1066	1344	3049	465	Tyrosine-protein kinase ABL2
B47R08C02	47-2-8	Hs~Ref:NM_007314.1~N/A	1290	983	1809	678	1491	695	1097	1322	3109	489	Tyrosine-protein kinase ABL2
B47R08C03	47-3-8	Hs~Ref:NM_004441.2~N/A	1660	1476	3281	1205	1847	2371	2432	3716	3562	676	Ephrin type-B receptor 1
B47R08C04	47-4-8	Hs~Ref:NM_004441.2~N/A	1647	1484	3170	1132	1900	2126	2528	3431	3579	691	Ephrin type-B receptor 1
B47R08C05	47-5-8	Hs~Ref:NM_000142.2~N/A	1126	933	1170	527	1548	520	1065	913	1751	244	fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) (FGFR3), transcript variant 1
B47R08C06	47-6-8	Hs~Ref:NM_000142.2~N/A	1117	1012	1161	517	1516	571	1025	960	1833	351	fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) (FGFR3), transcript variant 1
B47R08C07	47-7-8	Hs~MGC:BC010876.1~uORF:IOH9862	1022	997	1294	841	779	1410	3757	922	1930	479	nei endonuclease VIII-like 1 (E. coli) (NEIL1)
B47R08C08	47-8-8	Hs~MGC:BC010876.1~uORF:IOH9862	1048	1635	1203	840	827	1310	3696	865	1959	452	nei endonuclease VIII-like 1 (E. coli) (NEIL1)
B47R08C09	47-9-8	Hs~MGC:NM_194279.1~uORF:IOH27677	574	3524	973	1252	630	736	2016	1093	1391	413	iron-sulfur cluster assembly 2 homolog (S. cerevisiae) (ISCA2)
B47R08C10	47-10-8	Hs~MGC:NM_194279.1~uORF:IOH27677	617	1961	960	1324	448	704	1993	1038	1431	336	iron-sulfur cluster assembly 2 homolog (S. cerevisiae) (ISCA2)
B47R08C11	47-11-8	Hs~MGC:BC036094.1~uORF:IOH27258	645	548	1340	633	933	1296	1723	814	1290	429	G antigen 1 (GAGE1)
B47R08C12	47-12-8	Hs~MGC:BC036094.1~uORF:IOH27258	664	518	1389	595	922	1218	1751	771	1309	409	G antigen 1 (GAGE1)
B47R08C13	47-13-8	Hs~MGC:BC035568.1~uORF:IOH27552	658	679	3638	498	647	5040	2415	831	1373	349	acylphosphatase 1, erythrocyte (common) type (ACYP1)
B47R08C14	47-14-8	Hs~MGC:BC035568.1~uORF:IOH27552	634	697	3479	477	719	4692	2445	795	1315	351	acylphosphatase 1, erythrocyte (common) type (ACYP1)
B47R08C15	47-15-8	Hs~MGC:BC015818.1~uORF:IOH14254	1694	1986	3247	2596	1817	2136	3967	2850	3555	964	lectin, galactoside-binding, soluble, 8 (galectin 8) (LGALS8)
B47R08C16	47-16-8	Hs~MGC:BC015818.1~uORF:IOH14254	1626	1909	3128	2571	1762	2201	3924	2767	3574	935	lectin, galactoside-binding, soluble, 8 (galectin 8) (LGALS8)
B47R08C17	47-17-8	Hs~MGC:NM_020319.1~uORF:IOH27320	903	1531	1861	1378	1266	1203	2196	754	1124	620	ankyrin repeat and MYND domain containing 2 (ANKMY2)
B47R08C18	47-18-8	Hs~MGC:NM_020319.1~uORF:IOH27320	897	1530	1941	1357	1389	1186	2391	768	1502	649	ankyrin repeat and MYND domain containing 2 (ANKMY2)
B47R08C19	47-19-8	Hs~MGC:BC036246.1~uORF:IOH27524	2018	10420	5011	1856	1395	1461	2368	1767	2861	868	hypothetical protein FLJ32549 (FLJ32549)
B47R08C20	47-20-8	Hs~MGC:BC036246.1~uORF:IOH27524	1997	9985	5062	1852	1075	1321	2408	1786	2960	880	hypothetical protein FLJ32549 (FLJ32549)
B47R08C21	47-21-8	Hs~MGC:BC021906.1~uORF:IOH25790	2265	14433	3342	1168	1702	1426	3244	1801	3164	1001	formin-like 1 (FMNL1)
B47R08C22	47-22-8	Hs~MGC:BC021906.1~uORF:IOH25790	2257	13822	3247	1072	1514	1635	3131	1747	3211	911	formin-like 1 (FMNL1)
B47R09C01	47-1-9	Hs~Ref:NM_152770.1~uORF:IOH22874	1683	1487	2363	753	1477	1266	3290	1352	2172	588	Uncharacterized protein C4orf22
B47R09C02	47-2-9	Hs~Ref:NM_152770.1~uORF:IOH22874	1688	1463	2254	707	1451	1331	3251	1198	2077	904	Uncharacterized protein C4orf22
B47R09C03	47-3-9	Hs~MGC:BC034821.1~uORF:IOH22860	722	798	768	284	488	604	581	619	592	80	synaptonemal complex central element protein 1 (SYCE1)
B47R09C04	47-4-9	Hs~MGC:BC034821.1~uORF:IOH22860	726	860	830	266	501	566	625	596	538	95	synaptonemal complex central element protein 1 (SYCE1)
B47R09C05	47-5-9	Hs~Ref:NM_144638.1~uORF:IOH10667	1068	1865	1699	418	950	816	671	536	949	336	transmembrane protein 42 (TMEM42)
B47R09C06	47-6-9	Hs~Ref:NM_144638.1~uORF:IOH10667	1076	1295	1667	497	923	779	667	536	882	415	transmembrane protein 42 (TMEM42)
B47R09C07	47-7-9	Hs~MGC:BC016853.1~uORF:IOH10348	1398	1593	2030	731	1167	1341	934	409	853	415	cytochrome P450, family 4, subfamily F, polypeptide 11 (CYP4F11)
B47R09C08	47-8-9	Hs~MGC:BC016853.1~uORF:IOH10348	1383	1595	2010	732	811	1339	1021	466	910	421	cytochrome P450, family 4, subfamily F, polypeptide 11 (CYP4F11)
B47R09C09	47-9-9	Hs~MGC:BC000770.1~uORF:IOH4688	9872	7991	2313	4479	8014	3960	4550	3872	6095	1283	death inducer-obliterator 1 (DIDO1)
B47R09C10	47-10-9	Hs~MGC:BC000770.1~uORF:IOH4688	10053	5972	2369	4528	5496	3658	4654	3809	5969	1178	death inducer-obliterator 1 (DIDO1)
B47R09C11	47-11-9	Hs~Ref:NM_020317.2~uORF:IOH4823	11563	15937	3896	10243	9927	8198	37253	6362	6851	3169	chromosome 1 open reading frame 63 (C1orf63)
B47R09C12	47-12-9	Hs~Ref:NM_020317.2~uORF:IOH4823	11389	16597	3894	9771	9352	7842	35438	6164	6693	3104	chromosome 1 open reading frame 63 (C1orf63)
B47R09C13	47-13-9	Hs~MGC:BC003573.1~uORF:IOH4891	772	2616	528	389	2352	757	964	1095	851	210	farnesyl-diphosphate farnesyltransferase 1 (FDFT1)
B47R09C14	47-14-9	Hs~MGC:BC003573.1~uORF:IOH4891	754	2560	511	369	2250	739	956	1081	829	272	farnesyl-diphosphate farnesyltransferase 1 (FDFT1)
B47R09C15	47-15-9	Hs~Ref:NM_006163.1~uORF:IOH6673	1043	901	1537	423	704	727	1095	525	1444	280	nuclear factor (erythroid-derived 2), 45kDa (NFE2)
B47R09C16	47-16-9	Hs~Ref:NM_006163.1~uORF:IOH6673	1024	899	1480	431	739	721	1100	563	1415	126	nuclear factor (erythroid-derived 2), 45kDa (NFE2)
B47R09C17	47-17-9	Hs~MGC:BC002385.2~uORF:IOH46075	761	1268	991	354	584	468	693	430	714	122	Protein FAM127A
B47R09C18	47-18-9	Hs~MGC:BC002385.2~uORF:IOH46075	767	1273	1247	313	670	483	599	485	724	148	Protein FAM127A
B47R09C19	47-19-9	Hs~MGC:BC005871.2~uORF:IOH46098	1026	2260	1825	424	577	1709	1846	2438	1073	349	chromosome 10 open reading frame 58 (C10orf58)
B47R09C20	47-20-9	Hs~MGC:BC005871.2~uORF:IOH46098	1014	2179	1838	425	2756	1393	1825	2168	1087	171	chromosome 10 open reading frame 58 (C10orf58)
B47R09C21	47-21-9	Hs~MGC:BC021245.2~uORF:IOH46078	2144	1167	810	277	460	48	546	355	502	1	AFG3 ATPase family gene 3-like 1 (S. cerevisiae) (AFG3L1)
B47R09C22	47-22-9	Hs~MGC:BC021245.2~uORF:IOH46078	2269	1229	721	310	688	459	525	294	476	-2	AFG3 ATPase family gene 3-like 1 (S. cerevisiae) (AFG3L1)
B47R10C01	47-1-10	Hs~MGC:BC012183.1~uORF:IOH46141	3385	2242	1232	544	1909	470	516	405	682	203	Ubiquilin-like protein
B47R10C02	47-2-10	Hs~MGC:BC012183.1~uORF:IOH46141	3902	2432	1268	492	2093	512	548	393	693	226	Ubiquilin-like protein
B47R10C03	47-3-10	Hs~Ref:NM_144676.1~uORF:IOH13348	953	428	1546	300	671	297	452	330	521	26	transmembrane emp24 protein transport domain containing 6 (TMED6)
B47R10C04	47-4-10	Hs~Ref:NM_144676.1~uORF:IOH13348	945	416	1568	274	578	326	560	335	521	-4	transmembrane emp24 protein transport domain containing 6 (TMED6)
B47R10C05	47-5-10	Hs~Ref:NM_053283.1~uORF:IOH40723	1108	639	2114	825	687	1239	3989	1677	1021	35	dermcidin (DCD)
B47R10C06	47-6-10	Hs~Ref:NM_053283.1~uORF:IOH40723	1116	291	2132	846	878	1191	3894	1601	1002	110	dermcidin (DCD)
B47R10C07	47-7-10	Hs~MGC:BC008744.2~uORF:IOH40663	1981	205	3401	2673	1389	1500	4235	2022	2816	1406	Pleckstrin homology domain-containing family O member 2
B47R10C08	47-8-10	Hs~MGC:BC008744.2~uORF:IOH40663	1943	558	3232	2576	863	1361	4072	1826	2540	1266	Pleckstrin homology domain-containing family O member 2
B47R10C09	47-9-10	Hs~Ref:NM_080621.3~uORF:IOH40705	1045	812	918	1216	743	855	1268	544	1178	304	sterile alpha motif domain containing 10 (SAMD10)
B47R10C10	47-10-10	Hs~Ref:NM_080621.3~uORF:IOH40705	992	814	948	1292	251	773	1256	530	1113	294	sterile alpha motif domain containing 10 (SAMD10)
B47R11C21	47-21-11	Hs~MGC:BC053667.1~uORF:IOH29009	763	653	3238	1594	1422	1296	803	3054	1352	388	lectin, galactoside-binding, soluble, 3 (LGALS3)
B47R11C22	47-22-11	Hs~MGC:BC053667.1~uORF:IOH29009	710	731	2473	1873	1415	1196	747	2739	1379	109	lectin, galactoside-binding, soluble, 3 (LGALS3)
B47R12C01	47-1-12	Hs~MGC:BC035573.1~uORF:IOH27592	665	378	1771	350	517	448	664	601	591	197	transcription elongation factor A (SII)-like 8 (TCEAL8)
B47R12C02	47-2-12	Hs~MGC:BC035573.1~uORF:IOH27592	638	358	1770	331	523	492	689	479	495	199	transcription elongation factor A (SII)-like 8 (TCEAL8)
B47R12C03	47-3-12	Hs~MGC:BC001234.1~uORF:IOH3198	2036	953	6800	0	1139	0	1	-1	-2	-1	loss of heterozygosity, 11, chromosomal region 2, gene A (LOH11CR2A)
B47R12C04	47-4-12	Hs~MGC:BC001234.1~uORF:IOH3198	1990	942	6746	6	1132	317	0	-3	3	-3	loss of heterozygosity, 11, chromosomal region 2, gene A (LOH11CR2A)
B47R12C05	47-5-12	Hs~Ref:NM_013330.3~uORF:IOH7339	1871	831	5993	2234	1203	1307	1849	1430	1151	543	non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase) (NME7), transcript variant 1
B47R12C06	47-6-12	Hs~Ref:NM_013330.3~uORF:IOH7339	2060	826	6019	2100	1267	1305	1782	1390	1097	257	non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase) (NME7), transcript variant 1
B47R12C07	47-7-12	Hs~MGC:BC031827.1~uORF:IOH22190	4391	1558	981	478	1265	2226	1137	1568	2485	213	cDNA clone MGC:25008 IMAGE:4453355, complete cds
B47R12C08	47-8-12	Hs~MGC:BC031827.1~uORF:IOH22190	4356	1565	932	455	1221	2092	1149	1430	2396	219	cDNA clone MGC:25008 IMAGE:4453355, complete cds
B47R12C09	47-9-12	Hs~MGC:BC020867.1~uORF:IOH12282	1152	962	954	473	684	576	851	585	1311	891	solute carrier family 6 (neurotransmitter transporter, GABA), member 13 (SLC6A13)
B47R12C10	47-10-12	Hs~MGC:BC020867.1~uORF:IOH12282	1200	1039	929	499	913	565	881	594	1216	1295	solute carrier family 6 (neurotransmitter transporter, GABA), member 13 (SLC6A13)
B47R12C11	47-11-12	Hs~MGC:BC006370.2~uORF:IOH6467	1573	1361	1006	969	1272	888	1274	1129	1954	602	inversin (INVS)
B47R12C12	47-12-12	Hs~MGC:BC006370.2~uORF:IOH6467	1576	1281	1021	913	851	884	1275	1105	2026	550	inversin (INVS)
B47R12C13	47-13-12	Hs~Ref:NM_000281.1~uORF:IOH6468	2265	1555	983	3014	1736	2070	4350	2684	5138	1349	pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) (PCBD1)
B47R12C14	47-14-12	Hs~Ref:NM_000281.1~uORF:IOH6468	2211	1580	1013	2831	1692	1935	4209	2597	5063	1262	pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) (PCBD1)
B47R12C15	47-15-12	Hs~Ref:NM_016954.2~uORF:IOH46151	1401	1140	1373	846	819	1362	1852	1132	2613	810	T-box 22 (TBX22), transcript variant 2
B47R12C16	47-16-12	Hs~Ref:NM_016954.2~uORF:IOH46151	1594	1176	1364	767	868	1284	1894	1134	2507	751	T-box 22 (TBX22), transcript variant 2
B47R12C17	47-17-12	Hs~MGC:BC001946.1~uORF:IOH46145	1675	1076	1394	846	842	1340	2052	976	2242	1815	bruno-like 4, RNA binding protein (Drosophila) (BRUNOL4)
B47R12C18	47-18-12	Hs~MGC:BC001946.1~uORF:IOH46145	1600	1032	1382	856	868	1578	1911	950	2313	1743	bruno-like 4, RNA binding protein (Drosophila) (BRUNOL4)
B47R12C19	47-19-12	Hs~MGC:BC006206.2~uORF:IOH46182	1970	1383	1530	914	1024	1615	1900	1157	2710	960	NIK and IKK{beta} binding protein (NIBP)
B47R12C20	47-20-12	Hs~MGC:BC006206.2~uORF:IOH46182	1947	1245	1500	1056	979	1435	1964	1517	2636	929	NIK and IKK{beta} binding protein (NIBP)
B47R12C21	47-21-12	Hs~Ref:NM_023083.1~uORF:IOH29699	3952	1726	1589	1124	1425	1635	2132	1350	2905	833	calpain 10 (CAPN10), transcript variant 1
B47R12C22	47-22-12	Hs~Ref:NM_023083.1~uORF:IOH29699	3975	1777	1465	1118	1224	1537	2067	1234	2948	986	calpain 10 (CAPN10), transcript variant 1
B47R13C01	47-1-13	Hs~MGC:BC000226.1~uORF:IOH4362	697	320	479	608	311	609	675	424	700	162	ubiquitin specific peptidase 47 (USP47)
B47R13C02	47-2-13	Hs~MGC:BC000226.1~uORF:IOH4362	702	383	512	612	318	582	708	451	668	188	ubiquitin specific peptidase 47 (USP47)
B47R13C03	47-3-13	Hs~MGC:NM_152516.1~uORF:IOH23070	643	454	554	356	346	616	708	479	814	227	copper metabolism (Murr1) domain containing 1 (COMMD1)
B47R13C04	47-4-13	Hs~MGC:NM_152516.1~uORF:IOH23070	666	393	558	359	326	609	705	428	668	228	copper metabolism (Murr1) domain containing 1 (COMMD1)
B47R13C05	47-5-13	Hs~MGC:BC006233.1~uORF:IOH6288	564	476	568	284	298	373	578	339	452	66	ketohexokinase (fructokinase) (KHK)
B47R13C06	47-6-13	Hs~MGC:BC006233.1~uORF:IOH6288	670	481	517	284	385	396	494	343	482	33	ketohexokinase (fructokinase) (KHK)
B47R13C07	47-7-13	Hs~Ref:NM_001526.2~uORF:IOH29555	946	589	737	387	369	380	656	291	589	702	hypocretin (orexin) receptor 2 (HCRTR2)
B47R13C08	47-8-13	Hs~Ref:NM_001526.2~uORF:IOH29555	749	480	758	332	377	386	626	300	546	78	hypocretin (orexin) receptor 2 (HCRTR2)
B47R13C09	47-9-13	Hs~Ref:NM_023932.1~uORF:IOH4371	399	402	534	324	283	439	697	353	619	153	delta-like 2 homolog (Drosophila) (DLK2), transcript variant 1
B47R13C10	47-10-13	Hs~Ref:NM_023932.1~uORF:IOH4371	375	387	582	316	236	409	688	321	618	112	delta-like 2 homolog (Drosophila) (DLK2), transcript variant 1
B47R13C11	47-11-13	Hs~MGC:BC006839.1~uORF:IOH3171	336	570	1996	218	427	482	627	298	684	58	GATA binding protein 3 (GATA3)
B47R13C12	47-12-13	Hs~MGC:BC006839.1~uORF:IOH3171	414	565	1905	264	293	462	634	285	690	-12	GATA binding protein 3 (GATA3)
B47R13C13	47-13-13	Hs~MGC:BC001788.1~uORF:IOH4396	877	1815	1088	559	630	725	1073	718	1326	474	signal peptide peptidase-like 2B (SPPL2B)
B47R13C14	47-14-13	Hs~MGC:BC001788.1~uORF:IOH4396	904	1861	1023	631	617	692	1059	728	1316	399	signal peptide peptidase-like 2B (SPPL2B)
B47R13C15	47-15-13	Hs~MGC:BC000876.1~uORF:IOH3233	1232	12436	1914	1698	1341	1758	2010	1506	3773	515	zinc finger protein 174 (ZNF174)
B47R13C16	47-16-13	Hs~MGC:BC000876.1~uORF:IOH3233	1259	12445	2017	1593	1195	1729	1889	1363	3792	565	zinc finger protein 174 (ZNF174)
B47R13C17	47-17-13	Hs~Ref:NM_145266.1~uORF:IOH13512	990	653	827	278	495	401	947	498	596	172	NudC domain containing 2 (NUDCD2)
B47R13C18	47-18-13	Hs~Ref:NM_145266.1~uORF:IOH13512	973	588	829	281	367	473	930	496	620	260	NudC domain containing 2 (NUDCD2)
B47R13C19	47-19-13	Hs~Ref:NM_006667.2~uORF:IOH1787	2129	1103	2799	1181	1684	1741	2097	1284	2047	447	progesterone receptor membrane component 1 (PGRMC1)
B47R13C20	47-20-13	Hs~Ref:NM_006667.2~uORF:IOH1787	2157	1069	2844	1263	1749	1679	2038	1249	2071	455	progesterone receptor membrane component 1 (PGRMC1)
B47R13C21	47-21-13	Hs~MGC:BC018441.1~uORF:IOH10768	1032	726	990	599	742	994	1946	565	854	311	chromosome 19 open reading frame 25 (C19orf25)
B47R13C22	47-22-13	Hs~MGC:BC018441.1~uORF:IOH10768	1034	789	891	561	1069	988	1937	584	934	281	chromosome 19 open reading frame 25 (C19orf25)
B47R14C01	47-1-14	Hs~MGC:BC018519.1~uORF:IOH10796	675	847	945	593	918	771	775	763	1434	228	family with sequence similarity 36, member A (FAM36A)
B47R14C02	47-2-14	Hs~MGC:BC018519.1~uORF:IOH10796	681	887	899	601	873	677	764	714	1415	181	family with sequence similarity 36, member A (FAM36A)
B47R14C03	47-3-14	Hs~Ref:NM_001868.1~uORF:IOH53980	330	355	577	284	261	525	1261	560	833	211	Carboxypeptidase A1
B47R14C04	47-4-14	Hs~Ref:NM_001868.1~uORF:IOH53980	577	355	586	280	289	562	1232	533	901	196	Carboxypeptidase A1
B47R14C05	47-5-14	Hs~Ref:NM_006404.3~uORF:IOH53863	201	281	425	212	252	663	501	295	512	106	Endothelial protein C receptor
B47R14C06	47-6-14	Hs~Ref:NM_006404.3~uORF:IOH53863	411	275	429	230	240	372	481	316	527	205	Endothelial protein C receptor
B47R14C11	47-11-14	Hs~MGC:BC039654.1~uORF:IOH29351	371	371	545	288	172	426	497	308	629	61	tubulin folding cofactor D (TBCD)
B47R14C12	47-12-14	Hs~MGC:BC039654.1~uORF:IOH29351	333	376	483	285	316	413	539	345	621	117	tubulin folding cofactor D (TBCD)
B47R14C13	47-13-14	Hs~Ref:NM_005206.2~uORF:IOH1805	414	514	1078	431	352	3198	948	1051	715	290	v-crk sarcoma virus CT10 oncogene homolog (avian) (CRK), transcript variant I
B47R14C14	47-14-14	Hs~Ref:NM_005206.2~uORF:IOH1805	400	523	1062	454	312	2938	943	1000	717	297	v-crk sarcoma virus CT10 oncogene homolog (avian) (CRK), transcript variant I
B47R14C15	47-15-14	Hs~MGC:BC021992.1~uORF:IOH13921	718	507	598	378	286	895	564	309	625	259	protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) (PRKRIR)
B47R14C16	47-16-14	Hs~MGC:BC021992.1~uORF:IOH13921	740	494	617	370	280	941	583	377	624	252	protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) (PRKRIR)
B47R14C17	47-17-14	Hs~MGC:BC000043.1~uORF:IOH4765	816	1035	773	756	512	810	1858	582	1308	344	ADP-ribosylation factor-like 4D (ARL4D)
B47R14C18	47-18-14	Hs~MGC:BC000043.1~uORF:IOH4765	789	1057	798	929	501	846	1872	577	1371	371	ADP-ribosylation factor-like 4D (ARL4D)
B47R14C21	47-21-14	Hs~MGC:BC035030.1~uORF:IOH62115	1005	602	533	351	479	612	643	583	796	345	RAP1 GTPase activating protein, mRNA (cDNA clone MGC:33806 IMAGE:5261027), complete cds
B47R14C22	47-22-14	Hs~MGC:BC035030.1~uORF:IOH62115	996	672	540	472	332	552	623	573	800	335	RAP1 GTPase activating protein, mRNA (cDNA clone MGC:33806 IMAGE:5261027), complete cds
B47R15C05	47-5-15	Hs~MGC:BC042333.1~uORF:IOH28769	108	243	277	215	176	130	343	236	250	47	F-box protein 21 (FBXO21)
B47R15C06	47-6-15	Hs~MGC:BC042333.1~uORF:IOH28769	61	221	299	210	154	152	329	251	175	42	F-box protein 21 (FBXO21)
B47R15C07	47-7-15	Hs~MGC:BC053343.1~uORF:IOH28926	460	250	774	317	305	302	450	306	508	126	karyopherin alpha 2 (RAG cohort 1, importin alpha 1) (KPNA2)
B47R15C08	47-8-15	Hs~MGC:BC053343.1~uORF:IOH28926	494	254	829	315	359	305	468	298	534	199	karyopherin alpha 2 (RAG cohort 1, importin alpha 1) (KPNA2)
B47R15C09	47-9-15	Hs~MGC:BC014051.1~uORF:IOH14549	558	282	920	473	301	599	1045	435	1092	265	small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating) (SCYE1)
B47R15C10	47-10-15	Hs~MGC:BC014051.1~uORF:IOH14549	567	318	921	459	342	609	1056	411	1087	192	small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating) (SCYE1)
B47R15C11	47-11-15	Hs~MGC:BC010032.1~uORF:IOH14597	338	292	3099	243	153	414	408	308	467	67	LAG1 homolog, ceramide synthase 2 (LASS2)
B47R15C12	47-12-15	Hs~MGC:BC010032.1~uORF:IOH14597	324	314	3024	221	369	379	390	287	517	134	LAG1 homolog, ceramide synthase 2 (LASS2)
B47R15C15	47-15-15	Hs~Ref:NM_004755.2~CAT:PV3681	395	255	458	632	732	484	1158	335	1977	148	ribosomal protein S6 kinase, 90kDa, polypeptide 5 (RPS6KA5), transcript variant 1
B47R15C16	47-16-15	Hs~Ref:NM_004755.2~CAT:PV3681	407	217	467	606	705	920	1124	325	1938	101	ribosomal protein S6 kinase, 90kDa, polypeptide 5 (RPS6KA5), transcript variant 1
B47R16C01	47-1-16	Hs~Ref:NM_002011.3~CAT:P3054	78	34	169	31	119	673	224	55	52	38	fibroblast growth factor receptor 4 (FGFR4), transcript variant 1
B47R16C02	47-2-16	Hs~Ref:NM_002011.3~CAT:P3054	86	46	168	31	91	64	220	78	47	28	fibroblast growth factor receptor 4 (FGFR4), transcript variant 1
B47R16C03	47-3-16	Hs~Ref:NM_002759.1~CAT:PV4821	126	301	214	257	56	285	319	253	267	161	Interferon-induced, double-stranded RNA-activated protein kinase
B47R16C04	47-4-16	Hs~Ref:NM_002759.1~CAT:PV4821	113	333	213	261	123	145	360	227	5	177	Interferon-induced, double-stranded RNA-activated protein kinase
B47R16C07	47-7-16	Hs~Ref:NM_139016.2~uORF:IOH27635	5083	2983	4252	65465	3260	4359	10867	11152	5584	4758	chromosome 20 open reading frame 198 (C20orf198)
B47R16C08	47-8-16	Hs~Ref:NM_139016.2~uORF:IOH27635	5077	2887	4199	65457	3475	4287	10967	10827	5528	4703	chromosome 20 open reading frame 198 (C20orf198)
B47R16C09	47-9-16	Hs~Ref:NM_173822.1~uORF:IOH27491	2445	1594	2716	3997	2005	2206	6442	5655	2672	666	family with sequence similarity 126, member B (FAM126B)
B47R16C10	47-10-16	Hs~Ref:NM_173822.1~uORF:IOH27491	2359	1606	2736	3942	1888	2107	6227	5276	2708	610	family with sequence similarity 126, member B (FAM126B)
B47R16C11	47-11-16	Hs~MGC:BC050434.1~uORF:IOH26685	3131	3264	1962	1730	2097	3027	10869	1835	2876	731	hypothetical protein FLJ10154 (FLJ10154)
B47R16C12	47-12-16	Hs~MGC:BC050434.1~uORF:IOH26685	3243	3183	1924	1705	2732	2822	10998	1780	2878	728	hypothetical protein FLJ10154 (FLJ10154)
B47R16C13	47-13-16	Hs~Ref:NM_003403.3~uORF:IOH27684	3012	1373	1724	1785	1585	3164	5191	6692	1752	393	YY1 transcription factor (YY1)
B47R16C14	47-14-16	Hs~Ref:NM_003403.3~uORF:IOH27684	2698	1311	1687	1811	1501	2975	5129	6395	1765	358	YY1 transcription factor (YY1)
B47R16C15	47-15-16	Hs~MGC:BC007315.1~uORF:IOH5888	503	568	563	161	296	46	250	216	185	32	CCR4-NOT transcription complex, subunit 7 (CNOT7)
B47R16C16	47-16-16	Hs~MGC:BC007315.1~uORF:IOH5888	536	555	565	171	294	77	214	193	182	7	CCR4-NOT transcription complex, subunit 7 (CNOT7)
B47R16C17	47-17-16	Hs~MGC:BC035194.2~uORF:IOH28718	911	1188	1558	523	806	681	752	628	886	934	DnaJ (Hsp40) homolog, subfamily C, member 5 gamma (DNAJC5G)
B47R16C18	47-18-16	Hs~MGC:BC035194.2~uORF:IOH28718	885	1211	1640	731	799	803	780	613	844	1164	DnaJ (Hsp40) homolog, subfamily C, member 5 gamma (DNAJC5G)
B47R16C19	47-19-16	Hs~MGC:BC053629.1~uORF:IOH29041	1846	2534	6775	905	2655	1437	3645	686	3720	1615	Uncharacterized protein C3orf62
B47R16C20	47-20-16	Hs~MGC:BC053629.1~uORF:IOH29041	1794	2570	6576	847	2430	1398	3590	657	3824	1237	Uncharacterized protein C3orf62
B47R16C21	47-21-16	Hs~Ref:NM_001414.1~uORF:IOH29608	1030	863	1171	6902	1004	810	1715	1057	1081	318	eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa (EIF2B1)
B47R16C22	47-22-16	Hs~Ref:NM_001414.1~uORF:IOH29608	877	855	1216	7174	719	772	1601	951	1084	266	eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa (EIF2B1)
B47R17C03	47-3-17	Hs~MGC:BC069323.1~uORF:IOH61861	206	360	429	210	233	357	845	419	410	129	Leptin
B47R17C04	47-4-17	Hs~MGC:BC069323.1~uORF:IOH61861	184	375	453	239	312	183	849	419	327	44	Leptin
B47R17C07	47-7-17	Hs~MGC:BC031057.1~uORF:IOH61614	759	443	566	376	308	826	1342	736	948	209	RING finger and CHY zinc finger domain-containing protein 1
B47R17C08	47-8-17	Hs~MGC:BC031057.1~uORF:IOH61614	732	473	569	342	303	718	1376	737	894	188	RING finger and CHY zinc finger domain-containing protein 1
B47R17C09	47-9-17	Hs~Ref:NM_017583.2~uORF:IOH12577	847	529	1069	1411	791	1282	915	884	1232	438	tripartite motif-containing 44 (TRIM44)
B47R17C10	47-10-17	Hs~Ref:NM_017583.2~uORF:IOH12577	845	551	1057	1502	787	1308	946	852	1262	451	tripartite motif-containing 44 (TRIM44)
B47R17C11	47-11-17	Hs~MGC:BC016866.1~uORF:IOH10396	6119	888	595	899	1288	3155	5928	1475	1432	440	tripartite motif-containing 31 (TRIM31)
B47R17C12	47-12-17	Hs~MGC:BC016866.1~uORF:IOH10396	6257	867	621	830	1635	2518	5728	1342	1478	416	tripartite motif-containing 31 (TRIM31)
B47R17C13	47-13-17	Hs~Ref:NM_023930.1~uORF:IOH3701	1279	1416	1190	2985	944	2908	5427	3953	1831	1186	potassium channel tetramerisation domain containing 14 (KCTD14)
B47R17C14	47-14-17	Hs~Ref:NM_023930.1~uORF:IOH3701	1357	1433	1168	2960	972	3099	5291	4245	1763	1185	potassium channel tetramerisation domain containing 14 (KCTD14)
B47R17C15	47-15-17	Hs~Ref:NM_024958.1~uORF:IOH3105	331	382	1577	301	357	383	467	526	523	167	neurensin 2 (NRSN2)
B47R17C16	47-16-17	Hs~Ref:NM_024958.1~uORF:IOH3105	304	389	1563	320	354	858	492	548	593	97	neurensin 2 (NRSN2)
B47R17C17	47-17-17	Hs~Ref:NM_182631.1~uORF:IOH28980	1019	2290	807	685	586	1111	1577	819	1196	742	hypothetical protein LOC348840 (LOC348840)
B47R17C18	47-18-17	Hs~Ref:NM_182631.1~uORF:IOH28980	958	2372	807	657	543	1130	1697	798	1101	622	hypothetical protein LOC348840 (LOC348840)
B47R17C19	47-19-17	Hs~Ref:NM_017573.2~uORF:IOH27381	471	1031	595	287	294	489	610	366	476	-40	proprotein convertase subtilisin/kexin type 4 (PCSK4)
B47R17C20	47-20-17	Hs~Ref:NM_017573.2~uORF:IOH27381	477	1010	568	280	307	536	648	615	458	243	proprotein convertase subtilisin/kexin type 4 (PCSK4)
B47R17C21	47-21-17	Hs~MGC:BC038983.1~uORF:IOH26136	617	363	823	294	371	639	1669	1014	825	295	ubiquitin specific peptidase 36 (USP36)
B47R17C22	47-22-17	Hs~MGC:BC038983.1~uORF:IOH26136	563	398	826	298	389	487	1711	644	719	208	ubiquitin specific peptidase 36 (USP36)
B47R18C01	47-1-18	Hs~MGC:BC036884.1~uORF:IOH25943	731	439	959	472	531	357	557	589	566	253	zinc finger protein 462 (ZNF462)
B47R18C02	47-2-18	Hs~MGC:BC036884.1~uORF:IOH25943	759	452	969	529	517	417	569	624	632	203	zinc finger protein 462 (ZNF462)
B47R18C03	47-3-18	Hs~Ref:NM_006274.2~uORF:IOH11962	16279	22586	2416	2827	899	1049	2470	1126	1280	354	chemokine (C-C motif) ligand 19 (CCL19)
B47R18C04	47-4-18	Hs~Ref:NM_006274.2~uORF:IOH11962	16173	21608	2416	2864	887	1025	2436	1180	1246	305	chemokine (C-C motif) ligand 19 (CCL19)
B47R18C05	47-5-18	Hs~Ref:NM_007284.1~uORF:IOH5114	16634	21311	3211	10851	1383	808	3087	1565	1145	277	twinfilin, actin-binding protein, homolog 2 (Drosophila) (TWF2)
B47R18C06	47-6-18	Hs~Ref:NM_007284.1~uORF:IOH5114	16519	21983	3178	10262	1420	749	3208	1530	1113	225	twinfilin, actin-binding protein, homolog 2 (Drosophila) (TWF2)
B47R18C07	47-7-18	Hs~MGC:BC013959.1~uORF:IOH14481	721	842	2039	1250	3371	1671	6562	2592	1821	476	guanine nucleotide binding protein-like 1 (GNL1)
B47R18C08	47-8-18	Hs~MGC:BC013959.1~uORF:IOH14481	663	827	2006	1241	3316	1558	6514	2514	1772	457	guanine nucleotide binding protein-like 1 (GNL1)
B47R18C09	47-9-18	Hs~Ref:NM_024516.1~uORF:IOH5156	635	805	1200	502	6913	1261	2198	2535	1596	112	chromosome 16 open reading frame 53 (C16orf53)
B47R18C10	47-10-18	Hs~Ref:NM_024516.1~uORF:IOH5156	721	759	1212	498	6655	1141	2234	2493	1593	162	chromosome 16 open reading frame 53 (C16orf53)
B47R18C11	47-11-18	Hs~Ref:NM_004458.1~uORF:IOH28633	1149	1450	514	809	496	968	1103	834	664	1341	acyl-CoA synthetase long-chain family member 4 (ACSL4), transcript variant 1
B47R18C12	47-12-18	Hs~Ref:NM_004458.1~uORF:IOH28633	1160	1427	534	727	897	816	1095	813	668	1321	acyl-CoA synthetase long-chain family member 4 (ACSL4), transcript variant 1
B47R18C13	47-13-18	Hs~Ref:NM_138424.1~uORF:IOH9715	1269	1772	440	281	528	415	682	299	581	225	kinesin family member 12 (KIF12)
B47R18C14	47-14-18	Hs~Ref:NM_138424.1~uORF:IOH9715	1333	1775	417	293	409	274	695	310	546	197	kinesin family member 12 (KIF12)
B47R18C15	47-15-18	Hs~MGC:BC050548.1~uORF:IOH26914	2614	4210	505	364	416	590	876	333	629	259	kinesin family member 4A (KIF4A)
B47R18C16	47-16-18	Hs~MGC:BC050548.1~uORF:IOH26914	2566	4207	521	394	446	563	746	344	646	274	kinesin family member 4A (KIF4A)
B47R18C17	47-17-18	Hs~MGC:BC057768.1~uORF:IOH29152	5336	8428	669	738	557	442	509	363	578	957	chorionic somatomammotropin hormone 1 (placental lactogen) (CSH1)
B47R18C18	47-18-18	Hs~MGC:BC057768.1~uORF:IOH29152	5205	8572	664	552	507	449	477	370	574	91	chorionic somatomammotropin hormone 1 (placental lactogen) (CSH1)
B47R18C19	47-19-18	Hs~Ref:NM_006755.1~uORF:IOH2052	1	-1	-2	6	-2	-3	0	-8	0	1	transaldolase 1 (TALDO1)
B47R18C20	47-20-18	Hs~Ref:NM_006755.1~uORF:IOH2052	-1	3	3	0	0	1	0	7	-2	-6	transaldolase 1 (TALDO1)
B47R18C21	47-21-18	Hs~Ref:NM_001071.1~uORF:IOH4024	2	3	0	141	-1	1190	2284	1489	2852	296	thymidylate synthetase (TYMS)
B47R18C22	47-22-18	Hs~Ref:NM_001071.1~uORF:IOH4024	1	2	1	-1	-4	1222	2414	1590	2853	255	thymidylate synthetase (TYMS)
B47R19C01	47-1-19	Hs~MGC:BC015749.1~uORF:IOH13588	1102	933	1426	5	1214	2	-3	1	1	-1	syntaxin binding protein 1 (STXBP1)
B47R19C02	47-2-19	Hs~MGC:BC015749.1~uORF:IOH13588	1242	952	1407	1	1232	-2	0	0	-1	-1	syntaxin binding protein 1 (STXBP1)
B47R19C03	47-3-19	Hs~MGC:BC011461.1~uORF:IOH11995	1128	766	1478	705	1064	1282	2246	1275	1552	362	microphthalmia-associated transcription factor (MITF)
B47R19C04	47-4-19	Hs~MGC:BC011461.1~uORF:IOH11995	1076	793	1454	680	1047	1170	2210	1200	1595	363	microphthalmia-associated transcription factor (MITF)
B47R19C05	47-5-19	Hs~MGC:BC029046.1~uORF:IOH27332	4963	1711	2930	1483	827	2409	17849	1010	2388	422	H1 histone family, member 0 (H1F0)
B47R19C06	47-6-19	Hs~MGC:BC029046.1~uORF:IOH27332	3711	1725	2856	1424	864	2228	16858	922	2356	405	H1 histone family, member 0 (H1F0)
B47R19C09	47-9-19	Hs~MGC:BC032477.1~uORF:IOH21714	767	845	734	617	653	882	1201	550	1005	354	transmembrane channel-like 4 (TMC4)
B47R19C10	47-10-19	Hs~MGC:BC032477.1~uORF:IOH21714	788	860	763	547	686	932	1088	546	1059	371	transmembrane channel-like 4 (TMC4)
B47R19C11	47-11-19	Hs~MGC:BC024245.2~uORF:IOH22398	905	544	928	490	591	817	1545	648	1324	355	sal-like 2 (Drosophila) (SALL2)
B47R19C12	47-12-19	Hs~MGC:BC024245.2~uORF:IOH22398	949	596	937	453	713	733	1560	605	1211	304	sal-like 2 (Drosophila) (SALL2)
B47R19C13	47-13-19	Hs~MGC:BC029608.1~uORF:IOH21623	2	4	272	-1	493	19	243	135	307	31	rapamycin-insensitive companion of mTOR (RICTOR)
B47R19C14	47-14-19	Hs~MGC:BC029608.1~uORF:IOH21623	17	1	375	0	357	219	231	124	266	27	rapamycin-insensitive companion of mTOR (RICTOR)
B47R19C15	47-15-19	Hs~Ref:NM_152397.1~uORF:IOH21608	-2	288	319	206	942	375	417	316	504	116	IQ motif containing F1 (IQCF1)
B47R19C16	47-16-19	Hs~Ref:NM_152397.1~uORF:IOH21608	-1	-2	1	198	508	446	430	374	542	62	IQ motif containing F1 (IQCF1)
B47R19C17	47-17-19	Hs~Ref:NM_012088.2~uORF:IOH13028	2133	1488	2381	595	762	793	1835	2977	2637	598	6-phosphogluconolactonase (PGLS)
B47R19C18	47-18-19	Hs~Ref:NM_012088.2~uORF:IOH13028	2100	1523	2376	-12	76	805	1723	2808	2512	161	6-phosphogluconolactonase (PGLS)
B47R19C19	47-19-19	Hs~Ref:NM_032747.1~uORF:IOH7454	3126	1007	2018	825	832	967	1355	959	1846	386	upregulated during skeletal muscle growth 5 homolog (mouse) (USMG5)
B47R19C20	47-20-19	Hs~Ref:NM_032747.1~uORF:IOH7454	2726	990	1970	812	1129	940	1226	1155	1806	373	upregulated during skeletal muscle growth 5 homolog (mouse) (USMG5)
B47R19C21	47-21-19	Hs~MGC:NM_022085.3~uORF:IOH28133	1898	272	637	327	314	582	643	742	817	225	thioredoxin domain containing 5 (TXNDC5), transcript variant 2
B47R19C22	47-22-19	Hs~MGC:NM_022085.3~uORF:IOH28133	523	261	617	316	256	560	682	606	812	84	thioredoxin domain containing 5 (TXNDC5), transcript variant 2
B47R20C01	47-1-20	Hs~Ref:NM_138998.1~uORF:IOH21408	502	299	387	245	278	412	449	331	557	619	DEAD (Asp-Glu-Ala-Asp) box polypeptide 39 (DDX39), transcript variant 2
B47R20C02	47-2-20	Hs~Ref:NM_138998.1~uORF:IOH21408	572	323	428	259	302	379	429	340	614	253	DEAD (Asp-Glu-Ala-Asp) box polypeptide 39 (DDX39), transcript variant 2
B47R20C03	47-3-20	Hs~MGC:BC002752.1~uORF:IOH5351	628	420	457	511	384	1029	1387	1489	1241	984	chromosome 11 open reading frame 67 (C11orf67)
B47R20C04	47-4-20	Hs~MGC:BC002752.1~uORF:IOH5351	621	408	459	489	316	952	1388	1599	1232	1000	chromosome 11 open reading frame 67 (C11orf67)
B47R20C05	47-5-20	Hs~MGC:BC004277.1~uORF:IOH5499	52	23	32	25	10	297	97	128	153	13	Fanconi anemia, complementation group I (FANCI)
B47R20C06	47-6-20	Hs~MGC:BC004277.1~uORF:IOH5499	1004	24	37	19	27	1144	105	9	142	80	Fanconi anemia, complementation group I (FANCI)
B47R20C07	47-7-20	Hs~MGC:NM_152788.2~uORF:IOH11108	958	688	869	524	711	722	1093	519	1318	198	Ankyrin repeat and sterile alpha motif domain-containing protein 1B
B47R20C08	47-8-20	Hs~MGC:NM_152788.2~uORF:IOH11108	949	684	848	546	661	650	1073	554	1548	202	Ankyrin repeat and sterile alpha motif domain-containing protein 1B
B47R20C09	47-9-20	Hs~Ref:NM_032042.2~uORF:IOH11050	789	493	707	991	571	2723	2666	5394	1272	601	chromosome 5 open reading frame 21 (C5orf21)
B47R20C10	47-10-20	Hs~Ref:NM_032042.2~uORF:IOH11050	766	434	709	854	236	2620	2611	5328	1288	543	chromosome 5 open reading frame 21 (C5orf21)
B47R20C11	47-11-20	Hs~Ref:NM_012391.1~uORF:IOH12673	1028	1378	846	663	576	1025	798	555	1153	126	SAM pointed domain containing ets transcription factor (SPDEF)
B47R20C12	47-12-20	Hs~Ref:NM_012391.1~uORF:IOH12673	1108	1379	829	649	718	973	862	510	1176	172	SAM pointed domain containing ets transcription factor (SPDEF)
B47R20C13	47-13-20	Hs~Ref:NM_025061.2~uORF:IOH10684	713	503	627	413	361	1056	11250	489	870	236	Leucine-rich repeat-containing protein 8E
B47R20C14	47-14-20	Hs~Ref:NM_025061.2~uORF:IOH10684	625	461	661	378	285	968	11191	456	875	198	Leucine-rich repeat-containing protein 8E
B48R02C11	48-11-2	Hs~Ref:NM_012407.1~uORF:IOH12174	1048	425	610	317	166	524	1250	339	1007	104	PRKCA-binding protein
B48R02C12	48-12-2	Hs~Ref:NM_012407.1~uORF:IOH12174	1169	405	556	290	250	666	1469	400	616	111	PRKCA-binding protein
B48R02C13	48-13-2	Hs~MGC:NM_033082.1~uORF:IOH7469	6690	1146	1189	1	1034	1152	-3	-1	135	5	Nuclear protein Hcc-1
B48R02C14	48-14-2	Hs~MGC:NM_033082.1~uORF:IOH7469	6892	1082	1100	-2	906	650	0	83	214	-3	Nuclear protein Hcc-1
B48R02C15	48-15-2	Hs~MGC:BC025276.1~uORF:IOH14043	7863	1226	1356	1498	1010	3116	4468	2844	5397	830	U3 small nucleolar RNA-associated protein 18 homolog
B48R02C16	48-16-2	Hs~MGC:BC025276.1~uORF:IOH14043	7998	1256	1330	1508	1448	2631	4463	2246	5400	204	U3 small nucleolar RNA-associated protein 18 homolog
B48R02C17	48-17-2	Hs~MGC:BC025279.1~uORF:IOH14049	7567	1009	894	1216	561	1364	5597	864	3586	-335	Scaffold attachment factor B2
B48R02C18	48-18-2	Hs~MGC:BC025279.1~uORF:IOH14049	6870	964	855	1164	625	1268	5717	847	3537	1819	Scaffold attachment factor B2
B48R02C19	48-19-2	Hs~MGC:BC031044.1~uORF:IOH22543	1588	761	1124	365	446	231	855	449	1423	3236	DnaJ (Hsp40) homolog, subfamily A, member 4 (DNAJA4)
B48R02C20	48-20-2	Hs~MGC:BC031044.1~uORF:IOH22543	1585	809	1111	370	533	720	840	446	1218	2612	DnaJ (Hsp40) homolog, subfamily A, member 4 (DNAJA4)
B48R02C21	48-21-2	Hs~MGC:BC033842.1~uORF:IOH21761	2627	1157	1670	2630	1102	1580	1992	3844	1019	449	mitochondrial tumor suppressor 1 (MTUS1)
B48R02C22	48-22-2	Hs~MGC:BC033842.1~uORF:IOH21761	2604	1067	1655	2437	864	2576	1923	3556	2283	424	mitochondrial tumor suppressor 1 (MTUS1)
B48R03C01	48-1-3	Hs~MGC:BC029920.1~uORF:IOH22865	1698	3361	1208	2412	2553	1717	1621	4574	1888	1024	Homeobox protein TGIF2LX
B48R03C02	48-2-3	Hs~MGC:BC029920.1~uORF:IOH22865	1677	3275	1218	2195	885	2058	1689	4269	1764	986	Homeobox protein TGIF2LX
B48R03C03	48-3-3	Hs~MGC:BC029541.1~uORF:IOH22564	1455	3817	1096	277	1438	1653	3329	815	1818	373	leucine zipper-EF-hand containing transmembrane protein 2 (LETM2)
B48R03C04	48-4-3	Hs~MGC:BC029541.1~uORF:IOH22564	1404	3728	1081	281	462	1567	3419	751	1738	346	leucine zipper-EF-hand containing transmembrane protein 2 (LETM2)
B48R03C05	48-5-3	Hs~Ref:NM_138707.1~uORF:IOH40983	1066	1974	1306	2213	1959	1624	2035	474	2630	406	B-cell CLL/lymphoma 7B (BCL7B), transcript variant 2
B48R03C06	48-6-3	Hs~Ref:NM_138707.1~uORF:IOH40983	1150	1978	1274	2024	1958	1545	1991	446	3409	396	B-cell CLL/lymphoma 7B (BCL7B), transcript variant 2
B48R03C07	48-7-3	Hs~Ref:NM_207047.1~uORF:IOH44493	1941	2309	1044	1284	3491	2697	12947	1323	4378	524	endosulfine alpha (ENSA), transcript variant 7
B48R03C08	48-8-3	Hs~Ref:NM_207047.1~uORF:IOH44493	1969	2336	1005	1227	3301	2517	10982	1206	4365	474	endosulfine alpha (ENSA), transcript variant 7
B48R03C09	48-9-3	Hs~Ref:NM_002147.2~uORF:IOH40956	718	784	753	593	557	1013	1477	738	850	457	homeobox B5 (HOXB5)
B48R03C10	48-10-3	Hs~Ref:NM_002147.2~uORF:IOH40956	766	645	818	575	582	1062	924	811	941	390	homeobox B5 (HOXB5)
B48R03C11	48-11-3	Hs~Ref:NM_004296.3~uORF:IOH41050	1182	615	1293	620	474	4596	504	349	1347	306	regulator of G-protein signaling 6 (RGS6)
B48R03C12	48-12-3	Hs~Ref:NM_004296.3~uORF:IOH41050	1242	610	1320	631	3454	5610	522	365	1401	307	regulator of G-protein signaling 6 (RGS6)
B48R03C13	48-13-3	Hs~Ref:NM_194271.1~uORF:IOH41584	1097	1314	620	512	602	789	1052	647	861	-4	ring finger protein 34 (RNF34), transcript variant 1
B48R03C14	48-14-3	Hs~Ref:NM_194271.1~uORF:IOH41584	880	1348	623	498	610	1560	1004	841	845	-3	ring finger protein 34 (RNF34), transcript variant 1
B48R03C15	48-15-3	Hs~Ref:NM_018114.4~uORF:IOH45463	859	1433	600	357	409	952	603	1965	264	41	DALR anticodon-binding domain-containing protein 3
B48R03C16	48-16-3	Hs~Ref:NM_018114.4~uORF:IOH45463	875	1386	612	386	419	1051	595	913	299	8	DALR anticodon-binding domain-containing protein 3
B48R03C17	48-17-3	Hs~Ref:NM_003616.2~uORF:IOH44332	1003	1603	475	1591	3491	311	773	1105	96	55	survival of motor neuron protein interacting protein 1 (SIP1), transcript variant alpha
B48R03C18	48-18-3	Hs~Ref:NM_003616.2~uORF:IOH44332	1067	1513	461	1549	175	394	760	504	1239	733	survival of motor neuron protein interacting protein 1 (SIP1), transcript variant alpha
B48R03C19	48-19-3	Hs~Ref:NM_031303.1~uORF:IOH45470	1285	1001	1473	923	593	891	2001	1392	1415	163	katanin p60 subunit A-like 2 (KATNAL2)
B48R03C20	48-20-3	Hs~Ref:NM_031303.1~uORF:IOH45470	1219	1030	1457	965	400	187	2074	1292	1400	30	katanin p60 subunit A-like 2 (KATNAL2)
B48R03C21	48-21-3	Hs~Ref:NM_032809.2~uORF:IOH10281	906	714	1255	513	1126	4602	1420	881	907	286	Protein FAM73B
B48R03C22	48-22-3	Hs~Ref:NM_032809.2~uORF:IOH10281	875	641	1219	469	1125	4938	1454	1124	908	62	Protein FAM73B
B48R04C01	48-1-4	Hs~Ref:NM_080678.1~uORF:IOH10298	771	616	1732	446	1680	2422	1385	917	1519	148	ubiquitin-conjugating enzyme E2F (putative) (UBE2F)
B48R04C02	48-2-4	Hs~Ref:NM_080678.1~uORF:IOH10298	781	564	1745	401	1955	2624	1405	875	1620	134	ubiquitin-conjugating enzyme E2F (putative) (UBE2F)
B48R04C03	48-3-4	Hs~Ref:NM_138800.1~uORF:IOH10304	466	761	606	492	530	685	986	601	889	142	tripartite motif-containing 43 (TRIM43)
B48R04C04	48-4-4	Hs~Ref:NM_138800.1~uORF:IOH10304	535	742	652	479	399	743	956	650	684	25	tripartite motif-containing 43 (TRIM43)
B48R04C05	48-5-4	Hs~MGC:BC016934.1~uORF:IOH10340	557	828	655	383	315	565	617	532	631	315	superoxide dismutase 2, mitochondrial (SOD2)
B48R04C06	48-6-4	Hs~MGC:BC016934.1~uORF:IOH10340	610	825	674	408	314	658	628	545	767	302	superoxide dismutase 2, mitochondrial (SOD2)
B48R04C07	48-7-4	Hs~Ref:NM_001760.2~uORF:IOH14467	896	639	1002	597	552	1032	1668	720	2750	334	cyclin D3 (CCND3)
B48R04C08	48-8-4	Hs~Ref:NM_001760.2~uORF:IOH14467	917	697	1014	597	573	1019	1920	691	2624	316	cyclin D3 (CCND3)
B48R04C09	48-9-4	Hs~Ref:NM_145286.1~uORF:IOH10802	787	605	1716	540	395	1200	2579	621	1739	343	stomatin (EPB72)-like 3 (STOML3)
B48R04C10	48-10-4	Hs~Ref:NM_145286.1~uORF:IOH10802	857	586	1771	579	391	1199	1292	608	1736	391	stomatin (EPB72)-like 3 (STOML3)
B48R04C11	48-11-4	Hs~Ref:NM_001154.2~uORF:IOH5099	558	436	2272	273	371	812	679	287	11905	130	annexin A5 (ANXA5)
B48R04C12	48-12-4	Hs~Ref:NM_001154.2~uORF:IOH5099	547	465	2199	278	279	1135	647	299	11981	155	annexin A5 (ANXA5)
B48R04C13	48-13-4	Hs~MGC:BC028083.1~uORF:IOH11382	793	570	981	394	3291	997	1233	564	1473	124	T cell receptor beta variable 5-4 (TRBV5-4)
B48R04C14	48-14-4	Hs~MGC:BC028083.1~uORF:IOH11382	1092	554	930	366	1129	873	1229	696	1627	10	T cell receptor beta variable 5-4 (TRBV5-4)
B48R04C15	48-15-4	Hs~Ref:NM_005135.1~uORF:IOH38670	2720	1196	988	595	566	820	1087	2705	1246	113	Solute carrier family 12 member 6
B48R04C16	48-16-4	Hs~Ref:NM_005135.1~uORF:IOH38670	2629	1370	999	596	959	904	1111	2581	862	75	Solute carrier family 12 member 6
B48R04C17	48-17-4	Hs~Ref:NM_007360.1~uORF:IOH26288	6990	2699	1651	552	1740	647	1430	404	560	78	killer cell lectin-like receptor subfamily K, member 1 (KLRK1)
B48R04C18	48-18-4	Hs~Ref:NM_007360.1~uORF:IOH26288	7185	2685	1750	580	3183	441	1290	1151	112	97	killer cell lectin-like receptor subfamily K, member 1 (KLRK1)
B48R04C19	48-19-4	Hs~Ref:NM_031305.1~uORF:IOH38124	11731	4408	2591	3904	1543	9118	4080	6250	3056	349	Rho GTPase activating protein 24 (ARHGAP24), transcript variant 2
B48R04C20	48-20-4	Hs~Ref:NM_031305.1~uORF:IOH38124	10109	4488	2465	3934	1831	9413	4326	5626	2794	331	Rho GTPase activating protein 24 (ARHGAP24), transcript variant 2
B48R04C21	48-21-4	Hs~Ref:NM_000411.4~uORF:IOH29186	2077	3541	1781	23046	1253	575	3095	2514	1879	786	holocarboxylase synthetase (biotin-(proprionyl-Coenzyme A-carboxylase (ATP-hydrolysing)) ligase) (HLCS)
B48R04C22	48-22-4	Hs~Ref:NM_000411.4~uORF:IOH29186	2270	3519	1759	22361	1314	723	2948	2595	1802	803	holocarboxylase synthetase (biotin-(proprionyl-Coenzyme A-carboxylase (ATP-hydrolysing)) ligase) (HLCS)
B48R05C01	48-1-5	Hs~Ref:NM_016073.2~uORF:IOH10649	5337	2464	5402	1890	2862	1811	13710	1803	3376	1018	hepatoma-derived growth factor, related protein 3 (HDGFRP3)
B48R05C02	48-2-5	Hs~Ref:NM_016073.2~uORF:IOH10649	5397	2429	5695	1864	3706	1721	14083	1762	3480	1050	hepatoma-derived growth factor, related protein 3 (HDGFRP3)
B48R05C03	48-3-5	Hs~Ref:NM_021639.2~uORF:IOH10045	12472	4892	7489	11171	7381	36227	9713	7960	8510	3064	GC-rich promoter binding protein 1-like 1 (GPBP1L1)
B48R05C04	48-4-5	Hs~Ref:NM_021639.2~uORF:IOH10045	10585	4883	7463	9789	6217	33834	9600	7625	8309	2913	GC-rich promoter binding protein 1-like 1 (GPBP1L1)
B48R05C05	48-5-5	Hs~Ref:NM_031299.2~uORF:IOH4043	1287	837	2197	7651	672	5400	2532	1651	1329	332	cell division cycle associated 3 (CDCA3)
B48R05C06	48-6-5	Hs~Ref:NM_031299.2~uORF:IOH4043	1334	764	2117	7290	693	5222	2458	1531	1666	331	cell division cycle associated 3 (CDCA3)
B48R05C07	48-7-5	Hs~MGC:BC003512.1~uORF:IOH5479	1086	719	896	534	478	746	1080	712	1528	343	mesothelin (MSLN)
B48R05C08	48-8-5	Hs~MGC:BC003512.1~uORF:IOH5479	865	766	912	579	463	706	1070	649	1523	323	mesothelin (MSLN)
B48R05C09	48-9-5	Hs~Ref:NM_003384.1~N/A	1041	881	1316	653	555	1071	1636	706	1248	393	vaccinia related kinase 1 (VRK1)
B48R05C10	48-10-5	Hs~Ref:NM_003384.1~N/A	1083	822	1304	617	576	1095	1697	689	1248	372	vaccinia related kinase 1 (VRK1)
B48R05C11	48-11-5	Hs~Ref:NM_013257.2~N/A	1202	780	1112	541	540	913	1336	619	1171	408	Serine/threonine-protein kinase Sgk3
B48R05C12	48-12-5	Hs~Ref:NM_013257.2~N/A	1223	768	1082	566	555	1099	1306	598	1153	375	Serine/threonine-protein kinase Sgk3
B48R05C13	48-13-5	Hs~Ref:NM_003188.2~N/A	1459	974	1377	621	617	975	1648	644	1317	381	mitogen-activated protein kinase kinase kinase 7 (MAP3K7), transcript variant A
B48R05C14	48-14-5	Hs~Ref:NM_003188.2~N/A	1505	1000	1430	588	3340	864	1680	810	1294	273	mitogen-activated protein kinase kinase kinase 7 (MAP3K7), transcript variant A
B48R05C15	48-15-5	Hs~Ref:NM_021133.1~N/A	2677	1401	2697	1167	1921	887	1783	3309	2641	532	2-5A-dependent ribonuclease
B48R05C16	48-16-5	Hs~Ref:NM_021133.1~N/A	2560	1412	2696	1117	2196	921	1837	541	2834	-10	2-5A-dependent ribonuclease
B48R05C17	48-17-5	Hs~MGC:BC070109.1~uORF:IOH40086	1535	1294	1683	1075	1978	1116	2649	2784	2571	741	chromosome 22 open reading frame 13 (C22orf13)
B48R05C18	48-18-5	Hs~MGC:BC070109.1~uORF:IOH40086	1534	1324	1644	1015	2091	1022	2562	1628	2614	362	chromosome 22 open reading frame 13 (C22orf13)
B48R05C19	48-19-5	Hs~Ref:NM_001009993.1~uORF:IOH40129	1590	1390	2074	1111	4634	1818	2502	1531	2726	1000	p20 (LOC130074)
B48R05C20	48-20-5	Hs~Ref:NM_001009993.1~uORF:IOH40129	1381	1370	2130	1138	1146	849	2484	2137	2796	452	p20 (LOC130074)
B48R05C21	48-21-5	Hs~Ref:NM_144990.2~uORF:IOH40187	1432	1215	4326	2703	1989	2216	6355	5228	3639	1470	schlafen-like 1 (SLFNL1)
B48R05C22	48-22-5	Hs~Ref:NM_144990.2~uORF:IOH40187	1611	1192	4268	2558	1983	1865	6019	4647	3669	1399	schlafen-like 1 (SLFNL1)
B48R06C01	48-1-6	Hs~Ref:NM_001234.3~uORF:IOH40258	1677	1053	1783	1089	1084	1250	2696	1330	2615	629	caveolin 3 (CAV3), transcript variant 2
B48R06C02	48-2-6	Hs~Ref:NM_001234.3~uORF:IOH40258	1606	1189	1801	1068	1189	1184	2639	1265	2772	617	caveolin 3 (CAV3), transcript variant 2
B48R06C03	48-3-6	Hs~MGC:BC031695.1~uORF:IOH21499	639	952	686	1249	875	1273	3602	926	1299	216	deleted in a mouse model of primary ciliary dyskinesia (RP11-529I10.4)
B48R06C04	48-4-6	Hs~MGC:BC031695.1~uORF:IOH21499	630	897	700	1027	867	1244	3421	819	1247	175	deleted in a mouse model of primary ciliary dyskinesia (RP11-529I10.4)
B48R06C07	48-7-6	Hs~Ref:NM_024591.1~uORF:IOH13020	556	1533	1645	1040	708	2687	4672	5198	3592	812	chromatin modifying protein 6 (CHMP6)
B48R06C08	48-8-6	Hs~Ref:NM_024591.1~uORF:IOH13020	1205	1602	1603	1002	770	2611	4625	4893	3740	745	chromatin modifying protein 6 (CHMP6)
B48R06C09	48-9-6	Hs~Ref:NM_032117.1~uORF:IOH23109	1039	1513	2185	1182	1130	3110	3843	1142	2525	507	Meiotic nuclear division protein 1 homolog
B48R06C10	48-10-6	Hs~Ref:NM_032117.1~uORF:IOH23109	1329	1496	2171	1118	1154	3263	3969	1129	2599	506	Meiotic nuclear division protein 1 homolog
B48R06C11	48-11-6	Hs~Ref:NM_053049.2~uORF:IOH54667	1362	1163	1047	587	427	1115	4060	623	1053	289	Urocortin-3
B48R06C12	48-12-6	Hs~Ref:NM_053049.2~uORF:IOH54667	1454	1112	1128	580	474	1241	4129	654	1150	334	Urocortin-3
B48R06C13	48-13-6	Hs~Ref:NM_007226.1~uORF:IOH59414	1090	1705	1105	721	828	1058	2338	704	1536	165	Neurexophilin-2
B48R06C14	48-14-6	Hs~Ref:NM_007226.1~uORF:IOH59414	1085	1772	1110	720	5158	909	2281	1250	1542	-10	Neurexophilin-2
B48R06C15	48-15-6	Hs~Ref:NM_001013705.1~uORF:IOH54674	1186	989	881	758	1670	807	1816	1301	1218	532	hypothetical LOC440337, mRNA (cDNA clone MGC:163229 IMAGE:40146388), complete cds
B48R06C16	48-16-6	Hs~Ref:NM_001013705.1~uORF:IOH54674	1158	986	856	825	1627	723	1821	1155	1220	609	hypothetical LOC440337, mRNA (cDNA clone MGC:163229 IMAGE:40146388), complete cds
B48R06C17	48-17-6	Hs~Ref:NM_025104.2~uORF:IOH59472	1168	1846	1700	2096	1859	1881	3804	3289	2182	362	Protein DBF4 homolog B
B48R06C18	48-18-6	Hs~Ref:NM_025104.2~uORF:IOH59472	1140	1788	1657	1948	1424	1786	3942	4137	2142	292	Protein DBF4 homolog B
B48R06C19	48-19-6	Hs~Ref:NM_001259.5~uORF:IOH28111	783	522	993	710	1970	1795	1136	845	3735	1467	cyclin D1 and cyclin-dependent kinase 6 (CDK6): cyclin D1 and CDK6 sequences are seperated by -- (in the protein list file).
B48R06C20	48-20-6	Hs~Ref:NM_001259.5~uORF:IOH28111	748	503	943	688	474	2004	1096	1144	3681	709	cyclin D1 and cyclin-dependent kinase 6 (CDK6): cyclin D1 and CDK6 sequences are seperated by -- (in the protein list file).
B48R06C21	48-21-6	Hs~MGC:BC031520.1~uORF:IOH22122	863	1218	856	756	435	462	949	858	1512	20	MLF1 interacting protein (MLF1IP)
B48R06C22	48-22-6	Hs~MGC:BC031520.1~uORF:IOH22122	993	1240	840	737	455	518	953	884	1451	-23	MLF1 interacting protein (MLF1IP)
B48R07C01	48-1-7	Hs~MGC:BC051374.1~uORF:IOH28132	957	1471	1166	781	941	903	1142	654	1171	341	sodium channel, voltage-gated, type V, alpha subunit (SCN5A)
B48R07C02	48-2-7	Hs~MGC:BC051374.1~uORF:IOH28132	966	1376	1210	804	912	841	1210	724	1016	437	sodium channel, voltage-gated, type V, alpha subunit (SCN5A)
B48R07C03	48-3-7	Hs~MGC:BC047420.1~uORF:IOH26512	608	809	879	683	870	979	1615	719	781	205	UBX domain-containing protein 7
B48R07C04	48-4-7	Hs~MGC:BC047420.1~uORF:IOH26512	612	774	857	625	922	970	1537	643	73	191	UBX domain-containing protein 7
B48R07C05	48-5-7	Hs~Ref:NM_002853.2~uORF:IOH3151	3090	753	850	802	753	888	915	479	1373	1688	Cell cycle checkpoint protein RAD1
B48R07C06	48-6-7	Hs~Ref:NM_002853.2~uORF:IOH3151	3511	750	843	749	665	848	948	499	1324	1682	Cell cycle checkpoint protein RAD1
B48R07C07	48-7-7	Hs~Ref:NM_020145.1~uORF:IOH14380	5944	802	814	1340	1523	1180	1786	2862	1545	1996	Endophilin-B2
B48R07C08	48-8-7	Hs~Ref:NM_020145.1~uORF:IOH14380	6022	787	817	1243	692	1121	1788	2655	1533	2153	Endophilin-B2
B48R07C09	48-9-7	Hs~Ref:NM_004143.2~uORF:IOH5542	4591	580	1012	748	1726	17692	5174	2777	4752	524	Cbp/p300-interacting transactivator 1
B48R07C10	48-10-7	Hs~Ref:NM_004143.2~uORF:IOH5542	4736	564	956	707	1743	17679	5211	2510	4632	502	Cbp/p300-interacting transactivator 1
B48R07C11	48-11-7	Hs~MGC:BC001798.1~uORF:IOH4437	795	506	730	464	354	550	1265	410	776	262	Sorting nexin-6
B48R07C12	48-12-7	Hs~MGC:BC001798.1~uORF:IOH4437	619	486	697	447	360	619	1243	412	809	255	Sorting nexin-6
B48R07C13	48-13-7	Hs~Ref:NM_006256.1~N/A	1012	672	930	595	623	1004	1446	755	1585	639	Serine/threonine-protein kinase N2
B48R07C14	48-14-7	Hs~Ref:NM_006256.1~N/A	1082	675	850	650	475	913	1410	1096	1557	622	Serine/threonine-protein kinase N2
B48R07C15	48-15-7	Hs~Ref:NM_002755.2~N/A	1567	966	1147	731	3305	1094	2466	1252	2054	721	mitogen-activated protein kinase kinase 1 (MAP2K1); see catalog number for detailed information on wild-type or point mutant status
B48R07C16	48-16-7	Hs~Ref:NM_002755.2~N/A	1524	931	1135	781	1003	1212	2507	1479	2129	253	mitogen-activated protein kinase kinase 1 (MAP2K1); see catalog number for detailed information on wild-type or point mutant status
B48R07C17	48-17-7	Hs~Ref:NM_004336.1~N/A	1869	977	1101	698	1084	1471	2082	1233	1635	51	BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) (BUB1)
B48R07C18	48-18-7	Hs~Ref:NM_004336.1~N/A	1795	1042	1134	727	999	529	2014	1145	1862	-9	BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) (BUB1)
B48R07C19	48-19-7	Hs~Ref:NM_002595.1~N/A	2652	1192	1215	1186	3053	1477	4206	1890	2510	684	Serine/threonine-protein kinase PCTAIRE-2
B48R07C20	48-20-7	Hs~Ref:NM_002595.1~N/A	2955	1209	1138	1035	732	959	4001	1654	2472	1829	Serine/threonine-protein kinase PCTAIRE-2
B48R07C21	48-21-7	Hs~Ref:NM_001759.2~uORF:IOH13739	796	583	716	797	399	652	992	856	57	410	cyclin D2 (CCND2)
B48R07C22	48-22-7	Hs~Ref:NM_001759.2~uORF:IOH13739	944	630	728	828	408	773	1047	1013	813	366	cyclin D2 (CCND2)
B48R08C01	48-1-8	Hs~MGC:BC009368.2~uORF:IOH13824	1031	742	1005	1006	450	915	1260	1654	986	50	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 (SMARCD1)
B48R08C02	48-2-8	Hs~MGC:BC009368.2~uORF:IOH13824	1058	888	907	1035	477	801	1292	1541	1031	464	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 (SMARCD1)
B48R08C03	48-3-8	Hs~MGC:BC009395.2~uORF:IOH13852	1039	1037	977	782	528	4044	1159	686	898	379	interferon regulatory factor 3 (IRF3)
B48R08C04	48-4-8	Hs~MGC:BC009395.2~uORF:IOH13852	1059	934	919	891	582	3720	1308	684	840	353	interferon regulatory factor 3 (IRF3)
B48R08C05	48-5-8	Hs~Ref:NM_020236.2~uORF:IOH13751	3113	943	1618	2151	873	1764	2891	951	1993	547	mitochondrial ribosomal protein L1 (MRPL1), nuclear gene encoding mitochondrial protein
B48R08C06	48-6-8	Hs~Ref:NM_020236.2~uORF:IOH13751	2919	1037	1628	2114	862	1705	2914	902	1992	517	mitochondrial ribosomal protein L1 (MRPL1), nuclear gene encoding mitochondrial protein
B48R08C07	48-7-8	Hs~MGC:BC008730.2~uORF:IOH5942	1311	6601	633	277	358	963	684	585	584	331	hexokinase 1 (HK1)
B48R08C08	48-8-8	Hs~MGC:BC008730.2~uORF:IOH5942	1235	6573	628	310	762	926	604	570	606	245	hexokinase 1 (HK1)
B48R08C09	48-9-8	Hs~MGC:BC020256.1~uORF:IOH12255	941	578	983	688	219	1320	1533	620	1141	459	Protein KIAA1199
B48R08C10	48-10-8	Hs~MGC:BC020256.1~uORF:IOH12255	938	583	934	724	400	1407	1652	536	1123	417	Protein KIAA1199
B48R08C11	48-11-8	Hs~MGC:BC033091.1~uORF:IOH23281	883	579	793	533	380	808	893	414	817	271	solute carrier family 25, member 27 (SLC25A27)
B48R08C12	48-12-8	Hs~MGC:BC033091.1~uORF:IOH23281	940	583	836	528	383	823	919	445	898	313	solute carrier family 25, member 27 (SLC25A27)
B48R08C13	48-13-8	Hs~Ref:NM_000341.2~uORF:IOH12262	1116	672	866	639	529	1269	1831	532	1014	384	solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1 (SLC3A1)
B48R08C14	48-14-8	Hs~Ref:NM_000341.2~uORF:IOH12262	1160	644	824	609	115	1311	1752	286	981	396	solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1 (SLC3A1)
B48R08C15	48-15-8	Hs~MGC:BC000769.1~uORF:IOH3832	1651	4162	1782	1952	737	3327	1977	1330	1443	415	chromosome 7 open reading frame 25 (C7orf25)
B48R08C16	48-16-8	Hs~MGC:BC000769.1~uORF:IOH3832	1560	4009	1799	1865	3833	3074	2031	589	1513	436	chromosome 7 open reading frame 25 (C7orf25)
B48R08C17	48-17-8	Hs~Ref:NM_018070.2~uORF:IOH4968	1817	4718	2449	3512	576	2796	5793	204	4517	373	single stranded DNA binding protein 3 (SSBP3), transcript variant 2
B48R08C18	48-18-8	Hs~Ref:NM_018070.2~uORF:IOH4968	1811	4601	2418	3281	670	2727	5640	1184	4485	302	single stranded DNA binding protein 3 (SSBP3), transcript variant 2
B48R08C19	48-19-8	Hs~MGC:NM_177966.3~uORF:IOH26825	1342	1537	1220	769	3942	1284	2272	1558	2391	199	2prime,5prime-phosphodiesterase 12
B48R08C20	48-20-8	Hs~MGC:NM_177966.3~uORF:IOH26825	1515	1555	1123	770	668	1090	2326	1642	2491	909	2prime,5prime-phosphodiesterase 12
B48R08C21	48-21-8	Hs~MGC:BC001778.1~uORF:IOH4907	1477	3330	863	764	540	2291	2361	1739	2081	350	uroporphyrinogen decarboxylase (UROD)
B48R08C22	48-22-8	Hs~MGC:BC001778.1~uORF:IOH4907	1397	3438	847	769	473	2134	2145	1322	1798	-17	uroporphyrinogen decarboxylase (UROD)
B48R09C01	48-1-9	Hs~Ref:NM_005764.3~uORF:IOH58947	472	417	530	403	490	538	702	366	783	210	PDZK1-interacting protein 1
B48R09C02	48-2-9	Hs~Ref:NM_005764.3~uORF:IOH58947	428	512	533	415	459	482	679	380	853	205	PDZK1-interacting protein 1
B48R09C03	48-3-9	Hs~Ref:NM_000219.2~uORF:IOH54610	436	888	1095	981	473	671	956	573	1680	4	Potassium voltage-gated channel subfamily E member 1
B48R09C04	48-4-9	Hs~Ref:NM_000219.2~uORF:IOH54610	465	744	1103	1024	483	675	959	628	501	6	Potassium voltage-gated channel subfamily E member 1
B48R09C05	48-5-9	Hs~Ref:NM_005511.1~uORF:IOH58949	2604	1074	577	1070	469	682	1165	4220	791	382	Melanoma antigen recognized by T-cells 1
B48R09C06	48-6-9	Hs~Ref:NM_005511.1~uORF:IOH58949	3167	1018	561	1057	534	688	1271	3796	885	379	Melanoma antigen recognized by T-cells 1
B48R09C07	48-7-9	Hs~Ref:NM_005717.2~uORF:IOH59937	7856	1239	540	852	460	637	2661	564	3360	188	Actin-related protein 2/3 complex subunit 5
B48R09C08	48-8-9	Hs~Ref:NM_005717.2~uORF:IOH59937	7869	1081	549	807	483	630	2671	606	3491	258	Actin-related protein 2/3 complex subunit 5
B48R09C09	48-9-9	Hs~Ref:NM_145113.1~uORF:IOH58594	563	507	560	313	327	333	487	376	563	151	Protein max
B48R09C10	48-10-9	Hs~Ref:NM_145113.1~uORF:IOH58594	567	526	575	331	171	362	499	352	538	182	Protein max
B48R09C11	48-11-9	Hs~Ref:NM_002806.2~uORF:IOH57053	1176	1320	825	404	300	1149	693	516	707	225	26S protease regulatory subunit S10B
B48R09C12	48-12-9	Hs~Ref:NM_002806.2~uORF:IOH57053	1168	1279	825	366	305	1277	659	682	689	177	26S protease regulatory subunit S10B
B48R09C13	48-13-9	Hs~Ref:NM_006032.2~uORF:IOH55460	1483	1833	896	5424	547	2832	5057	2449	1825	612	Copine-6
B48R09C14	48-14-9	Hs~Ref:NM_006032.2~uORF:IOH55460	1479	1906	886	5610	470	2851	4815	2543	1766	600	Copine-6
B48R09C15	48-15-9	Hs~MGC:BC007035.1~uORF:IOH57050	714	434	490	523	346	534	681	704	1153	281	Nuclear transcription factor Y subunit beta
B48R09C16	48-16-9	Hs~MGC:BC007035.1~uORF:IOH57050	730	419	517	515	222	736	666	725	1171	137	Nuclear transcription factor Y subunit beta
B48R09C17	48-17-9	Hs~MGC:BC000284.1~uORF:IOH4482	731	867	1444	2014	2987	822	2708	2474	1909	329	golgi associated, gamma adaptin ear containing, ARF binding protein 2 (GGA2)
B48R09C18	48-18-9	Hs~MGC:BC000284.1~uORF:IOH4482	706	895	1512	1926	2768	872	2716	2237	1877	-105	golgi associated, gamma adaptin ear containing, ARF binding protein 2 (GGA2)
B48R09C19	48-19-9	Hs~MGC:BC004359.1~uORF:IOH6052	840	491	628	565	716	285	725	763	993	59	KIAA0174 (KIAA0174)
B48R09C20	48-20-9	Hs~MGC:BC004359.1~uORF:IOH6052	866	552	518	599	835	270	694	525	642	1114	KIAA0174 (KIAA0174)
B48R09C21	48-21-9	Hs~Ref:NM_018454.4~uORF:IOH3087	6943	2741	2084	1306	2203	1854	10509	1656	2924	921	nucleolar and spindle associated protein 1 (NUSAP1), transcript variant 2
B48R09C22	48-22-9	Hs~Ref:NM_018454.4~uORF:IOH3087	7628	2738	2141	1302	2494	1606	10471	1202	2781	558	nucleolar and spindle associated protein 1 (NUSAP1), transcript variant 2
B48R10C01	48-1-10	Hs~Ref:NM_001449.2~uORF:IOH13860	3942	3962	2210	8867	7199	3174	2521	6013	3640	9860	four and a half LIM domains 1 (FHL1)
B48R10C02	48-2-10	Hs~Ref:NM_001449.2~uORF:IOH13860	4041	3364	2083	9640	7163	2646	2599	6621	2884	8006	four and a half LIM domains 1 (FHL1)
B48R10C03	48-3-10	Hs~Ref:NM_024411.1~uORF:IOH11247	1063	1052	1316	861	868	1049	1920	841	2244	589	prodynorphin (PDYN)
B48R10C04	48-4-10	Hs~Ref:NM_024411.1~uORF:IOH11247	1147	1330	1292	805	884	1042	2149	858	1861	689	prodynorphin (PDYN)
B48R10C05	48-5-10	Hs~MGC:BC025990.1~uORF:IOH11070	1609	1371	1512	814	1133	1213	3639	1525	2698	791	heparan sulfate 2-O-sulfotransferase 1 (HS2ST1)
B48R10C06	48-6-10	Hs~MGC:BC025990.1~uORF:IOH11070	1651	1133	1497	798	1122	1150	2990	1399	2601	594	heparan sulfate 2-O-sulfotransferase 1 (HS2ST1)
B48R10C07	48-7-10	Hs~MGC:BC008912.2~uORF:IOH7034	885	922	970	996	2030	933	1102	812	1385	467	family with sequence similarity 3, member A (FAM3A)
B48R10C08	48-8-10	Hs~MGC:BC008912.2~uORF:IOH7034	923	924	1045	1060	2136	1009	1037	855	1389	434	family with sequence similarity 3, member A (FAM3A)
B48R10C09	48-9-10	Hs~MGC:BC013966.2~uORF:IOH12372	6014	6617	4647	5701	4034	4228	8541	4069	6470	5542	family with sequence similarity 64, member A (FAM64A)
B48R10C10	48-10-10	Hs~MGC:BC013966.2~uORF:IOH12372	6533	6483	4493	5486	4005	4275	8765	4063	6411	5164	family with sequence similarity 64, member A (FAM64A)
B48R11C21	48-21-11	Hs~MGC:BC005914.1~uORF:IOH7475	1710	1777	2192	1570	2043	1790	3455	3366	3626	589	Sp2 transcription factor (SP2)
B48R11C22	48-22-11	Hs~MGC:BC005914.1~uORF:IOH7475	1963	1651	2302	1503	2483	1760	3411	3297	3855	550	Sp2 transcription factor (SP2)
B48R12C01	48-1-12	Hs~MGC:BC001088.1~uORF:IOH3839	4436	5649	6585	3465	2852	17337	4129	2465	4689	1486	cell division cycle 20 homolog (S. cerevisiae) (CDC20)
B48R12C02	48-2-12	Hs~MGC:BC001088.1~uORF:IOH3839	4535	5476	5909	3832	2958	15127	4305	2436	5266	1371	cell division cycle 20 homolog (S. cerevisiae) (CDC20)
B48R12C03	48-3-12	Hs~Ref:NM_003491.1~uORF:IOH3480	2983	6271	1366	934	1628	969	2448	641	1106	394	ARD1 homolog A, N-acetyltransferase (S. cerevisiae) (ARD1A)
B48R12C04	48-4-12	Hs~Ref:NM_003491.1~uORF:IOH3480	3137	6263	1330	851	1604	961	3551	622	1136	301	ARD1 homolog A, N-acetyltransferase (S. cerevisiae) (ARD1A)
B48R12C05	48-5-12	Hs~Ref:NM_001014.2~uORF:IOH4063	6601	3852	4531	14999	4815	5074	17065	5226	5380	2893	ribosomal protein S10 (RPS10)
B48R12C06	48-6-12	Hs~Ref:NM_001014.2~uORF:IOH4063	6638	3921	4589	14974	4384	4863	16590	5123	6247	2704	ribosomal protein S10 (RPS10)
B48R12C07	48-7-12	Hs~MGC:BC038838.1~uORF:IOH28760	5323	8173	65483	7149	5082	5840	10253	4974	21462	1783	Proline-rich protein 16
B48R12C08	48-8-12	Hs~MGC:BC038838.1~uORF:IOH28760	4902	7878	65477	6851	4850	5920	10206	4512	22045	1620	Proline-rich protein 16
B48R12C09	48-9-12	Hs~MGC:BC012761.1~uORF:IOH14564	1243	1127	1042	914	1048	953	1274	814	1981	453	NIMA (never in mitosis gene a)-related kinase 6 (NEK6)
B48R12C10	48-10-12	Hs~MGC:BC012761.1~uORF:IOH14564	1124	1281	1100	902	1232	989	1234	851	2026	414	NIMA (never in mitosis gene a)-related kinase 6 (NEK6)
B48R12C11	48-11-12	Hs~MGC:BC056259.1~uORF:IOH29452	835	771	890	287	629	372	709	393	584	259	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 (SERPINA6)
B48R12C12	48-12-12	Hs~MGC:BC056259.1~uORF:IOH29452	822	833	903	296	905	461	719	344	538	209	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 (SERPINA6)
B48R12C13	48-13-12	Hs~Ref:NM_013254.2~N/A	1203	1034	1465	763	1522	2622	2392	1177	2447	567	TANK-binding kinase 1 (TBK1)
B48R12C14	48-14-12	Hs~Ref:NM_013254.2~N/A	1377	1053	1455	725	1674	2572	2429	1284	2463	428	TANK-binding kinase 1 (TBK1)
B48R12C15	48-15-12	Hs~Ref:NM_018370.1~uORF:IOH21486	1157	857	878	560	411	939	1433	1511	2099	423	Damage-regulated autophagy modulator
B48R12C16	48-16-12	Hs~Ref:NM_018370.1~uORF:IOH21486	892	782	829	580	524	864	1464	746	2434	316	Damage-regulated autophagy modulator
B48R12C17	48-17-12	Hs~MGC:BC014264.2~uORF:IOH14605	2062	2831	2133	297	716	3054	1250	3018	3337	395	chromosome 19 open reading frame 33 (C19orf33)
B48R12C18	48-18-12	Hs~MGC:BC014264.2~uORF:IOH14605	2054	2913	2584	3	1696	2591	1236	3384	3433	480	chromosome 19 open reading frame 33 (C19orf33)
B48R12C21	48-21-12	Hs~Ref:NM_021168.2~uORF:IOH40188	2801	6535	65479	772	2856	2118	621	710	1724	222	RAB40C, member RAS oncogene family (RAB40C)
B48R12C22	48-22-12	Hs~Ref:NM_021168.2~uORF:IOH40188	2765	6187	65477	755	3693	1853	634	156	1930	-2	RAB40C, member RAS oncogene family (RAB40C)
B48R13C01	48-1-13	Hs~MGC:NM_138501.3~uORF:IOH4169	7653	723	1090	855	672	904	1627	675	1287	327	glycoprotein, synaptic 2 (GPSN2)
B48R13C02	48-2-13	Hs~MGC:NM_138501.3~uORF:IOH4169	7486	741	1114	780	610	781	2108	659	1610	322	glycoprotein, synaptic 2 (GPSN2)
B48R13C03	48-3-13	Hs~MGC:BC000989.2~uORF:IOH2897	632	887	668	300	509	642	878	402	788	169	chromosome 14 open reading frame 124 (C14orf124)
B48R13C04	48-4-13	Hs~MGC:BC000989.2~uORF:IOH2897	668	1067	615	320	528	640	795	377	779	56	chromosome 14 open reading frame 124 (C14orf124)
B48R13C05	48-5-13	Hs~Ref:NM_145283.1~uORF:IOH10752	550	1486	584	282	557	426	625	375	382	148	nucleoredoxin-like 2 (NXNL2)
B48R13C06	48-6-13	Hs~Ref:NM_145283.1~uORF:IOH10752	549	1434	575	292	739	439	654	376	924	149	nucleoredoxin-like 2 (NXNL2)
B48R13C07	48-7-13	Hs~Ref:NM_015871.2~uORF:IOH4113	910	7093	1196	1283	1636	1220	1646	2660	3176	791	zinc finger protein 593 (ZNF593)
B48R13C08	48-8-13	Hs~Ref:NM_015871.2~uORF:IOH4113	857	7016	1199	1225	1629	1144	1577	2324	3208	737	zinc finger protein 593 (ZNF593)
B48R13C09	48-9-13	Hs~MGC:BC021256.2~uORF:IOH29344	1033	969	834	2770	518	1212	1235	769	1761	376	pellino homolog 3 (Drosophila) (PELI3)
B48R13C10	48-10-13	Hs~MGC:BC021256.2~uORF:IOH29344	890	903	875	2546	636	1178	1303	1354	1736	349	pellino homolog 3 (Drosophila) (PELI3)
B48R13C11	48-11-13	Hs~MGC:BC034702.1~uORF:IOH28627	1138	902	833	515	822	1003	4948	968	1441	514	peroxisomal D3,D2-enoyl-CoA isomerase (PECI)
B48R13C12	48-12-13	Hs~MGC:BC034702.1~uORF:IOH28627	1056	926	787	501	929	1100	4530	1243	1444	479	peroxisomal D3,D2-enoyl-CoA isomerase (PECI)
B48R13C13	48-13-13	Hs~MGC:BC050425.1~uORF:IOH28857	662	374	416	286	530	544	850	458	601	237	zinc finger protein 322A (ZNF322A)
B48R13C14	48-14-13	Hs~MGC:BC050425.1~uORF:IOH28857	727	358	416	262	773	471	845	320	616	57	zinc finger protein 322A (ZNF322A)
B48R13C15	48-15-13	Hs~MGC:BC035348.1~uORF:IOH28673	1085	370	370	294	732	361	599	612	591	292	cytoplasmic polyadenylation element binding protein 1 (CPEB1)
B48R13C16	48-16-13	Hs~MGC:BC035348.1~uORF:IOH28673	1008	383	386	316	313	250	614	502	596	60	cytoplasmic polyadenylation element binding protein 1 (CPEB1)
B48R13C17	48-17-13	Hs~Ref:NM_022786.1~uORF:IOH13057	1104	1559	717	861	920	847	1121	7197	1174	177	ARV1 homolog (S. cerevisiae) (ARV1)
B48R13C18	48-18-13	Hs~Ref:NM_022786.1~uORF:IOH13057	1110	1488	743	790	786	674	1092	6944	1170	100	ARV1 homolog (S. cerevisiae) (ARV1)
B48R13C19	48-19-13	Hs~MGC:BC053660.1~uORF:IOH28993	1555	1035	792	646	783	908	1515	1097	2544	277	polyribonucleotide nucleotidyltransferase 1 (PNPT1)
B48R13C20	48-20-13	Hs~MGC:BC053660.1~uORF:IOH28993	1493	1097	755	610	762	1407	1470	1649	2452	178	polyribonucleotide nucleotidyltransferase 1 (PNPT1)
B48R13C21	48-21-13	Hs~Ref:NM_018910.2~uORF:IOH29741	1471	2996	1035	822	769	2408	3615	1715	1798	587	protocadherin alpha 7 (PCDHA7), transcript variant 1
B48R13C22	48-22-13	Hs~Ref:NM_018910.2~uORF:IOH29741	1497	3101	973	851	1157	2103	3480	876	1734	722	protocadherin alpha 7 (PCDHA7), transcript variant 1
B48R14C01	48-1-14	Hs~MGC:BC006811.1~uORF:IOH3174	496	469	673	912	531	523	911	349	719	148	peroxisome proliferator-activated receptor gamma (PPARG)
B48R14C02	48-2-14	Hs~MGC:BC006811.1~uORF:IOH3174	639	401	657	955	454	522	1091	356	1376	137	peroxisome proliferator-activated receptor gamma (PPARG)
B48R14C03	48-3-14	Hs~Ref:NM_032324.1~uORF:IOH6602	4721	1294	4972	5878	1081	1937	2385	1416	1879	585	chromosome 1 open reading frame 57 (C1orf57)
B48R14C04	48-4-14	Hs~Ref:NM_032324.1~uORF:IOH6602	4546	1329	4870	5569	1135	1872	2584	1507	1930	397	chromosome 1 open reading frame 57 (C1orf57)
B48R14C05	48-5-14	Hs~Ref:NM_016000.2~uORF:IOH14202	787	750	1135	474	413	1620	1804	492	477	243	tRNA nucleotidyl transferase, CCA-adding, 1 (TRNT1), transcript variant 1
B48R14C06	48-6-14	Hs~Ref:NM_016000.2~uORF:IOH14202	837	709	1112	454	467	1442	1660	461	1109	238	tRNA nucleotidyl transferase, CCA-adding, 1 (TRNT1), transcript variant 1
B48R14C07	48-7-14	Hs~Ref:NM_018394.1~uORF:IOH22907	690	618	853	389	519	837	1075	719	723	321	abhydrolase domain containing 10 (ABHD10)
B48R14C08	48-8-14	Hs~Ref:NM_018394.1~uORF:IOH22907	650	733	845	402	436	877	1234	712	745	391	abhydrolase domain containing 10 (ABHD10)
B48R14C09	48-9-14	Hs~MGC:NM_015014.1~uORF:IOH23193	1790	1517	1097	722	504	1160	7057	723	1814	308	RNA binding motif protein 34 (RBM34)
B48R14C10	48-10-14	Hs~MGC:NM_015014.1~uORF:IOH23193	1913	1476	1085	773	579	1151	6826	1072	1706	308	RNA binding motif protein 34 (RBM34)
B48R14C11	48-11-14	Hs~Ref:NM_000405.3~uORF:IOH59020	454	199	420	196	1701	280	389	152	825	116	Ganglioside GM2 activator
B48R14C12	48-12-14	Hs~Ref:NM_000405.3~uORF:IOH59020	554	55	402	196	541	259	361	-15	854	41	Ganglioside GM2 activator
B48R14C13	48-13-14	Hs~MGC:BC028129.1~uORF:IOH11339	572	275	391	259	864	840	1007	107	635	86	Hexokinase-3
B48R14C14	48-14-14	Hs~MGC:BC028129.1~uORF:IOH11339	444	315	404	231	969	814	977	516	651	74	Hexokinase-3
B48R14C15	48-15-14	Hs~Ref:NM_001001568.1~uORF:IOH53504	1165	547	886	1682	1239	1751	1425	857	1549	342	phosphodiesterase 9A (PDE9A), transcript variant 3, mRNA.
B48R14C16	48-16-14	Hs~Ref:NM_001001568.1~uORF:IOH53504	1098	533	870	1659	1645	1725	1477	1106	1580	203	phosphodiesterase 9A (PDE9A), transcript variant 3, mRNA.
B48R14C17	48-17-14	Hs~Ref:NM_003480.2~uORF:IOH58997	1832	414	844	666	1214	617	695	410	749	201	Microfibrillar-associated protein 5
B48R14C18	48-18-14	Hs~Ref:NM_003480.2~uORF:IOH58997	1804	384	843	637	752	404	688	387	788	161	Microfibrillar-associated protein 5
B48R14C19	48-19-14	Hs~Ref:NM_017897.1~uORF:IOH3173	1472	1159	1464	649	3109	309	1893	1206	1568	473	3-oxoacyl-ACP synthase, mitochondrial (OXSM)
B48R14C20	48-20-14	Hs~Ref:NM_017897.1~uORF:IOH3173	1365	1116	1492	675	2951	546	2036	1227	1071	480	3-oxoacyl-ACP synthase, mitochondrial (OXSM)
B48R14C21	48-21-14	Hs~Ref:NM_203350.1~uORF:IOH36832	1647	1603	3362	2823	3122	2635	2845	2157	3451	1057	zinc finger, RAN-binding domain containing 2 (ZRANB2), transcript variant 1
B48R14C22	48-22-14	Hs~Ref:NM_203350.1~uORF:IOH36832	1621	1622	3363	2963	2228	2669	2850	2071	3430	1129	zinc finger, RAN-binding domain containing 2 (ZRANB2), transcript variant 1
B48R15C01	48-1-15	Hs~MGC:BC028218.1~uORF:IOH11616	1393	847	2287	757	1126	13942	2663	856	1726	11	Z-DNA binding protein 1 (ZBP1)
B48R15C02	48-2-15	Hs~MGC:BC028218.1~uORF:IOH11616	1322	805	2289	733	1102	13896	2651	787	1687	477	Z-DNA binding protein 1 (ZBP1)
B48R15C03	48-3-15	Hs~MGC:BC016673.1~uORF:IOH11748	737	614	870	979	563	788	1409	649	1816	568	cDNA clone MGC:21889 IMAGE:4345550, complete cds
B48R15C04	48-4-15	Hs~MGC:BC016673.1~uORF:IOH11748	754	621	831	1012	525	797	1497	657	992	382	cDNA clone MGC:21889 IMAGE:4345550, complete cds
B48R15C05	48-5-15	Hs~MGC:BC057806.1~uORF:IOH29150	845	570	739	441	441	650	973	573	1316	156	insulin-like growth factor binding protein 1 (IGFBP1)
B48R15C06	48-6-15	Hs~MGC:BC057806.1~uORF:IOH29150	759	597	733	429	533	663	921	554	1309	165	insulin-like growth factor binding protein 1 (IGFBP1)
B48R15C07	48-7-15	Hs~MGC:BC048217.1~uORF:IOH26167	926	556	786	499	685	858	2043	609	1308	281	spermatogenesis associated 5 (SPATA5)
B48R15C08	48-8-15	Hs~MGC:BC048217.1~uORF:IOH26167	923	577	784	504	563	844	2147	634	1160	256	spermatogenesis associated 5 (SPATA5)
B48R15C09	48-9-15	Hs~MGC:BC060765.1~uORF:IOH29157	822	591	943	716	805	845	1830	781	1302	357	mucolipin 3 (MCOLN3)
B48R15C10	48-10-15	Hs~MGC:BC060765.1~uORF:IOH29157	845	561	1025	781	765	865	1689	970	1224	311	mucolipin 3 (MCOLN3)
B48R15C11	48-11-15	Hs~Ref:NM_004457.3~uORF:IOH26199	894	1215	1576	1484	1285	6307	8105	1147	1401	322	acyl-CoA synthetase long-chain family member 3 (ACSL3), transcript variant 1
B48R15C12	48-12-15	Hs~Ref:NM_004457.3~uORF:IOH26199	878	1247	1586	1501	1264	6115	7929	182	1439	319	acyl-CoA synthetase long-chain family member 3 (ACSL3), transcript variant 1
B48R15C15	48-15-15	Hs~Ref:NM_004935.1~CAT:PV3000	878	621	395	235	252	377	374	255	458	176	cyclin-dependent kinase 5 (CDK5) and p25: CDK5 and p25 sequences are seperated by -- (in protein list file).
B48R15C16	48-16-15	Hs~Ref:NM_004935.1~CAT:PV3000	1031	663	414	292	670	404	388	184	423	61	cyclin-dependent kinase 5 (CDK5) and p25: CDK5 and p25 sequences are seperated by -- (in protein list file).
B48R15C19	48-19-15	Hs~Ref:NM_005157.2~CAT:PV3866	1671	851	2195	1271	1068	2188	3674	1473	2392	629	v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), transcript variant a; see catalog number for detailed information on wild-type or point mutant status
B48R15C20	48-20-15	Hs~Ref:NM_005157.2~CAT:PV3866	1583	858	2250	1246	1030	1862	3714	1606	2206	630	v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), transcript variant a; see catalog number for detailed information on wild-type or point mutant status
B48R16C01	48-1-16	Hs~Ref:NM_005409.3~CAT_PHC1695	1452	1859	1108	2097	1550	1597	1368	1580	3039	1224	C-X-C motif chemokine 11
B48R16C02	48-2-16	Hs~Ref:NM_005409.3~CAT_PHC1695	1309	1788	1174	1747	1602	1708	1409	1692	2592	1739	C-X-C motif chemokine 11
B48R16C03	48-3-16	Hs~Ref:NM_001261.2~CAT:PV4335	361	664	654	615	787	604	511	474	292	170	cyclin K and cyclin-dependent kinase 9 (CDC2-related kinase) (CDK9): cyclin K and CDK9 sequences are seperated by -- (in the protein list file).
B48R16C04	48-4-16	Hs~Ref:NM_001261.2~CAT:PV4335	399	669	630	553	755	595	599	424	1709	168	cyclin K and cyclin-dependent kinase 9 (CDC2-related kinase) (CDK9): cyclin K and CDK9 sequences are seperated by -- (in the protein list file).
B48R16C09	48-9-16	Hs~Ref:NM_001008234.1~uORF:IOH58628	2261	1478	1809	1338	970	1523	7425	1653	2227	879	hypothetical gene supported by BC036588, mRNA (cDNA clone MGC:42159 IMAGE:4799429), complete cds.
B48R16C10	48-10-16	Hs~Ref:NM_001008234.1~uORF:IOH58628	2298	1401	1840	1387	1035	1478	7304	2352	2375	823	hypothetical gene supported by BC036588, mRNA (cDNA clone MGC:42159 IMAGE:4799429), complete cds.
B48R16C11	48-11-16	Hs~Ref:NM_001002876.1~uORF:IOH58604	1266	793	1117	519	636	634	1391	1168	1205	294	Centromere protein M
B48R16C12	48-12-16	Hs~Ref:NM_001002876.1~uORF:IOH58604	1232	792	1111	530	613	668	1283	698	1126	306	Centromere protein M
B48R16C13	48-13-16	Hs~Ref:NM_006925.2~uORF:IOH58606	3524	1600	2298	1810	716	2369	23284	1701	3135	508	Splicing factor, arginine/serine-rich 5
B48R16C14	48-14-16	Hs~Ref:NM_006925.2~uORF:IOH58606	3875	1588	2198	1724	705	2343	22868	1299	3111	492	Splicing factor, arginine/serine-rich 5
B48R16C15	48-15-16	Hs~Ref:NM_003959.1~uORF:IOH60041	1162	3781	1145	1344	647	1931	1783	5276	2277	893	Huntingtin-interacting protein 1-related protein
B48R16C16	48-16-16	Hs~Ref:NM_003959.1~uORF:IOH60041	786	3518	1070	1339	1962	1795	1703	4284	2167	895	Huntingtin-interacting protein 1-related protein
B48R16C17	48-17-16	Hs~Ref:NM_003151.2~uORF:IOH56108	1442	701	785	1396	1186	1939	1653	1287	1662	435	Signal transducer and activator of transcription 4
B48R16C18	48-18-16	Hs~Ref:NM_003151.2~uORF:IOH56108	1383	695	774	1368	1258	1917	1617	1314	1643	431	Signal transducer and activator of transcription 4
B48R16C19	48-19-16	Hs~Ref:NM_001015878.1~uORF:IOH60102	598	793	599	395	1031	671	894	44	1002	109	aurora kinase C (AURKC), transcript variant 1
B48R16C20	48-20-16	Hs~Ref:NM_001015878.1~uORF:IOH60102	607	831	594	421	498	1165	884	81	1005	95	aurora kinase C (AURKC), transcript variant 1
B48R16C21	48-21-16	Hs~Ref:NM_173558.2~uORF:IOH57227	169	2389	696	969	1122	1881	879	723	1234	783	FYVE, RhoGEF and PH domain-containing protein 2
B48R16C22	48-22-16	Hs~Ref:NM_173558.2~uORF:IOH57227	231	2317	663	905	435	651	847	195	1303	741	FYVE, RhoGEF and PH domain-containing protein 2
B48R17C01	48-1-17	Hs~Ref:NM_002883.2~uORF:IOH13287	872	846	1462	1224	835	698	1296	672	1689	593	Ran GTPase activating protein 1 (RANGAP1)
B48R17C02	48-2-17	Hs~Ref:NM_002883.2~uORF:IOH13287	861	859	1451	1084	784	710	1206	681	1949	668	Ran GTPase activating protein 1 (RANGAP1)
B48R17C03	48-3-17	Hs~MGC:BC026060.2~uORF:IOH12294	1307	825	1418	915	1052	1141	1248	921	2275	509	calcium/calmodulin-dependent protein kinase kinase 2, beta (CAMKK2)
B48R17C04	48-4-17	Hs~MGC:BC026060.2~uORF:IOH12294	1437	730	1328	933	990	1104	1260	943	2560	434	calcium/calmodulin-dependent protein kinase kinase 2, beta (CAMKK2)
B48R17C05	48-5-17	Hs~Ref:NM_018294.3~uORF:IOH5944	1414	1286	1489	987	903	2019	2033	908	3181	938	CWF19-like protein 1
B48R17C06	48-6-17	Hs~Ref:NM_018294.3~uORF:IOH5944	1379	1641	1504	927	1023	1983	2021	1017	3426	816	CWF19-like protein 1
B48R17C07	48-7-17	Hs~MGC:BC000337.2~uORF:IOH3577	929	1738	2636	1797	741	1772	1131	829	5342	775	glucose-6-phosphate dehydrogenase (G6PD)
B48R17C08	48-8-17	Hs~MGC:BC000337.2~uORF:IOH3577	931	2094	2657	1819	702	1680	1170	857	5336	836	glucose-6-phosphate dehydrogenase (G6PD)
B48R17C09	48-9-17	Hs~MGC:BC012611.1~uORF:IOH13711	257	320	279	260	215	363	1210	547	502	95	eukaryotic translation initiation factor 4E (EIF4E)
B48R17C10	48-10-17	Hs~MGC:BC012611.1~uORF:IOH13711	173	457	303	318	238	373	1243	383	634	75	eukaryotic translation initiation factor 4E (EIF4E)
B48R17C11	48-11-17	Hs~Ref:NM_017811.2~uORF:IOH5652	199	345	542	635	247	4475	762	366	438	137	ubiquitin-conjugating enzyme E2R 2 (UBE2R2)
B48R17C12	48-12-17	Hs~Ref:NM_017811.2~uORF:IOH5652	88	238	580	615	225	4321	746	837	480	154	ubiquitin-conjugating enzyme E2R 2 (UBE2R2)
B48R17C13	48-13-17	Hs~Ref:NM_006769.2~uORF:IOH4472	269	179	339	277	285	514	382	79	519	130	LIM domain only 4 (LMO4)
B48R17C14	48-14-17	Hs~Ref:NM_006769.2~uORF:IOH4472	290	389	356	275	175	359	388	82	568	128	LIM domain only 4 (LMO4)
B48R17C15	48-15-17	Hs~Ref:NM_024041.1~uORF:IOH4477	1145	653	700	601	1158	1817	1464	815	1870	372	sodium channel modifier 1 (SCNM1)
B48R17C16	48-16-17	Hs~Ref:NM_024041.1~uORF:IOH4477	1027	657	679	603	612	1850	1615	833	1890	375	sodium channel modifier 1 (SCNM1)
B48R17C17	48-17-17	Hs~Ref:NM_018607.4~uORF:IOH6302	1297	529	1183	356	594	3670	1010	27	780	297	Protein midA homolog, mitochondrial
B48R17C18	48-18-17	Hs~Ref:NM_018607.4~uORF:IOH6302	583	567	1115	391	888	3766	996	78	793	201	Protein midA homolog, mitochondrial
B48R17C19	48-19-17	Hs~MGC:NM_178840.2~uORF:IOH23046	1250	925	5298	922	2277	1094	1596	1489	3177	316	chromosome 1 open reading frame 64 (C1orf64)
B48R17C20	48-20-17	Hs~MGC:NM_178840.2~uORF:IOH23046	1242	842	5427	926	857	1167	1553	1654	3344	320	chromosome 1 open reading frame 64 (C1orf64)
B48R17C21	48-21-17	Hs~MGC:BC000522.1~uORF:IOH3622	1871	1096	1533	962	923	1373	5788	1540	1861	545	serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 (SERPINF1)
B48R17C22	48-22-17	Hs~MGC:BC000522.1~uORF:IOH3622	1863	1084	1517	928	894	1273	5537	1716	1983	432	serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 (SERPINF1)
B48R18C01	48-1-18	Hs~Ref:NM_004528.2~uORF:IOH7518	563	503	516	392	387	584	889	468	780	397	microsomal glutathione S-transferase 3 (MGST3)
B48R18C02	48-2-18	Hs~Ref:NM_004528.2~uORF:IOH7518	536	459	559	426	324	584	942	474	1393	-33	microsomal glutathione S-transferase 3 (MGST3)
B48R18C03	48-3-18	Hs~MGC:BC000827.1~uORF:IOH3112	1599	328	601	978	570	908	905	718	6734	255	Condensin complex subunit 3
B48R18C04	48-4-18	Hs~MGC:BC000827.1~uORF:IOH3112	1674	382	600	877	348	873	880	678	6068	243	Condensin complex subunit 3
B48R18C05	48-5-18	Hs~Ref:NM_006189.1~uORF:IOH35144	433	452	505	439	756	583	699	1849	1270	116	olfactory marker protein (OMP)
B48R18C06	48-6-18	Hs~Ref:NM_006189.1~uORF:IOH35144	517	1092	500	444	769	573	707	1682	1793	118	olfactory marker protein (OMP)
B48R18C07	48-7-18	Hs~Ref:NM_024969.2~uORF:IOH35988	1651	1212	1760	2535	1243	1397	1961	1610	2602	851	family with sequence similarity 130, member A2 (FAM130A2)
B48R18C08	48-8-18	Hs~Ref:NM_024969.2~uORF:IOH35988	1617	1346	1750	2535	1688	1406	2032	1688	2497	837	family with sequence similarity 130, member A2 (FAM130A2)
B48R18C09	48-9-18	Hs~Ref:NM_152595.3~uORF:IOH35990	1744	2008	1194	2523	634	3951	8128	2507	1871	980	piggyBac transposable element derived 4 (PGBD4)
B48R18C10	48-10-18	Hs~Ref:NM_152595.3~uORF:IOH35990	1544	2169	1127	2733	668	3885	7844	2383	1946	878	piggyBac transposable element derived 4 (PGBD4)
B48R18C11	48-11-18	Hs~Ref:NM_023936.1~uORF:IOH4498	2207	1471	1316	1132	957	1538	3128	2819	2808	1155	mitochondrial ribosomal protein S34 (MRPS34), nuclear gene encoding mitochondrial protein
B48R18C12	48-12-18	Hs~Ref:NM_023936.1~uORF:IOH4498	2513	1471	1298	1228	997	1583	3115	2994	2807	1030	mitochondrial ribosomal protein S34 (MRPS34), nuclear gene encoding mitochondrial protein
B48R18C13	48-13-18	Hs~MGC:BC063127.1~uORF:IOH40747	949	927	874	696	775	1053	1417	1101	1747	623	pregnancy specific beta-1-glycoprotein 4 (PSG4)
B48R18C14	48-14-18	Hs~MGC:BC063127.1~uORF:IOH40747	1008	892	888	690	834	1019	1434	918	1740	603	pregnancy specific beta-1-glycoprotein 4 (PSG4)
B48R18C15	48-15-18	Hs~Ref:NM_207365.1~uORF:IOH40762	927	714	764	780	1196	856	1400	566	1388	449	Arylacetamide deacetylase-like 2
B48R18C16	48-16-18	Hs~Ref:NM_207365.1~uORF:IOH40762	922	771	679	767	1281	898	1372	621	1478	456	Arylacetamide deacetylase-like 2
B48R18C17	48-17-18	Hs~Ref:NM_014468.2~uORF:IOH36691	3174	5774	2230	6989	3696	2495	3713	5798	5368	1881	VENT homeobox homolog (Xenopus laevis) (VENTX)
B48R18C18	48-18-18	Hs~Ref:NM_014468.2~uORF:IOH36691	3144	5643	2195	6513	3279	2628	3795	5511	5187	1914	VENT homeobox homolog (Xenopus laevis) (VENTX)
B48R18C19	48-19-18	Hs~MGC:NM_153220.1~uORF:IOH22700	274	418	696	1471	822	479	886	955	1149	347	dpy-19-like 3 (C. elegans) (DPY19L3)
B48R18C20	48-20-18	Hs~MGC:NM_153220.1~uORF:IOH22700	419	299	571	1492	836	620	808	1660	1124	295	dpy-19-like 3 (C. elegans) (DPY19L3)
B48R18C21	48-21-18	Hs~MGC:BC032246.1~uORF:IOH21524	655	405	672	395	390	475	738	785	906	312	zinc finger protein 44 (ZNF44)
B48R18C22	48-22-18	Hs~MGC:BC032246.1~uORF:IOH21524	486	420	604	423	428	415	773	862	925	189	zinc finger protein 44 (ZNF44)
B48R19C01	48-1-19	Hs~MGC:BC032325.1~uORF:IOH21628	749	499	612	403	494	599	747	513	759	585	thioredoxin domain containing 10 (TXNDC10)
B48R19C02	48-2-19	Hs~MGC:BC032325.1~uORF:IOH21628	735	506	614	348	509	539	748	417	1862	499	thioredoxin domain containing 10 (TXNDC10)
B48R19C03	48-3-19	Hs~MGC:BC031966.1~uORF:IOH27672	1220	630	599	423	780	505	641	417	1017	213	hypothetical LOC402573 (LOC402573)
B48R19C04	48-4-19	Hs~MGC:BC031966.1~uORF:IOH27672	1088	625	515	410	314	479	717	414	1063	158	hypothetical LOC402573 (LOC402573)
B48R19C05	48-5-19	Hs~MGC:BC018764.1~uORF:IOH13523	1567	3438	1225	2073	734	1996	8046	2848	3409	528	KIAA1217 (KIAA1217)
B48R19C06	48-6-19	Hs~MGC:BC018764.1~uORF:IOH13523	1597	3969	1282	2065	722	2085	7654	2504	3755	591	KIAA1217 (KIAA1217)
B48R19C07	48-7-19	Hs~MGC:BC022325.1~uORF:IOH12465	1498	1012	940	1834	687	1037	1368	2539	1758	553	polyhomeotic homolog 3 (Drosophila) (PHC3)
B48R19C08	48-8-19	Hs~MGC:BC022325.1~uORF:IOH12465	1436	1065	894	1721	645	949	1663	3265	1728	827	polyhomeotic homolog 3 (Drosophila) (PHC3)
B48R19C09	48-9-19	Hs~Ref:NM_001494.2~uORF:IOH4622	735	544	2773	621	959	788	1301	3281	1412	547	GDP dissociation inhibitor 2 (GDI2)
B48R19C10	48-10-19	Hs~Ref:NM_001494.2~uORF:IOH4622	810	528	2674	601	970	751	1315	3288	1426	534	GDP dissociation inhibitor 2 (GDI2)
B48R19C11	48-11-19	Hs~MGC:BC031281.1~uORF:IOH21611	1139	597	735	573	512	974	2496	784	1236	210	tetratricopeptide repeat domain 16 (TTC16)
B48R19C12	48-12-19	Hs~MGC:BC031281.1~uORF:IOH21611	1169	746	757	574	541	831	2575	797	1279	182	tetratricopeptide repeat domain 16 (TTC16)
B48R19C13	48-13-19	Hs~MGC:BC053351.1~uORF:IOH28952	371	1286	426	294	530	687	1040	2522	1478	141	distal-less homeobox 1 (DLX1)
B48R19C14	48-14-19	Hs~MGC:BC053351.1~uORF:IOH28952	896	1257	405	283	528	628	1054	2390	1442	63	distal-less homeobox 1 (DLX1)
B48R19C15	48-15-19	Hs~MGC:BC013572.1~uORF:IOH9852	582	428	502	337	458	564	887	545	945	140	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
B48R19C16	48-16-19	Hs~MGC:BC013572.1~uORF:IOH9852	689	447	495	336	426	564	872	90	1005	147	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
B48R19C17	48-17-19	Hs~Ref:NM_031407.1~uORF:IOH1984	408	373	389	386	383	701	861	141	1557	237	E3 ubiquitin-protein ligase HUWE1 (Fragment)
B48R19C18	48-18-19	Hs~Ref:NM_031407.1~uORF:IOH1984	388	442	398	400	338	889	950	666	1569	8	E3 ubiquitin-protein ligase HUWE1 (Fragment)
B48R19C19	48-19-19	Hs~Ref:NM_018049.1~uORF:IOH3886	269	201	347	353	1514	2582	938	1954	1147	29	Pleckstrin homology domain-containing family J member 1
B48R19C20	48-20-19	Hs~Ref:NM_018049.1~uORF:IOH3886	253	363	339	357	449	2379	889	1823	1165	221	Pleckstrin homology domain-containing family J member 1
B48R19C21	48-21-19	Hs~MGC:BC070263.1~uORF:IOH62878	1040	544	445	821	160	2384	758	628	1262	193	40S ribosomal protein SA
B48R19C22	48-22-19	Hs~MGC:BC070263.1~uORF:IOH62878	1047	532	397	800	322	2177	723	1061	1288	184	40S ribosomal protein SA
B48R20C03	48-3-20	Hs~Ref:NM_014465.2~uORF:IOH54963	573	546	672	448	320	-5	-3	155	195	50	Sulfotransferase family cytosolic 1B member 1
B48R20C04	48-4-20	Hs~Ref:NM_014465.2~uORF:IOH54963	472	539	662	428	189	0	0	11	1	-1	Sulfotransferase family cytosolic 1B member 1
B48R20C05	48-5-20	Hs~Ref:NM_001018160.1~uORF:IOH59099	717	492	532	324	1693	0	-1	110	144	94	NEDD8-activating enzyme E1 regulatory subunit
B48R20C06	48-6-20	Hs~Ref:NM_001018160.1~uORF:IOH59099	761	462	588	322	343	-2	176	1	-5	-6	NEDD8-activating enzyme E1 regulatory subunit
B48R20C07	48-7-20	Hs~Ref:NM_015423.2~uORF:IOH11246	834	842	1283	482	592	2242	1492	1120	1842	272	aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (AASDHPPT)
B48R20C08	48-8-20	Hs~Ref:NM_015423.2~uORF:IOH11246	907	873	1210	565	596	2388	1680	765	1796	98	aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (AASDHPPT)
B48R20C09	48-9-20	Hs~Ref:NM_024048.2~uORF:IOH27955	338	328	501	188	226	282	437	787	348	48	hypothetical protein MGC3020 (MGC3020)
B48R20C10	48-10-20	Hs~Ref:NM_024048.2~uORF:IOH27955	365	399	518	215	146	326	434	124	411	42	hypothetical protein MGC3020 (MGC3020)
B48R20C11	48-11-20	Hs~MGC:BC036080.1~uORF:IOH27250	420	252	991	462	281	755	1478	601	2570	157	GA-binding protein subunit beta-1
B48R20C12	48-12-20	Hs~MGC:BC036080.1~uORF:IOH27250	387	269	1055	471	288	750	1550	769	2386	145	GA-binding protein subunit beta-1
B48R20C13	48-13-20	Hs~MGC:BC026342.1~uORF:IOH22235	2703	468	400	769	269	483	626	514	590	105	Guanine nucleotide-binding protein G(z) subunit alpha
B48R20C14	48-14-20	Hs~MGC:BC026342.1~uORF:IOH22235	2140	438	388	713	259	451	533	510	604	159	Guanine nucleotide-binding protein G(z) subunit alpha
